Citrus Sinensis ID: 014986

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-----
Protein Sequence
METTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccccccccccccccccHHHHHcHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEEccEEccccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHcccccccccEEEEEEEEccEEEEEEEEcccccHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEcccccccccccccccccccccccccHHcccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccEcccccccccccccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEEEccccEEEEEEEEEccEEEEEEEEHHHHHHccHHHHHHHHHHHHHHHHHccccEEEEEEEEcccccEEEEEEEccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccccHHHHcccccccccccHHHHHHHHHHHHHHcccccccHHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHcccHHcccccccccccccccccc
Coil and Loop (DISEMBL)
mettelppsglaessaccvssnyvkgikgvrppllkpppgmrqpvidnacsTWDIlrdfapkdgitpssvmndralssssddednekegeEADRAIVKeeeddmvlsescsftteheddssstttepmsnispngrfKRIITYWQkgdllgrgsfgsvyegisddgfFFAVKEVslldqgsqAKQSISQLEQEIALLSRFEHEnivqyygtdkdesKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKylhdqdvvhrdIKCANILvdangsvkladfglakatklndvkscrgtafwmapevinnknkgyglpadiWSLGCTVLEMLtsqipyapMECMAALFKigrgspppipdslskDAQDFIKQCVqvnpndrptaaqlldhpfVKRLLatnsgsaspylgrr
Flexible Loop (DISEMBL)
mettelppsglaessacCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFApkdgitpssvmndralssssddednekegeeadraivkeeeddmvLSESCSFTteheddssstttepmsnispngrFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLakatklndvKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRllatnsgsaspylgrr
Low Complexity Region (SEG)
METTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALssssddednekegeeadRAIVKEEEDDMVLSESCSFtteheddssstttePMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Disordered region (IsUnstruct)
***************ACCVSSNYVKGIKGVR************PVIDNACSTWDILRDFA***************************************************************************RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD***********LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG*****************FIKQCVQV*********QLLDHPFVKRL***************
Disordered Region (DISOPRED)
***********************************************************************************************************************************************WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS****************QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF*******************
Disordered Region (DISEMBL)
***************ACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN*******************ADRAIVKEEEDDMVLSES********************NISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL**********SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Disordered Region (DISPRO)
***********************VKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDF*******************************************************************************RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA*************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	415	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	yes	no	0.884	0.603	0.633	1e-127
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.826	0.181	0.567	1e-103
O22040	666	Mitogen-activated protein	no	no	0.638	0.397	0.469	7e-64
Q9FZ36	651	Mitogen-activated protein	no	no	0.607	0.387	0.471	7e-64
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.614	0.194	0.457	4e-60
Q56UN5	1328	Mitogen-activated protein	yes	no	0.609	0.190	0.438	8e-59
Q54R82	942	Mitogen-activated protein	no	no	0.614	0.270	0.441	6e-58
O22042	651	Mitogen-activated protein	no	no	0.604	0.385	0.439	6e-57
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.604	0.380	0.440	2e-55
Q61083	619	Mitogen-activated protein	no	no	0.643	0.431	0.442	2e-54

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  454 bits (1168), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 240/379 (63%), Positives = 287/379 (75%), Gaps = 12/379 (3%)

Query: 27  IKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALSSSSDDE 83
           IKG+RPP+LKPPP M++P ID+  S+WD L  FAP + +   + SS  ++         E
Sbjct: 221 IKGLRPPVLKPPPAMKRPPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKE 280

Query: 84  DNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITY 143
           +  +  E   R I   +  D    E+CSFTT +E DSSST +   S I P+G    IIT 
Sbjct: 281 EEAEAEEMGARFIQLGDTAD----ETCSFTT-NEGDSSSTVSN-TSPIYPDG--GAIITS 332

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           WQKG LLGRGSFGSVYEGIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+
Sbjct: 333 WQKGQLLGRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQ 392

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           NIV+Y GT KD S LYIFLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+  
Sbjct: 393 NIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGF 452

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLP 322
           +HRDIKCANILVDANG+VKLADFGLAK +K ND+KSC+GT FWMAPEVIN K+  GYG P
Sbjct: 453 IHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSP 512

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           ADIWSLGCTVLEM T QIPY+ +E + ALF+IGRG+ P +PD+LS DA+ FI +C++VNP
Sbjct: 513 ADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLKVNP 572

Query: 383 NDRPTAAQLLDHPFVKRLL 401
            +RPTAA+LL+HPFV+R L
Sbjct: 573 EERPTAAELLNHPFVRRPL 591

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  374 bits (961), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 215/379 (56%), Positives = 252/379 (66%), Gaps = 36/379 (9%)

Query: 27   IKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNE 86
            IKG+RPP+L+  P M+   I    STWD +  FAP + + P S  ++        +E   
Sbjct: 1527 IKGLRPPVLQLQPAMKLSHIPRG-STWDFVTHFAPPETVAPPSSSSEAREEEVETEETGA 1585

Query: 87   KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP----NGRFKRIIT 142
                  D+             E+CSFT  ++ DSS T    +SN SP     G F   IT
Sbjct: 1586 MFIPLGDK-------------ETCSFTV-NKGDSSRT----ISNTSPIYASEGSF---IT 1624

Query: 143  YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             WQKG LLGRGS GSVYEGIS DG FFA KEVSLLDQGSQA + I Q+E  IALLS+ +H
Sbjct: 1625 CWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684

Query: 203  ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
            +NIV+Y GT KDES LYIFLELVT+GSL  LYQR  L DS VS YTRQIL GLKYLHD+ 
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKG 1744

Query: 263  VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--WMAPEVINNKN--KG 318
             +HR+IKCAN+LVDANG+VKLADFGLAK      V S   T +  WMAPEVI N     G
Sbjct: 1745 FIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTPYWNWMAPEVILNPKDYDG 1798

Query: 319  YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
            YG PADIWSLGCTVLEMLT QIPY+ +E   AL+ IG G  P IPD LS DA+DFI  C+
Sbjct: 1799 YGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCL 1858

Query: 379  QVNPNDRPTAAQLLDHPFV 397
            +VNP +RPTAA+LL+HPFV
Sbjct: 1859 KVNPEERPTAAELLNHPFV 1877

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  244 bits (624), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 132/281 (46%), Positives = 185/281 (65%), Gaps = 16/281 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL---LDQGSQAKQSISQLEQEIALLSR 199
           W+KG L+GRG+FG+VY G++ D G   AVK+V +        + +  I +LE+E+ LL  
Sbjct: 69  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 258
             H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YTRQ+LLGL+YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 314
           H+  ++HRDIK ANILVD  G +KLADFG    +A+   +   KS +GT +WMAPEVI  
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI-- 246

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIG-RGSPPPIPDSLSKDAQD 372
              G+   ADIWS+GCTV+EM+T + P++   + +AA+F IG   S PPIPD+LS DA+D
Sbjct: 247 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKD 306

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 413
           F+ +C+Q  PN RPTA++LL HPFV   +  +  SAS  LG
Sbjct: 307 FLLKCLQEVPNLRPTASELLKHPFV---MGKHKESASTDLG 344

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  244 bits (624), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 125/265 (47%), Positives = 179/265 (67%), Gaps = 13/265 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS---ISQLEQEIALLSR 199
           W+KG L+GRG+FG+VY G++ D G   AVK+V +    +  +++   I +LE+E+ LL  
Sbjct: 68  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL 258
             H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YT Q+LLGL+YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 314
           H+  ++HRDIK ANILVD  G +KLADFG    +A+   ++  KS +GT +WMAPEVI  
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVI-- 245

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIG-RGSPPPIPDSLSKDAQD 372
              G+   ADIWS+GCTV+EM+T + P++   + +AA+F IG   S PPIPD++S DA D
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDAND 305

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFV 397
           F+ +C+Q  PN RPTA++LL HPFV
Sbjct: 306 FLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score =  232 bits (592), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 171/269 (63%), Gaps = 14/269 (5%)

Query: 143  YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE 201
            +W KG++LGRG++G+VY G++  G   AVK+V+L      A ++   +L++E+ LL   +
Sbjct: 1043 FWTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALK 1102

Query: 202  HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 260
            H NIV Y GT  +E+ L IF+E V  GS+ ++  R+  L +     YTRQIL G+ YLHD
Sbjct: 1103 HVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHD 1162

Query: 261  QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 312
              VVHRDIK  N+++   G +KL DFG AK         T  + +KS RGT +WMAPEVI
Sbjct: 1163 NCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPEVI 1222

Query: 313  NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDSLSKDA 370
            N    GYG  +DIWS+GCTV EM T + P A M+ MAA+F IG  RG  PP+P   S+ A
Sbjct: 1223 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPARFSEPA 1280

Query: 371  QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             DF++ C+  + ++RP+A QLL H F+KR
Sbjct: 1281 ADFVRLCLTRDQHERPSALQLLKHSFLKR 1309

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score =  228 bits (580), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 118/269 (43%), Positives = 173/269 (64%), Gaps = 16/269 (5%)

Query: 144  WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ--AKQSISQLEQEIALLSRFE 201
            W KG++LG+G++G+VY G++  G   AVK+V+L D  ++  A++   +L++E+ LL   +
Sbjct: 1061 WTKGEILGKGAYGTVYCGLTSQGQLIAVKQVAL-DTSNKLAAEKEYRKLQEEVDLLKALK 1119

Query: 202  HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 260
            H NIV Y GT   E+ + IF+E V  GS+ ++  R+  L +     YT+QIL G+ YLH+
Sbjct: 1120 HVNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYTKQILQGVAYLHE 1179

Query: 261  QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 312
              VVHRDIK  N+++   G +KL DFG A+         T  + +KS  GT +WMAPEVI
Sbjct: 1180 NCVVHRDIKGNNVMLMPTGIIKLIDFGCARRLAWAGLNGTHSDMLKSMHGTPYWMAPEVI 1239

Query: 313  NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDSLSKDA 370
            N    GYG  +DIWS+GCTV EM T + P A M+ MAA+F IG  RG  PP+PD  S++A
Sbjct: 1240 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPDHFSENA 1297

Query: 371  QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             DF++ C+  + ++RP+A QLL H F++R
Sbjct: 1298 ADFVRMCLTRDQHERPSALQLLKHSFLER 1326

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  225 bits (573), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 117/265 (44%), Positives = 171/265 (64%), Gaps = 10/265 (3%)

Query: 144 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 200
           WQKG +LGRG +GSVY G++ D G  FAVK++ ++D  S  + K  I    +EI ++   
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 229

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 259
            H+NIV+Y GT  D+S L +FLE +  GS+ +L  ++    ++ +  YT+QIL GL +LH
Sbjct: 230 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 289

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRGTAFWMAPEVINNKNK 317
              ++HRDIK ANIL+D  G VKL+DFG +K+    ++  KS +GT +WMAPEVI  K  
Sbjct: 290 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQT 347

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIG-RGSPPPIPDSLSKDAQDFIK 375
           G+G  +DIWSLGC ++EM T+Q P++ + E  A ++ I    S P IP  +S++A DF+ 
Sbjct: 348 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLN 407

Query: 376 QCVQVNPNDRPTAAQLLDHPFVKRL 400
            C + +P +RP A QLL HPF+  L
Sbjct: 408 LCFKRDPKERPDANQLLKHPFIMNL 432

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  221 bits (564), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 117/266 (43%), Positives = 172/266 (64%), Gaps = 15/266 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 198
           W+KG+L+G G+FG VY G++ D G   A+K+V L+   S +K+     I +LE+E+ LL 
Sbjct: 68  WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126

Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 257
              H NIV+Y GT ++   L I +E V  GS+ +L +++    +  +  YT+Q+LLGL+Y
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMAPEVIN 313
           LH+  ++HRDIK ANILVD  G ++LADFG +K       +N  KS +GT +WMAPEVI 
Sbjct: 187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI- 245

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGR-GSPPPIPDSLSKDAQ 371
               G+   ADIWS+GCTV+EM T + P++   +  AA+  IGR  + PPIP+ LS +A+
Sbjct: 246 -LQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAK 304

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFV 397
           DF+ +C+   P+ R +A +LL HPFV
Sbjct: 305 DFLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  216 bits (551), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 118/268 (44%), Positives = 165/268 (61%), Gaps = 17/268 (6%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAK----QSISQLEQEIALLS 198
           W +G L+G GSFG VY G+ +  G   AVK+V +LD  S++K    + +  L  EIALL 
Sbjct: 394 WIRGALIGSGSFGQVYLGMNASSGELMAVKQV-ILDSVSESKDRHAKLLDALAGEIALLQ 452

Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 257
              HE+IVQY G++ +   L IFLE V  GS+  L   Y    ++ V  + +Q L GL+Y
Sbjct: 453 ELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEY 512

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--------SCRGTAFWMAP 309
           LH + +VHRDIK ANILVD  G +K++DFG++K  +LN           S +G++FWMAP
Sbjct: 513 LHSRGIVHRDIKGANILVDNKGKIKISDFGISKKLELNSTSTKTGGARPSFQGSSFWMAP 572

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
           EV+  K   +    DIWSLGC V+EMLTS+ PY   + M A+F+IG    P  P ++S  
Sbjct: 573 EVV--KQTMHTEKTDIWSLGCLVIEMLTSKHPYPNCDQMQAIFRIGENILPEFPSNISSS 630

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           A DF+++   ++ N RPTA++LL HPFV
Sbjct: 631 AIDFLEKTFAIDCNLRPTASELLSHPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus GN=Map3k2 PE=1 SV=2

 Score =  213 bits (542), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 124/280 (44%), Positives = 169/280 (60%), Gaps = 13/280 (4%)

Query: 128 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 186
           +++ISP  R  R  T W+ G LLG+G+FG VY     D G   AVK+V    +  +  + 
Sbjct: 340 VTDISPPSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFNPESPETSKE 399

Query: 187 ISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           ++ LE EI LL    HE IVQYYG   D  E  L IF+EL   GS+ +  + Y  L ++ 
Sbjct: 400 VNALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMELSPGGSIKDQLKAYGALTENV 459

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVK 298
              YTRQIL G+ YLH   +VHRDIK ANIL D+ G++KL DFG +K  +        +K
Sbjct: 460 TRKYTRQILEGVHYLHSNMIVHRDIKGANILRDSTGNIKLGDFGASKRLQTICLSGTGMK 519

Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RG 357
           S  GT +WM+PEVI+   +GYG  ADIWS+ CTV+EMLT + P+A  E MAA+FKI  + 
Sbjct: 520 SVTGTPYWMSPEVIS--GEGYGRKADIWSVACTVVEMLTEKPPWAEFEAMAAIFKIATQP 577

Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           + P +P  +S   +DF+K+ + V    RP+A +LL H FV
Sbjct: 578 TNPKLPPHVSDYTRDFLKR-IFVEAKLRPSAEELLRHMFV 616

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. Plays a role in caveolae kiss-and-run dynamics.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	415
255545546	555	Mitogen-activated protein kinase kinase	0.920	0.688	0.743	1e-171
224066881	558	predicted protein [Populus trichocarpa]	0.920	0.684	0.758	1e-162
224082218	548	predicted protein [Populus trichocarpa]	0.898	0.680	0.780	1e-162
356509460	566	PREDICTED: mitogen-activated protein kin	0.927	0.680	0.702	1e-158
356548642	594	PREDICTED: mitogen-activated protein kin	0.934	0.653	0.659	1e-155
356552843	590	PREDICTED: mitogen-activated protein kin	0.946	0.666	0.674	1e-155
402169211	564	protein kinase [Nicotiana benthamiana]	0.922	0.679	0.710	1e-152
357489127	593	Mitogen-activated protein kinase kinase	0.963	0.674	0.681	1e-151
356518515	555	PREDICTED: mitogen-activated protein kin	0.939	0.702	0.705	1e-151
359486016	559	PREDICTED: mitogen-activated protein kin	0.966	0.717	0.664	1e-149

>gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  606 bits (1562), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 301/405 (74%), Positives = 339/405 (83%), Gaps = 23/405 (5%)

Query: 26  GIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDN 85
           GIKGVRPPLLKPPP M  PVID  CSTWDILRDFAP++    S ++ +  LSS  DDE  
Sbjct: 158 GIKGVRPPLLKPPPSMTLPVIDKCCSTWDILRDFAPENDRRSSMLIAEGGLSS--DDE-- 213

Query: 86  EKEGEEADRAIVKEEEDDM---------------VLSESCSFTTEHEDDSSSTTTEPMSN 130
               EE   AI K EE++                VLSESCSFTT ++DDSSSTTTE MSN
Sbjct: 214 ----EEVAAAINKGEEEEEEEDDDDNLSRIREIGVLSESCSFTTSNDDDSSSTTTELMSN 269

Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           ISP+ RF+R+I+ W+KGDLLGRGSFGSVYEGI+ DGFFFA+KEVSLLDQGSQ KQSI QL
Sbjct: 270 ISPHERFRRMISDWEKGDLLGRGSFGSVYEGIAHDGFFFAIKEVSLLDQGSQGKQSIYQL 329

Query: 191 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           EQEIALLS+FEHENIV+YYGTDKD+S LYIFLELVT+GSL+NLYQRYHLRDSQVSAYTRQ
Sbjct: 330 EQEIALLSQFEHENIVRYYGTDKDDSNLYIFLELVTQGSLMNLYQRYHLRDSQVSAYTRQ 389

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           IL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLNDVKSC+GTAFWMAPE
Sbjct: 390 ILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSCKGTAFWMAPE 449

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 370
           V+N K  GYGLPADIWSLGCTVLEMLT Q+PY+ +ECM ALF+IG+G PPP+PDSLS DA
Sbjct: 450 VVNRKTHGYGLPADIWSLGCTVLEMLTRQVPYSHLECMQALFRIGKGVPPPVPDSLSNDA 509

Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 415
           +DFI QC+QVNPN RPTAAQLL+H FV++ L  +SGSASPY GRR
Sbjct: 510 RDFILQCLQVNPNGRPTAAQLLEHSFVRQPLPMSSGSASPYYGRR 554

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa]

 Score =  577 bits (1488), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 307/405 (75%), Positives = 343/405 (84%), Gaps = 23/405 (5%)

Query: 26  GIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSD---- 81
           GIKG+RPPLLKPPP M  PVID  CSTWD+ RDFAP++      V+N+   S+  D    
Sbjct: 161 GIKGLRPPLLKPPPSMTLPVIDKECSTWDLFRDFAPEN----DRVVNNNIESTYDDGEEE 216

Query: 82  -----------DEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSN 130
                      D DN++E EE    I     + +VLSESCSF+T ++DDSSS+TTEPMSN
Sbjct: 217 KEERREQVINADADNKREEEENLLRI----GETVVLSESCSFSTSNDDDSSSSTTEPMSN 272

Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           ISPN RF+R ITYW+KG+LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS+ KQSI QL
Sbjct: 273 ISPNVRFRRAITYWEKGELLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSKGKQSIYQL 332

Query: 191 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL  LYQRY+LRDSQVS+YTRQ
Sbjct: 333 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLQKLYQRYNLRDSQVSSYTRQ 392

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           IL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADFGLAKATKLNDVKSC+GTAFWMAPE
Sbjct: 393 ILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADFGLAKATKLNDVKSCKGTAFWMAPE 452

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 370
           V+NNKN+GYGLPADIWSLGCTVLEMLT QIPY+ +E M ALF+IGRG PP +PDSLS DA
Sbjct: 453 VVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSELESMQALFRIGRGVPPLVPDSLSNDA 512

Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 415
           ++FI QC+QVNPNDRPTAA LLDHPFVK+LL T+SGSASPY+GRR
Sbjct: 513 REFILQCIQVNPNDRPTAAVLLDHPFVKKLLPTSSGSASPYIGRR 557

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa]

 Score =  576 bits (1484), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 305/391 (78%), Positives = 333/391 (85%), Gaps = 18/391 (4%)

Query: 26  GIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDED 84
           GIKG RPPLLKPPP M  PVID  CSTWD+ RDFAP+ DG+    V N++  SS  DD+ 
Sbjct: 174 GIKGPRPPLLKPPPSMTLPVIDKECSTWDLFRDFAPENDGV----VNNNKEFSSGDDDDG 229

Query: 85  NEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYW 144
            E+  +  D A             SCSFTT ++DDSSS+TTEPMSNISPN RF+R IT W
Sbjct: 230 RERRPQVIDAA-------------SCSFTTSNDDDSSSSTTEPMSNISPNLRFRRSITDW 276

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +KG+LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ KQSI QLEQEIALLSRFEHEN
Sbjct: 277 EKGELLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHEN 336

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           IVQYYGTDKDESKLYIFLELVTKGSLL LYQRY+LRDSQVSAYTRQIL GLKYLHDQ+VV
Sbjct: 337 IVQYYGTDKDESKLYIFLELVTKGSLLKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVV 396

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           HRDIKCAN+LVDANGSVKLADFGLAKATK NDVKSC+GTAFWMAPEV+NNKN+GYGLPAD
Sbjct: 397 HRDIKCANLLVDANGSVKLADFGLAKATKFNDVKSCKGTAFWMAPEVVNNKNQGYGLPAD 456

Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 384
           IWSLGCTVLEMLT QIPY+ +E M ALF+IGRG PP +PDSLS DA+DFI QC+QVNPND
Sbjct: 457 IWSLGCTVLEMLTRQIPYSELESMQALFRIGRGVPPLVPDSLSNDARDFILQCLQVNPND 516

Query: 385 RPTAAQLLDHPFVKRLLATNSGSASPYLGRR 415
           RPTAA LLDHPF+KR L T SGSASPY+GRR
Sbjct: 517 RPTAAVLLDHPFMKRPLPTFSGSASPYIGRR 547

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  565 bits (1457), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 286/407 (70%), Positives = 333/407 (81%), Gaps = 22/407 (5%)

Query: 26  GIKGVRPPLLKPPPGMRQPVIDN-ACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDED 84
           GIKG+RPP+LKPPPG R  V+D+ ACS+WD+LRD AP+ G      +N    S+   +  
Sbjct: 164 GIKGIRPPMLKPPPGTRVQVVDDSACSSWDLLRDLAPQGG--EGLPLNH---SNEEREVA 218

Query: 85  NEKEGEEADRAIVKEEEDDMV------------LSESCSFTTEHEDDSSSTTTEPMSN-I 131
            ++EGE   +   K EE+  V            LSESCSF+T +EDDSSS+TT+P SN I
Sbjct: 219 EKEEGEVGTKESPKREEEQNVDNAARIAEIVAGLSESCSFSTSNEDDSSSSTTDPRSNNI 278

Query: 132 SPNGRFKRIITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ 189
           SP GR KRIIT   WQKG+ LG GSFGSVYEGISDDGFFFAVKEVSLLDQG+Q KQS+ Q
Sbjct: 279 SPQGRIKRIITAGSWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGTQGKQSVYQ 338

Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 249
           LEQEIALLS+FEH+NIVQYYGT+ D+SKLYIFLELVTKGSL +LYQ+Y LRDSQVSAYTR
Sbjct: 339 LEQEIALLSQFEHDNIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRDSQVSAYTR 398

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAP 309
           QIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLNDVKS +GTAFWMAP
Sbjct: 399 QILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMKGTAFWMAP 458

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
           EV+  KNKGYGLPAD+WSLGCTVLEMLT Q+PY  +ECM ALF+IG+G  PPIPDSLS+D
Sbjct: 459 EVVKGKNKGYGLPADMWSLGCTVLEMLTGQLPYRDLECMQALFRIGKGERPPIPDSLSRD 518

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL-GRR 415
           AQDFI QC+QVNPNDRPTAAQLL+H FV+R L+ +SGS+ P++ GR+
Sbjct: 519 AQDFILQCLQVNPNDRPTAAQLLNHSFVQRPLSQSSGSSFPHIHGRK 565

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356548642|ref|XP_003542709.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  555 bits (1430), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 287/435 (65%), Positives = 333/435 (76%), Gaps = 47/435 (10%)

Query: 12  AESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPK-DGITPSS 69
           AESS CC       GIKG RPP+LKPPPG+R  V+D+A CSTWD++RDFAP  +G    S
Sbjct: 174 AESSGCC------GGIKGFRPPMLKPPPGVRVSVVDDATCSTWDLMRDFAPNGEGEGKDS 227

Query: 70  VMNDRALSSSSDDEDNE--------------------------KEGEEADRAIVKEEEDD 103
            +      +S DDED+                           K  EE + A + E  DD
Sbjct: 228 YVE----LNSFDDEDDHERVEKEEEEDEEDEEEEEGEVGGVREKSVEEENAARIAEIVDD 283

Query: 104 MVLSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIITY--WQKGDLLGRGSFGSVYE 160
                   F+T +EDDSSSTTT P SN ISPNGR KR+IT   WQKGDLLGRGSFGSVYE
Sbjct: 284 F-----SGFSTPNEDDSSSTTTGPRSNSISPNGRIKRVITAGNWQKGDLLGRGSFGSVYE 338

Query: 161 GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 220
           GIS+DGFFFAVKEVSLLDQG+  +QS+ QLEQEIALLS+FEHENIVQY GT+ D S LYI
Sbjct: 339 GISEDGFFFAVKEVSLLDQGNHGRQSVYQLEQEIALLSQFEHENIVQYIGTEMDASNLYI 398

Query: 221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 280
           F+ELVTKGSL NLYQRY+LRDSQVSAYTRQIL GLKYLH++++VHRDIKCANILVDANGS
Sbjct: 399 FIELVTKGSLRNLYQRYNLRDSQVSAYTRQILHGLKYLHERNIVHRDIKCANILVDANGS 458

Query: 281 VKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
           VKLADFGLAKATKLNDVKSC+GTAFWMAPEV+  K++GYGLPADIWSLGCTVLEMLT + 
Sbjct: 459 VKLADFGLAKATKLNDVKSCKGTAFWMAPEVVKGKSRGYGLPADIWSLGCTVLEMLTGEF 518

Query: 341 PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR- 399
           PY+ +ECM AL +IGRG PPP+PDSLS+DAQDFI QC++VNP++RP AAQLL+H FV+R 
Sbjct: 519 PYSHLECMQALLRIGRGEPPPVPDSLSRDAQDFIMQCLKVNPDERPGAAQLLNHTFVQRP 578

Query: 400 LLATNSGSASPYLGR 414
           L + +SGS SPY+ R
Sbjct: 579 LHSQSSGSTSPYIRR 593

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552843|ref|XP_003544772.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 288/427 (67%), Positives = 339/427 (79%), Gaps = 34/427 (7%)

Query: 12  AESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPK-DGITPSS 69
           AESS CC       GIKG RPP+LKPPPG+R  V+D+A CSTWD++RDFAPK +G    S
Sbjct: 173 AESSGCC------GGIKGFRPPMLKPPPGVRVSVVDDATCSTWDLMRDFAPKGEGGGKDS 226

Query: 70  VMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCS------------------ 111
            +      +SSDDED+ +  E+ +    +EEE ++      S                  
Sbjct: 227 YVE----LNSSDDEDDHEREEKEEEEEEEEEEGEVGGVRVESVEEENAAAIAEIVGDFSG 282

Query: 112 FTTEHEDDSSSTTTEPMSN-ISPNGRFKRIITY--WQKGDLLGRGSFGSVYEGISDDGFF 168
           F+T +EDDSSST+T P SN ISPNGR KR+IT   WQKG+LLGRGSFGSVYEGIS+DGFF
Sbjct: 283 FSTSNEDDSSSTSTGPRSNNISPNGRIKRVITAGNWQKGELLGRGSFGSVYEGISEDGFF 342

Query: 169 FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 228
           FAVKEVSLLDQG+Q +QS+ QLEQEIALLS+FEHENIVQY GT+ D S LYIF+ELVTKG
Sbjct: 343 FAVKEVSLLDQGNQGRQSVYQLEQEIALLSQFEHENIVQYIGTEMDASNLYIFIELVTKG 402

Query: 229 SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 288
           SL NLYQRY+LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVKLADFGL
Sbjct: 403 SLRNLYQRYNLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKLADFGL 462

Query: 289 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM 348
           AKATK NDVKSC+GTAFWMAPEV+  KN GYGLPADIWSLGCTVLEMLT QIPY+ +ECM
Sbjct: 463 AKATKFNDVKSCKGTAFWMAPEVVKGKNTGYGLPADIWSLGCTVLEMLTGQIPYSHLECM 522

Query: 349 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR-LLATNSGS 407
            ALF+IGRG PP +PDSLS+DA+DFI QC++V+P++RP+AAQLL+H FV+R L + +SGS
Sbjct: 523 QALFRIGRGEPPHVPDSLSRDARDFILQCLKVDPDERPSAAQLLNHTFVQRPLHSQSSGS 582

Query: 408 ASPYLGR 414
           ASPY+ R
Sbjct: 583 ASPYIRR 589

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|402169211|dbj|BAM36967.1| protein kinase [Nicotiana benthamiana]

 Score =  544 bits (1402), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 282/397 (71%), Positives = 326/397 (82%), Gaps = 14/397 (3%)

Query: 27  IKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPKD----GITPSSVMNDRALSSSSD 81
           IKGVRPPLL PPP M  P++D++ CSTWDI R F PKD    G+  S V+N  A      
Sbjct: 173 IKGVRPPLLAPPPVMSLPIVDDSSCSTWDIFRAFGPKDQRESGLCRSEVVNGDA--ECVK 230

Query: 82  DEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTT-EPMSNISPNGRFKRI 140
           +E +E+E   + R I        +LSESCSFTT   DD SS++T E MS+ISPNGRF R 
Sbjct: 231 NEVDEEENSTSRRRIGVSN----LLSESCSFTTTSNDDDSSSSTTERMSSISPNGRFARY 286

Query: 141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           ITYW KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG   +QS+ QLEQEI LLS+F
Sbjct: 287 ITYWDKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGDGGRQSLYQLEQEIELLSQF 346

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
           EHENIV+YYGTDKD+SKLYIFLELVT+GSLL+LYQ+YHLRDSQVS YTRQIL GLKYLHD
Sbjct: 347 EHENIVRYYGTDKDDSKLYIFLELVTQGSLLSLYQKYHLRDSQVSVYTRQILHGLKYLHD 406

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           ++VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC+GTA WMAPEV+N KN+GYG
Sbjct: 407 RNVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCKGTALWMAPEVVNRKNQGYG 466

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             ADIWSLGCTVLEMLT Q PY+ +E  M ALF+IG+G PPP+P++LS DA++FI QC+Q
Sbjct: 467 QAADIWSLGCTVLEMLTRQFPYSHLENQMQALFRIGKGEPPPVPNTLSIDARNFINQCLQ 526

Query: 380 VNPNDRPTAAQLLDHPFVKRLLATNSGSASPY-LGRR 415
           V+P+ RPTA+QLL+HPFVKR L ++SGSASP  LG+R
Sbjct: 527 VDPSARPTASQLLEHPFVKRTLPSSSGSASPQNLGKR 563

Source: Nicotiana benthamiana

Species: Nicotiana benthamiana

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357489127|ref|XP_003614851.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355516186|gb|AES97809.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  542 bits (1397), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 280/411 (68%), Positives = 333/411 (81%), Gaps = 11/411 (2%)

Query: 10  GLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSS 69
           G  E+S+C   S    GIKG+RPP+LKPPPG+R  V+D+ CSTWDILRDFAP+       
Sbjct: 188 GFDETSSCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDTCSTWDILRDFAPE---GEGK 241

Query: 70  VMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV--LSESCSFTTEHEDDSSSTTTEP 127
              +       D+ + + E +E    I +EE  D++   S SCSFTT  EDDSSSTTT+ 
Sbjct: 242 EREEEEEEEKVDEVEEKGEADEVGLKIEEEENGDIIGEFSRSCSFTTSQEDDSSSTTTDT 301

Query: 128 MSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK 184
            SN ISPN R K +IT   WQKG+LLGRGSFG+VYEGIS+DGFFFAVK+VSLLDQGSQ K
Sbjct: 302 RSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDGFFFAVKQVSLLDQGSQGK 361

Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           QS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VTKGSLL+LY+RY LRDSQV
Sbjct: 362 QSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVTKGSLLSLYRRYKLRDSQV 421

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
           SAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADFGLAKA KLNDVKSC+GTA
Sbjct: 422 SAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADFGLAKAIKLNDVKSCQGTA 481

Query: 305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD 364
           FWMAPEV+  K KGYGLPADIWSLGCTVLEMLT Q+PYAPMEC++A+F+IG+G  PP+PD
Sbjct: 482 FWMAPEVVRGKVKGYGLPADIWSLGCTVLEMLTGQVPYAPMECISAVFRIGKGELPPVPD 541

Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 415
           +LS+DA+DFI  C++VNP+DRPTAAQLLDH FV+R  + +SGSASP++ RR
Sbjct: 542 TLSRDARDFILHCLKVNPDDRPTAAQLLDHKFVQRSFSQSSGSASPHIPRR 592

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518515|ref|XP_003527924.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  541 bits (1394), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 282/400 (70%), Positives = 333/400 (83%), Gaps = 10/400 (2%)

Query: 26  GIKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPK--DGITPSSVMNDRALSSSSDD 82
           GIKG RPP+LKPPPG R  V+D++ CSTWD+LRD AP+  +G+  +   N+  ++   + 
Sbjct: 155 GIKGTRPPMLKPPPGARVQVVDDSTCSTWDLLRDLAPQGEEGLPLNRSENESEVAREVER 214

Query: 83  EDNEKE-GEEADRAIVKEEEDDMV--LSESCSFTTEHEDDSSSTTTEPM-SNISPNGRFK 138
              EKE GE   R   K EE++ V  LSESCSF+T +EDDSSS+TT+P  +NISP GR K
Sbjct: 215 GAVEKEEGEVGTRESPKREEEENVAGLSESCSFSTSNEDDSSSSTTDPTSNNISPQGRIK 274

Query: 139 RIITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           RIIT   WQKG+ LG GSFGSVYEGISDDGFFFAVKEVSLLDQG+Q KQS+ QLEQEIAL
Sbjct: 275 RIITAESWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGTQGKQSVYQLEQEIAL 334

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLK 256
           LS+FEHENIVQYYGT+ D+SKLYIFLELVTKGSL +LYQ+Y LRDSQVS+YTRQIL GLK
Sbjct: 335 LSQFEHENIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRDSQVSSYTRQILHGLK 394

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN 316
           YLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLNDVKS +GTAFWMAPEV+  KN
Sbjct: 395 YLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMKGTAFWMAPEVVKGKN 454

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
           KGYGLPADIWSLGCTVLEMLT Q+PY  +E + AL++IG+G  P IPDSLS+DAQDFI Q
Sbjct: 455 KGYGLPADIWSLGCTVLEMLTGQLPYCDLESVRALYRIGKGERPRIPDSLSRDAQDFILQ 514

Query: 377 CVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL-GRR 415
           C+QV+PNDR TAAQLL+H FV+R L+ +SGS+ P++ GR+
Sbjct: 515 CLQVSPNDRATAAQLLNHSFVQRPLSQSSGSSFPHIHGRK 554

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486016|ref|XP_002264549.2| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  533 bits (1372), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 277/417 (66%), Positives = 328/417 (78%), Gaps = 16/417 (3%)

Query: 12  AESSACCVSSNYVK----GIKGVRPPLLKPPPG-MRQPVIDNACSTWDILRDFAPKDGIT 66
           +E+   CV  N V+    GIKGVRPP +  PP  MR+PV+DN  STWD+L+ FAP+    
Sbjct: 138 SENELNCVDLNSVRSGGGGIKGVRPPPVLAPPPVMRRPVVDNVSSTWDLLKSFAPQGDEP 197

Query: 67  PSSVMNDRALSSSSDDED-----NEKEGEE---ADRAIVKEEE---DDMVLSESCSFTTE 115
             S+     ++SSSD+ED     N  +GEE    +R  V  E    +++   ESCS T+ 
Sbjct: 198 LDSLRGGSKVASSSDEEDVSGIVNPSDGEEHTEIERNKVDGENVDGENIGTEESCSSTSN 257

Query: 116 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS 175
            ED+ SS T EP+  ISPNG+FKR I  WQ+G+LLG GSFG+VYEG +DDGFFFAVKEVS
Sbjct: 258 DEDEDSSMTLEPIYGISPNGQFKRTINSWQRGELLGSGSFGTVYEGYTDDGFFFAVKEVS 317

Query: 176 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ 235
           LLDQGSQ KQSI QLEQEI+LLS+FEHENIV+YYGTDKD+SKLYIFLELVTKGSLL+LYQ
Sbjct: 318 LLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLELVTKGSLLSLYQ 377

Query: 236 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 295
           +Y LR+SQ SAYTRQIL GLKYLH+Q+VVHRDIKCANILVD NGSVKLADFGLAKATKLN
Sbjct: 378 KYDLRESQASAYTRQILNGLKYLHEQNVVHRDIKCANILVDVNGSVKLADFGLAKATKLN 437

Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
           DVKSC+GT FWMAPEV+N KNKGYGL ADIWSLGCTVLE+LT + PY+ +E M ALF+IG
Sbjct: 438 DVKSCKGTVFWMAPEVVNRKNKGYGLAADIWSLGCTVLEILTRRPPYSHLEGMQALFRIG 497

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 412
           +G PPP+ +SLS DA++FI +C+QVNP+DRPTA QLLDHPFVKR L T SG  SP +
Sbjct: 498 KGEPPPVSNSLSSDARNFILKCLQVNPSDRPTAGQLLDHPFVKRPLHTFSGPQSPRM 554

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	415
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.918	0.626	0.602	4.4e-116
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.906	0.486	0.568	4.9e-112
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.643	0.476	0.675	3.1e-106
TAIR|locus:2118116	1895	WRKY19 [Arabidopsis thaliana (	0.701	0.153	0.624	1.8e-93
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.619	0.291	0.526	5.1e-67
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.633	0.431	0.5	1.4e-64
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.636	0.368	0.481	9e-61
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.638	0.397	0.476	8.1e-60
TAIR|locus:2080394	651	NP3 "NPK1-related protein kina	0.604	0.385	0.439	2.9e-56
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.607	0.365	0.449	2.3e-55

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
 Identities = 239/397 (60%), Positives = 283/397 (71%)

Query:    26 GIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALXXXXXX 82
             GIKG+RPP+LKPPP M++P ID+  S+WD L  FAP + +   + SS  ++         
Sbjct:   220 GIKGLRPPVLKPPPAMKRPPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGK 279

Query:    83 XXXXXXXXXXXRAIVKEEEDDMVLSESCSFXXXXXXXXXXXXXXPMSNISPNGRFKRIIT 142
                        R I   +  D    E+CSF                S I P+G    IIT
Sbjct:   280 EEEAEAEEMGARFIQLGDTAD----ETCSFTTNEGDSSSTVSNT--SPIYPDGG--AIIT 331

Query:   143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
              WQKG LLGRGSFGSVYEGIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H
Sbjct:   332 SWQKGQLLGRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQH 391

Query:   203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
             +NIV+Y GT KD S LYIFLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+ 
Sbjct:   392 QNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKG 451

Query:   263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK-GYGL 321
              +HRDIKCANILVDANG+VKLADFGLAK +K ND+KSC+GT FWMAPEVIN K+  GYG 
Sbjct:   452 FIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGS 511

Query:   322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             PADIWSLGCTVLEM T QIPY+ +E + ALF+IGRG+ P +PD+LS DA+ FI +C++VN
Sbjct:   512 PADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLKVN 571

Query:   382 PNDRPTAAQLLDHPFVKRLLAT----NSGSASPYLGR 414
             P +RPTAA+LL+HPFV+R L +     SGSASP L R
Sbjct:   572 PEERPTAAELLNHPFVRRPLPSVGSGGSGSASPLLRR 608

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1067 (380.7 bits), Expect = 4.9e-112, Sum P(2) = 4.9e-112
 Identities = 228/401 (56%), Positives = 276/401 (68%)

Query:    25 KGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALXXXXXXXX 84
             +GIKGVRP +LKPPP M+ P +D   S+WDIL  FAP   I        R          
Sbjct:   387 RGIKGVRPSVLKPPPVMKLPPVDLPGSSWDILTHFAPDSEIV-------RRPSSSSSSEN 439

Query:    85 XXXXXXXXXRAIVKEEEDDMVLS------ESCSFXXXXXXXXXXXXXXPMSNISP---NG 135
                        + KEE  DM +       E+CSF               +SN SP   +G
Sbjct:   440 GCDEEEAEDDKVEKEETGDMFIQLEDTTDEACSFTTNEGDSSST-----VSNTSPICVSG 494

Query:   136 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
                 I T WQKG LL +GSFGSVYE IS+DG FFAVKEVSLLDQGSQA++ I QLE EIA
Sbjct:   495 G--SINTSWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIA 552

Query:   196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
             LLS+ EH+NI++Y GTDKD S LYIFLELVT+GSLL LY+RY +RDS +S YT+QIL GL
Sbjct:   553 LLSQLEHQNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGL 612

Query:   256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 315
             KYLH +  +HRDIKCA ILVDANG+VKLADFGLAK +KLND+KS + T FWMAPEVIN K
Sbjct:   613 KYLHHKGFIHRDIKCATILVDANGTVKLADFGLAKVSKLNDIKSRKETLFWMAPEVINRK 672

Query:   316 -NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              N GY  PADIWSLGCTVLEM T QIPY+ +E + ALF+I RG+ P +PD+LS DA+ FI
Sbjct:   673 DNDGYRSPADIWSLGCTVLEMCTGQIPYSDLEPVEALFRIRRGTLPEVPDTLSLDARHFI 732

Query:   375 KQCVQVNPNDRPTAAQLLDHPFVKRLL-ATNSGSASPYLGR 414
              +C+++NP +RPTA +LL+HPFV+R L ++ SGS SP + R
Sbjct:   733 LKCLKLNPEERPTATELLNHPFVRRPLPSSGSGSTSPLIRR 773

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 922 (329.6 bits), Expect = 3.1e-106, Sum P(2) = 3.1e-106
 Identities = 181/268 (67%), Positives = 214/268 (79%)

Query:   134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
             N R    IT W KG LLGRGS+ SVYE IS+DG FFAVKEVSLLD+G QA++ I QLE E
Sbjct:   293 NFRKPEDITSWLKGQLLGRGSYASVYEAISEDGDFFAVKEVSLLDKGIQAQECIQQLEGE 352

Query:   194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 253
             IALLS+ +H+NIV+Y GT KD SKLYIFLELVT+GS+  LY+RY L  + VS YTRQIL 
Sbjct:   353 IALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTVVSLYTRQILA 412

Query:   254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN 313
             GL YLHD+  VHRDIKCAN+LVDANG+VKLADFGLA+A+K ND+ SC+GT FWMAPEVIN
Sbjct:   413 GLNYLHDKGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDIMSCKGTLFWMAPEVIN 472

Query:   314 NKNK-GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
              K+  G G PADIWSLGCTVLEM T QIPY+ ++ + A FKIGRG+ P +PD+LS DA+ 
Sbjct:   473 RKDSDGNGSPADIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGTLPDVPDTLSLDARH 532

Query:   373 FIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
             FI  C++VNP +RPTAA+LL HPFV  L
Sbjct:   533 FILTCLKVNPEERPTAAELLHHPFVINL 560

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 1.8e-93, Sum P(2) = 1.8e-93
 Identities = 196/314 (62%), Positives = 223/314 (71%)

Query:   108 ESCSFXXXXXXXXXXXXXXPMSNISP----NGRFKRIITYWQKGDLLGRGSFGSVYEGIS 163
             E+CSF               +SN SP     G F   IT WQKG LLGRGS GSVYEGIS
Sbjct:  1594 ETCSFTVNKGDSSRT-----ISNTSPIYASEGSF---ITCWQKGQLLGRGSLGSVYEGIS 1645

Query:   164 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 223
              DG FFA KEVSLLDQGSQA + I Q+E  IALLS+ +H+NIV+Y GT KDES LYIFLE
Sbjct:  1646 ADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLE 1705

Query:   224 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 283
             LVT+GSL  LYQR  L DS VS YTRQIL GLKYLHD+  +HR+IKCAN+LVDANG+VKL
Sbjct:  1706 LVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKL 1765

Query:   284 ADFGLAKATKLNDVKSCRGTAFW--MAPEVI-NNKN-KGYGLPADIWSLGCTVLEMLTSQ 339
             ADFGLAK      V S   T +W  MAPEVI N K+  GYG PADIWSLGCTVLEMLT Q
Sbjct:  1766 ADFGLAK------VMSLWRTPYWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQ 1819

Query:   340 IPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             IPY+ +E   AL+ IG G  P IPD LS DA+DFI  C++VNP +RPTAA+LL+HPFV  
Sbjct:  1820 IPYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNM 1879

Query:   400 LL-ATNSGSASPYL 412
              L ++ SGS S  L
Sbjct:  1880 PLPSSGSGSVSSLL 1893

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005622 "intracellular" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006952 "defense response" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA

GO:0043531 "ADP binding" evidence=IEA

GO:0043565 "sequence-specific DNA binding" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 681 (244.8 bits), Expect = 5.1e-67, P = 5.1e-67
 Identities = 138/262 (52%), Positives = 185/262 (70%)

Query:   144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             W+KG LLG GSFG VY G  S+ G   A+KEV+L     ++++S  QL QEI++LSR  H
Sbjct:   400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459

Query:   203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
             +NIVQYYG++  + KLYI+LE V+ GS+  L Q Y    ++ +  YT+QIL GL YLH +
Sbjct:   460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519

Query:   262 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
             + VHRDIK ANILVD +G VK+ADFG+AK  T  +   S +G+ +WMAPEVI N N G  
Sbjct:   520 NTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIKNSN-GSN 578

Query:   321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPDSLSKDAQDFIKQCVQ 379
             L  DIWSLGCTVLEM T++ P++  E + A+FKIG     P IPD LS++ +DF+++C+Q
Sbjct:   579 LAVDIWSLGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQ 638

Query:   380 VNPNDRPTAAQLLDHPFVKRLL 401
              NP +RPTAAQLLDH FV+ ++
Sbjct:   639 RNPANRPTAAQLLDHAFVRNVM 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
 Identities = 134/268 (50%), Positives = 180/268 (67%)

Query:   144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             W+KG  LG G+FG VY G  S+ G   A+KEV ++     +K+ + QL QEI LL++  H
Sbjct:   214 WKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCH 273

Query:   203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
              NIVQYYG++  E  L ++LE V+ GS+  L + Y    +  +  YTRQIL GL YLH +
Sbjct:   274 PNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHGR 333

Query:   262 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
             + VHRDIK ANILVD NG +KLADFG+AK  T  + + S +G+ +WMAPEV+ ++N GY 
Sbjct:   334 NTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEVVMSQN-GYT 392

Query:   321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDAQDFIKQCVQ 379
                DIWSLGCT+LEM TS+ P++  E +AA+FKIG     P IPD LS DA++FI+ C+Q
Sbjct:   393 HAVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFIRLCLQ 452

Query:   380 VNPNDRPTAAQLLDHPFVKRLLATNSGS 407
              NP  RPTA+QLL+HPF++      S S
Sbjct:   453 RNPTVRPTASQLLEHPFLRNTTRVASTS 480

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 622 (224.0 bits), Expect = 9.0e-61, P = 9.0e-61
 Identities = 133/276 (48%), Positives = 180/276 (65%)

Query:   144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             W+KG L+GRG+FGSVY    S+ G   A+KEV L     ++ + I QLEQEI LLS  +H
Sbjct:   346 WKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQH 405

Query:   203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 259
              NIVQY+G++  E + +I+LE V  GS+ N Y R H   + +S V  +TR IL GL YLH
Sbjct:   406 PNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAYLH 464

Query:   260 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVIN----- 313
             ++  VHRDIK AN+LVDA+G VKLADFG+AK  T      S +G+ +WMAPE++      
Sbjct:   465 NKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQK 524

Query:   314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 373
             + N       DIWSLGCT++EM T + P++  E  AA+FK+ R SPP IP+S+S + +DF
Sbjct:   525 DSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDSPP-IPESMSPEGKDF 583

Query:   374 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 409
             ++ C Q NP +RPTA+ LL+H F+K  L   S S S
Sbjct:   584 LRLCFQRNPAERPTASMLLEHRFLKNSLQPTSPSNS 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
 Identities = 134/281 (47%), Positives = 186/281 (66%)

Query:   144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ-GSQAKQS--ISQLEQEIALLSR 199
             W+KG L+GRG+FG+VY G++ D G   AVK+V +     S+ K    I +LE+E+ LL  
Sbjct:    69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query:   200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 258
               H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YTRQ+LLGL+YL
Sbjct:   129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query:   259 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 314
             H+  ++HRDIK ANILVD  G +KLADFG    +A+   +   KS +GT +WMAPEVI  
Sbjct:   189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI-- 246

Query:   315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRG-SPPPIPDSLSKDAQD 372
                G+   ADIWS+GCTV+EM+T + P++   + +AA+F IG   S PPIPD+LS DA+D
Sbjct:   247 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKD 306

Query:   373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 413
             F+ +C+Q  PN RPTA++LL HPFV   +  +  SAS  LG
Sbjct:   307 FLLKCLQEVPNLRPTASELLKHPFV---MGKHKESASTDLG 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 2.9e-56, Sum P(2) = 2.9e-56
 Identities = 117/266 (43%), Positives = 171/266 (64%)

Query:   144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 198
             W+KG+L+G G+FG VY G++ D G   A+K+V L+   S +K+     I +LE+E+ LL 
Sbjct:    68 WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126

Query:   199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 257
                H NIV+Y GT ++   L I +E V  GS+ +L +++    +  +  YT+Q+LLGL+Y
Sbjct:   127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186

Query:   258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMAPEVIN 313
             LH+  ++HRDIK ANILVD  G ++LADFG +K       +N  KS +GT +WMAPEVI 
Sbjct:   187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI- 245

Query:   314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSP-PPIPDSLSKDAQ 371
                 G+   ADIWS+GCTV+EM T + P++   +  AA+  IGR    PPIP+ LS +A+
Sbjct:   246 -LQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAK 304

Query:   372 DFIKQCVQVNPNDRPTAAQLLDHPFV 397
             DF+ +C+   P+ R +A +LL HPFV
Sbjct:   305 DFLMKCLHKEPSLRLSATELLQHPFV 330

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048046 "apoplast" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006270 "DNA replication initiation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0016572 "histone phosphorylation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

GO:0051726 "regulation of cell cycle" evidence=RCA

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
 Identities = 119/265 (44%), Positives = 173/265 (65%)

Query:   144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSR 199
             W+KG+++G G+FG VY G++ D G   A+KEVS+   G+   +A+  + +LE+E+ LL  
Sbjct:    80 WRKGEMIGCGAFGRVYMGMNVDSGELLAIKEVSIAMNGASRERAQAHVRELEEEVNLLKN 139

Query:   200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL 258
               H NIV+Y GT ++   L I LE V  GS+ +L  ++    +S +  YT+Q+LLGL+YL
Sbjct:   140 LSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 199

Query:   259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMAPEVINN 314
             H   ++HRDIK ANILVD  G +KLADFG +K       +   KS +GT +WMAPEVI  
Sbjct:   200 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTGAKSMKGTPYWMAPEVI-- 257

Query:   315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRG-SPPPIPDSLSKDAQD 372
                G+   ADIWS+GCT++EM T + P++   + +AALF IG   S PPIP+ LS +++D
Sbjct:   258 LQTGHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSAESKD 317

Query:   373 FIKQCVQVNPNDRPTAAQLLDHPFV 397
             F+ +C+Q  P+ R +A+ LL HPFV
Sbjct:   318 FLLKCLQKEPHLRHSASNLLQHPFV 342

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39008	M3K1_ARATH	2, ., 7, ., 1, 1, ., 2, 5	0.6332	0.8843	0.6036	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	gw1.V.5114.1	hypothetical protein (544 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	estExt_fgenesh4_pg.C_LG_II1481	hypothetical protein (372 aa)			•			•		•	0.821
	eugene3.00080074	mitogen-activated protein kinase kinase Group C (EC-2.7.12.2) (356 aa)			•			•		•	0.817
	estExt_fgenesh4_pm.C_LG_VI0403	hypothetical protein (355 aa)			•			•		•	0.817
	estExt_Genewise1_v1.C_1450125	hypothetical protein (357 aa)			•			•		•	0.817
	eugene3.00180195	hypothetical protein (364 aa)			•			•		•	0.817
	gw1.IV.2493.1	hypothetical protein (1122 aa)						•		•	0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	415
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-145
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-122
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-105
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-95
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-90
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-89
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-88
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-83
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-81
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-81
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-81
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-73
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-71
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-70
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-69
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-69
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-69
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-68
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-67
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-67
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-66
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-64
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-61
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-58
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-58
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-57
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-57
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-56
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-55
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-55
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-54
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-54
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-53
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-53
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-52
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-50
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-50
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-49
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-49
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-49
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-48
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-47
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-47
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-46
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-46
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-46
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-45
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-45
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-45
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-45
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-44
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-44
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-44
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-44
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-43
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-42
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-42
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-42
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-41
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-41
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-41
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-40
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-40
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-40
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-40
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-40
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-39
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-39
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-38
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-38
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-38
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-38
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-38
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-37
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-37
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-37
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-37
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-37
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-36
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-36
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-36
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-36
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-35
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-34
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-34
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-34
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-34
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-33
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-33
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-33
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-32
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-32
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-32
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-32
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-31
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-31
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-31
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-31
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-31
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-30
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-30
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-30
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-30
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-30
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-30
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-30
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-30
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-29
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-29
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-29
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-29
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-29
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-29
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-29
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-28
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-28
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-28
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-28
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-28
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-28
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-28
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-28
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-27
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-27
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-27
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-27
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-27
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-27
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-26
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-26
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-26
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-26
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-25
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-25
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-25
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-24
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-24
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-24
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-24
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-24
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-24
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-23
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-23
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-23
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-23
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-23
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-23
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-23
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-22
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-22
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-22
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-22
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-22
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-22
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-22
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-21
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-21
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-21
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-21
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-21
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-21
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-21
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-21
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-20
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-20
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-20
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-20
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-20
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-20
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-19
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-19
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-19
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-18
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-18
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-18
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-18
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-18
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-17
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-17
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-16
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-16
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-15
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-14
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-12
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  413 bits (1063), Expect = e-145
 Identities = 159/258 (61%), Positives = 200/258 (77%), Gaps = 5/258 (1%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W+KG+LLG GSFGSVYEG++ DDG FFAVKEVSL D G   ++++ QLEQEIALLS+ +H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
            NIVQY GT+++E  LYIFLELV  GSL  L ++Y    +  +  YTRQILLGL+YLHD+
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           + VHRDIK ANILVD NG VKLADFG+AK   + +  KS +G+ +WMAPEVI  +  GYG
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG-GYG 180

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQ 379
           L ADIWSLGCTVLEM T + P++ +E +AA+FKIGR    PPIPD LS +A+DFI +C+Q
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 380 VNPNDRPTAAQLLDHPFV 397
            +P+ RPTAA+LL+HPFV
Sbjct: 241 RDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  355 bits (914), Expect = e-122
 Identities = 137/266 (51%), Positives = 183/266 (68%), Gaps = 19/266 (7%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W +G+LLGRGSFGSVY  +  D G   AVK V L      +++ +  LE+EI +LS  +H
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL---SGDSEEELEALEREIRILSSLQH 58

Query: 203 ENIVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 259
            NIV+YYG+++DE K  L IFLE V+ GSL +L +++  L +  +  YTRQIL GL YLH
Sbjct: 59  PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV------KSCRGTAFWMAPEVIN 313
              +VHRDIK ANILVD++G VKLADFG AK  +L D+       S RGT +WMAPEVI 
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAK--RLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGR-GSPPPIPDSLSKDAQ 371
              + YG  ADIWSLGCTV+EM T + P++ +   MAAL+KIG  G PP IP+ LS++A+
Sbjct: 177 --GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFV 397
           DF+++C++ +P  RPTA +LL HPF+
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  309 bits (795), Expect = e-105
 Identities = 127/259 (49%), Positives = 169/259 (65%), Gaps = 13/259 (5%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           Q GDL+GRG+FG VY+G++ + G F A+K++SL     +A +SI Q   EI LL   +H 
Sbjct: 3   QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ---EIDLLKNLKHP 59

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 262
           NIV+Y G+ +    LYI LE    GSL  + +++    +S V+ Y  Q+L GL YLH+Q 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKG 318
           V+HRDIK ANIL   +G VKLADFG+A  TKLNDV     S  GT +WMAPEVI     G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMS--G 175

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
               +DIWSLGCTV+E+LT   PY  +  MAALF+I +   PP+P+ +S + +DF+ QC 
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235

Query: 379 QVNPNDRPTAAQLLDHPFV 397
           Q +PN RPTA QLL HP++
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  285 bits (733), Expect = 3e-95
 Identities = 97/260 (37%), Positives = 144/260 (55%), Gaps = 12/260 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++  + LG GSFG VY       G   A+K +       + K+   ++ +EI +L + +H
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKH 56

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
            NIV+ Y   +DE KLY+ +E    G L +L ++   L + +   Y RQIL  L+YLH +
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 320
            +VHRD+K  NIL+D +G VKLADFGLA+     +   +  GT  +MAPEV+    KGYG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL--LGKGYG 174

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP---DSLSKDAQDFIKQC 377
              DIWSLG  + E+LT + P+   + +  LFK      PP P     +S +A+D I++ 
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 378 VQVNPNDRPTAAQLLDHPFV 397
           +  +P  R TA + L HPF 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  274 bits (702), Expect = 1e-90
 Identities = 102/260 (39%), Positives = 156/260 (60%), Gaps = 13/260 (5%)

Query: 143 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
            ++  + +G+G FG VY+      G   A+K + L     ++K+   ++  EI +L + +
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCK 55

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 259
           H NIV+YYG+   + +L+I +E  + GSL +L +  +    +SQ++   +++L GL+YLH
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKG 318
              ++HRDIK ANIL+ ++G VKL DFGL+   +      +  GT +WMAPEVIN   K 
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN--GKP 173

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQ 376
           Y   ADIWSLG T +E+   + PY+ +  M ALFKI    PP + +    S + +DF+K+
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233

Query: 377 CVQVNPNDRPTAAQLLDHPF 396
           C+Q NP  RPTA QLL HPF
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  270 bits (693), Expect = 3e-89
 Identities = 119/264 (45%), Positives = 165/264 (62%), Gaps = 10/264 (3%)

Query: 142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           T W++G LLG+G+FG VY     D G   AVK+V       + K+ ++ LE EI LL   
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 259
           +HE IVQYYG  +D+  L IF+E +  GS+ +  + Y  L ++    YTRQIL G++YLH
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVINN 314
              +VHRDIK ANIL D+ G+VKL DFG +K      +    +KS  GT +WM+PEVI+ 
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS- 180

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPDSLSKDAQDF 373
             +GYG  AD+WS+GCTV+EMLT + P+A  E MAA+FKI      P +P  +S DA++F
Sbjct: 181 -GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           +++    N   RP+A +LL H FV
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  268 bits (687), Expect = 2e-88
 Identities = 118/266 (44%), Positives = 166/266 (62%), Gaps = 15/266 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           WQ+G+ +G G+FG VY  ++ D G   AVKE+ +  Q +  K +I ++  E+ +L   +H
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI--QDNDPK-TIKEIADEMKVLELLKH 58

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQ 261
            N+V+YYG +    K+YIF+E  + G+L  L +   + D  V   YT Q+L GL YLH  
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLN------DVKSCRGTAFWMAPEVI-NN 314
            +VHRDIK ANI +D NG +KL DFG A   K N      +V+S  GT  +MAPEVI   
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIPDS--LSKDAQ 371
           K KG+G  ADIWSLGC VLEM T + P++ ++     +F +G G  PPIPDS  LS + +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFV 397
           DF+ +C++ +P  RPTA++LL HPFV
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  256 bits (655), Expect = 2e-83
 Identities = 103/261 (39%), Positives = 152/261 (58%), Gaps = 14/261 (5%)

Query: 145 QKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
              + +G+GSFG VY+ I        A+K + L     +A+  I  ++QEI  LS+    
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQCRSP 59

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            I +YYG+    SKL+I +E    GS L+L +   L ++ ++   R++LLGL+YLH++  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK ANIL+   G VKLADFG+  + +L    S R    GT FWMAPEVI  K  GY
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGV--SGQLTSTMSKRNTFVGTPFWMAPEVI--KQSGY 175

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 378
              ADIWSLG T +E+   + P + +  M  LF I + +PP +  +  SK  +DF+  C+
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235

Query: 379 QVNPNDRPTAAQLLDHPFVKR 399
             +P +RP+A +LL H F+K+
Sbjct: 236 NKDPKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  254 bits (650), Expect = 7e-83
 Identities = 93/264 (35%), Positives = 141/264 (53%), Gaps = 14/264 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++    LG GSFG+VY+      G   AVK +    + S+  Q      +EI +L R  H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ---TARREIRILRRLSH 57

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
            NIV+     +D+  LY+ +E    G L +   R   L + +      QIL GL+YLH  
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC--RGTAFWMAPEVINNKNKGY 319
            ++HRD+K  NIL+D NG VK+ADFGLAK    +        GT ++MAPEV+     GY
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL-LGGNGY 176

Query: 320 GLPADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRG---SPPPIPDSLSKDAQDF 373
           G   D+WSLG  + E+LT + P++    ++ +  + +I         P   S S++A+D 
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           IK+C+  +P+ RPTA ++L HP+ 
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  251 bits (642), Expect = 2e-81
 Identities = 121/268 (45%), Positives = 166/268 (61%), Gaps = 16/268 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 198
           W KG L+G GSFGSVY G+ +  G   AVK+V L    + +K      +  L +EIALL 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 257
             +HENIVQY G+  D   L IFLE V  GS+  L   Y    ++ V  + RQIL GL Y
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--------SCRGTAFWMAP 309
           LH++ ++HRDIK ANILVD  G +K++DFG++K  + N +         S +G+ FWMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
           EV+  K   Y   ADIWSLGC V+EMLT + P+     + A+FKIG  + P IP ++S +
Sbjct: 182 EVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           A DF+++  +++ N RPTAA+LL HPF+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  250 bits (640), Expect = 2e-81
 Identities = 119/267 (44%), Positives = 170/267 (63%), Gaps = 16/267 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ--AKQSISQLEQEIALLSRFE 201
           W KG++LG+G++G+VY G+++ G   AVK+V L D  +   A++   +L++E+ LL   +
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVEL-DTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 260
           H NIVQY GT  D++ + IF+E V  GS+ ++  R+  L +     YT+QIL G+ YLH+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 312
             VVHRDIK  N+++  NG +KL DFG A+         T  N +KS  GT +WMAPEVI
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDSLSKDA 370
           N    GYG  +DIWS+GCTV EM T + P A M+ +AA+F IG  RG  P +PDS S  A
Sbjct: 181 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238

Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            DF+  C+  + ++RP+A QLL H F+
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  250 bits (639), Expect = 4e-81
 Identities = 115/269 (42%), Positives = 165/269 (61%), Gaps = 16/269 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL----LDQGSQAKQSI-SQLEQEIALL 197
           W KG+L+G+G++G VY  ++   G   AVK+V L      +    ++ +   L  EI  L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-VSAYTRQILLGLK 256
              +H NIVQY G +  E  L IFLE V  GS+ +  + Y   + Q V  +T Q+L GL 
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK---LNDVK-SCRGTAFWMAPEVI 312
           YLH + ++HRD+K  N+LVDA+G  K++DFG++K +     ND   S +G+ FWMAPEVI
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPD----SLS 367
           ++ ++GY    DIWSLGC VLEM   + P++  E +AA+FK+G + S PPIP     +LS
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
             A DF+  C  +NP++RPTA +LL HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  229 bits (587), Expect = 2e-73
 Identities = 99/260 (38%), Positives = 150/260 (57%), Gaps = 22/260 (8%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           + LG GS+GSVY+ I  + G   A+K V +       ++ + ++ +EI++L + +   IV
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIV 61

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           +YYG+    + L+I +E    GS+ ++ +     L + +++A   Q L GL+YLH    +
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYG 320
           HRDIK  NIL++  G  KLADFG+  + +L D      +  GT FWMAPEVI     GY 
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYN 177

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKDAQDFIKQC 377
             ADIWSLG T +EM   + PY+ +  M A+F I    PPP    P+  S +  DF+K+C
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-KPPPTLSDPEKWSPEFNDFVKKC 236

Query: 378 VQVNPNDRPTAAQLLDHPFV 397
           +  +P +RP+A QLL HPF+
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  225 bits (575), Expect = 1e-71
 Identities = 87/262 (33%), Positives = 143/262 (54%), Gaps = 21/262 (8%)

Query: 148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
             +G+GSFG VY      DG  + +KE+ L +   + ++       E+ +L +  H NI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLNHPNII 62

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ 261
           +YY + +++ KL I +E    G L    ++         + Q+  +  Q+ L LKYLH +
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNK 317
            ++HRDIK  NI + +NG VKL DFG++K   L+      K+  GT ++++PE+   +NK
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC--QNK 178

Query: 318 GYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIK 375
            Y   +DIWSLGC + E+ T + P     E +  L  KI +G  PPIP   S + ++ + 
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEG--ENLLELALKILKGQYPPIPSQYSSELRNLVS 236

Query: 376 QCVQVNPNDRPTAAQLLDHPFV 397
             +Q +P +RP+ AQ+L  PF+
Sbjct: 237 SLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  223 bits (571), Expect = 1e-70
 Identities = 102/265 (38%), Positives = 151/265 (56%), Gaps = 22/265 (8%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
            +K   +G G+ G VY+      G   A+K++ L       KQ+   +  EI ++   +H
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRL------RKQNKELIINEILIMKDCKH 74

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 260
            NIV YY +     +L++ +E +  GSL ++  +  +R  + Q++   R++L GL+YLH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKN 316
           Q+V+HRDIK  NIL+  +GSVKLADFG   A +L   KS R    GT +WMAPEVI  K 
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGF--AAQLTKEKSKRNSVVGTPYWMAPEVI--KR 190

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFI 374
           K YG   DIWSLG   +EM   + PY     + ALF I     PP+  P+  S + +DF+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250

Query: 375 KQCVQVNPNDRPTAAQLLDHPFVKR 399
            +C+  +P  RP+A +LL HPF+K+
Sbjct: 251 NKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  220 bits (563), Expect = 1e-69
 Identities = 102/258 (39%), Positives = 141/258 (54%), Gaps = 17/258 (6%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G VY+      G   A+K + L             ++QEI++L    H NIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAY 65

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
           +G+     KL+I +E    GSL ++YQ  R  L + Q++   R+ L GL YLH+   +HR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 267 DIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVI-NNKNKGYGLP 322
           DIK ANIL+  +G VKLADFG++    AT +   KS  GT +WMAPEV    +  GY   
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEVAAVERKGGYDGK 184

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPI---PDSLSKDAQDFIKQCV 378
            DIW+LG T +E+   Q P   +  M ALF I +   PPP     +  S    DFIK+C+
Sbjct: 185 CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCL 244

Query: 379 QVNPNDRPTAAQLLDHPF 396
             +P  RPTA +LL HPF
Sbjct: 245 TKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  219 bits (560), Expect = 3e-69
 Identities = 92/265 (34%), Positives = 144/265 (54%), Gaps = 19/265 (7%)

Query: 145 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           ++  +LG+GS G VY+      G  +A+K++ +            QL +E+  L   E  
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF----RKQLLRELKTLRSCESP 59

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH-DQ 261
            +V+ YG    E ++ I LE +  GSL +L ++   + +  ++   RQIL GL YLH  +
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNK 317
            ++HRDIK +N+L+++ G VK+ADFG++K   L +         GT  +M+PE I  ++ 
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGES- 176

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSL-SKDAQDF 373
            Y   ADIWSLG T+LE    + P+ P         +  I  G PP +P    S + +DF
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           I  C+Q +P  RP+AA+LL HPF+K
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  219 bits (559), Expect = 3e-69
 Identities = 120/265 (45%), Positives = 165/265 (62%), Gaps = 13/265 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W++G LLG+G+FG VY     D G   A K+V    +  +  + +S LE EI LL   +H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 203 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 259
           E IVQYYG   D+ E  L IF+E +  GS+ +  + Y  L +S    YTRQIL G+ YLH
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 314
              +VHRDIK ANIL D+ G+VKL DFG +K  +        ++S  GT +WM+PEVI+ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS- 182

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDF 373
             +GYG  AD+WSLGCTV+EMLT + P+A  E MAA+FKI  + + P +P  +S+ A+DF
Sbjct: 183 -GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           +  C+ V    RP+A +LL HPF +
Sbjct: 242 LG-CIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  216 bits (552), Expect = 3e-68
 Identities = 122/264 (46%), Positives = 163/264 (61%), Gaps = 13/264 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W+ G LLGRG+FG VY    +D G   AVK+V       +  + ++ LE EI LL    H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 203 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 259
           + IVQYYG   D +E KL IF+E +  GS+ +  + Y  L ++    YTRQIL G+ YLH
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 314
              +VHRDIK ANIL D+ G+VKL DFG +K  +        +KS  GT +WM+PEVI+ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS- 182

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDF 373
             +GYG  AD+WS+ CTV+EMLT + P+A  E MAA+FKI  + + P +PD +S   +DF
Sbjct: 183 -GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           +KQ + V    RPTA  LL HPFV
Sbjct: 242 LKQ-IFVEEKRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  215 bits (549), Expect = 1e-67
 Identities = 110/261 (42%), Positives = 156/261 (59%), Gaps = 19/261 (7%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G++G VY           A+KE+   D      + +  L +EIAL S  +H NIVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQ 69

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Y G+D +     IF+E V  GSL  L +         +  +  YT+QIL GLKYLHD  +
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 264 VHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKG 318
           VHRDIK  N+LV+  +G VK++DFG +K  +L  +  C     GT  +MAPEVI+   +G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEVIDKGPRG 187

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQ 376
           YG PADIWSLGCT++EM T + P+  + E  AA+FK+G     P IP+SLS +A++FI +
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247

Query: 377 CVQVNPNDRPTAAQLLDHPFV 397
           C + +P+ R +A  LL  PF+
Sbjct: 248 CFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  213 bits (544), Expect = 2e-67
 Identities = 83/252 (32%), Positives = 128/252 (50%), Gaps = 43/252 (17%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G FG+VY       G   A+K +        +   + +L +EI +L +  H NIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
           YG  +DE+ LY+ +E    GSL +L +     L + ++     QIL GL+YLH   ++HR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 267 DIKCANILVDA-NGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           D+K  NIL+D+ NG VKLADFGL+K   +  + +K+  GT  +MAPEV+  K   Y   +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY-YSEKS 175

Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           DIWSLG  + E+                                 + +D I++ +Q +P 
Sbjct: 176 DIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE 203

Query: 384 DRPTAAQLLDHP 395
            RP+A ++L+H 
Sbjct: 204 KRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  211 bits (537), Expect = 6e-66
 Identities = 120/266 (45%), Positives = 164/266 (61%), Gaps = 13/266 (4%)

Query: 142 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           T W+ G LLG+G+FG VY    +D G   AVK+V    +  +  + ++ LE EI LL   
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 201 EHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 257
            HE IVQYYG  +D  E  L IF+E +  GS+ +  + Y  L ++    YTRQIL G+ Y
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVI 312
           LH   +VHRDIK ANIL D+ G+VKL DFG +K  +        +KS  GT +WM+PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQ 371
           +   +GYG  ADIWS+GCTV+EMLT + P+A  E MAA+FKI  + + P +P  +S   +
Sbjct: 182 S--GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFV 397
           DF+K+ + V    RP+A +LL H FV
Sbjct: 240 DFLKR-IFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  205 bits (524), Expect = 6e-64
 Identities = 93/267 (34%), Positives = 154/267 (57%), Gaps = 18/267 (6%)

Query: 144 WQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRF 200
           W KG  LG G+F S Y    D   G   AVK+V+ +   S  ++ + + L +EI L++R 
Sbjct: 2   WLKGQQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 259
            H +I++  G   ++S   +F+E +  GS+ +L  +Y   +++ +  YT Q+L GL YLH
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 260 DQDVVHRDIKCANILVDANGS-VKLADFGLA-----KATKLNDVK-SCRGTAFWMAPEVI 312
           +  ++HRD+K AN+L+D+ G  +++ADFG A     K T   + +    GT  +MAPEV+
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGS-PPPIPDSLSK 368
             +   YG   D+WS+GC ++EM T++ P+   +    +A +FKI   +  P IP+ LS 
Sbjct: 181 RGEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHP 395
             +D   +C+++ P DRP + +LL HP
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  199 bits (508), Expect = 2e-61
 Identities = 99/269 (36%), Positives = 145/269 (53%), Gaps = 15/269 (5%)

Query: 141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
              W+    LG G+FG VY+    + G F A K + +     ++++ +     EI +LS 
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSE 58

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKY 257
            +H NIV  Y     E+KL+I +E    G+L ++       L + Q+    RQ+L  L +
Sbjct: 59  CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVI--- 312
           LH   V+HRD+K  NIL+  +G VKLADFG++   K    K  +  GT +WMAPEV+   
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDA 370
             K+  Y   ADIWSLG T++E+   + P+  +  M  L KI +  PP +  P   S   
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238

Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            DF+K C+  +P+DRPTAA+LL HPFV  
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  191 bits (488), Expect = 2e-58
 Identities = 101/282 (35%), Positives = 154/282 (54%), Gaps = 16/282 (5%)

Query: 142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           + +Q+ +L+GRG++G+VY G     G   A+K ++L          +S +++E+ALLS+ 
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL----DTPDDDVSDIQREVALLSQL 56

Query: 201 EH---ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
                 NI +YYG+     +L+I +E    GS+  L +   + +  +S   R++L+ LKY
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVIN 313
           +H   V+HRDIK ANILV   G+VKL DFG+  A  LN   S R    GT +WMAPEVI 
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGV--AALLNQNSSKRSTFVGTPYWMAPEVI- 173

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKDAQD 372
            + K Y   ADIWSLG T+ EM T   PY+ ++   A+  I +  PP + D   SK  ++
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGR 414
           F+  C+   P +R +A +LL   ++K    T        + R
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELISR 275

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  191 bits (487), Expect = 3e-58
 Identities = 90/274 (32%), Positives = 146/274 (53%), Gaps = 26/274 (9%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           ++  +++G G++G VY+      G   A+K + ++      +    ++++E  +L ++  
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSN 61

Query: 202 HENIVQYYGT------DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQ 250
           H NI  +YG         ++ +L++ +EL   GS+ +L +    +  ++     AY  R+
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMA 308
            L GL YLH+  V+HRDIK  NIL+  N  VKL DFG++    + L    +  GT +WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 309 PEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 363
           PEVI      +  Y   +D+WSLG T +E+   + P   M  M ALFKI R  PP +  P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           ++ SK   DFI +C+  N   RP   +LL+HPF+
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  189 bits (481), Expect = 2e-57
 Identities = 105/267 (39%), Positives = 155/267 (58%), Gaps = 13/267 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           + K + +G+GSFG VY+GI +      A+K + L     +A+  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
             I +YYG+    +KL+I +E +  GS L+L +   L ++ ++   R+IL GL YLH + 
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG 318
            +HRDIK AN+L+   G VKLADFG+A   +L D +  R    GT FWMAPEVI  K   
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--KQSA 177

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
           Y   ADIWSLG T +E+   + P + +  M  LF I + SPP +    SK  ++F++ C+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237

Query: 379 QVNPNDRPTAAQLLDHPFVKRLLATNS 405
             +P  RPTA +LL H F+ R     S
Sbjct: 238 NKDPRFRPTAKELLKHKFITRYTKKTS 264

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  188 bits (480), Expect = 3e-57
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 18/260 (6%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           + G  LG G+FG VY+G             AVK    L +G+  ++      +E +++ +
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREE-FLEEASIMKK 57

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 257
             H NIV+  G       LYI  E +  G LL+  +++   L    +     QI  G++Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVIN 313
           L  ++ VHRD+   N LV  N  VK++DFGL++    +D    RG       WMAPE + 
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL- 176

Query: 314 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
            K+  +   +D+WS G  + E+ T  + PY  M     L  +  G   P P++   +  +
Sbjct: 177 -KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE 235

Query: 373 FIKQCVQVNPNDRPTAAQLL 392
            + QC   +P DRPT ++L+
Sbjct: 236 LMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  186 bits (474), Expect = 2e-56
 Identities = 77/260 (29%), Positives = 125/260 (48%), Gaps = 17/260 (6%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
             G  LG G+FG VY+G             AVK    L + +  +Q I +  +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQ-IEEFLREARIMRK 57

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 257
            +H N+V+  G   +E  LYI +E +  G LL+     R  L  S + ++  QI  G++Y
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVINN 314
           L  ++ +HRD+   N LV  N  VK++DFGL++          +  +    WMAPE +  
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL-- 175

Query: 315 KNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 373
           K   +   +D+WS G  + E+ T  + PY  M     L  +  G   P P +   +  D 
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDL 235

Query: 374 IKQCVQVNPNDRPTAAQLLD 393
           + QC   +P DRPT ++L++
Sbjct: 236 MLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  184 bits (467), Expect = 2e-55
 Identities = 102/260 (39%), Positives = 159/260 (61%), Gaps = 11/260 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 6   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 62

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK AN+L+  +G VKLADFG+A   +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--KQSAY 178

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              ADIWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+ 
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238

Query: 380 VNPNDRPTAAQLLDHPFVKR 399
             P+ RPTA +LL H F+ R
Sbjct: 239 KEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  182 bits (464), Expect = 4e-55
 Identities = 78/261 (29%), Positives = 127/261 (48%), Gaps = 20/261 (7%)

Query: 146 KGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
            G  LG G+FG VY+G             AVK +    +   ++Q I +  +E  ++ + 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKL 58

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLK 256
           +H NIV+  G   +E  L I +E +  G LL+ Y R +    L  S + ++  QI  G++
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLD-YLRKNRPKELSLSDLLSFALQIARGME 117

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVIN 313
           YL  ++ +HRD+   N LV  N  VK++DFGL++         VK  +    WMAPE + 
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL- 176

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
            K   +   +D+WS G  + E+ T  + PY  M     L  + +G   P P +   +   
Sbjct: 177 -KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235

Query: 373 FIKQCVQVNPNDRPTAAQLLD 393
            + QC   +P DRPT ++L++
Sbjct: 236 LMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  182 bits (464), Expect = 5e-55
 Identities = 90/270 (33%), Positives = 134/270 (49%), Gaps = 30/270 (11%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           + +G+GSFG+V +     DG     KE   +D G+  ++   QL  E+ +L   +H NIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 207 QYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLH 259
           +YY    D S   LYI +E    G L  L Q+      ++ +  +     Q+LL L   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 260 -----DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVI 312
                   V+HRD+K ANI +DAN +VKL DFGLAK      +  K+  GT ++M+PE +
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-----KIGRGSPPPIPDSLS 367
           N+ +  Y   +DIWSLGC + E+     P+      A        KI  G    IP   S
Sbjct: 183 NHMS--YDEKSDIWSLGCLIYELCALSPPFT-----ARNQLQLASKIKEGKFRRIPYRYS 235

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            +  + IK  + V+P+ RP+  +LL  P +
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  181 bits (461), Expect = 1e-54
 Identities = 101/263 (38%), Positives = 143/263 (54%), Gaps = 25/263 (9%)

Query: 148 DLLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRF 200
             LG+GS+GSVY  + +SD   F+A+KEV L         S+SQ E+     EI +L+  
Sbjct: 6   KKLGKGSYGSVYKVKRLSD-NQFYALKEVDL--------GSMSQKEREDAVNEIRILASV 56

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGL 255
            H NI+ Y     D +KL I +E    G L     +       + + ++     Q+L GL
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 315
           + LH+Q ++HRD+K ANIL+ AN  VK+ D G++K  K N  K+  GT  +MAPEV   K
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW--K 174

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL-FKIGRGSPPPIPDSLSKDAQDFI 374
            + Y   +DIWSLGC + EM T   P+     M  L +K+ RG  PPIP   S+D Q+FI
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233

Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
           +  +QV P  RP   ++L  P V
Sbjct: 234 RSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  180 bits (458), Expect = 3e-54
 Identities = 90/262 (34%), Positives = 135/262 (51%), Gaps = 28/262 (10%)

Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 202
           LG+GSFG V      D G  +A+K +         K+ I + ++      E  +LSR  H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRINH 52

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             IV+ +   + E KLY+ LE    G L + L +     + +   Y  +I+L L+YLH  
Sbjct: 53  PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG 318
            +++RD+K  NIL+DA+G +KL DFGLAK    ++        GT  ++APEV+    KG
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVL--LGKG 169

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQC 377
           YG   D WSLG  + EMLT + P+   E    ++ KI +  P   P+ LS +A+D I   
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFY-AEDRKEIYEKILKD-PLRFPEFLSPEARDLISGL 227

Query: 378 VQVNPNDRPT---AAQLLDHPF 396
           +Q +P  R     A ++  HPF
Sbjct: 228 LQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  179 bits (455), Expect = 1e-53
 Identities = 100/259 (38%), Positives = 152/259 (58%), Gaps = 13/259 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           + K + +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
             + +YYG+    +KL+I +E +  GS L+L +     + Q++   ++IL GL YLH + 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG 318
            +HRDIK AN+L+   G VKLADFG+A   +L D +  R    GT FWMAPEVI  +   
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--QQSA 177

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
           Y   ADIWSLG T +E+   + P + M  M  LF I + +PP +    SK  ++FI  C+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237

Query: 379 QVNPNDRPTAAQLLDHPFV 397
             +P+ RPTA +LL H F+
Sbjct: 238 NKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  178 bits (453), Expect = 3e-53
 Identities = 85/262 (32%), Positives = 137/262 (52%), Gaps = 20/262 (7%)

Query: 150 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G+ G V +      G   AVK + L       +    Q+ +E+ +L +     IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQ-DVVH 265
           YG   +   + I +E +  GSL  + +    R  +  +      +L GL YLH++  ++H
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKL-NDV-KSCRGTAFWMAPEVINNKNKGYGLPA 323
           RD+K +NILV++ G +KL DFG++   +L N + K+  GT+ +MAPE I      Y + +
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVS--GQLVNSLAKTFVGTSSYMAPERIQGN--DYSVKS 180

Query: 324 DIWSLGCTVLEMLTSQIPYAP-----MECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 377
           DIWSLG +++E+ T + PY P           L  I    PP +P    S D QDF+  C
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240

Query: 378 VQVNPNDRPTAAQLLDHPFVKR 399
           +  +P +RP+  +LL+HPF+K+
Sbjct: 241 LIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  175 bits (446), Expect = 3e-52
 Identities = 86/263 (32%), Positives = 140/263 (53%), Gaps = 21/263 (7%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G+   VY  I   +    A+K + L     + + S+ +L +E+  +S+  H N+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 209 YGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           Y +     +L++ +  ++ GSLL++    Y R  L ++ ++   +++L GL+YLH    +
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEVINNKNKG 318
           HRDIK  NIL+  +GSVK+ADFG++ +      ++ +      GT  WMAPEV+   + G
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH-G 183

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS-----LSKDAQDF 373
           Y   ADIWS G T +E+ T   PY+    M  L    +  PP +         SK  +  
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKM 243

Query: 374 IKQCVQVNPNDRPTAAQLLDHPF 396
           I  C+Q +P+ RPTA +LL H F
Sbjct: 244 ISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  171 bits (435), Expect = 3e-50
 Identities = 87/255 (34%), Positives = 140/255 (54%), Gaps = 10/255 (3%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GSFG+VY           A+K++S    G Q+ +    + +E+  L +  H N ++Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 209 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            G    E   ++ +E  L +   +L ++++  L++ +++A     L GL YLH  + +HR
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 325
           DIK  NIL+   G+VKLADFG   A+ ++   S  GT +WMAPEVI   ++G Y    D+
Sbjct: 140 DIKAGNILLTEPGTVKLADFG--SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQCVQVNPND 384
           WSLG T +E+   + P   M  M+AL+ I +   P +  +  S   ++F+  C+Q  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQD 257

Query: 385 RPTAAQLLDHPFVKR 399
           RP++ +LL H FV R
Sbjct: 258 RPSSEELLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 5e-50
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 25/266 (9%)

Query: 148 DLLGRGSFGSVYEGISDDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
             LG G+FG VY+G            AVK +    +   +++      +E  ++ +  H 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDASEEERKDFLKEARVMKKLGHP 56

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLL----------NLYQRYHLRDSQVSAYTRQILL 253
           N+V+  G   +E  LY+ LE +  G LL             ++  L    + ++  QI  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAF---WMAP 309
           G++YL  +  VHRD+   N LV  +  VK++DFGL++    +D  +   G      WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK 368
           E + +    +   +D+WS G  + E+ T    PY  +     L  + +G   P P+    
Sbjct: 177 ESLKDGI--FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDH 394
           +  + +  C Q++P DRPT ++L++ 
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  168 bits (428), Expect = 9e-50
 Identities = 81/257 (31%), Positives = 135/257 (52%), Gaps = 21/257 (8%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-----LSRFEHE 203
           +G+GSFG V++ +   D   +A+K++ L          +++ E+E A+     L++ +  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDL--------SKMNRREREEAIDEARVLAKLDSS 59

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHD 260
            I++YY +  D+ KL I +E    G L  L +      L + QV  +  QILLGL +LH 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKG 318
           + ++HRDIK  N+ +DA  +VK+ D G+AK    N     +  GT ++++PE+   ++K 
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC--EDKP 177

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
           Y   +D+W+LG  + E  T + P+      A + KI RG  PP+    S+     I QC+
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237

Query: 379 QVNPNDRPTAAQLLDHP 395
             +   RP   QLL +P
Sbjct: 238 TKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  168 bits (427), Expect = 1e-49
 Identities = 87/258 (33%), Positives = 145/258 (56%), Gaps = 18/258 (6%)

Query: 150 LGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +G GSFG +Y  +  SD      +KE+ L     + K++    ++E+ LL++ +H NIV 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHC-VIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVT 63

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVV 264
           ++ + ++  +L+I +E    G L+    R       + Q+ ++  QI LGLK++HD+ ++
Sbjct: 64  FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123

Query: 265 HRDIKCANILVDANGSV-KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGY 319
           HRDIK  NI +  NG V KL DFG+A+  +LND      +C GT ++++PE+   +N+ Y
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC--QNRPY 179

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
               DIWSLGC + E+ T + P+        + KI +G   PI  + S+D +  I Q  +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239

Query: 380 VNPNDRPTAAQLLDHPFV 397
           V+P DRP+   +L  PF+
Sbjct: 240 VSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  168 bits (428), Expect = 2e-49
 Identities = 81/284 (28%), Positives = 136/284 (47%), Gaps = 44/284 (15%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--LLDQGSQAKQSISQLEQEI-ALLSRFEH 202
           G ++G GSF +V      +    +A+K +    L +  + K    ++E+E+   L+   H
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNG--H 61

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
             I++ Y T +DE  LY  LE    G LL   ++Y   D + +  Y  +ILL L+YLH +
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAK---------ATKLNDVKSCR----------- 301
            ++HRD+K  NIL+D +  +K+ DFG AK         + K +                 
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 302 --GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGR 356
             GTA +++PE++N K  G    +D+W+LGC + +MLT + P+           + K+  
Sbjct: 182 FVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE- 238

Query: 357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA----AQLLDHPF 396
                 P +   DA+D I++ + ++P DR        +L  HPF
Sbjct: 239 ---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  167 bits (426), Expect = 3e-49
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 31/271 (11%)

Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G+ GSV +  + + G  FA+K ++        KQ    + +E+ +    +   IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64

Query: 209 YGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 261
           YG   D+  S + I +E    GSL ++Y++   R  ++           +L GL YLH +
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
            ++HRDIK +NIL+   G VKL DFG++     +   +  GT+F+MAPE I  K   Y +
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP--YSI 182

Query: 322 PADIWSLGCTVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSL------S 367
            +D+WSLG T+LE+  ++ P+         P+E ++    I     P + D        S
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY---IVNMPNPELKDEPGNGIKWS 239

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           ++ +DFIKQC++ +P  RPT   +L+HP++K
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  166 bits (421), Expect = 2e-48
 Identities = 97/268 (36%), Positives = 150/268 (55%), Gaps = 21/268 (7%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENI 205
           D LG+G++GSVY+ +    G   A+KE+ L LD+        +Q+  E+ +L +     I
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-----FNQIIMELDILHKAVSPYI 61

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           V +YG    E  +Y+ +E +  GSL  LY        + +  +   T  ++ GLK+L ++
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 262 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN----NKN 316
            +++HRD+K  N+LV+ NG VKL DFG++     +  K+  G   +MAPE I     N+N
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK----IGRGSPPPIPDSLSKDAQD 372
             Y + +D+WSLG ++LEM   + PY P E  A +F     I  G PP +P   S DAQD
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           F+ +C+   PN RPT AQLL+HP++ + 
Sbjct: 241 FVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  168 bits (425), Expect = 4e-48
 Identities = 91/289 (31%), Positives = 138/289 (47%), Gaps = 31/289 (10%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 202
           ++    LG GSFG VY     D    A+K ++   +     + + +  +EI +L+     
Sbjct: 2   YRILRKLGEGSFGEVYLAR--DRKLVALKVLAK--KLESKSKEVERFLREIQILASLNHP 57

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYL 258
            NIV+ Y   +DE  LY+ +E V  GSL +L ++      L +S+      QIL  L+YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 259 HDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDV--------KSCRGTAFWMAP 309
           H + ++HRDIK  NIL+D +G  VKL DFGLAK                +  GT  +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 310 EVINNKNKGYGLPA-DIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPP---- 361
           EV+   +  Y   + DIWSLG T+ E+LT   P+         +   KI    P P    
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 362 -----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                 P+ +SK A D +K+ +  +P +R +++  L H  +  L    S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  164 bits (415), Expect = 1e-47
 Identities = 95/267 (35%), Positives = 146/267 (54%), Gaps = 15/267 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+   H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNH 68

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L+YLH 
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 315
             ++HRD+K  N+L+  +G +KLADFG+ AK  K L    S  GT +WMAPEV+     K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 373
           +  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           +K  +  +P  RP+AAQLL+HPFV  +
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  161 bits (409), Expect = 8e-47
 Identities = 92/264 (34%), Positives = 148/264 (56%), Gaps = 13/264 (4%)

Query: 143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +W+    LG G+FG VY+  + +    A  +V  +D  +++++ +     EI +L+  +H
Sbjct: 6   FWEIIGELGDGAFGKVYKAQNKETGVLAAAKV--ID--TKSEEELEDYMVEIDILASCDH 61

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+ L+I +E    G++  + L     L + Q+    +Q L  L YLH+
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 315
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV+    +K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 373
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           +K+C++ N + R T  QLL HPFV
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  160 bits (407), Expect = 2e-46
 Identities = 85/253 (33%), Positives = 137/253 (54%), Gaps = 25/253 (9%)

Query: 170 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 229
           AVK++ L  Q     Q    L  E+ ++  ++H NIV+ Y +     +L++ +E +  G+
Sbjct: 48  AVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 230 LLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL- 288
           L ++     + + Q++     +L  L +LH Q V+HRDIK  +IL+ ++G VKL+DFG  
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162

Query: 289 AKATKLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY--- 342
           A+ +K  +V   KS  GT +WMAPEVI+     YG   DIWSLG  V+EM+  + PY   
Sbjct: 163 AQVSK--EVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNE 218

Query: 343 APMECMAALFKIGRGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            P++ M  +    R + PP       +S   + F+ + +  +P  R TAA+LL+HPF+ +
Sbjct: 219 PPLQAMKRI----RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274

Query: 400 LLATNSGSASPYL 412
             A    S  P +
Sbjct: 275 --AGPPSSIVPLM 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  159 bits (403), Expect = 5e-46
 Identities = 96/256 (37%), Positives = 144/256 (56%), Gaps = 14/256 (5%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G VY+  + + G   A+K + L     +  +  + ++QEI ++   +H NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           +G+     KL+I +E    GSL ++Y     L +SQ++  +R+ L GL YLH +  +HRD
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 268 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLPAD 324
           IK ANIL+  NG VKLADFG++      +   KS  GT +WMAPEV   + K GY    D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--PPPIPDSL--SKDAQDFIKQCVQV 380
           IW++G T +E+   Q P   +  M ALF + + +  PP + D +  S     F+K  +  
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTK 251

Query: 381 NPNDRPTAAQLLDHPF 396
           NP  RPTA +LL HPF
Sbjct: 252 NPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  158 bits (402), Expect = 5e-46
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 13/254 (5%)

Query: 150 LGRGSFGS--VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG+G+FG   +Y    DD      KEV+L     + ++       EI +LS  +H NI+ 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIA 63

Query: 208 YYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           YY    D++ L I +E    G+L   +   +     +  V  Y  QI+  + Y+H   ++
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123

Query: 265 HRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           HRDIK  NI +   G +KL DFG++K   ++ +  ++  GT ++M+PE+   +   Y   
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC--QGVKYNFK 181

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           +DIW+LGC + E+LT +  +     +  + KI +G+  P+    S +    +   +Q +P
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDP 241

Query: 383 NDRPTAAQLLDHPF 396
             RPTA ++LD P 
Sbjct: 242 EKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  157 bits (399), Expect = 2e-45
 Identities = 99/256 (38%), Positives = 140/256 (54%), Gaps = 14/256 (5%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G VY+  +   G   AVK + L + G       S ++QEI ++   +H NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGD----DFSLIQQEIFMVKECKHCNIVAY 71

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           +G+     KL+I +E    GSL ++Y     L + Q++   R+ L GL YLH +  +HRD
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 268 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVIN-NKNKGYGLPAD 324
           IK ANIL+  NG VKLADFG+A      +   KS  GT +WMAPEV    KN GY    D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--PPPIPDSL--SKDAQDFIKQCVQV 380
           IW++G T +E+   Q P   +  M ALF + + +  PP + D    S    +F+K  +  
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTK 251

Query: 381 NPNDRPTAAQLLDHPF 396
           NP  RPTA +LL H F
Sbjct: 252 NPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  156 bits (397), Expect = 3e-45
 Identities = 82/259 (31%), Positives = 147/259 (56%), Gaps = 21/259 (8%)

Query: 150 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GSFG ++     +DG  + +KE+++     + ++   +  +E+A+LS  +H NIVQY
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGLKYLHDQD 262
             + ++   LYI ++    G   +LY++ + +      + Q+  +  QI L LK++HD+ 
Sbjct: 65  QESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKG 318
           ++HRDIK  NI +  +G++KL DFG+A+   LN      ++C GT ++++PE+   +N+ 
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC--ENRP 177

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
           Y   +DIW+LGC + EM T +  +        + KI RGS PP+    S D ++ + Q  
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237

Query: 379 QVNPNDRPTAAQLLDHPFV 397
           + NP DRP+   +L+  F+
Sbjct: 238 KRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  158 bits (401), Expect = 3e-45
 Identities = 85/262 (32%), Positives = 130/262 (49%), Gaps = 25/262 (9%)

Query: 148 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRF 200
             LG GSFG V        G ++A+K +S        K  I +L+Q      E  +L   
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILS--------KAKIVKLKQVEHVLNEKRILQSI 58

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLH 259
            H  +V  YG+ +D+S LY+ +E V  G L +  ++       V+  Y  Q++L L+YLH
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
             D+V+RD+K  N+L+D++G +K+ DFG AK  K      C GT  ++APE+I   +KGY
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-GTPEYLAPEII--LSKGY 175

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           G   D W+LG  + EML    P+     +    KI        P   S DA+D I+  +Q
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-LEGKVRFPSFFSPDAKDLIRNLLQ 234

Query: 380 VNP-----NDRPTAAQLLDHPF 396
           V+      N +     + +HP+
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  156 bits (397), Expect = 7e-45
 Identities = 94/274 (34%), Positives = 151/274 (55%), Gaps = 14/274 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           + + + +G+G+ G+VY  I    G   A+K+++L  Q    K+ I     EI ++   +H
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIIN---EILVMRENKH 75

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
            NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 263 VVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYG 320
           V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+  K   YG
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YG 193

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCV 378
              DIWSLG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253

Query: 379 QVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 412
           +++   R +A +LL HPF+K  +A    S +P +
Sbjct: 254 EMDVEKRGSAKELLQHPFLK--IAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  154 bits (392), Expect = 2e-44
 Identities = 83/255 (32%), Positives = 135/255 (52%), Gaps = 15/255 (5%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G+G F  VY+ I   DG   A+K+V + +    AK     L +EI LL + +H N+++Y
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCL-KEIDLLKQLDHPNVIKY 67

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
             +  + ++L I LEL   G L  +      Q+  + +  +  Y  Q+   L+++H + +
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127

Query: 264 VHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           +HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I     GY  
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--HENGYNF 185

Query: 322 PADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQCV 378
            +DIWSLGC + EM   Q P+    M   +   KI +   PP+P D  S++ +D + +C+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCI 245

Query: 379 QVNPNDRPTAAQLLD 393
             +P  RP  + +L 
Sbjct: 246 NPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  154 bits (392), Expect = 3e-44
 Identities = 86/254 (33%), Positives = 122/254 (48%), Gaps = 34/254 (13%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 202
           LG G FG V           FA+K V         K+ I +  Q      E  +L    H
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK--------KRHIVETGQQEHIFSEKEILEECNH 52

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             IV+ Y T KD+  +Y+ +E    G L   L  R    +     Y   ++L  +YLH++
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS----CRGTAFWMAPEVINNKNK 317
            +++RD+K  N+L+D+NG VKL DFG AK  KL   +     C GT  ++APE+I   NK
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYVAPEII--LNK 167

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYA-----PMECMAA-LFKIGRGSPPPIPDSLSKDAQ 371
           GY    D WSLG  + E+LT + P+      PME     L   G+   P     + K A+
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY---IDKAAK 224

Query: 372 DFIKQCVQVNPNDR 385
           D IKQ ++ NP +R
Sbjct: 225 DLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 4e-44
 Identities = 87/292 (29%), Positives = 137/292 (46%), Gaps = 52/292 (17%)

Query: 145 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFE 201
           +K + LG G++G VY+      G   A+K++ L       ++ I    L +EI+LL   +
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL----DNEEEGIPSTAL-REISLLKELK 56

Query: 202 HENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 259
           H NIV+       E KLY+  E         L+      L  + + +   Q+L GL Y H
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCH 115

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVIN 313
              ++HRD+K  NIL++ +G +KLADFGLA+A  +      ++V     T ++ APE++ 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPEILL 171

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP----------- 359
             +K Y    DIWS+GC   EM+T + P  P +  +  LFKI +  G+P           
Sbjct: 172 G-SKHYSTAVDIWSVGCIFAEMITGK-PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 360 ----------PPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                     PP         L  +  D + + +Q NP  R +A + L HP+
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  153 bits (389), Expect = 7e-44
 Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 22/266 (8%)

Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           + +G++G V+       G  +A+K +   D     K  + Q+  E  +LS+ +   +V+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 267
           Y + + +  LY+ +E +  G L +L +     D  V+  Y  +I+L L+YLH   ++HRD
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 268 IKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCR---GTAFWMAPEVINNKNK 317
           +K  NIL+D+NG +KL DFGL+K           +D K  +   GT  ++APEVI    +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL--GQ 176

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS-PPPIPDSLSKDAQDFIK 375
           G+    D WSLGC + E L    P+   E    +F  I  G    P    +S +A D I 
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFH-GETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235

Query: 376 QCVQVNPNDRPTAA---QLLDHPFVK 398
           + +  +P  R  A    ++ +HPF K
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  152 bits (384), Expect = 9e-43
 Identities = 92/255 (36%), Positives = 143/255 (56%), Gaps = 10/255 (3%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GSFG+VY    S      AVK++S    G Q  +    + +E+  L + +H N ++Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 209 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 325
           DIK  NIL+   G VKLADFG   A+K +   S  GT +WMAPEVI   ++G Y    D+
Sbjct: 146 DIKAGNILLTEPGQVKLADFG--SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA-QDFIKQCVQVNPND 384
           WSLG T +E+   + P   M  M+AL+ I +   P +  +   D+ + F+  C+Q  P +
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQE 263

Query: 385 RPTAAQLLDHPFVKR 399
           RP +A+LL H FV+R
Sbjct: 264 RPASAELLRHDFVRR 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  153 bits (387), Expect = 1e-42
 Identities = 87/289 (30%), Positives = 149/289 (51%), Gaps = 16/289 (5%)

Query: 120 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 178
           SSS+++   S         + ++  ++ + +G G+ G+VY+ I    G  +A+K +    
Sbjct: 52  SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---- 107

Query: 179 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 238
            G+       Q+ +EI +L    H N+V+ +       ++ + LE +  GSL      + 
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THI 164

Query: 239 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLND 296
             +  ++   RQIL G+ YLH + +VHRDIK +N+L+++  +VK+ADFG+++  A  ++ 
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 297 VKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSLGCTVLEMLTSQIPYA---PMECMAA 350
             S  GT  +M+PE IN   N     G   DIWSLG ++LE    + P+      +  + 
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284

Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +  I    PP  P + S++ + FI  C+Q  P  R +A QLL HPF+ R
Sbjct: 285 MCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333

Length = 353

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 2e-42
 Identities = 84/292 (28%), Positives = 138/292 (47%), Gaps = 49/292 (16%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 201
           +QK   +G G++G VY+      G   A+K++ L  +     K ++    +EI LL    
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLK 256
           H NI++     + +  LY+  E +      +LY+     +  L +S + +Y  Q+L GL 
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINN 314
           + H   ++HRD+K  N+L++  G +KLADFGLA+   + +        T ++ APE++  
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP----------- 361
            +KGY  P DIWS+GC   E+L+ +  +     +  LFKI R  G+P P           
Sbjct: 173 -DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231

Query: 362 -----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                             P+  S  A D + Q +  +P+ R TA Q L HP+
Sbjct: 232 NYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  147 bits (374), Expect = 8e-42
 Identities = 80/263 (30%), Positives = 124/263 (47%), Gaps = 31/263 (11%)

Query: 151 GRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           G+G+FG V      D    FA+K ++   Q    K S+  +  E  +L    H  +V  +
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMN--KQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYHL------RDSQVSAYTRQILLGLKYLHDQDV 263
            + +DE  +Y+ ++L+  G L     RYHL       + QV  +  +I+L L+YLH + +
Sbjct: 67  YSFQDEENMYLVVDLLLGGDL-----RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 264 VHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           +HRDIK  NIL+D  G V + DF +A       L    S  GT  +MAPEV+    +GY 
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVL--CRQGYS 177

Query: 321 LPADIWSLGCTVLEMLTSQIPY-----APMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
           +  D WSLG T  E L  + PY        + + A  +         P + S +A D I 
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD---VLYPATWSTEAIDAIN 234

Query: 376 QCVQVNPNDR--PTAAQLLDHPF 396
           + ++ +P  R       L +HP+
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  148 bits (375), Expect = 1e-41
 Identities = 100/277 (36%), Positives = 144/277 (51%), Gaps = 31/277 (11%)

Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           W+  + +G+G++G VY+  +  DG   AVK   +LD  S   + I   E E  +L     
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEI---EAEYNILQSLPN 77

Query: 202 HENIVQYYG----TDK-DESKLYIFLELVTKGS-------LLNLYQRYHLRDSQVSAYTR 249
           H N+V++YG     DK    +L++ LEL   GS       LL   QR  L ++ +S    
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILY 135

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFW 306
             LLGL++LH+  ++HRD+K  NIL+   G VKL DFG++    +T+L    S  GT FW
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFW 194

Query: 307 MAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI- 362
           MAPEVI      +  Y    D+WSLG T +E+     P   M  +  LFKI R  PP + 
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 363 -PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P+   +    FI QC+  +   RP+   LL+HPF+K
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  147 bits (373), Expect = 3e-41
 Identities = 92/257 (35%), Positives = 143/257 (55%), Gaps = 14/257 (5%)

Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G GSFG+VY   + D       A+K++S    G Q+ +    + +E+  L R +H N +
Sbjct: 33  IGHGSFGAVY--FARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 207 QYYGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           +Y G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++
Sbjct: 89  EYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPA 323
           HRDIK  NIL+   G VKLADFG   A+  +   S  GT +WMAPEVI   ++G Y    
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG--SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA-QDFIKQCVQVNP 382
           D+WSLG T +E+   + P   M  M+AL+ I +   P +  +   D  ++F+  C+Q  P
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265

Query: 383 NDRPTAAQLLDHPFVKR 399
            DRPT+ +LL H FV R
Sbjct: 266 QDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  146 bits (369), Expect = 4e-41
 Identities = 96/269 (35%), Positives = 143/269 (53%), Gaps = 27/269 (10%)

Query: 148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 205
           +L+G G++G VY+G     G   A+K   ++D     ++ I   +QEI +L ++  H NI
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 65

Query: 206 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 256
             YYG    K+    + +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 312
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEVI
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 313 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSK 368
               N +  Y   +D+WSLG T +EM     P   M  M ALF I R   P +     SK
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
             Q FI+ C+  N + RPT  QL+ HPF+
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  145 bits (368), Expect = 1e-40
 Identities = 85/234 (36%), Positives = 137/234 (58%), Gaps = 20/234 (8%)

Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 233
           V ++D   Q ++ +  L  E+ ++  ++H+N+V+ Y +     +L++ +E +  G+L ++
Sbjct: 51  VKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108

Query: 234 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKAT 292
             +  L + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG  A+ +
Sbjct: 109 VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168

Query: 293 KLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APME 346
           K  DV   KS  GT +WMAPEVI+     YG   DIWSLG  V+EM+  + PY   +P++
Sbjct: 169 K--DVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224

Query: 347 CMAALFKIGRGSPPPIPDSLSKDA---QDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            M  L    R SPPP   +  K +   +DF+++ +   P +R TA +LLDHPF+
Sbjct: 225 AMKRL----RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 1e-40
 Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 71/297 (23%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EI-ALLSRFEH 202
           LG G+FGSVY   + + G   A+K         + K+     E+     E+ +L    EH
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK---------KMKKKFYSWEECMNLREVKSLRKLNEH 57

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------SQVSAYTRQILLGLK 256
            NIV+     ++  +LY   E +      NLYQ    R       S + +   QIL GL 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPE 310
           ++H     HRD+K  N+LV     VK+ADFGLA+     +++S         T ++ APE
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPE 168

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-------------------------- 344
           ++  ++  Y  P DIW+LGC + E+ T + P  P                          
Sbjct: 169 IL-LRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226

Query: 345 MECMAAL-FKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
            +  + L F+  + +P      IP++ S +A D IK  ++ +P  RPTA+Q L HP+
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  145 bits (366), Expect = 2e-40
 Identities = 94/269 (34%), Positives = 141/269 (52%), Gaps = 27/269 (10%)

Query: 148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 205
           +++G G++G VY+G     G   A+K + + +   +      +++ EI +L ++  H NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75

Query: 206 VQYYGTDKDES------KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 256
             YYG    +S      +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 312
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEVI
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 313 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSK 368
               N +  Y   +DIWSLG T +EM     P   M  M ALF I R  PP +     SK
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
              DFI+ C+  N   RP+  QLL HPF+
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  144 bits (365), Expect = 3e-40
 Identities = 98/292 (33%), Positives = 158/292 (54%), Gaps = 17/292 (5%)

Query: 126 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 184
           E + +I   G  K+  T ++K   +G+G+ G+VY  I    G   A+K+++L  Q  +  
Sbjct: 6   EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-- 60

Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
                +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q+
Sbjct: 61  ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 302
           +A  R+ L  L +LH   V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   G
Sbjct: 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           T +WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +
Sbjct: 178 TPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Query: 363 --PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 412
             P+ LS   +DF+ +C++++ + R +A +LL HPF+K  LA    S +P +
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK--LAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  144 bits (365), Expect = 4e-40
 Identities = 88/255 (34%), Positives = 138/255 (54%), Gaps = 10/255 (3%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 209 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 325
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEVI   ++G Y    D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQCVQVNPND 384
           WSLG T +E+   + P   M  M+AL+ I +   P +     S+  ++F+  C+Q  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 385 RPTAAQLLDHPFVKR 399
           RPT+  LL H FV R
Sbjct: 258 RPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  143 bits (361), Expect = 1e-39
 Identities = 95/274 (34%), Positives = 148/274 (54%), Gaps = 27/274 (9%)

Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           W+  + +G+G++G V++ ++  +G   AVK   +LD      + I   E E  +L    +
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEI---EAEYNILKALSD 73

Query: 202 HENIVQYYGT-----DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQI 251
           H N+V++YG       K+  +L++ LEL   GS+ +L + +  R  ++     AY   + 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMA 308
           L+GL++LH    +HRD+K  NIL+   G VKL DFG++    +T+L    S  GT FWMA
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192

Query: 309 PEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 363
           PEVI      +  Y    D+WSLG T +E+     P A +  M ALFKI R  PP +  P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           +  S +  DFI++C+  +   RPT + LL H F+
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  142 bits (359), Expect = 2e-39
 Identities = 95/292 (32%), Positives = 158/292 (54%), Gaps = 17/292 (5%)

Query: 126 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAK 184
           E +  I   G  K+  T ++K   +G+G+ G+V+  I    G   A+K+++L     Q +
Sbjct: 6   EKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQ 57

Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
                +  EI ++   ++ NIV +  +     +L++ +E +  GSL ++     + ++Q+
Sbjct: 58  PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 302
           +A  R+ L  L++LH   V+HRDIK  N+L+  +GSVKL DFG  A+ T     +S   G
Sbjct: 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           T +WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +
Sbjct: 178 TPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Query: 363 --PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 412
             P+ LS   +DF+ +C++++   R +A +LL HPF+K  LA    S +P +
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK--LAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  140 bits (354), Expect = 1e-38
 Identities = 87/282 (30%), Positives = 140/282 (49%), Gaps = 36/282 (12%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LGRG++G V +      G   AVK +       + K+ +  L+  I++ S  +    V +
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD--ISMRSV-DCPYTVTF 65

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-----SAYTRQILLGLKYLHDQ-D 262
           YG    E  ++I +E V   SL   Y++ + +   +           I+  L+YLH +  
Sbjct: 66  YGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 263 VVHRDIKCANILVDANGSVKLADFG--------LAKATKLNDVKSCRGTAFWMAPEVIN- 313
           V+HRD+K +N+L++ NG VKL DFG        +AK           G   +MAPE IN 
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA-------GCKPYMAPERINP 177

Query: 314 -NKNKGYGLPADIWSLGCTVLEMLTSQIPYA----PMECMAALFKIGRGSPPPIP-DSLS 367
               KGY + +D+WSLG T++E+ T + PY     P +    L ++     P +P +  S
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---QLKQVVEEPSPQLPAEKFS 234

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 409
            + QDF+ +C++ N  +RP   +LL HPF +  L+ N+  AS
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVAS 276

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  139 bits (352), Expect = 2e-38
 Identities = 89/283 (31%), Positives = 144/283 (50%), Gaps = 13/283 (4%)

Query: 120 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ 179
           S     E + +I   G  K+  T ++K   +G+G+ G+VY  +         +EV++   
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQM 53

Query: 180 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL 239
             Q +     +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     +
Sbjct: 54  NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM 113

Query: 240 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 299
            + Q++A  R+ L  L++LH   V+HRDIK  NIL+  +GSVKL DFG          K 
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

Query: 300 CR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG 357
               GT +WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I   
Sbjct: 174 STMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 358 SPPPI--PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             P +  P+ LS   +DF+ +C+ ++   R +A +LL H F+K
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  139 bits (351), Expect = 3e-38
 Identities = 86/268 (32%), Positives = 144/268 (53%), Gaps = 20/268 (7%)

Query: 150 LGRGSFGSVY----EGISDDGFFFAVK---EVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG G++G V+     G  D G  +A+K   + +++ +   A+ + ++  Q +  + R   
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTE-RQVLEAVRRCPF 66

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             +V  +   + ++KL++ L+ V  G L  +LYQR H  +S+V  Y  +I+L L +LH  
Sbjct: 67  --LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEVINNKNKG 318
            +++RDIK  NIL+D+ G V L DFGL+K   A +     S  GT  +MAPEVI   + G
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIK 375
           +    D WSLG    E+LT   P+       +  +I R    S PP P ++S +A+DFI+
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQ 244

Query: 376 QCVQVNPNDR---PTAAQLLDHPFVKRL 400
           + ++ +P  R     A ++ +HPF + +
Sbjct: 245 KLLEKDPKKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  138 bits (350), Expect = 4e-38
 Identities = 84/283 (29%), Positives = 127/283 (44%), Gaps = 34/283 (12%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 194
           KR + + ++   LG G FG V         D     V   SL    S  +Q  S  E+EI
Sbjct: 3   KRHLKFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREI 57

Query: 195 ALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQ 250
            +L   +HENIV+Y G         L + +E +  GSL +  QR+   +   ++  ++ Q
Sbjct: 58  EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ 117

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AF 305
           I  G+ YL  Q  +HRD+   NILV++   VK++DFGLAK    +     VK    +  F
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALFKIGRGSPP---- 360
           W APE +  +   +   +D+WS G T+ E+ T   P  +P      +  I +G       
Sbjct: 178 WYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 361 ----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                     P P S   +  D +K C +  P DRP+ A L+ 
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  139 bits (353), Expect = 6e-38
 Identities = 79/296 (26%), Positives = 133/296 (44%), Gaps = 51/296 (17%)

Query: 149 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIV 206
            +G G++G V   +    G   A+K++S +      AK+ +    +EI LL    HENI+
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENII 62

Query: 207 Q----YYGTDKDE-SKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLH 259
                      ++ + +YI  EL    + L+  +     L D  +  +  QIL GLKYLH
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTEL--METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINN 314
             +V+HRD+K +NILV++N  +K+ DFGLA+    ++ +    T +    W  APE++ +
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180

Query: 315 KNKGYGLPADIWSLGCTVLEMLT------------------SQIPYAPMECMAAL----- 351
            +  Y    DIWS+GC   E+LT                    +     E +  +     
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239

Query: 352 --FKIGRGSPPPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
             +       P  P        S +A D +++ +  +P  R TA + L HP++ +L
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 7e-38
 Identities = 79/291 (27%), Positives = 132/291 (45%), Gaps = 55/291 (18%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ--SISQLEQEIALLSRFEHENIV 206
           +G G++G VY+  +   G   A+K++ +       K+   I+ +  EI LL +  H NIV
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIR-EIKLLQKLRHPNIV 61

Query: 207 QYYG--TDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           +     T K +  +Y+  E +     G L +        +SQ+  Y +Q+L GL+YLH  
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT----AFWM-APEVINNKN 316
            ++HRDIK +NIL++ +G +KLADFGLA+        S   T      W   PE++    
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSP-------------- 359
           + YG   D+WS+GC + E+   +  +     +E +  +F++  GSP              
Sbjct: 178 R-YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL-CGSPTDENWPGVSKLPWF 235

Query: 360 ------PPIPDSL--------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                  P    L           A D + + + ++P  R +A Q L H +
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  136 bits (344), Expect = 2e-37
 Identities = 81/252 (32%), Positives = 126/252 (50%), Gaps = 21/252 (8%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L  G+ + ++     QE  ++ +  H+ +VQ Y
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEA---FLQEAQIMKKLRHDKLVQLY 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +      LR  Q+     QI  G+ YL  ++ +HR
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG--- 320
           D+   NILV  N   K+ADFGLA+  + ++  +  G  F   W APE  N     YG   
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN-----YGRFT 182

Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+WS G  + E++T  ++PY  M     L ++ RG   P P +  ++  D + QC  
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWD 242

Query: 380 VNPNDRPTAAQL 391
            +P +RPT   L
Sbjct: 243 KDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  136 bits (343), Expect = 3e-37
 Identities = 71/255 (27%), Positives = 129/255 (50%), Gaps = 18/255 (7%)

Query: 148 DLLGRGSFGSVY--EGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLS----R 199
           + LG G+FG VY     ++     A+KE+++     G   ++    +   ++ ++    +
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLG 254
             H NIV+YY T  +  +LYI ++L+    L   +     ++    + ++     Q++L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 255 LKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI 312
           L+YLH ++ +VHRD+   NI++  +  V + DFGLAK  +    + S  GT  +  PE++
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQ 371
             KN+ YG  AD+W+ GC + +M T Q P+     ++   KI      P+P+ + S+D  
Sbjct: 186 --KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVT 243

Query: 372 DFIKQCVQVNPNDRP 386
           D I  C+  +   RP
Sbjct: 244 DVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  135 bits (341), Expect = 5e-37
 Identities = 84/256 (32%), Positives = 133/256 (51%), Gaps = 17/256 (6%)

Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRG F  VY      DG   A+K+V + D   ++A+    +   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           YY +  ++++L I LEL   G L  +      Q+  + +  V  Y  Q+   L+++H + 
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I+    GY 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184

Query: 321 LPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 377
             +DIWSLGC + EM   Q P+    M   +   KI +   PP+P D  S++ +  +  C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244

Query: 378 VQVNPNDRPTAAQLLD 393
           +  +P  RP    + D
Sbjct: 245 INPDPEKRPDITYVYD 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  135 bits (342), Expect = 6e-37
 Identities = 79/231 (34%), Positives = 130/231 (56%), Gaps = 6/231 (2%)

Query: 172 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           K+V++     + +Q    L  E+ ++  + HEN+V  Y +     +L++ +E +  G+L 
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AK 290
           ++     + + Q++     +L  L YLH+Q V+HRDIK  +IL+ ++G +KL+DFG  A+
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167

Query: 291 ATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA 349
            +K +   KS  GT +WMAPEVI+     YG   DIWSLG  V+EM+  + PY     + 
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225

Query: 350 ALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           A+ +I    PP + DS  +S   + F+   +   P+ R TA +LL HPF+K
Sbjct: 226 AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  135 bits (342), Expect = 8e-37
 Identities = 90/284 (31%), Positives = 145/284 (51%), Gaps = 42/284 (14%)

Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           L+G GS+G V +    + G   A+K+  L  +  +  + I+   +EI +L +  HEN+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAM--REIRMLKQLRHENLVN 64

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 265
                + + +LY+  E V   ++L+  ++Y   L +S+V  Y  QIL G+++ H  +++H
Sbjct: 65  LIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 266 RDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           RDIK  NILV  +G VKL DFG A+  A           T ++ APE++    K YG   
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK-YGRAV 182

Query: 324 DIWSLGCTVLEMLTSQIPYAP-----------MECMAALFK----IGRGSPP----PIPD 364
           DIW++GC V EMLT + P  P           ++C+  L      I + +P      +P+
Sbjct: 183 DIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241

Query: 365 ------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                        LS    D  KQC++++P+DRP+++QLL H F
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  134 bits (338), Expect = 1e-36
 Identities = 77/246 (31%), Positives = 120/246 (48%), Gaps = 17/246 (6%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+EG+ ++    AVK    L  G+           E  ++ +  H  ++Q Y
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKT---LKPGTM---DPKDFLAEAQIMKKLRHPKLIQLY 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  EL+  GSLL   Q      L+  Q+     Q+  G+ YL  Q+ +HR
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVIN-NKNKGYGLP 322
           D+   N+LV  N   K+ADFGLA+  K +  ++  G  F   W APE    N+   + + 
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR---FSIK 184

Query: 323 ADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
           +D+WS G  + E++T  ++PY  M     L ++ +G   P P    K+  D +  C + +
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKED 244

Query: 382 PNDRPT 387
           P+DRPT
Sbjct: 245 PDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  133 bits (337), Expect = 1e-36
 Identities = 83/252 (32%), Positives = 131/252 (51%), Gaps = 16/252 (6%)

Query: 149 LLGRGSFGS---VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           ++G GSFG    V    SD    +A+KE+ L    S  + S     +E  LL++ +H NI
Sbjct: 7   VVGEGSFGRALLVQHVNSDQ--KYAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNI 60

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQ-VSAYTRQILLGLKYLHDQD 262
           V +  + + +  LYI +E    G L+     QR  L     +  +  Q+ LG++++H++ 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 320
           V+HRDIK  NI +  NG VKL DFG A+        +C   GT +++ PE+   +N  Y 
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW--ENMPYN 178

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
             +DIWSLGC + E+ T + P+        + K+ +GS  P+P   S + +  IKQ  + 
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238

Query: 381 NPNDRPTAAQLL 392
           NP  RP+A  +L
Sbjct: 239 NPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  134 bits (338), Expect = 2e-36
 Identities = 86/255 (33%), Positives = 138/255 (54%), Gaps = 12/255 (4%)

Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142

Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+  +G VKL+DFG  A+ +K +   KS  GT +WMAPE+I+     YG   DIW
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIW 200

Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260

Query: 385 RPTAAQLLDHPFVKR 399
           R TAA+LL HPF+ +
Sbjct: 261 RATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  132 bits (334), Expect = 4e-36
 Identities = 75/258 (29%), Positives = 138/258 (53%), Gaps = 18/258 (6%)

Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G+GS+G V       DG  + +K+++L +   + +++    EQE  LLS+ +H NIV Y
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAY 64

Query: 209 YGT-DKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQ 261
             + + ++  LYI +     G   +LY +        L ++QV  +  QI + L+YLH++
Sbjct: 65  RESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATK-LNDVKSCR-GTAFWMAPEVINNKNKGY 319
            ++HRD+K  N+ +     +K+ D G+A+  +   D+ S   GT ++M+PE+ +NK   Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP--Y 179

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              +D+W+LGC V EM T +  +   +  + +++I  G  PP+P   S +  + I   + 
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239

Query: 380 VNPNDRPTAAQLLDHPFV 397
             P  RP+   +L  P++
Sbjct: 240 KRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 5e-36
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 56/292 (19%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G G++G V +  +   G   A+K+    +     K++  +   E+ +L +  HENIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 265
                + + +LY+  E V + +LL L +     L    V +Y  Q+L  + Y H  +++H
Sbjct: 65  LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---------TAFWMAPEVINNKN 316
           RDIK  NILV  +G +KL DFG A+A         R          T ++ APE++   +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARAL------RARPASPLTDYVATRWYRAPELL-VGD 176

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAP-----------MECMAAL-------------F 352
             YG P D+W++GC + E+L  + P  P            +C+  L             F
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235

Query: 353 KIGRGSPPPIPDSL--------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                  P  P+SL        S  A DF+K C++++P +R T  +LL HP+
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  130 bits (330), Expect = 5e-35
 Identities = 89/293 (30%), Positives = 148/293 (50%), Gaps = 50/293 (17%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRFE 201
           ++KG  LG G++  VY+    + G   A+K++ L  +  +AK  I+    +EI LL   +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL-GERKEAKDGINFTALREIKLLQELK 60

Query: 202 HENI---VQYYGTDKDESKLYIF----LELVTK-GSLLNLYQRYHLRDSQVSAYTRQILL 253
           H NI   +  +G   + + ++ F    LE V K  S++       L  + + +Y    L 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-------LTPADIKSYMLMTLR 113

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWM-APEV 311
           GL+YLH   ++HRD+K  N+L+ ++G +KLADFGLA++    + K + +    W  APE+
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP--------- 359
           +      YG+  D+WS+GC   E+L  ++P+ P +  +  L KI    G+P         
Sbjct: 174 LFGARH-YGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231

Query: 360 -----------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                      PP P      + S DA D +++ + +NPN R TA Q L+HP+
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  130 bits (328), Expect = 1e-34
 Identities = 81/267 (30%), Positives = 137/267 (51%), Gaps = 29/267 (10%)

Query: 149 LLGRGSFGSV----YEGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 200
           +LG+GSFG V     +G  +    +AVK    +V L D   +     +  E+ +  L+  
Sbjct: 2   VLGKGSFGKVLLAELKGTDE---LYAVKVLKKDVILQDDDVEC----TMTEKRVLALAG- 53

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 259
           +H  + Q +   + + +L+  +E V  G L+   QR     + +   Y  +I+LGL++LH
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKN 316
           ++ +++RD+K  N+L+D+ G +K+ADFG+ K   L  V +   C GT  ++APE+++ + 
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQP 172

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
             YG   D W+LG  + EML  Q P+   +    LF+         P  LSK+A+  +K 
Sbjct: 173 --YGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKS 229

Query: 377 CVQVNPNDR----PTAAQ-LLDHPFVK 398
            +  NP  R    PT  Q +  HPF +
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 2e-34
 Identities = 73/255 (28%), Positives = 125/255 (49%), Gaps = 13/255 (5%)

Query: 152 RGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 210
           +G+FGSVY       G +FA+K +   D  ++ + +  + E+ I ++ + E   + + Y 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYY 64

Query: 211 TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 269
           + + +  LY+ +E +  G   +L +    L +     Y  +++LG++ LH + ++HRDIK
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124

Query: 270 CANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLG 329
             N+L+D  G +KL DFGL++    N  K   GT  ++APE I     G    +D WSLG
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETIL--GVGDDKMSDWWSLG 180

Query: 330 CTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRP 386
           C + E L    P+      A    I       P  + +  S +A D I + + ++P  R 
Sbjct: 181 CVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL 240

Query: 387 TA---AQLLDHPFVK 398
            A    ++  HPF K
Sbjct: 241 GANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  127 bits (320), Expect = 7e-34
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 45/290 (15%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L D  ++   S +   +EI+LL    H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELNH 58

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPEVINN 314
             V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++ APE++  
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLG 174

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--------PPIPD 364
             K Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P          +PD
Sbjct: 175 -CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233

Query: 365 ------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                              L +D +D + Q +  +PN R +A   L HPF
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  126 bits (318), Expect = 9e-34
 Identities = 79/249 (31%), Positives = 131/249 (52%), Gaps = 17/249 (6%)

Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRG F  VY      D    A+K+V + +   ++A+Q   +   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           Y  +  ++++L I LEL   G L  +      Q+  + +  V  Y  Q+   ++++H + 
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I+    GY 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184

Query: 321 LPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 377
             +DIWSLGC + EM   Q P+    M   +   KI +   PP+P +  S+  ++ +  C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMC 244

Query: 378 VQVNPNDRP 386
           +  +P+ RP
Sbjct: 245 IYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  126 bits (319), Expect = 1e-33
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 24/283 (8%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           Q  ++LG G+ G+VY+          AVK + L       KQ +S+LE    +L + +  
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSP 59

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            I+ +YG    E+++ I  E +  GSL ++Y++  + +  +      ++ GL YL    +
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+LV+  G VKL DFG++     +  K+  GT  +MAPE I+ +   YG+ +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ--YGIHS 174

Query: 324 DIWSLGCTVLEMLTSQIPY----------APMECMAALFKIGRGSPPPIPDSL-SKDAQD 372
           D+WSLG + +E+   + PY           P++ +     I    PP +P    S+    
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC---IVDEDPPVLPVGQFSEKFVH 231

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 415
           FI QC++  P +RP    L+DHPF+ +    N+   S ++ R 
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRA 274

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  126 bits (320), Expect = 1e-33
 Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 51/295 (17%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SR 199
           +++   +G G++G+VY+    + G F A+K+V +    S+    +S L +EIALL     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTL-REIALLKQLES 57

Query: 200 FEHENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQ 250
           FEH NIV+            E KL +  E V +   L  Y        L    +    RQ
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMRQ 115

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAP 309
           +L G+ +LH   +VHRD+K  NILV ++G VK+ADFGLA+       + S   T ++ AP
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAP 175

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEM-LTSQIPYAPMECMAALFKIGR--GSPP------ 360
           EV+   +  Y  P D+WS+GC   E+     +     E    L KI    G P       
Sbjct: 176 EVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR 232

Query: 361 -------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                               +P+ + ++  D +K+ +  NP+ R +A + L HP+
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  125 bits (315), Expect = 5e-33
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 27/270 (10%)

Query: 149 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
            +GRG+FG+V + +    G   AVK +       + K+ +  L+    ++   +   IV+
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD---VVMRSSDCPYIVK 67

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYL-HD 260
           +YG    E   +I +EL+   SL   Y+  +           +       +  L YL  +
Sbjct: 68  FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLA-----KATKLNDVKSCRGTAFWMAPEVIN-N 314
             ++HRD+K +NIL+D NG++KL DFG++        K  D   CR    +MAPE I+ +
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-GCRP---YMAPERIDPS 182

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDSL----SKD 369
              GY + +D+WSLG T+ E+ T + PY         L ++ +G PP + +S     S  
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPS 242

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             +FI  C+  + + RP   +LL+HPF+K 
Sbjct: 243 FVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  124 bits (312), Expect = 7e-33
 Identities = 74/249 (29%), Positives = 115/249 (46%), Gaps = 15/249 (6%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+EG+  +    A+K   +L      KQ     ++E+  L R  H++++  +
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIK---ILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLF 68

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 266
                   +YI  EL+ KGSLL   +    +   V++      Q+  G+ YL +Q+ +HR
Sbjct: 69  AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D+   NILV  +   K+ADFGLA+  K  DV           W APE  ++    +   +
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGT--FSTKS 185

Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + EM T  Q+PY  M       +I  G   P P    ++    + +C    P
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEP 245

Query: 383 NDRPTAAQL 391
            DRP+   L
Sbjct: 246 EDRPSFKAL 254

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 7e-33
 Identities = 89/292 (30%), Positives = 144/292 (49%), Gaps = 49/292 (16%)

Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+      G   A+K++ L +   +   S +   +EI+LL    H
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAI--REISLLKELNH 57

Query: 203 ENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 259
            NIV+       E+KLY+   FL+L  K  + +      L    + +Y  Q+L G+ Y H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCH 116

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPEVIN 313
              V+HRD+K  N+L+D  G++KLADFGLA+A      T  ++V     T ++ APE++ 
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILL 172

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP-----PPI--- 362
             ++ Y  P DIWS+GC   EM+  + P  P +  +  LF+I R  G+P     P +   
Sbjct: 173 G-SRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230

Query: 363 PD------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           PD                  +L +D  D + + +  +P  R +A   L HP+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  123 bits (310), Expect = 1e-32
 Identities = 72/261 (27%), Positives = 132/261 (50%), Gaps = 13/261 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K  ++GRG+FG V+      D     +K++ +       + +    + E  +L    H
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSH 58

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLH 259
            NI++YY    ++  L I +E    G+L    Q      L +  +  +  QILL L ++H
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 260 DQDVVHRDIKCANILVDANGSV-KLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKN 316
            + ++HRD+K  NIL+D +  V K+ DFG++K  ++K +   +  GT  +++PE+   + 
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELC--EG 175

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
           K Y   +DIW+LGC + E+ + +  +      A + KI  G+  PI D  S D +  I  
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235

Query: 377 CVQVNPNDRPTAAQLLDHPFV 397
            + ++P+ RP  +Q++  P  
Sbjct: 236 MLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  123 bits (312), Expect = 1e-32
 Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 54/289 (18%)

Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G G+ G V++    + G   A+K+V+L  L+ G       +Q  +EI  L   +H  +V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-----NQALREIKALQACQHPYVV 62

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQ 261
           +        S   + +E +       L +        L ++QV +Y R +L G+ Y+H  
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPSD----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG 318
            ++HRD+K AN+L+ A+G +K+ADFGLA+     + +       T ++ APE++    K 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK- 177

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP--------------- 359
           Y    D+W++GC   E+L    P  P    +E +A +F+   G+P               
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRT-LGTPNEETWPGLTSLPDYN 235

Query: 360 -------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   PIP        S +A D +K  +  +P+ R +AA+ L HP+
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  123 bits (310), Expect = 1e-32
 Identities = 75/267 (28%), Positives = 116/267 (43%), Gaps = 35/267 (13%)

Query: 148 DLLGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
             LG GSFG V  G            AVK +       +    +    +E A++   +HE
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK----SDKLSDIMDDFLKEAAIMHSLDHE 56

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--------YTRQILLGL 255
           N+++ YG       + +  EL   GSLL+      LR   +          Y  QI  G+
Sbjct: 57  NLIRLYGVVLTHPLMMVT-ELAPLGSLLD-----RLRKDALGHFLISTLCDYAVQIANGM 110

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMA 308
           +YL  +  +HRD+   NIL+ ++  VK+ DFGL +A   N+                W A
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSL 366
           PE +  +   +   +D+W  G T+ EM T  + P+A +     L KI + G     P++ 
Sbjct: 169 PESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC 226

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
            +D  + + QC   NP DRPT A L +
Sbjct: 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  124 bits (312), Expect = 2e-32
 Identities = 80/261 (30%), Positives = 135/261 (51%), Gaps = 17/261 (6%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V+   +     FFA+K    +V L+D   +     + +E+ +  L+ +EH 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 56

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 262
            +   Y T + +  L+  +E +  G L+   Q  H  D  + + Y  +I+ GL++LH + 
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 320
           +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+C   GT  ++APE++  +   Y 
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK--YN 174

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
              D WS G  + EML  Q P+   +    LF+  R   P  P  L+++A+D + +    
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHD-EEELFQSIRMDNPCYPRWLTREAKDILVKLFVR 233

Query: 381 NPNDR-PTAAQLLDHPFVKRL 400
            P  R      +  HPF + +
Sbjct: 234 EPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  123 bits (309), Expect = 3e-32
 Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 33/277 (11%)

Query: 143 YWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           Y +K  +LG G FG V    Y+  +D  G   AVK +    +    +Q+ S  ++EI +L
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL----KRECGQQNTSGWKKEINIL 60

Query: 198 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
               HENIV+Y G  +++    L + +E V  GSL +   ++ L  +Q+  + +QI  G+
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGM 120

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPE 310
            YLH Q  +HRD+   N+L+D +  VK+ DFGLAKA           +      FW A E
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFK-----------IG 355
            +  K   +   +D+WS G T+ E+LT     Q P    E M    +           + 
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           RG   P P +  ++    +K C +     RPT   L+
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  121 bits (304), Expect = 9e-32
 Identities = 76/263 (28%), Positives = 134/263 (50%), Gaps = 25/263 (9%)

Query: 150 LGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG+GSFG+VY   +  +       V KE+ +   G        Q  QE  LLS+ +H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV---GELNPNETVQANQEAQLLSKLDHPAI 64

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD 260
           V+++ +  +     I  E      L    +        L ++QV  +  Q+LLG+ Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFWMAPEVINN 314
           + ++HRD+K  NI +  N  +K+ DFG+++      + SC       GT ++M+PE +  
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL----MGSCDLATTFTGTPYYMSPEAL-- 177

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           K++GY   +DIWSLGC + EM      +     ++ + +I  G  P +P++ S+     +
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237

Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
           +  +  +P+ RP+AA++L +PF+
Sbjct: 238 QSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 1e-31
 Identities = 87/296 (29%), Positives = 136/296 (45%), Gaps = 52/296 (17%)

Query: 145 QKGDLLGRGSFGSVY---EGISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSR 199
           +   ++GRG+FG V+   +   D G  +A+K +  S + + +Q    I+ +  E  +L+ 
Sbjct: 4   EVIKVIGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQ----IAHVRAERDILAD 57

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 258
            +   IV+ Y + +DE  LY+ +E +  G L+NL  R     +     Y  +++L L  +
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-----------------ATKLNDVKSCR 301
           H    +HRDIK  NIL+DA+G +KLADFGL K                     ++V   R
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 302 --------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 347
                         GT  ++APEV+  +   YGL  D WSLG  + EML    P+     
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVL--RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 348 MAALFKIGRGSP----PPIPDSLSKDAQDFIKQCVQVNPNDRPTAA-QLLDHPFVK 398
                KI         PP P  +S +A D I + +  +P DR  +  ++  HPF K
Sbjct: 236 QETYNKIINWKESLRFPPDPP-VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  121 bits (305), Expect = 1e-31
 Identities = 80/271 (29%), Positives = 142/271 (52%), Gaps = 22/271 (8%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 208
           LG G+ GSV +           K+V  +     AK S+  Q+ +E+ ++       IV +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSF 68

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD-QDVVHR 266
           YG   +E+ + + +E +  GSL  +Y++   +    +      ++ GL YL++   ++HR
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           DIK +NILV++ G +KL DFG++     +   +  GT+ +M+PE I  +   Y + +D+W
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERI--QGGKYTVKSDVW 186

Query: 327 SLGCTVLEMLTSQIPYA-----------PMECMAALFKIGRGSPPPIPDS-LSKDAQDFI 374
           SLG +++E+   + P+A           PM  +  L +I +  PP +P S   +D +DF+
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV 246

Query: 375 KQCVQVNPNDRPTAAQLLD-HPFVKRLLATN 404
             C+  +P +RPT  QL    PF++ L A+N
Sbjct: 247 DACLLKDPTERPTPQQLCAMPPFIQALRASN 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  120 bits (303), Expect = 1e-31
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 22/248 (8%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     A+K    L QGS    S      E  L+ + +H  +V+ Y
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSM---SPEAFLAEANLMKQLQHPRLVRLY 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++  ++ +HR
Sbjct: 68  AVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG--- 320
           D++ ANILV      K+ADFGLA+  + N+  +  G  F   W APE IN     YG   
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFT 181

Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+WS G  + E++T  +IPY  M     +  + RG   P PD+  ++  + ++ C +
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWK 241

Query: 380 VNPNDRPT 387
             P +RPT
Sbjct: 242 EKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  121 bits (306), Expect = 2e-31
 Identities = 68/278 (24%), Positives = 129/278 (46%), Gaps = 52/278 (18%)

Query: 170 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 229
           AVK+++L    S +K+ +  L+QEI    + +H NI+ Y  +   +S+LY+   L+  GS
Sbjct: 29  AVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85

Query: 230 LLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 286
             +L + +    L +  ++   + +L  L Y+H +  +HR +K ++IL+  +G V L+  
Sbjct: 86  CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145

Query: 287 GLA--------KATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEM 335
             +        +   ++D    + +     W++PEV+    +GY   +DI+S+G T  E+
Sbjct: 146 RYSVSMIKHGKRQRVVHD--FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203

Query: 336 LTSQIPYAPMECMAALFKIGRGSPPPIPD------------------------------- 364
               +P+  M     L +  RG+ P + D                               
Sbjct: 204 ANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263

Query: 365 --SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
             + S+    F++ C+Q +P  RP+A+QLL+H F K+ 
Sbjct: 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 3e-31
 Identities = 70/252 (27%), Positives = 122/252 (48%), Gaps = 14/252 (5%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           + G  +G+G FG V  G    G   AVK   L D  + A+  ++    E ++++   H N
Sbjct: 9   KLGATIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLA----EASVMTTLRHPN 61

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           +VQ  G     + LYI  E + KGSL++  +   R  +  +Q   +   +  G++YL ++
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           + VHRD+   N+LV  +   K++DFGLAK        S +    W APE +  + K +  
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-QDSGKLPVKWTAPEAL--REKKFST 178

Query: 322 PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
            +D+WS G  + E+ +  ++PY  +     +  + +G     P+    +    +K C ++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWEL 238

Query: 381 NPNDRPTAAQLL 392
           +P  RPT  QL 
Sbjct: 239 DPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  119 bits (299), Expect = 5e-31
 Identities = 73/245 (29%), Positives = 124/245 (50%), Gaps = 15/245 (6%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 185

Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG   P  ++   +  D +K C +   
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKA 245

Query: 383 NDRPT 387
            +RPT
Sbjct: 246 EERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  118 bits (297), Expect = 7e-31
 Identities = 80/246 (32%), Positives = 124/246 (50%), Gaps = 18/246 (7%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++     QE  ++ +  HE +VQ Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
               +E  +YI  E ++KGSLL+       +Y LR  Q+     QI  G+ Y+   + VH
Sbjct: 68  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 125

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLP 322
           RD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + 
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183

Query: 323 ADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
           +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243

Query: 382 PNDRPT 387
           P +RPT
Sbjct: 244 PEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  119 bits (300), Expect = 1e-30
 Identities = 76/260 (29%), Positives = 131/260 (50%), Gaps = 19/260 (7%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V    +     FFA+K    +V L D   +     + +E+ +  L+ +EH 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC----TMVERRVLALA-WEHP 56

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 262
            +   + T + +  L+  +E +  G L+   Q     D ++   Y  +I+ GL++LH + 
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 319
           +++RD+K  N+L+D +G +K+ADFG+ K     + K+   C GT  ++APE++  K + Y
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEIL--KGQKY 173

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
               D WS G  + EML  Q P+   E    LF       P  P  +SK+A+D + +  +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232

Query: 380 VNPNDR-PTAAQLLDHPFVK 398
            +P  R      +  HPF +
Sbjct: 233 RDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  120 bits (301), Expect = 1e-30
 Identities = 82/269 (30%), Positives = 140/269 (52%), Gaps = 19/269 (7%)

Query: 149 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHE 203
           +LG G++G V+        D G  +A+K +       +AK    ++ E+ +    R +  
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSP 65

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
            +V  +   + E+KL++ L+ V+ G +  +LYQR +  + +V  Y+ +I+L L++LH   
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +V+RDIK  NIL+D+ G V L DFGL+K   + +     S  GT  +MAPE+I  K  G+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GH 184

Query: 320 GLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
           G   D WSLG  + E+LT   P+         + + +      PP P  +  +AQD + +
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244

Query: 377 CVQVNPNDR-----PTAAQLLDHPFVKRL 400
            ++ +P  R       A+++ +HPF K L
Sbjct: 245 LLRKDPKKRLGAGPQGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  119 bits (299), Expect = 1e-30
 Identities = 88/272 (32%), Positives = 136/272 (50%), Gaps = 36/272 (13%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
            +G G+ G VY+      G   AVK++       + K+ +  L+  + L S  +   IV+
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD--VVLKS-HDCPYIVK 78

Query: 208 YYGTDKDESKLYIFLELVTK--GSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYL 258
            YG    +S ++I +EL++     LL   Q          +  + V A        L YL
Sbjct: 79  CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA--------LHYL 130

Query: 259 HD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVI-- 312
            +   V+HRD+K +NIL+DA+G+VKL DFG++   +L D K+     G A +MAPE I  
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISG--RLVDSKAKTRSAGCAAYMAPERIDP 188

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIP--DSLS 367
            + N  Y + AD+WSLG +++E+ T Q PY    C      L KI +  PP +P  +  S
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYK--NCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            D   F+  C+  +   RP   +LL HPF++R
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  119 bits (301), Expect = 1e-30
 Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 68/260 (26%)

Query: 193 EIALLSRF-EHENIVQYYGT-----DKDESKLYIFLEL--------VTKGSLLNLYQRYH 238
           EI  L    +H NIV+         DKD   +Y+  E         +    L ++++RY 
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILEDVHKRYI 112

Query: 239 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
           +       Y  Q+L  LKY+H  +V+HRD+K +NIL++++  VKLADFGLA++  L++++
Sbjct: 113 M-------Y--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS--LSELE 161

Query: 299 SCRG---------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT------------ 337
                        T ++ APE++    + Y    D+WS+GC + EML             
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220

Query: 338 ------SQIPYAPMECMAAL-----FKIGRGSPPPIPDSL-------SKDAQDFIKQCVQ 379
                   I     E + ++       +    P      L       S DA D +K+ + 
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV 280

Query: 380 VNPNDRPTAAQLLDHPFVKR 399
            NPN R TA + L+HP+V +
Sbjct: 281 FNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  118 bits (298), Expect = 2e-30
 Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 26/264 (9%)

Query: 149 LLGRGSFGSVY-----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V+      G  D G  +A+K   +L + +   +   + + E  +L+   H 
Sbjct: 3   VLGQGSFGKVFLVRKITG-PDAGQLYAMK---VLKKATLKVRDRVRTKMERDILAEVNHP 58

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
            IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +LH   
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGYG 320
           +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEV+N   +G+ 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHT 176

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
             AD WS G  + EMLT  +P+      E M  + K   G    +P  LS +AQ  ++  
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQSLLRAL 232

Query: 378 VQVNPNDRPTAA-----QLLDHPF 396
            + NP +R  A      ++  HPF
Sbjct: 233 FKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  117 bits (294), Expect = 5e-30
 Identities = 86/285 (30%), Positives = 142/285 (49%), Gaps = 46/285 (16%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G VY+G +   G   A+K++ L    S+ +   S   +EI+LL   +H NIV  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 209 YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                 ES+LY+  E ++   K  L +L +  ++    V +Y  QIL G+ + H + V+H
Sbjct: 65  QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVINNKNKGY 319
           RD+K  N+L+D  G +KLADFGLA+A  +      ++V     T ++ APEV+    + Y
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPEVLLGSPR-Y 179

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--------PPIPD----- 364
             P DIWS+G    EM T +  +     +  LF+I R  G+P          +PD     
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239

Query: 365 -------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                        +L +D  D +++ +  +P  R +A + L+HP+
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  117 bits (295), Expect = 6e-30
 Identities = 81/305 (26%), Positives = 131/305 (42%), Gaps = 68/305 (22%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 207
           LG G+FG VY+      G   A+K++ + ++       I+ L +EI +L + +H N+V  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITAL-REIKILKKLKHPNVVPL 72

Query: 208 ----YYGTDKDESKLYIFLELVT-------KGSLLNLYQRYHLRDSQVSAYTRQILLGLK 256
                   DK + K      +VT        G L N      L +SQ+  Y  Q+L G+ 
Sbjct: 73  IDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLLEGIN 129

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK-------------ATKLNDVKSCRGT 303
           YLH+  ++HRDIK ANIL+D  G +K+ADFGLA+                     +   T
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189

Query: 304 AFWMAPE-VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGS 358
            ++  PE ++  +   Y    DIW +GC   EM T + P       ++ +  +FK+  G+
Sbjct: 190 RWYRPPELLLGERR--YTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKLC-GT 245

Query: 359 P-----------PPIPD----------------SLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           P           P                     L  +  D + + + ++P  R TA+  
Sbjct: 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305

Query: 392 LDHPF 396
           L+HP+
Sbjct: 306 LEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  115 bits (290), Expect = 8e-30
 Identities = 74/245 (30%), Positives = 124/245 (50%), Gaps = 16/245 (6%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+   ++     QE  ++ +  H+ +V  Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEA---FLQEAQIMKKLRHDKLVPLY 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E + KGSLL+  +     +L+  Q+     QI  G+ Y+   + +HR
Sbjct: 68  AVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 184

Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  ++PY  M     L ++ RG   P P    +   + +K C + +P
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244

Query: 383 NDRPT 387
           ++RPT
Sbjct: 245 DERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 8e-30
 Identities = 75/258 (29%), Positives = 117/258 (45%), Gaps = 28/258 (10%)

Query: 150 LGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG G+FGSV +G+     G    V  V  L Q   A     +  +E +++++ +H  IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVA-VKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVR 60

Query: 208 YYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
             G  K E  L + +EL   G LL  L +R  +  S +     Q+ +G+ YL  +  VHR
Sbjct: 61  LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVINNKNKGYGL 321
           D+   N+L+      K++DFG+++A        ++     +   W APE IN     YG 
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN-----YGK 174

Query: 322 ---PADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGR-GSPPPIPDSLSKDAQDF 373
               +D+WS G T+ E  +    PY  M   E +A L    R   P   P  +       
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI----YSI 230

Query: 374 IKQCVQVNPNDRPTAAQL 391
           +  C +  P DRPT ++L
Sbjct: 231 MLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 1e-29
 Identities = 83/255 (32%), Positives = 130/255 (50%), Gaps = 23/255 (9%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
            +RI T       +G G+FG V+   + IS    ++A+K +++ +   + KQ    +  E
Sbjct: 3   LERIKT-------VGTGTFGRVHLVRDRIS--EHYYALKVMAIPEV-IRLKQ-EQHVHNE 51

Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQI 251
             +L    H  I++ + T+ D+  LY+ +E V  G L + Y R   R S  +   Y  +I
Sbjct: 52  KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS-YLRNSGRFSNSTGLFYASEI 110

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPE 310
           +  L+YLH +++V+RD+K  NIL+D  G +KL DFG AK  KL D   +  GT  ++APE
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWTLCGTPEYLAPE 168

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 370
           VI  ++KG+    D W+LG  + EML    P+          KI  G     P  L   A
Sbjct: 169 VI--QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYA 225

Query: 371 QDFIKQCVQVNPNDR 385
           +D IK+ + V+   R
Sbjct: 226 KDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  116 bits (291), Expect = 1e-29
 Identities = 87/294 (29%), Positives = 143/294 (48%), Gaps = 53/294 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 201
           +++ + LG G++ +VY+G +   G   A+KE+ L  ++G+      S   +EI+L+   +
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-----STAIREISLMKELK 56

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLK 256
           HENIV+ +     E+KL +  E + K   L  Y   H     L  + V ++T Q+L G+ 
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPE 310
           + H+  V+HRD+K  N+L++  G +KLADFGLA+A      T  N+V     T ++ AP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRAPD 170

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--------- 359
           V+   ++ Y    DIWS+GC + EM+T +  +        L KI R  G+P         
Sbjct: 171 VLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229

Query: 360 ---------PPIPD--------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                    P  P                D + + +Q+NP  R +A   L HP+
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  116 bits (292), Expect = 2e-29
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 24/266 (9%)

Query: 149 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEH 202
           +LG+G +G V++      +D G  FA+K   +L + +  + ++  +  + E  +L   +H
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK---VLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 260
             IV      +   KLY+ LE ++ G L    +R    + D+    Y  +I L L++LH 
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT-ACFYLSEISLALEHLHQ 118

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNK 317
           Q +++RD+K  NIL+DA G VKL DFGL K +      +   C GT  +MAPE++     
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEIL--MRS 175

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
           G+G   D WSLG  + +MLT   P+        + KI +G    +P  L+ +A+D +K+ 
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKL 234

Query: 378 VQVNPNDR-----PTAAQLLDHPFVK 398
           ++ NP+ R       AA++  HPF +
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 2e-29
 Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 18/262 (6%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G+G +G V+     D G   A+K +            +  +  E  +L+  + E +V+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 209 YGTDKDESKLYIFLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
               +D+  LY+ +E V  G   +LLN      L +     Y  ++   +  LH+   +H
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIH 124

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RD+K  N L+DA+G +KL DFGL+K   +    S  G+  +MAPEV+    KGY    D 
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGI-VTYANSVVGSPDYMAPEVLR--GKGYDFTVDY 181

Query: 326 WSLGCTVLEMLTSQIPYA---PMECMAALFK----IGRGSPPPIPDSLSKDAQDFIKQCV 378
           WSLGC + E L    P++   P E    L      + R        +LS +A D I + +
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 379 QVNPNDRPTAAQLLDHPFVKRL 400
                   +   + +HPF K +
Sbjct: 242 NDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  114 bits (286), Expect = 5e-29
 Identities = 79/268 (29%), Positives = 141/268 (52%), Gaps = 16/268 (5%)

Query: 149 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG G++G V+    +S  D G  +A+K +       +AK +     +   L    +   
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           +V  +   + ++KL++ L+ +  G L  +L QR   ++ +V  Y+ +I+L L++LH   +
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKNKGYG 320
           ++RDIK  NIL+D+NG V L DFGL+K    ++V+   S  GT  +MAP+++   + G+ 
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQC 377
              D WS+G  + E+LT   P+       +  +I R    S PP P  +S  A+D I++ 
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246

Query: 378 VQVNPNDR----PTAAQ-LLDHPFVKRL 400
           +  +P  R    P+ A  +  HPF +++
Sbjct: 247 LMKDPKKRLGCGPSDADEIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  113 bits (284), Expect = 5e-29
 Identities = 74/246 (30%), Positives = 122/246 (49%), Gaps = 18/246 (7%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L  G+ + +S     +E  ++ +  H+ +VQ Y
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPES---FLEEAQIMKKLRHDKLVQLY 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
               +E  +YI  E ++KGSLL+  +    R  L+   +     Q+  G+ Y+   + +H
Sbjct: 68  AVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIH 125

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLP 322
           RD++ ANILV      K+ADFGLA+  + N+  + +G  F   W APE        + + 
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183

Query: 323 ADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
           +D+WS G  + E++T  ++PY  M     L ++ RG   P P        + + QC + +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243

Query: 382 PNDRPT 387
           P +RPT
Sbjct: 244 PEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  113 bits (284), Expect = 7e-29
 Identities = 82/271 (30%), Positives = 120/271 (44%), Gaps = 45/271 (16%)

Query: 149 LLGRGSFGSVYEGISDDGFFFAVKE----VSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
            LG G+FG VYEG + D            V  L +G+   Q   +  +E  L+S F H N
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----------- 253
           IV+  G        YI +EL+  G LL+     +LRD++V  +   +L            
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLS-----YLRDARVERFGPPLLTLKELLDICLDV 115

Query: 254 --GLKYLHDQDVVHRDIKCANILV-----DANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
             G  YL     +HRD+   N LV     DA+  VK+ DFGLA+    +D     G    
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 306 ---WMAPE-VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRG 357
              WMAPE +++ K   +   +D+WS G  + E+LT  Q PY  +   E +  +   GR 
Sbjct: 176 PVRWMAPESLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232

Query: 358 SPPP-IPDSLSKDAQDFIKQCVQVNPNDRPT 387
             P   PD +       +  C   +P++RPT
Sbjct: 233 QKPENCPDKI----YQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 1e-28
 Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 49/292 (16%)

Query: 148 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
             +G G++G V        G   A+K++S  +  +  ++++    +EI +L RF+HENI+
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENII 66

Query: 207 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                 +  S      +YI  EL+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINNKN 316
           +V+HRD+K +N+L++ N  +K+ DFGLA+        +   T +    W  APE++ N +
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-S 184

Query: 317 KGYGLPADIWSLGCTVLEMLT------------------------SQIPYAPMECMAALF 352
           KGY    DIWS+GC + EML+                        SQ     +  + A  
Sbjct: 185 KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARN 244

Query: 353 KIGRGSP--PPIP-DSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            I +  P  P +P + L       A D + + +  NP+ R T  + L HP++
Sbjct: 245 YI-KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  112 bits (283), Expect = 1e-28
 Identities = 71/255 (27%), Positives = 122/255 (47%), Gaps = 17/255 (6%)

Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG VY+G+     ++    AVK        S  ++ +    QE  ++ +F+H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL----QEAYIMRQFDH 66

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G   +   ++I +EL   G L +  Q  +Y L  + +  Y+ Q+   L YL  
Sbjct: 67  PHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +   VKL DFGL++  +     K+ +G     WMAPE IN +  
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR- 184

Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 185 -FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 243

Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 244 CWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  113 bits (285), Expect = 2e-28
 Identities = 75/246 (30%), Positives = 119/246 (48%), Gaps = 18/246 (7%)

Query: 147 GDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G+ LG GSFG V        G ++A+K   L  +     + +  + QE ++L    H  I
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSA-YTRQILLGLKYLH 259
           V    + +DE+++Y  LE V  G L       HLR +      V+  Y  +++L  +YLH
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFT-----HLRKAGRFPNDVAKFYHAELVLAFEYLH 135

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
            +D+++RD+K  N+L+D  G VK+ DFG AK         C GT  ++APEVI  ++KG+
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-GTPEYLAPEVI--QSKGH 192

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           G   D W++G  + E +    P+          KI  G     P+     A+D +K  +Q
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQ 251

Query: 380 VNPNDR 385
            +   R
Sbjct: 252 TDHTKR 257

Length = 329

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 2e-28
 Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 14/250 (5%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G        A+K   ++ +G+ ++       +E  ++ +  H N+VQ Y
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSED---DFIEEAKVMMKLSHPNLVQLY 65

Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN L +R   L    +      +   ++YL     +HRD
Sbjct: 66  GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125

Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV  +  VK++DFGLA+    +   S +GT F   W  PEV +     +   +D
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSSKSD 183

Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  ++PY        +  +  G     P     +    +  C    P 
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPE 243

Query: 384 DRPTAAQLLD 393
           DRP   +LL 
Sbjct: 244 DRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  112 bits (281), Expect = 3e-28
 Identities = 84/277 (30%), Positives = 127/277 (45%), Gaps = 45/277 (16%)

Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG G FG V    Y+   D+ G   AVK +     G+     I+ L++EI +L    HEN
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 67

Query: 205 IVQYYG--TDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 260
           IV+Y G  T+   + + + +E +  GSL     R    +   Q   Y  QI  G+ YL  
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AFWMAPE-VINN 314
           +  VHRD+   N+LV++   VK+ DFGL KA + +     VK    +  FW APE +I +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFK-IG---------------- 355
           K   + + +D+WS G T+ E+LT    Y   E   M    K IG                
Sbjct: 188 K---FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P P +  ++    +++C +  P+ R T   L+
Sbjct: 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  111 bits (279), Expect = 3e-28
 Identities = 69/245 (28%), Positives = 122/245 (49%), Gaps = 16/245 (6%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+    +     AVK +           S+     E  ++   +H+ +V+ +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 266
                E  +YI  E + KGSLL+  +        +     ++ QI  G+ ++  ++ +HR
Sbjct: 68  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 184

Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244

Query: 383 NDRPT 387
            +RPT
Sbjct: 245 EERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  111 bits (280), Expect = 4e-28
 Identities = 71/281 (25%), Positives = 129/281 (45%), Gaps = 38/281 (13%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS+G V++  + + G   A+K+    +     K+ I+   +EI +L + +H N+V  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-IAL--REIRMLKQLKHPNLVNL 65

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
               + + KL++  E      L  L +    + +  +     Q L  + + H  + +HRD
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125

Query: 268 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           +K  NIL+   G +KL DFG A+      +D      T ++ APE++    + YG P D+
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ-YGPPVDV 184

Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGR--------------------GSPPPIPDS 365
           W++GC   E+LT Q  +     +  L+ I +                    G   P P++
Sbjct: 185 WAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPET 244

Query: 366 ----------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                     +S  A  F+K C+Q++P +R +  +LL+HP+
Sbjct: 245 REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  110 bits (277), Expect = 8e-28
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 31/271 (11%)

Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL--SRFEHENIV 206
           LG+G FG V    +   G  +A K++       +  + ++  E++I     SRF    IV
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF----IV 56

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--------RDSQVSAYTRQILLGLKYL 258
                 + +  L + + L+  G L     +YH+         +++   Y  QI+ GL++L
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDL-----KYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNK 317
           H + +V+RD+K  N+L+D +G+V+++D GLA   K    +K   GT  +MAPEV+  + +
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--QGE 169

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFI 374
            Y    D ++LGCT+ EM+  + P+   +      ++ R         PD  S +A+D  
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229

Query: 375 KQCVQVNPNDR-----PTAAQLLDHPFVKRL 400
           +  +Q +P  R      +A ++ +HP  K L
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 8e-28
 Identities = 68/258 (26%), Positives = 118/258 (45%), Gaps = 23/258 (8%)

Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           + +G+G+FG VY+G+       AVK           ++ +    QE  +L +++H NIV+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIVK 56

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL-------LGLKYLHD 260
             G    +  +YI +ELV  GSLL       LR  +     +++L        G++YL  
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLT-----FLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKN 316
           ++ +HRD+   N LV  N  +K++DFG+++  +        G       W APE +N   
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 317 KGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
             Y   +D+WS G  + E  +    PY  M       +I  G   P P    ++    + 
Sbjct: 172 --YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML 229

Query: 376 QCVQVNPNDRPTAAQLLD 393
           QC   +P +RP+ +++ +
Sbjct: 230 QCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 9e-28
 Identities = 83/262 (31%), Positives = 132/262 (50%), Gaps = 18/262 (6%)

Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 205
           +G+G+FG VY+    D    +A+K +S   +   AK+ ++    E  +L R    E   I
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS--KKEIVAKKEVAHTIGERNILVRTLLDESPFI 58

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           V    + + +S LY+  + ++ G L  +L +     + +   Y  +++L L++LH  D+V
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 265 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           +RD+K  NIL+DA G + L DFGL+KA  T      +  GT  ++APEV+ ++ KGY   
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE-KGYTKH 177

Query: 323 ADIWSLGCTVLEMLTSQIP-YAP-MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
            D WSLG  V EM     P YA   + M      G+   P   + LS + + F+K  +  
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP--KNVLSDEGRQFVKGLLNR 235

Query: 381 NPNDR----PTAAQLLDHPFVK 398
           NP  R      A +L +HPF  
Sbjct: 236 NPQHRLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  110 bits (277), Expect = 1e-27
 Identities = 83/304 (27%), Positives = 139/304 (45%), Gaps = 48/304 (15%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           KR +  +     +G G++G VY+    D G   A+K+V L     +    I+ + +EI +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKI 59

Query: 197 LSRFEHENIVQYYG--TD--------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQV 244
           L +  H NIV      TD        KD+   Y+  E +    L+ L +    H  +  +
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRG 302
            ++ +Q+L GL Y H ++ +HRDIKC+NIL++  G +KLADFGLA+     + +  + + 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 360
              W  P  +    + YG   D+WS GC + E+ T +  +   + +A L  I R  GSP 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 361 PI--PDS-------------------------LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
           P   PD                          +   A D +   + ++P+ R TA + L+
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 394 HPFV 397
            P++
Sbjct: 299 SPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  111 bits (279), Expect = 2e-27
 Identities = 75/296 (25%), Positives = 135/296 (45%), Gaps = 55/296 (18%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +G G++G V   I +  G   A+K++    D  + AK+++    +E+ +L  F+H+NI+ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNIIA 68

Query: 208 ----YYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLH 259
                     D   +Y+ ++L+      +L+   H    L +  +  +  Q+L GLKY+H
Sbjct: 69  IRDILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEVIN 313
             +V+HRD+K +N+LV+ +  +++ DFG+A+    +  +          T ++ APE++ 
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 314 NKNKGYGLPADIWSLGCTVLEML-----------TSQIP----YAPMECMAALFKIGR-- 356
           +    Y    D+WS+GC   EML             Q+              L +IG   
Sbjct: 185 SLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243

Query: 357 --------GSPPPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                       P+P S      S +A D + Q +Q +P +R T  Q L HPF+ +
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  109 bits (275), Expect = 2e-27
 Identities = 76/293 (25%), Positives = 134/293 (45%), Gaps = 51/293 (17%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K + +G G++G+V++  + +     A+K V L D     +   S   +EI LL   +H
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKH 58

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLK 256
           +NIV+ Y     + KL +  E   +       ++Y       +    V ++  Q+L GL 
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---TAFWMAPEVIN 313
           + H  +V+HRD+K  N+L++ NG +KLADFGLA+A  +  V+       T ++  P+V+ 
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLF 172

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP---------- 359
              K Y    D+WS GC   E+  +  P  P     + +  +F++  G+P          
Sbjct: 173 GA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEESWPGVSK 230

Query: 360 ----PPIP------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                P P              L+   +D ++  +  NP  R +A + L HP+
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  110 bits (277), Expect = 2e-27
 Identities = 80/291 (27%), Positives = 135/291 (46%), Gaps = 48/291 (16%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQ 207
           LG G+ G V + +    G   A K + L     + K +I +Q+ +E+ +L       IV 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHL-----EIKPAIRNQIIRELKVLHECNSPYIVG 63

Query: 208 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVH 265
           +YG    + ++ I +E +  GSL   L +   + ++ +   +  +L GL YL ++  ++H
Sbjct: 64  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + +DI
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YTVQSDI 181

Query: 326 WSLGCTVLEMLTSQIPY------------------------------------APMECMA 349
           WSLG +++EM   + P                                      PM    
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241

Query: 350 ALFKIGRGSPPPIPDS-LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            L  I    PP +P    S + QDF+ +C++ NP +R    +L  HPF+KR
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  109 bits (273), Expect = 7e-27
 Identities = 73/264 (27%), Positives = 136/264 (51%), Gaps = 27/264 (10%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V    +   G +FAVK    +V L+D   +     + +E+ +  L+ +E+ 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC----TMVEKRVLALA-WENP 56

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLGLKY 257
            +   Y T + +  L+  +E +  G L+     +H++D       + + Y  +I+ GL++
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQF 111

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNK 315
           LH + +++RD+K  N+++D +G +K+ADFG+ K     D ++    GT  ++APE++   
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
              Y    D WS G  + EML  Q P+   +    LF+  R   P  P  ++K+++D ++
Sbjct: 172 K--YTFSVDWWSFGVLLYEMLIGQSPFHGDD-EDELFESIRVDTPHYPRWITKESKDILE 228

Query: 376 QCVQVNPNDR-PTAAQLLDHPFVK 398
           +  + +P  R      +  HPF K
Sbjct: 229 KLFERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  108 bits (272), Expect = 8e-27
 Identities = 83/313 (26%), Positives = 135/313 (43%), Gaps = 63/313 (20%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           F   ++ ++K   +G+G+FG V++          A+K+V L++   +    I+ L +EI 
Sbjct: 7   FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGF-PITAL-REIK 63

Query: 196 LLSRFEHENIVQYY--------GTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQV 244
           +L   +HEN+V             ++ +   Y+  E       G L N   ++ L  S++
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEI 121

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSC-- 300
               + +L GL Y+H   ++HRD+K ANIL+  +G +KLADFGLA+A  L  N   +   
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 301 -RGTAFWM-APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME-----CMAALF 352
            R    W   PE++    + YG P D+W  GC + EM T S I     E      ++ L 
Sbjct: 182 NRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL- 239

Query: 353 KIGRGSPPP------------------------IPDSL-----SKDAQDFIKQCVQVNPN 383
               GS  P                        + + L        A D I + + ++P 
Sbjct: 240 ---CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296

Query: 384 DRPTAAQLLDHPF 396
            R  A   L+H F
Sbjct: 297 KRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  107 bits (270), Expect = 9e-27
 Identities = 79/274 (28%), Positives = 116/274 (42%), Gaps = 42/274 (15%)

Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG       D     V   +L +  S+  +S      E  ++S+F H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES--DFLMEALIMSKFNHQNI 71

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKY 257
           V+  G   +    +I LEL+  G L +  +    R  + S+ T + LL        G KY
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ADFG+A+           G A     WM PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191

Query: 311 -----VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP 361
                +  +K        D+WS G  + E+ +   +PY      E M  +   GR  PP 
Sbjct: 192 AFLDGIFTSK-------TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244

Query: 362 -IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             P  + +     +  C Q  P DRP  A +L+ 
Sbjct: 245 GCPGPVYR----IMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  108 bits (272), Expect = 1e-26
 Identities = 77/284 (27%), Positives = 144/284 (50%), Gaps = 44/284 (15%)

Query: 143 YWQKGDLLGRGSFG---SVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLS 198
            ++    LG+G++G   S     + +    A+K+++ +  +   AK+++    +E+ LL 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLR 56

Query: 199 RF-EHENIVQYYGTD----KDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTR 249
            F  H+NI   Y  D     + ++LY++ EL+      +L+Q       L D+   ++  
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDAHFQSFIY 112

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GT 303
           QIL GLKY+H  +V+HRD+K  N+LV+A+  +K+ DFGLA+    N  ++         T
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP 361
            ++ APE++ +  + Y    D+WS+GC + E+L  +  +   + +  L +I +  G+P  
Sbjct: 173 RWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD- 230

Query: 362 IPDSLSK----DAQDFIKQC--------VQVNPNDRPTAAQLLD 393
             ++LS+     AQ++I+            + PN  P A  LL+
Sbjct: 231 -EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (268), Expect = 2e-26
 Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 41/275 (14%)

Query: 149 LLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
            LG+G+FGSV    Y+ + D+ G   AVK++    Q S A+  +   E+EI +L   +H+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKL----QHSTAEH-LRDFEREIEILKSLQHD 65

Query: 204 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 259
           NIV+Y G         L + +E +  GSL +  Q++  R    ++  Y  QI  G++YL 
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKS-CRGTAFWMAPEVINN 314
            +  VHRD+   NILV++   VK+ DFGL K    +     V+       FW APE +  
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL-T 184

Query: 315 KNKGYGLPADIWSLGCTVLEMLT-SQIPYAP----MECM-------------AALFKIGR 356
           ++K + + +D+WS G  + E+ T S    +P    M  M               L K   
Sbjct: 185 ESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK--N 241

Query: 357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
               P P     +    +K+C   +P+ RP+ ++L
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  106 bits (267), Expect = 3e-26
 Identities = 89/304 (29%), Positives = 149/304 (49%), Gaps = 64/304 (21%)

Query: 144 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           ++K + +G G++G VY+    ++++    A+K++ L +Q  +   S +   +EI+LL   
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRL-EQEDEGVPSTAI--REISLLKEM 58

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--------VSAYTRQIL 252
           +H NIV+       E +LY+  E       L+L  + H+  S         +  Y  QIL
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 253 LGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKA------TKLNDVKSCRGTAF 305
            G+ Y H   V+HRD+K  N+L+D    ++KLADFGLA+A      T  ++V     T +
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLW 168

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP--- 359
           + APE++   ++ Y  P DIWS+GC   EM+ +Q P  P +  +  LFKI R  G+P   
Sbjct: 169 YRAPEILLG-SRHYSTPVDIWSVGCIFAEMV-NQKPLFPGDSEIDELFKIFRILGTPNEE 226

Query: 360 -----PPIPD------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                  +PD                  +L     D + + ++++P+ R TA   L+H +
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Query: 397 VKRL 400
            K L
Sbjct: 287 FKDL 290

Length = 294

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  106 bits (266), Expect = 4e-26
 Identities = 82/303 (27%), Positives = 126/303 (41%), Gaps = 84/303 (27%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRFE-H 202
           +G G+F  V +  S   G ++A+K           K+    LEQ     EI  L R   H
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK---------CMKKHFKSLEQVNNLREIQALRRLSPH 57

Query: 203 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGL 255
            NI++      D+   +L +  EL+     +NLY     ++  L + +V +Y  Q+L  L
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG------------T 303
            ++H   + HRDIK  NIL+  +  +KLADFG           SCRG            T
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-----------SCRGIYSKPPYTEYIST 161

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-----------SQI------------ 340
            ++ APE +   +  YG   DIW++GC   E+L+            QI            
Sbjct: 162 RWYRAPECLLT-DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220

Query: 341 -------PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                      M       K G G    +P+  S +  D +K+ +  +P++R TA Q L 
Sbjct: 221 EVLKKFRKSRHMN-YNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALR 278

Query: 394 HPF 396
           HP+
Sbjct: 279 HPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  107 bits (269), Expect = 4e-26
 Identities = 89/305 (29%), Positives = 142/305 (46%), Gaps = 67/305 (21%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG GS G V+  + SD     AVK++ L D      QS+    +EI ++ R +H+NIV+ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 67

Query: 209 Y------GTDKDES--------KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 254
           Y      G+D  E          +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRG-------TAFW 306
           LKY+H  +V+HRD+K AN+ ++    V K+ DFGLA+   ++   S +G       T ++
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWY 184

Query: 307 MAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYA---PME-------------- 346
            +P ++   NN  K      D+W+ GC   EMLT +  +A    +E              
Sbjct: 185 RSPRLLLSPNNYTKA----IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240

Query: 347 -------CMAALFKIGRGSPP--PIPDSL---SKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
                   +   F    G  P  P+ D L   + +A DF++Q +  NP DR TA + L H
Sbjct: 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300

Query: 395 PFVKR 399
           P++  
Sbjct: 301 PYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  105 bits (263), Expect = 5e-26
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 22/252 (8%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G+++G G FG+V +G    G   AVK +   D  +QA        +E A++++  H+N+V
Sbjct: 11  GEIIGEGEFGAVLQG-EYTGQKVAVKNIKC-DVTAQA------FLEETAVMTKLHHKNLV 62

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           +  G       LYI +EL++KG+L+N  +   R  +   Q+  ++  +  G++YL  + +
Sbjct: 63  RLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           VHRD+   NILV  +G  K++DFGLA+   +  V + +    W APE +  K+K +   +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEAL--KHKKFSSKS 178

Query: 324 DIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           D+WS G  + E+ +  + PY  M   E    + K  R  P   P+    D    +  C +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP---PEGCPADVYVLMTSCWE 235

Query: 380 VNPNDRPTAAQL 391
             P  RP+  +L
Sbjct: 236 TEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  105 bits (264), Expect = 1e-25
 Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 27/268 (10%)

Query: 149 LLGRGSFGSVY---EGISDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEI-ALLSR--F 200
           +LG+GSFG V       +D+ +   +  K+V + D   +     + +E+ + AL  +  F
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVEC----TMVEKRVLALPGKPPF 62

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 259
               + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +LH
Sbjct: 63  ----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNK 317
            + +++RD+K  N+++DA G +K+ADFG+ K        +    GT  ++APE+I    +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQ 176

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
            YG   D W+ G  + EML  Q P+   E    LF+         P SLSK+A    K  
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Query: 378 VQVNPNDR----PTAAQ-LLDHPFVKRL 400
           +  +P  R    PT  + + +H F +R+
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFRRI 263

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/260 (26%), Positives = 123/260 (47%), Gaps = 17/260 (6%)

Query: 145 QKGDLLGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
           +K  +LG G+FG+VY+G+     +     V    L ++ S   ++  ++  E  +++  +
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVD 67

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 258
           H ++V+  G         I  +L+  G LL+ Y R H   +    +  +  QI  G+ YL
Sbjct: 68  HPHVVRLLGICLSSQVQLI-TQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTA--FWMAPEVINN 314
            ++ +VHRD+   N+LV     VK+ DFGLAK       +  +  G     WMA E I +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 315 KNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 373
           +   Y   +D+WS G TV E++T    PY  +  +     + +G   P P   + D    
Sbjct: 186 RI--YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMV 243

Query: 374 IKQCVQVNPNDRPTAAQLLD 393
           + +C  ++   RPT  +L++
Sbjct: 244 LVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 84/264 (31%), Positives = 120/264 (45%), Gaps = 22/264 (8%)

Query: 149 LLGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           L+GRG FG V    E  + D +   V K+  LL     A++++S  E+E  +LS      
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPW 62

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQD 262
           I Q     +D+  LY+ +E    G LL+L  RY     +     Y  +++L +  +H   
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEV---INNKN 316
            VHRDIK  N+L+D  G +KLADFG A     N +   K   GT  ++APEV   +N   
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 317 KG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI---GRGSPPPIPDSLSKDAQD 372
           KG YG+  D WSLG    EM+  + P+           I    R    P    +S D  D
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPF 396
            I+  +     +R     L  HPF
Sbjct: 243 LIQSLL-CGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (260), Expect = 3e-25
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 30/266 (11%)

Query: 150 LGRGSFGSVYEGI-----SDDGFF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG+GSFG VYEG+       +     A+K V+     + + +   +   E +++  F   
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASVMKEFNCH 69

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ----VSAYTRQILL------ 253
           ++V+  G         + +EL+ KG L + Y R    +++    +   T Q  +      
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 254 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGT--AFWM 307
             G+ YL  +  VHRD+   N +V  + +VK+ DFG+ +     D   K  +G     WM
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           APE +  K+  +   +D+WS G  + EM T ++ PY  +     L  +  G    +P++ 
Sbjct: 189 APESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENC 246

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RPT  +++
Sbjct: 247 PDKLLELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (257), Expect = 3e-25
 Identities = 69/251 (27%), Positives = 117/251 (46%), Gaps = 14/251 (5%)

Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LLG+G+FG V++G   D    AVK     D   + K    +   E  +L +++H NIV+
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKE-DLPQELK---IKFLSEARILKQYDHPNIVK 56

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
             G       +YI +ELV  G  L+  ++    L+  Q+  +      G+ YL  ++ +H
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKNKGYGL 321
           RD+   N LV  N  +K++DFG+++    + + S  G       W APE +N     Y  
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGR--YSS 173

Query: 322 PADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
            +D+WS G  + E  +  + PY  M    A  ++ +G     P     D    +++C   
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233

Query: 381 NPNDRPTAAQL 391
            P +RP  ++L
Sbjct: 234 KPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  102 bits (255), Expect = 6e-25
 Identities = 72/249 (28%), Positives = 114/249 (45%), Gaps = 14/249 (5%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G        A+K +   ++G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIE---EAKVMMKLSHPKLVQLY 65

Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  LYI  E +  G LLN L QR   L    + +  + +  G++YL     +HRD
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125

Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV + G VK++DFG+ +    ++  S  G  F   W  PEV N     Y   +D
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSD 183

Query: 325 IWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ T  ++P+        +  I RG     P   S    + +  C    P 
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPE 243

Query: 384 DRPTAAQLL 392
            RPT A+LL
Sbjct: 244 GRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  106 bits (265), Expect = 7e-25
 Identities = 77/274 (28%), Positives = 137/274 (50%), Gaps = 24/274 (8%)

Query: 143 YWQKGDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
           YW    +LG G+ G+V       DG  FAVK   ++D    ++   ++ + E+  L   +
Sbjct: 34  YWIS-RVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 202 HENIVQ-----YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR------- 249
             +IV+          ++   + +   ++   +  +L Q    R      +         
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 250 -QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDV-KSCRGTA 304
            Q+LL + ++H + ++HRDIK ANIL+ +NG VKL DFG +K   AT  +DV ++  GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD 364
           +++APE+   + K Y   AD++SLG  + E+LT + P+        + K   G   P+P 
Sbjct: 210 YYVAPEIW--RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267

Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           S+S + Q+ +   +  +P  RP++++LL+ P  K
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  103 bits (258), Expect = 1e-24
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 6/210 (2%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQ-SISQLEQEIALLSRFEHENIVQY 208
           LG GSFG V      +  F  V  +   ++    KQ  +  +  E  +L+   H   V  
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVA-IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 267
           YG+ KDES LY+ LE V  G      +R     + V   Y  QI+L  +YL   ++V+RD
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156

Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWS 327
           +K  N+L+D +G +K+ DFG AK         C GT  ++APE++   N G+G  AD W+
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-GTPEYIAPEIL--LNVGHGKAADWWT 213

Query: 328 LGCTVLEMLTSQIPYAPMECMAALFKIGRG 357
           LG  + E+L    P+   E +    KI  G
Sbjct: 214 LGIFIYEILVGCPPFYANEPLLIYQKILEG 243

Length = 340

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  101 bits (253), Expect = 1e-24
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 14/249 (5%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++ +  HE +VQ Y
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLY 65

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  +YI  E ++ G LLN  +      + SQ+    + +  G+ YL  +  +HRD
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125

Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LVD  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSSKSD 183

Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +W+ G  + E+ +  ++PY        + K+ +G     P   S+     +  C      
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAE 243

Query: 384 DRPTAAQLL 392
           +RPT  QLL
Sbjct: 244 ERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  101 bits (254), Expect = 3e-24
 Identities = 83/266 (31%), Positives = 127/266 (47%), Gaps = 22/266 (8%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V    + + G  +AVK    +V L D   +   +    E+ I  L+R  H 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 56

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 262
            + Q Y   +   +L+  +E V  G L+   Q+    D ++   Y  +I   L +LHD+ 
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 320
           +++RD+K  N+L+D  G  KLADFG+ K    N   +    GT  ++APE++  +   YG
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--QEMLYG 174

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
              D W++G  + EML    P+   E    LF+         P  LS+DA D +K  +  
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233

Query: 381 NPNDRPTAAQL------LDHPFVKRL 400
           NP  R  +  L      L HPF K L
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  100 bits (251), Expect = 4e-24
 Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 67/297 (22%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 205
           +G G++G+VY+      G F A+K V +  Q ++    +S + +E+ALL R   F+H NI
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTV-REVALLKRLEAFDHPNI 64

Query: 206 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           V+         TD+ E+K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 65  VRLMDVCATSRTDR-ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-------TAFWMAPE 310
           LH   +VHRD+K  NILV + G VKLADFGLA+      + SC+        T ++ APE
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKI--------- 354
           V+      Y  P D+WS+GC   EM   +    P+ C       +  +F +         
Sbjct: 178 VLLQST--YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDW 231

Query: 355 ------GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                  RG+  P         +P+     AQ  ++  +  NP+ R +A + L HPF
Sbjct: 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEM-LTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  103 bits (258), Expect = 5e-24
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 11/215 (5%)

Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-----LNLYQRYHLRDSQVSAY 247
           E+  L+  +H  IV+++   K + KL + +E  + G L       L +    ++ +V   
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDVKSCRGT 303
             QI+L L  +H + ++HRD+K ANI +   G +KL DFG +K    +  L+   S  GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
            +++APE+   K   Y   AD+WSLG  + E+LT   P+        + ++  G   P P
Sbjct: 235 PYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             +S   +  +   +  NP  RPT  QLL   F+K
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (250), Expect = 6e-24
 Identities = 71/263 (26%), Positives = 112/263 (42%), Gaps = 34/263 (12%)

Query: 150 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG V+ G        +D    AVK +    + + +  +    E+E  LL+ F+HE
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAY 247
           NIV++YG   +     +  E +  G L N + R H  D                SQ+   
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 305
             QI  G+ YL  Q  VHRD+   N LV  +  VK+ DFG+++     D     G     
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 306 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI 362
             WM PE I    + +   +D+WS G  + E+ T  + P+  +     +  I +G     
Sbjct: 188 IRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245

Query: 363 PDSLSKDAQDFIKQCVQVNPNDR 385
           P +   +  D +  C + +P  R
Sbjct: 246 PRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 27/261 (10%)

Query: 150 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +G G FG V  G            A+K    L  GS  KQ +  L  E +++ +F+H NI
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFL-TEASIMGQFDHPNI 67

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD 262
           ++  G       + I  E +  GSL + + R +       Q+    R I  G+KYL + +
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKG 318
            VHRD+   NILV++N   K++DFGL++  + ++     K  +    W APE I  +   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-- 184

Query: 319 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS--PPPI--PDSLSKDAQDF 373
           +   +D+WS G  + E+++  + PY  M     +  +  G   PPP+  P +L +   D 
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLD- 243

Query: 374 IKQCVQVNPNDRPTAAQLLDH 394
              C Q + N+RPT +Q++  
Sbjct: 244 ---CWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 6e-24
 Identities = 83/304 (27%), Positives = 132/304 (43%), Gaps = 58/304 (19%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           F ++ TY +K D LG GS+ +VY+G S   G   A+KE+ L  +      +I    +E +
Sbjct: 1   FGKLETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REAS 55

Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 252
           LL   +H NIV  +     +  L +  E +     L  Y       L    V  +  Q+L
Sbjct: 56  LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLL 113

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFW 306
            GL Y H + V+HRD+K  N+L+   G +KLADFGLA+A      T  N+V     T ++
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWY 169

Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-----MECMAALFKIGRGSPPP 361
             P+V+    + Y    D+W +GC   EM T + P  P      + +  +F++  G+P  
Sbjct: 170 RPPDVLLGSTE-YSTSLDMWGVGCIFYEMATGR-PLFPGSTDVEDQLHKIFRV-LGTPTE 226

Query: 362 --------------------IPDSL---------SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                                P  L             ++   + +Q  P  R +AA+ +
Sbjct: 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286

Query: 393 DHPF 396
            HP+
Sbjct: 287 KHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 99.5 bits (248), Expect = 6e-24
 Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 28/256 (10%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G +G VYEG+        AVK +       +    + +  +E A++   +H N+VQ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYLHD 260
            G    E   YI  E +T G+LL+     +LR+    +V+A        QI   ++YL  
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVNAVVLLYMATQISSAMEYLEK 122

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVIN-NKN 316
           ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +  NK 
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK- 181

Query: 317 KGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
             + + +D+W+ G  + E+ T  + PY  ++       + +G     P+       + ++
Sbjct: 182 --FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239

Query: 376 QCVQVNPNDRPTAAQL 391
            C Q NP+DRP+ A++
Sbjct: 240 ACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 6e-24
 Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 53/304 (17%)

Query: 136 RFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 194
            FK+I        LLG+G  G V+   +   G  FA+K +   +   + K      EQEI
Sbjct: 2   HFKKI-------KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI 54

Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQI 251
             L+  +H  +   Y + + E+ L + ++    G L  L QR     L +     Y  ++
Sbjct: 55  --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK------------------ 293
           LL L+YLH   +V+RD+K  NIL+  +G + L+DF L+K +                   
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 294 ----LNDVK---------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
                ++           S  GT  ++APEVI     G+G   D W+LG  + EML    
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEMLYGTT 230

Query: 341 PYAPMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDR----PTAAQLLDH 394
           P+           I +      P S  +S  A+D I++ +  +P+ R      AA++  H
Sbjct: 231 PFKGSNRDETFSNILKK-EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289

Query: 395 PFVK 398
           PF +
Sbjct: 290 PFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 99.6 bits (248), Expect = 8e-24
 Identities = 82/267 (30%), Positives = 137/267 (51%), Gaps = 21/267 (7%)

Query: 149 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEH 202
           ++GRG FG VY G   +D G  +A+K    LD+   + KQ  +    E   ++L+S  + 
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             IV          KL   L+L+  G L  +L Q     ++++  Y  +I+LGL+++H++
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
            VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y  
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDS 175

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 378
            AD +SLGC + ++L    P+   +      +I R +      +PDS S + +  ++  +
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLL 234

Query: 379 QVNPNDR-----PTAAQLLDHPFVKRL 400
           Q + N R       A ++ +HPF + L
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRSL 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  100 bits (250), Expect = 1e-23
 Identities = 85/268 (31%), Positives = 129/268 (48%), Gaps = 25/268 (9%)

Query: 149 LLGRGSFGSVYEGI---SDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V       +D+ +   V  K+V L D         +  E+ I  L+  +H 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC----TMTEKRILALAA-KHP 56

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQD 262
            +   +   + + +L+  +E V  G L+   QR    D   S  Y  ++ L L +LH   
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 319
           V++RD+K  NIL+DA G  KLADFG+ K   LN V +   C GT  ++APE++  +   Y
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEIL--QELEY 173

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           G   D W+LG  + EM+  Q P+   +    LF+         P  LSK+A   +K  + 
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232

Query: 380 VNPNDR--PTAAQ-----LLDHPFVKRL 400
            NPN R    A+Q     +  HPF K +
Sbjct: 233 KNPNKRLGCVASQGGEDAIKQHPFFKEI 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (247), Expect = 2e-23
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 14/259 (5%)

Query: 150 LGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G+GSFG V +    D    +A+K  ++      ++  ++    E  +L++     IV  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQDVVHRD 267
             + +   KLY+ L  +  G L +  QR    D S+   YT ++L  L+ LH  +V++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPAD 324
           +K  NIL+D  G + L DFGL K    +D K+   C GT  ++APE++     GY    D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLL--GHGYTKAVD 175

Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 384
            W+LG  + EMLT   P+   E +  +++     P   PD   +DA+D +   +  +P  
Sbjct: 176 WWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234

Query: 385 R---PTAAQLLDHPFVKRL 400
           R     A ++ +HPF  +L
Sbjct: 235 RLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 83/320 (25%), Positives = 137/320 (42%), Gaps = 84/320 (26%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-------------EIAL 196
           +G G++G V                S  D  +  K +I +L +             E+ L
Sbjct: 23  VGSGAYGQV---------------CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67

Query: 197 LSRFEHENIVQYYGTDKDESKLYIF-----LE------LVTK--GSLLNLYQRYH-LRDS 242
           L   +HEN++           L +F     LE      LVT   G+ LN   +   L D 
Sbjct: 68  LKHMDHENVI---------GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD 118

Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 302
            +     QIL GLKY+H   ++HRD+K +NI V+ +  +K+ DFGLA+ T  +++     
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-DEMTGYVA 177

Query: 303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 360
           T ++ APE++ N    Y    DIWS+GC + E+LT +  +   + +  L +I    G+P 
Sbjct: 178 TRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236

Query: 361 P--IPDSLSKDAQDFIKQCVQ--------------------------VNPNDRPTAAQLL 392
              +    S+ A+++I+   Q                          ++P+ R TAA+ L
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 393 DHPFVKRL-LATNSGSASPY 411
            HP++       +   A PY
Sbjct: 297 AHPYLAEYHDPEDEPVAPPY 316

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 97.7 bits (243), Expect = 5e-23
 Identities = 80/284 (28%), Positives = 119/284 (41%), Gaps = 43/284 (15%)

Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG GS+ +VY+GIS  +G   A+K +S+  +      +I    +E +LL   +H NIV  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIVLL 68

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVH 265
           +     +  L    E +     L  Y   H   L    V  +  Q+L GL Y+H Q ++H
Sbjct: 69  HDIIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           RD+K  N+L+   G +KLADFGLA+A  + +   S      W  P  +      Y    D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186

Query: 325 IWSLGCTVLEMLTSQIPYAPM-ECMAALFKIG-------------------------RGS 358
           IW  GC  +EML  Q  +  + +    L KI                             
Sbjct: 187 IWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246

Query: 359 PPP----IPDSLSK--DAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
            P     +   LS+   A+D   Q + + P DR +A   L HP+
Sbjct: 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 99.0 bits (246), Expect = 5e-23
 Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 47/286 (16%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI---SQLEQEIALLSRFEHENI 205
           +G G++GSV     +  G   AVK++S      +  QSI    +  +E+ LL   +HEN+
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 206 VQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
           +           L  F  + LVT      L N+ +   L D  V     QIL GLKY+H 
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
            D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y 
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YN 196

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--IPDSLSKDAQDFIKQ 376
              DIWS+GC + E+LT +  +   + +  L  I R  G+P    +    S+ A+++I+ 
Sbjct: 197 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 256

Query: 377 CVQV------------NP--------------NDRPTAAQLLDHPF 396
             Q+            NP              + R TAAQ L H +
Sbjct: 257 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 97.4 bits (242), Expect = 6e-23
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 46/287 (16%)

Query: 150 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHEN 204
           +G G++G V++   + + G F A+K V +  Q  +    +S + +E+A+L     FEH N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTI-REVAVLRHLETFEHPN 65

Query: 205 IVQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLK 256
           +V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL 
Sbjct: 66  VVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNK 315
           +LH   VVHRD+K  NILV ++G +KLADFGLA+        +      W  APEV+   
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--L 182

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFK-IGRGSPPPIPDSL----- 366
              Y  P D+WS+GC   EM   +  +   + ++ +  +   IG       P  +     
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 242

Query: 367 ---SKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPF 396
              SK AQ              D + +C+  NP  R +A   L HP+
Sbjct: 243 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 97.8 bits (244), Expect = 7e-23
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 18/209 (8%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R +T ++K + +G G++G VY    +  G   A+K+V + D   +    IS L +EI LL
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-DN-ERDGIPISSL-REITLL 60

Query: 198 SRFEHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
               H NIV+       +    IFL       +L    SLL+        +SQV     Q
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDL---ASLLDNMPT-PFSESQVKCLMLQ 116

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAFWMA 308
           +L GL+YLH+  ++HRD+K +N+L+   G +K+ADFGLA+   L    +     T ++ A
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLT 337
           PE++      Y    D+W++GC + E+L 
Sbjct: 177 PELLLG-CTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 97.8 bits (243), Expect = 7e-23
 Identities = 84/308 (27%), Positives = 135/308 (43%), Gaps = 61/308 (19%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           F ++ TY  K D LG G++ +VY+G   ++D+    A+KE+ L  +      +I    +E
Sbjct: 2   FGKLETY-IKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAI----RE 54

Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQV 244
           ++LL   +H NIV  +     E  L +  E + K         G+ +N++         V
Sbjct: 55  VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--------V 106

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGT 303
             +  Q+L GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A  +     S    
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP 359
             W  P  I   +  Y    D+W +GC   EM T + P  P     E +  +F+I  G+P
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRI-LGTP 224

Query: 360 -----PPI---------------PDSLSK-------DAQDFIKQCVQVNPNDRPTAAQLL 392
                P I                D L         D  + + + +Q     R +A + +
Sbjct: 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 393 DHPFVKRL 400
            HP+   L
Sbjct: 285 KHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  100 bits (251), Expect = 8e-23
 Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 38/285 (13%)

Query: 150 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G FG V+         FF  K +S   +G + ++  SQL  E+ ++   +H+NIV+Y
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISY--RGLKEREK-SQLVIEVNVMRELKHKNIVRY 77

Query: 209 YGT--DKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD- 260
                +K   KLYI +E    G L    Q+ +     + +  +   TRQ+L  L Y H+ 
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137

Query: 261 ------QDVVHRDIKCANILV---------------DANGS--VKLADFGLAKATKLNDV 297
                 + V+HRD+K  NI +               + NG    K+ DFGL+K   +  +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197

Query: 298 -KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIG 355
             SC GT ++ +PE++ ++ K Y   +D+W+LGC + E+ + + P+      + L  ++ 
Sbjct: 198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK 257

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           RG   PI    SK+    IK  + ++  +RP+A Q L +  +K +
Sbjct: 258 RGPDLPIKGK-SKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301

Length = 1021

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 97.4 bits (242), Expect = 9e-23
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 25/266 (9%)

Query: 148 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 205
           D++G G+FG V +  I  DG         + +  S+          E+ +L +   H NI
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNI 70

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYT 248
           +   G  +    LY+ +E    G+LL+  ++                   L   Q+  + 
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWM 307
             +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    WM
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190

Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           A E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P + 
Sbjct: 191 AIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 248

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
             +  D ++QC +  P +RP+ AQ+L
Sbjct: 249 DDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 80/292 (27%), Positives = 139/292 (47%), Gaps = 54/292 (18%)

Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--- 204
           +G G+FG V+  ++D  DG   A+K+   +    Q   S  ++ +E+ +L  F+H+N   
Sbjct: 8   IGYGAFGVVW-SVTDPRDGKRVALKK---MPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 205 ---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 260
              I+Q    D  E ++Y+  EL+ +  L  +      L    V  +  QIL GLKYLH 
Sbjct: 64  ALDILQPPHIDPFE-EIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNK 315
             ++HRDIK  N+LV++N  +K+ DFGLA+  + ++  S   T      ++ APE++   
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMG- 178

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPY---APME------------CMAALFKIGRG--- 357
           ++ Y    DIWS+GC   E+L  +I +   +P++             + A+     G   
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238

Query: 358 -------SPPPIP------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   PP +P         + +A   + + +  +P+ R +AA  L HP+
Sbjct: 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 82/294 (27%), Positives = 143/294 (48%), Gaps = 43/294 (14%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRG++G V     S+     A+K+++   D    AK+++    +EI LL   +HEN++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68

Query: 208 YYGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGLK 256
                    +     +YI  EL+      +L+Q   +R SQ  +      +  Q+L GLK
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDT----DLHQI--IRSSQTLSDDHCQYFLYQLLRGLK 122

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 314
           Y+H  +V+HRD+K +N+L++AN  +K+ DFGLA+ T      +     T ++ APE++ N
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--PPIPDSLSKDA 370
            ++ Y    D+WS+GC   E+L  +  +   + +  L  I    GSP    +    ++ A
Sbjct: 183 CSE-YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241

Query: 371 QDFIKQC--------VQVNPNDRPTAAQLLDHPFV----KRLLATNSGSASPYL 412
           + +I+           ++ P+  P A  LL+   V    KR+    +  A PYL
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA-LAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 83/317 (26%), Positives = 137/317 (43%), Gaps = 81/317 (25%)

Query: 151 GRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFEHENIV 206
           GRG++G VY+    +G     +A+K+        +    ISQ   +EIALL   +HEN+V
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 207 QYYGT--DKDESKLYIFLELVTKGSLLNLYQ--RYH-------LRDSQVSAYTRQILLGL 255
                  +  +  +Y+  +        +L+Q  ++H       +  S V +   QIL G+
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 256 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLA----KATK-LNDVKSCRGTAFW 306
            YLH   V+HRD+K ANILV       G VK+ D GLA       K L D+     T ++
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-------------SQIPYAPMECMAALFK 353
            APE++    + Y    DIW++GC   E+LT                P+   + +  +F+
Sbjct: 182 RAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ-RDQLERIFE 239

Query: 354 IGRGSPPP--------IP----------------DSLSK----------DAQDFIKQCVQ 379
           +  G+P          +P                +SL+K             D +++ ++
Sbjct: 240 V-LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298

Query: 380 VNPNDRPTAAQLLDHPF 396
            +P  R TA + L+HP+
Sbjct: 299 YDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 74/241 (30%), Positives = 108/241 (44%), Gaps = 40/241 (16%)

Query: 192 QEIALLSRFEHENIVQYYGTDKDESKL---YIFLELVTKGSLLNLYQRYHLRDSQVSAYT 248
           +E+ LL    HENI+    +D   S L   Y   EL+    L  L     L    +  + 
Sbjct: 58  RELKLLKHLRHENIISL--SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL 114

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 308
            QIL GLKY+H   VVHRD+K +NIL++ N  +K+ DFGLA+      +     T ++ A
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYVSTRYYRA 173

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPP----- 360
           PE++    K Y +  DIWS GC   EML  + P  P +     F I     G+PP     
Sbjct: 174 PEIMLTWQK-YDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPDDVIN 231

Query: 361 ------------------PIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
                             P+P S         A D +++ +  +P  R +AA+ L HP++
Sbjct: 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 398 K 398
            
Sbjct: 292 A 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 80/312 (25%), Positives = 138/312 (44%), Gaps = 60/312 (19%)

Query: 143 YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ--------- 192
           Y QKG  LG G++G V +   +  G   A+K+V +++  +   +    +           
Sbjct: 10  YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQI 251
           E+ +++  +HENI+       +   + + ++++    L  +   +  L +SQV     QI
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------TKLNDVKSCRG- 302
           L GL  LH    +HRD+  ANI +++ G  K+ADFGLA+         T   D    R  
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 303 -------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAAL 351
                  T ++ APE++    K Y    D+WS+GC   E+LT   P  P    ++ +  +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLT-GKPLFPGENEIDQLGRI 246

Query: 352 FKIGRGSP------------------PPIPDSL-------SKDAQDFIKQCVQVNPNDRP 386
           F++  G+P                  P  P  L       S DA D ++  +++NP +R 
Sbjct: 247 FEL-LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305

Query: 387 TAAQLLDHPFVK 398
           +A + L H + K
Sbjct: 306 SAKEALKHEYFK 317

Length = 335

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 24/264 (9%)

Query: 150 LGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQL--EQEIALL-SRFEH 202
           LGRG FG V    Y+   +    +A+K  +L      A+  +  L  E+ I    +   H
Sbjct: 7   LGRGHFGKVLLAEYKKTGE---LYAIK--ALKKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
             +V  +   + E  +   +E    G L+         + +   Y   ++LGL+YLH+  
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 319
           +V+RD+K  N+L+D  G VK+ADFGL K       ++   C GT  ++APEV+   +  Y
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTETS--Y 178

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
               D W LG  + EML  + P+ P +    +F          P  LS++A   +++ ++
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPF-PGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237

Query: 380 VNPNDR----PTAAQ-LLDHPFVK 398
            NP  R       A+ +   PF +
Sbjct: 238 RNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 63/265 (23%), Positives = 110/265 (41%), Gaps = 27/265 (10%)

Query: 149 LLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
            LGRG FG V+                 VK +         +   S+  +E+ +  +  H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD----ENLQSEFRRELDMFRKLSH 67

Query: 203 ENIVQYYGTDKDESKLYIFLE----------LVTKGSLLNLYQRYHLRDSQVSAYTRQIL 252
           +N+V+  G  ++    Y+ LE          L    S     +   L   Q  A   QI 
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAP 309
           LG+ +L +   VHRD+   N LV +   VK++   L+K    ++    R       W+AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPP-PIPDSLS 367
           E +   +  +   +D+WS G  + E+ T  ++P+  +     L ++  G    P+P+   
Sbjct: 188 EAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP 245

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLL 392
                 + +C  VNP DRP+ ++L+
Sbjct: 246 SRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 27/266 (10%)

Query: 148 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           D++G G+FG V +  I  DG         + +  S+        E E+ L     H NI+
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAYTRQILL- 253
              G  +    LY+ +E    G+LL+             +   +   S +S  ++Q+L  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS--SQQLLHF 117

Query: 254 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 306
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 178 MAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235

Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQL 391
              +  D ++QC +  P +RP+ AQ+
Sbjct: 236 CDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 18/248 (7%)

Query: 150 LGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H NIV+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
             G    +  +YI +ELV  G  L   +     L+  ++         G++YL  +  +H
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-----TAFWMAPEVINNKNKGYG 320
           RD+   N LV     +K++DFG+++  + + V +  G        W APE +N     Y 
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGR--YS 174

Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E  +   +PYA +        I +G   P P+         +++C +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234

Query: 380 VNPNDRPT 387
            +P  RP+
Sbjct: 235 YDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 95.5 bits (237), Expect = 4e-22
 Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 23/264 (8%)

Query: 148 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           D++G G+FG V    I  DG         L +  S+        E E+ L     H NI+
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNII 66

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ---------VSAYTRQILL---- 253
              G  ++   LYI +E    G+LL+  ++  + ++           S  T Q LL    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 254 ----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMA 308
               G++YL ++  +HRD+   N+LV  N + K+ADFGL++  ++   K+  R    WMA
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS 367
            E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +  
Sbjct: 187 IESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCD 244

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQL 391
            +  + ++QC +  P +RP  AQ+
Sbjct: 245 DEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 94.9 bits (236), Expect = 5e-22
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 21/268 (7%)

Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 64

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-----RDSQVSAYTRQILLGLKYLHDQD 262
                + +  L + L L+  G L   +  Y++      + +   Y  +I  GL+ LH + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGL 321
           +V+RD+K  NIL+D  G ++++D GLA      + ++   GT  +MAPEV+ N+   Y  
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER--YTF 180

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 378
             D W LGC + EM+  + P+   +      ++ R          +  S+ A+   +Q +
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240

Query: 379 QVNPNDR-----PTAAQLLDHPFVKRLL 401
             +P  R       A ++  HPF +   
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTAN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 94.9 bits (236), Expect = 6e-22
 Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 32/278 (11%)

Query: 149 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           L+  G++G+VY     +    FA+K+++   Q    +  I Q+  E  +L+  E+  +V 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFAENPFVVS 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            + + + +  L + +E V  G    L +    L       Y  + +L L+YLH+  +VHR
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLN------------------DVKSCRGTAFWMA 308
           D+K  N+L+ + G +KL DFGL+K   ++                  D + C GT  ++A
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIA 184

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 365
           PEVI    +GYG P D W++G  + E L   +P+    P E    +        P   ++
Sbjct: 185 PEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-DDIEWPEGDEA 241

Query: 366 LSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRL 400
           L  DAQD I + ++ NP +R     A ++  H F   L
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.9 bits (233), Expect = 7e-22
 Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 26/255 (10%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G FG V+ G   +    A+K +       +   S     +E  ++ +  H  +VQ Y
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYLHDQ 261
           G   + S + +  E +  G L +     +LR +Q   ++++ LL        G+ YL   
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSD-----YLR-AQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKG 318
           +V+HRD+   N LV  N  VK++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-- 177

Query: 319 YGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
           Y   +D+WS G  + E+ +  + PY        +  I  G     P   S+   + ++ C
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237

Query: 378 VQVNPNDRPTAAQLL 392
            +  P DRP+ + LL
Sbjct: 238 WKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 94.5 bits (235), Expect = 7e-22
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 82/313 (26%)

Query: 144 WQKGDLLGRGSFGSVY----------------------EGISDDGFFFAVKEVSLLDQGS 181
           ++K + +G G++G VY                      EGI       A++E+SLL    
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT----ALREISLL---- 54

Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYH- 238
              Q +S+    + LL        V++      +  LY+  E +       ++   R   
Sbjct: 55  ---QMLSESIYIVRLLD-------VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG 104

Query: 239 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN 295
             L    + ++  Q+L G+ + H   V+HRD+K  N+LVD   G +K+AD GL +A  + 
Sbjct: 105 RPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI- 163

Query: 296 DVKSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAAL 351
            VKS      T ++ APEV+      Y  P DIWS+GC   EM   Q P  P +  +  L
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ-PLFPGDSELQQL 221

Query: 352 FKIGR--GSP--------------------PP------IPDSLSKDAQDFIKQCVQVNPN 383
             I +  G+P                     P      +PD LS +  D +++ ++ +P 
Sbjct: 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPA 280

Query: 384 DRPTAAQLLDHPF 396
            R +A   L HP+
Sbjct: 281 KRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 215 ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 273
           ES+L+  +E V+ G L+   QR   L +     Y+ +I L L +LH++ +++RD+K  N+
Sbjct: 68  ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127

Query: 274 LVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
           L+DA G +KL D+G+ K   +  D  S  C GT  ++APE++  + + YG   D W+LG 
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEIL--RGEDYGFSVDWWALGV 184

Query: 331 TVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            + EM+  + P+                LF++       IP SLS  A   +K  +  +P
Sbjct: 185 LMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDP 244

Query: 383 NDR------PTAAQLLDHPFVK 398
            +R           +  HPF +
Sbjct: 245 KERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 72/265 (27%), Positives = 126/265 (47%), Gaps = 21/265 (7%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V    + + G  +A+K ++  +   +A+ +  + E+++  L   +   I  
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDRRWITN 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 318
           RDIK  N+L+D NG ++LADFG     +L    + +     GT  +++PE++     G  
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 319 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 373
            YG   D WSLG  + EML  + P+     +    KI         PP    +S++A+D 
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDL 243

Query: 374 IKQ--CVQVNPNDRPTAAQLLDHPF 396
           I++  C       R       DHPF
Sbjct: 244 IRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 77/266 (28%), Positives = 121/266 (45%), Gaps = 24/266 (9%)

Query: 145 QKGDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSR 199
             G  LG G+FG V E    G+S      AV +V++      A  S  + L  E+ ++S 
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSD---AVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 200 F-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILL 253
              HENIV   G       + +  E    G LLN  +R   R+S ++     +++ Q+  
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAK 152

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAP 309
           G+ +L  ++ +HRD+   N+L+     VK+ DFGLA+    +     +G A     WMAP
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSPPPIPDSLS 367
           E I N    Y   +D+WS G  + E+ +    PY  M   +  +K I  G     P+   
Sbjct: 213 ESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP 270

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLD 393
            +  D +K C   +P  RPT  Q++ 
Sbjct: 271 AEIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 55/249 (22%)

Query: 193 EIALLSRFEHENIVQY----YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVS 245
           EI +L + +H NIV       G++ D  K+Y+ +E V    K  +  + Q +    S+V 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQ--SEVK 109

Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-------KATKLNDVK 298
               Q+L G+ +LHD  ++HRD+K +N+L++  G +K+ DFGLA       K      V 
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168

Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-- 356
               T ++ APE++    + Y    D+WS+GC   E+LT +  +     +  L KI +  
Sbjct: 169 ----TLWYRAPELLLGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223

Query: 357 GSP------------------PPIPD-----------SLSKDAQDFIKQCVQVNPNDRPT 387
           G+P                                  SLS +  D + + +  +P  R +
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283

Query: 388 AAQLLDHPF 396
           A   L HP+
Sbjct: 284 AEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 73/259 (28%), Positives = 126/259 (48%), Gaps = 18/259 (6%)

Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LLG+G+FG V    E  S  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 2   LLGKGTFGKVILVREKAS--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                + + + +L   +E V  G L  +L +     + +   Y  +I+  L YLH   +V
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117

Query: 265 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           +RD+K  N+++D +G +K+ DFGL K   T    +K+  GT  ++APEV+ + +  YG  
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND--YGRA 175

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EM+  ++P+   +    LF++        P +LS DA+  +   +  +P
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234

Query: 383 NDR-----PTAAQLLDHPF 396
           N R       A +++ H F
Sbjct: 235 NKRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 85/310 (27%), Positives = 134/310 (43%), Gaps = 76/310 (24%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +++G+GS+G V   I +  G   A+K++  + +  S A    +++ +EI LL    H +I
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA----TRILREIKLLRLLRHPDI 61

Query: 206 VQ----YYGTDKDESK-LYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLG 254
           V+         + E K +Y+  EL+      +L+Q     D       Q   Y  Q+L  
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLY--QLLRA 115

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM------- 307
           LKY+H  +V HRD+K  NIL +A+  +K+ DFGLA+    ND        FW        
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTP---TAIFWTDYVATRW 171

Query: 308 --APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-------MECMAALFKIGRGS 358
             APE+  +    Y    DIWS+GC   E+LT + P  P       ++ +  L     G+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLL----GT 226

Query: 359 PPP---------------------IPDSLSKD-------AQDFIKQCVQVNPNDRPTAAQ 390
           P P                      P   S+        A   +++ +  +P DRPTA +
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286

Query: 391 LLDHPFVKRL 400
            L  P+ K L
Sbjct: 287 ALADPYFKGL 296

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 70/265 (26%), Positives = 127/265 (47%), Gaps = 17/265 (6%)

Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G FG V    +   G  +A K +       +  +S++  E++I  L +   + +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVVN 64

Query: 208 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVV 264
                + +  L + L ++  G L  ++Y   +    + +   Y  +IL GL+ LH ++ V
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 265 HRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +RD+K  NIL+D  G ++++D GLA K  +   ++   GT  +MAPEV+NN+   Y L  
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR--YTLSP 182

Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCVQV 380
           D W LGC + EM+  Q P+   +      ++ R    +        S++A+   K  +  
Sbjct: 183 DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTK 242

Query: 381 NPNDR-----PTAAQLLDHPFVKRL 400
           +P  R       A ++  HPF + +
Sbjct: 243 DPKQRLGCQEEGAGEVKRHPFFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 17/263 (6%)

Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 207
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 50  VIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167

Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG--YGLP 322
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++     YG  
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFIKQCVQ 379
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I  C  
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI--CAF 285

Query: 380 VNPND----RPTAAQLLDHPFVK 398
           +   +    R    ++  H F K
Sbjct: 286 LTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 24/251 (9%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 14  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65

Query: 210 GTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKNKGYGL 321
           RD+   N+LV  +   K++DFGL K     +  S + T      W APE +  + K +  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--REKKFST 178

Query: 322 PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
            +D+WS G  + E+ +  ++PY  +     + ++ +G     PD       D +KQC  +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHL 238

Query: 381 NPNDRPTAAQL 391
           +   RP+  QL
Sbjct: 239 DAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 13/200 (6%)

Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG+G FG V    + + G  +A K++       ++ + ++ LE+EI  L +     IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDV 263
               + ++ L + + L+  G L   Y  Y+     L   +V  Y+ QI  G+ +LH  D+
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLP 322
           V+RD+K  N+L+D  G+ +L+D GLA   K     + R GT  +MAPE++  K + Y  P
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--KEEPYSYP 174

Query: 323 ADIWSLGCTVLEMLTSQIPY 342
            D +++GC++ EM+  + P+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 71/267 (26%), Positives = 128/267 (47%), Gaps = 21/267 (7%)

Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G FG V    +   G  +A K++       +  +S++  E++I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVVS 64

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSAYTRQILLGLKYLHDQD 262
                + +  L + L L+  G L   +  YH+ ++     +   Y  +I  GL+ LH + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 263 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV+  KN+ Y  
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTF 180

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 378
             D W+LGC + EM+  Q P+   +      ++ R          +  S DA+   K  +
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240

Query: 379 QVNPNDR-----PTAAQLLDHPFVKRL 400
             +P +R       A ++ +HP  K++
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 56/183 (30%), Positives = 95/183 (51%), Gaps = 13/183 (7%)

Query: 213 KDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 271
           +  S+L++ +E V  G L+   QR   L +     Y  +I + L +LH++ +++RD+K  
Sbjct: 66  QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 272 NILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPADIWSL 328
           N+L+DA+G +KL D+G+ K      D  S  C GT  ++APE++  + + YG   D W+L
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEIL--RGEEYGFSVDWWAL 182

Query: 329 GCTVLEMLTSQIPY------APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           G  + EM+  + P+        M     LF++    P  IP  LS  A   +K  +  +P
Sbjct: 183 GVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDP 242

Query: 383 NDR 385
            +R
Sbjct: 243 KER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 92.0 bits (228), Expect = 6e-21
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 13/213 (6%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           F ++ TY  K D LG G++ +V++G S       A+KE+ L  +      +I    +E++
Sbjct: 1   FGKLETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 55

Query: 196 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 252
           LL   +H NIV  +    T++  + ++ +L+   K  L N      + +  V  +  Q+L
Sbjct: 56  LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--VKIFMFQLL 113

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEV 311
            GL Y H + ++HRD+K  N+L++  G +KLADFGLA+A  +     S      W  P  
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
           +   +  Y  P D+W +GC + EM T + P  P
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR-PMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 91.8 bits (228), Expect = 9e-21
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 36/268 (13%)

Query: 149 LLGRGSFGSVY---EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFE 201
           LLG+G+FG V    E  +  G ++A+K    EV +      AK  ++    E  +L    
Sbjct: 2   LLGKGTFGKVILVREKAT--GKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTR 53

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGL 255
           H  +     + +   +L   +E    G L      +HL   +V +      Y  +I+  L
Sbjct: 54  HPFLTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSAL 108

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVIN 313
            YLH  DVV+RD+K  N+++D +G +K+ DFGL K   +    +K+  GT  ++APEV+ 
Sbjct: 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 373
           + +  YG   D W LG  + EM+  ++P+   +    LF++        P +LS +A+  
Sbjct: 169 DND--YGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLSPEAKSL 225

Query: 374 IKQCVQVNPNDR-----PTAAQLLDHPF 396
           +   ++ +P  R       A ++++H F
Sbjct: 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 91.7 bits (227), Expect = 1e-20
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 21/217 (9%)

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 260
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 317
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  ++ 
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGED- 172

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSLSKD 369
            YG   D W+LG  + EM+  + P+                LF++       IP SLS  
Sbjct: 173 -YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231

Query: 370 AQDFIKQCVQVNPNDR----PTA--AQLLDHPFVKRL 400
           A   +K  +  +P +R    P    A +  HPF + +
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 21/266 (7%)

Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           ++GRG+FG V       S     +A+K +S  +   ++  +    E++I  ++    E I
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQ--VYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWI 105

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           VQ +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH 165

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYG 320
           RD+K  N+L+D +G +KLADFG       N +  C    GT  +++PEV+ ++  +  YG
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGS---PPPIPDSLSKDAQDFIK 375
              D WS+G  + EML    P+     +    KI   + S   P  I   +SK A+D I 
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EISKQAKDLIC 283

Query: 376 QCVQVNPN--DRPTAAQLLDHPFVKR 399
             +        R    ++  HPF K 
Sbjct: 284 AFLTDREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)

Query: 147 GDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+ +      V  V +L +    ++ +S L  E+ ++    +
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVA-VKML-KDDATEKDLSDLVSEMEMMKMIGK 74

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-------------------LNLYQRYHLRDS 242
           H+NI+   G    E  LY+ +E    G+L                       +    +D 
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSC 300
              AY  Q+  G+++L  +  +HRD+   N+LV  +  +K+ADFGLA+     D   K+ 
Sbjct: 135 VSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 301 RG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
            G     WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 193 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250

Query: 356 -RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
            R   P    + +++    ++ C    P+ RPT  QL++
Sbjct: 251 YRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 72/259 (27%), Positives = 129/259 (49%), Gaps = 18/259 (6%)

Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 2   LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 265 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           +RDIK  N+++D +G +K+ DFGL K   +    +K+  GT  ++APEV+ + +  YG  
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRA 175

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +P
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234

Query: 383 NDR----PTAAQ-LLDHPF 396
             R    P+ A+ +++H F
Sbjct: 235 KQRLGGGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 38/275 (13%)

Query: 150 LGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +G+G+FG V++    G+     F  V  V +L + + A    +  ++E AL++ F+H NI
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVA-VKMLKEEASA-DMQADFQREAALMAEFDHPNI 70

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------------YHLRDSQVS-- 245
           V+  G       + +  E +  G L    +                     L    +S  
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 246 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 302
                 +Q+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++     D      
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190

Query: 303 TAF----WMAPEVI-NNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR 356
                  WM PE I  N+   Y   +D+W+ G  + E+ +  + PY  M     ++ +  
Sbjct: 191 NDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247

Query: 357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           G+    PD+   +  + ++ C    P+DRP+ A +
Sbjct: 248 GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 37/289 (12%)

Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 245
           H+NI+   G    +  LY+ +E  +KG+L               Y    + D Q++    
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 246 -AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197

Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 198 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
                P   + + +    ++ C    P+ RPT  QL++       L TN
Sbjct: 256 HRMDKPA--NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 74/256 (28%), Positives = 121/256 (47%), Gaps = 14/256 (5%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G+GSFG V       DG F+AVK +       + +Q     E+ + LL   +H  +V  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           + + +   KLY  L+ V  G L    QR     + +   Y  +I   L YLH  ++++RD
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121

Query: 268 IKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPAD 324
           +K  NIL+D+ G V L DFGL K   + +   S  C GT  ++APEV+  + + Y    D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVL--RKQPYDRTVD 178

Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 384
            W LG  + EML    P+   +  A ++      P  +  ++S  A+  ++  +Q +   
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237

Query: 385 RPTAA----QLLDHPF 396
           R  A     ++ +H F
Sbjct: 238 RLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 81/273 (29%), Positives = 118/273 (43%), Gaps = 40/273 (14%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEV---SLLDQGSQAKQSISQLEQEIALLSRFEHE 203
            DLL  G+FG ++ GI  D      +EV   ++ D  S+ +  ++ L QE  LL    H+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQ 68

Query: 204 NI-----VQYYGTDKDE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           NI     V     +             L +FL    +  L        L   Q+     Q
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AF 305
           I  G+ YLH + V+H+DI   N ++D    VK+ D  L++     D   C G        
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVK 184

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA---PMECMAALFKIGRGSPPP 361
           WMA E + NK   Y   +D+WS G  + E++T  Q PY    P E MAA  K G     P
Sbjct: 185 WMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQP 241

Query: 362 I--PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           I  PD L       +  C  ++P +RP+ +QL+
Sbjct: 242 INCPDELF----AVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 8/200 (4%)

Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 207
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 50  VIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H   ++HRD
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167

Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG--YGLP 322
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++     YG  
Sbjct: 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 323 ADIWSLGCTVLEMLTSQIPY 342
            D WS+G  + EML    P+
Sbjct: 228 CDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 75/254 (29%), Positives = 115/254 (45%), Gaps = 20/254 (7%)

Query: 146 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           K  ++G G FG V+ GI    G       +  L  G   KQ    L  E +++ +F H N
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFSHHN 67

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----RQILLGLKYLH 259
           I++  G         I  E +  G+L + Y R H  D + S+Y      R I  G+KYL 
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA------FWMAPEVIN 313
           D + VHRD+   NILV++N   K++DFGL++  + +D +    T+       W APE I 
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 314 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
            +   +   +D+WS G  + E+++  + PY  M     +  I  G   P P         
Sbjct: 184 YRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241

Query: 373 FIKQCVQVNPNDRP 386
            + QC Q +   RP
Sbjct: 242 LMLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 90.0 bits (223), Expect = 6e-20
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 27/285 (9%)

Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
            +G G++GSV   I    G   A+K++S   +  Q++    +  +E+ LL   +HEN++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 208 YYGTDKDESKLYIFLE--LVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                        F +  LV      +L +   + L + +V     Q+L GLKY+H   +
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEVI N    Y    
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMH-YNQTV 196

Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFI----- 374
           DIWS+GC + EMLT +  +   + +  L +I + +  P P+ +     K A+ +I     
Sbjct: 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256

Query: 375 ---KQCVQVNPNDRPTAAQLLDHPFV----KRLLATNSGSASPYL 412
              K    + P   P A  LL+        KRL AT +    PY 
Sbjct: 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA-LEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.0 bits (220), Expect = 6e-20
 Identities = 75/262 (28%), Positives = 113/262 (43%), Gaps = 34/262 (12%)

Query: 150 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG V+           D    AVK  +L D    A++      +E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 248
           +IV++YG   +   L +  E +  G L N + R H               L  SQ+    
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 305
           +QI  G+ YL  Q  VHRD+   N LV  N  VK+ DFG+++     D     G      
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 306 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 363
            WM PE I  +   +   +D+WSLG  + E+ T  + P+  +     +  I +G     P
Sbjct: 187 RWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244

Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
            +  K+  D +  C Q  P+ R
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 21/265 (7%)

Query: 149 LLGRGSFGSVY-EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V           +A+K    +V + D   +     + +E+ + L  + +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC----TMVEKRV-LALQDKPP 61

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 262
            + Q +   +   +LY  +E V  G L+   Q+    ++ Q   Y  +I +GL +LH + 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKGYG 320
           +++RD+K  N+++D+ G +K+ADFG+ K   ++ V  ++  GT  ++APE+I    + YG
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPYG 179

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
              D W+ G  + EML  Q P+   E    LF+         P SLSK+A    K  +  
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK 238

Query: 381 NPNDRPTAAQ-----LLDHPFVKRL 400
           +P+ R          + +H F +R+
Sbjct: 239 HPSKRLGCGPEGERDIREHAFFRRI 263

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 70/248 (28%), Positives = 122/248 (49%), Gaps = 22/248 (8%)

Query: 149 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 200
           +LG+GSFG V     +G  +    +A+K    +V + D   +     + +E+ +  LS  
Sbjct: 7   VLGKGSFGKVMLAERKGTDE---LYAIKILKKDVVIQDDDVEC----TMVEKRVLALSG- 58

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +   + Q +   +   +LY  +E V  G L+  + Q    ++     Y  +I +GL +LH
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNK 317
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K+  GT  ++APE+I    +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII--AYQ 176

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
            YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K  
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235

Query: 378 VQVNPNDR 385
           +  +P  R
Sbjct: 236 MTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 88.5 bits (219), Expect = 8e-20
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 10/200 (5%)

Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEHE 203
           ++GRG FG VY    +D G  +A+K    LD+   + KQ  +    E   ++L+S  +  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
            IV          KL   L+L+  G L  +L Q     + ++  Y  +I+LGL+++H++ 
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGTAYDSS 176

Query: 323 ADIWSLGCTVLEMLTSQIPY 342
           AD +SLGC + ++L    P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 37/265 (13%)

Query: 150 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 245
           +IV++YG   D   L +  E +  G L N + R H  D                  SQ+ 
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 306 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 360
               WM PE I  +   +   +D+WS G  + E+ T  + P+  +     +  I +G   
Sbjct: 187 LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 244

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDR 385
             P    K+  D +  C Q  P  R
Sbjct: 245 ERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 9/199 (4%)

Query: 149 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G+GSFG V       DG F+AVK +       + +Q+    E+ + LL   +H  +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            + + +   KLY  L+ V  G L    QR     + +   Y  ++   + YLH  ++++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 267 DIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPA 323
           D+K  NIL+D+ G V L DFGL K   +  +  S  C GT  ++APEV+  + + Y    
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVL--RKEPYDRTV 177

Query: 324 DIWSLGCTVLEMLTSQIPY 342
           D W LG  + EML    P+
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 39/290 (13%)

Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G FG V      G+  +      K    + +    ++ +S L  E+ ++    +
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 245
           H+NI+   G    +  LY+ +E  +KG+L               Y    + + Q+S    
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 246 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 298
              AY  Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      
Sbjct: 143 VSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
           + R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K  
Sbjct: 201 NGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-- 256

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
            G     P + + +    ++ C    P+ RPT  QL++   + R+LA  S
Sbjct: 257 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILALTS 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 11/208 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K + LG GS+ +VY+G S  +G   A+K + L ++      +I    +E +LL   +H
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLKH 62

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 259
            NIV  +     +  L +  E V     L  Y   H   L    V  +  Q+L GL Y+H
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKG 318
            + ++HRD+K  N+L+   G +KLADFGLA+A  + +   S      W  P  +   +  
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPME 346
           Y    D+W +GC  +EM+     +  M+
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 93/333 (27%), Positives = 145/333 (43%), Gaps = 72/333 (21%)

Query: 117 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS 175
           ED+      +   N SPN  +K        G+++G GSFG VYE I  D     A+K+V 
Sbjct: 48  EDEDEEKMIDNDINRSPNKSYKL-------GNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100

Query: 176 LLDQGSQAKQSISQLEQEIALLSRFEHENIV---QYYGTD---KDESKLYIFLELVTK-- 227
              Q  Q K       +E+ ++    H NI+    YY T+   K+E    IFL +V +  
Sbjct: 101 ---QDPQYKN------RELLIMKNLNHINIIFLKDYYYTECFKKNEKN--IFLNVVMEFI 149

Query: 228 GSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-S 280
              ++ Y +++ R++       V  Y+ Q+   L Y+H + + HRD+K  N+L+D N  +
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209

Query: 281 VKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNKNKGYGLPADIWSLGCTVLEM 335
           +KL DFG AK    N +   R  +     F+ APE++      Y    D+WSLGC + EM
Sbjct: 210 LKLCDFGSAK----NLLAGQRSVSYICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEM 264

Query: 336 LTSQIPYAPMECMAALFKIGR--GSPP--------------PIPDSLSKD---------- 369
           +     ++    +  L +I +  G+P                 PD   KD          
Sbjct: 265 ILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTP 324

Query: 370 --AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
             A +FI Q ++  P  R    + L  PF   L
Sbjct: 325 DDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357

Length = 440

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 79/303 (26%), Positives = 129/303 (42%), Gaps = 60/303 (19%)

Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G+FG V      D    +A+K  +L  +    +  ++ ++ E  +L+  ++E +V+ 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMK--TLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 267
           Y + +D+  LY  ++ +  G +++L  R  +    ++  Y  ++ L ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 268 IKCANILVDANGSVKLADFGLAKATK------------------------LNDVKSCR-- 301
           IK  NIL+D +G +KL DFGL    +                         +DV +CR  
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 302 -----------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 338
                                  GT  ++APEV+    KGY    D WS+G  + EML  
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVILFEMLVG 244

Query: 339 QIPY-APMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQ--CVQVNPNDRPTAAQLLD 393
           Q P+ AP      L  I   +   IP    LS +A D I +  C       R  A  +  
Sbjct: 245 QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304

Query: 394 HPF 396
           HPF
Sbjct: 305 HPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 25/219 (11%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           F ++ TY  K + LG G++ +V++G S       A+KE+ L  +      +I    +E++
Sbjct: 2   FGKMETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 56

Query: 196 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSA 246
           LL   +H NIV  +    TDK  + ++ +L+   K      G++++++         V  
Sbjct: 57  LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKI 108

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAF 305
           +  QIL GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A  +     S      
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
           W  P  +   +  Y    D+W +GC   EM + + P  P
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 62/244 (25%), Positives = 109/244 (44%), Gaps = 10/244 (4%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G+           V +L   +       +L +E  ++ + ++  IV+  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES   + +EL   G L    Q+  H+ +  ++    Q+ +G+KYL + + VHRD+
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 269 KCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA----FWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA   ++     +        W APE +N     +   +
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--FSSKS 179

Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       I  G     P     +  D +K C     
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239

Query: 383 NDRP 386
           ++RP
Sbjct: 240 DERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 19/245 (7%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V    +      +A+K ++  +   +A+ +  + E+ +  L   + + I  
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDCQWITT 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 265
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 66  LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 318
           RDIK  N+L+D NG ++LADFG     K+N   + +     GT  +++PE++     G  
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 319 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 373
            YG   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D 
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDL 243

Query: 374 IKQCV 378
           I++ +
Sbjct: 244 IQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 78/305 (25%), Positives = 136/305 (44%), Gaps = 56/305 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-----EIKPAIRNQIIRELQVLHECN 61

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 261 Q-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 179

Query: 320 GLPADIWSLGCTVLEMLTSQIPY------------------------------------- 342
            + +DIWS+G +++EM   + P                                      
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239

Query: 343 -------APMECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
                   PM     L  I    PP +P  +   + QDF+ +C+  NP +R    QL+ H
Sbjct: 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299

Query: 395 PFVKR 399
            F+KR
Sbjct: 300 AFIKR 304

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 57/301 (18%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V      D G  +A+K+  L       K+ ++ +  E  +L+  ++  +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            Y + +DE+ LY+ +E +  G ++ L  +     + +   Y  + +L +  +H    +HR
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125

Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVK---------------------------- 298
           DIK  N+L+DA G +KL+DFGL    K +                               
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185

Query: 299 ------------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 346
                       S  GT  ++APEV      GY    D WSLG  + EML    P+    
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVF--LQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243

Query: 347 CMAALFKIGRGS-----PPPIPDSLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVK 398
                 KI         P  +P  LS +A+D IK+        R       ++  HPF K
Sbjct: 244 PQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300

Query: 399 R 399
            
Sbjct: 301 G 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.2 bits (213), Expect = 5e-19
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 60/292 (20%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVK--------EVSLLDQGSQAKQSISQLEQEIAL 196
             G  LG G FG V +        F +K         V +L + + + + +  L  E  L
Sbjct: 3   VLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNL 56

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------- 243
           L +  H ++++ YG    +  L + +E    GSL     R  LR+S+             
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL-----RSFLRESRKVGPSYLGSDGNR 111

Query: 244 -----------------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 286
                            + ++  QI  G++YL +  +VHRD+   N+LV     +K++DF
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171

Query: 287 GLAKATKLND--VKSCRG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQ 339
           GL++     D  VK  +G     WMA E + +    Y   +D+WS G  + E++T   + 
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 340 IPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P    E +  L K G       P++ S++  + +  C +  P+ RPT A +
Sbjct: 230 YPGIAPERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 87.6 bits (217), Expect = 6e-19
 Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 58/302 (19%)

Query: 150 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G+FG V      D    +A+K +   D     +   + ++ E  +L+  ++E +V+ 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 267
           Y + +D+  LY  ++ +  G +++L  R  + +  ++  Y  ++   ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 268 IKCANILVDANGSVKLADFGLAKATK------------------------LNDVKSCR-- 301
           IK  NIL+D +G +KL DFGL    +                         +++  CR  
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 302 -------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 342
                              GT  ++APEV+     GY    D WS+G  + EML  Q P+
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEMLVGQPPF 244

Query: 343 ---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPF 396
               P E    +         P    LS++A D I +       DR     A ++  HPF
Sbjct: 245 LADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303

Query: 397 VK 398
            K
Sbjct: 304 FK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 65/261 (24%), Positives = 118/261 (45%), Gaps = 51/261 (19%)

Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 246
           +Q+ +E+ +L       IV +YG    + ++ I +E +  GSL   L +   + +  +  
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107

Query: 247 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
            +  +L GL YL ++  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP--------------------- 344
           +M+PE +   +  Y + +DIWS+G +++E+   + P  P                     
Sbjct: 168 YMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE 225

Query: 345 -------------------------MECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 378
                                    M     L  I    PP +P+ + + D Q+F+ +C+
Sbjct: 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 285

Query: 379 QVNPNDRPTAAQLLDHPFVKR 399
             NP +R     L++H F+KR
Sbjct: 286 IKNPAERADLKMLMNHTFIKR 306

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 86.5 bits (214), Expect = 8e-19
 Identities = 78/284 (27%), Positives = 139/284 (48%), Gaps = 26/284 (9%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI---V 206
           +G G++G+V   +  D    A   +  L +  Q++    +  +E+ LL   +HEN+   +
Sbjct: 23  VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 207 QYYGTDKDESKLYIF-LELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
             +  D    + + F L +   G+ L  L +   L + ++     Q+L GLKY+H   ++
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           HRD+K  N+ V+ +  +K+ DFGLA+ T  +++     T ++ APEVI N    Y    D
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVVTRWYRAPEVILNWMH-YTQTVD 198

Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--IPDSLSKDAQDFIKQCVQV 380
           IWS+GC + EMLT +  +   + +  L +I +  G+P    +    S+DA++++K+  + 
Sbjct: 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258

Query: 381 N--------PNDRPTAAQLLDHPFV----KRLLATNSGSASPYL 412
                    PN  P A  +L+   V     R+ A  +  A PY 
Sbjct: 259 RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA-LAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 85.4 bits (211), Expect = 9e-19
 Identities = 75/257 (29%), Positives = 121/257 (47%), Gaps = 15/257 (5%)

Query: 145 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +K  LLG G FG+V++GI   +G    +       Q    +Q+  ++   +  +   +H 
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----QVSAYTRQILLGLKYLH 259
            IV+  G     S L +  +L   GSLL+ + R H RDS    ++  +  QI  G+ YL 
Sbjct: 70  YIVRLLGICPGAS-LQLVTQLSPLGSLLD-HVRQH-RDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVINNK 315
           +  +VHR++   NIL+ ++  V++ADFG+A     +D K      +    WMA E I   
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              Y   +D+WS G TV EM++    PYA M        + +G     P   + D    +
Sbjct: 187 R--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244

Query: 375 KQCVQVNPNDRPTAAQL 391
            +C  ++ N RPT  +L
Sbjct: 245 VKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 67/273 (24%), Positives = 124/273 (45%), Gaps = 32/273 (11%)

Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG+G FG V    +   G  +A K+++      +     + +E+ I  L++     IV  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI--LAKVHSRFIVSL 58

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH----------LRDSQVSAYTRQILLGLKYL 258
               + ++ L + + ++  G L     RYH            + +   YT QI+ GL++L
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDL-----RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKN 316
           H + +++RD+K  N+L+D +G+V+++D GLA       +  K   GT  +MAPE++  + 
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL--QG 171

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQD 372
           + Y    D ++LG T+ EM+ ++ P+      +E      +I        PD  S  ++ 
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKS 230

Query: 373 FIKQCVQVNPNDR-----PTAAQLLDHPFVKRL 400
           F +  +  +P  R          L  HP  + L
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 75/308 (24%), Positives = 128/308 (41%), Gaps = 62/308 (20%)

Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G+FG V      D    +A+K  +L  +    +  ++ ++ E  +L+  ++E +V+ 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMK--TLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           Y + +D+  LY  ++ +  G +++L  R  +  +     Y  ++   ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 268 IKCANILVDANGSVKLADFGLAK------------------------ATKLNDVKSCR-- 301
           IK  NIL+D +G +KL DFGL                          + +  D  +CR  
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 302 -----------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 338
                                  GT  ++APEV+     GY    D WS+G  + EML  
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEMLVG 244

Query: 339 QIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR---PTAAQLL 392
           Q P+    P+E    +         P    LS +A D I +  +  P DR     A ++ 
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIK 303

Query: 393 DHPFVKRL 400
            HPF K +
Sbjct: 304 AHPFFKTI 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 70/272 (25%), Positives = 126/272 (46%), Gaps = 31/272 (11%)

Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G FG V    +   G  +A K++       +  ++++  E+ I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVVS 64

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-------DSQVSA-YTRQILLGLKYLH 259
                + +  L + L ++  G L     ++H+        D Q +  Y  ++  GL+ L 
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKN 316
            + +V+RD+K  NIL+D  G ++++D GL  A ++ + ++ R   GT  +MAPEVINN+ 
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGL--AVQIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDF 373
             Y    D W LGC + EM+  Q P+   +      ++ R          +  S+DA+  
Sbjct: 178 --YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235

Query: 374 IKQCVQVNPNDR-----PTAAQLLDHPFVKRL 400
            +  +  NP +R       AA +  HP  K +
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 69/243 (28%), Positives = 123/243 (50%), Gaps = 15/243 (6%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V    + +    FA+K ++  +   +A+ +  + E+++  L   +++ I  
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDNQWITT 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 265
            +   +DE+ LY+ ++    G LL L  ++  R  +     Y  ++++ +  +H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 266 RDIKCANILVDANGSVKLADFG-LAKATKLNDVKS--CRGTAFWMAPEVINNKNKG---Y 319
           RDIK  NIL+D NG ++LADFG   K  +   V+S    GT  +++PE++     G   Y
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDFIK 375
           G   D WSLG  + EML  + P+     +    KI     R   P     +S+DA+D I+
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245

Query: 376 QCV 378
           + +
Sbjct: 246 RLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 73/274 (26%), Positives = 113/274 (41%), Gaps = 40/274 (14%)

Query: 140 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 7   IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 57

Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------ 241
             LL+  +H++IV++YG   +   L +  E +  G L N + R H  D            
Sbjct: 58  AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAP 116

Query: 242 -----SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 296
                 Q+ A   QI  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Query: 297 VKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 351
                G       WM PE I  +   +   +DIWS G  + E+ T  + P+  +    A+
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234

Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
             I +G     P +   +    ++ C Q  P  R
Sbjct: 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 60/293 (20%)

Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 233
           V + D  +  ++ +  L+ E+ L   F H NI+  +      S L++    +  GS  +L
Sbjct: 30  VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89

Query: 234 YQRYHLRDSQVSAYTRQILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 289
            + Y   +    A    IL G    L YLH    +HR+IK ++IL+  +G V L+     
Sbjct: 90  LKTYF-PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL 148

Query: 290 KATKLNDVKSCRGTAF---------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
            +   N  K+     F         W++PE++     GY + +DI+S+G T  E+ T ++
Sbjct: 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208

Query: 341 PYAPMECMAALFKIGRGSP----------------------------------------- 359
           P+  M     L +  +G P                                         
Sbjct: 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMT 268

Query: 360 -----PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 407
                 P   + S   Q+ ++ C+Q +P  RP+A+ LL H F K++     GS
Sbjct: 269 SERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGS 321

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 67/272 (24%), Positives = 120/272 (44%), Gaps = 40/272 (14%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEGI+       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 14  LGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 68

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 246
            ++V+  G         + +EL+T+G L     + +LR                  ++  
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 306 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP 361
              WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  M     L  +  G    
Sbjct: 184 PVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241

Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
            PD+      + ++ C Q NP  RP+  +++ 
Sbjct: 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 38/290 (13%)

Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G FG V      GI  D     V     + +     + +S L  E+ ++    +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-------------------QRYHLRDS 242
           H+NI+   G    +  LY+ +E  +KG+L                       ++   +D 
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 298
              AY  Q+  G++YL  Q  +HRD+   N+LV  +  +K+ADFGLA+     D      
Sbjct: 137 VSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
           + R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 195 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL-DHPFVKRLLATN 404
                P   + + +    +++C    P+ RPT  QL+ D   V  + +T+
Sbjct: 253 HRMDKPA--NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 45/279 (16%)

Query: 147 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G +LG G FGSV EG    DDG    V  V  +         I +   E A +  F+H N
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVA-VKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 205 IVQYYG---TDKDESKL---YIFLELVTKGSLLN--LYQR-----YHLRDSQVSAYTRQI 251
           +++  G         K+    + L  +  G L +  LY R       L    +  +   I
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----------VKSC 300
            LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D           VK  
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180

Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGR 356
                W+A E +   ++ Y   +D+W+ G T+ E+ T  Q PY  +   E    L    R
Sbjct: 181 -----WIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233

Query: 357 -GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
              P    D L     D +  C + +P DRPT  +L + 
Sbjct: 234 LKQPEDCLDEL----YDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE------IALLSRFE 201
           ++G+GSFG V       DG  +AVK +       Q K  +++ EQ+        LL   +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVL-------QKKIVLNRKEQKHIMAERNVLLKNVK 54

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
           H  +V  + + +   KLY  L+ V  G L  +L +     + +   Y  +I   L YLH 
Sbjct: 55  HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
            ++V+RD+K  NIL+D+ G V L DFGL K    + +   +  GT  ++APEVI  + + 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--RKQP 172

Query: 319 YGLPADIWSLGCTVLEMLTSQIPY 342
           Y    D W LG  + EML    P+
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 82.6 bits (204), Expect = 6e-18
 Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 22/258 (8%)

Query: 149 LLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G            A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKT---LKAGYTEKQRRDFL-SEASIMGQFDHPN 66

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 262
           I+   G       + I  E +  GSL    +++       Q+    R I  G+KYL D  
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NILV++N   K++DFGL++   L D      + RG      W APE I  +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  I  G   P P          +
Sbjct: 185 K--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242

Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 243 LDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 83.8 bits (207), Expect = 7e-18
 Identities = 66/271 (24%), Positives = 107/271 (39%), Gaps = 63/271 (23%)

Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 249
           L+ E+ +   F H NIV Y  T   +++L++    +  GS  +L    H  D        
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMSELAIA 104

Query: 250 QILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLADFGL----------AKATKLN 295
            IL G    L Y+H    VHR +K ++IL+  +G V L+  GL           +   ++
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVH 162

Query: 296 DV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-- 352
           D  K       W++PEV+    +GY   +DI+S+G T  E+    +P+  M     L   
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222

Query: 353 -----------------------------------------KIGRGSPP--PIPDSLSKD 369
                                                    +   G     P   + S  
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
              F++QC+Q NP+ RP+A+ LL+H F K++
Sbjct: 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 74/285 (25%), Positives = 130/285 (45%), Gaps = 45/285 (15%)

Query: 149 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G G++G V +    +     A+K+    ++  + K++  +   E+ +L   + ENIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVE 64

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                +   KLY+  E V K ++L L +     +   +V +Y  Q++  + + H  D+VH
Sbjct: 65  LKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 266 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLP 322
           RDIK  N+L+  N  +KL DFG A+  ++ ++        T ++ +PE++      YG  
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL--LGAPYGKA 181

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPPI----------------- 362
            D+WS+GC + E+   Q P  P E  +  LF I +  G  P                   
Sbjct: 182 VDMWSVGCILGELSDGQ-PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240

Query: 363 ----PDSLSKDAQ--------DFIKQCVQVNPNDRPTAAQLLDHP 395
               P SL +           D +K  +++NP DR    Q L+HP
Sbjct: 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 36/270 (13%)

Query: 150 LGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG+GSFG VYEG + D          AVK V   ++ +  ++ I  L  E +++  F   
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERIEFL-NEASVMKGFTCH 69

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---------------QVSAYT 248
           ++V+  G         + +EL+  G L + Y R    ++               Q++A  
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKS-YLRSLRPEAENNPGRPPPTLQEMIQMAA-- 126

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 305
            +I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G      
Sbjct: 127 -EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 306 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 363
            WMAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     P
Sbjct: 186 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
           D+  +   D ++ C Q NP  RPT  ++++
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 84/288 (29%), Positives = 127/288 (44%), Gaps = 57/288 (19%)

Query: 147 GDLLGRGSFGSVYE----GIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           G  LG G FG V      GI     D     AVK   L D  +   + ++ L  E+ L+ 
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATD--KDLADLISEMELMK 72

Query: 199 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR----------------- 240
              +H+NI+   G    E  LY+ +E   KG+L     R  LR                 
Sbjct: 73  LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL-----REFLRARRPPGPDYTFDITKVP 127

Query: 241 DSQVS-------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 293
           + Q+S       AY  Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+   
Sbjct: 128 EEQLSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 294 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 346
             D      + R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243

Query: 347 CMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
               LFK+ R G     P + + +    +++C    P  RPT  QL++
Sbjct: 244 ---ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 83.1 bits (205), Expect = 9e-18
 Identities = 69/259 (26%), Positives = 126/259 (48%), Gaps = 17/259 (6%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 265
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 322
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV+ + +  YG  
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND--YGRA 176

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +P
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235

Query: 383 NDR-----PTAAQLLDHPF 396
             R       A +++ H F
Sbjct: 236 KQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 73/269 (27%), Positives = 123/269 (45%), Gaps = 27/269 (10%)

Query: 147 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G +LG+G FGSV E    S+DG F  V  V +L     +   I +  +E A +  F+H N
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 205 IVQYYGTD---KDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----- 253
           +++  G     + + +L I    L  +  G L        + +   +    Q L+     
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL-PLQTLVRFMID 121

Query: 254 ---GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----- 305
              G++YL  ++ +HRD+   N +++ N +V +ADFGL+K     D    +G A      
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR-QGCASKLPVK 180

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD 364
           W+A E +   +  Y   +D+W+ G T+ E++T  Q PYA +E       + +G+    P 
Sbjct: 181 WLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238

Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
              +D  + + QC    P  RP+   L D
Sbjct: 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 70/264 (26%), Positives = 118/264 (44%), Gaps = 34/264 (12%)

Query: 149 LLGRGSFGSVYEG--ISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G+G FG VY G  I  DG     AVK ++ +       + + Q  +E  ++  F H N
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHPN 57

Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYLH 259
           ++   G     + S L + L  +  G L N + R    +  V     +  Q+  G++YL 
Sbjct: 58  VLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVIN 313
            +  VHRD+   N ++D + +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQI-PYA---PMECMAALFKIGRGSPPP--IPDSLS 367
            +   +   +D+WS G  + E++T    PY      +    L + GR    P   PD L 
Sbjct: 176 TQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPL- 231

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQL 391
               + +  C    P  RPT ++L
Sbjct: 232 ---YEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 50/292 (17%)

Query: 150 LGRGSFGSVY----EGISD----DGFFFAVKEVSLL--------DQGSQAKQSISQLEQE 193
           LG G FG V+    +G+ D            +  +L        D    A++      +E
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED---FLKE 69

Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---- 249
           + +LSR    NI +  G    +  L + +E +  G L    Q++    S ++  ++    
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 250 --------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 301
                   QI  G++YL   + VHRD+   N LV  N ++K+ADFG+++    +D    +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 302 GTAF----WMAPE-VINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPM------ECM 348
           G A     WMA E V+  K   +   +D+W+ G T+ E+LT   + PY  +      E  
Sbjct: 190 GRAPLPIRWMAWESVLLGK---FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENA 246

Query: 349 AALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
              F+  GR    P P +  KD  + + +C + +  DRPT  ++  H F++R
Sbjct: 247 GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 65/238 (27%), Positives = 114/238 (47%), Gaps = 9/238 (3%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 23  VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 210 GTDKDESKLYIFLE--LVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                 + +  F E  LVT      L N+ +   L D  V     Q+L GLKY+H   ++
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           HRD+K +N+ V+ +  +++ DFGLA+    +++     T ++ APE++ N    Y    D
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVD 198

Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           IWS+GC + E+L  +  +   + +  L +I      P P+ L K + +  ++ +Q  P
Sbjct: 199 IWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 20/249 (8%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG V +G+    +    K++     +L   ++ K    ++ +E  ++ + ++  I
Sbjct: 3   LGSGNFGCVKKGV----YKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYI 57

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           V+  G  + E+ L + +E+ + G L      ++  +  S V     Q+ +G+KYL  ++ 
Sbjct: 58  VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNKNKG 318
           VHRD+   N+L+      K++DFGL+KA   +D      +A      W APE IN +   
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-- 174

Query: 319 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
           +   +D+WS G T+ E  +  Q PY  M+    +  I +G     P     +    +K C
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234

Query: 378 VQVNPNDRP 386
                 DRP
Sbjct: 235 WIYKWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 36/267 (13%)

Query: 149 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 205
           ++G+GSFG V       +  F+AVK   +L + +  + K+    + +   LL   +H  +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V  + + +   KLY  L+ +  G L    QR     + +   Y  +I   L YLH  ++V
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 265 HRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKS--CRGTAFWMAPEVINNKNKGYGL 321
           +RD+K  NIL+D+ G + L DFGL K   + N   S  C GT  ++APEV++ +   Y  
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQP--YDR 175

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D W LG  + EML                    G PP    + ++   + + + +Q+ 
Sbjct: 176 TVDWWCLGAVLYEMLY-------------------GLPPFYSRNTAEMYDNILNKPLQLK 216

Query: 382 PNDRPTAAQLLDHPF----VKRLLATN 404
           PN   +A  LL+        KRL A +
Sbjct: 217 PNITNSARHLLEGLLQKDRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 75/267 (28%)

Query: 192 QEIALLSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ 243
           +E+ L+    H+NI+          + ++   +Y+ +EL+      NL Q     L   +
Sbjct: 64  RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHER 119

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +S    Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 170

Query: 304 AFWM----------APEVINNKNKGYGLPADIWSLGCTVLEM------------------ 335
           +F M          APEVI     GY    DIWS+GC + EM                  
Sbjct: 171 SFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228

Query: 336 LTSQIPYAPMECMAAL------------FKIGRGSPPPIPDSL------------SKDAQ 371
           +  Q+     E M+ L               G       PD L            +  A+
Sbjct: 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           D + + + ++P  R +    L HP++ 
Sbjct: 289 DLLSKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.5 bits (196), Expect = 8e-17
 Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 34/266 (12%)

Query: 148 DLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +++G G FG V  G          F A+K    L  G   KQ    L  E +++ +F+H 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKT---LKSGYTEKQRRDFL-SEASIMGQFDHP 65

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLGLKYL 258
           NI+   G       + I  E +  G+L +  +     D Q +        R I  G+KYL
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEV 311
            + + VHRD+   NILV++N   K++DFGL++  + +       S  G      W APE 
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP-IPDSL 366
           I  +   +   +D+WS G  + E+++  + PY  M   + + A+ +  R  PP   P +L
Sbjct: 183 IAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
            +   D    C Q + N RP   Q++
Sbjct: 241 HQLMLD----CWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 52/294 (17%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V      D G  +A+K +   D     K+ ++ +  E  +L   +   +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVK 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            + + +D+  LY+ +E +  G ++ L  +   L +     Y  + +L +  +H    +HR
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125

Query: 267 DIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCR----- 301
           DIK  N+L+DA G VKL+DFGL    K                      ++ S R     
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185

Query: 302 ------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APME 346
                       GT  ++APEV      GY    D WSLG  + EML    P+    P E
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 347 CMAAL--FKIGRGSPPPIPDSLSKDAQDFI-KQCVQV-NPNDRPTAAQLLDHPF 396
               +  +K     PP +P  +S+ A+D I + C    N        ++  HPF
Sbjct: 244 TYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 30/268 (11%)

Query: 147 GDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G  LG G FGSV EG ++ D     V  V  +      +  +     E   +  F+H N+
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVA-VKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 206 VQYYGT--DKDESKLY----IFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQIL 252
           ++  G      ES+ Y    + L  +  G L +  LY R      +L    +  +   I 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMA 308
            G++YL  +  +HRD+   N +++ N +V +ADFGL+K     D     +  +    W+A
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS----PPPIP 363
            E +   ++ Y   +D+WS G T+ E+ T  Q PY  +E       + +G+    PP   
Sbjct: 183 IESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           D L       +  C  +NP DRP+   L
Sbjct: 241 DGL----YSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 78/310 (25%), Positives = 139/310 (44%), Gaps = 62/310 (20%)

Query: 140 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQG-SQAKQSISQLEQEIALL 197
           ++  +Q+   +G G+ G V        G   AVK++S   Q  + AK++     +E+ LL
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLL 74

Query: 198 SRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTR 249
               H+NI+          + ++   +Y+ +EL+      NL Q  H  L   ++S    
Sbjct: 75  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIHMELDHERMSYLLY 130

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMA 308
           Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ A
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------------------PMECMAA 350
           PEVI     GY    DIWS+GC + E++   + +                     E M  
Sbjct: 191 PEVI--LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248

Query: 351 LFKIGRG---SPPPIP-------------------DSL-SKDAQDFIKQCVQVNPNDRPT 387
           L    R    + P  P                   D L +  A+D + + + ++P+ R +
Sbjct: 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308

Query: 388 AAQLLDHPFV 397
             + L HP++
Sbjct: 309 VDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 60/304 (19%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G+G+FG V      D G  +A+K  +LL      K  ++ ++ E  +L+  +   +V 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHR 266
            Y + +D   LY+ +E +  G L+ +  +Y      V+  Y  + +L ++ +H    +HR
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125

Query: 267 DIKCANILVDANGSVKLADFGLAKA----------------------------------- 291
           DIK  NIL+D  G +KL+DFGL+                                     
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185

Query: 292 ------TKLNDVKSCR--------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
                  ++   K  R        GT  ++APE+     +GYG   D WSLG  + E L 
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL--QQGYGQECDWWSLGAIMFECLI 243

Query: 338 SQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFIKQCVQVNPN--DRPTAAQLL 392
              P+          KI         PD   LS +A+D I++ +    N   R  A ++ 
Sbjct: 244 GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIK 303

Query: 393 DHPF 396
            HPF
Sbjct: 304 SHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 75/318 (23%), Positives = 140/318 (44%), Gaps = 78/318 (24%)

Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69

Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 248
           +    H+NI+          + ++   +Y+ +EL+      NL Q  +  L   ++S   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 125

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 308
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMT 176

Query: 309 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GS 358
           P V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 359 PPP----------------------------IPDSL-----------SKDAQDFIKQCVQ 379
           P P                             PDSL           +  A+D + + + 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 380 VNPNDRPTAAQLLDHPFV 397
           ++P  R +  + L HP++
Sbjct: 297 IDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 59/296 (19%)

Query: 138 KRIITYWQKGDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQA---------- 183
           ++ +T+ +K   LG G FG V+    EG+      F  K+ SL   G+Q           
Sbjct: 4   RKRLTFKEK---LGEGQFGEVHLCEAEGMEK----FMDKDFSLDVSGNQPVLVAVKMLRE 56

Query: 184 ---KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 240
              K + +   +EI ++SR +  NI++          L +  E +  G L     R+  +
Sbjct: 57  DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQ 116

Query: 241 DSQVSAYTR------------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 288
           ++   A               QI  G+KYL   + VHRD+   N LV  N ++K+ADFG+
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 289 AKATKLNDVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPY 342
           ++     D    +G A     WM+ E I      +   +D+W+ G T+ E+LT   + PY
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPY 234

Query: 343 APM------ECMAALFK-IGRGS----PPPIPDSLSKDAQDFIKQCVQVNPNDRPT 387
           + +      E     F+  GR      P   PDSL K     +  C + N  +RP+
Sbjct: 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYK----LMLSCWRRNAKERPS 286

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 78/268 (29%), Positives = 134/268 (50%), Gaps = 29/268 (10%)

Query: 142 TYWQKGDLLGRGSFGSVYEGI-SDDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           T ++K  +LG G+FG+VY+G+   +G       A+KE   L + +  K +   L+ E  +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILD-EAYV 62

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 252
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 63  MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 119

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMA 308
            G+ YL ++ +VHRD+   N+LV     VK+ DFGLAK      K    +  +    WMA
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPD 364
            E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + G   P PPI  
Sbjct: 180 LESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI-- 235

Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
             + D    + +C  ++ + RP   +L+
Sbjct: 236 -CTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 50/270 (18%)

Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V      D G  +A+K +   D     K+ +  +  E  +L   +   +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVK 65

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            + + +D+  LY+ +E +  G ++ L  +   L + +   Y  + +L +  +H    +HR
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 267 DIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCR----- 301
           DIK  N+L+D+ G VKL+DFGL    K                      ++ S R     
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185

Query: 302 ------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APME 346
                       GT  ++APEV      GY    D WSLG  + EML    P+    P E
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 347 CMAAL--FKIGRGSPPPIPDSLSKDAQDFI 374
               +  +K     PP +P  +S+ A+D I
Sbjct: 244 TYKKVMNWKETLIFPPEVP--ISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 77.8 bits (191), Expect = 9e-16
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 192 QEIALLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQ 243
           +E+ L+    H+NI+        +  L      YI +EL+      NL Q  +  L   +
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHER 127

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +S    Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 178

Query: 304 AFWMAPEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
           +F M P V+    +        GY    DIWS+GC + EM+   + +   + +    K+ 
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
                P P+ + K     ++  V+    +RP  A
Sbjct: 239 EQLGTPCPEFMKK-----LQPTVRTYVENRPKYA 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 59/255 (23%), Positives = 106/255 (41%), Gaps = 16/255 (6%)

Query: 149 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG G FG +  G     S      A+     L  G   KQ    L  E   L +F+H N
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIH---TLRAGCSDKQRRGFL-AEALTLGQFDHSN 67

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 262
           IV+  G     + + I  E ++ G+L +  +++   L   Q+      +  G+KYL +  
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC---RGTAFWMAPEVINNKNKGY 319
            VH+ +    +LV+++   K++ F   +  K   + +    +    W APE I   +  +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--F 185

Query: 320 GLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
              +D+WS G  + E+++  + PY  M     +  +  G   P P +        +  C 
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCW 245

Query: 379 QVNPNDRPTAAQLLD 393
           Q    +RP  +Q+  
Sbjct: 246 QKERGERPRFSQIHS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)

Query: 146 KGDLLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +G  +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACR---EIALLRELKH 57

Query: 203 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 250
            N++  Q       + K+++  +             + S  N  +   L  S V +   Q
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQ 116

Query: 251 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 301
           IL G+ YLH   V+HRD+K ANILV       G VK+AD G A+        L D+    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
            T ++ APE++    + Y    DIW++GC   E+LTS+
Sbjct: 177 VTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 66/262 (25%), Positives = 131/262 (50%), Gaps = 19/262 (7%)

Query: 142 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 199
           T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K ++  +++ + +++ 
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMAS 65

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 257
            +H ++V+  G     + + +  +L+  G LL+    +  ++    +  +  QI  G+ Y
Sbjct: 66  MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 313
           L ++ +VHRD+   N+LV +   VK+ DFGLA+      K  +    +    WMA E I+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 314 NKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPDSLSKD 369
            +   +   +D+WS G T+ E++T    PY   P   +  L + G   P PPI    + D
Sbjct: 185 YRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI---CTID 239

Query: 370 AQDFIKQCVQVNPNDRPTAAQL 391
               + +C  ++ + RP   +L
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 52/194 (26%), Positives = 97/194 (50%), Gaps = 26/194 (13%)

Query: 215 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 273
           E  +++ L+    G L +   ++ ++ +  V  +  ++++ L  LH + +V RD+   NI
Sbjct: 57  EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116

Query: 274 LVDANGSVKLADFGLAKATKLNDVK-SCRGTA---FWMAPEV--INNKNKGYGLPADIWS 327
           L+D  G ++L  F      + ++V+ SC G A    + APEV  I+ + +      D WS
Sbjct: 117 LLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGISEETEA----CDWWS 167

Query: 328 LGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPT 387
           LG  + E+LT +     +EC  +   I   +   IP+ +S++A+  ++Q +Q NP +R  
Sbjct: 168 LGAILFELLTGK---TLVECHPS--GINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222

Query: 388 AA-----QLLDHPF 396
           A       +  HPF
Sbjct: 223 AGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 68/262 (25%), Positives = 124/262 (47%), Gaps = 15/262 (5%)

Query: 142 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 199
           T  +K  +LG G+FG+VY+GI   DG    +   + +L + +  K +   L+ E  +++ 
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAG 65

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 256
                + +  G     S + +  +L+  G LL+ Y R +   +    +  +  QI  G+ 
Sbjct: 66  VGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLD-YVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVI 312
           YL +  +VHRD+   N+LV +   VK+ DFGLA+   +++ +      +    WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 371
            ++   +   +D+WS G TV E++T    PY  +        + +G   P P   + D  
Sbjct: 184 LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241

Query: 372 DFIKQCVQVNPNDRPTAAQLLD 393
             + +C  ++   RP   +L+D
Sbjct: 242 MIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 146 KGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +G  +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACR---EIALLRELKH 57

Query: 203 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 250
            N++  Q       + K+++  +             + S  N  +   L    V +   Q
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQ 116

Query: 251 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 301
           IL G+ YLH   V+HRD+K ANILV       G VK+AD G A+        L D+    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
            T ++ APE++    + Y    DIW++GC   E+LTS+
Sbjct: 177 VTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 69/283 (24%), Positives = 112/283 (39%), Gaps = 55/283 (19%)

Query: 150 LGRGSFGSVY----EGI-----------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 194
           LG G FG V+    EG+                  AVK +    +    K + +   +EI
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML----RADVTKTARNDFLKEI 68

Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-------- 246
            ++SR ++ NI++  G    +  L +  E +  G L     +  +  +   A        
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 247 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 301
                   QI  G+KYL   + VHRD+   N LV  + ++K+ADFG+++     D    +
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 302 GTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEM--LTSQIPYAPM------ECMA 349
           G A     WMA E I      +   +D+W+ G T+ EM  L  + PY+ +      E   
Sbjct: 189 GRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTG 246

Query: 350 ALFK-----IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPT 387
             F+     I     P  P  +       + +C   +  DRPT
Sbjct: 247 EFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 60/299 (20%)

Query: 150 LGRGSFGSVY-------EGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIA 195
           LG G FG V+       + +    F F V++       V +L +    K + +   +E+ 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLKEVK 71

Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------ 243
           +LSR +  NI++  G   DE  L +  E +  G L      +HL D +            
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 244 --VSAYTR------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 295
               +Y+       QI  G+KYL   + VHRD+   N LV  N ++K+ADFG+++     
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191

Query: 296 DVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPM---- 345
           D    +G A     WMA E I      +   +D+W+ G T+ E+L    + PY  +    
Sbjct: 192 DYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249

Query: 346 --ECMAALFK-----IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
             E     F+     +    PPP P  L     + + QC   +  +RP+ + +  H F+
Sbjct: 250 VIENAGEFFRDQGRQVYLFRPPPCPQGL----YELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 8/154 (5%)

Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
           ++T Q+  G+++L  ++ VHRD+   N+L+     VK+ DFGLA+    +     +G+ F
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 306 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSP 359
               WMAPE I +    Y   +D+WS G  + E+ +    PY  M   +  + KI  G  
Sbjct: 301 LPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358

Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
              PD  +++  D + +C    P  RP+   L D
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 22/167 (13%)

Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDS 242
            QLE EI  L R  HENI++     + E+  Y    ++T+    +LY     + +  +D 
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTY----MITQKYDFDLYSFMYDEAFDWKDR 263

Query: 243 ----QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
               Q  A  +Q+L  ++Y+HD+ ++HRDIK  NI ++ +G + L DFG   A      +
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG--TAMPFEKER 321

Query: 299 SCR-----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
                   GT    +PE++     GY    DIWS G  +L+ML+   
Sbjct: 322 EAFDYGWVGTVATNSPEIL--AGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 28/262 (10%)

Query: 150 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHEN 204
           LG+G+F ++Y+G+    SD       +EVS++ +   +    S    E A L+S+  H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 205 IVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
           +V+ YG   +DE+   +  E V  G L +++   H   + VS +      +Q+   L YL
Sbjct: 63  LVKLYGVCVRDENI--MVEEYVKFGPL-DVF--LHREKNNVSLHWKLDVAKQLASALHYL 117

Query: 259 HDQDVVHRDIKCANILV---DANGS----VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 311
            D+ +VH ++   NILV     N      +KL+D G+     +   +       W+APE 
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIPWIAPEC 175

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 370
           I N      + AD WS G T+LE+ +  + P + +               P+PD    + 
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD--CAEL 233

Query: 371 QDFIKQCVQVNPNDRPTAAQLL 392
            + I QC   +P  RP+   +L
Sbjct: 234 ANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)

Query: 228 GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLAD 285
           G L +L ++   L +++V    RQ++  L  LH  +++H DIK  N+L D A   + L D
Sbjct: 94  GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153

Query: 286 FGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-- 342
           +GL K        SC  GT  + +PE I   N  Y +  D W++G    E+LT + P+  
Sbjct: 154 YGLCKII---GTPSCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKE 208

Query: 343 APMECM--AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR-PTAAQLLDHPFVK 398
              E +   +L K  +    P   ++SK+A DF++  ++ N N R     +++ HPF+K
Sbjct: 209 DEDEELDLESLLKRQQ-KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 70.7 bits (173), Expect = 5e-13
 Identities = 46/143 (32%), Positives = 77/143 (53%), Gaps = 4/143 (2%)

Query: 152 RGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 210
           RG+FG VY G   ++   +AVK V   D  +  K  + Q++ E   L+  +   IV  Y 
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 211 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIK 269
           + +  + +Y+ +E +  G + +L   Y   D +++  Y  ++ L L YLH   ++HRD+K
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 270 CANILVDANGSVKLADFGLAKAT 292
             N+L+   G +KL DFGL+K T
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 77/274 (28%), Positives = 114/274 (41%), Gaps = 32/274 (11%)

Query: 148 DLLGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           D +G G FG V  G +  G   A   VKE+    + S          QE+       H N
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKEL----RASATPDEQLLFLQEVQPYRELNHPN 56

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLR-DSQVSAYTR---QILLGLKYL 258
           ++Q  G   +     + LE    G L N  +  R  +   +Q     R   ++  GL +L
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF-WMAPEVINN 314
           H  D +H D+   N  + A+ SVK+ D+GLA      D    K C      W+APE++  
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 315 KNKGYGLPAD------IWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGS----PPPIP 363
           + +   LP D      IWSLG T+ E+ T+   PY  +     L ++ R      P P  
Sbjct: 177 RGQDL-LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQ---LLDH 394
           D    D    + Q   ++P  RPTA +   LL +
Sbjct: 236 DLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)

Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
           +Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G A 
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 306 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF--KIGRGS 358
               WMAPE I +K   Y   +D+WS G  + E+ +    PY P   +   F  ++  G+
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPY-PGVQIDEEFCRRLKEGT 293

Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
               P+  + +    +  C   NP DRPT ++L++ 
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
           Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G A  
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 306 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSPP 360
              WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+  
Sbjct: 244 PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             PD  + +    +  C    P+ RPT ++L++H
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 34/265 (12%)

Query: 150 LGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG  +FG +Y+G       D     A+K  +L D  +   Q   + +QE +L++   H N
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINN--PQQWGEFQQEASLMAELHHPN 68

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA----------------- 246
           IV   G    E  + +  E + +G L   L  R    D   S+                 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
              QI  G++YL     VH+D+   NIL+     VK++D GL++     D    +  +  
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 306 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPP 361
              WM PE I      +   +DIWS G  + E+ +  + PY        +  + +    P
Sbjct: 189 PIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP 246

Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRP 386
             +         + +C Q  P+ RP
Sbjct: 247 CSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 24/156 (15%)

Query: 193 EIALLSRFEHENIVQYYGT-----------DKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
           E  LL    H ++++   T               S LY +L   TK S     +   +  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL---TKRS-----RPLPIDQ 158

Query: 242 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSC 300
           + +    +QIL GL+YLH Q ++HRD+K  NI ++    V + D G A+   +       
Sbjct: 159 ALI--IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216

Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML 336
            GT    APEV+      Y   ADIWS G  + EML
Sbjct: 217 AGTVETNAPEVL--ARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 66/257 (25%), Positives = 99/257 (38%), Gaps = 63/257 (24%)

Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VY+G     ++     +V   +L +      Q   +  QE  L+S  +H NI
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---------------- 249
           V   G    E    +  E +  G L      + +R+S  S                    
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 250 -----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
                QI  G++YL     VHRD+   N LV    +VK++DFGL++     D    +  +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 305 F----WMAPEVINNKNKGYG---LPADIWSLGCT-------------------VLEMLTS 338
                WM PE I      YG     +DIWS G                     V+EM+ S
Sbjct: 187 LLPVRWMPPEAIL-----YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241

Query: 339 -QIPYAPMECMAALFKI 354
            Q+   P +C A ++ +
Sbjct: 242 RQLLPCPEDCPARVYAL 258

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 64.0 bits (156), Expect = 4e-12
 Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 22/176 (12%)

Query: 239 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
           L + ++ A   Q L  L+ LH Q      +   + L+  +GSV       A  T      
Sbjct: 14  LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV-------AFKTPEQS-- 64

Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI---- 354
             R   ++MAPEVI  + + Y   ADI+SLG T+ E L  ++PY     ++A+ +I    
Sbjct: 65  --RPDPYFMAPEVI--QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120

Query: 355 -----GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                 R        S ++  +DF++ C    P  R  A   L H           
Sbjct: 121 MPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 10/153 (6%)

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
           ++ Q+  G+++L  ++ VHRD+   N+L+     VK+ DFGLA+    +     +G+ F 
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 306 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF--KIGRGSP 359
              WMAPE I N    Y   +D+WS G  + E+ T    PY P   M   F   I RG  
Sbjct: 304 PLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPY-PELPMNEQFYNAIKRGYR 360

Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
              P   S +  + +++C +     RP  +QL+
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 8/153 (5%)

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
           Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G+A  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 306 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSPP 360
              WMAPE I +K   Y   +D+WS G  + E+ +    PY  ++      + +  G+  
Sbjct: 239 PLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             P++ + +    +  C Q +P +RPT + L++
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 10/152 (6%)

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK-SCR 301
           ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+   +ND    VK + R
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNAR 275

Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSP 359
               WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K + RG  
Sbjct: 276 LPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333

Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
              PD    +    +K C  + P +RPT +Q+
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 8/154 (5%)

Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
           +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  + +     +G A 
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 306 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSP 359
               WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K I  G  
Sbjct: 278 LPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
              P+    +  D +K C   +P  RPT  Q++ 
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 45/150 (30%), Positives = 64/150 (42%), Gaps = 5/150 (3%)

Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 252
           E  +L    H +I+Q  GT        + L          L  + ++    + A  R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAP 309
             ++YLH+  ++HRDIK  NI ++  G V L DFG A        N      GT    AP
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           E++      YG   DIWS G  + EM T  
Sbjct: 253 ELL--ARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 65/270 (24%), Positives = 107/270 (39%), Gaps = 44/270 (16%)

Query: 150 LGRGSFGSVYEGISDDGFFFA------VKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEH 202
           LG   FG VY+G       F        + V++     +A+  +  + + E  + SR +H
Sbjct: 13  LGEDRFGKVYKG-----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67

Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLR-----------DSQVSA---- 246
            NIV   G   K++    IF    +  S  +L++   +R           D  V +    
Sbjct: 68  PNIVCLLGVVTKEQPLSMIF----SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123

Query: 247 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 301
                   QI  G+++L    VVH+D+   N+LV    +VK++D GL +     D     
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183

Query: 302 GTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR 356
           G +     WM+PE I      + + +DIWS G  + E+ +  + PY        +  I  
Sbjct: 184 GNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241

Query: 357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRP 386
               P PD         + +C    P+ RP
Sbjct: 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 48/161 (29%), Positives = 68/161 (42%), Gaps = 31/161 (19%)

Query: 239 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
           L  +QV+A  RQ+L  + Y+H + ++HRDIK  N+LV+    + L DFG A        +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF-----AR 311

Query: 299 SCRGTAFWM---------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA 349
               T F           APEV+      Y    DIWS G  + E              A
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVL--AGDPYTPSVDIWSAGLVIFEAAVHT---------A 360

Query: 350 ALFKIGRGSPPPIPDSLSKDAQDF-IKQCVQVNPNDRPTAA 389
           +LF   RG      +    DAQ   I +  QV+ ++ P  A
Sbjct: 361 SLFSASRG-----DERRPYDAQILRIIRQAQVHVDEFPQHA 396

Length = 461

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 150 LGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G G FG V  G  + G+  A   VKE+    + S + Q   +  +E       +H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKEL----RVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--------QVSAYTRQILLGLKYL 258
           Q  G   + +   + +E    G L    +     +         Q  A   +I LGL +L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEVINN 314
           H  + +H D+   N L+ A+ +VK+ D+GL+      D        +    W+APE+++ 
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 315 KNKGYGLPAD------IWSLGCTVLEM--LTSQIPY 342
            + G  L  D      +WSLG T+ E+  L SQ PY
Sbjct: 177 VH-GNLLVVDQTKESNVWSLGVTIWELFELGSQ-PY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 33/259 (12%)

Query: 150 LGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+G+F  +++GI     D       EV L       +       +  +++S+  H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 207 QYYGTD--KDESKLYIFLELVTKGSL-LNLYQRYHLRDS----QVSAYTRQILLGLKYLH 259
             YG     DES +    E V  GSL   L +  +L +     +V+   +Q+   L +L 
Sbjct: 63  LNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVA---KQLAWALHFLE 117

Query: 260 DQDVVHRDIKCANILV-----DANGS---VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 311
           D+ + H ++   N+L+        G+   +KL+D G++      ++   R    W+ PE 
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--WVPPEC 175

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAAL-FKIGRGS-PPPIPDSLSK 368
           I N  +   L AD WS G T+ E+ +    P + ++    L F   R   P P    L+ 
Sbjct: 176 IENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELA- 233

Query: 369 DAQDFIKQCVQVNPNDRPT 387
              + I QC+   P+ RP+
Sbjct: 234 ---NLINQCMDYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 33/260 (12%)

Query: 150 LGRGSFGSVYEGI-------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FE 201
           LGRG+   +Y GI        DDG+ +  +   +L     + + IS    E A + R   
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 202 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLG 254
           H++IV  YG   +D     I +E   +   L+L+     R S V          +Q+   
Sbjct: 63  HKHIVLLYGVCVRDVEN--IMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASA 117

Query: 255 LKYLHDQDVVHRDIKCANILVDANG-------SVKLADFGLAKATKLNDVKSCRGTAFWM 307
           L YL D+D+VH ++   NIL+   G        +KL+D G+   T L+  + C     W+
Sbjct: 118 LSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSR-QECVERIPWI 175

Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEM-LTSQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           APE + + +K   + AD WS G T+ E+    +IP                     P   
Sbjct: 176 APECVED-SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS-- 232

Query: 367 SKDAQDFIKQCVQVNPNDRP 386
            K+  D +  C+  +PN RP
Sbjct: 233 CKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 8/98 (8%)

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWM 307
           R++L  L YLH + ++HRD+K  NI +D   +  L DFG A K     D   C G   W 
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG---WS 248

Query: 308 APEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIP 341
                N+        Y    DIWS G  + EM    + 
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 29/230 (12%)

Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDE-SKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
           ++  +E AL +R  H NIV    + +     L+   E V   +L  +       D  + A
Sbjct: 23  ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA----DGALPA 78

Query: 247 YTR-----QILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGL---------A 289
                   Q+L  L   H+Q +VHRD+K  NI+V   G     K+ DFG+         A
Sbjct: 79  GETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 290 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA 349
               L       GT  + APE +  + +     +D+++ G   LE LT Q          
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAE 196

Query: 350 ALFKIGRGSPPP--IPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
            L++  + SP    +P  +        +++ +  +P  R  +A  L   F
Sbjct: 197 ILYQ--QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 67/292 (22%), Positives = 111/292 (38%), Gaps = 73/292 (25%)

Query: 150 LGRGSFGSVYEGI---------SDDGFFFAVKEVSLLDQGSQAKQSISQLE---QEIAL- 196
           LG+G+  ++Y+G           +D        V   + G + +  +  L+   ++IAL 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 197 -------LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT- 248
                  +S+  H ++   +G     S+  +  E V  G L    ++   R       T 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122

Query: 249 -RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGT 303
            +Q+   L YL D+++VH ++   NIL        LA  GLA+ T    KL+D     G 
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNIL--------LARLGLAEGTSPFIKLSD----PGV 170

Query: 304 AF-------------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
           +F             W+APE +   N      AD WS G T+LE+           C   
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGN-SLSTAADKWSFGTTLLEI-----------CFDG 218

Query: 351 LFKIGRGSPPP----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
              +   +P            +P+   K+    I QC+   P  RP+   +L
Sbjct: 219 EVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 48/222 (21%), Positives = 94/222 (42%), Gaps = 18/222 (8%)

Query: 184 KQSISQLEQEIALLSRFEHENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHL 239
           K  I   E EI  L R +  NI++ YG   D      +L + LE  T+G L         
Sbjct: 59  KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE----VLD 114

Query: 240 RDSQVSAYTR-QILL----GLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKATK 293
           ++  +S  T+  + +    GL  L+      ++++   + LV  N  +K+   GL K   
Sbjct: 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174

Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 353
               K+     +  + +++N+    Y +  DI+SLG  + E+ T +IP+  +     ++ 
Sbjct: 175 SPPFKNVNFMVY-FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYD 232

Query: 354 --IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             I + +   +P     + +  ++ C   +   RP   ++L 
Sbjct: 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274

Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 51/151 (33%), Positives = 66/151 (43%), Gaps = 33/151 (21%)

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +    RQ+L GL+ LH   +VHRDIK  N+LV  +G VK+ DFG A       V  C G 
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA-------VDMCTGI 363

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFK-----IGRG 357
            F          N  YG+    +S      E++  Q  P AP   MAAL        GR 
Sbjct: 364 NF----------NPLYGMLDPRYS---PPEELVMPQSCPRAPAPAMAALLSPFAWLYGR- 409

Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA 388
             P + DS +      ++ CV   P  RP A
Sbjct: 410 --PDLFDSYTAGVL-LMQMCV---PELRPVA 434

Length = 507

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 30/117 (25%)

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL----------NDVKS 299
           +I   ++Y+H + V+HRD+K  NIL+   G V + D+G A   KL          ++   
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 300 CR----------GTAFWMAPEVINNKNKGYGLPA----DIWSLGCTVLEMLTSQIPY 342
           C           GT  +MAPE      +  G+PA    DI++LG  + +MLT   PY
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE------RLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 62/281 (22%), Positives = 111/281 (39%), Gaps = 46/281 (16%)

Query: 150 LGRGSFGSV-----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR----- 199
           +G G FG V     Y           VKE+         K + S  EQ   L        
Sbjct: 3   IGNGWFGKVLLSEIYTDTG--VARVVVKEL---------KANASSKEQNEFLQQGDPYRI 51

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTR---QILLG 254
            +H NI+Q  G   +     +  E    G L +    +++H R+SQ+    R   +I  G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           + ++H  + +H D+   N  + ++ +VK+ D+G+  +    D             W+APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 311 VINNKNKGY-----GLPADIWSLGCTVLEML-TSQIPYAPMECMAALFKIGRGS----PP 360
           ++   + G        P+++W+LG T+ E+   +  PY+ +     L  + +        
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           P  +    +    + Q   ++P  R TA +      V RLL
Sbjct: 232 PQLELPYSERWYEVLQFCWLSPEKRATAEE------VHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFF---AVKEVSLLDQGSQAKQSI---SQLEQE-IAL 196
           W+   L+G G FG VYE            AV ++  L+  +   +++   +  + + IAL
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 197 LSRF---EHENIVQYYGTDK-DESKLY---IFLELVTKGSLLNLYQRYHLRDSQ-VSAYT 248
                  +H  I +YYG       ++Y   I LE + + +   +++R   ++ + +    
Sbjct: 74  WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIM 132

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 289
           + +L  L+Y+H+  + H DIK  NI+VD N    + D+G+A
Sbjct: 133 KDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 72/315 (22%), Positives = 131/315 (41%), Gaps = 60/315 (19%)

Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI 187
           S +S +     I++  ++ +++ RG  G+ Y+G S  +G  F VKE++ ++       SI
Sbjct: 677 SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-------SI 729

Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS----LLNL-YQRYHLRDS 242
                EIA + + +H NIV+  G  + E   Y+  E +   +    L NL ++R      
Sbjct: 730 P--SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWER------ 781

Query: 243 QVSAYTRQILLG----LKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 295
                 R+I +G    L++LH      VV  ++    I++D      L    L+    L 
Sbjct: 782 -----RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC 833

Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKI 354
               C  ++ ++APE    + K     +DI+  G  ++E+LT + P  A      ++ + 
Sbjct: 834 TDTKCFISSAYVAPE--TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Query: 355 GRGS----------PPPIPDSLSKDAQDFIK------QCVQVNPNDRPTAAQLLDHPFVK 398
            R             P I   +S +  + ++       C   +P  RP A  +L     K
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL-----K 946

Query: 399 RLLATNSGSASPYLG 413
            L + +  S+S   G
Sbjct: 947 TLESASRSSSSCVTG 961

Length = 968

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 20/42 (47%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 289
           RQIL  L  LH   +VHRD+K  NI+    +GS K+ D G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 6/98 (6%)

Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK--IGRGSP 359
           GT  ++APE++    K +G   D W+LG  + E LT  IP    E    +F+  + R  P
Sbjct: 542 GTPDYLAPELL--LGKPHGPAVDWWALGVCLFEFLTG-IPPFNDETPQQVFQNILNRDIP 598

Query: 360 PPIPD-SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
            P  +  LS +AQ+ I+  + ++P  R    +L  HP 
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	415
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
smart00090	237	RIO RIO-like kinase.	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
KOG1243	690	consensus Protein kinase [General function predict	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.43
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.1
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.94
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.9
COG4248	637	Uncharacterized protein with protein kinase and he	98.9
PRK09902	216	hypothetical protein; Provisional	98.83
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.68
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.6
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.58
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.53
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.38
KOG2270	520	consensus Serine/threonine protein kinase involved	98.36
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.35
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.34
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.13
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.09
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.99
PRK10593	297	hypothetical protein; Provisional	97.89
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.76
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.66
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.63
PRK05231	319	homoserine kinase; Provisional	97.48
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.41
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.3
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.27
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.26
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.89
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.76
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.67
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.59
PLN02756	418	S-methyl-5-thioribose kinase	96.57
PLN02236	344	choline kinase	96.57
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.54
PRK12396	409	5-methylribose kinase; Reviewed	96.25
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.24
PRK06148	1013	hypothetical protein; Provisional	96.08
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.08
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.07
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.75
PRK11768	325	serine/threonine protein kinase; Provisional	95.68
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.21
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.93
PTZ00384	383	choline kinase; Provisional	94.91

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-59  Score=437.31  Aligned_cols=263  Identities=32%  Similarity=0.485  Sum_probs=224.4

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchh--HHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      +.+.+.|.+.+.||+|+||.|-+|.. ++++.||||++.+.......  ......+.+|+++|++++|||||+++++|..
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            34677899999999999999999998 89999999999865433322  1122346799999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEeecccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAK  290 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vkl~DFGla~  290 (415)
                      .+..||||||++||+|++.+-. ..+.+...+.+++|++.||.|||++||+||||||+|||+..+   ..+||+|||+|+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            9999999999999999997755 468888889999999999999999999999999999999866   679999999999


Q ss_pred             ccccCC-cccCCCCccccccccccccccCC-CchhhHHHHHHHHHHHHcCCCCCCCccHHH-HHHHHhcCCC---CCCCC
Q 014986          291 ATKLND-VKSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRGSP---PPIPD  364 (415)
Q Consensus       291 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~-~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~---~~~~~  364 (415)
                      ...... ..+.||||.|.|||++..++..+ ..++|+|||||+||-+|+|.+||....... ....|.++..   ++...
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            886443 56789999999999997765544 448999999999999999999997654333 4445555543   34556


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+++++.+||++||.+||++|||++|+|+||||+..
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            899999999999999999999999999999999943

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4e-58  Score=427.01  Aligned_cols=258  Identities=33%  Similarity=0.541  Sum_probs=234.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      -.++|+++++||+|+||+||+++. ++++.||+|++++..-.  .....++..+|..||..++||+||+++..|++..++
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv--~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV--EKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh--hhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            357899999999999999999998 88999999999764432  234567899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      |||+||+.||.|+.++++ ..|++..++.|+.+|+.||.|||++|||||||||+|||++.+|+++|+|||||+.....  
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999999985 67999999999999999999999999999999999999999999999999999865433  


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      .....|||+.|||||++.+.  +|+.++|+||||+++|+|++|..||.+.+......+|.++.....+..++.++++||+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK  258 (357)
T ss_pred             ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence            34557999999999999765  4999999999999999999999999999999999999988877777789999999999


Q ss_pred             HhhhhCCCCCC----CHHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRP----TAAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rp----s~~eil~hp~f~~~~  401 (415)
                      ++|..||++|.    .+.+|-+||||+.+-
T Consensus       259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             HHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            99999999996    689999999998763

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-57  Score=443.71  Aligned_cols=253  Identities=36%  Similarity=0.638  Sum_probs=229.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .+|..+++||+|||++||++++ .+|+.||+|+|.+....  .....+.+.+|++|.+.++|||||+++++|++.+++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~--k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK--KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc--CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            5699999999999999999999 99999999999853322  23345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Cc
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~  297 (415)
                      |+|+|..++|..++++ ..+++.+++.+++||+.||.|||+++|+|||||..|+|++.+.+|||+|||||......  ..
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            9999999999999875 57999999999999999999999999999999999999999999999999999987644  45


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      .+.||||.|.|||+++..+  ++..+||||+||+||.||+|++||....-.+.+.+|..... .+|..++.++++||.+|
T Consensus       176 ~TlCGTPNYIAPEVl~k~g--HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSG--HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             ceecCCCcccChhHhccCC--CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHH
Confidence            6789999999999997544  89999999999999999999999999888888877766554 47889999999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      |+.||.+|||+++||.|+||+.
T Consensus       253 L~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             hcCCcccCCCHHHHhcCHhhhC
Confidence            9999999999999999999943

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-57  Score=419.65  Aligned_cols=262  Identities=31%  Similarity=0.600  Sum_probs=237.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  216 (415)
                      ....+.+.++.||+|..|+||++++ .+++.+|+|++..    .......+++.+|+++++.++||+||++|+.|..+. 
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            3345677889999999999999999 7899999999954    223445678899999999999999999999999998 


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .++|+||||++|+|.+++.. .++++.....++.++++||.|||. ++||||||||+|||++..|.|||||||.++....
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            59999999999999998876 579999999999999999999996 8999999999999999999999999999987776


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc-----cHHHHHHHHhcCCCCCCCCc-ccH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-----ECMAALFKIGRGSPPPIPDS-LSK  368 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~  368 (415)
                      ....+..||..|||||.+.+..  |+.++||||||+.++|+++|+.||...     ...+.+..|..+.++.+|.. +|+
T Consensus       232 S~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  232 SIANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP  309 (364)
T ss_pred             hhcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence            6667888999999999997654  999999999999999999999999774     77889999999999999987 999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      ++++|+..||++||.+|+++.++++|||+++....+..
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence            99999999999999999999999999999987765544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-56  Score=401.87  Aligned_cols=255  Identities=31%  Similarity=0.529  Sum_probs=233.2

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||.|+||+|.+++. .+|..||+|++.+.+.  -..++.++..+|.++|+.+.||+++++++.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v--VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV--VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH--HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            67899999999999999999998 7899999999875332  23456788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      |||||++||.|+.++++ .+|++..++.|+.||+.||+|||+++|+||||||+|||+|.+|.+||+|||+|+..... ..
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~  199 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TW  199 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EE
Confidence            99999999999999987 57999999999999999999999999999999999999999999999999999988766 55


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..||||.|+|||++..++  |+.++|+||||+++|||+.|.+||......+...+|..+... +|..++.++++||.++|
T Consensus       200 TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-FPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-CCcccCHHHHHHHHHHH
Confidence            678999999999996654  999999999999999999999999999999999999887655 78999999999999999


Q ss_pred             hhCCCCC-----CCHHHHHcChhhHhhh
Q 014986          379 QVNPNDR-----PTAAQLLDHPFVKRLL  401 (415)
Q Consensus       379 ~~dP~~R-----ps~~eil~hp~f~~~~  401 (415)
                      ++|-.+|     ....+|.+||||+.+.
T Consensus       277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  277 QVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             hhhhHhhhcCcCCCccccccCccccccc
Confidence            9999999     3578999999999653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-55  Score=396.68  Aligned_cols=259  Identities=29%  Similarity=0.528  Sum_probs=223.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|+.+.++|+|+||+||++++ .+|+.||||++.-..   ......+-..||+++|++++|+|+|.++.+|.....+++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese---dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE---DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC---ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            4688999999999999999999 789999999987422   223444567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc-c-CC
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-L-ND  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~-~-~~  296 (415)
                      |+|||+. ++.+.+++  .+++...++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... + ..
T Consensus        79 VFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             Eeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            9999998 56566655  479999999999999999999999999999999999999999999999999999765 3 33


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--------------  362 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------  362 (415)
                      .+..+.|.+|+|||++.+.. .|+.++||||+||++.||++|.+.|.+.+..+++..|.+.....+              
T Consensus       158 YTDYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            55677899999999998743 489999999999999999999999999999999887754322211              


Q ss_pred             ----C------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          363 ----P------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       363 ----~------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                          |            ..++..+.+|+++||..||.+|++.+++|.|+||+.+.....
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~  295 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIEREL  295 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHH
Confidence                1            135667889999999999999999999999999998877543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-54  Score=415.18  Aligned_cols=259  Identities=32%  Similarity=0.556  Sum_probs=228.0

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  215 (415)
                      ++...+|..++.||+|+|++||+|++ .+++.||||++.+..-  ...+..+.+.+|-..|..| .||+|++||..|+++
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I--ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI--IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH--HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            45567899999999999999999999 8999999998864322  2223345567888889888 899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..+|+|+||+++|+|.+++++. .|++..++.|+.||+.||+|||++|||||||||+|||++.|+++||+|||.|+....
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999999999999886 599999999999999999999999999999999999999999999999999986532


Q ss_pred             CC---------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC
Q 014986          295 ND---------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  359 (415)
Q Consensus       295 ~~---------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  359 (415)
                      ..               ..+.+||..|.+||+|....  .+..+|+|+||||||.|+.|.+||.+....-..++|.....
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y  304 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY  304 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence            11               13467999999999997654  78899999999999999999999999988888888776544


Q ss_pred             CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       360 ~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                       .+|+.+++.+++||+++|..||.+|+|+++|.+||||..+.
T Consensus       305 -~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  305 -EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             -cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence             47889999999999999999999999999999999998764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-53  Score=412.44  Aligned_cols=259  Identities=30%  Similarity=0.502  Sum_probs=226.7

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +...++|+++..||+|+||.||+|+. .+|..||+|++++....  ....+++++.|-.+|....+|+||++|..|++..
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~--~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML--KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH--hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            34578999999999999999999998 88999999999865443  3456788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc-
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~-  294 (415)
                      ++||||||++||++..+|.+. .|++..++.|+.+++.||..||+.|+|||||||+|+|||..|++||+||||++.... 
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999999988765 699999999999999999999999999999999999999999999999999852210 


Q ss_pred             ---------------------CC---------------------------cccCCCCccccccccccccccCCCchhhHH
Q 014986          295 ---------------------ND---------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIW  326 (415)
Q Consensus       295 ---------------------~~---------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~Dvw  326 (415)
                                           .+                           ..+.+|||.|||||++.+.+  |+..+|+|
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg--Y~~~cDwW  372 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG--YGKECDWW  372 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC--CCccccHH
Confidence                                 00                           01235999999999997765  99999999


Q ss_pred             HHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC---CCCCCCcccHHHHHHHHHhhhhCCCCCCC---HHHHHcChhhHhh
Q 014986          327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRL  400 (415)
Q Consensus       327 SlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~Rps---~~eil~hp~f~~~  400 (415)
                      |||||+||||.|.+||.+....+...+|.+-.   ..|....++.+++|||.+||. ||++|..   ++||..||||+.+
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            99999999999999999988888877776543   223345688999999999999 9999975   9999999999987


Q ss_pred             h
Q 014986          401 L  401 (415)
Q Consensus       401 ~  401 (415)
                      .
T Consensus       452 ~  452 (550)
T KOG0605|consen  452 D  452 (550)
T ss_pred             C
Confidence            5

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=398.99  Aligned_cols=258  Identities=29%  Similarity=0.550  Sum_probs=228.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ....+|.+.+.||+|+||+||+|++ .++..||||.+.+...   .++..+-+..|+.+|+.++|||||+++++..+++.
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            4567899999999999999999999 7889999999986432   34556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC------CcEEEEeecccc
Q 014986          218 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------GSVKLADFGLAK  290 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~------~~vkl~DFGla~  290 (415)
                      +|||||||.||+|..++++. .+++..++.++.||+.||++||+++||||||||+|||++..      -.+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999876 89999999999999999999999999999999999999864      358999999999


Q ss_pred             ccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--CCCCCCccc
Q 014986          291 ATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--PPPIPDSLS  367 (415)
Q Consensus       291 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s  367 (415)
                      ...... ....||++.|||||+++...  |+.|+|+||+|+|+|+|++|+.||......+.+..+.++.  .+.++..++
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~~--YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s  241 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQQ--YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS  241 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhcc--ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence            887654 45678999999999996544  9999999999999999999999999888777777666554  345667788


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ....+|+...|+.++..|.++.+-+.|+++..-.
T Consensus       242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            8889999999999999999999999999886543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=410.42  Aligned_cols=260  Identities=31%  Similarity=0.528  Sum_probs=229.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  216 (415)
                      ...+.|.+++.||+|+||+|++|.+ .++..||+|++.............+.+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4467899999999999999999988 78999999976643221111234556779999999999 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeecccccc--
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKAT--  292 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFGla~~~--  292 (415)
                      ++|||||||.||+|++++.. .++.+..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++...  
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999999999998876 689999999999999999999999999999999999999999 99999999999987  


Q ss_pred             ccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcc-cHHHH
Q 014986          293 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQ  371 (415)
Q Consensus       293 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-s~~l~  371 (415)
                      ........|||+.|+|||++.+.....+.++||||+|++||.|++|+.||..........++..+ ...+|..+ +.+++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-~~~~p~~~~S~~~~  252 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-EFKIPSYLLSPEAR  252 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-CccCCCCcCCHHHH
Confidence            34456788999999999999776534478999999999999999999999997777677675554 44478888 99999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      +||.+||.+||.+|+|+.+|++||||+.
T Consensus       253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  253 SLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            9999999999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-54  Score=387.40  Aligned_cols=254  Identities=35%  Similarity=0.614  Sum_probs=225.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeee-eeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~  216 (415)
                      ....+|++.++||+|+||+||++++ .+|..+|.|.+....   ...+..+....|+.+|++++|||||++|+ .|.+++
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~---md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM---MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh---ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            3467899999999999999999998 899999999987432   33445567889999999999999999999 566665


Q ss_pred             E-EEEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCcEEEcCCCcEEEEee
Q 014986          217 K-LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHD--QD--VVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       217 ~-~~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~--~~--IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                      . ++||||||.+|+|..+++.+     .+++..+++++.|++.||.++|+  ..  |+||||||.||+++.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 89999999999999988653     59999999999999999999999  44  999999999999999999999999


Q ss_pred             ccccccccCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC-
Q 014986          287 GLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-  363 (415)
Q Consensus       287 Gla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-  363 (415)
                      ||++......  ..+.+|||.||+||.+.+.+  |+.++||||+||++|||+.-+.||.+....+...+|.++..+++| 
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESG--YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCC--CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            9999876554  45678999999999996654  999999999999999999999999999888899999999988888 


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ...|.+++.||..|+.+||++||+.     +|+++.+.+
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence            7889999999999999999999986     566666655

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-53  Score=397.53  Aligned_cols=256  Identities=52%  Similarity=0.842  Sum_probs=222.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC--E
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--K  217 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~  217 (415)
                      ...|..++.||+|+||+||++.+ ++|..+|||.+.....    . ..+.+.+|+.+|+.++|||||++++......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            34688999999999999999999 6699999999976411    1 1667899999999999999999999744444  6


Q ss_pred             EEEEEeccCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEeecccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKL  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~--l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~DFGla~~~~~  294 (415)
                      ++|+|||+.+|+|.+++.+++  +++..++.+++||++||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999998865  899999999999999999999999999999999999999 79999999999986652


Q ss_pred             -----CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC-ccHHHHHHHHhcCC-CCCCCCccc
Q 014986          295 -----NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGS-PPPIPDSLS  367 (415)
Q Consensus       295 -----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~-~~~~~~~~s  367 (415)
                           .......||+.|||||++.. +.....++|||||||++.||+||..||.. ......+..+.... .+.+|..++
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls  249 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS  249 (313)
T ss_pred             ccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence                 23445779999999999974 22233599999999999999999999988 56666677776555 457899999


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .++++||.+||..||.+||||.++|+|||++....
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999999987654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-52  Score=383.44  Aligned_cols=261  Identities=28%  Similarity=0.423  Sum_probs=224.6

Q ss_pred             CcceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee-
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-  212 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-  212 (415)
                      ....+.++.|+.++.|++|+||.||+|++ ++++.||+|+++......  ..-+ ...|||.+|.+++|||||.+-.+. 
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~--GFPI-tsLREIniLl~~~H~NIV~vkEVVv  145 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE--GFPI-TSLREINILLKARHPNIVEVKEVVV  145 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC--CCcc-hhHHHHHHHHhcCCCCeeeeEEEEe
Confidence            45667788999999999999999999999 899999999998644221  1112 345999999999999999987764 


Q ss_pred             -ecCCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          213 -KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       213 -~~~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                       .+-+.+|||||||+. +|..++...  .|...+++.++.|++.||+|||.++|+|||||++|+|++..|.+||+|||||
T Consensus       146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLA  224 (419)
T KOG0663|consen  146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLA  224 (419)
T ss_pred             ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchh
Confidence             455679999999998 899988764  6999999999999999999999999999999999999999999999999999


Q ss_pred             cccccC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC------
Q 014986          290 KATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------  361 (415)
Q Consensus       290 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------  361 (415)
                      +.+...  ..+..+.|.+|+|||++.+. +.|+.++||||+|||+.||+++++.|.+....+++.+|.+....|      
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            987654  35667799999999999875 458999999999999999999999999999988888875533222      


Q ss_pred             ------------------------CCC-cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          362 ------------------------IPD-SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       362 ------------------------~~~-~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                                              ++. .+++...+|++.+|..||.+|.||.+.|+|+||.+.
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                                    111 156889999999999999999999999999999983

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.7e-52  Score=368.32  Aligned_cols=254  Identities=30%  Similarity=0.485  Sum_probs=222.2

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .+|...++||+|.||.||+|++ .+|+.||||+++.......   ......||++.|+.++|+||+.++++|...+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG---i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG---INRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC---ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            4688899999999999999999 8999999999987533211   12345699999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc-
Q 014986          221 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-  297 (415)
                      |+||++. +|...++..  -++...++.|+.+++.||+|||+++|+||||||.|+||+.+|.+||+|||+|+.....+. 
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9999987 899988764  589999999999999999999999999999999999999999999999999998765543 


Q ss_pred             -ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC-------------
Q 014986          298 -KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-------------  363 (415)
Q Consensus       298 -~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------  363 (415)
                       ...+.|.+|+|||++.|.. .|+..+||||.|||+.||+-|.+-|.+.+..+++..|.+...+|.+             
T Consensus       158 ~~~~V~TRWYRAPELLfGsr-~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSR-QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             cccceeeeeccChHHhccch-hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence             3336899999999998754 4899999999999999999999999999999999888665544322             


Q ss_pred             --------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          364 --------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       364 --------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                                    ...+.++.+|+.+||..||.+|+|+.|+|+|+||+..
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                          1345678999999999999999999999999999974

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-52  Score=411.32  Aligned_cols=260  Identities=27%  Similarity=0.464  Sum_probs=229.1

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  214 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  214 (415)
                      .....++|...++||+|+||+|+++.. .+++.||||++++..-  .....++.++.|.+|+.... ||++++++.+|++
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I--l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT  440 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI--LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT  440 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce--eccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence            345577999999999999999999998 7889999999986433  33445677888999988775 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc-
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-  293 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~-  293 (415)
                      .+++|+||||+.||++..+.+...|++..++.|++.|+.||.|||++||||||||.+|||+|.+|++||+||||++... 
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            9999999999999996666666789999999999999999999999999999999999999999999999999999654 


Q ss_pred             -cCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          294 -LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       294 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                       .+...+.||||.|||||++.+..  |+.++|+|||||+|||||+|..||.+.+..+....|.. .....|..++.++.+
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~--Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQS--YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-DEVRYPRFLSKEAIA  597 (694)
T ss_pred             CCCccccccCChhhcChhhhccCc--ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-CCCCCCCcccHHHHH
Confidence             33456688999999999996654  99999999999999999999999998776666665554 555689999999999


Q ss_pred             HHHHhhhhCCCCCCC-----HHHHHcChhhHhhh
Q 014986          373 FIKQCVQVNPNDRPT-----AAQLLDHPFVKRLL  401 (415)
Q Consensus       373 Li~~~L~~dP~~Rps-----~~eil~hp~f~~~~  401 (415)
                      +++++|..||++|+.     +.+|..||||+.+.
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            999999999999986     58999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-52  Score=408.36  Aligned_cols=263  Identities=30%  Similarity=0.567  Sum_probs=237.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      .++-|++++-||.|+.|.|-+|++ .+|+..|||+|.+......  .....+++||-||+.+.||||+++|+++.+..++
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~--s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSS--SQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeecccccccc--ccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            356799999999999999999999 8999999999986543322  2345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-C
Q 014986          219 YIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~  296 (415)
                      |+|+||+.||.|++++- ++++++.++.++++||+.|+.|+|..+|+||||||+|+|++..++|||+|||+|.....+ -
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            99999999999999774 568999999999999999999999999999999999999999999999999999754433 4


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      ..+.||+|.|.+||++.|.. +.+.++||||-|+|||.||+|++||++.+....+.++.+|... +|..++.++++||.+
T Consensus       168 LeTSCGSPHYA~PEIV~G~p-YdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~-MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRP-YDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE-MPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccCCCcccCCchhhcCCC-CCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc-CCCcCCHHHHHHHHH
Confidence            66788999999999998765 3589999999999999999999999998888899999888765 689999999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      ||.+||.+|+|.+||++|||++.....+..
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCCCCChh
Confidence            999999999999999999999998876655

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=398.49  Aligned_cols=263  Identities=29%  Similarity=0.466  Sum_probs=226.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  216 (415)
                      .+.++|.+.+.||.|+||.||+|.. .++..||||.++.+-..   .+. ..-.||++-|++++ |||||++..++.+.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee-~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            3457899999999999999999998 78999999988743222   111 22358999999998 999999999999888


Q ss_pred             -EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 -KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 -~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                       .+|+|||||+. +|+.+++..  .|++..++.|+.||++||+|+|.+|+.||||||+|||+..+..|||+|||||+...
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence             99999999987 899998753  69999999999999999999999999999999999999989999999999999876


Q ss_pred             cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC----------
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI----------  362 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------  362 (415)
                      .. ..+..+.|.+|+|||++... ..|+.++|||++|||++|+++-++.|.+.+..+++.+|......|.          
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            55 45667799999999999754 4589999999999999999999999999999999998865433321          


Q ss_pred             -------------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          363 -------------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       363 -------------------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                         -...+.++.+||.+||..||++||||.++|+||||+........+
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~~a  304 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGSSA  304 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccccc
Confidence                               123678999999999999999999999999999999887764443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-52  Score=396.32  Aligned_cols=259  Identities=28%  Similarity=0.499  Sum_probs=224.4

Q ss_pred             CcceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      +...+..+.|+.+++||+|+||.||+|++ .+|+.||+|++.......   .......+||.||++|+||||++|.+...
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~---~~~~t~~REI~ILr~l~HpNIikL~eivt  186 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE---GFPITAIREIKILRRLDHPNIIKLEEIVT  186 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC---cchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence            33455677899999999999999999999 899999999998754332   23345679999999999999999999876


Q ss_pred             cC--CEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          214 DE--SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       214 ~~--~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      +.  ..+|||+|||+. +|.-++...  .|++.+++.|++||+.||+|+|++||+|||||.+|||||.+|.+||+|||||
T Consensus       187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence            65  689999999998 888888764  7999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-----
Q 014986          290 KATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----  361 (415)
Q Consensus       290 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  361 (415)
                      +++....   .+..+.|.+|+|||++.+.. .|+.++|+||.||||.||++|++.|.+....+++.+|.+.-..+     
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t-~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGAT-SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCc-ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            9765443   66778999999999998754 58999999999999999999999999999888888775422211     


Q ss_pred             ----C-------------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          362 ----I-------------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       362 ----~-------------------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                          +                   ...++..+.+|+..||..||.+|.||.++|+|+||.
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                0                   124677889999999999999999999999999993

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.3e-51  Score=393.85  Aligned_cols=260  Identities=30%  Similarity=0.533  Sum_probs=232.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|.+.+.||+|+||+||+|+. .+.+.||+|.+.+..+   ..+.++.+.+|++|++.++|||||.++++|++..++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr---~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR---NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC---chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            5789999999999999999998 7899999999976443   34567788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      |+||+.| +|+.++.. ..++++.++.++.|++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+....+.  .
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            9999998 99998875 579999999999999999999999999999999999999999999999999999877654  4


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      .++.|||.|||||++.+  ..|+..+|+||||||+|||++|++||...+..+....|.. .+..+|..++..+..||+.+
T Consensus       158 tsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~-d~v~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK-DPVKPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-CCCCCcccccHHHHHHHHHH
Confidence            56779999999999964  4599999999999999999999999998877766666554 55567789999999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhhhhCCCCC
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLLATNSGSA  408 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~  408 (415)
                      |.+||.+|+|-.+++.|||.+.-+.-....+
T Consensus       235 L~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~  265 (808)
T KOG0597|consen  235 LIKDPAQRLTWTDLLGHPFWKGKINIAELPA  265 (808)
T ss_pred             hhcChhhcccHHHHhcChHHhhhhhhhcccc
Confidence            9999999999999999999998776444333

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-51  Score=396.48  Aligned_cols=253  Identities=34%  Similarity=0.621  Sum_probs=229.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|.....||+|+.|.||.|+. .+++.||+|.+....+..     .+-+.+|+.+|+..+|+|||++++.|...+.++
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            45688888999999999999998 889999999998644332     345779999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      .||||++||+|.+.+....+++.++..+++++++||+|||.+||+|||||.+|||++.+|.+||+|||+|.......  .
T Consensus       347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998765544  4


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~  375 (415)
                      ...+|||+|||||++..  +.|+.++||||||++++||+-|++||-+.....+++.|.....+.  .++.+|..+++||.
T Consensus       427 ~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             ccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence            55779999999999955  449999999999999999999999999888888888887776654  46789999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +||..|+++|+++.|+|+||||+..
T Consensus       505 ~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHhhcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999999543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-51  Score=359.97  Aligned_cols=257  Identities=29%  Similarity=0.496  Sum_probs=231.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ..+++|++++.||+|.||.||+|+. +++..||+|++.+..  ....+...++.+|+.|.+.|+||||+++|++|.+...
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            3478999999999999999999998 789999999987533  2334455789999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHh--h-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQ--R-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~--~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +|+++||...|+|+..++  . ..+++..+..|+.|++.||.|+|.+++|||||||+|+|++.+|.+||+|||.+.....
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999999998  3 3599999999999999999999999999999999999999999999999999988777


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      +.....|||..|.+||+..+..  ++..+|+|++|++.||++.|..||......+...+|.+. ...+|..++.+++|||
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKFPSTISGGAADLI  253 (281)
T ss_pred             CCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccCCcccChhHHHHH
Confidence            7778889999999999996654  889999999999999999999999998866666666544 4457899999999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+||..+|.+|.+..|+++|||+...
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999999764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-50  Score=372.19  Aligned_cols=267  Identities=28%  Similarity=0.451  Sum_probs=226.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec---
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  214 (415)
                      .+..+|...+.||+|+||.|+.|.+ .+|+.||+|++...-   ...-..++..+|+++|+.++|+||+.+++++..   
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F---~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF---ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh---hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            3455677789999999999999999 899999999986211   223345677899999999999999999998765   


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                        -+.+|+|+|+++- +|...++... +++..++.++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||+|+.
T Consensus        96 ~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              3568999999955 8999998876 99999999999999999999999999999999999999999999999999998


Q ss_pred             cc----cCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC------
Q 014986          292 TK----LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------  361 (415)
Q Consensus       292 ~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------  361 (415)
                      ..    ....+....|.+|+|||++.. ...|+.++||||+|||+.|||+|+..|.+.+...++..|......+      
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            75    344567789999999999854 4459999999999999999999999999988777766554332221      


Q ss_pred             ------------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCCCC
Q 014986          362 ------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP  410 (415)
Q Consensus       362 ------------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~~~  410 (415)
                                              +....++.+.+|+.+||..||.+|+|++|+|.||||..+-..++.+..+
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~  326 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ  326 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence                                    1235788999999999999999999999999999999998877776443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-49  Score=372.12  Aligned_cols=264  Identities=31%  Similarity=0.587  Sum_probs=230.6

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +..-.+.|++.+.||.|.-++||+|+. ..+..||||++...    .-...+..+++|+..|+.++||||++++..|..+
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE----kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE----KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh----hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            444567899999999999999999998 78899999999862    2233467899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ..+|+||.||.+|++.++++..   ++++..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+-..
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999999999753   7999999999999999999999999999999999999999999999999976433


Q ss_pred             ccCC------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-----
Q 014986          293 KLND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----  361 (415)
Q Consensus       293 ~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  361 (415)
                      ....      .....||+.|||||++.....+|+.|+||||||++..||.+|..||.....++.+....++.++.     
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            2211      14457999999999987777789999999999999999999999999999888877776666552     


Q ss_pred             CC----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          362 IP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       362 ~~----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .+    ..++..++.+|..||..||.+|||++++|+|+||+......
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence            11    24677899999999999999999999999999999887643

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-51  Score=360.41  Aligned_cols=258  Identities=29%  Similarity=0.497  Sum_probs=226.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.+.|++.+.||+|.|+.||++.+ .+|+.||+|.+........   ..+.+.+|++|-+.++|||||++.+....+..
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence            4567899999999999999999998 8999999999875443332   45778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHH-HHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~-~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vkl~DFGla~~~~  293 (415)
                      .|||+|++.|++|.. +.++.-+++..+..+++||+.||.|+|.+||+|||+||+|+|+-..   .-+||+|||+|....
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999999999975 5677778999999999999999999999999999999999999643   469999999998776


Q ss_pred             cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC---CCCCCcccHH
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPDSLSKD  369 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~  369 (415)
                      .. ......|||.|||||++..  ..|+..+|||+-|+|||-||.|.+||.+.+.......|..+..   .+..+.++++
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~  242 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE  242 (355)
T ss_pred             CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence            33 2455679999999999954  4599999999999999999999999999887778888877654   3355689999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +++|+++||..||.+|+|+.|+|+|||+++-.
T Consensus       243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  243 AKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            99999999999999999999999999997643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-49  Score=382.21  Aligned_cols=249  Identities=33%  Similarity=0.573  Sum_probs=219.6

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-EEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~l  220 (415)
                      ....+.+.||+|+||+||+|.+.....||+|++.........   .+.|.+|+.+|.+++|||||+++|++.+.. .++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            445666779999999999999876666999999754433322   678999999999999999999999999887 7999


Q ss_pred             EEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEcCCC-cEEEEeecccccccc-
Q 014986          221 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG-SVKLADFGLAKATKL-  294 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~-IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~~-  294 (415)
                      ||||+.+|+|..++..   ..++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++.... 
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999999965   57999999999999999999999999 99999999999999998 999999999987665 


Q ss_pred             -CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-cCCCCCCCCcccHHHHH
Q 014986          295 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       295 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~  372 (415)
                       .......||+.|||||++.+....|+.++||||||+++|||+||+.||......+....+. .+.++.+|..++..+..
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~  277 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSS  277 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence             4455578999999999997433459999999999999999999999999998877777665 55667778889999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~  393 (415)
                      |+..||..||.+||++.+|+.
T Consensus       278 l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  278 LMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999975

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-49  Score=369.82  Aligned_cols=269  Identities=27%  Similarity=0.413  Sum_probs=227.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      -...|+++++||.|.-|+||++.. .++..+|+|++.+....  ..+.+.+.+.|-.||+.++||+++.||..|+.+...
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~--~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA--SRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh--hhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            356899999999999999999998 66799999999753322  244566777899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--
Q 014986          219 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--  293 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--  293 (415)
                      |+|||||.||+|..+.++.   .|++..++.|+.+++.||+|||..|||||||||+||||.++|+|.|+||.|+....  
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999999988753   69999999999999999999999999999999999999999999999999863210  


Q ss_pred             -----c--------------------------C-C------------------------cccCCCCcccccccccccccc
Q 014986          294 -----L--------------------------N-D------------------------VKSCRGTAFWMAPEVINNKNK  317 (415)
Q Consensus       294 -----~--------------------------~-~------------------------~~~~~gt~~y~aPE~l~~~~~  317 (415)
                           .                          . .                        ..+++||-.|+|||++.+.+ 
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-
Confidence                 0                          0 0                        11245899999999997655 


Q ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-CCCCcccHHHHHHHHHhhhhCCCCCCC----HHHHH
Q 014986          318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-PIPDSLSKDAQDFIKQCVQVNPNDRPT----AAQLL  392 (415)
Q Consensus       318 ~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~Li~~~L~~dP~~Rps----~~eil  392 (415)
                       ++.++|||+||+++||||.|..||.+....+.+..+...... +-...++..++|||+++|.+||.+|+.    |+||.
T Consensus       312 -HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 -HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence             889999999999999999999999999999999888765543 122367899999999999999999998    99999


Q ss_pred             cChhhHhhh-hhCCCCCCCCC
Q 014986          393 DHPFVKRLL-ATNSGSASPYL  412 (415)
Q Consensus       393 ~hp~f~~~~-~~~~~~~~~~~  412 (415)
                      +||||+.+. +.-.....|++
T Consensus       391 ~HpFF~gVnWaLir~~~PP~i  411 (459)
T KOG0610|consen  391 RHPFFEGVNWALIRCARPPEI  411 (459)
T ss_pred             cCccccCCChhheeccCCCcC
Confidence            999999875 33344444444

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-50  Score=356.05  Aligned_cols=272  Identities=28%  Similarity=0.477  Sum_probs=238.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  213 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~---~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  213 (415)
                      .+...|.-.+.||+|..++|-++++ .+++.+|+|++......   .......+...+|+.||+++ .||+|+++.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3456788889999999999999988 88999999998754322   22445566778899999998 6999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      .+..+++|+|+|+.|.|++++... .+++...+.|++|++.|+.|||.++|+||||||+|||++.+-++||+|||+++..
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            999999999999999999999764 7999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC-cccCCCCcccccccccc----ccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC---CCCCC
Q 014986          293 KLND-VKSCRGTAFWMAPEVIN----NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPD  364 (415)
Q Consensus       293 ~~~~-~~~~~gt~~y~aPE~l~----~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~  364 (415)
                      .... ....||||+|+|||.+.    ....+|+..+|+|+.|+|||.||.|.+||.....+-.+..|..+..   .+-..
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa  253 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA  253 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence            6554 56788999999999973    3345589999999999999999999999998887777777776653   34456


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCCCC
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP  410 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~~~  410 (415)
                      .++...++||.+||++||.+|+|+.|+|.||||+++.-+....-+|
T Consensus       254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence            7899999999999999999999999999999999998877766666

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-49  Score=373.33  Aligned_cols=264  Identities=30%  Similarity=0.504  Sum_probs=221.7

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccc---------hhHHHHHHHHHHHHHHhcCCCCcEEE
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---------QAKQSISQLEQEIALLSRFEHENIVQ  207 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~  207 (415)
                      +..++.|++++.||+|.||.|-+|++ .+++.||||++.+.....         .....+++..+||.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            45678999999999999999999999 889999999997532211         11112467889999999999999999


Q ss_pred             eeeeeec--CCEEEEEEeccCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 014986          208 YYGTDKD--ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  284 (415)
Q Consensus       208 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~  284 (415)
                      |+.+..+  .+++|||+|||..|.+...-.... +++.+++.|+++++.||+|||.+|||||||||+|+|++.+|+|||+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence            9999765  468999999999998865443344 8999999999999999999999999999999999999999999999


Q ss_pred             eeccccccccC-------CcccCCCCccccccccccccc--cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHh
Q 014986          285 DFGLAKATKLN-------DVKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG  355 (415)
Q Consensus       285 DFGla~~~~~~-------~~~~~~gt~~y~aPE~l~~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~  355 (415)
                      |||.+......       ......|||.|+|||++.+..  ...+.+.||||+|++||.|+.|+.||-+....+...+|.
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            99998755211       133467999999999986522  224778999999999999999999999888888888887


Q ss_pred             cCCCCCCCC--cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          356 RGSPPPIPD--SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       356 ~~~~~~~~~--~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.... +|.  .+.+++++||++||.+||++|++..+|..|||..+-..
T Consensus       333 n~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  333 NDPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             cCccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            65432 333  47899999999999999999999999999999987644

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=363.06  Aligned_cols=261  Identities=25%  Similarity=0.434  Sum_probs=229.5

Q ss_pred             CcceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      .+.+...++|..+++||+|+||.|-+++. .+++.||+|++++.  ....+..+.+...|-++|+..+||++..+...|+
T Consensus       161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKe--viiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKE--VIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ  238 (516)
T ss_pred             ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhh--heeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence            34455678999999999999999999998 89999999988742  2344556778889999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ..+++|+||||+.||.|+-++.+ ..|++..++.+-..|+.||.|||+++|++||||.+|+|+|.||++||+|||||+.-
T Consensus       239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999999999988876 46999999999999999999999999999999999999999999999999999853


Q ss_pred             --ccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          293 --KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       293 --~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                        ........||||.|+|||++...  .|+.++|+|.+|+++|||++|++||++.+..... .+.......+|..+++++
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-eLIl~ed~kFPr~ls~eA  395 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-ELILMEDLKFPRTLSPEA  395 (516)
T ss_pred             ccccceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhHHH-HHHHhhhccCCccCCHHH
Confidence              33456778999999999999554  4999999999999999999999999987755444 444444556899999999


Q ss_pred             HHHHHHhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          371 QDFIKQCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      +.|+..+|.+||++|..     +.||.+|+||..+
T Consensus       396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            99999999999999974     8999999999865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=372.18  Aligned_cols=252  Identities=29%  Similarity=0.452  Sum_probs=219.0

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            688899999999999999998 6899999999874221  1223456688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccC
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC  300 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  300 (415)
                      |||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ....
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~~  158 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTL  158 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-cccc
Confidence            999999999998865 46899999999999999999999999999999999999999999999999998765433 2345


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  380 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  380 (415)
                      +||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...........+..+. ..++..++..+++||++||+.
T Consensus       159 ~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         159 CGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             cCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCC
Confidence            6999999999986543  7899999999999999999999998877666666665543 346777899999999999999


Q ss_pred             CCCCCCC-----HHHHHcChhhHhh
Q 014986          381 NPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       381 dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      ||.+|++     ++++++||||+.+
T Consensus       236 dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         236 DRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             CHHHccCCccCCHHHHhcCccccCC
Confidence            9999995     9999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-48  Score=377.90  Aligned_cols=263  Identities=33%  Similarity=0.537  Sum_probs=231.3

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  214 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  214 (415)
                      ...+...|++.+.||+|.||.||+++. .+|+.+|+|.+.+......  .....+.+|+.+|+++. |||||.++++|++
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~--~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~  107 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK--EDREDVRREVAILQQLSGHPNIVQLKDAFED  107 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc--ccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence            344567899999999999999999999 6699999999986443322  24567889999999998 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC----CcEEEEeecccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAK  290 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~----~~vkl~DFGla~  290 (415)
                      ...+++|||+|.||.|++.+.+..+++..+..+++|++.+++|||+.||+||||||+|+|+...    +.+|++|||++.
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999998866569999999999999999999999999999999999999643    579999999999


Q ss_pred             ccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC---CCCCCcc
Q 014986          291 ATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPDSL  366 (415)
Q Consensus       291 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~  366 (415)
                      ..... .....+||+.|+|||++...  .|+..+||||+|+++|.|++|..||..........++..+..   .+..+.+
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i  265 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI  265 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence            87653 46678899999999999653  499999999999999999999999999988888888877754   3345678


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +..+.+||++||..||.+|+|+.++|+|||++.....
T Consensus       266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence            9999999999999999999999999999999886433

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-48  Score=378.44  Aligned_cols=253  Identities=28%  Similarity=0.499  Sum_probs=220.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++||||+++++.+.+++.+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            56899999999999999999998 6789999999874221  12234567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      +||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~  173 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-F  173 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-c
Confidence            99999999999998865 468999999999999999999999999999999999999999999999999998664332 3


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ...||+.|+|||++.+..  ++.++|||||||++|+|++|..||.+.........+..+. ..++..++..+++||.+||
T Consensus       174 ~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             eecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHh
Confidence            456999999999996544  7889999999999999999999998877666666665543 4567789999999999999


Q ss_pred             hhCCCCCCC-----HHHHHcChhhHh
Q 014986          379 QVNPNDRPT-----AAQLLDHPFVKR  399 (415)
Q Consensus       379 ~~dP~~Rps-----~~eil~hp~f~~  399 (415)
                      +.||.+|++     ++++++||||+.
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            999999997     799999999976

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-49  Score=366.92  Aligned_cols=255  Identities=27%  Similarity=0.488  Sum_probs=230.0

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..-+|++.+.||+|+||.|-+|.. ..|+.||||.+++..  ...++.+-++++||+||+.++||||+.+|.+|+..+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            445899999999999999999998 899999999987533  45677788999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      .|||||..+|.|++++.. ..+++.+++.+++||++|+.|+|+++++|||||.+|||+|.++++||+||||+..+.... 
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            999999999999999965 579999999999999999999999999999999999999999999999999998766554 


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      ...+||+|-|.+||++++... -+..+|-||||++||.|+.|.+||++.+....+..|.++....  ..-+.++.-||+.
T Consensus       209 LqTFCGSPLYASPEIvNG~PY-~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRw  285 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPY-KGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRW  285 (668)
T ss_pred             HHHhcCCcccCCccccCCCCC-CCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHH
Confidence            567899999999999988753 4788999999999999999999999998888888887776542  3446678899999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ||.+||++|.|+.+|..|-|+.-
T Consensus       286 mLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  286 MLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHhcCcccchhHHHHhhhheeec
Confidence            99999999999999999999864

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-48  Score=361.72  Aligned_cols=259  Identities=32%  Similarity=0.547  Sum_probs=221.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc-EEEeeeeeecCC--
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES--  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~--  216 (415)
                      ...|...++||+|+||+||+|+. .+|+.||+|++......   +-.-....+|+.+|+.++|+| ||.+++++.+.+  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~---EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE---EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc---cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            45688889999999999999999 88999999999864332   112234569999999999999 999999998877  


Q ss_pred             ----EEEEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeec
Q 014986          217 ----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  287 (415)
Q Consensus       217 ----~~~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFG  287 (415)
                          .+++|+||+.. +|..++...     +++...++.+++||+.||+|||+++|+||||||+||||+.+|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence                89999999987 899988753     57888999999999999999999999999999999999999999999999


Q ss_pred             cccccc--cCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---
Q 014986          288 LAKATK--LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---  362 (415)
Q Consensus       288 la~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  362 (415)
                      +|+...  ........+|.+|+|||++.+.. .|+...||||+|||++||++++..|.+....+++.+|.+...++-   
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            998655  23356677999999999998764 489999999999999999999999999998888888755433321   


Q ss_pred             --------------C------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          363 --------------P------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       363 --------------~------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                    +            ...+.+..+|+.+||+.+|.+|.|+..+|.||||+......
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence                          0            12235889999999999999999999999999999886544

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=379.97  Aligned_cols=252  Identities=40%  Similarity=0.729  Sum_probs=230.5

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|...++||+|+||.||+|.+ .+++.||+|++.+    ...+..++.+++|+.+|.+++++||.++|+.+..+..++++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L----e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL----EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEech----hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            577779999999999999999 8999999999986    34455678889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCC-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          222 LELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~~l-~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      ||||.||++.++++...+ .+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+.......  ..
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            999999999999998776 888899999999999999999999999999999999999999999999987654332  25


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ...|||.|||||++.+  ..|+.++||||||++.+||++|.+||.....+..++-|.+..++.+...+++.+++|+..||
T Consensus       170 tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             cccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence            6779999999999974  44999999999999999999999999998888888888888888888899999999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhh
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +.||+.||+|.++|+|+|++..
T Consensus       248 ~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             hcCcccCcCHHHHhhhHHHHhc
Confidence            9999999999999999999983

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.6e-48  Score=375.76  Aligned_cols=248  Identities=27%  Similarity=0.467  Sum_probs=213.5

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      ++||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++.+...+.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4699999999999998 7899999999874221  123344567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCCC
Q 014986          227 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT  303 (415)
Q Consensus       227 ~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~gt  303 (415)
                      +|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ......+||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            9999988865 4689999999999999999999999999999999999999999999999999875322  223345699


Q ss_pred             ccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       304 ~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      +.|+|||++.+.  .++.++|||||||++|+|++|..||...........+... ...++..++.++.+||.+||..||+
T Consensus       159 ~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999998654  3889999999999999999999999887665555544443 3456788999999999999999999


Q ss_pred             CCC-----CHHHHHcChhhHhh
Q 014986          384 DRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       384 ~Rp-----s~~eil~hp~f~~~  400 (415)
                      +||     ++.++++||||+.+
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCC
Confidence            999     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-49  Score=364.84  Aligned_cols=251  Identities=30%  Similarity=0.473  Sum_probs=214.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC-----
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  215 (415)
                      -.|...+++|+|+||.||+|.. .+++.||||++......         -.+|+.+|+.+.|||||++..+|...     
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            3578889999999999999998 67899999998753322         13799999999999999998887532     


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeeccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA  289 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFGla  289 (415)
                      -++.+||||++. +|...++.     .+++.-.++.++.||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            245689999988 89988873     468888999999999999999999999999999999999976 99999999999


Q ss_pred             cccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-------
Q 014986          290 KATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------  361 (415)
Q Consensus       290 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------  361 (415)
                      +....+. ..+...|..|+|||.+.+. +.|+.+.||||.||++.||+.|++.|.+.+..+++..|.+....|       
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            9765443 3556689999999999865 458999999999999999999999999998888887765433222       


Q ss_pred             ---------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          362 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       362 ---------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                                           +...+++++.+|+.++|..+|.+|.++.+++.||||+.+...
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                                 223578899999999999999999999999999999999876

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.5e-47  Score=371.42  Aligned_cols=257  Identities=31%  Similarity=0.526  Sum_probs=213.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ...+|+..+.||+|+||.||+|++ .+++.||+|++....    .......+.+|+.+++.++|+||+++++++.+.+.+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            356788999999999999999998 689999999986421    233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      |+||||+.+|+|...   ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       148 ~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        148 QVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            999999999998643   23567778899999999999999999999999999999999999999999998765432  2


Q ss_pred             cccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCc---cHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          297 VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      .....||..|+|||++...   ....+.++|||||||++|+|++|+.||...   ........+........+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            2345699999999987432   223456899999999999999999999742   2223333444444555667889999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .+||.+||..||++|||+.|+++||||......
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            999999999999999999999999999987544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-47  Score=363.28  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=213.5

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |++.+.||+|+||.||+|.+ .+++.||+|.+......  .......+.+|+.++..++|+||+++++.+.+.+.+++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            67788999999999999998 78999999998743221  1222345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-Ccc
Q 014986          223 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK  298 (415)
Q Consensus       223 E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~~  298 (415)
                      ||+.+|+|..++..   ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            99999999887643   25889999999999999999999999999999999999999999999999999765432 234


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH---HHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---AALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ...||..|+|||++.+.  .++.++|||||||++|+|++|+.||......   +............++..++.++.+||+
T Consensus       160 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         160 GRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             CCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            45699999999999654  4889999999999999999999999765332   222222233334566778999999999


Q ss_pred             HhhhhCCCCCCC-----HHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRPT-----AAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rps-----~~eil~hp~f~~~~  401 (415)
                      +||+.||.+||+     ++++++||||+.+.
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999997     89999999998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-47  Score=374.25  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=220.9

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~-~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ....++|++.+.||+|+||.||+|.+ .+ +..||+|.+.....  ........+.+|+.+++.++||||+++++++.+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34467899999999999999999986 33 46899999864221  1223445678999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +.+|+||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999999998865 4689999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      . .....||+.|+|||++.+..  ++.++|||||||++|+|++|..||...........+..+. ..++..++..+.+||
T Consensus       184 ~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li  259 (340)
T PTZ00426        184 R-TYTLCGTPEYIAPEILLNVG--HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHLM  259 (340)
T ss_pred             C-cceecCChhhcCHHHHhCCC--CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHH
Confidence            3 33456999999999986543  7889999999999999999999998877666666665543 346778899999999


Q ss_pred             HHhhhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ++||+.||.+|+     +++++++||||+.+
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999995     89999999999865

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-48  Score=372.97  Aligned_cols=249  Identities=30%  Similarity=0.523  Sum_probs=222.5

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +..-.+.+++++.||+|-||.||+|.++....||+|.++....      ....|.+|+++|++|+|++||++++++..+.
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc------ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            3334456788899999999999999998888999999985422      2356779999999999999999999999988


Q ss_pred             EEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .+||||||+..|+|.++++.   ..+...+...++.||++|++||.++++|||||...||||+.++.+||+|||||+...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999999986   468889999999999999999999999999999999999999999999999999665


Q ss_pred             cCCcccCCC---CccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          294 LNDVKSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       294 ~~~~~~~~g---t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      .+......|   ...|.|||.++...  ++.++||||||++||||+| |+.||..+...+.+..+.++.+.+-|..+|..
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~--FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGK--FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE  432 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCC--cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence            554433333   45699999997654  8999999999999999998 99999999999999999999999999999999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +.++++.||..+|++|||++.+..
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999996643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.1e-47  Score=363.09  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=207.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++......    .....+.+|+.+++.++||||+++++++.+....+
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            35799999999999999999998 68999999998643221    12235668999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          220 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      +||||+.+ +|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99999986 898887653  4788999999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--------------
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------------  361 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------  361 (415)
                      ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......+              
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            22345689999999998543 347889999999999999999999998766554443332111000              


Q ss_pred             ---------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          362 ---------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       362 ---------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                     ....++.++.+||++||+.||.+|||+.|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                           012467899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-47  Score=373.78  Aligned_cols=254  Identities=27%  Similarity=0.460  Sum_probs=212.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++.....  ........+.+|+.++..++|+||+++++.+.+...+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            3688999999999999999998 6799999999974221  123345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      ||||+.+|+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999999999998865 568999999999999999999999999999999999999999999999999987532110   


Q ss_pred             ----------------------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCC
Q 014986          297 ----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  342 (415)
Q Consensus       297 ----------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf  342 (415)
                                                        ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              1234699999999998654  4889999999999999999999999


Q ss_pred             CCccHHHHHHHHhcCC-CCCCC--CcccHHHHHHHHHhhhhCCC---CCCCHHHHHcChhhHhh
Q 014986          343 APMECMAALFKIGRGS-PPPIP--DSLSKDAQDFIKQCVQVNPN---DRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       343 ~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~Li~~~L~~dP~---~Rps~~eil~hp~f~~~  400 (415)
                      ......+...++.... ...++  ..++.++++||.+|+. +|.   .||++++|++||||+.+
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            8877666666665432 22233  2478999999999764 444   45899999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-47  Score=365.55  Aligned_cols=246  Identities=30%  Similarity=0.497  Sum_probs=212.2

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.++..++||||+++++.+.+.+.+|+||||+.+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            79999999999998 6789999999874221  12334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccCCCCcc
Q 014986          229 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF  305 (415)
Q Consensus       229 sL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~gt~~  305 (415)
                      +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....+||+.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence            99998865 46899999999999999999999999999999999999999999999999998754322  2334569999


Q ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCC
Q 014986          306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR  385 (415)
Q Consensus       306 y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  385 (415)
                      |+|||++.+.  .++.++|||||||++|+|++|+.||......+....+... ...++..++..+.+||.+||..||.+|
T Consensus       159 y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         159 YLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             cCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            9999999654  4889999999999999999999999887666655555543 445678899999999999999999999


Q ss_pred             C---CHHHHHcChhhHhh
Q 014986          386 P---TAAQLLDHPFVKRL  400 (415)
Q Consensus       386 p---s~~eil~hp~f~~~  400 (415)
                      |   ++.+++.||||+..
T Consensus       236 ~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence            7   58999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.4e-47  Score=367.67  Aligned_cols=252  Identities=27%  Similarity=0.474  Sum_probs=215.1

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH---hcCCCCcEEEeeeeeecCCEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      |++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|++++   +.++||||+++++++.+.+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            67789999999999999998 6899999999974321  1122344566666554   5678999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCc
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~  297 (415)
                      +||||+.+|+|..++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999875322  223


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ...+|++.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+..... ..+..++..+.+||.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~  235 (324)
T cd05589         159 STFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRL  235 (324)
T ss_pred             cccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence            345699999999998654  378899999999999999999999988776666666655433 46778999999999999


Q ss_pred             hhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          378 VQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       378 L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      |+.||.+||     ++.++++||||+.+
T Consensus       236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         236 LRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             hhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999     79999999999874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.3e-47  Score=367.62  Aligned_cols=248  Identities=27%  Similarity=0.476  Sum_probs=212.5

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +.||+|+||.||++.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++.+...+.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            4699999999999998 7899999999874221  123345667789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccCCCC
Q 014986          227 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGT  303 (415)
Q Consensus       227 ~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~gt  303 (415)
                      +|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ......||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            9999988765 46899999999999999999999999999999999999999999999999998753222  23345699


Q ss_pred             ccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       304 ~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      +.|+|||++.+.  .++.++|||||||++|+|++|+.||...........+... ...++..++.++.+||.+||..||+
T Consensus       159 ~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999998654  3789999999999999999999999877665555444433 3346778999999999999999999


Q ss_pred             CCC-----CHHHHHcChhhHhh
Q 014986          384 DRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       384 ~Rp-----s~~eil~hp~f~~~  400 (415)
                      +|+     ++.++++|+||...
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCC
Confidence            998     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.7e-47  Score=374.73  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=211.3

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|++++.||+|+||+||+|++ .+++.||+|++.....  ........+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            588899999999999999998 7889999999974221  1233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-----
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----  295 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-----  295 (415)
                      |||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            999999999998866 46899999999999999999999999999999999999999999999999997532100     


Q ss_pred             --------------------------------------------CcccCCCCccccccccccccccCCCchhhHHHHHHH
Q 014986          296 --------------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT  331 (415)
Q Consensus       296 --------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~i  331 (415)
                                                                  .....+||+.|+|||++.+.  .++.++|||||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG~i  237 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceeehhhH
Confidence                                                        01234699999999998654  38899999999999


Q ss_pred             HHHHHcCCCCCCCccHHHHHHHHhcCC-CCCC--CCcccHHHHHHHHHhh--hhCCCCCCCHHHHHcChhhHhh
Q 014986          332 VLEMLTSQIPYAPMECMAALFKIGRGS-PPPI--PDSLSKDAQDFIKQCV--QVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       332 l~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~s~~l~~Li~~~L--~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +|+|++|..||......+...++.... ...+  ...++.++.+||.+||  ..++..|+++.+++.||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999998776655555554321 1222  3358999999999955  4555669999999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=365.75  Aligned_cols=271  Identities=27%  Similarity=0.406  Sum_probs=240.9

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .++.+-|.+.+.||+|.|++|-+|++ -+|..||||++.+.+...   ....++.+|++.|+.++|||||++|.+..+..
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~---~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT---LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT   90 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch---hhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence            35667899999999999999999999 899999999998655433   34467889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-~~~~vkl~DFGla~~~~  293 (415)
                      .+|||+|+-.+|+|++++.+  .++++..+++|++||+.||.|+|+..++||||||+|+.+- .-|-|||+|||++..+.
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            99999999999999999865  4899999999999999999999999999999999998765 56999999999998765


Q ss_pred             cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      +. .....||+..|-|||++.+... ..+++||||||+|||.|++|++||.....-+.+-.|...... +|..++.++++
T Consensus       171 PG~kL~TsCGSLAYSAPEILLGDsY-DAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-vPshvS~eCrd  248 (864)
T KOG4717|consen  171 PGKKLTTSCGSLAYSAPEILLGDSY-DAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-VPSHVSKECRD  248 (864)
T ss_pred             CcchhhcccchhhccCchhhhcCcc-CCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-CchhhhHHHHH
Confidence            54 4677889999999999987653 357899999999999999999999998888888777766554 78999999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCCCCCCCC
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGR  414 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~~~~~~~  414 (415)
                      ||..||..||++|.+.++|..|+|+|......++. .|.+.|
T Consensus       249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~-iPLvsr  289 (864)
T KOG4717|consen  249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA-IPLVSR  289 (864)
T ss_pred             HHHHHHhcCchhhccHHHHhccccccCCCCCcccc-Cceeeh
Confidence            99999999999999999999999999998877774 677665

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.3e-47  Score=367.90  Aligned_cols=248  Identities=27%  Similarity=0.473  Sum_probs=212.6

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +.||+|+||.||++.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++.+...+.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            3699999999999998 7899999999874221  123345677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCCC
Q 014986          227 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT  303 (415)
Q Consensus       227 ~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~gt  303 (415)
                      +|+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ......+||
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            9999988765 4689999999999999999999999999999999999999999999999999875322  223345699


Q ss_pred             ccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       304 ~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      +.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+.. ....++..++.++.+||.+||..||.
T Consensus       159 ~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EDIKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-CCccCCCCCCHHHHHHHHHHcCCCHH
Confidence            999999998654  378999999999999999999999987765555444433 33457788999999999999999999


Q ss_pred             CCC-----CHHHHHcChhhHhh
Q 014986          384 DRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       384 ~Rp-----s~~eil~hp~f~~~  400 (415)
                      +|+     ++.++++||||...
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCC
Confidence            997     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-47  Score=368.72  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=216.5

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.++..++||||+++++++.+.+.+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            3688999999999999999998 6789999999974221  112344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCccc
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  299 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  299 (415)
                      ||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus        79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~  157 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANS  157 (333)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCC
Confidence            9999999999999875 4689999999999999999999999999999999999999999999999999976543 3345


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC---CCCCC----CcccHHHHH
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIP----DSLSKDAQD  372 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~----~~~s~~l~~  372 (415)
                      ..||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+....   ..+..    ..++.++.+
T Consensus       158 ~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         158 VVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             cccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            5699999999998654  48899999999999999999999998876655544443221   11111    256899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ||.+||..+|.+||++.++++||||+..
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            9999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-47  Score=369.54  Aligned_cols=256  Identities=33%  Similarity=0.604  Sum_probs=233.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE-E
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-L  218 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~  218 (415)
                      .+.|..++++|+|+||.++++++ .+++.|++|++..........   ...++|+.++++++|||||.+++.|..++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            35799999999999999999998 778899999998755443322   366799999999999999999999999888 9


Q ss_pred             EEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          219 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +|||+||+||+|.+.+.+.   .|+++.+..++.||+.|+.|||+++|+|||||+.|||++.++.|+|+|||+|+.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999999988653   5999999999999999999999999999999999999999999999999999988766


Q ss_pred             C--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          296 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       296 ~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      .  ..+..||+.||.||++.+.  .|+.++|||||||++|||++-+.+|...+....+.++.++...++|...+.+++.|
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence            4  4567899999999999654  49999999999999999999999999999999999999999899999999999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      |+.||..+|..||++.++|.+|.++...
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            9999999999999999999999998655

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.3e-47  Score=359.02  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=207.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++......   ......+.+|+.+++.++|+||+++++++..++.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            3688999999999999999999 67899999998753221   2234567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      ||||+.++.+..+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......   
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            9999999777655443 468999999999999999999999999999999999999999999999999997654322   


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------------  359 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  359 (415)
                      .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+....+.....                 
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            23356899999999986543  78899999999999999999999987655444333221100                 


Q ss_pred             ----C----------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 ----P----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 ----~----------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                          +          .....++.++.+||++||+.||++|||++++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                0          0112368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.9e-47  Score=373.10  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=219.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            56899999999999999999998 6899999999864221  11223345778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      +||||+.+|+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus       120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987654322   


Q ss_pred             cccCCCCccccccccccccc--cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-CCCCC--cccHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPD--SLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~--~~s~~l~  371 (415)
                      ....+||+.|+|||++.+..  ..++.++|||||||++|+|++|+.||..........++..... ..++.  .++.++.
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  279 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK  279 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHH
Confidence            23456999999999986432  2378899999999999999999999998777666666654322 22333  5799999


Q ss_pred             HHHHHhhhhCCCC--CCCHHHHHcChhhHh
Q 014986          372 DFIKQCVQVNPND--RPTAAQLLDHPFVKR  399 (415)
Q Consensus       372 ~Li~~~L~~dP~~--Rps~~eil~hp~f~~  399 (415)
                      +||++||+.+|.+  |+++.++++||||+.
T Consensus       280 ~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         280 DLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            9999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-47  Score=372.85  Aligned_cols=254  Identities=29%  Similarity=0.497  Sum_probs=214.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||+||+|++ .+++.||||++.....  ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            3688999999999999999998 6899999999974221  122345667899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      ||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||+++......   
T Consensus        79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            9999999999998865 468999999999999999999999999999999999999999999999999986532110   


Q ss_pred             -------------------------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCC
Q 014986          297 -------------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ  339 (415)
Q Consensus       297 -------------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~  339 (415)
                                                           ....+||+.|+|||++...  .++.++|||||||++|+|++|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhhcCC
Confidence                                                 1124599999999998544  4889999999999999999999


Q ss_pred             CCCCCccHHHHHHHHhcCCC-CCCC--CcccHHHHHHHHHhhhhCCCCCCC---HHHHHcChhhHhh
Q 014986          340 IPYAPMECMAALFKIGRGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRL  400 (415)
Q Consensus       340 ~pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l~~Li~~~L~~dP~~Rps---~~eil~hp~f~~~  400 (415)
                      .||......+....+..... ..++  ..+++++.+||.+||. +|.+|++   +.+++.||||+..
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99988776666655544321 1222  3578999999999996 9999998   9999999999765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.8e-46  Score=362.79  Aligned_cols=256  Identities=27%  Similarity=0.472  Sum_probs=214.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||++++ .++..+|+|.+....    .......+.+|+.+|+.++||||+++++++.+++.++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            46799999999999999999998 688999999887421    2234567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      +||||+.+|+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            99999999999998876 4689999999999999999999986 699999999999999999999999999986655545


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH-----------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-----------------------  354 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i-----------------------  354 (415)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+                       
T Consensus       160 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         160 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             ccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            556799999999998654  3889999999999999999999999764432221111                       


Q ss_pred             -----------------------hcCCCCCC-CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          355 -----------------------GRGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       355 -----------------------~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                             .....+.. ...++.++++||.+||+.||++|||+.+|++||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                                   11111111 1246789999999999999999999999999999987644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.8e-47  Score=375.19  Aligned_cols=253  Identities=28%  Similarity=0.483  Sum_probs=213.1

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|++++.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            588899999999999999998 7889999999874221  1234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-----
Q 014986          222 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----  295 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-----  295 (415)
                      |||+.+|+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            9999999999988664 5889999999999999999999999999999999999999999999999997532100     


Q ss_pred             --------------------------------------------CcccCCCCccccccccccccccCCCchhhHHHHHHH
Q 014986          296 --------------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT  331 (415)
Q Consensus       296 --------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~i  331 (415)
                                                                  .....+||+.|+|||++.+..  ++.++|||||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvi  237 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC--CCCeeeEEechHH
Confidence                                                        012346999999999986543  8899999999999


Q ss_pred             HHHHHcCCCCCCCccHHHHHHHHhcCC---CCCCCCcccHHHHHHHHHhhhhCCCCCCC---HHHHHcChhhHhh
Q 014986          332 VLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRL  400 (415)
Q Consensus       332 l~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~Rps---~~eil~hp~f~~~  400 (415)
                      +|+|++|+.||......+...++....   ..+....+++++.+||.+|+ .+|.+|++   +.++++||||+.+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999999999998877666555554322   12223468999999999987 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-47  Score=371.94  Aligned_cols=255  Identities=33%  Similarity=0.506  Sum_probs=217.7

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||+||+|++ .+++.||+|++.....  ........+.+|+.++..++|+||+++++++.+++.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            3688999999999999999998 6899999999874221  112344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          221 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      ||||+.+++|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999999988764 79999999999999999999999999999999999999999999999999987654332   


Q ss_pred             ----------------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH
Q 014986          297 ----------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM  348 (415)
Q Consensus       297 ----------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~  348 (415)
                                                  .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                        2334699999999999665  4889999999999999999999999887766


Q ss_pred             HHHHHHhcC---CCCCCCCcccHHHHHHHHHhhhhCCCCCCC-HHHHHcChhhHhhh
Q 014986          349 AALFKIGRG---SPPPIPDSLSKDAQDFIKQCVQVNPNDRPT-AAQLLDHPFVKRLL  401 (415)
Q Consensus       349 ~~~~~i~~~---~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps-~~eil~hp~f~~~~  401 (415)
                      ....++...   ...+....++.++.+||.+||. ||.+|++ +.++++||||+.+.
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            665555541   1222233469999999999997 9999999 99999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-46  Score=361.87  Aligned_cols=254  Identities=28%  Similarity=0.453  Sum_probs=205.5

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++......    .....+.+|+.+++.++||||+++++++.+....|+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            5799999999999999999998 58999999998743221    112345689999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      ||||+. ++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999996 478777754  35899999999999999999999999999999999999999999999999998754322  2


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH-HHHHHHhcCCCC----C----------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPP----P----------  361 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~----~----------  361 (415)
                      .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.... +.+..+......    .          
T Consensus       160 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            3345689999999998543 33788999999999999999999999865332 222222110000    0          


Q ss_pred             --------CC---------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          362 --------IP---------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       362 --------~~---------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                              .+         ...+..+.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                    00         12356789999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-46  Score=372.15  Aligned_cols=258  Identities=26%  Similarity=0.442  Sum_probs=218.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||++.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++.+.+++.+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            356899999999999999999998 67899999998642211  122345577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |+||||+.+|+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999999988889999999999999999999999999999999999999999999999999998654332  


Q ss_pred             -cccCCCCccccccccccccc--cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-CCCCC--cccHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPD--SLSKDA  370 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~--~~s~~l  370 (415)
                       ....+||+.|+|||++.+..  ..++.++|||||||++|+|++|+.||..........++..... ..++.  .++..+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence             23456999999999986532  2378899999999999999999999988776666666654332 22333  579999


Q ss_pred             HHHHHHhhhhCCCC--CCCHHHHHcChhhHh
Q 014986          371 QDFIKQCVQVNPND--RPTAAQLLDHPFVKR  399 (415)
Q Consensus       371 ~~Li~~~L~~dP~~--Rps~~eil~hp~f~~  399 (415)
                      ++||.+||..++.+  |+++.++++||||+.
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            99999999855544  899999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-47  Score=373.69  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=211.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            3688999999999999999998 7899999999864221  123345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      ||||+.+|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9999999999998865 468999999999999999999999999999999999999999999999999986321100   


Q ss_pred             ----------------------------------------------cccCCCCccccccccccccccCCCchhhHHHHHH
Q 014986          297 ----------------------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC  330 (415)
Q Consensus       297 ----------------------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~  330 (415)
                                                                    ....+||+.|+|||++.+.  .++.++|||||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv  236 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEecch
Confidence                                                          0124699999999998654  3889999999999


Q ss_pred             HHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCCC--cccHHHHHHHHHhhhhCCCCC---CCHHHHHcChhhHhh
Q 014986          331 TVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPD--SLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRL  400 (415)
Q Consensus       331 il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~--~~s~~l~~Li~~~L~~dP~~R---ps~~eil~hp~f~~~  400 (415)
                      ++|+|++|..||......+....+.... ...++.  .++.++.+||.+||. +|.+|   +++.+++.||||+..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999998776665555554322 122333  578999999999997 67765   599999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.8e-47  Score=374.51  Aligned_cols=252  Identities=30%  Similarity=0.450  Sum_probs=214.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-C-----CcEEEeeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H-----ENIVQYYGTDK  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~  213 (415)
                      .-+|.++++||+|+||.|-+|++ .+++.||||+++..      +....+...|+.+|..++ |     -|||+++++|.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~  258 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY  258 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence            34799999999999999999999 88999999999842      334556678999999997 4     38999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--CcEEEEeecc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGL  288 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~--~~vkl~DFGl  288 (415)
                      ..+++|||+|++.. +|.++++.+   +++...++.++.||+.||.+||+.||||+||||+||||..-  ..|||+|||.
T Consensus       259 fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  259 FRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             cccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            99999999999977 899999875   68899999999999999999999999999999999999743  4799999999


Q ss_pred             ccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-------
Q 014986          289 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------  361 (415)
Q Consensus       289 a~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------  361 (415)
                      ++.....-. ..+.+..|+|||++.+..  |+.+.||||||||++||++|.+.|.+.+..+++..|......+       
T Consensus       338 Sc~~~q~vy-tYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  338 SCFESQRVY-TYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             ccccCCcce-eeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            988765544 677899999999998766  9999999999999999999999999988877776653211100       


Q ss_pred             --------------------------------------------CC-----------CcccHHHHHHHHHhhhhCCCCCC
Q 014986          362 --------------------------------------------IP-----------DSLSKDAQDFIKQCVQVNPNDRP  386 (415)
Q Consensus       362 --------------------------------------------~~-----------~~~s~~l~~Li~~~L~~dP~~Rp  386 (415)
                                                                  .|           ..-...+.+||++||..||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                                                        01           01123578999999999999999


Q ss_pred             CHHHHHcChhhHhhhh
Q 014986          387 TAAQLLDHPFVKRLLA  402 (415)
Q Consensus       387 s~~eil~hp~f~~~~~  402 (415)
                      |+.++|+||||.....
T Consensus       495 tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  495 TPAQALNHPFLTGTSL  510 (586)
T ss_pred             CHHHHhcCcccccccc
Confidence            9999999999995443

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-46  Score=363.68  Aligned_cols=249  Identities=32%  Similarity=0.526  Sum_probs=213.2

Q ss_pred             cccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      +.||+|+||.||++++    .+++.||+|++...... ........+.+|+.+|+.++||||+++++.+..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            6799999999999985    36889999998742211 122334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccC
Q 014986          224 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  300 (415)
Q Consensus       224 ~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~  300 (415)
                      |+.+|+|.+++.+. .+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999988654 5788899999999999999999999999999999999999999999999998754322  23345


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  380 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  380 (415)
                      .||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...........+..+. ..++..++..+.+||.+||..
T Consensus       161 ~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         161 CGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             CCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccc
Confidence            6999999999986543  7889999999999999999999999887776666666554 346778999999999999999


Q ss_pred             CCCCCC-----CHHHHHcChhhHhh
Q 014986          381 NPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       381 dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ||.+||     ++.++++||||+..
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-46  Score=362.79  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=215.4

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC-cEEEeeeeeecCCEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~l  220 (415)
                      +|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+..|+.++..+.|+ +|+++++++.+.+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            478899999999999999998 6788999999874221  1123445677899999998764 68899999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--cCCc
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~~~~  297 (415)
                      ||||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....  ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            9999999999998865 468999999999999999999999999999999999999999999999999987532  2233


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ...+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+....+... ...++..++..+.+||.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             eeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHH
Confidence            3456999999999996543  788999999999999999999999887766666666544 3446778999999999999


Q ss_pred             hhhCCCCCCCH-----HHHHcChhhHhh
Q 014986          378 VQVNPNDRPTA-----AQLLDHPFVKRL  400 (415)
Q Consensus       378 L~~dP~~Rps~-----~eil~hp~f~~~  400 (415)
                      |..||.+|++.     +++++||||+.+
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999976     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-46  Score=363.58  Aligned_cols=248  Identities=30%  Similarity=0.486  Sum_probs=211.3

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|.+ .+++.||+|++.....  ........+.+|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 6789999999874211  1122345566788888776 6999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            99999988865 4689999999999999999999999999999999999999999999999999875422  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+.... ...+..++.++.+||.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         159 TPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             CccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999998654  37889999999999999999999998877766666665443 34677899999999999999999


Q ss_pred             CCCCCH------HHHHcChhhHhh
Q 014986          383 NDRPTA------AQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rps~------~eil~hp~f~~~  400 (415)
                      .+|+++      ++++.||||+.+
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCC
Confidence            999998      999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-46  Score=364.28  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=207.3

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC-----C
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----S  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  216 (415)
                      +|++.+.||+|+||.||+|++ .+++.||+|++......   ......+.+|+.+++.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            488899999999999999998 68999999988642211   12234678999999999999999999987533     3


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            5899999996 588888765 46899999999999999999999999999999999999999999999999999754322


Q ss_pred             C-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---------------
Q 014986          296 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG---------------  355 (415)
Q Consensus       296 ~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~---------------  355 (415)
                      .     .....||+.|+|||++.+....++.++|||||||++|+|++|+.||........+..+.               
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1     23456999999999986533458899999999999999999999997654433221110               


Q ss_pred             ------------cCCCCCC---CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          356 ------------RGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       356 ------------~~~~~~~---~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                  .....+.   ...++..+.+||.+||..||++|||+.++++||||+.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence                        0001111   124677899999999999999999999999999999876643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.9e-47  Score=373.53  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=211.9

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+|+.++|+||+++++.+.+++.+|+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV--LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH--HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            689999999999999999998 7799999999864221  1123346678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc------
Q 014986          222 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------  294 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~------  294 (415)
                      |||+.+|+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....      
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9999999999998764 578999999999999999999999999999999999999999999999999753210      


Q ss_pred             ---------------------------------------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHH
Q 014986          295 ---------------------------------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEM  335 (415)
Q Consensus       295 ---------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~el  335 (415)
                                                             ......+||+.|+|||++.+.  .++.++|||||||++|+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyel  237 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccceeeeh
Confidence                                                   001134699999999999654  378999999999999999


Q ss_pred             HcCCCCCCCccHHHHHHHHhcCC---CCCCCCcccHHHHHHHHHhhhhCCCCCC---CHHHHHcChhhHhh
Q 014986          336 LTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRP---TAAQLLDHPFVKRL  400 (415)
Q Consensus       336 l~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---s~~eil~hp~f~~~  400 (415)
                      ++|+.||......+....+....   ..+....++..+.+||.+|+ .+|.+|+   ++.++++||||+.+
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999998876655555443322   11223468999999999977 5999999   99999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-46  Score=364.53  Aligned_cols=249  Identities=27%  Similarity=0.500  Sum_probs=209.3

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|.+ .+++.||+|++.....  ........+.+|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            4699999999999998 6899999999974221  1223456678899999888 7999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--cCCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~~~~~~~~g  302 (415)
                      .+|+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999988754 579999999999999999999999999999999999999999999999999987432  222334579


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc--------cHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||...        ...+...+........+|..++..+.+||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  236 (329)
T cd05588         159 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL  236 (329)
T ss_pred             CccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999654  3788999999999999999999999631        11223333344445567788999999999


Q ss_pred             HHhhhhCCCCCCC------HHHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRPT------AAQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps------~~eil~hp~f~~~  400 (415)
                      ++||+.||.+|++      ++++++||||+.+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999987      7899999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.3e-46  Score=376.45  Aligned_cols=251  Identities=28%  Similarity=0.438  Sum_probs=204.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----  214 (415)
                      .++|+++++||+|+||.||+|++ .+++.||||++....         ....+|+.+|+.++|+||+++++++..     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            45799999999999999999998 688999999885321         123479999999999999999887643     


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEe
Q 014986          215 ---ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLAD  285 (415)
Q Consensus       215 ---~~~~~lV~E~~~~gsL~~~l~-----~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~D  285 (415)
                         ...+++||||+.+ +|.+++.     ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence               2357899999986 6766554     24688999999999999999999999999999999999998665 699999


Q ss_pred             eccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----
Q 014986          286 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----  359 (415)
Q Consensus       286 FGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----  359 (415)
                      ||+++..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+....+.+.++.....     
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9999865432 23345689999999998543 2478999999999999999999999988765555444432110     


Q ss_pred             -----------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          360 -----------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       360 -----------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                             ..++...+.++.+||.+||..||.+|||+.++|.||||+.+..
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                                   0123456789999999999999999999999999999998765

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-46  Score=364.79  Aligned_cols=256  Identities=30%  Similarity=0.501  Sum_probs=212.0

Q ss_pred             ccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      +|++.+.||+|+||.||++.+    .+++.||+|++..... .........+.+|+.++..+ +|+||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            478899999999999999876    3689999999874221 11223345678899999999 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999998754 568999999999999999999999999999999999999999999999999987643222


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhcCCCCCCCCcccHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                         ....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||....   ....+..........++..++..+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence               2245699999999998643 236789999999999999999999996422   122222222333455677899999


Q ss_pred             HHHHHHhhhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          371 QDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      .+||.+||..||++||     +++++++||||+..
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-46  Score=365.16  Aligned_cols=248  Identities=27%  Similarity=0.469  Sum_probs=211.9

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +.||+|+||.||++.+ .+++.||+|++.....  ........+.+|+.++..++||||+++++.+.+.+.+|+||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999998 7899999999974221  122344567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          227 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       227 ~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      +|+|..++.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            9999988765 468999999999999999999997 7999999999999999999999999999875332  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.. ....++..++.++.+||.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         159 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             CcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999998654  378999999999999999999999987765555444433 3445677899999999999999999


Q ss_pred             CCCC-----CHHHHHcChhhHhh
Q 014986          383 NDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ++|+     ++.++++||||+..
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCC
Confidence            9997     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-45  Score=376.73  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=220.2

Q ss_pred             cccccccccccCCcEEEEEEEc-CC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~-~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..|.+.+.||+|+||.||+|.+ .+ +..||+|.+...     .......+.+|+.+|+.++|||||++++.+...+.+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            3589999999999999999987 44 678888876532     2233456778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          220 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      |||||+.+|+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999987753     2588999999999999999999999999999999999999999999999999986543


Q ss_pred             CC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          295 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       295 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ..    ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+.+..+..+...+.+..++.++
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~  299 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM  299 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence            22    2345699999999998654  48899999999999999999999999887777777777777777778899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .+||.+||..||++||++.+++.|+|++...
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~  330 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKYVA  330 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence            9999999999999999999999999997643

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.5e-46  Score=352.94  Aligned_cols=250  Identities=30%  Similarity=0.506  Sum_probs=201.4

Q ss_pred             cccccccccccCCcEEEEEEEc-C-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC---CCCcEEEeeeeee---
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-D-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK---  213 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~-~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~---  213 (415)
                      ++|++.+.||+|+||.||+|++ . +++.||+|.+.........   ...+.+|+.+++.+   +||||+++++++.   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc---hHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            3688999999999999999987 3 4688999988753322111   12334566665554   7999999999874   


Q ss_pred             --cCCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          214 --DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       214 --~~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                        ....+++||||+.+ +|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          78 TDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence              34578999999974 89888864   3489999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC------
Q 014986          289 AKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------  361 (415)
Q Consensus       289 a~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------  361 (415)
                      ++...... .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+.+.++......+      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            97654332 3345689999999998554  37889999999999999999999998877666555553321110      


Q ss_pred             --------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          362 --------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       362 --------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                          +...++..+.+||.+||+.||++|||+.++|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-45  Score=362.81  Aligned_cols=262  Identities=25%  Similarity=0.430  Sum_probs=209.9

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  215 (415)
                      .+.++|++.+.||+|+||.||++++ .+++.||+|++.....   .......+.+|+.+++.++||||+++++++...  
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence            3567899999999999999999998 6799999999864321   122345677899999999999999999988654  


Q ss_pred             ----CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ----~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                          ..+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          95 LEEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             ccccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence                357999999986 5666554 3588899999999999999999999999999999999999999999999999976


Q ss_pred             cccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----------
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------  360 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  360 (415)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+.+....+..+......          
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            4332 23345689999999998654  3888999999999999999999999876543332221110000          


Q ss_pred             -------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          361 -------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       361 -------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                                     ......+..+++||.+||..||++|||+.|+|+||||+.++......
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~  328 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE  328 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccccc
Confidence                                           01112467899999999999999999999999999999877655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.7e-46  Score=360.58  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=211.3

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|++ .+++.||+|++.....  ........+..|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            4699999999999998 6789999999874221  1123345566788888765 7999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ......|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            99999988765 46899999999999999999999999999999999999999999999999998754322  2334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+.... ...+..++.++.+||.+||..||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         159 TPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             CccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCH
Confidence            9999999998554  37889999999999999999999999887777666665543 34567789999999999999999


Q ss_pred             CCCC-------CHHHHHcChhhHhh
Q 014986          383 NDRP-------TAAQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rp-------s~~eil~hp~f~~~  400 (415)
                      ++|+       ++.++++||||+.+
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCCC
Confidence            9999       99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.5e-46  Score=359.93  Aligned_cols=253  Identities=26%  Similarity=0.429  Sum_probs=215.0

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+..|..++..+ +|++|+++++++.+.+.+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            478889999999999999998 6788999999875321  1122344566788888776 58999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Cc
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~  297 (415)
                      ||||+.+|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            9999999999988865 46899999999999999999999999999999999999999999999999998754322  23


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ...+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...........+.... ..++..++.++.+|+.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHH
Confidence            345699999999999654  38899999999999999999999999877766666665443 346778999999999999


Q ss_pred             hhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          378 VQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       378 L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      |+.||.+|++     ..++++||||+.+
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999998     4899999999854

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-45  Score=350.36  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=206.1

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||+|+||+||++.+ .+++.||+|++.....  ........+..|+.+++.++|+||+++++++.....+|+||||+.+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            79999999999998 6899999999874221  12233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cccCC
Q 014986          229 SLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR  301 (415)
Q Consensus       229 sL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~  301 (415)
                      +|..++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......  .....
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            99887632     358999999999999999999999999999999999999999999999999987654332  23456


Q ss_pred             CCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH---HHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---AALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       302 gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......   .............++..++..+.+|+.+||
T Consensus       159 g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         159 GTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             CCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            89999999999654  3788999999999999999999999764321   111222222234456778999999999999


Q ss_pred             hhCCCCCC-----CHHHHHcChhhHhh
Q 014986          379 QVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       379 ~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      +.||.+||     +++++++||||+..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999999     88999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.8e-46  Score=367.90  Aligned_cols=253  Identities=28%  Similarity=0.488  Sum_probs=213.1

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.++..++|+||+++++.+.+.+.+|+|
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            688899999999999999998 6899999999974221  1233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----  296 (415)
                      |||+.+|+|.+++.+ ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.++|+|||+++......    
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            999999999998865 468999999999999999999999999999999999999999999999999986432110    


Q ss_pred             ---------------------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCC
Q 014986          297 ---------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA  343 (415)
Q Consensus       297 ---------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~  343 (415)
                                                       ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCCCCCC
Confidence                                             1134699999999998654  48899999999999999999999998


Q ss_pred             CccHHHHHHHHhcCC-CCCCCC--cccHHHHHHHHHhhhhCCCCCC---CHHHHHcChhhHhh
Q 014986          344 PMECMAALFKIGRGS-PPPIPD--SLSKDAQDFIKQCVQVNPNDRP---TAAQLLDHPFVKRL  400 (415)
Q Consensus       344 ~~~~~~~~~~i~~~~-~~~~~~--~~s~~l~~Li~~~L~~dP~~Rp---s~~eil~hp~f~~~  400 (415)
                      .........++.... ...++.  .++.++++||.+|+. ||.+|+   ++.+++.||||+.+
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            877666666655422 122232  478999999999874 999998   48999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2e-45  Score=358.02  Aligned_cols=258  Identities=29%  Similarity=0.505  Sum_probs=213.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||++.+ .++..+|+|.+....    .......+.+|+++++.++|+||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            36799999999999999999998 678899999886421    1233456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          220 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      +||||+.+|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  159 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence            999999999999988754 588999999999999999999985 799999999999999999999999999876544444


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHH------------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK------------------------  353 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~------------------------  353 (415)
                      ....|+..|+|||++.+.  .++.++|||||||++|+|++|+.||......+....                        
T Consensus       160 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         160 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             ccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            455799999999998654  378899999999999999999999976443222111                        


Q ss_pred             --------------------HhcCCCCCCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          354 --------------------IGRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       354 --------------------i~~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                          +.....+..+ ...+.++++||.+||+.||.+|||+.+++.|+||+...+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~  309 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEE  309 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcccc
Confidence                                1111111111 13578899999999999999999999999999999876543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-45  Score=371.60  Aligned_cols=245  Identities=26%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|.+.+.||+|+||.||+|.+ .+++.||+|....           ..+.+|+++|+.++|+|||++++++...+..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            34699999999999999999998 6789999995431           23458999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      +|||++. ++|..++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9999996 588887754  358999999999999999999999999999999999999999999999999997653322 


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-------HHHHHHHHhcCCC---CCC-
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-------CMAALFKIGRGSP---PPI-  362 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~---~~~-  362 (415)
                         .....||+.|+|||++.+..  ++.++|||||||++|||++|..++-...       ....+.++.....   ..+ 
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~--~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDP--YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCC--CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence               22356999999999996543  8899999999999999999876542211       0111111111100   000 


Q ss_pred             ----------------------------C--CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          363 ----------------------------P--DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       363 ----------------------------~--~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                                                  .  ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                        0  134568999999999999999999999999999974

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.5e-46  Score=358.88  Aligned_cols=249  Identities=27%  Similarity=0.479  Sum_probs=209.3

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc-CCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|++ .+++.||+|++......  .......+..|..++.. ++||||+++++++.+.+++|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            4699999999999998 68899999999742211  11233455677777765 48999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--cCCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~~~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...  .......+|
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            99999988865 468999999999999999999999999999999999999999999999999987432  223345669


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.. ....++..++.++++||.+||..||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         159 TPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-DTPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             CcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999999654  388999999999999999999999987766555544433 3455677899999999999999999


Q ss_pred             CCCCCH-HHHHcChhhHhhh
Q 014986          383 NDRPTA-AQLLDHPFVKRLL  401 (415)
Q Consensus       383 ~~Rps~-~eil~hp~f~~~~  401 (415)
                      .+|+++ +++++||||+...
T Consensus       236 ~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         236 TRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHcCCChHHHHcCCCcCCCC
Confidence            999997 5899999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=342.76  Aligned_cols=254  Identities=46%  Similarity=0.788  Sum_probs=218.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|++.+.||+|+||.||+|++ .+++.||+|.+...............+.+|+.+++.++||||+++++++.+...+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999998 689999999987544333344456778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc--
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~--  297 (415)
                      ||||+.+++|.+++.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++.......  
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999998865 4588999999999999999999999999999999999999999999999999875432211  


Q ss_pred             ---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCCCCCcccHHHHHH
Q 014986          298 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSKDAQDF  373 (415)
Q Consensus       298 ---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~L  373 (415)
                         ....++..|+|||++.+..  ++.++||||||+++|+|++|+.||...+.......+... ....++..++..+.+|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF  239 (263)
T ss_pred             ccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence               2345788999999996544  789999999999999999999999877665555444333 3445677889999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      |.+||..+|.+|||+.++++|+||
T Consensus       240 i~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         240 LRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.8e-46  Score=361.25  Aligned_cols=249  Identities=28%  Similarity=0.508  Sum_probs=208.0

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|++ .+++.||+|++......  .......+.+|+.++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            4699999999999998 67899999999753211  223445677888888776 7999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            99999988765 4699999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc--------cHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||...        .....+.+........+|..++..+.+||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll  236 (329)
T cd05618         159 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL  236 (329)
T ss_pred             CccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            9999999999654  4788999999999999999999999521        11222333333444567888999999999


Q ss_pred             HHhhhhCCCCCCC------HHHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRPT------AAQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps------~~eil~hp~f~~~  400 (415)
                      ++||+.||++|++      +.++++||||+.+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.2e-46  Score=365.94  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=217.6

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++.+.+...+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            357899999999999999999998 6889999999864221  1122345577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |+||||+.+|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999997654322  


Q ss_pred             -cccCCCCccccccccccccc--cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-C--CCCCcccHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-P--PIPDSLSKDA  370 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~s~~l  370 (415)
                       ....+||+.|+|||++.+..  ..++.++|||||||++|+|++|..||..........++..... .  +....++..+
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence             23456999999999986532  2378899999999999999999999998777666666654332 2  2234689999


Q ss_pred             HHHHHHhhhhCCCC--CCCHHHHHcChhhHh
Q 014986          371 QDFIKQCVQVNPND--RPTAAQLLDHPFVKR  399 (415)
Q Consensus       371 ~~Li~~~L~~dP~~--Rps~~eil~hp~f~~  399 (415)
                      ++||.+||..++.+  |+++.+|++|+||+.
T Consensus       279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            99999999844433  789999999999976

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.3e-46  Score=362.94  Aligned_cols=256  Identities=30%  Similarity=0.445  Sum_probs=216.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++|+||+++++.+.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            3688999999999999999998 7899999999975321  122345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ||||+.+|+|.+++.+.  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999998764  68999999999999999999999999999999999999999999999999997654332  


Q ss_pred             -cccCCCCcccccccccccc----ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-C--CCCCcccH
Q 014986          297 -VKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-P--PIPDSLSK  368 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~----~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~s~  368 (415)
                       .....||+.|+|||++...    ...++.++|||||||++|+|++|..||..........++..... .  +....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS  238 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence             2234689999999998532    23478899999999999999999999988766666555544321 1  22235789


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+.+||.+||. +|.+||++.+++.||||+.+
T Consensus       239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            99999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-45  Score=357.67  Aligned_cols=248  Identities=29%  Similarity=0.496  Sum_probs=211.6

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||+||+|.+ .+++.||+|++.....  ........+.+|+.++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 6789999999974221  1123345567888888877 6999999999999999999999999


Q ss_pred             CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccCCC
Q 014986          226 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~g  302 (415)
                      .+|+|..++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            999999888765 7999999999999999999999999999999999999999999999999998753222  2334568


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+..  ++.++|||||||++|+|++|+.||...........+... ...++..++..+.+||++||..||
T Consensus       159 ~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         159 TPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             CccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHccCCH
Confidence            99999999996543  789999999999999999999999887766555555443 344677899999999999999999


Q ss_pred             CCCCCH-----HHHHcChhhHhh
Q 014986          383 NDRPTA-----AQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rps~-----~eil~hp~f~~~  400 (415)
                      .+||++     .+++.||||+..
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     999999999874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-45  Score=356.85  Aligned_cols=249  Identities=29%  Similarity=0.493  Sum_probs=209.6

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc-CCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      +.||+|+||.||+|++ .+++.||+|++......  ..........|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            4699999999999998 67899999999752211  11223445567777775 58999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            99999998876 4689999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+... ...++..++.++.+||.+||..||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         159 TPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             CccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHHhccCH
Confidence            9999999998654  3889999999999999999999999887766555555443 344667899999999999999999


Q ss_pred             CCCCCHH-HHHcChhhHhhh
Q 014986          383 NDRPTAA-QLLDHPFVKRLL  401 (415)
Q Consensus       383 ~~Rps~~-eil~hp~f~~~~  401 (415)
                      .+|+++. +++.||||+.+.
T Consensus       236 ~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         236 ERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             hhcCCChHHHHcCcccCCCC
Confidence            9999996 899999998853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-46  Score=357.89  Aligned_cols=260  Identities=29%  Similarity=0.507  Sum_probs=213.3

Q ss_pred             CcceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeee
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK  213 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  213 (415)
                      ..+..-...|++++.||+||.+.||++...+.+.||+|++....   ...+.+.-+.+|+.+|.+|+ |.+||++|++..
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~---~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE---ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh---cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            34555566899999999999999999999888899999876533   33556778899999999995 999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~~--l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .++++||||||-+. +|..+|+++.  +....++.|..||+.|+.++|.+||||.||||.|+|+ -.|.+||+|||.|..
T Consensus       431 ~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  431 TDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             cCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            99999999998655 9999998764  3445889999999999999999999999999999999 679999999999998


Q ss_pred             cccCCc----ccCCCCccccccccccccccC---------CCchhhHHHHHHHHHHHHcCCCCCCCccHHH-HHHHHhcC
Q 014986          292 TKLNDV----KSCRGTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRG  357 (415)
Q Consensus       292 ~~~~~~----~~~~gt~~y~aPE~l~~~~~~---------~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~  357 (415)
                      +.....    .+-+||+.||+||.+......         .+.++||||||||||+|+.|+.||....... .+..|...
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P  588 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP  588 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence            776542    345799999999998532211         5789999999999999999999997654322 22223222


Q ss_pred             -CCCCCCCcccHH-HHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          358 -SPPPIPDSLSKD-AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       358 -~~~~~~~~~s~~-l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                       ...++|+.-+.. +.++++.||..||++|||..++|.|||++-
T Consensus       589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence             112344444444 999999999999999999999999999986

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-45  Score=356.80  Aligned_cols=248  Identities=27%  Similarity=0.493  Sum_probs=208.1

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc-CCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|.+ .+++.||+|++......  .......+..|..++.. .+||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            3699999999999998 67899999998742211  11223344566666654 48999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            99999998865 4689999999999999999999999999999999999999999999999999975432  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+..  ++.++|||||||++|+|++|..||.+....+....+.. ..+.++..++.++.+||.+||..||
T Consensus       159 t~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         159 TPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             CccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHccCCH
Confidence            99999999986543  78999999999999999999999988776665555543 4455778899999999999999999


Q ss_pred             CCCCCH-HHHHcChhhHhh
Q 014986          383 NDRPTA-AQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rps~-~eil~hp~f~~~  400 (415)
                      .+||++ .++++||||+.+
T Consensus       236 ~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         236 TKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHcCCChHHHHcCcccCCC
Confidence            999986 588899999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.3e-46  Score=358.83  Aligned_cols=248  Identities=29%  Similarity=0.445  Sum_probs=207.4

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHH-HHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      +.||+|+||+||+|++ .+++.||+|++......  .......+.+|.. +++.++||||+++++.+.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL--KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            4699999999999998 68999999998742211  1122234445544 567899999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            99999998865 4689999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+.... ...+..++..+.+||.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         159 TPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999998654  38889999999999999999999998877666655555443 33556789999999999999999


Q ss_pred             CCCCCH----HHHHcChhhHhh
Q 014986          383 NDRPTA----AQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rps~----~eil~hp~f~~~  400 (415)
                      .+||++    .++++||||..+
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCC
Confidence            999987    699999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-45  Score=357.81  Aligned_cols=250  Identities=26%  Similarity=0.483  Sum_probs=210.9

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            4699999999999998 7789999999974221  2233456678899999887 6999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--cCCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~~~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            99999988765 479999999999999999999999999999999999999999999999999987532  222344669


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc------cHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM------ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...      ...+............+|..++..+.++|++
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~  236 (327)
T cd05617         159 TPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG  236 (327)
T ss_pred             CcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999998654  4789999999999999999999999532      2233444444445556788899999999999


Q ss_pred             hhhhCCCCCCC------HHHHHcChhhHhhh
Q 014986          377 CVQVNPNDRPT------AAQLLDHPFVKRLL  401 (415)
Q Consensus       377 ~L~~dP~~Rps------~~eil~hp~f~~~~  401 (415)
                      ||..||.+|++      +.++++||||+.+.
T Consensus       237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999998      57999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=348.84  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=215.9

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|++.++||+|+||.||++.+ .+++.||+|++......  .......+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            377889999999999999998 68999999998642211  122345567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-c
Q 014986          222 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~  297 (415)
                      |||+.+|+|..++..   ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            999999999987743   358999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHH---HHHHhcCCCCCCCCcccHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA---LFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      ....|++.|+|||++.+.  .++.++|||||||++|+|++|+.||.+......   +...........+..++..+.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            345689999999998653  378899999999999999999999987543222   222223334445667899999999


Q ss_pred             HHhhhhCCCCCC-----CHHHHHcChhhHh--hhhhCCCCC
Q 014986          375 KQCVQVNPNDRP-----TAAQLLDHPFVKR--LLATNSGSA  408 (415)
Q Consensus       375 ~~~L~~dP~~Rp-----s~~eil~hp~f~~--~~~~~~~~~  408 (415)
                      .+||..||.+||     ++.++++||||..  +........
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  277 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGML  277 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCC
Confidence            999999999999     8999999999996  444433333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.3e-45  Score=373.00  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=222.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC--
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  216 (415)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||.+.....   .......+.+|+.++..++|+||++++..+....  
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            346899999999999999999998 7899999999875332   2334566789999999999999999987764322  


Q ss_pred             ------EEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          217 ------KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       217 ------~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                            .+++||||+.+|+|.+++..     ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence                  47899999999999998864     2588999999999999999999999999999999999999999999999


Q ss_pred             eccccccccC----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC
Q 014986          286 FGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP  361 (415)
Q Consensus       286 FGla~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  361 (415)
                      ||+++.....    .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+..+...+
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            9998764322    22345699999999999654  38899999999999999999999999887777777777777777


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ++..++.++.+|+.+||..||.+||++.++++|||++....
T Consensus       265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence            88899999999999999999999999999999999987544

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.8e-46  Score=359.42  Aligned_cols=247  Identities=31%  Similarity=0.517  Sum_probs=212.1

Q ss_pred             cccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      +.||+|+||.||++.+    .+++.||+|++.....   .......+.+|+.+|++++||||+++++.+.+++.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            5799999999999875    4689999999974221   11233456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccC
Q 014986          224 LVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  300 (415)
Q Consensus       224 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~  300 (415)
                      |+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999998865 46899999999999999999999999999999999999999999999999998765433  23345


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  380 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  380 (415)
                      .||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+.... ..++..++..+.+||++||+.
T Consensus       159 ~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         159 CGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence            699999999998654  37889999999999999999999998877766666665443 346778999999999999999


Q ss_pred             CCCCCCC-----HHHHHcChhhHhh
Q 014986          381 NPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       381 dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      ||.+||+     +.+++.||||+.+
T Consensus       236 ~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         236 NPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-45  Score=353.67  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=209.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|.+.+.||+|+||.||+|++ .+++.||+|.+.......    ....+.+|+.+++.++|+||+++++++..++..|+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            5689999999999999999998 678899999987533221    12345689999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ||||+.+ +|..++...  .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            9999986 788777543  47889999999999999999999999999999999999999999999999987543222  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------------  359 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  359 (415)
                      .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+....+.....                 
T Consensus       161 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2334578999999998543 2478899999999999999999999987654443332221100                 


Q ss_pred             ----C--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          360 ----P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       360 ----~--------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                          +        .....++.++.+||.+||..||.+|||+.|+++||||+.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence                0        0112468899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3e-45  Score=361.04  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=211.3

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC---
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  215 (415)
                      +.++|++.+.||+|+||.||+|.+ .+++.||||++.....   .......+.+|+.+++.++||||+++++++...   
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            467899999999999999999998 6789999998864221   122345677899999999999999999987543   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ---~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                         ..+|+||||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence               457999999976 6776665 35888999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----------
Q 014986          293 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  361 (415)
Q Consensus       293 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  361 (415)
                      .... .....||..|+|||++.+.  .++.++|||||||++|+|++|+.||......+...++......+          
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            4332 2345689999999999654  38899999999999999999999998776555444433211110          


Q ss_pred             -------------------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          362 -------------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       362 -------------------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                                     .....+..+++||.+||+.||.+|||+.++|+||||+.+.......
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~  331 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE  331 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence                                           0111346789999999999999999999999999999876655444

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-44  Score=367.99  Aligned_cols=254  Identities=21%  Similarity=0.356  Sum_probs=197.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC------CCcEEEeeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE------HENIVQYYGTDK  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~  213 (415)
                      .++|++.++||+|+||+||+|++ .+++.||||++.....      .......|+.++..++      |.+|+++++++.
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            46799999999999999999998 6789999999864211      1223345555555554      556899998887


Q ss_pred             cC-CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCC-----------
Q 014986          214 DE-SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANG-----------  279 (415)
Q Consensus       214 ~~-~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~-----------  279 (415)
                      .+ .++|+||+++ +++|.+++.+ ..+++..++.++.||+.||.|||+ .|||||||||+|||++.++           
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            64 5789999988 5578887754 469999999999999999999998 5999999999999998765           


Q ss_pred             -----cEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Q 014986          280 -----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI  354 (415)
Q Consensus       280 -----~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i  354 (415)
                           .+||+|||++.... ......+||+.|+|||++.+.  .++.++|||||||++|||++|+.||......+.+..+
T Consensus       281 ~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             CCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                 49999999876433 223456799999999999654  4899999999999999999999999876654433322


Q ss_pred             hcCCCC-------------------------C---------------CC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          355 GRGSPP-------------------------P---------------IP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       355 ~~~~~~-------------------------~---------------~~-~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ......                         +               .. ...+..+.+||.+||..||++|||+.|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            211000                         0               00 011356789999999999999999999999


Q ss_pred             ChhhHhhhhhC
Q 014986          394 HPFVKRLLATN  404 (415)
Q Consensus       394 hp~f~~~~~~~  404 (415)
                      ||||+..+...
T Consensus       438 Hp~~~~~~~~~  448 (467)
T PTZ00284        438 HPYVLKYYPEC  448 (467)
T ss_pred             CccccccCCcc
Confidence            99999876644

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-45  Score=364.60  Aligned_cols=247  Identities=26%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|++.+.||+|+||.||+|++ .+++.||+|....           ..+.+|+.+|+.++||||+++++++......+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            45799999999999999999998 7899999996431           24568999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc---C
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---N  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~---~  295 (415)
                      +|||++. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....   .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999996 578877654 5789999999999999999999999999999999999999999999999999865322   2


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-------HHHHHHHHhc------------
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-------CMAALFKIGR------------  356 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~------------  356 (415)
                      ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||....       ....+..+..            
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            23345799999999998654  48999999999999999999998764321       0011111100            


Q ss_pred             --------------C-CCCC--CC-----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          357 --------------G-SPPP--IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       357 --------------~-~~~~--~~-----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                    . ...+  .+     ..++.++.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                          0 0000  00     13467899999999999999999999999999998864

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-45  Score=358.59  Aligned_cols=260  Identities=25%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  215 (415)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||+|++....   ........+.+|+.+|+.++|+||+++++++...  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            3457899999999999999999998 788999999886421   1122345577899999999999999999887543  


Q ss_pred             ----CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ----~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                          ..+|++|+++ +++|..++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence                4579999988 66999888878899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-----------
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------  360 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  360 (415)
                      .... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......           
T Consensus       168 ~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADDE-MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCCC-cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            5433 3445689999999998542 24788999999999999999999999876554443333211100           


Q ss_pred             -----------C--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          361 -----------P--------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       361 -----------~--------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                 .        .....++.+.+||.+||..||.+|||+.+++.||||.......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence                       0        0123566789999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=355.57  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=212.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||++.+ .+++.||+|++.....  ........+.+|+.++..++|+||+++++++.+++++|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            3688999999999999999998 6799999999874211  112234567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc-
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-  297 (415)
                      ||||+.+|+|.+++.+  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999999875  4689999999999999999999999999999999999999999999999999876543221 


Q ss_pred             --ccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC----CCCCCCcccH
Q 014986          298 --KSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----PPPIPDSLSK  368 (415)
Q Consensus       298 --~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~s~  368 (415)
                        ....||+.|+|||++...   ...++.++|||||||++|+|++|+.||......+....+....    .+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence              224599999999998632   2336789999999999999999999998876665555554322    1222235799


Q ss_pred             HHHHHHHHhhhhCCCC--CCCHHHHHcChhhHhh
Q 014986          369 DAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  400 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~--Rps~~eil~hp~f~~~  400 (415)
                      .+++||++||..++++  |+++.++++||||...
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            9999999998664443  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.8e-45  Score=353.35  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=214.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l  220 (415)
                      .|+..+.||+|+||.||+|.+ .+++.||+|++.....  ........+..|+.++..+. |++|+++++++.+.+.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            367788999999999999998 6899999999874221  11223456678888888875 5778889999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Cc
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~  297 (415)
                      ||||+.+|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            9999999999998876 46899999999999999999999999999999999999999999999999998754322  23


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.... ...+..++.++.+|+.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHH
Confidence            345699999999998654  37889999999999999999999998877666666655433 346778899999999999


Q ss_pred             hhhCCCCCCC-----HHHHHcChhhHhhh
Q 014986          378 VQVNPNDRPT-----AAQLLDHPFVKRLL  401 (415)
Q Consensus       378 L~~dP~~Rps-----~~eil~hp~f~~~~  401 (415)
                      |..+|.+|++     ..++++||||+.+.
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            9999999997     57999999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=358.27  Aligned_cols=248  Identities=32%  Similarity=0.507  Sum_probs=206.8

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC---CCCcEEEeeeeeecCCEEEEEEecc
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ||+|+||+||+|++ .+++.||+|++.....  ...........|..++...   +||||+++++.+.+.+.+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            79999999999998 6799999999864221  1122334455666776655   6999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++....  ......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            99999988765 4689999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+. ..++.++|||||||++|+|++|..||......+....+..+........++.++.+||++||..||
T Consensus       159 t~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P  237 (330)
T cd05586         159 TTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP  237 (330)
T ss_pred             CccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence            9999999998543 337889999999999999999999998877666666665554433334579999999999999999


Q ss_pred             CCCC----CHHHHHcChhhHhh
Q 014986          383 NDRP----TAAQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rp----s~~eil~hp~f~~~  400 (415)
                      .+||    ++.++++||||+..
T Consensus       238 ~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         238 QHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHCCCCCCCHHHHhcCccccCC
Confidence            9998    79999999999764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.9e-45  Score=355.63  Aligned_cols=248  Identities=29%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHH-HHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      +.||+|+||+||+|.+ .+++.||+|++......  .......+.+|.. +++.++||||+++++.+...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL--NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            4699999999999998 78999999998743211  1222334455554 567899999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--cCCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~~~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            99999988765 468999999999999999999999999999999999999999999999999987532  223344569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+.... ...+..++..+.++|++||..+|
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         159 TPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCH
Confidence            9999999998654  37889999999999999999999998877666666655543 33455689999999999999999


Q ss_pred             CCCCCH----HHHHcChhhHhh
Q 014986          383 NDRPTA----AQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rps~----~eil~hp~f~~~  400 (415)
                      .+||++    .++++||||+..
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCC
Confidence            999976    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6e-45  Score=357.66  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=207.8

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC---
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  215 (415)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|+.+++.++||||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            467899999999999999999998 6799999998864321   122345677899999999999999999987643   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ---~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                         ..+|+||||+.+ +|...+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence               357999999976 5666654 35888999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-----------
Q 014986          293 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------  360 (415)
Q Consensus       293 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  360 (415)
                      .... .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+......           
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            4332 2345689999999998654  3889999999999999999999999876544333222111000           


Q ss_pred             ------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          361 ------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       361 ------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                                                    ......+..+++||.+||..||.+|||+.|+|+||||+.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                                          0112245678999999999999999999999999999977654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8e-45  Score=353.67  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=213.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||++++ .+++.||+|++.....  ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            3688999999999999999998 6788999999864221  112233457789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ||||+.+|+|.+++.+  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999999976  468999999999999999999999999999999999999999999999999987543222  


Q ss_pred             -cccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC----CCCCCcccH
Q 014986          297 -VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----PPIPDSLSK  368 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~s~  368 (415)
                       .....||+.|+|||++...   ...++.++|||||||++|+|++|+.||......+...++.....    +.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence             2235699999999998531   23478899999999999999999999998877776666654332    122246799


Q ss_pred             HHHHHHHHhhhhCCCC--CCCHHHHHcChhhHhh
Q 014986          369 DAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  400 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~--Rps~~eil~hp~f~~~  400 (415)
                      ++++||++||..++.+  |+++.++++||||+.+
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            9999999999665444  6899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.2e-45  Score=353.88  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=205.4

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHH-HHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI-ALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      +.||+|+||+||+|++ .+++.||+|++......  .......+..|. .+++.++|+||+++++.+.+.+.+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            4699999999999998 67889999998742211  111223334444 4568899999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.. ..+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            99999998865 4588999999999999999999999999999999999999999999999999875322  22344569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+... ....+..++..+.+||.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         159 TPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             CccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999998654  4888999999999999999999999887766665555443 333556789999999999999999


Q ss_pred             CCCCCHH----HHHcChhhHh
Q 014986          383 NDRPTAA----QLLDHPFVKR  399 (415)
Q Consensus       383 ~~Rps~~----eil~hp~f~~  399 (415)
                      .+|+++.    ++++|+||..
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCC
Confidence            9999865    8999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.5e-45  Score=353.03  Aligned_cols=247  Identities=28%  Similarity=0.450  Sum_probs=206.3

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHH-HHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI-ALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ++||+|+||.||+|++ .+++.||+|++......  .......+.+|. .+++.++||||+++++.+.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 67899999998742211  112233444554 4678899999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CCcccCCC
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  302 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~g  302 (415)
                      .+|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  ......+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            99999987765 4689999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+... ...++...+..+.++|.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         159 TPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             CcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999998553  3788999999999999999999999887765555555443 445667889999999999999999


Q ss_pred             CCCCCH----HHHHcChhhHh
Q 014986          383 NDRPTA----AQLLDHPFVKR  399 (415)
Q Consensus       383 ~~Rps~----~eil~hp~f~~  399 (415)
                      .+|+++    .++++|+||..
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCC
Confidence            999875    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-44  Score=341.90  Aligned_cols=247  Identities=25%  Similarity=0.405  Sum_probs=202.7

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||+|+||.||++++ .+++.||+|.+.......  ......+..|+.+++.++||||+++++.+.++..+|+||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            79999999999998 679999999986422111  112234557999999999999999999999999999999999999


Q ss_pred             CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-cccCCCCc
Q 014986          229 SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA  304 (415)
Q Consensus       229 sL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~gt~  304 (415)
                      +|..++..   ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... .....|+.
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            99887754   258888999999999999999999999999999999999999999999999987654332 23456899


Q ss_pred             cccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH----HHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhh
Q 014986          305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  380 (415)
Q Consensus       305 ~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  380 (415)
                      .|+|||++.+..  ++.++|||||||++|+|++|..||.....    .+................++.++.+||.+||+.
T Consensus       159 ~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            999999986544  88999999999999999999999975422    222222222222222346899999999999999


Q ss_pred             CCCCCCCH----HHHHcChhhHhh
Q 014986          381 NPNDRPTA----AQLLDHPFVKRL  400 (415)
Q Consensus       381 dP~~Rps~----~eil~hp~f~~~  400 (415)
                      ||++||++    ++++.|+||+.+
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    778899999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.7e-45  Score=359.24  Aligned_cols=253  Identities=28%  Similarity=0.482  Sum_probs=208.1

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-----
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  216 (415)
                      +|++.+.||+|+||.||+|++ .+++.||+|++.....   .......+.+|+.+++.++|+||+++++++....     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ---NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc---chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            478889999999999999998 7899999998853211   1223456789999999999999999999998776     


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          78 EIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            89999999975 77776654 56899999999999999999999999999999999999999999999999999765432


Q ss_pred             C---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---------------
Q 014986          296 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---------------  357 (415)
Q Consensus       296 ~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---------------  357 (415)
                      .   .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+...               
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            2   2334578999999998653 23688999999999999999999999876554444333211               


Q ss_pred             ---------CCC-------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          358 ---------SPP-------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       358 ---------~~~-------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                               ...       ......+.++.+||.+||+.||.+|||+.++++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                     000       1223467899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-45  Score=356.48  Aligned_cols=250  Identities=28%  Similarity=0.502  Sum_probs=215.1

Q ss_pred             eeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ....+.+.++..||+|+||+||+|.+..  .||||++......   ....+.|++|+.++++-+|.||+-+.|++..+..
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt---~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPT---PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCC---HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            3345567789999999999999998833  6999999875443   3367889999999999999999999999998877


Q ss_pred             EEEEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc---
Q 014986          218 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---  292 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~---  292 (415)
                       .||+.+|+|.+|+.++.  +..|.....+.|++||++|+.|||.++|||||||..||++..++.|||+||||+...   
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence             99999999999999875  457888899999999999999999999999999999999999999999999998643   


Q ss_pred             -ccCCcccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC----CCcc
Q 014986          293 -KLNDVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI----PDSL  366 (415)
Q Consensus       293 -~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  366 (415)
                       .........|...|||||+++.. ...|+..+||||||+++|||++|.+||......+.++.++++...+.    ...+
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence             22334445588889999999643 34589999999999999999999999997777778888888865442    3467


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +.++++|+..||..++++||.+.+||.
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            889999999999999999999999986

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-44  Score=343.59  Aligned_cols=253  Identities=26%  Similarity=0.451  Sum_probs=210.7

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |++.+.||+|+||.||++.+ .+++.||+|.+......  .......+.+|+.+++.++|++|+.+++.+.+.+.+|+||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            67778899999999999998 78999999988743221  1223345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-Ccc
Q 014986          223 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK  298 (415)
Q Consensus       223 E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~~  298 (415)
                      ||+.+++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            99999999988753   35889999999999999999999999999999999999999999999999998754332 223


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ...|+..|+|||++.+..  ++.++|||||||++|+|++|+.||.....   ...............+..++.++.+|+.
T Consensus       160 ~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05630         160 GRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK  237 (285)
T ss_pred             CCCCCccccChHHHcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence            456899999999986543  78999999999999999999999976432   1222222222223355678899999999


Q ss_pred             HhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          376 QCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       376 ~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      +||+.||.+|||     +.++++||||++.
T Consensus       238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         238 MLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999     9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.6e-44  Score=337.25  Aligned_cols=253  Identities=47%  Similarity=0.856  Sum_probs=218.8

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccc----hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      +|.+.+.||.|+||.||+|.+ .+++.+|+|.+.......    ......+.+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999998 678999999886533221    223345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      .++||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++....+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999998764 58889999999999999999999999999999999999999999999999987654221


Q ss_pred             --------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          297 --------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       297 --------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                              .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|+.||...........+.....+..+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS  238 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence                    1123478899999998654  378899999999999999999999988776666666666666667788999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .+.++|.+||+.||.+||++.+|++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-44  Score=343.34  Aligned_cols=249  Identities=31%  Similarity=0.502  Sum_probs=199.2

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc---CCCCcEEEeeeeeec----
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDKD----  214 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~---l~hpnIv~l~~~~~~----  214 (415)
                      +|++.+.||+|+||+||+|++ .+++.||+|.+.........   ...+.+|+.+++.   ++||||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            478889999999999999998 68999999998753222111   1223456655554   479999999998764    


Q ss_pred             -CCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          215 -ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       215 -~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                       ...+++||||+.+ +|..++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             3568999999985 888887653   48999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC----------
Q 014986          291 ATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----------  359 (415)
Q Consensus       291 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------  359 (415)
                      ...... .....||..|+|||++.+.  .++.++|||||||++|+|++|..||......+.+.++.....          
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            654332 3345689999999998654  388999999999999999999999977655544443322100          


Q ss_pred             --------C--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 --------P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 --------~--------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                              .        .....++..+.+||.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                    0        0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.6e-44  Score=349.20  Aligned_cols=257  Identities=26%  Similarity=0.468  Sum_probs=207.1

Q ss_pred             cccccccC--CcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          146 KGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       146 ~~~~LG~G--~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      ++++||+|  +||+||++++ .+++.||+|.+.....   .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            56789999  7899999998 7899999999864322   1233456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC----
Q 014986          223 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----  295 (415)
Q Consensus       223 E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~----  295 (415)
                      ||+.+|+|.+++..   ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+......    
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999998864   35899999999999999999999999999999999999999999999999865332111    


Q ss_pred             -----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----------
Q 014986          296 -----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------  360 (415)
Q Consensus       296 -----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  360 (415)
                           ......++..|+|||++.+....++.++|||||||++|+|++|..||..............+..+          
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 01123467789999998654445889999999999999999999999865443333222211110          


Q ss_pred             -----------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          361 -----------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       361 -----------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                                                         +....++..+.+||.+||+.||++|||++++++||||+++....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~~~  318 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRAS  318 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchhhh
Confidence                                               011235678999999999999999999999999999998765443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-44  Score=339.32  Aligned_cols=255  Identities=38%  Similarity=0.696  Sum_probs=222.5

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||.|+||.||+|.+ .+++.||+|.+....    .......+.+|+.+++.++|+||+++++.+.++..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            3688899999999999999998 689999999987432    12234567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Ccc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~  298 (415)
                      |+||+.+++|.+++....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.....  ...
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999999776543  233


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCc-ccHHHHHHHHHh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS-LSKDAQDFIKQC  377 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~l~~Li~~~  377 (415)
                      ...+++.|+|||.+.+..  ++.++||||||+++|+|++|..||...........+.....+..+.. ++..+.+++.+|
T Consensus       157 ~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             cccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            456888999999986544  88999999999999999999999987766666666666655555555 889999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      |..+|++|||+++++.||||+....
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999999987544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-44  Score=341.60  Aligned_cols=258  Identities=35%  Similarity=0.610  Sum_probs=220.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||++.+ .++..||+|.+....    .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3688999999999999999998 589999999886421    22234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          221 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      ||||+.+++|..++...    .+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999888764    78999999999999999999997 59999999999999999999999999998766544


Q ss_pred             CcccCCCCccccccccccccc----cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH---HHHHHhcCCCCCCCCcccH
Q 014986          296 DVKSCRGTAFWMAPEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA---ALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~s~  368 (415)
                      ......+++.|+|||.+.+..    ..++.++|+|||||++|+|++|+.||.......   .+..+..+....++..++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD  236 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence            445556888999999985432    235789999999999999999999997644322   3334445555667777999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ++.+||.+||..+|.+||++.++++||||......
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            99999999999999999999999999999888654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.5e-44  Score=339.54  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=210.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.++||+|+||.||+|++ .+++.||+|.+....    .......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence            3578889999999999999998 789999999886421    12234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccC
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC  300 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  300 (415)
                      ||||+.+++|..+   ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...........
T Consensus        77 v~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  153 (279)
T cd06619          77 CTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY  153 (279)
T ss_pred             EEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCC
Confidence            9999999998654   3578888999999999999999999999999999999999999999999999987655555556


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH-------HHHHHHHhcCCCCCC-CCcccHHHHH
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKIGRGSPPPI-PDSLSKDAQD  372 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~-~~~~s~~l~~  372 (415)
                      .||..|+|||++.+.  .++.++|+|||||++|+|++|..||.....       ......+........ ....+.++.+
T Consensus       154 ~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         154 VGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence            799999999998654  378899999999999999999999965321       111222222222222 3457889999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      |+.+||+.+|.+||++.++++||||+.....
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence            9999999999999999999999999877443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.8e-44  Score=335.70  Aligned_cols=253  Identities=45%  Similarity=0.798  Sum_probs=215.9

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEeccccc-chhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||.|+||.||+|.+.+++.+|+|.+...... ........++.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47889999999999999999888999999998753221 22334456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc------
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------  294 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~------  294 (415)
                      |||+.+++|.+++.+ ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....      
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT  160 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence            999999999999876 4689999999999999999999999999999999999999999999999999875421      


Q ss_pred             --CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCCCCCcccHHH
Q 014986          295 --NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG--SPPPIPDSLSKDA  370 (415)
Q Consensus       295 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~l  370 (415)
                        .......++..|+|||.+.+..  ++.++|+||||+++|+|++|..||...........+...  ..+..+..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         161 HSNMLKSMHGTPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             ccccccccCCCccccChhhhcCCC--CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence              1122345889999999986543  788999999999999999999999876655544444332  3345667889999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .+||.+||..+|.+||++.+++.||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-44  Score=352.19  Aligned_cols=257  Identities=25%  Similarity=0.410  Sum_probs=213.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||++++ .+++.||+|.+.....  ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3688999999999999999998 6789999999864211  122334557789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc-
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-  297 (415)
                      ||||+.+|+|.+++.+  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999999999875  4689999999999999999999999999999999999999999999999999876543322 


Q ss_pred             --ccCCCCccccccccccccc---cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCC---CcccH
Q 014986          298 --KSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP---DSLSK  368 (415)
Q Consensus       298 --~~~~gt~~y~aPE~l~~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~---~~~s~  368 (415)
                        ....||+.|+|||++.+..   ..++.++|||||||++|+|++|+.||......+...++.... ..+++   ..++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence              2346999999999986421   236789999999999999999999998877666665554432 12222   34689


Q ss_pred             HHHHHHHHhhhhCCCC--CCCHHHHHcChhhHhh
Q 014986          369 DAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  400 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~--Rps~~eil~hp~f~~~  400 (415)
                      ++++||.+||..++.+  |++++++++|+||+.+
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            9999999999876554  5789999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-44  Score=351.34  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=204.9

Q ss_pred             ecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  213 (415)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|++....    .......+.+|+.++..+ +||||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            46799999999999999999974      345789999886321    122345688999999999 8999999999876


Q ss_pred             cC-CEEEEEEeccCCCCHHHHHhhc-------------------------------------------------------
Q 014986          214 DE-SKLYIFLELVTKGSLLNLYQRY-------------------------------------------------------  237 (415)
Q Consensus       214 ~~-~~~~lV~E~~~~gsL~~~l~~~-------------------------------------------------------  237 (415)
                      .. ..+++||||+.+|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999988642                                                       


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----cccCCCCcc
Q 014986          238 --------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF  305 (415)
Q Consensus       238 --------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~  305 (415)
                              .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    .....++..
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                    26677888999999999999999999999999999999999999999999997543221    112345678


Q ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHH-HHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA-ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       306 y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      |+|||++.+.  .++.++|||||||++|+|++ |..||....... ....+..+.....+..++..+.+|+.+||..||.
T Consensus       242 y~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         242 WMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999998654  37899999999999999997 999998754322 2333444444556678899999999999999999


Q ss_pred             CCCCHHHHHcChhhHhhhh
Q 014986          384 DRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       384 ~Rps~~eil~hp~f~~~~~  402 (415)
                      +|||+.+|++  .|+.++.
T Consensus       320 ~RPs~~el~~--~l~~~~~  336 (338)
T cd05102         320 ERPTFSALVE--ILGDLLQ  336 (338)
T ss_pred             hCcCHHHHHH--HHHHHHh
Confidence            9999999986  3555543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.1e-44  Score=345.54  Aligned_cols=256  Identities=28%  Similarity=0.455  Sum_probs=210.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|.+.......    ....+.+|+.+++.++|+||+++++++...+.+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            45789999999999999999998 678999999987533221    1234568999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      +||||+.+ +|..++..  ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... 
T Consensus        81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999985 88887764  358899999999999999999999999999999999999999999999999987543222 


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC----------------
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----------------  359 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------  359 (415)
                       .....+++.|+|||++.+. ..++.++|||||||++|+|++|+.||......+....+.....                
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             2234578999999998543 3478899999999999999999999987665444333221100                


Q ss_pred             -----C--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          360 -----P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       360 -----~--------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                           +        .....++..+++||.+||+.||.+|||+.++++||||+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                 0        011346888999999999999999999999999999988764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.2e-44  Score=332.90  Aligned_cols=254  Identities=63%  Similarity=1.063  Sum_probs=220.4

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|+..+.||+|+||.||+|++ .+++.|++|.+.............+.+.+|+.+++.++|+||+++++.+.+...+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            477889999999999999998 5899999999876544444455667889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-ccc
Q 014986          222 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~~~  299 (415)
                      |||+.+++|.+++.+.. +++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999987654 8999999999999999999999999999999999999999999999999987654333 344


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CCCCCCCCcccHHHHHHHHHhh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..++..|++||.+.... .++.++|+||||+++|+|++|+.||..........++.. .....++..++..+.+|+.+||
T Consensus       161 ~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         161 FKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             cCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            56899999999985433 378899999999999999999999987765555555554 3444567788999999999999


Q ss_pred             hhCCCCCCCHHHHHcChhh
Q 014986          379 QVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f  397 (415)
                      ..+|.+||++.+++.|||+
T Consensus       240 ~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         240 QRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hcCcccCcCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=341.94  Aligned_cols=251  Identities=38%  Similarity=0.690  Sum_probs=223.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+-|.++++||+|+||.||+|++ .+|..+|+|.+.+       ...++.+..|+.++++++.+++|++|+.+-....++
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            34688999999999999999999 7899999999975       234567789999999999999999999998899999


Q ss_pred             EEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          220 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      ||||||..|+..++++  +..+++.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|......  
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            9999999999999875  457999999999999999999999999999999999999999999999999998654332  


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CCcccHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF  373 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~L  373 (415)
                      ....+.|||.|||||++...+  |+.++||||||+...||..|++||.....+.+++.|....++.+  |+..+.++.+|
T Consensus       185 KRNTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             hhCccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence            234567999999999996655  99999999999999999999999999888888877776665544  56789999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +++||.++|++|-|+.++++|+|++..
T Consensus       263 i~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            999999999999999999999999853

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-45  Score=332.23  Aligned_cols=270  Identities=30%  Similarity=0.510  Sum_probs=220.7

Q ss_pred             eeccccc-ccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCC
Q 014986          140 IITYWQK-GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  216 (415)
Q Consensus       140 ~~~~y~~-~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  216 (415)
                      +.+.|++ .++||+|+|+.|--++. .++..||||++.+.     ......++.+|++++.+++ |+||++++++|+++.
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            4455665 56899999999999988 89999999999753     2334567789999999985 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEeecccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKAT  292 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~---~vkl~DFGla~~~  292 (415)
                      .+|||||.+.||+|..++++ ..|++.++.+++++|+.||.|||.+||.||||||+|||...-.   -||||||.|..-.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            99999999999999987765 6799999999999999999999999999999999999997554   4899999987644


Q ss_pred             ccC---------CcccCCCCcccccccccc---ccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--------------
Q 014986          293 KLN---------DVKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--------------  346 (415)
Q Consensus       293 ~~~---------~~~~~~gt~~y~aPE~l~---~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--------------  346 (415)
                      +.+         ...+.+|+..|||||+..   +....|+.+.|.||||+|+|-||+|.+||.+.-              
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~  309 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV  309 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence            332         233456888999999863   344558999999999999999999999996532              


Q ss_pred             HHHHHHHHhcCCCCCCC----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCCCCCCCC
Q 014986          347 CMAALFKIGRGSPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGR  414 (415)
Q Consensus       347 ~~~~~~~i~~~~~~~~~----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~~~~~~~  414 (415)
                      ..+.++..++.....+|    ..+|.++++||..+|..|+.+|.++.++++|||++.+..+..-+..+-++|
T Consensus       310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~r  381 (463)
T KOG0607|consen  310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQR  381 (463)
T ss_pred             HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccccc
Confidence            22233333333333344    358999999999999999999999999999999999988755544444443

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.4e-44  Score=378.92  Aligned_cols=263  Identities=28%  Similarity=0.494  Sum_probs=217.3

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  214 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  214 (415)
                      .....+|++++.||+|+||+||+|.+ .++..||+|++......   ......+.+|+.+|..++|||||+++++|.+  
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~---e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK---EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC---HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            34567899999999999999999998 77889999988753222   2334678899999999999999999998854  


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCcEEEcC-----
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-------DVVHRDIKCANILVDA-----  277 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~-------~IiHrDLkp~NILl~~-----  277 (415)
                      ...+||||||+.+|+|.+++..     ..+++..++.|+.||+.||.|||+.       +||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4679999999999999998864     3589999999999999999999985       4999999999999964     


Q ss_pred             ------------CCcEEEEeeccccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014986          278 ------------NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  344 (415)
Q Consensus       278 ------------~~~vkl~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~  344 (415)
                                  .+.+||+|||++....... ...+.||+.|+|||++.+....++.++||||||||||+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        2358999999997654332 234579999999999866555588999999999999999999999987


Q ss_pred             ccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          345 MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       345 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ......+.......+.......+.++.+||..||..+|.+||++.++|.|+||+.+...
T Consensus       246 ~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        246 ANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             CCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            65554444443333332234578999999999999999999999999999999987654

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-46  Score=362.44  Aligned_cols=256  Identities=36%  Similarity=0.653  Sum_probs=225.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|.|+.-||.|+||.||+|.. .++-..|.|+|.     ......++.+.-||.||..+.||+||++++.|..++.++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            35688999999999999999998 455666777765     345667788899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--C
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~  295 (415)
                      |+.|||.||-...++-.  ..+++.++..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+.....  .
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            99999999988886643  5799999999999999999999999999999999999999999999999998754322  2


Q ss_pred             CcccCCCCccccccccccc---cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CCcccHHH
Q 014986          296 DVKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDA  370 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~---~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l  370 (415)
                      ...++.|||+|||||++.-   +..+|+.++||||||++|.+|..+.+|......+..+.++.+..++.+  |...+..+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            3456789999999999752   344589999999999999999999999999999999999999887754  56789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .||+++||..||..||+++++|+||||+..-
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999999999999999999998643

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-44  Score=355.90  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=201.9

Q ss_pred             eecccccccccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ...+|++.+.||+|+||.||++..   ..++.||+|.+...          ....+|+.+|+.++||||+++++.+....
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            345799999999999999999975   35678999987531          12458999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+|+|||++. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9999999997 478887754 46899999999999999999999999999999999999999999999999998755432


Q ss_pred             C----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcC-----------
Q 014986          296 D----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRG-----------  357 (415)
Q Consensus       296 ~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~-----------  357 (415)
                      .    .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+...   ...+..+...           
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            2    2245699999999998654  388999999999999999999999965321   1111111100           


Q ss_pred             ---------------CCC--CCC-----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          358 ---------------SPP--PIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       358 ---------------~~~--~~~-----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                     ...  ..+     ..++.++++||.+||..||++|||+.++|.||||+..-
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                           000  011     23467899999999999999999999999999998643

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-43  Score=331.35  Aligned_cols=250  Identities=32%  Similarity=0.560  Sum_probs=219.1

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|.+.+.||+|+||.||+|++ .+++.|++|.+......   ......+.+|+.+++.++||||+++++.+.+.+..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            477888999999999999998 68999999998743222   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          222 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |||+.+++|.+++...   .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++......  
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999988653   58899999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....|++.|+|||++.+..  ++.++|+||||+++|+|++|+.||..........++..+....++..++..+.++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             hhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            22345889999999986543  7889999999999999999999998887777777777777777777889999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ||+.+|++||++.++++|||+
T Consensus       236 ~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         236 CLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=364.10  Aligned_cols=255  Identities=41%  Similarity=0.720  Sum_probs=220.8

Q ss_pred             ccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCC
Q 014986          149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  227 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~  227 (415)
                      +||+|+||+||.|++ .+...+|||.+...     ..+..+.+..||.+-+.++|.|||+++|.+..++++-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek-----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK-----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc-----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            599999999999999 77889999999742     233456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc--CC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEeeccccccccC--CcccC
Q 014986          228 GSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN--DVKSC  300 (415)
Q Consensus       228 gsL~~~l~~~--~l--~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-~~~~vkl~DFGla~~~~~~--~~~~~  300 (415)
                      |+|.++++..  .+  ++..+..|.+||++||+|||.+.|+|||||-+|+||+ -.|.+||+|||-++....-  .....
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            9999999763  45  7888999999999999999999999999999999997 4689999999998865432  23456


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH-HHHHHHHhcCC-CCCCCCcccHHHHHHHHHhh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGS-PPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~s~~l~~Li~~~L  378 (415)
                      .||..|||||++.....+|+.++|||||||++.||.||++||..... ..+.++++.-. .+++|..++.+++.||.+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            79999999999998888899999999999999999999999976543 34455554333 46789999999999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhhhhhCCCCC
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRLLATNSGSA  408 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~~~~~~~~~  408 (415)
                      .+||..||++.++|..||++.-.....+..
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~~kk~r~~l  846 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHNNKKPRPKL  846 (1226)
T ss_pred             CCCcccCccHHHhccCcccccCCCCCCCCC
Confidence            999999999999999999998744443333

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.7e-44  Score=341.12  Aligned_cols=257  Identities=32%  Similarity=0.585  Sum_probs=218.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ....+|++.+.||+|+||.||+|++ .+++.||+|.+.....     .....+.+|+.+++.+.|+||+++++.+.....
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            3456889999999999999999998 6889999998875322     123567799999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          218 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      .|+||||+.+++|.+++....+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....... 
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             EEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999999999999987789999999999999999999999999999999999999999999999999987544332 


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCcccHHHHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDF  373 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~L  373 (415)
                       .....+++.|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+......  ..+..++..+.+|
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF  249 (296)
T ss_pred             ccCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence             2234688999999998543  3788999999999999999999999876654444333322222  2355688999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      |.+||..+|++||++.++++||||.....
T Consensus       250 i~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            99999999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.8e-45  Score=339.84  Aligned_cols=250  Identities=36%  Similarity=0.580  Sum_probs=207.0

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |++++.||+|+||+||++.+ .+++.||+|.+......   ........+|+.+++.++|+||+++++++.+....++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE---EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH---HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc---ccccchhhhhhhccccccccccccccccccccccccccc
Confidence            77889999999999999999 67789999999864322   222233456999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc--ccCCccc
Q 014986          223 ELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KLNDVKS  299 (415)
Q Consensus       223 E~~~~gsL~~~l~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~--~~~~~~~  299 (415)
                      ||+.+++|.+++. ...+++..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+...  .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999997 678999999999999999999999999999999999999999999999999998753  2333455


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhcCCCC---CCCCcccHHHHHH
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPP---PIPDSLSKDAQDF  373 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~---~~~~~~s~~l~~L  373 (415)
                      ..++..|+|||++. ....++.++||||||+++|+|++|..||....   ......+.......   ......+..+.+|
T Consensus       158 ~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQ-QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSSGGGSCHHHHT-TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence            67899999999985 12347899999999999999999999998863   22222222211110   0111224899999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      |.+||+.||++||++.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.5e-43  Score=333.48  Aligned_cols=253  Identities=47%  Similarity=0.828  Sum_probs=212.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--CCEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLY  219 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~  219 (415)
                      .|+..+.||+|+||.||+|.+ .++..||+|++..........+....+.+|+.+++.++||||+++++.+.+  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            588899999999999999998 679999999987544333344456778899999999999999999998765  46789


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC---
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~---  295 (415)
                      ++|||+.+++|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+||+++.++.++|+|||++......   
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            99999999999998865 46889999999999999999999999999999999999999999999999998754321   


Q ss_pred             --CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCCCcccHHHHH
Q 014986          296 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQD  372 (415)
Q Consensus       296 --~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~  372 (415)
                        ......++..|+|||.+.+.  .++.++|||||||++|+|++|+.||..........++.... .+.++..++..+++
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             CCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence              12234588899999998653  37889999999999999999999998776555554443322 34456678899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                      || +||..+|++||++++|++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=381.16  Aligned_cols=270  Identities=27%  Similarity=0.419  Sum_probs=229.6

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      -.++|.++++||+|+||.|.+++. .+++.||+|++.+.....  .....-|..|-.+|...+.+=|++++.+|+++.++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            456899999999999999999998 889999999987532211  11235678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          219 YIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      ||||||++||+|..++.++. +++..++.|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.|-....+. 
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            99999999999999999887 9999999999999999999999999999999999999999999999999987766443 


Q ss_pred             --cccCCCCccccccccccccc---cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCC--CcccH
Q 014986          297 --VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP--DSLSK  368 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~  368 (415)
                        ....+|||.|.+||++...+   ..|+...|+||+||++|||+.|..||+.....+.+.+|.... ...+|  ..+|.
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe  310 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE  310 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence              23456999999999996332   348999999999999999999999999998888888886652 12233  46899


Q ss_pred             HHHHHHHHhhhhCCCCCCC---HHHHHcChhhHhhhh-hCCCCCCCCC
Q 014986          369 DAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLLA-TNSGSASPYL  412 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps---~~eil~hp~f~~~~~-~~~~~~~~~~  412 (415)
                      ++++||++++. +|+.|..   ++++..||||.++.= .-....+|++
T Consensus       311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~v  357 (1317)
T KOG0612|consen  311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVV  357 (1317)
T ss_pred             HHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCC
Confidence            99999999985 7899988   999999999998753 3334444443

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=336.74  Aligned_cols=254  Identities=38%  Similarity=0.674  Sum_probs=218.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||.|+||.||+|.+ .++..+|+|.+...     .......+.+|+.+++.++|+||+++++.+.++..+|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            5699999999999999999998 67899999998642     23344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ||||+.+++|.+++..  ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......  
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            9999999999998865  358999999999999999999999999999999999999999999999999886543222  


Q ss_pred             cccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~  371 (415)
                      .....+++.|+|||++...   ...++.++|+||||+++|+|++|+.||..........++.....+.  .+..++.++.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN  239 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence            2334589999999997532   2336789999999999999999999998877666666666554432  3557889999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +||.+||..+|.+||++.++++||||...
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-43  Score=335.55  Aligned_cols=255  Identities=38%  Similarity=0.682  Sum_probs=221.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|+..+.||.|+||.||+|++ .++..||+|.+....    .......+.+|+.+++.+.|+||+++++.+.+...+|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            4688889999999999999998 678999999887421    22345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      ||||+.+++|.+++....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ...++..|+|||++.+.  .++.++|+|||||++|+|++|..||...........+.....+..+..++..+.+|+.+||
T Consensus       160 ~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         160 TFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             cccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            34578899999998644  3788999999999999999999999877666655555555555666678899999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhhhh
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ..+|++||++.+++.|+||.+...
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         238 NKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ccCcccCcCHHHHHhChHhhhcch
Confidence            999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.7e-44  Score=342.17  Aligned_cols=259  Identities=33%  Similarity=0.596  Sum_probs=218.9

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ...+|++.+.||+|+||.||+|.+ .+++.||+|.+.....     ...+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            356899999999999999999998 7899999999874322     1235577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |+||||+++++|.+++.+..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......  
T Consensus        92 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             EEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            999999999999999988889999999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCcccHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFI  374 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li  374 (415)
                      .....+++.|+|||.+.+.  .++.++|+|||||++|+|++|..||...........+.....+  ..+..++..+.+|+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  249 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL  249 (297)
T ss_pred             cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence            2234688999999998553  3788999999999999999999999775543333333222221  23556889999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      .+||..+|++||++.++++||||+......+
T Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             HHHccCChhhCcCHHHHhcCchhcccccccc
Confidence            9999999999999999999999987665443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-43  Score=339.28  Aligned_cols=255  Identities=32%  Similarity=0.593  Sum_probs=218.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..+|++.+.||.|+||.||+|++ .+++.||+|.+.....     .....+.+|+.+++.++|+||+++++.+.....+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            45689999999999999999998 7899999999874321     22356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      +||||+.+++|..++....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......  .
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          93 VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987654332  2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPIPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li~  375 (415)
                      ....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||...........+.....  ...+..++..+.+||.
T Consensus       173 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         173 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            234688999999998543  378899999999999999999999988766555444433322  2245678899999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||..||.+||++.+++.||||+....
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhhhccc
Confidence            999999999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.2e-43  Score=338.61  Aligned_cols=254  Identities=31%  Similarity=0.513  Sum_probs=219.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||++.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++.+.+...+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            3688999999999999999998 6789999998864221  122345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCccc
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  299 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  299 (415)
                      ||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++...... ...
T Consensus        79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~  157 (290)
T cd05580          79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT  157 (290)
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCC
Confidence            9999999999998865 46899999999999999999999999999999999999999999999999998876544 334


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ  379 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  379 (415)
                      ..+++.|+|||.+.+.  .++.++||||||+++|+|++|..||...........+.. ....++..++..++++|.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~  234 (290)
T cd05580         158 LCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-GKVRFPSFFSPDAKDLIRNLLQ  234 (290)
T ss_pred             CCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCccCCccCCHHHHHHHHHHcc
Confidence            5689999999998544  378899999999999999999999987765555555543 3445677889999999999999


Q ss_pred             hCCCCCC-----CHHHHHcChhhHhhh
Q 014986          380 VNPNDRP-----TAAQLLDHPFVKRLL  401 (415)
Q Consensus       380 ~dP~~Rp-----s~~eil~hp~f~~~~  401 (415)
                      .||.+|+     +++++++||||+.+.
T Consensus       235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         235 VDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             CCHHHccCcccCCHHHHHcCcccccCC
Confidence            9999999     999999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-43  Score=337.50  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=211.4

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |+..+.||+|+||+||+|.+ .+++.+|+|.+.....  ........+.+|+.+++.++|+||+.+++.+.+++.+|+||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            66778899999999999998 7899999999864221  11223345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-Ccc
Q 014986          223 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK  298 (415)
Q Consensus       223 E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~~  298 (415)
                      ||+.+++|..++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence            99999999887753   25899999999999999999999999999999999999999999999999998654322 223


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH---hcCCCCCCCCcccHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI---GRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ...|+..|+|||++.+.  .++.++|+|||||++|+|++|..||...........+   .......++..++..+.+|+.
T Consensus       160 ~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             CCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            45689999999998654  3788999999999999999999999875443222222   222233456678899999999


Q ss_pred             HhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          376 QCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       376 ~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      +||+.||++||+     +.+++.|+||+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999999     8999999999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=391.38  Aligned_cols=266  Identities=41%  Similarity=0.763  Sum_probs=235.1

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +..+.-+|+.+..||.|.||.||-|.+ .+|...|+|.++.....   ......+.+|.++|..++|||+|++||+-.+.
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecH
Confidence            344556899999999999999999999 89999999999865443   44567788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcCC-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~l-~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +.++|+||||++|+|.++++..+. .+...+.+..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|.....
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999999999998764 4555677889999999999999999999999999999999999999999987665


Q ss_pred             CC------cccCCCCccccccccccccc-cCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCCcc
Q 014986          295 ND------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       295 ~~------~~~~~gt~~y~aPE~l~~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~  366 (415)
                      +.      .....||+.|||||++.+.. ++...+.|||||||++.||+||+-||...+ ......++..+..+++|..+
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~l 1466 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERL 1466 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhh
Confidence            43      33567999999999997654 667889999999999999999999998765 45778899999999999999


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      +.+.++||.+||..||++|+++.||++|.|-+....+.+
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~s 1505 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDEDS 1505 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccch
Confidence            999999999999999999999999999999877665544

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-44  Score=351.59  Aligned_cols=245  Identities=26%  Similarity=0.356  Sum_probs=195.7

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ..|++.+.||+|+||.||+|++ .+++.||+|+...           .....|+.+++.++|+||+++++++......++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            4699999999999999999998 6788999996432           112468999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-Cc
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~  297 (415)
                      |||++.+ +|..++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999965 78877754  46899999999999999999999999999999999999999999999999998754322 23


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCC-CCCccH---------HHHHHHHhcC---CCCCCC-
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMEC---------MAALFKIGRG---SPPPIP-  363 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~---------~~~~~~i~~~---~~~~~~-  363 (415)
                      ....||..|+|||++.+..  ++.++|||||||++|+|+++..+ |.....         ...+.++...   .+..++ 
T Consensus       214 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccCCeecCCCC--CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            4456999999999986543  88999999999999999985444 332110         1111111110   000011 


Q ss_pred             -----------------------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          364 -----------------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       364 -----------------------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                                                   ..++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                                         1356678889999999999999999999999999864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.9e-44  Score=338.72  Aligned_cols=255  Identities=39%  Similarity=0.699  Sum_probs=219.7

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|+..+.||+|+||.||+|.+ .++..||+|.+....    .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            4688889999999999999988 678899999876322    12344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      ||||+.+++|.+++....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987654332  12


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ...++..|+|||++.+.  .++.++|+|||||++|+|++|..||...........+........+..++..+.+||.+||
T Consensus       160 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         160 TFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             cccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            34578899999998654  3788999999999999999999999766555555555555555556678899999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhhhh
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ..+|.+||++.+++.||||+.+..
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHHhh
Confidence            999999999999999999997664

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-43  Score=329.14  Aligned_cols=250  Identities=29%  Similarity=0.573  Sum_probs=213.8

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-CCEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l  220 (415)
                      .|++.+.||+|+||.||++.+ .+++.||+|++.....   .......+.+|+.+++.++|+|++++++.+.. +..+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA---SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            488899999999999999998 6788999999864322   12334567889999999999999999988764 457899


Q ss_pred             EEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          221 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      ||||+.+++|.+++..   ..+++..++.++.|++.||.+||+.||+||||||+||+++.++.++|+|||++......  
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            9999999999998865   24899999999999999999999999999999999999999999999999998765432  


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ......+++.|+|||++.+.  .++.++||||||+++|+|++|+.||...........+..+.....+..++..+.+|+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            22334588999999998554  3788999999999999999999999877666665566666665667788999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      +||+.||++||++.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.7e-43  Score=340.62  Aligned_cols=255  Identities=30%  Similarity=0.529  Sum_probs=210.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||++.+ .++..+|+|.+....    ......++.+|+.+++.++||||+++++.+.+++.+|+|
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            688999999999999999998 678899999876421    123345678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccccccCCccc
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  299 (415)
                      |||+.+++|.+++.+ ..+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++..........
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  157 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence            999999999999865 468999999999999999999997 599999999999999999999999999987654444455


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHh------------------------
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG------------------------  355 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~------------------------  355 (415)
                      ..++..|+|||++.+.  .++.++|+||||+++|+|++|+.||.............                        
T Consensus       158 ~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            6789999999998543  37889999999999999999999996544222211111                        


Q ss_pred             ------------cCCCCCCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          356 ------------RGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       356 ------------~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                                  ....+..+ ..++.++.+|+.+||..||++||++.++++||||++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                        01111111 1367889999999999999999999999999999886433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=347.44  Aligned_cols=256  Identities=26%  Similarity=0.423  Sum_probs=220.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|..-++||+|+||.||-++. .+|+.||.|++.++.  .+.++......+|..||.+++.++||.+-..|++.+.+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR--iKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR--IKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH--HHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            34577788999999999999987 899999999876432  223344456678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-c--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQR-Y--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||..|.||+|.-++-+ .  +|++..+..|+.+|+.||++||+.+|++|||||+|||+|..|+|.|+|+|||..+....
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            99999999999876643 3  79999999999999999999999999999999999999999999999999999876655


Q ss_pred             c-ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 V-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~-~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      . ....||.+|||||+++...  |+...|+|||||++|+|+.|+.||.....   .+.+.+........+++.+|+++++
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             ccccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence            4 4458999999999997654  89999999999999999999999975432   2344445555566678999999999


Q ss_pred             HHHHhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          373 FIKQCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       373 Li~~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      |.+.+|..||.+|..     ++++.+||||+.+
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            999999999999975     6799999999875

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3e-43  Score=336.04  Aligned_cols=257  Identities=35%  Similarity=0.625  Sum_probs=216.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|++.+.||.|+||.||+|.+ .+++.+++|.+...     .......+.+|+.+++.++|+||+++++.+..+..+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            35799999999999999999998 67899999998642     2334567888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      +||||+.+++|..++.+  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......  
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            99999999999887753  46899999999999999999999999999999999999999999999999988654322  


Q ss_pred             CcccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCcccHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDA  370 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l  370 (415)
                      ......+++.|+|||++.+.   ...++.++|||||||++|+|++|..||..........++.....+  ..+..++.++
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence            22344588999999998532   233678999999999999999999999876655555555444332  2345678899


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+||.+||..||++||++.++++||||..+..
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            99999999999999999999999999986554

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.2e-44  Score=344.23  Aligned_cols=242  Identities=28%  Similarity=0.434  Sum_probs=188.9

Q ss_pred             ccccccCCcEEEEEEEcC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--CCEEEEE
Q 014986          147 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLYIF  221 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV  221 (415)
                      +++||+|+||+||+|++.   +++.||+|.+.....       ...+.+|+.+|+.++||||+++++.+..  +..+|+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            467999999999999863   678999998863211       1235689999999999999999998853  5678999


Q ss_pred             EeccCCCCHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEeec
Q 014986          222 LELVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG  287 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~----------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl----~~~~~vkl~DFG  287 (415)
                      |||+.+ +|..++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            999875 78777642          148889999999999999999999999999999999999    456789999999


Q ss_pred             cccccccC-----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---------HHHHHH
Q 014986          288 LAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---------MAALFK  353 (415)
Q Consensus       288 la~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---------~~~~~~  353 (415)
                      +++.....     ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.....         ...+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99765322     22345689999999998653 2378899999999999999999999964321         111111


Q ss_pred             HhcCCCC-------------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          354 IGRGSPP-------------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       354 i~~~~~~-------------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                      +......                                     ......+..+.+||++||+.||.+|||++|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            1110000                                     001123567889999999999999999999999999


Q ss_pred             h
Q 014986          397 V  397 (415)
Q Consensus       397 f  397 (415)
                      |
T Consensus       317 f  317 (317)
T cd07868         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-43  Score=339.19  Aligned_cols=263  Identities=29%  Similarity=0.464  Sum_probs=214.9

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|.+ .+++.||+|.+...............+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477888999999999999998 6799999999975433222223345667899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          222 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      |||+ +++|.+++...  .+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||+++......  .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 88999999765  48999999999999999999999999999999999999999999999999997654332  2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-----------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------------  360 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------------  360 (415)
                      ....+++.|+|||.+.+. ..++.++|+|||||++|+|++|..+|......+.+.++......                 
T Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T cd07841         160 THQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE  238 (298)
T ss_pred             cccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence            233467889999988543 34688999999999999999998888766554444333221100                 


Q ss_pred             ----------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          361 ----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       361 ----------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                ......+..+.+||.+||..||++|||+.++++|+||++........
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~  295 (298)
T cd07841         239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS  295 (298)
T ss_pred             ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence                      01134578899999999999999999999999999999977655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-43  Score=334.49  Aligned_cols=254  Identities=35%  Similarity=0.633  Sum_probs=214.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|++.+.||.|+||.||+|.+ .++..+++|.+...     .......+.+|+.+++.++|+||+++++.+...+..|+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~   79 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   79 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence            3578899999999999999998 57888899988532     22345667889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      ||||+.+++|..++.+  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......  .
T Consensus        80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            9999999999887754  46899999999999999999999999999999999999999999999999998654322  1


Q ss_pred             cccCCCCccccccccccc---cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCcccHHHH
Q 014986          297 VKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~---~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~  371 (415)
                      .....++..|+|||++..   ....++.++|||||||++|+|++|..||...........+......  ..+..++..+.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK  239 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence            233468999999999742   2234678999999999999999999999877666655555444332  34556889999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +||.+||..||.+||++.++++||||+..
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.7e-43  Score=334.54  Aligned_cols=250  Identities=32%  Similarity=0.506  Sum_probs=204.2

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|++ .++..||+|++......   ......+.+|+.+++.++||||+++++.+.++..+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            478889999999999999998 68999999988643221   11234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          222 LELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      |||+. ++|.+++..    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99998 588887754    358999999999999999999999999999999999999999999999999987543222 


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-----------------
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-----------------  358 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------------  358 (415)
                       .....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+....                 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             cccCCcccccccChHHhcCCC-CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             22335788999999885432 36889999999999999999999998654433322221100                 


Q ss_pred             -----------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          359 -----------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       359 -----------~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                 .......++.++.+||.+||..||.+|||+.+|++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                       001123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-43  Score=337.89  Aligned_cols=255  Identities=29%  Similarity=0.491  Sum_probs=215.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|.+ .+++.||+|.+.....  ........+.+|+.+++.++|+||+++++.+.+....|+|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM--IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc--chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            688899999999999999998 5799999999875322  1123456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          222 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |||+.+++|.+++.+   ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            999999999998875   358999999999999999999999999999999999999999999999999886442211  


Q ss_pred             -----------------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH
Q 014986          297 -----------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC  347 (415)
Q Consensus       297 -----------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~  347 (415)
                                                   .....||..|+|||++.+.  .++.++||||||+++|+|++|..||.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         1123578899999998654  378899999999999999999999988776


Q ss_pred             HHHHHHHhcCCCC-CCCCcccHHHHHHHHHhhhhCCCCCCC----HHHHHcChhhHhhh
Q 014986          348 MAALFKIGRGSPP-PIPDSLSKDAQDFIKQCVQVNPNDRPT----AAQLLDHPFVKRLL  401 (415)
Q Consensus       348 ~~~~~~i~~~~~~-~~~~~~s~~l~~Li~~~L~~dP~~Rps----~~eil~hp~f~~~~  401 (415)
                      .....++...... +....++..+.++|.+||..||++|||    +++++.||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            6666555433322 122237899999999999999999999    99999999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.2e-43  Score=329.38  Aligned_cols=254  Identities=46%  Similarity=0.779  Sum_probs=212.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--CCEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL  218 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~  218 (415)
                      ++|++.++||+|+||.||+|.+ .++..||+|.+...............+.+|+.+++.+.|+||+++++.+.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688899999999999999998 679999999886433222333456788899999999999999999998876  3578


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc---
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~---  294 (415)
                      ++||||+.+++|.+++.+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.....   
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999998866 4578899999999999999999999999999999999999999999999999875432   


Q ss_pred             --CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCCCcccHHHH
Q 014986          295 --NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQ  371 (415)
Q Consensus       295 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~  371 (415)
                        .......++..|+|||++.+.  .++.++|||||||++|+|++|+.||..........++.... .+..+..++..+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR  239 (265)
T ss_pred             cccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence              123345588999999998553  37889999999999999999999998766555554444332 3445667888999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                      ++|.+||. +|++||++++++.|||+.
T Consensus       240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         240 DFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            99999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.9e-43  Score=331.41  Aligned_cols=255  Identities=38%  Similarity=0.700  Sum_probs=220.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +-|++.+.||+|+||.||+|++ .++..||+|.+....    .......+.+|+.+++.++|+||+++++.+..+..+|+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence            3578889999999999999987 678999999875321    22334678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      ||||+.+++|..++....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987554332  22


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ...++..|+|||.+.+.  .++.++|+|||||++|+|++|..||...........+.....+.++..++.++.++|.+||
T Consensus       160 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         160 TFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             cccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence            34578899999998543  3688999999999999999999999877666666666555555566778999999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhhhh
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ..+|.+||++.+++.||||.+...
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhhhh
Confidence            999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.4e-43  Score=327.26  Aligned_cols=250  Identities=32%  Similarity=0.610  Sum_probs=219.2

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||++++ .+++.||+|.+......   ......+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            478899999999999999998 68899999998753221   22345778999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          222 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |||+.+++|.+++...   .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.......  
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999999988653   47899999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....|++.|+|||++.+..  ++.++|+|||||++|+|++|..||......+....+..+...+.+..++.++.++|.+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhhccCCccccCHHHhCCCC--CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence            22345888999999986543  7889999999999999999999998877777777777777777788899999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ||+.+|.+||++.++++||||
T Consensus       236 ~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         236 LFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.7e-43  Score=332.06  Aligned_cols=253  Identities=32%  Similarity=0.578  Sum_probs=215.8

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|+..+.||+|+||.||++.+ .+++.+|+|.+.....    ......+.+|+.+++.++||||+++++.+.....+++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            578889999999999999998 6799999998875321    23456778999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      |||+.+++|.+++..  ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            999999999999875  468899999999999999999999 99999999999999999999999999998765433333


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc-----cHHHHHHHHhcCCCCCCCCc-ccHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-----ECMAALFKIGRGSPPPIPDS-LSKDAQD  372 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~~l~~  372 (415)
                      ...++..|+|||.+.+.  .++.++||||||+++|+|++|..||...     ...+....+.....+..+.. ++..+.+
T Consensus       158 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            36688999999998654  4789999999999999999999999654     23334444444444444444 8899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ||.+||..||++|||+.+++.||||++..
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=331.67  Aligned_cols=255  Identities=38%  Similarity=0.682  Sum_probs=216.4

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC---CCcEEEeeeeeecCCEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKL  218 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~  218 (415)
                      .|++.+.||+|+||.||+|.+ .+++.||+|.+....    .......+.+|+.+++.++   ||||+++++.+.....+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            578889999999999999998 789999999886422    1223456778999998886   99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |+||||+.+++|.+++....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999987654432  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCC-cccHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKDAQDFIK  375 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~s~~l~~Li~  375 (415)
                      .....|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+.....+.++. ..+.++.+++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            2234588999999988542 346889999999999999999999998776555444443333333333 37889999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||+.||++||++.+++.|+||++...
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhcccc
Confidence            999999999999999999999987653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.8e-43  Score=333.04  Aligned_cols=242  Identities=21%  Similarity=0.295  Sum_probs=205.1

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----CCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E  223 (415)
                      ..||+|++|.||+|.. +++.||+|.+.....  ......+.+.+|+.+|.+++||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999987 788999999875322  223345778899999999999999999999876    457899999


Q ss_pred             ccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCC
Q 014986          224 LVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR  301 (415)
Q Consensus       224 ~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  301 (415)
                      |+.+|+|.+++.. ..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...... ....
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~  181 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNV  181 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-cccc
Confidence            9999999999865 4688889999999999999999984 99999999999999999999999999987654322 3345


Q ss_pred             CCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CCCCCCCCcccHHHHHHHHHhhhh
Q 014986          302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQV  380 (415)
Q Consensus       302 gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L~~  380 (415)
                      |+..|+|||++.+....++.++|||||||++|+|++|..||......+....+.. ....+.+..++..+.+|+.+||+.
T Consensus       182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  261 (283)
T PHA02988        182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH  261 (283)
T ss_pred             CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence            8899999999865434589999999999999999999999998776665555533 334455667899999999999999


Q ss_pred             CCCCCCCHHHHHc
Q 014986          381 NPNDRPTAAQLLD  393 (415)
Q Consensus       381 dP~~Rps~~eil~  393 (415)
                      ||++|||+.++++
T Consensus       262 dp~~Rps~~ell~  274 (283)
T PHA02988        262 DSIKRPNIKEILY  274 (283)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999986

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.1e-43  Score=331.00  Aligned_cols=251  Identities=36%  Similarity=0.657  Sum_probs=208.2

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeec----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----  214 (415)
                      .+.|++.+.||+|+||.||+|.+ .+++.||+|.+.....      ....+.+|+.++..+ +|+||+++++.+..    
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            45788899999999999999998 6789999998864321      124567899999988 69999999998864    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                        ...+|+||||+.+++|.+++...   .+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence              35689999999999999988752   4889999999999999999999999999999999999999999999999998


Q ss_pred             cccccC--CcccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCC
Q 014986          290 KATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP  363 (415)
Q Consensus       290 ~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~  363 (415)
                      ......  ......|+..|+|||++...   ...++.++|||||||++|+|++|..||...........+.... ....+
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            754322  23345689999999998532   2347889999999999999999999997765554444443332 22234


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ..++..+.+||.+||..||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            4678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.2e-43  Score=336.38  Aligned_cols=246  Identities=26%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             ecccccccccccCCcEEEEEEEcC-----------------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE  203 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp  203 (415)
                      .++|++.+.||+|+||.||+|++.                 ++..||+|.+....    .......+.+|+.++..++||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCC
Confidence            357889999999999999999752                 23479999886421    233456788999999999999


Q ss_pred             cEEEeeeeeecCCEEEEEEeccCCCCHHHHHhhc--------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014986          204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--------------------HLRDSQVSAYTRQILLGLKYLHDQDV  263 (415)
Q Consensus       204 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------------~l~~~~~~~i~~qil~aL~~LH~~~I  263 (415)
                      ||+++++++.+.+..++||||+.+|+|.+++...                    .+++..+..++.||+.||.|||++||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999999999999999999999999999988543                    25667788999999999999999999


Q ss_pred             eecCCCCCcEEEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc--
Q 014986          264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--  337 (415)
Q Consensus       264 iHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~--  337 (415)
                      +||||||+|||++.++.+||+|||+++.......    ....++..|+|||++...  .++.++||||||+++|+|++  
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHcc
Confidence            9999999999999999999999999976543321    223357889999998654  38899999999999999986  


Q ss_pred             CCCCCCCccHHHHHHHHhc-------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 014986          338 SQIPYAPMECMAALFKIGR-------GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL  392 (415)
Q Consensus       338 g~~pf~~~~~~~~~~~i~~-------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil  392 (415)
                      +..||......+.+..+..       ......+..++..+.+|+.+||..||.+|||+.+|.
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            6678876654443332211       111223456789999999999999999999999993

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.8e-43  Score=330.20  Aligned_cols=246  Identities=22%  Similarity=0.402  Sum_probs=210.0

Q ss_pred             cccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ..|++.+.||+|+||.||+|.+    ..+..||+|.+....    .......+.+|+.++..++||||+++++.+...+.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            4688999999999999999975    346789999886421    12334568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .++||||+.+|+|.+++...  .+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999988753  5899999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHH
Q 014986          296 DV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  371 (415)
Q Consensus       296 ~~---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  371 (415)
                      ..   ....++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......+....+..+...+.+..++..+.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            11   122356789999998553  48899999999999999775 9999988877777777777766677888999999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHc
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +++.+||+.+|.+||++.+|++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999965

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-42  Score=324.57  Aligned_cols=250  Identities=30%  Similarity=0.536  Sum_probs=219.3

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|+..+.||.|+||.||.+.+ .+++.+++|.+......   ......+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            488899999999999999988 78999999998653322   23345678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          222 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |||+.+++|.+++.+.   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999988654   58899999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....+++.|+|||.+.+..  ++.++|+||||+++|+|++|..||......+....+..+...+.+..++.++.++|.+
T Consensus       158 ~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS  235 (256)
T ss_pred             ccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            23456899999999986543  6789999999999999999999998877777777777776666777889999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ||..+|.+||++.++++|+|+
T Consensus       236 ~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6e-43  Score=329.17  Aligned_cols=251  Identities=37%  Similarity=0.632  Sum_probs=208.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|.+....     ......+.+|+.+++.++||||+++++.+...+.+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            45899999999999999999998 679999999987432     223345778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      +||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......  .
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            99999999999998865 46899999999999999999999999999999999999999999999999998654322  2


Q ss_pred             cccCCCCccccccccccc-cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCC--CCcccHHHH
Q 014986          297 VKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPI--PDSLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~-~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~--~~~~s~~l~  371 (415)
                      .....|+..|+|||++.. ....++.++|+|||||++|+|++|..||.................  ...  ...++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            234468999999999742 123478899999999999999999999965543333333222211  111  124678899


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                      +||.+||..+|++||++++|++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.7e-43  Score=331.36  Aligned_cols=252  Identities=27%  Similarity=0.488  Sum_probs=207.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++......   ....+.+.+|+.+++.++|+||+++++.+.....+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            3688899999999999999998 57999999988643211   1123456789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      ||||++++.|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            9999999888877654 468999999999999999999999999999999999999999999999999987654332  2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------------  359 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  359 (415)
                      ....++..|+|||++.+. ..++.++||||||+++|+|++|..||.+....+....+.....                  
T Consensus       158 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         158 TDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            234578899999998543 2368899999999999999999999987665544433321100                  


Q ss_pred             --CCC----------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 --PPI----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 --~~~----------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                        .+.          ...++..+.+||.+||+.+|++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              000          12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-43  Score=336.64  Aligned_cols=257  Identities=33%  Similarity=0.550  Sum_probs=217.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|.....||+|+||.||++.+ .++..||+|++...     .....+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            45666678899999999999998 67899999988642     2234456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      +||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  .
T Consensus        96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            99999999999999887789999999999999999999999999999999999999999999999999987543222  2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~  375 (415)
                      ....|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||...........+.......  ....++..+.+|+.
T Consensus       176 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  253 (292)
T cd06658         176 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD  253 (292)
T ss_pred             ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence            334588999999998543  37889999999999999999999998766655554444333222  22357889999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      +||..||.+|||+.++++||||+......
T Consensus       254 ~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         254 LMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            99999999999999999999999765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.2e-43  Score=329.57  Aligned_cols=251  Identities=38%  Similarity=0.596  Sum_probs=207.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++....     ......+.+|+.+++.++||||+++++.+.....+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            45799999999999999999998 788999999986432     122345778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      +||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......  
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            99999999999998864 468999999999999999999999999999999999999999999999999987654222  


Q ss_pred             cccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-C---CCCcccHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-P---IPDSLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~---~~~~~s~~l~  371 (415)
                      .....|+..|+|||.+... ...++.++|+|||||++|+|++|..||...........+...... +   ....++..+.
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence            2334688999999987532 233678999999999999999999999655433333222222111 1   1234688999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                      +||++||..+|.+|||+++|++|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.9e-43  Score=327.52  Aligned_cols=251  Identities=34%  Similarity=0.621  Sum_probs=213.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||.|+||+||+|.. .++..+|+|++.....    ......+.+|+.+++.++|+||+++++.+......++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            3688999999999999999997 6788999998864221    1245678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          221 FLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      |||++.+++|.+++..    ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999999865    348999999999999999999999999999999999999999999999999987554332


Q ss_pred             c------ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC-----Cc
Q 014986          297 V------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-----DS  365 (415)
Q Consensus       297 ~------~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----~~  365 (415)
                      .      ....|+..|+|||++... ..++.++|+||||+++|+|++|+.||..........+.........+     ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK  235 (267)
T ss_pred             cccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence            1      234588999999998654 34788999999999999999999999877666555555544333222     25


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ++..+.+|+.+||..||.+||++.+|+.||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            67899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.9e-43  Score=331.28  Aligned_cols=250  Identities=27%  Similarity=0.450  Sum_probs=208.8

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||.|+||.||+|.+ .+++.||+|++......   ......+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            478899999999999999998 68999999998753321   22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      |||+ +++|.+++..  ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......   
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 9999998864  358999999999999999999999999999999999999999999999999987665433   


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------------  360 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------  360 (415)
                      .....++..|+|||++.+. ..++.++|||||||++|+|++|..+|........+..+......                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         157 YSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            3345689999999998543 33688999999999999999999888776554444333221100                


Q ss_pred             -------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          361 -------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       361 -------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                   ......+..+.+||++||..+|.+|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence                         0112457899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.4e-43  Score=331.77  Aligned_cols=248  Identities=26%  Similarity=0.411  Sum_probs=211.8

Q ss_pred             ecccccccccccCCcEEEEEEEcC-CC-----cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD-DG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~-----~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++|++.+.||+|+||.||+|... .+     ..||+|.+....    .......+.+|+.++..++||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            457899999999999999999862 22     679999876321    22344568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  277 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~  277 (415)
                      ....|++|||+.+|+|.+++..                 ..+++..+..++.|++.||.|||++||+|+||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            9999999999999999998865                 34778889999999999999999999999999999999999


Q ss_pred             CCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHH
Q 014986          278 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF  352 (415)
Q Consensus       278 ~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~  352 (415)
                      ++.++|+|||+++......    .....+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||.+....+...
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999987543222    2233467889999998543  37899999999999999998 999998877777777


Q ss_pred             HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       353 ~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+........+..++.++.+|+.+||+.||.+||++.+|+++
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777776677788899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.5e-43  Score=330.04  Aligned_cols=251  Identities=29%  Similarity=0.472  Sum_probs=216.8

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||.|+||.||+|.+ .+++.||+|.+......  .......+.+|+.++++++||||+++++.+.+...+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV--EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc--chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            478899999999999999998 57999999999743221  123456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-Cccc
Q 014986          222 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~  299 (415)
                      |||+.+++|..++... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... ....
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            9999999999998765 8999999999999999999999999999999999999999999999999998765443 2344


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH--HHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ..|+..|+|||.+....  ++.++|+||||+++|+|++|..||.....  ...............+..++..+.++|.+|
T Consensus       159 ~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         159 TSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             cCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence            56888999999986544  78899999999999999999999987653  333333334345567778899999999999


Q ss_pred             hhhCCCCCCCH--HHHHcChhh
Q 014986          378 VQVNPNDRPTA--AQLLDHPFV  397 (415)
Q Consensus       378 L~~dP~~Rps~--~eil~hp~f  397 (415)
                      |..||.+||++  .++++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.6e-43  Score=331.18  Aligned_cols=255  Identities=29%  Similarity=0.496  Sum_probs=214.0

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||+||++.+ .+++.||+|++....    .......+.+|+.+++.++||||+++++.+.....+|+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            5789999999999999999998 678999999886421    12334678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          221 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      ||||+.+++|..++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~  160 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD  160 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence            99999999999988764 58999999999999999999997 69999999999999999999999999998755433344


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH-----------HHHHHHHhcCCCCCCCC-cc
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-----------MAALFKIGRGSPPPIPD-SL  366 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~~~~~~~~-~~  366 (415)
                      ...|+..|+|||++.+.  .++.++|+|||||++|+|++|..||.....           .+....+.......++. .+
T Consensus       161 ~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         161 TFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             ccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence            45689999999998544  478899999999999999999999975433           12233333333333333 37


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +..+.+|+.+||..||.+|||+.++++|+||.+...
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            889999999999999999999999999999977543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-42  Score=324.61  Aligned_cols=250  Identities=34%  Similarity=0.577  Sum_probs=216.6

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee--cCCEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLY  219 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~  219 (415)
                      +|++.+.||.|+||.||+|.+ .+++.||+|.+.....   .....+++.+|+.+++.++|+||+++++.+.  ....+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            478889999999999999998 7889999998864322   2333467889999999999999999999765  456789


Q ss_pred             EEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          220 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLH-----DQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH-----~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      ++|||+.+++|.+++..     ..+++..++.++.||+.||.|||     +.+|+|+||+|+||+++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999998864     35889999999999999999999     899999999999999999999999999999


Q ss_pred             cccccCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCccc
Q 014986          290 KATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       290 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      .......  .....+++.|+|||.+....  ++.++|+||||+++|+|++|..||...........+..+....++..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS  235 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence            8765443  33456899999999986543  7889999999999999999999998877666666777766667788899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ..+.+|+.+||..+|.+||++.+|++|||+
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.9e-42  Score=324.34  Aligned_cols=253  Identities=36%  Similarity=0.633  Sum_probs=219.6

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|++|.||+|++ .+++.|++|++......    .....+.+|+..+..++|+||+++++.+.....+++|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            588899999999999999998 57999999988753221    3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc-
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-  298 (415)
                      |||+.+++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            999999999999875 578999999999999999999999 99999999999999999999999999998866543322 


Q ss_pred             -cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc---cHHHHHHHHhcCCCCCCCCc-ccHHHHHH
Q 014986          299 -SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDS-LSKDAQDF  373 (415)
Q Consensus       299 -~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~-~s~~l~~L  373 (415)
                       ...++..|+|||.+...  .++.++|+||||+++|+|++|..||...   ...+....+........+.. ++..+.++
T Consensus       158 ~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         158 NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence             34578899999998654  4788999999999999999999999776   44455555555555556666 89999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      |.+||..+|++||++.++++||||+.+.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            9999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.6e-43  Score=327.91  Aligned_cols=254  Identities=35%  Similarity=0.717  Sum_probs=211.4

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccc-hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .|+..+.||+|+||.||+|.+ .+++.||+|++....... ........+.+|+.+++.++|+||+++++.+.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999998 789999999987533221 222346788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~--  296 (415)
                      ||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            9999999999998865 4688999999999999999999999999999999999998776 59999999987654321  


Q ss_pred             ----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---HHHHHHHh-cCCCCCCCCcccH
Q 014986          297 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIG-RGSPPPIPDSLSK  368 (415)
Q Consensus       297 ----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~-~~~~~~~~~~~s~  368 (415)
                          .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.....   ......+. .......+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP  238 (268)
T ss_pred             CCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence                1123578899999998543  478899999999999999999999965432   22222222 2233456677899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                      ++.+++.+||..+|.+||++.++++||||+
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=299.98  Aligned_cols=253  Identities=29%  Similarity=0.493  Sum_probs=215.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|...++||+|+||+||+|++ .+++.||+|.++..+....   .-....+|+-+|+.++|.|||++++....++.+-+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg---vpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC---CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            577788999999999999998 7899999999987544322   223456999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      +|||.. +|..++..  ..+..+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++.....-  .
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            999987 88888865  458899999999999999999999999999999999999999999999999999776442  3


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCC----CC---------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP----IP---------  363 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~----~~---------  363 (415)
                      .....|.+|++|.++.+. +-|+...|+||.|||+.|+.. |++.|.+.+-.+++.+|.+....+    +|         
T Consensus       159 saevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            445689999999999765 448999999999999999986 888899988888887775433221    11         


Q ss_pred             ---------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          364 ---------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       364 ---------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                                     +.++...++|++++|..+|.+|++++++++||||...
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                           1344567899999999999999999999999999753

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-44  Score=351.17  Aligned_cols=259  Identities=33%  Similarity=0.634  Sum_probs=218.5

Q ss_pred             CCCCCcceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEee
Q 014986          131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY  209 (415)
Q Consensus       131 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  209 (415)
                      .+|.+++.++      ..+||+|+|-+||+|.| .+|..||=-.++..+ ..+.....++|..|+.+|+.|+|+|||++|
T Consensus        35 ~~p~gRy~k~------~evLGrGafKtVYka~De~~giEVAWnqvk~~d-~~q~~~~leR~~~Ev~lLKsL~H~NIirfy  107 (632)
T KOG0584|consen   35 KDPTGRYLKF------DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD-VTQSPEELERLYSEVHLLKSLKHPNIIRFY  107 (632)
T ss_pred             cCCCCceeeh------hhhcccccceeeeeccccccchhhHHHHHhHHH-hhcChHHHHHHHHHHHHHccCCCCceeeee
Confidence            3455666544      46799999999999999 678777755554322 234455678899999999999999999999


Q ss_pred             eeeecCCE--EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCC-CcEEE
Q 014986          210 GTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDAN-GSVKL  283 (415)
Q Consensus       210 ~~~~~~~~--~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~-~~vkl  283 (415)
                      +++.+...  +.+|+|++..|+|..++++. +++...++.|++||+.||.|||++.  |||||||++||+|+.+ |.|||
T Consensus       108 ~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI  187 (632)
T KOG0584|consen  108 DSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI  187 (632)
T ss_pred             eheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence            99887665  88999999999999999875 6888999999999999999999985  9999999999999854 89999


Q ss_pred             EeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCC-
Q 014986          284 ADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPP-  361 (415)
Q Consensus       284 ~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~-  361 (415)
                      +|+|||+........++.|||.|||||++.   ..|++.+||||||++|+||+|+..||..- ...+.+.++..|..+. 
T Consensus       188 GDLGLAtl~r~s~aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s  264 (632)
T KOG0584|consen  188 GDLGLATLLRKSHAKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA  264 (632)
T ss_pred             cchhHHHHhhccccceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence            999999998888888899999999999984   34999999999999999999999999764 4455666666655442 


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +...-.+++++||.+||.. ...|+|+.|+|.||||+.-
T Consensus       265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            2233367999999999999 9999999999999999985

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-42  Score=326.76  Aligned_cols=255  Identities=44%  Similarity=0.796  Sum_probs=212.0

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEeccccc-----chhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +|.+.+.||.|+||.||+|.+ .+++.+|+|.+......     .......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            478889999999999999988 67999999988642111     112234567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+++||||+.+++|.+++.+ ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999998876 46889999999999999999999999999999999999999999999999998754322


Q ss_pred             C----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCC----Ccc
Q 014986          296 D----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP----DSL  366 (415)
Q Consensus       296 ~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~----~~~  366 (415)
                      .    .....++..|+|||.+......++.++|+||||+++|+|++|..||...........+.... ...++    ..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            1    22345888999999986544447889999999999999999999998766555554433222 22222    346


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      +..+.+||.+||.++|.+||++.++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-42  Score=329.03  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=202.1

Q ss_pred             ccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHH---HHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      +||+|+||.||++.+ .+++.+|+|.+..........  .....+|.   .++....|+||+.+++.+...+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            489999999999998 678999999887533221111  12223333   344445799999999999999999999999


Q ss_pred             cCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCC
Q 014986          225 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT  303 (415)
Q Consensus       225 ~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt  303 (415)
                      +.+|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++............|+
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence            999999988765 4689999999999999999999999999999999999999999999999999876544444445699


Q ss_pred             ccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhC
Q 014986          304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN  381 (415)
Q Consensus       304 ~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  381 (415)
                      ..|+|||.+.. ...++.++|+|||||++|+|++|..||....  ................+..++.++.+||++||..|
T Consensus       159 ~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  237 (279)
T cd05633         159 HGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD  237 (279)
T ss_pred             cCccCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence            99999998753 2337889999999999999999999996432  12222233323334466788999999999999999


Q ss_pred             CCCCC-----CHHHHHcChhhHhhh
Q 014986          382 PNDRP-----TAAQLLDHPFVKRLL  401 (415)
Q Consensus       382 P~~Rp-----s~~eil~hp~f~~~~  401 (415)
                      |.+|+     +++++++||||+.+.
T Consensus       238 p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         238 VSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHhcCCCCCCHHHHHhCccccCCC
Confidence            99999     699999999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-42  Score=323.43  Aligned_cols=247  Identities=39%  Similarity=0.712  Sum_probs=211.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||.|+||.||+|++ .+++.+++|.+....       ....+.+|+.+++.++|+||+++++.+.+...+|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            5789999999999999999998 558999999886421       15678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ++||+.+++|.+++..  ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.......  
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999999999998864  458999999999999999999999999999999999999999999999999988654432  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCcccHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFI  374 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li  374 (415)
                      .....++..|+|||++.+.  .++.++||||||+++|+|++|+.||...........+......  ..+..++..+.+||
T Consensus       156 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence            2334588899999998654  4788999999999999999999999876555444443332222  22345788999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .+||+.||++|||+.+++.||||
T Consensus       234 ~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-42  Score=329.25  Aligned_cols=251  Identities=36%  Similarity=0.647  Sum_probs=208.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee-----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK-----  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----  213 (415)
                      .+.|++.+.||.|+||.||+|.+ .+++.+|+|.+...      ......+..|+.++..+ +|+||+++++.+.     
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            45788999999999999999998 77899999988642      12335677899999888 6999999999885     


Q ss_pred             -cCCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          214 -DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       214 -~~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                       ....+|++|||+.+|+|.+++..   ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence             35678999999999999998865   34788889999999999999999999999999999999999999999999998


Q ss_pred             cccccC--CcccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-CCC
Q 014986          290 KATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-PIP  363 (415)
Q Consensus       290 ~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~  363 (415)
                      ......  ......|++.|+|||.+...   ...++.++|+|||||++|+|++|..||...........+...... ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  248 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS  248 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence            754322  23345689999999987532   234788999999999999999999999776655544444333222 223


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ..++..+.+||.+||..||.+||++.+|++||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            4678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.4e-43  Score=332.42  Aligned_cols=250  Identities=30%  Similarity=0.506  Sum_probs=201.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|++ .+|+.+|+|.+......   ......+.+|+.+++.++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            478889999999999999998 68999999998753221   11224566899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Cc
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~  297 (415)
                      +||+.+ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.....  ..
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            999975 78777654  46899999999999999999999999999999999999999999999999998755432  22


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC-ccHHHHHHHHhcCC------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGS------------------  358 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~------------------  358 (415)
                      ....++..|+|||++.+. ..++.++|||||||++|+|++|..||.. .+..+.+..+....                  
T Consensus       157 ~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            334578899999998553 3368899999999999999999888633 32222222221100                  


Q ss_pred             -CC---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          359 -PP---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       359 -~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                       ..         .....++.++.+||.+||+.||.+|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             00         1123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-42  Score=323.85  Aligned_cols=246  Identities=30%  Similarity=0.548  Sum_probs=214.4

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||++.+ .+++.||+|.+....    .....+.+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            478889999999999999998 689999999986432    123346678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          222 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |||+++++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999999998754   247899999999999999999999999999999999999999999999999987654322  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....|++.|+|||++.+..  ++.++|+||||+++|+|++|..||...........+..+...+.+..++..+.+||.+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMP--YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             cccccCCccccCHHHHccCC--cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            22345889999999985543  7889999999999999999999999877777777777777777788899999999999


Q ss_pred             hhhhCCCCCCCHHHHHcC
Q 014986          377 CVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~h  394 (415)
                      ||+.||++||++.+|+.-
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-42  Score=324.69  Aligned_cols=244  Identities=27%  Similarity=0.456  Sum_probs=210.4

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ++|++.+.||+|+||.||++...++..+|+|.+....      .....+.+|+.+++.++||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            4688889999999999999988878899999875321      1124677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc--
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~--  297 (415)
                      |||+.+|+|.+++..  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999998864  3588999999999999999999999999999999999999999999999999875533222  


Q ss_pred             -ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          298 -KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       298 -~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                       ....++..|+|||++.+.  .++.++|+||||+++|+|++ |+.||......+....+..+.....+...+..+.+|+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY  235 (256)
T ss_pred             cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence             122345679999998644  37889999999999999999 99999888777777777777666667778899999999


Q ss_pred             HhhhhCCCCCCCHHHHHc
Q 014986          376 QCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~  393 (415)
                      +||..+|++||++.++++
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=325.81  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=209.3

Q ss_pred             eeccccc-ccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeec--
Q 014986          140 IITYWQK-GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD--  214 (415)
Q Consensus       140 ~~~~y~~-~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--  214 (415)
                      ++++|.+ -++||-|-.|.|-.+.+ .+++.+|+|++.-          ....++|+++--.. .|||||.++++|+.  
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            3455655 35799999999999988 8999999998752          12345777775444 69999999998754  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEee
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF  286 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~DF  286 (415)
                        ...+.+|||.++||.|+..++..   .|++.++..|++||..|+.|||+.+|.||||||+|+|...   |..+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              56789999999999999998764   3999999999999999999999999999999999999974   457999999


Q ss_pred             ccccccc-cCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH----HHHHHHhcCC---
Q 014986          287 GLAKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----AALFKIGRGS---  358 (415)
Q Consensus       287 Gla~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~---  358 (415)
                      |+|+... .....+.|.||+|.|||++..  ..|+...|+||+|+++|-||+|.+||+.....    ....+|..+.   
T Consensus       209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  209 GFAKETQEPGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccCCCccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9999776 456777889999999999843  34899999999999999999999999865421    2223443332   


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      +.+-...+|++++++|+++|..+|.+|.|..++++|||+.+..+-...
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t  334 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT  334 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence            233345789999999999999999999999999999999887654443

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.1e-42  Score=329.84  Aligned_cols=254  Identities=35%  Similarity=0.640  Sum_probs=211.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE-  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-  215 (415)
                      ...++|++.+.||+|+||.||+|.+ .+++.+|+|.+....      .....+.+|+.++..+ +||||+++++++... 
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3467899999999999999999998 789999999886421      1234567889999988 799999999988643 


Q ss_pred             ----CEEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEee
Q 014986          216 ----SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       216 ----~~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                          ..+|+||||+.+++|.++++.     ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df  172 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF  172 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence                468999999999999988752     46899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC--cccCCCCccccccccccccc---cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC
Q 014986          287 GLAKATKLND--VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP  361 (415)
Q Consensus       287 Gla~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  361 (415)
                      |++.......  .....|+..|+|||++....   ..++.++|||||||++|+|++|+.||........+..+.......
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  252 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT  252 (291)
T ss_pred             ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence            9987654322  22345889999999975332   125789999999999999999999998876666665555443332


Q ss_pred             --CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          362 --IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       362 --~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                        .+...+..+.+||.+||+.+|++||++.+|+.||||+
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence              2445778899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.7e-42  Score=323.55  Aligned_cols=252  Identities=45%  Similarity=0.849  Sum_probs=213.5

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|++ .+++.||+|.+......   ......+.+|+.+++.++|+||+++++.+.+.+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            488899999999999999997 68899999998754322   34567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc---
Q 014986          222 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~---  297 (415)
                      +||+.+++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........   
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            9999999999988764 488899999999999999999999999999999999999999999999999876543322   


Q ss_pred             ---ccCCCCccccccccccccc-cCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCCcc--cHHH
Q 014986          298 ---KSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPDSL--SKDA  370 (415)
Q Consensus       298 ---~~~~gt~~y~aPE~l~~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~--s~~l  370 (415)
                         ....++..|+|||++.+.. ..++.++||||||+++|+|++|+.||.... .......+.......++...  +..+
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG  237 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence               1245788999999986543 336889999999999999999999997653 33333344444444455544  8999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .+||.+||+.+|.+||++.+++.|||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         238 KDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=347.96  Aligned_cols=253  Identities=34%  Similarity=0.592  Sum_probs=223.5

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|.-++-||.|+||.||.|++ .+.+.||||++.....  ........+..|++.|++++|||++.+.++|..+...+||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            466678899999999999999 8999999999875433  2334456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCccc
Q 014986          222 LELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  299 (415)
                      ||||-| +-.+++.  +.++.+..+..|+.+.+.||+|||+++.||||||..|||++..|.|||+|||.|....+.  .+
T Consensus       105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--ns  181 (948)
T KOG0577|consen  105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--NS  181 (948)
T ss_pred             HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch--hc
Confidence            999976 7777764  467999999999999999999999999999999999999999999999999988765443  45


Q ss_pred             CCCCccccccccccccc-cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC-CcccHHHHHHHHHh
Q 014986          300 CRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC  377 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~l~~Li~~~  377 (415)
                      ++|||+|||||++.... ..|+-++||||||++..||.-.++|+-+++.+.++..|..+..+.++ ...+..++.|+..|
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C  261 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  261 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence            67999999999986432 23889999999999999999999999999999999999988877665 45789999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      |++-|..|||.+++|.|+|+.+-
T Consensus       262 LqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  262 LQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             HhhCcccCCcHHHHhhcchhccC
Confidence            99999999999999999998764

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-42  Score=340.86  Aligned_cols=260  Identities=26%  Similarity=0.431  Sum_probs=209.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC---
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  215 (415)
                      +.++|++.+.||+|+||.||+|.+ .+++.||+|.+.....   .......+.+|+.+++.++|+||+++++++...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            457899999999999999999998 6899999998853221   122335567899999999999999999987643   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ---~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                         ...|+||||+.+ +|.+.+... ++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          91 EEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence               357999999975 888877654 899999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----------
Q 014986          293 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  361 (415)
Q Consensus       293 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  361 (415)
                      .... .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||...+......++......+          
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            4332 2334588999999998654  48899999999999999999999998665443333221110000          


Q ss_pred             ----------------C----------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          362 ----------------I----------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       362 ----------------~----------------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                                      +                +...+..+++||.+||+.||.+|||+.++|.||||+.++...+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~  323 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV  323 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence                            0                11345678999999999999999999999999999988875443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-42  Score=322.99  Aligned_cols=250  Identities=29%  Similarity=0.519  Sum_probs=216.9

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+.....   .......+.+|+.+++.++||||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            478889999999999999998 7899999999875322   223356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeeccccccccCC-
Q 014986          222 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLND-  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFGla~~~~~~~-  296 (415)
                      |||+.+++|.+++...   .+++..+..++.|++.||+|||++||+|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999998753   38899999999999999999999999999999999999865 458999999998654432 


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....++..|+|||.+.+.  .++.++||||||+++|+|++|..||...........+......+++..++..+.+|+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         158 AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            2335588999999998654  37889999999999999999999998877666666666666667778899999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ||..+|.+|||+.+++.||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-42  Score=324.92  Aligned_cols=246  Identities=43%  Similarity=0.731  Sum_probs=204.7

Q ss_pred             ccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ...||+|+||.||+|++ .++..||+|.+...     .....+.+.+|+.+++.++|+||+++++++..++.+++||||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            35799999999999997 67889999988642     2234467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc--CC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEeeccccccccCC--cc
Q 014986          226 TKGSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       226 ~~gsL~~~l~~~--~l--~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      .+++|.+++...  .+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.......  ..
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            999999988753  34  77888899999999999999999999999999999976 6799999999987553222  22


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH-HHHHH-hcCCCCCCCCcccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKI-GRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i-~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      ...++..|+|||.+......++.++|+||||+++|+|++|..||....... ..... .....+.++..++.++.+|+.+
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  247 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR  247 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence            345889999999986544457889999999999999999999997643221 22222 1223345677889999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ||..+|.+|||+.+++.||||
T Consensus       248 ~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         248 CFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-42  Score=329.36  Aligned_cols=255  Identities=34%  Similarity=0.644  Sum_probs=209.5

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeee--
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD--  212 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~--  212 (415)
                      +....++|++.+.||+|+||.||+|.+ .+++.+|+|++....      .....+.+|+.+++.+ +|+||+++++.+  
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344567899999999999999999998 678999999875321      1124567899999998 699999999987  


Q ss_pred             ---ecCCEEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 014986          213 ---KDESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  284 (415)
Q Consensus       213 ---~~~~~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~  284 (415)
                         ..+..+++||||+++++|.+++..     ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence               345679999999999999987642     357888899999999999999999999999999999999999999999


Q ss_pred             eeccccccccCC--cccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC
Q 014986          285 DFGLAKATKLND--VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  359 (415)
Q Consensus       285 DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  359 (415)
                      |||+++......  .....|++.|+|||++...   ...++.++|||||||++|+|++|+.||........+.+......
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            999987654322  2334589999999998532   23378899999999999999999999987665555444433322


Q ss_pred             C--CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 P--PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 ~--~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .  ..+..++..+.+||.+||+.||++|||+.+|++|+||
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2  2344568899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-42  Score=343.63  Aligned_cols=250  Identities=28%  Similarity=0.464  Sum_probs=204.3

Q ss_pred             eeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT  211 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  211 (415)
                      .-.++|++.+.||+|+||.||+|++      .++..||+|+++....    ....+.+.+|+.+|..+ +||||++++++
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            3355799999999999999999963      3567899998863221    22345678999999999 89999999999


Q ss_pred             eecCCEEEEEEeccCCCCHHHHHhhc------------------------------------------------------
Q 014986          212 DKDESKLYIFLELVTKGSLLNLYQRY------------------------------------------------------  237 (415)
Q Consensus       212 ~~~~~~~~lV~E~~~~gsL~~~l~~~------------------------------------------------------  237 (415)
                      +.+.+..++||||+.+|+|.+++...                                                      
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            99999999999999999999988542                                                      


Q ss_pred             ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          238 ----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       238 ----------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                                            .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                  2567788899999999999999999999999999999999999999999999765433


Q ss_pred             Ccc----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHH-HHhcCCCCCCCCcccHH
Q 014986          296 DVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       296 ~~~----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~s~~  369 (415)
                      ...    ...++..|+|||++.+.  .++.++|||||||++|+|++ |..||.......... .+..+.....+...+.+
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE  345 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence            221    12345679999998654  38899999999999999997 899997754433333 33334344456677899


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +++||.+||+.||++|||+.+|++.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.4e-43  Score=344.49  Aligned_cols=251  Identities=27%  Similarity=0.487  Sum_probs=204.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      +..-.++|++.+.||+|+||.||+|++      .++..||+|.+.....    ......+.+|+.+++.+ +|+|||+++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            334456899999999999999999874      2345899998864221    22346688999999999 899999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc----------------------------------------------------
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY----------------------------------------------------  237 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~----------------------------------------------------  237 (415)
                      +++.....+|+||||+.+|+|.+++...                                                    
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            9999999999999999999999987531                                                    


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          238 -------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       238 -------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                                         .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                               3677888999999999999999999999999999999999999999999998765433211


Q ss_pred             ----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHh-cCCCCCCCCcccHHHHH
Q 014986          299 ----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       299 ----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~  372 (415)
                          ...++..|+|||++...  .++.++|||||||++|+|++ |+.||..........+.. .+.....+..++.++.+
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  346 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS  346 (374)
T ss_pred             eeccCCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHH
Confidence                12345679999998543  38999999999999999997 999998765433333333 33344456678999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ++.+||+.||.+|||+.+|++
T Consensus       347 li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         347 IMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.6e-42  Score=328.30  Aligned_cols=247  Identities=27%  Similarity=0.438  Sum_probs=211.2

Q ss_pred             ecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .+.|.+.+.||+|+||.||+|.+.      +++.||+|.+....    .......+.+|+++++.++|+||+++++.+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----SNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC----CHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            356889999999999999999863      35789999886421    12234678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  279 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~---------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~  279 (415)
                      ....++||||+.+++|.+++...               .+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            99999999999999999998643               367888999999999999999999999999999999999999


Q ss_pred             cEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHH
Q 014986          280 SVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI  354 (415)
Q Consensus       280 ~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i  354 (415)
                      .++|+|||+++......    .....+++.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999987543222    12234577899999986543  8889999999999999998 99999887777777777


Q ss_pred             hcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       355 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+.....+..++..+.+|+.+||..||.+||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            776666667789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=323.46  Aligned_cols=250  Identities=39%  Similarity=0.652  Sum_probs=211.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||.|+||.||+|.+ .+++.+++|.+....     ......+.+|+.+++.++||||+++++.+.+...+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            5788999999999999999998 678899999987532     1245678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      +|||+.+++|.+++..  ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......  .
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            9999999999998865  47999999999999999999999999999999999999999999999999998765432  2


Q ss_pred             cccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----CCCCcccHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----PIPDSLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~s~~l~  371 (415)
                      .....++..|+|||.+... ...++.++|+||||+++|+|++|..||...........+......    ..+...+.++.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            2334688899999998543 114778999999999999999999999876655554444433111    12334678899


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                      +||.+||..+|.+|||+.+|+.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-42  Score=328.67  Aligned_cols=256  Identities=30%  Similarity=0.548  Sum_probs=206.6

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHH-HhcCCCCcEEEeeeeeecCCEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +|++.+.||+|+||.||+|++ .+++.||+|++.......    ....+..|+.+ ++.++||||+++++.+..++.+|+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH----HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            688899999999999999998 689999999887532211    12234455554 667789999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          221 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ||||++ |+|.+++..     ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999997 578777653     2589999999999999999999997 999999999999999999999999999876543


Q ss_pred             CCc-ccCCCCccccccccccccc--cCCCchhhHHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCC-CcccHH
Q 014986          295 NDV-KSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPPIP-DSLSKD  369 (415)
Q Consensus       295 ~~~-~~~~gt~~y~aPE~l~~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~-~~~s~~  369 (415)
                      ... ....++..|+|||.+.+..  ..++.++|+|||||++|+|++|+.||... ...+.+..+.......++ ..++.+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE  236 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence            322 2245888999999885421  34688999999999999999999999753 223334444443333333 457899


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +.+||.+||..+|.+||++.++++||||+.....
T Consensus       237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            9999999999999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.5e-42  Score=323.03  Aligned_cols=247  Identities=31%  Similarity=0.496  Sum_probs=211.0

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||.|+||.||+|++ .+++.+|+|++.....  ........+.+|+.+++.++||||+++++.+.++..+|+||||+.++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            79999999999998 6799999999874322  12233467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-cccCCCCccc
Q 014986          229 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFW  306 (415)
Q Consensus       229 sL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~gt~~y  306 (415)
                      +|.+++.+. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....++..|
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence            999998764 58999999999999999999999999999999999999999999999999988665432 2334588999


Q ss_pred             cccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhc-CCCCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       307 ~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      ++||.+...  .++.++|+||||+++|+|++|..||....  ..+...++.. ......+...+..+.++|.+||..+|.
T Consensus       159 ~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  236 (262)
T cd05572         159 VAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE  236 (262)
T ss_pred             cChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            999998543  37889999999999999999999998765  4444444443 334456667799999999999999999


Q ss_pred             CCCC-----HHHHHcChhhHhh
Q 014986          384 DRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       384 ~Rps-----~~eil~hp~f~~~  400 (415)
                      +||+     +.|+++||||+.+
T Consensus       237 ~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         237 ERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hCcCCcccCHHHHhcChhhhCC
Confidence            9999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-43  Score=339.43  Aligned_cols=259  Identities=30%  Similarity=0.530  Sum_probs=208.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----  215 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++....    .......+.+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            46899999999999999999998 789999999886321    122345567899999999999999999876543    


Q ss_pred             -CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 -SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 -~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                       ..+|+||||+.+ +|..++....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          80 FNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             cceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence             468999999975 888888888899999999999999999999999999999999999999999999999999875432


Q ss_pred             CC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-----------
Q 014986          295 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-----------  358 (415)
Q Consensus       295 ~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  358 (415)
                      ..     .....||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+....           
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            21     1234689999999987432 347889999999999999999999997654332221111000           


Q ss_pred             ----------------CCC---CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          359 ----------------PPP---IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       359 ----------------~~~---~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                                      ..+   .....+.++.+||.+||+.+|.+|||+.++++||||+......+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~  303 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD  303 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence                            000   11245778999999999999999999999999999999886533

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=346.50  Aligned_cols=260  Identities=26%  Similarity=0.470  Sum_probs=230.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .....|.+.+.||+|.|+.|.+|++ .++..||+|.+.+....   ......+.+|+++|+.++|||||+++.+......
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            3456899999999999999999998 88999999988754332   2334558899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+||||+.+|.+++++.+. ++.+..++.++.|+++|++|||+++|+|||||.+|||++.+-++||+|||++.......
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence            99999999999999998764 67788999999999999999999999999999999999999999999999999876553


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                       ..+.||++.|.|||++++.. ..+..+|+||+|+++|.|++|.+||++........+...+... ++..++-++.+||+
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-Ip~~ms~dce~lLr  287 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-IPFYMSCDCEDLLR  287 (596)
T ss_pred             cccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec-ccceeechhHHHHH
Confidence             56788999999999998776 4688999999999999999999999987766555555554433 67889999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ++|.++|.+|++.++|+.|.|.....+.
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999999887776

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.1e-42  Score=332.95  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=209.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--C
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--S  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  216 (415)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.......   .....+.+|+.+++.++|+||+++++++...  +
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            356899999999999999999998 679999999987532211   1112345799999999999999999998654  5


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+++||||+.+ +|.+++..  ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            78999999975 78887765  4589999999999999999999999999999999999999999999999999886543


Q ss_pred             C--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-----------
Q 014986          295 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----------  361 (415)
Q Consensus       295 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  361 (415)
                      .  ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+......+           
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             ccCCCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            3  22333467889999998543 337889999999999999999999998877666555443311100           


Q ss_pred             -------C-----------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          362 -------I-----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       362 -------~-----------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                             .           ....+..+.+||.+||..||++|||+.+++.||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~  298 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL  298 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence                   0           0135788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.1e-42  Score=323.21  Aligned_cols=245  Identities=29%  Similarity=0.506  Sum_probs=210.4

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||+|+||.||+|...++..||+|.+...      ....+.+.+|+.+++.++|+||+++++.+.+.+..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            4578999999999999999999888889999987632      1124578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          221 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ||||+.+++|.+++..   ..++...+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999999998864   3578888999999999999999999999999999999999999999999999986543321


Q ss_pred             ---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          298 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       298 ---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                         ....++..|+|||.+.+..  ++.++|||||||++|+|++ |..||...........+......+....++.++.+|
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eccCCCccceecCCHHHhccCC--CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence               1223567799999986543  7889999999999999998 999998776666666666665555666789999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHc
Q 014986          374 IKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~  393 (415)
                      +.+||..+|++||+++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4e-42  Score=320.76  Aligned_cols=240  Identities=26%  Similarity=0.505  Sum_probs=203.5

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +.||+|+||.||+|++ .+++.+|+|.+...    ........+.+|+.+++.++||||+++++++.....+|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            4699999999999998 68999999987531    123344678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccC----
Q 014986          227 KGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC----  300 (415)
Q Consensus       227 ~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~----  300 (415)
                      +++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...........    
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99999998653  488999999999999999999999999999999999999999999999999875443221111    


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ  379 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~  379 (415)
                      ..+..|+|||.+.+..  ++.++||||||+++|+|++ |..||...........+........+..++..+.+|+.+||.
T Consensus       157 ~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         157 QIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence            1245699999986544  7889999999999999997 999998776666666666665666777889999999999999


Q ss_pred             hCCCCCCCHHHHHc
Q 014986          380 VNPNDRPTAAQLLD  393 (415)
Q Consensus       380 ~dP~~Rps~~eil~  393 (415)
                      .+|++|||+.+++.
T Consensus       235 ~~p~~Rps~~~~~~  248 (252)
T cd05084         235 YDPGQRPSFSTVHQ  248 (252)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999964

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-42  Score=326.88  Aligned_cols=256  Identities=33%  Similarity=0.556  Sum_probs=209.8

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--CCEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLY  219 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~  219 (415)
                      .|+..+.||.|++|.||++.+ .+++.+|+|.+.....    ......+.+|+++++.++||||+++++.+.+  .+.+|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            577889999999999999998 6789999998874322    2334667899999999999999999998764  44789


Q ss_pred             EEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          220 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +||||+++++|.+++..     ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999999887653     3478899999999999999999999999999999999999999999999999876554


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc-----cHHHHHHHHhcCCCCCCC------
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-----ECMAALFKIGRGSPPPIP------  363 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~------  363 (415)
                      .......++..|+|||.+.+.  .++.++|||||||++|+|++|..||...     ...+....+........+      
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         158 SLAGTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             cccccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            444445688899999998544  3788999999999999999999999765     222333333332222221      


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ...++.+.+||.+||..+|.+|||+.|++.||||+....+.
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence            23467899999999999999999999999999998776653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-42  Score=322.56  Aligned_cols=245  Identities=24%  Similarity=0.422  Sum_probs=209.7

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+.....      ....+.+|+.+++.++|+||+++++++...+..|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            46888999999999999999987788999998753211      123567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCccc
Q 014986          222 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  299 (415)
                      |||+++++|.+++...  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999988653  58899999999999999999999999999999999999999999999999987654332222


Q ss_pred             CC---CCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          300 CR---GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       300 ~~---gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ..   ++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......+....+........+..++..+.+++.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY  235 (256)
T ss_pred             cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence            22   34579999998654  37889999999999999998 89999887777777777666666677788999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcC
Q 014986          376 QCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~h  394 (415)
                      +||..+|++|||+.++++.
T Consensus       236 ~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         236 SCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHhcCChhhCcCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.3e-42  Score=325.37  Aligned_cols=252  Identities=28%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             ccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhH-HHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +||+|+||.||+|.+ .+++.||+|.+.......... .........+.+++...||+|+++++.+...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999998 678999999987532221111 111111223445556689999999999999999999999999


Q ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCcc
Q 014986          227 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  305 (415)
Q Consensus       227 ~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~  305 (415)
                      +|+|..++.. ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++............|+..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence            9999988765 458999999999999999999999999999999999999999999999999987655444445679999


Q ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       306 y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      |+|||++... ..++.++||||+|+++|+|++|+.||....  ......+........++..++..+.+++.+||..+|.
T Consensus       161 y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         161 YMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             CcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            9999998542 237889999999999999999999997652  1222223333334456677899999999999999999


Q ss_pred             CCC-----CHHHHHcChhhHhhh
Q 014986          384 DRP-----TAAQLLDHPFVKRLL  401 (415)
Q Consensus       384 ~Rp-----s~~eil~hp~f~~~~  401 (415)
                      +|+     ++.++++||||+...
T Consensus       240 ~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         240 RRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hccCCCCCCHHHHHhCccccCCC
Confidence            999     999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.1e-42  Score=330.71  Aligned_cols=254  Identities=33%  Similarity=0.612  Sum_probs=215.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..+|.+.+.||+|+||.||++.+ .++..||+|.+....     ......+.+|+.+++.++||||+++++.+...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            46789999999999999999987 678999999886322     122356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      +|+||+.+++|.+++.+..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999886544332  2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~  375 (415)
                      ....+++.|+|||.+...  .++.++|+||||+++|+|++|..||...........+.....+.  .+..++..+.+||.
T Consensus       173 ~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         173 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            234588899999998553  37889999999999999999999998765544433333222222  23457889999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||..+|.+||++.+++.|+||+...
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999998766

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=322.92  Aligned_cols=245  Identities=31%  Similarity=0.502  Sum_probs=210.3

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .+.|++.+.||+|+||.||+|.+.+++.||+|.+.....      ....+.+|+.+++.++|+||+++++++...+..|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            457889999999999999999987778999998864221      13457789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          221 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ||||+.+++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999999998653   489999999999999999999999999999999999999999999999999987653332


Q ss_pred             ccCCC---CccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          298 KSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       298 ~~~~g---t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      ....+   +..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||...........+......+.+..++..+.++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            22223   4579999988543  37889999999999999999 999998877666666666665555667789999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHc
Q 014986          374 IKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~  393 (415)
                      +.+||+.+|.+||++.+++.
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=324.68  Aligned_cols=251  Identities=35%  Similarity=0.685  Sum_probs=209.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC--
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES--  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~--  216 (415)
                      .++|++.+.||+|+||.||+|.+ .+++.+++|.+....      .....+.+|+.+++.+ .|+||+++++.+....  
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            46899999999999999999998 678899999886422      1235678999999998 6999999999986544  


Q ss_pred             ----EEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeec
Q 014986          217 ----KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  287 (415)
Q Consensus       217 ----~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFG  287 (415)
                          .+|+||||+.+++|.+++..     ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence                58999999999999998754     368999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC--cccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC
Q 014986          288 LAKATKLND--VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI  362 (415)
Q Consensus       288 la~~~~~~~--~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  362 (415)
                      ++.......  .....|+..|+|||++...   ...++.++||||||+++|+|++|..||...........+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            987543222  2345589999999987532   23367889999999999999999999987666556555555433222


Q ss_pred             --CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          363 --PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       363 --~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                        +..++..+++||.+||..||++|||+.+++.|||+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence              23467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7e-42  Score=328.78  Aligned_cols=255  Identities=29%  Similarity=0.441  Sum_probs=212.3

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||++.+ .+++.||+|.+.....  ........+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            588899999999999999998 6789999998864321  1223446778999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----  296 (415)
                      |||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++......    
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            999999999999865 458899999999999999999999999999999999999999999999999886321110    


Q ss_pred             -------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CC
Q 014986          297 -------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PP  361 (415)
Q Consensus       297 -------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~  361 (415)
                                   .....++..|+|||.+...  .++.++|+|||||++|+|++|..||.+....+....+.....  +.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                         1123478889999998543  378999999999999999999999987766555555544322  22


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCC---HHHHHcChhhHhhh
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLL  401 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps---~~eil~hp~f~~~~  401 (415)
                      ....++.++.+||.+||+.||++||+   +.++++||||....
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            22367899999999999999999998   79999999996644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.9e-42  Score=326.03  Aligned_cols=247  Identities=24%  Similarity=0.419  Sum_probs=209.2

Q ss_pred             cccccccccccCCcEEEEEEEc-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ..|++.+.||+|+||.||+|..     .++..+|+|.+....    .......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            5688889999999999999984     356789999886421    2334467889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014986          217 KLYIFLELVTKGSLLNLYQR------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  278 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~------------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~  278 (415)
                      ..|+||||+.+++|.+++..                  ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            99999999999999998842                  236788889999999999999999999999999999999999


Q ss_pred             CcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHH
Q 014986          279 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK  353 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  353 (415)
                      +.+||+|||+++......    .....++..|+|||.+.+.  .++.++|||||||++|+|++ |..||...........
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999997653322    2233456779999998554  37899999999999999998 9999987766666666


Q ss_pred             HhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       354 i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +......+.+..++..+.+++.+||+.||.+||++.+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66666666778899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.9e-42  Score=325.85  Aligned_cols=248  Identities=28%  Similarity=0.454  Sum_probs=206.8

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||+|+||+||+|.+ .+++.||+|.+......  .......+.+|+.+++.++||||+++++.+...+.+|+||||+.++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK--KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh--hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            79999999999987 67999999998742211  1223445678999999999999999999999999999999999999


Q ss_pred             CHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-CcccCCCCc
Q 014986          229 SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTA  304 (415)
Q Consensus       229 sL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~gt~  304 (415)
                      +|.+++.+.   .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ......++.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            999988653   5899999999999999999999999999999999999999999999999998755422 223445788


Q ss_pred             cccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhC
Q 014986          305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN  381 (415)
Q Consensus       305 ~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  381 (415)
                      .|+|||.+.+..  ++.++||||||+++|+|++|+.||.....   ...+.+.........+..++..+.+||.+||+.|
T Consensus       159 ~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         159 GYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            999999986544  78899999999999999999999976543   2222233333344566778999999999999999


Q ss_pred             CCCCC-----CHHHHHcChhhHhhh
Q 014986          382 PNDRP-----TAAQLLDHPFVKRLL  401 (415)
Q Consensus       382 P~~Rp-----s~~eil~hp~f~~~~  401 (415)
                      |.+||     ++.+++.||||+.+.
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCC
Confidence            99999     889999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.3e-42  Score=326.54  Aligned_cols=253  Identities=33%  Similarity=0.576  Sum_probs=214.4

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|...+.||+|++|.||++.+ .+++.+++|++....     ......+.+|+.+++.++|+||+++++.+...+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            355567899999999999997 688999999886421     22345578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--ccc
Q 014986          222 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~~  299 (415)
                      +||+.+++|.+++....+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.......  ...
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999876543222  223


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CCcccHHHHHHHHHh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQC  377 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~~~  377 (415)
                      ..|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||...........+........  +..++..+.+|+.+|
T Consensus       175 ~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         175 LVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             ccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            45899999999985543  78899999999999999999999987666555555554433222  234788999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      |..+|++||++.++++|+||+....
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999988653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.2e-42  Score=327.54  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=210.2

Q ss_pred             ecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+....    .......+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            468999999999999999998642      35589999875321    12223457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                      ....|+||||+.+|+|.+++...           .++...+..++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            99999999999999999998642           2356678899999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Q 014986          284 ADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  358 (415)
Q Consensus       284 ~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  358 (415)
                      +|||+++.......    ....++..|+|||.+.+..  ++.++|+|||||++|+|++ |..||......+....+..+.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCC--CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999875432221    1223567899999985543  7889999999999999998 789998877666666666665


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc------ChhhHhh
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD------HPFVKRL  400 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~------hp~f~~~  400 (415)
                      ....+..++..+.+++.+||+.||++|||+.++++      ||||+.+
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            55667778899999999999999999999999986      7877653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.2e-42  Score=326.88  Aligned_cols=253  Identities=27%  Similarity=0.454  Sum_probs=214.2

Q ss_pred             cccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .+|.+.+.||+|+||.||++.+      .++..+|+|.+...     .......+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4688999999999999999974      24567899987632     233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  281 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~--------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~v  281 (415)
                      +.+++||||+.+++|.+++...              .+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            9999999999999999988643              38999999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhc
Q 014986          282 KLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR  356 (415)
Q Consensus       282 kl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  356 (415)
                      +|+|||+++.......    ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9999999875533221    223357789999998654  37889999999999999998 9999988777777777777


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       357 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +.....+..++..+.+|+.+||+.||.+|||+.+++.  +|+.+...
T Consensus       238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~~~~  282 (288)
T cd05093         238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNLAKA  282 (288)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHHHHh
Confidence            7666667788999999999999999999999999954  57666643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-42  Score=330.99  Aligned_cols=254  Identities=33%  Similarity=0.572  Sum_probs=215.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ..|.....||+|+||.||+|.+ .+++.||+|.+.....     .....+.+|+.++..++||||+++++.+...+..|+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            3455566799999999999998 6799999999864221     223557789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      ||||+++++|..++....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......  ..
T Consensus        96 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659          96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             EEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            9999999999998888889999999999999999999999999999999999999999999999999987543322  23


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCcccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~  376 (415)
                      ...|+..|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+......  .....++..+.++|.+
T Consensus       176 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         176 SLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             ceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            45689999999998654  3788999999999999999999999876665555554433222  2234678899999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ||+.+|.+||++.+++.||||.+...
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhccCCC
Confidence            99999999999999999999987753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-42  Score=322.08  Aligned_cols=245  Identities=27%  Similarity=0.465  Sum_probs=209.8

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+.....      ....+.+|+.+++.++||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            46888999999999999999887777899998763211      124578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCccc
Q 014986          222 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  299 (415)
                      |||+.+|+|.+++...  .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999988653  58999999999999999999999999999999999999999999999999987554332222


Q ss_pred             ---CCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          300 ---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       300 ---~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                         ..++..|+|||.+.+..  ++.++||||||+++|+|++ |..||......+....+........+...+..+++++.
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSK--FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             cCCCccChhhCCHHHHhcCc--ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence               23556799999986433  7889999999999999998 99999877766666677666666667778999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcC
Q 014986          376 QCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~h  394 (415)
                      +||..||.+||++.+|+.+
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-42  Score=320.67  Aligned_cols=253  Identities=47%  Similarity=0.795  Sum_probs=213.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--CEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL  218 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~  218 (415)
                      .+|++.++||+|+||.||+|++ .+++.||+|.+...............+.+|+.+++.++|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688999999999999999998 7799999998864332223344567888999999999999999999988653  568


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      ++||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999998865 46889999999999999999999999999999999999999999999999999754321  


Q ss_pred             ---CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCCCCCcccHHHH
Q 014986          296 ---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSKDAQ  371 (415)
Q Consensus       296 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~  371 (415)
                         ......++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||..........++... ....++..+++.+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  239 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR  239 (264)
T ss_pred             cCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence               12234588999999998653  3788999999999999999999999877666655555433 33456888999999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ++|.+||. +|.+||++.+++.|||.
T Consensus       240 ~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         240 DFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.8e-42  Score=327.52  Aligned_cols=250  Identities=32%  Similarity=0.528  Sum_probs=205.0

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||.|+||.||+|++ .+++.||+|.+......   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc---cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            478889999999999999998 68999999988643221   12234677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          222 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |||+. ++|..++..   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99996 588887754   458899999999999999999999999999999999999999999999999987554322  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------------  360 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------  360 (415)
                      .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||..........++......                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            2233478899999988543 23578899999999999999999999776554443333221110                


Q ss_pred             ------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          361 ------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       361 ------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                  .....++.++++||.+||+.||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        0123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=354.16  Aligned_cols=249  Identities=25%  Similarity=0.441  Sum_probs=204.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCC-cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeee-ee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGT-DK  213 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~-~~  213 (415)
                      +..-.-++++.++|.+|||+.||+|.+..+ ..||+|++..     ..+..+..+.+|+.+|+.|. |+|||.+++. ..
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~-----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV-----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec-----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            333344788999999999999999999544 9999999875     35667788999999999997 9999999993 21


Q ss_pred             c------CCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEE
Q 014986          214 D------ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVK  282 (415)
Q Consensus       214 ~------~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~~~vk  282 (415)
                      .      .-.++|+||||.||.|.++++.   .+|++.++++|+.|+++|+.+||...  |||||||-+||||+.+|++|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            1      2357899999999999999874   47999999999999999999999998  99999999999999999999


Q ss_pred             EEeeccccccccCC-cc----------cCCCCccccccccccc-cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHH
Q 014986          283 LADFGLAKATKLND-VK----------SCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA  350 (415)
Q Consensus       283 l~DFGla~~~~~~~-~~----------~~~gt~~y~aPE~l~~-~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~  350 (415)
                      |||||.|+...... ..          ...-|+.|+|||+++- .+...++|+|||+|||+||.|+....||+.....  
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--  264 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--  264 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence            99999987433222 10          1126899999999863 3455899999999999999999999999875432  


Q ss_pred             HHHHhcCCCC-CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          351 LFKIGRGSPP-PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       351 ~~~i~~~~~~-~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                        .|..+... |..+.++..+.+||+.||++||.+||++-+++++
T Consensus       265 --aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  265 --AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             --eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence              34444332 2235789999999999999999999999999864

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=328.01  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=202.0

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|++.+.||+|+||.||+|.+ .+++.||+|.+.......    ....+.+|+.+++.++|+||+++++++.+.+..|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            46789999999999999999998 578999999987532211    1123568999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          220 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      +||||+.+ +|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99999985 898887653  57899999999999999999999999999999999999999999999999987543221 


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCC---------------
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSP---------------  359 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~---------------  359 (415)
                       .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||.... ..+.+..+.....               
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             2223468889999988643 236889999999999999999999997654 2222221111000               


Q ss_pred             -----------CC---CCCccc--HHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 -----------PP---IPDSLS--KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 -----------~~---~~~~~s--~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                 ..   ....++  .++.++|.+||+.+|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                       00   001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.6e-42  Score=318.49  Aligned_cols=250  Identities=34%  Similarity=0.647  Sum_probs=219.8

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||++.+ .++..|++|++......   ......+.+|+++++.++|+|++++++.+......++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            478889999999999999998 67999999998753321   23455678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          222 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999998865     458999999999999999999999999999999999999999999999999987654432


Q ss_pred             --cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          297 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                        .....|++.|+|||.+.+..  ++.++|+||||+++|+|++|..||...+..+...........+++..++..+.+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             ceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              23345889999999986543  78899999999999999999999988777676667777667777888999999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .+||..+|.+||++.++|+||||
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.5e-42  Score=332.22  Aligned_cols=242  Identities=29%  Similarity=0.435  Sum_probs=187.6

Q ss_pred             ccccccCCcEEEEEEEcC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee--cCCEEEEE
Q 014986          147 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLYIF  221 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV  221 (415)
                      +.+||+|+||.||+|++.   ++..||+|.+.....       ...+.+|+.+++.++||||+++++++.  .+..+++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            457999999999999863   567899998863211       134668999999999999999999874  46678999


Q ss_pred             EeccCCCCHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEeec
Q 014986          222 LELVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG  287 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~----------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl----~~~~~vkl~DFG  287 (415)
                      |||+.+ +|.+++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            999876 77776542          147888899999999999999999999999999999999    456799999999


Q ss_pred             cccccccC-----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH---------HHHHH
Q 014986          288 LAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---------AALFK  353 (415)
Q Consensus       288 la~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---------~~~~~  353 (415)
                      +++.....     ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||......         ....+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            99765432     22345689999999998643 23788999999999999999999999643210         01100


Q ss_pred             HhcCCC-------------------------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          354 IGRGSP-------------------------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       354 i~~~~~-------------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                      +.....                                     .......+..+.+||.+||..||.+|||+.|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            000000                                     0001123567889999999999999999999999999


Q ss_pred             h
Q 014986          397 V  397 (415)
Q Consensus       397 f  397 (415)
                      |
T Consensus       317 f  317 (317)
T cd07867         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.6e-42  Score=327.84  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=207.5

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--CE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  217 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  217 (415)
                      .+.|++.+.||.|+||.||+|.+ .+++.+|+|.+......   ......+.+|+.++..++||||+++++++...  ..
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            46799999999999999999998 57899999998753322   12224566899999999999999999988777  89


Q ss_pred             EEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .|+||||+.+ +|.+++...  .+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9999999985 898887653  4899999999999999999999999999999999999999999999999998865443


Q ss_pred             --CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--------------
Q 014986          296 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--------------  359 (415)
Q Consensus       296 --~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------  359 (415)
                        ......+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||......+...++.....              
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 LKPYTQLVVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccccccccccccccCchhhcCCc-cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence              223345788999999985432 367899999999999999999999987665544433321110              


Q ss_pred             ----------------CCCCCc-ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 ----------------PPIPDS-LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 ----------------~~~~~~-~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                      ..++.. ++..+.+||++||+.||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                            112222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.9e-42  Score=321.97  Aligned_cols=246  Identities=27%  Similarity=0.476  Sum_probs=210.5

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|.+.+.||+|+||.||+|.+ .+++.||+|.+...      ......+.+|+.+++.++|+||+++++++..++.++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            34688889999999999999998 67899999987631      122456789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||+.+++|.+++...   .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999988653   48889999999999999999999999999999999999999999999999987655433


Q ss_pred             ccc---CCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 VKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~~~---~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      ...   ..++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......+....+........+..++..+.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             eeccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            221   2245679999988544  37889999999999999998 99999887766666666666566677889999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcC
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ||.+||..||++||++.++++.
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHH
Confidence            9999999999999999999753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=340.92  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=213.9

Q ss_pred             ccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      .++||.|.||+||-|++ ++|+.||||++.+.....+.   ..++++|+.||+++.||.||.+...|++.+.++.|||.+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq---esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl  645 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ---ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL  645 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch---HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence            57899999999999998 89999999999865544332   367899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEeeccccccccCCc-cc
Q 014986          226 TKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDV-KS  299 (415)
Q Consensus       226 ~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vkl~DFGla~~~~~~~~-~~  299 (415)
                      .|..|.-++.  +.++++...+.++.||+.||.|||-+||+|.||||+|||+...   -++||||||+|+.+..... .+
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            8865655553  4689999999999999999999999999999999999999754   4799999999998876654 56


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH-HHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..|||.|+|||+++.++  |+...||||+|+|+|--|.|..||...+.. ++++....-.++.-...++.++.+||+.+|
T Consensus       726 VVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL  803 (888)
T ss_pred             hcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence            77999999999996554  999999999999999999999999765543 333333333333344679999999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhhh
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ++.-.+|.|.+..|.|||+|...
T Consensus       804 qVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHhcchHhhccchhhhcch
Confidence            99999999999999999998753

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=343.22  Aligned_cols=233  Identities=33%  Similarity=0.571  Sum_probs=206.5

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      ++-||.|+.|.||+|+. .++.||||+++.            .-+.+|+-|++|+||||+.+.|+|.....+|||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl-~netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeec-cCceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            56699999999999987 457899998752            12367888999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-CcccCCCCc
Q 014986          227 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTA  304 (415)
Q Consensus       227 ~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~gt~  304 (415)
                      .|-|...|+.. .++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++..... ...+++||.
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV  275 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV  275 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence            99999999864 6889999999999999999999999999999999999999999999999988765433 445688999


Q ss_pred             cccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       305 ~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      .|||||++..  ...++|+|||||||+|||||||..||.+.....+++-++... ..+.|..+++.++-||++||+-.|.
T Consensus       276 aWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  276 AWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             hhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            9999999954  458999999999999999999999999887776666665543 3568899999999999999999999


Q ss_pred             CCCCHHHHHcC
Q 014986          384 DRPTAAQLLDH  394 (415)
Q Consensus       384 ~Rps~~eil~h  394 (415)
                      +||++.+||.|
T Consensus       354 NRPSFrqil~H  364 (904)
T KOG4721|consen  354 NRPSFRQILLH  364 (904)
T ss_pred             CCccHHHHHHH
Confidence            99999999988

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.1e-42  Score=324.34  Aligned_cols=249  Identities=25%  Similarity=0.418  Sum_probs=208.0

Q ss_pred             eecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4567999999999999999998752      35689999875321    1223456789999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEE
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  282 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vk  282 (415)
                      +....++||||+.+|+|.+++...           .++...+..++.|++.||.|||+.|++||||||+|||++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            999999999999999999988642           246678889999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcC
Q 014986          283 LADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  357 (415)
Q Consensus       283 l~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  357 (415)
                      |+|||+++.......    ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...........+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999875432221    123457789999998653  37899999999999999998 78999887766666666666


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5566677889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=330.51  Aligned_cols=257  Identities=27%  Similarity=0.421  Sum_probs=219.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      -..+|..+.+||+|+||.|.+|.. .+.+.||||++++.....  ....+-...|.++|... +-|++++++.+|++-+.
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ--dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee--cCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            356899999999999999999987 678899999987532211  11223334677777766 46899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--c
Q 014986          218 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~  294 (415)
                      +|+||||+.||+|.-++++. ++.+..+..|+.+|+-||-|||++|||+||||.+|||++.+|+|||+|||+++..-  .
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            99999999999999988874 69999999999999999999999999999999999999999999999999998543  3


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      ......||||.|+|||++...  +|+.++|+||+|++|||||.|+.||++.+..+....|.. ....+|..+|.++.++.
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e-hnvsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME-HNVSYPKSLSKEAVAIC  581 (683)
T ss_pred             cceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-ccCcCcccccHHHHHHH
Confidence            445678999999999999554  499999999999999999999999999877666655544 44558899999999999


Q ss_pred             HHhhhhCCCCCCCH-----HHHHcChhhHhhh
Q 014986          375 KQCVQVNPNDRPTA-----AQLLDHPFVKRLL  401 (415)
Q Consensus       375 ~~~L~~dP~~Rps~-----~eil~hp~f~~~~  401 (415)
                      +.+|.+.|.+|...     .+|-+||||+.+.
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            99999999999754     7899999999874

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=315.93  Aligned_cols=250  Identities=47%  Similarity=0.819  Sum_probs=220.6

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|++|.||++++ .+++.||+|.+......   ......+.+|+++++.++|+|++++++++.+...+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            478889999999999999988 57889999998753321   24456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc--c
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~--~  298 (415)
                      |||+.+++|.+++.. ..+++..+..++.|++.||.+||++||+||||+|+||+++.++.++|+|||++........  .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999999999998876 4689999999999999999999999999999999999999999999999999986654433  3


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ...++..|+|||.+.+..  ++.++||||||+++|+|++|..||..........+........++..++..+.+++.+||
T Consensus       158 ~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             ccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence            446889999999986544  788999999999999999999999887776666676666666778889999999999999


Q ss_pred             hhCCCCCCCHHHHHcChhh
Q 014986          379 QVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f  397 (415)
                      ..+|++||++.+++.||||
T Consensus       236 ~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         236 QKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hCChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5e-42  Score=321.61  Aligned_cols=247  Identities=28%  Similarity=0.478  Sum_probs=213.7

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...+|++.+.||.|+||.||+|++.+++.+|+|.+....     ......+.+|+.+++.++|+||+++++++.+...++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            346799999999999999999999779999999886421     223456789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||+.+++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999999875   358899999999999999999999999999999999999999999999999987654322


Q ss_pred             --cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          297 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                        .....++..|+|||.+...  .++.++||||||+++|+|++ |+.||......+....+......+.+..++..+.++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             ccccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence              1223356789999998543  47889999999999999998 899998877777777777666667778899999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHc
Q 014986          374 IKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~  393 (415)
                      +.+||+.||.+|||+.+|++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.8e-42  Score=320.06  Aligned_cols=250  Identities=32%  Similarity=0.627  Sum_probs=214.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|.+ .++..+|+|.+......   ......+.+|+.+++.++|+||+++++.+.+....|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP---VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc---chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            478889999999999999998 67899999998753221   12335677999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc-EEEEeeccccccccCC-
Q 014986          222 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLND-  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~-vkl~DFGla~~~~~~~-  296 (415)
                      +||+.+++|.+++...   .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++. ++|+|||.+....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999999988653   4789999999999999999999999999999999999998864 6999999987654332 


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                       .....|++.|+|||.+...  .++.++|+||||+++|+|++|..||......+....+......+....++..+.++|.
T Consensus       158 ~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             cccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence             2234588999999988543  3788999999999999999999999877666666666666666666778999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      +||..+|++|||+.+++.||||
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         236 QLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.9e-42  Score=326.70  Aligned_cols=252  Identities=33%  Similarity=0.554  Sum_probs=207.0

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|++ .+++.||+|.+......   ....+.+.+|+.+++.++||||+++++++.++...|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            3688899999999999999998 57899999987643221   1234567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      ||||+.+++|..+... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            9999999988887654 368999999999999999999999999999999999999999999999999987653322  2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG--------------------  357 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--------------------  357 (415)
                      ....++..|+|||++.+. ..++.++||||||+++|+|++|+.||......+...++...                    
T Consensus       158 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         158 TDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             CcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            334578899999998543 23678999999999999999999999765543332222210                    


Q ss_pred             CC-C---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          358 SP-P---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       358 ~~-~---------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .. +         .....++..+.+|+.+||..+|.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00 0         0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.5e-42  Score=330.74  Aligned_cols=251  Identities=25%  Similarity=0.461  Sum_probs=207.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .+|++.+.||+|+||.||+|.+ .++.    .||+|.+...    ........+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            4799999999999999999986 3444    3899987532    1223345688999999999999999999998765 


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..++|+||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            578999999999999988764  588889999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          295 NDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       295 ~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ...    ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.+....+....+......+.+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            221    122346689999998554  37899999999999999997 99999877655554445555555667788999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +.+++.+||..+|.+||++.+++.+  |..+.
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~--l~~~~  269 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIE--FSKMA  269 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence            9999999999999999999999986  44443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-41  Score=326.81  Aligned_cols=260  Identities=27%  Similarity=0.464  Sum_probs=214.0

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEE
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  207 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~  207 (415)
                      +....++|.+++.||+|+||.||+|.+.        +...+|+|.+....    .......+.+|+.+++.+ +|+||++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIIN   88 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence            4444578999999999999999999752        23579999886421    123345678899999999 7999999


Q ss_pred             eeeeeecCCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       208 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++++...+.+|+||||+.+|+|.+++...                 .+++..+..++.|++.||+|||++|++||||||
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence            999999999999999999999999998653                 377888999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~  246 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  246 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            99999999999999999987553221    1112245689999998654  37889999999999999998 89999877


Q ss_pred             cHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          346 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       346 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ...+....+........+..++.++.+|+.+||..+|.+||++.+++++  |++++..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~--l~~~~~~~  303 (307)
T cd05098         247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILALT  303 (307)
T ss_pred             CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHHHHHh
Confidence            6655555555555556677889999999999999999999999999886  66665543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=317.31  Aligned_cols=241  Identities=29%  Similarity=0.523  Sum_probs=211.9

Q ss_pred             cccccCCcEEEEEEEcC-C---CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~---~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      +.||+|+||.||+|.+. .   +..||+|.+......    .....+.+|+.++..++|+||+++++++.+...+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            46999999999999984 3   889999988753221    145778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          224 LVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       224 ~~~~gsL~~~l~~----------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      |+.+++|.+++..          ..+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999999875          458999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          294 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       294 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ...    .....++..|+|||.+...  .++.++||||||+++|+|++ |..||......+....+..+.....+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence            432    3345578899999998654  48899999999999999999 6999998887777777777777777888999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ++.+++.+||..+|.+|||+.+++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-41  Score=322.62  Aligned_cols=248  Identities=27%  Similarity=0.454  Sum_probs=206.8

Q ss_pred             ecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .+.|++.+.||+|+||.||+|.+.      .+..||+|.+....    .......+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            357889999999999999999883      56788999775321    12233567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEE
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL  283 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~--------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~---~vkl  283 (415)
                      ....++||||+.+++|.+++...        .+++..+..++.||+.||.|||+++++||||||+|||++.++   .+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            99999999999999999988654        378899999999999999999999999999999999998655   5999


Q ss_pred             EeeccccccccCCcc----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Q 014986          284 ADFGLAKATKLNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  358 (415)
Q Consensus       284 ~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  358 (415)
                      +|||+++........    ....+..|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  238 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG  238 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999765322211    112356799999985443  8999999999999999997 999998876666555555555


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ....+..++..+.+++.+||+.+|++||++.++++|
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            555677889999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-42  Score=353.00  Aligned_cols=254  Identities=27%  Similarity=0.460  Sum_probs=222.9

Q ss_pred             cccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .+.+..+.||+|.||+||+|+-      .+...||||.++.    ....+...+|++|+.+|..++|||||+++|++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            3556678899999999999974      3567899998874    22344668899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc-----------C----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY-----------H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  280 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~-----------~----l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~  280 (415)
                      +.+|||+||+..|+|.++|...           .    ++..+.+.|+.||+.|+.||-++.++||||...|+||.++..
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            9999999999999999998632           1    778889999999999999999999999999999999999999


Q ss_pred             EEEEeeccccccccCCcccCC----CCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHh
Q 014986          281 VKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIG  355 (415)
Q Consensus       281 vkl~DFGla~~~~~~~~~~~~----gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  355 (415)
                      |||+||||++.....+.....    -..+|||||.+....  ++.++||||+||+|||+++ |+.||.+....+.+..+.
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            999999999976655544433    356799999997654  8999999999999999998 999999999999999999


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       356 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .+...+.|+.+|.++++|+..||+.+|++||++.||  |--++.+...
T Consensus       720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI--~~~L~~~~~~  765 (774)
T KOG1026|consen  720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI--HSRLQAWAQA  765 (774)
T ss_pred             cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH--HHHHHHHHhc
Confidence            999989999999999999999999999999999999  4455555443

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.1e-43  Score=319.26  Aligned_cols=256  Identities=29%  Similarity=0.457  Sum_probs=203.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-C--C--CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-D--D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~--~--~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  214 (415)
                      ...|+....||+|+||.||+|.. +  +  .+.||+|+++..+...-   .-...-+|+.+++.++||||+.+..+|.. 
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG---iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG---ISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC---cCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            45799999999999999999965 2  2  34799998875432211   11234589999999999999999998877 


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC----CcEEEE
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLA  284 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~----~~vkl~  284 (415)
                      +..++|++||.+. +|..+++-      ..++...++.|+.||+.|+.|||++.|+||||||.|||+..+    |+|||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            8899999999998 78887752      248888999999999999999999999999999999999988    899999


Q ss_pred             eeccccccccC-----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---------HHH
Q 014986          285 DFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---------MAA  350 (415)
Q Consensus       285 DFGla~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---------~~~  350 (415)
                      |||+++.+...     ....++.|.+|+|||++.+. ..|+.++|||++|||+.|||+-.+.|.+.+.         .++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999876533     23456689999999999875 4589999999999999999998888865331         233


Q ss_pred             HHHHhcCCCCC----C------CC--------------------------cccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          351 LFKIGRGSPPP----I------PD--------------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       351 ~~~i~~~~~~~----~------~~--------------------------~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +.+|......|    +      |+                          .-++.+.+|+.+||+.||.+|+|+.++|+|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            33333222211    1      10                          113347899999999999999999999999


Q ss_pred             hhhHhhh
Q 014986          395 PFVKRLL  401 (415)
Q Consensus       395 p~f~~~~  401 (415)
                      +||..-.
T Consensus       338 ~yF~~d~  344 (438)
T KOG0666|consen  338 PYFTEDP  344 (438)
T ss_pred             cccccCC
Confidence            9998763

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-41  Score=313.71  Aligned_cols=247  Identities=41%  Similarity=0.753  Sum_probs=213.2

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|.+.+.||+|++|.||++.+ .+++.+++|++.....     .....+.+|+.+++.++|+||+++++.+......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            477889999999999999998 5789999999874222     3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-cc
Q 014986          222 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~~  298 (415)
                      +||+.+++|.+++...  .+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+....... ..
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            9999999999998765  78999999999999999999999999999999999999999999999999987765443 34


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCc--ccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~Li~~  376 (415)
                      ...++..|++||.+.+..  ++.++|+||||+++|+|++|..||....................+..  ++..+.++|.+
T Consensus       156 ~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         156 TMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            456889999999986543  78899999999999999999999987755555544444333333333  38899999999


Q ss_pred             hhhhCCCCCCCHHHHHcChh
Q 014986          377 CVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~  396 (415)
                      ||+.||++|||+.+++.|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.9e-41  Score=324.80  Aligned_cols=256  Identities=32%  Similarity=0.573  Sum_probs=214.0

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|++.+.||+|+||.||+|.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++.+.+.+..|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            35688999999999999999998 67999999988643222  2233456789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          220 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      +||||+.+ +|.+++.  ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......  
T Consensus        92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            99999975 7777664  346899999999999999999999999999999999999999999999999998755432  


Q ss_pred             ccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC-CCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~Li~  375 (415)
                      ....++..|+|||++.+. ...++.++||||||+++|+|++|..||...........+........ +..++..+.+||.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD  248 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHH
Confidence            234588899999987532 23478899999999999999999999988776666555554433333 3357889999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||..||++||++.+|+.||||+.-.
T Consensus       249 ~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         249 SCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHhcCChhhCcCHHHHhcChhhcccC
Confidence            99999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.9e-42  Score=324.25  Aligned_cols=249  Identities=31%  Similarity=0.509  Sum_probs=204.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||.|++|.||+|++ .++..||+|++......    .....+.+|+.+++.++|+||+++++.+.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            478899999999999999998 67999999998753221    1224566899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          222 LELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      |||+.+ +|.+++...    .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......  
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            999986 888877643    4899999999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---------------
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---------------  360 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------  360 (415)
                      ......++..|++||++.+. ..++.++||||||+++|+|++|..||......+...++......               
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            22334578899999998543 23688999999999999999999999876554443333211100               


Q ss_pred             --C-----------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          361 --P-----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       361 --~-----------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                        .           +...++..+.++|.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              0           112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-41  Score=330.24  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=205.8

Q ss_pred             cccccC--CcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G--~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      ..||+|  +||+||+|.+ .+++.||+|++......   ....+.+.+|+.+++.++||||+++++++...+.+++||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456766  9999999998 68999999988743222   23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-----
Q 014986          225 VTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  296 (415)
Q Consensus       225 ~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-----  296 (415)
                      +.+++|.+++.+.   .+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+.......     
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999988753   58899999999999999999999999999999999999999999999998543221110     


Q ss_pred             ----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-------------
Q 014986          297 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------  359 (415)
Q Consensus       297 ----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------  359 (415)
                          .....++..|+|||++.+....++.++|||||||++|+|++|..||.................             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                111234567999999866444578999999999999999999999987654433332221110             


Q ss_pred             ---------------------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          360 ---------------------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       360 ---------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                                                       .+.+..++..+.+||++||..||++|||+.++++||||+.+......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~~  320 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQG  320 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhccc
Confidence                                             01122356789999999999999999999999999999999876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.6e-41  Score=314.65  Aligned_cols=250  Identities=54%  Similarity=0.961  Sum_probs=215.9

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--CEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLY  219 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~  219 (415)
                      +|++.+.||+|++|.||+|.+ .+++.|++|++......   ......+.+|+.+++.++|+||+++++.+.+.  ..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            477889999999999999998 58999999998753322   34457788999999999999999999999988  8999


Q ss_pred             EEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          220 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      +||||+.+++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            999999999999988765 78999999999999999999999999999999999999999999999999988765554  


Q ss_pred             --cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhc-CCCCCCCCcccHHHHH
Q 014986          297 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGR-GSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~~s~~l~~  372 (415)
                        .....++..|+|||.+....  .+.++||||||+++|+|++|..||.... .......+.. .....++..++..+++
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence              34456889999999985543  7889999999999999999999998765 3333333332 3445567788999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ||.+||..||.+||++.+++.||||
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.7e-42  Score=323.84  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             cccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ..|++.+.||+|+||.||+|.+.      .++.||+|++....    .......+.+|+.++..++||||+++++.+.+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            46889999999999999999862      35789999886422    123346688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  278 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~  278 (415)
                      ...++++||+.+++|.+++..                 ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            999999999999999998742                 237788889999999999999999999999999999999999


Q ss_pred             CcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHH
Q 014986          279 GSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK  353 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  353 (415)
                      +.+||+|||+++.......    ....+++.|+|||.+.+..  ++.++|||||||++|+|++ |..||.+....+....
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999876533221    2233577899999985443  7889999999999999998 8899988877777777


Q ss_pred             HhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       354 i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +......+.+..++..+.+|+.+||+.+|.+||++++|+..
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            77777777788999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.4e-41  Score=321.80  Aligned_cols=252  Identities=37%  Similarity=0.679  Sum_probs=215.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|+..+.||.|+||.||+|.+ .++..|++|++.....      ....+.+|+.+++.++|+||+++++.+......|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            45688889999999999999998 5789999999874322      3466789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          220 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      +|+||+.+++|.+++...  .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999999999876  69999999999999999999999999999999999999999999999999876543221 


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC--CcccHHHHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP--DSLSKDAQDF  373 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~s~~l~~L  373 (415)
                       .....++..|++||.+.+.  .++.++|+||||+++|+|++|..||...........+.........  ..++..+.+|
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF  249 (286)
T ss_pred             hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence             2234578899999998543  3788999999999999999999999877665555554443333332  3378999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      |.+||+.+|.+||++.++++|+||++.
T Consensus       250 i~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-41  Score=322.60  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=209.4

Q ss_pred             ccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          143 YWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +|++.+.||+|+||.||+|.+.      ....+|+|.+....    .......+.+|+.+++.++||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            4788899999999999999862      23568888775321    1233467889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  271 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-------------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~  271 (415)
                      ..++||||+.+|+|.+++...                         .+++..+..++.|++.||.|||++||+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999987542                         3678888999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCcc
Q 014986          272 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  346 (415)
Q Consensus       272 NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~  346 (415)
                      |||++.++.+||+|||+++......    .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.+..
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999987543222    1223456789999988543  37899999999999999998 999998776


Q ss_pred             HHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       347 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .......+........+..++.++.+|+.+||+.+|.+||++.++++  .|++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~--~l~~~~~~  289 (290)
T cd05045         235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK--ELEKMMVK  289 (290)
T ss_pred             HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH--HHHHHHhc
Confidence            65555555555555567788999999999999999999999999987  47766543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.9e-41  Score=323.74  Aligned_cols=256  Identities=30%  Similarity=0.499  Sum_probs=207.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|++|.||+|.+ .+++.||+|.+......   ......+.+|+.+++.++|+||+++++++.+...+|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            5688999999999999999998 57899999988643221   1233567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEeeccccccccC-
Q 014986          221 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN-  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~DFGla~~~~~~-  295 (415)
                      ||||+.+ +|.+++...   .+++..++.++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++...... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999965 787776543   3578888999999999999999999999999999999985 567999999999754322 


Q ss_pred             -CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-------------
Q 014986          296 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------------  361 (415)
Q Consensus       296 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------  361 (415)
                       ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||......+.+.++......+             
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22334578899999988543 347889999999999999999999998766555544432111000             


Q ss_pred             ---------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          362 ---------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       362 ---------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                     ....++..+.+++.+||+.+|++||++.++++||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                           12346788999999999999999999999999999998764

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-41  Score=319.01  Aligned_cols=245  Identities=29%  Similarity=0.488  Sum_probs=209.2

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..++|++.+.||+|+||.||+|.+.++..+|+|.+......      ...+.+|+.+++.++|+||+++++.+. ....|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS------PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC------HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            34679999999999999999998888888999998743221      245789999999999999999999875 45689


Q ss_pred             EEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||+.+++|.+++...   .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999988653   48899999999999999999999999999999999999999999999999997654332


Q ss_pred             cc---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 VK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      ..   ...++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......+....+..+...+.+...+..+.+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE  234 (260)
T ss_pred             cccccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            21   22345679999988543  37889999999999999999 99999887777777777776666777888999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~  393 (415)
                      |+.+||..+|.+|||++++++
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-42  Score=324.48  Aligned_cols=251  Identities=29%  Similarity=0.546  Sum_probs=208.1

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            688999999999999999998 5789999998864222   122346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---c
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---V  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---~  297 (415)
                      |||+.++.+..+..+ ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......   .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            999998777665544 468999999999999999999999999999999999999999999999999987654432   2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------------  359 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  359 (415)
                      ....++..|+|||++.+. ..++.++||||||+++|+|++|+.||......+.+..+.....                  
T Consensus       159 ~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         159 TDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             cCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            334578899999998654 2478899999999999999999999987655444333221000                  


Q ss_pred             ----C---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 ----P---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 ----~---------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                          .         ..+..++.++.+||++||..+|++||++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                0         1223458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.4e-42  Score=319.71  Aligned_cols=246  Identities=31%  Similarity=0.545  Sum_probs=209.6

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||.|+||.||++++ .+++.+++|.+.....  ........+.+|+.+++.++|+||+++++.+......|+||||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            69999999999998 5699999998864322  12345667889999999999999999999999999999999999999


Q ss_pred             CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC----------Cc
Q 014986          229 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----------DV  297 (415)
Q Consensus       229 sL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~----------~~  297 (415)
                      +|.+++.+ ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......          ..
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            99998876 46899999999999999999999999999999999999999999999999998754333          22


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcc--cHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL--SKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--s~~l~~Li~  375 (415)
                      ....++..|++||.+....  ++.++||||||+++|+|++|..||......+....+..+. ...+...  +..+.+|+.
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCccccCCHHHHHHHH
Confidence            2345788999999986544  7889999999999999999999998777666655555433 2234444  899999999


Q ss_pred             HhhhhCCCCCCCH---HHHHcChhhHhh
Q 014986          376 QCVQVNPNDRPTA---AQLLDHPFVKRL  400 (415)
Q Consensus       376 ~~L~~dP~~Rps~---~eil~hp~f~~~  400 (415)
                      +||+.+|.+|||+   .++++||||+.+
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            9999999999999   999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-41  Score=325.08  Aligned_cols=252  Identities=28%  Similarity=0.458  Sum_probs=203.5

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCE--
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK--  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~--  217 (415)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++......   ......+.+|+.+++.+. |+||+++++++.....  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            3688899999999999999998 68999999987643211   112345678999999995 6999999999877665  


Q ss_pred             ---EEEEEeccCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEeec
Q 014986          218 ---LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFG  287 (415)
Q Consensus       218 ---~~lV~E~~~~gsL~~~l~~------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~DFG  287 (415)
                         .|+||||+.+ +|.+++..      ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence               8999999986 78887653      24789999999999999999999999999999999999998 8899999999


Q ss_pred             cccccccC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-----
Q 014986          288 LAKATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----  360 (415)
Q Consensus       288 la~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----  360 (415)
                      ++......  ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||...+......++......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            98754322  22233578889999988543 33688999999999999999999999876665554443221100     


Q ss_pred             ----------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          361 ----------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       361 ----------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                                            .....++..+.+||.+||..||.+||++.+++.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                  00134788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=318.81  Aligned_cols=247  Identities=26%  Similarity=0.456  Sum_probs=210.2

Q ss_pred             cccccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ++|++.+.||+|+||.||+|.+.    +...||+|.+....    .......+.+|+.+++.++|+||+++++.+...+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            46889999999999999999873    24589999876422    23334567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .++||||+.+++|.+++..  ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999999865  35899999999999999999999999999999999999999999999999999876421


Q ss_pred             C--cc--cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          296 D--VK--SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       296 ~--~~--~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      .  ..  ...++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......+....+......+.+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL  237 (266)
T ss_pred             ccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            1  11  12345789999998554  37889999999999999998 999998777666666776666666677889999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+|+.+||+.+|++||++.+|+++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         238 YQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-41  Score=338.07  Aligned_cols=253  Identities=28%  Similarity=0.460  Sum_probs=206.4

Q ss_pred             CcceeeecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEE
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ  207 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~  207 (415)
                      +++..-.+.|+++++||+|+||.||+|++.      .+..||+|++....    .....+.+.+|+.+|+.+. ||||++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnIv~  105 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNIVN  105 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCeee
Confidence            345555678999999999999999999852      23579999886422    1223457889999999996 999999


Q ss_pred             eeeeeecCCEEEEEEeccCCCCHHHHHhhc--------------------------------------------------
Q 014986          208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--------------------------------------------------  237 (415)
Q Consensus       208 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------------------  237 (415)
                      +++++.+...+||||||+.+|+|.+++.+.                                                  
T Consensus       106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (400)
T cd05105         106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT  185 (400)
T ss_pred             EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence            999999999999999999999999887532                                                  


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          238 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       238 -----------------------------------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                                                                     .+++..+..++.||+.||.|||+.+|+||||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp  265 (400)
T cd05105         186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA  265 (400)
T ss_pred             cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence                                                           366777889999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            99999999999999999987653322    1223467789999998654  37899999999999999997 99999765


Q ss_pred             cHHHH-HHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          346 ECMAA-LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       346 ~~~~~-~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..... ...+..+...+.+..++..+.+|+.+||+.||++||++.+|.+
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            43333 2334444445566788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-41  Score=322.21  Aligned_cols=247  Identities=28%  Similarity=0.438  Sum_probs=199.0

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecC--CEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--SKLY  219 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~  219 (415)
                      |++.+.||+|+||.||+|.+ .+++.||+|++.......   .. ....+|+.++..+. |+||+++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            67788999999999999998 689999999886432211   11 22347888888885 99999999999887  8899


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      +||||+.+ +|.+++..  ..+++..+..++.|++.||+|||+.||+||||+|+||+++. +.+||+|||+++...... 
T Consensus        77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            99999975 77777764  35899999999999999999999999999999999999999 999999999997654332 


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------------  359 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  359 (415)
                      .....++..|+|||++... ..++.++|||||||++|+|++|..||...+..+....+.....                 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         155 YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            2344588999999987443 3368899999999999999999999987654443333221000                 


Q ss_pred             CC-----------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 PP-----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 ~~-----------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ..           ....++..+.+||.+||.++|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00           112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=316.48  Aligned_cols=247  Identities=29%  Similarity=0.488  Sum_probs=202.7

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHH-HhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      +.||.|+||.||+|.+ .+++.||+|.+......  .......+..|..+ ....+|+||+++++.+...+.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh--HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            5699999999999998 67899999988642211  11222333445444 45568999999999999999999999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCc
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA  304 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~  304 (415)
                      .+++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....  .....++.
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~  157 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTP  157 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCc
Confidence            99999999876 4689999999999999999999999999999999999999999999999999876443  22345888


Q ss_pred             cccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC---CCCCCCcccHHHHHHHHHhhhhC
Q 014986          305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVN  381 (415)
Q Consensus       305 ~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~~L~~d  381 (415)
                      .|+|||.+.+..  ++.++||||||+++|+|++|..||...........+....   .......++..+.++|.+||+.|
T Consensus       158 ~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         158 DYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            999999986543  7889999999999999999999998776655554443332   22234468999999999999999


Q ss_pred             CCCCC---CHHHHHcChhhHhh
Q 014986          382 PNDRP---TAAQLLDHPFVKRL  400 (415)
Q Consensus       382 P~~Rp---s~~eil~hp~f~~~  400 (415)
                      |++||   +++|++.||||+.+
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcC
Confidence            99999   45899999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-41  Score=332.28  Aligned_cols=264  Identities=25%  Similarity=0.433  Sum_probs=215.4

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ..+.++|++.+.||+|+||.||+|.+ .++..||+|++....   ........+.+|+.+++.++|+||+++++++..+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            34567899999999999999999997 789999999885321   12233456779999999999999999999887654


Q ss_pred             ------EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          217 ------KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       217 ------~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                            .+++||||+ +++|..++....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence                  468999999 6699998888889999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----------
Q 014986          291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------  360 (415)
Q Consensus       291 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  360 (415)
                      ..... .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||..........++......          
T Consensus       167 ~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDSE-MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             ccccC-ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            65432 3344678999999998542 23788999999999999999999999876544333332211100          


Q ss_pred             --------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          361 --------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       361 --------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                          .....++..+.++|.+||..||.+|||+.+++.||||+.+.......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~  311 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET  311 (343)
T ss_pred             chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc
Confidence                                11235678899999999999999999999999999999987655443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.7e-41  Score=322.95  Aligned_cols=259  Identities=29%  Similarity=0.536  Sum_probs=208.4

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY  219 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  219 (415)
                      ++|+..+.||+|+||.||++.+ .+++.+|+|.+.....    ......+.+|+.++.++. |+||+++++++..+...+
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            3567788999999999999998 6789999998874322    133456788999999986 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          220 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~------~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ++|||+.. +|.++..      ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99999875 5544332      24689999999999999999999975 9999999999999999999999999998754


Q ss_pred             ccC-CcccCCCCccccccccccccc-cCCCchhhHHHHHHHHHHHHcCCCCCCCccH-HHHHHHHhcCCCCCC----CCc
Q 014986          293 KLN-DVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPI----PDS  365 (415)
Q Consensus       293 ~~~-~~~~~~gt~~y~aPE~l~~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~----~~~  365 (415)
                      ... ......|+..|+|||++.... ..++.++|||||||++|+|++|+.||..... .+.+.++..+..+.+    +..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            332 223446889999999986442 3478899999999999999999999976542 233333333222222    234


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      ++..+.+||.+||+.||.+|||+.+|+.||||+.....+.
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~  278 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNV  278 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcch
Confidence            7889999999999999999999999999999998776554

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-41  Score=318.52  Aligned_cols=245  Identities=28%  Similarity=0.500  Sum_probs=209.2

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..+.|++.++||+|+||.||+|...+++.||+|.+.....      ....+.+|+.+++.++|+||+++++.+. .+..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            3467999999999999999999998889999998864221      2346788999999999999999999874 45789


Q ss_pred             EEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||+.+++|.+++..   ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999999999998864   358889999999999999999999999999999999999999999999999987654322


Q ss_pred             c---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      .   ....++..|+|||++....  ++.++||||||+++|+|++ |+.||......+....+......+.+..++.++.+
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE  234 (260)
T ss_pred             cccccCCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            2   1233567899999986543  7889999999999999998 99999887766666666666666677788999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~  393 (415)
                      |+.+||..+|++||+++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.2e-41  Score=315.79  Aligned_cols=250  Identities=37%  Similarity=0.592  Sum_probs=218.9

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|++.+.||+|+||.||++.+ .+++.+|+|.+......   ......+.+|+.+++.++|+||+++++.+.+....|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            478889999999999999987 68899999998743221   23345667899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          222 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      |||+.+++|..++.+     ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999998865     468899999999999999999999999999999999999999999999999998765554


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....++..|++||.+.+.  .++.++|+||||+++|+|++|+.||...+.......+.....+..+..++.++.+++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHH
Confidence            4445688999999998554  37889999999999999999999998887766666677776677777889999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ||..+|++||++.+++.||++
T Consensus       236 ~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         236 MLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.6e-41  Score=325.05  Aligned_cols=247  Identities=28%  Similarity=0.527  Sum_probs=205.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCc--EEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~--~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      ++|++.+.||+|+||.||+|++ .++.  .+++|.++...    .....+.+.+|+.++.++ +||||+++++.+...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            4688999999999999999987 4443  46887765311    122345678999999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc
Q 014986          218 LYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  280 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~  280 (415)
                      +|+||||+.+++|.+++...                 .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            99999999999999998643                 3778899999999999999999999999999999999999999


Q ss_pred             EEEEeeccccccccCCcc-cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Q 014986          281 VKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  358 (415)
Q Consensus       281 vkl~DFGla~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  358 (415)
                      +||+|||++......... ....+..|+|||++...  .++.++|||||||++|+|++ |..||......+...++..+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            999999998643221111 12235579999998543  37889999999999999997 999998877777677776666


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ....+..++..+.+|+.+||..+|.+||+++++++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            666677899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=306.60  Aligned_cols=260  Identities=31%  Similarity=0.525  Sum_probs=215.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  214 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  214 (415)
                      +..-.++.+.+..||.|+.|+|++++. .+|...|||......    +++..+++...+.++.... .|+||+.+|+|..
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~----Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC----CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            334455677788899999999999998 779999999998643    3445567777787776654 8999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      +..++|.||.+.. .+..++++  ..+++..+-++...++.||.||.. +||||||+||+|||+|..|++||||||++..
T Consensus       163 n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  163 NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            9999999998854 45566654  468888889999999999999975 5899999999999999999999999999865


Q ss_pred             cc-cCCcccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCCC--cc
Q 014986          292 TK-LNDVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPPIPD--SL  366 (415)
Q Consensus       292 ~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~--~~  366 (415)
                      .- ........|-+.|||||.+.-. ...|+.++||||||+.++||.||+.||.+- ...+.+.++.+..++.++.  .+
T Consensus       242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF  321 (391)
T KOG0983|consen  242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF  321 (391)
T ss_pred             eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence            43 3334445688999999999755 344899999999999999999999999873 4567777888777665554  47


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      |+++++|+..||++|+.+||...++|+|||++...
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            99999999999999999999999999998766543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=316.81  Aligned_cols=258  Identities=26%  Similarity=0.464  Sum_probs=223.2

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      ..++|.++++||+|+|+.|.+++. ++.+.||+|++++.-.  ...+.+..++.|..+..+. +||++|.++.+|+++..
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            367899999999999999999998 8899999999875221  2233456677788887665 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc-c-
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-L-  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~-~-  294 (415)
                      +++|.||+.||+|.-++++ ..++++.++.|...|+.||.|||++|||+||||.+|+|++..|++||+|+|+++..- . 
T Consensus       326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            9999999999999887765 679999999999999999999999999999999999999999999999999998643 2 


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC-------ccHHHHHHHHhcCCCCCCCCccc
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-------MECMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      ......||||.|.|||++++..  |+..+|+|+||++++||+.|+.||+-       ....+.++.+.......+|..++
T Consensus       406 d~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls  483 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS  483 (593)
T ss_pred             cccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence            3345678999999999997654  89999999999999999999999953       34456677777666777899999


Q ss_pred             HHHHHHHHHhhhhCCCCCC------CHHHHHcChhhHhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRP------TAAQLLDHPFVKRLL  401 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rp------s~~eil~hp~f~~~~  401 (415)
                      -.+..+++..|++||++|.      .+.++..|+||+.+.
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            9999999999999999995      479999999999653

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.4e-41  Score=317.03  Aligned_cols=248  Identities=29%  Similarity=0.529  Sum_probs=207.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|++ .+++.||+|.+......  .......+.+|+.+++.++||||+++++.+.+.+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM--DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC--CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            5789999999999999999998 68999999988643222  23344667899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          221 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      ||||+.+|+|.+++..     ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999988742     34788999999999999999999999999999999999999999999999998765432


Q ss_pred             C--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCCCCC-CCcccHHH
Q 014986          296 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPI-PDSLSKDA  370 (415)
Q Consensus       296 ~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~-~~~~s~~l  370 (415)
                      .  .....+++.|+|||.+.+..  ++.++|+||||+++|+|++|..||....  .......+.....++. ....+..+
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCC--CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            2  22345888999999986543  7889999999999999999999996542  2334444444333333 34678899


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHc
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .+|+.+||..+|.+||++.++++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHH
Confidence            99999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=339.88  Aligned_cols=263  Identities=29%  Similarity=0.516  Sum_probs=225.1

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc--CCC--cE-EEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS--DDG--FF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT  211 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~--~~~--~~-vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  211 (415)
                      +....++..+.++||+|+||.||+|..  .++  .. ||+|..+...  ......+..+.+|+++|++++|||||++||+
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~--~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS--ELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc--cccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            444455667789999999999999986  222  23 8999876411  2335667889999999999999999999999


Q ss_pred             eecCCEEEEEEeccCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          212 DKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       212 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      ......+|+|||+|.||+|.+++++++  ++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+||||+
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            999999999999999999999999875  999999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC-cc-cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHH-hcCCCCCCCCc
Q 014986          290 KATKLND-VK-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI-GRGSPPPIPDS  365 (415)
Q Consensus       290 ~~~~~~~-~~-~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i-~~~~~~~~~~~  365 (415)
                      +...... .. ...-...|+|||.+...  .++.++|||||||++||+++ |..||.+....+...++ ..+.+.+.+..
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~  387 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK  387 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence            7654211 12 22356789999999655  48999999999999999998 88899999999999999 66888888999


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      .+.++..++.+||..+|++||++.++.+  +++.+.....
T Consensus       388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~~~~  425 (474)
T KOG0194|consen  388 TPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEALEKKKE  425 (474)
T ss_pred             CHHHHHHHHHHhccCChhhccCHHHHHH--HHHHHHhccc
Confidence            9999999999999999999999999965  6666665543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-42  Score=350.06  Aligned_cols=259  Identities=25%  Similarity=0.335  Sum_probs=193.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc--CCCcEEEEEEEecc------------cccchhHHHHHHHHHHHHHHhcCCCCc
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLL------------DQGSQAKQSISQLEQEIALLSRFEHEN  204 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~i~~~------------~~~~~~~~~~~~~~~E~~il~~l~hpn  204 (415)
                      .+.++|++++.||+|+||+||++..  .++...+.|.+...            ............+.+|+.+|+.++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            3567899999999999999999865  22333333311100            000111233456889999999999999


Q ss_pred             EEEeeeeeecCCEEEEEEeccCCCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014986          205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  278 (415)
Q Consensus       205 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~  278 (415)
                      ||++++++.+.+..|+||+++.+ +|..++....      .....++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            99999999999999999999965 6776654322      3356678899999999999999999999999999999999


Q ss_pred             CcEEEEeeccccccccCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCC-CCCc--cHHHHHH
Q 014986          279 GSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPM--ECMAALF  352 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~p-f~~~--~~~~~~~  352 (415)
                      +.+||+|||+++......   .....||..|+|||++.+..  ++.++|||||||++|+|++|..+ |...  .....+.
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999998654332   22356999999999996543  88999999999999999998764 4221  1122222


Q ss_pred             HHhcCCC---C-----------------------CC-----CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          353 KIGRGSP---P-----------------------PI-----PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       353 ~i~~~~~---~-----------------------~~-----~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ++.....   .                       .+     ...++.++.++|.+||+.||.+|||+.|+|.||||+..
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            2211100   0                       00     01356678889999999999999999999999999764

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-41  Score=323.44  Aligned_cols=251  Identities=31%  Similarity=0.452  Sum_probs=199.5

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|++.+.||+|+||.||+|.+ .+++.||+|.+.......    ....+.+|+.+++.++|+||+++++++.++...|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            36789999999999999999998 679999999986432211    1234568999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      +||||+. ++|..++..  ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++...... 
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9999996 577766543  357888899999999999999999999999999999999999999999999987543221 


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH-HHHHHHhcCCC---------------
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSP---------------  359 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~---------------  359 (415)
                       .....+++.|+|||.+.+. ..++.++||||||+++|+|++|..||...... +.+.++.....               
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             2334478999999998543 23678999999999999999999999764432 22222110000               


Q ss_pred             ---C----CCC---------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 ---P----PIP---------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 ---~----~~~---------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                         .    ..+         ...+..+.+|+.+||..||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence               0    000         0125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2e-41  Score=323.88  Aligned_cols=254  Identities=33%  Similarity=0.548  Sum_probs=214.3

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |.....||+|+||.||++.. .+++.||+|++....     ......+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence            44456799999999999988 789999999875321     223456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccC
Q 014986          223 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  300 (415)
Q Consensus       223 E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~  300 (415)
                      ||+.+++|.+++....+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++......  .....
T Consensus        97 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          97 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            9999999999888778999999999999999999999999999999999999999999999999988654332  22335


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHHHHHHHhh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~~L  378 (415)
                      .+++.|+|||.+...  .++.++|+||||+++|+|++|..||...........+.......  ....++..+.+++.+||
T Consensus       177 ~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         177 VGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             ccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            588999999988543  37889999999999999999999998766555444443333222  23457889999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ..+|.+||++.+++.||||......+
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccCCCc
Confidence            99999999999999999999988633

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=318.40  Aligned_cols=246  Identities=27%  Similarity=0.477  Sum_probs=206.7

Q ss_pred             cccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE--
Q 014986          144 WQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK--  217 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--  217 (415)
                      |++++.||+|+||.||+|...    .+..||+|.+.....   .......+.+|+.+++.++|+||+++++.+.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            578899999999999999862    347899998864221   23345678899999999999999999998765443  


Q ss_pred             ----EEEEEeccCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEee
Q 014986          218 ----LYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       218 ----~~lV~E~~~~gsL~~~l~~-------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                          .++||||+.+|+|..++..       ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                7999999999999988743       25888999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCC
Q 014986          287 GLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP  361 (415)
Q Consensus       287 Gla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  361 (415)
                      |+++.......    ....++..|+|||.+...  .++.++|||||||++|+|++ |..||......+....+..+....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99986543321    112356789999998543  47889999999999999999 999998877777777777776667


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+..++..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-41  Score=319.92  Aligned_cols=247  Identities=25%  Similarity=0.418  Sum_probs=208.6

Q ss_pred             ecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+.++..++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            467899999999999999999863      34789999875321    22234567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                      ....|+||||+.+|+|.+++...           .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            99999999999999999988642           2577788999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Q 014986          284 ADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  358 (415)
Q Consensus       284 ~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  358 (415)
                      +|||+++.......    ....++..|+|||.+...  .++.++|||||||++|+|++ |..||......+....+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            99999876543321    223467889999998543  37889999999999999998 999998777666666666555


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ....+..++..+.+||.+||+.+|++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            66677888999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-41  Score=332.78  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=206.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----  215 (415)
                      ..+|++.+.||.|+||.||+|++ .+++.||+|++.....     ...+.+.+|+.+++.++||||+++++.+...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            46799999999999999999998 7899999999875332     3346677899999999999999999766543    


Q ss_pred             ----------CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEE
Q 014986          216 ----------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLA  284 (415)
Q Consensus       216 ----------~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~  284 (415)
                                ...|+||||+.+ +|.+++....+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                      468999999974 8998888778999999999999999999999999999999999999974 5678999


Q ss_pred             eeccccccccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC
Q 014986          285 DFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  359 (415)
Q Consensus       285 DFGla~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  359 (415)
                      |||+++......     .....++..|+|||.+... ..++.++|||||||++|+|++|+.||...........+....+
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999987543211     1223578899999987432 3478899999999999999999999976654443333221110


Q ss_pred             C-----------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          360 P-----------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       360 ~-----------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .                             .....++.++.+||.+||+.||.+|||+.+++.||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            0                             012357788999999999999999999999999999987644

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-41  Score=327.17  Aligned_cols=248  Identities=28%  Similarity=0.514  Sum_probs=204.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcE--EEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      .++|++.+.||+|+||.||+|.+ .++..  +|+|.+..  .  ........+.+|+.++..+ +|+||+++++++.+.+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--Y--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--c--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            35788999999999999999997 45554  46665542  1  1233456788899999999 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  279 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~  279 (415)
                      .+|+||||+.+++|.+++.+.                 .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            999999999999999988643                 368889999999999999999999999999999999999999


Q ss_pred             cEEEEeeccccccccCCc-ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcC
Q 014986          280 SVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  357 (415)
Q Consensus       280 ~vkl~DFGla~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  357 (415)
                      .+||+|||++........ ....++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......+....+...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            999999999864321111 112246679999988543  37889999999999999998 99999877666655555554


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .....+..++..+.+||.+||+.+|++||++.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444556688999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=316.69  Aligned_cols=245  Identities=31%  Similarity=0.515  Sum_probs=212.1

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||+|+||.||+|.+.+++.+|+|.+.....      ....+.+|+.+++.++|+||+++++.+.+....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            568999999999999999999987788999998864221      23467899999999999999999999999899999


Q ss_pred             EEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          221 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ||||+.+++|.+++...   .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999999998653   589999999999999999999999999999999999999999999999999876543221


Q ss_pred             c---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          298 K---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       298 ~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      .   ...++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||..........++......+.+...+.++.++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1   22245679999998644  37889999999999999998 999998887777777777766666777889999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHc
Q 014986          374 IKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~  393 (415)
                      +.+||..+|.+||++++++.
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-41  Score=322.77  Aligned_cols=258  Identities=28%  Similarity=0.478  Sum_probs=212.5

Q ss_pred             ccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      .|++.+.||.|+||.||+|.+    .+++.||+|.+..... .......+++.+|+.++..+ +|+||+++++.+..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            378889999999999999986    3789999999864221 11223345678899999999 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            9999999999999998865 468899999999999999999999999999999999999999999999999987654322


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCCCCcccHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                         .....|+..|+|||.+......++.++||||||+++|+|++|..||.....   ...+.........+.+..++..+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA  239 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence               223458899999999865444467899999999999999999999964321   12222222223445677889999


Q ss_pred             HHHHHHhhhhCCCCCC-----CHHHHHcChhhHhhh
Q 014986          371 QDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRLL  401 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rp-----s~~eil~hp~f~~~~  401 (415)
                      .+|+.+||..||.+|+     ++.+++.||||+.+.
T Consensus       240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            9999999999999997     899999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-41  Score=321.96  Aligned_cols=252  Identities=28%  Similarity=0.439  Sum_probs=211.6

Q ss_pred             cccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .+|.+.+.||+|+||.||+|.+      .++..+++|.+..     ........+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            4688889999999999999974      2456788887753     2223345688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  278 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~  278 (415)
                      ...++||||+.+++|.+++...                 .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            9999999999999999998643                 27888999999999999999999999999999999999999


Q ss_pred             CcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHH
Q 014986          279 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK  353 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  353 (415)
                      +.++|+|||+++......    .....++..|+|||.+.+..  ++.++|||||||++|+|++ |..||......+....
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999987554322    12334678899999986543  7889999999999999998 9999987776666666


Q ss_pred             HhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       354 i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +..+.....+..++..+.+|+.+||+.||++||++.++++  .++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~--~l~~~~~  284 (291)
T cd05094         238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK--ILHALGK  284 (291)
T ss_pred             HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH--HHHHHHh
Confidence            6666666666778999999999999999999999999976  4555544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.5e-41  Score=317.81  Aligned_cols=249  Identities=31%  Similarity=0.498  Sum_probs=208.3

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||+|+||.||+|.+.++..||+|++.....      ....+.+|+.+++.++|+||+++++.+. ....|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            357999999999999999999986667799998864221      1245788999999999999999999875 456899


Q ss_pred             EEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          221 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ||||+.+|+|.+++..   ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999999875   3478899999999999999999999999999999999999999999999999976543322


Q ss_pred             c---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          298 K---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       298 ~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      .   ...++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+......+.+..++..+.+|
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             ccccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            1   23356789999988543  37899999999999999999 899998876666666666555555667789999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +.+||+.||.+||++.++++  +++..
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~--~l~~~  260 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA--FLEDY  260 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH--HHHHh
Confidence            99999999999999999865  45544

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=320.87  Aligned_cols=249  Identities=31%  Similarity=0.538  Sum_probs=205.1

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |++.+.||.|++|.||+|.+ .++..||+|++......   ......+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            67788999999999999998 68999999998753221   112245678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          223 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       223 E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      ||+. ++|.+++...   .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.......  .
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9996 5899988664   48999999999999999999999999999999999999999999999999987543221  2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------------  359 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  359 (415)
                      ....++..|+|||++.+. ..++.++||||||+++|+|++|..||...+......++.....                  
T Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         157 THEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             CccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            233468899999987543 2368899999999999999999999987665444433322100                  


Q ss_pred             ----------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          360 ----------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       360 ----------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                ......++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                      01124567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-42  Score=333.58  Aligned_cols=263  Identities=28%  Similarity=0.463  Sum_probs=216.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++....   ........+.+|+.+++.++|+||+++++++.....
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            3456899999999999999999998 678999999876421   112234567789999999999999999988766554


Q ss_pred             ------EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          218 ------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       218 ------~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                            +|+|+||+ +++|.+++....+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence                  89999999 55999999888899999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----------
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  361 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  361 (415)
                      .... .....++..|+|||.+.+.. .++.++||||||+++|+|++|+.||........+..+......+          
T Consensus       168 ~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE-MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc-ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            5433 34456889999999985432 47889999999999999999999998766555444433221110          


Q ss_pred             --------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          362 --------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       362 --------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                          ....++..+.+||.+||..||++|||+.+|+.||||+++.......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~  311 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP  311 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc
Confidence                                1123588999999999999999999999999999999987765544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-42  Score=322.84  Aligned_cols=242  Identities=31%  Similarity=0.531  Sum_probs=202.9

Q ss_pred             cccccccCCcEEEEEEEcC-----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          146 KGDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.+.||.|.||.||+|...     .+..|+||.+..    .........+.+|++.+++++||||+++++++...+.+++
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeecccccccccccccccccccccccccccc
Confidence            4578999999999999875     467899998853    1223346778899999999999999999999998888999


Q ss_pred             EEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          221 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      ||||+.+|+|.+++...   .+++..+..++.||+.||.|||+++|+|++|+++|||++.++.+||+|||++....... 
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999998775   79999999999999999999999999999999999999999999999999987662211 


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                         .....+...|+|||.+....  ++.++||||||+++|||++ |+.||......+...++..+.....+..++..+.+
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYS  236 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHH
Confidence               22234677899999986544  7999999999999999999 78999988888877888777777778889999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +|.+||..||++|||+.+|++
T Consensus       237 li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5e-41  Score=314.58  Aligned_cols=239  Identities=26%  Similarity=0.446  Sum_probs=202.8

Q ss_pred             ccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          149 LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      .||+|+||.||+|.+   .++..+|+|++....   ........+.+|+.+++.+.|+||+++++.+. ....++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            589999999999964   467899999876432   22334567889999999999999999999875 45678999999


Q ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc-----cc
Q 014986          226 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KS  299 (415)
Q Consensus       226 ~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-----~~  299 (415)
                      .+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++........     ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            99999998865 4689999999999999999999999999999999999999999999999999876543321     12


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..++..|+|||.+...  .++.++|+|||||++|+|++ |..||......+....+..+...+.+..++.++.+||.+||
T Consensus       158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~  235 (257)
T cd05116         158 GKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW  235 (257)
T ss_pred             CCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence            2345789999988543  37889999999999999997 99999887777777777777667778889999999999999


Q ss_pred             hhCCCCCCCHHHHHc
Q 014986          379 QVNPNDRPTAAQLLD  393 (415)
Q Consensus       379 ~~dP~~Rps~~eil~  393 (415)
                      +.||.+||++++|..
T Consensus       236 ~~~p~~Rp~~~~i~~  250 (257)
T cd05116         236 TYGVDERPGFAVVEL  250 (257)
T ss_pred             ccCchhCcCHHHHHH
Confidence            999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.8e-41  Score=329.27  Aligned_cols=264  Identities=29%  Similarity=0.465  Sum_probs=212.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeec--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD--  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--  214 (415)
                      .+.++|++.+.||+|+||.||+|.+ .+++.+|+|++......   ......+.+|+.+++++ +|+||+++++++..  
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            4567899999999999999999998 57899999988532111   12234566899999999 99999999998764  


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ...+|+||||+.+ +|..++....+.+..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          81 DKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             CceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            3468999999985 999988877889999999999999999999999999999999999999999999999999875433


Q ss_pred             CC-------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--------
Q 014986          295 ND-------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--------  359 (415)
Q Consensus       295 ~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------  359 (415)
                      ..       .....|+..|+|||.+.+. ..++.++||||||+++|+|++|+.||......+...++.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            22       1234588899999987543 3468899999999999999999999976544433222211110        


Q ss_pred             ----------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          360 ----------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       360 ----------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                            ......++.++.+||.+||+.||.+|||+.++++||||+.+.......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence                                  011123688999999999999999999999999999999986654443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.5e-41  Score=321.04  Aligned_cols=251  Identities=32%  Similarity=0.574  Sum_probs=214.2

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY  219 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  219 (415)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++......  .......+.+|+.+++.+. |+||+++++.+.+.+.++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            3688999999999999999998 68999999988642221  1223456788999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc-
Q 014986          220 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-  297 (415)
                      +||||+.+++|.+++.+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999999998775 789999999999999999999999999999999999999999999999999875543221 


Q ss_pred             ---------------------ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc
Q 014986          298 ---------------------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR  356 (415)
Q Consensus       298 ---------------------~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  356 (415)
                                           ....++..|+|||.+....  ++.++|+||||+++++|++|..||...........+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCC--CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                 2234788999999885433  78899999999999999999999988765554444442


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCH----HHHHcChhh
Q 014986          357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA----AQLLDHPFV  397 (415)
Q Consensus       357 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~----~eil~hp~f  397 (415)
                       ....++..+++.+.+||.+||+.+|.+||++    .+++.||||
T Consensus       237 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 -LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             3334667889999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=339.54  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=227.6

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCc-EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++++++..||-|+||.|=++...+.. .+|+|++++..-.  .....+++..|-+||..++.|+||++|..|.+..++|
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV--dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV--DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc--chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            456777888999999999998774433 5999988754432  3345578889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-c
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~  297 (415)
                      |+||-|-||.|...++. ..|.+..++.++..+++|++|||++|||+|||||+|++++.+|.+||.|||+|+...... .
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            99999999999998865 579999999999999999999999999999999999999999999999999999887665 4


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-CCCCCcccHHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l~~Li~~  376 (415)
                      ...||||.|.|||++..++  ++.++|.||||+++||||+|.+||.+.+.+.....|.++-. ..+|..++..+.+||++
T Consensus       577 wTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            4578999999999997655  88999999999999999999999999999988888877754 35788999999999999


Q ss_pred             hhhhCCCCCCC-----HHHHHcChhhHhhh
Q 014986          377 CVQVNPNDRPT-----AAQLLDHPFVKRLL  401 (415)
Q Consensus       377 ~L~~dP~~Rps-----~~eil~hp~f~~~~  401 (415)
                      ++..+|.+|..     ..+|.+|.||..+.
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            99999999986     79999999998753

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.6e-41  Score=329.07  Aligned_cols=267  Identities=28%  Similarity=0.435  Sum_probs=212.5

Q ss_pred             cccc-cccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhH---H------HHHHHHHHHHHHhcCCCCcEEEeee
Q 014986          142 TYWQ-KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK---Q------SISQLEQEIALLSRFEHENIVQYYG  210 (415)
Q Consensus       142 ~~y~-~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~---~------~~~~~~~E~~il~~l~hpnIv~l~~  210 (415)
                      ++|. +.+.||.|+||+||+|.+ .+++.||+|++..........   +      ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 567899999999999998 689999999986532221100   0      0124678999999999999999999


Q ss_pred             eeecCCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          211 TDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       211 ~~~~~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      ++...+..|+||||+. |+|.+++.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999997 488888765 46899999999999999999999999999999999999999999999999998


Q ss_pred             ccccc----------------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHH
Q 014986          290 KATKL----------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK  353 (415)
Q Consensus       290 ~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~  353 (415)
                      .....                .......++..|+|||.+.+.. .++.++|+|||||++|+|++|..||......+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            75541                1122234688899999986532 368899999999999999999999987766554443


Q ss_pred             HhcCCCC---------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          354 IGRGSPP---------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       354 i~~~~~~---------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      +......                           ......+..+.+||.+||+.+|.+|||+++++.||||+.....-..
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~  325 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDP  325 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCc
Confidence            3221100                           0112457889999999999999999999999999999988766554


Q ss_pred             CCCC
Q 014986          407 SASP  410 (415)
Q Consensus       407 ~~~~  410 (415)
                      ...|
T Consensus       326 ~~~~  329 (335)
T PTZ00024        326 SQLP  329 (335)
T ss_pred             ccCC
Confidence            4444

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.9e-41  Score=317.61  Aligned_cols=243  Identities=26%  Similarity=0.419  Sum_probs=197.7

Q ss_pred             eccccccccc--ccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc-CCCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLL--GRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~L--G~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~  216 (415)
                      .+.|.+.+.+  |.|+||.||++.+ .++..+|+|.+.......          .|+..... .+|+||+++++.+...+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            3456666665  9999999999998 788999999886422110          12222221 26999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~~  294 (415)
                      .+|+||||+.+++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            999999999999999998765 789999999999999999999999999999999999999988 999999999876543


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH----HHHHHHhcCCCCCCCCcccHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----AALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      .  ....++..|+|||++.+..  ++.++||||||+++|+|++|..||......    ..+.... ......+..++..+
T Consensus       163 ~--~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (267)
T PHA03390        163 P--SCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA  237 (267)
T ss_pred             C--ccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence            3  2345889999999986543  788999999999999999999999754322    1122222 23334556789999


Q ss_pred             HHHHHHhhhhCCCCCCC-HHHHHcChhhH
Q 014986          371 QDFIKQCVQVNPNDRPT-AAQLLDHPFVK  398 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps-~~eil~hp~f~  398 (415)
                      .+||.+||+.+|.+|++ ++++|+||||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            99999999999999996 69999999996

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-41  Score=313.10  Aligned_cols=243  Identities=27%  Similarity=0.487  Sum_probs=209.5

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||.|+||.||+|... ++.||+|.+....      ....++.+|+.+++.++|+||+++++.+.+.+..++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            357889999999999999999874 7889999886421      145678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          221 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ||||+.+++|.+++...   .+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999999999998754   589999999999999999999999999999999999999999999999999986643322


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                       ....+..|+|||.+...  .++.++||||||+++|+|++ |..||......+....+........+..++..+.+||.+
T Consensus       158 -~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         158 -SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence             33356679999998543  37889999999999999997 999998877666655655555555667889999999999


Q ss_pred             hhhhCCCCCCCHHHHHc
Q 014986          377 CVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~  393 (415)
                      ||..+|.+||++.++++
T Consensus       235 ~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         235 CWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-41  Score=330.87  Aligned_cols=265  Identities=28%  Similarity=0.436  Sum_probs=212.5

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ...+.++|++.+.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|+.+++.++|+||+++++++...
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            334567899999999999999999998 7899999998864211   122345677899999999999999999987543


Q ss_pred             ------CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          216 ------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       216 ------~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                            ...|++++++ +++|.++++...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence                  3478888887 679998888778999999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---------
Q 014986          290 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---------  360 (415)
Q Consensus       290 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------  360 (415)
                      ..... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+......         
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         168 RHTDD-EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccc-cccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            76543 23345688999999987542 23788999999999999999999999765543332222111000         


Q ss_pred             ---------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          361 ---------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       361 ---------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                           ......+..+.+||.+||+.||.+||++.++++||||+++.......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~  313 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  313 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence                                 01123577899999999999999999999999999999877655433

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-41  Score=318.32  Aligned_cols=252  Identities=28%  Similarity=0.527  Sum_probs=211.1

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +|.+.+.||+|+||.||++.+ ..+..+++|.++.............++.+|+.+++.++||||+++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            488889999999999999988 4556677776654322222222334566899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          222 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      |||+.+++|..++..     ..+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988753     35899999999999999999999999999999999999964 679999999987654322


Q ss_pred             --cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          297 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                        .....|++.|+|||.+.+.  .++.++|+||||+++|+|++|..||...........+..+..+..+..++.++.++|
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             ccccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence              2234578899999988543  377899999999999999999999987777666667666666667778899999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .+||..||.+||++.++++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.5e-41  Score=315.45  Aligned_cols=243  Identities=29%  Similarity=0.498  Sum_probs=205.8

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ++|.+.+.||+|+||.||+|.+..+..+|+|.+.....      ....+.+|+.+++.++|+||+++++++. .+..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            56888999999999999999987777899998763221      2245778999999999999999999875 4568999


Q ss_pred             EeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          222 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      |||+.+++|.+++...   .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999998653   3788899999999999999999999999999999999999999999999999765433221


Q ss_pred             ---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          299 ---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       299 ---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                         ...++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......+....+......+.+..++..+.+|+
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM  236 (260)
T ss_pred             ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence               23356789999988543  37889999999999999999 9999988776666666666655666778899999999


Q ss_pred             HHhhhhCCCCCCCHHHHHc
Q 014986          375 KQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~  393 (415)
                      .+||..||.+||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4e-41  Score=319.48  Aligned_cols=245  Identities=26%  Similarity=0.433  Sum_probs=208.0

Q ss_pred             cccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .+|+..+.||+|+||.||++..      .++..+|+|.+...     .......+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4678889999999999999963      34668889877532     233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  279 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~  279 (415)
                      ...++||||+.+++|.+++...                .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            9999999999999999988653                378889999999999999999999999999999999999999


Q ss_pred             cEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHH
Q 014986          280 SVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI  354 (415)
Q Consensus       280 ~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i  354 (415)
                      .+||+|||++........    ....+++.|+|||.+.+..  ++.++|||||||++|+|++ |..||......+....+
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            999999999875433221    1223467899999986543  7899999999999999998 99999877766666667


Q ss_pred             hcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       355 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+.....+..++..+.+||.+||..||.+||++.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            666666667789999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.7e-41  Score=317.51  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=205.0

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcE----EEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~----vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ++|++.+.||+|+||.||+|.+ .+++.    +++|.+..    .........+..|+.++..+.||||+++++++. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence            5788999999999999999987 45553    66665532    222334466778888999999999999999875 45


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..++++||+.+|+|.+++..  ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            67899999999999999865  3589999999999999999999999999999999999999999999999999975432


Q ss_pred             CC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          295 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       295 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ..    .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||...........+..+...+.+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            22    1233467789999998544  38899999999999999998 99999877655544455555555666778889


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +.+++.+||..||.+|||+.++++.  |..+.
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~~--l~~~~  269 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELANE--FTRMA  269 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH--HHHHH
Confidence            9999999999999999999999763  44443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-42  Score=338.63  Aligned_cols=268  Identities=28%  Similarity=0.464  Sum_probs=217.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|..++.||-|+||.|.+++. ++...||+|.+.+.+.  ..+....+++.|-.||.....+-||+||..|++.+.+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV--l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV--LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH--HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            44688889999999999999987 7788999999876443  23455678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc-----
Q 014986          220 IFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-----  293 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~-----  293 (415)
                      +||+|+.||++..+|.+.+ |.+..++.|+.++.+|++++|..|+|||||||+|||||.+|+|||+|||||+-+.     
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            9999999999999887654 7888899999999999999999999999999999999999999999999996321     


Q ss_pred             ----cCC-----------------------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHH
Q 014986          294 ----LND-----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE  334 (415)
Q Consensus       294 ----~~~-----------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~e  334 (415)
                          .++                                   .+..+||+.|+|||++...+  |+...|+||.|+||||
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g--~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG--YTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC--ccccchhhHhhHHHHH
Confidence                000                                   01235999999999996554  8999999999999999


Q ss_pred             HHcCCCCCCCccHHHHHHHHhc---CCCCCCCCcccHHHHHHHHHhhhhCCCCCC---CHHHHHcChhhHhhhh-hCCCC
Q 014986          335 MLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCVQVNPNDRP---TAAQLLDHPFVKRLLA-TNSGS  407 (415)
Q Consensus       335 ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---s~~eil~hp~f~~~~~-~~~~~  407 (415)
                      |+.|++||......+...++.+   ....+....++.++.+||.+++. +++.|+   .+++|..||||+.+.= ...--
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq  942 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQ  942 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhc
Confidence            9999999976554443333322   11223345789999999998764 678886   4778999999999853 22333


Q ss_pred             CCCCCC
Q 014986          408 ASPYLG  413 (415)
Q Consensus       408 ~~~~~~  413 (415)
                      .+||+.
T Consensus       943 ~ApYIP  948 (1034)
T KOG0608|consen  943 RAPYIP  948 (1034)
T ss_pred             cCCcCc
Confidence            344554

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.7e-41  Score=323.37  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=213.4

Q ss_pred             eeeecccccccccccCCcEEEEEEEc--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEe
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  208 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~--------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l  208 (415)
                      ....++|.+.+.||+|+||.||+|.+        .....+|+|.+....    .......+.+|+.+++.+ +||||+++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            34456889999999999999999974        235578999876321    223456688999999999 69999999


Q ss_pred             eeeeecCCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014986          209 YGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  271 (415)
Q Consensus       209 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~  271 (415)
                      ++++.+.+.+|+||||+.+|+|.+++...                 .+++..+..++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  163 (314)
T cd05099          84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR  163 (314)
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence            99999999999999999999999988642                 3788889999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCcc
Q 014986          272 NILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  346 (415)
Q Consensus       272 NILl~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~  346 (415)
                      |||++.++.+||+|||+++.......    ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||....
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999976543211    112244679999998653  37889999999999999999 899998877


Q ss_pred             HHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       347 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ..+....+........+..++.++.+|+.+||..+|++|||+.++++  .++++....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~--~l~~~~~~~  297 (314)
T cd05099         242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE--ALDKVLAAV  297 (314)
T ss_pred             HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHHHHh
Confidence            66666666665555567788999999999999999999999999986  466665543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.2e-41  Score=321.83  Aligned_cols=252  Identities=26%  Similarity=0.480  Sum_probs=211.0

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      +....++|++.+.||+|+||.||++...      ....+|+|.+....    .......+.+|+.++..+ +|+||++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            4444568999999999999999999862      23689999876421    123345688999999999 799999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  272 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~N  272 (415)
                      +++...+.++++|||+.+|+|..++..                 ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            999999999999999999999998854                 247888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccH
Q 014986          273 ILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC  347 (415)
Q Consensus       273 ILl~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~  347 (415)
                      ||++.++.+||+|||+++.......    ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.....
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            9999999999999999986543321    112245679999988543  37889999999999999997 9999988776


Q ss_pred             HHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          348 MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       348 ~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+....+........+..++..+.+|+.+||..||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         241 EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66666666665556677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.3e-41  Score=323.81  Aligned_cols=256  Identities=28%  Similarity=0.482  Sum_probs=201.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +....++|++.+.||+|+||.||+|.+ .+++.||+|.+.......   .....+.+|+.+++.++||||+++++++...
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            344567899999999999999999998 689999999886432211   1123456899999999999999999987654


Q ss_pred             C--------EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          216 S--------KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       216 ~--------~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                      .        ..++||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence            3        46999999975 788777654  689999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCc------ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---
Q 014986          286 FGLAKATKLNDV------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---  356 (415)
Q Consensus       286 FGla~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---  356 (415)
                      ||++........      ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+..   
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999875533221      233477889999987543 2367899999999999999999999977554333222111   


Q ss_pred             CCCCC---------------C-------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          357 GSPPP---------------I-------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       357 ~~~~~---------------~-------------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .....               .             +...+..+.+||.+||..||.+|||++++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            00000               0             11235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.2e-41  Score=311.05  Aligned_cols=240  Identities=27%  Similarity=0.506  Sum_probs=204.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCC
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  227 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~  227 (415)
                      ++||+|+||.||+|...++..+|+|.+....    .......+.+|+.+++.++||||+++++.+...+..++||||+.+
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            3699999999999988888999999876321    122334678999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc---ccCCC
Q 014986          228 GSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRG  302 (415)
Q Consensus       228 gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~g  302 (415)
                      ++|.+++...  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........   ....+
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9999988643  478999999999999999999999999999999999999999999999999875432221   11234


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN  381 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~d  381 (415)
                      +..|+|||++....  ++.++||||||+++|+|++ |..||...........+..+.....+..++..+.+|+.+||..+
T Consensus       157 ~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         157 PIKWTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             cccccCHHHhccCC--CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            56799999985443  7889999999999999998 99999887766666666666666667788999999999999999


Q ss_pred             CCCCCCHHHHHc
Q 014986          382 PNDRPTAAQLLD  393 (415)
Q Consensus       382 P~~Rps~~eil~  393 (415)
                      |++||++.++++
T Consensus       235 p~~Rp~~~~l~~  246 (250)
T cd05085         235 PENRPKFSELQK  246 (250)
T ss_pred             cccCCCHHHHHH
Confidence            999999999965

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.2e-41  Score=314.18  Aligned_cols=241  Identities=26%  Similarity=0.481  Sum_probs=205.0

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee-ecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~l  220 (415)
                      .+|++.+.||+|+||.||++... +..+|+|.+...       .....+.+|+.+++.++|+||+++++++ ...+..|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            47889999999999999999764 778999987531       1234678999999999999999999875 45677999


Q ss_pred             EEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          221 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ||||+.+++|.+++...   .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            99999999999988753   37888999999999999999999999999999999999999999999999987544332 


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      ....++..|+|||++.+.  .++.++|||||||++|+|++ |+.||......+....+..+.....+..++..+.+++.+
T Consensus       157 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05082         157 DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ  234 (256)
T ss_pred             CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            233456789999998544  37889999999999999997 999998777666666666666666677889999999999


Q ss_pred             hhhhCCCCCCCHHHHHc
Q 014986          377 CVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~  393 (415)
                      ||..+|++|||+.++++
T Consensus       235 ~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         235 CWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=326.23  Aligned_cols=251  Identities=29%  Similarity=0.470  Sum_probs=198.7

Q ss_pred             ccccccccccCCcEEEEEEEc-C--CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--CE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-D--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  217 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~--~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  217 (415)
                      .|++.+.||+|+||.||+|.+ .  +++.||+|.+.....  ........+.+|+.+++.++||||+++++++.+.  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            478889999999999999998 4  689999999875321  1112234567899999999999999999999988  88


Q ss_pred             EEEEEeccCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC----CCcEEEEeec
Q 014986          218 LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFG  287 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~----~~~vkl~DFG  287 (415)
                      +++||||+.+ +|.+++..      ..+++..++.++.||+.||.|||+++|+||||||+|||++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999986 67666532      25788999999999999999999999999999999999999    8999999999


Q ss_pred             cccccccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH---------HHHH
Q 014986          288 LAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA---------ALFK  353 (415)
Q Consensus       288 la~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~---------~~~~  353 (415)
                      ++.......     .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.......         .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            987653322     2344678999999987543 336889999999999999999999997543211         0000


Q ss_pred             Hh-------------------------cCCCCCCC-----------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          354 IG-------------------------RGSPPPIP-----------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       354 i~-------------------------~~~~~~~~-----------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      +.                         .......+           ...+..+.++|.+||+.||++|||+.++++||||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00                         00001111           1456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.6e-41  Score=324.09  Aligned_cols=257  Identities=27%  Similarity=0.459  Sum_probs=203.9

Q ss_pred             cccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEe
Q 014986          144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      |.+++.+|.|+++.||++.. +++.||+|++....   ........+.+|+.+++.++|+||+++++++.+.+..|++||
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence            44555566666666665544 79999999987532   123345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----
Q 014986          224 LVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  296 (415)
Q Consensus       224 ~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----  296 (415)
                      |+.+|+|.+++..   ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+.......    
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999999998875   358899999999999999999999999999999999999999999999999886442211    


Q ss_pred             -----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC------------
Q 014986          297 -----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------  359 (415)
Q Consensus       297 -----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------  359 (415)
                           .....++..|+|||++......++.++|||||||++|+|++|..||..............+..            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                 122346778999999865444578899999999999999999999987654433222211110            


Q ss_pred             ---------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          360 ---------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       360 ---------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                           ......++.++.+|+.+||..||.+|||+.++|+||||+.+...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~  305 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN  305 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence                                 001123456789999999999999999999999999999887443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.9e-41  Score=315.41  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=202.2

Q ss_pred             cccccccccCCcEEEEEEEcC-CCc--EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec------
Q 014986          144 WQKGDLLGRGSFGSVYEGISD-DGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD------  214 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------  214 (415)
                      |.+++.||+|+||.||+|.+. ++.  .+|+|.+....   ........+.+|+.+++.++|+||+++++.+..      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            356788999999999999873 343  68999876422   123345678899999999999999999987532      


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeec
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  287 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFG  287 (415)
                      ....+++|||+.+|+|..++..       ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence            2357899999999999987632       237889999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCC
Q 014986          288 LAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI  362 (415)
Q Consensus       288 la~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  362 (415)
                      +++.......    ....+++.|++||.+.+.  .++.++|||||||++|+|++ |+.||......+....+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ  235 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9986543321    122356789999998544  37899999999999999999 8999988776666666666655566


Q ss_pred             CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       363 ~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +..++..+.++|.+||+.||++|||+.+|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            67889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=311.65  Aligned_cols=239  Identities=27%  Similarity=0.496  Sum_probs=201.0

Q ss_pred             cccccCCcEEEEEEEc-CC---CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGIS-DD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~---~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      +.||+|+||.||+|.. ..   +..+|+|.+......    .....+.+|+.+++.+.|+||+++++++. .+.+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            4699999999999976 32   378999988643221    34467889999999999999999999876 456899999


Q ss_pred             ccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc----
Q 014986          224 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----  298 (415)
Q Consensus       224 ~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~----  298 (415)
                      |+.+|+|.+++... .+++..+..++.|++.||+|||..+++|+||||+|||++.++.+||+|||+++........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999999998765 4999999999999999999999999999999999999999999999999998765433211    


Q ss_pred             -cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          299 -SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 -~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                       ...++..|+|||.+.+..  ++.++||||||+++|+|++ |..||......+....+......+.+..++..++++|.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05060         156 TAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS  233 (257)
T ss_pred             cCccccccccCHHHhcCCC--CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence             112346799999985543  8889999999999999998 999998877666666666666666778899999999999


Q ss_pred             hhhhCCCCCCCHHHHHc
Q 014986          377 CVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~  393 (415)
                      ||..+|++||++.++++
T Consensus       234 cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         234 CWKYRPEDRPTFSELES  250 (257)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.6e-41  Score=315.07  Aligned_cols=248  Identities=31%  Similarity=0.575  Sum_probs=206.2

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .+|++.+.||+|+||.||+|++ .+++.+|+|.+.....  ........+.+|+.+++.++|+||+++++.+.+++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            4788999999999999999997 7899999998864332  223344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          221 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +|||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999998763     35789999999999999999999999999999999999999999999999998765433


Q ss_pred             C--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH--HHHHHHHhcCCCCCC-CCcccHHH
Q 014986          296 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPI-PDSLSKDA  370 (415)
Q Consensus       296 ~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~-~~~~s~~l  370 (415)
                      .  .....++..|+|||.+.+..  ++.++|+||||+++|+|++|..||.....  ......+.....++. +..++..+
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence            2  23346889999999986543  78899999999999999999999965422  233333333333333 34588899


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHc
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .+||.+||..||++|||+.+|++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-41  Score=328.08  Aligned_cols=259  Identities=30%  Similarity=0.497  Sum_probs=214.3

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-----
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  216 (415)
                      +|++.+.||.|+||.||+|++ .+++.||+|++.....   .....+.+.+|+.+++.++|+||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            488899999999999999998 5699999998874321   1233456889999999999999999999988775     


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+|+||||+.+ +|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            78999999985 788887654 6899999999999999999999999999999999999999999999999999866543


Q ss_pred             C-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---------
Q 014986          296 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---------  361 (415)
Q Consensus       296 ~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------  361 (415)
                      .     .....++..|+|||++.+.. .++.++|+||||+++|+|++|..||......+....+......+         
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            2     33445788999999986542 47899999999999999999999998776554444332211110         


Q ss_pred             ---------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          362 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       362 ---------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                                           ....++..+.+||.+||+.+|.+||++.+++.||||+++......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence                                 113367889999999999999999999999999999998765433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-40  Score=312.05  Aligned_cols=248  Identities=30%  Similarity=0.570  Sum_probs=208.2

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+......  .......+.+|+.+++.++|+||+++++.+.+.+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM--DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            5789999999999999999999 58999999988743221  12334678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          221 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      ||||+.+|+|..++..     ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999998853     24789999999999999999999999999999999999999999999999998755433


Q ss_pred             C--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCCCCCCC-cccHHH
Q 014986          296 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPD-SLSKDA  370 (415)
Q Consensus       296 ~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~-~~s~~l  370 (415)
                      .  .....++..|+|||.+.+..  ++.++|+||||+++|+|++|..||....  ..+....+..+...+.+. .++..+
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             CcccceecCCccccCHHHhccCC--CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            2  23345888999999986543  7889999999999999999999996543  223333444444455555 788899


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHc
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .++|.+||..+|.+|||+.+|++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-40  Score=312.78  Aligned_cols=237  Identities=27%  Similarity=0.470  Sum_probs=200.8

Q ss_pred             cccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccC
Q 014986          150 LGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       150 LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      ||+|+||.||+|.+   ..+..||+|.+...    ......+.+.+|+.+++.++|+||+++++.+. ....++||||++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            89999999999976   24557999988642    12334467889999999999999999999876 457899999999


Q ss_pred             CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc-----cc
Q 014986          227 KGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KS  299 (415)
Q Consensus       227 ~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-----~~  299 (415)
                      +++|.+++..  ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++........     ..
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999998854  4689999999999999999999999999999999999999999999999999875433221     11


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..++..|+|||.+....  ++.++|||||||++|+|++ |..||......+....+..+.....+..++.++.++|.+||
T Consensus       158 ~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         158 GKWPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCcccCCHHHHccCC--CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            22357899999985433  7889999999999999996 99999888777777777777777778889999999999999


Q ss_pred             hhCCCCCCCHHHHHc
Q 014986          379 QVNPNDRPTAAQLLD  393 (415)
Q Consensus       379 ~~dP~~Rps~~eil~  393 (415)
                      ..+|++||++.+|++
T Consensus       236 ~~~~~~Rp~~~~i~~  250 (257)
T cd05115         236 IYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999965

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=318.41  Aligned_cols=249  Identities=29%  Similarity=0.525  Sum_probs=205.0

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--CEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLYI  220 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l  220 (415)
                      |++.+.||.|+||.||+|++ .+++.+|+|.+.....   .......+.+|+.+++.++|+||+++++.+.+.  ...++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc---cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            67788999999999999998 5789999999985421   122234577899999999999999999999888  89999


Q ss_pred             EEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ||||+.+ +|..++...  .+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9999985 888888654  78999999999999999999999999999999999999999999999999988665443  


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--------------
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------------  361 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------  361 (415)
                       .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........+..+......+              
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence             3334568889999987543 236889999999999999999999998766544433332211000              


Q ss_pred             ----------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          362 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       362 ----------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                      +...++..+.++|.+||..+|.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                            011137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-40  Score=316.31  Aligned_cols=246  Identities=26%  Similarity=0.450  Sum_probs=204.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ..+|++.+.||+|+||+||+|++ .++.    .||+|.+....    .......+.+|+.++..+.|+||+++++.+...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            35788999999999999999986 4554    48899876422    223345678999999999999999999988754


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                       ..+++|||+++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             578999999999999988653  58999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          294 LNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       294 ~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ....    ....++..|+|||.+.+.  .++.++|||||||++|||++ |..||...........+..+...+.+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI  238 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCH
Confidence            3221    112346789999998544  37889999999999999998 9999987665555555555555566678899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ++.+++.+||..||++||++.++++
T Consensus       239 ~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         239 DVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-41  Score=329.37  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=209.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----  215 (415)
                      ..+|.+.+.||+|+||+||+|++ .+++.||+|.+.....   .......+.+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            45789999999999999999998 7899999998864221   122234567899999999999999999987644    


Q ss_pred             -CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 -SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 -~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                       ..+|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence             35899999997 588887765 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---------------
Q 014986          294 LN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---------------  356 (415)
Q Consensus       294 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---------------  356 (415)
                      ..  ......++..|+|||.+.... .++.++|||||||++|+|++|+.||...+.......+..               
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCcccccccccccCccChHHHhcCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            33  123345788999999885432 378899999999999999999999976543222111110               


Q ss_pred             ------------CCC---CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          357 ------------GSP---PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       357 ------------~~~---~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                  ...   ......++..+.+||++||+.+|.+|||+.++++||||+.+...+..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~  304 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP  304 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCc
Confidence                        000   011235788999999999999999999999999999999876555443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-41  Score=327.93  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=204.0

Q ss_pred             ecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  213 (415)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|++....    .......+.+|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            45799999999999999999964      235789999886321    122345677899999999 7999999999876


Q ss_pred             c-CCEEEEEEeccCCCCHHHHHhh--------------------------------------------------------
Q 014986          214 D-ESKLYIFLELVTKGSLLNLYQR--------------------------------------------------------  236 (415)
Q Consensus       214 ~-~~~~~lV~E~~~~gsL~~~l~~--------------------------------------------------------  236 (415)
                      . +..++++|||+.+++|.+++..                                                        
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 5678999999999999988743                                                        


Q ss_pred             ------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----cccCCCCccc
Q 014986          237 ------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFW  306 (415)
Q Consensus       237 ------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y  306 (415)
                            ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......    .....++..|
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence                  157888899999999999999999999999999999999999999999999998653322    1223456789


Q ss_pred             cccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHH-HHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCC
Q 014986          307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL-FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND  384 (415)
Q Consensus       307 ~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  384 (415)
                      +|||++.+.  .++.++|||||||++|+|++ |..||......+.+ ..+..+.....+...+.++.+++.+||+.+|++
T Consensus       242 ~aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         242 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cCcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            999998654  38899999999999999997 99999764433322 233333444456678899999999999999999


Q ss_pred             CCCHHHHHcChhhHhhh
Q 014986          385 RPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       385 Rps~~eil~hp~f~~~~  401 (415)
                      ||++.++++|  +++++
T Consensus       320 RPs~~ell~~--l~~~~  334 (337)
T cd05054         320 RPTFSELVEI--LGDLL  334 (337)
T ss_pred             CcCHHHHHHH--HHHHH
Confidence            9999999986  55444

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9e-41  Score=314.66  Aligned_cols=246  Identities=26%  Similarity=0.444  Sum_probs=206.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CC---CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~---~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+|++.+.||+|+||.||+|.+ .+   +..+|+|.+....    .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            4788999999999999999987 23   3378998875321    12335678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .|+||||+++++|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999998754  4789999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc-----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          296 DV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       296 ~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ..     ....++..|+|||.+.+.  .++.++|+|||||++|++++ |..||......+....+......+.+..++..
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA  237 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHH
Confidence            21     111235679999998653  37889999999999999886 99999877666666666666555666778999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +.+++.+||+.+|.+||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         238 LHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHcccCchhCCCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.6e-41  Score=353.45  Aligned_cols=250  Identities=23%  Similarity=0.297  Sum_probs=202.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.++||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            5799999999999999999998 6799999999864221  223345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          221 FLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                      ||||++||+|.+++...            .++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999999988531            244566788999999999999999999999999999999999999999999


Q ss_pred             ccccccCC--------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH
Q 014986          289 AKATKLND--------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM  348 (415)
Q Consensus       289 a~~~~~~~--------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~  348 (415)
                      ++......                    .....||+.|+|||++.+..  ++.++|||||||++|+|++|..||......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            97652110                    11245999999999986543  789999999999999999999999775443


Q ss_pred             HHHHHHhcCCCCC--CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcCh
Q 014986          349 AALFKIGRGSPPP--IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP  395 (415)
Q Consensus       349 ~~~~~i~~~~~~~--~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp  395 (415)
                      ..........+..  ....++..+.+++.+||..||++|++..+.+.+.
T Consensus       238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~  286 (932)
T PRK13184        238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD  286 (932)
T ss_pred             hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            3322211111111  1236788999999999999999998877766554

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-40  Score=319.97  Aligned_cols=259  Identities=27%  Similarity=0.485  Sum_probs=214.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEE
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  207 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~--------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~  207 (415)
                      +.....+|++.+.||+|+||.||+|+.        .++..+|+|.+...    ........+.+|+.+++.+ +||||++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchh
Confidence            344567899999999999999999963        23457899987531    1233456788999999999 8999999


Q ss_pred             eeeeeecCCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       208 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++.+.....+|+||||+.+|+|.+++...                 .++...+..++.||+.||.|||++||+||||||
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp  165 (304)
T cd05101          86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA  165 (304)
T ss_pred             eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            999999999999999999999999988642                 366778899999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999997654322    1122356789999998553  37889999999999999998 88999887


Q ss_pred             cHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          346 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       346 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ...+....+........+..++..+.+|+.+||..+|.+|||+.++++.  +++++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~--l~~~~~~  299 (304)
T cd05101         244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED--LDRILTL  299 (304)
T ss_pred             CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH--HHHHHHh
Confidence            7766666666655555677889999999999999999999999999875  5666553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-40  Score=316.17  Aligned_cols=244  Identities=31%  Similarity=0.479  Sum_probs=197.8

Q ss_pred             cccccccccCCcEEEEEEE----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--CC
Q 014986          144 WQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ES  216 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  216 (415)
                      |++.+.||+|+||+||++.    . .++..||+|.+.....    ......+.+|+.+|+.++||||+++++++..  ..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            4889999999999998764    2 5688999998864211    2234567789999999999999999998765  34


Q ss_pred             EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          217 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      .+++||||+.+++|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            68999999999999999988889999999999999999999999999999999999999999999999999987654322


Q ss_pred             c-----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH---------------HHHHHHhc
Q 014986          297 V-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---------------AALFKIGR  356 (415)
Q Consensus       297 ~-----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---------------~~~~~i~~  356 (415)
                      .     ....++..|+|||.+...  .++.++||||||+++|+|++|..||......               .....+..
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            1     122356679999998543  3788999999999999999999998543210               01111112


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       357 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ....+.+..++..+.+++.+||+.+|.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2233446678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-40  Score=324.53  Aligned_cols=258  Identities=27%  Similarity=0.481  Sum_probs=212.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEE
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  207 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~  207 (415)
                      +.....+|++++.||+|+||.||+|.+.        .+..||+|.+...    ........+.+|+.+++++ +|+||++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIIN   82 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            3334557999999999999999999752        1236899977531    1223456788999999999 7999999


Q ss_pred             eeeeeecCCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       208 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++.+...+.++++|||+.+|+|.+++.+.                 .++...+..++.||+.||.|||++||+||||||
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            999999999999999999999999988642                 266778889999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    .....++..|+|||++.+..  ++.++||||||+++|+|++ |..||...
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC--cCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999987654322    11222456799999985543  7889999999999999998 89999887


Q ss_pred             cHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          346 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       346 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ...+....+........+..++..+.+|+.+||+.+|.+||++.+++++  |+.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~--l~~~~~  295 (334)
T cd05100         241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED--LDRVLT  295 (334)
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHHhh
Confidence            7766666666666666677889999999999999999999999999986  566653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-40  Score=311.63  Aligned_cols=245  Identities=24%  Similarity=0.426  Sum_probs=207.4

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+.....      ....+.+|+++++.++||||+++++++......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            36788899999999999999887788999998763221      123577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc-
Q 014986          222 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-  298 (415)
                      |||+.+++|.+++...  .+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999988653  4889999999999999999999999999999999999999999999999998755433221 


Q ss_pred             --cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          299 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       299 --~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                        ...++..|+|||.+.+.  .++.++||||||+++|+|++ |..||...........+..+.....+...+..+.+|+.
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence              22345689999998643  37889999999999999998 99999877666666666555444456678999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcC
Q 014986          376 QCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~h  394 (415)
                      +||..+|++|||+.+++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.2e-41  Score=328.48  Aligned_cols=263  Identities=25%  Similarity=0.466  Sum_probs=211.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee----cC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----DE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~  215 (415)
                      ..+|++.+.||+|+||.||+|++ .+++.||+|++......   ......+.+|+.+|+.++||||+++++++.    ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV---PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc---ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            36789999999999999999998 68999999988743211   123456778999999999999999998875    34


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            57899999996 588888754 4589999999999999999999999999999999999999999999999999876533


Q ss_pred             CCc------ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-----------
Q 014986          295 NDV------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-----------  357 (415)
Q Consensus       295 ~~~------~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------  357 (415)
                      ...      ....++..|+|||.+... ..++.++|||||||++|+|++|+.||...+....+..+...           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            221      234688999999998543 23788999999999999999999999776543322221110           


Q ss_pred             --------------CCCCC-----CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCC
Q 014986          358 --------------SPPPI-----PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSA  408 (415)
Q Consensus       358 --------------~~~~~-----~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~  408 (415)
                                    .....     ....+.++.+||++||+.+|.+||++.+++.||||++.....+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~  308 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT  308 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence                          00111     1346889999999999999999999999999999998877665443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-40  Score=317.15  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=207.9

Q ss_pred             ecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++|++.+.||+|+||.||+|.+.      ++..+|+|.+....    .......+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            357889999999999999999863      57899999886321    12334668899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY-----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  271 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~-----------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~  271 (415)
                      +..+++||||+.+|+|.+++...                       .+++..+..++.||+.||.|||++|++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            99999999999999999988632                       3677888999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCcc
Q 014986          272 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  346 (415)
Q Consensus       272 NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~  346 (415)
                      |||++.++.++|+|||++.......    ......+..|+|||.+.+.  .++.++|||||||++|+|++ |..||.+..
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999987543221    1122346679999998544  38899999999999999997 888998777


Q ss_pred             HHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       347 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+....+..+...+.+..++..+.+||.+||+.+|.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            66666666666666667788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.8e-41  Score=319.72  Aligned_cols=254  Identities=29%  Similarity=0.532  Sum_probs=205.9

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  216 (415)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|.+.......   .....+.+|+.+++.++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc---CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            4467899999999999999999998 678999999987533211   12245678999999999999999999887654 


Q ss_pred             ---------EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          217 ---------KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       217 ---------~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                               .+|+||||+.+ +|..++..  ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                     79999999987 67776654  3689999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCc---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--
Q 014986          286 FGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--  360 (415)
Q Consensus       286 FGla~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--  360 (415)
                      ||++........   ....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+..+.+..+......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999876543321   223457789999988543 23678999999999999999999999876655544333221100  


Q ss_pred             ---------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          361 ---------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       361 ---------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                                 .....++..+.+||.+||+.||.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                       0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-40  Score=311.42  Aligned_cols=245  Identities=27%  Similarity=0.489  Sum_probs=208.0

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..++|++.+.||+|+||.||++.+..+..+|+|.+...      ......+.+|+.+++.++|+||+++++.+.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            35689999999999999999998877788999987631      2234578899999999999999999999887 7789


Q ss_pred             EEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      ++|||+.+++|.+++...   .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999998653   47788889999999999999999999999999999999999999999999987554322


Q ss_pred             cc---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 VK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      ..   ...++..|+|||++...  .++.++|+|||||++|+|++ |..||...........+......+.+...+..+.+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  234 (260)
T ss_pred             cccccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence            11   22355679999998543  37889999999999999998 99999887766666666666665666788999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ++.+||+.+|++||++.+++.
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.2e-40  Score=311.88  Aligned_cols=246  Identities=26%  Similarity=0.448  Sum_probs=206.6

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCc---EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~---~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+|+..+.||+|+||.||+|++ .++.   .+|+|.+....    .......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            4678889999999999999987 3343   78999876421    12234568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .|+||||+.+++|.+++..  ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999998865  35889999999999999999999999999999999999999999999999998755432


Q ss_pred             Ccc-----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          296 DVK-----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       296 ~~~-----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ...     ....+..|+|||++...  .++.++|||||||++|+|++ |..||......+....+......+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  238 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA  238 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence            211     11234579999998554  37889999999999999997 99999877766666666666555666778999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +.+|+.+||+.+|++||++.+|++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=354.11  Aligned_cols=245  Identities=30%  Similarity=0.524  Sum_probs=215.4

Q ss_pred             ccccccccccCCcEEEEEEEc--CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS--DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~--~~~~----~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ..++.+.||+|.||.||.|..  ..+.    .||+|.+..    ....+....|.+|..+|+.++|||||+++|++-+..
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            456778899999999999985  3333    488888764    234556788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                      ..+|++|||.||+|..++++.        .++......++.||+.|+.||+++++|||||...|+|++....|||+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999999865        388889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcccCCC----CccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCC
Q 014986          289 AKATKLNDVKSCRG----TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP  363 (415)
Q Consensus       289 a~~~~~~~~~~~~g----t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  363 (415)
                      |+.+...+.....+    ...|||||.+...  .++.++|||||||++||+++ |..||.+....+.+.....+.+.+.|
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~--iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDG--IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhc--ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            99655444433322    3679999999653  38999999999999999998 99999999999988877777788889


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..++..+.+++.+||+.+|++||++..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            999999999999999999999999999987

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.3e-41  Score=353.84  Aligned_cols=255  Identities=36%  Similarity=0.607  Sum_probs=208.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee--
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--  213 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--  213 (415)
                      +.+...+|+.+++||+||||.||++++ -+|+.||||+|....    .......+.+|+.+|.+++|||||++|..+.  
T Consensus       474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs  549 (1351)
T KOG1035|consen  474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVES  549 (1351)
T ss_pred             hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence            356788999999999999999999999 799999999998632    3455677889999999999999999983210  


Q ss_pred             ----------------------------------------------------------------------------c---
Q 014986          214 ----------------------------------------------------------------------------D---  214 (415)
Q Consensus       214 ----------------------------------------------------------------------------~---  214 (415)
                                                                                                  +   
T Consensus       550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~  629 (1351)
T KOG1035|consen  550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN  629 (1351)
T ss_pred             CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence                                                                                        0   


Q ss_pred             ------------------------------C--------CEEEEEEeccCCCCHHHHHhhcCCC--HHHHHHHHHHHHHH
Q 014986          215 ------------------------------E--------SKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLG  254 (415)
Q Consensus       215 ------------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~l~--~~~~~~i~~qil~a  254 (415)
                                                    +        ..+||-||||+.-+|.+++.++.+.  ...++++++||++|
T Consensus       630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEG  709 (1351)
T ss_pred             cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHH
Confidence                                          0        1379999999998888888888775  77899999999999


Q ss_pred             HHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--------------------cCCcccCCCCccccccccccc
Q 014986          255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCRGTAFWMAPEVINN  314 (415)
Q Consensus       255 L~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--------------------~~~~~~~~gt~~y~aPE~l~~  314 (415)
                      |+|+|+.|||||||||.||+++.++.|||+|||+|+...                    ..+.++..||..|+|||++.+
T Consensus       710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            999999999999999999999999999999999998621                    012345679999999999965


Q ss_pred             ccc-CCCchhhHHHHHHHHHHHHcCCCCCC-CccHHHHHHHHhcCCCCCC---CCcccHHHHHHHHHhhhhCCCCCCCHH
Q 014986          315 KNK-GYGLPADIWSLGCTVLEMLTSQIPYA-PMECMAALFKIGRGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAA  389 (415)
Q Consensus       315 ~~~-~~~~~~DvwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~Li~~~L~~dP~~Rps~~  389 (415)
                      ... .|+.|+||||||+|++||+.   ||. .++....+..+..+..+..   ...--+.-..+|+.||+.||.+||||.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence            542 58999999999999999984   464 4556666666655444322   222234566899999999999999999


Q ss_pred             HHHcChhhH
Q 014986          390 QLLDHPFVK  398 (415)
Q Consensus       390 eil~hp~f~  398 (415)
                      |+|++.||.
T Consensus       867 eLL~s~llp  875 (1351)
T KOG1035|consen  867 ELLNSELLP  875 (1351)
T ss_pred             HHhhccCCC
Confidence            999999987

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=313.05  Aligned_cols=240  Identities=29%  Similarity=0.544  Sum_probs=198.0

Q ss_pred             cccccCCcEEEEEEEc-CCCc--EEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~--~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      ++||+|+||.||+|++ .++.  .+++|.+...    ........+.+|+.++..+ +||||+++++++...+.+|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3699999999999998 4554  4677776521    1223345678999999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEee
Q 014986          224 LVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       224 ~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                      |+.+|+|.+++...                 .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            99999999998643                 3688899999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCC
Q 014986          287 GLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD  364 (415)
Q Consensus       287 Gla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  364 (415)
                      |++....... ......+..|+|||++...  .++.++|||||||++|+|++ |..||......+....+........+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            9986332111 1112245679999998543  37889999999999999997 999998776666666665555555666


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .++.++.+|+.+||..||.+|||+.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            78899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=332.03  Aligned_cols=244  Identities=29%  Similarity=0.407  Sum_probs=208.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc-CCCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~  216 (415)
                      .+.+.|.....+|.|+|+.|-.+.+ .+++.+++|++....         ....+|+.++.. -+||||+++++.+.+..
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc---------cccccccchhhhhcCCCcceeecceecCCc
Confidence            3567889999999999999999998 889999999997531         122356655544 47999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-cCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV-DANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl-~~~~~vkl~DFGla~~~~~~  295 (415)
                      +.|+|||++.|+.|.+.+.........+..|+++|+.|+.|||++|++||||||+|||+ +..|+++|+|||.++.....
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999999999988887766554447888999999999999999999999999999999 68899999999999876655


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH-HHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                       ....+-|..|.|||++.  ...|+.++||||||++||+||+|+.||...... +...++..+   ++...+|..+++||
T Consensus       470 -~~tp~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl  543 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLL  543 (612)
T ss_pred             -hcccchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHH
Confidence             44556899999999996  445999999999999999999999999876555 444444433   33488999999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .+||++||.+|+++.+++.||||
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-40  Score=316.51  Aligned_cols=247  Identities=27%  Similarity=0.398  Sum_probs=203.2

Q ss_pred             ecccccccccccCCcEEEEEEEcC-----------------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE  203 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp  203 (415)
                      .++|++.+.||+|+||.||+|.+.                 .+..||+|.+....    .......+.+|+++++.++||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCCC
Confidence            357899999999999999998762                 23468999876422    124456788999999999999


Q ss_pred             cEEEeeeeeecCCEEEEEEeccCCCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014986          204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  271 (415)
Q Consensus       204 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~  271 (415)
                      ||+++++++..+...++||||+.+++|..++...            .+++..++.++.|++.||+|||++||+||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            9999999999999999999999999999988654            3889999999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc--CCCCCCCc
Q 014986          272 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPM  345 (415)
Q Consensus       272 NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~--g~~pf~~~  345 (415)
                      ||+++.++.++|+|||+++......    .....++..|+|||.+.+.  .++.++|||||||++|+|++  +..||...
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999987543332    1223467789999998653  37899999999999999998  78888776


Q ss_pred             cHHHHHHHHhcC-------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          346 ECMAALFKIGRG-------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       346 ~~~~~~~~i~~~-------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ...+.+......       ...+.+..++.++.+|+.+||+.||.+|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            555544444322       112234567889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=316.13  Aligned_cols=249  Identities=32%  Similarity=0.551  Sum_probs=207.4

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |++.+.||.|++|.||+|.+ .+++.+++|.+......   ......+.+|+.+++.++|+||+++++.+.+...+++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            56778899999999999998 68999999988643221   123456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          223 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       223 E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      ||+.+ +|..++...  .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99986 888877654  78999999999999999999999999999999999999999999999999987654432  22


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-----------------
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----------------  361 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------------  361 (415)
                      ...++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+..+...++......+                 
T Consensus       157 ~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         157 HYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             CccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            34578889999998653 247889999999999999999999998877665554443211110                 


Q ss_pred             ------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          362 ------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       362 ------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                  ....++.++.+||.+||..||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=302.49  Aligned_cols=253  Identities=28%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ...-.++|++.+.||+|||+-||++.. .++..||+|++....     .+.++..++|+...++++||||++++++...+
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            444567899999999999999999998 889999999998632     45567788999999999999999999876443


Q ss_pred             C-----EEEEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEE
Q 014986          216 S-----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       216 ~-----~~~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~~~vkl  283 (415)
                      .     ..||++.|...|+|.+.++..     .+++.++..|+.+|++||++||+..  ++||||||.|||+...+.++|
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence            3     489999999999999987642     5899999999999999999999998  999999999999999999999


Q ss_pred             EeeccccccccC-----------CcccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH--
Q 014986          284 ADFGLAKATKLN-----------DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA--  349 (415)
Q Consensus       284 ~DFGla~~~~~~-----------~~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~--  349 (415)
                      .|||.++.....           +......|..|+|||+++-+ ....++++|||||||+||+|+.|..||.......  
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            999988743211           12233478899999998633 2336889999999999999999999996421100  


Q ss_pred             HHHHHhcCC-CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          350 ALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       350 ~~~~i~~~~-~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ....+..+. .-|-...+|+.+.+||+.||++||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000111100 011123489999999999999999999999999864

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-40  Score=318.14  Aligned_cols=251  Identities=28%  Similarity=0.486  Sum_probs=206.5

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      .....++|.+.+.||+|+||.||+|.+      .++..+|+|.+.....    ....+.+.+|+.+++.+ +|+||++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEE
Confidence            344456899999999999999999974      2456899998764221    22346788999999999 799999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEee
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                      +.+...+.+|+||||+.+|+|.+++...   .+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+||
T Consensus       106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence            9999999999999999999999998753   2899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHH-hcCCCC
Q 014986          287 GLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI-GRGSPP  360 (415)
Q Consensus       287 Gla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i-~~~~~~  360 (415)
                      |+++.......    ....++..|+|||.+.+..  ++.++|||||||++|+|++ |..||..........+. ..+...
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM  263 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence            99875543221    1233567899999986544  7889999999999999998 99999776544433333 333334


Q ss_pred             CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       361 ~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+...+..+.+|+.+||..+|++|||+.+++.
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            455678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.2e-40  Score=317.81  Aligned_cols=255  Identities=33%  Similarity=0.586  Sum_probs=212.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|...+.||+|+||+||+|++ .+++.|++|++......  .......+.+|+.+++.++|+|++++++.+.+....|+
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ--TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3466778899999999999998 68899999998743222  22344567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      ||||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....  ..
T Consensus        99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--~~  175 (313)
T cd06633          99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--AN  175 (313)
T ss_pred             EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--CC
Confidence            9999965 77776654  3588999999999999999999999999999999999999999999999999865432  23


Q ss_pred             cCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC-CCcccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~Li~~  376 (415)
                      ...|+..|+|||++... ...++.++|||||||++|+|++|..||..........++.....+.. ...++..+++|+.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY  255 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            45688999999998431 23378899999999999999999999988776666666655443332 34577889999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ||+.+|.+||++.+++.||||+...
T Consensus       256 ~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         256 CLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HccCChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=308.54  Aligned_cols=243  Identities=35%  Similarity=0.561  Sum_probs=210.8

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||+|+||.||++.+ .+++.+|+|.+.....  ........+.+|+.+++.++|+||+++++.+..+..+|+||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            79999999999998 5789999998875322  22234567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccCCCCcc
Q 014986          229 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF  305 (415)
Q Consensus       229 sL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~gt~~  305 (415)
                      +|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......  ......++..
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence            999998765 6899999999999999999999999999999999999999999999999998765543  2344568899


Q ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCC
Q 014986          306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR  385 (415)
Q Consensus       306 y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  385 (415)
                      |++||.+.+..  .+.++|+||||+++|+|++|..||...+.......+.. ....++..++..+.++|++||..||++|
T Consensus       159 ~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         159 YLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             ccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            99999986543  78899999999999999999999987766555555544 4455777889999999999999999999


Q ss_pred             CCH---HHHHcChhh
Q 014986          386 PTA---AQLLDHPFV  397 (415)
Q Consensus       386 ps~---~eil~hp~f  397 (415)
                      |++   .++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.8e-41  Score=326.24  Aligned_cols=258  Identities=27%  Similarity=0.460  Sum_probs=207.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  215 (415)
                      .+..+|.+.+.||+|+||.||+|++ .+++.||+|++.....   .......+.+|+.+++.++|+||+++++++...  
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            3456889999999999999999998 6799999998864221   112234577899999999999999999988654  


Q ss_pred             ----CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ----~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                          ..+|+||||+.. +|..+. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          89 GDEFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             CCCCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence                356999999975 676654 34689999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-----------
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------  360 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  360 (415)
                      ... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+......           
T Consensus       167 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA-EMTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC-CCCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            533 23344578899999998542 23788999999999999999999999876544443332221100           


Q ss_pred             -----------C--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          361 -----------P--------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       361 -----------~--------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                                 .        .....+..+.+||.+||+.||.+||++.+++.||||+.+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                       0        012467789999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=307.23  Aligned_cols=240  Identities=27%  Similarity=0.503  Sum_probs=203.6

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCC
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  227 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~  227 (415)
                      ++||.|+||.||++.+..++.||+|.+.....    ......+.+|+.+++.++|+||+++++++.+....++||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            46999999999999986699999998864322    13456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc----cCC
Q 014986          228 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCR  301 (415)
Q Consensus       228 gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~----~~~  301 (415)
                      ++|.+++..  ..++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.........    ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999998865  35788899999999999999999999999999999999999999999999998755422211    122


Q ss_pred             CCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhh
Q 014986          302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  380 (415)
Q Consensus       302 gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~  380 (415)
                      ++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||...........+......+.+..++..+.+|+.+||..
T Consensus       157 ~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         157 IPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             ceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence            35679999998554  37889999999999999998 8999987766665556655555556778899999999999999


Q ss_pred             CCCCCCCHHHHHc
Q 014986          381 NPNDRPTAAQLLD  393 (415)
Q Consensus       381 dP~~Rps~~eil~  393 (415)
                      +|++|||+.++++
T Consensus       235 ~p~~Rp~~~ell~  247 (251)
T cd05041         235 DPENRPSFSEIYN  247 (251)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999976

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-40  Score=308.35  Aligned_cols=244  Identities=30%  Similarity=0.541  Sum_probs=209.9

Q ss_pred             cccccccccCCcEEEEEEEc-CCC----cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~----~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +++.+.||+|+||.||++.+ ..+    ..+|+|.+.....    ......+.+|+.++..++|+||+++++.+.+.+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            35678899999999999998 334    8899998864221    22456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          219 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~---l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +++|||+.+++|.+++....   +++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999999987543   899999999999999999999999999999999999999999999999998765543


Q ss_pred             Ccc---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHH
Q 014986          296 DVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  371 (415)
Q Consensus       296 ~~~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  371 (415)
                      ...   ...+++.|+|||.+..  ..++.++|+||||+++|+|++ |..||...........+........+..++.++.
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIY  234 (258)
T ss_pred             cccccccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence            221   1236788999999844  347889999999999999998 8999988777777777777777777778999999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHc
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +++.+||..||++|||+.++++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2e-40  Score=312.41  Aligned_cols=246  Identities=26%  Similarity=0.459  Sum_probs=207.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCC---cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~---~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+|++.+.||+|+||.||+|.+ .++   ..||+|.+...    ........+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            4688899999999999999987 333   36999987642    123345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +++||||+.+++|.+++..  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999998865  35889999999999999999999999999999999999999999999999998754322


Q ss_pred             Ccc----c-C--CCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCccc
Q 014986          296 DVK----S-C--RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       296 ~~~----~-~--~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      ...    . .  ..+..|+|||.+.+.  .++.++|||||||++|||++ |..||......+....+......+.+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  237 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCP  237 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCC
Confidence            211    1 1  124579999998543  37889999999999999886 999998877766666666655556667889


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+.+++.+||..+|.+||++.+|+.
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7e-40  Score=316.78  Aligned_cols=256  Identities=34%  Similarity=0.581  Sum_probs=214.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|...+.||+|+||.||+|.+ .++..+|+|++......  .......+.+|+.+++.++|+|++++++++.++...|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            4588899999999999999998 67899999988743222  22344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          221 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      ||||+.+ +|.+++.  ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......  .
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--~  179 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--N  179 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--c
Confidence            9999975 7777664  346899999999999999999999999999999999999999999999999998654332  2


Q ss_pred             cCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-CCCcccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~  376 (415)
                      ...++..|+|||.+... ...++.++|||||||++|+|++|..||...........+....... ....++..+++|+.+
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  259 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS  259 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHH
Confidence            34588999999997431 2337889999999999999999999998877666666665544333 334678899999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ||+.+|.+||++.++++|+|+.....
T Consensus       260 ~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         260 CLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HccCCcccCcCHHHHHhChhhhccCc
Confidence            99999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-40  Score=314.40  Aligned_cols=247  Identities=27%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             ecccccccccccCCcEEEEEEEcCC-----CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  214 (415)
                      .++|++.+.||+|+||.||+|.+..     +..|++|.+...    ........+.+|+.+++.++|+||+++++++.. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4578899999999999999999844     788999987531    223345678899999999999999999998655 


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~---------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                      ....+++++|+.+++|.+++..         ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            5678999999999999998865         3478999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCC
Q 014986          286 FGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP  360 (415)
Q Consensus       286 FGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  360 (415)
                      ||+++.......    ....++..|+|||++.+.  .++.++|||||||++|++++ |+.||......+....+......
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  238 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL  238 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence            999976533321    123456779999998543  37899999999999999998 99999877666655555555555


Q ss_pred             CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       361 ~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+..++..+.+++.+||..||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            556678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-40  Score=324.32  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=204.4

Q ss_pred             ecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  213 (415)
                      .++|++.+.||+|+||.||+|++      .+++.||||.+....    .......+.+|+.++..+ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            45799999999999999999973      457899999986422    122345678999999999 6899999999775


Q ss_pred             c-CCEEEEEEeccCCCCHHHHHhhc-------------------------------------------------------
Q 014986          214 D-ESKLYIFLELVTKGSLLNLYQRY-------------------------------------------------------  237 (415)
Q Consensus       214 ~-~~~~~lV~E~~~~gsL~~~l~~~-------------------------------------------------------  237 (415)
                      . +..+++||||+.+|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 45689999999999999987532                                                       


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc----ccC
Q 014986          238 -------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSC  300 (415)
Q Consensus       238 -------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~  300 (415)
                                   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........    ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                         256777888999999999999999999999999999999999999999999876432211    122


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHH-HHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      .++..|+|||.+.+.  .++.++||||||+++|+|++ |..||...... .....+..+.....+..++..+.+++.+||
T Consensus       242 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         242 RLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence            356779999998554  37899999999999999996 99999765432 223333444445566678899999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHhhhh
Q 014986          379 QVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.||.+|||+.+|++|  ++.++.
T Consensus       320 ~~~p~~Rps~~eil~~--l~~~~~  341 (343)
T cd05103         320 HGEPSQRPTFSELVEH--LGNLLQ  341 (343)
T ss_pred             cCChhhCcCHHHHHHH--HHHHHh
Confidence            9999999999999987  666553

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=317.07  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             cccccccccccCCcEEEEEEEcCC---------------CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDD---------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV  206 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv  206 (415)
                      .+|++.+.||+|+||.||++++..               ...||+|.+....    .......+.+|+++++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            578999999999999999987632               2358999886321    123345788999999999999999


Q ss_pred             EeeeeeecCCEEEEEEeccCCCCHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014986          207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  273 (415)
Q Consensus       207 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NI  273 (415)
                      ++++++...+..++||||+.+++|.+++...             .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999999999999999999999999988543             257788899999999999999999999999999999


Q ss_pred             EEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc--CCCCCCCccH
Q 014986          274 LVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPMEC  347 (415)
Q Consensus       274 Ll~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~--g~~pf~~~~~  347 (415)
                      +++.++.+||+|||++........    ....++..|+|||++....  ++.++|||||||++|+|++  |..||.....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC--cCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999875433221    1223467899999986543  7899999999999999987  6788877654


Q ss_pred             HHHHHHHhc-------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          348 MAALFKIGR-------GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       348 ~~~~~~i~~-------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .+.+..+..       ......+..++..+.+|+.+||..||++|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            444333221       1122334567899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-40  Score=316.13  Aligned_cols=259  Identities=30%  Similarity=0.481  Sum_probs=210.5

Q ss_pred             ccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      +|++.+.||+|+||.||++++    .+++.||+|.+..... .........+.+|+.++..+ +|+||+++++.+..+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            377889999999999999875    3678999998874221 12223445678999999999 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+||||+.+|+|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999998765 468999999999999999999999999999999999999999999999999987643332


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhcCCCCCCCCcccHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                         .....|+..|+|||.+.+.....+.++|+||||+++|+|++|..||....   ....+.+.......+.+..++..+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA  239 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence               12245889999999986544346789999999999999999999995322   111222222223345677789999


Q ss_pred             HHHHHHhhhhCCCCCCC---HHHHHcChhhHhhhh
Q 014986          371 QDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLLA  402 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps---~~eil~hp~f~~~~~  402 (415)
                      .+||.+||+.||++|||   +.++|+||||+.+..
T Consensus       240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            99999999999999998   567799999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.9e-40  Score=327.86  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=206.6

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~  209 (415)
                      +..-.++|.+++.||+|+||.||+|++      .+++.||+|++.....    ......+.+|+.+|..+. ||||++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            444456788999999999999999985      3457899999964221    222346789999999997 99999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc----------------------------------------------------
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY----------------------------------------------------  237 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~----------------------------------------------------  237 (415)
                      +++...+.+++||||+.+|+|.+++.+.                                                    
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            9999999999999999999999988542                                                    


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          238 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       238 -----------------------------------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                                                                     .+++..+..++.||+.||.|||+.+|+||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                           245667788999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    .....++..|+|||.+...  .++.++||||||+++|||++ |..||...
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999997543221    1223467889999998553  37889999999999999998 89999765


Q ss_pred             cHHHHHHH-HhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          346 ECMAALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       346 ~~~~~~~~-i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ...+.... +..+.....+..++.++.+|+.+||..+|.+||++.+|++.
T Consensus       346 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            54444333 34444555677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-41  Score=326.45  Aligned_cols=250  Identities=28%  Similarity=0.460  Sum_probs=198.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +...++.|...++||+|+||.||+|...++..||||++.......     ..+|.+|+.+|.+++|||+|+++|+|.+.+
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~  144 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEGG  144 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence            445677899999999999999999999888999999776422211     345999999999999999999999999988


Q ss_pred             -EEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          217 -KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       217 -~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~---IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                       ..+||+||+..|+|.+++...   .++|....+|+.+++.||+|||...   |||||||++|||+|.+...||+|||+|
T Consensus       145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa  224 (361)
T KOG1187|consen  145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA  224 (361)
T ss_pred             ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence             599999999999999988653   6799999999999999999999864   999999999999999999999999999


Q ss_pred             ccccc-CCcccC--CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc------HHHH-HHHHhcCC-
Q 014986          290 KATKL-NDVKSC--RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME------CMAA-LFKIGRGS-  358 (415)
Q Consensus       290 ~~~~~-~~~~~~--~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~------~~~~-~~~i~~~~-  358 (415)
                      +.... ......  .||.+|+|||.+...  ..+.++||||||++|+||++|+.+.+...      ..+- ...+..+. 
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g--~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~  302 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYASTG--KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL  302 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhccC--CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence            76554 332222  799999999998653  37899999999999999999998876421      1111 01111111 


Q ss_pred             ----CCCCC-Cccc--H---HHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          359 ----PPPIP-DSLS--K---DAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       359 ----~~~~~-~~~s--~---~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                          .+.+. ...+  .   .+..+..+|++.+|+.||++.++++
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                11111 1222  2   3556778999999999999999854

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.8e-40  Score=308.14  Aligned_cols=239  Identities=32%  Similarity=0.547  Sum_probs=199.6

Q ss_pred             cccccCCcEEEEEEEcC--CC--cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGISD--DG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~--~~--~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      ++||+|+||.||+|.+.  ++  ..||+|.+......    ...+.+.+|+.+++.++|+||+++++.+.+ ..+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            46899999999999873  33  36899988643221    456788899999999999999999999988 89999999


Q ss_pred             ccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----
Q 014986          224 LVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  296 (415)
Q Consensus       224 ~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----  296 (415)
                      |+.+++|.+++...   .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++......    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999999988764   48899999999999999999999999999999999999999999999999987654321    


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhc-CCCCCCCCcccHHHHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~L  373 (415)
                       .....++..|+|||.+....  ++.++|||||||++|+|++ |..||......+....+.. ......+..++..+.++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV  233 (257)
T ss_pred             cccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence             11234678899999985543  7889999999999999998 9999977665555544442 23334556788999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHc
Q 014986          374 IKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~  393 (415)
                      +.+||..+|++||++.++++
T Consensus       234 i~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         234 MLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-40  Score=311.26  Aligned_cols=247  Identities=27%  Similarity=0.468  Sum_probs=207.9

Q ss_pred             ecccccccccccCCcEEEEEEEcCC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ..+|.+.++||+|+||.||+|.+.+    ...+|+|......    .....+.+.+|+.+++.++|+||+++++++.+ .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            3468889999999999999998632    3468889775322    13344678899999999999999999998875 4


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..|+||||+.+|+|.+++...  .+++..+..++.|++.||+|||+.|++|+||||+|||++.++.++|+|||+++....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            578999999999999998754  489999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcc---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          295 NDVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       295 ~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ....   ...++..|+|||.+...  .++.++||||||+++|+|++ |..||......+...++..+...+.+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             ccceecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence            3221   12244679999988543  37889999999999999986 999998887777777777777777788899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+||.+||..+|.+|||+.+++..
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.8e-40  Score=320.28  Aligned_cols=261  Identities=28%  Similarity=0.430  Sum_probs=210.9

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-C
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-E  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  215 (415)
                      ..+.++|++.+.||+|+||.||+|.+ .+++.||+|++......   ....+.+.+|+.+++.++||||+++++++.. .
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST---PVLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            34567899999999999999999998 68999999988642211   1234567789999999999999999998865 5


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      ...|+||||+. ++|..++....+++..+..++.||+.||.|||++||+||||+|.|||++.++.++|+|||++......
T Consensus        83 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          83 EDIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             CcEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            67899999985 58999888888999999999999999999999999999999999999999999999999998765432


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------------------
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-------------------  356 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------  356 (415)
                       .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+..                   
T Consensus       162 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         162 -MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             -cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence             2334578899999987542 3478899999999999999999999976543221111100                   


Q ss_pred             --------CCCCC---CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          357 --------GSPPP---IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       357 --------~~~~~---~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                              ....+   ....++..+.++|.+||+.+|++||++.+++.||||+......
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence                    00001   1134678999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.2e-40  Score=315.78  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=199.1

Q ss_pred             cccccccccccCCcEEEEEEEcC-----------------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN  204 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn  204 (415)
                      ++|++.+.||+|+||.||++.+.                 +...+|+|.+...    ........+.+|+.+++.++|+|
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCC
Confidence            56899999999999999998532                 3457899987632    12334567889999999999999


Q ss_pred             EEEeeeeeecCCEEEEEEeccCCCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014986          205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  272 (415)
Q Consensus       205 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~N  272 (415)
                      |+++++++...+..++||||+.+|+|.+++...            .+++..+..++.||+.||+|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999999999999999999999999999988653            25667899999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEeeccccccccCCcc----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc--CCCCCCCcc
Q 014986          273 ILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPME  346 (415)
Q Consensus       273 ILl~~~~~vkl~DFGla~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~--g~~pf~~~~  346 (415)
                      ||++.++.++|+|||+++........    ...++..|++||...+.  .++.++|||||||++|+|++  |..||....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            99999999999999998765333211    12345789999987543  38899999999999999998  788997655


Q ss_pred             HHHHHHHHh-------cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          347 CMAALFKIG-------RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       347 ~~~~~~~i~-------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+......       .....+.+..++..+.+|+.+||+.||++||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            444333221       11122345667899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.6e-40  Score=315.44  Aligned_cols=261  Identities=31%  Similarity=0.542  Sum_probs=208.3

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      ..+.|++.+.||+|+||.||+|.+ .+++.||+|.+.....    ......+.+|+.++... .|+||+++++++.+...
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            356789999999999999999998 5699999999874322    12234455677666555 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +|+||||+.+ +|.+++..  ..+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9999999865 77776654  358899999999999999999997 5999999999999999999999999999875432


Q ss_pred             C-CcccCCCCccccccccccccc--cCCCchhhHHHHHHHHHHHHcCCCCCCCccH-HHHHHHHhcCCCCCCC--CcccH
Q 014986          295 N-DVKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIP--DSLSK  368 (415)
Q Consensus       295 ~-~~~~~~gt~~y~aPE~l~~~~--~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~--~~~s~  368 (415)
                      . ......++..|+|||.+.+..  ..++.++||||||+++|+|++|+.||..... .+.+.++........+  ..++.
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            2 223345788999999986442  3367899999999999999999999976432 2333344333332222  24788


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      ++.+|+.+||..||.+||++.+++.|+||+......+
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  284 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV  284 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence            9999999999999999999999999999998765543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.1e-40  Score=307.66  Aligned_cols=241  Identities=24%  Similarity=0.457  Sum_probs=198.1

Q ss_pred             cccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee-cCCEEEEEE
Q 014986          148 DLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DESKLYIFL  222 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~  222 (415)
                      +.||+|+||.||+|.+.    ....+|+|.+...    ........+.+|+.+++.++||||+++++.+. .+...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            46999999999999852    3457999987531    12234567789999999999999999999765 456689999


Q ss_pred             eccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----
Q 014986          223 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  296 (415)
Q Consensus       223 E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----  296 (415)
                      ||+.+|+|.+++.+.  .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999998653  46777788999999999999999999999999999999999999999999987543221    


Q ss_pred             --cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          297 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                        .....++..|+|||.+.+.  .++.++|||||||++|+|++ |.+||......+....+..+.....+..++..+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             cccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence              1233467789999998543  37899999999999999999 567787766666666666666666677789999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcC
Q 014986          374 IKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~h  394 (415)
                      +.+||..+|++||++.+++..
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5e-40  Score=312.50  Aligned_cols=247  Identities=28%  Similarity=0.494  Sum_probs=199.8

Q ss_pred             cccccccccccCCcEEEEEEEc-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC-
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  215 (415)
                      ..|++.+.||+|+||.||++..     .++..||+|.+....    .......+.+|+.+++.++|+||+++++++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   79 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            3578999999999999999973     468899999886422    233346788999999999999999999988775 


Q ss_pred             -CEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 -SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 -~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                       ...++||||+++++|.+++.+.  .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++..
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence             6789999999999999998653  4789999999999999999999999999999999999999999999999998765


Q ss_pred             ccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---------------HHHHHH
Q 014986          293 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---------------CMAALF  352 (415)
Q Consensus       293 ~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---------------~~~~~~  352 (415)
                      ....     .....++..|+|||.+.+.  .++.++|||||||++|+|++++.|+....               ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            4322     1234467789999998543  37889999999999999999876642210               011112


Q ss_pred             HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       353 ~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+..+...+.+..++..+.+|+.+||+.||++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            222333444566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.2e-40  Score=318.25  Aligned_cols=252  Identities=28%  Similarity=0.495  Sum_probs=200.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----  214 (415)
                      .++|++.++||+|+||.||+|++ .+++.+|+|++........   ....+.+|+.+++.++|+||+++++.+.+     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            57899999999999999999998 6789999999875332211   12345689999999999999999987643     


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          215 ---ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       215 ---~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                         ...+++||||+.+ +|...+..  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence               3457999999976 67766653  36999999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC-------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc
Q 014986          290 KATKLND-------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR  356 (415)
Q Consensus       290 ~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  356 (415)
                      .......             .....+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            7543221             1223468889999987543 3378899999999999999999999987665444333221


Q ss_pred             CCCC----------------------CC-------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          357 GSPP----------------------PI-------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       357 ~~~~----------------------~~-------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ....                      ..       ...++..+.+||.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            1000                      00       02345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.6e-40  Score=307.41  Aligned_cols=241  Identities=28%  Similarity=0.545  Sum_probs=203.8

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||+|+||.||++.. +++.||+|.+....       ....+.+|+.+++.++||||+++++.+..+ ..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            36799999999999999999864 67889999886311       234678899999999999999999998765 4799


Q ss_pred             EEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          221 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ||||+.+++|.+++...   .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-V  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-C
Confidence            99999999999998653   4788899999999999999999999999999999999999999999999998754322 2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....+..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......+....+..+.....+..++..+.+|+.+
T Consensus       155 ~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         155 DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence            223356779999998543  37889999999999999997 999998877666666666655555567789999999999


Q ss_pred             hhhhCCCCCCCHHHHHc
Q 014986          377 CVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~  393 (415)
                      ||+.+|++||++++++.
T Consensus       233 ~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         233 CWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.6e-40  Score=308.54  Aligned_cols=240  Identities=26%  Similarity=0.415  Sum_probs=191.7

Q ss_pred             ccccCCcEEEEEEEcC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          149 LLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      .||+|+||.||+|...   ....+|+|.+...    ........+.+|+.+++.++|+||+++++.+.+...+|+||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            5999999999999653   3456777766431    12333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          226 TKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       226 ~~gsL~~~l~~~~------l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      .+|+|.+++....      .++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999999886532      3567788999999999999999999999999999999999999999999986543221   


Q ss_pred             -cccCCCCcccccccccccc-----ccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCC-----CCCCC
Q 014986          297 -VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP-----PPIPD  364 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~-----~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-----~~~~~  364 (415)
                       .....++..|+|||++...     ...++.++|||||||++|+|++ |..||......+.+........     +.++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence             1223356789999997532     2346889999999999999998 8899987766555554433332     22344


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .++..+.+++..|| .||++|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            67888999999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.8e-40  Score=315.57  Aligned_cols=254  Identities=33%  Similarity=0.580  Sum_probs=211.7

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ..|...+.||+|+||.||+|++ .++..+|+|.+......  .......+.+|+.+++.++|+|++++++++......++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            4588889999999999999998 67899999988642221  22334567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      ||||+. |+|.+++..  ..+++..+..++.|++.||.|||+++++||||+|+|||++.++.++|+|||++......  .
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~  169 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--N  169 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--c
Confidence            999997 577776643  35889999999999999999999999999999999999999999999999998765432  2


Q ss_pred             cCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-CCCcccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~  376 (415)
                      ...++..|+|||.+... ...++.++|||||||++|+|++|..||...........+.....+. ....++..+.+||.+
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  249 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  249 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence            34588999999997532 2236789999999999999999999998776655555555544433 244688899999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ||..+|.+||++.++++|+|+...
T Consensus       250 cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         250 CLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HhhCCcccCCCHHHHhhCcccccc
Confidence            999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=313.62  Aligned_cols=249  Identities=32%  Similarity=0.519  Sum_probs=205.9

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |++.+.||+|+||.||+|+. .+++.||+|.+.....   .......+.+|+.+++.++|+||+++++.+.+...+++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            56778899999999999998 6799999999875331   1222355678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          223 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       223 E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      ||+.+ +|.+++.+.  .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......  ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            99985 899998765  79999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC------------------
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP------------------  360 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------  360 (415)
                      ...++..|+|||.+.+. ..++.++||||||+++|+|++|..||......+.+.++......                  
T Consensus       157 ~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         157 HEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             ccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            34467889999998644 24788999999999999999999999876655444433221100                  


Q ss_pred             ----------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          361 ----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       361 ----------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                .....++..+.++|.+||..||++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                      0012347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-39  Score=309.69  Aligned_cols=245  Identities=28%  Similarity=0.481  Sum_probs=196.5

Q ss_pred             cccccccccccCCcEEEEEEEc-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  214 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  214 (415)
                      .+|++.+.||+|+||.||++..     .++..||+|.+...     .......+.+|+.+++.++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            4688899999999999999873     46889999988642     23345678899999999999999999987643  


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ...+++||||+.+++|.+++...  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            45689999999999999998653  5889999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCcc-----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH----------------HHH
Q 014986          293 KLNDVK-----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----------------AAL  351 (415)
Q Consensus       293 ~~~~~~-----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----------------~~~  351 (415)
                      ......     ...++..|+|||++.+.  .++.++||||||+++|+|++|..++......                ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            432211     11234569999998654  3788999999999999999987765432211                011


Q ss_pred             HHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       352 ~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+......+.+..++..+.+|+.+||..+|++|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            112222233455678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.6e-40  Score=309.01  Aligned_cols=247  Identities=26%  Similarity=0.486  Sum_probs=205.0

Q ss_pred             cccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ++|++.+.||+|+||.||+|+..      +.+.+++|.+...    ........+.+|+++++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            57888999999999999999862      3567888877532    1222456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~----------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                      +..|+||||+.+|+|.+++...          .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999999998653          389999999999999999999999999999999999999999999999


Q ss_pred             eccccccccC---CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCC-C
Q 014986          286 FGLAKATKLN---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP-P  360 (415)
Q Consensus       286 FGla~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-~  360 (415)
                      ||++......   ......++..|+|||.+.+..  ++.++||||||+++|+|++ |..||...........+..+.. .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9998644322   122334677899999885443  6889999999999999998 8899977665555555543332 2


Q ss_pred             CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       361 ~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +.+..++..+.+++.+||..+|.+||++.+++.+
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            3456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=308.46  Aligned_cols=252  Identities=27%  Similarity=0.470  Sum_probs=210.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .+|++.+.||+|+||.||+|.+ .++.    .+|+|.+....    .......+.+|+.++..++|+||+++++++.. .
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            5788999999999999999987 3343    58888775322    23445678899999999999999999999887 7


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..++||||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            899999999999999988753  589999999999999999999999999999999999999999999999999976543


Q ss_pred             CCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          295 NDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       295 ~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ...    ....++..|+|||.+...  .++.++|+||||+++|+|++ |..||......+....+..+...+.+...+..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            221    112235679999988543  37889999999999999998 99999887766666666666666677788899


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.+++.+||..||..||++.++++  .|+++..
T Consensus       240 ~~~~~~~~l~~~p~~Rp~~~~l~~--~l~~~~~  270 (279)
T cd05057         240 VYMVLVKCWMIDAESRPTFKELIN--EFSKMAR  270 (279)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH--HHHHHHh
Confidence            999999999999999999999876  4555543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-40  Score=310.82  Aligned_cols=248  Identities=31%  Similarity=0.519  Sum_probs=202.6

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV  221 (415)
                      |++.+.||+|+||.||+|+. .+++.||+|.+......    .......+|+..+..++ |+||+++++.+.+++..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            67788999999999999998 57889999988643221    11223457889999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-Cc
Q 014986          222 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~  297 (415)
                      |||+ +|+|.+++...   .+++..+..++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++...... ..
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 77898877653   5899999999999999999999999999999999999999999999999998765433 22


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------------  361 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------------  361 (415)
                      ....++..|+|||++... ..++.++|+||||+++++|++|+.||......+...++......+                
T Consensus       156 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         156 TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            345688899999988543 336889999999999999999999997765554443332211100                


Q ss_pred             -------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          362 -------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       362 -------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                   .....+.++.+||++||+.||.+|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                         011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=315.97  Aligned_cols=252  Identities=26%  Similarity=0.407  Sum_probs=204.9

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC--CC----cEEEeeeee
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HE----NIVQYYGTD  212 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~--hp----nIv~l~~~~  212 (415)
                      +..+|.+..++|+|+||.|-.+++ .++..||||+++..      ....+..+-|+++|.++.  .|    -+|++.++|
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            467899999999999999999998 66899999998742      223345567899999983  22    378889999


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC------------
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------  277 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~------------  277 (415)
                      .-.++.|||+|.++. ++++++..+   .++...++.+++|++++++|||+.+++|.||||+|||+..            
T Consensus       161 dyrghiCivfellG~-S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELLGL-STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEeccCh-hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            999999999999854 899999875   5889999999999999999999999999999999999832            


Q ss_pred             --------CCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH
Q 014986          278 --------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA  349 (415)
Q Consensus       278 --------~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~  349 (415)
                              +..|+|+|||.|+..... ....+.|..|+|||++.+.+  ++.+.||||+||||+||++|...|...+..+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-hs~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH-HSTIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC-cceeeeccccCCchheeccC--cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    235899999999876543 35567899999999998766  9999999999999999999999998877655


Q ss_pred             HHHHHhcCCCC--------------------CCCC-------------------------cccHHHHHHHHHhhhhCCCC
Q 014986          350 ALFKIGRGSPP--------------------PIPD-------------------------SLSKDAQDFIKQCVQVNPND  384 (415)
Q Consensus       350 ~~~~i~~~~~~--------------------~~~~-------------------------~~s~~l~~Li~~~L~~dP~~  384 (415)
                      .+..+.+...+                    .+++                         .-...+.|||++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            44322211110                    0110                         01125789999999999999


Q ss_pred             CCCHHHHHcChhhHhhh
Q 014986          385 RPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       385 Rps~~eil~hp~f~~~~  401 (415)
                      |+|+.|+|.||||+...
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998764

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.5e-40  Score=308.64  Aligned_cols=240  Identities=30%  Similarity=0.515  Sum_probs=200.0

Q ss_pred             cccccCCcEEEEEEEcCC-------CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          148 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.||+|+||.||+|++.+       ++.+|+|.+....    .......+.+|+.+++.++||||+++++++......++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            369999999999998632       2689999875321    12234567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-----cEEEEeec
Q 014986          221 FLELVTKGSLLNLYQR--------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFG  287 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-----~vkl~DFG  287 (415)
                      ||||+.+++|.+++..        ..+++..+..++.|++.||.|||+++++|+||||+||+++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999999998854        2367888999999999999999999999999999999999877     89999999


Q ss_pred             cccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCC
Q 014986          288 LAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI  362 (415)
Q Consensus       288 la~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  362 (415)
                      ++........    ....++..|+|||.+.+..  ++.++|||||||++|+|++ |..||......+....+..+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCC--cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence            9875433221    1223567899999986543  7899999999999999998 9999987766666666655555566


Q ss_pred             CCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       363 ~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +..++..+.+||.+||..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            7788999999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-39  Score=344.27  Aligned_cols=148  Identities=30%  Similarity=0.527  Sum_probs=132.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.++||+|+||.||+|++ .+++.||||++......  .......+.+|+.++..++|+||+++++.+....++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI--NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc--CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            46799999999999999999998 58999999998753321  2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          220 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      |||||+.+++|.+++... .+++..++.|+.||+.||.|||.+||+||||||+|||++.++.+||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999998754 57899999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=308.67  Aligned_cols=248  Identities=30%  Similarity=0.506  Sum_probs=199.8

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC---CCCcEEEeeeeeecCCE--
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESK--  217 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~--  217 (415)
                      |++.+.||+|+||.||+|++ .+++.||+|.+.......   .....+.+|+.+++.+   +|+||+++++.+.+...  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc---hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            67788999999999999998 569999999987432211   1123455677666555   69999999999988776  


Q ss_pred             ---EEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          218 ---LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       218 ---~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                         ++++|||+.+ +|.+++...   .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               9999999985 788877652   589999999999999999999999999999999999999999999999999876


Q ss_pred             cccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----------
Q 014986          292 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------  360 (415)
Q Consensus       292 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  360 (415)
                      ..... .....++..|+|||.+.+..  ++.++|+|||||++|+|++|..||......+...++......          
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            54332 23345788999999986543  788999999999999999999999876655544443221100          


Q ss_pred             ----------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          361 ----------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       361 ----------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                                      .....++..+.+||.+||+.||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                            0012346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-39  Score=317.53  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=201.6

Q ss_pred             ccccccccccCCcEEEEEEEc-CC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeec----
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----  214 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~--~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----  214 (415)
                      +|++.+.||+|+||.||++++ .+  +..||+|++.....   .......+.+|+.+++.+ +|+||+++++.+..    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            478889999999999999998 45  78999998863211   122345677899999998 59999999986432    


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      ...+|++|+|+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            356789999987 488887754 568999999999999999999999999999999999999999999999999997543


Q ss_pred             cCC------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC---------
Q 014986          294 LND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---------  358 (415)
Q Consensus       294 ~~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------  358 (415)
                      ...      .....||+.|+|||.+.+. ..++.++||||||+++|+|++|..||........+..+....         
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            221      2234689999999987542 347889999999999999999999997654333222211100         


Q ss_pred             ------------------CC---CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          359 ------------------PP---PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       359 ------------------~~---~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                        ..   .....++..+.+|+.+||+.||.+|||+.+++.||||+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                              00   111235788999999999999999999999999999998854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.4e-39  Score=305.24  Aligned_cols=241  Identities=23%  Similarity=0.373  Sum_probs=191.1

Q ss_pred             cccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      +.||+|+||.||+|..   .++..+|+|.+.....    ......+.+|+.+++.++||||+++++.+.+...+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            3599999999999975   3456799998764321    22334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          225 VTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       225 ~~~gsL~~~l~~~------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      +.+|+|.+++...      ..++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++......  
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            9999999988642      34566778899999999999999999999999999999999999999999987543222  


Q ss_pred             --cccCCCCccccccccccccc-----cCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCC-----CCC
Q 014986          297 --VKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP-----PIP  363 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~-----~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~-----~~~  363 (415)
                        .....++..|+|||++....     ..++.++||||||+++|+|++ |..||......+...........     ...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              12234678899999985422     125789999999999999996 99999876555443333222211     222


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ...+..+.+++.+|+ .+|++|||+++|+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-39  Score=304.63  Aligned_cols=250  Identities=29%  Similarity=0.573  Sum_probs=207.8

Q ss_pred             ccccccccccCCcEEEEEEEcC--CCcEEEEEEEeccccc-----chhHHHHHHHHHHHHHHhc-CCCCcEEEeeeeeec
Q 014986          143 YWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKD  214 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~i~~~~~~-----~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~  214 (415)
                      .|++.+.||+|+||.||+|++.  +++.+|+|.+......     .........+.+|+.++.. ++|+||+++++.+.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999999983  5789999988643211     1223445667788888865 799999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                      ++..++||||+.+++|.+++..     ..+++..++.++.|++.||.|||+ .+|+|+||+|+|||++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999987742     358899999999999999999996 7899999999999999999999999999


Q ss_pred             ccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCC-cc
Q 014986          289 AKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SL  366 (415)
Q Consensus       289 a~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~  366 (415)
                      +...... ......|+..|++||.+.+.  .++.++|+||||+++|+|++|..||...........+......+.+. .+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY  238 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence            8765444 23445688999999998653  37889999999999999999999998776665555555554444433 67


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +..+.+||.+||+.||++||++.++..+
T Consensus       239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         239 SEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            8999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-40  Score=307.88  Aligned_cols=237  Identities=22%  Similarity=0.401  Sum_probs=192.0

Q ss_pred             cccccCCcEEEEEEEc-CCC-------cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          148 DLLGRGSFGSVYEGIS-DDG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~-------~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      +.||+|+||.||+|.+ ..+       ..+|+|.+..     ......+.+.+|+.+++.+.||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            3699999999999987 322       3477776642     22334456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--------EEEEeeccc
Q 014986          220 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VKLADFGLA  289 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~--------vkl~DFGla  289 (415)
                      +||||+.+|+|..++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++++|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999998754  4889999999999999999999999999999999999987764        699999988


Q ss_pred             cccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          290 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       290 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ......  ....++..|+|||++.+. ..++.++||||||+++|+|++| ..||.............  ....++...+.
T Consensus       156 ~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  230 (258)
T cd05078         156 ITVLPK--EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQLPAPKWT  230 (258)
T ss_pred             cccCCc--hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccCCCCCcH
Confidence            655432  234578899999998542 2368899999999999999998 56776655443332222  23345666778


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ++.+||.+||+.||++|||+++|++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-39  Score=311.39  Aligned_cols=247  Identities=25%  Similarity=0.462  Sum_probs=201.5

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .++|++.+.||+|+||.||+|.+ .++.    .+|+|.+....    .......+.+|+.+++.++||||+++++.+...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            35788899999999999999987 4554    46777765321    122334678999999999999999999988754


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                       ..++++||+.+|+|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             467999999999999988754  57889999999999999999999999999999999999999999999999997654


Q ss_pred             cCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          294 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       294 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ...    .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.+.........+..+...+.+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI  238 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            322    1223356789999998543  37899999999999999997 9999987654444444444555555667889


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+.+++.+||..+|++||++.+++..
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-39  Score=304.01  Aligned_cols=237  Identities=24%  Similarity=0.418  Sum_probs=188.8

Q ss_pred             cccccCCcEEEEEEEcCC-------------CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          148 DLLGRGSFGSVYEGISDD-------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      +.||+|+||.||+|+..+             ...+++|.+..     ........+.+|+.++..++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            368999999999998521             23577777643     122334567789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc-------EEEEe
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-------VKLAD  285 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~-------vkl~D  285 (415)
                      ....++||||+++|+|..++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999999888764  35899999999999999999999999999999999999987664       89999


Q ss_pred             eccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHH-cCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 014986          286 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML-TSQIPYAPMECMAALFKIGRGSPPPIPD  364 (415)
Q Consensus       286 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~  364 (415)
                      ||++......  ....++..|+|||.+.. ...++.++|||||||++|+|+ .|..||......+... ..... .....
T Consensus       156 ~g~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~-~~~~~  230 (262)
T cd05077         156 PGIPITVLSR--QECVERIPWIAPECVED-SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ-CMLVT  230 (262)
T ss_pred             CCCCccccCc--ccccccccccChhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC-ccCCC
Confidence            9998654322  23457889999998753 234788999999999999998 5899987654433222 21221 12233


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ..+.++.+||.+||+.||.+||++.+|+++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.3e-39  Score=305.66  Aligned_cols=236  Identities=22%  Similarity=0.347  Sum_probs=188.4

Q ss_pred             ccccCCcEEEEEEEcC-------------------------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC
Q 014986          149 LLGRGSFGSVYEGISD-------------------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE  203 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~-------------------------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp  203 (415)
                      +||+|+||.||+|...                         ....||+|.+..     ........+.+|+.+++.++||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence            6999999999998641                         123577887653     1223345677889999999999


Q ss_pred             cEEEeeeeeecCCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--
Q 014986          204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--  279 (415)
Q Consensus       204 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~--  279 (415)
                      ||+++++++.+....++||||+.+|+|..++.+  ..+++..+..++.||+.||+|||++||+||||||+|||++..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999988854  4688999999999999999999999999999999999997643  


Q ss_pred             -----cEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHH-cCCCCCCCccHHHHHHH
Q 014986          280 -----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML-TSQIPYAPMECMAALFK  353 (415)
Q Consensus       280 -----~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~  353 (415)
                           .+||+|||++......  ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||......+....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cCccceeeecCCccccccccc--cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                 4899999987644322  223478889999988543 34789999999999999984 79999977654333222


Q ss_pred             HhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       354 i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ...  ....+...+..+.+||.+||+.+|.+|||+.+|+++
T Consensus       234 ~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            221  222344566789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-39  Score=302.94  Aligned_cols=235  Identities=24%  Similarity=0.398  Sum_probs=188.7

Q ss_pred             cccccCCcEEEEEEEcC-CC----------cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          148 DLLGRGSFGSVYEGISD-DG----------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~----------~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +.||+|+||.||+|.+. ++          ..+++|.+....     . ....+.+|+.+++.++|+||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----R-DSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----h-hHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46999999999999984 33          246777654311     1 14677899999999999999999999887 7


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-------cEEEEeec
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------SVKLADFG  287 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-------~vkl~DFG  287 (415)
                      ..++||||+.+|+|.+++...  .++...+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            789999999999999988754  488999999999999999999999999999999999999887       79999999


Q ss_pred             cccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          288 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       288 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ++.....  .....++..|+|||++.+....++.++||||||+++|+|++ |..||.................  .+...
T Consensus       154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~  229 (259)
T cd05037         154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPD  229 (259)
T ss_pred             ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCC
Confidence            9876543  22334677899999986653357899999999999999999 6888866543332222222222  22223


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ...+.+||.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            478999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.6e-39  Score=302.80  Aligned_cols=240  Identities=20%  Similarity=0.331  Sum_probs=189.1

Q ss_pred             ccccCCcEEEEEEEcCCCc---EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          149 LLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      .||+|+||.||+|...++.   .+++|.+...    ........+.+|+.+++.++||||+++++.+.+....|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            5999999999999764333   4455554431    11233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC----C
Q 014986          226 TKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----D  296 (415)
Q Consensus       226 ~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~----~  296 (415)
                      .+|+|.+++.+.     .+....++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++......    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999988653     3556677889999999999999999999999999999999999999999998643221    1


Q ss_pred             cccCCCCcccccccccccc-----ccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC-----CCCCCCc
Q 014986          297 VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS-----PPPIPDS  365 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~-----~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~  365 (415)
                      .....++..|+|||++...     ...++.++||||||+++|+|++ |..||......+.+.++....     .+.++..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            2334578899999997432     1235778999999999999996 677887766555555443332     2234456


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ++..+.+++..|| .+|++||++.+|++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7889999999999 68999999999965

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-39  Score=305.12  Aligned_cols=246  Identities=32%  Similarity=0.511  Sum_probs=201.5

Q ss_pred             cccccccccccCCcEEEEEEEc-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  214 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  214 (415)
                      +.|++.+.||+|+||.||+|+.     .+++.+|+|.+......    .....+.+|+.+++.+.|+||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            4678889999999999999985     34789999998743221    345678999999999999999999998877  


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~~--l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ....++||||+.+++|.+++....  +++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            668999999999999999987654  899999999999999999999999999999999999999999999999999866


Q ss_pred             ccCCc-----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH--------------H-HHH
Q 014986          293 KLNDV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM--------------A-ALF  352 (415)
Q Consensus       293 ~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--------------~-~~~  352 (415)
                      .....     ....++..|++||.+...  .++.++||||||+++|+|++|..||......              . ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            52221     112345669999998544  3788999999999999999999998653211              1 112


Q ss_pred             HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       353 ~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .+......+.+..++..+.+|+.+||..+|.+|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22333334445677889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=300.04  Aligned_cols=258  Identities=28%  Similarity=0.491  Sum_probs=207.2

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  214 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  214 (415)
                      +....+.|....+||+|.||.||+|+. ++++.||+|++.......  .. -....+|+++|..++|+|++.++..|.. 
T Consensus        12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--Gf-pitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--GF-PITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--CC-cHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            445567899999999999999999998 778899999765421111  11 1234589999999999999999887643 


Q ss_pred             -------CCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          215 -------ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       215 -------~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                             ...+|+||.+|+. +|.-++..  -+++...++.+++++..||.|+|...|+|||+|++|+||+.+|.+||+|
T Consensus        89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeec
Confidence                   3458999999988 88888854  3799999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCC------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--
Q 014986          286 FGLAKATKLND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG--  357 (415)
Q Consensus       286 FGla~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--  357 (415)
                      ||+++......      .+....|.+|++||.+.+.. .|+.+.|||..|||+.+|.+|.+-|.+....+++..|...  
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhccc-ccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99997654322      33445699999999998754 5899999999999999999999999887666655544211  


Q ss_pred             --CC-----------------CCCCC-------------cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          358 --SP-----------------PPIPD-------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       358 --~~-----------------~~~~~-------------~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                        ..                 .|++.             .-++++.+|+.++|..||.+|+.++++++|.||..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence              00                 11111             12457889999999999999999999999999964

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.6e-39  Score=299.81  Aligned_cols=227  Identities=22%  Similarity=0.332  Sum_probs=188.2

Q ss_pred             CCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCCCHH
Q 014986          153 GSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL  231 (415)
Q Consensus       153 G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~  231 (415)
                      |.||.||++++ .+++.||+|.+....          ...+|...+....||||+++++.+.+.+.+++||||+.+|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            89999999999 789999999986421          1224445555567999999999999999999999999999999


Q ss_pred             HHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCccccccc
Q 014986          232 NLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE  310 (415)
Q Consensus       232 ~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE  310 (415)
                      +++.+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|||
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE  152 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCc
Confidence            98765 46899999999999999999999999999999999999999999999999987655432 23344677899999


Q ss_pred             cccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCH--
Q 014986          311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA--  388 (415)
Q Consensus       311 ~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~--  388 (415)
                      .+.+.  .++.++|+||+|+++|+|++|..||......     +.......++..++..+++||.+||+.||.+|+++  
T Consensus       153 ~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         153 VGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             ccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            88543  3788999999999999999999887643211     11111223567789999999999999999999985  


Q ss_pred             ---HHHHcChhh
Q 014986          389 ---AQLLDHPFV  397 (415)
Q Consensus       389 ---~eil~hp~f  397 (415)
                         +++++||||
T Consensus       226 ~~~~~~~~h~~~  237 (237)
T cd05576         226 AGVEDIKSHPFF  237 (237)
T ss_pred             cchHHHHcCCCC
Confidence               999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=305.47  Aligned_cols=266  Identities=28%  Similarity=0.406  Sum_probs=204.7

Q ss_pred             CCCCCCCCcceeee-cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC----
Q 014986          128 MSNISPNGRFKRII-TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE----  201 (415)
Q Consensus       128 ~~~~~~~~~~~~~~-~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~----  201 (415)
                      ...+.|-.....+. .+|.+.++||.|.|++||+|.+ .+.++||+|+++.      ++...+....||++|++++    
T Consensus        63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~v~~~Dp  136 (590)
T KOG1290|consen   63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQVREGDP  136 (590)
T ss_pred             cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHHHHhcCC
Confidence            34455655555666 7999999999999999999999 8899999999973      3444566779999999884    


Q ss_pred             -C---CcEEEeeeeee----cCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC-CceecCCC
Q 014986          202 -H---ENIVQYYGTDK----DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIK  269 (415)
Q Consensus       202 -h---pnIv~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLk  269 (415)
                       |   ..||+|++.|.    .+.++|||+|++.. .|..+++..   +++...++.|++||+.||.|||.. ||||.|||
T Consensus       137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK  215 (590)
T KOG1290|consen  137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK  215 (590)
T ss_pred             CCCCCceeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence             2   36999999886    46789999999965 788888653   799999999999999999999975 99999999


Q ss_pred             CCcEEEc-------------------------------------------------------------------------
Q 014986          270 CANILVD-------------------------------------------------------------------------  276 (415)
Q Consensus       270 p~NILl~-------------------------------------------------------------------------  276 (415)
                      |+|||+.                                                                         
T Consensus       216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~  295 (590)
T KOG1290|consen  216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE  295 (590)
T ss_pred             cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence            9999990                                                                         


Q ss_pred             -----------------------------------------CC-------------------------------------
Q 014986          277 -----------------------------------------AN-------------------------------------  278 (415)
Q Consensus       277 -----------------------------------------~~-------------------------------------  278 (415)
                                                               ..                                     
T Consensus       296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~  375 (590)
T KOG1290|consen  296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA  375 (590)
T ss_pred             ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence                                                     00                                     


Q ss_pred             ---------------CcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCC
Q 014986          279 ---------------GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA  343 (415)
Q Consensus       279 ---------------~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~  343 (415)
                                     -+|||+|||-|+.... .++.-..|..|+|||++.+.+  |+..+||||++|+++||+||...|.
T Consensus       376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~k-hFT~DIQTRQYRapEVllGsg--Y~~~ADiWS~AC~~FELaTGDyLFe  452 (590)
T KOG1290|consen  376 SNPLVNPDIPLPECDIRVKIADLGNACWVHK-HFTEDIQTRQYRAPEVLLGSG--YSTSADIWSTACMAFELATGDYLFE  452 (590)
T ss_pred             cccccCCCCCCCccceeEEEeeccchhhhhh-hhchhhhhhhccCcceeecCC--CCCchhHHHHHHHHHHhhcCceeec
Confidence                           0257777776665432 233345789999999997765  9999999999999999999999996


Q ss_pred             Ccc------HHHHHHHHh-----------------------cCCC------CC------------CCCcccHHHHHHHHH
Q 014986          344 PME------CMAALFKIG-----------------------RGSP------PP------------IPDSLSKDAQDFIKQ  376 (415)
Q Consensus       344 ~~~------~~~~~~~i~-----------------------~~~~------~~------------~~~~~s~~l~~Li~~  376 (415)
                      ..+      ..+.+..|.                       ++..      .+            ++..-..++.+||.-
T Consensus       453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P  532 (590)
T KOG1290|consen  453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP  532 (590)
T ss_pred             CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence            532      111111110                       0000      01            111223467799999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ||+.+|++|+||.++|+|||+......
T Consensus       533 mLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  533 MLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHhcCccccccHHHHhcCccccCCCCC
Confidence            999999999999999999999977665

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-38  Score=300.00  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=200.6

Q ss_pred             cccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC---
Q 014986          144 WQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---  216 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  216 (415)
                      |++.+.||+|+||.||+|.+    .+++.+|+|.+.....   .....+++.+|+++++.++||||+++++.+....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF---SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC---ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            66788999999999999975    3578999998864322   2233566889999999999999999999875432   


Q ss_pred             ---EEEEEEeccCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEee
Q 014986          217 ---KLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       217 ---~~~lV~E~~~~gsL~~~l~~-------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                         ..+++++|+.+|+|..++..       ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               34789999999999887632       14788889999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCC
Q 014986          287 GLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP  361 (415)
Q Consensus       287 Gla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  361 (415)
                      |+++......    .....+++.|++||.+....  ++.++|||||||++|+|++ |..||......+....+.......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9988654322    11223567899999985443  7889999999999999999 899998776655555555555555


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            556788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=320.73  Aligned_cols=256  Identities=28%  Similarity=0.456  Sum_probs=223.2

Q ss_pred             eecccccccccccCCcEEEEEEEc--CCC--cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~--~~~--~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      -.+...+.++||+|.||.|++|.+  .+|  -.||||++.....    ......|.+|+.+|.+++|+|+++|||+..+ 
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----~~~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----chhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            345677889999999999999988  334  3689999875332    2256789999999999999999999999887 


Q ss_pred             CEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ..+.||||++.+|+|.+.|.+   ..|-......|+.||+.|+.||-++++|||||...|+|+-....|||+||||.+..
T Consensus       183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence            788999999999999998876   24777888999999999999999999999999999999999899999999999987


Q ss_pred             ccCCcccCC-----CCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          293 KLNDVKSCR-----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       293 ~~~~~~~~~-----gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ..+......     ....|+|||.++...  ++.++|||++||++|||++ |..||.+....+.+.++..+...+-|..+
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~k--FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~c  340 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRK--FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYC  340 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhcccc--ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCC
Confidence            766533322     345699999997655  8999999999999999998 89999999999999999999999999999


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ++++++++++||..+|.+|||+..|.+.-++++...
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~l~eaqp  376 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP  376 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence            999999999999999999999999987777666543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=317.38  Aligned_cols=255  Identities=26%  Similarity=0.489  Sum_probs=225.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..+.....+||-|.||.||.|.+ +-.-.||||.++      +..-.++.|..|+.+|+.++|||+|+++++|..+..+|
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            34455667899999999999999 668899999886      23345678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~---l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      ||+|||..|+|.+++++..   ++.-...+++.||..|++||..+++|||||...|+|+..+..|||+||||++.+..+.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999999998653   5566677889999999999999999999999999999999999999999999988777


Q ss_pred             cccCCC---CccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 VKSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~~~~~g---t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      .+...|   ...|.|||.+....  ++.++|||+||++|||+.| |-.||.+.+.-+...-+.++.+..-|+.|++...+
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNt--FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNT--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             eecccCccCcccccCcccccccc--cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHH
Confidence            766655   45699999985433  8999999999999999998 88899999988888888899999999999999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      |++.||+.+|..||+++||  |.=|..++..++
T Consensus       498 LMraCW~WsPsDRPsFaei--HqafEtmf~~sS  528 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEI--HQAFETMFSSSS  528 (1157)
T ss_pred             HHHHHhcCCcccCccHHHH--HHHHHHHhcccc
Confidence            9999999999999999999  667887776554

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=309.43  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=211.9

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +...+.++||+|-||.|.++.......||+|.++...    .......|.+|+++|.+++|||||+++++|..++.++|+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a----~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA----TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCccc----chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            3456788999999999999998888999999987532    234457899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCC---CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          222 LELVTKGSLLNLYQRYHL---RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~~l---~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      |||++.|+|..++.+...   .......++.||+.|++||.+.+++||||.+.|+|++.++++||+|||+++-....+..
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            999999999999987632   33455679999999999999999999999999999999999999999999865555444


Q ss_pred             cCC----CCccccccccccccccCCCchhhHHHHHHHHHHHHc--CCCCCCCccHHHHHHHHhcCCC-------CCCCCc
Q 014986          299 SCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPMECMAALFKIGRGSP-------PPIPDS  365 (415)
Q Consensus       299 ~~~----gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~--g~~pf~~~~~~~~~~~i~~~~~-------~~~~~~  365 (415)
                      ...    -...|||+|.+....  ++.++|+|+||+++||+++  ...||......+.......-..       ...|..
T Consensus       694 ~vqgr~vlpiRwmawEsillgk--FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~  771 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA  771 (807)
T ss_pred             eeecceeeeeeehhHHHHHhcc--ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence            333    357899999986544  8999999999999999864  7889998887776665543332       245778


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ++..+.+|+.+||..|-++||+++++  |.+|++.
T Consensus       772 cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~~  804 (807)
T KOG1094|consen  772 CPQGLYELMLRCWRRESEQRPSFEQL--HLFLQED  804 (807)
T ss_pred             CcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHHh
Confidence            99999999999999999999999999  6667654

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=315.51  Aligned_cols=250  Identities=28%  Similarity=0.487  Sum_probs=214.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcC---CC--cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISD---DG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT  211 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~--~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  211 (415)
                      +....+...+.++||.|-||.||+|+..   .|  --||||..+....    ....+.|..|.-+|+.++|||||+++|+
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t----~d~tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT----PDDTEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC----hhhHHHHHHHHHHHHhCCCcchhheeee
Confidence            3334456677889999999999999862   23  3577887764222    2235778999999999999999999999


Q ss_pred             eecCCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          212 DKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       212 ~~~~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      +.+ ...+||||+++.|.|..+++.+  .++......|+.||+.||+|||+..++||||...|||+.....|||+||||+
T Consensus       460 ~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  460 CVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             eec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence            875 4689999999999999999865  5788888899999999999999999999999999999999999999999999


Q ss_pred             cccccCCccc-CC--CCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCc
Q 014986          290 KATKLNDVKS-CR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS  365 (415)
Q Consensus       290 ~~~~~~~~~~-~~--gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  365 (415)
                      +......... ..  -...|||||.++-..  ++.++|||.||+++||++. |..||.+....+.+.++.++.+.|.|+.
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRr--FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRR--FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN  616 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhc--ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC
Confidence            9877655322 22  345699999997655  8999999999999999986 9999999999999999999999999999


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +++.+..|+.+||..+|.+||.+.+|..
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999999999988753

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.4e-38  Score=301.86  Aligned_cols=248  Identities=22%  Similarity=0.337  Sum_probs=184.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CC---CcEEEEEEEecccccchhHH-H-----HHHHHHHHHHHhcCCCCcEEEeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DD---GFFFAVKEVSLLDQGSQAKQ-S-----ISQLEQEIALLSRFEHENIVQYYG  210 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~---~~~vavK~i~~~~~~~~~~~-~-----~~~~~~E~~il~~l~hpnIv~l~~  210 (415)
                      .++|++.++||+|+||+||+|.+ .+   +..+|+|............. .     ......++..+..+.|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35799999999999999999997 33   45666665433221111110 0     011223445566778999999998


Q ss_pred             eeecCC----EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          211 TDKDES----KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       211 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                      .+....    ..+++|+++.. ++.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            765443    45788888755 666666554 367888999999999999999999999999999999999999999999


Q ss_pred             eccccccccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH--------
Q 014986          286 FGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM--------  348 (415)
Q Consensus       286 FGla~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--------  348 (415)
                      ||+++......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99997653211         1234699999999998654  3899999999999999999999999766321        


Q ss_pred             -HHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          349 -AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       349 -~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                       +.+..+..+..  ....++..+.++++.||..+|++||++++|++
T Consensus       248 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             11122222211  23456889999999999999999999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=290.30  Aligned_cols=256  Identities=30%  Similarity=0.498  Sum_probs=210.7

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH-hcCCCCcEEEeeeeeecCCEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ++.+-+..||.|+||+|++-.+ .+|+..|||.++....    ....++++.|.... +.-+.||||++||..-.++..+
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            3455667899999999999988 8899999999985332    33445677777654 5557999999999988888999


Q ss_pred             EEEeccCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          220 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~------~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      |.||++.- +|..+++      +..+++..+-.+.-.++.||.||.. ..|||||+||+|||++..|.|||||||.+...
T Consensus       140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            99999976 7766653      4579999999999999999999975 58999999999999999999999999998654


Q ss_pred             ccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCC-----c
Q 014986          293 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPD-----S  365 (415)
Q Consensus       293 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~-----~  365 (415)
                      ... ..+.-.|-..|||||.+....++|+.++|+||||++|||+.||..||.... ..+++..+..+.++.+..     .
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence            322 223345777899999998777779999999999999999999999998754 346666666666654322     3


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+..+..||.-||.+|-..||...+++++||++...-
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            6889999999999999999999999999999986553

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.9e-39  Score=280.83  Aligned_cols=256  Identities=24%  Similarity=0.444  Sum_probs=211.0

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecC--
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--  215 (415)
                      ..++|++.+++|+|.|+.||.|+. .+++.++||+++.        ...+.+.+|+.||..+. ||||++++++..+.  
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            357899999999999999999998 7889999999874        22356789999999996 99999999987764  


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFGla~~~~~  294 (415)
                      ....+++||+..-+...+...  ++...++.++.|++.||.|+|+.||+|||+||.|++|+.. ..++|+|+|||.+..+
T Consensus       108 ktpaLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             cCchhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            346799999999888777654  7788899999999999999999999999999999999954 6799999999998876


Q ss_pred             CCccc-CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCC-CCccHHHHHHHHhcCCCC------------
Q 014986          295 NDVKS-CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPP------------  360 (415)
Q Consensus       295 ~~~~~-~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~------------  360 (415)
                      ..... ...+..|.-||++..-. .|+.+.|+|||||++..|+..+-|| .+.+..+++.+|.+...+            
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~-~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CceeeeeeehhhcCCchheeech-hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            65433 44677899999986543 3788999999999999999988886 555556665555332111            


Q ss_pred             ----------------CCC--------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          361 ----------------PIP--------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       361 ----------------~~~--------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                                      ++.        ...++++.|||.++|..|-.+|+|+.|++.||||.......+.
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~  334 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS  334 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence                            110        1246899999999999999999999999999999998876554

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=302.95  Aligned_cols=268  Identities=24%  Similarity=0.400  Sum_probs=216.2

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccc--cchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~--~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      ...+.++|-++.+||+|||+.||+|.+ ...++||+|+-.+.+.  ........++..+|.+|-+.|.||.||++|++|.
T Consensus       458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS  537 (775)
T ss_pred             CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence            344577899999999999999999999 7788999997543222  1222334567889999999999999999999986


Q ss_pred             -cCCEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEc---CCCcEEEEee
Q 014986          214 -DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVD---ANGSVKLADF  286 (415)
Q Consensus       214 -~~~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~--~IiHrDLkp~NILl~---~~~~vkl~DF  286 (415)
                       +.+.+|-|+|||+|.+|..+++.. .+++.+++.|+.||+.||.||...  .|||-||||.|||+-   ..|.+||+||
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence             556789999999999999998875 589999999999999999999976  599999999999995   3478999999


Q ss_pred             ccccccccCCcc---------cCCCCcccccccccccc--ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH---
Q 014986          287 GLAKATKLNDVK---------SCRGTAFWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF---  352 (415)
Q Consensus       287 Gla~~~~~~~~~---------~~~gt~~y~aPE~l~~~--~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---  352 (415)
                      ||++.+......         ...||.+|++||.+.-.  ....+.++||||+|||+|.++.|+.||......+.+.   
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            999987654322         34599999999998533  2337889999999999999999999997654333222   


Q ss_pred             HHhcCCCCCCC--CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          353 KIGRGSPPPIP--DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       353 ~i~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .|.+.....+|  +.++.++++||++||+.--+.|....++..||||.--....
T Consensus       698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs  751 (775)
T KOG1151|consen  698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRS  751 (775)
T ss_pred             chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhc
Confidence            22222222233  46899999999999999999999999999999998644443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=294.03  Aligned_cols=260  Identities=25%  Similarity=0.410  Sum_probs=215.0

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC---
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---  215 (415)
                      ...+|.-+..+|.|.- .|.-|-+ -.++.||+|++...-..   ....++..+|..++..++|+||++++.+|.-.   
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n---~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN---QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc---CccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            3457888899999999 7777777 68999999988643211   22334566899999999999999999988644   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ---~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                         ..+|+|||++.. +|...+. ..+.-..++.++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus        91 ~~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence               357999999977 7877665 56777889999999999999999999999999999999999999999999999877


Q ss_pred             ccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---------
Q 014986          293 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---------  362 (415)
Q Consensus       293 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------  362 (415)
                      ... ..+....|..|+|||++.+.+  +.+.+||||+||++.||++|+..|.+....++..++......+.         
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             CcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            666 556677999999999998776  89999999999999999999999999888777776654433321         


Q ss_pred             ---------------------CC-----------cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          363 ---------------------PD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       363 ---------------------~~-----------~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                                           |+           .-+..+++|+.+||..||++|.|++++|+||||+-|+......
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~  323 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVE  323 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccccc
Confidence                                 11           1134688999999999999999999999999999776654433

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-39  Score=317.93  Aligned_cols=239  Identities=29%  Similarity=0.550  Sum_probs=192.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-----
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  216 (415)
                      -|...+.||+|+||.||++++ .+|+.||||.+....    .....+...+|+++|++++|+|||+++++-++..     
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            466778999999999999997 899999999887532    2334566779999999999999999999866544     


Q ss_pred             -EEEEEEeccCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCC--cEEEEeec
Q 014986          217 -KLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADFG  287 (415)
Q Consensus       217 -~~~lV~E~~~~gsL~~~l~~----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~--~~~--~vkl~DFG  287 (415)
                       ...+|||||.||+|+..+++    +++++.+.+.++..+..||.|||++||+||||||.||++-  .+|  ..||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             46899999999999999964    5899999999999999999999999999999999999984  334  47999999


Q ss_pred             cccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH----HHHHHHHhcCCC---
Q 014986          288 LAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP---  359 (415)
Q Consensus       288 la~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~---  359 (415)
                      .|+....+. ..+..||+.|++||++.. .+.|+..+|.|||||++|+++||..||.....    .+....+....+   
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            999876554 667889999999999853 45589999999999999999999999965332    223333322211   


Q ss_pred             -----------------CCCCCcccHH----HHHHHHHhhhhCCCCCC
Q 014986          360 -----------------PPIPDSLSKD----AQDFIKQCVQVNPNDRP  386 (415)
Q Consensus       360 -----------------~~~~~~~s~~----l~~Li~~~L~~dP~~Rp  386 (415)
                                       .|.|..++..    +...+..+|..+|.+|.
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                             1233344443    44667788999999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=319.65  Aligned_cols=252  Identities=26%  Similarity=0.450  Sum_probs=221.7

Q ss_pred             ccccccccccCCcEEEEEEEc-C---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ...+.++||.|.||.||+|+. .   ....||||.++.    ....+....|+.|+.||-++.||||++|.|+......+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            456788999999999999987 2   346899999985    33455667899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          219 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||+|||++|+|..+|+.+  .|+..+...+++.|+.|++||-+.|++||||...|||++.+..+|++||||++....+.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999999999764  58888999999999999999999999999999999999999999999999999765443


Q ss_pred             cc--cCC---CCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          297 VK--SCR---GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       297 ~~--~~~---gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ..  +..   ...+|.|||.+....  ++.++||||+|++|||.++ |.-||..+...+.+..|..+.+.|-|-.+|..+
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RK--FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL  863 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL  863 (996)
T ss_pred             CccccccCCccceeecChhHhhhcc--cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence            11  111   246799999996654  8999999999999999886 999999999999999999999999999999999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+|+..||++|..+||.+.+|+.+  |.++..
T Consensus       864 ~qLMldCWqkdR~~RP~F~qiV~~--lDklIr  893 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKFAQIVST--LDKLIR  893 (996)
T ss_pred             HHHHHHHHHHHhhcCCCHHHHHHH--HHHHhc
Confidence            999999999999999999999875  444443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=318.12  Aligned_cols=252  Identities=34%  Similarity=0.655  Sum_probs=218.7

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee-----c
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK-----D  214 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~  214 (415)
                      .-|++.+.||.|.||.||+++. ++++..|+|+.......      -+.++.|.++|+.. .|||++.+|++|.     .
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            4577889999999999999998 88999999987643222      24566788898887 6999999999875     3


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      +++++||||||.+|+..++++.   .++.|..+..|++.++.||.|||.+.++|||||-.|||++.+|.|||+|||++..
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            6789999999999999999875   3689999999999999999999999999999999999999999999999999875


Q ss_pred             cccC--CcccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CC
Q 014986          292 TKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PD  364 (415)
Q Consensus       292 ~~~~--~~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~  364 (415)
                      ....  ....+.|||.|||||++.-.   ...|+..+|+||||++..||.-|.+|+-.+..+.+++.|.+..++.+  |.
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence            5432  34456799999999998532   23377889999999999999999999999999999999988776654  56


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ..++.+.+||..||.+|..+||+..++|+|||+++
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            78999999999999999999999999999999974

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.3e-39  Score=308.49  Aligned_cols=251  Identities=27%  Similarity=0.482  Sum_probs=209.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC------CCcEEEeeeee
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE------HENIVQYYGTD  212 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~  212 (415)
                      +-.+|.+....|+|-||+|..|.+ .-++.||||+|..      .....+.-+.|+.||++|+      --++++++..|
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            445789999999999999999999 6788999999973      2333445568999999995      24789999999


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeec
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFG  287 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFG  287 (415)
                      ...+++|||+|-+.. +|.++++++    +|....++.|++|++.||..|..+||+|.||||+|||++.. ..+||||||
T Consensus       504 ~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            999999999999876 899999876    47888999999999999999999999999999999999865 578999999


Q ss_pred             cccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH--hcCCCC-----
Q 014986          288 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPP-----  360 (415)
Q Consensus       288 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~-----  360 (415)
                      .|.....+..+.+..+..|+|||++.|..  |+...|+||+||+||||+||+..|.+....+.+.-.  .++..+     
T Consensus       583 SA~~~~eneitPYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  583 SASFASENEITPYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             cccccccccccHHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            99999988888888999999999997765  888999999999999999999999887654443211  111100     


Q ss_pred             ------------------------------------C-------------CCC---cccHHHHHHHHHhhhhCCCCCCCH
Q 014986          361 ------------------------------------P-------------IPD---SLSKDAQDFIKQCVQVNPNDRPTA  388 (415)
Q Consensus       361 ------------------------------------~-------------~~~---~~s~~l~~Li~~~L~~dP~~Rps~  388 (415)
                                                          |             ++.   .+-..+++||.+||..||.+|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                                                0             000   112368899999999999999999


Q ss_pred             HHHHcChhhHh
Q 014986          389 AQLLDHPFVKR  399 (415)
Q Consensus       389 ~eil~hp~f~~  399 (415)
                      .++|.||||+.
T Consensus       741 nqAL~HpFi~~  751 (752)
T KOG0670|consen  741 NQALKHPFITE  751 (752)
T ss_pred             HHHhcCCcccC
Confidence            99999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.3e-37  Score=319.34  Aligned_cols=252  Identities=22%  Similarity=0.297  Sum_probs=175.3

Q ss_pred             eecccccccccccCCcEEEEEEEc-CC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeee---
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT---  211 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~----~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~---  211 (415)
                      ..++|++.+.||+|+||.||+|++ .+    +..||+|++.....   .    +....+  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~----e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---V----EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---h----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            456899999999999999999998 56    79999998753111   0    111111  1111112222222111   


Q ss_pred             ---eecCCEEEEEEeccCCCCHHHHHhhcCC---------------------CHHHHHHHHHHHHHHHHHHHHCCceecC
Q 014986          212 ---DKDESKLYIFLELVTKGSLLNLYQRYHL---------------------RDSQVSAYTRQILLGLKYLHDQDVVHRD  267 (415)
Q Consensus       212 ---~~~~~~~~lV~E~~~~gsL~~~l~~~~l---------------------~~~~~~~i~~qil~aL~~LH~~~IiHrD  267 (415)
                         ......+++||||+.+++|.+++....+                     ....+..++.||+.||.|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456789999999999999998865432                     1234567999999999999999999999


Q ss_pred             CCCCcEEEcC-CCcEEEEeeccccccccC---CcccCCCCcccccccccccccc--------------------CCCchh
Q 014986          268 IKCANILVDA-NGSVKLADFGLAKATKLN---DVKSCRGTAFWMAPEVINNKNK--------------------GYGLPA  323 (415)
Q Consensus       268 Lkp~NILl~~-~~~vkl~DFGla~~~~~~---~~~~~~gt~~y~aPE~l~~~~~--------------------~~~~~~  323 (415)
                      |||+|||++. ++.+||+|||+++.....   ......+|+.|+|||.+.....                    .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999985 589999999999754322   2334568999999997643221                    134567


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-C----------CC----------CCCCcccHHHHHHHHHhhhhCC
Q 014986          324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-S----------PP----------PIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       324 DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~----------~~----------~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |||||||++|||+++..++...  ...+.++... .          ..          ...+.....+.+||.+||+.||
T Consensus       361 DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            9999999999999987765432  1111111000 0          00          0011223456699999999999


Q ss_pred             CCCCCHHHHHcChhhHhhhh
Q 014986          383 NDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       383 ~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+|||+.++|+||||+....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999987554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-36  Score=279.47  Aligned_cols=238  Identities=38%  Similarity=0.670  Sum_probs=200.7

Q ss_pred             CcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCCCHHH
Q 014986          154 SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN  232 (415)
Q Consensus       154 ~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~  232 (415)
                      +||.||+|.+ .+++.+|+|++........    ...+.+|+..++.++|+||+++++.+......+++|||+.+++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            5899999998 5699999999875322211    5678899999999999999999999999999999999999999999


Q ss_pred             HHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-CcccCCCCccccccc
Q 014986          233 LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPE  310 (415)
Q Consensus       233 ~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~gt~~y~aPE  310 (415)
                      ++.... ++...+..++.+++.+|.+||+.+|+|+||+|.||+++.++.++|+|||++...... ......++..|++||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            987654 899999999999999999999999999999999999999999999999998876544 344556888999999


Q ss_pred             cccccccCCCchhhHHHHHHHHHHHHcCCCCCCC-ccHHHHHHHHhcCCCCCCCCc--ccHHHHHHHHHhhhhCCCCCCC
Q 014986          311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDRPT  387 (415)
Q Consensus       311 ~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~--~s~~l~~Li~~~L~~dP~~Rps  387 (415)
                      .+.+.  .++.++|+||||+++++|++|..||.. .....................  ++..+.+++.+||..+|++||+
T Consensus       157 ~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      157 VLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            98643  367899999999999999999999987 333333333333333322222  8899999999999999999999


Q ss_pred             HHHHHcChhh
Q 014986          388 AAQLLDHPFV  397 (415)
Q Consensus       388 ~~eil~hp~f  397 (415)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=304.14  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=185.9

Q ss_pred             eecccccccccccCCcEEEEEEEc-----------------CCCcEEEEEEEecccccchhH---------HHHHHHHHH
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-----------------DDGFFFAVKEVSLLDQGSQAK---------QSISQLEQE  193 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~i~~~~~~~~~~---------~~~~~~~~E  193 (415)
                      ..++|++.++||+|+||+||+|..                 ..++.||||.+..........         ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            466899999999999999999964                 245689999986432211000         011223346


Q ss_pred             HHHHhcCCCCcE-----EEeeeeeec--------CCEEEEEEeccCCCCHHHHHhhc-----------------------
Q 014986          194 IALLSRFEHENI-----VQYYGTDKD--------ESKLYIFLELVTKGSLLNLYQRY-----------------------  237 (415)
Q Consensus       194 ~~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~-----------------------  237 (415)
                      +.++..++|.++     +++++++..        ....+|||||+.+++|.+++...                       
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     566665532        35689999999999999887531                       


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-cc--cCCCCccccccccc
Q 014986          238 --HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK--SCRGTAFWMAPEVI  312 (415)
Q Consensus       238 --~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~~--~~~gt~~y~aPE~l  312 (415)
                        .+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++....... ..  ...+|+.|+|||++
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence              13456788899999999999999999999999999999999999999999986543221 11  22358899999997


Q ss_pred             ccccc--------------------CCCchhhHHHHHHHHHHHHcCCC-CCCCccHHHHH----------HHHhcCC--C
Q 014986          313 NNKNK--------------------GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAAL----------FKIGRGS--P  359 (415)
Q Consensus       313 ~~~~~--------------------~~~~~~DvwSlG~il~ell~g~~-pf~~~~~~~~~----------~~i~~~~--~  359 (415)
                      .....                    ....+.||||+||++|+|++|.+ ||.........          ++.....  .
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            53211                    11234799999999999999886 77542211110          1111111  1


Q ss_pred             CCCCCcccHHHHHHHHHhhhhCC---CCCCCHHHHHcChhhHh
Q 014986          360 PPIPDSLSKDAQDFIKQCVQVNP---NDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       360 ~~~~~~~s~~l~~Li~~~L~~dP---~~Rps~~eil~hp~f~~  399 (415)
                      ....+..+..+++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            22345678999999999999866   68999999999999964

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=314.61  Aligned_cols=243  Identities=33%  Similarity=0.515  Sum_probs=194.1

Q ss_pred             ccccccccccCCcEE-EEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEE
Q 014986          143 YWQKGDLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~-Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .|.-.+++|.|+-|+ ||+|.. .++.||||.+.        ........+|+.+|+.- +|||||++|+...+....||
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI  580 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI  580 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence            455667899999987 788876 67799999765        23334567999999887 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcC--C---CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---C--CcEEEEeecccc
Q 014986          221 FLELVTKGSLLNLYQRYH--L---RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---N--GSVKLADFGLAK  290 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~--l---~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~--~~vkl~DFGla~  290 (415)
                      ..|.|.. +|.+++....  +   .....+.++.|++.||+|||+.+||||||||.||||..   +  .+++|+|||+++
T Consensus       581 alELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  581 ALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             EehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9999987 9999998631  1   11345778999999999999999999999999999976   3  368999999999


Q ss_pred             ccccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHhcCCCCC--C
Q 014986          291 ATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPP--I  362 (415)
Q Consensus       291 ~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~--~  362 (415)
                      ....+.     ...+.||.+|+|||++....  ...++|||||||++|+.++| ..||...-..+.  .|..+....  +
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L  735 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHL  735 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeee
Confidence            765443     33466999999999997655  46699999999999999985 999987544433  344433321  1


Q ss_pred             CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       363 ~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ......++.+||.+||.++|..||+|.++|.||||=.
T Consensus       736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            1112228999999999999999999999999999843

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=283.93  Aligned_cols=254  Identities=30%  Similarity=0.489  Sum_probs=205.3

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-----
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  216 (415)
                      +.+-.+.||-|+||.||.+++ ++|+.||+|++...   ...-...+.+.+|+++|..++|.|++..++..+...     
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv---fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV---FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH---HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            445567899999999999999 89999999987632   223344567889999999999999999988766543     


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+|.++|++.. +|.+++-. ..++.+.++-++.||+.||+|||+.||.||||||.|+|++.+..+||||||+++.....
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            25778887765 66665543 47899999999999999999999999999999999999999999999999999987655


Q ss_pred             C---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-----------
Q 014986          296 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----------  361 (415)
Q Consensus       296 ~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  361 (415)
                      +   .+....|.+|+|||++.+.. .|+.++||||+|||+.|||.++..|......+++.-|.....++           
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaR-hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGAR-RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcch-hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            4   33445789999999998754 48999999999999999999999998777666655443221111           


Q ss_pred             --------------C--------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          362 --------------I--------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       362 --------------~--------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                    .        +..-..+...++.++|..||++|.+..+++.|+|+.+..
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                          0        112234677899999999999999999999999987643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=307.72  Aligned_cols=256  Identities=28%  Similarity=0.509  Sum_probs=215.6

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc----C----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEE
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS----D----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  207 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~----~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~  207 (415)
                      +....++..+.+.||+|.||.|++|.-    .    ....||||.++...    .....+.+..|+.+|+.+ .|+||+.
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~----~~~~~~~~~~El~~m~~~g~H~niv~  366 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA----SSSEKKDLMSELNVLKELGKHPNIVN  366 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc----CcHHHHHHHHHHHHHHHhcCCcchhh
Confidence            444444556777999999999999963    1    25678999876422    224567788999999998 5999999


Q ss_pred             eeeeeecCCEEEEEEeccCCCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       208 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++++.....+++|+||+..|+|.++++..+                 ++......++.||+.|++||++..++||||..
T Consensus       367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa  446 (609)
T KOG0200|consen  367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA  446 (609)
T ss_pred             heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence            9999999999999999999999999998777                 88899999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCCccc---CCC--CccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 014986          271 ANILVDANGSVKLADFGLAKATKLNDVKS---CRG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAP  344 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~~~~---~~g--t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~  344 (415)
                      .|||+..+..+||+|||+|+.........   ..+  ...|||||.+..  ..++.++||||+|++||||++ |..||.+
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999655444332   222  334999999966  348999999999999999998 8999988


Q ss_pred             cc-HHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          345 ME-CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       345 ~~-~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .. ..+....+..+.....|..++.++.++++.||+.+|++||++.++.+  +|...
T Consensus       525 ~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~~  579 (609)
T KOG0200|consen  525 IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEKH  579 (609)
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHHH
Confidence            54 44556678888888999999999999999999999999999999975  45553

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5e-35  Score=322.58  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=192.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|...++||+|+||.||+|.+ .++..||+|++.....         ....|+.++++++|||||++++++.+....|
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            34567778999999999999998 7899999998863221         1124578899999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH---~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||+++|+|.++++.  +++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......  
T Consensus       760 lv~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             EEEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            99999999999999864  888999999999999999999   6699999999999999998887775 665543322  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHHhcC------CCC-----
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-----CMAALFKIGRG------SPP-----  360 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~------~~~-----  360 (415)
                      .....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||....     ..+........      ..+     
T Consensus       835 ~~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 DTKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             CCCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence            1233688999999998654  48999999999999999999999985321     11110000000      000     


Q ss_pred             -CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCC
Q 014986          361 -PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSA  408 (415)
Q Consensus       361 -~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~  408 (415)
                       ..+.....++.+++.+||+.||++|||+.++++.  ++.+....+..+
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~~~~~~~  959 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESASRSSSSCV  959 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHhhccccccc
Confidence             0111122357789999999999999999999875  666655444333

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=277.68  Aligned_cols=240  Identities=28%  Similarity=0.433  Sum_probs=188.4

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc--CCCCcEEEeeeeeecCC----
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDES----  216 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~----  216 (415)
                      ..++.++||+|.||.||+|... ++.||||++..        +..+.+.+|.+|.+.  ++|+||+++++..+...    
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            4567788999999999999774 49999999873        344567778777665  57999999999876555    


Q ss_pred             EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEcCCCcEEEEeec
Q 014986          217 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLADFG  287 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~---------~IiHrDLkp~NILl~~~~~vkl~DFG  287 (415)
                      .++||++|.+.|+|.+++..+-+++....+++..++.||+|||+.         .|+|||||..|||+..|+...|+|||
T Consensus       282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            799999999999999999999999999999999999999999963         59999999999999999999999999


Q ss_pred             cccccccC----CcccCCCCccccccccccccccCC----CchhhHHHHHHHHHHHHcCCC------------CCCC---
Q 014986          288 LAKATKLN----DVKSCRGTAFWMAPEVINNKNKGY----GLPADIWSLGCTVLEMLTSQI------------PYAP---  344 (415)
Q Consensus       288 la~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~----~~~~DvwSlG~il~ell~g~~------------pf~~---  344 (415)
                      ||......    +....+||.+|||||++.+...-.    -.+.||||+|.+||||+++..            ||..   
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99866533    234467999999999996543221    246899999999999998533            3321   


Q ss_pred             ----ccHHHHHHHHhcCCCCCCCCc-----ccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 014986          345 ----MECMAALFKIGRGSPPPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLL  392 (415)
Q Consensus       345 ----~~~~~~~~~i~~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~Rps~~eil  392 (415)
                          .+.++.+ .+.+..++.+++.     -...+.+.+..||..|++.|+|+.=+.
T Consensus       442 ~hPt~e~mq~~-VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  442 NHPTLEEMQEL-VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             CCCCHHHHHHH-HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence                1111111 2223334444432     234688999999999999999987664

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=247.70  Aligned_cols=216  Identities=30%  Similarity=0.519  Sum_probs=174.3

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc-CCCCcEEEeeeeeecCCEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ....+..||+|+||.|-+.++ .+|...|+|.+...-+    .+..+++.+|+.+... ..+|++|.+||....+..++|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            344556799999999999888 8999999999986433    3444667788887655 579999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          221 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .||.+.- +|..+..+     ..+++..+-+++..+++||.|||++ .+||||+||+||||+.+|+||+||||.+-....
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            9999976 77766542     3588999999999999999999987 899999999999999999999999999876544


Q ss_pred             CCccc-CCCCcccccccccccc--ccCCCchhhHHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCC
Q 014986          295 NDVKS-CRGTAFWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPPIP  363 (415)
Q Consensus       295 ~~~~~-~~gt~~y~aPE~l~~~--~~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~  363 (415)
                      .-..+ -.|--.|||||.++..  .+.|+.++||||||+.+.||.+++.||... ...+++..+.....+.+|
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence            43333 3466779999998643  335999999999999999999999999764 345566666554444333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=6.8e-35  Score=275.27  Aligned_cols=256  Identities=29%  Similarity=0.443  Sum_probs=201.7

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-C---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD  212 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  212 (415)
                      ..+.+.|.+.++||+|+|++||++++ .   ..+.||+|.+.....       ..++.+|+++|..+ .+.||+++.+++
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhhh
Confidence            34566899999999999999999988 4   678999999875332       24577999999988 499999999999


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEeeccccc
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKA  291 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~DFGla~~  291 (415)
                      ..+++..+||||++.....+++..  ++...++.|++.++.||+++|.+|||||||||.|||.+. .+.-.|+|||||..
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            999999999999999988888776  556779999999999999999999999999999999985 47899999999862


Q ss_pred             cc-----------------c-----------------CC------------cccCCCCccccccccccccccCCCchhhH
Q 014986          292 TK-----------------L-----------------ND------------VKSCRGTAFWMAPEVINNKNKGYGLPADI  325 (415)
Q Consensus       292 ~~-----------------~-----------------~~------------~~~~~gt~~y~aPE~l~~~~~~~~~~~Dv  325 (415)
                      ..                 .                 ..            .....||++|+|||++...+ ..+.++||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~QttaiDi  261 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQTTAIDI  261 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-CcCCccce
Confidence            10                 0                 00            00123999999999997654 36889999


Q ss_pred             HHHHHHHHHHHcCCCCCCCc-cHHHHHHHH------------h----c-----------------C--------------
Q 014986          326 WSLGCTVLEMLTSQIPYAPM-ECMAALFKI------------G----R-----------------G--------------  357 (415)
Q Consensus       326 wSlG~il~ell~g~~pf~~~-~~~~~~~~i------------~----~-----------------~--------------  357 (415)
                      ||.|+|+..+++++.||-.. ...+.+..+            .    .                 .              
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999998321 111111000            0    0                 0              


Q ss_pred             ---CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          358 ---SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       358 ---~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                         ......+..+..+.+|+.+||..||.+|+|++++|.||||......
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence               0001112345689999999999999999999999999999866543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=270.08  Aligned_cols=245  Identities=29%  Similarity=0.449  Sum_probs=189.1

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc--CCCCcEEEeeeeeecC--
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE--  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~--  215 (415)
                      +.....+.+.||+|.||.||+|.+ -|+.||||++...+.        ..+.+|.+|.+.  ++|+||+.+++....+  
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--------RSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch--------hhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            445678889999999999999987 578999999974332        234466666554  6999999999986543  


Q ss_pred             --CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEcCCCcEEEEe
Q 014986          216 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       216 --~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~--------~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                        .+++||++|.+.|+|+++|+++.++-..+.+++..++.||+|||..        .|.|||||..|||+..+|.+.|+|
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence              3689999999999999999999999999999999999999999953        499999999999999999999999


Q ss_pred             eccccccccCC------cccCCCCccccccccccccccC----CCchhhHHHHHHHHHHHHcC----------CCCCCCc
Q 014986          286 FGLAKATKLND------VKSCRGTAFWMAPEVINNKNKG----YGLPADIWSLGCTVLEMLTS----------QIPYAPM  345 (415)
Q Consensus       286 FGla~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~----~~~~~DvwSlG~il~ell~g----------~~pf~~~  345 (415)
                      +|||.......      ....+||-+|||||+++..-..    .-..+||||||.++||++.+          ++||.+.
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            99997554331      3445799999999999654211    12358999999999999873          5788543


Q ss_pred             c----HHHHHHHH--hcCCCCCCCCccc-----HHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          346 E----CMAALFKI--GRGSPPPIPDSLS-----KDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       346 ~----~~~~~~~i--~~~~~~~~~~~~s-----~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .    ..+...++  .+..++.+|....     ..+..|++.||..||.-|.|+-.|.+
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            2    22333322  1223333443221     24667899999999999999877643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=280.33  Aligned_cols=203  Identities=30%  Similarity=0.487  Sum_probs=174.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchh---HHHHHHHHHHHHHHhcCC---CCcEEEeeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA---KQSISQLEQEIALLSRFE---HENIVQYYGTDK  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~---~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~  213 (415)
                      ...|..++.+|.|+||.|++|++ .+...|++|.+.+..-.-..   ...+-.+-.||.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            34689999999999999999999 66788999988642110000   001123446999999997   999999999999


Q ss_pred             cCCEEEEEEeccCC-CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          214 DESKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       214 ~~~~~~lV~E~~~~-gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      +++++||+||-... -+|++++.. ..+++.+++.|++|++.|+++||+.||||||||-+|+.++.+|.+||+|||.+..
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            99999999998744 489999975 4799999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  344 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~  344 (415)
                      .+........||..|.|||++.+. +..+..-|||+||++||.++....||++
T Consensus       720 ~ksgpfd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSGPFDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCCCcceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            998889999999999999999654 4468889999999999999999999975

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=290.78  Aligned_cols=256  Identities=39%  Similarity=0.621  Sum_probs=217.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ..+|++...+|.|+||.||+|++ .+++..|+|.|+..     ....+.-+.+|+-+++.++|||||.+++.+...+.++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-----p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-----PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeecc-----CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            46789999999999999999999 89999999999852     2334556779999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CC
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--ND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~  296 (415)
                      |.||||.+|+|.+...- ..+++.++....+..++||+|||+.|=+|||||-.|||++..|.+|++|||.+..+..  ..
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            99999999999998765 4689999999999999999999999999999999999999999999999998765432  23


Q ss_pred             cccCCCCcccccccccc-ccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----CCCcccHHHH
Q 014986          297 VKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----IPDSLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~-~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~s~~l~  371 (415)
                      .++..||++|||||+-. +....|.+..|||++|+...|+---+.|--....+..++-..+....+    .+...++.+.
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence            45678999999999863 334458999999999999999987777765555566665554444332    2345788999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +|++.+|..+|++||+++.+|.|||..+-.
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccch
Confidence            999999999999999999999999987754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=286.15  Aligned_cols=244  Identities=28%  Similarity=0.485  Sum_probs=208.7

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ..+..++||.|+||+||+|++ ..++    +||+|++...    ...+.-..+..|+-+|.+++|||++++++++.... 
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            456678999999999999998 4444    6777776532    23334467889999999999999999999998766 


Q ss_pred             EEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +.||++|+++|.|.++++..  .+-....+.|..||++||.|||.+.++||||-..|||+..-..+||.|||+++.....
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            88999999999999998753  5777888999999999999999999999999999999999999999999999876554


Q ss_pred             Ccc----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          296 DVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       296 ~~~----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ...    .....+.|||=|.+....  |+.++|||||||.+||++| |..|+.+....+.-.-+..+.+.+.|+.++.++
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~--~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRK--YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccC--CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHH
Confidence            322    122356699999885443  8999999999999999998 999999998888887888888888899999999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHc
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..++.+||..|+..||+++++..
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999998864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.2e-31  Score=240.32  Aligned_cols=209  Identities=41%  Similarity=0.694  Sum_probs=184.8

Q ss_pred             cccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      ||+|++|.||++.. .+++.+++|++.......    ....+.+|+..++.+.|++|+++++++......+++||++.++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            68999999999998 559999999987532211    3467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEeeccccccccCC--cccCCCC
Q 014986          229 SLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--VKSCRGT  303 (415)
Q Consensus       229 sL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~DFGla~~~~~~~--~~~~~gt  303 (415)
                      +|..++...  .++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+.......  .....+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999875  6899999999999999999999999999999999999998 8999999999998665543  4445588


Q ss_pred             ccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 014986          304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  383 (415)
Q Consensus       304 ~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  383 (415)
                      ..|++||.+... ..++.++|+|+||+++++|                                ..+.+++.+||..||.
T Consensus       157 ~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~  203 (215)
T cd00180         157 PAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE  203 (215)
T ss_pred             CCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcc
Confidence            899999998553 2478899999999999999                                6789999999999999


Q ss_pred             CCCCHHHHHcCh
Q 014986          384 DRPTAAQLLDHP  395 (415)
Q Consensus       384 ~Rps~~eil~hp  395 (415)
                      +||++.++++|+
T Consensus       204 ~R~~~~~l~~~~  215 (215)
T cd00180         204 KRPSAKEILEHL  215 (215)
T ss_pred             cCcCHHHHhhCC
Confidence            999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=249.78  Aligned_cols=259  Identities=22%  Similarity=0.322  Sum_probs=205.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeee-eeecC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG-TDKDE  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-~~~~~  215 (415)
                      .+.+.|.+.+.||+|.||.+.++.+ .++..+++|.+..      .....+.|.+|...--.| .|.||+.-|+ .|++.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            3467899999999999999999999 7888999998863      233456788898876666 4899998876 58888


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-C-CCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-A-NGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-~-~~~vkl~DFGla~~~~  293 (415)
                      +.++++|||++.|+|..-+...++-+...+.++.|+++||.|||+++++|||||.+||||- . ..+|||||||+.+..+
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            8999999999999999999889999999999999999999999999999999999999994 2 3489999999987654


Q ss_pred             cCCcccCCCCcccccccccccccc---CCCchhhHHHHHHHHHHHHcCCCCCCCccHHH----HHHHHhcCCC---CCCC
Q 014986          294 LNDVKSCRGTAFWMAPEVINNKNK---GYGLPADIWSLGCTVLEMLTSQIPYAPMECMA----ALFKIGRGSP---PPIP  363 (415)
Q Consensus       294 ~~~~~~~~gt~~y~aPE~l~~~~~---~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~---~~~~  363 (415)
                      .. .....-+..|.+||++.....   .....+|+|.||+++|.+|+|++||......+    ...+-..+..   +...
T Consensus       175 ~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  175 TT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             ce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence            22 222335667999998754321   24678999999999999999999997432211    1112222222   2233


Q ss_pred             CcccHHHHHHHHHhhhhCCCCC---CCHHHHHcChhhHhhhhhC
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~R---ps~~eil~hp~f~~~~~~~  404 (415)
                      ..+++.+..+.++-|..++++|   .++.......|......+.
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~  297 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTV  297 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccc
Confidence            4678999999999999999999   6777777888887776644

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.8e-30  Score=236.71  Aligned_cols=213  Identities=37%  Similarity=0.610  Sum_probs=178.7

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      |.+.+.||.|++|.||++.. .+++.+|+|.+......    .....+.+|+..+..++|+|++++++.+......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            56778899999999999998 45899999998753221    24567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC---Cc
Q 014986          223 ELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---DV  297 (415)
Q Consensus       223 E~~~~gsL~~~l~~~~--l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~---~~  297 (415)
                      |++.+++|.+++....  +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++......   ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999999987654  899999999999999999999999999999999999999999999999998866543   22


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC-ccHH-HHHHHHhcCCCCC
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECM-AALFKIGRGSPPP  361 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~-~~~~~i~~~~~~~  361 (415)
                      ....++..|++||.+. ....++.++|+|+||+++++|++|+.||.. .... .....+..+.+.+
T Consensus       157 ~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (225)
T smart00221      157 KTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL  221 (225)
T ss_pred             cceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence            3445788899999985 334467799999999999999999999977 4444 4444555544343

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=243.62  Aligned_cols=246  Identities=26%  Similarity=0.428  Sum_probs=205.6

Q ss_pred             ecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      ..+++...++-+|+||+||.|++.      +.+.+-+|.++.    ..+.-+...+..|.-++..+.|||+..+.++..+
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            345777888999999999999763      344556665542    2234455678899999999999999999987654


Q ss_pred             -CCEEEEEEeccCCCCHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 014986          215 -ESKLYIFLELVTKGSLLNLYQRY---------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  284 (415)
Q Consensus       215 -~~~~~lV~E~~~~gsL~~~l~~~---------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~  284 (415)
                       ....+.++.+..-|+|..++...         .++..+...++.|++.|++|||++||||.||...|++|+..-+|||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence             45567888899999999988732         25667778899999999999999999999999999999999999999


Q ss_pred             eeccccccccCCcccCCC-----CccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Q 014986          285 DFGLAKATKLNDVKSCRG-----TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  358 (415)
Q Consensus       285 DFGla~~~~~~~~~~~~g-----t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  358 (415)
                      |=.|++...+.+.. +.|     ...||+||.+....  |+.++|+||||++||||++ |+.||...+..+...-+..+.
T Consensus       439 DsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n~~--yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy  515 (563)
T KOG1024|consen  439 DSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY  515 (563)
T ss_pred             cchhccccCccccc-ccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence            99999876655432 223     45699999996544  8999999999999999998 999999998888888888888


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +...|-.+|+++..++.-||...|++||+++++..
T Consensus       516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            88889999999999999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.8e-31  Score=286.33  Aligned_cols=194  Identities=15%  Similarity=0.214  Sum_probs=142.6

Q ss_pred             CcEEEeeeee-------ecCCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014986          203 ENIVQYYGTD-------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  273 (415)
Q Consensus       203 pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NI  273 (415)
                      .||++++++|       .....++++||++ +++|.+++..  ..+++..++.+++||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4677777766       2334678889987 4599999964  3589999999999999999999999999999999999


Q ss_pred             EEcCC-------------------CcEEEEeeccccccccC------------------CcccCCCCccccccccccccc
Q 014986          274 LVDAN-------------------GSVKLADFGLAKATKLN------------------DVKSCRGTAFWMAPEVINNKN  316 (415)
Q Consensus       274 Ll~~~-------------------~~vkl~DFGla~~~~~~------------------~~~~~~gt~~y~aPE~l~~~~  316 (415)
                      ||+..                   +.+||+|||+++.....                  ......||+.|||||++.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99654                   44556666665432100                  001135788999999986544


Q ss_pred             cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       317 ~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                        ++.++|||||||+||||++|..|+.....  ....+.....++..........+++.+||.++|.+||++.+|++|||
T Consensus       192 --~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        192 --SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             --CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence              89999999999999999999988764321  11111111111111122445678999999999999999999999999


Q ss_pred             hHhhh
Q 014986          397 VKRLL  401 (415)
Q Consensus       397 f~~~~  401 (415)
                      |+...
T Consensus       268 ~~~~~  272 (793)
T PLN00181        268 INEPR  272 (793)
T ss_pred             hhhhh
Confidence            98753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=9e-29  Score=218.24  Aligned_cols=161  Identities=31%  Similarity=0.409  Sum_probs=128.5

Q ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCcc
Q 014986          228 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  305 (415)
Q Consensus       228 gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~  305 (415)
                      |+|.+++..  ..+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++......   ..||+.
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~g~~~   69 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SRVDPY   69 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---CCCccc
Confidence            689998874  35999999999999999999999998      999999999999999  99987654332   258999


Q ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH-HHHHHhcCCCCC------CCCcccH--HHHHHHHH
Q 014986          306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRGSPPP------IPDSLSK--DAQDFIKQ  376 (415)
Q Consensus       306 y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~------~~~~~s~--~l~~Li~~  376 (415)
                      |+|||++.+..  ++.++|||||||++|+|++|+.||....... .+..+.......      .+..++.  .+.+||.+
T Consensus        70 y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       70 FMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             ccChHHhcCCC--CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            99999996543  8899999999999999999999997643322 222222211111      1223344  69999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ||..||.+||++.++++|+|+....
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHHHH
Confidence            9999999999999999999987543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.5e-29  Score=259.30  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=200.5

Q ss_pred             ccccccccCCcEEEEEEEc-CCCcEEEEEEEeccc-ccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~-~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      ....++|.|++|.|+.+.. ...+.++.|.+.... ...........+..|+.+-..+.|+|++..+....+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999998888776 555556666554210 11122222233778888889999999998888777766666679


Q ss_pred             eccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC------
Q 014986          223 ELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN------  295 (415)
Q Consensus       223 E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~------  295 (415)
                      |||++ +|+.++... .++...+..+++|++.|++|||..||.|||||++|+++..+|.+||+|||.+......      
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 999999886 8999999999999999999999999999999999999999999999999998755432      


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhc-------CCCCCCCCccc
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGR-------GSPPPIPDSLS  367 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~-------~~~~~~~~~~s  367 (415)
                      .....+|+..|+|||++.+.. ......||||.|++++.|++|+.||......+..+ ....       .....+...++
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~-ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKE-YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhcCcccCCcCcCcccccccc-cCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence            234567999999999996654 23567999999999999999999997654333221 1111       11112334678


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ...+.+|.+||++||.+|.|+++|++.+||+.+..-
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            899999999999999999999999999999998653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-29  Score=250.24  Aligned_cols=241  Identities=28%  Similarity=0.470  Sum_probs=203.7

Q ss_pred             ccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEEEEEe
Q 014986          149 LLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      .+|.|+||.|++++.    ..+..||+|+.++.........   +...|..++..++ ||++|++...++.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999998753    5688999998876544333322   5567888888887 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCC
Q 014986          224 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG  302 (415)
Q Consensus       224 ~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~g  302 (415)
                      +..+|.|+..+... .+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.....  ||
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cg  155 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CG  155 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--cc
Confidence            99999999877654 5778888999999999999999999999999999999999999999999999865444333  89


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |..|||||+++    .+..++|+||||+++++|++|..||..    +....|. ......|..++..+++++..++..+|
T Consensus       156 t~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il-~~~~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  156 TYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL-KAELEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             chhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh-hhccCCchhhhHHHHHHHHHHHhhCH
Confidence            99999999996    267789999999999999999999987    3333333 33445788999999999999999999


Q ss_pred             CCCCC-----HHHHHcChhhHhhhhh
Q 014986          383 NDRPT-----AAQLLDHPFVKRLLAT  403 (415)
Q Consensus       383 ~~Rps-----~~eil~hp~f~~~~~~  403 (415)
                      .+|..     +.++++|+||+.+.-.
T Consensus       227 ~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  227 ENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHhccCcchhHHHhccchheeeeHh
Confidence            99975     5899999999987654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=3.9e-26  Score=217.40  Aligned_cols=257  Identities=35%  Similarity=0.509  Sum_probs=206.4

Q ss_pred             cccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC-cEEEeeeeeecCCEEEEEE
Q 014986          144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~  222 (415)
                      |.+.+.||.|+||.||++.+.  ..+++|.+........  .....+.+|+.++..+.|+ +|+++++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            677888999999999999887  7889998875333221  2456788999999999988 7999999998888899999


Q ss_pred             eccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEeeccccccccCC-
Q 014986          223 ELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND-  296 (415)
Q Consensus       223 E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~-  296 (415)
                      +++.++++.+++...    .+....+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++...... 
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999999777665    689999999999999999999999999999999999999988 79999999987544332 


Q ss_pred             -------cccCCCCccccccccccccc-cCCCchhhHHHHHHHHHHHHcCCCCCCCccH----HHHHHHHhcCCCC----
Q 014986          297 -------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSPP----  360 (415)
Q Consensus       297 -------~~~~~gt~~y~aPE~l~~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~----  360 (415)
                             .....||..|++||.+.+.. ..++...|+|++|++++++++|..||.....    ......+......    
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                   35567999999999986532 3478899999999999999999999877653    2333333222222    


Q ss_pred             CCCCcc----cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          361 PIPDSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       361 ~~~~~~----s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ......    ...+.+++.+++..+|..|.+..+...++|........
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~  285 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE  285 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence            111111    25789999999999999999999999887666554433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-27  Score=217.69  Aligned_cols=239  Identities=22%  Similarity=0.347  Sum_probs=187.2

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      +.-.|+++++||+|+||.+++|.+ -+++.||||.-..+..       ..+++.|.+..+.| ..++|...|.++++..+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCC-------cchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            344799999999999999999998 8999999997654322       24567787777776 47999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-----cEEEEeecccc
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFGLAK  290 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-----~vkl~DFGla~  290 (415)
                      -.||||++.- +|.+++.-  .+|+...+..++.|++.-++++|++++|+|||||+|+||..-+     .|.|+|||+|+
T Consensus        99 NiLVidLLGP-SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   99 NILVIDLLGP-SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhhhhCc-CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            9999999854 99998864  4699999999999999999999999999999999999997543     58999999998


Q ss_pred             ccccC---------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhcCC
Q 014986          291 ATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGS  358 (415)
Q Consensus       291 ~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~  358 (415)
                      .+...         ..++..||..||+-.-..+.  ..+.+.|+-|||.+++++|-|.+||.+..   ..+...+|+...
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            65433         34566799999997766554  48999999999999999999999998753   445555665444


Q ss_pred             CCCC----CCcccHHHHHHHHHhhhhCCCCCCCH
Q 014986          359 PPPI----PDSLSKDAQDFIKQCVQVNPNDRPTA  388 (415)
Q Consensus       359 ~~~~----~~~~s~~l~~Li~~~L~~dP~~Rps~  388 (415)
                      ...-    -..+|.++..-+.-.-..+-.+-|..
T Consensus       256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            3221    23456666555555444444444543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-26  Score=222.49  Aligned_cols=252  Identities=25%  Similarity=0.299  Sum_probs=192.0

Q ss_pred             ccccccccccCCcEEEEEEEcCC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC----CCcEEEeeeee-ecC
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE----HENIVQYYGTD-KDE  215 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~----hpnIv~l~~~~-~~~  215 (415)
                      .|.+.+.||+|+||.||++.+..  ...+|+|..........     ..+..|..++..+.    ..++..+++.+ ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            79999999999999999999844  35889988764221111     13557777777776    25899999999 588


Q ss_pred             CEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-----CcEEEEeec
Q 014986          216 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GSVKLADFG  287 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-----~~vkl~DFG  287 (415)
                      ...||||+.+.. +|.++...   ..++...+..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||
T Consensus        94 ~~~~iVM~l~G~-sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLLGP-SLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEeccCc-cHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            889999999855 89998754   369999999999999999999999999999999999999865     369999999


Q ss_pred             cccccc--cC---------C-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH---
Q 014986          288 LAKATK--LN---------D-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF---  352 (415)
Q Consensus       288 la~~~~--~~---------~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---  352 (415)
                      +++...  ..         . .....||..|+++.+..+.  ..+.+.|+||++.++.+|+.|.+||..........   
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            998221  11         1 1234599999999987554  48999999999999999999999997765322222   


Q ss_pred             HHhcCCCCC-CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          353 KIGRGSPPP-IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       353 ~i~~~~~~~-~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      +........ .....+..+.++...+-..+...+|....+...  |+......
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~--l~~~~~~~  301 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL--LKDVFDSE  301 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH--HHHHHHhc
Confidence            222221111 234456778888888888999999999888664  55555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.4e-26  Score=225.10  Aligned_cols=168  Identities=19%  Similarity=0.165  Sum_probs=130.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-C-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEE-eeeeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-D-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ-YYGTDK  213 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~-~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~  213 (415)
                      ...+...|.+.+.||+|+||+||+|++ . +++.+|||++...............+.+|+++|+.++|+||+. +++.  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            445667899999999999999999987 3 6788899987522110012234466899999999999999984 5543  


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEcCCCcEEEEeecccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL-kp~NILl~~~~~vkl~DFGla~~~  292 (415)
                        +..||||||+.|++|... ..  ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus        91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence              357999999999999632 21  11   2467899999999999999999999 999999999999999999999854


Q ss_pred             ccCC----------cccCCCCccccccccccc
Q 014986          293 KLND----------VKSCRGTAFWMAPEVINN  314 (415)
Q Consensus       293 ~~~~----------~~~~~gt~~y~aPE~l~~  314 (415)
                      ....          .....+++.|+|||.+..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            3322          234557888999999853

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=5.1e-26  Score=200.79  Aligned_cols=239  Identities=21%  Similarity=0.290  Sum_probs=184.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC-CcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~  217 (415)
                      ..+.|++++.||.|+||.+|+|.. .+|..||+|.-.....       ..++..|.++...+++ ..|..+..++.+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-------CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            457899999999999999999998 8999999997753221       2356678888888864 678888888888899


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEeecccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKAT  292 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vkl~DFGla~~~  292 (415)
                      -.+||+++. -+|.++++-  ..|+...++.++-|++.-++|+|.+++|||||||+|+|+.-+   ..+.|+||||++..
T Consensus        86 nvlVMdLLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeeccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            999999985 499998863  478999999999999999999999999999999999999743   57999999999865


Q ss_pred             ccC---------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHH---HHHHhcCCCC
Q 014986          293 KLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA---LFKIGRGSPP  360 (415)
Q Consensus       293 ~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~  360 (415)
                      ...         ......||..|.+-....+.  ..+...|+-|+|.+|.++.-|.+||.+......   ..+|......
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            322         23345699999997776443  378899999999999999999999987643322   2233222111


Q ss_pred             ----CCCCcccHHHHHHHHHhhhhCCCCCCCH
Q 014986          361 ----PIPDSLSKDAQDFIKQCVQVNPNDRPTA  388 (415)
Q Consensus       361 ----~~~~~~s~~l~~Li~~~L~~dP~~Rps~  388 (415)
                          .+-..+|.++...+.-|-..--++-|..
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence                1224567777777777766555555553

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=1.4e-24  Score=202.88  Aligned_cols=234  Identities=24%  Similarity=0.305  Sum_probs=152.0

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC----------CcEEEeeee
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH----------ENIVQYYGT  211 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h----------pnIv~l~~~  211 (415)
                      ....++.||.|+++.||.+++ .+++.+|+|++....  ......++++++|.-....+.+          -.++..++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            346678999999999999999 889999999998655  3344456777777655554332          122222222


Q ss_pred             e---------ecC---C-----EEEEEEeccCCCCHHHHHhh---cC-----CCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014986          212 D---------KDE---S-----KLYIFLELVTKGSLLNLYQR---YH-----LRDSQVSAYTRQILLGLKYLHDQDVVHR  266 (415)
Q Consensus       212 ~---------~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~-----l~~~~~~~i~~qil~aL~~LH~~~IiHr  266 (415)
                      .         ...   .     +.+++|+-+.+ +|.+++.-   ..     +.......+..|++..+++||..||+|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            1         111   1     23678887754 88776542   11     2223335566999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCcccccccccccc------ccCCCchhhHHHHHHHHHHHHcCCC
Q 014986          267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK------NKGYGLPADIWSLGCTVLEMLTSQI  340 (415)
Q Consensus       267 DLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~~DvwSlG~il~ell~g~~  340 (415)
                      ||+|+|+|++.+|.++|+||+.....+..... ...+..|.+||.....      ...++.+.|.|+||+++|.|+|+..
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999999977655433222 3356779999986432      1237889999999999999999999


Q ss_pred             CCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCC
Q 014986          341 PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR  385 (415)
Q Consensus       341 pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  385 (415)
                      ||...........    ...... .+++.++.||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9976532211110    111223 788999999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=6.6e-25  Score=227.27  Aligned_cols=218  Identities=29%  Similarity=0.463  Sum_probs=165.3

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      .-.+|..+++|..|+||.||++++ .+.+.+|+| +.+.      ..   -+++   ++.....|++|            
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq------~l---ilRn---ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ------NL---ILRN---ILTFAGNPFVV------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-cccc------ch---hhhc---cccccCCccee------------
Confidence            346788999999999999999998 578889994 3210      00   0111   45555566666            


Q ss_pred             EEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          219 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                               |+-..+++.. .++.        +++.+++|||+.||+|||+||+|.+|+.-|++|++|||+.+.....  
T Consensus       136 ---------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence                     3334444432 2322        2388999999999999999999999999999999999998643211  


Q ss_pred             ---------------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-
Q 014986          296 ---------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-  359 (415)
Q Consensus       296 ---------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-  359 (415)
                                     ..+..+||+.|+|||++...+  |+..+|||++|+|+|+++.|+.||.+....+.+........ 
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg--ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhc--cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                           134568999999999996544  99999999999999999999999988766655555443322 


Q ss_pred             -CCCCCcccHHHHHHHHHhhhhCCCCCC---CHHHHHcChhhHhhh
Q 014986          360 -PPIPDSLSKDAQDFIKQCVQVNPNDRP---TAAQLLDHPFVKRLL  401 (415)
Q Consensus       360 -~~~~~~~s~~l~~Li~~~L~~dP~~Rp---s~~eil~hp~f~~~~  401 (415)
                       +.-.+.++.+++++|.++|+.+|..|.   .+-++.+|+||+.+.
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence             222456889999999999999999994   578889999998765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=4.5e-24  Score=190.80  Aligned_cols=144  Identities=17%  Similarity=0.162  Sum_probs=111.5

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchh---------------------HHHHHHHHHHHHHHhcCCCCcE
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA---------------------KQSISQLEQEIALLSRFEHENI  205 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~---------------------~~~~~~~~~E~~il~~l~hpnI  205 (415)
                      .+.||+|+||.||+|.+.+|+.||+|+++........                     ........+|++++..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999999753211110                     0012234569999999987766


Q ss_pred             EEeeeeeecCCEEEEEEeccCCCCHHHH-HhhcCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEcCCCcEEE
Q 014986          206 VQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       206 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~l~~~~~~~i~~qil~aL~~L-H~~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                      ..........  .+|||||++++++... +....++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L  158 (190)
T cd05147          82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI  158 (190)
T ss_pred             CCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence            4333322222  3899999999877654 4556789999999999999999999 799999999999999998 588999


Q ss_pred             Eeeccccccc
Q 014986          284 ADFGLAKATK  293 (415)
Q Consensus       284 ~DFGla~~~~  293 (415)
                      +|||+|....
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05147         159 IDVSQSVEHD  168 (190)
T ss_pred             EEccccccCC
Confidence            9999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-23  Score=197.38  Aligned_cols=264  Identities=23%  Similarity=0.341  Sum_probs=187.9

Q ss_pred             eeeecccccccccccCCcEEEEEEEcCC-C-----------------------------------cEEEEEEEecccccc
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISDD-G-----------------------------------FFFAVKEVSLLDQGS  181 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~-----------------------------------~~vavK~i~~~~~~~  181 (415)
                      +..+++|+++..||+|.-..||.|+..+ +                                   -+.|+|.+...+..+
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            3457889999999999999999886421 0                                   123444443333333


Q ss_pred             hhHHHHHHHHHHH------H-----------HHh----c-CCCCcEEEeeeeeec-------------------------
Q 014986          182 QAKQSISQLEQEI------A-----------LLS----R-FEHENIVQYYGTDKD-------------------------  214 (415)
Q Consensus       182 ~~~~~~~~~~~E~------~-----------il~----~-l~hpnIv~l~~~~~~-------------------------  214 (415)
                      .....++.+-+|.      .           .+.    + -+|||||++.++|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence            3333333333331      0           111    1 259999999987643                         


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCC--cEEEEeecc
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADFGL  288 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~--~~~--~vkl~DFGl  288 (415)
                        ...+|+||..... +|..++.....+.....-++.|+++|+.|||++||.|||||.+|||+.  .|+  .+.|+|||+
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC  391 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC  391 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence              2358999998877 999999888899999999999999999999999999999999999985  333  489999998


Q ss_pred             ccccccCC--------cccCCCCccccccccccccccC----CCchhhHHHHHHHHHHHHcCCCCCCCccHHHH-HHHHh
Q 014986          289 AKATKLND--------VKSCRGTAFWMAPEVINNKNKG----YGLPADIWSLGCTVLEMLTSQIPYAPMECMAA-LFKIG  355 (415)
Q Consensus       289 a~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~----~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-~~~i~  355 (415)
                      |-..+...        .....|.-.-||||+.......    .-.++|.|+.|.+.||++....||+....+.. .....
T Consensus       392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq  471 (598)
T KOG4158|consen  392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ  471 (598)
T ss_pred             eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence            75433211        1223477789999998543221    12478999999999999999999987433211 11233


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHH---HHH------cChhhHhhhh
Q 014986          356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA---QLL------DHPFVKRLLA  402 (415)
Q Consensus       356 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~---eil------~hp~f~~~~~  402 (415)
                      ....+.+|+.+++.+++|+..+|+.||.+|++..   .+|      .|.|++....
T Consensus       472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~  527 (598)
T KOG4158|consen  472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMME  527 (598)
T ss_pred             hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcc
Confidence            4446778899999999999999999999999854   333      4666665543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.8e-23  Score=185.07  Aligned_cols=144  Identities=18%  Similarity=0.176  Sum_probs=113.9

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccc---------------------hhHHHHHHHHHHHHHHhcCCCCcE
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---------------------QAKQSISQLEQEIALLSRFEHENI  205 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~---------------------~~~~~~~~~~~E~~il~~l~hpnI  205 (415)
                      .+.||+|+||.||+|.+.+|+.||||++.......                     ........+.+|+..+..+.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            56899999999999998889999999988542110                     001112345689999999998887


Q ss_pred             EEeeeeeecCCEEEEEEeccCCCCHH-HHHhhcCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEE
Q 014986          206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       206 v~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                      .....+....  .||||||++|+++. ..+....++...+..++.|++.+|.+||. .||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l  158 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI  158 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence            5433333222  38999999988554 34566678888999999999999999999 9999999999999998 899999


Q ss_pred             Eeeccccccc
Q 014986          284 ADFGLAKATK  293 (415)
Q Consensus       284 ~DFGla~~~~  293 (415)
                      +|||+++...
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05145         159 IDVSQAVELD  168 (190)
T ss_pred             EEcccceecC
Confidence            9999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=5.2e-24  Score=193.37  Aligned_cols=174  Identities=16%  Similarity=0.161  Sum_probs=132.4

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHH------HHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      +.++|++.++||.|+||.||++.+ ++..+|+|++.......  .....      .+++|++.+.++.|++|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            456899999999999999999655 67789999987433222  22222      2689999999999999999888765


Q ss_pred             cC--------CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          214 DE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       214 ~~--------~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                      ..        ...+|||||++|.+|.++..   +++    ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            33        35799999999999987632   233    3466999999999999999999999999999988 99999


Q ss_pred             eccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHH
Q 014986          286 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML  336 (415)
Q Consensus       286 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell  336 (415)
                      ||............          .++...  .++.++|+|+||+.+..+.
T Consensus       178 fg~~~~~~e~~a~d----------~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAKD----------RIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhHH----------HHHHHh--HhcccccccceeEeehHHH
Confidence            99876543221111          022222  2567999999999877654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=4.9e-23  Score=183.31  Aligned_cols=187  Identities=17%  Similarity=0.099  Sum_probs=138.9

Q ss_pred             ccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEEEEEe
Q 014986          145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      .+...|++|+||+||++.. .+..++.+.+.....- ........+.+|+++|+++. |++|.+++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~-~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWW-LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhh-hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567799999999998766 7778877766532110 01111225789999999995 5788888886    34699999


Q ss_pred             ccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEcCCCcEEEEeeccccccccCCc-----
Q 014986          224 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKATKLNDV-----  297 (415)
Q Consensus       224 ~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL-kp~NILl~~~~~vkl~DFGla~~~~~~~~-----  297 (415)
                      |+.|.+|...+..      ....++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++........     
T Consensus        79 yI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         79 YLAGAAMYQRPPR------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             eecCccHHhhhhh------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence            9999998754322      12357889999999999999999999 79999999999999999999985543321     


Q ss_pred             c----------cCCCCccccccccccccccCCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 014986          298 K----------SCRGTAFWMAPEVINNKNKGYG-LPADIWSLGCTVLEMLTSQIPYAP  344 (415)
Q Consensus       298 ~----------~~~gt~~y~aPE~l~~~~~~~~-~~~DvwSlG~il~ell~g~~pf~~  344 (415)
                      .          -..+++.|+.|+....... .+ ...++++.|+.+|.++|+.+++..
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~-~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKR-TSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhcc-chhHHHHHHHhcchHHHHHhccCCccc
Confidence            0          1126788888886533221 23 467888999999999999988754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=5.2e-24  Score=220.90  Aligned_cols=244  Identities=22%  Similarity=0.261  Sum_probs=182.4

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      +|...+-||++.|=+|.+|.+..|. |+||++.+.+.... -....+...|++ ....++||.+.+.-+...+...|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~s-L~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTIS-LRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCC-chHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            5777888999999999999998887 89998876553322 233344445666 66678999999988888888889999


Q ss_pred             eccCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc-----CC
Q 014986          223 ELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----ND  296 (415)
Q Consensus       223 E~~~~gsL~~~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~-----~~  296 (415)
                      +|+.. +|.+.+.-.. +..-+.+.|+.|++.||..+|..||+|||||.+||||+.=+=+.|+||..-+....     .+
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99977 8888876554 56667888999999999999999999999999999999888899999976553221     11


Q ss_pred             cccCCCC----ccccccccccccc--------cC-CCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCC-
Q 014986          297 VKSCRGT----AFWMAPEVINNKN--------KG-YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP-  361 (415)
Q Consensus       297 ~~~~~gt----~~y~aPE~l~~~~--------~~-~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~-  361 (415)
                      ..-...|    ..|.|||.+....        .. .+.+-||||+||+++||++ |++||.-    .++.....+.... 
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDP  255 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCH
Confidence            2222223    3499999986522        11 4568899999999999998 7889853    2222222221000 


Q ss_pred             ---CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          362 ---IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       362 ---~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                         +...-+..++.||..|++.||.+|.++++.|+.
T Consensus       256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence               011123478999999999999999999999976

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-22  Score=180.54  Aligned_cols=241  Identities=20%  Similarity=0.362  Sum_probs=188.6

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      ...+..+|.+...|..|+|+++.+ .+++|++....-   ....-..|..|.-.|+-+.||||+.+++.+....++.++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~---t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREV---TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc-chhhhhhhhhhc---chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            344566788999999999998543 455666654221   1222356778888899999999999999999999999999


Q ss_pred             eccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEE--eeccccccccC
Q 014986          223 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLA--DFGLAKATKLN  295 (415)
Q Consensus       223 E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~~~vkl~--DFGla~~~~~~  295 (415)
                      .|++.|+|+..+...   -.+..++.+++.+|+.|++|||+..  |.---|....++|+.+-..+|.  |--++   .  
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---f--  341 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---F--  341 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---e--
Confidence            999999999998754   2677889999999999999999974  4444688889999988765553  32221   1  


Q ss_pred             CcccCCCCccccccccccccccC-CCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH-hcCCCCCCCCcccHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~L  373 (415)
                      ........|.||+||.+..+... .-.+.|+|||++++|||.|...||.....++.--++ ..+....+|+.++..+..|
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl  421 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL  421 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence            11223467889999999765443 235789999999999999999999887776655454 3566778999999999999


Q ss_pred             HHHhhhhCCCCCCCHHHHH
Q 014986          374 IKQCVQVNPNDRPTAAQLL  392 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil  392 (415)
                      ++-|++.||.+||.++.|+
T Consensus       422 m~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  422 MNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHhcCCCCcCCCcceeh
Confidence            9999999999999998764

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=2.7e-21  Score=174.74  Aligned_cols=133  Identities=22%  Similarity=0.322  Sum_probs=105.4

Q ss_pred             cccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-----CCCcEEEeeeeeecCC---
Q 014986          146 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-----EHENIVQYYGTDKDES---  216 (415)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---  216 (415)
                      -.++||+|+||.||.  + .+... +||++.....     .....+.+|+.+++.+     .||||++++++++++.   
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            346799999999996  5 44444 6888865221     1235688999999999     5799999999998874   


Q ss_pred             EEE-EEEec--cCCCCHHHHHhhcCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCcEEEcCC----CcEEEEeecc
Q 014986          217 KLY-IFLEL--VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL-KYLHDQDVVHRDIKCANILVDAN----GSVKLADFGL  288 (415)
Q Consensus       217 ~~~-lV~E~--~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL-~~LH~~~IiHrDLkp~NILl~~~----~~vkl~DFGl  288 (415)
                      .++ +||||  +.+|+|.+++++..+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            434 78999  558999999987777666  35678888777 99999999999999999999743    3799999543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.8e-21  Score=202.98  Aligned_cols=203  Identities=22%  Similarity=0.273  Sum_probs=154.2

Q ss_pred             CCCCCCcceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEee
Q 014986          130 NISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY  209 (415)
Q Consensus       130 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  209 (415)
                      ...+...+....+.|.|.+.||+|+||.||+|...+|+.||+|+-+....  ..-....+++.-++ +..  -+.|..+.
T Consensus       686 ~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~~q~~~RLk-~~~--~~~~~~~~  760 (974)
T KOG1166|consen  686 KLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYICLQVMERLK-PQM--LPSIMHIS  760 (974)
T ss_pred             ccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeehHHHHHhhc-hhh--hcchHHHH
Confidence            33444555666778999999999999999999997799999997653211  10001111211111 111  23455555


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-------CCcE
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSV  281 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-------~~~v  281 (415)
                      ..+.-.+.-++|+||.+.|+|.++++.. .+++..+..++.|++..|++||..+|||+||||+|+||..       .-.+
T Consensus       761 ~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  761 SAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             HHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence            5555566668999999999999999864 5899999999999999999999999999999999999953       2359


Q ss_pred             EEEeeccccccc---cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCC
Q 014986          282 KLADFGLAKATK---LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ  339 (415)
Q Consensus       282 kl~DFGla~~~~---~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~  339 (415)
                      +|+|||.+-.+.   .. .....++|-.+-.+|++.+..  |+..+|.|.|+.+++-||.|+
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHHHHHHHH
Confidence            999999875432   22 355677899999999996654  999999999999999999986

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.1e-20  Score=174.60  Aligned_cols=146  Identities=19%  Similarity=0.168  Sum_probs=113.5

Q ss_pred             ccccccccccCCcEEEEEEE-c-CCCcEEEEEEEecccccc-------------------hhHHHHHHHHHHHHHHhcCC
Q 014986          143 YWQKGDLLGRGSFGSVYEGI-S-DDGFFFAVKEVSLLDQGS-------------------QAKQSISQLEQEIALLSRFE  201 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~-~-~~~~~vavK~i~~~~~~~-------------------~~~~~~~~~~~E~~il~~l~  201 (415)
                      .|.+.+.||+|+||.||+|+ + .+|+.||+|++.......                   ........+.+|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999999 4 789999999987532110                   00112234678999999997


Q ss_pred             CCc--EEEeeeeeecCCEEEEEEeccCCCCHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEcC
Q 014986          202 HEN--IVQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDA  277 (415)
Q Consensus       202 hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l-~~~~l~~~~~~~i~~qil~aL~~LH~~~-IiHrDLkp~NILl~~  277 (415)
                      +.+  +.++++.    ...++||||+.+++|.... ....+....+..++.||+.+|.+||+.| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3344432    2348999999998887654 4445666677899999999999999999 99999999999998 


Q ss_pred             CCcEEEEeeccccccc
Q 014986          278 NGSVKLADFGLAKATK  293 (415)
Q Consensus       278 ~~~vkl~DFGla~~~~  293 (415)
                      ++.++|+|||++....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999876543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1e-19  Score=165.31  Aligned_cols=139  Identities=21%  Similarity=0.265  Sum_probs=114.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      +.||+|++|.||+|.. .+..+++|.........   ........+.+|+.++..+.|++|.....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 67789999765322111   1122335678899999999999887766666677788999999


Q ss_pred             cCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          225 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       225 ~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      ++|++|.+++.....   ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998865332   7788999999999999999999999999999998 88999999998765

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=4.8e-21  Score=186.80  Aligned_cols=175  Identities=28%  Similarity=0.463  Sum_probs=136.4

Q ss_pred             CEEEEEEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .++||.|++|...+|.+|+.+.    ..+....+.++.|+..|++|   +|.+|+|+||.||++..+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            3689999999999999999754    35667788999999999999   9999999999999999999999999999876


Q ss_pred             cccCC--------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCC
Q 014986          292 TKLND--------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI  362 (415)
Q Consensus       292 ~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  362 (415)
                      .....        .+.-.||..||+||.+.+..  |+.++||||||+||+||+. -...|   +.......+..+..++.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~  480 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPE  480 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChH
Confidence            54333        33456999999999997655  9999999999999999997 22222   22333334444433322


Q ss_pred             CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       363 ~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                      ...--+.-..|+.+||.+.|.+||++.+.--|.|.+
T Consensus       481 ~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  481 FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            111223456899999999999999888887777753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.3e-19  Score=163.29  Aligned_cols=143  Identities=20%  Similarity=0.191  Sum_probs=111.0

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccch-----------------hHHHHHHHHHHHHHHhcCCCCc-
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ-----------------AKQSISQLEQEIALLSRFEHEN-  204 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~-----------------~~~~~~~~~~E~~il~~l~hpn-  204 (415)
                      .|.+.+.||+|+||.||++...+++.||||++........                 .........+|+.++..+.|.+ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            3788899999999999999988899999998764221100                 0011223667899998887773 


Q ss_pred             -EEEeeeeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 014986          205 -IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       205 -Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                       +...++.    ...++||||+.|++|..+...     .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l  166 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI  166 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence             4444432    345899999999998765431     345678999999999999999999999999999999999999


Q ss_pred             Eeecccccccc
Q 014986          284 ADFGLAKATKL  294 (415)
Q Consensus       284 ~DFGla~~~~~  294 (415)
                      +|||++.....
T Consensus       167 iDfg~~~~~~~  177 (198)
T cd05144         167 IDWPQMVSTDH  177 (198)
T ss_pred             EECCccccCCC
Confidence            99999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.7e-19  Score=162.50  Aligned_cols=135  Identities=24%  Similarity=0.284  Sum_probs=107.8

Q ss_pred             ccccCCcEEEEEEEcCCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      +||+|+||.||+|.. ++..+++|.........   .......++.+|++++..+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 56789999865322111   12233467789999999998887654444445566679999999


Q ss_pred             CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          226 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       226 ~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      +|++|.+++.....      .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988754321      7899999999999999999999999999998 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=4.5e-19  Score=183.20  Aligned_cols=142  Identities=20%  Similarity=0.232  Sum_probs=112.6

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..|...++||+|+||+||++.+.... +++|+........   ........+.+|++++..++|++|+..+.++.+....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34566889999999999999874443 4444332211111   1222345688999999999999998877777777778


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ++||||+++++|.+++.       ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       412 ~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999998875       356789999999999999999999999999999 6789999999998653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.7e-19  Score=176.54  Aligned_cols=196  Identities=26%  Similarity=0.508  Sum_probs=154.5

Q ss_pred             HhcCCCCcEEEeeeeeecCCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCcE
Q 014986          197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDV-VHRDIKCANI  273 (415)
Q Consensus       197 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~I-iHrDLkp~NI  273 (415)
                      |+.+.|.|+.++++.+.+....++|.+||..|+|.+.+...  .+++.-...++++|+.||.|||...| .|+.|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45688999999999999999999999999999999988753  56777778899999999999999876 9999999999


Q ss_pred             EEcCCCcEEEEeecccccccc----CCcccCCCCcccccccccccccc-----CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014986          274 LVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVINNKNK-----GYGLPADIWSLGCTVLEMLTSQIPYAP  344 (415)
Q Consensus       274 Ll~~~~~vkl~DFGla~~~~~----~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~~DvwSlG~il~ell~g~~pf~~  344 (415)
                      +++....+||+|||+......    .......-..-|.|||.+.....     ..+.+.|+||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999866532    11122223455999999865311     136779999999999999999999975


Q ss_pred             c----cHHHHHHHHhcCCCCCC-CC-----cccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 014986          345 M----ECMAALFKIGRGSPPPI-PD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLL  392 (415)
Q Consensus       345 ~----~~~~~~~~i~~~~~~~~-~~-----~~s~~l~~Li~~~L~~dP~~Rps~~eil  392 (415)
                      .    ...+.+.++..+...++ |.     .+.+++..++++||.-+|..||++++|-
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            2    22344455544222221 21     3455789999999999999999998874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=5.1e-21  Score=197.80  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=203.1

Q ss_pred             cccccccccccCCcEEEEEEEc--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL  218 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  218 (415)
                      ..|.+.+-||+|+|+.|-....  .....+|+|.+....   .......+...|..+-..+. |.|++.+++...+....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            3566777799999999998876  445566777665432   23334455666787777776 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHH-hhc--CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCC-cEEEEeeccccccc
Q 014986          219 YIFLELVTKGSLLNLY-QRY--HLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANG-SVKLADFGLAKATK  293 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l-~~~--~l~~~~~~~i~~qil~aL~~LH-~~~IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~  293 (415)
                      +++++|..|++++.-+ ...  +.+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|....
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999877 432  6778889999999999999999 99999999999999999999 99999999998765


Q ss_pred             c-CC----cccCCC-CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH--HHhc--CCCCCCC
Q 014986          294 L-ND----VKSCRG-TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF--KIGR--GSPPPIP  363 (415)
Q Consensus       294 ~-~~----~~~~~g-t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~--~i~~--~~~~~~~  363 (415)
                      . +.    ....+| ++.|+|||...+. .......|+||.|+++..+++|..||..........  .+..  .......
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            5 22    334568 9999999998653 235778999999999999999999997654332211  1111  1112344


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ..++....+++.++|..+|..|.+..++..++|+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            678889999999999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=6.9e-18  Score=150.33  Aligned_cols=141  Identities=23%  Similarity=0.252  Sum_probs=99.4

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHH-------------------HHHHHHHHHHHhcCCCCc--E
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-------------------ISQLEQEIALLSRFEHEN--I  205 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~-------------------~~~~~~E~~il~~l~hpn--I  205 (415)
                      .+.||+|+||+||+|.+.+++.||||++............                   ......|...+..+.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5679999999999999888999999988743211111100                   011135566666554332  3


Q ss_pred             EEeeeeeecCCEEEEEEeccCCCCHHH-HHhhcCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEE
Q 014986          206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       206 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                      .++++.    ...++||||+.++.+.. .+...... ..+..++.+++.++.++|. .||+||||||+||+++ ++.++|
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l  155 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI  155 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence            344433    23589999999954321 12221111 5678899999999999999 9999999999999999 999999


Q ss_pred             Eeeccccccc
Q 014986          284 ADFGLAKATK  293 (415)
Q Consensus       284 ~DFGla~~~~  293 (415)
                      +|||.+....
T Consensus       156 iDfg~a~~~~  165 (187)
T cd05119         156 IDVPQAVEID  165 (187)
T ss_pred             EECccccccc
Confidence            9999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=2e-17  Score=153.16  Aligned_cols=141  Identities=18%  Similarity=0.214  Sum_probs=106.2

Q ss_pred             ccccc-cCCcEEEEEEEcCCCcEEEEEEEecccc--------cchhHHHHHHHHHHHHHHhcCCCCcE--EEeeeeeecC
Q 014986          147 GDLLG-RGSFGSVYEGISDDGFFFAVKEVSLLDQ--------GSQAKQSISQLEQEIALLSRFEHENI--VQYYGTDKDE  215 (415)
Q Consensus       147 ~~~LG-~G~~g~Vy~~~~~~~~~vavK~i~~~~~--------~~~~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~  215 (415)
                      ...|| .|+.|+||.+... +..++||.+.....        ..........+.+|+.++..+.|++|  +..++.....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34577 7888888888664 77899998753111        00111234567889999999998775  6666654332


Q ss_pred             -C---EEEEEEeccCC-CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          216 -S---KLYIFLELVTK-GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       216 -~---~~~lV~E~~~~-gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                       .   ..++|||+++| .+|.+++....+++.    .+.||+.+|.+||++||+||||||.|||++.++.++|+|||.+.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence             2   23599999997 689988877666654    36789999999999999999999999999999999999999876


Q ss_pred             cc
Q 014986          291 AT  292 (415)
Q Consensus       291 ~~  292 (415)
                      ..
T Consensus       191 ~~  192 (239)
T PRK01723        191 LR  192 (239)
T ss_pred             cC
Confidence            53

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.4e-16  Score=135.58  Aligned_cols=131  Identities=21%  Similarity=0.247  Sum_probs=109.6

Q ss_pred             cccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC--CcEEEeeeeeecCCEEEEEEe
Q 014986          146 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E  223 (415)
                      +.+.||.|.++.||++...+ ..+++|.+.....       ...+.+|+.++..++|  .++.+++..+...+..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            35679999999999998854 7899998753221       3467789999998876  588899888888888999999


Q ss_pred             ccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          224 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       224 ~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~---~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      |+.++.+..+      +......++.+++.+|++||..   +++|+||+|.||+++..+.++++|||++.
T Consensus        74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            9999877644      4556677899999999999985   69999999999999998999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=8.7e-17  Score=167.58  Aligned_cols=262  Identities=21%  Similarity=0.270  Sum_probs=205.3

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +......+.+.+-+-+|+++.++.+.- .++-..+.|.......-  ....++...++-+++-...+|.++.....+...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i--~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI--RTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhh--ccccccccCCccCccccCCCCceecccCCCCCC
Confidence            455667888888999999999999876 45656666654432111  111233344555556666789999888888888


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~-l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ...++||+|+.+++|...+...+ .+.+.++.++..+..++++||...+.|+|++|.|+|+..+|+.++.|||.......
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            89999999999999999887754 77778888999999999999999999999999999999999999999984321100


Q ss_pred             ---------------------------------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCC
Q 014986          295 ---------------------------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP  341 (415)
Q Consensus       295 ---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~p  341 (415)
                                                       .......||+.|.+||.+.+..  ....+|+|++|+++++.++|..|
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~--hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR--HGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc--CCCcchhhhhhhhhhhhhcCCCC
Confidence                                             0012345899999999997765  67789999999999999999999


Q ss_pred             CCCccHHHHHHHHhcCCCC--CCCCcccHHHHHHHHHhhhhCCCCCCCHH---HHHcChhhHhhhh
Q 014986          342 YAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFIKQCVQVNPNDRPTAA---QLLDHPFVKRLLA  402 (415)
Q Consensus       342 f~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~~L~~dP~~Rps~~---eil~hp~f~~~~~  402 (415)
                      |......+....+.+...+  ..+...+..+++++..+|..+|.+|..+.   ++-.|+||+...-
T Consensus      1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred             CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence            9887777666666554432  23557899999999999999999999887   8899999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=4e-16  Score=155.21  Aligned_cols=251  Identities=25%  Similarity=0.298  Sum_probs=189.5

Q ss_pred             eccccccccccc--CCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGR--GSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~--G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  214 (415)
                      ...|.+...+|.  |.+|.||.+..   .++..+|+|.-+......   .....-.+|+.....++ |+|.++.+..+..
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p---~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP---LDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc---cccccccchhhcccccCccccccccCccccc
Confidence            345667788999  99999999876   568899999743221111   11111235665555664 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeec
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILL----GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFG  287 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~----aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFG  287 (415)
                      .+..|+-+|+|. .+|..+...  ..+++..++..+.+...    ||.++|..+|+|-|+||.||++..+ ...+++|||
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            999999999997 477776643  34788889999999999    9999999999999999999999999 889999999


Q ss_pred             cccccccCCccc-------CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc--cHHHHHHHHhcCC
Q 014986          288 LAKATKLNDVKS-------CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGS  358 (415)
Q Consensus       288 la~~~~~~~~~~-------~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~  358 (415)
                      +...+.......       ..|...|++||.+++.   ++.+.|+|+||.++.+..++..++...  ....   .+.+..
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---~~r~~~  342 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---QLRQGY  342 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHhhcccccCCCCCCcc---cccccc
Confidence            998776554322       2477889999998654   678999999999999998876665432  1111   111111


Q ss_pred             -CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          359 -PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       359 -~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                       ...+-...+..+...+..|++.+|..|++++.+++|+++....
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence             1122345567778899999999999999999999999987543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=9.2e-15  Score=146.79  Aligned_cols=143  Identities=20%  Similarity=0.124  Sum_probs=98.1

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchh-----------------------------HHHH------HHHHH
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----------------------------KQSI------SQLEQ  192 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~-----------------------------~~~~------~~~~~  192 (415)
                      +.||.|++|.||+|+..+|+.||||+.+........                             ....      -.+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            579999999999999999999999998642111000                             0000      12445


Q ss_pred             HHHHHhcCC-----CCcEEEeeeeeecCCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHH-HHHHHHHCCce
Q 014986          193 EIALLSRFE-----HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILL-GLKYLHDQDVV  264 (415)
Q Consensus       193 E~~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~-aL~~LH~~~Ii  264 (415)
                      |+..+..+.     +++|.-..-+.......+|||||++|++|.++...  .+..   ...++.+++. .+..+|..|++
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence            555555542     34332211112223446999999999999876543  2332   3445666665 47889999999


Q ss_pred             ecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          265 HRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       265 HrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      |+|+||.||+++.+|.++|+|||++....
T Consensus       280 H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       280 HADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=1e-13  Score=123.37  Aligned_cols=142  Identities=17%  Similarity=0.140  Sum_probs=103.4

Q ss_pred             ccccccCCcEEEEEEEcCC-------CcEEEEEEEecccc---------------------cchhHHHHHHHHHHHHHHh
Q 014986          147 GDLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQ---------------------GSQAKQSISQLEQEIALLS  198 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~-------~~~vavK~i~~~~~---------------------~~~~~~~~~~~~~E~~il~  198 (415)
                      ...||.|.-+.||.|...+       +..+|||+.+....                     ...........++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998743       58999998764110                     0111122234458999998


Q ss_pred             cCCC--CcEEEeeeeeecCCEEEEEEeccCCCCHH-HHHhhcCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEE
Q 014986          199 RFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANIL  274 (415)
Q Consensus       199 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~l~~~~~~~i~~qil~aL~~L-H~~~IiHrDLkp~NIL  274 (415)
                      ++..  -++.+++++    ...+|||||+.++.+. ..++...++...+..+..+++.+|..| |+.||+|+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8853  344555554    3458999999875442 234444566667778899999999999 8999999999999999


Q ss_pred             EcCCCcEEEEeeccccccc
Q 014986          275 VDANGSVKLADFGLAKATK  293 (415)
Q Consensus       275 l~~~~~vkl~DFGla~~~~  293 (415)
                      +. ++.+.|+|||.+....
T Consensus       158 ~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE-CCcEEEEECCCceeCC
Confidence            96 5789999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=7.4e-15  Score=135.81  Aligned_cols=198  Identities=25%  Similarity=0.393  Sum_probs=142.6

Q ss_pred             HHHHhcCCCCcEEEeeeeeecC-----CEEEEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-
Q 014986          194 IALLSRFEHENIVQYYGTDKDE-----SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD-  262 (415)
Q Consensus       194 ~~il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~-  262 (415)
                      +..|-++-|.|||+++.++.+.     ....+++||+..|+|..+|++.     .+.....++|+.||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            4445666799999998876543     4578999999999999998753     4777788899999999999999984 


Q ss_pred             -ceecCCCCCcEEEcCCCcEEEEeeccccc------cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHH
Q 014986          263 -VVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEM  335 (415)
Q Consensus       263 -IiHrDLkp~NILl~~~~~vkl~DFGla~~------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~el  335 (415)
                       |+|+++..+.|++..+|-+||+---....      ..........+-++|.+||.  +.....+.++|||++|.+..+|
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s--g~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES--GTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc--CcccccccchhhhhhhHHHHHH
Confidence             99999999999999999888863221111      00111222347788999996  3333456789999999999999


Q ss_pred             HcCCCCCCCccH----HHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          336 LTSQIPYAPMEC----MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       336 l~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ..+..--.+.+.    .+.+.....+..       ...-++++.+||+..|..||++.+++.||.+-+.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            988765332221    111111111111       1123578999999999999999999999976443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.52  E-value=3.2e-13  Score=135.99  Aligned_cols=162  Identities=25%  Similarity=0.362  Sum_probs=125.4

Q ss_pred             CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHH
Q 014986          164 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ  243 (415)
Q Consensus       164 ~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~  243 (415)
                      .++.++.|...+....     .......+-++.|+.++||||+++++.++.+..+|||+|.+.  .|...+++.+  ...
T Consensus        35 ~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--KEE  105 (690)
T ss_pred             ccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--HHH
Confidence            6788888887764222     334556678888999999999999999999999999999986  4666666533  667


Q ss_pred             HHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc--ccCCCCccccccccccccccCCC
Q 014986          244 VSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKGYG  320 (415)
Q Consensus       244 ~~~i~~qil~aL~~LH-~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~  320 (415)
                      +..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++........  ....---.|..|+.+...    .
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s----~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS----E  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc----c
Confidence            7888999999999997 67899999999999999999999999988754432221  111122236777765221    1


Q ss_pred             chhhHHHHHHHHHHHHcC
Q 014986          321 LPADIWSLGCTVLEMLTS  338 (415)
Q Consensus       321 ~~~DvwSlG~il~ell~g  338 (415)
                      ...|.|-|||++++++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            357999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=1.9e-14  Score=146.37  Aligned_cols=146  Identities=16%  Similarity=0.117  Sum_probs=94.0

Q ss_pred             eecccccccccccCCcEEEEEEEcCC-CcEEEEEEEecccccc-----------------------------hhHHHHHH
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS-----------------------------QAKQSISQ  189 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~-----------------------------~~~~~~~~  189 (415)
                      +...|.. +.||+|++|.||+|+..+ |+.||||+++......                             ...+..+.
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3445666 789999999999999865 9999999997421100                             00011122


Q ss_pred             ------HHHHHHHHhcCC----CCcEEEeeeeeec-CCEEEEEEeccCCCCHHHH--HhhcCC-----CHHHHHHHHHHH
Q 014986          190 ------LEQEIALLSRFE----HENIVQYYGTDKD-ESKLYIFLELVTKGSLLNL--YQRYHL-----RDSQVSAYTRQI  251 (415)
Q Consensus       190 ------~~~E~~il~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~l-----~~~~~~~i~~qi  251 (415)
                            +.+|+..+.++.    +...+.+-.++.+ ....+|||||+.|+.+.++  +...+.     .+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                  333444433332    3322332222221 3445799999999999774  333333     233334444444


Q ss_pred             HHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEeeccccccc
Q 014986          252 LLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKATK  293 (415)
Q Consensus       252 l~aL~~LH~~~IiHrDLkp~NILl~~~~----~vkl~DFGla~~~~  293 (415)
                             ...|++|+|+||.||+++.+|    .++++|||++....
T Consensus       277 -------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   469999999999999999888    99999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=7.4e-14  Score=139.12  Aligned_cols=255  Identities=24%  Similarity=0.204  Sum_probs=183.7

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  213 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  213 (415)
                      ......+|..+..||.|.|+.|+....  .++..|++|.+...-...  ...+. -..|+-+...+ .|.++++++..+.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASDIF-SLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--Hhhhc-chhhhhHhhHhhcccccCCCCCCcc
Confidence            344567899999999999999998653  678899999876422211  11112 22455555554 4888999888888


Q ss_pred             cCCEEEEEEeccCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeeccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKA  291 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFGla~~  291 (415)
                      ...+.|+-.|||.++++..... ..-+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||..+.
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence            8888889999999998765442 2246777889999999999999999999999999999999876 7889999998865


Q ss_pred             cccCCcccCCCCcccc-ccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          292 TKLNDVKSCRGTAFWM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ......... ...++. ..|++.. ...+..+.|++|||.-+.+.+++...-...   .....+..+..+..+ .....+
T Consensus       417 ~~~~~~~~~-~~~r~~p~~~~~~e-~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~-~~~~~~  490 (524)
T KOG0601|consen  417 LAFSSGVFH-HIDRLYPIAEILLE-DYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLP-GLKLQL  490 (524)
T ss_pred             cceeccccc-ccccccccchhhcc-ccccccccccccccccccccccCcccCccc---ccceeeecccccCCC-chHHhh
Confidence            322222222 333344 2555543 344788999999999999999986543221   122234444333333 344889


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +.+.+.++.+++..|+.+.++..|.=|.+.
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            999999999999999999999888766543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=1.8e-13  Score=119.70  Aligned_cols=126  Identities=21%  Similarity=0.192  Sum_probs=93.0

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCEEEEEEeccC
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +.|+.|.++.||++... ++.|++|.......      ....+.+|+.++..+.+.++ .+++....+  ..++||||++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~   74 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE   74 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence            56899999999998764 77899997653211      11234678888888765443 345554432  3479999999


Q ss_pred             CCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          227 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-----VHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       227 ~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~I-----iHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      |.++...       ......++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887643       11123467899999999999985     9999999999998 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=2.3e-12  Score=111.33  Aligned_cols=137  Identities=20%  Similarity=0.231  Sum_probs=102.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      .++++|+-+.+|.+... |..+++|.-..+.-.   ...+-...+..+|++++..++--.|.-.+-++.+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999998553 333555543222111   12233445677899999998766666555566677778999999


Q ss_pred             cCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          225 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       225 ~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ++|-.|.+.+...      ...++..+=.-+.-||..||+|+||.++||++..+ .+.++||||+...
T Consensus        81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence            9998888888765      24567778888899999999999999999999654 4999999998654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=2.5e-11  Score=104.50  Aligned_cols=146  Identities=23%  Similarity=0.268  Sum_probs=106.6

Q ss_pred             cccccccCCcEEEEEEEcCCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          146 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      .+.+|-+|+-+.|+++.+ .|+.+.||.-..+.-.   -..+-...+..+|++.|.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            457789999999999866 5677777754322211   123334567889999999887555554444555666668899


Q ss_pred             eccCCC-CHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEeecccccc
Q 014986          223 ELVTKG-SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKAT  292 (415)
Q Consensus       223 E~~~~g-sL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~---~vkl~DFGla~~~  292 (415)
                      ||++|. ++.+++...   .........++++|=+.|.-||..+|||+||..+||++..+|   .+.++|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999884 566666542   233334478899999999999999999999999999998665   3589999998654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.28  E-value=2.1e-11  Score=108.10  Aligned_cols=131  Identities=27%  Similarity=0.290  Sum_probs=87.3

Q ss_pred             EEEEEEcCCCcEEEEEEEeccc---------------------ccchhHHHHHHHHHHHHHHhcCCCCc--EEEeeeeee
Q 014986          157 SVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDK  213 (415)
Q Consensus       157 ~Vy~~~~~~~~~vavK~i~~~~---------------------~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~  213 (415)
                      .||.|...++..+|||..+...                     ............++|++.|..+..-+  +.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999999999999876421                     01122334566789999999997664  45666543 


Q ss_pred             cCCEEEEEEeccC--CCCHHHHHhhcCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          214 DESKLYIFLELVT--KGSLLNLYQRYHLRDSQVSAYTRQILLGLKY-LHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       214 ~~~~~~lV~E~~~--~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~-LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                       .  .+|||||++  |..+..+ ....++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.+.
T Consensus        80 -~--~~ivME~I~~~G~~~~~l-~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   80 -R--NVIVMEYIGEDGVPLPRL-KDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             -T--TEEEEE--EETTEEGGCH-HHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             -C--CEEEEEecCCCccchhhH-HhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence             2  279999998  5445433 33333345567788888886665 579999999999999999876 99999999876


Q ss_pred             ccc
Q 014986          291 ATK  293 (415)
Q Consensus       291 ~~~  293 (415)
                      ...
T Consensus       155 ~~~  157 (188)
T PF01163_consen  155 DSS  157 (188)
T ss_dssp             ETT
T ss_pred             ecC
Confidence            543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=1.4e-11  Score=112.30  Aligned_cols=139  Identities=19%  Similarity=0.202  Sum_probs=102.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC--cEEEeeeeeecC---CEEEEEE
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDE---SKLYIFL  222 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~---~~~~lV~  222 (415)
                      +.||.|.++.||++...+|+.+++|........    .....+.+|+.++..+.+.  .+.+++.+....   +..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            568999999999998866789999987532211    1234577899999988753  345666665543   3678999


Q ss_pred             eccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014986          223 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------  260 (415)
Q Consensus       223 E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------------------  260 (415)
                      ||++|.++...+....++......++.+++.+|..||+                                          
T Consensus        80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99999887664432345666666777777777777773                                          


Q ss_pred             --------------CCceecCCCCCcEEEcC--CCcEEEEeecccc
Q 014986          261 --------------QDVVHRDIKCANILVDA--NGSVKLADFGLAK  290 (415)
Q Consensus       261 --------------~~IiHrDLkp~NILl~~--~~~vkl~DFGla~  290 (415)
                                    ..++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          23699999999999998  5678999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=9.5e-10  Score=108.11  Aligned_cols=209  Identities=17%  Similarity=0.241  Sum_probs=150.0

Q ss_pred             cEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----CCEEEEEEeccCCC-
Q 014986          155 FGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLELVTKG-  228 (415)
Q Consensus       155 ~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~~g-  228 (415)
                      -.+.|+++. .+|..|++|.+.........+     ...-++.++++.|.|||++..+|.+    +..+++|++|.++. 
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-----~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK-----DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCccc-----chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            356899988 899999999984221111111     1244677899999999999998873    55689999998764 


Q ss_pred             CHHHHHh----------------hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          229 SLLNLYQ----------------RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       229 sL~~~l~----------------~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      +|.++.-                ..+.++..+|.|+.|+..||.++|+.|+.-+-|.+.+||++.+-+++|.-.|.....
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            7777541                113678899999999999999999999999999999999998888999888876555


Q ss_pred             ccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCC-CCCccHHHH-HHHHhcCCCCCCCCcccHHH
Q 014986          293 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAA-LFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       293 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ..+..            +-+.     .-++-|.=.||.+++.|.||..- +......+. +..        +-...+.++
T Consensus       444 ~~d~~------------~~le-----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------I~~~yS~D~  498 (655)
T KOG3741|consen  444 QEDPT------------EPLE-----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------ITTTYSTDL  498 (655)
T ss_pred             cCCCC------------cchh-----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------hhhhhhHHH
Confidence            43331            1121     12357888999999999999643 221111111 111        335678899


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +++|.-+...+++. -+..+++.|
T Consensus       499 rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  499 RNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHhcCccc-ccHHHHHHH
Confidence            99999998888886 566666543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=1.3e-09  Score=102.34  Aligned_cols=141  Identities=12%  Similarity=0.066  Sum_probs=93.3

Q ss_pred             cccCCcEEEEEEEcCCCcEEEEEEEecccccchhH------HHHHHHHHHHHHHhcCCCCcE--EEeeeeeec-----CC
Q 014986          150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK------QSISQLEQEIALLSRFEHENI--VQYYGTDKD-----ES  216 (415)
Q Consensus       150 LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~------~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~-----~~  216 (415)
                      +-......|+++. -+|+.|.||......-....+      .....+.+|...+..+..-+|  ..+++++..     ..
T Consensus        30 v~~~~~rrvvr~~-~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFE-LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEE-ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            3333334466653 356789999663211000000      001135688887777643332  223333322     23


Q ss_pred             EEEEEEeccCCC-CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-------CCcEEEEe
Q 014986          217 KLYIFLELVTKG-SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSVKLAD  285 (415)
Q Consensus       217 ~~~lV~E~~~~g-sL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-------~~~vkl~D  285 (415)
                      .-+||||++++- +|.+++..   ..........++.+++..+..||..||+|+||++.|||++.       ++.+.|+|
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            578999999986 78888753   34556677899999999999999999999999999999975       46899999


Q ss_pred             eccccc
Q 014986          286 FGLAKA  291 (415)
Q Consensus       286 FGla~~  291 (415)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            997753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.10  E-value=9.7e-10  Score=100.62  Aligned_cols=139  Identities=25%  Similarity=0.266  Sum_probs=105.2

Q ss_pred             cccccccccCCcEEEEEEEcCCCcEEEEEEEecc-----------------cccchhHHHHHHHHHHHHHHhcCCCC--c
Q 014986          144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL-----------------DQGSQAKQSISQLEQEIALLSRFEHE--N  204 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~-----------------~~~~~~~~~~~~~~~E~~il~~l~hp--n  204 (415)
                      +.++..||-|.-|.||.|.+..|..+|||.=+..                 ...+.........++|...|..+...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            5678899999999999999999999999964321                 01111123345567899999988654  4


Q ss_pred             EEEeeeeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 014986          205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  284 (415)
Q Consensus       205 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~  284 (415)
                      |.+.++    .+...+||||++|-.|...    ++.......++..|+.-+..+-..||+|+|+.+-||+++.||.+.++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI  244 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI  244 (304)
T ss_pred             CCCccc----cccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence            555554    3456899999999776542    22455666778888888888889999999999999999999999999


Q ss_pred             eecccc
Q 014986          285 DFGLAK  290 (415)
Q Consensus       285 DFGla~  290 (415)
                      ||=-+.
T Consensus       245 DwPQ~v  250 (304)
T COG0478         245 DWPQAV  250 (304)
T ss_pred             eCcccc
Confidence            996443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=2.2e-11  Score=123.31  Aligned_cols=152  Identities=22%  Similarity=0.280  Sum_probs=112.5

Q ss_pred             HHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc-----------cCCCCccccccccccccc
Q 014986          249 RQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-----------SCRGTAFWMAPEVINNKN  316 (415)
Q Consensus       249 ~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-----------~~~gt~~y~aPE~l~~~~  316 (415)
                      .+++.|+.|+|.. ++||+.|.|++|.++.+|..||+.|+++.........           -..-...|.|||.+.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3455999999976 8999999999999999999999999987654432111           112456799999997643


Q ss_pred             cCCCchhhHHHHHHHHHHHH-cCCCCCCCccHHHHHHHH---hcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 014986          317 KGYGLPADIWSLGCTVLEML-TSQIPYAPMECMAALFKI---GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL  392 (415)
Q Consensus       317 ~~~~~~~DvwSlG~il~ell-~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil  392 (415)
                        .+.++|+||||+++|.++ .|+.-+............   ......-....++.++++=|.++|..+...||++..++
T Consensus       186 --~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  186 --NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             --ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence              678999999999999999 555555433211111111   11111123467899999999999999999999999999


Q ss_pred             cChhhHhhhh
Q 014986          393 DHPFVKRLLA  402 (415)
Q Consensus       393 ~hp~f~~~~~  402 (415)
                      ..+||+....
T Consensus       264 ~~~ff~D~~~  273 (700)
T KOG2137|consen  264 SIPFFSDPGL  273 (700)
T ss_pred             cccccCCchh
Confidence            9999986543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=7.1e-09  Score=93.90  Aligned_cols=104  Identities=25%  Similarity=0.319  Sum_probs=79.0

Q ss_pred             HHHHHHHHHHhcCCCCcE--EEeeeeeecC----CEEEEEEeccCCC-CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH
Q 014986          188 SQLEQEIALLSRFEHENI--VQYYGTDKDE----SKLYIFLELVTKG-SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLH  259 (415)
Q Consensus       188 ~~~~~E~~il~~l~hpnI--v~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH  259 (415)
                      ....+|...+..+..-+|  .+.+++....    ...+||+|++++. +|.+++.. ...+......++.+++..++-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            345677777666643222  3334433321    3458999999885 78888876 34666778899999999999999


Q ss_pred             HCCceecCCCCCcEEEcCCC---cEEEEeeccccc
Q 014986          260 DQDVVHRDIKCANILVDANG---SVKLADFGLAKA  291 (415)
Q Consensus       260 ~~~IiHrDLkp~NILl~~~~---~vkl~DFGla~~  291 (415)
                      ..||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.90  E-value=1.7e-08  Score=91.59  Aligned_cols=141  Identities=18%  Similarity=0.198  Sum_probs=100.6

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEeccccc-------------------chhHHHHHHHHHHHHHHhcCCCC--cEE
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-------------------SQAKQSISQLEQEIALLSRFEHE--NIV  206 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~-------------------~~~~~~~~~~~~E~~il~~l~hp--nIv  206 (415)
                      ..|+.|.-+.||+|...++..+|+|+++.....                   ..........+.|+..|+.+..-  .+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            367788889999999989999999998742111                   11122233455677777776432  233


Q ss_pred             EeeeeeecCCEEEEEEeccCCCC-HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEE
Q 014986          207 QYYGTDKDESKLYIFLELVTKGS-LLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLA  284 (415)
Q Consensus       207 ~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~  284 (415)
                      +.+.+..    -.|||||++... -.-.|+...+....+..+..++++.+.-|-. .+++|+||+.-|||+. ++.+.|+
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI  208 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII  208 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence            4444332    379999997642 1223444455555788899999999999976 8999999999999998 8999999


Q ss_pred             eeccccccc
Q 014986          285 DFGLAKATK  293 (415)
Q Consensus       285 DFGla~~~~  293 (415)
                      |||-|....
T Consensus       209 D~~QaV~~~  217 (268)
T COG1718         209 DVSQAVTID  217 (268)
T ss_pred             ECccccccC
Confidence            999876554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.90  E-value=4.5e-08  Score=94.36  Aligned_cols=236  Identities=20%  Similarity=0.224  Sum_probs=149.9

Q ss_pred             ccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeee------eecCCE
Q 014986          145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT------DKDESK  217 (415)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~------~~~~~~  217 (415)
                      ..++-||+|+-+.+|-.-.  -...+.|++.........        +....|... .||-+-.-+.+      +.+...
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a--------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA--------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             CCCccccCCccceeeecch--hhchhheeecCCCchHHH--------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            3466799999999996432  112244555432211111        222334333 46644331211      222333


Q ss_pred             -EEEEEeccCCC-CHHHHHh------hc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          218 -LYIFLELVTKG-SLLNLYQ------RY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       218 -~~lV~E~~~~g-sL~~~l~------~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                       +-++|..+.+. ....++.      .+ ...+.-+.+.++.++.+.+.||..|.+-+|+.++|||++.++.|.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence             77889988775 2333332      11 367888899999999999999999999999999999999999999998654


Q ss_pred             ccccccCCc-ccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcC-CCCCCCccH-------HHH-H----
Q 014986          289 AKATKLNDV-KSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTS-QIPYAPMEC-------MAA-L----  351 (415)
Q Consensus       289 a~~~~~~~~-~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~-------~~~-~----  351 (415)
                      -........ .-..|.+.|.+||..+-.   +..-+...|.|.||++++++|.| +.||.+...       .+. +    
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            333322222 223489999999987521   22246678999999999999986 999976321       110 0    


Q ss_pred             ----HHHhcCCCCC---C-CCcccHHHHHHHHHhhhh--CCCCCCCHHH
Q 014986          352 ----FKIGRGSPPP---I-PDSLSKDAQDFIKQCVQV--NPNDRPTAAQ  390 (415)
Q Consensus       352 ----~~i~~~~~~~---~-~~~~s~~l~~Li~~~L~~--dP~~Rps~~e  390 (415)
                          .+...+..++   + ...++++++.|..+|+..  ++.-|||++.
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                0111111111   1 135788999999999975  3668999863

>PRK09902 hypothetical protein; Provisional

Probab=98.83  E-value=3.4e-08  Score=88.44  Aligned_cols=140  Identities=17%  Similarity=0.167  Sum_probs=97.8

Q ss_pred             cccCCcEEEEEEEcCCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHhcCCCCc--EEEeeeee--ec--CCEEEEEE
Q 014986          150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHEN--IVQYYGTD--KD--ESKLYIFL  222 (415)
Q Consensus       150 LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~-~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~--~~--~~~~~lV~  222 (415)
                      -|+||-+-|+.... .|+.|-+|.-...-..+.. ......+.+|+..|..+..-+  +.++....  ..  .-..+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            47789999998654 3346888865421111100 123456789998888875332  33333221  11  22468999


Q ss_pred             eccCC-CCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--EEEEeecccc
Q 014986          223 ELVTK-GSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK  290 (415)
Q Consensus       223 E~~~~-gsL~~~l~~~~---l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~--vkl~DFGla~  290 (415)
                      |-+.+ -+|.+++....   .+......++.+++..|.-||+.|+.|+|+-+.|||++.+|.  ++++||--++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 38888887644   466667889999999999999999999999999999987777  9999997554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.78  E-value=3.1e-08  Score=100.60  Aligned_cols=145  Identities=17%  Similarity=0.171  Sum_probs=94.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccc-------------------------hhHHHH----------HHHHH
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-------------------------QAKQSI----------SQLEQ  192 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~-------------------------~~~~~~----------~~~~~  192 (415)
                      +.|+.++-|.||+|+..+|+.||||+.+..-...                         .-...+          -.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5699999999999999999999999876411100                         000011          12334


Q ss_pred             HHHHHhcCC-----CCcEEEeeeeeecCCEEEEEEeccCCCCHHHH--HhhcCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014986          193 EIALLSRFE-----HENIVQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH  265 (415)
Q Consensus       193 E~~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~--l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiH  265 (415)
                      |+..+..++     .++|.-..-+.+-.+.-.|+|||+.|-.+.+.  ++..+++...+.....++  -+..+=..|++|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffH  288 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccc
Confidence            555555542     34332211122223445899999999888876  555667644443332222  233334489999


Q ss_pred             cCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          266 RDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       266 rDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .|.+|.||+++.+|++.+.|||+......
T Consensus       289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         289 ADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999866543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.68  E-value=2.7e-07  Score=83.03  Aligned_cols=137  Identities=15%  Similarity=0.171  Sum_probs=81.7

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHH------HHHHHHHHHhcCCC---CcEEEeee---
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEH---ENIVQYYG---  210 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~------~~~~E~~il~~l~h---pnIv~l~~---  210 (415)
                      +|...+++-......|.+. .-+++.+++|..+......  .+...      ...+++..+..++.   -.+..++.   
T Consensus        32 ~~~~~kv~k~~~r~~ValI-ei~~~kyIlK~pr~~~~r~--er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALI-EIDGKKYILKEPREENRRP--ERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CceEEEeecCCCccEEEEE-EECCcEEEEeccchhhhhH--HHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            4555555555444445443 2467888888766422211  11111      12233333333322   22222222   


Q ss_pred             --eeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          211 --TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       211 --~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                        .+.-....+|+|||++|..|.++..   +++    .+...+.+++.-||+.|++|+|..|.|++++. +.++++||+.
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~~  180 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQG  180 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECcc
Confidence              2223345679999999988765432   222    24567778899999999999999999999975 5599999986


Q ss_pred             cc
Q 014986          289 AK  290 (415)
Q Consensus       289 a~  290 (415)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.60  E-value=3.8e-07  Score=97.74  Aligned_cols=212  Identities=22%  Similarity=0.303  Sum_probs=149.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE----EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHH
Q 014986          184 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYL  258 (415)
Q Consensus       184 ~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~L  258 (415)
                      ++.+...+.|+..+..+.|+|++.++.+.......    .+..++|.+-++..+++. ...+....+.+..++++||+++
T Consensus       223 k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  223 KKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHH
Confidence            44556667788889999999999998876544332    344567888888887776 4578888999999999999999


Q ss_pred             HHCCceecCCCCC---cEEEcCCCcEEEE--eeccccccccCCc-ccCCCCccccccccccccccCCCchhhHHHHHHHH
Q 014986          259 HDQDVVHRDIKCA---NILVDANGSVKLA--DFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTV  332 (415)
Q Consensus       259 H~~~IiHrDLkp~---NILl~~~~~vkl~--DFGla~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il  332 (415)
                      |+....|.-|...   +...+..+.+.++  ||+..+....... .....+..+.++|.........+...|+|++|.++
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            9997666655554   4444556677777  8887766544332 22334566788888755543345567999999999


Q ss_pred             HHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          333 LEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       333 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      ..+..|..+-.......   .       -.+........+++.+|+.-++++|+++.+++.|+|.+--.....
T Consensus       383 ~~~~~~~~i~~~~~~~~---~-------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVPV---S-------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhhhcCcccccccchh---h-------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            99998765422111000   0       011122226788999999999999999999999999876554444

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.58  E-value=3.9e-09  Score=106.19  Aligned_cols=245  Identities=22%  Similarity=0.189  Sum_probs=170.4

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc-EEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~  219 (415)
                      .+.|....-+++|+++.+|+.+..-.+....+.+...          ....-++.+|.+++||| .+..++.++.+.+..
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~  310 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW  310 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence            3445666679999999999998854444457766531          22345788999999999 788888888899999


Q ss_pred             EEEeccCCC-CHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-
Q 014986          220 IFLELVTKG-SLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  295 (415)
Q Consensus       220 lV~E~~~~g-sL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-  295 (415)
                      ++|+++.++ +......  ...+.+.+...+.+.-+.++++||+.-=+|+|    ||+.. .+..+..||+........ 
T Consensus       311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc
Confidence            999999887 3222211  12344445566777888999999998878998    77764 478999999987655433 


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCccc------HH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLS------KD  369 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s------~~  369 (415)
                      ......+|+.++|||+.....  +....|.|++|.-..+|.-|.+|-....  .....+..+.  ..+...+      ..
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p--~s~~L~~~~aw~~~~  459 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGP--NSPMLTDKSAWSPVF  459 (829)
T ss_pred             ccccCCCCCCCCCchhhcccc--cccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCC--CccccchhhhcCccc
Confidence            244566999999999875443  7788999999987777777776653311  0111111111  0000011      11


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      -+++...|+...|..|+....++.|.+|.++-.....
T Consensus       460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~  496 (829)
T KOG0576|consen  460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHC  496 (829)
T ss_pred             ccCCcccccCCCCCCCcchhhHHHHHHhccCccccee
Confidence            1247788999999999999999999999988655443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.53  E-value=6.1e-07  Score=82.40  Aligned_cols=132  Identities=12%  Similarity=0.143  Sum_probs=80.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc--EEEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~  225 (415)
                      ..||.|..+.||+.   .+..+++|......       ....+.+|.++++.+..-+  +.+.+++..+.+...+|||++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            46899999999984   24467788765311       1233578888888875433  356677777777889999999


Q ss_pred             CCCC-HHHHH------------------h---hc---CCCHHH-HHHHHH----------HHHH-HHHHHHH----CCce
Q 014986          226 TKGS-LLNLY------------------Q---RY---HLRDSQ-VSAYTR----------QILL-GLKYLHD----QDVV  264 (415)
Q Consensus       226 ~~gs-L~~~l------------------~---~~---~l~~~~-~~~i~~----------qil~-aL~~LH~----~~Ii  264 (415)
                      .|.. +...+                  .   ..   ...... ...+..          .+.. ...+|..    ..++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            9963 11111                  0   00   011000 001100          0111 1222221    2478


Q ss_pred             ecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          265 HRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       265 HrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      |+|+.|.||+++.++ +.|+||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999998664

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=1.3e-06  Score=79.80  Aligned_cols=134  Identities=22%  Similarity=0.281  Sum_probs=78.9

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC--cEEEeeeee---ecCCEEEEEE
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTD---KDESKLYIFL  222 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~---~~~~~~~lV~  222 (415)
                      +.|+.|..+.||++...+ ..+++|....     .  .....+.+|..+++.+...  -+.+++...   ......+++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~-----~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRP-----P--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESS-----H--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCC-----C--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            568999999999998866 6999998653     1  3345666788887776422  234555432   3344579999


Q ss_pred             eccCCCCHHH----------------HHh---hc-----CCCHHH------HHH---------------HHHHHHH-HHH
Q 014986          223 ELVTKGSLLN----------------LYQ---RY-----HLRDSQ------VSA---------------YTRQILL-GLK  256 (415)
Q Consensus       223 E~~~~gsL~~----------------~l~---~~-----~l~~~~------~~~---------------i~~qil~-aL~  256 (415)
                      ++++|..+..                .+.   ..     .+....      ...               ....+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11     001000      000               0111222 333


Q ss_pred             HHHH-------CCceecCCCCCcEEEc-CCCcEEEEeeccc
Q 014986          257 YLHD-------QDVVHRDIKCANILVD-ANGSVKLADFGLA  289 (415)
Q Consensus       257 ~LH~-------~~IiHrDLkp~NILl~-~~~~vkl~DFGla  289 (415)
                      .+++       ..++|+|+.+.|||++ .++.+.|+||+.+
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence            3332       3599999999999999 6677789999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=1.5e-06  Score=88.23  Aligned_cols=145  Identities=17%  Similarity=0.140  Sum_probs=93.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchh--------------------------HHHHH------HHHHHHH
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA--------------------------KQSIS------QLEQEIA  195 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~--------------------------~~~~~------~~~~E~~  195 (415)
                      +.||.-+.|.||+|+.++|+.||||+-+..-.....                          .+..+      .|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            569999999999999999999999986532110000                          00001      1223433


Q ss_pred             HHhc----CCCCc------EEEeeeeeecCCEEEEEEeccCCCCHHH--HHhhcCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014986          196 LLSR----FEHEN------IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV  263 (415)
Q Consensus       196 il~~----l~hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~--~l~~~~l~~~~~~~i~~qil~aL~~LH~~~I  263 (415)
                      ...+    +.|-+      |.++|..+.  ..-.|+||||.|..+.+  .+.+.+++...+...+-++..-  -|=..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhcCC
Confidence            3222    23444      334443332  34589999999986654  5677788887654444443222  2234689


Q ss_pred             eecCCCCCcEEEcC----CCcEEEEeeccccccccCC
Q 014986          264 VHRDIKCANILVDA----NGSVKLADFGLAKATKLND  296 (415)
Q Consensus       264 iHrDLkp~NILl~~----~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+|=+|.||++..    ++.+.+-|||+........
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~  359 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT  359 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence            99999999999984    6789999999987665443

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.36  E-value=3.5e-06  Score=80.61  Aligned_cols=146  Identities=18%  Similarity=0.198  Sum_probs=103.9

Q ss_pred             ccccccccCCcEEEEEEEcCCCcEEEEEEEeccc---------------------ccchhHHHHHHHHHHHHHHhcCCCC
Q 014986          145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHE  203 (415)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~---------------------~~~~~~~~~~~~~~E~~il~~l~hp  203 (415)
                      .+-.+|..|.-+.||.|+..+|..+|||+++..-                     .....+-..-..+.|++.|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456788999999999999999999999875311                     0011122233456788888877654


Q ss_pred             cEEEeeeeeecCCEEEEEEeccCCCCH-HHHHhhcCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEcCCCcE
Q 014986          204 NIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSV  281 (415)
Q Consensus       204 nIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~l~~~~~~~i~~qil~aL~~L-H~~~IiHrDLkp~NILl~~~~~v  281 (415)
                      .|.-.--+..  ....|||+++.+... .-.|+...++...+..+-.|++.-+.-| |.+++||.||.--|+|+ .+|.+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            4321110000  123799999975322 3356667788888999999999999988 67799999999999999 68999


Q ss_pred             EEEeeccccccc
Q 014986          282 KLADFGLAKATK  293 (415)
Q Consensus       282 kl~DFGla~~~~  293 (415)
                      .|+|.+-+....
T Consensus       304 yiIDVSQSVE~D  315 (520)
T KOG2270|consen  304 YIIDVSQSVEHD  315 (520)
T ss_pred             EEEEccccccCC
Confidence            999999765443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.35  E-value=9.5e-06  Score=72.66  Aligned_cols=134  Identities=22%  Similarity=0.310  Sum_probs=95.3

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccc-----------hhHHHHHHHHHHHHHHhcCC------CCcEEEee
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-----------QAKQSISQLEQEIALLSRFE------HENIVQYY  209 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~-----------~~~~~~~~~~~E~~il~~l~------hpnIv~l~  209 (415)
                      ...||+|+.-.||.  +.+....+||+........           .......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            35699999999995  5666778889887533000           00112344556655554444      78899999


Q ss_pred             eeeecCCEEEEEEeccCC------CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--C--
Q 014986          210 GTDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--G--  279 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~--~--  279 (415)
                      |+.+++-..-+|+|.+..      -+|.+++....++. .   +...+-.-..+|-+.+|+.+||+|.||++...  +  
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~  159 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF  159 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence            999999999999998743      26888888777776 3   34444556678889999999999999999643  2  


Q ss_pred             cEEEEee
Q 014986          280 SVKLADF  286 (415)
Q Consensus       280 ~vkl~DF  286 (415)
                      .+.|+|-
T Consensus       160 ~lvlIDG  166 (199)
T PF10707_consen  160 RLVLIDG  166 (199)
T ss_pred             EEEEEeC
Confidence            4677764

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=2.9e-06  Score=73.28  Aligned_cols=128  Identities=20%  Similarity=0.159  Sum_probs=91.2

Q ss_pred             ccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEE-EeeeeeecCCEEEEEEe
Q 014986          145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-QYYGTDKDESKLYIFLE  223 (415)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lV~E  223 (415)
                      +..+.||+|++|.||++.+.. ..+|+|+-+..       .....++.|+++|..+.-.++- ++|.+..+    ++.||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d-------s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRD-------SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC-ceEEEEEecCC-------cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            456779999999999998754 47888866531       1234577899999888766654 45555443    45699


Q ss_pred             ccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCcEEEcCCCcEEEEeecccc
Q 014986          224 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK-CANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       224 ~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLk-p~NILl~~~~~vkl~DFGla~  290 (415)
                      |+.|-.|.++....  +    ++-+..++++---|-..||-|+.|. |..+++-.++.+.|+||.-|+
T Consensus        93 ~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          93 YIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            99998887664432  1    2334556677667788899999997 555555566699999999876

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.34  E-value=4.6e-06  Score=77.40  Aligned_cols=74  Identities=14%  Similarity=0.095  Sum_probs=49.7

Q ss_pred             cccCCc-EEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEEEEEeccCC
Q 014986          150 LGRGSF-GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTK  227 (415)
Q Consensus       150 LG~G~~-g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~  227 (415)
                      |-.|.. ..||+.... +..+.+|......        ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            445555 789998664 4678888664311        234567888877774 33355677777766678999999999


Q ss_pred             CCHHH
Q 014986          228 GSLLN  232 (415)
Q Consensus       228 gsL~~  232 (415)
                      .+|..
T Consensus        77 ~~l~~   81 (244)
T cd05150          77 VPAAA   81 (244)
T ss_pred             ccHhH
Confidence            77653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.16  E-value=5.2e-05  Score=67.55  Aligned_cols=131  Identities=25%  Similarity=0.262  Sum_probs=90.2

Q ss_pred             ecccccccccccCCc-EEEEEEEcCCCcEEEEEEEeccccc----------chh------HHHHHHHHHHHHHHh---cC
Q 014986          141 ITYWQKGDLLGRGSF-GSVYEGISDDGFFFAVKEVSLLDQG----------SQA------KQSISQLEQEIALLS---RF  200 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~i~~~~~~----------~~~------~~~~~~~~~E~~il~---~l  200 (415)
                      ...++.++.||.|.- |.||++.. +|+.||+|.++.....          ...      ......|..|.+...   .+
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            367889999999999 99999866 5679999994321100          000      012234666766544   44


Q ss_pred             CCCcE--EEeeeeeecC------------------CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH
Q 014986          201 EHENI--VQYYGTDKDE------------------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD  260 (415)
Q Consensus       201 ~hpnI--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~  260 (415)
                      .+.++  |+++|+..-.                  ....||.||+....        .+.    ..=+.+|++-|..+|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKILHK  182 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHHHH
Confidence            56667  8998875211                  12468888887643        122    2336778888899999


Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          261 QDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      .||+-+|+++.|..     .-+|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999985     3489999854

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=1.4e-05  Score=87.12  Aligned_cols=79  Identities=15%  Similarity=0.204  Sum_probs=53.6

Q ss_pred             ccccccCCcEEEEEEEcCCC---cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcE--EEeeeeeecC---CE
Q 014986          147 GDLLGRGSFGSVYEGISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENI--VQYYGTDKDE---SK  217 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---~~  217 (415)
                      .+.|+.|.+..+|+....++   ..+++|+.......    .....+.+|+++|+.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~----~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL----QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC----ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            35589999999999876443   46777755321111    11235779999999985 6654  6777776654   45


Q ss_pred             EEEEEeccCCCC
Q 014986          218 LYIFLELVTKGS  229 (415)
Q Consensus       218 ~~lV~E~~~~gs  229 (415)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            789999998864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.09  E-value=2.8e-06  Score=80.01  Aligned_cols=138  Identities=18%  Similarity=0.224  Sum_probs=97.8

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecc-----------------cccchhHHHHHHHHHHHHHHhcCCC-Cc
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL-----------------DQGSQAKQSISQLEQEIALLSRFEH-EN  204 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~-----------------~~~~~~~~~~~~~~~E~~il~~l~h-pn  204 (415)
                      -+.+++.||-|.-+.||.+-+..|+.+++|.=+..                 ...+.-....-...+|+..|+.+.. -+
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            36778999999999999999999999999953221                 0111111222334568888887742 22


Q ss_pred             -EEEeeeeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 014986          205 -IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       205 -Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                       +.+.+    +.+..++|||++.|-.|...-+   +  ..+..+...+..-|--|..+|+||+|+.--||+++.++.+++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~---v--~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v  243 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH---V--EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV  243 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeee---c--CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence             22333    3455689999999977764321   1  223456667777788899999999999999999999999999


Q ss_pred             Eeeccc
Q 014986          284 ADFGLA  289 (415)
Q Consensus       284 ~DFGla  289 (415)
                      +||--+
T Consensus       244 IDFPQm  249 (465)
T KOG2268|consen  244 IDFPQM  249 (465)
T ss_pred             eechHh
Confidence            999644

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.08  E-value=1.6e-06  Score=95.09  Aligned_cols=227  Identities=15%  Similarity=0.017  Sum_probs=149.9

Q ss_pred             EEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--CCEEEEEEeccCCCCHHHHHhhc-----CCCH
Q 014986          169 FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRY-----HLRD  241 (415)
Q Consensus       169 vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~-----~l~~  241 (415)
                      +.+|+.+..+.....+-..+....|...++...|+++...+.-...  ....|.+++|+.+|.+++.+.++     .+.+
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            4445444322222223333445556666777789999877664432  33468999999999999987543     2334


Q ss_pred             HHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccCCCCccccccccccc
Q 014986          242 SQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAFWMAPEVINN  314 (415)
Q Consensus       242 ~~~~~i~~qil~aL~~LH~~~-----IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~gt~~y~aPE~l~~  314 (415)
                      .-+....++.+.+..-+|+..     -+|++||+-|.+|..+..+|++++|+.+...+.  ......+++.|+.|++.+.
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence            444444455577777777652     789999999999999999999999999832222  1233457889999999866


Q ss_pred             cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       315 ~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      -.  ++.++|+|..|+.+|.+-.|..+|-..........+..+....++...|.++......+|-..-..||.-..++.-
T Consensus      1415 ik--~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~ 1492 (2724)
T KOG1826|consen 1415 IK--FTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSR 1492 (2724)
T ss_pred             Hh--hhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccc
Confidence            54  6777999999999999998887774432222222233333334444445566666666666667788887777765


Q ss_pred             hhh
Q 014986          395 PFV  397 (415)
Q Consensus       395 p~f  397 (415)
                      +.|
T Consensus      1493 d~~ 1495 (2724)
T KOG1826|consen 1493 DHF 1495 (2724)
T ss_pred             ccc
Confidence            554

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=1.9e-05  Score=72.87  Aligned_cols=29  Identities=28%  Similarity=0.347  Sum_probs=24.5

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          262 DVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       262 ~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      +++|+|+.+.|||++.++..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            48999999999999866556799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.99  E-value=2.2e-05  Score=69.91  Aligned_cols=95  Identities=25%  Similarity=0.213  Sum_probs=78.7

Q ss_pred             HHHHHHhcCCC-CcEEEeeeeeecCCEEEEEEeccCCCCHHH----HHhhcCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q 014986          192 QEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN----LYQRYHLRDSQVSAYTRQILLGLKYLHD---QDV  263 (415)
Q Consensus       192 ~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~----~l~~~~l~~~~~~~i~~qil~aL~~LH~---~~I  263 (415)
                      .|.-+|+.+++ +++.+++|+|-.    ++|.||+..+++..    +.+-...++..+..++.+++..+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888876 689999999843    67999999876642    2222356889999999999999999987   458


Q ss_pred             eecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          264 VHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       264 iHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .-.|++++||-++.+|++|++|...+.
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcc
Confidence            899999999999999999999998654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.89  E-value=0.00015  Score=69.52  Aligned_cols=76  Identities=13%  Similarity=0.079  Sum_probs=52.2

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC---CcEEEeeeeeec---CCEEEE
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKD---ESKLYI  220 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~---~~~~~l  220 (415)
                      .+.||.|..+.||.....++ .+.+|..+. .      .....+.+|+..|+.+..   -.+.++++++..   .+..+|
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARS-F------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecc-c------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            45699999999999876555 466676431 0      011356788888887743   246677766543   466899


Q ss_pred             EEeccCCCCH
Q 014986          221 FLELVTKGSL  230 (415)
Q Consensus       221 V~E~~~~gsL  230 (415)
                      |||+++++++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.79  E-value=0.00015  Score=66.76  Aligned_cols=73  Identities=12%  Similarity=0.117  Sum_probs=45.8

Q ss_pred             cccccCCcEEEEEEEcCC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc-EEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~  224 (415)
                      +.|..|-...+|++...+  ++.|++|.......      ......+|+.+++.+...+ ..++++.+. .   .+||||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEe
Confidence            457888888999987654  67888996642111      1112346787887774333 344444433 2   479999


Q ss_pred             cCCCCH
Q 014986          225 VTKGSL  230 (415)
Q Consensus       225 ~~~gsL  230 (415)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            988654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.76  E-value=0.00044  Score=68.58  Aligned_cols=80  Identities=14%  Similarity=0.126  Sum_probs=52.1

Q ss_pred             cccccCCcEEEEEEEcCCC-cEEEEEEEeccccc--chhHHHHHHHHHHHHHHhcCC---CCcEEEeeeeeecCCEEEEE
Q 014986          148 DLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQG--SQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~-~~vavK~i~~~~~~--~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +.||.|.+..||++.+.+| +.++||.-......  ........+...|...|..+.   -..+.+++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            4589999999999998766 58999974321110  100123345566777777652   245667777643  556899


Q ss_pred             EeccCCCC
Q 014986          222 LELVTKGS  229 (415)
Q Consensus       222 ~E~~~~gs  229 (415)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998744

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.66  E-value=0.0002  Score=71.48  Aligned_cols=162  Identities=21%  Similarity=0.332  Sum_probs=105.5

Q ss_pred             HHHHHHHHHhcCCCCcEEEeeeeeec-CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 014986          189 QLEQEIALLSRFEHENIVQYYGTDKD-ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD  267 (415)
Q Consensus       189 ~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrD  267 (415)
                      ++.-...+++.+.|+|...++++-.. .....+|||++.. +|.+.+....+.....       +       .+++.|  
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~-------~-------~~~~~~--   90 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESL-------L-------AHGVLH--   90 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhh-------c-------ccccce--
Confidence            34566788999999999999987653 3347899999976 8888876543222111       1       222222  


Q ss_pred             CCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH
Q 014986          268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC  347 (415)
Q Consensus       268 Lkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~  347 (415)
                         -       +.++++| -++..              |  |-.       ..+++|||++|.++.++..|...|.....
T Consensus        91 ---~-------~~~~~td-~~~t~--------------~--~~~-------~~pKsdVwsl~~i~~el~L~~~l~~~~~~  136 (725)
T KOG1093|consen   91 ---L-------NIIYITD-HFLTK--------------Y--PSP-------IGPKSDVWSLGFIILELYLGISLEAELTE  136 (725)
T ss_pred             ---e-------hhhhccc-ccccc--------------C--CCC-------CCcchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence               1       2233343 01000              0  111       12489999999999999999888876655


Q ss_pred             HHHHHHHhcCCCCCC-----------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          348 MAALFKIGRGSPPPI-----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       348 ~~~~~~i~~~~~~~~-----------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .+....+.+-...+.           ...++....+++++|+...|..||...++.+|+-|.+..
T Consensus       137 s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  137 SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            555544433322211           123566777899999999999999999999998887654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.63  E-value=0.00015  Score=67.79  Aligned_cols=131  Identities=18%  Similarity=0.240  Sum_probs=73.0

Q ss_pred             cccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCEEEEEEeccCCC
Q 014986          150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELVTKG  228 (415)
Q Consensus       150 LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~g  228 (415)
                      +..|-...+|+.. .+++.+++|........    .. ....+|..+++.+...++ .+++..+.    -++||||++|.
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~----~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKA----LG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCccccc----cc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            5667788899876 45667888864321100    00 123578888877753323 23343332    26899999986


Q ss_pred             CHHH--------------HHhh---cC-----CCH-HHHHHHHHHH---------HHHHHHHHH--------CCceecCC
Q 014986          229 SLLN--------------LYQR---YH-----LRD-SQVSAYTRQI---------LLGLKYLHD--------QDVVHRDI  268 (415)
Q Consensus       229 sL~~--------------~l~~---~~-----l~~-~~~~~i~~qi---------l~aL~~LH~--------~~IiHrDL  268 (415)
                      .+..              .+.+   ..     +.. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5421              1111   11     111 1112222111         111222221        24899999


Q ss_pred             CCCcEEEcCCCcEEEEeeccccc
Q 014986          269 KCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       269 kp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .|.||+++.++ +.|+||..+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999998877 78999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.48  E-value=0.0026  Score=61.40  Aligned_cols=30  Identities=27%  Similarity=0.411  Sum_probs=25.5

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          261 QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .++||+|+.+.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999866556899999764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.41  E-value=0.0017  Score=62.48  Aligned_cols=136  Identities=18%  Similarity=0.151  Sum_probs=77.2

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc--EEEeeee------eecCCEE
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT------DKDESKL  218 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~~~~~  218 (415)
                      .+.++.|....+|+....++ .+++|......    .   ...+..|+.++..+...+  +.+++..      ....+..
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC----C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            45678888889999865544 57788764311    0   122334555555553211  3333332      1224567


Q ss_pred             EEEEeccCCCCHH-----H------HH---hh--cCCC--------HHH-----HH----------HHHHHHHHHHHHHH
Q 014986          219 YIFLELVTKGSLL-----N------LY---QR--YHLR--------DSQ-----VS----------AYTRQILLGLKYLH  259 (415)
Q Consensus       219 ~lV~E~~~~gsL~-----~------~l---~~--~~l~--------~~~-----~~----------~i~~qil~aL~~LH  259 (415)
                      +++|+|++|..+.     .      .+   ..  .+++        ...     ..          .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999885421     1      11   10  0110        000     00          01112333455554


Q ss_pred             H-------CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          260 D-------QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       260 ~-------~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .       .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            2       589999999999999988877899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.30  E-value=0.00079  Score=64.51  Aligned_cols=72  Identities=17%  Similarity=0.211  Sum_probs=43.6

Q ss_pred             ccccCCcEEEEEEEcCC-------CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCEEEE
Q 014986          149 LLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYI  220 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~l  220 (415)
                      .|..|-...||+....+       ++.+++|.......      ......+|+.++..+...++ .++++.+..    .+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            45666667899887644       57888998653211      11234577777777643333 345555432    35


Q ss_pred             EEeccCCCCH
Q 014986          221 FLELVTKGSL  230 (415)
Q Consensus       221 V~E~~~~gsL  230 (415)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999888655

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.27  E-value=0.0021  Score=60.92  Aligned_cols=30  Identities=33%  Similarity=0.495  Sum_probs=24.9

Q ss_pred             CceecCCCCCcEEEcCCCc-EEEEeeccccc
Q 014986          262 DVVHRDIKCANILVDANGS-VKLADFGLAKA  291 (415)
Q Consensus       262 ~IiHrDLkp~NILl~~~~~-vkl~DFGla~~  291 (415)
                      .++|+|+++.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987565 46999997643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.26  E-value=0.0027  Score=60.59  Aligned_cols=135  Identities=16%  Similarity=0.114  Sum_probs=78.6

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc--EEEeeee------eecCCEE
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT------DKDESKL  218 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~~~~~  218 (415)
                      .+.|..|....+|+....+ ..+++|....   .     ....+..|+.++..+.+.+  +.+++..      ....+..
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---V-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---C-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            4567888888999986544 4688887652   1     1133556677666664322  3444332      1234567


Q ss_pred             EEEEeccCCCCHHH----H-------Hhh-----cCCC----------HHHH--H--------HHHHHHHHHHHHHHH--
Q 014986          219 YIFLELVTKGSLLN----L-------YQR-----YHLR----------DSQV--S--------AYTRQILLGLKYLHD--  260 (415)
Q Consensus       219 ~lV~E~~~~gsL~~----~-------l~~-----~~l~----------~~~~--~--------~i~~qil~aL~~LH~--  260 (415)
                      ++|+++++|..+..    .       +.+     ..+.          +...  .        .....+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999999865421    1       100     0110          0000  0        011122334444443  


Q ss_pred             -----CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          261 -----QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       261 -----~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                           .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                 379999999999999987777899998653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.89  E-value=0.013  Score=56.42  Aligned_cols=29  Identities=21%  Similarity=0.284  Sum_probs=26.6

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          262 DVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       262 ~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      +++|+|+.+.|||++.++.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998654

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.87  E-value=0.0068  Score=59.08  Aligned_cols=78  Identities=14%  Similarity=0.115  Sum_probs=47.1

Q ss_pred             ccccCCcEEEEEEEcCCC-cEEEEEEEeccccc--chhHHHHHHHHHHHHHHhcCC--CC-cEEEeeeeeecCCEEEEEE
Q 014986          149 LLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQG--SQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~-~~vavK~i~~~~~~--~~~~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV~  222 (415)
                      .||-|....||++.+.++ +.++||.-......  ........+..-|...|+...  -| .+.++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            379999999999998544 68999964321111  111222344456666676553  34 34555554  444557999


Q ss_pred             eccCCC
Q 014986          223 ELVTKG  228 (415)
Q Consensus       223 E~~~~g  228 (415)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.76  E-value=0.029  Score=53.84  Aligned_cols=29  Identities=28%  Similarity=0.468  Sum_probs=25.3

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          261 QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.67  E-value=0.0067  Score=57.84  Aligned_cols=76  Identities=16%  Similarity=0.199  Sum_probs=43.7

Q ss_pred             ccCCcEEEEEEEc-C----C----CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-------------CCcEEEe
Q 014986          151 GRGSFGSVYEGIS-D----D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-------------HENIVQY  208 (415)
Q Consensus       151 G~G~~g~Vy~~~~-~----~----~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-------------hpnIv~l  208 (415)
                      |.|-.|.+|++.. -    +    ...++||.................+.+|+.+.+.+-             ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            6778888888653 1    2    245677765421111222233456777776655441             1245667


Q ss_pred             eeeeecCCEEEEEEeccC
Q 014986          209 YGTDKDESKLYIFLELVT  226 (415)
Q Consensus       209 ~~~~~~~~~~~lV~E~~~  226 (415)
                      +....+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            776666667789998653

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.59  E-value=0.021  Score=54.87  Aligned_cols=32  Identities=25%  Similarity=0.422  Sum_probs=28.3

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          262 DVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       262 ~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .++|+|+.+.|++++.++-+-|+||+++..-.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            37999999999999999889999999886543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.57  E-value=0.02  Score=56.90  Aligned_cols=78  Identities=15%  Similarity=0.137  Sum_probs=47.4

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEeccccc-ch-hHHHHHHHHHHHHHHhcCC---CCcEEEeeeeeecCCEEEEE
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-SQ-AKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~-~~-~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .+.||-|.--.||+..+. +..++||.-...... .. ......+-..|+..|+.+.   ...+.++|.++.+.  .+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            355899999999998874 456888865421110 00 0011223334555555543   24677888877644  5788


Q ss_pred             EeccCC
Q 014986          222 LELVTK  227 (415)
Q Consensus       222 ~E~~~~  227 (415)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PLN02236 choline kinase

Probab=96.57  E-value=0.014  Score=57.23  Aligned_cols=132  Identities=13%  Similarity=0.141  Sum_probs=73.1

Q ss_pred             ccccCCcEEEEEEEcC-----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCEEEEEE
Q 014986          149 LLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFL  222 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~  222 (415)
                      .|-.|-.-.+|++...     .++.|++|......     ...+ ...+|+.+++.+..-++ .++++.+...    .|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            3555777788987642     24678888664321     1111 12467777777754333 2455655432    578


Q ss_pred             eccCCCCHHH--------------HHhh---cC------CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 014986          223 ELVTKGSLLN--------------LYQR---YH------LR-DSQVSAYTRQI-----------------LLGLKYL---  258 (415)
Q Consensus       223 E~~~~gsL~~--------------~l~~---~~------l~-~~~~~~i~~qi-----------------l~aL~~L---  258 (415)
                      +|+.+.+|..              .+.+   ..      .. ...+..++.++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            8887765421              1111   01      10 12222222211                 1112222   


Q ss_pred             -H----HCCceecCCCCCcEEEcC-CCcEEEEeecccc
Q 014986          259 -H----DQDVVHRDIKCANILVDA-NGSVKLADFGLAK  290 (415)
Q Consensus       259 -H----~~~IiHrDLkp~NILl~~-~~~vkl~DFGla~  290 (415)
                       .    ...++|+|+++.|||++. ++.+.|+||..+.
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             1    225899999999999986 4789999998764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.54  E-value=0.0076  Score=57.31  Aligned_cols=73  Identities=18%  Similarity=0.187  Sum_probs=43.9

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC---CCCcEEEeeeeeecCCEEEEEEe
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      .+.|+-|....+|+.. .+++.+.||.-...        ....+..|+.-|+.+   .--.+.+++++....+.-|||||
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            3458889999999876 67788999976521        113456677766666   34457788888877777799999


Q ss_pred             ccCCC
Q 014986          224 LVTKG  228 (415)
Q Consensus       224 ~~~~g  228 (415)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.25  E-value=0.016  Score=57.27  Aligned_cols=79  Identities=16%  Similarity=0.144  Sum_probs=49.1

Q ss_pred             cccccCCcEEEEEEEcC-CCcEEEEEEEeccccc-chhHHHHHHHHHHHHHHhcCC--CC-cEEEeeeeeecCCEEEEEE
Q 014986          148 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQG-SQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~-~~~~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV~  222 (415)
                      +.||-|.-..||++.+. .++.++||.-...-.. ....-...+..-|...|+...  .| .+.++|.+  +.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            45899999999999874 3678999864321111 122233455556777776653  34 45556654  344557899


Q ss_pred             eccCCC
Q 014986          223 ELVTKG  228 (415)
Q Consensus       223 E~~~~g  228 (415)
                      |+++..
T Consensus       113 EdL~~~  118 (409)
T PRK12396        113 EDLSDH  118 (409)
T ss_pred             HhCccc
Confidence            998653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.24  E-value=0.021  Score=55.59  Aligned_cols=28  Identities=21%  Similarity=0.547  Sum_probs=24.7

Q ss_pred             ceecCCCCCcEEEcC-CCcEEEEeecccc
Q 014986          263 VVHRDIKCANILVDA-NGSVKLADFGLAK  290 (415)
Q Consensus       263 IiHrDLkp~NILl~~-~~~vkl~DFGla~  290 (415)
                      ++|.||.+.|||++. ++.++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 5789999998764

>PRK06148 hypothetical protein; Provisional

Probab=96.08  E-value=0.11  Score=58.16  Aligned_cols=31  Identities=45%  Similarity=0.622  Sum_probs=26.1

Q ss_pred             CCceecCCCCCcEEEcCCC--cEE-EEeeccccc
Q 014986          261 QDVVHRDIKCANILVDANG--SVK-LADFGLAKA  291 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~--~vk-l~DFGla~~  291 (415)
                      .++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999775  555 999997753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.08  E-value=0.018  Score=56.42  Aligned_cols=59  Identities=17%  Similarity=0.167  Sum_probs=47.4

Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEc
Q 014986          218 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVD  276 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH-~~~IiHrDLkp~NILl~  276 (415)
                      ..||-+|..|-++..+++....++.....++.-.+.||-.+- -.+++|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            467778888889999998877777777777777777766553 45899999999999994

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.07  E-value=0.022  Score=55.12  Aligned_cols=103  Identities=20%  Similarity=0.308  Sum_probs=68.4

Q ss_pred             CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .-+.|++|++-.+ ++...   ..-...++..++++.+..++-+-.+ .+-|||+...||||+ +|+|.|+||-+++...
T Consensus       298 ~~y~yl~~kdhgt-~is~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         298 TLYLYLHFKDHGT-PISII---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             ceEEEEEEecCCc-eeeee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            3456788887533 44321   2235677888999988888877665 689999999999999 9999999999998543


Q ss_pred             cCCcccCCCCccccccccccccccCCCchhhHHHH
Q 014986          294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSL  328 (415)
Q Consensus       294 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSl  328 (415)
                      ....-   --..+-.|-.++|..   +..-+||-+
T Consensus       373 ~q~~i---sy~rldhp~lF~G~d---d~QFeIYrl  401 (488)
T COG5072         373 SQGII---SYNRLDHPDLFNGVD---DYQFEIYRL  401 (488)
T ss_pred             CCcee---eccccCchhhhcCcc---ceeeeHHHH
Confidence            33221   112234455554432   445677653

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.75  E-value=0.046  Score=49.72  Aligned_cols=58  Identities=19%  Similarity=0.228  Sum_probs=41.5

Q ss_pred             CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC---CCcEEEeeeeeecCCEEEEEEeccCCCCH
Q 014986          165 DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLELVTKGSL  230 (415)
Q Consensus       165 ~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  230 (415)
                      ....|.||+-.        ......+..|+.-|..+.   .-.+.+++.+..+..+.|+||||++-|.+
T Consensus        38 g~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          38 GTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             CCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            45677777432        334456677776666553   45577889999999999999999987654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.68  E-value=0.37  Score=46.73  Aligned_cols=28  Identities=25%  Similarity=0.253  Sum_probs=23.6

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          261 QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            3689999999999995 4 57899999663

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.21  E-value=0.04  Score=52.54  Aligned_cols=137  Identities=18%  Similarity=0.138  Sum_probs=91.8

Q ss_pred             cccccccCCcEEEEEEEc-------C----CCcEEEEEEEeccc------------------ccc-hhHHH--HHHHHHH
Q 014986          146 KGDLLGRGSFGSVYEGIS-------D----DGFFFAVKEVSLLD------------------QGS-QAKQS--ISQLEQE  193 (415)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~-------~----~~~~vavK~i~~~~------------------~~~-~~~~~--~~~~~~E  193 (415)
                      +..+|..|.-+.|+-|.-       .    .-..+|||+++..-                  +.+ .....  .-..++|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            456788999999987732       1    12457888664210                  000 00001  1123345


Q ss_pred             HHHHhcC-----CCCcEEEeeeeeecCCEEEEEEeccCCCCHH-HHHhhcCCCHHHHHHHHHHHHHHHHHH-HHCCceec
Q 014986          194 IALLSRF-----EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHR  266 (415)
Q Consensus       194 ~~il~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~l~~~~~~~i~~qil~aL~~L-H~~~IiHr  266 (415)
                      +..|.++     ..|.+|.+..       ..|||-++...-+. --++...++..+.+....|++.++..| |.+-++|.
T Consensus       336 mhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHA  408 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHA  408 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeec
Confidence            5555444     4677777643       47899998664443 244555789999999999999999988 78899999


Q ss_pred             CCCCCcEEEcCCCcEEEEeecccc
Q 014986          267 DIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       267 DLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      ||.--|+|...+ .|-++|..-+.
T Consensus       409 DlSEyN~Lw~~g-Kvw~IDVsQsv  431 (531)
T KOG2269|consen  409 DLSEYNLLWTPG-KVWVIDVSQSV  431 (531)
T ss_pred             chhhhhheecCC-ceEEEechhcc
Confidence            999999999765 99999987554

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.93  E-value=0.13  Score=47.99  Aligned_cols=75  Identities=24%  Similarity=0.221  Sum_probs=53.3

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHH---HHHhcCCCCcEEEeeeeeecCCEEEEEEe
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTDKDESKLYIFLE  223 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lV~E  223 (415)
                      ...+-.|..+.|+.++..+|...++|+......          ...|.   ..|+..+-...|++++...+  .-.|++|
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~----------~~~E~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLE   74 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE----------AEHEARGEAALRWWNGRGAVRLLAADPE--RGALLLE   74 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc----------chhhhhHHhHhheeCCCCceeeeccccc--cchhhhh
Confidence            345678999999999999999999998763221          11222   45777777888999987533  3478899


Q ss_pred             ccCCC-CHHHH
Q 014986          224 LVTKG-SLLNL  233 (415)
Q Consensus       224 ~~~~g-sL~~~  233 (415)
                      .+.+| +|.++
T Consensus        75 rl~~g~~L~~~   85 (253)
T PF04655_consen   75 RLDPGRSLASL   85 (253)
T ss_pred             hccCCCchhhc
Confidence            98444 66544

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00384 choline kinase; Provisional

Probab=94.91  E-value=0.12  Score=51.40  Aligned_cols=78  Identities=14%  Similarity=0.207  Sum_probs=43.1

Q ss_pred             cccccCCcEEEEEEEcCC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~  224 (415)
                      +.|..|-...+|++...+  +..+.+|.+...... ......-.-.+|+.+++.+...++ .++++.+..    ++|.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            346568888999986532  223333322111100 111111223478888888865444 456666653    689999


Q ss_pred             cCCCCH
Q 014986          225 VTKGSL  230 (415)
Q Consensus       225 ~~~gsL  230 (415)
                      ++|..|
T Consensus       131 IeGr~l  136 (383)
T PTZ00384        131 VEGNTM  136 (383)
T ss_pred             eccccC
Confidence            988755

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	415
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-45
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-45
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-45
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-45
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-45
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-44
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-43
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-43
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-42
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-40
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-40
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-39
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-39
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-39
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-38
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-36
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-36
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-35
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-35
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-34
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-34
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-34
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-34
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-33
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-33
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-33
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-33
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-33
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-32
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-32
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-32
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-32
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-32
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-32
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-32
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-31
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-31
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-31
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-30
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-30
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-30
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-30
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-29
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-29
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-29
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-29
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-28
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-28
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-28
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-28
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-28
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-28
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-28
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-28
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-28
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-28
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-28
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-28
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-28
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-28
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-28
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-28
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-28
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-28
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-28
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-28
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-28
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-28
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-28
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-28
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-28
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-28
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-28
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-28
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-28
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-28
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-28
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-28
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-28
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-28
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-28
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-28
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-28
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-27
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-27
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-27
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-27
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-27
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-27
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-27
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-27
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-27
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-27
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-27
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-26
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-26
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-26
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-26
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-26
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-26
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-26
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-26
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-26
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-26
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-25
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-25
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-25
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-25
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-25
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-25
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-25
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-25
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-25
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-25
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-25
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-25
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-25
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-25
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-25
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-25
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-25
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-25
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-25
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-25
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-25
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-25
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-25
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-25
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-25
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-25
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-25
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-25
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-25
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-25
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-25
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-25
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-25
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-25
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-25
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-25
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-25
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-25
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-25
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-25
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-25
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-25
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-25
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-25
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-25
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-25
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-25
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-25
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-25
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-25
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-25
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-25
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-25
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-25
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-25
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-25
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-25
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-25
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-25
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-25
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-24
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-24
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-24
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-24
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-24
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-24
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-24
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-24
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-24
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-24
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-24
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-24
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-24
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-24
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-24
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-24
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-24
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-24
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-24
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-24
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-24
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-24
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-24
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-24
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-24
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-24
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-24
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-24
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-24
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-24
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-24
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-24
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-24
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-24
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-24
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-24
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-24
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-23
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-23
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-23
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-23
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-23
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-23
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-23
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-23
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-23
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-23
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-23
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-23
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-23
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-23
3soa_A	444	Full-Length Human Camkii Length = 444		3e-23
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-23
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-23
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-23
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-23
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-23
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-23
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-23
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-23
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-23
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-23
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-23
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-23
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-23
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-23
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-23
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-23
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-23
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-23
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-23
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-23
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-23
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-23
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-23
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-23
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-23
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-23
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-23
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-23
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-23
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-23
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-23
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-23
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-23
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-23
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-23
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-23
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-23
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-23
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-23
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-23
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-22
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-22
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-22
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-22
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-22
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-22
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-22
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-22
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-22
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-22
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-22
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-22
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-22
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-22
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-22
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-22
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-22
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-22
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-22
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-22
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-22
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-22
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-22
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-22
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-22
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-22
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-22
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-22
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-22
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-22
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-22
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-22
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-22
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-22
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-22
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-22
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-22
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-22
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-22
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-22
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-22
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-22
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-22
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-22
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-22
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-22
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-22
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-22
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-22
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-22
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-22
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-22
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-22
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-22
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-22
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-22
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-22
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-22
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-22
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-22
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-22
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-22
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-22
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-22
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-22
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-22
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-22
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-22
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-22
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-22
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-22
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-22
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-22
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-22
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-22
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-22
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-22
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-22
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-22
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-22
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-22
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-22
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-22
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-21
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-21
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-21
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-21
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-21
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-21
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-21
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-21
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-21
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-21
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-21
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-21
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-21
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-21
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-21
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-21
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-21
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-21
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-21
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-21
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-21
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-21
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-21
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-20
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-20
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-20
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-20
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-20
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-20
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-20
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-20
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-20
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-20
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-20
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-20
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-20
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-20
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-20
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-20
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-20
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-20
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-20
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-20
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-20
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-20
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-20
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-20
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-20
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-20
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-20
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-20
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-20
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-20
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-20
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-20
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-20
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-20
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-20
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-20
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-20
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-20
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-20
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-20
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-20
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-20
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-20
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-20
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-20
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-20
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-20
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-20
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-20
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-20
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-20
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-20
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-20
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-20
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-20
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-20
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-20
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-20
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-20
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-20
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-20
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-20
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-20
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-20
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-20
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-20
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-20
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-19
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-19
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-19
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-19
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-19
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-19
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-19
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-19
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-19
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-19
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-19
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-19
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-19
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-19
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-19
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-19
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-19
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-19
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-19
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-19
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-19
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-19
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-19
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-19
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-19
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-19
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-19
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-19
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-19
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-19
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-19
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-19
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-19
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-19
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-19
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-19
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-19
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-18
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-18
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-18
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-18
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-18
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-18
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-18
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-18
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-18
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-18
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-18
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-18
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-18
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-18
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-18
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-18
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-18
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-18
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-18
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-18
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-18
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-18
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-17
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-17
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-17
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-17
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-17
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-17
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-17
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-17
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-17
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-17
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-17
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-17
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-17
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-17
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-17
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-16
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-16
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-16
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-16
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-15
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-15
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-15
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-15
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-15
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-15
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-14
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-14
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-14
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-14
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-14
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-13
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-13

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 159/260 (61%), Gaps = 11/260 (4%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 29  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 85
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  
Sbjct: 86  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAY 201
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              ADIWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+ 
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 261
Query: 380 VNPNDRPTAAQLLDHPFVKR 399
             P+ RPTA +LL H F+ R
Sbjct: 262 KEPSFRPTAKELLKHKFILR 281

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 159/260 (61%), Gaps = 11/260 (4%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 24  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 80
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAY 196
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              ADIWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+ 
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 256
Query: 380 VNPNDRPTAAQLLDHPFVKR 399
             P+ RPTA +LL H F+ R
Sbjct: 257 KEPSFRPTAKELLKHKFILR 276

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 159/260 (61%), Gaps = 11/260 (4%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 65
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAY 181
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              ADIWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+ 
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 241
Query: 380 VNPNDRPTAAQLLDHPFVKR 399
             P+ RPTA +LL H F+ R
Sbjct: 242 KEPSFRPTAKELLKHKFILR 261

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 159/260 (61%), Gaps = 11/260 (4%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 65
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAY 181
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              ADIWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+ 
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 241
Query: 380 VNPNDRPTAAQLLDHPFVKR 399
             P+ RPTA +LL H F+ R
Sbjct: 242 KEPSFRPTAKELLKHKFILR 261

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 105/266 (39%), Positives = 155/266 (58%), Gaps = 11/266 (4%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + K D +G+GSFG VY+GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 21  FTKLDRIGKGSFGEVYKGI--DNHTKEVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 77
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            I +Y+G+    +KL+I +E +  GS L+L +   L ++ ++   R+IL GL YLH +  
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK AN+L+   G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAY 193
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              ADIWSLG T +E+   + P + +  M  LF I + SPP +    SK  ++F++ C+ 
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLN 253
Query: 380 VNPNDRPTAAQLLDHPFVKRLLATNS 405
            +P  RPTA +LL H F+ R     S
Sbjct: 254 KDPRFRPTAKELLKHKFITRYTKKTS 279

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 164/270 (60%), Gaps = 21/270 (7%)
Query: 143 YWQKGD--LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           Y + GD  +LG+G++G VY G    +    A+KE+   D  S+  Q    L +EIAL   
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQP---LHEEIALHKH 75
Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ--VSAYTRQILLGL 255
            +H+NIVQY G+  +   + IF+E V  GSL  L +     L+D++  +  YT+QIL GL
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 256 KYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPE 310
           KYLHD  +VHRDIK  N+L++  +G +K++DFG +K  +L  +  C     GT  +MAPE
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPE 193
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGS-PPPIPDSLSK 368
           +I+   +GYG  ADIWSLGCT++EM T + P+  + E  AA+FK+G     P IP+S+S 
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +A+ FI +C + +P+ R  A  LL   F+K
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 164/270 (60%), Gaps = 21/270 (7%)
Query: 143 YWQKGD--LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           Y + GD  +LG+G++G VY G    +    A+KE+   D  S+  Q    L +EIAL   
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQP---LHEEIALHKH 61
Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ--VSAYTRQILLGL 255
            +H+NIVQY G+  +   + IF+E V  GSL  L +     L+D++  +  YT+QIL GL
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 256 KYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPE 310
           KYLHD  +VHRDIK  N+L++  +G +K++DFG +K  +L  +  C     GT  +MAPE
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPE 179
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGS-PPPIPDSLSK 368
           +I+   +GYG  ADIWSLGCT++EM T + P+  + E  AA+FK+G     P IP+S+S 
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 239
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +A+ FI +C + +P+ R  A  LL   F+K
Sbjct: 240 EAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/258 (38%), Positives = 152/258 (58%), Gaps = 11/258 (4%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 25  FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSS 81
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
            + +YYG+    SKL+I +E +  GS L+L +     + Q++   ++IL GL YLH +  
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 319
           +HRDIK AN+L+   G VKLADFG+  A +L D +  R    GT FWMAPEVI  +   Y
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI--QQSAY 197
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
              ADIWSLG T +E+   + P + M  M  LF I + +PP +    +K  ++FI  C+ 
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLN 257
Query: 380 VNPNDRPTAAQLLDHPFV 397
            +P+ RPTA +LL H F+
Sbjct: 258 KDPSFRPTAKELLKHKFI 275

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 99/258 (38%), Positives = 150/258 (58%), Gaps = 20/258 (7%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG GS+GSVY+ I  + G   A+K+V +       +  + ++ +EI+++ + +  ++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
           YG+    + L+I +E    GS+ ++ +  +  L + +++   +  L GL+YLH    +HR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLP 322
           DIK  NIL++  G  KLADFG+  A +L D  + R    GT FWMAPEVI  +  GY   
Sbjct: 150 DIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEVI--QEIGYNCV 205
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQV 380
           ADIWSLG T +EM   + PYA +  M A+F I    PP    P+  S +  DF+KQC+  
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265
Query: 381 NPNDRPTAAQLLDHPFVK 398
           +P  R TA QLL HPFV+
Sbjct: 266 SPEQRATATQLLQHPFVR 283

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 148/264 (56%), Gaps = 13/264 (4%)
Query: 143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 315
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV+    +K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 373
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 273
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           +K+C++ N + R T +QLL HPFV
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 148/264 (56%), Gaps = 13/264 (4%)
Query: 143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 315
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV+    +K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 373
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 273
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           +K+C++ N + R T +QLL HPFV
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 315
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +       GT +WMAPEV+    +K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 373
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 273
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           +K+C++ N + R T +QLL HPFV
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 148/272 (54%), Gaps = 15/272 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+  +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 315
           + ++HRD+K  N+L+   G ++LADFG+ AK  K L    S  GT +WMAPEV+     K
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 373
           +  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +K  +  NP  RP+AAQLL+HPFV  + +  +
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 148/272 (54%), Gaps = 15/272 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+  +H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 67
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L +LH 
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 315
           + ++HRD+K  N+L+   G ++LADFG+ AK  K L    S  GT +WMAPEV+     K
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 373
           +  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 247
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +K  +  NP  RP+AAQLL+HPFV  + +  +
Sbjct: 248 LKIALDKNPETRPSAAQLLEHPFVSSITSNKA 279

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 95/270 (35%), Positives = 143/270 (52%), Gaps = 27/270 (10%)
Query: 148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 205
           +L+G G++G VY+G     G   A+K   ++D     ++ I   +QEI +L ++  H NI
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 83
Query: 206 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 256
             YYG    K+    + +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 312
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEVI
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 313 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSK 368
               N +  Y   +D+WSLG T +EM     P   M  M ALF I R   P +     SK
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             Q FI+ C+  N + RP   QL+ HPF++
Sbjct: 262 KFQSFIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 146/256 (57%), Gaps = 11/256 (4%)
Query: 150 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GSFG ++    ++DG  + +KE+++    S+ ++   +  +E+A+L+  +H NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNIVQY 88
Query: 209 YGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
             + ++   LYI ++    G L   +N  +    ++ Q+  +  QI L LK++HD+ ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 266 RDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           RDIK  NI +  +G+V+L DFG+A+   + +   ++C GT ++++PE+   +NK Y   +
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--ENKPYNNKS 206
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           DIW+LGC + E+ T +  +        + KI  GS PP+    S D +  + Q  + NP 
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPR 266
Query: 384 DRPTAAQLLDHPFVKR 399
           DRP+   +L+  F+ +
Sbjct: 267 DRPSVNSILEKGFIAK 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 138/255 (54%), Gaps = 10/255 (3%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 209 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 325
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEVI   ++G Y    D+
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKDAQDFIKQCVQVNPND 384
           WSLG T +E+   + P   M  M+AL+ I +   P +     S+  ++F+  C+Q  P D
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296
Query: 385 RPTAAQLLDHPFVKR 399
           RPT+  LL H FV R
Sbjct: 297 RPTSEVLLKHRFVLR 311

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 138/255 (54%), Gaps = 10/255 (3%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 209 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 325
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEVI   ++G Y    D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKDAQDFIKQCVQVNPND 384
           WSLG T +E+   + P   M  M+AL+ I +   P +     S+  ++F+  C+Q  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 385 RPTAAQLLDHPFVKR 399
           RPT+  LL H FV R
Sbjct: 258 RPTSEVLLKHRFVLR 272

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 147/275 (53%), Gaps = 13/275 (4%)
Query: 128 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 187
           + +I   G  K+  T ++K   +G+G+ G+VY  +         +EV++     Q +   
Sbjct: 9   LRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKK 61
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY 247
             +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A 
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAF 305
            R+ L  L++LH   V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   GT +
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 181
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 363
           WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P
Sbjct: 182 WMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + LS   +DF+ +C++++   R +A +LL H F+K
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 146/275 (53%), Gaps = 13/275 (4%)
Query: 128 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 187
           + +I   G  K+  T ++K   +G+G+ G+VY  +         +EV++     Q +   
Sbjct: 9   LRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKK 61
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY 247
             +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A 
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAF 305
            R+ L  L++LH   V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   GT +
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 363
           WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P
Sbjct: 182 WMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + LS   +DF+ +C+ ++   R +A +LL H F+K
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 147/275 (53%), Gaps = 13/275 (4%)
Query: 128 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 187
           + +I   G  K+  T ++K   +G+G+ G+VY  +         +EV++     Q +   
Sbjct: 10  LRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKK 62
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY 247
             +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A 
Sbjct: 63  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 122
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAF 305
            R+ L  L++LH   V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   GT +
Sbjct: 123 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 182
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 363
           WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P
Sbjct: 183 WMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 240
Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + LS   +DF+ +C++++   R +A +L+ H F+K
Sbjct: 241 EKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 142/275 (51%), Gaps = 13/275 (4%)
Query: 128 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 187
           + +I   G  K+  T ++K   +G+G+ G+VY  +         +EV++     Q +   
Sbjct: 9   LRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKK 61
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY 247
             +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A 
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAF 305
            R+ L  L++LH   V+HRDIK  NIL+  +GSVKL DFG          K     GT +
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPY 181
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 363
           WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P
Sbjct: 182 WMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + LS   +DF+ +C+ ++   R +A +LL H F+K
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 139/255 (54%), Gaps = 30/255 (11%)
Query: 170 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 229
           A+K ++L     + + S+ +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS
Sbjct: 39  AIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 94
Query: 230 LLNLYQRY-----H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 280
           +L++ +       H    L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GS
Sbjct: 95  VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 154
Query: 281 VKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 333
           V++ADFG++         T+    K+  GT  WMAPEV+  + +GY   ADIWS G T +
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAI 213
Query: 334 EMLTSQIPYAPMECMAALFKIGRGSPPPI------PDSLSKDAQDF---IKQCVQVNPND 384
           E+ T   PY     M  L    +  PP +       + L K  + F   I  C+Q +P  
Sbjct: 214 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 273
Query: 385 RPTAAQLLDHPFVKR 399
           RPTAA+LL H F ++
Sbjct: 274 RPTAAELLRHKFFQK 288

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 139/255 (54%), Gaps = 30/255 (11%)
Query: 170 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 229
           A+K ++L     + + S+ +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS
Sbjct: 44  AIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 230 LLNLYQRY-----H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 280
           +L++ +       H    L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GS
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 281 VKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 333
           V++ADFG++         T+    K+  GT  WMAPEV+  + +GY   ADIWS G T +
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAI 218
Query: 334 EMLTSQIPYAPMECMAALFKIGRGSPPPI------PDSLSKDAQDF---IKQCVQVNPND 384
           E+ T   PY     M  L    +  PP +       + L K  + F   I  C+Q +P  
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 278
Query: 385 RPTAAQLLDHPFVKR 399
           RPTAA+LL H F ++
Sbjct: 279 RPTAAELLRHKFFQK 293

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/233 (35%), Positives = 131/233 (56%), Gaps = 18/233 (7%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 233
           V ++D   Q ++ +  L  E+ ++  ++H N+V+ Y +     +L++ +E +  G+L ++
Sbjct: 75  VKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132
Query: 234 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 293
             +  L + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG   A  
Sbjct: 133 VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQI 191
Query: 294 LNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMEC 347
             DV   K   GT +WMAPEVI+     Y    DIWSLG  V+EM+  + PY   +P++ 
Sbjct: 192 SKDVPKRKXLVGTPYWMAPEVISRSL--YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249
Query: 348 MAALFKIGRGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           M  L    R SPPP       +S   +DF+++ +  +P +R TA +LLDHPF+
Sbjct: 250 MKRL----RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 140/259 (54%), Gaps = 10/259 (3%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           + + + +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ 
Sbjct: 23  YTRFEKIGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 78
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 264 VHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGL 321
           +HR+IK  NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+    K YG 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGP 196
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQ 379
             DIWSLG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C++
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 380 VNPNDRPTAAQLLDHPFVK 398
           ++   R +A +L+ H F+K
Sbjct: 257 MDVEKRGSAKELIQHQFLK 275

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRFE 201
           ++ G+LLG+GSF  VY   S   G   A+K   ++D+ +  K  + Q ++ E+ +  + +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR---DSQVSAYTRQILLGLKYL 258
           H +I++ Y   +D + +Y+ LE+   G + N Y +  ++   +++   +  QI+ G+ YL
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKN 316
           H   ++HRD+  +N+L+  N ++K+ADFGLA   K+   K  +  GT  +++PE+     
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT--R 186
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
             +GL +D+WSLGC    +L  + P+        L K+       +P  LS +A+D I Q
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDLIHQ 245
Query: 377 CVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
            ++ NP DR + + +LDHPF+ R  +T S
Sbjct: 246 LLRRNPADRLSLSSVLDHPFMSRNSSTKS 274

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 213
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 273
Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 331
Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 391
Query: 385 RPTAAQLLDHPFVKR 399
           R TAA+LL HPF+ +
Sbjct: 392 RATAAELLKHPFLAK 406

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 136
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 196
Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 254
Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 314
Query: 385 RPTAAQLLDHPFVKR 399
           R TAA+LL HPF+ +
Sbjct: 315 RATAAELLKHPFLAK 329

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 93
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 153
Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 211
Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 271
Query: 385 RPTAAQLLDHPFVKR 399
           R TAA+LL HPF+ +
Sbjct: 272 RATAAELLKHPFLAK 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 91
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 151
Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDIW 209
Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 269
Query: 385 RPTAAQLLDHPFVKR 399
           R TAA+LL HPF+ +
Sbjct: 270 RATAAELLKHPFLAK 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 142
Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 200
Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 385 RPTAAQLLDHPFVKR 399
           R TAA+LL HPF+ +
Sbjct: 261 RATAAELLKHPFLAK 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 86
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 146
Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 204
Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 264
Query: 385 RPTAAQLLDHPFVKR 399
           R TAA+LL HPF+ +
Sbjct: 265 RATAAELLKHPFLAK 279

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 12/254 (4%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS G V        G   AVK++ L  Q     Q    L  E+ ++  + H+N+V  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYHHDNVVDM 107
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           Y +     +L++ +E +  G+L ++     + + Q++     +L  L YLH+Q V+HRDI
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 167
Query: 269 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           K  +IL+ ++G +KL+DFG  A+ +K +   K   GT +WMAPEVI+     YG   DIW
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP--YGTEVDIW 225
Query: 327 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 384
           SLG  V+EM+  + PY     + A+ +I    PP + D   +S   + F+   +   P+ 
Sbjct: 226 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQ 285
Query: 385 RPTAAQLLDHPFVK 398
           R TA +LL HPF+K
Sbjct: 286 RATAQELLGHPFLK 299

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 140/270 (51%), Gaps = 19/270 (7%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRG F  VY      DG   A+K+V + D   ++A+   +   +EI LL +  H N+++
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIK 96
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQD 262
           YY +  ++++L I LEL   G L  + + +      + +  V  Y  Q+   L+++H + 
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I+    GY 
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 214
Query: 321 LPADIWSLGCTVLEMLTSQIPYA--PMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 377
             +DIWSLGC + EM   Q P+    M   +   KI +   PP+P D  S++ +  +  C
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274
Query: 378 VQVNPNDRPTAAQLLDHPFVKRLLATNSGS 407
           +  +P  RP    + D    KR+ A  + S
Sbjct: 275 INPDPEKRPDVTYVYD--VAKRMHACTASS 302

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 138/254 (54%), Gaps = 13/254 (5%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 83
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 143
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 322
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV++   KG+   
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS--KKGHSFE 201
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 260
Query: 383 NDRPTAAQLLDHPF 396
             RPT  +LL+  F
Sbjct: 261 TARPTINELLNDEF 274

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 138/254 (54%), Gaps = 13/254 (5%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 79
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 322
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV++   KG+   
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS--KKGHSFE 197
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 256
Query: 383 NDRPTAAQLLDHPF 396
             RPT  +LL+  F
Sbjct: 257 TARPTINELLNDEF 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 138/254 (54%), Gaps = 13/254 (5%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 79
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 322
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV++   KG+   
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS--KKGHSFE 197
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 256
Query: 383 NDRPTAAQLLDHPF 396
             RPT  +LL+  F
Sbjct: 257 TARPTINELLNDEF 270

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 13/254 (5%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 101
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 161
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 322
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV++   KG+   
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFE 219
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 278
Query: 383 NDRPTAAQLLDHPF 396
             RPT  +LL+  F
Sbjct: 279 TARPTINELLNDEF 292

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 13/254 (5%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 103
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 322
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV++   KG+   
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFE 221
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 280
Query: 383 NDRPTAAQLLDHPF 396
             RPT  +LL+  F
Sbjct: 281 TARPTINELLNDEF 294

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 13/254 (5%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 77
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 322
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV++   KG+   
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFE 195
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 383 NDRPTAAQLLDHPF 396
             RPT  +LL+  F
Sbjct: 255 TARPTINELLNDEF 268

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 195
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 254
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 312
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL 214
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 215 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 373 FIKQCVQVNPNDRPTAAQLLDHPF 396
            I++ +  +P  RP+ A+LL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 195
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 254
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 312
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 214
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 215 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 373 FIKQCVQVNPNDRPTAAQLLDHPF 396
            I++ +  +P  RP+ A+LL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 195
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 254
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 312
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL 214
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 215 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 373 FIKQCVQVNPNDRPTAAQLLDHPF 396
            I++ +  +P  RP+ A+LL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 195
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 78
Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 254
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 79  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 138
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 312
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV+
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 198
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 199 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 255
Query: 373 FIKQCVQVNPNDRPTAAQLLDHPF 396
            I++ +  +P  RP+ A+LL   F
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEF 279

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 147/281 (52%), Gaps = 30/281 (10%)
Query: 148 DLLGRGSFGSVYEGISD-DGFFFAVKEVS---LLDQGS------------------QAKQ 185
           D +G+GS+G V    ++ D  ++A+K +S   L+ Q                    Q + 
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 186 SISQLEQEIALLSRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 243
            I Q+ QEIA+L + +H N+V+      D +E  LY+  ELV +G ++ +     L + Q
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR 301
              Y + ++ G++YLH Q ++HRDIK +N+LV  +G +K+ADFG++   K +D  + +  
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 302 GTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAP--MECMAALFKIGRGS 358
           GT  +MAPE ++   K + G   D+W++G T+   +  Q P+    + C+ +  K     
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE 258
Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            P  PD +++D +D I + +  NP  R    ++  HP+V R
Sbjct: 259 FPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 144/279 (51%), Gaps = 14/279 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +Q+   LG G++G V   +  D      + + ++ + S +  S S+L +E+A+L   +H 
Sbjct: 39  YQRVKKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NI++ Y   +D+   Y+ +E    G L + +  R    +   +   +Q+L G+ YLH  +
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 263 VVHRDIKCANILVDA---NGSVKLADFGLAKA-TKLNDVKSCRGTAFWMAPEVINNKNKG 318
           +VHRD+K  N+L+++   +  +K+ DFGL+        +K   GTA+++APEV+  K   
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--- 213
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIK 375
           Y    D+WS+G  +  +L    P+        L K+ +G      P   ++S+ A+D IK
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 376 QCVQVNPNDRPTAAQLLDHPFVKRLLA-TNSGSASPYLG 413
           Q +Q +   R +A Q L+HP++K + +   SG   P L 
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLA 312

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 5/253 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ +NG +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 193
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L    P+          +I R      PD +++ A+D I + ++ N + R
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISR-VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 386 PTAAQLLDHPFVK 398
            T A++L+HP++K
Sbjct: 253 LTLAEVLEHPWIK 265

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 209 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 268 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV+      Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKC 203
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQV 380
           D+WS G  +  +L+   P+        L ++  G      P   ++S DA+D I++ +  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 381 NPNDRPTAAQLLDHPFVKR 399
           +P+ R TA Q L+HP++++
Sbjct: 264 HPSLRITATQCLEHPWIQK 282

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE   +G +    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 209 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 268 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV+      Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKC 203
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQV 380
           D+WS G  +  +L+   P+        L ++  G      P   ++S DA+D I++ +  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 381 NPNDRPTAAQLLDHPFVKR 399
           +P+ R TA Q L+HP++++
Sbjct: 264 HPSLRITATQCLEHPWIQK 282

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 5/253 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ +NG +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDL 193
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L    P+          +I R      PD +++ A+D I + ++ N + R
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISR-VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 386 PTAAQLLDHPFVK 398
            T A++L+HP++K
Sbjct: 253 LTLAEVLEHPWIK 265

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 209 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 268 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV+      Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKC 203
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQV 380
           D+WS G  +  +L+   P+        L ++  G      P   ++S DA+D I++ +  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 381 NPNDRPTAAQLLDHPFVKR 399
           +P+ R TA Q L+HP++++
Sbjct: 264 HPSLRITATQCLEHPWIQK 282

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE   +G +    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 126/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI +E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 249
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 97
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 215
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 274
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 275 PMLREVLEHPWI 286

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 126/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI +E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY     +  F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQDTYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 135
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  +   +    D+
Sbjct: 136 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEKVDL 193
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 194 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 252
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 253 PMLREVLEHPWI 264

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 88
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 89  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 148
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 206
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 207 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 265
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 266 PMLREVLEHPWI 277

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 70
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 71  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 130
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 188
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 189 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 247
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 248 PMLREVLEHPWI 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 132/255 (51%), Gaps = 11/255 (4%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 97
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 266 RDIKCANILVDANGSVKLADFGL---AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           RDIK  N+L+ + G +K+ADFG    A +++ +D+  C GT  ++ PE+I  + + +   
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C-GTLDYLPPEMI--EGRMHDEK 212
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNP 271
Query: 383 NDRPTAAQLLDHPFV 397
           + RP   ++L+HP++
Sbjct: 272 SQRPMLREVLEHPWI 286

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 249
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 68
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 69  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 185
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 245
Query: 383 NDRPTAAQL 391
            +RPT   L
Sbjct: 246 EERPTFEYL 254

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 70
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 71  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 187
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 247
Query: 383 NDRPTAAQL 391
            +RPT   L
Sbjct: 248 EERPTFEYL 256

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI--EGRXHDEKVDL 194
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 254 PXLREVLEHPWI 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 124/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 72
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 73  AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 131
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 189
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 249
Query: 383 NDRPT 387
            +RPT
Sbjct: 250 EERPT 254

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKIRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 124/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 76
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E + KGSLL+  +     +LR  Q+   + QI  G+ Y+   + VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 193
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 253
Query: 383 NDRPT 387
            +RPT
Sbjct: 254 EERPT 258

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 68
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 69  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 128
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 186
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 187 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 245
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 246 PMLREVLEHPWI 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI +E ++KG LL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 249
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  +   +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRM--HDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 73
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDL 191
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 250
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 251 PMLREVLEHPWI 262

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 131/255 (51%), Gaps = 11/255 (4%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 266 RDIKCANILVDANGSVKLADFGL---AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           RDIK  N+L+ + G +K+ADFG    A +++ +D+  C GT  ++ PE+I  +   +   
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C-GTLDYLPPEMIEGRM--HDEK 189
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 383 NDRPTAAQLLDHPFV 397
           + RP   ++L+HP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  +   +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM--HDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 124/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 76
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E + KGSLL+  +     +LR  Q+   + QI  G+ Y+   + VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGR--FTIKS 193
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 253
Query: 383 NDRPT 387
            +RPT
Sbjct: 254 EERPT 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 124/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 328
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 445
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 505
Query: 383 NDRPT 387
            +RPT
Sbjct: 506 EERPT 510

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 124/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D+  ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+A+FG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 73
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 265
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RDIK  N+L+ + G +K+A+FG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 191
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 250
Query: 386 PTAAQLLDHPFV 397
           P   ++L+HP++
Sbjct: 251 PMLREVLEHPWI 262

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 362
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 383 NDRPTAAQL 391
            +RPT   L
Sbjct: 423 EERPTFEYL 431

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 362
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 383 NDRPTAAQL 391
            +RPT   L
Sbjct: 423 EERPTFEYL 431

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 15/259 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +GRGSF +VY+G+ D      V    L D+    K    + ++E   L   +H NIV++Y
Sbjct: 34  IGRGSFKTVYKGL-DTETTVEVAWCELQDR-KLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 210 ----GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQD-- 262
                T K +  + +  EL T G+L    +R+ +   +V  ++ RQIL GL++LH +   
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 263 VVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           ++HRD+KC NI +    GSVK+ D GLA   + +  K+  GT  + APE    K   Y  
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK---YDE 208
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPIPDSLS-KDAQDFIKQCVQ 379
             D+++ G   LE  TS+ PY+  +  A ++ ++  G  P   D ++  + ++ I+ C++
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 380 VNPNDRPTAAQLLDHPFVK 398
            N ++R +   LL+H F +
Sbjct: 269 QNKDERYSIKDLLNHAFFQ 287

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 124/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KG LL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 383 NDRPT 387
            +RPT
Sbjct: 257 EERPT 261

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 17/277 (6%)
Query: 133 PNGRFKRIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSI 187
           P+ + K  I  ++   +LG+GSFG V+         FFA+K    +V L+D   +     
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---- 64
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSA 246
           + +E+ +  L+ +EH  +   + T + +  L+  +E +  G L+   Q  H  D S+ + 
Sbjct: 65  TMVEKRVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 123
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTA 304
           Y  +I+LGL++LH + +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+    GT 
Sbjct: 124 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD 364
            ++APE++  +   Y    D WS G  + EML  Q P+   +    LF   R   P  P 
Sbjct: 184 DYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPFYPR 240
Query: 365 SLSKDAQDFIKQCVQVNPNDR-PTAAQLLDHPFVKRL 400
            L K+A+D + +     P  R      +  HP  + +
Sbjct: 241 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 277

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 362
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 383 NDRPTAAQL 391
            +RPT   L
Sbjct: 423 EERPTFEYL 431

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGNMSPEAFLQ---EAQVMKKLRHEKLVQLY 246
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 247 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 305
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGL +  + N+  + +G  F   W APE        + + +
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 363
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 423
Query: 383 NDRPTAAQL 391
            +RPT   L
Sbjct: 424 EERPTFEYL 432

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 69
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  + I  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 70  AVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 128
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKS 186
Query: 324 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 246
Query: 383 NDRPT 387
            +RPT
Sbjct: 247 EERPT 251

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 17/261 (6%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V+         FFA+K    +V L+D   +     + +E+ +  L+ +EH 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 78
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 262
            +   + T + +  L+  +E +  G L+   Q  H  D S+ + Y  +I+LGL++LH + 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 320
           +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+    GT  ++APE++  +   Y 
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK--YN 196
Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
              D WS G  + EML  Q P+   +    LF   R   P  P  L K+A+D + +    
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255
Query: 381 NPNDR-PTAAQLLDHPFVKRL 400
            P  R      +  HP  + +
Sbjct: 256 EPEKRLGVRGDIRQHPLFREI 276

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 129/247 (52%), Gaps = 19/247 (7%)
Query: 149 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG+GSFG V+    ++  D G  +A+K   +L + +   +   + + E  +L+   H  
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMK---VLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           +V+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ LGL +LH   +
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGI 151
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 321
           ++RD+K  NIL+D  G +KL DFGL+K    ++ K+    GT  +MAPEV+N   +G+  
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN--RQGHSH 209
Query: 322 PADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
            AD WS G  + EMLT  +P+      E M  + K   G    +P  LS +AQ  ++   
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG----MPQFLSTEAQSLLRALF 265
Query: 379 QVNPNDR 385
           + NP +R
Sbjct: 266 KRNPANR 272

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 23/263 (8%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G GSFG+V+      G   AVK   L++Q   A++ +++  +E+A++ R  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQD--V 263
           G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 264 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           VHR++K  N+LVD   +VK+ DFGL+  KA+     KS  GT  WMAPEV+  +++    
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--RDEPSNE 218
Query: 322 PADIWSLGCTVLEMLTSQIPYA---PMECMAAL-FKIGRGSPPPIPDSLSKDAQDFIKQC 377
            +D++S G  + E+ T Q P+    P + +AA+ FK  R     IP +L+      I+ C
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---IPRNLNPQVAAIIEGC 275
Query: 378 VQVNPNDRPTAAQLLD--HPFVK 398
               P  RP+ A ++D   P +K
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 138/263 (52%), Gaps = 23/263 (8%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G GSFG+V+      G   AVK   L++Q   A++ +++  +E+A++ R  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQD--V 263
           G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 264 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           VHRD+K  N+LVD   +VK+ DFGL+  KA+     K   GT  WMAPEV+  +++    
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVL--RDEPSNE 218
Query: 322 PADIWSLGCTVLEMLTSQIPYA---PMECMAAL-FKIGRGSPPPIPDSLSKDAQDFIKQC 377
            +D++S G  + E+ T Q P+    P + +AA+ FK  R     IP +L+      I+ C
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---IPRNLNPQVAAIIEGC 275
Query: 378 VQVNPNDRPTAAQLLD--HPFVK 398
               P  RP+ A ++D   P +K
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIK 298

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 209 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 262 D-----VVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 314
                 V+HRD+K AN+ +D   +VKL DFGLA+    ++   K   GT ++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
            +  Y   +DIWSLGC + E+     P+          KI  G    IP   S +  + I
Sbjct: 191 MS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
            + + +    RP+  ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 135/259 (52%), Gaps = 17/259 (6%)
Query: 148 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           ++LG G+F  V+       G  FA+K +    + S A +  S LE EIA+L + +HENIV
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCI----KKSPAFRD-SSLENEIAVLKKIKHENIV 69
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                 +  +  Y+ ++LV+ G L + + +R    +   S   +Q+L  +KYLH+  +VH
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129
Query: 266 RDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           RD+K  N+L    + N  + + DFGL+K  +   + +  GT  ++APEV+    K Y   
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL--AQKPYSKA 187
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCV 378
            D WS+G     +L    P+   E  + LF KI  G      P  D +S+ A+DFI   +
Sbjct: 188 VDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246
Query: 379 QVNPNDRPTAAQLLDHPFV 397
           + +PN+R T  + L HP++
Sbjct: 247 EKDPNERYTCEKALSHPWI 265

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 209 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 262 D-----VVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 314
                 V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
            +  Y   +DIWSLGC + E+     P+          KI  G    IP   S +  + I
Sbjct: 191 MS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
            + + +    RP+  ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 20/263 (7%)
Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 209 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 262 D-----VVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 314
                 V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
            +  Y   +DIWSLGC + E+     P+          KI  G    IP   S +  + I
Sbjct: 191 MS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
            + + +    RP+  ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 129/251 (51%), Gaps = 19/251 (7%)
Query: 149 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG+GSFG V+  + IS  D    +A+K   +L + +   +   + + E  +L    H  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMK---VLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +LH   +
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 147
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 321
           ++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MAPEV+N   +G+  
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHTQ 205
Query: 322 PADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
            AD WS G  + EMLT  +P+      E M  + K   G    +P  LS +AQ  ++   
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQSLLRMLF 261
Query: 379 QVNPNDRPTAA 389
           + NP +R  A 
Sbjct: 262 KRNPANRLGAG 272

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 11/270 (4%)
Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
           +GR K  I ++  GD LG G+FG V  G     G   AVK ++   Q  ++   + ++++
Sbjct: 5   DGRVK--IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQ 250
           EI  L  F H +I++ Y      +  ++ +E V+ G L + Y   H R  ++ A    +Q
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQ 119
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAP 309
           IL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      + +++  G+  + AP
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
           EVI+ +    G   DIWS G  +  +L   +P+   E +  LFK  RG    IP+ L++ 
Sbjct: 180 EVISGRLYA-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
               +   +QV+P  R T   + +H + K+
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 140/296 (47%), Gaps = 61/296 (20%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G++ +VY+G++   G + A+KEV L  +      +I    +EI+L+   +HENIV+ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIVRL 68
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTRQILLGLKY 257
           Y     E+KL +  E +      N  ++Y            L  + V  +  Q+L GL +
Sbjct: 69  YDVIHTENKLTLVFEFMD-----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNK 315
            H+  ++HRD+K  N+L++  G +KL DFGLA+A    +N   S   T ++ AP+V+   
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG- 182
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP------------ 359
           ++ Y    DIWS GC + EM+T + P  P     E +  +F I  G+P            
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDI-MGTPNESLWPSVTKLP 240
Query: 360 -------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                              P   + L  +  DF+   +Q+NP+ R +A Q L HP+
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 129/251 (51%), Gaps = 19/251 (7%)
Query: 149 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG+GSFG V+  + IS  D    +A+K   +L + +   +   + + E  +L    H  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMK---VLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +LH   +
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 147
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 321
           ++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MAPEV+N   +G+  
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHTQ 205
Query: 322 PADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
            AD WS G  + EMLT  +P+      E M  + K   G    +P  LS +AQ  ++   
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQSLLRMLF 261
Query: 379 QVNPNDRPTAA 389
           + NP +R  A 
Sbjct: 262 KRNPANRLGAG 272

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 129/251 (51%), Gaps = 19/251 (7%)
Query: 149 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG+GSFG V+  + IS  D    +A+K   +L + +   +   + + E  +L    H  
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMK---VLKKATLKVRDRVRTKMERDILVEVNHPF 88
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +LH   +
Sbjct: 89  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 148
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 321
           ++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MAPEV+N   +G+  
Sbjct: 149 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHTQ 206
Query: 322 PADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
            AD WS G  + EMLT  +P+      E M  + K   G    +P  LS +AQ  ++   
Sbjct: 207 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQSLLRMLF 262
Query: 379 QVNPNDRPTAA 389
           + NP +R  A 
Sbjct: 263 KRNPANRLGAG 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
           +GR K  I ++  GD LG G+FG V  G     G   AVK ++   Q  ++   + ++++
Sbjct: 5   DGRVK--IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQ 250
           EI  L  F H +I++ Y      +  ++ +E V+ G L + Y   H R  ++ A    +Q
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQ 119
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMA 308
           IL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + A
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC-GSPNYAA 178
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK 368
           PEVI+ +    G   DIWS G  +  +L   +P+   E +  LFK  RG    IP+ L++
Sbjct: 179 PEVISGRLYA-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNR 236
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                +   +QV+P  R T   + +H + K+
Sbjct: 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 136/268 (50%), Gaps = 16/268 (5%)
Query: 149 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG G++G V+    IS  D G  +A+K +       +AK +     +   L    +   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           +V  +   + E+KL++ L+ +  G L  +L QR    + +V  Y  +I+L L++LH   +
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYG 320
           ++RDIK  NIL+D+NG V L DFGL+K    ++ +      GT  +MAP+++   + G+ 
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQC 377
              D WSLG  + E+LT   P+       +  +I R    S PP P  +S  A+D I++ 
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 300
Query: 378 VQVNPNDR-----PTAAQLLDHPFVKRL 400
           +  +P  R       A ++ +H F +++
Sbjct: 301 LMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 120/261 (45%), Gaps = 20/261 (7%)
Query: 148 DLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +++G G FG VY    I D+    A +     D      Q+I  + QE  L +  +H NI
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV- 264
           +   G    E  L + +E    G L  +     +    +  +  QI  G+ YLHD+ +V 
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 265 --HRDIKCANILV--------DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINN 314
             HRD+K +NIL+         +N  +K+ DFGLA+        S  G   WMAPEVI  
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA 188
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQDF 373
                G  +D+WS G  + E+LT ++P+  ++ +A  + +       PIP +  +     
Sbjct: 189 SMFSKG--SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246
Query: 374 IKQCVQVNPNDRPTAAQLLDH 394
           ++ C   +P+ RP+   +LD 
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQ 267

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 136/261 (52%), Gaps = 30/261 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G GSFG+VY+G        AVK + ++D   +  Q+      E+A+L +  H NI+ + 
Sbjct: 44  IGSGSFGTVYKGKWHGDV--AVKILKVVDPTPEQFQA---FRNEVAVLRKTRHVNILLFM 98
Query: 210 GTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 261
           G    ++     L +VT+   GS  +LY+  H+++++   +      RQ   G+ YLH +
Sbjct: 99  GYMTKDN-----LAIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINNK-N 316
           +++HRD+K  NI +    +VK+ DFGLA    + +    V+   G+  WMAPEVI  + N
Sbjct: 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDFIK 375
             +   +D++S G  + E++T ++PY+ +      +F +GRG   P    L K+    +K
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMK 271
Query: 376 Q----CVQVNPNDRPTAAQLL 392
           +    CV+    +RP   Q+L
Sbjct: 272 RLVADCVKKVKEERPLFPQIL 292

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 136/261 (52%), Gaps = 12/261 (4%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 65
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++            GT  +M+PE +   +  Y
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTH--Y 183
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 378
            + +DIWS+G +++EM   + P  PM     L  I    PP +P ++ S + QDF+ +C+
Sbjct: 184 SVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCL 243
Query: 379 QVNPNDRPTAAQLLDHPFVKR 399
             NP +R    QL+ H F+KR
Sbjct: 244 IKNPAERADLKQLMVHAFIKR 264

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 136/293 (46%), Gaps = 35/293 (11%)
Query: 143 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DAGPQHR---SGWKQEIDIL 87
Query: 198 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
               HE+I++Y G   D   + L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 310
            YLH Q  +HRD+   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIP-----------YAPMECMAALFKIG 355
            +      Y   +D+WS G T+ E+LT    SQ P              M  +     + 
Sbjct: 208 CLKEYKFYYA--SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSA 408
           RG   P PD    +    +K C +   + RPT   L+  P +K +     G A
Sbjct: 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI--PILKTVHEKYQGQA 316

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 83
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 84  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 200
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 260
Query: 383 NDRPT 387
            DRPT
Sbjct: 261 EDRPT 265

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E V +   + ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 75
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 76  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 192
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 252
Query: 383 NDRPT 387
            DRPT
Sbjct: 253 EDRPT 257

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 68
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-XKY 187
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 80
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 81  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 197
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 257
Query: 383 NDRPT 387
            DRPT
Sbjct: 258 EDRPT 262

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 41  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 96  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQIL 292

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 76
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 77  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 193
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 253
Query: 383 NDRPT 387
            DRPT
Sbjct: 254 EDRPT 258

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 383 NDRPT 387
            DRPT
Sbjct: 252 EDRPT 256

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 82
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 83  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 199
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 259
Query: 383 NDRPT 387
            DRPT
Sbjct: 260 EDRPT 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 80
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 81  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 197
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 257
Query: 383 NDRPT 387
            DRPT
Sbjct: 258 EDRPT 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 79
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 80  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 196
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 256
Query: 383 NDRPT 387
            DRPT
Sbjct: 257 EDRPT 261

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 383 NDRPT 387
            DRPT
Sbjct: 252 EDRPT 256

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 33  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 88  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 140
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 141 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 260
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 261 AMKRLMAECLKKKRDERPLFPQIL 284

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +   + ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 18  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 73  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 246 AMKRLMAECLKKKRDERPLFPQIL 269

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 383 NDRPT 387
            DRPT
Sbjct: 252 EDRPT 256

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 18  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 73  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 246 AMKRLMAECLKKKRDERPLFPQIL 269

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 69
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 70  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 186
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 246
Query: 383 NDRPT 387
            DRPT
Sbjct: 247 EDRPT 251

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 15  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 70  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 242
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 243 AMKRLMAECLKKKRDERPLFPQIL 266

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 40  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 95  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 147
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 148 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 267
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 268 AMKRLMAECLKKKRDERPLFPQIL 291

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 84
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 85  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 201
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 261
Query: 383 NDRPT 387
            DRPT
Sbjct: 262 EDRPT 266

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-XKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 41  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 96  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQIL 292

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 15/258 (5%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFEHENI 205
           G  LG+G FG+VY        F  +  + +L +    K+ +  QL +EI + S   H NI
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKF--IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVV 264
           ++ Y    D  ++Y+ LE   +G L    Q++   D Q SA +  ++   L Y H++ V+
Sbjct: 78  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 137
Query: 265 HRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           HRDIK  N+L+   G +K+ADFG +  A  L     C GT  ++ PE+I  K   +    
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMIEGKT--HDEKV 194
Query: 324 DIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
           D+W  G    E L    P+   +  E    +  +    PP     LS  ++D I + ++ 
Sbjct: 195 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRY 250
Query: 381 NPNDRPTAAQLLDHPFVK 398
           +P  R     +++HP+VK
Sbjct: 251 HPPQRLPLKGVMEHPWVK 268

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 142/273 (52%), Gaps = 26/273 (9%)
Query: 140 IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSL---LDQGSQAKQSISQLEQEIA 195
           +  Y+   + LG G+FG V+  +    G  F  K ++    LD+ +        ++ EI+
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--------VKNEIS 100
Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILL 253
           ++++  H  ++  +   +D+ ++ + LE ++ G L +    + Y + +++V  Y RQ   
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 254 GLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATKLND---VKSCRGTAFWMA 308
           GLK++H+  +VH DIK  NI+ +     SVK+ DFGL  ATKLN    VK    TA + A
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL--ATKLNPDEIVKVTTATAEFAA 218
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD---S 365
           PE+++ +  G+    D+W++G     +L+   P+A  + +  L  + R       D   S
Sbjct: 219 PEIVDREPVGFY--TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +S +A+DFIK  +Q  P  R T    L+HP++K
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 184
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 368
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP   Q+L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 140/276 (50%), Gaps = 14/276 (5%)
Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQ 192
           N  F+ +   +Q+   LG G++G V   +  D    A + + ++ + S    S S  L  
Sbjct: 13  NLYFQGLSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLD 70
Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 251
           E+A+L + +H NI++ Y   +D+   Y+ +E+   G L + +  R    +   +   +Q+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKL-NDVKSCRGTAFWM 307
           L G  YLH  ++VHRD+K  N+L+++   +  +K+ DFGL+   ++   +K   GTA+++
Sbjct: 131 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPD 364
           APEV+  K   Y    D+WS G  +  +L    P+        L ++ +G     PP   
Sbjct: 191 APEVLRKK---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWT 247
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
            +S +A+  +K  +   P+ R +A + L+HP++ + 
Sbjct: 248 QVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKF 283

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 181
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 138/268 (51%), Gaps = 15/268 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++  +++G+G+F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 257
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 258 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEVI 312
            HD +++HRD+K  N+L+   + +  VKL DFG+A +  +   V   R GT  +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIPDSLSKDA 370
             K + YG P D+W  G  +  +L+  +P+          + K      P     +S+ A
Sbjct: 206 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +D +++ + ++P +R T  + L+HP++K
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 68
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 187
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E V +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 184
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 76
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 77  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 193
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 253
Query: 383 NDRPT 387
            +RPT
Sbjct: 254 EERPT 258

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 123/255 (48%), Gaps = 15/255 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFEHENIVQY 208
           LG+G FG+VY        F  +  + +L +    K+ +  QL +EI + S   H NI++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKF--IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 267
           Y    D  ++Y+ LE   +G L    Q++   D Q SA +  ++   L Y H++ V+HRD
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139
Query: 268 IKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           IK  N+L+   G +K+ADFG +  A  L     C GT  ++ PE+I  K   +    D+W
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMIEGKT--HDEKVDLW 196
Query: 327 SLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
             G    E L    P+   +  E    +  +    PP     LS  ++D I + ++ +P 
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPP 252
Query: 384 DRPTAAQLLDHPFVK 398
            R     +++HP+VK
Sbjct: 253 QRLPLKGVMEHPWVK 267

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPPI--------PD---- 364
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P  +        PD    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 365 --------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                          L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 209 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 268 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 321
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 209
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 378
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 210 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 269
Query: 379 QVNPNDRPTAAQLLDHPFV 397
            VNP  R TA Q L  P++
Sbjct: 270 TVNPKKRITADQALKVPWI 288

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 143 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHR---SGWKQEIDIL 70
Query: 198 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
               HE+I++Y G   D+ E  L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 310
            YLH Q  +HR++   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 131 AYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIP-----------YAPMECMAALFKIG 355
            +      Y   +D+WS G T+ E+LT    SQ P              M  +     + 
Sbjct: 191 CLKEYKFYYA--SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 130/261 (49%), Gaps = 24/261 (9%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 17  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYLHDQ 261
            + G    + +L I  +     SL   Y   H  +++          RQ   G+ YLH +
Sbjct: 72  LFMGYST-KPQLAIVTQWCEGSSL---YHHLHASETKFEMKKLIDIARQTARGMDYLHAK 127
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  ++ 
Sbjct: 128 SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 187
Query: 318 G-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSKDAQ 371
             Y   +D+++ G  + E++T Q+PY+ +     + + +GRGS  P    +  +  K  +
Sbjct: 188 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 247
Query: 372 DFIKQCVQVNPNDRPTAAQLL 392
             + +C++   ++RP+  ++L
Sbjct: 248 RLMAECLKKKRDERPSFPRIL 268

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 249
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 250 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 366
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 426
Query: 383 NDRPT 387
            +RPT
Sbjct: 427 EERPT 431

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 145/302 (48%), Gaps = 42/302 (13%)
Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           N  F+ ++  +QK + +G G++G VY+     G   A+K + L    ++ +   S   +E
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIRE 69
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQIL 252
           I+LL    H NIV        E  L +  E + K     L + +  L+DSQ+  Y  Q+L
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---TAFWMAP 309
            G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A  +  V+S      T ++ AP
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAP 188
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRGSPPP---- 361
           +V+   +K Y    DIWS+GC   EM+T + P  P     + +  +F I  G+P P    
Sbjct: 189 DVLMG-SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSI-LGTPNPREWP 245
Query: 362 -----------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                                  I     ++  D +   +  +PN R +A   ++HP+ K
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
Query: 399 RL 400
            L
Sbjct: 306 DL 307

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 70
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 71  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           +++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 187
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 247
Query: 383 NDRPT 387
            DRPT
Sbjct: 248 EDRPT 252

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 209 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 268 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 321
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 186
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 378
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246
Query: 379 QVNPNDRPTAAQLLDHPFV 397
            VNP  R TA Q L  P++
Sbjct: 247 TVNPKKRITADQALKVPWI 265

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 145/302 (48%), Gaps = 42/302 (13%)
Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           N  F+ ++  +QK + +G G++G VY+     G   A+K + L    ++ +   S   +E
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIRE 69
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQIL 252
           I+LL    H NIV        E  L +  E + K     L + +  L+DSQ+  Y  Q+L
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---TAFWMAP 309
            G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A  +  V+S      T ++ AP
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAP 188
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRGSPPP---- 361
           +V+   +K Y    DIWS+GC   EM+T + P  P     + +  +F I  G+P P    
Sbjct: 189 DVLMG-SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSI-LGTPNPREWP 245
Query: 362 -----------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                                  I     ++  D +   +  +PN R +A   ++HP+ K
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
Query: 399 RL 400
            L
Sbjct: 306 DL 307

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 142/277 (51%), Gaps = 21/277 (7%)
Query: 143 YWQKGDLLGRGSFGSVYE------GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           +++ G+ LG G F  V +      G      F   + +S     S+   S  ++E+E+ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS----SSRRGVSREEIEREVNI 61
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 255
           L    H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 256 KYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLA-KATKLNDVKSCRGTAFWMAPE 310
            YLH + + H D+K  NI L+D N     +KL DFG+A K    N+ K+  GT  ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLS 367
           ++N   +  GL AD+WS+G     +L+   P+      E +  +  +          + S
Sbjct: 182 IVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
           + A+DFI++ +  +P  R T AQ L+H ++K +   N
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 9/269 (3%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           ++I  +  GDLLG GS+G V E +  +       ++    +  +     + +++EI LL 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 199 RFEHENIVQYYGT--DKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLG 254
           R  H+N++Q      ++++ K+Y+ +E    G   +L+          Q   Y  Q++ G
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPE 310
           L+YLH Q +VH+DIK  N+L+   G++K++  G+A+A       +  ++ +G+  +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 370
           + N  +   G   DIWS G T+  + T   P+           IG+GS   IP       
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPL 240
Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            D +K  ++  P  R +  Q+  H + ++
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 130/261 (49%), Gaps = 24/261 (9%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 29  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYLHDQ 261
            + G    + +L I  +     SL   Y   H  +++          RQ   G+ YLH +
Sbjct: 84  LFMGYST-KPQLAIVTQWCEGSSL---YHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  ++ 
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 318 G-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSKDAQ 371
             Y   +D+++ G  + E++T Q+PY+ +     + + +GRGS  P    +  +  K  +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 372 DFIKQCVQVNPNDRPTAAQLL 392
             + +C++   ++RP+  ++L
Sbjct: 260 RLMAECLKKKRDERPSFPRIL 280

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 143 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHR---SGWKQEIDIL 70
Query: 198 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
               HE+I++Y G   D+ E  L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 310
            YLH Q  +HR++   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 131 AYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIP-----------YAPMECMAALFKIG 355
            +      Y   +D+WS G T+ E+LT    SQ P              M  +     + 
Sbjct: 191 CLKEYKFYYA--SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 209 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 268 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 321
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 186
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 378
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246
Query: 379 QVNPNDRPTAAQLLDHPFV 397
            VNP  R TA Q L  P++
Sbjct: 247 TVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 209 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 129
Query: 268 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 321
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 185
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 378
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 245
Query: 379 QVNPNDRPTAAQLLDHPFV 397
            VNP  R TA Q L  P++
Sbjct: 246 TVNPKKRITADQALKVPWI 264

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 29  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 207 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYL 258
            + G           L +VT+   GS  +LY   H  +++          RQ   G+ YL
Sbjct: 84  LFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 314
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 315 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSK 368
           ++   Y   +D+++ G  + E++T Q+PY+ +     + + +GRGS  P    +  +  K
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLL 392
             +  + +C++   ++RP+  ++L
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRIL 280

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 128/266 (48%), Gaps = 15/266 (5%)
Query: 148 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           + LG G+F  V        G  FAVK   +  +  + K+S   +E EIA+L + +HENIV
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVK--CIPKKALKGKES--SIENEIAVLRKIKHENIV 83
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                 +  + LY+ ++LV+ G L + + ++    +   S   RQ+L  + YLH   +VH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 266 RDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGL 321
           RD+K  N+L    D    + ++DFGL+K     DV S   GT  ++APEV+    K Y  
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVL--AQKPYSK 201
Query: 322 PADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
             D WS+G     +L    P+      +    + K       P  D +S  A+DFI+  +
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 379 QVNPNDRPTAAQLLDHPFVKRLLATN 404
           + +PN R T  Q   HP++    A N
Sbjct: 262 EKDPNKRYTCEQAARHPWIAGDTALN 287

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 139/274 (50%), Gaps = 13/274 (4%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQE 193
           R + +  Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 252
           +++L   +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 253 LGLKYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWM 307
            G+ YLH   + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPD 364
           APE++N   +  GL AD+WS+G     +L+   P+      E +A +  +          
Sbjct: 184 APEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + S  A+DFI++ +  +P  R T    L HP++K
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 139/274 (50%), Gaps = 13/274 (4%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQE 193
           R + +  Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 252
           +++L   +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 253 LGLKYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWM 307
            G+ YLH   + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPD 364
           APE++N   +  GL AD+WS+G     +L+   P+      E +A +  +          
Sbjct: 185 APEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + S  A+DFI++ +  +P  R T    L HP++K
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 139/274 (50%), Gaps = 13/274 (4%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQE 193
           R + +  Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 252
           +++L   +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 253 LGLKYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWM 307
            G+ YLH   + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPD 364
           APE++N   +  GL AD+WS+G     +L+   P+      E +A +  +          
Sbjct: 184 APEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + S  A+DFI++ +  +P  R T    L HP++K
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 139/268 (51%), Gaps = 18/268 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFEH 202
           +Q+   LG G++G V   +  D    A + + ++ + S    S S  L  E+A+L + +H
Sbjct: 6   YQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN---LYQRYHLRDSQVSAYTRQILLGLKYLH 259
            NI++ Y   +D+   Y+ +E+   G L +   L Q++   D+ V    +Q+L G  YLH
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLSGTTYLH 121
Query: 260 DQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNK 315
             ++VHRD+K  N+L+++   +  +K+ DFGL+   ++   +K   GTA+++APEV+  K
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQD 372
              Y    D+WS G  +  +L    P+        L ++ +G     PP    +S +A+ 
Sbjct: 182 ---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQ 238
Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
            +K  +   P+ R +A + L+HP++ + 
Sbjct: 239 LVKLMLTYEPSKRISAEEALNHPWIVKF 266

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 139/274 (50%), Gaps = 13/274 (4%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQE 193
           R + +  Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 252
           +++L   +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 253 LGLKYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWM 307
            G+ YLH   + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPD 364
           APE++N   +  GL AD+WS+G     +L+   P+      E +A +  +          
Sbjct: 185 APEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + S  A+DFI++ +  +P  R T    L HP++K
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 15/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVK---TLKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 74
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGCFTIKS 192
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY        +  + +G   P  ++   +  D +K C +   
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKA 252
Query: 383 NDRPT 387
            +RPT
Sbjct: 253 EERPT 257

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 136/262 (51%), Gaps = 17/262 (6%)
Query: 150 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G+ G V++      G   AVK++       + K+ +  L+    +L   +   IVQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD---VVLKSHDCPYIVQC 89
Query: 209 YGTDKDESKLYIFLELV-TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHR 266
           +GT    + ++I +EL+ T    L    +  + +  +   T  I+  L YL ++  V+HR
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKN---KGYG 320
           D+K +NIL+D  G +KL DFG+  + +L D K+     G A +MAPE I+  +     Y 
Sbjct: 150 DVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIPDSL--SKDAQDFIKQC 377
           + AD+WSLG +++E+ T Q PY   +     L K+ +  PP +P  +  S D Q F+K C
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 378 VQVNPNDRPTAAQLLDHPFVKR 399
           +  +   RP   +LL+H F+KR
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKR 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+ ++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 37/288 (12%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+ ++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 362 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 16/249 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  +     A+K    L  G+ + +S  +   E  ++ + +H+ +VQ Y
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT---LKPGTMSPESFLE---EAQIMKKLKHDKLVQLY 70
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
               +E  +YI  E + KGSLL+     +   L+   +     Q+  G+ Y+   + +HR
Sbjct: 71  AVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV      K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKS 187
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  ++PY  M     L ++ RG   P P        + +  C + +P
Sbjct: 188 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDP 247
Query: 383 NDRPTAAQL 391
            +RPT   L
Sbjct: 248 EERPTFEYL 256

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 143 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 260 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 314
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 371
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 139/282 (49%), Gaps = 48/282 (17%)
Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 208 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 251
           YY                K +S L+I +E    G+L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 295
           L  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKI 354
           ++ S  GTA ++A EV++     Y    D++SLG    EM+    P++  ME +  L K+
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241
Query: 355 GRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
              S   PP   D+  K  +  I+  +  +PN RP A  LL+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 122/245 (49%), Gaps = 15/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 73
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGCFTIKS 191
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           ++WS G  + E++T  +IPY        +  + +G   P  ++   +  D +K C +   
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMKMCWKEKA 251
Query: 383 NDRPT 387
            +RPT
Sbjct: 252 EERPT 256

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/225 (35%), Positives = 124/225 (55%), Gaps = 26/225 (11%)
Query: 192 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 248
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + SA  
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVL 122
Query: 249 RQILLGLKYLHDQDVVHRDIKCANIL-VDANG---SVKLADFGLAKATKLND---VKSCR 301
             I   ++YLH Q VVHRD+K +NIL VD +G   S+++ DFG AK  +  +   +  C 
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAALFKIG 355
            TA ++APEV+  + +GY    DIWSLG  +  MLT   P+A      P E +A   +IG
Sbjct: 183 -TANFVAPEVL--ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIG 236
Query: 356 RGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            G         +S+S  A+D + + + V+P+ R TAA +L HP++
Sbjct: 237 SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 135/269 (50%), Gaps = 15/269 (5%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R    +Q  + LG+G+F  V   +       +A K ++     ++  Q   +LE+E  + 
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARIC 84
Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLK 256
              +H NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S    QIL  + 
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN 144
Query: 257 YLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 311
           ++H  D+VHRD+K  N+L+ +     +VKLADFGLA   +          GT  +++PEV
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 368
           +  +   YG P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ 
Sbjct: 205 L--RKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTP 262
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           +A++ I Q + +NP  R TA Q L HP+V
Sbjct: 263 EAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 142/275 (51%), Gaps = 17/275 (6%)
Query: 143 YWQKGDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           +++ G+ LG G F  V     +G   +     +K+  L    S+   S  ++E+E+ +L 
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL--XSSRRGVSREEIEREVNILR 84
Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKY 257
              H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+ Y
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 258 LHDQDVVHRDIKCANI-LVDANG---SVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVI 312
           LH + + H D+K  NI L+D N     +KL DFG+A K    N+ K+  GT  ++APE++
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKD 369
           N   +  GL AD+WS+G     +L+   P+      E +  +  +          + S+ 
Sbjct: 205 N--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 262
Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
           A+DFI++ +  +P  R   AQ L+H ++K +   N
Sbjct: 263 AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 23/264 (8%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG GSFG V+   S  +G ++A+K   L  +     + +     E  +LS   H  I++ 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMK--VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYLHDQD 262
           +GT +D  ++++ ++ +  G L +L     LR SQ         Y  ++ L L+YLH +D
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSL-----LRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           +++RD+K  NIL+D NG +K+ DFG AK         C GT  ++APEV++   K Y   
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-GTPDYIAPEVVS--TKPYNKS 183
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D WS G  + EML    P+     M    KI   +    P   ++D +D + + +  + 
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITRDL 242
Query: 383 NDRPTAAQ-----LLDHPFVKRLL 401
           + R    Q     + +HP+ K ++
Sbjct: 243 SQRLGNLQNGTEDVKNHPWFKEVV 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 293 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 132 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQL 190
           + N  F+ +  Y   G L+G GS+G V +  + D G   A+K+    D     K+   + 
Sbjct: 16  TENLYFQSMEKYENLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR- 73
Query: 191 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTR 249
             EI LL +  HEN+V      K + + Y+  E V    L +L    +  D QV   Y  
Sbjct: 74  --EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWM 307
           QI+ G+ + H  +++HRDIK  NILV  +G VKL DFG A+  A           T ++ 
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQ--IP--------YAPMECMAALF----K 353
           APE++    K YG   D+W++GC V EM   +   P        Y  M C+  L     +
Sbjct: 192 APELLVGDVK-YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 354 IGRGSP-------PPIPD---------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           +   +P       P I +          LS+   D  K+C+ ++P+ RP  A+LL H F 
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 398 K 398
           +
Sbjct: 311 Q 311

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 139/282 (49%), Gaps = 39/282 (13%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 208
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 209 YGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEVINNKNKGYGLPAD 324
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+   +K Y    D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG-SKKYSTTID 183
Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------------PP 361
           IWS+GC   EM+     +  +     L +I R  G+P                      P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 362 IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +P       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 293 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 139/282 (49%), Gaps = 39/282 (13%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 208
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 209 YGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEVINNKNKGYGLPAD 324
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+   +K Y    D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYSTTID 183
Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------------PP 361
           IWS+GC   EM+     +  +     L +I R  G+P                      P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 362 IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +P       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 139/282 (49%), Gaps = 39/282 (13%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 208
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 209 YGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEVINNKNKGYGLPAD 324
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+   +K Y    D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG-SKKYSTTID 183
Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------------PP 361
           IWS+GC   EM+     +  +     L +I R  G+P                      P
Sbjct: 184 IWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 362 IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +P       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 293 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 126/242 (52%), Gaps = 8/242 (3%)
Query: 150 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G+GSFG V     +D    +A+K ++   Q    +  +  + +E+ ++   EH  +V  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMN--KQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 209 YGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           + + +DE  +++ ++L+  G L  +L Q  H ++  V  +  ++++ L YL +Q ++HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 268 IKCANILVDANGSVKLADFGLAKAT-KLNDVKSCRGTAFWMAPEVINN-KNKGYGLPADI 325
           +K  NIL+D +G V + DF +A    +   + +  GT  +MAPE+ ++ K  GY    D 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 326 WSLGCTVLEMLTSQIPYAPMECMAA--LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           WSLG T  E+L  + PY      ++  +      +    P + S++    +K+ ++ NP+
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPD 260
Query: 384 DR 385
            R
Sbjct: 261 QR 262

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 139/271 (51%), Gaps = 21/271 (7%)
Query: 143 YWQKGDLLGRGSFGSVYE------GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           +++ G+ LG G F  V +      G      F   + +S     S+   S  ++E+E+ +
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS----SSRRGVSREEIEREVNI 68
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 255
           L    H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 256 KYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLA-KATKLNDVKSCRGTAFWMAPE 310
            YLH + + H D+K  NI L+D N     +KL DFG+A K    N+ K+  GT  ++APE
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLS 367
           ++N   +  GL AD+WS+G     +L+   P+      E +  +  +          + S
Sbjct: 189 IVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 246
Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + A+DFI++ +  +P  R   AQ L+H ++K
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 194
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 254 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 308
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 365
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 194
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 254 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 308
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 365
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 194
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 254 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 308
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 365
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 15/258 (5%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H NIV+ 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRLLKHSNIVRL 68
Query: 209 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H   VVHRD
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRD 128
Query: 268 IKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGYGLP 322
           +K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV+  + + YG P
Sbjct: 129 LKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL--RKEAYGKP 186
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQ 379
            DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A++ I Q + 
Sbjct: 187 VDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLT 246
Query: 380 VNPNDRPTAAQLLDHPFV 397
           +NP  R TA + L HP+V
Sbjct: 247 INPAKRITAHEALKHPWV 264

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 194
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 254 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 308
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 365
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 138/282 (48%), Gaps = 33/282 (11%)
Query: 143 YWQK---GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           ++QK    D++GRG    V   +    G  FAVK + +    +  + S  QLE E+   +
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV----TAERLSPEQLE-EVREAT 146
Query: 199 RFE---------HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
           R E         H +I+    + +  S +++  +L+ KG L + L ++  L + +  +  
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTA 304
           R +L  + +LH  ++VHRD+K  NIL+D N  ++L+DFG    L    KL ++  C GT 
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--C-GTP 263
Query: 305 FWMAPEVI----NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-- 358
            ++APE++    +  + GYG   D+W+ G  +  +L    P+     +  L  I  G   
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323
Query: 359 -PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
              P  D  S   +D I + +QV+P  R TA Q L HPF +R
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 194
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 254 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 308
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 365
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 198
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 199 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 256
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVI--- 312
            LH  ++VHRD+K  NIL+D + ++KL DFG + +      ++S  GT  ++APE+I   
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECS 198
Query: 313 -NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 368
            N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D  S 
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 258
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA 402
             +D + + + V P  R TA + L HPF ++ + 
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 138/265 (52%), Gaps = 16/265 (6%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 81
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 199
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK----IGRGSPPPIPDSL-SKDAQDFI 374
            + +DIWS+G +++EM   + P        A+F+    I    PP +P  + S + QDF+
Sbjct: 200 SVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 259
Query: 375 KQCVQVNPNDRPTAAQLLDHPFVKR 399
            +C+  NP +R    QL+ H F+KR
Sbjct: 260 NKCLIKNPAERADLKQLMVHAFIKR 284

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 118/221 (53%), Gaps = 4/221 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 293 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
              N +    G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDEFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 118/221 (53%), Gaps = 4/221 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 293 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
              N + +  G   + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 137/271 (50%), Gaps = 22/271 (8%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 320 GLPADIWSLGCTVLEMLTSQIPY----------APMECMAALFKIGRGSPPPIPDSL-SK 368
            + +DIWS+G +++EM   + P            PM     L  I    PP +P  + S 
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 240
Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           + QDF+ +C+  NP +R    QL+ H F+KR
Sbjct: 241 EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 21/263 (7%)
Query: 150 LGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG G+FG V+  E  S  G    +K ++      +++  + Q+E EI +L   +H NI++
Sbjct: 30  LGSGAFGDVHLVEERSS-GLERVIKTIN----KDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGLKYLHDQD 262
            +   +D   +YI +E    G LL        R     +  V+   +Q++  L Y H Q 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 263 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEVINNKNKG 318
           VVH+D+K  NIL      +  +K+ DFGLA+  K ++  +   GTA +MAPEV     + 
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF---KRD 201
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQ 376
                DIWS G  +  +LT  +P+          K     P    +   L+  A D +KQ
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 377 CVQVNPNDRPTAAQLLDHPFVKR 399
            +  +P  RP+AAQ+L H + K+
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 142 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           + +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    
Sbjct: 22  SMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLL 78
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H
Sbjct: 79  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 260 DQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINN 314
              VVHRD+K  N+L+ +     +VKLADFGLA   +          GT  +++PEV+  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-- 196
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQ 371
           +   YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 256
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFV 397
           D I + + +NP+ R TAA+ L HP++
Sbjct: 257 DLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 37  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 96
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 97  LVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 156
Query: 293 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 157 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 215
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 216 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 255

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 138/274 (50%), Gaps = 13/274 (4%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQE 193
           R + +  Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 252
           +++L   +H N++  +   ++++ + +  ELV  G L + L ++  L + + + + +QIL
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 253 LGLKYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWM 307
            G+ YLH   + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPD 364
           APE++N   +  GL AD+WS+G     +L+   P+      E +A +  +          
Sbjct: 185 APEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           + S  A+DFI++ +  +P  R T    L HP++K
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 137/272 (50%), Gaps = 11/272 (4%)
Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
           +GR K  I ++  GD LG G+FG V  G  +  G   AVK ++   Q  ++   + ++ +
Sbjct: 10  DGRVK--IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRR 65
Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 251
           EI  L  F H +I++ Y      S +++ +E V+ G L + + +   L + +     +QI
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 309
           L G+ Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + AP
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-GSPNYAAP 184
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
           EVI+ +    G   DIWS G  +  +L   +P+   + +  LFK         P  L+  
Sbjct: 185 EVISGRLYA-GPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLNPS 242
Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
               +K  +QV+P  R T   + +H + K+ L
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 137/277 (49%), Gaps = 21/277 (7%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 198
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 199 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 256
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVI 312
            LH  ++VHRD+K  NIL+D + ++KL DFG    L    KL +V  C GT  ++APE+I
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEII 195
Query: 313 ----NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDS 365
               N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA 402
            S   +D + + + V P  R TA + L HPF ++ + 
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   E +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 121/245 (49%), Gaps = 16/245 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G  G V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D++ ANILV    S K+ADFGLA+  +  +  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 383 NDRPT 387
            DRPT
Sbjct: 252 EDRPT 256

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 136/274 (49%), Gaps = 21/274 (7%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 198
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 199 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 256
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVI 312
            LH  ++VHRD+K  NIL+D + ++KL DFG    L    KL +V  C GT  ++APE+I
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEII 182
Query: 313 ----NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDS 365
               N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D 
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 242
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            S   +D + + + V P  R TA + L HPF ++
Sbjct: 243 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 141/272 (51%), Gaps = 15/272 (5%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEI 194
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +   ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVCREEIEREV 66
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
           ++L +  H NI+  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 254 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 308
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 365
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 138/282 (48%), Gaps = 48/282 (17%)
Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 208 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 251
           YY                K +S L+I +E     +L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 295
           L  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKI 354
           ++ S  GTA ++A EV++     Y    D++SLG    EM+    P++  ME +  L K+
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241
Query: 355 GRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
              S   PP   D+  K  +  I+  +  +PN RP A  LL+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 137/270 (50%), Gaps = 17/270 (6%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIAL 196
           R    +Q  + LG+G+F  V   +       A +E +  +++    + +   +LE+E  +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVK----VLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGL 255
               +H NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  +
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 256 KYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPE 310
            + H   VVHR++K  N+L+ +     +VKLADFGLA   +          GT  +++PE
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLS 367
           V+  +   YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++
Sbjct: 184 VL--RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241
Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            +A+D I + + +NP+ R TAA+ L HP++
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 135/268 (50%), Gaps = 15/268 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++  +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 257
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 258 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEVI 312
            HD +++HRD+K   +L+   + +  VKL  FG+A +  +   V   R GT  +MAPEV+
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIPDSLSKDA 370
             K + YG P D+W  G  +  +L+  +P+          + K      P     +S+ A
Sbjct: 208 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESA 265
Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +D +++ + ++P +R T  + L+HP++K
Sbjct: 266 KDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 8/261 (3%)
Query: 141 ITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLS 198
           I  +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLR 68
Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
              H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y 
Sbjct: 69  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 128
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNK 317
           H   +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K  
Sbjct: 129 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 188
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
             G   D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ 
Sbjct: 189 A-GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246
Query: 378 VQVNPNDRPTAAQLLDHPFVK 398
           + VNP +R +  +++   + K
Sbjct: 247 LIVNPLNRISIHEIMQDDWFK 267

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 8/261 (3%)
Query: 141 ITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLS 198
           I  +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLR 63
Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
              H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y 
Sbjct: 64  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 123
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNK 317
           H   +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K  
Sbjct: 124 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 183
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
             G   D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ 
Sbjct: 184 A-GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 241
Query: 378 VQVNPNDRPTAAQLLDHPFVK 398
           + VNP +R +  +++   + K
Sbjct: 242 LIVNPLNRISIHEIMQDDWFK 262

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 26  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 75
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 135
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 136 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 194
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 195 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 251
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 252 SHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 8/261 (3%)
Query: 141 ITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLS 198
           I  +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLR 69
Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
              H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y 
Sbjct: 70  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 129
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNK 317
           H   +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K  
Sbjct: 130 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 189
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
             G   D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ 
Sbjct: 190 A-GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 247
Query: 378 VQVNPNDRPTAAQLLDHPFVK 398
           + VNP +R +  +++   + K
Sbjct: 248 LIVNPLNRISIHEIMQDDWFK 268

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 103
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 163
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 222
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 223 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 279
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 280 SHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 8/258 (3%)
Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFE 201
           +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L    
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y H  
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
            +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K    G
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-G 181
Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
              D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ + V
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 240
Query: 381 NPNDRPTAAQLLDHPFVK 398
           NP +R +  +++   + K
Sbjct: 241 NPLNRISIHEIMQDDWFK 258

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 103
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 163
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 222
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 223 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 279
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 280 SHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E +  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E +  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 26  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 75
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 135
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 136 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 194
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 195 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 251
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 252 SHFSSDLKDLLRNLLQVDLTKR 273

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFGLAK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 20  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 69
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 70  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 129
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 130 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-GT 188
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 189 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 245
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 246 SHFSSDLKDLLRNLLQVDLTKR 267

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 135/268 (50%), Gaps = 15/268 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++  +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 257
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 258 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEVI 312
            HD +++HRD+K   +L+   + +  VKL  FG+A +  +   V   R GT  +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIPDSLSKDA 370
             K + YG P D+W  G  +  +L+  +P+          + K      P     +S+ A
Sbjct: 206 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +D +++ + ++P +R T  + L+HP++K
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 28  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 77
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 78  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 137
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 138 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 196
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 197 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 253
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 254 SHFSSDLKDLLRNLLQVDLTKR 275

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 140/265 (52%), Gaps = 26/265 (9%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 203
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 56  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 263 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 316
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV++   
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGT- 226
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 373
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 227 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 284
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           I++ +   P+ R +A   LDH +++
Sbjct: 285 IRKMLTYVPSMRISARDALDHEWIQ 309

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 140/265 (52%), Gaps = 26/265 (9%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 203
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 33  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 263 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 316
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV++   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGT- 203
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDF 373
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           I++ +   P+ R +A   LDH +++
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQ 286

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 140/265 (52%), Gaps = 26/265 (9%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 203
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 57  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 263 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 316
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV++   
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGT- 227
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 373
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 228 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 285
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           I++ +   P+ R +A   LDH +++
Sbjct: 286 IRKMLTYVPSMRISARDALDHEWIQ 310

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 137/263 (52%), Gaps = 22/263 (8%)
Query: 149 LLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 203
           +LG+GSFG V   +  D   G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 39  VLGKGSFGEVI--LCKDKITGQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 263 VVHRDIKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKG 318
           +VHRD+K  N+L+++   + ++++ DFGL+   + +  +K   GTA+++APEV++     
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--- 209
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIK 375
           Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D I+
Sbjct: 210 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 269
Query: 376 QCVQVNPNDRPTAAQLLDHPFVK 398
           + +   P+ R +A   LDH +++
Sbjct: 270 KMLTYVPSMRISARDALDHEWIQ 292

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/224 (34%), Positives = 122/224 (54%), Gaps = 24/224 (10%)
Query: 192 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 248
           +EI +L R+ +H NI+       D   +Y+  EL   G LL+  L Q++   + + SA  
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVL 122
Query: 249 RQILLGLKYLHDQDVVHRDIKCANIL-VDANG---SVKLADFGLAKATKLND--VKSCRG 302
             I   ++YLH Q VVHRD+K +NIL VD +G   S+++ DFG AK  +  +  + +   
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAALFKIGR 356
           TA ++APEV+  + +GY    DIWSLG  +   LT   P+A      P E +A   +IG 
Sbjct: 183 TANFVAPEVL--ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILA---RIGS 237
Query: 357 GS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           G         +S+S  A+D + + + V+P+ R TAA +L HP++
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIRT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +        +V+   + KD S LY+ LE    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 19  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 68
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 69  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 128
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 129 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GT 187
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 188 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 244
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 245 SHFSSDLKDLLRNLLQVDLTKR 266

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 103
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 163
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-GT 222
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 223 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 279
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 280 SHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 122/258 (47%), Gaps = 17/258 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVN 381
              S D +D ++  +QV+
Sbjct: 259 SHFSSDLKDLLRNLLQVD 276

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 140/266 (52%), Gaps = 24/266 (9%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRG++GSV + +    G   AVK + S +D+  Q KQ +  L+    ++   +   IVQ
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLD---VVMRSSDCPYIVQ 85
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQV-----SAYTRQILLGLKYLHDQ 261
           +YG    E   +I +EL++  S    Y+  Y + D  +        T   +  L +L + 
Sbjct: 86  FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 262 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVIN--NKN 316
             ++HRDIK +NIL+D +G++KL DFG++    ++ +   R  G   +MAPE I+     
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQ---- 371
           +GY + +D+WSLG T+ E+ T + PY     +   L ++ +G PP + +S  ++      
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI 263
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFV 397
           +F+  C+  + + RP   +LL HPF+
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--ISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 136/264 (51%), Gaps = 15/264 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 262 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKN 316
            +VHRD+K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV+  + 
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL--RK 180
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 373
             YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+D 
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           I + + +NP  R TA++ L HP++
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 133/262 (50%), Gaps = 22/262 (8%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LGRG++G V E +     G   AVK +       + K+ +  L+  +  +   +    V 
Sbjct: 59  LGRGAYG-VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV---DCPFTVT 114
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ- 261
           +YG    E  ++I +EL+   SL   Y++       + +  +      I+  L++LH + 
Sbjct: 115 FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNK--NKG 318
            V+HRD+K +N+L++A G VK+ DFG++     +  K+   G   +MAPE IN +   KG
Sbjct: 174 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           Y + +DIWSLG T++E+   + PY     P + +  +  +   SP    D  S +  DF 
Sbjct: 234 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADKFSAEFVDFT 291
Query: 375 KQCVQVNPNDRPTAAQLLDHPF 396
            QC++ N  +RPT  +L+ HPF
Sbjct: 292 SQCLKKNSKERPTYPELMQHPF 313

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 143 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           Y +K   LG G FG V    Y+  +D  G   AVK    L +G    Q  S  ++EI +L
Sbjct: 10  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKEGC-GPQLRSGWQREIEIL 65
Query: 198 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
               HE+IV+Y G   D+ E  + + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 66  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGM 125
Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 310
            YLH Q  +HR +   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 126 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIPYAP-----------MECMAALFKIG 355
            +  K   +   +D+WS G T+ E+LT    +Q P+             M  +     + 
Sbjct: 186 CL--KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 243
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 244 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + +M     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 143 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           Y +K   LG G FG V    Y+  +D  G   AVK    L +G    Q  S  ++EI +L
Sbjct: 9   YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKEGC-GPQLRSGWQREIEIL 64
Query: 198 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
               HE+IV+Y G   D+ E  + + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 65  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGM 124
Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 310
            YLH Q  +HR +   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 125 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIPYAP-----------MECMAALFKIG 355
            +      Y   +D+WS G T+ E+LT    +Q P+             M  +     + 
Sbjct: 185 CLKECKFYYA--SDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 242
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 243 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 28/228 (12%)
Query: 192 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 248
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + S   
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVL 127
Query: 249 RQILLGLKYLHDQDVVHRDIKCANIL-VDANGS---VKLADFGLAKATKLND---VKSCR 301
             I   ++YLH Q VVHRD+K +NIL VD +G+   +++ DFG AK  +  +   +  C 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAAL---- 351
            TA ++APEV+  K +GY    DIWSLG  +  ML    P+A      P E +  +    
Sbjct: 188 -TANFVAPEVL--KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           F +  G+     +++S+ A+D + + + V+P+ R TA Q+L HP+V +
Sbjct: 245 FTLSGGNW----NTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFGLAK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 28/228 (12%)
Query: 192 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 248
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + S   
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVL 127
Query: 249 RQILLGLKYLHDQDVVHRDIKCANIL-VDANGS---VKLADFGLAKATKLND---VKSCR 301
             I   ++YLH Q VVHRD+K +NIL VD +G+   +++ DFG AK  +  +   +  C 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAAL---- 351
            TA ++APEV+  K +GY    DIWSLG  +  ML    P+A      P E +  +    
Sbjct: 188 -TANFVAPEVL--KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           F +  G+     +++S+ A+D + + + V+P+ R TA Q+L HP+V +
Sbjct: 245 FTLSGGNW----NTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 124/244 (50%), Gaps = 22/244 (9%)
Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQL 190
           N R+K +       D LG G   +VY  +++D       A+K + +  +  + ++++ + 
Sbjct: 10  NERYKIV-------DKLGGGGMSTVY--LAEDTILNIKVAIKAIFIPPR--EKEETLKRF 58
Query: 191 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYT 248
           E+E+   S+  H+NIV     D+++   Y+ +E + +G  L+ Y   H  L       +T
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSVDTAINFT 117
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAF 305
            QIL G+K+ HD  +VHRDIK  NIL+D+N ++K+ DFG+AKA   T L       GT  
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           + +PE    K +      DI+S+G  + EML  + P+     ++   K  + S P +   
Sbjct: 178 YFSPE--QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235
Query: 366 LSKD 369
           + KD
Sbjct: 236 VRKD 239

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 136/264 (51%), Gaps = 15/264 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 262 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKN 316
            +VHRD+K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV+  + 
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL--RK 180
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 373
             YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+D 
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFV 397
           I + + +NP  R TA++ L HP++
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  AVK   ++ +GS ++    Q  Q +  LS   H  +V++Y
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSEDEFFQEAQTMMKLS---HPKLVKFY 69
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
           G    E  +YI  E ++ G LLN Y R H   L  SQ+      +  G+ +L     +HR
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
           D+   N LVD +  VK++DFG+ +    +   S  GT F   W APEV +     Y   +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSSKS 186
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+W+ G  + E+ +  ++PY        + K+ +G     P   S      +  C    P
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELP 246
Query: 383 NDRPTAAQLL 392
             RPT  QLL
Sbjct: 247 EKRPTFQQLL 256

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 127/266 (47%), Gaps = 22/266 (8%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +LG+GSFG V    + + G  +AVK    +V L D   +   +    E+ I  L+R  H 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 84
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 262
            + Q +   +   +L+  +E V  G L+   Q+    D ++   Y  +I+  L +LHD+ 
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 320
           +++RD+K  N+L+D  G  KLADFG+ K    N V +    GT  ++APE++  +   YG
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL--QEMLYG 202
Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
              D W++G  + EML    P+   E    LF+         P  L +DA   +K  +  
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261
Query: 381 NPNDRPTA------AQLLDHPFVKRL 400
           NP  R  +        +L HPF K +
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKEI 287

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS----QLEQEIALLSRFEHE 203
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 263 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKG 318
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+    K 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQKP 194
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFI 374
           Y    D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
           +  ++ +P  R T  Q L HP++
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS----QLEQEIALLSRFEHE 203
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 263 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKG 318
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+  K   
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-- 194
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFI 374
           Y    D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
           +  ++ +P  R T  Q L HP++
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS----QLEQEIALLSRFEHE 203
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 263 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKG 318
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+    K 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQKP 194
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFI 374
           Y    D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 375 KQCVQVNPNDRPTAAQLLDHPFV 397
           +  ++ +P  R T  Q L HP++
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 121/242 (50%), Gaps = 20/242 (8%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 243
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 266
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 244 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 326
           D++ ANILV A+   K+ADFGLA+      +K       W APE IN  +  + + +D+W
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIK-------WTAPEAINFGS--FTIKSDVW 353
Query: 327 SLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           S G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P +R
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 413
Query: 386 PT 387
           PT
Sbjct: 414 PT 415

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
              +APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 129/259 (49%), Gaps = 15/259 (5%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           D+LG G+F  V   +++D     +  +  + + +   +  S +E EIA+L + +H NIV 
Sbjct: 24  DVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKHPNIVA 80
Query: 208 YYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  +VHR
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 267 DIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLP 322
           D+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+  K   Y   
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP--YSKA 198
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFIKQCV 378
            D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI+  +
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 257
Query: 379 QVNPNDRPTAAQLLDHPFV 397
           + +P  R T  Q L HP++
Sbjct: 258 EKDPEKRFTCEQALQHPWI 276

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY- 184
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELM 243
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 244 RACWQWNPSDRPSFAEI 260

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 133/263 (50%), Gaps = 24/263 (9%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LGRG++G V E +     G   AVK +       + K+ +  L+     +   +    V 
Sbjct: 15  LGRGAYG-VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVT 70
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ- 261
           +YG    E  ++I +EL+   SL   Y++       + +  +      I+  L++LH + 
Sbjct: 71  FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK--NK 317
            V+HRD+K +N+L++A G VK+ DFG++    ++DV      G   +MAPE IN +   K
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQDF 373
           GY + +DIWSLG T++E+   + PY     P + +  +  +   SP    D  S +  DF
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADKFSAEFVDF 246
Query: 374 IKQCVQVNPNDRPTAAQLLDHPF 396
             QC++ N  +RPT  +L+ HPF
Sbjct: 247 TSQCLKKNSKERPTYPELMQHPF 269

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 144/295 (48%), Gaps = 55/295 (18%)
Query: 150 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 207 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKN 316
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-S 202
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA----- 349
           KGY    DIWS+GC + EML+++ P  P                      + C+      
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 261
Query: 350 -ALFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 262 NYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI +E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 195
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K        GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWXLXGT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 22  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI +E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY-NK-FS 191
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 252 WNPSDRPSFAEI 263

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGV--------WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 191
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 192 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 250
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 251 RACWQWNPSDRPSFAEI 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G FG VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQFGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY- 184
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELM 243
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 244 RACWQWNPSDRPSFAEI 260

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 204
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 88
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 206
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 142/287 (49%), Gaps = 28/287 (9%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV        G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 115
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  + L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 116 LDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 175
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y +  
Sbjct: 176 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNMTV 233
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--IPDSLSKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L +I R  G+PP   I    S +A+++I    Q
Sbjct: 234 DIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQ 293
Query: 380 VNPND--------RPTAAQLLDHPFV----KRLLATNSGSASPYLGR 414
           +   +         P A  LL+   V    KR+ A+ +  A PY  +
Sbjct: 294 MPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEA-LAHPYFSQ 339

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++AP +I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPAII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 121/226 (53%), Gaps = 4/226 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           + ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 42  IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 101
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 291
           L     +++ +  +  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG + + 
Sbjct: 102 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 161
Query: 292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
           T    + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 162 TVGGKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 220
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            ++ RG    IP  +S D ++ +K+ + +NP  R T  Q++   ++
Sbjct: 221 ERVLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 265

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 124/259 (47%), Gaps = 11/259 (4%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           ++ G  LG+G FG+VY        F    +V L     + +    QL +EI + +   H 
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKV-LFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-GLKYLHDQD 262
           NI++ Y    D  ++Y+ LE   +G L    Q+    D Q +A   + L   L Y H + 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 322
           V+HRDIK  N+L+   G +K+ADFG +        K+  GT  ++ PE+I  + + +   
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMI--EGRMHNEK 201
Query: 323 ADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
            D+W +G    E+L    P+   +  E    + K+    P  +P      AQD I + ++
Sbjct: 202 VDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTG----AQDLISKLLR 257
Query: 380 VNPNDRPTAAQLLDHPFVK 398
            NP++R   AQ+  HP+V+
Sbjct: 258 HNPSERLPLAQVSAHPWVR 276

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL----REIKILLRFRHENIIGI 90
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K        GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWXLAGT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 137/265 (51%), Gaps = 26/265 (9%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 203
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 33  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           NI + Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 263 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 316
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K    K   GTA+++APEV++   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KXKDKIGTAYYIAPEVLHGT- 203
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDF 373
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           I++ +   P+ R +A   LDH +++
Sbjct: 262 IRKXLTYVPSXRISARDALDHEWIQ 286

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 94
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 212
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 213 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 271
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 272 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 204
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 142/294 (48%), Gaps = 53/294 (18%)
Query: 150 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 207 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKN 316
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-S 202
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPP------------- 361
           KGY    DIWS+GC + EML+++  +     +  L  I    GSP               
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 362 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                            P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 142/294 (48%), Gaps = 53/294 (18%)
Query: 150 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 207 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKN 316
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-S 202
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPP------------- 361
           KGY    DIWS+GC + EML+++  +     +  L  I    GSP               
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 362 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                            P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 202
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 261
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 14/265 (5%)
Query: 138 KRIITYWQKGDLLGRGSFGSV-----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
           KR I  +   + LG GSFG V     Y+        F  ++  LL +         ++E+
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMH----MRVER 58
Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 252
           EI+ L    H +I++ Y      + + + +E         + ++  + + +   + +QI+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEV 311
             ++Y H   +VHRD+K  N+L+D N +VK+ADFGL+   T  N +K+  G+  + APEV
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 371
           IN K    G   D+WS G  +  ML  ++P+   E +  LFK        +PD LS  AQ
Sbjct: 179 INGKLYA-GPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPF 396
             I++ +  +P  R T  ++   P+
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPW 261

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 202
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNY 261
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN-SKG 208
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN-SKG 209
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 209
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 92
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 210
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 211 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 269
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 270 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 83
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 201
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 202 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 260
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 261 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 224
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 184
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 243
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 364 DSLSKDAQDFIKQCVQVNPNDR 385
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY-NK-FS 195
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 25  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 194
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 254
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 255 WNPSDRPSFAEI 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 120/226 (53%), Gaps = 4/226 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           + ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 45  IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 104
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 291
           L     +++ +  +  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG + + 
Sbjct: 105 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
Query: 292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
           T    + +  G   + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 165 TVGGKLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 223
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
            ++ RG    IP  +S D ++ +K+ + +NP  R T  Q++   ++
Sbjct: 224 ERVLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 195
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 258
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY- 184
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELM 243
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 244 RACWQWNPSDRPSFAEI 260

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 140/293 (47%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +Y+   L+    L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 224
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 190
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 139/290 (47%), Gaps = 52/290 (17%)
Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 201
           ++K D LG G F +VY+    +     A+K++ L    S+AK  I++   +EI LL    
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL-GHRSEAKDGINRTALREIKLLQELS 70
Query: 202 HENIV---QYYGTDKDESKLYIFLE-----LVTKGSLLNLYQRYHLRDSQVSAYTRQILL 253
           H NI+     +G   + S ++ F+E     ++   SL+       L  S + AY    L 
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYMLMTLQ 123
Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEV 311
           GL+YLH   ++HRD+K  N+L+D NG +KLADFGLAK+    +        T ++ APE+
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPEL 183
Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP-------- 359
           +    + YG+  D+W++GC + E+L  ++P+ P    ++ +  +F+   G+P        
Sbjct: 184 LFGA-RMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFET-LGTPTEEQWPDM 240
Query: 360 ------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
                       P IP      +   D  D I+     NP  R TA Q L
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 195
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A++++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 192
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 253 WNPSDRPSFAEI 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 190
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 34  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 85
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 203
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 204 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 263
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 264 WNPSDRPSFAEI 275

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 136/278 (48%), Gaps = 25/278 (8%)
Query: 140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----KQSISQLEQEI 194
           I  Y+   + +GRGS+G V           AV++ + + + ++       + + + +QEI
Sbjct: 7   INQYYTLENTIGRGSWGEVK---------IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 57
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
            ++   +H NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L 
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117
Query: 254 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAP 309
            + Y H  +V HRD+K  N L      +  +KL DFGLA   K   +   + GT ++++P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSL 366
           +V+      YG   D WS G  +  +L    P++       + KI  G+   P     ++
Sbjct: 178 QVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 234
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
           S  A+  I++ +  +P  R T+ Q L+H + ++ L+++
Sbjct: 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 75
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 76  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 193
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 194 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 252
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 253 CWAYDPSRRPRFTEL 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 192
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 253 WNPSDRPSFAEI 264

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 113/220 (51%), Gaps = 4/220 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ +     H NIV+ +   + E  LY+  E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDY 103
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
           L      ++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF 163
Query: 293 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
              N + +  G   + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            ++ RG    IP   S D ++ +K+ + +NP+ R T  Q+
Sbjct: 223 ERVLRGK-YRIPFYXSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 142/325 (43%), Gaps = 69/325 (21%)
Query: 143 YWQKGDLL------------GRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK---QSI 187
           Y+Q G LL            G+GS+G V   I +     A++ + ++++    +   + +
Sbjct: 15  YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR--AIRAIKIMNKNKIRQINPKDV 72
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY---------- 237
            +++ E+ L+ +  H NI + Y   +DE  + + +EL   G LL+    +          
Sbjct: 73  ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 238 ----------------------H---------LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                                 H          R+  +S   RQI   L YLH+Q + HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 267 DIKCANILVDANGS--VKLADFGLAKA-TKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           DIK  N L   N S  +KL DFGL+K   KLN+     + +  GT +++APEV+N  N+ 
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
           YG   D WS G  +  +L   +P+  +   + ++ +         P  + LS  A+D + 
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLS 312
Query: 376 QCVQVNPNDRPTAAQLLDHPFVKRL 400
             +  N ++R  A + L HP++ + 
Sbjct: 313 NLLNRNVDERFDAMRALQHPWISQF 337

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 73
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 74  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 191
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 192 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 250
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 251 CWAYDPSRRPRFTEL 265

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 188
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 72
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 73  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 190
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 191 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 249
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 250 CWAYDPSRRPRFTEL 264

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY-NK-FS 192
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 253 WNPSDRPSFAEI 264

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 320
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 196
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 378
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 197 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 256
Query: 379 QVNPNDRPTAAQLLD 393
              P DRPT   L D
Sbjct: 257 AHKPEDRPTFVALRD 271

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 136/278 (48%), Gaps = 25/278 (8%)
Query: 140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----KQSISQLEQEI 194
           I  Y+   + +GRGS+G V           AV++ + + + ++       + + + +QEI
Sbjct: 24  INQYYTLENTIGRGSWGEVK---------IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
            ++   +H NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L 
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 134
Query: 254 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAP 309
            + Y H  +V HRD+K  N L      +  +KL DFGLA   K   +   + GT ++++P
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSL 366
           +V+      YG   D WS G  +  +L    P++       + KI  G+   P     ++
Sbjct: 195 QVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 251
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
           S  A+  I++ +  +P  R T+ Q L+H + ++ L+++
Sbjct: 252 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 98
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 99  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 216
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 217 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 275
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 276 CWAYDPSRRPRFTEL 290

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 188
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 320
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL--KTRTFS 202
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 378
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 262
Query: 379 QVNPNDRPTAAQLLD 393
              P DRPT   L D
Sbjct: 263 AHKPEDRPTFVALRD 277

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 22  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY-NK-FS 191
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 252 WNPSDRPSFAEI 263

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 228 LGGGQYGEVYEGV--------WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSA-----YTRQILLGLKYL 258
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AY 393
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 394 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452
Query: 375 KQCVQVNPNDRPTAAQL 391
           + C Q NP+DRP+ A++
Sbjct: 453 RACWQWNPSDRPSFAEI 469

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 320
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 192
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 378
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 252
Query: 379 QVNPNDRPTAAQLLD 393
              P DRPT   L D
Sbjct: 253 AHKPEDRPTFVALRD 267

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 142/294 (48%), Gaps = 53/294 (18%)
Query: 150 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G G++G   S Y+ +       A+K++S  +  +  ++++    +EI +L RF HEN++
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRV--AIKKISPFEHQTYCQRTL----REIQILLRFRHENVI 104
Query: 207 QYY-----GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                    T +    +YI  +L+ +  L  L +   L +  +  +  QIL GLKY+H  
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA 163
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLND----VKSCRGTAFWMAPEVINNKN 316
           +V+HRD+K +N+L++    +K+ DFGLA+ A   +D    +     T ++ APE++ N +
Sbjct: 164 NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN-S 222
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPP------------- 361
           KGY    DIWS+GC + EML+++  +     +  L  I    GSP               
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARN 282
Query: 362 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                            P S SK A D + + +  NPN R T  + L HP++++
Sbjct: 283 YLQSLPSKTKVAWAKLFPKSDSK-ALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 67
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 68  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 185
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 186 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 245 CWAYDPSRRPRFTEL 259

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 320
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 202
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 378
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 262
Query: 379 QVNPNDRPTAAQLLD 393
              P DRPT   L D
Sbjct: 263 AHKPEDRPTFVALRD 277

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 320
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL--KTRTFS 192
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 378
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 252
Query: 379 QVNPNDRPTAAQLLD 393
              P DRPT   L D
Sbjct: 253 AHKPEDRPTFVALRD 267

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 36/271 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 69
Query: 205 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 260
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 315
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAP----MECMAALFKIGR-------GSPP 360
              +   +D+WS G  + E+ T    S  P A     M C   +  + R       G   
Sbjct: 190 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 247
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           P P +   +  + +K C   +P DRP+ + L
Sbjct: 248 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 150 LGRGSFGSVYEGISDDGF---FFAVKEVSLLDQG--SQAKQSISQLEQEI----ALLSRF 200
           LG G++G V      +G       V + S  D+G  S   ++I +  +EI    +LL   
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +H NI++ +   +D+   Y+  E    G L   +  R+   +   +   +QIL G+ YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 260 DQDVVHRDIKCANILVDANGS---VKLADFGL----AKATKLNDVKSCRGTAFWMAPEVI 312
             ++VHRDIK  NIL++   S   +K+ DFGL    +K  KL D     GTA+++APEV+
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAYYIAPEVL 220
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-PIPD--SLSKD 369
             K   Y    D+WS G  +  +L    P+        + K+ +G       D  ++S +
Sbjct: 221 KKK---YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDE 277
Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           A++ IK  +  + N R TA + L+  ++K+
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 320
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 196
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 378
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 197 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 256
Query: 379 QVNPNDRPTAAQLLD 393
              P DRPT   L D
Sbjct: 257 AHKPEDRPTFVALRD 271

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 150 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 320
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 192
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 378
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 252
Query: 379 QVNPNDRPTAAQLLD 393
              P DRPT   L D
Sbjct: 253 AHKPEDRPTFVALRD 267

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 146/302 (48%), Gaps = 47/302 (15%)
Query: 135 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           G+F+ +  Y    +LLG G++  V   +S  +G  +AVK +       QA  S S++ +E
Sbjct: 8   GKFEDM--YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE-----KQAGHSRSRVFRE 60
Query: 194 IALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQI 251
           +  L + + ++NI++     +D+++ Y+  E +  GS+L ++ ++ H  + + S   R +
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDV 120
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKLNDVKSCR------- 301
              L +LH + + HRD+K  NIL ++      VK+ DF L    KLN+  SC        
Sbjct: 121 AAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNN--SCTPITTPEL 178
Query: 302 ----GTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--------- 345
               G+A +MAPEV+    ++   Y    D+WSLG  +  ML+   P+            
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 346 -----ECMAALFKIGRGSPPPIPDS----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                 C   LF+  +      PD     +S +A+D I + +  +   R +AAQ+L HP+
Sbjct: 239 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPW 298
Query: 397 VK 398
           V+
Sbjct: 299 VQ 300

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 36/271 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 85
Query: 205 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 260
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 315
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAP----MECMAALFKIGR-------GSPP 360
              +   +D+WS G  + E+ T    S  P A     M C   +  + R       G   
Sbjct: 206 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           P P +   +  + +K C   +P DRP+ + L
Sbjct: 264 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATK-LNDVKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  +     K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR- 188
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 36/271 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 73
Query: 205 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 260
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 315
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAP----MECMAALFKIGR-------GSPP 360
              +   +D+WS G  + E+ T    S  P A     M C   +  + R       G   
Sbjct: 194 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 251
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           P P +   +  + +K C   +P DRP+ + L
Sbjct: 252 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 46/291 (15%)
Query: 150 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHEN 204
           +G G++G V++   + + G F A+K V +  Q  +    +S + +E+A+L     FEH N
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTI-REVAVLRHLETFEHPN 75
Query: 205 IVQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLK 256
           +V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL 
Sbjct: 76  VVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNK 315
           +LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI------------GRGSPPPIP 363
           +  Y  P D+WS+GC   EM   +  +     +  L KI             R    P  
Sbjct: 195 S--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 364 DSLSKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
              SK AQ              D + +C+  NP  R +A   L HP+ + L
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 267 LGGGQYGEVYEGV--------WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK-FS 436
Query: 321 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 437 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 496
Query: 380 VNPNDRPTAAQL 391
            NP+DRP+ A++
Sbjct: 497 WNPSDRPSFAEI 508

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 46/291 (15%)
Query: 150 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHEN 204
           +G G++G V++   + + G F A+K V +  Q  +    +S + +E+A+L     FEH N
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTI-REVAVLRHLETFEHPN 75
Query: 205 IVQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLK 256
           +V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL 
Sbjct: 76  VVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNK 315
           +LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV+   
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI------------GRGSPPPIP 363
           +  Y  P D+WS+GC   EM   +  +     +  L KI             R    P  
Sbjct: 195 S--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 364 DSLSKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
              SK AQ              D + +C+  NP  R +A   L HP+ + L
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 139/292 (47%), Gaps = 53/292 (18%)
Query: 150 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L  F HENI+
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENII 86
Query: 207 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKN 316
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +
Sbjct: 146 NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-S 204
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPP------------- 361
           KGY    DIWS+GC + EML+++  +     +  L  I    GSP               
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARN 264
Query: 362 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
                            P++ SK A D + + +  NP+ R    Q L HP++
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 196 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 197 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 254
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 255 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 121/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL    Q++  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 196 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 139/291 (47%), Gaps = 51/291 (17%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L  F HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENIIGI 88
Query: 209 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 206
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 350
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 351 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 198 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 255
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 256 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 211 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 193 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 211 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 193 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 199 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 256
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 257 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 224 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 192 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 249
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 250 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 191 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 248
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 249 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 150 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENI 205
           +G G++G V++   + + G F A+K V +  Q  +    +S + +   L  L  FEH N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 206 VQYYG------TDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL +
Sbjct: 77  VRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKN 316
           LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV+   +
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI------------GRGSPPPIPD 364
             Y  P D+WS+GC   EM   +  +     +  L KI             R    P   
Sbjct: 196 --YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 365 SLSKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             SK AQ              D + +C+  NP  R +A   L HP+ +
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 200 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 257
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 258 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 193 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV A   VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 188
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 450
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 451 PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 568
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 569 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 627
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 628 CWAYDPSRRPRFTEL 642

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 128/271 (47%), Gaps = 36/271 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 72
Query: 205 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 260
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 315
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAA-----------LFKIGRGSPP 360
              +   +D+WS G  + E+ T    S  P A    M             L  +  G   
Sbjct: 193 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRL 250
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           P P +   +  + +K C   +P DRP+ + L
Sbjct: 251 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 30  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 141
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 142 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 254 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 148 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 87
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 253
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 254 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 306
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 208 MAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLL 392
              +  D ++QC +  P +RP+ AQ+L
Sbjct: 266 CDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 121
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 122 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 179 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 233
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 234 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 281

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 148 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 77
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 253
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 254 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 306
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 197
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 198 MAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 255
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLL 392
              +  D ++QC +  P +RP+ AQ+L
Sbjct: 256 CDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 121
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 122 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 179 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 233
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 234 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 281

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 234
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 235 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 282

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 43  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 102
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 103 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 154
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 155 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 211
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 212 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 266
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 267 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 314

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 246
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 247 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 234
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 235 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 282

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 133/269 (49%), Gaps = 23/269 (8%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR 199
           +Q G LLG G FGSVY GI   D    A+K V    + D G     +  ++  E+ LL +
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPMEVVLLKK 67
Query: 200 FEHE-----NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
                     ++ ++  ++ +S + I   +     L + + +R  L++    ++  Q+L 
Sbjct: 68  VSSGFSGVIRLLDWF--ERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 254 GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 312
            +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  +  PE I
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 185
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
              ++ +G  A +WSLG  + +M+   IP+   E      +I RG        +S + Q 
Sbjct: 186 -RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQRVSSECQH 237
Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
            I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 182
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 182
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 149
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 150 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 207 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 261
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 262 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 182
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 46/281 (16%)
Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 208 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--RQIL 252
           YY                K +S L+I  E     +L +L    +L   +   +   RQIL
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------ND 296
             L Y+H Q ++HR++K  NI +D + +VK+ DFGLAK         KL         ++
Sbjct: 127 EALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALF 352
           + S  GTA ++A EV++     Y    D +SLG    E +    P++     +  +  L 
Sbjct: 187 LTSAIGTAXYVATEVLDGTGH-YNEKIDXYSLGIIFFEXI---YPFSTGXERVNILKKLR 242
Query: 353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
            +    PP   D+  K  +  I+  +  +PN RP A  LL+
Sbjct: 243 SVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 249
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 250 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVK-EVSLLDQGSQ----------AKQSISQLEQEIALLS 198
           L +G F  +     D+ F+   K E SLL++              K      + E+ +++
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT---------R 249
             ++E  +   G   +  ++YI  E +   S+L   + + + D   + +          +
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 250 QILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 308
            +L    Y+H++ ++ HRD+K +NIL+D NG VKL+DFG ++      +K  RGT  +M 
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP 218
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP----- 363
           PE  +N++   G   DIWSLG  +  M  + +P++    +  LF   R      P     
Sbjct: 219 PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNH 278
Query: 364 --------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
                         + LS +  DF+K  ++ NP +R T+   L H ++
Sbjct: 279 FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 149
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 150 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 207 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 261
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 262 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 249
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 250 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 182
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 17/255 (6%)
Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 450
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 451 PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 317
           +  VHRDI   N+LV A   VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 568
Query: 318 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 569 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 627
Query: 377 CVQVNPNDRPTAAQL 391
           C   +P+ RP   +L
Sbjct: 628 CWAYDPSRRPRFTEL 642

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 144 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEIXINKML 62
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 259
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNK 315
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KR 181
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPY 342
            + +  P D+WS G  +  ML  ++P+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 317
            + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRRE 182
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPY 342
            +  P D+WS G  +  ML  ++P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIXINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 317
            + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRRE 182
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPY 342
            +  P D+WS G  +  ML  ++P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 317
            + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  + +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KRRE 182
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPY 342
            +  P D+WS G  +  ML  ++P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEI 194
           +   ++ ++   + LG G+FG V+       G  FA K V    +  +       + +EI
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEI 205
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQIL 252
             +S   H  +V  +   +D++++ +  E ++ G L       H + S+  A  Y RQ+ 
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGL-AKATKLNDVKSCRGTAFWMAP 309
            GL ++H+ + VH D+K  NI+     S  +KL DFGL A       VK   GTA + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS---- 365
           EV   K  GY    D+WS+G     +L+   P+        L  + +     + DS    
Sbjct: 326 EVAEGKPVGYY--TDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSG 382
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           +S+D +DFI++ +  +PN R T  Q L+HP++
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 144 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           W     LG G++G V      ++++    AVK V +     +A      +++EI + +  
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINAML 62
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 259
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 314
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY 342
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 249
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 250 ------GGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 181
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 64
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 182
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HR++   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 194 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 251
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 252 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 144 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 259
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNK 315
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KR 180
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPY 342
            + +  P D+WS G  +  ML  ++P+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 62
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 180
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 131/257 (50%), Gaps = 27/257 (10%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +++GRG+FG V +        +  K+V++  ++  S+ K  I +L Q    LSR  H NI
Sbjct: 15  EVVGRGAFGVVCKAK------WRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNI 64
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD- 260
           V+ YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH  
Sbjct: 65  VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 261 --QDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 317
             + ++HRD+K  N+L+ A G+V K+ DFG A   + +   + +G+A WMAPEV    N 
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEVFEGSN- 180
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
            Y    D++S G  + E++T + P+  +       ++ +  G+ PP+  +L K  +  + 
Sbjct: 181 -YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 239
Query: 376 QCVQVNPNDRPTAAQLL 392
           +C   +P+ RP+  +++
Sbjct: 240 RCWSKDPSQRPSMEEIV 256

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEI 194
           +   ++ ++   + LG G+FG V+       G  FA K V    +  +       + +EI
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEI 99
Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQIL 252
             +S   H  +V  +   +D++++ +  E ++ G L       H + S+  A  Y RQ+ 
Sbjct: 100 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 159
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGL-AKATKLNDVKSCRGTAFWMAP 309
            GL ++H+ + VH D+K  NI+     S  +KL DFGL A       VK   GTA + AP
Sbjct: 160 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 219
Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS---- 365
           EV   K  GY    D+WS+G     +L+   P+        L  + +     + DS    
Sbjct: 220 EVAEGKPVGYY--TDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSG 276
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           +S+D +DFI++ +  +PN R T  Q L+HP++
Sbjct: 277 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE +   ++ Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 131/257 (50%), Gaps = 27/257 (10%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +++GRG+FG V +        +  K+V++  ++  S+ K  I +L Q    LSR  H NI
Sbjct: 14  EVVGRGAFGVVCKAK------WRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNI 63
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD- 260
           V+ YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH  
Sbjct: 64  VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 261 --QDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 317
             + ++HRD+K  N+L+ A G+V K+ DFG A   + +   + +G+A WMAPEV    N 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEVFEGSN- 179
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
            Y    D++S G  + E++T + P+  +       ++ +  G+ PP+  +L K  +  + 
Sbjct: 180 -YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 238
Query: 376 QCVQVNPNDRPTAAQLL 392
           +C   +P+ RP+  +++
Sbjct: 239 RCWSKDPSQRPSMEEIV 255

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 121/272 (44%), Gaps = 37/272 (13%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 205 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 260
           IV+Y G         L + +E +  GSL +  Q +  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 315
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 316 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 359
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 196 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P PD    +    + +C   N N RP+   L
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 128/296 (43%), Gaps = 58/296 (19%)
Query: 144 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           + K D LG G++ +VY+G   ++D+    A+KE+ L  +      +I    +E++LL   
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDN--LVALKEIRLEHEEGAPCTAI----REVSLLKDL 57
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQVSAYTRQI 251
           +H NIV  +     E  L +  E + K         G+++N++         V  +  Q+
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--------VKLFLFQL 109
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPE 310
           L GL Y H Q V+HRD+K  N+L++  G +KLADFGLA+A  +            W  P 
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKI-GRGSPPPIPDS 365
            I   +  Y    D+W +GC   EM T + P  P     E +  +F+I G  +    P  
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 366 LSK-------------------------DAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           LS                          D  D + + +Q    +R +A   + HPF
Sbjct: 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE +   ++ Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 181
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 38/296 (12%)
Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGS 181
           P + + P    KR +   +    LG G FG V    Y+   D+ G   AVK +     G+
Sbjct: 9   PATEVDPTHFEKRFLKRIRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN 65
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY--QRY 237
                I+ L++EI +L    HENIV+Y G  T+   + + + +E +  GSL       + 
Sbjct: 66  H----IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 238 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 296
            +   Q   Y  QI  G+ YL  +  VHRD+   N+LV++   VK+ DFGL KA + +  
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 297 ---VKSCRGT-AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 351
              VK  R +  FW APE +      + + +D+WS G T+ E+LT      +PM     +
Sbjct: 182 XXTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 352 F--------------KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                           +  G   P P +   +    +++C +  P++R +   L++
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 181
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 37/291 (12%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 179
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 180 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 231
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 232 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 234
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             +I RG        +S + Q  I+ C+ + P DRPT  ++ +HP+++ +L
Sbjct: 235 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVL 282

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 144 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 259
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 314
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY 342
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIXINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 181
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 144 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 259
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 314
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY 342
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 144 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 259
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 314
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY 342
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 144 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 259
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 314
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPY 342
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 70
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV+  G VK++DFGL++    ++  S RG+ F   W  PEV+      +   +D
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSK--FSSKSD 188
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 384 DRPTAAQLL 392
           +RPT   LL
Sbjct: 249 ERPTFKILL 257

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 226
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 227 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 131/265 (49%), Gaps = 18/265 (6%)
Query: 149 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG+G +G V++      ++ G  FA+K +        AK + +  + E  +L   +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPF 82
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDV 263
           IV      +   KLY+ LE ++ G L    +R  +  +     Y  +I + L +LH + +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYG 320
           ++RD+K  NI+++  G VKL DFGL K + ++D     +  GT  +MAPE++     G+ 
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVTHTFCGTIEYMAPEIL--MRSGHN 199
Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
              D WSLG  + +MLT   P+        + KI +     +P  L+++A+D +K+ ++ 
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-CKLNLPPYLTQEARDLLKKLLKR 258
Query: 381 NPNDR-----PTAAQLLDHPFVKRL 400
           N   R       A ++  HPF + +
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFFRHI 283

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 143/303 (47%), Gaps = 54/303 (17%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 124
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 242
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 348
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 302
Query: 349 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   A+F+    I    PP +P ++ S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 303 GMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 362
Query: 397 VKR 399
           +KR
Sbjct: 363 IKR 365

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 263
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE +   ++ Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 264 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 322 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 131/294 (44%), Gaps = 52/294 (17%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 205
           +G G++G+VY+      G F A+K V + + G           +E+ALL R   FEH N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 206 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 77  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNKN 316
           LH   +VHRD+K  NILV + G+VKLADFGLA+        +      W  APEV+    
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 354
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 196 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249
Query: 355 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 250 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 302

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 180 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 231
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 180 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 231
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 148 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 84
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 253
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 254 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 306
                 G+ YL  +  +HR++   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 204
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 205 MAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 262
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLL 392
              +  D ++QC +  P +RP+ AQ+L
Sbjct: 263 CDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 180 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 231
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 118
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 119 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 178
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 179 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 230
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 231 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 149 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +LG+G +G V++      ++ G  FA+K +        AK + +  + E  +L   +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPF 82
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDV 263
           IV      +   KLY+ LE ++ G L    +R  +  +     Y  +I + L +LH + +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 321
           ++RD+K  NI+++  G VKL DFGL K +  +   +    GT  +MAPE++     G+  
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEIL--MRSGHNR 200
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D WSLG  + +MLT   P+        + KI +     +P  L+++A+D +K+ ++ N
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-CKLNLPPYLTQEARDLLKKLLKRN 259
Query: 382 PNDR-----PTAAQLLDHPFVKRL 400
              R       A ++  HPF + +
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHI 283

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 226
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 141
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 142 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 201
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 202 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 253
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 254 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 289

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 152 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 209
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 210 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 267
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 268 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 117
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 118 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 177
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 178 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 229
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 230 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 265

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 149 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 206
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 207 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 264
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 265 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 147 VSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 204
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE +   ++ Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 205 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 262
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 263 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 127/258 (49%), Gaps = 16/258 (6%)
Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPA 323
           DIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV+ + +  YG   
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND--YGRAV 186
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +P 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 245
Query: 384 DR-----PTAAQLLDHPF 396
            R       A ++++H F
Sbjct: 246 QRLGGGPSDAKEVMEHRF 263

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 127/258 (49%), Gaps = 16/258 (6%)
Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 266
                +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV+R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 267 DIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPA 323
           DIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV+ + +  YG   
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND--YGRAV 186
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +P 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 245
Query: 384 DR-----PTAAQLLDHPF 396
            R       A ++++H F
Sbjct: 246 QRLGGGPSDAKEVMEHRF 263

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 127/276 (46%), Gaps = 37/276 (13%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 193
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 194 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 305
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +        G        
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------GGQVFFRQR 226
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 380 V 380
           +
Sbjct: 267 M 267

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 20/260 (7%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 15  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 130
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 321
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV+ + +  YG 
Sbjct: 131 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND--YGR 187
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 246
Query: 382 PNDR-----PTAAQLLDHPF 396
           P  R       A ++++H F
Sbjct: 247 PKQRLGGGPSDAKEVMEHRF 266

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +++ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR--DINNIDYYKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 380 V 380
           +
Sbjct: 271 M 271

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 141/303 (46%), Gaps = 54/303 (17%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 89
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 207
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM--------------------AALFKI 354
            + +DIWS+G +++EM   + P  P     +E M                      L K 
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 355 GRGS-----------------PPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           G  S                 PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 397 VKR 399
           +KR
Sbjct: 328 IKR 330

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 348
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 349 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 397 VKR 399
           +KR
Sbjct: 301 IKR 303

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNA-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 348
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 349 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 397 VKR 399
           +KR
Sbjct: 301 IKR 303

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 380 V 380
           +
Sbjct: 270 M 270

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 35/273 (12%)
Query: 150 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           LG G FG V    Y+   D+ G   AVK +     G+     I+ L++EI +L    HEN
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 72
Query: 205 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHD 260
           IV+Y G  T+   + + + +E +  GSL       +  +   Q   Y  QI  G+ YL  
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AFWMAPEVINNK 315
           +  VHRD+   N+LV++   VK+ DFGL KA + +     VK  R +  FW APE +   
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF--------------KIGRGSPP 360
              + + +D+WS G T+ E+LT      +PM     +                +  G   
Sbjct: 193 K--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 250
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
           P P +   +    +++C +  P++R +   L++
Sbjct: 251 PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 136/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 SKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 268
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGXVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 380 V 380
           +
Sbjct: 270 M 270

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 157
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 215
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 275
Query: 380 V 380
           +
Sbjct: 276 M 276

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 201
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 380 V 380
           +
Sbjct: 262 M 262

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 348
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 349 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 397 VKR 399
           +KR
Sbjct: 301 IKR 303

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 144 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 201
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 260
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 261 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 348
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 349 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 397 VKR 399
           +KR
Sbjct: 301 IKR 303

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 133/294 (45%), Gaps = 55/294 (18%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 205
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 206 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNKN 316
           LH   +VHRD+K  NILV + G+VKLADFGLA+        +      W  APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 354
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 188 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 355 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G+ G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 63
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKN 316
            + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 181
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
           + +  P D+WS G  +  ML  ++P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 380 V 380
           +
Sbjct: 272 M 272

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 84
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 85  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 144
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 202
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 203 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 262
Query: 380 V 380
           +
Sbjct: 263 M 263

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 201
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 380 V 380
           +
Sbjct: 262 M 262

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 200
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 380 V 380
           +
Sbjct: 261 M 261

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 321
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 184
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 382 PNDR-----PTAAQLLDHPF 396
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 380 V 380
           +
Sbjct: 267 M 267

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTV 224
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 284
Query: 380 V 380
           +
Sbjct: 285 M 285

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 380 V 380
           +
Sbjct: 272 M 272

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---KPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 216
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 380 V 380
           +
Sbjct: 277 M 277

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 380 V 380
           +
Sbjct: 272 M 272

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 223
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 283
Query: 380 V 380
           +
Sbjct: 284 M 284

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 169
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 227
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 287
Query: 380 V 380
           +
Sbjct: 288 M 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 260
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR-GTAFWMAPEVINNKNKG 318
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S   GT  ++APE++  + + 
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL--RGED 229
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSLSKDA 370
           YG   D W+LG  + EM+  + P+                LF++       IP SLS  A
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289
Query: 371 QDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 400
              +K  +  +P +R         A +  HPF + +
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGL + T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCRHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 380 V 380
           +
Sbjct: 270 M 270

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 380 V 380
           +
Sbjct: 267 M 267

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 380 V 380
           +
Sbjct: 267 M 267

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 380 V 380
           +
Sbjct: 272 M 272

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 216
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 380 V 380
           +
Sbjct: 277 M 277

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 157
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 215
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 275
Query: 380 V 380
           +
Sbjct: 276 M 276

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 321
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 184
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 382 PNDR-----PTAAQLLDHPF 396
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 93
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 258
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 149
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 314
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE +  
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-- 207
Query: 315 KNKGYGLP-ADIWSLGCTVLEMLT 337
             +G   P +DI+S G  +LE++T
Sbjct: 208 --RGEITPKSDIYSFGVVLLEIIT 229

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 216
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 380 V 380
           +
Sbjct: 277 M 277

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 380 V 380
           +
Sbjct: 270 M 270

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 85
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 86  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 145
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 203
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 204 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 263
Query: 380 V 380
           +
Sbjct: 264 M 264

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 134/267 (50%), Gaps = 34/267 (12%)
Query: 143 YWQKGDL------LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           ++Q  DL      LG GSF    + +       FAVK +S        K+  +  ++EI 
Sbjct: 6   FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQKEIT 57
Query: 196 LLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
            L   E H NIV+ +    D+   ++ +EL+  G L   + ++ H  +++ S   R+++ 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 254 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLND--VKSCRGTAFWMA 308
            + ++HD  VVHRD+K  N+L    + N  +K+ DFG A+    ++  +K+   T  + A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA----PMECMAA---LFKIGRGS--- 358
           PE++N    GY    D+WSLG  +  ML+ Q+P+      + C +A   + KI +G    
Sbjct: 178 PELLN--QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDR 385
                 ++S++A+D I+  + V+PN R
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKR 262

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 380 V 380
           +
Sbjct: 271 M 271

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 136/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 35  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++  K+ 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 213 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 269
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 270 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 308

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 321
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 184
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 382 PNDR-----PTAAQLLDHPF 396
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 17  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 132
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 321
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 133 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 189
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 248
Query: 382 PNDR-----PTAAQLLDHPF 396
           P  R       A ++++H F
Sbjct: 249 PKQRLGGGPSDAKEVMEHRF 268

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 380 V 380
           +
Sbjct: 271 M 271

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 169
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGYVATRWYRAPEIMLNW-MHYNQTV 227
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 287
Query: 380 V 380
           +
Sbjct: 288 M 288

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K + +G G++G+V++  + +     A+K V L D       S  +   EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLK 256
           +NIV+ +     + KL +  E   +       ++Y       L    V ++  Q+L GL 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNK 315
           + H ++V+HRD+K  N+L++ NG +KLADFGLA+A  +     S      W  P  +   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRGSP--------PPIP 363
            K Y    D+WS GC   E+  +  P  P     + +  +F++  G+P          +P
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRL-LGTPTEEQWPSMTKLP 234
Query: 364 D------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           D                   L+   +D ++  ++ NP  R +A + L HP+
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 135/294 (45%), Gaps = 55/294 (18%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 205
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 206 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKN 316
           LH   +VHRD+K  NILV + G+VKLADFGLA+       +     T ++ APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST 187
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 354
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 188 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 355 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 304
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 305 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 362
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 363 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 304
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 305 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 362
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 363 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 304
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 305 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 362
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 239
Query: 363 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 240 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 304
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 305 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 362
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 363 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 304
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 305 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 362
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 246
Query: 363 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 247 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 200
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 380 V 380
           +
Sbjct: 261 M 261

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 140/300 (46%), Gaps = 61/300 (20%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G  G V+  + +D     A+K++ L D      QS+    +EI ++ R +H+NIV+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 73
Query: 209 Y--------------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 254
           +              G+  + + +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRG-------TAFW 306
           LKY+H  +V+HRD+K AN+ ++    V K+ DFGLA+   ++   S +G       T ++
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI--MDPHYSHKGHLSEGLVTKWY 190
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------- 359
            +P ++ + N  Y    D+W+ GC   EMLT +  +A    +  +  I    P       
Sbjct: 191 RSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 360 -----------------PPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
                            P  P +     +S++A DF++Q +  +P DR TA + L HP++
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 93
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 258
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 149
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 314
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE +  
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-- 207
Query: 315 KNKGYGLP-ADIWSLGCTVLEMLT 337
             +G   P +DI+S G  +LE++T
Sbjct: 208 --RGEITPKSDIYSFGVVLLEIIT 229

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNW-MHYNQTV 200
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 380 V 380
           +
Sbjct: 261 M 261

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 223
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 283
Query: 380 V 380
           +
Sbjct: 284 M 284

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGXVATRWYRAPEIMLNWMH-YNQTV 224
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 380 V 380
           +
Sbjct: 285 M 285

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 156
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 214
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 215 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 274
Query: 380 V 380
           +
Sbjct: 275 M 275

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
           +  EI +L R  H NI++     +  +++ + LELVT G L + + ++ +  +   +   
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKLNDV-KSCRGTA 304
           +QIL  + YLH+  +VHRD+K  N+L      +  +K+ADFGL+K  +   + K+  GT 
Sbjct: 155 KQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214
Query: 305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----P 360
            + APE++  +   YG   D+WS+G     +L    P+        +F+           
Sbjct: 215 GYCAPEIL--RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS 272
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           P  D +S +A+D +++ + ++P  R T  Q L HP+V
Sbjct: 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 224
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 380 V 380
           +
Sbjct: 285 M 285

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 11/220 (5%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 247
            +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGT 303
             Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 304 AFWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPP 361
             ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 362 IPD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           IP+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +   +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 200
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 380 V 380
           +
Sbjct: 261 M 261

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 87
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 258
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 143
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 314
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE +  
Sbjct: 144 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-- 201
Query: 315 KNKGYGLP-ADIWSLGCTVLEMLT 337
             +G   P +DI+S G  +LE++T
Sbjct: 202 --RGEITPKSDIYSFGVVLLEIIT 223

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 22/262 (8%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LGRG++G V +      G   AVK +       + K+ +  L+     +   +    V +
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTV---DCPFTVTF 98
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ-D 262
           YG    E  ++I  EL    SL   Y++       + +  +      I+  L++LH +  
Sbjct: 99  YGALFREGDVWICXEL-XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK--NKG 318
           V+HRD+K +N+L++A G VK  DFG++    ++DV      G   + APE IN +   KG
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDIDAGCKPYXAPERINPELNQKG 216
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
           Y + +DIWSLG T +E+   + PY     P + +  +  +   SP    D  S +  DF 
Sbjct: 217 YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADKFSAEFVDFT 274
Query: 375 KQCVQVNPNDRPTAAQLLDHPF 396
            QC++ N  +RPT  +L  HPF
Sbjct: 275 SQCLKKNSKERPTYPELXQHPF 296

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 270
Query: 380 V 380
           +
Sbjct: 271 M 271

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 260
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 317
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  + +
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGE 181
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSLSKD 369
            YG   D W+LG  + EM+  + P+                LF++       IP SLS  
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 241
Query: 370 AQDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 400
           A   +K  +  +P +R         A +  HPF + +
Sbjct: 242 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 17/263 (6%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 207
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 82  VIGRGAFGEV--QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 139
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H   ++HRD
Sbjct: 140 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 199
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 322
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 200 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRE 259
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQ 379
            D WS+G  + EML    P+     +    KI         P    +SK A++ I  C  
Sbjct: 260 CDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLI--CAF 317
Query: 380 VNPND----RPTAAQLLDHPFVK 398
           +   +    R    ++  HPF K
Sbjct: 318 LTDREVRLGRNGVEEIKQHPFFK 340

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 118/221 (53%), Gaps = 4/221 (1%)
Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 45  VKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 104
Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA- 291
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+D + ++K+ADFG +   
Sbjct: 105 LVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF 164
Query: 292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 351
           T  N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 165 TVGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 223
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            ++ RG    IP  +S D ++ +K+ + +NP  R +  Q++
Sbjct: 224 ERVLRGK-YRIPFYMSTDCENLLKKLLVLNPIKRGSLEQIM 263

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 14/251 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 203
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 384 DRPTAAQLLDH 394
           +RPT   LL +
Sbjct: 264 ERPTFKILLSN 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 11/220 (5%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 247
            +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGT 303
             Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT
Sbjct: 259 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 304 AFWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPP 361
             ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 378
Query: 362 IPD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           IP+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 379 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 260
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 317
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  + +
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGE 185
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSLSKD 369
            YG   D W+LG  + EM+  + P+                LF++       IP SLS  
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 370 AQDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 400
           A   +K  +  +P +R         A +  HPF + +
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 136/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 31  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++  K+ 
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 209 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEKFFPKARDLVEKL 265
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 266 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 304

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 131/289 (45%), Gaps = 29/289 (10%)
Query: 139 RIITYWQKGDL-LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           R   +W    L LGRGSFG V+  + D   GF  AVK+V L          + + E E+ 
Sbjct: 89  REEVHWATHQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRL---------EVFRAE-ELM 137
Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 254
             +      IV  YG  ++   + IF+EL+  GSL  L +    L + +   Y  Q L G
Sbjct: 138 ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEG 197
Query: 255 LKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDVKSCR-------GTAFW 306
           L+YLH + ++H D+K  N+L+ ++GS   L DFG A   + + +           GT   
Sbjct: 198 LEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETH 257
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPD 364
           MAPEV+  ++       D+WS  C +L ML    P+          KI    PP   IP 
Sbjct: 258 MAPEVVLGRS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPP 315
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 413
           S +      I++ ++  P  R +AA+L     V R L    G  SP+ G
Sbjct: 316 SCAPLTAQAIQEGLRKEPIHRVSAAELGGK--VNRALQQVGGLKSPWRG 362

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 135/294 (45%), Gaps = 55/294 (18%)
Query: 150 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 205
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 206 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKN 316
           LH   +VHRD+K  NILV + G+VKLADFGLA+       +     T ++ APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 354
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 188 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 355 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 244
           H+NI+   G    +  LY+ +   +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 305 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 355
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 260
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 317
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  + +
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGE 196
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKD 369
            YG   D W+LG  + EM+  + P+  +             LF++       IP S+S  
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVK 256
Query: 370 AQDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 400
           A   +K  +  +P +R         A +  HPF + +
Sbjct: 257 AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ D+GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 69
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 129
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 187
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 188 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 247
Query: 384 DRPTAAQLL 392
           +RPT   LL
Sbjct: 248 ERPTFKILL 256

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 76
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 136
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 194
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 195 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 254
Query: 384 DRPTAAQLL 392
           +RPT   LL
Sbjct: 255 ERPTFKILL 263

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 136/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 32  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K     +  GTA +++PE++  K+ 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 210 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 266
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 12  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 190 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 246
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 247 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 285

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSK--FSSKSD 203
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 384 DRPTAAQLL 392
           +RPT   LL
Sbjct: 264 ERPTFKILL 272

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 11  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 189 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 245
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 246 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 284

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 9   FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 187 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 243
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 244 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 282

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 70
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 188
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 384 DRPTAAQLL 392
           +RPT   LL
Sbjct: 249 ERPTFKILL 257

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 131/289 (45%), Gaps = 29/289 (10%)
Query: 139 RIITYWQKGDL-LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           R   +W    L LGRGSFG V+  + D   GF  AVK+V L          + + E E+ 
Sbjct: 70  REEVHWATHQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRL---------EVFRAE-ELM 118
Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 254
             +      IV  YG  ++   + IF+EL+  GSL  L +    L + +   Y  Q L G
Sbjct: 119 ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEG 178
Query: 255 LKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDVKS-------CRGTAFW 306
           L+YLH + ++H D+K  N+L+ ++GS   L DFG A   + + +           GT   
Sbjct: 179 LEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETH 238
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPD 364
           MAPEV+  ++       D+WS  C +L ML    P+          KI    PP   IP 
Sbjct: 239 MAPEVVLGRS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPP 296
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 413
           S +      I++ ++  P  R +AA+L     V R L    G  SP+ G
Sbjct: 297 SCAPLTAQAIQEGLRKEPIHRVSAAELGGK--VNRALQQVGGLKSPWRG 343

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 65
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 183
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 243
Query: 384 DRPTAAQLL 392
           +RPT   LL
Sbjct: 244 ERPTFKILL 252

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 116/255 (45%), Gaps = 15/255 (5%)
Query: 149 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           ++G G FG VY+G+  +  G       +  L  G   KQ +  L  E  ++ +F H NI+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNII 109
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 264
           +  G       + I  E +  G+L    +      S  Q+    R I  G+KYL + + V
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA------FWMAPEVINNKNKG 318
           HRD+   NILV++N   K++DFGL++  + +D ++   T+       W APE I+ +   
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAISYRK-- 226
Query: 319 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
           +   +D+WS G  + E++T  + PY  +     +  I  G   P P          + QC
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQC 286
Query: 378 VQVNPNDRPTAAQLL 392
            Q     RP  A ++
Sbjct: 287 WQQERARRPKFADIV 301

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 36/270 (13%)
Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G++LG+G FG   +    + G    +KE+   D+ +Q         +E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ-----RTFLKEVKVMRCLEHPNV 69
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD--SQVSAYTRQILLGLKYLHDQDV 263
           +++ G    + +L    E +  G+L  + +    +   SQ  ++ + I  G+ YLH  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 264 VHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCR-----------GTAFWM 307
           +HRD+   N LV  N +V +ADFGLA+      T+   ++S +           G  +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 308 APEVINNKNKGYGLPADIWSLG---CTVLEMLTSQIPYAPMECMAALFKIG---RGSPPP 361
           APE+IN ++  Y    D++S G   C ++  + +   Y P      L   G   R  PP 
Sbjct: 190 APEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247
Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
            P S          +C  ++P  RP+  +L
Sbjct: 248 CPPSFFP----ITVRCCDLDPEKRPSFVKL 273

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 30/256 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 206
           LG G +G VY G+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 40  LGGGQYGEVYVGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 91
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYL 258
           Q  G    E   YI  E +  G+LL+     +LR+      T  +LL         ++YL
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLD-----YLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 147 EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 206
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              + + +D+W+ G  + E+ T  + PY  ++       + +G     P+       + +
Sbjct: 207 T--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELM 264
Query: 375 KQCVQVNPNDRPTAAQ 390
           + C + +P DRP+ A+
Sbjct: 265 RACWKWSPADRPSFAE 280

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 35  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 213 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 269
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 270 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 308

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 10  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 188 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 244
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 245 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 268
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 32  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 210 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 266
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 205
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 31  ILGEGFFGEVYEGVYTN---HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 263
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 88  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN +   + 
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--FT 204
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+W     + E+L+  + P+  +E    +  + +G   P PD         + +C  
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 264
Query: 380 VNPNDRPTAAQLL 392
            +P+DRP   +L+
Sbjct: 265 YDPSDRPRFTELV 277

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 147/312 (47%), Gaps = 41/312 (13%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS 188
           S  S +GRF+ +  Y  + D+LG G+   V   I+        +E ++     Q     S
Sbjct: 2   STDSFSGRFEDV--YQLQEDVLGEGAHARVQTCIN----LITSQEYAVKIIEKQPGHIRS 55
Query: 189 QLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSA 246
           ++ +E+ +L + + H N+++     ++E + Y+  E +  GS+L ++++R H  + + S 
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN-------- 295
             + +   L +LH++ + HRD+K  NIL +       VK+ DFGL    KLN        
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 296 -DVKSCRGTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPY--------- 342
            ++ +  G+A +MAPEV+   + +   Y    D+WSLG  +  +L+   P+         
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 343 -----APMECMAALFKIGRGSPPPIPDS----LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                A   C   LF+  +      PD     +S  A+D I + +  +   R +AAQ+L 
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 394 HPFVKRLLATNS 405
           HP+V+     N+
Sbjct: 296 HPWVQGCAPENT 307

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 268
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEKFFPKARDLVEKL 268
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 136/282 (48%), Gaps = 23/282 (8%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDAQDFI 374
                +D+W+LGC + +++    P+         A + K+        P+     A+D +
Sbjct: 212 XKS--SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----FPEKFFPKARDLV 265
Query: 375 KQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           ++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 205
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 19  ILGEGFFGEVYEGVYTN---HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 263
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 76  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN +   + 
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--FT 192
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+W     + E+L+  + P+  +E    +  + +G   P PD         + +C  
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 252
Query: 380 VNPNDRPTAAQLL 392
            +P+DRP   +L+
Sbjct: 253 YDPSDRPRFTELV 265

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 205
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 15  ILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 263
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 72  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN +   + 
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--FT 188
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+W     + E+L+  + P+  +E    +  + +G   P PD         + +C  
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 248
Query: 380 VNPNDRPTAAQLL 392
            +P+DRP   +L+
Sbjct: 249 YDPSDRPRFTELV 261

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 32  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 210 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 266
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 11/235 (4%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 207
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 76  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 322
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFI 374
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 16  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 194 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 250
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 251 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 289

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K + +G G++G+V++  + +     A+K V L D       S  +   EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLK 256
           +NIV+ +     + KL +  E   +       ++Y       L    V ++  Q+L GL 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNK 315
           + H ++V+HRD+K  N+L++ NG +KLA+FGLA+A  +     S      W  P  +   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRGSP--------PPIP 363
            K Y    D+WS GC   E+  +  P  P     + +  +F++  G+P          +P
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEEQWPSMTKLP 234
Query: 364 D------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           D                   L+   +D ++  ++ NP  R +A + L HP+
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 11/235 (4%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQ 207
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 81  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 198
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 322
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 199 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFI 374
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I
Sbjct: 259 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 11/235 (4%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQ 207
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 81  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 198
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 322
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 199 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFI 374
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I
Sbjct: 259 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-LEYDFPEKFFPKARDLVEKL 268
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 206 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 263
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 264 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 307

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 37  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P +    A+D +++ 
Sbjct: 215 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPAAFFPKARDLVEKL 271
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 272 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 310

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 202 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 259
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 260 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 303

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 198 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 256 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 130/260 (50%), Gaps = 22/260 (8%)
Query: 150 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 206
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQD-- 262
           + YG   +  ++   +E V  G L + L  + H ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 263 VVHRDIKCANILV---DANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 317
           +VHRD++  NI +   D N  V  K+ADFGL++ + ++ V    G   WMAPE I  + +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-VHSVSGLLGNFQWMAPETIGAEEE 203
Query: 318 GYGLPADIWSLGCTVLEMLTSQIP-----YAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
            Y   AD +S    +  +LT + P     Y  ++ +  + +   G  P IP+      ++
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EGLRPTIPEDCPPRLRN 261
Query: 373 FIKQCVQVNPNDRPTAAQLL 392
            I+ C   +P  RP  + ++
Sbjct: 262 VIELCWSGDPKKRPHFSYIV 281

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 31  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 209 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEKFFPKARDLVEKL 265
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 266 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 304

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+  FGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 205 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 262
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 263 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 306

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 254 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 312 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 355

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------------HLRDSQVSAY-- 247
           H+NI+   G    +  LY+ +E  +KG+L    Q              H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 248 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 300
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 357
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V    + +    +A+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWITA 138
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 265
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 139 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 198
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 318
           RDIK  N+L+D NG ++LADFG     K+ND  + +     GT  +++PE++     G  
Sbjct: 199 RDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 319 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 373
            YG   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 316
Query: 374 IKQCV 378
           I++ +
Sbjct: 317 IQRLI 321

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 133/263 (50%), Gaps = 17/263 (6%)
Query: 149 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +LG+GSFG V       +++ +   + +  ++ Q    + ++ + ++ +ALL +     +
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVE-KRVLALLDK--PPFL 82
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
            Q +   +   +LY  +E V  G L+ ++ Q    ++ Q   Y  +I +GL +LH + ++
Sbjct: 83  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGII 142
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLP 322
           +RD+K  N+++D+ G +K+ADFG+ K   ++ V +    GT  ++APE+I    + YG  
Sbjct: 143 YRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII--AYQPYGKS 200
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W+ G  + EML  Q P+   E    LF+         P SLSK+A    K  +  +P
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 259
Query: 383 NDR----PTAAQ-LLDHPFVKRL 400
             R    P   + + +H F +R+
Sbjct: 260 AKRLGCGPEGERDVREHAFFRRI 282

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 203 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------------KLNDVKSCRGTAF 305
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+              + + +     T +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEML 336
           + APEV+    K Y    D+WS GC + E+ 
Sbjct: 188 YRAPEVMLTSAK-YSRAMDVWSCGCILAELF 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 203 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------------KLNDVKSCRGTAF 305
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+              + + +     T +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEML 336
           + APEV+    K Y    D+WS GC + E+ 
Sbjct: 188 YRAPEVMLTSAK-YSRAMDVWSCGCILAELF 217

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 133/262 (50%), Gaps = 11/262 (4%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-EIALLSRFEHENIV 206
           ++GRG FG VY    +D G  +A+K +       +  ++++  E+  ++L+S  +   IV
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 207 QYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                     KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ VV+
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   AD 
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADW 373
Query: 326 WSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q + N
Sbjct: 374 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 433
Query: 384 DR-----PTAAQLLDHPFVKRL 400
            R       A ++ + PF + L
Sbjct: 434 RRLGCLGRGAQEVKESPFFRSL 455

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 133/262 (50%), Gaps = 11/262 (4%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-EIALLSRFEHENIV 206
           ++GRG FG VY    +D G  +A+K +       +  ++++  E+  ++L+S  +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 207 QYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                     KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADW 374
Query: 326 WSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q + N
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 384 DR-----PTAAQLLDHPFVKRL 400
            R       A ++ + PF + L
Sbjct: 435 RRLGCLGRGAQEVKESPFFRSL 456

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 133/262 (50%), Gaps = 11/262 (4%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-EIALLSRFEHENIV 206
           ++GRG FG VY    +D G  +A+K +       +  ++++  E+  ++L+S  +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 207 QYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                     KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADW 374
Query: 326 WSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q + N
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 384 DR-----PTAAQLLDHPFVKRL 400
            R       A ++ + PF + L
Sbjct: 435 RRLGCLGRGAQEVKESPFFRSL 456

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 133/262 (50%), Gaps = 11/262 (4%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-EIALLSRFEHENIV 206
           ++GRG FG VY    +D G  +A+K +       +  ++++  E+  ++L+S  +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 207 QYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                     KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 325
           RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADW 374
Query: 326 WSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q + N
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 384 DR-----PTAAQLLDHPFVKRL 400
            R       A ++ + PF + L
Sbjct: 435 RRLGCLGRGAQEVKESPFFRSL 456

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 134/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +    ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 32  FKFGKILGEGSFSTTV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 210 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 266
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 144 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 203 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------------GTAF 305
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+    +   +               T +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEML 336
           + APEV+    K Y    D+WS GC + E+ 
Sbjct: 188 YRAPEVMLTSAK-YSRAMDVWSCGCILAELF 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V    + +    +A+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWITA 154
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 265
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 155 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 214
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 318
           RDIK  N+L+D NG ++LADFG     K+ND  + +     GT  +++PE++     G  
Sbjct: 215 RDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 319 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 373
            YG   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 332
Query: 374 IKQCV 378
           I++ +
Sbjct: 333 IQRLI 337

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ DF LA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 209 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 379
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 380 V 380
           +
Sbjct: 265 M 265

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 150 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++GSV   I    G   A+K++S   +  Q++    +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 209 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVV 264
                  S L  F +  LV      +L +   L+  + ++     Q+L GLKY+H   VV
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           HRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEVI +    Y    D
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEVILSWMH-YNQTVD 206
Query: 325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------------------IPDS 365
           IWS+GC + EMLT +  +   + +  L +I + +  P                   +P +
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 266
Query: 366 LSKD-----------AQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             KD           A D +++ ++++ + R TAAQ L HPF +
Sbjct: 267 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 146 KGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           K ++LG G FG V++   +  G   A K +    +G + K+   +++ EI+++++ +H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKE---EVKNEISVMNQLDHAN 147
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           ++Q Y   + ++ + + +E V  G L +  + + Y+L +     + +QI  G++++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 263 VVHRDIKCANILV---DANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKG 318
           ++H D+K  NIL    DA   +K+ DFGLA+  K  + +K   GT  ++APEV+N     
Sbjct: 208 ILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
           +  P D+WS+G     +L+   P+      E +  +              +S++A++FI 
Sbjct: 267 F--PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324
Query: 376 QCVQVNPNDRPTAAQLLDHPFV 397
           + +    + R +A++ L HP++
Sbjct: 325 KLLIKEKSWRISASEALKHPWL 346

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 134/279 (48%), Gaps = 17/279 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 39  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
              V+ Y   +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 217 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 273
Query: 378 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 410
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 274 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 312

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 210 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTV 210
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           DIWS+GC + E+L  +  +   + +  L +I      P P+ L+K + +  +  +Q  P
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 139/293 (47%), Gaps = 42/293 (14%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K   +G GS+G V++  + D G   A+K+  L  +     + I+   +EI +L + +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
            N+V      + + +L++  E      L  L+ YQR  + +  V + T Q L  + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHK 120
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR-GTAFWMAPEVINNKNKG 318
            + +HRD+K  NIL+  +  +KL DFG A+  T  +D       T ++ +PE++    + 
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ- 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRG------------------SP 359
           YG P D+W++GC   E+L S +P  P +  +  L+ I +                   S 
Sbjct: 180 YGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 360 PPIPD------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
             IPD            ++S  A   +K C+ ++P +R T  QLL HP+ + +
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEH 202
            +  GS+G+V  G+  +G   A+K V       +    +S      ++ +EI LL+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 203 ENI-----VQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLK 256
            NI     +  +  +    KLY+  EL+       ++ QR  +    +  +   ILLGL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNK 315
            LH+  VVHRD+   NIL+  N  + + DF LA+    +  K+   T  W  APE++  +
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQ 207
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP----------PPIP 363
            KG+    D+WS GC + EM   +  +        L KI    G+P          P   
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267
Query: 364 DSLSKD-------------------AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           D L                      A D I + ++ NP  R +  Q L HP+ + L 
Sbjct: 268 DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEH 202
            +  GS+G+V  G+  +G   A+K V       +    +S      ++ +EI LL+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 203 ENI-----VQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLK 256
            NI     +  +  +    KLY+  EL+       ++ QR  +    +  +   ILLGL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNK 315
            LH+  VVHRD+   NIL+  N  + + DF LA+    +  K+   T  W  APE++  +
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQ 207
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP----------PPIP 363
            KG+    D+WS GC + EM   +  +        L KI    G+P          P   
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267
Query: 364 DSLSKD-------------------AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           D L                      A D I + ++ NP  R +  Q L HP+ + L 
Sbjct: 268 DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 119/287 (41%), Gaps = 41/287 (14%)
Query: 150 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG V+           D    AVK  +L D    A++      +E  LL+  +HE
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 75
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 248
           +IV++YG   +   L +  E +  G L N + R H               L  SQ+    
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 305
           +QI  G+ YL  Q  VHRD+   N LV  N  VK+ DFG+++     D     G      
Sbjct: 135 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 306 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 363
            WM PE I  +   +   +D+WSLG  + E+ T  + P+  +     +  I +G     P
Sbjct: 195 RWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 252
Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 410
            +  ++  + +  C Q  P+ R     +         L  N   ASP
Sbjct: 253 RTCPQEVYELMLGCWQREPHMRKNIKGI-------HTLLQNLAKASP 292

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 140/314 (44%), Gaps = 48/314 (15%)
Query: 128 MSNISPNGRFKRII--TYWQ------KGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLD 178
           MS I   G +K+ +  T W+          +G G++GSV   I    G   A+K++S   
Sbjct: 20  MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--- 76
Query: 179 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL----LNLY 234
           +  Q++    +  +E+ LL   +HEN++         S L  F +           L   
Sbjct: 77  RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI 136
Query: 235 QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 294
                 + ++     Q+L GLKY+H   VVHRD+K  N+ V+ +  +K+ DFGLA+    
Sbjct: 137 MGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195
Query: 295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI 354
            ++     T ++ APEVI +    Y    DIWS+GC + EMLT +  +   + +  L +I
Sbjct: 196 AEMTGYVVTRWYRAPEVILSWMH-YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254
Query: 355 GRGSPPP-------------------IPDSLSKD-----------AQDFIKQCVQVNPND 384
            + +  P                   +P +  KD           A D +++ ++++ + 
Sbjct: 255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 314
Query: 385 RPTAAQLLDHPFVK 398
           R TAAQ L HPF +
Sbjct: 315 RLTAAQALTHPFFE 328

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 22/260 (8%)
Query: 150 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 206
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQD-- 262
           + YG   +  ++   +E V  G L + L  + H ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 263 VVHRDIKCANILV---DANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 317
           +VHRD++  NI +   D N  V  K+ADFG ++ + ++ V    G   WMAPE I  + +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-VHSVSGLLGNFQWMAPETIGAEEE 203
Query: 318 GYGLPADIWSLGCTVLEMLTSQIP-----YAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
            Y   AD +S    +  +LT + P     Y  ++ +  + +   G  P IP+      ++
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EGLRPTIPEDCPPRLRN 261
Query: 373 FIKQCVQVNPNDRPTAAQLL 392
            I+ C   +P  RP  + ++
Sbjct: 262 VIELCWSGDPKKRPHFSYIV 281

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 146/312 (46%), Gaps = 41/312 (13%)
Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS 188
           S  S +GRF+ +  Y  + D+LG G+   V   I+        +E ++     Q     S
Sbjct: 2   STDSFSGRFEDV--YQLQEDVLGEGAHARVQTCIN----LITSQEYAVKIIEKQPGHIRS 55
Query: 189 QLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSA 246
           ++ +E+ +L + + H N+++     ++E + Y+  E +  GS+L ++++R H  + + S 
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN-------- 295
             + +   L +LH++ + HRD+K  NIL +       VK+ DF L    KLN        
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 296 -DVKSCRGTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPY--------- 342
            ++ +  G+A +MAPEV+   + +   Y    D+WSLG  +  +L+   P+         
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 343 -----APMECMAALFKIGRGSPPPIPD----SLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                A   C   LF+  +      PD     +S  A+D I + +  +   R +AAQ+L 
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 394 HPFVKRLLATNS 405
           HP+V+     N+
Sbjct: 296 HPWVQGCAPENT 307

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 39/277 (14%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           KR    +++ +L+G G FG V++     DG  + +K V         K +  + E+E+  
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---------KYNNEKAEREVKA 57
Query: 197 LSRFEHENIVQYYG-----------TDKDESK-----LYIFLELVTKGSLLN-LYQRYHL 239
           L++ +H NIV Y G           + K+ S+     L+I +E   KG+L   + +R   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 240 RDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 297
           +  +V A     QI  G+ Y+H + +++RD+K +NI +     VK+ DFGL  + K ND 
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDG 176
Query: 298 KSCR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
           K  R  GT  +M+PE I++++  YG   D+++LG  + E+L   +     E       + 
Sbjct: 177 KRXRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLR 232
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G    I D   K  +  +++ +   P DRP  +++L
Sbjct: 233 DG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 37/265 (13%)
Query: 150 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 77
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 245
           +IV++YG   D   L +  E +  G L N + R H  D                  SQ+ 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 306 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 360
               WM PE I  +   +   +D+WS G  + E+ T  + P+  +     +  I +G   
Sbjct: 197 LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 254
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDR 385
             P    K+  D +  C Q  P  R
Sbjct: 255 ERPRVCPKEVYDVMLGCWQREPQQR 279

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 141 ITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           ++Y +  +++G G FG V  G +   G   +   +  L  G   +Q   +   E +++ +
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQ 73
Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLG 254
           FEH NI++  G   +   + I  E +  G+L +  +   L D Q +        R I  G
Sbjct: 74  FEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASG 130
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WM 307
           ++YL +   VHRD+   NILV++N   K++DFGL++  + N       ++        W 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP-I 362
           APE I  +   +   +D WS G  + E+++  + PY  M   + + A+ +  R  PPP  
Sbjct: 191 APEAIAFRK--FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDC 248
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQ-------LLDHPFVKRLLATNSGSAS 409
           P SL +   D    C Q + N RP   Q       ++ +P   +++A  +G AS
Sbjct: 249 PTSLHQLMLD----CWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGAS 298

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 210 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTV 210
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           DIWS+GC + E+L  +  +   + +  L +I      P P+ L+K + +  +  +Q  P
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 248
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGLKYLHDQD 262
                + +  L + L L+  G L   +  YH+      +++   Y  +I  GL+ LH + 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 263 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV+  KN+ Y  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTF 364
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 378
             D W+LGC + EM+  Q P+   +      ++ R     P    +  S  A+    Q +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 379 QVNPNDR-----PTAAQLLDHPFVKRL 400
             +P +R      +A ++ +HP  K+L
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 248
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGLKYLHDQD 262
                + +  L + L L+  G L   +  YH+      +++   Y  +I  GL+ LH + 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 263 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV+  KN+ Y  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTF 364
Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 378
             D W+LGC + EM+  Q P+   +      ++ R     P    +  S  A+    Q +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 379 QVNPNDR-----PTAAQLLDHPFVKRL 400
             +P +R      +A ++ +HP  K+L
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 51/261 (19%)
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 246
           +Q+ +E+ +L       IV +YG    + ++ I +E +  GSL   L +   + +  +  
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 247 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
            +  +L GL YL ++  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178
Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP--------------------- 344
           +MAPE +   +  Y + +DIWS+G +++E+   + P  P                     
Sbjct: 179 YMAPERLQGTH--YSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGE 236
Query: 345 -------------------------MECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 378
                                    M     L  I    PP +P+ + + D Q+F+ +C+
Sbjct: 237 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 296
Query: 379 QVNPNDRPTAAQLLDHPFVKR 399
             NP +R     L +H F+KR
Sbjct: 297 IKNPAERADLKMLTNHTFIKR 317

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 22/260 (8%)
Query: 150 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 206
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQD-- 262
           + YG   +  ++   +E V  G L + L  + H ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 263 VVHRDIKCANILV---DANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 317
           +VHRD++  NI +   D N  V  K+ADF L++ + ++ V    G   WMAPE I  + +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-VHSVSGLLGNFQWMAPETIGAEEE 203
Query: 318 GYGLPADIWSLGCTVLEMLTSQIP-----YAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
            Y   AD +S    +  +LT + P     Y  ++ +  + +   G  P IP+      ++
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EGLRPTIPEDCPPRLRN 261
Query: 373 FIKQCVQVNPNDRPTAAQLL 392
            I+ C   +P  RP  + ++
Sbjct: 262 VIELCWSGDPKKRPHFSYIV 281

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 135/269 (50%), Gaps = 32/269 (11%)
Query: 148 DLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 205
           D+LG G+ G+ VY G+ D+    AVK +          +  S  ++E+ LL    EH N+
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDV-AVKRI--------LPECFSFADREVQLLRESDEHPNV 80
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 263
           ++Y+ T+KD    YI +EL        + Q+   HL    ++   +Q   GL +LH  ++
Sbjct: 81  IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHLHSLNI 139
Query: 264 VHRDIKCANILV---DANGSVK--LADFGLAKATKLNDVKSCR-----GTAFWMAPEVIN 313
           VHRD+K  NIL+   +A+G +K  ++DFGL K   +      R     GT  W+APE+++
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 314 N---KNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
               +N  Y +  DI+S GC    +++    P+       A   +G  S   +     +D
Sbjct: 200 EDCKENPTYTV--DIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 370 --AQDFIKQCVQVNPNDRPTAAQLLDHPF 396
             A++ I++ + ++P  RP+A  +L HPF
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 200 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 248
            +HEN+V             ++ ++ +Y+   F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 303
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 117/245 (47%), Gaps = 12/245 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FGSV +G+           + +L QG++ K    ++ +E  ++ + ++  IV+  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G  + E+ L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ VHRD
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNKNKGYGLP 322
           +   N+L+      K++DFGL+KA   +D      +A      W APE IN +   +   
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSR 193
Query: 323 ADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
           +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C    
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 253
Query: 382 PNDRP 386
             DRP
Sbjct: 254 WEDRP 258

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 130/285 (45%), Gaps = 27/285 (9%)
Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 191 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT 248
             EIA L++ +   + I++ Y  +  +  +Y+ +E         L ++  +   +  +Y 
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW 161
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTA 304
           + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    GT 
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 305 FWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-- 353
            +M PE I + +               +D+WSLGC +  M   + P+  +    +     
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           I        PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 41/291 (14%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G++G+V   +  DG   A   +  L +  Q++    +  +E+ LL    HEN++   
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 210 G------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  T  D +  Y+ +  +    L  L +   L + ++     Q+L GL+Y+H   +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEVI N  + Y    
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMXGXVVTRWYRAPEVILNWMR-YTQTV 207
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP-----------------IPD 364
           DIWS+GC + EM+T +  +   + +  L +I +  G+PP                  +P+
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267
Query: 365 SLSKD-----------AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
              KD           A + +++ + ++   R TA + L HP+ + L  T 
Sbjct: 268 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 132/261 (50%), Gaps = 23/261 (8%)
Query: 150 LGRGSFGSVYEGISDDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG V+  +  +         +K+  +L+        + ++  EIA+LSR EH NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYT-RQILLGLKYLHDQ 261
           ++    D  E++ +  L +   GS L+L+    R+   D  +++Y  RQ++  + YL  +
Sbjct: 92  IKV--LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 320
           D++HRDIK  NI++  + ++KL DFG A   +   +  +  GT  + APEV+   N   G
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-NPYRG 208
Query: 321 LPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
              ++WSLG T+  ++  + P+  +E    AA+       PP +   +SK+    +   +
Sbjct: 209 PELEMWSLGVTLYTLVFEENPFCELEETVEAAI------HPPYL---VSKELMSLVSGLL 259
Query: 379 QVNPNDRPTAAQLLDHPFVKR 399
           Q  P  R T  +L+  P+V +
Sbjct: 260 QPVPERRTTLEKLVTDPWVTQ 280

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 7   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 57
Query: 191 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT 248
             EIA L++ +   + I++ Y  +  +  +Y+ +E         L ++  +   +  +Y 
Sbjct: 58  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW 117
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTA 304
           + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    GT 
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 305 FWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
            +M PE I + +               +D+WSLGC +  M   + P+   + +  + K+ 
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLH 234
Query: 356 RGSPP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
               P      PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 235 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 200 FEHENIVQYYGTDKDESK-----------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYT 248
            +HEN+V      + ++            ++ F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 303
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 201 IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 252
Query: 210 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 266 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  + K +   +D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REKKFSTKSD 368
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       D +K C  ++  
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAA 428
Query: 384 DRPTAAQL---LDH 394
            RPT  QL   L+H
Sbjct: 429 TRPTFLQLREQLEH 442

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------------YTRQ 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NPN RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+FG V    + +    FA+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITT 138
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 265
            +   +D++ LY+ ++    G LL L  ++  R  +     Y  ++++ +  +H    VH
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 266 RDIKCANILVDANGSVKLADFG-LAKATKLNDVKS--CRGTAFWMAPEVINNKNKG---Y 319
           RDIK  NIL+D NG ++LADFG   K  +   V+S    GT  +++PE++     G   Y
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258
Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDFIK 375
           G   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D I+
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIR 318
Query: 376 Q--CVQVNPNDRPTAAQLLDHPFVKRLLATN-SGSASPYL 412
           +  C + +   +        HPF   +   N     +PY+
Sbjct: 319 RLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYI 358

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 72
Query: 200 FEHENIVQYYGTDKDESK-----------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYT 248
            +HEN+V      + ++            ++ F E    G L N+  ++ L  S++    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 130
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 303
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 28  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 210 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 144
Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE++ N    Y    
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTV 202
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           DIWS+GC + E+L  +  +   + +  L +I      P P+ L+K + +  +  +Q  P
Sbjct: 203 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 109/251 (43%), Gaps = 18/251 (7%)
Query: 147 GDLLGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G+ +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD 262
           IV+  G    +  +YI +ELV  G  L   +     LR   +         G++YL  + 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AFWMAPEVINNKNK 317
            +HRD+   N LV     +K++DFG+++  + + V +  G        W APE +N    
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAPEALNYGR- 291
Query: 318 GYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            Y   +D+WS G  + E  +    PY  +        + +G   P P+         ++Q
Sbjct: 292 -YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ 350
Query: 377 CVQVNPNDRPT 387
           C    P  RP+
Sbjct: 351 CWAYEPGQRPS 361

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 12/245 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FGSV +G+           + +L QG++ K    ++ +E  ++ + ++  IV+  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G  + E+ L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ VHR+
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVINNKNKGYGLP 322
           +   N+L+      K++DFGL+KA   +D      +A      W APE IN +   +   
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSR 519
Query: 323 ADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
           +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C    
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 579
Query: 382 PNDRP 386
             DRP
Sbjct: 580 WEDRP 584

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 20/259 (7%)
Query: 149 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G          F A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKT---LKSGYTEKQRRDFL-SEASIMGQFDHPN 95
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 262
           ++   G     + + I  E +  GSL +  ++        Q+    R I  G+KYL D +
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 155
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMAPEVINNK 315
            VHRD+   NILV++N   K++DFGL++  + +       +A        W APE I  +
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--Q 213
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
            + +   +D+WS G  + E+++  + PY  M     +  I +    P P          +
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 273
Query: 375 KQCVQVNPNDRPTAAQLLD 393
             C Q + N RP   Q+++
Sbjct: 274 LDCWQKDRNHRPKFGQIVN 292

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 191 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 245
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 158
Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 301
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 302 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 352
           GT  +M PE I + +               +D+WSLGC +  M   + P+  +    +  
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277
Query: 353 K--IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
              I        PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 130/285 (45%), Gaps = 27/285 (9%)
Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 3   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 53
Query: 191 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT 248
             EIA L++ +   + I++ Y  +  +  +Y+ +E         L ++  +   +  +Y 
Sbjct: 54  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW 113
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTA 304
           + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    GT 
Sbjct: 114 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 305 FWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-- 353
            +M PE I + +               +D+WSLGC +  M   + P+  +    +     
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 232
Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           I        PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 233 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 200 FEHENIVQYYGTDKDESK-----------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYT 248
            +HEN+V      + ++            ++ F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 303
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 60/292 (20%)
Query: 166 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 225
           G +  V+ ++L    + + + ++ L+ E+ +   F H NIV Y  T   +++L++    +
Sbjct: 36  GEYVTVRRINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 92
Query: 226 TKGSLLNLYQRYHL--RDSQVSAYTRQ-ILLGLKYLHDQDVVHRDIKCANILVDANGSVK 282
             GS  +L   + +   +    AY  Q +L  L Y+H    VHR +K ++IL+  +G V 
Sbjct: 93  AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 152
Query: 283 LADF---------GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 333
           L+           G  +    +  K       W++PEV+    +GY   +DI+S+G T  
Sbjct: 153 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 212
Query: 334 EMLTSQIPYAPMECMAALFKIGRGSPP--------------------------------- 360
           E+    +P+  M     L +   G+ P                                 
Sbjct: 213 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 272
Query: 361 ------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                       P   + S     F++QC+Q NP+ RP+A+ LL+H F K++
Sbjct: 273 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 324

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 4   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 54
Query: 191 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 245
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 111
Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 301
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 302 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 352
           GT  +M PE I + +               +D+WSLGC +  M   + P+  +    +  
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230
Query: 353 K--IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
              I        PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 200
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 201 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR----------YHLRDSQVSA- 246
              +HENIV   G       + +  E    G LLN  +R          + + +S +S  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 247 ----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 302
               ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 303 TAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR- 356
            A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + 
Sbjct: 225 NARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 200
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 41  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 201 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-------------YHLRDSQV 244
              +HENIV   G       + +  E    G LLN  +R               LRD  +
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD--L 154
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
             ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G A
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 305 F----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR-GS 358
                WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + G 
Sbjct: 215 RLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 272
Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
               P    K+    ++ C  + P  RPT  Q+
Sbjct: 273 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 109/251 (43%), Gaps = 18/251 (7%)
Query: 147 GDLLGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G+ +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD 262
           IV+  G    +  +YI +ELV  G  L   +     LR   +         G++YL  + 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AFWMAPEVINNKNK 317
            +HRD+   N LV     +K++DFG+++  + + V +  G        W APE +N    
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGR- 291
Query: 318 GYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            Y   +D+WS G  + E  +    PY  +        + +G   P P+         ++Q
Sbjct: 292 -YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ 350
Query: 377 CVQVNPNDRPT 387
           C    P  RP+
Sbjct: 351 CWAYEPGQRPS 361

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 60/292 (20%)
Query: 166 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 225
           G +  V+ ++L    + + + ++ L+ E+ +   F H NIV Y  T   +++L++    +
Sbjct: 52  GEYVTVRRINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 226 TKGSLLNLYQRYHL--RDSQVSAYTRQ-ILLGLKYLHDQDVVHRDIKCANILVDANGSVK 282
             GS  +L   + +   +    AY  Q +L  L Y+H    VHR +K ++IL+  +G V 
Sbjct: 109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168
Query: 283 LADF---------GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 333
           L+           G  +    +  K       W++PEV+    +GY   +DI+S+G T  
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228
Query: 334 EMLTSQIPYAPMECMAALFKIGRGSPP--------------------------------- 360
           E+    +P+  M     L +   G+ P                                 
Sbjct: 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 288
Query: 361 ------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                       P   + S     F++QC+Q NP+ RP+A+ LL+H F K++
Sbjct: 289 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 34/275 (12%)
Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 200
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 201 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR----------YHLRDSQVSA- 246
              +HENIV   G       + +  E    G LLN  +R          + + +S  S  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 247 ----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 302
               ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 303 TAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR- 356
            A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + 
Sbjct: 225 NARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 200
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 201 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-------------YHLRDSQV 244
              +HENIV   G       + +  E    G LLN  +R               LRD  +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD--L 162
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
             ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G A
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 305 F----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR-GS 358
                WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + G 
Sbjct: 223 RLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 280
Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
               P    K+    ++ C  + P  RPT  Q+
Sbjct: 281 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQ 207
           +G G    V++ +++    +A+K V+L +  +Q   ++     EIA L++ +   + I++
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            Y  +  +  +Y+ +E         L ++  +   +  +Y + +L  +  +H   +VH D
Sbjct: 93  LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 152
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG----- 318
           +K AN L+  +G +KL DFG+A   + +     +    GT  +M PE I + +       
Sbjct: 153 LKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 319 ----YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----PIPDSLSKDA 370
                   +D+WSLGC +  M   + P+   + +  + K+     P      PD   KD 
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           QD +K C++ +P  R +  +LL HP+V+
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 87
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 207
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 208 AFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 262
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 263 PGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 200
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 201 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------------HLRDSQVS 245
              +HENIV   G       + +  E    G LLN  +R             H  + Q+S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 246 A-----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 300
           +     ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 301 RGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIG 355
           +G A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ 
Sbjct: 225 KGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 282
Query: 356 R-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           + G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 283 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 216 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 270
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 68
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 186
Query: 325 IWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 246
Query: 384 DRPTAAQLL 392
           DRP  ++LL
Sbjct: 247 DRPAFSRLL 255

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 52/290 (17%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           KR    +++ +L+G G FG V++     DG  + ++ V         K +  + E+E+  
Sbjct: 8   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---------KYNNEKAEREVKA 58
Query: 197 LSRFEHENIVQYYGT--------------------DKDESK---------LYIFLELVTK 227
           L++ +H NIV Y G                     D + SK         L+I +E   K
Sbjct: 59  LAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 228 GSLLN-LYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA 284
           G+L   + +R   +  +V A     QI  G+ Y+H + ++HRD+K +NI +     VK+ 
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 285 DFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 342
           DFGL  + K ND K  R  GT  +M+PE I++++  YG   D+++LG  + E+L   +  
Sbjct: 179 DFGLVTSLK-NDGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELL--HVCD 233
Query: 343 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
              E       +  G    I D   K  +  +++ +   P DRP  +++L
Sbjct: 234 TAFETSKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGLA+   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 18  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 72
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 73  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 132
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 133 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 193 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 250
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 251 PDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 217 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 271
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQ 207
           +G G    V++ +++    +A+K V+L +  +Q   ++     EIA L++ +   + I++
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
            Y  +  +  +Y+ +E         L ++  +   +  +Y + +L  +  +H   +VH D
Sbjct: 93  LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 152
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG----- 318
           +K AN L+  +G +KL DFG+A   + +     +    GT  +M PE I + +       
Sbjct: 153 LKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 319 ----YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----PIPDSLSKDA 370
                   +D+WSLGC +  M   + P+   + +  + K+     P      PD   KD 
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           QD +K C++ +P  R +  +LL HP+V+
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 112
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 232
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 233 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 287
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 288 PGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 81
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 82  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 202 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 259
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 260 PDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 22/274 (8%)
Query: 130 NISPNGRFKRII-----TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK 184
            + P G    +I     T+ Q+   +G G FG V+ G   +    A+K +    +GS ++
Sbjct: 13  GLVPRGSLHMVIDPSELTFVQE---IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSE 66
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDS 242
               +   E  ++ +  H  +VQ YG   +++ + +  E +  G L +    QR      
Sbjct: 67  DDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE 123
Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 302
            +      +  G+ YL +  V+HRD+   N LV  N  +K++DFG+ +    +   S  G
Sbjct: 124 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 183
Query: 303 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGS 358
           T F   W +PEV +     Y   +D+WS G  + E+ +  +IPY        +  I  G 
Sbjct: 184 TKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 241
Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
               P   S      +  C +  P DRP  ++LL
Sbjct: 242 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 275

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 125/259 (48%), Gaps = 17/259 (6%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 265
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 322
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV+ + +  YG  
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDND--YGRA 332
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 333 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 391
Query: 383 NDR-----PTAAQLLDHPF 396
             R       A +++ H F
Sbjct: 392 KQRLGGGSEDAKEIMQHRF 410

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 102
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 222
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 223 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 277
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 278 PGPVYRIMTQCWQHQPEDRPNFAIILE 304

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 125/259 (48%), Gaps = 17/259 (6%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 265
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 322
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV+ + +  YG  
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDND--YGRA 329
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 388
Query: 383 NDR-----PTAAQLLDHPF 396
             R       A +++ H F
Sbjct: 389 KQRLGGGSEDAKEIMQHRF 407

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G+  G G FG VY+G  ++      K  +++D  ++  +   Q +QEI + ++ +HEN+V
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVXAKCQHENLV 84
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 258
           +  G   D   L +       GSLL+            +H R             G+ +L
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAAN----GINFL 140
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 314
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  + APE +  
Sbjct: 141 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-- 198
Query: 315 KNKGYGLP-ADIWSLGCTVLEMLT 337
             +G   P +DI+S G  +LE++T
Sbjct: 199 --RGEITPKSDIYSFGVVLLEIIT 220

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 136
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 257 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 311
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 312 PGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 113
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 174 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 233
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 234 AFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 288
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 289 PGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I +EL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 216 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 270
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSE--QDELDFLMEALIISKFNHQNI 110
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 231 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 285
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 120/264 (45%), Gaps = 23/264 (8%)
Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           G+L+G+G FG VY G      +     + L+D     +  +   ++E+    +  HEN+V
Sbjct: 38  GELIGKGRFGQVYHG-----RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
            + G       L I   L    +L ++ +  +  L  ++     ++I+ G+ YLH + ++
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 265 HRDIKCANILVDANGSVKLADFGLAKAT-------KLNDVKSCRGTAFWMAPEVINNKNK 317
           H+D+K  N+  D NG V + DFGL   +       + + ++   G    +APE+I   + 
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 318 G-------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKD 369
                   +   +D+++LG    E+   + P+      A ++++G G  P +    + K+
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE 271
Query: 370 AQDFIKQCVQVNPNDRPTAAQLLD 393
             D +  C      +RPT  +L+D
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMD 295

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 217 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 271
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 122
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 242
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 243 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 297
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 298 PGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 126/270 (46%), Gaps = 28/270 (10%)
Query: 141 ITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           ++Y +  +++G G FG V  G +   G   +   +  L  G   +Q   +   E +++ +
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQ 71
Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLG 254
           FEH NI++  G   +   + I  E +  G+L +  +   L D Q +        R I  G
Sbjct: 72  FEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASG 128
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WM 307
           ++YL +   VHRD+   NILV++N   K++DFGL++  + N       ++        W 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP-I 362
           APE I  +   +   +D WS G  + E+++  + PY  M   + + A+ +  R  PPP  
Sbjct: 189 APEAIAFRK--FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDC 246
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           P SL +   D    C Q + N RP   Q++
Sbjct: 247 PTSLHQLMLD----CWQKDRNARPRFPQVV 272

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 66
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 184
Query: 325 IWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 244
Query: 384 DRPTAAQLL 392
           DRP  ++LL
Sbjct: 245 DRPAFSRLL 253

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 71
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 189
Query: 325 IWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 249
Query: 384 DRPTAAQLL 392
           DRP  ++LL
Sbjct: 250 DRPAFSRLL 258

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 68
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 186
Query: 325 IWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 246
Query: 384 DRPTAAQLL 392
           DRP  ++LL
Sbjct: 247 DRPAFSRLL 255

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 134/288 (46%), Gaps = 33/288 (11%)
Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 191 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 245
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 158
Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 301
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 302 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 352
           G   +M PE I + +               +D+WSLGC +  M   + P+  +    +  
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277
Query: 353 K--IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
              I        PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 110
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I +EL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 231 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 285
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 80
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----------------Q 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 196 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 253
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NP  RPT  ++++
Sbjct: 254 CPERVTDLMRMCWQFNPKMRPTFLEIVN 281

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 84
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----------------Q 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHR++   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 200 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 257
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NPN RPT  ++++
Sbjct: 258 CPERVTDLMRMCWQFNPNMRPTFLEIVN 285

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 40  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 95
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 214 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 271
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 272 LDCWQKDRNNRPKFEQIV 289

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 94
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 265
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVH 154
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF---WMAPEVINNKNKGYG 320
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE I  +   + 
Sbjct: 155 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FT 212
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C Q
Sbjct: 213 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQ 272
Query: 380 VNPNDRPTAAQLLD 393
              +DRP   Q+++
Sbjct: 273 KERSDRPKFGQIVN 286

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------------YTRQ 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NP  RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 50  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 105
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 106 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 224 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 281
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 282 LDCWQKDRNNRPKFEQIV 299

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 24  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 78
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 79  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 138
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 139 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 199 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 256
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 257 PDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----------------Q 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHR++   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NPN RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 81
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 82  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 201
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 202 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 259
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 260 PDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 74
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 75  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 195 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 252
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 253 PDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL +   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 80
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 81  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 201 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 258
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 259 PDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 87
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 147
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 208 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 265
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 266 PDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 23  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 78
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 197 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 255 LDCWQKDRNNRPKFEQIV 272

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 69
Query: 210 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 267
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 268 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 324
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 187
Query: 325 IWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 247
Query: 384 DRPTAAQLL 392
           DRP  ++LL
Sbjct: 248 DRPAFSRLL 256

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 23  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 78
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 262
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 315
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 197 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 375 KQCVQVNPNDRPTAAQLL 392
             C Q + N+RP   Q++
Sbjct: 255 LDCWQKDRNNRPKFEQIV 272

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 17/259 (6%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 265
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 322
           RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV+ + +  YG  
Sbjct: 135 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDND--YGRA 191
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 250
Query: 383 NDR-----PTAAQLLDHPF 396
             R       A +++ H F
Sbjct: 251 KQRLGGGSEDAKEIMQHRF 269

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 437 GICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 553
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 554 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 613
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 614 ENRPGFA 620

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 438 GICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 497 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 554
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 555 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 614
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 615 ENRPGFA 621

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 22/248 (8%)
Query: 149 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 200
           +LG+GSFG V     +G  +    +AVK    +V + D   +     + +E+ +  L   
Sbjct: 348 VLGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVEC----TMVEKRVLALPG- 399
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +   + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNK 317
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K   GT  ++APE+I    +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII--AYQ 517
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
            YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K  
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576
Query: 378 VQVNPNDR 385
           +  +P  R
Sbjct: 577 MTKHPGKR 584

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 55  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 109
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 110 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 169
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 170 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 229
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 230 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 287
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 288 PDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 123/258 (47%), Gaps = 15/258 (5%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 265
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPA 323
           RD+K  N+++D +G +K+ DFGL K    +   +K   GT  ++APEV+ + +  YG   
Sbjct: 133 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND--YGRAV 190
Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P 
Sbjct: 191 DWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPK 249
Query: 384 DR-----PTAAQLLDHPF 396
            R       A +++ H F
Sbjct: 250 QRLGGGSEDAKEIMQHRF 267

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 17/259 (6%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 73
Query: 208 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 265
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 322
           RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV+ + +  YG  
Sbjct: 134 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDND--YGRA 190
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 249
Query: 383 NDR-----PTAAQLLDHPF 396
             R       A +++ H F
Sbjct: 250 KQRLGGGSEDAKEIMQHRF 268

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 80
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 81  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 201 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 258
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 259 PDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 73
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 265
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 133
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF---WMAPEVINNKNKGYG 320
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE I  +   + 
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FT 191
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C Q
Sbjct: 192 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQ 251
Query: 380 VNPNDRPTAAQLLD 393
              +DRP   Q+++
Sbjct: 252 KERSDRPKFGQIVN 265

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 22/248 (8%)
Query: 149 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 200
           +LG+GSFG V     +G  +    +AVK    +V + D   +     + +E+ +  L   
Sbjct: 27  VLGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVEC----TMVEKRVLALPG- 78
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 259
           +   + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +L 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNK 317
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K   GT  ++APE+I    +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII--AYQ 196
Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
            YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K  
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 255
Query: 378 VQVNPNDR 385
           +  +P  R
Sbjct: 256 MTKHPGKR 263

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 126/262 (48%), Gaps = 17/262 (6%)
Query: 150 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQ 207
           LGRG F  V + IS   G  +A K    L +  + +   +++  EIA+L   +    ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
            +   ++ S++ + LE    G + +L        + ++ V    +QIL G+ YLH  ++V
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 265 HRDIKCANILVDAN---GSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           H D+K  NIL+ +    G +K+ DFG++ K     +++   GT  ++APE++N       
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN--YDPIT 211
Query: 321 LPADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
              D+W++G     +LT   P+      E    + ++          S+S+ A DFI+  
Sbjct: 212 TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 378 VQVNPNDRPTAAQLLDHPFVKR 399
           +  NP  RPTA   L H ++++
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQ 293

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 79
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 265
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 139
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF---WMAPEVINNKNKGYG 320
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE I  +   + 
Sbjct: 140 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FT 197
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C Q
Sbjct: 198 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQ 257
Query: 380 VNPNDRPTAAQLLD 393
              +DRP   Q+++
Sbjct: 258 KERSDRPKFGQIVN 271

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 269 KCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAF---WMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA +   N  K+     +   W APE IN     +   +
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK--FSSKS 195
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 196 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 255
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 256 ENRPGFA 262

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 13  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 68
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 69  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 125
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 126 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 185
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 186 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 243
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 244 KGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 151
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 152 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 209
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 210 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 269
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 270 ENRPGFA 276

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 211
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 212 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 271
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 272 ENRPGFA 278

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 211
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 212 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 271
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 272 ENRPGFA 278

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 30/251 (11%)
Query: 149 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 205
           ++G+GSFG V       +  F+AVK   +L + +  + K+    + +   LL   +H  +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 264
           V  + + +   KLY  L+ +  G L    QR     + +   Y  +I   L YLH  ++V
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLP 322
           +RD+K  NIL+D+ G + L DFGL K    ++  +    GT  ++APEV++   + Y   
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH--KQPYDRT 219
Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
            D W LG  + EML                    G PP    + ++   + + + +Q+ P
Sbjct: 220 VDWWCLGAVLYEMLY-------------------GLPPFYSRNTAEMYDNILNKPLQLKP 260
Query: 383 NDRPTAAQLLD 393
           N   +A  LL+
Sbjct: 261 NITNSARHLLE 271

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 195
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 196 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 255
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 256 ENRPGFA 262

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 106
Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 244
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDELA 164
Query: 245 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 299 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 353
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 225 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 282
Query: 354 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 82
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------------YTRQ 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 198 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 255
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NP  RPT  ++++
Sbjct: 256 CPERVTDLMRMCWQFNPKMRPTFLEIVN 283

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 1   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 56
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGXLLD-YVREH-KD 113
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 114 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 174 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 231
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 232 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------------YTRQ 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NP  RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 20/259 (7%)
Query: 149 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           ++G G FG V  G          F A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKT---LKSGYTEKQRRDFLS-EASIMGQFDHPN 69
Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 262
           ++   G     + + I  E +  GSL +  ++        Q+    R I  G+KYL D +
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMAPEVINNK 315
            VHR +   NILV++N   K++DFGL++  + +       +A        W APE I  +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--Q 187
Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
            + +   +D+WS G  + E+++  + PY  M     +  I +    P P          +
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 247
Query: 375 KQCVQVNPNDRPTAAQLLD 393
             C Q + N RP   Q+++
Sbjct: 248 LDCWQKDRNHRPKFGQIVN 266

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 1   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 56
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 113
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 114 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 174 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 231
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 232 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 40/271 (14%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 23  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 77
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 246
            ++V+  G         + +EL+T+G L     + +LR                 S++  
Sbjct: 78  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 133 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 192
Query: 306 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP 361
              WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G    
Sbjct: 193 PVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 250
Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            PD+      + ++ C Q NP  RP+  +++
Sbjct: 251 KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 201
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 261
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 262 ENRPGFA 268

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 4   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 59
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 60  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 116
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 117 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 176
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 177 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 234
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 235 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 115
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 131
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 132 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 189
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 190 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 249
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 250 ENRPGFA 256

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 99
Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 244
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 100 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 157
Query: 245 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 299 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 353
             +G A     WMAPE I   N  Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 218 VVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 275
Query: 354 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 276 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 14  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65
Query: 210 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 125
Query: 266 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  + K +   +D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REKKFSTKSD 181
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  ++  
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA 241
Query: 384 DRPTAAQL---LDH 394
            RP+  QL   L+H
Sbjct: 242 MRPSFLQLREQLEH 255

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 40/271 (14%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 87
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 246
            ++V+  G         + +EL+T+G L     + +LR                 S++  
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 306 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP 361
              WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G    
Sbjct: 203 PVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260
Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            PD+      + ++ C Q NP  RP+  +++
Sbjct: 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 110/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+  H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 110
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 231 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 285
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 110/267 (41%), Gaps = 30/267 (11%)
Query: 150 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+  H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 96
Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 257
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 258 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 310
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 366
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 217 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 271
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  + QC Q  P DRP  A +L+
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 269 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 323
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 191
Query: 324 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 382
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 192 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 251
Query: 383 NDRPTAA 389
            +RP  A
Sbjct: 252 ENRPGFA 258

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 89/168 (52%), Gaps = 9/168 (5%)
Query: 235 QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATK 293
           +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K
Sbjct: 150 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 209
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 353
                   GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +
Sbjct: 210 DTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E 262
Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 263 IIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 118
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 30/266 (11%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 74
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 251
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 75  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 307
             G+ YL+    VHRD+   N  V  + +VK+ DFG+ +     D     G       WM
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 195 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 252
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLL 392
                + ++ C Q NP  RP+  +++
Sbjct: 253 PDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + +   R I   +++LH  ++ HRD+K  N+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 275 V---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 331
               + +  +KL DFG AK T  N +++   T +++APEV+  +   Y    D+WSLG  
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVI 218
Query: 332 VLEMLTSQIPY------APMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPND 384
           +  +L    P+      A    M    ++G+ G P P    +S+DA+  I+  ++ +P +
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 385 RPTAAQLLDHPFVKR 399
           R T  Q ++HP++ +
Sbjct: 279 RLTITQFMNHPWINQ 293

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 29  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 80
Query: 210 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 266 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  + K +   +D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REKKFSTKSD 196
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  ++  
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA 256
Query: 384 DRPTAAQL---LDH 394
            RP+  QL   L+H
Sbjct: 257 MRPSFLQLREQLEH 270

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 83
Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 244
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 141
Query: 245 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 299 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 353
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 202 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 354 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 106
Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 244
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 164
Query: 245 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 299 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 353
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 225 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 282
Query: 354 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 101
Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 244
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 102 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 159
Query: 245 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 298
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 299 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 353
             +G A     WMAPE I   N  Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 220 VVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 277
Query: 354 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 278 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + +   R I   +++LH  ++ HRD+K  N+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 275 V---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 331
               + +  +KL DFG AK T  N +++   T +++APEV+  +   Y    D+WSLG  
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVI 199
Query: 332 VLEMLTSQIPY------APMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPND 384
           +  +L    P+      A    M    ++G+ G P P    +S+DA+  I+  ++ +P +
Sbjct: 200 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 385 RPTAAQLLDHPFVKR 399
           R T  Q ++HP++ +
Sbjct: 260 RLTITQFMNHPWINQ 274

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 112/254 (44%), Gaps = 14/254 (5%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H N+V 
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFL-CEASIMGQFDHPNVVH 108
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
             G       + I +E +  G+L    +++       Q+    R I  G++YL D   VH
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVH 168
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT------AFWMAPEVINNKNKGY 319
           RD+   NILV++N   K++DFGL++  + +D ++   T        W APE I  +   +
Sbjct: 169 RDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGGKIPVRWTAPEAIQYRK--F 225
Query: 320 GLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
              +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C 
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCW 285
Query: 379 QVNPNDRPTAAQLL 392
           Q    +RP   Q++
Sbjct: 286 QKERAERPKFEQIV 299

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 31/284 (10%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSL--------------LNLYQRYHLRDSQVSAY 247
            N+V   G   K    L + +E    G+L               +LY+ + L    +  Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLIXY 149
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 305
           + Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A   
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 306 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSPPP 361
             WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+   
Sbjct: 210 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMR 267
Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
            PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 309

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 134/274 (48%), Gaps = 15/274 (5%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAK 184
           S  +PN    RI+  T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K
Sbjct: 23  SGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK 82
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDS 242
            ++  +++ + +++  +H ++V+  G     + + +  +L+  G LL     +  ++   
Sbjct: 83  ANVEFMDEAL-IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVK 298
            +  +  QI  G+ YL ++ +VHRD+   N+LV +   VK+ DFGLA+      K  +  
Sbjct: 141 LLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200
Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG 357
             +    WMA E I+ +   +   +D+WS G T+ E++T    PY  +        + +G
Sbjct: 201 GGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 258
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
              P P   + D    + +C  ++ + RP   +L
Sbjct: 259 ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 31/284 (10%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSL--------------LNLYQRYHLRDSQVSAY 247
            N+V   G   K    L + +E    G+L               +LY+ + L    +  Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLICY 149
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 305
           + Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A   
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 306 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSPPP 361
             WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+   
Sbjct: 210 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 267
Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
            PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 309

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL----------------NLYQRYHLRDSQVS 245
            N+V   G   K    L + +E    G+L                 +LY+ + L    + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF-LTLEHLI 151
Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
            Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A 
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 306 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSP 359
               WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+ 
Sbjct: 212 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
              PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +Q+   LG GS+G V++  S +DG  +AVK      +G   K    +L +  +     +H
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KDRARKLAEVGSHEKVGQH 116
Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 260
              V+     ++   LY+  EL    SL    + +   L ++QV  Y R  LL L +LH 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGY 319
           Q +VH D+K ANI +   G  KL DFGL            + G   +MAPE++      Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS---Y 232
Query: 320 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQC 377
           G  AD++SLG T+LE+  + ++P+          ++ +G  PP     LS + +  +   
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288
Query: 378 VQVNPNDRPTAAQLLDHPFVKR 399
           ++ +P  R TA  LL  P +++
Sbjct: 289 LEPDPKLRATAEALLALPVLRQ 310

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGXLLD-YVREH-KDNIG 115
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 114
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 139/279 (49%), Gaps = 23/279 (8%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ 185
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+   +G    +    +  + + + +
Sbjct: 34  SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPK 93
Query: 186 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS 245
           +  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S
Sbjct: 94  ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGS 150
Query: 246 AYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDV 297
            Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K    
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKI 354
           +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + 
Sbjct: 211 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 268
Query: 355 GRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 269 GERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 47/286 (16%)
Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 200
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 34  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 201 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--------------------- 236
              +HENIV   G       + +  E    G LLN  +R                     
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 237 -----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 291
                  LRD  +  ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+ 
Sbjct: 150 EDGRPLELRD--LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 292 TKLNDVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPME 346
              +     +G A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  + 
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGIL 265
Query: 347 CMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
             +  +K+ + G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 266 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 106
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 226
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 227 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 254

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 6   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 61
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 62  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 118
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 119 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 179 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 236
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 120/254 (47%), Gaps = 21/254 (8%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 20  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 71
Query: 210 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 131
Query: 266 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  +   +   +D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REAAFSTKSD 187
Query: 325 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  ++  
Sbjct: 188 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA 247
Query: 384 DRPTAAQL---LDH 394
            RP+  QL   L+H
Sbjct: 248 MRPSFLQLREQLEH 261

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL-----------------NLYQRYHLRDSQV 244
            N+V   G   K    L + +E    G+L                  +LY+ + L    +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF-LTLEHL 150
Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
             Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 305 F----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGS 358
                WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+
Sbjct: 211 RLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
               PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 106
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 226
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 227 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H NIV+
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDHCNIVR 115
Query: 208 --YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLGLKY 257
             Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+   L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 258 LHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNK 315
           +H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE+I   
Sbjct: 176 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 235
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQ 339
              Y    D+WS GC + E+L  Q
Sbjct: 236 TD-YTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 108
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 169 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 228
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 229 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 256

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 25  SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 80
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 81  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 137
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 138 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 198 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 255
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 256 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W   D+LG+G+  +V+ G     G  FA+K   + +  S  +    Q+ +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQM-REFEVLKKLNH 66
Query: 203 ENIVQYYGTDKDESKLY--IFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLK 256
           +NIV+ +  +++ +  +  + +E    GSL  + +     Y L +S+     R ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 257 YLHDQDVVHRDIKCANIL----VDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 311
           +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 312 IN------NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP 359
                   +  K YG   D+WS+G T     T  +P+ P E        ++KI  G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 100
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 161 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 220
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 221 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 248

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 84
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 204
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 205 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 23/261 (8%)
Query: 147 GDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G +LG+G FGSV E     +DG F  V  V +L     A   I +  +E A +  F+H +
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVA-VKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 205 IVQYYGTD---KDESKL---YIFLELVTKGSL--LNLYQR-----YHLRDSQVSAYTRQI 251
           + +  G     + + +L    + L  +  G L    L  R     ++L    +  +   I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGT--AFWM 307
             G++YL  ++ +HRD+   N ++  + +V +ADFGL++     D   + C       W+
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           A E +   +  Y + +D+W+ G T+ E++T  Q PYA +E       +  G+    P   
Sbjct: 207 ALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPEC 264
Query: 367 SKDAQDFIKQCVQVNPNDRPT 387
            ++  D + QC   +P  RP+
Sbjct: 265 MEEVYDLMYQCWSADPKQRPS 285

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 151
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 212 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 271
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 272 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 299

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 114
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 23/267 (8%)
Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV---SLLDQGSQAKQSISQLEQEIALLSR 199
           ++ G LLG+G FG+V+ G    D    A+K +    +L     +      LE  +ALL +
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE--VALLWK 90
Query: 200 FE----HENIVQYYGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILL 253
                 H  +++     + +    + LE  L  +     + ++  L +     +  Q++ 
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 254 GLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 312
            +++ H + VVHRDIK  NIL+D   G  KL DFG              GT  +  PE I
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWI 210
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYA-PMECMAALFKIGRGSPPPIPDSLSKDAQ 371
            ++++ + LPA +WSLG  + +M+   IP+    E + A            P  +S D  
Sbjct: 211 -SRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH--------FPAHVSPDCC 261
Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             I++C+   P+ RP+  ++L  P+++
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 80
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 141 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 200
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 201 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 210 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 84
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 204
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 205 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 91
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 152 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 211
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 212 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 33/213 (15%)
Query: 148 DLLGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           + +G G++G V        G   A+K++ +  D  + AK+++    +E+ +L  F+H+NI
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNI 116
Query: 206 VQY---------YGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQIL 252
           +           YG  K    +Y+ L+L+      +L+Q  H    L    V  +  Q+L
Sbjct: 117 IAIKDILRPTVPYGEFKS---VYVVLDLMES----DLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 306
            GLKY+H   V+HRD+K +N+LV+ N  +K+ DFG+A+      A     +     T ++
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
            APE++ + ++ Y    D+WS+GC   EML  +
Sbjct: 230 RAPELMLSLHE-YTQAIDLWSVGCIFGEMLARR 261

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 73
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 134 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 193
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 194 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 77
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 138 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 197
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 198 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 147 GDLLGRGSFGSVYEG--ISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHE 203
           G +LG G FGSV EG    +DG    V   ++ LD  SQ  + I +   E A +  F H 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDFSHP 96
Query: 204 NIVQYYGTDKDES-----KLYIFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQI 251
           N+++  G   + S     K  + L  +  G L    LY R      H+    +  +   I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWM 307
            LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D     +  +    W+
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           A E +   ++ Y   +D+W+ G T+ E+ T    PY  ++       +  G     P+  
Sbjct: 217 AIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC 274
Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQL 391
             +  + +  C + +P DRPT + L
Sbjct: 275 LDELYEIMYSCWRTDPLDRPTFSVL 299

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 137/300 (45%), Gaps = 66/300 (22%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 207
           ++G GSFG V++    +    A+K+V L D+  + +        E+ ++   +H N+V  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKNR--------ELQIMRIVKHPNVVDL 97
Query: 208 ---YY--GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLG 254
              +Y  G  KDE    +FL LV +     +Y+  R++ +  Q      +  Y  Q+L  
Sbjct: 98  KAFFYSNGDKKDE----VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 255 LKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPE 310
           L Y+H   + HRDIK  N+L+D  +G +KL DFG AK   A + N    C  + ++ APE
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAPE 211
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP------- 359
           +I      Y    DIWS GC + E++  Q P  P E     +  + K+  G+P       
Sbjct: 212 LIFGAT-NYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKV-LGTPSREQIKT 268
Query: 360 ----------PPI-PDSLSK--------DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                     P I P   SK        DA D I + ++  P+ R TA + L HPF   L
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 136/314 (43%), Gaps = 70/314 (22%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 252
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 312
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 313 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP- 361
               +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 362 ---------------------------IPDSL-----------SKDAQDFIKQCVQVNPN 383
                                       PDSL           +  A+D + + + ++P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 384 DRPTAAQLLDHPFV 397
            R +    L HP++
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 85
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 146 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 205
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 206 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 135/303 (44%), Gaps = 63/303 (20%)
Query: 148 DLLGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           + +G G++G V        G   A+K++ +  D  + AK+++    +E+ +L  F+H+NI
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNI 115
Query: 206 VQY---------YGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQIL 252
           +           YG  K    +Y+ L+L+      +L+Q  H    L    V  +  Q+L
Sbjct: 116 IAIKDILRPTVPYGEFKS---VYVVLDLMES----DLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 306
            GLKY+H   V+HRD+K +N+LV+ N  +K+ DFG+A+      A     +     T ++
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ--IPYAPMECMAALFKIGRGSPPP--- 361
            APE++ + ++ Y    D+WS+GC   EML  +   P         L  +  G+P P   
Sbjct: 229 RAPELMLSLHE-YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287
Query: 362 -------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                                    +     + A   + + ++  P+ R +AA  L HPF
Sbjct: 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347
Query: 397 VKR 399
           + +
Sbjct: 348 LAK 350

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGAT-DYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 119
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 76
Query: 203 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 252
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 310
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 137 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 196
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
           +I      Y    D+WS GC + E+L  Q
Sbjct: 197 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 136/314 (43%), Gaps = 70/314 (22%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 252
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 312
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 313 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP- 361
               +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 362 ---------------------------IPDSL-----------SKDAQDFIKQCVQVNPN 383
                                       PDSL           +  A+D + + + ++P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 384 DRPTAAQLLDHPFV 397
            R +    L HP++
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 210 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 7   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 62
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 119
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K   
Sbjct: 120 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 179
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 180 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 237
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPY 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 360
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 361 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 381
           P                             PDSL           +  A+D + + + ++
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 382 PNDRPTAAQLLDHPFV 397
           P  R +    L HP++
Sbjct: 306 PAKRISVDDALQHPYI 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 141/319 (44%), Gaps = 54/319 (16%)
Query: 140 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSL-LDQGSQAKQSISQLEQEIALL 197
           ++  +Q+   +G G+ G V        G   AVK++S      + AK++     +E+ LL
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLL 75
Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQRYH--LRDSQVSAYTRQILL 253
               H+NI+        +  L  F ++     L+  NL Q  H  L   ++S    Q+L 
Sbjct: 76  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 135
Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEVI 312
           G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ APEVI
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------------------PMECMAAL--- 351
                GY    DIWS+GC + E++   + +                     E MAAL   
Sbjct: 196 --LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 253
Query: 352 ---FKIGRGSPPPI------PDSL-----------SKDAQDFIKQCVQVNPNDRPTAAQL 391
              +   R + P I      PD +           +  A+D + + + ++P+ R +  + 
Sbjct: 254 VRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 392 LDHPFVKRLLATNSGSASP 410
           L HP++          A P
Sbjct: 314 LRHPYITVWYDPAEAEAPP 332

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF-LTLEH 151
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 212 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 269
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 270 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 315

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 40/292 (13%)
Query: 150 LGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           +G G+FG V++  +  G      F +  V +L + + A    +  ++E AL++ F++ NI
Sbjct: 55  IGEGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNI 112
Query: 206 VQYYGTDKDESKLYIFLELVTKGSL------LNLYQRYHLRDSQVSA------------- 246
           V+  G       + +  E +  G L      ++ +    L  S +S              
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 247 ------YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 300
                   RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++     D    
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232
Query: 301 RGT----AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIG 355
            G       WM PE I      Y   +D+W+ G  + E+ +  + PY  M     ++ + 
Sbjct: 233 DGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290
Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 407
            G+    P++   +  + ++ C    P DRP+   +  H  ++R+     G+
Sbjct: 291 DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI--HRILQRMCERAEGT 340

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 118/268 (44%), Gaps = 32/268 (11%)
Query: 150 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------------YTRQ 250
           +  G         + +EL+  G L     + +LR  +  A                   +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 306
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +           G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 365
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             +   D ++ C Q NP  RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 186
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 247 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 305 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 350

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 38/267 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ-MELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPE 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 40/276 (14%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLE 191
           + I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     +
Sbjct: 41  RDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQ 91
Query: 192 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--------- 242
           +E  LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+         
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDV 150
Query: 243 --------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 294
                   Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++    
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 295 NDVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA 349
            D     G       WM PE I  +   +   +D+WS G  + E+ T  + P+  +    
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268
Query: 350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           A+  I +G     P +   +    ++ C Q  P  R
Sbjct: 269 AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 210 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 40/276 (14%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLE 191
           + I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     +
Sbjct: 12  RDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQ 62
Query: 192 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--------- 242
           +E  LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+         
Sbjct: 63  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDV 121
Query: 243 --------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 294
                   Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++    
Sbjct: 122 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 181
Query: 295 NDVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA 349
            D     G       WM PE I  +   +   +D+WS G  + E+ T  + P+  +    
Sbjct: 182 TDYYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 239
Query: 350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
           A+  I +G     P +   +    ++ C Q  P  R
Sbjct: 240 AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 38/267 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-MELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPE 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    D+WS+GC + EM+  +I +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/319 (25%), Positives = 140/319 (43%), Gaps = 54/319 (16%)
Query: 140 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSL-LDQGSQAKQSISQLEQEIALL 197
           ++  +Q+   +G G+ G V        G   AVK++S      + AK++     +E+ LL
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLL 77
Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQRYH--LRDSQVSAYTRQILL 253
               H+NI+        +  L  F ++     L+  NL Q  H  L   ++S    Q+L 
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 137
Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEVI 312
           G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ APEVI
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 313 NNKNKGYGLPADIWSLGCTVLEM------------------LTSQIPYAPMECMAAL--- 351
                GY    DIWS+GC + E+                  +  Q+     E MAAL   
Sbjct: 198 --LGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 255
Query: 352 ---FKIGRGSPPPI------PDSL-----------SKDAQDFIKQCVQVNPNDRPTAAQL 391
              +   R   P I      PD +           +  A+D + + + ++P+ R +  + 
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 392 LDHPFVKRLLATNSGSASP 410
           L HP++          A P
Sbjct: 316 LRHPYITVWYDPAEAEAPP 334

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 123/260 (47%), Gaps = 34/260 (13%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-MELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPE 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 363 PDSLSKDAQDFIKQCVQVNP 382
           P +  K  Q  ++  V+  P
Sbjct: 246 P-AFMKKLQPTVRNYVENRP 264

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 138 KRIITYWQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           +R++T+  +  ++G+G FG VY G     + +    A+K +S + +     Q +    +E
Sbjct: 19  ERVVTHSDR--VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE----MQQVEAFLRE 72
Query: 194 IALLSRFEHENIVQYYGTDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVS---AYTR 249
             L+    H N++   G       L ++ L  +  G LL  + R   R+  V    ++  
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-FIRSPQRNPTVKDLISFGL 131
Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGT 303
           Q+  G++YL +Q  VHRD+   N ++D + +VK+ADFGLA+         +   +  R  
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPI 362
             W A E +      +   +D+WS G  + E+LT    PY  ++       + +G   P 
Sbjct: 192 VKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ 249
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPT 387
           P+         ++QC + +P  RPT
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPT 274

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 140 IITYWQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 20  IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 70
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----------- 242
             LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+           
Sbjct: 71  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAP 129
Query: 243 ------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 296
                 Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 130 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189
Query: 297 VKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 351
                G       WM PE I  +   +   +D+WS G  + E+ T  + P+  +    A+
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 247
Query: 352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 385
             I +G     P +   +    ++ C Q  P  R
Sbjct: 248 DCITQGRELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 133/271 (49%), Gaps = 15/271 (5%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSI 187
           +PN    RI+  T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K ++
Sbjct: 3   APNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVS 245
             +++ + +++  +H ++V+  G     + + +  +L+  G LL     +  ++    + 
Sbjct: 63  EFMDEAL-IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLL 120
Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCR 301
            +  QI  G+ YL ++ +VHRD+   N+LV +   VK+ DFGLA+      K  +    +
Sbjct: 121 NWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 180
Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 360
               WMA E I+ +   +   +D+WS G T+ E++T    PY  +        + +G   
Sbjct: 181 MPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 238
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           P P   + D    + +C  ++ + RP   +L
Sbjct: 239 PQPPICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 122/258 (47%), Gaps = 30/258 (11%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 252
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 312
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 180
Query: 313 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD 364
               +        GY    DIWS+GC + EM+  +I +   + +    K+      P P+
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 365 SLSKDAQDFIKQCVQVNP 382
            + K  Q  ++  V+  P
Sbjct: 241 FMKK-LQPTVRNYVENRP 257

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 136/314 (43%), Gaps = 70/314 (22%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 252
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 312
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 313 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP- 361
               +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 362 ---------------------------IPDSL-----------SKDAQDFIKQCVQVNPN 383
                                       PDSL           +  A+D + + + ++P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 384 DRPTAAQLLDHPFV 397
            R +    L HP++
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVK---EVSLLDQGSQAKQSISQLEQEIALLSR 199
           W   D+LG+G+  +V+ G     G  FA+K    +S L       + +    +E  +L +
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-------RPVDVQMREFEVLKK 63
Query: 200 FEHENIVQYYGTDKDESKLY--IFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILL 253
             H+NIV+ +  +++ +  +  + +E    GSL  + +     Y L +S+     R ++ 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 254 GLKYLHDQDVVHRDIKCANIL----VDANGSVKLADFGLAKATKLND-VKSCRGTAFWMA 308
           G+ +L +  +VHR+IK  NI+     D     KL DFG A+  + ++      GT  ++ 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLH 183
Query: 309 PEVIN------NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGS 358
           P++        +  K YG   D+WS+G T     T  +P+ P E        ++KI  G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 359 P 359
           P
Sbjct: 244 P 244

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 139/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 114
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 172
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 223
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 360
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 361 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 381
           P                             PDSL           +  A+D + + + ++
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 382 PNDRPTAAQLLDHPFV 397
           P  R +    L HP++
Sbjct: 344 PAKRISVDDALQHPYI 359

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 150 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           LGRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 80  LGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 128
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 267 DIKCANILVDANGS-VKLADFGLAKATKLNDVKSCR-------GTAFWMAPEVINNKNKG 318
           D+K  N+L+ ++GS   L DFG A   + + +           GT   MAPEV+  K   
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-- 246
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY 342
                DIWS  C +L ML    P+
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 135
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 360
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 361 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 381
           P                             PDSL           +  A+D + + + ++
Sbjct: 247 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 382 PNDRPTAAQLLDHPFV 397
           P  R +    L HP++
Sbjct: 307 PAKRISVDDALQHPYI 322

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 33/246 (13%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 114
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 172
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 223
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 363 PDSLSK 368
           P+ + K
Sbjct: 284 PEFMKK 289

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 33/246 (13%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 363 PDSLSK 368
           P+ + K
Sbjct: 246 PEFMKK 251

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 360
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 361 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 381
           P                             PDSL           +  A+D + + + ++
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 382 PNDRPTAAQLLDHPFV 397
           P  R +    L HP++
Sbjct: 306 PAKRISVDDALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 33/246 (13%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 363 PDSLSK 368
           P+ + K
Sbjct: 240 PEFMKK 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 243
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 357
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 135
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 360
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 361 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 381
           P                             PDSL           +  A+D + + + ++
Sbjct: 247 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 382 PNDRPTAAQLLDHPFV 397
           P  R +    L HP++
Sbjct: 307 PAKRISVDDALQHPYI 322

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 132 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 184
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 245 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 296
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 175
Query: 297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 353
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 354 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 33/246 (13%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 21  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 75
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 133
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 134 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 184
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 185 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 244
Query: 363 PDSLSK 368
           P+ + K
Sbjct: 245 PEFMKK 250

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 139/283 (49%), Gaps = 31/283 (10%)
Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 181
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 182 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 241
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 242 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 293
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 179
Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 350
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 351 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 110/254 (43%), Gaps = 12/254 (4%)
Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIH 87
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
             G       + I  E +  GSL    ++        Q+    R I  G+KYL D   VH
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVH 147
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF---WMAPEVINNKNKGYG 320
           RD+   NIL+++N   K++DFGL++  + +     + RG      W APE I  +   + 
Sbjct: 148 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK--FT 205
Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E+++  + PY  M     +  +  G   P P          +  C Q
Sbjct: 206 SASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQ 265
Query: 380 VNPNDRPTAAQLLD 393
              N RP   ++++
Sbjct: 266 KERNSRPKFDEIVN 279

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 33/246 (13%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 363 PDSLSK 368
           P+ + K
Sbjct: 240 PEFMKK 245

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 33/246 (13%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 197 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 127
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 178
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 363 PDSLSK 368
           P+ + K
Sbjct: 239 PEFMKK 244

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 128/253 (50%), Gaps = 25/253 (9%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 257
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 315
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPY-APMECM--AALFKIGRGSPPPIPDSLSKDAQD 372
              Y    D ++LG T+ EM+ ++ P+ A  E +    L +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 373 FIKQCVQVNPNDR 385
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 128/253 (50%), Gaps = 25/253 (9%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 257
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 315
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPY-APMECM--AALFKIGRGSPPPIPDSLSKDAQD 372
              Y    D ++LG T+ EM+ ++ P+ A  E +    L +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 373 FIKQCVQVNPNDR 385
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 128/253 (50%), Gaps = 25/253 (9%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 257
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 315
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPY-APMECM--AALFKIGRGSPPPIPDSLSKDAQD 372
              Y    D ++LG T+ EM+ ++ P+ A  E +    L +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 373 FIKQCVQVNPNDR 385
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 126/253 (49%), Gaps = 25/253 (9%)
Query: 149 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 257
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 315
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQD 372
              Y    D ++LG T+ EM+ ++ P+          ++ +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 373 FIKQCVQVNPNDR 385
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 124/263 (47%), Gaps = 16/263 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G+FG     +  D     +  V  +++G +  +++   ++EI       H NIV++ 
Sbjct: 27  IGAGNFGVAR--LMRDKQANELVAVKYIERGEKIDENV---KREIINHRSLRHPNIVRFK 81
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
                 + L I +E  + G L   +       + +   + +Q++ G+ Y H   V HRD+
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDL 141
Query: 269 KCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 325
           K  N L+D + +  +K+ADFG +KA+ L+   KS  GT  ++APEV+  K    G  AD+
Sbjct: 142 KLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYD-GKVADV 200
Query: 326 WSLGCTVLEMLTSQIPYA-PMECMAALFKIGR--GSPPPIPD--SLSKDAQDFIKQCVQV 380
           WS G T+  ML    P+  P E       I R       IPD   +S + +  I +    
Sbjct: 201 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVA 260
Query: 381 NPNDRPTAAQLLDHP-FVKRLLA 402
           +P  R +  ++ +H  F+K L A
Sbjct: 261 DPAKRISIPEIRNHEWFLKNLPA 283

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 126/270 (46%), Gaps = 44/270 (16%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 195
           ++  +Q    +G G+ G V   Y+ I +     A+K++S      + AK++     +E+ 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY----RELV 75
Query: 196 LLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAY 247
           L+    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYL 131
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM 307
             Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMM 182
Query: 308 APEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP 359
            P V+    +        GY    DIWS+GC + EM+   + +   + +    K+     
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
            P P+ + K     ++  V+    +RP  A
Sbjct: 243 TPSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 147 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 243
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 244 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 293
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 294 LND--VKSCRGT--AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 346
             D  VK  +G     WMA E + +    Y   +D+WS G  + E++T   +  P  P E
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR 399
            +  L K G       PD+ S++    + QC +  P+ RP  A +   L+   VKR
Sbjct: 260 RLFNLLKTGHRMER--PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 147 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 243
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 244 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 293
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 294 LND--VKSCRGT--AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 346
             D  VK  +G     WMA E + +    Y   +D+WS G  + E++T   +  P  P E
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR 399
            +  L K G       PD+ S++    + QC +  P+ RP  A +   L+   VKR
Sbjct: 260 RLFNLLKTGHRMER--PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 150 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 82  VGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 130
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 267 DIKCANILVDANGS-VKLADFGLAKATKLNDVKSCR-------GTAFWMAPEVINNKNKG 318
           D+K  N+L+ ++GS   L DFG A   + + +           GT   MAPEV+  K   
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-- 248
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY 342
                DIWS  C +L ML    P+
Sbjct: 249 CDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 23/267 (8%)
Query: 149 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++GRG+F  V    +   G  +A+K ++  D   + +  +S   +E  +L   +   I Q
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE--VSCFREERDVLVNGDRRWITQ 125
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 265
            +   +DE+ LY+ +E    G LL L  ++  R        Y  +I++ +  +H    VH
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKGYG 320
           RDIK  NIL+D  G ++LADFG     KL    + R     GT  +++PE++     G G
Sbjct: 186 RDIKPDNILLDRCGHIRLADFG--SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 321 L-----PADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQ 371
                   D W+LG    EM   Q P+          KI       S P + + + ++A+
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303
Query: 372 DFIKQ--CVQVNPNDRPTAAQLLDHPF 396
           DFI++  C       R  A     HPF
Sbjct: 304 DFIQRLLCPPETRLGRGGAGDFRTHPF 330

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 122/262 (46%), Gaps = 19/262 (7%)
Query: 142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           T  +K  +LG G FG+V++G+   +G    +     + +    +QS   +   +  +   
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTK----GSLLNLYQRYH--LRDSQVSAYTRQILLG 254
           +H +IV+  G     S     L+LVT+    GSLL+  +++   L    +  +  QI  G
Sbjct: 91  DHAHIVRLLGLCPGSS-----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 145
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPE 310
           + YL +  +VHR++   N+L+ +   V++ADFG+A     +D +     A     WMA E
Sbjct: 146 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
            I+     Y   +D+WS G TV E++T    PYA +        + +G     P   + D
Sbjct: 206 SIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 263
Query: 370 AQDFIKQCVQVNPNDRPTAAQL 391
               + +C  ++ N RPT  +L
Sbjct: 264 VYMVMVKCWMIDENIRPTFKEL 285

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 147 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 243
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 244 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 293
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 294 LND--VKSCRGT--AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 346
             D  VK  +G     WMA E + +    Y   +D+WS G  + E++T   +  P  P E
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR 399
            +  L K G       PD+ S++    + QC +  P+ RP  A +   L+   VKR
Sbjct: 260 RLFNLLKTGHRMER--PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 150 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +GRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 66  VGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 114
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 266
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 267 DIKCANILVDANGS-VKLADFGLAKATKLNDVKSCR-------GTAFWMAPEVINNKNKG 318
           D+K  N+L+ ++GS   L DFG A   + + +           GT   MAPEV+  K   
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-- 232
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY 342
                DIWS  C +L ML    P+
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 122/262 (46%), Gaps = 19/262 (7%)
Query: 142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           T  +K  +LG G FG+V++G+   +G    +     + +    +QS   +   +  +   
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 201 EHENIVQYYGTDKDESKLYIFLELVTK----GSLLNLYQRYH--LRDSQVSAYTRQILLG 254
           +H +IV+  G     S     L+LVT+    GSLL+  +++   L    +  +  QI  G
Sbjct: 73  DHAHIVRLLGLCPGSS-----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPE 310
           + YL +  +VHR++   N+L+ +   V++ADFG+A     +D +     A     WMA E
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
            I+     Y   +D+WS G TV E++T    PYA +        + +G     P   + D
Sbjct: 188 SIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245
Query: 370 AQDFIKQCVQVNPNDRPTAAQL 391
               + +C  ++ N RPT  +L
Sbjct: 246 VYMVMVKCWMIDENIRPTFKEL 267

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 29/268 (10%)
Query: 142 TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           T ++K  +LG G+FG+VY+G+            A+KE+    + + + ++  ++  E  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSPKANKEILDEAYV 67
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 252
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 68  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 124
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDVKSCRGTAFWMA 308
            G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K    +  +    WMA
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPD 364
            E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + G   P PPI  
Sbjct: 185 LESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI-- 240
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
             + D    + +C  ++ + RP   +L+
Sbjct: 241 -CTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 29/268 (10%)
Query: 142 TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           T ++K  +LG G+FG+VY+G+            A+KE+    + + + ++  ++  E  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSPKANKEILDEAYV 64
Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 252
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 65  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 121
Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDVKSCRGTAFWMA 308
            G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K    +  +    WMA
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPD 364
            E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + G   P PPI  
Sbjct: 182 LESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI-- 237
Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
             + D    + +C  ++ + RP   +L+
Sbjct: 238 -CTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 125/270 (46%), Gaps = 44/270 (16%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 195
           ++  +Q    +G G+ G V   Y+ I +     A+K++S      + AK++     +E+ 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY----RELV 75
Query: 196 LLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAY 247
           L+    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYL 131
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM 307
             Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMM 182
Query: 308 APEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP 359
            P V+    +        GY    DIWS+GC + EM+   + +   + +    K+     
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
            P P+ + K     ++  V+    +RP  A
Sbjct: 243 TPSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 38/267 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 27  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 81
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 139
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 140 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 190
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    D+WS+GC + EM+  +I +   + +    K+      P 
Sbjct: 191 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 250
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P+ + K     ++  V+    +RP  A
Sbjct: 251 PEFMKK-----LQPTVRTYVENRPKYA 272

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 45/285 (15%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 74
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 260
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 261 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAK------ATKLNDVKSCR 301
             ++HRD+K  NILV               N  + ++DFGL K      ++   ++ +  
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 302 GTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIG 355
           GT+ W APE++   N     +      DI+S+GC    +L+  + P+       +    G
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 253
Query: 356 RGSPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
             S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 13/275 (4%)
Query: 128 MSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 184
           MS  +PN    RI+  T  +K  +LG G+FG+VY+GI   DG    +     + + + + 
Sbjct: 1   MSGAAPNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP 60
Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDS 242
           ++  ++  E  +++      + +  G     S + +  +L+  G LL+  +  R  L   
Sbjct: 61  KANKEILDEAYVMAGVGSPYVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQ 119
Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---- 298
            +  +  QI  G+ YL D  +VHRD+   N+LV +   VK+ DFGLA+   +++ +    
Sbjct: 120 DLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 179
Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG 357
             +    WMA E I  +   +   +D+WS G TV E++T    PY  +        + +G
Sbjct: 180 GGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 237
Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
              P P   + D    + +C  ++   RP   +L+
Sbjct: 238 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 272

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 38/267 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 128
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    D+WS+GC + EM+  +I +   + +    K+      P 
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P+ + K     ++  V+    +RP  A
Sbjct: 240 PEFMKK-----LQPTVRTYVENRPKYA 261

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++LGRG FG VY+G   DG   AVK   L ++  Q  +   Q + E+ ++S   H N+++
Sbjct: 44  NILGRGGFGKVYKGRLADGTLVAVK--RLKEERXQGGEL--QFQTEVEMISMAVHRNLLR 99
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-----GLKYLHDQ- 261
             G     ++  +    +  GS+ +  +        +    RQ +      GL YLHD  
Sbjct: 100 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 159
Query: 262 --DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKN 316
              ++HRD+K ANIL+D      + DFGLAK     D     + RGT   +APE ++   
Sbjct: 160 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGK 219
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
                  D++  G  +LE++T Q  +
Sbjct: 220 SSE--KTDVFGYGVMLLELITGQRAF 243

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 248
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 308
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 309 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 360
           P V+    +        GY    DIWS+GC + EM+   + +   + +    K+      
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P P+ + K     ++  V+    +RP  A
Sbjct: 244 PSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 92
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 260
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 261 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 299
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 209
Query: 300 CRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG 357
             GT+ W APE++    K       DI+S+GC    +L+  + P+       +    G  
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 358 SPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 136/288 (47%), Gaps = 41/288 (14%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R +T ++    LGRG FG V+E  +  D   +A+K + L ++   A++ + +   E+  L
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMR---EVKAL 57
Query: 198 SRFEHENIVQYYGT--DKDESK----------LYIFLELVTKGSL---LNLYQRYHLRDS 242
           ++ EH  IV+Y+    +K+ ++          LYI ++L  K +L   +N       R+ 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 243 QVSAYT-RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC- 300
            V  +   QI   +++LH + ++HRD+K +NI    +  VK+ DFGL  A   ++ +   
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 301 -------------RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-ME 346
                         GT  +M+PE I+  +  Y    DI+SLG  + E+L    P++  ME
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELL---YPFSTQME 232
Query: 347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            +  L  +     PP+           ++  +  +P +RP A  ++++
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-MELDHERMSYLLYQ 135
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P+ + K     ++  V+    +RP  A
Sbjct: 247 PEFMKK-----LQPTVRTYVENRPKYA 268

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 92
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 260
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 261 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 299
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 209
Query: 300 CRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG 357
             GT+ W APE++    K       DI+S+GC    +L+  + P+       +    G  
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 358 SPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTR 249
           E +++ +F+H NI++  G         I  E +  GSL + + R H       Q+    R
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----- 304
            +  G++YL D   VHRD+   N+LVD+N   K++DFGL++  + +D  +   T      
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAXTTTGGKIP 217
Query: 305 -FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI 362
             W APE I  +   +   +D+WS G  + E+L   + PY  M     +  +  G   P 
Sbjct: 218 IRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           P          +  C   +   RP  +Q++
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 125/268 (46%), Gaps = 40/268 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 195
           ++  +Q    +G G+ G V   Y+ I +     A+K++S      + AK++     +E+ 
Sbjct: 24  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY----RELV 77
Query: 196 LLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 249
           L+    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    
Sbjct: 78  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-MELDHERMSYLLY 135
Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAP 309
           Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMVP 186
Query: 310 EVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP 361
            V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P
Sbjct: 187 FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 246
Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
            P+ + K     ++  V+    +RP  A
Sbjct: 247 CPEFMKK-----LQPTVRTYVENRPKYA 269

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 27/276 (9%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G+FG     +  D     +  V  +++G+   +++   ++EI       H NIV++ 
Sbjct: 28  IGSGNFGVA--RLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFK 82
Query: 210 GTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                 + L I +E  + G    LY+R        + +   + +Q+L G+ Y H   + H
Sbjct: 83  EVILTPTHLAIIMEYASGG---ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 266 RDIKCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLP 322
           RD+K  N L+D + +  +K+ DFG +K++ L+   KS  GT  ++APEV+  +    G  
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD-GKI 198
Query: 323 ADIWSLGCTVLEMLTSQIPYA-PMECMAALFKIGR--GSPPPIPDS--LSKDAQDFIKQC 377
           AD+WS G T+  ML    P+  P E       I R       IPD   +S +    I + 
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258
Query: 378 VQVNPNDRPTAAQLLDHP-FVKRLLA-----TNSGS 407
              +P  R +  ++  H  F+K L A     +N+GS
Sbjct: 259 FVADPATRISIPEIKTHSWFLKNLPADLMNESNTGS 294

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTR 249
           E +++ +F+H NI++  G         I  E +  GSL + + R H       Q+    R
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----- 304
            +  G++YL D   VHRD+   N+LVD+N   K++DFGL++  + +D  +   T      
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIP 217
Query: 305 -FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI 362
             W APE I  +   +   +D+WS G  + E+L   + PY  M     +  +  G   P 
Sbjct: 218 IRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           P          +  C   +   RP  +Q++
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 74
Query: 209 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 260
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 261 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 299
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 191
Query: 300 CRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFK 353
             GT+ W APE++   N     +      DI+S+GC    +L+  + P+       +   
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 354 IGRGSPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
            G  S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 250
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 311 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAA 389
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 128/280 (45%), Gaps = 27/280 (9%)
Query: 150 LGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LGRG FG V+   E  S   +     +V   DQ          +++EI++L+   H NI+
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--------VLVKKEISILNIARHRNIL 64
Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ 261
             + + +   +L +  E +   S L++++R     + L + ++ +Y  Q+   L++LH  
Sbjct: 65  HLHESFESMEELVMIFEFI---SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 262 DVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCRGTA-FWMAPEVINNKNKG 318
           ++ H DI+  NI+     + ++K+ +FG A+  K  D      TA  + APEV  +++  
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQHDV 179
Query: 319 YGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
                D+WSLG  V  +L+   P+      + +  +              +S +A DF+ 
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 376 QCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 415
           + +      R TA++ L HP++K+ +   S      L  R
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 125/270 (46%), Gaps = 44/270 (16%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 195
           ++  +Q    +G G+ G V   Y+ I +     A+K++S      + AK++     +E+ 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY----RELV 75
Query: 196 LLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAY 247
           L+    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S  
Sbjct: 76  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYL 131
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM 307
             Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMM 182
Query: 308 APEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP 359
            P V+    +        GY    DIWS+GC + EM+   + +   + +    K+     
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
            P P+ + K     ++  V+    +RP  A
Sbjct: 243 TPSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           ++LGRG FG VY+G   DG   AVK   L ++ +Q  +   Q + E+ ++S   H N+++
Sbjct: 36  NILGRGGFGKVYKGRLADGXLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 91
Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-----GLKYLHDQ- 261
             G     ++  +    +  GS+ +  +        +    RQ +      GL YLHD  
Sbjct: 92  LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 262 --DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKN 316
              ++HRD+K ANIL+D      + DFGLAK     D     + RG    +APE ++   
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGK 211
Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPY 342
                  D++  G  +LE++T Q  +
Sbjct: 212 SSE--KTDVFGYGVMLLELITGQRAF 235

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 89
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 209 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 149
Query: 203 ENIVQYYGTD-KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+K+L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 269 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 125/270 (46%), Gaps = 44/270 (16%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 195
           ++  +Q    +G G+ G V   Y+ I +     A+K++S      + AK++     +E+ 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY----RELV 75
Query: 196 LLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAY 247
           L+    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYL 131
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM 307
             Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMM 182
Query: 308 APEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP 359
            P V+    +        GY    DIWS+G  + EM+   + +   + +    K+     
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
            P P+ + K     ++  V+    +RP  A
Sbjct: 243 TPSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 16/263 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G+FG     +  D     +  V  +++G +  +++   ++EI       H NIV++ 
Sbjct: 26  IGSGNFGVA--RLMRDKQSNELVAVKYIERGEKIDENV---KREIINHRSLRHPNIVRFK 80
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
                 + L I +E  + G L   +       + +   + +Q++ G+ Y H   V HRD+
Sbjct: 81  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 140
Query: 269 KCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 325
           K  N L+D + +  +K+ DFG +K++ L+   KS  GT  ++APEV+  K    G  AD+
Sbjct: 141 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKVADV 199
Query: 326 WSLGCTVLEMLTSQIPYA-PMECMAALFKIGR--GSPPPIPD--SLSKDAQDFIKQCVQV 380
           WS G T+  ML    P+  P E       I R       IPD   +S + +  I +    
Sbjct: 200 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVA 259
Query: 381 NPNDRPTAAQLLDHP-FVKRLLA 402
           +P  R +  ++ +H  F+K L A
Sbjct: 260 DPAKRISIPEIRNHEWFLKNLPA 282

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 125/270 (46%), Gaps = 44/270 (16%)
Query: 140 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 195
           ++  +Q    +G G+ G V   Y+ I +     A+K++S      + AK++     +E+ 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERNV--AIKKLSRPFQNQTHAKRAY----RELV 75
Query: 196 LLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAY 247
           L+    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S  
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYL 131
Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM 307
             Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMM 182
Query: 308 APEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP 359
            P V+    +        GY    DIWS+G  + EM+   + +   + +    K+     
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
            P P+ + K     ++  V+    +RP  A
Sbjct: 243 TPSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+K+L
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 210 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQV 244
           +  +E    +   H  IV  Y T + E+      YI +E V   +L ++    H      
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMT 114
Query: 245 SAYTRQILL----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLN 295
                +++      L + H   ++HRD+K ANIL+ A  +VK+ DFG+A+A       + 
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
              +  GTA +++PE    +       +D++SLGC + E+LT + P+     ++  ++  
Sbjct: 175 QTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 356 RGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 391
           R  P PP    + LS D    + + +  NP +R  TAA++
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 91
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+K+L
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             + + +   +D+WS G  + E++T   P  P
Sbjct: 211 --QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 88
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+K+L
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E +
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             + + +   +D+WS G  + E++T   P  P
Sbjct: 208 --QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 95
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+K+L
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E +
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             + + +   +D+WS G  + E++T   P  P
Sbjct: 215 --QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 109
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 229 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQV 244
           +  +E    +   H  IV  Y T + E+      YI +E V   +L ++    H      
Sbjct: 58  RFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMT 114
Query: 245 SAYTRQILL----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLN 295
                +++      L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       + 
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
              +  GTA +++PE    +       +D++SLGC + E+LT + P+     ++  ++  
Sbjct: 175 QTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 356 RGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 391
           R  P PP    + LS D    + + +  NP +R  TAA++
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 27/222 (12%)
Query: 136 RFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEI 194
           R ++ +  +Q   + G+G+FG+V  G     G   A+K+V    Q  + +    Q+ Q++
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQIMQDL 73
Query: 195 ALLSRFEHENIVQ---YYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQ----- 243
           A+L    H NIVQ   Y+ T  +  +  I+L +V +    +L    + Y+ R        
Sbjct: 74  AVL---HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 244 VSAYTRQIL--LGLKYLHDQDVVHRDIKCANILV-DANGSVKLADFGLAKA---TKLNDV 297
           +  +  Q++  +G  +L   +V HRDIK  N+LV +A+G++KL DFG AK    ++ N  
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
             C  + ++ APE+I   N+ Y    DIWS+GC   EM+  +
Sbjct: 191 YIC--SRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+K+L
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             + + +   +D+WS G  + E++T   P  P
Sbjct: 210 --QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 91
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+K+L
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             + + +   +D+WS G  + E++T   P  P
Sbjct: 211 --QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 108
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 228 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 82
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 202 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 87
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 207 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 210 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 16/263 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G+FG     +  D     +  V  +++G +   ++   ++EI       H NIV++ 
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIAANV---KREIINHRSLRHPNIVRFK 81
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
                 + L I +E  + G L   +       + +   + +Q++ G+ Y H   V HRD+
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 269 KCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 325
           K  N L+D + +  +K+ DFG +K++ L+   KS  GT  ++APEV+  K    G  AD+
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKVADV 200
Query: 326 WSLGCTVLEMLTSQIPYA-PMECMAALFKIGR--GSPPPIPD--SLSKDAQDFIKQCVQV 380
           WS G T+  ML    P+  P E       I R       IPD   +S + +  I +    
Sbjct: 201 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVA 260
Query: 381 NPNDRPTAAQLLDHP-FVKRLLA 402
           +P  R +  ++ +H  F+K L A
Sbjct: 261 DPAKRISIPEIRNHEWFLKNLPA 283

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 88
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 208 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 85
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 205 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G +LG G+FG V      GIS  G    V  V +L + + + +    L  E+ ++++   
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVA-VKMLKEKADSSER-EALMSELKMMTQLGS 107
Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVS-------------- 245
           HENIV   G       +Y+  E    G LLN    +R    + ++               
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 246 --------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 297
                    +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 298 KSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALF 352
              RG A     WMAPE +      Y + +D+WS G  + E+ +  + PY  +   A  +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 353 K-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           K I  G     P   +++    ++ C   +   RP+   L
Sbjct: 286 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 210 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQV 244
           +  +E    +   H  IV  Y T + E+      YI +E V   +L ++    H      
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMT 114
Query: 245 SAYTRQILL----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLN 295
                +++      L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       + 
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
              +  GTA +++PE    +       +D++SLGC + E+LT + P+     ++  ++  
Sbjct: 175 QTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 356 RGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 391
           R  P PP    + LS D    + + +  NP +R  TAA++
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQV 244
           +  +E    +   H  IV  Y T + E+      YI +E V   +L ++    H      
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMT 114
Query: 245 SAYTRQILL----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLN 295
                +++      L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       + 
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
              +  GTA +++PE    +       +D++SLGC + E+LT + P+     ++  ++  
Sbjct: 175 QTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 356 RGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 391
           R  P PP    + LS D    + + +  NP +R  TAA++
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 148 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 202
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 89
Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYL 258
            N++   G   + E    + L  +  G L N + R    +  V     +  Q+  G+KYL
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVI 312
             +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 344
             +   +   +D+WS G  + E++T   P  P
Sbjct: 209 QTQK--FTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQV 244
           +  +E    +   H  IV  Y T + E+      YI +E V   +L ++    H      
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMT 131
Query: 245 SAYTRQILL----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLN 295
                +++      L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       + 
Sbjct: 132 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
              +  GTA +++PE    +       +D++SLGC + E+LT + P+     ++  ++  
Sbjct: 192 QTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 249
Query: 356 RGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 391
           R  P PP    + LS D    + + +  NP +R  TAA++
Sbjct: 250 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 289

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 252
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 64  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 253 LGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKATKLN 295
            GL+Y+H   +VH DIK +NI +                  A+  V      L   T+++
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 181
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFKI 354
             +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +      +I
Sbjct: 182 SPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVXAAGAEPLPRNGDQW----HEI 236
Query: 355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 237 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 276

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/341 (24%), Positives = 142/341 (41%), Gaps = 98/341 (28%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEIALLSRFEHENIV 206
           L+GRGS+G VY     +      K V++       +  I   ++ +EI +L+R + + I+
Sbjct: 33  LIGRGSYGYVYLAYDKN----TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 207 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 260
           + Y     +      +LYI LE +    L  L++    L +  +      +LLG  ++H+
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE 147
Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATK-------LNDVK--------------- 298
             ++HRD+K AN L++ + SVK+ DFGLA+          +ND++               
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 299 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT---VLEML-------TSQIPYAP-- 344
             S   T ++ APE+I  + + Y    DIWS GC    +L ML       T++ P  P  
Sbjct: 208 LTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 345 -------------------MECMAALFKIGRGSPP-----------------------PI 362
                               + +  +F I  G+P                        PI
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNII-GTPTEDDLKNINKPEVIKYIKLFPHRKPI 325
Query: 363 P-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                  S+S D  + ++  ++ NPN R T  Q LDHP++K
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 86/360 (23%), Positives = 148/360 (41%), Gaps = 101/360 (28%)
Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEIALLSRFE 201
           ++   L+GRGS+G VY     +    A K V++       +  I   ++ +EI +L+R +
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKN----ANKNVAIKKVNRMFEDLIDCKRILREITILNRLK 85
Query: 202 HENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGL 255
            + I++ +     E      +LYI LE +    L  L++    L +  V      +LLG 
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGE 144
Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-------LNDVK---------- 298
           K++H+  ++HRD+K AN L++ + SVK+ DFGLA+          +ND++          
Sbjct: 145 KFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 299 ----------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML----------TS 338
                     S   T ++ APE+I  + + Y    DIWS GC   E+L          T+
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTNSIDIWSTGCIFAELLNMMKSHINNPTN 263
Query: 339 QIPYAP---------------------MECMAALFKIGRGSPP----------------- 360
           + P  P                      + +  +F +  G+PP                 
Sbjct: 264 RFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVI-GTPPEEDLKCITKQEVIKYIK 322
Query: 361 --PIPD---------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 409
             P  D         S+SK+  D ++  ++ N   R T  + L HP++K +   N  + S
Sbjct: 323 LFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFS 382

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 133/284 (46%), Gaps = 31/284 (10%)
Query: 135 GRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE 193
           G   R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +    
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYT 248
            A+L   +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++    
Sbjct: 64  HAVLG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKA 291
            Q+  GL+Y+H   +VH DIK +NI +                  A+  V      L   
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAA 350
           T+++  +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +    
Sbjct: 182 TRISSPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236
Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             +I +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 189 QLEQEIALLSRFEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQV 244
           +  +E    +   H  IV  Y T + E+      YI +E V   +L ++    H      
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMT 114
Query: 245 SAYTRQILL----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLN 295
                +++      L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       + 
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 355
              +  GTA +++PE    +       +D++SLGC + E+LT + P+      +  ++  
Sbjct: 175 QTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHV 232
Query: 356 RGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 391
           R  P PP    + LS D    + + +  NP +R  TAA++
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 16/263 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G+FG     +  D     +  V  +++G +  +++   ++EI       H NIV++ 
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENV---KREIINHRSLRHPNIVRFK 81
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
                 + L I +E  + G L   +       + +   + +Q++ G+ Y H   V HRD+
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 269 KCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 325
           K  N L+D + +  +K+  FG +K++ L+   KS  GT  ++APEV+  K    G  AD+
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKVADV 200
Query: 326 WSLGCTVLEMLTSQIPYA-PMECMAALFKIGR--GSPPPIPD--SLSKDAQDFIKQCVQV 380
           WS G T+  ML    P+  P E       I R       IPD   +S + +  I +    
Sbjct: 201 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVA 260
Query: 381 NPNDRPTAAQLLDHP-FVKRLLA 402
           +P  R +  ++ +H  F+K L A
Sbjct: 261 DPAKRISIPEIRNHEWFLKNLPA 283

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 252
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 66  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 253 LGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKATKLN 295
            GL+Y+H   +VH DIK +NI +                  A+  V      L   T+++
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFKI 354
             +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +      +I
Sbjct: 184 SPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEI 238
Query: 355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 239 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 139 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 252
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 66  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 253 LGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKATKLN 295
            GL+Y+H   +VH DIK +NI +                  A+  V      L   T+++
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFKI 354
             +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +      +I
Sbjct: 184 SPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEI 238
Query: 355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 239 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 43/294 (14%)
Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ 207
           +L  G F  VYE   D G   + +E +L    S  ++    + QE+  + +   H NIVQ
Sbjct: 35  VLAEGGFAFVYEA-QDVG---SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 208 Y---YGTDKDESKL----YIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGL 255
           +       K+ES      ++ L  + KG L+   ++   R     D+ +  +  Q    +
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY-QTCRAV 149
Query: 256 KYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKATK-------------LNDVKSC 300
           +++H Q   ++HRD+K  N+L+   G++KL DFG A                 L + +  
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 301 RGTA-FWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GR 356
           R T   +  PE+I+   N   G   DIW+LGC +  +   Q P+       A  +I  G+
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGK 265
Query: 357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 410
            S PP  D+        I+  +QVNP +R + A+++ H   +   A N    SP
Sbjct: 266 YSIPP-HDTQYTVFHSLIRAMLQVNPEERLSIAEVV-HQLQEIAAARNVNPKSP 317

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/336 (24%), Positives = 144/336 (42%), Gaps = 77/336 (22%)
Query: 135 GRFKR-IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
           GR  R ++  ++    LG+G++G V++ I    G   AVK++    Q S   Q   +  +
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFR 57
Query: 193 EIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-RQ 250
           EI +L+    HENIV      + ++   ++L      + L+   R ++ +     Y   Q
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ 117
Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------------TKLND-- 296
           ++  +KYLH   ++HRD+K +NIL++A   VK+ADFGL+++              +N+  
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 297 ---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML----------- 336
                    +     T ++ APE++    K Y    D+WSLGC + E+L           
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTK-YTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 337 --------------------TSQIPYAP--MECMAALFKIGRGSPPPI------------ 362
                               + Q P+A   +E +    +I + +   I            
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 363 -PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
                +++A D + + +Q NPN R +A   L HPFV
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 55/251 (21%)
Query: 133 PNGRFKRIITYWQKGD------LLGRGSFGSVYEGISD-DGFFFAVKEV-----SLLDQG 180
           P     R  + WQ  D      L+G GS+G V E     +    A+K++      L+D  
Sbjct: 38  PTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-- 95
Query: 181 SQAKQSISQLEQEIALLSRFEHENIVQYYGT--DKDESK---LYIFLELVTKGSLLNLYQ 235
                   ++ +EIA+L+R  H+++V+       KD  K   LY+ LE+           
Sbjct: 96  ------CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT 149
Query: 236 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 294
             +L +  +      +L+G+KY+H   ++HRD+K AN LV+ + SVK+ DFGLA+     
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
Query: 295 -------------------------NDVKSCRG---TAFWMAPEVINNKNKGYGLPADIW 326
                                    N  +   G   T ++ APE+I  + + Y    D+W
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVW 268
Query: 327 SLGCTVLEMLT 337
           S+GC   E+L 
Sbjct: 269 SIGCIFAELLN 279

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 43/281 (15%)
Query: 148 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           ++  RG FG V++  + +D  F AVK   L D+ S       Q E+EI      +HEN++
Sbjct: 21  EIKARGRFGCVWKAQLMND--FVAVKIFPLQDKQSW------QSEREIFSTPGMKHENLL 72
Query: 207 QYYGTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ- 261
           Q+   +K  S L + L L+T    KGSL +  +   +  +++      +  GL YLH+  
Sbjct: 73  QFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDV 132
Query: 262 ----------DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWM 307
                      + HRD K  N+L+ ++ +  LADFGLA          D     GT  +M
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 308 APEVIN---NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIP 363
           APEV+    N  +   L  D++++G  + E+++  +    P++     F+   G  P + 
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLE 252
Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAA-QLLDHPFVKRLLAT 403
           +           Q V V+   RPT     L HP + +L  T
Sbjct: 253 EL----------QEVVVHKKMRPTIKDHWLKHPGLAQLCVT 283

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 16/263 (6%)
Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
           +G G+FG     +  D     +  V  +++G +  +++   ++EI       H NIV++ 
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENV---KREIINHRSLRHPNIVRFK 81
Query: 210 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 268
                 + L I +E  + G L   +       + +   + +Q++ G+ Y H   V HRD+
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 269 KCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 325
           K  N L+D + +  +K+  FG +K++ L+   K   GT  ++APEV+  K    G  AD+
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYD-GKVADV 200
Query: 326 WSLGCTVLEMLTSQIPYA-PMECMAALFKIGR--GSPPPIPD--SLSKDAQDFIKQCVQV 380
           WS G T+  ML    P+  P E       I R       IPD   +S + +  I +    
Sbjct: 201 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVA 260
Query: 381 NPNDRPTAAQLLDHP-FVKRLLA 402
           +P  R +  ++ +H  F+K L A
Sbjct: 261 DPAKRISIPEIRNHEWFLKNLPA 283

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 221
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 222 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 281
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 282 QRMTITEFMNHPWI 295

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 213
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 214 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 273
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 274 QRMTITEFMNHPWI 287

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 211
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 212 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 271
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 272 QRMTITEFMNHPWI 285

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 251
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 312 QRMTITEFMNHPWI 325

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 257
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 258 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 317
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 318 QRMTITEFMNHPWI 331

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 212
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 213 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 272
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 273 QRMTITEFMNHPWI 286

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 146 KGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +G  +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACR---EIALLRELKH 77
Query: 203 ENIV--QYYGTDKDESKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQ 250
            N++  Q       + K+++  +   +  L ++ + +           L    V +   Q
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 251 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATK-----LNDVKSCR 301
           IL G+ YLH   V+HRD+K ANILV       G VK+AD G A+        L D+    
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 339
            T ++ APE++    + Y    DIW++GC   E+LTS+
Sbjct: 197 VTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 206
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 207 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 266
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 267 QRMTITEFMNHPWI 280

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 218 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 275 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 205
Query: 331 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 384 DRPTAAQLLDHPFV 397
            R T  + ++HP++
Sbjct: 266 QRMTITEFMNHPWI 279
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	415
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-148
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-128
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-126
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-111
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-105
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-102
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-98
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-97
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-92
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-90
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-88
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-87
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-87
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-87
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-86
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-86
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-85
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-84
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-84
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-82
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-82
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-80
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-78
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-77
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-76
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-74
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-71
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-70
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-70
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-69
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-69
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-69
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-68
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-65
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-65
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-64
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-64
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-64
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-63
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-63
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-62
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-62
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-62
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-61
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-61
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-61
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-60
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-60
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-59
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-59
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-59
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-59
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-59
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-59
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-58
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-58
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-58
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-58
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-57
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-57
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-57
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-57
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-57
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-57
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-56
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-56
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-56
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-56
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-56
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-55
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-55
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-54
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-54
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-54
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-54
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-54
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-54
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-54
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-53
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-53
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-53
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-52
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-51
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-51
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-51
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-50
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-50
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-50
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-50
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-49
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-49
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-48
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-47
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-47
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-47
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-46
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-46
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-46
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-46
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-45
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-45
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-45
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-45
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-44
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-44
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-44
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-44
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-44
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-44
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-43
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-43
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-43
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-43
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-43
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-42
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-42
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-42
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-42
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-42
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-42
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-41
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-41
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-41
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-41
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-41
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-41
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-41
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-41
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-41
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-41
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-40
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-40
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-40
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-40
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-40
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-39
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-39
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-39
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-39
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-39
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-39
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-38
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-38
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-37
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-36
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-36
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-36
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-36
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-35
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-35
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-35
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-35
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-34
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-33
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-33
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-32
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-30
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-28
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-25
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-17
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-05

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  420 bits (1083), Expect = e-148
 Identities = 107/289 (37%), Positives = 159/289 (55%), Gaps = 15/289 (5%)

Query: 121 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 179
           S  +TE     S    +           +LG+G++G VY G    +    A+KE+   D 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 180 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 238
                +    L +EIAL    +H+NIVQY G+  +   + IF+E V  GSL  L +    
Sbjct: 61  -----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115

Query: 239 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAK--AT 292
                +  +  YT+QIL GLKYLHD  +VHRDIK  N+L++  +G +K++DFG +K  A 
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 293 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAAL 351
                ++  GT  +MAPE+I+   +GYG  ADIWSLGCT++EM T + P+  + E  AA+
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

Query: 352 FKIGRG-SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           FK+G     P IP+S+S +A+ FI +C + +P+ R  A  LL   F+K 
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  370 bits (952), Expect = e-128
 Identities = 82/296 (27%), Positives = 148/296 (50%), Gaps = 23/296 (7%)

Query: 115 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKE 173
             + D           +S +GR      + +    +GRGSF +VY+G+ ++     A  E
Sbjct: 5   NQQQDDIEELETKAVGMSNDGR------FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCE 58

Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGS 229
           +         K    + ++E  +L   +H NIV++Y     T K +  + +  EL+T G+
Sbjct: 59  LQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115

Query: 230 LLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLAD 285
           L    +R+  ++   + ++ RQIL GL++LH +   ++HRD+KC NI +    GSVK+ D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175

Query: 286 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 345
            GLA   + +  K+  GT  +MAPE+       Y    D+++ G  +LEM TS+ PY+  
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSEC 232

Query: 346 ECMAALFKIG-RGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +  A +++    G  P   D +   + ++ I+ C++ N ++R +   LL+H F + 
Sbjct: 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  366 bits (942), Expect = e-126
 Identities = 88/313 (28%), Positives = 131/313 (41%), Gaps = 28/313 (8%)

Query: 114 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK 172
            E ED+     TE +  +  +  ++  + +      +GRGSFG V+       GF  AVK
Sbjct: 32  PETEDNEGVLLTEKLKPV--DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89

Query: 173 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 232
           +V L               +E+   +      IV  YG  ++   + IF+EL+  GSL  
Sbjct: 90  KVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 233 LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAK 290
           L ++   L + +   Y  Q L GL+YLH + ++H D+K  N+L+ ++GS   L DFG A 
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199

Query: 291 -------ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 343
                     L       GT   MAPEV+    K      DIWS  C +L ML    P+ 
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257

Query: 344 PMECMAALFKIGRGSPP--PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                    KI    PP   IP S +      I++ ++  P  R +A +L         L
Sbjct: 258 QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA--L 315

Query: 402 ATNSGSASPYLGR 414
               G  SP+ G 
Sbjct: 316 QEVGGLKSPWKGE 328

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  326 bits (839), Expect = e-111
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 33/286 (11%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+   L +  A  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA--LREVYAHA 65

Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQIL 252
              +H ++V+Y+    ++  + I  E    GSL +          + +++++     Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGS-------------------VKLADFGLAKATK 293
            GL+Y+H   +VH DIK +NI +                         K+ D G    T+
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV--TR 183

Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 353
           ++  +   G + ++A EV+   N  +   ADI++L  TV+    ++      +      +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQE-NYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HE 239

Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           I +G  P IP  LS++  + +K  +  +P  RP+A  L+ H  +  
Sbjct: 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  313 bits (804), Expect = e-105
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 14/289 (4%)

Query: 115 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 173
               ++S T   P  +  P+         +Q+   LG GS+G V++  S +DG  +AVK 
Sbjct: 32  SFRGEASETLQSPGYD--PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89

Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 233
                +G + +     L +  +     +H   V+     ++   LY+  EL    SL   
Sbjct: 90  SMSPFRGPKDRARK--LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQH 146

Query: 234 YQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 291
            + +   L ++QV  Y R  LL L +LH Q +VH D+K ANI +   G  KL DFGL   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206

Query: 292 -TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
                  +   G   +MAPE++      YG  AD++SLG T+LE+  +       E    
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263

Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L +     PP     LS + +  +   ++ +P  R TA  LL  P +++
Sbjct: 264 LRQG--YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  309 bits (792), Expect = e-102
 Identities = 70/303 (23%), Positives = 133/303 (43%), Gaps = 23/303 (7%)

Query: 115 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 174
             +     T  +  ++ S N         +     +G G    V++ +++    +A+K V
Sbjct: 29  HMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 88

Query: 175 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 232
           +L        Q++     EIA L++ +   + I++ Y  +  +  +Y+ +E      L +
Sbjct: 89  NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 144

Query: 233 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 291
            L ++  +   +  +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A  
Sbjct: 145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203

Query: 292 ----TKLNDVKSCRGTAFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTS 338
               T      S  G   +M PE I + +               +D+WSLGC +  M   
Sbjct: 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

Query: 339 QIPYA-PMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           + P+   +  ++ L  I   +     PD   KD QD +K C++ +P  R +  +LL HP+
Sbjct: 264 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

Query: 397 VKR 399
           V+ 
Sbjct: 324 VQI 326

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  295 bits (757), Expect = 2e-98
 Identities = 84/291 (28%), Positives = 139/291 (47%), Gaps = 16/291 (5%)

Query: 120 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD 178
                 +P   + P+  +  +  + +    +GRG F  VY      DG   A+K+V + D
Sbjct: 11  PPVPQFQPQKALRPDMGYNTLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69

Query: 179 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY- 237
                 ++ +   +EI LL +  H N+++YY +  ++++L I LEL   G L  + + + 
Sbjct: 70  LMDA--KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127

Query: 238 ----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-- 291
                + +  V  Y  Q+   L+++H + V+HRDIK AN+ + A G VKL D GL +   
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187

Query: 292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA--PMECMA 349
           +K     S  GT ++M+PE I     GY   +DIWSLGC + EM   Q P+    M   +
Sbjct: 188 SKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245

Query: 350 ALFKIGRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
              KI +   PP+P D  S++ +  +  C+  +P  RP    + D      
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  293 bits (752), Expect = 3e-97
 Identities = 71/287 (24%), Positives = 132/287 (45%), Gaps = 29/287 (10%)

Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 190
           IS  GR       +     +G G    V++ +++    +A+K V+L        Q++   
Sbjct: 4   ISVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSY 54

Query: 191 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 247
             EIA L++ +   + I++ Y  +  +  +Y+ +E      L + L ++  +   +  +Y
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 113

Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGT 303
            + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +       S  GT
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 304 AFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTSQIPYA-PMECMAALFK 353
             +M PE I + +               +D+WSLGC +  M   + P+   +  ++ L  
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232

Query: 354 IGRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           I   +     PD   KD QD +K C++ +P  R +  +LL HP+V+ 
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  291 bits (748), Expect = 5e-97
 Identities = 72/303 (23%), Positives = 134/303 (44%), Gaps = 24/303 (7%)

Query: 115 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 174
            H    SS       N+       +   Y      +G G    V++ +++    +A+K V
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSVKGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60

Query: 175 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 232
           +L        Q++     EIA L++ +   + I++ Y  +  +  +Y+ +E      L +
Sbjct: 61  NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116

Query: 233 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 291
            L ++  +   +  +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A  
Sbjct: 117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175

Query: 292 TKLNDV----KSCRGTAFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTS 338
            + +       S  GT  +M PE I + +               +D+WSLGC +  M   
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

Query: 339 QIPYA-PMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
           + P+   +  ++ L  I   +     PD   KD QD +K C++ +P  R +  +LL HP+
Sbjct: 236 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

Query: 397 VKR 399
           V+ 
Sbjct: 296 VQI 298

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  285 bits (731), Expect = 5e-94
 Identities = 83/283 (29%), Positives = 151/283 (53%), Gaps = 12/283 (4%)

Query: 125 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 183
           +  +   + N  F+ +  Y  +   +G GSFG      S +DG  + +KE+++    S+ 
Sbjct: 8   SSGVDLGTENLYFQSMEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 184 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLR 240
           ++      +E+A+L+  +H NIVQY  + ++   LYI ++    G L   +N  +    +
Sbjct: 67  REES---RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123

Query: 241 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K 298
           + Q+  +  QI L LK++HD+ ++HRDIK  NI +  +G+V+L DFG+A+         +
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183

Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS 358
           +C GT ++++PE+   +NK Y   +DIW+LGC + E+ T +  +        + KI  GS
Sbjct: 184 ACIGTPYYLSPEIC--ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS 241

Query: 359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
            PP+    S D +  + Q  + NP DRP+   +L+  F+ + +
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  279 bits (717), Expect = 1e-92
 Identities = 105/290 (36%), Positives = 162/290 (55%), Gaps = 20/290 (6%)

Query: 115 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 173
            H    S           P   F ++       + +G+GSFG V++GI        A+K 
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKL-------EKIGKGSFGEVFKGIDNRTQKVVAIKI 54

Query: 174 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 233
           + L     +A+  I  ++QEI +LS+ +   + +YYG+   ++KL+I +E +  GS L+L
Sbjct: 55  IDL----EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 110

Query: 234 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 293
            +   L ++Q++   R+IL GL YLH +  +HRDIK AN+L+  +G VKLADFG+  A +
Sbjct: 111 LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV--AGQ 168

Query: 294 LNDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA 349
           L D +  R    GT FWMAPEVI  K   Y   ADIWSLG T +E+   + P++ +  M 
Sbjct: 169 LTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

Query: 350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            LF I + +PP +  + SK  ++F++ C+   P+ RPTA +LL H F+ R
Sbjct: 227 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  273 bits (700), Expect = 6e-90
 Identities = 90/268 (33%), Positives = 141/268 (52%), Gaps = 19/268 (7%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W+    LG G+FG VY+  + + G   A K +       ++++ +     EI +L+  +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDH 75

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 260
             IV+  G    + KL+I +E    G++  +       L + Q+    RQ+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI---N 313
           + ++HRD+K  N+L+   G ++LADFG+  + K       R    GT +WMAPEV+    
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGV--SAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQ 371
            K+  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           DF+K  +  NP  RP+AAQLL+HPFV  
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSS 281

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  268 bits (686), Expect = 7e-88
 Identities = 84/265 (31%), Positives = 142/265 (53%), Gaps = 16/265 (6%)

Query: 142 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
             + + + +G+G+ G+VY  +    G   A+++++L  Q          +  EI ++   
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMREN 74

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
           ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH 
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKN 316
             V+HRDIK  NIL+  +GSVKL DFG     ++   +S R    GT +WMAPEV+    
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSTMVGTPYWMAPEVV--TR 190

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFI 374
           K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250

Query: 375 KQCVQVNPNDRPTAAQLLDHPFVKR 399
            +C++++   R +A +LL H F+K 
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFLKI 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  267 bits (684), Expect = 2e-87
 Identities = 99/267 (37%), Positives = 151/267 (56%), Gaps = 20/267 (7%)

Query: 142 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
             +   + LG GS+GSVY+ I  + G   A+K+V +          + ++ +EI+++ + 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQC 81

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYL 258
           +  ++V+YYG+    + L+I +E    GS+ ++ +  +  L + +++   +  L GL+YL
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINN 314
           H    +HRDIK  NIL++  G  KLADFG+  A +L D  + R    GT FWMAPEVI  
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGV--AGQLTDTMAKRNTVIGTPFWMAPEVI-- 197

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQD 372
           +  GY   ADIWSLG T +EM   + PYA +  M A+F I    PP    P+  S +  D
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           F+KQC+  +P  R TA QLL HPFV+ 
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRS 284

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  267 bits (684), Expect = 2e-87
 Identities = 83/285 (29%), Positives = 140/285 (49%), Gaps = 22/285 (7%)

Query: 128 MSNISPNGRFKRIIT------YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 180
           +++       + ++              +G GS G V        G   AVK + L  Q 
Sbjct: 25  VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ- 83

Query: 181 SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 240
               Q    L  E+ ++  ++H N+V+ Y +     +L++ +E +  G+L ++  +  L 
Sbjct: 84  ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN 139

Query: 241 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 300
           + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG     +++     
Sbjct: 140 EEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF--CAQISKDVPK 197

Query: 301 R----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR 356
           R    GT +WMAPEVI      Y    DIWSLG  V+EM+  + PY     + A+ ++  
Sbjct: 198 RKSLVGTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD 255

Query: 357 GSPPPI--PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             PP +     +S   +DF+++ +  +P +R TA +LLDHPF+ +
Sbjct: 256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  267 bits (684), Expect = 5e-87
 Identities = 90/280 (32%), Positives = 138/280 (49%), Gaps = 17/280 (6%)

Query: 125 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 183
            E      P   F  +         +G GSFG+VY      +    A+K++S   +  Q+
Sbjct: 44  AELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QS 94

Query: 184 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRD 241
            +    + +E+  L +  H N +QY G    E   ++ +E    GS  +L + +   L++
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 153

Query: 242 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 301
            +++A T   L GL YLH  +++HRD+K  NIL+   G VKL DFG   A+ +    S  
Sbjct: 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS--ASIMAPANSFV 211

Query: 302 GTAFWMAPEVI-NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 360
           GT +WMAPEVI       Y    D+WSLG T +E+   + P   M  M+AL+ I +   P
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 271

Query: 361 PI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            +     S+  ++F+  C+Q  P DRPT+  LL H FV R
Sbjct: 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  268 bits (688), Expect = 1e-86
 Identities = 74/310 (23%), Positives = 130/310 (41%), Gaps = 39/310 (12%)

Query: 106 LSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 165
           +  S S   +  D+ +S            G+       +   D+LG G+ G++      D
Sbjct: 1   MGSSPSLEQDDGDEETSVVIV--------GKIS-----FCPKDVLGHGAEGTIVYRGMFD 47

Query: 166 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLEL 224
               AVK +          +  S  ++E+ LL    EH N+++Y+ T+KD    YI +EL
Sbjct: 48  NRDVAVKRIL--------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99

Query: 225 VTKGSLLNLYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGS-- 280
               +L    ++       +   T  +Q   GL +LH  ++VHRD+K  NIL+    +  
Sbjct: 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158

Query: 281 ---VKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCT 331
                ++DFGL K         +      GT  W+APE+++ +  +      DI+S GC 
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218

Query: 332 VLEMLTS-QIPYAPMECMAALFKIGRGS--PPPIPDSLSKDAQDFIKQCVQVNPNDRPTA 388
              +++    P+       A   +G  S             A++ I++ + ++P  RP+A
Sbjct: 219 FYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA 278

Query: 389 AQLLDHPFVK 398
             +L HPF  
Sbjct: 279 KHVLKHPFFW 288

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  264 bits (677), Expect = 3e-86
 Identities = 96/299 (32%), Positives = 147/299 (49%), Gaps = 35/299 (11%)

Query: 128 MSNISPNGRFKRII--------TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 178
           M++ SP      I           ++  +L+G G++G VY+G     G   A+K + +  
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-- 59

Query: 179 QGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDESKLYIFLELVTKGSLL 231
                     +++QEI +L ++  H NI  YYG          + +L++ +E    GS+ 
Sbjct: 60  ----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 232 NLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 288
           +L +      L++  ++   R+IL GL +LH   V+HRDIK  N+L+  N  VKL DFG+
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 289 AKATKLNDVKSCR----GTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIP 341
             + +L+     R    GT +WMAPEVI    N +  Y   +D+WSLG T +EM     P
Sbjct: 176 --SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

Query: 342 YAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
              M  M ALF I R   P +     SK  Q FI+ C+  N + RP   QL+ HPF++ 
Sbjct: 234 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  260 bits (666), Expect = 7e-85
 Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 44/296 (14%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R  + +++  +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLL 56

Query: 198 SRFEHENIVQYYGTDKDE-------------SKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           +   H+ +V+YY    +              S L+I +E    G+L +L    +L   + 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 245 SA--YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------------ 290
                 RQIL  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK            
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 291 ----ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 346
                   +++ S  GTA ++A EV++     Y    D++SLG    EM+        ME
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 347 CMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
            +  L K+   S   PP   D+  K  +  I+  +  +PN RP A  LL+  ++  
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  259 bits (663), Expect = 1e-84
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           ++ +L+G G FG V++     DG  + +K V   ++         + E+E+  L++ +H 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHV 64

Query: 204 NIVQYYG----------------TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQV 244
           NIV Y G                +      L+I +E   KG+L    ++     L     
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT 303
                QI  G+ Y+H + +++RD+K +NI +     VK+ DFGL  + K +      +GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
             +M+PE I   ++ YG   D+++LG  + E+L   +     E  +  F   R     I 
Sbjct: 185 LRYMSPEQI--SSQDYGKEVDLYALGLILAELLH--VCDTAFE-TSKFFTDLR--DGIIS 237

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           D   K  +  +++ +   P DRP  +++L    V +
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  258 bits (661), Expect = 4e-84
 Identities = 88/298 (29%), Positives = 145/298 (48%), Gaps = 31/298 (10%)

Query: 128 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 186
           MS  S    +      ++  +++G G+   V            A+K ++L     + + S
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTS 56

Query: 187 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------- 238
           + +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS+L++ +           
Sbjct: 57  MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116

Query: 239 -LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKL 294
            L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GSV++ADFG++        
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 295 NDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 350
                 R    GT  WMAPEV+  + +GY   ADIWS G T +E+ T   PY     M  
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235

Query: 351 LFKIGRGSPPPIPDS---------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           L    +  PP +              K  +  I  C+Q +P  RPTAA+LL H F ++
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  254 bits (650), Expect = 1e-82
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 22/271 (8%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +    +G GS+G   +     DG     KE+         KQ    L  E+ LL   +H 
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ---MLVSEVNLLRELKHP 65

Query: 204 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLK 256
           NIV+YY    D+  + LYI +E    G L ++  +      +L +  V     Q+ L LK
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 257 YLHDQ-----DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 309
             H +      V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPIPDSLSK 368
           E +      Y   +DIWSLGC + E+     P+        L  KI  G    IP   S 
Sbjct: 186 EQM--NRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYSD 242

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +  + I + + +    RP+  ++L++P +  
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  253 bits (648), Expect = 4e-82
 Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 39/287 (13%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +    LGRG FG V+E  +  D   +A+K + L       + +  ++ +E+  L++ EH 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63

Query: 204 NIVQYYGTDKDESK------------LYIFLELVTKGSLLNLYQR----YHLRDSQVSAY 247
            IV+Y+    +++             LYI ++L  K +L +             S     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------------TK 293
             QI   +++LH + ++HRD+K +NI    +  VK+ DFGL  A                
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 353
                   GT  +M+PE I+     Y    DI+SLG  + E+L        ME +  L  
Sbjct: 184 YARHTGQVGTKLYMSPEQIH--GNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239

Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           +     PP+           ++  +  +P +RP A  ++++   + L
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  252 bits (645), Expect = 1e-80
 Identities = 71/344 (20%), Positives = 136/344 (39%), Gaps = 69/344 (20%)

Query: 116 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRG--SFGSVYEGI-SDDGFFFAVK 172
           H     +   + MS+  P G        ++   ++G+G     +V        G +  V+
Sbjct: 5   HHHHMENLYFQGMSSFLPEG------GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58

Query: 173 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 232
            ++L    + + + ++ L+ E+ +   F H NIV Y  T   +++L++    +  GS  +
Sbjct: 59  RINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 115

Query: 233 LYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 289
           L   +    + +  ++   + +L  L Y+H    VHR +K ++IL+  +G V L+     
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175

Query: 290 ---------KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
                    +    +  K       W++PEV+    +GY   +DI+S+G T  E+    +
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

Query: 341 PYAPMECMAALFKIGRGSPP---------------------------------------- 360
           P+  M     L +   G+ P                                        
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295

Query: 361 -----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                P   + S     F++QC+Q NP+ RP+A+ LL+H F K+
Sbjct: 296 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  243 bits (622), Expect = 6e-78
 Identities = 80/297 (26%), Positives = 143/297 (48%), Gaps = 26/297 (8%)

Query: 122 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 180
           S  +     ISP   +       +    +GRG++GSV + +    G   AVK +      
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---- 57

Query: 181 SQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 238
           +  ++   QL  ++  ++   +   IVQ+YG    E   +I +EL++  S    Y+  + 
Sbjct: 58  TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116

Query: 239 -----LRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKAT 292
                + +  +   T   +  L +L +   ++HRDIK +NIL+D +G++KL DFG++   
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS--G 174

Query: 293 KLNDVKSCR---GTAFWMAPEVIN--NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 347
           +L D  +     G   +MAPE I+     +GY + +D+WSLG T+ E+ T + PY     
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

Query: 348 M-AALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +   L ++ +G PP + +S     S    +F+  C+  + + RP   +LL HPF+  
Sbjct: 235 VFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  239 bits (612), Expect = 6e-77
 Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 22/271 (8%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFE 201
            +    LGRG++G V +      G   AVK +      +   Q   +L  ++   +   +
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVD 64

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-----SQVSAYTRQILLGLK 256
               V +YG    E  ++I +EL+   SL   Y++   +        +      I+  L+
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 257 YLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVI 312
           +LH +  V+HRD+K +N+L++A G VK+ DFG++    L D  +     G   +MAPE I
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERI 181

Query: 313 NN--KNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIP-DSLSK 368
           N     KGY + +DIWSLG T++E+   + PY         L ++     P +P D  S 
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +  DF  QC++ N  +RPT  +L+ HPF   
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  237 bits (607), Expect = 7e-76
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 21/264 (7%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQ 207
           +G G+ G V++      G   AVK++      S  K+   ++  ++  +L   +   IVQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRR----SGNKEENKRILMDLDVVLKSHDCPYIVQ 88

Query: 208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQ-DVV 264
            +GT    + ++I +EL+       L +R    + +  +   T  I+  L YL ++  V+
Sbjct: 89  CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVIN---NKNKG 318
           HRD+K +NIL+D  G +KL DFG++   +L D K+     G A +MAPE I+        
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPDSL--SKDAQDFIK 375
           Y + AD+WSLG +++E+ T Q PY   +     L K+ +  PP +P  +  S D Q F+K
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 376 QCVQVNPNDRPTAAQLLDHPFVKR 399
            C+  +   RP   +LL+H F+KR
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKR 289

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  226 bits (577), Expect = 7e-71
 Identities = 78/304 (25%), Positives = 138/304 (45%), Gaps = 56/304 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K   LG G+ G V++      G   A K + L           +Q+ +E+ +L     
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 90

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQ 261
             IV +YG    + ++ I +E +  GSL  + ++   + +  +   +  ++ GL YL ++
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 262 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKG 318
             ++HRD+K +NILV++ G +KL DFG+  + +L D    S  GT  +M+PE +  +   
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERL--QGTH 206

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAP---------------------------------- 344
           Y + +DIWS+G +++EM   + P  P                                  
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 345 ----MECMAALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHP 395
                    A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 396 FVKR 399
           F+KR
Sbjct: 327 FIKR 330

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  223 bits (570), Expect = 1e-70
 Identities = 78/273 (28%), Positives = 140/273 (51%), Gaps = 16/273 (5%)

Query: 135 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLE 191
                 I  ++ G+LLG+GSF  VY   S   G   A+K +    + +    ++    ++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----VQ 59

Query: 192 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTR 249
            E+ +  + +H +I++ Y   +D + +Y+ LE+   G +    +       +++   +  
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFW 306
           QI+ G+ YLH   ++HRD+  +N+L+  N ++K+ADFGLA   K+   K    C GT  +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNY 178

Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           ++PE+       +GL +D+WSLGC    +L  + P+        L K+       +P  L
Sbjct: 179 ISPEIAT--RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFL 235

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           S +A+D I Q ++ NP DR + + +LDHPF+ R
Sbjct: 236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  221 bits (566), Expect = 7e-70
 Identities = 81/269 (30%), Positives = 137/269 (50%), Gaps = 16/269 (5%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEI 194
           +    Y  +G  LG+G F   +E    D    FA K V  SLL +  Q ++    +  EI
Sbjct: 12  RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEI 66

Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
           ++     H+++V ++G  +D   +++ LEL  + SLL    +R  L + +   Y RQI+L
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPE 310
           G +YLH   V+HRD+K  N+ ++ +  VK+ DFGLA   + +  +    C GT  ++APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 185

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 370
           V++   KG+    D+WS+GC +  +L  + P+          +I +     IP  ++  A
Sbjct: 186 VLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVA 242

Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
              I++ +Q +P  RPT  +LL+  F   
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTS 271

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  222 bits (567), Expect = 2e-69
 Identities = 83/287 (28%), Positives = 140/287 (48%), Gaps = 15/287 (5%)

Query: 120 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SL 176
            +     P   I       R    + +G  LG+G F   +E    D    FA K V  SL
Sbjct: 19  GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78

Query: 177 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 235
           L +  Q ++    +  EI++     H+++V ++G  +D   +++ LEL  + SLL    +
Sbjct: 79  LLKPHQREK----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 134

Query: 236 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 295
           R  L + +   Y RQI+LG +YLH   V+HRD+K  N+ ++ +  VK+ DFGLA   + +
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194

Query: 296 DVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 352
             +    C GT  ++APEV++   KG+    D+WS+GC +  +L  + P+          
Sbjct: 195 GERKKVLC-GTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251

Query: 353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +I +     IP  ++  A   I++ +Q +P  RPT  +LL+  F   
Sbjct: 252 RIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  221 bits (564), Expect = 2e-69
 Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 29/279 (10%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
                LG G F  V       DG F+A+K +   +     +Q   + ++E  +   F H 
Sbjct: 32  LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHP 86

Query: 204 NIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLG 254
           NI++           + + ++ L    +G+L N  +R       L + Q+      I  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-----------KATKLNDVKSCRGT 303
           L+ +H +   HRD+K  NIL+   G   L D G             +A  L D  + R T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 304 AFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPP 360
             + APE+ + + +       D+WSLGC +  M+  + PY     +  +    +      
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           P     S      +   + V+P+ RP    LL      +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  223 bits (571), Expect = 5e-69
 Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 50/310 (16%)

Query: 129 SNISPNGRFKRIIT-YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 187
           S I+    F++ +        +LG GS G+V    S  G   AVK +             
Sbjct: 1   SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFC 52

Query: 188 SQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 246
                EI LL+   +H N+++YY ++  +  LYI LEL    +L +L +  ++ D  +  
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111

Query: 247 YT--------RQILLGLKYLHDQDVVHRDIKCANILVD-------------ANGSVKLAD 285
                     RQI  G+ +LH   ++HRD+K  NILV               N  + ++D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171

Query: 286 FGLAK------ATKLNDVKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLE 334
           FGL K      ++   ++ +  GT+ W APE++   N     +      DI+S+GC    
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231

Query: 335 MLTSQIP--YAPMECMAALFKIGRGS----PPPIPDSLSKDAQDFIKQCVQVNPNDRPTA 388
           +L+             + + + G  S          SL  +A D I Q +  +P  RPTA
Sbjct: 232 ILSKGKHPFGDKYSRESNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290

Query: 389 AQLLDHPFVK 398
            ++L HP   
Sbjct: 291 MKVLRHPLFW 300

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  215 bits (550), Expect = 9e-68
 Identities = 75/256 (29%), Positives = 127/256 (49%), Gaps = 9/256 (3%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G  LG+G FG+VY        F  A+K V    Q  +A     QL +E+ + S   H NI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGV-EHQLRREVEIQSHLRHPNI 71

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVV 264
           ++ YG   D +++Y+ LE    G++    Q+     + + + Y  ++   L Y H + V+
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGLPA 323
           HRDIK  N+L+ + G +K+ADFG +     +     C GT  ++ PE+I    + +    
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-GTLDYLPPEMIE--GRMHDEKV 188

Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 383
           D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPS 247

Query: 384 DRPTAAQLLDHPFVKR 399
            RP   ++L+HP++  
Sbjct: 248 QRPMLREVLEHPWITA 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  210 bits (537), Expect = 5e-65
 Identities = 70/323 (21%), Positives = 132/323 (40%), Gaps = 43/323 (13%)

Query: 117 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS- 175
           +D  S+ +     N     +  + I  ++    L +G F  +      D  F+A+K+   
Sbjct: 7   KDILSNYSNLIYLNKYVKEK-DKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEK 64

Query: 176 -----------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 224
                        +     K      + E+ +++  ++E  +   G   +  ++YI  E 
Sbjct: 65  SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124

Query: 225 VTKGSL---------LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANIL 274
           +   S+         L+      +    +    + +L    Y+H++ ++ HRD+K +NIL
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184

Query: 275 VDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 334
           +D NG VKL+DFG ++      +K  RGT  +M PE  +N++   G   DIWSLG  +  
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244

Query: 335 MLTSQIPYAPMECMAALF-KIGRG------------------SPPPIPDSLSKDAQDFIK 375
           M  + +P++    +  LF  I                           + LS +  DF+K
Sbjct: 245 MFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK 304

Query: 376 QCVQVNPNDRPTAAQLLDHPFVK 398
             ++ NP +R T+   L H ++ 
Sbjct: 305 LFLRKNPAERITSEDALKHEWLA 327

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  211 bits (538), Expect = 7e-65
 Identities = 51/382 (13%), Positives = 114/382 (29%), Gaps = 53/382 (13%)

Query: 74  RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP 133
              SS  ++   +  G+     +        V + S    +  +   S++          
Sbjct: 5   HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64

Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
                       +G +LG+    +  E    + G  F V      ++      +I Q+++
Sbjct: 65  ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKE 122

Query: 193 EIALLSRF-------------------------EHENIVQYYGTDKDESKLYIFLEL-VT 226
           E+  L                            + + +++    ++D   L  F      
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182

Query: 227 KGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 278
           + +L                L        T Q++  L  LH   +VH  ++  +I++D  
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242

Query: 279 GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLG 329
           G V L  F      +         +  +  PE+   +                 D W+LG
Sbjct: 243 GGVFLTGFEHLV--RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300

Query: 330 CTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 389
             +  +  + +P      +     I R        ++ +  +  ++  ++    DR    
Sbjct: 301 LVIYWIWCADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 390 QLLDHPFVKRLLATNSGSASPY 411
           Q ++ P  ++L    S +   Y
Sbjct: 356 QAMETPEYEQLRTELSAALPLY 377

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  206 bits (526), Expect = 3e-64
 Identities = 73/260 (28%), Positives = 120/260 (46%), Gaps = 16/260 (6%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
            +++G G FG VY      G   AVK  +  D      Q+I  + QE  L +  +H NI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DV 263
              G    E  L + +E    G L  +     +    +  +  QI  G+ YLHD+    +
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 264 VHRDIKCANILVD--------ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 315
           +HRD+K +NIL+         +N  +K+ DFGLA+        S  G   WMAPEVI   
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRAS 189

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+LT ++P+  ++ +A  + +       PIP +  +     +
Sbjct: 190 M--FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247

Query: 375 KQCVQVNPNDRPTAAQLLDH 394
           + C   +P+ RP+   +LD 
Sbjct: 248 EDCWNPDPHSRPSFTNILDQ 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  210 bits (536), Expect = 5e-64
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 17/267 (6%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 202
              LG G+ G V            A++ +S        ++       +E EI +L +  H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             I++      D    YI LEL+  G L + +     L+++    Y  Q+LL ++YLH+ 
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258

Query: 262 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKN 316
            ++HRD+K  N+L+   + +  +K+ DFG +K      +    C GT  ++APEV+ +  
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 317

Query: 317 -KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQ 371
             GY    D WSLG  +   L+   P++      +L  +I  G     P +   +S+ A 
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           D +K+ + V+P  R T  + L HP+++
Sbjct: 378 DLVKKLLVVDPKARFTTEEALRHPWLQ 404

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  205 bits (524), Expect = 7e-64
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 13/258 (5%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           G  LG+G FG+VY      + F  A+K +  S L++     Q    L +EI + S   H 
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHP 74

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 262
           NI++ Y    D  ++Y+ LE   +G L    Q++    + + + +  ++   L Y H++ 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGL 321
           V+HRDIK  N+L+   G +K+ADFG +        +  C GT  ++ PE+I    K +  
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-GTLDYLPPEMIE--GKTHDE 191

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D+W  G    E L    P+          +I        P  LS  ++D I + ++ +
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKLLRYH 250

Query: 382 PNDRPTAAQLLDHPFVKR 399
           P  R     +++HP+VK 
Sbjct: 251 PPQRLPLKGVMEHPWVKA 268

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  204 bits (522), Expect = 3e-63
 Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 34/299 (11%)

Query: 132 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------------- 175
           S +      +  +   D +G+GS+G V    + +D  ++A+K +S               
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 176 ------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTK 227
                       Q +  I Q+ QEIA+L + +H N+V+      D +E  LY+  ELV +
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 228 GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 287
           G ++ +     L + Q   Y + ++ G++YLH Q ++HRDIK +N+LV  +G +K+ADFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 288 LAKATKLNDV---KSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYA 343
           ++   K +D     +  GT  +MAPE ++   K + G   D+W++G T+   +  Q P+ 
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 344 PMECMAALF-KIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             E +  L  KI        PD   +++D +D I + +  NP  R    ++  HP+V R
Sbjct: 242 D-ERIMCLHSKIKSQ-ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  205 bits (523), Expect = 5e-63
 Identities = 77/339 (22%), Positives = 130/339 (38%), Gaps = 59/339 (17%)

Query: 116 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 174
           H     S+  E +      G    +   +     +G+GS+G V   I        A+K +
Sbjct: 2   HHHHHHSSGRENL--YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM 59

Query: 175 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--- 231
           +         + + +++ E+ L+ +  H NI + Y   +DE  + + +EL   G LL   
Sbjct: 60  NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119

Query: 232 --------------------------------------NLYQRYHLRDSQVSAYTRQILL 253
                                                      +  R+  +S   RQI  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 254 GLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSCR------GTAF 305
            L YLH+Q + HRDIK  N L   + +  +KL DFGL+K     +           GT +
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGS---PP 360
           ++APEV+N  N+ YG   D WS G  +  +L   +P        A    ++         
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG--VNDADTISQVLNKKLCFEN 297

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           P  + LS  A+D +   +  N ++R  A + L HP++ +
Sbjct: 298 PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (518), Expect = 1e-62
 Identities = 77/258 (29%), Positives = 129/258 (50%), Gaps = 17/258 (6%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
            + +G GSFG+V+      G   AVK   +L +     + +++  +E+A++ R  H NIV
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
            + G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 263 --VVHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEVINNKNKG 318
             +VHR++K  N+LVD   +VK+ DFGL+  KA+     KS  GT  WMAPEV+ ++   
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-- 215

Query: 319 YGLPADIWSLGCTVL-EMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQ 376
               +D++S G  +L E+ T Q P+  +     +  +G       IP +L+      I+ 
Sbjct: 216 SNEKSDVYSFG-VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274

Query: 377 CVQVNPNDRPTAAQLLDH 394
           C    P  RP+ A ++D 
Sbjct: 275 CWTNEPWKRPSFATIMDL 292

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  203 bits (519), Expect = 2e-62
 Identities = 67/334 (20%), Positives = 120/334 (35%), Gaps = 76/334 (22%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK----------------EVSLLDQ-- 179
           R +T ++    +GRG FG V+E  +  D   +A+K                EV  L +  
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 180 -----------------------------------GSQAKQSISQLEQEIALLSRFEHEN 204
                                                 +   +     +I  +  F  +N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQILLGLKYLHD 260
            V        +  LYI ++L  K +L +   R    +            QI   +++LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--------------GTAFW 306
           + ++HRD+K +NI    +  VK+ DFGL  A   ++ +                 GT  +
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           M+PE I+  N  Y    DI+SLG  + E+L S      ME +  +  +     P +    
Sbjct: 243 MSPEQIHGNN--YSHKVDIFSLGLILFELLYS--FSTQMERVRIITDVRNLKFPLLFTQK 298

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                  ++  +  +P +RP A  ++++   + L
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (514), Expect = 3e-62
 Identities = 65/266 (24%), Positives = 118/266 (44%), Gaps = 24/266 (9%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 203
              +G+G FG V++G    D    A+K +     +  ++  +   + ++E+ ++S   H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR-----QILLGLKYL 258
           NIV+ YG   +     + +E V  G L   Y R   +   +    +      I LG++Y+
Sbjct: 84  NIVKLYGLMHN--PPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 259 HDQD--VVHRDIKCANILVDANG-----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 311
            +Q+  +VHRD++  NI + +         K+ADFGL++   ++ V    G   WMAPE 
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPET 197

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG---RGSPPPIPDSLSK 368
           I  + + Y   AD +S    +  +LT + P+         F       G  P IP+    
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP 257

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDH 394
             ++ I+ C   +P  RP  + ++  
Sbjct: 258 RLRNVIELCWSGDPKKRPHFSYIVKE 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  201 bits (513), Expect = 3e-62
 Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 22/262 (8%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G  +G GSFG+VY+G    D    AVK   +L+  +   Q +   + E+ +L +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           + + G      +L I  +     SL +            ++    RQ   G+ YLH + +
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVINNKNKG- 318
           +HRD+K  NI +  + +VK+ DFGLA         +  +   G+  WMAPEVI  ++   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 319 YGLPADIWSLGCTVL-EMLTSQIPYAPMECM-AALFKIGRG----SPPPIPDSLSKDAQD 372
           Y   +D+++ G  VL E++T Q+PY+ +      +  +GRG        +  +  K  + 
Sbjct: 202 YSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260

Query: 373 FIKQCVQVNPNDRPTAAQLLDH 394
            + +C++   ++RP+  ++L  
Sbjct: 261 LMAECLKKKRDERPSFPRILAE 282

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  201 bits (514), Expect = 5e-62
 Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 50/299 (16%)

Query: 143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
            W   D+LG+G+  +V+ G     G  FA+K  +         + +    +E  +L +  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65

Query: 202 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 255
           H+NIV+ +    +       + +E    GSL   L +    Y L +S+     R ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 256 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 310
            +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 311 VINNK------NKGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPP 360
           +           K YG   D+WS+G T     T  +P+     P      ++KI  G P 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 361 --------------------PIPDSLSKDAQD----FIKQCVQVNPNDRPTAAQLLDHP 395
                               P+  SLS+  Q      +   ++ +        Q     
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  202 bits (516), Expect = 1e-61
 Identities = 40/342 (11%), Positives = 93/342 (27%), Gaps = 47/342 (13%)

Query: 113 TTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAV 171
                +  ++T     +  + +    +     +  + L  G    V+     +    FA+
Sbjct: 33  PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92

Query: 172 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-------------------- 211
           K          ++  + +L +     +R   E+  +                        
Sbjct: 93  K--VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150

Query: 212 ------DKDESKLYIFLELVTKGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKY 257
                 D   +   + +       L  L+         R       +   T Q++     
Sbjct: 151 LSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 317
           L  + +VH      N+ +  +G + L D             +      +   E +N    
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-TRGPASSVPVTYAPREFLNASTA 268

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKIGRGSPP-PIPDSLSKD 369
            +    + W LG ++  +    +P+  +           +L   G  S        L   
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPY 411
            +  I + +  +   R    + ++ P   +L    S S S  
Sbjct: 329 VKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTG 370

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  200 bits (511), Expect = 2e-61
 Identities = 65/282 (23%), Positives = 125/282 (44%), Gaps = 27/282 (9%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G+L+G+G FG VY G    +    A++   L+D     +  +   ++E+    +  HEN+
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           V + G       L I   L    +L ++    +  L  ++     ++I+ G+ YLH + +
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 264 VHRDIKCANILVDANGSVKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVINNKN 316
           +H+D+K  N+  D NG V + DFGL           + + ++   G    +APE+I   +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 317 KGYGLP-------ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSK 368
                        +D+++LG    E+   + P+      A ++++G G  P      + K
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 410
           +  D +  C      +RPT  +L+D   +++L   N   + P
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDM--LEKLPKRNRRLSHP 310

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  200 bits (511), Expect = 2e-61
 Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 17/267 (6%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 202
              LG G+ G V            A+K +S        ++       +E EI +L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             I++      D    YI LEL+  G L + +     L+++    Y  Q+LL ++YLH+ 
Sbjct: 75  PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133

Query: 262 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKN 316
            ++HRD+K  N+L+   + +  +K+ DFG +K      +    C GT  ++APEV+ +  
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 192

Query: 317 K-GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQ 371
             GY    D WSLG  +   L+   P++      +L  +I  G     P +   +S+ A 
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           D +K+ + V+P  R T  + L HP+++
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQ 279

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  198 bits (505), Expect = 5e-61
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 28/290 (9%)

Query: 124 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 182
            +    N+   G        +     LG G+FG V+       G    +K ++      +
Sbjct: 7   HSSGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINK----DR 59

Query: 183 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRY 237
           ++  + Q+E EI +L   +H NI++ +   +D   +YI +E    G LL        +  
Sbjct: 60  SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119

Query: 238 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKL 294
            L +  V+   +Q++  L Y H Q VVH+D+K  NIL      +  +K+ DFGLA+  K 
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

Query: 295 NDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAAL 351
           ++   +  GTA +MAPEV     +      DIWS G  V+  L +              +
Sbjct: 180 DEHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGV-VMYFLLTGCLPFTGTSL--EEV 233

Query: 352 F-KIGRGSP--PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             K     P        L+  A D +KQ +  +P  RP+AAQ+L H + K
Sbjct: 234 QQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  196 bits (501), Expect = 3e-60
 Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 21/270 (7%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            ++LG G+F  V+       G  FA+K +             S LE EIA+L + +HENI
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-----KSPAFRDSSLENEIAVLKKIKHENI 68

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           V      +  +  Y+ ++LV+ G L + + +R    +   S   +Q+L  +KYLH+  +V
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 265 HRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           HRD+K  N+L    + N  + + DFGL+K  +   + +  GT  ++APEV+    K Y  
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL--AQKPYSK 186

Query: 322 PADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIK 375
             D WS+G  +  +L    P  Y   E  + LF KI  G      P  D +S+ A+DFI 
Sbjct: 187 AVDCWSIGV-ITYILLCGYPPFYEETE--SKLFEKIKEGYYEFESPFWDDISESAKDFIC 243

Query: 376 QCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
             ++ +PN+R T  + L HP++    A + 
Sbjct: 244 HLLEKDPNERYTCEKALSHPWIDGNTALHR 273

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  196 bits (501), Expect = 7e-60
 Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 30/284 (10%)

Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
           +  F +      K   LG GSF    + +       FAVK +S        K+  +  ++
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQK 54

Query: 193 EIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQ 250
           EI  L     H NIV+ +    D+   ++ +EL+  G L   + ++ H  +++ S   R+
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114

Query: 251 ILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVK---SCRGTA 304
           ++  + ++HD  VVHRD+K  N+L    + N  +K+ DFG A+    ++      C  T 
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173

Query: 305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP------YAPMECMAALF-KIGRG 357
            + APE++     GY    D+WSLG  +  ML+ Q+P               +  KI +G
Sbjct: 174 HYAAPELL--NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231

Query: 358 S---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                     ++S++A+D I+  + V+PN R   + L  + +++
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  200 bits (511), Expect = 1e-59
 Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 15/272 (5%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
              LG G++G V            A+K +      S +  S S+L +E+A+L   +H NI
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT---SVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           ++ Y   +D+   Y+ +E    G L + +  R    +   +   +Q+L G+ YLH  ++V
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 265 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 320
           HRD+K  N+L+   + +  +K+ DFGL+   +     K   GTA+++APEV+    K Y 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---KKYD 215

Query: 321 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQC 377
              D+WS+G  +  +L    P+        L K+ +G      P   ++S+ A+D IKQ 
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275

Query: 378 VQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 409
           +Q +   R +A Q L+HP++K + +       
Sbjct: 276 LQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  197 bits (502), Expect = 1e-59
 Identities = 85/369 (23%), Positives = 149/369 (40%), Gaps = 44/369 (11%)

Query: 71  MNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSN 130
           M+     SS  D    KE   A R I      +     +   +   +   S+        
Sbjct: 1   MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK 60

Query: 131 ISP----------------------NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGF 167
           ++                           K     +   D++GRG    V   +    G 
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 168 FFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLE 223
            FAVK +          Q ++      +E  +L +   H +I+    + +  S +++  +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 224 LVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 282
           L+ KG L + L ++  L + +  +  R +L  + +LH  ++VHRD+K  NIL+D N  ++
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240

Query: 283 LADFGLAKATKLNDV--KSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEML 336
           L+DFG +   +  +   + C GT  ++APE++       + GYG   D+W+ G  +L  L
Sbjct: 241 LSDFGFSCHLEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGV-ILFTL 298

Query: 337 TSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQ 390
            +  P  +   +    +   I  G      P  D  S   +D I + +QV+P  R TA Q
Sbjct: 299 LAGSPPFWHRRQ--ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356

Query: 391 LLDHPFVKR 399
            L HPF +R
Sbjct: 357 ALQHPFFER 365

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  194 bits (495), Expect = 3e-59
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 21/271 (7%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS----LLDQGSQAKQSISQLEQEIALLSR-F 200
            ++LGRG    V   I       +AVK +           + ++      +E+ +L +  
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 259
            H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVI----NN 314
             ++VHRD+K  NIL+D + ++KL DFG +      +  +   GT  ++APE+I    N+
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSK 368
            + GYG   D+WS G  ++  L +  P  +   +    +   I  G+     P  D  S 
Sbjct: 202 NHPGYGKEVDMWSTGV-IMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSD 258

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             +D + + + V P  R TA + L HPF ++
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  198 bits (505), Expect = 7e-59
 Identities = 76/286 (26%), Positives = 135/286 (47%), Gaps = 18/286 (6%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
                 ++   +LG+GSFG V        G   AVK +S   +  + K     L +E+ L
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK--RQVKQKTDKESLLREVQL 79

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 255
           L + +H NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139

Query: 256 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 311
            Y+H   +VHRD+K  N+L+     + ++++ DFGL+   + +   K   GTA+++APEV
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGS---PPPIPDSL 366
           ++     Y    D+WS G  +  +L+   P     E    +  K+ +G      P    +
Sbjct: 200 LH---GTYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKKV 254

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 412
           S+ A+D I++ +   P+ R +A   LDH +++           P L
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSL 300

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  192 bits (491), Expect = 8e-59
 Identities = 80/273 (29%), Positives = 140/273 (51%), Gaps = 21/273 (7%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
                 +    +LG+GSFG V +         +AVK   ++++ S   +  S + +E+ L
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVEL 74

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 255
           L + +H NI++ +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 256 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 311
            Y+H  ++VHRD+K  NIL+   + +  +K+ DFGL+   + N   K   GTA+++APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDS 365
           +      Y    D+WS G  +L +L S  P  Y   E    +  ++  G      P   +
Sbjct: 195 LR---GTYDEKCDVWSAGV-ILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRT 248

Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +S DA+D I++ +  +P+ R TA Q L+HP+++
Sbjct: 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  198 bits (506), Expect = 9e-59
 Identities = 73/296 (24%), Positives = 134/296 (45%), Gaps = 24/296 (8%)

Query: 136 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------LLDQGSQAKQS 186
           +  +I   + K   LG G++G V      +     A+K +           D     ++ 
Sbjct: 30  KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89

Query: 187 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVS 245
             ++  EI+LL   +H NI++ +   +D+   Y+  E    G L   +  R+   +   +
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149

Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCR 301
              +QIL G+ YLH  ++VHRDIK  NIL+   ++  ++K+ DFGL+     +   +   
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGSP 359
           GTA+++APEV+    K Y    D+WS G  +  +L    P     +    +  K+ +G  
Sbjct: 210 GTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEKGKY 264

Query: 360 ---PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 412
                   ++S +A++ IK  +  + N R TA + L+  ++K+     + S    L
Sbjct: 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTL 320

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  192 bits (490), Expect = 1e-58
 Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 20/264 (7%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            + LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           V+ + + ++ES  Y+  +LVT G L   +  R    ++  S   +QIL  + Y H   +V
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 265 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 320
           HR++K  N+L+       +VKLADFGLA     ++      GT  +++PEV+  K   Y 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYS 185

Query: 321 LPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFI 374
            P DIW+ G  +L +L    P  +   +    L+ +I  G+   P P  D+++ +A+  I
Sbjct: 186 KPVDIWACGV-ILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242

Query: 375 KQCVQVNPNDRPTAAQLLDHPFVK 398
              + VNP  R TA Q L  P++ 
Sbjct: 243 DSMLTVNPKKRITADQALKVPWIC 266

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (486), Expect = 2e-58
 Identities = 49/258 (18%), Positives = 98/258 (37%), Gaps = 18/258 (6%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              L     G +++G    G    VK   +L     + +      +E   L  F H N++
Sbjct: 15  LTKLNENHSGELWKGR-WQGNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 207 QYYG--TDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ 261
              G           +    +  GSL N+      + +  SQ   +   +  G+ +LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 262 D--VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK-NKG 318
           +  +    +   ++++D + + +++   +  +              W+APE +  K    
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRMYAPAWVAPEALQKKPEDT 187

Query: 319 YGLPADIWSLGCTVL-EMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDFIKQ 376
               AD+WS    +L E++T ++P+A +  M    K+   G  P IP  +S      +K 
Sbjct: 188 NRRSADMWSFA-VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI 246

Query: 377 CVQVNPNDRPTAAQLLDH 394
           C+  +P  RP    ++  
Sbjct: 247 CMNEDPAKRPKFDMIVPI 264

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  193 bits (493), Expect = 2e-58
 Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 29/272 (10%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H +I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS----QVSAYTRQILLGLKYLHD 260
           V+   T   +  LY+  E +    L   + +R            S Y RQIL  L+Y HD
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 261 QDVVHRDIKCANILV---DANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 312
            +++HRD+K   +L+   + +  VKL  FG+A                 GT  +MAPEV+
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--V-GTPHFMAPEVV 205

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSL 366
             K + YG P D+W  G  +L +L S     Y   E    LF  I +G     P     +
Sbjct: 206 --KREPYGKPVDVWGCGV-ILFILLSGCLPFYGTKE---RLFEGIIKGKYKMNPRQWSHI 259

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           S+ A+D +++ + ++P +R T  + L+HP++K
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  196 bits (501), Expect = 3e-58
 Identities = 82/293 (27%), Positives = 144/293 (49%), Gaps = 22/293 (7%)

Query: 124 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 182
            +    N+   G F     Y     +LG+GSFG V +         +AVK ++     S 
Sbjct: 7   HSSGRENLYFQGTFAER--Y-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA---SA 60

Query: 183 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRD 241
             +  S + +E+ LL + +H NI++ +   +D S  YI  EL T G L + + +R    +
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 242 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV- 297
              +   +Q+  G+ Y+H  ++VHRD+K  NIL+   + +  +K+ DFGL+   + N   
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180

Query: 298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIG 355
           K   GTA+++APEV+      Y    D+WS G  +  +L+   P Y   E    +  ++ 
Sbjct: 181 KDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVE 235

Query: 356 RGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
            G      P   ++S DA+D I++ +  +P+ R TA Q L+HP++++  +   
Sbjct: 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP 288

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  190 bits (484), Expect = 5e-58
 Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE---QEIALLSRFEH 202
            + +GRGS+G V   +        A K++         K  +  ++   QEI ++   +H
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--------KYFVEDVDRFKQEIEIMKSLDH 65

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
            NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L  + Y H  
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 262 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNK 317
           +V HRD+K  N L      +  +KL DFGLA   K   + ++  GT ++++P+V+     
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---G 182

Query: 318 GYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQ 371
            YG   D WS G  ++ +L    P   AP +  + +  KI  G+   P     ++S  A+
Sbjct: 183 LYGPECDEWSAGV-MMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWLNVSPQAE 239

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 410
             I++ +  +P  R T+ Q L+H + +        S+SP
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFE-----KQLSSSP 273

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  193 bits (493), Expect = 6e-58
 Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 50/298 (16%)

Query: 143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
            W   D+LG+G+  +V+ G     G  FA+K  +         + +    +E  +L +  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65

Query: 202 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 255
           H+NIV+ +    +       + +E    GSL   L +    Y L +S+     R ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 256 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 310
            +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 311 VI------NNKNKGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPP 360
           +        +  K YG   D+WS+G T     T  +P+     P      ++KI  G P 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 361 --------------------PIPDSLSKDAQD----FIKQCVQVNPNDRPTAAQLLDH 394
                               P+  SLS+  Q      +   ++ +        Q    
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  191 bits (486), Expect = 6e-58
 Identities = 66/258 (25%), Positives = 125/258 (48%), Gaps = 23/258 (8%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
            +++GRG+FG V +         A+K++       +++        E+  LSR  H NIV
Sbjct: 13  EEVVGRGAFGVVCKAK-WRAKDVAIKQI-------ESESERKAFIVELRQLSRVNHPNIV 64

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           + YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 263 ---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 318
              ++HRD+K  N+L+ A G+V K+ DFG A   +   + + +G+A WMAPEV   +   
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-THMTNNKGSAAWMAPEVF--EGSN 179

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
           Y    D++S G  + E++T + P+  +       ++ +  G+ PP+  +L K  +  + +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239

Query: 377 CVQVNPNDRPTAAQLLDH 394
           C   +P+ RP+  +++  
Sbjct: 240 CWSKDPSQRPSMEEIVKI 257

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (483), Expect = 2e-57
 Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 28/268 (10%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G++LG+G FG   +    + G    +KE  L+    + ++      +E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQR---TFLKEVKVMRCLEHPNV 69

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 263
           +++ G    + +L    E +  G+L  + +        SQ  ++ + I  G+ YLH  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 264 VHRDIKCANILVDANGSVKLADFGLA----------------KATKLNDVKSCRGTAFWM 307
           +HRD+   N LV  N +V +ADFGLA                K        +  G  +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDS 365
           APE+IN ++  Y    D++S G  + E++               F +          P +
Sbjct: 190 APEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247

Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
                     +C  ++P  RP+  +L  
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  188 bits (481), Expect = 2e-57
 Identities = 75/272 (27%), Positives = 135/272 (49%), Gaps = 19/272 (6%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G+ LG G F  V +      G  +A K +       S+   S  ++E+E+ +L    H N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           I+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+ YLH + +
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129

Query: 264 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 318
            H D+K  NI++      N  +KL DFG+A   +  +  K+  GT  ++APE++N   + 
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN--YEP 187

Query: 319 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 372
            GL AD+WS+G  +  +L S         +        I   +         + S+ A+D
Sbjct: 188 LGLEADMWSIGV-ITYILLSGASPFLGETK--QETLTNISAVNYDFDEEYFSNTSELAKD 244

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
           FI++ +  +P  R T AQ L+H ++K +   N
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  190 bits (485), Expect = 4e-57
 Identities = 78/265 (29%), Positives = 132/265 (49%), Gaps = 22/265 (8%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            + LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NI
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           V+ + + ++ES  Y+  +LVT G L   +  R    ++  S   +QIL  + Y H   +V
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 265 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKGY 319
           HR++K  N+L+       +VKLADFGLA     ++       GT  +++PEV+  K   Y
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-GTPGYLSPEVL--KKDPY 207

Query: 320 GLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDF 373
             P DIW+ G  +L +L    P  +   +    L+ +I  G+   P P  D+++ +A+  
Sbjct: 208 SKPVDIWACGV-ILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           I   + VNP  R TA Q L  P++ 
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWIC 289

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  189 bits (483), Expect = 5e-57
 Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 28/269 (10%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHEN 204
            + +G GS+      I       FAVK +          +S     +EI +L R+ +H N
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID---------KSKRDPTEEIEILLRYGQHPN 77

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           I+       D   +Y+  EL+  G LL+ + ++    + + SA    I   ++YLH Q V
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 264 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKN 316
           VHRD+K +NIL         S+++ DFG AK  +  +      C  TA ++APEV+  + 
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVL--ER 194

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYA--PMECMAALF-KIGRGS---PPPIPDSLSKDA 370
           +GY    DIWSLG  +  MLT   P+A  P +    +  +IG G         +S+S  A
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +D + + + V+P+ R TAA +L HP++  
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVH 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  188 bits (480), Expect = 8e-57
 Identities = 73/265 (27%), Positives = 130/265 (49%), Gaps = 17/265 (6%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G+ LG G F  V +      G  +A K +     + S+   S  ++E+E+++L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           ++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 264 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 318
            H D+K  NI++         +KL DFGLA   +     K+  GT  ++APE++N   + 
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEP 194

Query: 319 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 373
            GL AD+WS+G  +  +L S         +    L  I   S           S+ A+DF
Sbjct: 195 LGLEADMWSIGV-ITYILLSGASPFLGDTK-QETLANITSVSYDFDEEFFSHTSELAKDF 252

Query: 374 IKQCVQVNPNDRPTAAQLLDHPFVK 398
           I++ +      R T  + L HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  189 bits (482), Expect = 8e-57
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 21/263 (7%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
              LGRG+   VY          +A+K +               +  EI +L R  H NI
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNI 110

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           ++     +  +++ + LELVT G L + + ++ +  +   +   +QIL  + YLH+  +V
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 265 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 320
           HRD+K  N+L      +  +K+ADFGL+K  +   + K+  GT  + APE++  +   YG
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL--RGCAYG 228

Query: 321 LPADIWSLGCTVLEMLTSQIP--YAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIK 375
              D+WS+G  +  +L       Y          +I         P  D +S +A+D ++
Sbjct: 229 PEVDMWSVGI-ITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287

Query: 376 QCVQVNPNDRPTAAQLLDHPFVK 398
           + + ++P  R T  Q L HP+V 
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVT 310

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  187 bits (476), Expect = 3e-56
 Identities = 60/274 (21%), Positives = 118/274 (43%), Gaps = 23/274 (8%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           K +   +   + LGRG FG V+  +       +  K V +             +++EI++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLG 254
           L+   H NI+  + + +   +L +  E ++   +        + L + ++ +Y  Q+   
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 255 LKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 311
           L++LH  ++ H DI+  NI+     + ++K+ +FG A+  K  D  +       + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDS 365
               +       D+WSLG  ++ +L S I    A       +   I              
Sbjct: 175 HQ--HDVVSTATDMWSLGT-LVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKE 229

Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +S +A DF+ + +      R TA++ L HP++K+
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  187 bits (477), Expect = 3e-56
 Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 40/283 (14%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEH 202
           +   +L  G F  VYE      G  +A+K +   +     ++    + QE+  + +   H
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGH 85

Query: 203 ENIVQYYG-------TDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQI 251
            NIVQ+                 ++ L  + KG L+   ++   R       V     Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 252 LLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLA--------------KATKLN 295
              ++++H Q   ++HRD+K  N+L+   G++KL DFG A              +   + 
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 296 DVKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI 354
           +  +   T  +  PE+I+   N   G   DIW+LGC +  +   Q P+       A  +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRI 261

Query: 355 GRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
             G    P  D+        I+  +QVNP +R + A+++    
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  187 bits (477), Expect = 5e-56
 Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 19/266 (7%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G+ LG G F  V +      G  +A K +     + S+      ++E+E+++L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           I+  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL G+ YLH + +
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 264 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 318
            H D+K  NI++         +KL DFGLA   +     K+  GT  ++APE++N   + 
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEP 194

Query: 319 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 372
            GL AD+WS+G  +  +L S         +        I   S           S+ A+D
Sbjct: 195 LGLEADMWSIGV-ITYILLSGASPFLGDTK--QETLANITAVSYDFDEEFFSQTSELAKD 251

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVK 398
           FI++ +      R T  + L HP++ 
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWIT 277

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  186 bits (474), Expect = 7e-56
 Identities = 70/266 (26%), Positives = 128/266 (48%), Gaps = 19/266 (7%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   +H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           ++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH   +
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135

Query: 264 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 318
            H D+K  NI++         +K+ DFGLA      +  K+  GT  ++APE++N   + 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN--YEP 193

Query: 319 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 372
            GL AD+WS+G  +  +L S         +        +   +         + S  A+D
Sbjct: 194 LGLEADMWSIGV-ITYILLSGASPFLGDTK--QETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVK 398
           FI++ +  +P  R T    L HP++K
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWIK 276

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  185 bits (473), Expect = 8e-56
 Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 43/303 (14%)

Query: 132 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQL 190
           S +GRF+ +  Y  + D+LG G+   V   I+      +AVK +       Q     S++
Sbjct: 5   SFSGRFEDV--YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK-----QPGHIRSRV 57

Query: 191 EQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 248
            +E+ +L + + H N+++     ++E + Y+  E +  GS+L+ +++R H  + + S   
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR---- 301
           + +   L +LH++ + HRD+K  NIL    +    VK+ DF L    KLN   S      
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 302 -----GTAFWMAPEVIN---NKNKGYGLPADIWSLG-------C-------TVLEMLTSQ 339
                G+A +MAPEV+     +   Y    D+WSLG                        
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237

Query: 340 IPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP 395
              A   C   LF  I  G    P      +S  A+D I + +  +   R +AAQ+L HP
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297

Query: 396 FVK 398
           +V+
Sbjct: 298 WVQ 300

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  183 bits (468), Expect = 2e-55
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 17/273 (6%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
             +  W     LG G++G V   +        AVK V +     +A      +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59

Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 256
               HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 311
           YLH   + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 312 INNKNKGY-GLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPPPIP-DSLSK 368
           +    + +   P D+WS G  +  ML  ++P+  P +                P   +  
Sbjct: 179 LK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                + + +  NP+ R T   +    +  + L
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  188 bits (480), Expect = 2e-55
 Identities = 75/266 (28%), Positives = 133/266 (50%), Gaps = 23/266 (8%)

Query: 147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
            + LG+G+F  V   +    G  +A   +   +    + +   +LE+E  +    +H NI
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           V+ + +  +E   Y+  +LVT G L   +  R +  ++  S   +QIL  + + H   VV
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132

Query: 265 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKG 318
           HR++K  N+L+       +VKLADFGLA   +           GT  +++PEV+  +   
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL--RKDP 189

Query: 319 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 372
           YG P D+W+ G  +L +L    P  +   +    L+ +I  G+   P P  D+++ +A+D
Sbjct: 190 YGKPVDLWACGV-ILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDFPSPEWDTVTPEAKD 246

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVK 398
            I + + +NP+ R TAA+ L HP++ 
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWIS 272

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  184 bits (470), Expect = 1e-54
 Identities = 73/312 (23%), Positives = 138/312 (44%), Gaps = 20/312 (6%)

Query: 98  KEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 157
                  V  +         D       +         +   +  Y+   + LG G+FG 
Sbjct: 7   HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66

Query: 158 VYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 216
           V+  +    G  F  K ++     +        ++ EI+++++  H  ++  +   +D+ 
Sbjct: 67  VHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 217 KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           ++ + LE ++ G L +    + Y + +++V  Y RQ   GLK++H+  +VH DIK  NI+
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181

Query: 275 V--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 331
                  SVK+ DFGLA     +++ K    TA + APE+++   +  G   D+W++G  
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGV- 238

Query: 332 VLEMLTSQIP--YAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRP 386
           +  +L S +       + +  L  + R           S+S +A+DFIK  +Q  P  R 
Sbjct: 239 LGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 297

Query: 387 TAAQLLDHPFVK 398
           T    L+HP++K
Sbjct: 298 TVHDALEHPWLK 309

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  182 bits (464), Expect = 2e-54
 Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 29/301 (9%)

Query: 116 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 174
           H   S                F     Y      LGRG F  V + IS   G  +A K  
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNF--YILTSKELGRGKFAVVRQCISKSTGQEYAAK-- 60

Query: 175 SLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN- 232
             L +  + +   +++  EIA+L   +    ++  +   ++ S++ + LE    G + + 
Sbjct: 61  -FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 233 ----LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLAD 285
               L +     D  V    +QIL G+ YLH  ++VH D+K  NIL+      G +K+ D
Sbjct: 120 CLPELAEMVSEND--VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177

Query: 286 FGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP--Y 342
           FG+++        +   GT  ++APE++N          D+W++G  +  ML +      
Sbjct: 178 FGMSRKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIG-IIAYMLLTHTSPFV 234

Query: 343 APMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                    +  I + +         S+S+ A DFI+  +  NP  RPTA   L H +++
Sbjct: 235 GEDN--QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

Query: 399 R 399
           +
Sbjct: 293 Q 293

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  181 bits (462), Expect = 4e-54
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 17/273 (6%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
             +  W     LG G++G V   +        AVK V +     +A      +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59

Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 256
               HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 311
           YLH   + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 312 INNKNKGY-GLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPPPIP-DSLSK 368
           +    + +   P D+WS G  +  ML  ++P+  P +                P   +  
Sbjct: 179 LK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
                + + +  NP+ R T   +    +  + L
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  182 bits (463), Expect = 7e-54
 Identities = 72/345 (20%), Positives = 148/345 (42%), Gaps = 33/345 (9%)

Query: 77  SSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGR 136
              +++   +      D+       +   +  +   T      S  T+   +   +P   
Sbjct: 13  DLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAP 72

Query: 137 FKRIITYWQKGDL-----------LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 184
           F   I   ++G +           LG G FG V++      G   A K +      ++  
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGM 127

Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 242
           +   +++ EI+++++ +H N++Q Y   + ++ + + +E V  G L +  + + Y+L + 
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187

Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 300
               + +QI  G++++H   ++H D+K  NIL        +K+ DFGLA+  K  +    
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 301 R-GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGR 356
             GT  ++APEV+N        P D+WS+G  +  ML S +       +  A     I  
Sbjct: 248 NFGTPEFLAPEVVN--YDFVSFPTDMWSVG-VIAYMLLSGLSPFLGDND--AETLNNILA 302

Query: 357 GS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                       +S++A++FI + +    + R +A++ L HP++ 
Sbjct: 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  181 bits (461), Expect = 8e-54
 Identities = 65/269 (24%), Positives = 117/269 (43%), Gaps = 29/269 (10%)

Query: 148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
            +LG G  G V E      G   A+K +             ++ E +          +IV
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDH-HWQASGGPHIV 85

Query: 207 QYYGT----DKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLH 259
                       +  L I +E +  G L + + +R     +  + +   R I   +++LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 260 DQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN 316
             ++ HRD+K  N+L    + +  +KL DFG AK T  N +++   T +++APEV+    
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVL--GP 203

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAALF-KIGRGS---PPPIPDSLSKD 369
           + Y    D+WSLG  +  +L    P Y+         +  +I  G    P P    +S+D
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           A+  I+  ++ +P +R T  Q ++HP++ 
Sbjct: 264 AKQLIRLLLKTDPTERLTITQFMNHPWIN 292

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  180 bits (458), Expect = 9e-54
 Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 19/274 (6%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIA 195
           ++I  +  GDLLG GS+G V E + S+     AVK   +L +    +     + +++EI 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQ 58

Query: 196 LLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGS--LLNLYQRYHLRDSQVSAYTRQI 251
           LL R  H+N++Q      ++++ K+Y+ +E    G   +L+          Q   Y  Q+
Sbjct: 59  LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-----SCRGTAFW 306
           + GL+YLH Q +VH+DIK  N+L+   G++K++  G+A+A            S  G+  +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAF 177

Query: 307 MAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 365
             PE+ N     + G   DIWS G T+  + T   P+           IG+G    IP  
Sbjct: 178 QPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-SYAIPGD 235

Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                 D +K  ++  P  R +  Q+  H + ++
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  186 bits (475), Expect = 9e-54
 Identities = 72/332 (21%), Positives = 135/332 (40%), Gaps = 22/332 (6%)

Query: 79  SSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK 138
                     G+E  R    + ++   +       + + D+      +         +  
Sbjct: 94  CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153

Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
            ++ ++   + LG G+FG V+       G  FA K V      +  +     + +EI  +
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTM 208

Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGL 255
           S   H  +V  +   +D++++ +  E ++ G L      +   + + +   Y RQ+  GL
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268

Query: 256 KYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI 312
            ++H+ + VH D+K  NI+     +  +KL DFGL         VK   GTA + APEV 
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSL 366
             K    G   D+WS+G  +  +L S +       +        +              +
Sbjct: 329 EGKP--VGYYTDMWSVGV-LSYILLSGLSPFGGEND--DETLRNVKSCDWNMDDSAFSGI 383

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           S+D +DFI++ +  +PN R T  Q L+HP++ 
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  179 bits (457), Expect = 1e-53
 Identities = 73/304 (24%), Positives = 134/304 (44%), Gaps = 37/304 (12%)

Query: 114 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK 172
           T  E    + + +         + +     ++ G +LG GSF +V           +A+K
Sbjct: 4   TAAEPRPGAGSLQHAQPPPQPRKKR--PEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 173 EVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 226
            +         K+ I +  +      E  ++SR +H   V+ Y T +D+ KLY  L    
Sbjct: 62  ILE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113

Query: 227 KGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 285
            G LL   ++    D   +  YT +I+  L+YLH + ++HRD+K  NIL++ +  +++ D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173

Query: 286 FGLAKATKLNDVKS-----CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
           FG AK       ++       GTA +++PE++    K     +D+W+LGC + +++    
Sbjct: 174 FGTAKVLSPESKQARANSFV-GTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLP 230

Query: 341 P-YAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPT------AAQLL 392
           P  A  E    +F KI +      P+     A+D +++ + ++   R           L 
Sbjct: 231 PFRAGNE--YLIFQKIIKL-EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 393 DHPF 396
            HPF
Sbjct: 288 AHPF 291

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  181 bits (460), Expect = 5e-53
 Identities = 59/377 (15%), Positives = 117/377 (31%), Gaps = 62/377 (16%)

Query: 89  GEEADRAIVK---EEEDDMVLSESCSFTTEHEDDSSSTT----TEPMSNISPNGRFKRII 141
           G +    +++          +  +  +     D   ST+     +P    S  G   R +
Sbjct: 21  GTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTL 80

Query: 142 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
               +G +LG+    +  E    + G  F V      ++      +I Q+++E+  L   
Sbjct: 81  V---RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLL 135

Query: 201 -------------------------EHENIVQYYGTDKDESKLYIFL-------ELVTKG 228
                                    + + +++    ++D   L  F         L T G
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195

Query: 229 SLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 286
            +L  +   H  L        T Q++  L  LH   +VH  ++  +I++D  G V L  F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 287 GLAKATKLNDVKSCRGTAFWMAPEVI--------NNKNKGYGLPADIWSLGCTVLEMLTS 338
                 +            +  PE           +         D W+LG  +  +  +
Sbjct: 256 EHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 339 QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
            +P      +     I R     IP       +  ++  ++    DR    Q ++ P  +
Sbjct: 314 DLPNTDDAALGGSEWIFRS-CKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYE 368

Query: 399 RLLATNSGSASPYLGRR 415
           +L    S +   Y    
Sbjct: 369 QLRTELSAALPLYQTDG 385

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  178 bits (454), Expect = 5e-53
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 21/289 (7%)

Query: 120 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS--- 175
            +       + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V    
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80

Query: 176 LLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELVT-KGSLLN 232
           + D G     +  ++  E+ LL +       +++     +      + LE       L +
Sbjct: 81  ISDWGELPNGT--RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 138

Query: 233 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 290
            + +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198

Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMA 349
             K        GT  +  PE I      Y G  A +WSLG  + +M+   IP+   E   
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--- 253

Query: 350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
              +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++
Sbjct: 254 ---EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  177 bits (451), Expect = 2e-52
 Identities = 68/276 (24%), Positives = 136/276 (49%), Gaps = 12/276 (4%)

Query: 129 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI 187
           ++I+     +  I  ++    +G+G+F  V        G   A+K   ++D+      S+
Sbjct: 2   NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSL 58

Query: 188 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 246
            +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + L     +++ +  +
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTA 304
             RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +    +       C G  
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAP 177

Query: 305 FWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 363
            + APE+     K Y G   D+WSLG  +  +++  +P+          ++ RG    IP
Sbjct: 178 PYAAPELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRIP 234

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             +S D ++ +K+ + +NP  R T  Q++   ++  
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  176 bits (449), Expect = 1e-51
 Identities = 67/267 (25%), Positives = 125/267 (46%), Gaps = 33/267 (12%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 201
            +G+GSFG V      D    +A+K ++        KQ   +  +      E+ ++   E
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLE 73

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGL 255
           H  +V  + + +DE  +++ ++L+  G L     RYHL+      +  V  +  ++++ L
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-----RYHLQQNVHFKEETVKLFICELVMAL 128

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVIN 313
            YL +Q ++HRD+K  NIL+D +G V + DF +A         +    GT  +MAPE+ +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFS 187

Query: 314 NKN-KGYGLPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIPDSLSKDA 370
           ++   GY    D WSLG T  E+L  + PY          +      +    P + S++ 
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM 247

Query: 371 QDFIKQCVQVNPNDR-PTAAQLLDHPF 396
              +K+ ++ NP+ R    + + + P+
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  173 bits (441), Expect = 1e-51
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 13/273 (4%)

Query: 133 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQL 190
                +  I ++  GD LG G+FG V  G     G   AVK   +L++        + ++
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKI 58

Query: 191 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTR 249
           ++EI  L  F H +I++ Y      +  ++ +E V+ G L + + +   + + +     +
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWM 307
           QIL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + 
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYA 177

Query: 308 APEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL 366
           APEVI+   + Y G   DIWS G  +  +L   +P+          KI  G    IP+ L
Sbjct: 178 APEVIS--GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYL 234

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           ++     +   +QV+P  R T   + +H + K+
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  175 bits (446), Expect = 4e-51
 Identities = 68/315 (21%), Positives = 127/315 (40%), Gaps = 35/315 (11%)

Query: 107 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---IITYWQKGDLLGRGSFGSVYEGIS 163
                     +         P  ++    + K+   I  Y     +LG G  G V +  +
Sbjct: 24  PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83

Query: 164 -DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----ESK 217
                 FA+K +              +  +E+ L  R  +  +IV+     ++       
Sbjct: 84  KRTQEKFALKMLQ----------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133

Query: 218 LYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 274
           L I +E +  G L + +  R     +  + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193

Query: 275 V---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 330
                 N  +KL DFG AK T  ++   +   T +++APEV+    + Y    D+WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGV 251

Query: 331 TVLEMLTSQIP-YA--PMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPN 383
            +  +L    P Y+   +     +  +I  G    P P    +S++ +  I+  ++  P 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311

Query: 384 DRPTAAQLLDHPFVK 398
            R T  + ++HP++ 
Sbjct: 312 QRMTITEFMNHPWIM 326

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  181 bits (460), Expect = 5e-51
 Identities = 63/282 (22%), Positives = 104/282 (36%), Gaps = 21/282 (7%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
            +    W+  + LG G FG V   I  D G   A+K+     Q    K +  +   EI +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ---CRQELSPK-NRERWCLEIQI 65

Query: 197 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSL---LNLYQRYH-LRDSQVSA 246
           + +  H N+V          KL       + +E    G L   LN ++    L++  +  
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDV-KSCRG 302
               I   L+YLH+  ++HRD+K  NI++         K+ D G AK     ++     G
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185

Query: 303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           T  ++APE++  + K Y +  D WS G    E +T   P+ P           R      
Sbjct: 186 TLQYLAPELL--EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243

Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
                          V   PN            +++ +L  +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (438), Expect = 6e-51
 Identities = 75/300 (25%), Positives = 112/300 (37%), Gaps = 57/300 (19%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
              + +G+G +G V+ G    G   AVK  S     S+ ++S  + E E+       HEN
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFS-----SRDEKSWFR-ETELYNTVMLRHEN 63

Query: 205 IVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
           I+ +  +D        +L++       GSL +  Q   L           I  GL +LH 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 261 QD--------VVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 306
           +         + HRD+K  NILV  NG   +AD GLA                  GT  +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 307 MAPEVINNK----NKGYGLPADIWSLGCTVL-EMLTS----------QIPYAPMECMAAL 351
           MAPEV++              DIW+ G  VL E+             + P+  +      
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 352 FKIGR------GSPPPIPDSLSKDA-----QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           F+  R         P IP+    D         +K+C   NP+ R TA ++      K L
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI-----KKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (438), Expect = 2e-50
 Identities = 79/333 (23%), Positives = 126/333 (37%), Gaps = 71/333 (21%)

Query: 117 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 176
           E   SS +   +  +      K+I    Q    +G+G +G V+ G    G   AVK    
Sbjct: 16  EQSQSSGSGSGLPLLVQRTIAKQI----QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT 70

Query: 177 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSLLN 232
            ++ S  +      E EI       HENI+ +   D   +  +  L L+T     GSL  
Sbjct: 71  TEEASWFR------ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL-- 122

Query: 233 LYQRYHLRDSQVSAYTR-----QILLGLKYLHDQD--------VVHRDIKCANILVDANG 279
                +L+ + + A +        + GL +LH +         + HRD+K  NILV  NG
Sbjct: 123 ---YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179

Query: 280 SVKLADFGLA------KATKLNDVKSCRGTAFWMAPEVI----NNKNKGYGLPADIWSLG 329
           +  +AD GLA               +  GT  +M PEV+    N  +    + AD++S G
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

Query: 330 CTVL-EMLT----------SQIPYAPMECMAALFKI------GRGSPPPIPDSLSKDA-- 370
             +L E+             Q+PY  +      ++        +   P  P+  S D   
Sbjct: 240 L-ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298

Query: 371 ---QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                 + +C   NP  R TA ++      K L
Sbjct: 299 RQMGKLMTECWAHNPASRLTALRV-----KKTL 326

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  171 bits (436), Expect = 2e-50
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 38/307 (12%)

Query: 111 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFF 169
           S  T+      +    P        R +     ++ G LLG+G FG+V+ G    D    
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDR-EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59

Query: 170 AVKEVS---LLDQGSQAKQSISQLEQEIALLSR----FEHENIVQYYGTDKDESKLYIFL 222
           A+K +    +L     +         E+ALL +      H  +++     + +    + L
Sbjct: 60  AIKVIPRNRVLGWSPLSDSV--TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117

Query: 223 ELVTKGS-LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NG 279
           E       L + + ++  L +     +  Q++  +++ H + VVHRDIK  NIL+D   G
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177

Query: 280 SVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEM 335
             KL DFG           D     GT  +  PE I+     Y  LPA +WSLG  + +M
Sbjct: 178 CAKLIDFGSGALLHDEPYTD--FD-GTRVYSPPEWIS--RHQYHALPATVWSLGILLYDM 232

Query: 336 LTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 391
           +   IP          F    +I        P  +S D    I++C+   P+ RP+  ++
Sbjct: 233 VCGDIP----------FERDQEILEA-ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281

Query: 392 LDHPFVK 398
           L  P+++
Sbjct: 282 LLDPWMQ 288

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  171 bits (436), Expect = 3e-50
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 19/271 (7%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS---LLDQGSQAKQSISQLEQE 193
                 +     LG G+FG V+  +  +      VK +    +L+        + ++  E
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQI 251
           IA+LSR EH NI++     +++    + +E    G  L  +  +   L +   S   RQ+
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 309
           +  + YL  +D++HRDIK  NI++  + ++KL DFG A   +   +    C GT  + AP
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCAP 198

Query: 310 EVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK 368
           EV+      Y G   ++WSLG T+  ++  + P+        L +    +    P  +SK
Sbjct: 199 EVLM--GNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAA-IHPPYLVSK 249

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +    +   +Q  P  R T  +L+  P+V +
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  171 bits (434), Expect = 4e-50
 Identities = 81/334 (24%), Positives = 123/334 (36%), Gaps = 73/334 (21%)

Query: 115 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 174
            H   S                        Q  ++  RG FG V++       + AVK  
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPL--------QLLEVKARGRFGCVWKAQLL-NEYVAVKIF 55

Query: 175 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSL 230
                  Q KQS  Q E E+  L   +HENI+Q+ G +K  + + + L L+T    KGSL
Sbjct: 56  P-----IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109

Query: 231 LNLYQRYHLRDSQVSAYTR-QILL----GLKYLHDQD----------VVHRDIKCANILV 275
                   L+ + VS      I      GL YLH+            + HRDIK  N+L+
Sbjct: 110 -----SDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164

Query: 276 DANGSVKLADFGLAK----ATKLNDVKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSL 328
             N +  +ADFGLA          D     GT  +MAPEV+    N  +   L  D++++
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224

Query: 329 GCTVLEMLTSQIPYAPM--ECMAALFKIGRGSP---------------PPIPDSLSKDAQ 371
           G  + E+ +          E M    +     P               P + D   K A 
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284

Query: 372 -----DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                + I++C   +   R +A  +      +R+
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCV-----GERI 313

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  169 bits (429), Expect = 4e-49
 Identities = 82/342 (23%), Positives = 130/342 (38%), Gaps = 59/342 (17%)

Query: 102 DDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG 161
           D   +SE  +      D ++S +   +  +      + I       + +G+G FG V+ G
Sbjct: 6   DRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTI----VLQESIGKGRFGEVWRG 61

Query: 162 ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 221
               G   AVK  S     S+ ++S  + E EI       HENI+ +   D  ++  +  
Sbjct: 62  KWR-GEEVAVKIFS-----SREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114

Query: 222 LELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIK 269
           L LV+     GSL +   RY +    +         GL +LH +         + HRD+K
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 270 CANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVI----NNKNKGY 319
             NILV  NG+  +AD GLA        T         GT  +MAPEV+    N K+   
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234

Query: 320 GLPADIWSLGCTVLEMLT----------SQIPYAPMECMAALFK------IGRGSPPPIP 363
              ADI+++G    E+             Q+PY  +       +        +   P IP
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294

Query: 364 DSLSKDAQ-----DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           +              +++C   N   R TA ++      K L
Sbjct: 295 NRWQSCEALRVMAKIMRECWYANGAARLTALRI-----KKTL 331

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  168 bits (428), Expect = 5e-49
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 14/267 (5%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIA 195
           KR I  +   + LG GSFG V            A+K    + +    K     ++E+EI+
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREIS 61

Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLG 254
            L    H +I++ Y      + + + +E    G L + + ++  + + +   + +QI+  
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVI 312
           ++Y H   +VHRD+K  N+L+D N +VK+ADFGL+      +    SC G+  + APEVI
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVI 179

Query: 313 NNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 371
           N   K Y G   D+WS G  +  ML  ++P+          K+       +PD LS  AQ
Sbjct: 180 N--GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV-YVMPDFLSPGAQ 236

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             I++ +  +P  R T  ++   P+  
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFN 263

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  170 bits (433), Expect = 2e-48
 Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 14/278 (5%)

Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQ 185
           PM+        +  I ++  GD LG G+FG V  G     G   AVK   +L++      
Sbjct: 2   PMAE-KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSL 57

Query: 186 S-ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQ 243
             + ++ +EI  L  F H +I++ Y      S +++ +E V+ G L + + +   L + +
Sbjct: 58  DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE 117

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCR 301
                +QIL G+ Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC 
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC- 176

Query: 302 GTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 360
           G+  + APEVI+   + Y G   DIWS G  +  +L   +P+          KI  G   
Sbjct: 177 GSPNYAAPEVIS--GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-F 233

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             P  L+      +K  +QV+P  R T   + +H + K
Sbjct: 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  165 bits (420), Expect = 1e-47
 Identities = 54/304 (17%), Positives = 97/304 (31%), Gaps = 41/304 (13%)

Query: 125 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLD 178
              +  I P   F+          LLG G+F  VYE    D         F +K      
Sbjct: 48  QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--- 104

Query: 179 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 238
                        Q +  L        +++Y     ++   +  EL + G+LLN    Y 
Sbjct: 105 --PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162

Query: 239 LRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILV-----------DANGSV 281
               +      V ++  ++L  ++ +HD +++H DIK  N ++           D +  +
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222

Query: 282 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
            L D G +   KL        +   T+ +   E+++  NK +    D + +  TV  ML 
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--NKPWNYQIDYFGVAATVYCMLF 280

Query: 338 SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA-QDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   E      +               D   +F    + +       +  LL    
Sbjct: 281 GTYMKVKNEGGECKPEG------LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

Query: 397 VKRL 400
            K  
Sbjct: 335 KKVF 338

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  163 bits (415), Expect = 3e-47
 Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 66/308 (21%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
            +L+GRG +G+VY+G  D     AVK  S        +Q+    E+ I  +   EH+NI 
Sbjct: 18  LELIGRGRYGAVYKGSLD-ERPVAVKVFS-----FANRQNFIN-EKNIYRVPLMEHDNIA 70

Query: 207 QYYGTDK-----DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           ++   D+        +  + +E    GSL      +             +  GL YLH +
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130

Query: 262 D---------VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----------G 302
                     + HRD+   N+LV  +G+  ++DFGL+     N +              G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 303 TAFWMAPEVINN-----KNKGYGLPADIWSLGCTVLEML---TSQIPYAPMECMAALFKI 354
           T  +MAPEV+         +      D+++LG    E+    T   P   +      F+ 
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250

Query: 355 GRGSP----------------PPIPDSLSKDAQDF------IKQCVQVNPNDRPTAAQLL 392
             G+                 P  P++  +++         I+ C   +   R TA    
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA- 309

Query: 393 DHPFVKRL 400
                +R+
Sbjct: 310 ----EERM 313

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  162 bits (413), Expect = 6e-47
 Identities = 77/267 (28%), Positives = 134/267 (50%), Gaps = 37/267 (13%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 201
            LG GSFG V+   S  +G ++A+K +         K+ + +L+Q      E  +LS   
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVT 64

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHD 260
           H  I++ +GT +D  ++++ ++ +  G L +L ++     + V+  Y  ++ L L+YLH 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNKNKG 318
           +D+++RD+K  NIL+D NG +K+ DFG AK   + DV    C GT  ++APEV++   K 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTLC-GTPDYIAPEVVS--TKP 179

Query: 319 YGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAALF-KIGRGSPPPIPDSLSKDAQDFI 374
           Y    D WS G  + EML    P Y    M+     + KI        P   ++D +D +
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNA-ELRFPPFFNEDVKDLL 234

Query: 375 KQCVQVNPNDR-----PTAAQLLDHPF 396
            + +  + + R          + +HP+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  162 bits (412), Expect = 1e-46
 Identities = 78/266 (29%), Positives = 119/266 (44%), Gaps = 35/266 (13%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 201
            LG GSFG V      + G  +A+K +         KQ + +L+Q      E  +L    
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV----SA--YTRQILLGL 255
              +V+   + KD S LY+ +E V  G +       HLR         A  Y  QI+L  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-----SHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 315
           +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT   +APE+I   
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEII--L 211

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
           +KGY    D W+LG  + EM     P+   + +    KI  G     P   S D +D ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSHFSSDLKDLLR 270

Query: 376 QCVQVNPNDR-----PTAAQLLDHPF 396
             +QV+   R          + +H +
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKW 296

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  161 bits (410), Expect = 1e-46
 Identities = 74/320 (23%), Positives = 125/320 (39%), Gaps = 43/320 (13%)

Query: 120 SSSTTTEPMSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVK 172
           + +   +     +   R        + +    LG+G+FGSV          + G   AVK
Sbjct: 17  TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76

Query: 173 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSL 230
           +   L   ++        E+EI +L   +H+NIV+Y G         L + +E +  GSL
Sbjct: 77  K---LQHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131

Query: 231 LNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 288
            +  Q++   +   ++  YT QI  G++YL  +  +HRD+   NILV+    VK+ DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191

Query: 289 AKATKLNDV--KSCRGTAF---WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT----- 337
            K    +    K          W APE +  +K   + + +D+WS G  + E+ T     
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKS 248

Query: 338 -----------SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRP 386
                             M     +  +      P PD    +    + +C   N N RP
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308

Query: 387 TAAQLLDHPFVKRLLATNSG 406
           +   L     V ++    +G
Sbjct: 309 SFRDL--ALRVDQIRDQMAG 326

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  160 bits (407), Expect = 2e-46
 Identities = 59/275 (21%), Positives = 104/275 (37%), Gaps = 51/275 (18%)

Query: 143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF- 200
           Y     +LG G  G V +  +      FA+K +              +  +E+ L  R  
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHWRAS 68

Query: 201 EHENIVQYYG----TDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILL 253
           +  +IV+              L I +E +  G L + +  R     +  + S   + I  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 254 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 310
            ++YLH  ++ HRD+K  N+L      N  +KL DFG A                    E
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------KE 169

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAALF-KIGRGS---PPPIP 363
                 + Y    D+WSLG  +  +L    P Y+   +     +  +I  G    P P  
Sbjct: 170 TTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
             +S++ +  I+  ++  P  R T  + ++HP++ 
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  160 bits (408), Expect = 2e-46
 Identities = 85/292 (29%), Positives = 125/292 (42%), Gaps = 35/292 (11%)

Query: 145 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           +K   LG G FG V            G   AVK    L   +  +   S  +QEI +L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQH-RSGWKQEIDILRT 89

Query: 200 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
             HE+I++Y G   D   + L + +E V  GSL +   R+ +  +Q+  + +QI  G+ Y
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTA--FWMAPEVI 312
           LH Q  +HRD+   N+L+D +  VK+ DFGLAKA             G +  FW APE +
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLT---------------SQIPYAPMECMAALFKIGRG 357
               K +   +D+WS G T+ E+LT                 I    M  +     + RG
Sbjct: 210 KE-YK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267

Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 409
              P PD    +    +K C +   + RPT   L   P +K +     G A 
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL--IPILKTVHEKYQGQAP 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  160 bits (406), Expect = 3e-46
 Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 41/293 (13%)

Query: 145 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           +    LG+G+FGSV          + G   AVK+   L   ++        E+EI +L  
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLR--DFEREIEILKS 67

Query: 200 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGL 255
            +H+NIV+Y G         L + +E +  GSL +  Q++   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPE 310
           +YL  +  +HRD+   NILV+    VK+ DFGL K    +    K          W APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

Query: 311 VIN-NKNKGYGLPADIWSLGCTVLEMLT----------------SQIPYAPMECMAALFK 353
            +  +K   + + +D+WS G  + E+ T                       M     +  
Sbjct: 188 SLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG 406
           +      P PD    +    + +C   N N RP+   L     V ++    +G
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL--ALRVDQIRDNMAG 295

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  160 bits (408), Expect = 6e-46
 Identities = 82/334 (24%), Positives = 142/334 (42%), Gaps = 40/334 (11%)

Query: 87  KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQK 146
              EE   +                  T   +  ++  T     +     F+ +      
Sbjct: 7   HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-NFELL------ 59

Query: 147 GDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA------- 195
             +LG G++G V+        D G  +A+K +         K +I Q  +          
Sbjct: 60  -KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK--------KATIVQKAKTTEHTRTERQ 110

Query: 196 -LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 253
            L    +   +V  +   + E+KL++ L+ +  G L   L QR    + +V  Y  +I+L
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 310
            L++LH   +++RDIK  NIL+D+NG V L DFGL+K    ++ +      GT  +MAP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLS 367
           ++   + G+    D WSLG  + E+LT   P+         A + +    S PP P  +S
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290

Query: 368 KDAQDFIKQCVQVNPNDR----PT-AAQLLDHPF 396
             A+D I++ +  +P  R    P  A ++ +H F
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  159 bits (404), Expect = 2e-45
 Identities = 84/320 (26%), Positives = 136/320 (42%), Gaps = 54/320 (16%)

Query: 119 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 177
                      ++     + + +  ++   L+G GS+G V +  + D G   A+K+    
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61

Query: 178 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 237
           D     K     + +EI LL +  HEN+V      K + + Y+  E V   ++L+  + +
Sbjct: 62  DDDKMVK--KIAM-REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117

Query: 238 --HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 295
              L    V  Y  QI+ G+ + H  +++HRDIK  NILV  +G VKL DFG A+     
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART---- 173

Query: 296 DVKSCRGTAF-------WM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 347
              +  G  +       W  APE++    K YG   D+W++GC V EM   + P  P + 
Sbjct: 174 --LAAPGEVYDDEVATRWYRAPELLVGDVK-YGKAVDVWAIGCLVTEMFMGE-PLFPGDS 229

Query: 348 -MAALFKIGR--GSPPP--------IPD--------------------SLSKDAQDFIKQ 376
            +  L+ I    G+  P         P                      LS+   D  K+
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289

Query: 377 CVQVNPNDRPTAAQLLDHPF 396
           C+ ++P+ RP  A+LL H F
Sbjct: 290 CLHIDPDKRPFCAELLHHDF 309

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  158 bits (401), Expect = 3e-45
 Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 40/296 (13%)

Query: 145 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           +    LG+G+FGSV          + G   AVK   L   G   ++     ++EI +L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRD---FQREIQILKA 80

Query: 200 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLG 254
              + IV+Y G         L + +E +  G L + +    R  L  S++  Y+ QI  G
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKG 139

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAP 309
           ++YL  +  VHRD+   NILV++   VK+ADFGLAK   L+               W AP
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP-------- 360
           E +++ N  +   +D+WS G  + E+ T      +P      +    R  P         
Sbjct: 200 ESLSD-NI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 361 ------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 410
                 P P +   +  + +K C   +P DRP+ + L   P +  L + + G  + 
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL--GPQLDMLWSGSRGCETH 311

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  165 bits (418), Expect = 5e-45
 Identities = 84/360 (23%), Positives = 153/360 (42%), Gaps = 42/360 (11%)

Query: 74  RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCS--FTTEHEDDSSSTTTEPMSNI 131
           R +  +   ++         ++ ++  +  +V  +     F    E+   +   +     
Sbjct: 106 REIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKF 165

Query: 132 SPNGRFKRIITY-WQKGD------------LLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 177
             + +F R   +   + +            ++GRG FG VY     D G  +A+K    L
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CL 222

Query: 178 DQGSQAKQSISQLEQE---------IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 228
           D     K+ I   + E         ++L+S  +   IV          KL   L+L+  G
Sbjct: 223 D-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 229 SLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 287
            L   L Q     ++ +  Y  +I+LGL+++H++ VV+RD+K ANIL+D +G V+++D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 288 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPME 346
           LA         +  GT  +MAPEV+  K   Y   AD +SLGC + ++L    P      
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

Query: 347 CMAA-LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR-----PTAAQLLDHPFVKRL 400
                + ++       +PDS S + +  ++  +Q + N R       A ++ + PF + L
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  157 bits (400), Expect = 5e-45
 Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 29/280 (10%)

Query: 133 PNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 185
           PN    RI+   +  K  +LG G+FG+VY+G+   +G       A+KE   L + +  K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKA 60

Query: 186 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 243
           +   L  E  +++  ++ ++ +  G     + + +  +L+  G LL+     + ++    
Sbjct: 61  NKEIL-DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRG 302
           +  +  QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +      G
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 303 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIG 355
                 WMA E I ++   Y   +D+WS G TV E++T    PY  +   E  + L K  
Sbjct: 179 GKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

Query: 356 RGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
           R   PPI    +       +++C  ++ + RP   +L+  
Sbjct: 237 RLPQPPICTIDVY----MIMRKCWMIDADSRPKFRELIIE 272

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  156 bits (397), Expect = 6e-45
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 16/254 (6%)

Query: 150 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG G+FG+V +G           AVK    L   +       +L  E  ++ + ++  IV
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI---LKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           +  G  + ES   + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VH
Sbjct: 82  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVINNKNKGYG 320
           RD+   N+L+      K++DFGL+KA + ++   K+     +   W APE IN     + 
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FS 198

Query: 321 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C  
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 258

Query: 380 VNPNDRPTAAQLLD 393
            +  +RP  A +  
Sbjct: 259 YDVENRPGFAAVEL 272

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (402), Expect = 8e-45
 Identities = 66/260 (25%), Positives = 108/260 (41%), Gaps = 24/260 (9%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
           G+ +GRG+FG V+ G    D    AVK      +          L QE  +L ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFL-QEARILKQYSHPNI 174

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           V+  G    +  +YI +ELV  G  L  +   +   LR   +         G++YL  + 
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEVINNKNKG 318
            +HRD+   N LV     +K++DFG+++        +  G       W APE +N     
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-- 291

Query: 319 YGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDF 373
           Y   +D+WS G  + E  +    PY  +        + +G     P   PD++       
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV----FRL 347

Query: 374 IKQCVQVNPNDRPTAAQLLD 393
           ++QC    P  RP+ + +  
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQ 367

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  155 bits (395), Expect = 1e-44
 Identities = 74/284 (26%), Positives = 115/284 (40%), Gaps = 28/284 (9%)

Query: 129 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQ 182
           +   P      +I     +  + LG GSFG V  G     S      AVK   L      
Sbjct: 3   AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLS 60

Query: 183 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLR 240
             +++    +E+  +   +H N+++ YG       + +  EL   GSLL+     + H  
Sbjct: 61  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL 119

Query: 241 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 298
              +S Y  Q+  G+ YL  +  +HRD+   N+L+     VK+ DFGL +A   ND    
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179

Query: 299 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAAL 351
                     W APE +  +   +   +D W  G T+ EM T  Q P+  +   + +  +
Sbjct: 180 MQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

Query: 352 FKIG-RGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
            K G R   P   P  +     + + QC    P DRPT   L D
Sbjct: 238 DKEGERLPRPEDCPQDIY----NVMVQCWAHKPEDRPTFVALRD 277

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  155 bits (393), Expect = 1e-44
 Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 22/257 (8%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              LG G FG V  G     +  AVK   ++ +GS ++    +  QE   + +  H  +V
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPKLV 66

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           ++YG    E  +YI  E ++ G LLN  +     L  SQ+      +  G+ +L     +
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 321
           HRD+   N LVD +  VK++DFG+ +    +   S  GT F   W APEV +     Y  
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSS 184

Query: 322 PADIWSLGCTVLEMLTS-QIPYAPM---ECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQ 376
            +D+W+ G  + E+ +  ++PY      E +  + +  R   P +  D++       +  
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI----YQIMYS 240

Query: 377 CVQVNPNDRPTAAQLLD 393
           C    P  RPT  QLL 
Sbjct: 241 CWHELPEKRPTFQQLLS 257

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  157 bits (399), Expect = 2e-44
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 26/293 (8%)

Query: 119 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLL 177
           D +  TT P+               +     +G G+FG              AVK    +
Sbjct: 2   DRAPVTTGPLDM-----PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YI 53

Query: 178 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQR 236
           ++G         +++EI       H NIV++       + L I +E  + G L   +   
Sbjct: 54  ERG---AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110

Query: 237 YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATKL 294
               + +   + +Q+L G+ Y H   + HRD+K  N L+D +    +K+ DFG +K++ L
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170

Query: 295 NDV-KSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPY----APMECM 348
           +   KS  GT  ++APEV+    + Y G  AD+WS G T+  ML    P+     P +  
Sbjct: 171 HSQPKSTVGTPAYIAPEVLL--RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228

Query: 349 AALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             + +I       IPD   +S +    I +    +P  R +  ++  H +  +
Sbjct: 229 KTIQRILSVK-YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  153 bits (390), Expect = 3e-44
 Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 22/257 (8%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              +G G FG V+ G   +    A+K    + +G+ +++      +E  ++ +  H  +V
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKLV 66

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           Q YG   +++ + +  E +  G L +  +  R       +      +  G+ YL +  V+
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 321
           HRD+   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y  
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSS 184

Query: 322 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFIKQ 376
            +D+WS G  + E+ +  +IPY        +  I  G     P      +       +  
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY----QIMNH 240

Query: 377 CVQVNPNDRPTAAQLLD 393
           C +  P DRP  ++LL 
Sbjct: 241 CWRERPEDRPAFSRLLR 257

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  155 bits (395), Expect = 3e-44
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 30/266 (11%)

Query: 149 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSR 199
           +LG+GSFG V+       SD    +A+K +         K ++   ++     E  +L  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVE 82

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 258
             H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +L
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 315
           H   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+   C GT  +MAPEV+N  
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVN-- 199

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
            +G+   AD WS G  + EMLT  +P+   +       +   +   +P  LS +AQ  ++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258

Query: 376 QCVQVNPNDR----PT-AAQLLDHPF 396
              + NP +R    P    ++  H F
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSF 284

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  155 bits (393), Expect = 3e-44
 Identities = 75/289 (25%), Positives = 132/289 (45%), Gaps = 42/289 (14%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K   +G GS+G V++  + D G   A+K+    +     K     L +EI +L + +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIAL-REIRMLKQLKH 61

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 260
            N+V      + + +L++  E     ++L+   RY   + +  V + T Q L  + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWM-APEVINNKNKG 318
            + +HRD+K  NIL+  +  +KL DFG A+     +D         W  +PE++    + 
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ- 179

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPP-------------- 361
           YG P D+W++GC   E+L+   P  P +  +  L+ I +  G   P              
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 362 --IPD------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
             IPD            ++S  A   +K C+ ++P +R T  QLL HP+
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  155 bits (393), Expect = 5e-44
 Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 32/268 (11%)

Query: 149 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-------LL 197
           +LG+G +G V+       ++ G  FA+K +         K  I +  ++ A       +L
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--------KAMIVRNAKDTAHTKAERNIL 75

Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 256
              +H  IV      +   KLY+ LE ++ G L   L +     +     Y  +I + L 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVIN 313
           +LH + +++RD+K  NI+++  G VKL DFGL K +  +   +   C GT  +MAPE++ 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILM 194

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 373
               G+    D WSLG  + +MLT   P+   E               +P  L+++A+D 
Sbjct: 195 --RSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQEARDL 251

Query: 374 IKQCVQVNPNDR----PT-AAQLLDHPF 396
           +K+ ++ N   R    P  A ++  HPF
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  157 bits (398), Expect = 1e-43
 Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 16/254 (6%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              LG+G FG V+ G  +     A+K    L  G+ + +      QE  ++ +  HE +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 242

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q Y    +E  +YI  E ++KGSLL+        +LR  Q+     QI  G+ Y+   + 
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           VHRD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 359

Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 419

Query: 380 VNPNDRPTAAQLLD 393
             P +RPT   L  
Sbjct: 420 KEPEERPTFEYLQA 433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  156 bits (395), Expect = 2e-43
 Identities = 73/313 (23%), Positives = 132/313 (42%), Gaps = 32/313 (10%)

Query: 105 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYE-GI 162
            L     F    ++ +         +     R  R+    ++   ++GRG+FG V     
Sbjct: 31  ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90

Query: 163 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDES 216
                 +A+K +S        K  + +         E  +++      +VQ +   +D+ 
Sbjct: 91  KSTRKVYAMKLLS--------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142

Query: 217 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD 276
            LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD+K  N+L+D
Sbjct: 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202

Query: 277 ANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLPADIWSLGCT 331
            +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG   D WS+G  
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262

Query: 332 VLEMLTSQIP-YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDR- 385
           + EML    P YA  + +   + KI         P  + +SK+A++ I      +   R 
Sbjct: 263 LYEMLVGDTPFYA--DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRL 319

Query: 386 --PTAAQLLDHPF 396
                 ++  H F
Sbjct: 320 GRNGVEEIKRHLF 332

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  156 bits (395), Expect = 2e-43
 Identities = 83/332 (25%), Positives = 135/332 (40%), Gaps = 66/332 (19%)

Query: 117 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS 175
            D   S  T  ++         + ++Y     ++G GSFG VY+    D G   A+K+V 
Sbjct: 30  RDKDGSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV- 87

Query: 176 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGS 229
           L D+  + +        E+ ++ + +H NIV+        G  KDE  L + L+ V +  
Sbjct: 88  LQDKRFKNR--------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-- 137

Query: 230 LLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GS 280
              +Y+  R++ R  Q      V  Y  Q+   L Y+H   + HRDIK  N+L+D +   
Sbjct: 138 --TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195

Query: 281 VKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
           +KL DFG AK     +      C  + ++ APE+I      Y    D+WS GC + E+L 
Sbjct: 196 LKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLL 252

Query: 338 SQIPYAPME-CMAALFKIGR--GSP--------------------PPIPDS------LSK 368
            Q P  P +  +  L +I +  G+P                       P +         
Sbjct: 253 GQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 311

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           +A     + ++  P  R T  +   H F   L
Sbjct: 312 EAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  151 bits (385), Expect = 3e-43
 Identities = 64/258 (24%), Positives = 115/258 (44%), Gaps = 22/258 (8%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +V
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           Q YG    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 321
           HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +  
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSS 200

Query: 322 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFIKQ 376
            +DIW+ G  + E+ +  ++PY           I +G     P    + +       +  
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV----YTIMYS 256

Query: 377 CVQVNPNDRPTAAQLLDH 394
           C     ++RPT   LL +
Sbjct: 257 CWHEKADERPTFKILLSN 274

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  152 bits (386), Expect = 3e-43
 Identities = 72/279 (25%), Positives = 119/279 (42%), Gaps = 35/279 (12%)

Query: 145 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           ++   LG G FG V          + G   AVK    L   S     I+ L++EI +L  
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNH-IADLKKEIEILRN 79

Query: 200 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGL 255
             HENIV+Y G  T+   + + + +E +  GSL       +  +   Q   Y  QI  G+
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPE 310
            YL  +  VHRD+   N+LV++   VK+ DFGL KA + +               W APE
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 311 VINNKNKGYGLPADIWSLGCTVLEMLT---------------SQIPYAPMECMAALFKIG 355
            +   +K + + +D+WS G T+ E+LT                   +  M     +  + 
Sbjct: 200 CLMQ-SK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            G   P P +   +    +++C +  P++R +   L++ 
Sbjct: 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  155 bits (394), Expect = 3e-43
 Identities = 74/335 (22%), Positives = 139/335 (41%), Gaps = 32/335 (9%)

Query: 86  EKEGEEADRAIVKEEEDD--MVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-IT 142
           +   +   +    E   D  + L + C+ +    + +     E     +   +  R+   
Sbjct: 15  DGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE 74

Query: 143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIA 195
            ++   ++GRG+FG V      +    FA+K ++        K  + +  +      E  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--------KWEMLKRAETACFREERD 126

Query: 196 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILL 253
           +L   + + I   +   +D++ LY+ ++    G LL L  ++  R  +  A  Y  ++++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 310
            +  +H    VHRDIK  NIL+D NG ++LADFG       +         GT  +++PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 311 VINNK---NKGYGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAA-LFKIGRGSPPPIP 363
           ++         YG   D WSLG  + EML  + P YA   +E     +    R   P   
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306

Query: 364 DSLSKDAQDFIKQCVQVNPN--DRPTAAQLLDHPF 396
             +S++A+D I++ +    +   +        HPF
Sbjct: 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  151 bits (384), Expect = 4e-43
 Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 29/263 (11%)

Query: 147 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI  S +      A+K        +        L QE   + +F+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFL-QEALTMRQFDH 75

Query: 203 ENIVQYYG--TDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYL 258
            +IV+  G  T   E+ ++I +EL T G L +    ++Y L  + +  Y  Q+   L YL
Sbjct: 76  PHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
             +  VHRDI   N+LV +N  VKL DFGL++  + +             WMAPE IN +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 316 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSKDA 370
              +   +D+W  G  + E+L     P+  +   + +  +    R   PP  P +L    
Sbjct: 193 R--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL---- 246

Query: 371 QDFIKQCVQVNPNDRPTAAQLLD 393
              + +C   +P+ RP   +L  
Sbjct: 247 YSLMTKCWAYDPSRRPRFTELKA 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  151 bits (384), Expect = 4e-43
 Identities = 68/255 (26%), Positives = 118/255 (46%), Gaps = 18/255 (7%)

Query: 150 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG G+FGSV +G+          A+K    L QG++   +  ++ +E  ++ + ++  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADT-EEMMREAQIMHQLDNPYIV 73

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           +  G  + E+ L + +E+   G L       R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 74  RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPEVINNKNKGY 319
           HRD+   N+L+      K++DFGL+KA   +D    +     +   W APE IN +   +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 190

Query: 320 GLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
              +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C 
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 250

Query: 379 QVNPNDRPTAAQLLD 393
                DRP    +  
Sbjct: 251 IYKWEDRPDFLTVEQ 265

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  153 bits (389), Expect = 9e-43
 Identities = 88/331 (26%), Positives = 138/331 (41%), Gaps = 68/331 (20%)

Query: 117 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 176
           +D +           +     +R I Y     ++G GSFG V++    +    A+K+V L
Sbjct: 19  DDPNKVIKVLASDGKTG---EQREIAY-TNCKVIGNGSFGVVFQAKLVESDEVAIKKV-L 73

Query: 177 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSL 230
            D+  + +        E+ ++   +H N+V         G  KDE  L + LE V +   
Sbjct: 74  QDKRFKNR--------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE--- 122

Query: 231 LNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSV 281
             +Y+  R++ +  Q      +  Y  Q+L  L Y+H   + HRDIK  N+L+D   G +
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181

Query: 282 KLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 338
           KL DFG AK     +      C  + ++ APE+I      Y    DIWS GC + E++  
Sbjct: 182 KLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQG 238

Query: 339 QIPYAPME-CMAALFKIGR--GSP--------------------PPIP------DSLSKD 369
           Q P  P E  +  L +I +  G+P                     P P           D
Sbjct: 239 Q-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPD 297

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           A D I + ++  P+ R TA + L HPF   L
Sbjct: 298 AIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  150 bits (381), Expect = 1e-42
 Identities = 70/262 (26%), Positives = 115/262 (43%), Gaps = 27/262 (10%)

Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             +LG G FG VYEG+      +    AVK      +          +  E  ++   +H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFM-SEAVIMKNLDH 72

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLH 259
            +IV+  G  ++E   +I +EL   G L + Y    +  L+   +  Y+ QI   + YL 
Sbjct: 73  PHIVKLIGIIEEEP-TWIIMELYPYGELGH-YLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKN 316
             + VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN + 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190

Query: 317 KGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQ 371
             +   +D+W     + E+L+  + P+  +E    +  + +G     P   P  L     
Sbjct: 191 --FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL----Y 244

Query: 372 DFIKQCVQVNPNDRPTAAQLLD 393
             + +C   +P+DRP   +L+ 
Sbjct: 245 TLMTRCWDYDPSDRPRFTELVC 266

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  156 bits (395), Expect = 1e-42
 Identities = 70/280 (25%), Positives = 131/280 (46%), Gaps = 44/280 (15%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 201
           +LGRG FG V+   +   G  +A K+++        K+ + + +       E  +L++  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKVH 243

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------YTRQI 251
              IV      + ++ L + + ++  G +     RYH+ +               YT QI
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMA 308
           + GL++LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+     GT  +MA
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAA--LFKIGRGSPPPIPDS 365
           PE++    + Y    D ++LG T+ EM+ ++ P  A  E +    L +         PD 
Sbjct: 358 PELL--LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

Query: 366 LSKDAQDFIKQCVQVNPNDR-----PTAAQLLDHPFVKRL 400
            S  ++DF +  +Q +P  R      +   L  HP  + +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  156 bits (395), Expect = 2e-42
 Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 29/271 (10%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 201
           +LG+G FG V    +   G  +A K++         K+ I + +       E  +L +  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKVN 242

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYL 258
              +V      + +  L + L L+  G L   +    +    +++   Y  +I  GL+ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNK 317
           H + +V+RD+K  NIL+D +G ++++D GLA        +K   GT  +MAPEV+  KN+
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNE 360

Query: 318 GYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAA--LFKIGRGSPPPIPDSLSKDAQDFI 374
            Y    D W+LGC + EM+  Q P     + +    + ++ +  P    +  S  A+   
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420

Query: 375 KQCVQVNPNDR-----PTAAQLLDHPFVKRL 400
            Q +  +P +R      +A ++ +HP  K+L
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  155 bits (392), Expect = 3e-42
 Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 16/254 (6%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              LG+G FG V+ G  +     A+K    L  G+ + +      QE  ++ +  HE +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 325

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q Y    +E  +YI  E ++KGSLL+        +LR  Q+     QI  G+ Y+   + 
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 320
           VHRD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 442

Query: 321 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 502

Query: 380 VNPNDRPTAAQLLD 393
             P +RPT   L  
Sbjct: 503 KEPEERPTFEYLQA 516

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  150 bits (380), Expect = 3e-42
 Identities = 86/311 (27%), Positives = 143/311 (45%), Gaps = 54/311 (17%)

Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAK 184
             S+   N  F+ ++  +QK + +G G++G VY+     G   A+K + L   D+G    
Sbjct: 6   HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI--- 62

Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRD 241
              + + +EI+LL    H NIV        E  L +   F+E   K  L     +  L+D
Sbjct: 63  -PSTAI-REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQD 118

Query: 242 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------N 295
           SQ+  Y  Q+L G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A  +      +
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

Query: 296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKI 354
           +V     T ++ AP+V+   +K Y    DIWS+GC   EM+T + P  P       L KI
Sbjct: 179 EVV----TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKI 232

Query: 355 GR--GSP----------------------PPIP-----DSLSKDAQDFIKQCVQVNPNDR 385
               G+P                         P         ++  D +   +  +PN R
Sbjct: 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292

Query: 386 PTAAQLLDHPF 396
            +A   ++HP+
Sbjct: 293 ISARDAMNHPY 303

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  148 bits (376), Expect = 5e-42
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 24/260 (9%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
              LG G +G VYEG+        AVK    L + +   +   +  +E A++   +H N+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNL 71

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           VQ  G    E   YI  E +T G+LL+      R  +    +     QI   ++YL  ++
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 319
            +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +      +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F 189

Query: 320 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFI 374
            + +D+W+ G  + E+ T    PY  ++       + +      P   P+ +     + +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV----YELM 245

Query: 375 KQCVQVNPNDRPTAAQLLDH 394
           + C Q NP+DRP+ A++   
Sbjct: 246 RACWQWNPSDRPSFAEIHQA 265

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  153 bits (388), Expect = 6e-42
 Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 16/256 (6%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
              LG G +G VYEG+        AVK    L + +   +      +E A++   +H N+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEE---FLKEAAVMKEIKHPNL 278

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
           VQ  G    E   YI  E +T G+LL+      R  +    +     QI   ++YL  ++
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 319
            +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE +      +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F 396

Query: 320 GLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
            + +D+W+ G  + E+ T    PY  ++       + +      P+   +   + ++ C 
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 456

Query: 379 QVNPNDRPTAAQLLDH 394
           Q NP+DRP+ A++   
Sbjct: 457 QWNPSDRPSFAEIHQA 472

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  150 bits (380), Expect = 8e-42
 Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 69/334 (20%)

Query: 121 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 179
            S  +   +  +     K +  + Q   + G+G+FG+V  G     G   A+K+V  +  
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQD 59

Query: 180 GSQAKQSISQLEQEIALLSRFEHENIVQYY-------GTDKDESKLYIFLELVTKGSLLN 232
                + +    Q +  L+   H NIVQ           D+ +  L + +E V       
Sbjct: 60  PRFRNREL----QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD----T 111

Query: 233 LYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVD-ANGSV 281
           L++  R + R         +  +  Q++  +  LH    +V HRDIK  N+LV+ A+G++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171

Query: 282 KLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 338
           KL DFG AK    ++      C  + ++ APE+I   N+ Y    DIWS+GC   EM+  
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLG 228

Query: 339 QIPYAP----------------------MECMA---ALFKIGRGSPPPIPDSLSK----- 368
           + P                         +  +        +      P  +  S      
Sbjct: 229 E-PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD 287

Query: 369 --DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
             +A D +   +Q  P +R    + L HP+   L
Sbjct: 288 AKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  152 bits (385), Expect = 8e-42
 Identities = 75/330 (22%), Positives = 141/330 (42%), Gaps = 30/330 (9%)

Query: 84  DNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITY 143
           +  +E EE   AI +   D +    +          S ++  E M       + +  +  
Sbjct: 91  ETPEEREEWTTAI-QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149

Query: 144 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIAL 196
           ++   LLG+G+FG V        G ++A+K +         K+ I   ++      E  +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--------KEVIVAKDEVAHTLTENRV 201

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 255
           L    H  +     + +   +L   +E    G L   L +     + +   Y  +I+  L
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 256 KYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 311
            YLH +++VV+RD+K  N+++D +G +K+ DFGL K    +       C GT  ++APEV
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 371
           +   +  YG   D W LG  + EM+  ++P+   +    LF++        P +L  +A+
Sbjct: 321 LE--DNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLGPEAK 377

Query: 372 DFIKQCVQVNPNDR----PT-AAQLLDHPF 396
             +   ++ +P  R       A +++ H F
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  149 bits (378), Expect = 1e-41
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 28/264 (10%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 201
           LLG+G+FG V        G ++A+K +         K+ I   ++      E  +L    
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILR--------KEVIIAKDEVAHTVTESRVLQNTR 63

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD 260
           H  +       +   +L   +E    G L   L +     + +   Y  +I+  L+YLH 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNK 317
           +DVV+RDIK  N+++D +G +K+ DFGL K    +       C GT  ++APEV+  ++ 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL--EDN 180

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
            YG   D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

Query: 378 VQVNPNDR----PTAAQ-LLDHPF 396
           ++ +P  R    P+ A+ +++H F
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRF 263

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (376), Expect = 2e-41
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 30/265 (11%)

Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             ++G G  G V  G            A+K    L  G   +Q    L  E +++ +F+H
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFL-SEASIMGQFDH 109

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 259
            NI++  G         I  E +  GSL   + R H       Q+    R +  G++YL 
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN- 313
           D   VHRD+   N+LVD+N   K++DFGL++  + +     +  G      W APE I  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 314 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSK 368
                +   +D+WS G  + E+L   + PY  M   + ++++ +  R   P   P +L  
Sbjct: 229 RT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH- 284

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLD 393
                +  C   +   RP  +Q++ 
Sbjct: 285 ---QLMLDCWHKDRAQRPRFSQIVS 306

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  154 bits (390), Expect = 2e-41
 Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 26/323 (8%)

Query: 86  EKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI----I 141
           +KEGE A  +I K   ++     S + +    DD +    E  +   P+ R   I    I
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392

Query: 142 TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
                G  +G G FG V++GI     +     A+K        +        L QE   +
Sbjct: 393 E---LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFL-QEALTM 445

Query: 198 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLG 254
            +F+H +IV+  G   +   ++I +EL T G L + + +     L  + +  Y  Q+   
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTA 503

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 311
           L YL  +  VHRDI   N+LV +N  VKL DFGL++  + +             WMAPE 
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 370
           IN +   +   +D+W  G  + E+L     P+  ++    + +I  G   P+P +     
Sbjct: 564 INFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621

Query: 371 QDFIKQCVQVNPNDRPTAAQLLD 393
              + +C   +P+ RP   +L  
Sbjct: 622 YSLMTKCWAYDPSRRPRFTELKA 644

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (374), Expect = 2e-41
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 21/277 (7%)

Query: 132 SPNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAK 184
           +PN    RI+   +  K  +LG G+FG+VY+G+   +G       A+KE   L + +  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPK 59

Query: 185 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 242
               ++  E  +++  ++ ++ +  G     + + +  +L+  G LL+     + ++   
Sbjct: 60  A-NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 243 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCR 301
            +  +  QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +      
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

Query: 302 GTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG 357
           G      WMA E I ++   Y   +D+WS G TV E++T    PY  +        + +G
Sbjct: 178 GGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

Query: 358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
              P P   + D    + +C  ++ + RP   +L+  
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (374), Expect = 3e-41
 Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 29/280 (10%)

Query: 133 PNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 185
                 RI   T  +K  +LG G FG+V++G+   +G        +K    ++  S   Q
Sbjct: 2   AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV---IEDKSGR-Q 57

Query: 186 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 243
           S   +   +  +   +H +IV+  G     S L +  + +  GSLL+     R  L    
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQL 116

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRG 302
           +  +  QI  G+ YL +  +VHR++   N+L+ +   V++ADFG+A     +D       
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176

Query: 303 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIG 355
                 WMA E I+     Y   +D+WS G TV E++T    PYA +   E    L K  
Sbjct: 177 AKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234

Query: 356 RGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
           R + P I    +       + +C  ++ N RPT  +L + 
Sbjct: 235 RLAQPQICTIDVY----MVMVKCWMIDENIRPTFKELANE 270

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  146 bits (371), Expect = 3e-41
 Identities = 80/293 (27%), Positives = 139/293 (47%), Gaps = 53/293 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 201
           +   + +G G++G VY+  ++ G  FA+K++ L   D+G       + + +EI++L   +
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTI-REISILKELK 58

Query: 202 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
           H NIV+ Y     + +L +    L+   K  L        L      ++  Q+L G+ Y 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVI 312
           HD+ V+HRD+K  N+L++  G +K+ADFGLA+A  +      +++     T ++ AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVL 172

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP---------- 359
              +K Y    DIWS+GC   EM+    P  P       L +I R  G+P          
Sbjct: 173 MG-SKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 360 -----------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                       P+P       L +   D + + ++++PN R TA Q L+H +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  149 bits (379), Expect = 3e-41
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 46/323 (14%)

Query: 105 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGD-----LLGRGSFGSVY 159
            + +    +   +D   +   +    I    +  R+    Q+ D     ++GRG+F  V 
Sbjct: 23  GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRL----QRDDFEILKVIGRGAFSEVA 78

Query: 160 EGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTD 212
                  G  +A+K ++        K  + +  +      E  +L   +   I Q +   
Sbjct: 79  VVKMKQTGQVYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130

Query: 213 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILLGLKYLHDQDVVHRDIKC 270
           +DE+ LY+ +E    G LL L  ++  R     A  Y  +I++ +  +H    VHRDIK 
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190

Query: 271 ANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG-----YGLP 322
            NIL+D  G ++LADFG     + +         GT  +++PE++     G     YG  
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250

Query: 323 ADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRG----SPPPIPDSLSKDAQDFIKQ 376
            D W+LG    EM   Q P YA  +  A  + KI       S P + + + ++A+DFI++
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYA--DSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR 308

Query: 377 CVQVNPNDR---PTAAQLLDHPF 396
            +   P  R     A     HPF
Sbjct: 309 LLC-PPETRLGRGGAGDFRTHPF 330

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  148 bits (375), Expect = 3e-41
 Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 39/275 (14%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 199
           ++GRGS+  V    +      +A+K V         K+ ++          E+ +     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK--------KELVNDDEDIDWVQTEKHV-FEQA 66

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 258
             H  +V  +   + ES+L+  +E V  G L+  + ++  L +     Y+ +I L L YL
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 315
           H++ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GT  ++APE++  +
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEIL--R 183

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA--------LFKIGRGSPPPIPDSLS 367
            + YG   D W+LG  + EM+  + P+  +             LF++       IP SLS
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243

Query: 368 KDAQDFIKQCVQVNPNDR------PTAAQLLDHPF 396
             A   +K  +  +P +R         A +  HPF
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  146 bits (371), Expect = 3e-41
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 53/294 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRF 200
           ++K + +G G++G+V++  + +     A+K V L   D+G       S L +EI LL   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSAL-REICLLKEL 58

Query: 201 EHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           +H+NIV+ +     + KL +   F +   K    +      L    V ++  Q+L GL +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGF 116

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEV 311
            H ++V+HRD+K  N+L++ NG +KLA+FGLA+A  +       +V     T ++  P+V
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDV 172

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPP------- 361
           +    K Y    D+WS GC   E+  +  P  P       L +I R  G+P         
Sbjct: 173 LFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 362 -IPD------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
            +PD                   L+   +D ++  ++ NP  R +A + L HP+
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  146 bits (370), Expect = 4e-41
 Identities = 55/270 (20%), Positives = 105/270 (38%), Gaps = 37/270 (13%)

Query: 147 GDLLGRGSFGSVYEGI---SDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 201
            + LG+G+F  +++G+     D       EV L  LD+  +         +  +++S+  
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLS 70

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 259
           H+++V  YG      +  +  E V  GSL    +  +  +         +Q+   + +L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 260 DQDVVHRDIKCANILVDA--------NGSVKLADFGLAKATKLND-----VKSCRGTAFW 306
           +  ++H ++   NIL+             +KL+D G++      D     +        W
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-------W 183

Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGS--PPPIP 363
           + PE I N  K   L  D WS G T+ E+ +    P + ++    L         P P  
Sbjct: 184 VPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKA 242

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
             L     + I  C+   P+ RP+   ++ 
Sbjct: 243 AEL----ANLINNCMDYEPDHRPSFRAIIR 268

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  146 bits (370), Expect = 4e-41
 Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 22/258 (8%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
            + LG G FG V+ G  +     AVK    L QGS +         E  L+ + +H+ +V
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRLV 71

Query: 207 QYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHD 260
           + Y   T   +  +YI  E +  GSL++ +        L  +++     QI  G+ ++ +
Sbjct: 72  RLYAVVT---QEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNK 317
           ++ +HRD++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT- 186

Query: 318 GYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            + + +D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ 
Sbjct: 187 -FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245

Query: 377 CVQVNPNDRPTAAQLLDH 394
           C +  P DRPT   L   
Sbjct: 246 CWKERPEDRPTFDYLRSV 263

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  150 bits (380), Expect = 4e-41
 Identities = 71/255 (27%), Positives = 126/255 (49%), Gaps = 18/255 (7%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              LG G FG V+    +     AVK    +  GS + +       E  ++   +H+ +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVE---AFLAEANVMKTLQHDKLV 246

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----YTRQILLGLKYLHDQD 262
           + +     E  +YI  E + KGSLL+ + +      Q       ++ QI  G+ ++  ++
Sbjct: 247 KLHAVVTKEP-IYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 319
            +HRD++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--F 362

Query: 320 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
            + +D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCW 422

Query: 379 QVNPNDRPTAAQLLD 393
           +  P +RPT   +  
Sbjct: 423 KNRPEERPTFEYIQS 437

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  147 bits (373), Expect = 5e-41
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 29/265 (10%)

Query: 147 GDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
             ++G G FG VY+G+            A+K    L  G   KQ +  L  E  ++ +F 
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFL-GEAGIMGQFS 104

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 258
           H NI++  G       + I  E +  G+L   + R         Q+    R I  G+KYL
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN 313
            + + VHRD+   NILV++N   K++DFGL++  + +     +  G      W APE I+
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 314 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSK 368
            +   +   +D+WS G  + E++T  + PY  +   E M A+    R   P   P ++  
Sbjct: 224 YRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI-- 279

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLD 393
                + QC Q     RP  A ++ 
Sbjct: 280 --YQLMMQCWQQERARRPKFADIVS 302

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  146 bits (370), Expect = 7e-41
 Identities = 82/299 (27%), Positives = 124/299 (41%), Gaps = 44/299 (14%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 195
               + ++    +G G++G+VY+      G F A+K V +    G      IS + +E+A
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVA 63

Query: 196 LL---SRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVS 245
           LL     FEH N+V+            E K+ +  E V +   + L+      L    + 
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123

Query: 246 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
              RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+        +      
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183

Query: 306 WM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPP 361
           W  APEV+      Y  P D+WS+GC   EM   + P          L KI    G PP 
Sbjct: 184 WYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDLIGLPPE 240

Query: 362 --------IPDS----------------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                   +P                  + +     + + +  NP+ R +A + L H +
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  147 bits (373), Expect = 7e-41
 Identities = 87/300 (29%), Positives = 134/300 (44%), Gaps = 52/300 (17%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIA 195
           K     ++K D LG G F +VY+    +     A+K++  L   S+AK  I     +EI 
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIK 64

Query: 196 LLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 252
           LL    H NI+        +S + +   F+E   +  + +      L  S + AY    L
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------TKLNDVKSCRGTA 304
            GL+YLH   ++HRD+K  N+L+D NG +KLADFGLAK+        T  + V     T 
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVV----TR 176

Query: 305 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP-- 359
           ++ APE++    + YG+  D+W++GC + E+L    P+ P +  +  L +I    G+P  
Sbjct: 177 WYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTE 234

Query: 360 ------------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                             P IP      +   D  D I+     NP  R TA Q L   +
Sbjct: 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  146 bits (370), Expect = 8e-41
 Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 29/271 (10%)

Query: 147 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G +LG+G FGSV E     +DG F   AVK   +L     A   I +  +E A +  F+H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACMKEFDH 84

Query: 203 ENIVQYYG--TDKD----ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--- 253
            ++ +  G               + L  +  G L   +               Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA-FLLASRIGENPFNLPLQTLVRFM 143

Query: 254 -----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 305
                G++YL  ++ +HRD+   N ++  + +V +ADFGL++     D       +    
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 306 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 363
            W+A E + +    Y + +D+W+ G T+ E++T  Q PYA +E       +  G+    P
Sbjct: 204 KWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP 261

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
               ++  D + QC   +P  RP+   L   
Sbjct: 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  151 bits (383), Expect = 1e-40
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 26/259 (10%)

Query: 150 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG G+FGSV +G+          A+K    L QG++   +   + +E  ++ + ++  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMM-REAQIMHQLDNPYIV 399

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           +  G  + E+ L + +E+   G L    + +R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPEVINNKNKGY 319
           HR++   N+L+      K++DFGL+KA   +D    +     +   W APE IN +   +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 516

Query: 320 GLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSKDAQDFI 374
              +D+WS G T+ E L+  Q PY  M   E MA + +  R   PP  P  L       +
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY----ALM 572

Query: 375 KQCVQVNPNDRPTAAQLLD 393
             C      DRP    +  
Sbjct: 573 SDCWIYKWEDRPDFLTVEQ 591

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  146 bits (370), Expect = 1e-40
 Identities = 68/332 (20%), Positives = 133/332 (40%), Gaps = 59/332 (17%)

Query: 111 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 169
                H     + T  P S           I  +++   LG G++G VY+ I        
Sbjct: 3   HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 170 AVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 227
           A+K + L   ++G       + + +E++LL   +H NI++         +L++  E    
Sbjct: 63  AIKRIRLEHEEEGV----PGTAI-REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 228 --GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GS 280
                ++  +   +    + ++  Q++ G+ + H +  +HRD+K  N+L+  +       
Sbjct: 118 DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 281 VKLADFGLAKATKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 334
           +K+ DFGLA+A  +      +++     T ++  PE++   ++ Y    DIWS+ C   E
Sbjct: 176 LKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEILLG-SRHYSTSVDIWSIACIWAE 230

Query: 335 MLTSQIPYAPMEC-MAALFKIGR--GSP---------------------PP------IPD 364
           ML    P  P +  +  LFKI    G P                             +  
Sbjct: 231 MLMKT-PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGA 289

Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
            L  +  D +   ++++P  R +A   L+HP+
Sbjct: 290 LLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  146 bits (371), Expect = 2e-40
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 30/265 (11%)

Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             ++G G FG V  G     S      A+K    L  G   KQ    L  E +++ +F+H
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFL-GEASIMGQFDH 105

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 259
            NI++  G       + I  E +  GSL + + R H       Q+    R I  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN- 313
           D   VHRD+   NIL+++N   K++DFGL +  + +     + RG      W +PE I  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 314 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG----SPPPIPDSLSK 368
            K   +   +D+WS G  + E+++  + PY  M     +  +  G     P   P +L  
Sbjct: 225 RK---FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL-- 279

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLD 393
                +  C Q + N+RP   Q++ 
Sbjct: 280 --YQLMLDCWQKDRNNRPKFEQIVS 302

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  146 bits (371), Expect = 3e-40
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 39/275 (14%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 199
           ++GRGS+  V    +      +A++ V         K+ ++          E+ +     
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVK--------KELVNDDEDIDWVQTEKHV-FEQA 109

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 258
             H  +V  +   + ES+L+  +E V  G L+  + ++  L +     Y+ +I L L YL
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 315
           H++ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GT  ++APE++  +
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEIL--R 226

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA--------LFKIGRGSPPPIPDSLS 367
            + YG   D W+LG  + EM+  + P+  +             LF++       IP SLS
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286

Query: 368 KDAQDFIKQCVQVNPNDR------PTAAQLLDHPF 396
             A   +K  +  +P +R         A +  HPF
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  145 bits (368), Expect = 3e-40
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 27/262 (10%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 199
           +LG+GSFG V+         FFA+K +         K  +          +E+ + L   
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALK--------KDVVLMDDDVECTMVEKRV-LSLA 74

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 258
           +EH  +   + T + +  L+  +E +  G L+  +   +    S+ + Y  +I+LGL++L
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 315
           H + +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+   C GT  ++APE++   
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL--L 191

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
            + Y    D WS G  + EML  Q P+   +    LF   R   P  P  L K+A+D + 
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250

Query: 376 QCVQVNPNDRPTAAQ-LLDHPF 396
           +     P  R      +  HP 
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPL 272

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  146 bits (370), Expect = 3e-40
 Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 42/271 (15%)

Query: 149 LLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLS 198
           ++G+GSFG V        +  F+AVK +         K++I +         E+ + LL 
Sbjct: 45  VIGKGSFGKVLLARHK-AEEVFYAVKVLQ--------KKAILKKKEEKHIMSERNV-LLK 94

Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQIL 252
             +H  +V  + + +   KLY  L+ +  G L      YHL+  +         Y  +I 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIA 149

Query: 253 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAP 309
             L YLH  ++V+RD+K  NIL+D+ G + L DFGL K    ++  +   C GT  ++AP
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAP 208

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
           EV++   + Y    D W LG  + EML    P+      A ++      P  +  +++  
Sbjct: 209 EVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNITNS 265

Query: 370 AQDFIKQCVQVNPNDR----PTAAQLLDHPF 396
           A+  ++  +Q +   R        ++  H F
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  145 bits (368), Expect = 4e-40
 Identities = 76/267 (28%), Positives = 120/267 (44%), Gaps = 32/267 (11%)

Query: 149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 199
           +LG+GSFG V      + G  +AVK +         K  I Q         E+ I L   
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK--------KDVILQDDDVECTMTEKRI-LSLA 80

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 258
             H  + Q +   +   +L+  +E V  G L+  + +     +++   Y  +I+  L +L
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 315
           HD+ +++RD+K  N+L+D  G  KLADFG+ K    N V +   C GT  ++APE++  +
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEIL--Q 197

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
              YG   D W++G  + EML    P+   E    LF+         P  L +DA   +K
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLHEDATGILK 256

Query: 376 QCVQVNPNDR----PTAA--QLLDHPF 396
             +  NP  R           +L HPF
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPF 283

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  144 bits (365), Expect = 5e-40
 Identities = 79/300 (26%), Positives = 125/300 (41%), Gaps = 48/300 (16%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSL--LDQG--SQAKQSISQLE 191
            R    ++    +G G++G V++     + G F A+K V +   ++G      + ++ L 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 192 QEIALLSRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQV 244
                L  FEH N+V+            E+KL +  E V +   + L+      +    +
Sbjct: 67  H----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 245 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
                Q+L GL +LH   VVHRD+K  NILV ++G +KLADFGLA+        +     
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 305 FWM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP- 359
            W  APEV+   +  Y  P D+WS+GC   EM   + P       +  L KI    G P 
Sbjct: 183 LWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPG 239

Query: 360 ------------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                                P       + +  +D + +C+  NP  R +A   L HP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  142 bits (360), Expect = 1e-39
 Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 30/260 (11%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              +G+G FG V  G    G   AVK    +   + A+        E +++++  H N+V
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVK---CIKNDATAQA----FLAEASVMTQLRHSNLV 77

Query: 207 QYYGT-DKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 262
           Q  G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   +
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 319
            VHRD+   N+LV  +   K++DFGL K        +         W APE +  K   +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKK--F 191

Query: 320 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFI 374
              +D+WS G  + E+ +  ++PY  +     + ++ +G    +P   P ++     + +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY----EVM 247

Query: 375 KQCVQVNPNDRPTAAQLLDH 394
           K C  ++   RP+  QL + 
Sbjct: 248 KNCWHLDAAMRPSFLQLREQ 267

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  145 bits (368), Expect = 2e-39
 Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 30/259 (11%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE--QEIALLSRFEHEN 204
              +G+G FG V  G    G   AVK +         K   +      E +++++  H N
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQAFLAEASVMTQLRHSN 247

Query: 205 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYL 258
           +VQ  G    +++  LYI  E + KGSL++ Y     R  L    +  ++  +   ++YL
Sbjct: 248 LVQLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 315
              + VHRD+   N+LV  +   K++DFGL K        +         W APE +  K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREK 361

Query: 316 NKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 374
              +   +D+WS G  + E+ +  ++PY  +     + ++ +G     PD       D +
Sbjct: 362 K--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419

Query: 375 KQCVQVNPNDRPTAAQLLD 393
           K C  ++   RPT  QL +
Sbjct: 420 KNCWHLDAATRPTFLQLRE 438

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  148 bits (375), Expect = 3e-39
 Identities = 88/423 (20%), Positives = 155/423 (36%), Gaps = 47/423 (11%)

Query: 6   LPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILR--DFAPKD 63
           L P   +ES     +       +       +     +   +      WD+    DF    
Sbjct: 201 LIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSL 260

Query: 64  GITPSSVMNDRALSSSSDDEDNEKE----GEEADRAIVKEEEDDMVLSESCSFTTEHEDD 119
               S +               E E        + +   EE             T+  ++
Sbjct: 261 SFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEE 320

Query: 120 SSSTTTEPMSNISPNGRFK----RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 174
            ++ T     N     R K      +       +LG+GSFG V           +AVK +
Sbjct: 321 KTANTISKFDNNGNRDRMKLTDFNFLM------VLGKGSFGKVMLSERKGTDELYAVKIL 374

Query: 175 SLLDQGSQAKQSISQ--------LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 226
                    K  + Q        +E+ + L    +   + Q +   +   +LY  +E V 
Sbjct: 375 K--------KDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425

Query: 227 KGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 285
            G L  ++ Q    ++     Y  +I +GL +L  + +++RD+K  N+++D+ G +K+AD
Sbjct: 426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIAD 485

Query: 286 FGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 342
           FG+ K    + V +   C GT  ++APE+I    + YG   D W+ G  + EML  Q P+
Sbjct: 486 FGMCKENIWDGVTTKTFC-GTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPF 542

Query: 343 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR-----PTAAQLLDHPFV 397
              E    LF+         P S+SK+A    K  +  +P  R          + +H F 
Sbjct: 543 -EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

Query: 398 KRL 400
           + +
Sbjct: 602 RYI 604

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  142 bits (360), Expect = 3e-39
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 54/294 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 201
           + K D LG G++ +VY+G S       A+KE+ L  ++G+      + + +E++LL   +
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAI-REVSLLKDLK 58

Query: 202 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
           H NIV  +     E  L +   +L+   K  L +      +    V  +  Q+L GL Y 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVI 312
           H Q V+HRD+K  N+L++  G +KLADFGLA+A  +      N+V     T ++  P+++
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDIL 172

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP---------- 359
                 Y    D+W +GC   EM T + P  P       L  I R  G+P          
Sbjct: 173 LGS-TDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230

Query: 360 ------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                                  L  D  D + + +Q    +R +A   + HPF
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  143 bits (362), Expect = 3e-39
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 31/266 (11%)

Query: 149 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 199
           +LG+GSFG V           +AVK +         K  + Q        +E+ + L   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALP 77

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 258
            +   + Q +   +   +LY  +E V  G L+  + Q    ++     Y  +I +GL +L
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 315
             + +++RD+K  N+++D+ G +K+ADFG+ K    + V +   C GT  ++APE+I   
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA-- 194

Query: 316 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 375
            + YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253

Query: 376 QCVQVNPNDR----PTAAQ-LLDHPF 396
             +  +P  R    P   + + +H F
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAF 279

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  141 bits (359), Expect = 3e-39
 Identities = 85/301 (28%), Positives = 145/301 (48%), Gaps = 59/301 (19%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 201
           +++ + LG G++ +VY+G++   G + A+KEV L  ++G+      + + +EI+L+   +
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAI-REISLMKELK 61

Query: 202 HENIVQYYGTDKDESKLYI---FLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGL 255
           HENIV+ Y     E+KL +   F++   K    S         L  + V  +  Q+L GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAP 309
            + H+  ++HRD+K  N+L++  G +KL DFGLA+A  +      ++V     T ++ AP
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRAP 177

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP------- 359
           +V+   ++ Y    DIWS GC + EM+T + P  P       L  I    G+P       
Sbjct: 178 DVLMG-SRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPS 235

Query: 360 --------------PPIP----------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP 395
                         PP            + L  +  DF+   +Q+NP+ R +A Q L HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 396 F 396
           +
Sbjct: 296 W 296

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  143 bits (362), Expect = 3e-39
 Identities = 76/303 (25%), Positives = 119/303 (39%), Gaps = 61/303 (20%)

Query: 150 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE------QEIALLSRFEHE 203
           +  GS+G+V  G+  +G   A+K V       +    +S         +EI LL+ F H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 204 NIVQYYGTDKDESK-----LYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILL 253
           NI+          +     LY+  EL+      +L Q     R  +    +  +   ILL
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHILL 145

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMA 308
           GL  LH+  VVHRD+   NIL+  N  + + DF LA+    +      V       ++ A
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV----THRWYRA 201

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP----- 361
           PE++    KG+    D+WS GC + EM   +  +        L KI    G+P       
Sbjct: 202 PELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260

Query: 362 ---------IPDSL---------------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
                    + +SL                  A D I + ++ NP  R +  Q L HP+ 
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

Query: 398 KRL 400
           + L
Sbjct: 321 ESL 323

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  140 bits (356), Expect = 5e-39
 Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 22/275 (8%)

Query: 147 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
            +++GRG FG VY G    +DG     AVK    L++ +   + +SQ   E  ++  F H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85

Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 259
            N++   G   + E    + L  +  G L N  +   ++     +  +  Q+  G+KYL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVIN 313
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S            WMA E + 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205

Query: 314 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
            +   +   +D+WS G  + E++T    PY  +        + +G     P+       +
Sbjct: 206 TQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 263

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 407
            + +C       RP+ ++L+    +  + +T  G 
Sbjct: 264 VMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGE 296

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  141 bits (357), Expect = 6e-39
 Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 28/270 (10%)

Query: 147 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G +LG G FGSV EG    +DG     AVK    +   + +++ I +   E A +  F H
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACMKDFSH 95

Query: 203 ENIVQYYG--TDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------R 249
            N+++  G   +       K  + L  +  G L   Y  Y   ++               
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT-YLLYSRLETGPKHIPLQTLLKFMV 154

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 305
            I LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D       A     
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD 364
           W+A E + +    Y   +D+W+ G T+ E+ T    PY  ++       +  G     P+
Sbjct: 215 WIAIESLAD-RV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272

Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
               +  + +  C + +P DRPT + L   
Sbjct: 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  142 bits (360), Expect = 6e-39
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 55/300 (18%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           LG G++G V        G   A+K++   D+   A +++    +EI +L  F+HENI+  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENIITI 74

Query: 209 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           +   + +S      +YI  EL+    L  +     L D  +  +  Q L  +K LH  +V
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV 133

Query: 264 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWM----------APEV 311
           +HRD+K +N+L+++N  +K+ DFGLA        D     G    M          APEV
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPPIPD----- 364
           +   +  Y    D+WS GC + E+   +  +   +    L  I    G+P    D     
Sbjct: 194 MLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252

Query: 365 ---------SL---------------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                    SL               +    D +++ +  +P  R TA + L+HP+++  
Sbjct: 253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  143 bits (362), Expect = 2e-38
 Identities = 79/408 (19%), Positives = 143/408 (35%), Gaps = 106/408 (25%)

Query: 92  ADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLG 151
           +  A   ++ +            E +      +++P +++       +I   ++   L+G
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 152 RGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 209
            GS+G V E     +    A+K++    +     K+ +    +EIA+L+R  H+++V+  
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHVVKVL 118

Query: 210 GTDKDES-----KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
                +      +LY+ LE+    S          +L +  +      +L+G+KY+H   
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM--------------- 307
           ++HRD+K AN LV+ + SVK+ DFGLA+     +  + +                     
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236

Query: 308 --------------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP------------ 341
                         APE+I    + Y    D+WS+GC   E+L                 
Sbjct: 237 KRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295

Query: 342 ----YAPMECMAA---------------LFKIGR--GSP--------------------- 359
                 P+                    L  I    G+P                     
Sbjct: 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355

Query: 360 --PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                       + S DA   +K+ +  NPN R T  + L HPF K +
Sbjct: 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 2e-38
 Identities = 66/280 (23%), Positives = 118/280 (42%), Gaps = 28/280 (10%)

Query: 145 QKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
               ++G+G FG VY G     + +    A+K +S         Q +    +E  L+   
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS----RITEMQQVEAFLREGLLMRGL 79

Query: 201 EHENIVQYYGT-DKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 257
            H N++   G     E   ++ L  +  G LL      + +     + ++  Q+  G++Y
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF---WMAPEV 311
           L +Q  VHRD+   N ++D + +VK+ADFGLA+     +   V+  R       W A E 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 312 INNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS 367
           +             +D+WS G  + E+LT    PY  ++       + +G   P P+   
Sbjct: 200 LQ-----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP 254

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 407
                 ++QC + +P  RPT   L     V+++++   G 
Sbjct: 255 DSLYQVMQQCWEADPAVRPTFRVL--VGEVEQIVSALLGD 292

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  139 bits (352), Expect = 7e-38
 Identities = 76/322 (23%), Positives = 127/322 (39%), Gaps = 61/322 (18%)

Query: 128 MSNISPNGRFK--RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 184
           M+    +        ++ ++K   +G+G+FG V++      G   A+K+V +       K
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM----ENEK 56

Query: 185 QSI-SQLEQEIALLSRFEHENIVQ--------YYGTDKDESKLYI---FLELVTKGSLLN 232
           +       +EI +L   +HEN+V             ++ +  +Y+   F E    G L N
Sbjct: 57  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116

Query: 233 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 292
                    S++    + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A 
Sbjct: 117 --VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 293 KLNDVKSCRG------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 346
            L              T ++  PE++    + YG P D+W  GC + EM T   P     
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS-PIMQGN 232

Query: 347 C-MAALFKIGR--GSPPP--------IPD---------------------SLSKDAQDFI 374
                L  I +  GS  P                                     A D I
Sbjct: 233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292

Query: 375 KQCVQVNPNDRPTAAQLLDHPF 396
            + + ++P  R  +   L+H F
Sbjct: 293 DKLLVLDPAQRIDSDDALNHDF 314

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (353), Expect = 8e-38
 Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 28/278 (10%)

Query: 147 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
            +++GRG FG VY G    +DG     AVK    L++ +   + +SQ   E  ++  F H
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 149

Query: 203 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 259
            N++   G   + E    + L  +  G L N  +   ++     +  +  Q+  G+K+L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVIN 313
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S            WMA E + 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 314 NKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 369
                       +D+WS G  + E++T    PY  +        + +G     P+     
Sbjct: 270 -----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 407
             + + +C       RP+ ++L+    +  + +T  G 
Sbjct: 325 LYEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGE 360

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  137 bits (348), Expect = 3e-37
 Identities = 77/293 (26%), Positives = 137/293 (46%), Gaps = 49/293 (16%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90

Query: 209 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
               +  +      +YI  +L+    L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINNKNKG 318
           +HRD+K +N+L++    +K+ DFGLA+    +   +   T +    W  APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--------------- 361
           Y    DIWS+GC + EML+++  +     +  L  I    GSP                 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268

Query: 362 --------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                          P++    A D + + +  NP+ R    Q L HP++++ 
Sbjct: 269 LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  136 bits (344), Expect = 4e-37
 Identities = 76/291 (26%), Positives = 117/291 (40%), Gaps = 42/291 (14%)

Query: 147 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
             L+GRG  G VYE   +D       A+K   L+            L  +    +R + E
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALK---LMS---------ETLSSDPVFRTRMQRE 84

Query: 204 ----------NIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQI 251
                     ++V  +   + + +LY+ + L+  G  L   L ++  L   +  A  RQI
Sbjct: 85  ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI-NGVDLAAMLRRQGPLAPPRAVAIVRQI 143

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMA 308
              L   H     HRD+K  NILV A+    L DFG+A A    KL  + +  GT ++MA
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD---S 365
           PE  +  +  Y   ADI++L C + E LT   PY   + ++ +      + P        
Sbjct: 204 PERFSESHATY--RADIYALTCVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPSTVRPG 260

Query: 366 LSKDAQDFIKQCVQVNPNDR-PTAAQLLDHPFVKRLLATNSGSASPYLGRR 415
           +       I + +  NP DR  T   L         LAT     +  + RR
Sbjct: 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAA--AHAALATADQDRATDILRR 309

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  135 bits (342), Expect = 6e-37
 Identities = 74/274 (27%), Positives = 112/274 (40%), Gaps = 39/274 (14%)

Query: 150 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARK---DFQREAELLTNLQHE 77

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 248
           +IV++YG   D   L +  E +  G L   + R H  D+ +                   
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNK-FLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 249 ---RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 305
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 306 ----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP 359
               WM PE I   K   +   +D+WS G  + E+ T  + P+  +     +  I +G  
Sbjct: 197 LPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 253

Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
              P    K+  D +  C Q  P  R    ++  
Sbjct: 254 LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  135 bits (343), Expect = 8e-37
 Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 46/295 (15%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
              LG+GSFG VYEG++            A+K    +++ +  ++   +   E +++  F
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYT 248
              ++V+  G         + +EL+T+G L + Y R                 S++    
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 305
            +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G      
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204

Query: 306 -WMAPEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRG 357
            WM+PE +       G+    +D+WS G  + E+ T ++ PY   +  + +  + + G  
Sbjct: 205 RWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259

Query: 358 SPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPY 411
             P   PD L     + ++ C Q NP  RP+  ++     +K  +       S Y
Sbjct: 260 DKPDNCPDML----FELMRMCWQYNPKMRPSFLEI--ISSIKEEMEPGFREVSFY 308

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  136 bits (345), Expect = 1e-36
 Identities = 67/303 (22%), Positives = 124/303 (40%), Gaps = 62/303 (20%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +G G+ G V     +      A+K++S      + AK++     +E+ L+    H+NI+ 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIG 88

Query: 208 YYGTDKDESK------LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 259
                  +        +YI +EL+      NL Q  +  L   ++S    Q+L G+K+LH
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLH 144

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKG 318
              ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEVI     G
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMG 202

Query: 319 YGLPADIWSLGCTVLEMLT----------------------------------------S 338
           Y    DIWS+GC + EM+                                          
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262

Query: 339 QIPYAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
             P         LF  +   +        +  A+D + + + ++ + R +  + L HP++
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

Query: 398 KRL 400
              
Sbjct: 323 NVW 325

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  138 bits (349), Expect = 1e-36
 Identities = 75/360 (20%), Positives = 138/360 (38%), Gaps = 67/360 (18%)

Query: 100 EEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---------IITYWQKGDLL 150
           E    V    C    +  D S       MS    + +F           ++  +Q    +
Sbjct: 11  EPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70

Query: 151 GRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           G G+ G V     +      A+K++S      + AK++     +E+ L+    H+NI+  
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISL 126

Query: 209 Y------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
                   T ++   +Y+ +EL+   + L    +  L   ++S    Q+L G+K+LH   
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 184

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKGYGL 321
           ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEVI     GY  
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKE 242

Query: 322 PADIWSLGCTVLEMLT----------------------------------------SQIP 341
             DIWS+GC + EM+                                            P
Sbjct: 243 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 302

Query: 342 YAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                    LF      +        +  A+D + + + ++P  R +    L HP++   
Sbjct: 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  134 bits (340), Expect = 1e-36
 Identities = 77/298 (25%), Positives = 137/298 (45%), Gaps = 29/298 (9%)

Query: 127 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQA 183
            M     N R+ +I+      D LG G   +VY     D       A+K  ++     + 
Sbjct: 3   HMIGKIINERY-KIV------DKLGGGGMSTVYLAE--DTILNIKVAIK--AIFIPPREK 51

Query: 184 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRD 241
           ++++ + E+E+   S+  H+NIV     D+++   Y+ +E + +G  L+  +     L  
Sbjct: 52  EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSV 110

Query: 242 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVK 298
                +T QIL G+K+ HD  +VHRDIK  NIL+D+N ++K+ DFG+AKA   T L    
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170

Query: 299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS 358
              GT  + +PE    K +      DI+S+G  + EML  + P+     ++   K  + S
Sbjct: 171 HVLGTVQYFSPEQA--KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228

Query: 359 PPPIP----DSLSKDAQDFIKQCVQVNPNDRP-TAAQLLDHPFVKRLLATNSGSASPY 411
            P +       + +   + I +  + +  +R  T  ++ D   +  +L  N  +   Y
Sbjct: 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD--LSSVLHENRANEDVY 284

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (342), Expect = 1e-36
 Identities = 75/278 (26%), Positives = 109/278 (39%), Gaps = 44/278 (15%)

Query: 147 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
              LG G+FG VYEG    + +D      AVK    L +    +        E  ++S+F
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKF 90

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQI 251
            H+NIV+  G        +I +EL+  G L + + R           L    +    R I
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF--- 305
             G +YL +   +HRDI   N L+   G     K+ DFG+A+           G A    
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 306 -WMAPEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRG 357
            WM PE         G+     D WS G  + E+ +   +PY      E +  +   GR 
Sbjct: 210 KWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264

Query: 358 SPPP-IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            PP   P  +       + QC Q  P DRP  A +L+ 
Sbjct: 265 DPPKNCPGPV----YRIMTQCWQHQPEDRPNFAIILER 298

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  135 bits (342), Expect = 2e-36
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 52/292 (17%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +G G++GSV   I    G   A+K++S        AK++     +E+ LL   +HEN++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87

Query: 208 YY------GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 259
                    + ++    Y+ +  +      +L +       + ++     Q+L GLKY+H
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 319
              VVHRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEVI +    Y
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEVILS-WMHY 201

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP---------------- 361
               DIWS+GC + EMLT +  +   + +  L +I +  G P                  
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261

Query: 362 -------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                         P + S  A D +++ ++++ + R TAAQ L HPF +  
Sbjct: 262 SLPQTPRKDFTQLFPRA-SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  134 bits (340), Expect = 5e-36
 Identities = 69/344 (20%), Positives = 122/344 (35%), Gaps = 97/344 (28%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
            +     +  G  LG GSFG V E    + G  FA+K+V         +       +E+ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKN----RELD 52

Query: 196 LLSRFEHENIVQ----YYGTD----------------------------------KDESK 217
           ++   +H NI++    +Y T                                        
Sbjct: 53  IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112

Query: 218 LYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIK 269
           L + +E V       L++  +  +R  +      +S Y  Q+   + ++H   + HRDIK
Sbjct: 113 LNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168

Query: 270 CANILVDAN-GSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADI 325
             N+LV++   ++KL DFG AK    ++      C  + F+ APE++      Y    D+
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLG-ATEYTPSIDL 225

Query: 326 WSLGCTVLEMLTSQIPYAP----------------------MECM---AALFKIGRGSPP 360
           WS+GC   E++  + P                         M  M       +       
Sbjct: 226 WSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284

Query: 361 P----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                +P+     A D ++Q ++  P+ R    + + HPF   L
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (336), Expect = 8e-36
 Identities = 65/274 (23%), Positives = 110/274 (40%), Gaps = 38/274 (13%)

Query: 150 LGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG V+     +          AVK    L + S  + +    ++E  LL+  +H+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEAS--ESARQDFQREAELLTMLQHQ 103

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 248
           +IV+++G   +   L +  E +  G L   + R H  D+++ A                 
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 249 --RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 305
              Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D     G    
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 306 ---WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 360
              WM PE I   K   +   +D+WS G  + E+ T  + P+  +    A+  I +G   
Sbjct: 223 PIRWMPPESILYRK---FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             P +   +    ++ C Q  P  R +   +   
Sbjct: 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  132 bits (335), Expect = 1e-35
 Identities = 78/316 (24%), Positives = 131/316 (41%), Gaps = 69/316 (21%)

Query: 120 SSSTTTEPMSNISPNGRFKRIITYWQ---------KGDLLGRGSFGSVYEGISDDGFFFA 170
           ++++  + +S+          +                L+G G FG VY+G+  DG   A
Sbjct: 8   ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67

Query: 171 VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKL-YIFLELVTK 227
           +K        S   Q I + E EI  LS   H ++V   G   +++E  L Y   + +  
Sbjct: 68  LK---RRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY---KYMEN 119

Query: 228 GSLLNLYQRYHLRDSQVSAY-----TR-QILL----GLKYLHDQDVVHRDIKCANILVDA 277
           G+L     + HL  S +         R +I +    GL YLH + ++HRD+K  NIL+D 
Sbjct: 120 GNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174

Query: 278 NGSVKLADFGLAKATKLND-------VKSCRGTAFWMAPE-VINNK--NKGYGLPADIWS 327
           N   K+ DFG++K     D       VK   GT  ++ PE  I  +   K     +D++S
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVK---GTLGYIDPEYFIKGRLTEK-----SDVYS 226

Query: 328 LGCTVLEMLTSQ---IPYAPMECMA----ALFKIGRGSPPPIPDSL------SKDAQDFI 374
            G  + E+L ++   +   P E +     A+     G    I D         +  + F 
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFG 286

Query: 375 K---QCVQVNPNDRPT 387
               +C+ ++  DRP+
Sbjct: 287 DTAVKCLALSSEDRPS 302

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  132 bits (334), Expect = 2e-35
 Identities = 72/301 (23%), Positives = 131/301 (43%), Gaps = 57/301 (18%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-- 206
           LG G  G V+  + +D     A+K++ L D     K ++    +EI ++ R +H+NIV  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL----REIKIIRRLDHDNIVKV 73

Query: 207 ------------QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 254
                          G+  + + +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132

Query: 255 LKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAF----WM-A 308
           LKY+H  +V+HRD+K AN+ ++  +  +K+ DFGLA+    +       +      W  +
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQI---------------------PYAPMEC 347
           P ++ +    Y    D+W+ GC   EMLT +                           + 
Sbjct: 193 PRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251

Query: 348 M---AALFKIGRGSPPPIP-DSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +     ++     + P  P   L    S++A DF++Q +  +P DR TA + L HP++  
Sbjct: 252 LLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311

Query: 400 L 400
            
Sbjct: 312 Y 312

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  133 bits (336), Expect = 2e-35
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 67/300 (22%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +G G++GSV     +  G   AVK++S        AK++     +E+ LL   +HEN++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92

Query: 208 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                    + ++ + +Y+   L+    L N+ +   L D  V     QIL GLKY+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM----------APEV 311
           D++HRD+K +N+ V+ +  +K+ DFGLA           R TA  M          APE+
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHTADEMTGYVATRWYRAPEI 200

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP-------- 361
           + N    Y    DIWS+GC + E+LT +  +   + +  L  I R  G+P          
Sbjct: 201 MLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 362 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                                   + +  A D +++ + ++ + R TAAQ L H +  + 
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  133 bits (336), Expect = 2e-35
 Identities = 72/271 (26%), Positives = 102/271 (37%), Gaps = 36/271 (13%)

Query: 150 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           LG G+FG VYEG              AVK    L +    +        E  ++S+F H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKFNHQ 134

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQILLG 254
           NIV+  G        +I LEL+  G L + + R           L    +    R I  G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 255 LKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WM 307
            +YL +   +HRDI   N L+   G     K+ DFG+A+           G A     WM
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 308 APEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 363
            PE         G+     D WS G  + E+ +   +PY        L  +  G     P
Sbjct: 254 PPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308

Query: 364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            +        + QC Q  P DRP  A +L+ 
Sbjct: 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  130 bits (330), Expect = 2e-35
 Identities = 62/282 (21%), Positives = 100/282 (35%), Gaps = 46/282 (16%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
            + LG   FG VY+G              A+K    L   ++      +   E  L +R 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPL-REEFRHEAMLRARL 69

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 248
           +H N+V   G    +  L +     + G L   +       S V +              
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE-FLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 249 ------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 302
                  QI  G++YL    VVH+D+   N+LV    +VK++D GL +     D     G
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 303 TAF----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFK 353
            +     WMAPE I   K   + + +DIWS G  + E+ +    PY      + +  +  
Sbjct: 189 NSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245

Query: 354 IGRGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
                 P   P  +       + +C    P+ RP    +   
Sbjct: 246 RQVLPCPDDCPAWV----YALMIECWNEFPSRRPRFKDIHSR 283

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  133 bits (337), Expect = 2e-35
 Identities = 70/323 (21%), Positives = 115/323 (35%), Gaps = 77/323 (23%)

Query: 143 YWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
           +  +G  +GRG++G VY+    D      +A+K++        A +       EIALL  
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRE 74

Query: 200 FEHENIVQYYG--TDKDESKLYI---FLE------LVTKGSLLNLYQRYHLRDSQVSAYT 248
            +H N++          + K+++   + E      +    +     +   L    V +  
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 249 RQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFGLAKATKLNDVKSCRGTA 304
            QIL G+ YLH   V+HRD+K ANILV       G VK+AD G A+              
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 305 ----FWM-APEVINNKNKGYGLPADIWSLGCTVLEMLT--------SQIPYAPMECMAA- 350
               FW  APE++    + Y    DIW++GC   E+LT         +            
Sbjct: 195 VVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253

Query: 351 LFKIGR--GSP------------------PPIP-----------------DSLSKDAQDF 373
           L +I    G P                                             A   
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313

Query: 374 IKQCVQVNPNDRPTAAQLLDHPF 396
           +++ + ++P  R T+ Q +  P+
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPY 336

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  132 bits (334), Expect = 4e-35
 Identities = 70/290 (24%), Positives = 132/290 (45%), Gaps = 47/290 (16%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 207
           +G G++G+V   +    G   A+K++         AK++     +E+ LL    HEN++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENVIG 88

Query: 208 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
                    T  D +  Y+ +  +    L  L +   L + ++     Q+L GL+Y+H  
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
            ++HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEVI N    Y  
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN-WMRYTQ 205

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP------------------ 361
             DIWS+GC + EM+T +  +   + +  L +I +  G+PP                   
Sbjct: 206 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265

Query: 362 -----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                      + ++ S  A + +++ + ++   R TA + L HP+ + L
Sbjct: 266 PELEKKDFASILTNA-SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  131 bits (331), Expect = 5e-35
 Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 39/280 (13%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           G  LG G+FG V    +              AVK   L D  ++  + +S L  E+ ++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 95

Query: 199 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 248
              +H+NI+   G    +  LY+ +E  +KG+L   Y R         +Y          
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 154

Query: 249 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 298
                     Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+     D  K
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 299 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI 354
                     WMAPE + ++   Y   +D+WS G  + E+ T    PY  +        +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

Query: 355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             G     P + + +    ++ C    P+ RPT  QL++ 
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  130 bits (329), Expect = 6e-35
 Identities = 74/281 (26%), Positives = 107/281 (38%), Gaps = 40/281 (14%)

Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTE-REALMSELKVLSYL 83

Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 248
             H NIV   G         +  E    G LLN + R        S  +           
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 249 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 298
                     Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 299 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK- 353
                     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K 
Sbjct: 203 VKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
           I  G     P+    +  D +K C   +P  RPT  Q++  
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  130 bits (330), Expect = 6e-35
 Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 54/290 (18%)

Query: 150 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 207
           LGRG +  V+E I   +     VK +  +      K+      +EI +L       NI+ 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIK----REIKILENLRGGPNIIT 95

Query: 208 YYGTDKDES--KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                KD       +  E V       LYQ   L D  +  Y  +IL  L Y H   ++H
Sbjct: 96  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMH 153

Query: 266 RDIKCANILVD-ANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLPA 323
           RD+K  N+++D  +  ++L D+GLA+        + R  + ++  PE++ +  + Y    
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQMYDYSL 212

Query: 324 DIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGR--GSP--------------------- 359
           D+WSLGC +  M+  + P+    +    L +I +  G+                      
Sbjct: 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272

Query: 360 ---PPIP----------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 396
                              +S +A DF+ + ++ +   R TA + ++HP+
Sbjct: 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (328), Expect = 9e-35
 Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 41/281 (14%)

Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LGRG+FG V E        +      AVK   L +  +        L  E+ +L   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATH--SEHRALMSELKILIHI 87

Query: 201 -EHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH------------------L 239
             H N+V   G  T      L + +E    G+L   Y R                    L
Sbjct: 88  GHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLST-YLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 240 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 298
               +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +    
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 299 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK- 353
                     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++      + 
Sbjct: 206 RKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263

Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
           +  G+    PD  + +    +  C    P+ RPT ++L++H
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  130 bits (328), Expect = 2e-34
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 39/280 (13%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           G  LG G FG V    +              AVK   L D  ++  + +S L  E+ ++ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 141

Query: 199 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 248
              +H+NI+   G    +  LY+ +E  +KG+L   Y R         +Y          
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 200

Query: 249 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 298
                     Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+     D  K
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 299 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI 354
                     WMAPE + ++   Y   +D+WS G  + E+ T    PY  +        +
Sbjct: 261 KTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

Query: 355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             G     P + + +    ++ C    P+ RPT  QL++ 
Sbjct: 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  129 bits (327), Expect = 4e-34
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 41/298 (13%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           G  LG G+FG V    +              AVK   L    ++  + +S L  E+ ++ 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATE--KDLSDLISEMEMMK 129

Query: 199 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 248
              +H+NI+   G    +  LY+ +E  +KG+L   Y +         +Y          
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQL 188

Query: 249 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 298
                     Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D  K
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 299 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI 354
                     WMAPE + ++   Y   +D+WS G  + E+ T    PY  +        +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

Query: 355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 412
             G     P + + +    ++ C    P+ RPT  QL++   + R++A  S     Y 
Sbjct: 307 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTSNQEMGYY 362

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (323), Expect = 5e-34
 Identities = 66/285 (23%), Positives = 112/285 (39%), Gaps = 44/285 (15%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G FG V +  +            AVK   +L + +   + +  L  E  +L + 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE-LRDLLSEFNVLKQV 83

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------------- 238
            H ++++ YG    +  L + +E    GSL   + R                        
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG-FLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 239 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 294
               L    + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++    
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 295 NDV-KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA 349
            D             WMA E + +    Y   +D+WS G  + E++T    PY  +    
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

Query: 350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
               +  G     PD+ S++    + QC +  P+ RP  A +   
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  129 bits (326), Expect = 1e-33
 Identities = 79/377 (20%), Positives = 131/377 (34%), Gaps = 102/377 (27%)

Query: 116 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEV 174
           H     S+  E +           +   +    L+GRGS+G VY     +     A+K+V
Sbjct: 2   HHHHHHSSGRENLYFQGIK-NVH-VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59

Query: 175 S-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-----LYIFLELVTKG 228
           + + +     K+ +    +EI +L+R + + I++ Y     +       LYI LE+    
Sbjct: 60  NRMFEDLIDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--D 113

Query: 229 SLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 286
           S L         L +  +      +LLG  ++H+  ++HRD+K AN L++ + SVK+ DF
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173

Query: 287 GLA--------------KATKLNDVKSCRGTAFWM----------APEVINNKNKGYGLP 322
           GLA                         +     +          APE+I    + Y   
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKS 232

Query: 323 ADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGR------------------------- 356
            DIWS GC   E+L     +         LF  G                          
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFP-GSSCFPLSPDRNSKKVHEKSNRDQLNI 291

Query: 357 -----GSPPP--IPDSLSKDAQDFIKQ--------------------------CVQVNPN 383
                G+P    + +    +   +IK                            ++ NPN
Sbjct: 292 IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351

Query: 384 DRPTAAQLLDHPFVKRL 400
            R T  Q LDHP++K +
Sbjct: 352 KRITIDQALDHPYLKDV 368

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  126 bits (319), Expect = 2e-33
 Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 49/279 (17%)

Query: 142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 200
                G+ +G G FG VY+G  ++    AVK+++ ++D  +  ++   Q +QEI ++++ 
Sbjct: 31  PISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITT--EELKQQFDQEIKVMAKC 87

Query: 201 EHENIVQYYG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSA----YTR-QIL 252
           +HEN+V+  G  +D D+  L Y     +  GSLL+      L     +     + R +I 
Sbjct: 88  QHENLVELLGFSSDGDDLCLVY---VYMPNGSLLD-----RLSCLDGTPPLSWHMRCKIA 139

Query: 253 L----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCR--GTA 304
                G+ +LH+   +HRDIK ANIL+D   + K++DFGLA+A++       + R  GT 
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199

Query: 305 FWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAA----LFKIG 355
            +MAPE +  +   K     +DI+S G  +LE++T           + +      +    
Sbjct: 200 AYMAPEALRGEITPK-----SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254

Query: 356 RGSP----PPIPDSLSKDAQDFIK---QCVQVNPNDRPT 387
           +         + D+ S   +       QC+    N RP 
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  127 bits (321), Expect = 2e-33
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 46/286 (16%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
              +G G+FG V++  +     +      AVK   +L + + A    +  ++E AL++ F
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 248
           ++ NIV+  G       + +  E +  G L   + R     +  S               
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE-FLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 249 --------------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 294
                         RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++    
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 295 NDVKSCRGTAF----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM 348
            D     G       WM PE I  N+   Y   +D+W+ G  + E+ +    PY  M   
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283

Query: 349 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             ++ +  G+    P++   +  + ++ C    P DRP+   +   
Sbjct: 284 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (327), Expect = 6e-33
 Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 30/257 (11%)

Query: 147 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
              +  G  G +Y  + D   +G    +K   L+  G    Q+++  E++    +   H 
Sbjct: 85  KGCIAHGGLGWIYLAL-DRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFL--AEVVHP 139

Query: 204 NIVQYY--GTDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
           +IVQ +      D   +   YI +E V  G  L   +   L  ++  AY  +IL  L YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVG-GQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 318
           H   +V+ D+K  NI++     +KL D G      +N      GT  + APE++    + 
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR--INSFGYLYGTPGFQAPEIV----RT 251

Query: 319 YGLPA-DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
               A DI+++G T+  +            +  L +          DS        +++ 
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPE--DDPVLKTYDSY----GRLLRRA 304

Query: 378 VQVNPNDRP-TAAQLLD 393
           +  +P  R  TA ++  
Sbjct: 305 IDPDPRQRFTTAEEMSA 321

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  125 bits (315), Expect = 7e-33
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 35/274 (12%)

Query: 147 GDLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 202
            D++G G+FG V +  I  DG     A+K    + + +           E+ +L +   H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-------------- 248
            NI+   G  +    LY+ +E    G+LL+ + R         A+               
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 249 ----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 304
                 +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++              
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202

Query: 305 F---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 360
               WMA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G   
Sbjct: 203 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260

Query: 361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             P +   +  D ++QC +  P +RP+ AQ+L  
Sbjct: 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (316), Expect = 8e-33
 Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 45/286 (15%)

Query: 147 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G +LG G+FG V       IS  G     AVK   L ++   +++    L  E+ ++++ 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSERE--ALMSELKMMTQL 105

Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 238
             HENIV   G       +Y+  E    G LLN Y R                       
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN-YLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 239 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 294
               L    +  +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 295 NDV-KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA 349
           +              WMAPE +      Y + +D+WS G  + E+ +    PY  +   A
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282

Query: 350 ALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
             +K I  G     P   +++    ++ C   +   RP+   L   
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  125 bits (317), Expect = 1e-32
 Identities = 68/334 (20%), Positives = 123/334 (36%), Gaps = 94/334 (28%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF-EHEN 204
             LG+G++G V++ I    G   AVK++       + A+++     +EI +L+    HEN
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70

Query: 205 IVQYYGTDKDESK--LYIFLEL-------VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 255
           IV      + ++   +Y+  +        V + ++L                  Q++  +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--------PVHKQYVVYQLIKVI 122

Query: 256 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-------------KATKLNDVKSCRG 302
           KYLH   ++HRD+K +NIL++A   VK+ADFGL+               +   + ++   
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 303 TAFWM----------APEVINNKNKGYGLPADIWSLGCTVLEMLT--------------- 337
               +          APE++   +  Y    D+WSLGC + E+L                
Sbjct: 183 DQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241

Query: 338 --------------------------SQIPYAPMECMAALFKIGRGSPPPIPDSL----- 366
                                       +        +    I       +         
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           +++A D + + +Q NPN R +A   L HPFV   
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (312), Expect = 2e-32
 Identities = 67/275 (24%), Positives = 115/275 (41%), Gaps = 45/275 (16%)

Query: 147 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-- 201
           G++LG G    V+     D       AVK   +L          + L ++ +   RF   
Sbjct: 17  GEILGFGGMSEVHLAR--DLRDHRDVAVK---VLR---------ADLARDPSFYLRFRRE 62

Query: 202 --------HENIVQYY--GTDKDESKL--YIFLELVTKGSLLN--LYQRYHLRDSQVSAY 247
                   H  IV  Y  G  +  +    YI +E V  G  L   ++    +   +    
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEV 121

Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----G 302
                  L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A   +     +     G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 362
           TA +++PE    +       +D++SLGC + E+LT + P+     ++  ++  R  P P 
Sbjct: 182 TAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239

Query: 363 PD---SLSKDAQDFIKQCVQVNPNDRP-TAAQLLD 393
                 LS D    + + +  NP +R  TAA++  
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  123 bits (312), Expect = 2e-32
 Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 40/279 (14%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E  +            AVK   +L   + A +    L  E+ ++S  
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADE-KEALMSELKIMSHL 106

Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 248
            +HENIV   G       + +  E    G LLN + R   R  +                
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRKSRVLETDPAFAIANSTASTRD 165

Query: 249 -----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 303
                 Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 304 AF----WMAPEVINNKNKGYGLPADIWSLGCTVL--EMLT-SQIPYAPMECMAALFK-IG 355
           A     WMAPE I +    Y + +D+WS G  +L  E+ +    PY  +   +  +K + 
Sbjct: 226 ARLPVKWMAPESIFDCV--YTVQSDVWSYG--ILLWEIFSLGLNPYPGILVNSKFYKLVK 281

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            G     P    K+    ++ C  + P  RPT  Q+   
Sbjct: 282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  118 bits (297), Expect = 2e-30
 Identities = 78/287 (27%), Positives = 119/287 (41%), Gaps = 67/287 (23%)

Query: 149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 208
           +LGRG FG VY+G   DG   AVK   L ++ +Q  +   Q + E+ ++S   H N+++ 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 92

Query: 209 YG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TR-QILLG----L 255
            G      E  L Y     +  GS+        LR+   S        R +I LG    L
Sbjct: 93  RGFCMTPTERLLVY---PYMANGSV-----ASCLRERPESQPPLDWPKRQRIALGSARGL 144

Query: 256 KYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFW 306
            YLHD     ++HRD+K ANIL+D      + DFGLA   KL D K        RGT   
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDTHVTTAVRGTIGH 201

Query: 307 MAPE-----VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFK---- 353
           +APE       + K        D++  G  +LE++T Q  +       +    L      
Sbjct: 202 IAPEYLSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 354 -IGRGSPPPIPDSL------SKDAQDFIK---QCVQVNPNDRPTAAQ 390
            +       + D         ++ +  I+    C Q +P +RP  ++
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  114 bits (287), Expect = 1e-28
 Identities = 68/359 (18%), Positives = 126/359 (35%), Gaps = 108/359 (30%)

Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLD 178
           + R+  ++        LG G F +V+      +    A+K              E+ LL 
Sbjct: 18  DARYI-LV------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70

Query: 179 QGSQAKQSISQLEQE---IALLSRFEHEN-------IVQYYGTDKDESKLYIFLELVTKG 228
           + + A  +          + LL  F H+        +V     +     L   ++     
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMV----FEVLGENLLALIKK---- 122

Query: 229 SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD------ANGSV 281
                ++   L    V   ++Q+LLGL Y+H +  ++H DIK  N+L++          +
Sbjct: 123 ---YEHRGIPL--IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177

Query: 282 KLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 338
           K+AD G A        N +++      + +PEV+      +G  ADIWS  C + E++T 
Sbjct: 178 KIADLGNACWYDEHYTNSIQTR----EYRSPEVL--LGAPWGCGADIWSTACLIFELITG 231

Query: 339 QIPYAP------------MECMAALF-------------------------KIGRGSPPP 361
              + P            +  +  L                           I +    P
Sbjct: 232 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291

Query: 362 IPDSLSKDAQ----------DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 410
           + D L++  +          DF+   +Q++P  R  A  L++HP++K  L         
Sbjct: 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  110 bits (278), Expect = 6e-28
 Identities = 35/257 (13%), Positives = 66/257 (25%), Gaps = 47/257 (18%)

Query: 147 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
               G       ++ + D       A+    +  QG      + +       LSR +   
Sbjct: 36  LIFHGGVPPLQFWQAL-DTALDRQVALTF--VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           + +        +   +  E +  GSL  +               + +       H   V 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVA 151

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 324
                 + + V  +G V LA                      M                D
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPAT------------------MPDA---------NPQDD 184

Query: 325 IWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPP-------IPDSLSKDAQDFI 374
           I  +G ++  +L ++ P         +A   +   G P         IP  +S       
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS----AVA 240

Query: 375 KQCVQVNPNDRPTAAQL 391
            + VQ +   R  +  L
Sbjct: 241 ARSVQGDGGIRSASTLL 257

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  105 bits (265), Expect = 1e-25
 Identities = 68/362 (18%), Positives = 118/362 (32%), Gaps = 125/362 (34%)

Query: 148 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 191
             LG G+FG V E +  +      A+K              E+++L       + I + +
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVL-------KKIKEKD 77

Query: 192 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 243
           +E     + +   F       I      +      + FL+        N +Q Y L    
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIA----FELLGKNTFEFLKE-------NNFQPYPL--PH 124

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 284
           V     Q+   L++LH+  + H D+K  NIL   +                    S+++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 285 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
           DFG   AT  ++  +     R    +  PEVI     G+  P D+WS+GC + E      
Sbjct: 185 DFG--SATFDHEHHTTIVATR---HYRPPEVI--LELGWAQPCDVWSIGCILFEYYRGFT 237

Query: 341 PYAP------MECMAALFKIGRGSPP---------------------------------- 360
            +        +  M  +     G  P                                  
Sbjct: 238 LFQTHENREHLVMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293

Query: 361 -PIPDSLSKDAQ------DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 413
            P+   + +D+       D +++ ++ +P  R T A+ L HPF   L        +    
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353

Query: 414 RR 415
            R
Sbjct: 354 SR 355

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  105 bits (263), Expect = 2e-25
 Identities = 70/343 (20%), Positives = 112/343 (32%), Gaps = 117/343 (34%)

Query: 148 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 191
           D LG G+FG V E I     G   AVK              E+ +L       + ++  +
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVL-------EHLNTTD 72

Query: 192 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 243
                  + +L  FEH     IV     +      Y F++        N +  + L    
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIV----FELLGLSTYDFIKE-------NGFLPFRL--DH 119

Query: 244 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 284
           +     QI   + +LH   + H D+K  NIL   +                     +K+ 
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 285 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
           DFG   AT  ++  S     R    + APEVI     G+  P D+WS+GC ++E      
Sbjct: 180 DFG--SATYDDEHHSTLVSTR---HYRAPEVI--LALGWSQPCDVWSIGCILIEYYLGFT 232

Query: 341 PYAP------MECMAAL-----------------FKIGRGSPP--------------PIP 363
            +        +  M  +                 F   R                  P+ 
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 364 DSLSKDAQ------DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
           + +           D I++ ++ +P  R T  + L HPF   L
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  103 bits (258), Expect = 9e-25
 Identities = 68/347 (19%), Positives = 116/347 (33%), Gaps = 123/347 (35%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 192
             +G G+FG V      D+  ++AVK              E  +L +      + + +  
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI-- 98

Query: 193 EIALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 249
            +    +F + +   ++     +     LY  +         N Y  +H+    +  Y  
Sbjct: 99  -VKYHGKFMYYDHMCLI----FEPLGPSLYEIITR-------NNYNGFHI--EDIKLYCI 144

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANG-------------------------SVKLA 284
           +IL  L YL    + H D+K  NIL+D                             +KL 
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 285 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 340
           DFG   AT  +D        R    + APEVI   N G+ + +D+WS GC + E+ T  +
Sbjct: 205 DFG--CATFKSDYHGSIINTR---QYRAPEVI--LNLGWDVSSDMWSFGCVLAELYTGSL 257

Query: 341 PYAP------MECMAALFKIGRGSPP---------------------------------- 360
            +        +  M ++        P                                  
Sbjct: 258 LFRTHEHMEHLAMMESII----QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313

Query: 361 --PIPDSLS-----KDAQ--DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
              +   L      K     DF+   +Q++P  RP+ A+LL H F++
Sbjct: 314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 38/210 (18%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRF-- 200
            ++G+GSFG V +          A+K V        Q            +EI +L     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----------AEEIRILEHLRK 152

Query: 201 ----EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYH-LRDSQVSAYTRQ 250
                  N++         + + +  EL++    +NLY+     ++       V  +   
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 251 ILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKLND-VKSCRGTAFWM 307
           IL  L  LH   ++H D+K  NIL+   G   +K+ DFG   +   +  V +   + F+ 
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS--SCYEHQRVYTYIQSRFYR 266

Query: 308 APEVINNKNKGYGLPADIWSLGCTVLEMLT 337
           APEVI      YG+P D+WSLGC + E+LT
Sbjct: 267 APEVI--LGARYGMPIDMWSLGCILAELLT 294

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA---TNSGSASP 410
           DF+KQC++ +P  R T  Q L HP+++R L    T   ++  
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVK 428

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 10/176 (5%)

Query: 236 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 295
           +  L    +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 296 DVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAA 350
                +G A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++    
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

Query: 351 LFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
             + +  G+    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 32/160 (20%), Positives = 53/160 (33%), Gaps = 11/160 (6%)

Query: 147 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           G  LGRG+FG V E    GI        V    L +  +        L  E+ +L     
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGH 84

Query: 202 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
           H N+V   G   K    L + +E    G+L    +              +   G  Y+  
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 300
              +  D+K     + ++ S   + F   K+    + +  
Sbjct: 145 ---IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 58/221 (26%)

Query: 148 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 192
            L+G+GSFG V +     +  + A+K              EV LL+        +++ + 
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL-------MNKHDT 112

Query: 193 E-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 244
           E     + L   F   N   +V     +     LY  L           ++   L  +  
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLV----FEMLSYNLYDLLRN-------TNFRGVSL--NLT 159

Query: 245 SAYTRQILLGLKYLHDQD--VVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 300
             + +Q+   L +L   +  ++H D+K  NIL+      ++K+ DFG   + +L      
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQ 217

Query: 301 ----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 337
               R   F+ +PEV+      Y L  D+WSLGC ++EM T
Sbjct: 218 YIQSR---FYRSPEVL--LGMPYDLAIDMWSLGCILVEMHT 253

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 8/30 (26%), Positives = 12/30 (40%)

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
           D I + +  +P  R      L H F K+  
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKKTA 380

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 51/267 (19%), Positives = 79/267 (29%), Gaps = 101/267 (37%)

Query: 229 SLLNLYQRYHLR---DSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLA 284
            LL    + + +      V    +Q+L GL YLH +  ++H DIK  NIL+  N      
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189

Query: 285 DFGLAKATKLNDVKSCR----------------------------------GTAFWM--- 307
               A   + +                                        G A W+   
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249

Query: 308 -----------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--------- 347
                      + EV+     GY  PADIWS  C   E+ T    + P            
Sbjct: 250 FTEDIQTRQYRSLEVL--IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307

Query: 348 ---MAALF-------------------------KIGRGSPPPIPDSL-------SKDAQ- 371
              +  L                           I +  P  + + L        ++A  
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367

Query: 372 --DFIKQCVQVNPNDRPTAAQLLDHPF 396
             DF+   +++ P  R TAA+ L HP+
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPW 394

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 49/232 (21%), Positives = 85/232 (36%), Gaps = 42/232 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           W+ G  +G+G FG +Y    +           ++            L  E+    R    
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE---PSDNGPLFTELKFYQRAAKP 93

Query: 204 NIVQ-----------------YYGTDKDESKLYIFL--ELVTKGSLLNLYQRYHLRDSQ- 243
             +Q                   G      K Y F+  +      L  +Y+    R S+ 
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK 152

Query: 244 -VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------A 291
            V   + +IL  L+Y+H+ + VH DIK +N+L++      V L D+GLA          A
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 341
              +  +   GT  + +   I+  + G       D+  LG  +++ LT  +P
Sbjct: 213 YAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 39/235 (16%)

Query: 128 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 186
           MS  +       +  +++ G  +G GSFG ++EG +  +    A+K           +  
Sbjct: 1   MSGQN-----NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-------RRSD 48

Query: 187 ISQLEQEIALLSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 243
             QL  E            I  V Y+G +   +   + ++L+   SL +L      + S 
Sbjct: 49  APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSV 105

Query: 244 --VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----A 291
             V+   +Q+L  ++ +H++ +V+RDIK  N L+    S     + + DFG+ K      
Sbjct: 106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165

Query: 292 TKL----NDVKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 341
           TK      + K+  GTA +M+   IN    +      D+ +LG   +  L   +P
Sbjct: 166 TKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 40/226 (17%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R+   ++ G  +G GSFG +Y G     G   A+K           K    QL  E  + 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-------VKTKHPQLHIESKIY 58

Query: 198 SRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----R 249
              +    I  +++ G + D +   + +EL+      +L   ++    + S  T      
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYN--VMVMELLGP----SLEDLFNFCSRKFSLKTVLLLAD 112

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKATKLN---------DV 297
           Q++  ++Y+H ++ +HRD+K  N L+        V + DFGLAK  +           + 
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 298 KSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 341
           K+  GTA + +   IN  + G       D+ SLG  ++      +P
Sbjct: 173 KNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 75.3 bits (184), Expect = 3e-15
 Identities = 34/217 (15%), Positives = 66/217 (30%), Gaps = 51/217 (23%)

Query: 121 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ- 179
           S     P S+  P  + +R     +K   +G G FG V++ I+D     A+K +++    
Sbjct: 6   SQKGPVPFSHCLPTEKLQRC----EK---IGEGVFGEVFQTIADHTPV-AIKIIAIEGPD 57

Query: 180 --GSQAKQSISQLEQEIALLSRFE---------HENIVQYYG------------------ 210
                 +++  ++  EI +               E  +                      
Sbjct: 58  LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117

Query: 211 ------------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
                           + +L+I LE    G  L   +      +   +   Q+   L   
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177

Query: 259 HDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL 294
                  HRD+   N+L+      KL      K++ +
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 47/233 (20%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W  G  +G G FG +Y     +     A   V +        Q    L  E+    R   
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV------EYQENGPLFSELKFYQRVAK 92

Query: 203 ENIVQ-----------------YYGTDKDESKLYIFL--ELVTK--GSLLNLYQRYHLRD 241
           ++ ++                   G  + + + Y F+  E +      +      +    
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152

Query: 242 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK--------- 290
             V     ++L  L+Y+H+ + VH DIK AN+L+       V LAD+GL+          
Sbjct: 153 --VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 341
             + N  K   GT  + +   ++  +KG  L   +D+  LG  +L  L  ++P
Sbjct: 211 QYQENPRKGHNGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 32/223 (14%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
            R+   ++ G  +G GSFG +Y G +       A+K  +        K    QL  E  +
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-------VKTKHPQLLYESKI 55

Query: 197 LSRFE-HENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 251
               +    I  V+++G + D +   + ++L+   SL +L+     + S   V     Q+
Sbjct: 56  YRILQGGTGIPNVRWFGVEGDYN--VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQM 112

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN---------DVKS 299
           +  ++++H +  +HRDIK  N L+        V + DFGLAK  +           + K+
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 300 CRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 341
             GTA + +   +N           D+ SLG  ++  L   +P
Sbjct: 173 LTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 45/227 (19%), Positives = 81/227 (35%), Gaps = 32/227 (14%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFF---------FAVK---EVSLLDQGSQAKQSISQLE 191
           W+      R + G +YE                 F++K   +   L       Q  ++  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 192 Q--EIALLSRFEHENIVQYYGTDKDESKLYIF-LELVTK--GSLLNLYQRYHLRDSQVSA 246
           Q  +   L       I    G    + K     L  + +   S L++  ++ L +  V  
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------ATKLN 295
              ++L  L++LH+ + VH ++   NI VD      V LA +G A          A    
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 296 DVKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 341
                 G   +++   ++  K  G    +D+ SLG  +L+ L   +P
Sbjct: 224 SRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIAL 196
            +   ++ G  +G G+FG +  G +     + A+K E          K    QL  E   
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE--------PMKSRAPQLHLEYRF 57

Query: 197 LSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 251
             +    + I  V Y+G     +   + LEL+   SL +L+       S   V     Q+
Sbjct: 58  YKQLGSGDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQL 114

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----ATKL----NDV 297
           +  ++Y+H +++++RD+K  N L+   G+     + + DF LAK      TK      + 
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

Query: 298 KSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 341
           KS  GTA +M+   IN    K      D+ +LG   +  L   +P
Sbjct: 175 KSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.9 bits (126), Expect = 1e-07
 Identities = 57/451 (12%), Positives = 127/451 (28%), Gaps = 127/451 (28%)

Query: 35  LKPPP-----GM----RQPVIDNACSTWDILRDFAPKDGI---------TPSSVMN---- 72
           L+P       G+    +  V  + C ++ +         I         +P +V+     
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLKNCNSPETVLEMLQK 204

Query: 73  -----DRALSSSSDDEDNEK----EGEEADRAIVKEEE--------DDMVLSESC--SFT 113
                D   +S SD   N K      +   R ++K +          + V +     +F 
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN-VQNAKAWNAF- 262

Query: 114 TEHEDDSSST--TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGF---- 167
               + S     TT          RFK++       D L   +   +             
Sbjct: 263 ----NLSCKILLTT----------RFKQVT------DFLSAATTTHISLDHHSMTLTPDE 302

Query: 168 ---FFA-VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-----QYYGTDKDESKL 218
                    +    D   +     +     +++++    + +      ++   DK  + +
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLT-TNPRR--LSIIAESIRDGLATWDNWKHVNCDKLTTII 359

Query: 219 YIFLELVTKGSLLNLYQRYHL--RDSQVSAYTRQIL-LGLKYLHDQDVVHRDIKCANI-L 274
              L ++       ++ R  +    + +      ++   +       VV+   K     L
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVN---KLHKYSL 416

Query: 275 VD---ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN--NKNKGYGLPADIWSLG 329
           V+      ++ +    L    KL +  +       +   +++  N  K +    D   L 
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYA-------LHRSIVDHYNIPKTF----DSDDLI 465

Query: 330 CTVLEM-LTSQIPY----APMECMAALF------------KIGR-GSPPPIPDSLSKDAQ 371
              L+    S I +            LF            KI    +      S+    Q
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525

Query: 372 DFIKQCVQVNPNDRPTAAQLLDH--PFVKRL 400
                   +  ND P   +L++    F+ ++
Sbjct: 526 QLKFYKPYICDND-PKYERLVNAILDFLPKI 555

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 6e-05
 Identities = 51/395 (12%), Positives = 118/395 (29%), Gaps = 108/395 (27%)

Query: 54  DILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFT 113
           DIL  F                     D+ D  K+ ++  ++I+ +EE D ++    + +
Sbjct: 20  DILSVFEDA----------------FVDNFDC-KDVQDMPKSILSKEEIDHIIMSKDAVS 62

Query: 114 TEH------EDDSSSTTTEPMSNI-SPNGRFKRIITYWQ---KGDLLGRGSFGSVYEGIS 163
                             + +  +   N +F  +++  +   +   +    +    + + 
Sbjct: 63  GTLRLFWTLLSKQEEMVQKFVEEVLRINYKF--LMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 164 DDGFFFAVKEVSLLDQGSQAKQSISQLE-----------------------QEIALLSRF 200
           +D   FA   VS L    + +Q++ +L                            +  + 
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180

Query: 201 EHE----NIVQYYGTDKDESKLYIFLELVTK-----GSLLNLYQRYHLRDSQVSAYTRQI 251
           + +    N+      +  E+ L +  +L+ +      S  +      LR   + A  R++
Sbjct: 181 DFKIFWLNLKNC---NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 252 LLGLKYLH-----DQDVVHR------DIKCANILV---DANGSVKLADFGLAKATKLNDV 297
           L    Y +       +V +       ++ C  IL+          + DF  A  T     
Sbjct: 238 LKSKPYENCLLVLL-NVQNAKAWNAFNLSC-KILLTTRFKQ----VTDFLSAATTT---- 287

Query: 298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-----APMEC--MAA 350
                         +++ +     P ++ SL    L+     +P       P     +A 
Sbjct: 288 -----------HISLDHHSMTLT-PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335

Query: 351 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQV-NPND 384
             + G  +               I+  + V  P +
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	415
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.59
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.81
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.81
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.73
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.6
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.58
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.31
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.99
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.96
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.9
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.58
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.24
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.51
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.32
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.17
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.77

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.3e-64  Score=485.37  Aligned_cols=255  Identities=31%  Similarity=0.582  Sum_probs=225.5

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++++.||+|+||+||+|++ .+++.||||++......   ....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999998 78999999999754332   234577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      ||||||.||+|.+++...   .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999999998643   47899999999999999999999999999999999999999999999999998765332


Q ss_pred             --cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          297 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                        ....+||+.|||||++.+.  .|+.++|||||||++|+|++|+.||.+....+.+.++..+..++.+..++.++++||
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV  257 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence              3456799999999999654  489999999999999999999999999988888899988888888899999999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+||+.||++|||++|+|+||||++-
T Consensus       258 ~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.9e-64  Score=484.41  Aligned_cols=253  Identities=33%  Similarity=0.565  Sum_probs=227.1

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|++.+.||+|+||+||+|++ .+|+.||||++.......     .+.+.+|+.+|+.++|||||+++++|.+++.+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            5688899999999999999998 789999999997543322     2457799999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Ccc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~  298 (415)
                      |||||.||+|.+++.+.++++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....  ...
T Consensus       149 vmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             EECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999876433  345


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CCcccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~~  376 (415)
                      ..+||+.|||||++.+.  .|+.++|||||||++|||++|+.||.+....+.+..+.....+.+  +..+++++++||.+
T Consensus       229 ~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          229 SLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence            67899999999999654  489999999999999999999999999888888877776654433  35789999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ||..||++|||++|+|+||||++..
T Consensus       307 ~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          307 LLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.1e-64  Score=477.92  Aligned_cols=255  Identities=26%  Similarity=0.462  Sum_probs=227.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++++.||+|+||+||+|++ .+++.||||++.+...  ......+.+.+|+++|+.++|||||+++++|++++++|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            46899999999999999999998 7899999999975321  11223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC---
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~---  295 (415)
                      ||||||.||+|.+++.+ ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....   
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999876 57999999999999999999999999999999999999999999999999999876432   


Q ss_pred             -CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          296 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       296 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                       .....+||+.|||||++.+..  |+.++|||||||++|+|++|+.||.+.+..+.+.++..... .+|..+++++++||
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli  265 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLV  265 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHH
Confidence             234568999999999996644  89999999999999999999999998888888778777654 47889999999999


Q ss_pred             HHhhhhCCCCCCCHHH------HHcChhhHhh
Q 014986          375 KQCVQVNPNDRPTAAQ------LLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~e------il~hp~f~~~  400 (415)
                      .+||.+||++|||++|      |++||||+.+
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            9999999999999887      6899999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4e-62  Score=483.73  Aligned_cols=254  Identities=33%  Similarity=0.552  Sum_probs=228.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|++.+.||+|+||+||+|++ .+|+.||||++.......     .+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            35799999999999999999998 789999999997543322     245779999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Cc
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~  297 (415)
                      ||||||.||+|.+++...++++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....  ..
T Consensus       225 iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             EEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             EEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876433  34


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~  375 (415)
                      ...+||+.|||||++.+.  .|+.++|||||||++|||++|+.||.+....+.+..+.......  .+..++.++++||.
T Consensus       305 ~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             CCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             cccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            567899999999999654  48999999999999999999999999988888888777665433  34578999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||..||++|||+.|||+||||++..
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.7e-62  Score=460.49  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=209.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      +++|++.+.||+|+||+||+|++ .+++.||+|++......  .......+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA--KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            47899999999999999999998 78999999999753222  1223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-Cc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~~  297 (415)
                      |||||| +|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus        90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence            999999 5789888765 57999999999999999999999999999999999999999999999999999865543 34


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ...+||+.|||||++.+.. .++.++|||||||++|+|++|+.||.+.........+..+. ..+|..+++++++||.+|
T Consensus       169 ~~~~GT~~Y~APE~~~~~~-y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~  246 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRM  246 (275)
T ss_dssp             ------CTTSCHHHHSSSS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             CCeeECcccCChhhhcCCC-CCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence            5578999999999996543 24689999999999999999999999877776666666554 457788999999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      |+.||++|||++|+++||||+.
T Consensus       247 L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          247 LIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             SCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-61  Score=459.67  Aligned_cols=250  Identities=30%  Similarity=0.565  Sum_probs=215.0

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----CCEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKL  218 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~  218 (415)
                      |++.+.||+|+||+||+|++ .++..||+|++......   ....+.+.+|+.+|+.++|||||+++++|.+    +..+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            46667899999999999998 78999999999754322   3345678999999999999999999999865    4568


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcC-CCcEEEEeecccccccc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKATKL  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~-~~~vkl~DFGla~~~~~  294 (415)
                      |||||||.+|+|.+++.+ ..+++..++.++.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+|+....
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999999876 46999999999999999999999998  999999999999984 79999999999987666


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCC-CCCCcccHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPP-PIPDSLSKDAQD  372 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~-~~~~~~s~~l~~  372 (415)
                      ......+||+.|||||++.+   .|+.++|||||||++|+|++|+.||........+. .+..+..+ .++..+++++++
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence            66667889999999999853   38999999999999999999999997755544444 44443332 345678899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ||.+||..||++|||++|+|+||||++
T Consensus       262 li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.1e-62  Score=465.40  Aligned_cols=253  Identities=29%  Similarity=0.478  Sum_probs=217.7

Q ss_pred             cccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ++|++++.||+|+||+||+|++    .+++.||+|++.........   ...+.+|+.+|+.++|||||++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            5799999999999999999986    35789999999753322211   2356789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--  294 (415)
                      +|||||||.||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999999876 5799999999999999999999999999999999999999999999999999986533  


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      ......+||+.|||||++.+.  .|+.++|||||||++|+|++|+.||.+.+..+.+.++.+... .+|..+|+++++||
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  257 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLL  257 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred             ccccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHH
Confidence            234567899999999999654  489999999999999999999999999888888878776654 47889999999999


Q ss_pred             HHhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      .+||+.||++|||     ++|+++||||+.+
T Consensus       258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999998     5899999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.8e-61  Score=462.45  Aligned_cols=250  Identities=31%  Similarity=0.469  Sum_probs=215.9

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..+.|++.++||+|+||+||+|++ .+|+.||||++.....          ..+|+.+|+.++|||||++++++.+++.+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            346788999999999999999998 7899999999975321          13799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEeeccccccccCC
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~  296 (415)
                      |||||||+||+|.+++++ ..+++..++.|+.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+......
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999999999976 4699999999999999999999999999999999999999988 69999999998764332


Q ss_pred             -------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCccc
Q 014986          297 -------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLS  367 (415)
Q Consensus       297 -------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s  367 (415)
                             ....+||+.|||||++.+.  .|+.++|||||||++|+|++|+.||.+....+...++.....+  .++..++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred             cccceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence                   2235799999999999664  4899999999999999999999999876655555566555432  3677899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHH-------------HcChhhHhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQL-------------LDHPFVKRLL  401 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~ei-------------l~hp~f~~~~  401 (415)
                      +++.+||.+||+.||.+|||+.|+             |+|||+++..
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            999999999999999999999998             4688877654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-59  Score=448.22  Aligned_cols=253  Identities=26%  Similarity=0.450  Sum_probs=204.0

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC--
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  216 (415)
                      +.++|++++.||+|+||+||+|++ .+++.||||++....    .....+.+.+|+.+|+.++|||||++++++.+.+  
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            457899999999999999999998 789999999997532    2334567889999999999999999999987544  


Q ss_pred             ----------EEEEEEeccCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEE
Q 014986          217 ----------KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  282 (415)
Q Consensus       217 ----------~~~lV~E~~~~gsL~~~l~~~~----l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vk  282 (415)
                                ++|||||||.+|+|.+++....    ..+..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence                      4799999999999999997643    45567889999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCC--------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-H
Q 014986          283 LADFGLAKATKLND--------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-C  347 (415)
Q Consensus       283 l~DFGla~~~~~~~--------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~  347 (415)
                      |+|||+|+......              ....+||+.|||||++.+.  .|+.++|||||||++|||++   ||.... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~~  233 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQMER  233 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccHH
Confidence            99999998654322              2235799999999999654  48999999999999999996   786543 2


Q ss_pred             HHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          348 MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       348 ~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ...+..+.....++.....++.+.+||++||+.||.+|||+.|+|+||||+.+.
T Consensus       234 ~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            344445555444444445677889999999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.6e-59  Score=446.42  Aligned_cols=254  Identities=27%  Similarity=0.459  Sum_probs=224.1

Q ss_pred             cccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ++|.+.+.||+|+||+||+|++      .++..||||++...     .....+.+.+|+.+|++++|||||++++++.+.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            5788999999999999999975      25789999998642     234457799999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  281 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~--------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~v  281 (415)
                      +.+|||||||++|+|.+++...              .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence            9999999999999999999653              48999999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhc
Q 014986          282 KLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR  356 (415)
Q Consensus       282 kl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  356 (415)
                      ||+|||+|+.......    ....||+.|||||++.+..  |+.++|||||||++|||+| |+.||......+.+..+..
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~--~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999986543321    2345899999999996544  8999999999999999998 8999999988888888988


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       357 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      +...+.|..+++++.+|+.+||+.||++|||+.+|  |+||+++....
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~~~  291 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKAS  291 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHHHS
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHhcC
Confidence            88888899999999999999999999999999999  67999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.3e-58  Score=442.55  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=217.3

Q ss_pred             ecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++|.+.+.||+|+||+||+|++      .+++.||||++...     .....+.|.+|+.+|++++|||||++++++.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            35788889999999999999975      35889999998632     23445779999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  278 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~  278 (415)
                      .+.+|||||||++|+|.+++...                .+++..+..|+.||+.||+|||+++||||||||+|||++.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            99999999999999999998643                48899999999999999999999999999999999999999


Q ss_pred             CcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHH
Q 014986          279 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK  353 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~  353 (415)
                      +.+||+|||+++......    ....+||+.|||||++.+.  .++.++|||||||++|||+| |+.||......+.+..
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999998654332    2345699999999999654  48999999999999999999 8999999988888888


Q ss_pred             HhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       354 i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +..+...+.|..+++++.+|+.+||+.||++|||+.||++  +++.+..
T Consensus       273 i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~l~~  319 (329)
T 4aoj_A          273 ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA--RLQALAQ  319 (329)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH--HHHHHHH
T ss_pred             HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH--HHHHHhh
Confidence            8888888889999999999999999999999999999976  4776654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-58  Score=454.04  Aligned_cols=257  Identities=25%  Similarity=0.427  Sum_probs=217.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee------
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK------  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------  213 (415)
                      .++|++++.||+|+||+||+|++ .+|+.||||++.....   .....+.+.+|+.+|+.++|||||++++++.      
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            45799999999999999999998 7899999999964322   2233467889999999999999999999865      


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      +.+.+|||||||. |+|.+++.+ ..+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            3468999999996 579988865 57999999999999999999999999999999999999999999999999999865


Q ss_pred             cc------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-----
Q 014986          293 KL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----  361 (415)
Q Consensus       293 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  361 (415)
                      ..      ......+||+.|||||++.+.. .++.++|||||||++|+|++|+.||.+.+..+.+..+......+     
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~-~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCC-CCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            32      2244578999999999986543 47899999999999999999999999888777776664322111     


Q ss_pred             -------------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          362 -------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       362 -------------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                               ....++.++.+||.+||..||.+|||++|+|+||||++...
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                     01246889999999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-57  Score=470.83  Aligned_cols=261  Identities=27%  Similarity=0.415  Sum_probs=222.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccc-hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ...++|+++++||+|+||+||+|++ .+|+.||||++.+..... ..........+++.+++.++|||||+++++|++.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            3467899999999999999999998 789999999997532111 11112223344577788899999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      ++|||||||.||+|..++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            99999999999999999876 46999999999999999999999999999999999999999999999999999987777


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      .....+||+.|||||++... ..|+.++|||||||++|+|++|..||.+..  ....+.+........+|..+|+++++|
T Consensus       346 ~~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dL  424 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL  424 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHH
Confidence            77778999999999998532 348999999999999999999999997642  122223333334456788999999999


Q ss_pred             HHHhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          374 IKQCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       374 i~~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      |.+||+.||.+|++     ++||++||||+.+
T Consensus       425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            99999999999998     7999999999975

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-57  Score=445.00  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=207.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  213 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  213 (415)
                      .+.++|++.+.||+|+||+||+|++    .+++.||+|.+.....       ..++.+|+++|+.+ +|||||+++++|.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-------PIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-------HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-------HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            3457899999999999999999986    3578999998864221       23567899999988 6999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeecccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKAT  292 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFGla~~~  292 (415)
                      +.+++||||||+++|+|.++++  .+++..++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            9999999999999999999985  58999999999999999999999999999999999999877 89999999999754


Q ss_pred             ccC------------------------------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCC
Q 014986          293 KLN------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  342 (415)
Q Consensus       293 ~~~------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf  342 (415)
                      ...                              .....+||+.|||||++.+. ..|+.++||||+||++|+|++|+.||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCC
Confidence            321                              12345799999999998653 34899999999999999999999999


Q ss_pred             CC-ccHHHHHHHHhc-------------------------------------CC----------------CCCCCCcccH
Q 014986          343 AP-MECMAALFKIGR-------------------------------------GS----------------PPPIPDSLSK  368 (415)
Q Consensus       343 ~~-~~~~~~~~~i~~-------------------------------------~~----------------~~~~~~~~s~  368 (415)
                      .. .+..+++..+..                                     ..                .......+++
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            54 333333332211                                     00                0011245789


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ++.+||.+||+.||.+|+|++|+|+||||+++
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-57  Score=435.99  Aligned_cols=248  Identities=24%  Similarity=0.396  Sum_probs=218.0

Q ss_pred             ecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      ...+++.+.||+|+||+||+|+.      .+++.||||++.....    ....+.|.+|+.+|++++|||||++++++.+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            34677888999999999999985      3578999999864221    2234678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  277 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~  277 (415)
                      ++.+|||||||++|+|.+++..                 ..+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            9999999999999999999853                 24899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHH
Q 014986          278 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF  352 (415)
Q Consensus       278 ~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~  352 (415)
                      ++.+||+|||+++.....+    ....+||+.|||||++.+..  |+.++|||||||++|||+| |..||.+....+...
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~--~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999998654322    33457999999999996544  8999999999999999998 899999998888888


Q ss_pred             HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       353 ~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+..+...+.|..++.++.+|+.+||+.||.+|||+.+|+++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            888888888999999999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.5e-57  Score=429.23  Aligned_cols=249  Identities=28%  Similarity=0.504  Sum_probs=206.3

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      -.+++++.+.||+|+||+||+|++..  .||||+++....   .....+.|.+|+.+|++++|||||++++++.+ +.+|
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP---TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            34678889999999999999998743  599998864332   23456789999999999999999999998764 5689


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      ||||||++|+|.+++..  ..+++..+..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.....  
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999999864  46999999999999999999999999999999999999999999999999999865422  


Q ss_pred             --CcccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH-hcCCC----CCCCCccc
Q 014986          296 --DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSP----PPIPDSLS  367 (415)
Q Consensus       296 --~~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~----~~~~~~~s  367 (415)
                        .....+||+.|||||++.+. ...|+.++|||||||++|||+||+.||.+......+..+ ..+..    ...+..++
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  267 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP  267 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence              23456799999999999653 234899999999999999999999999876554444333 33322    23456789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ..+.+|+.+||+.||++|||+.+|+++
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.5e-56  Score=460.17  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=226.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++++.||+|+||+||+|++ .+|+.||+|++....     ....+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3467899999999999999999998 789999999997532     2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--CcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~--~~vkl~DFGla~~~~  293 (415)
                      +|||||||.||+|.+++..  ..+++..++.|++||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+...
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999998853  469999999999999999999999999999999999999854  899999999998765


Q ss_pred             cCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCcccHH
Q 014986          294 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  369 (415)
Q Consensus       294 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~  369 (415)
                      ... ....+||+.|||||++.+.  .|+.++|||||||++|+|++|..||.+....+.+..+......   ..+..++++
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             CCCceeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            443 4456799999999999664  4899999999999999999999999998888888888765533   233578999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +++||++||..||.+|||+.|+|+||||+...
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            99999999999999999999999999998643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-55  Score=428.45  Aligned_cols=256  Identities=27%  Similarity=0.441  Sum_probs=216.5

Q ss_pred             eeecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC-CcEEEeeee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGT  211 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~  211 (415)
                      .-.++|++++.||+|+||+||+|.+.      +++.||||.+....    .....+.+.+|+.+|.++.| ||||+++++
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            33578999999999999999999862      34689999886422    22345678899999999965 899999999


Q ss_pred             eec-CCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014986          212 DKD-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  273 (415)
Q Consensus       212 ~~~-~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NI  273 (415)
                      |.+ .+.+|||||||.+|+|.++++..                 .+++..+..++.||+.||+|||+++||||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            865 46799999999999999998642                 378999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccH-
Q 014986          274 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC-  347 (415)
Q Consensus       274 Ll~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~-  347 (415)
                      |++.++.+||+|||+|+......    ....+||+.|||||++.+..  |+.++|||||||++|||+| |+.||.+... 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~--y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC--CCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998654332    22356899999999996644  8999999999999999998 9999987653 


Q ss_pred             HHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          348 MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       348 ~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ......+..+...+.|..+++++.+||.+||+.||.+|||+.+|++|  ++.+..
T Consensus       295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~--L~~llq  347 (353)
T 4ase_A          295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ  347 (353)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHHH
Confidence            33445566677778889999999999999999999999999999998  555544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-53  Score=403.73  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC----E
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----K  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~  217 (415)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++....      ......+.|+..+..++|||||++++++.+++    .
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            5688899999999999999987 68999999986421      11223456777778899999999999987654    6


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          218 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~--------~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      +|||||||++|+|.+++++..+++..+..++.|++.||+|||++        +|+||||||+|||++.++.+||+|||++
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            89999999999999999999999999999999999999999987        9999999999999999999999999999


Q ss_pred             cccccCC------cccCCCCccccccccccccc----cCCCchhhHHHHHHHHHHHHcCCCCCCCc--------------
Q 014986          290 KATKLND------VKSCRGTAFWMAPEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIPYAPM--------------  345 (415)
Q Consensus       290 ~~~~~~~------~~~~~gt~~y~aPE~l~~~~----~~~~~~~DvwSlG~il~ell~g~~pf~~~--------------  345 (415)
                      +......      ....+||+.|||||++.+..    ..++.++|||||||++|||++|..||...              
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8654332      22356999999999996532    13678999999999999999997765321              


Q ss_pred             cHHHHHHH-Hh-cCCCCCCCCc-----ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          346 ECMAALFK-IG-RGSPPPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       346 ~~~~~~~~-i~-~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ...+.+.+ +. ....+.+|..     .+..+.+|+.+||+.||.+|||+.+|++.  ++++..+
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~--L~~l~~~  298 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHHC
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHHHH
Confidence            11222222 22 2333444433     34578899999999999999999999874  6665543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.1e-52  Score=401.21  Aligned_cols=259  Identities=24%  Similarity=0.446  Sum_probs=228.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++.....   .......+.+|+.+|+.++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            3567899999999999999999998 7899999999975332   23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-  295 (415)
                      +|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999999998854 57999999999999999999999999999999999999999999999999999865433 


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      .....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+....+...++..+.. .+|..++.++.+||+
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLK  246 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCC-CCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred             ccccccCCcceeCcccccCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHH
Confidence            345567999999999996543 235899999999999999999999999887777777766544 467789999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||..||.+|||++++++||||+....
T Consensus       247 ~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          247 RFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.9e-52  Score=397.28  Aligned_cols=256  Identities=32%  Similarity=0.574  Sum_probs=224.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++.......     .+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            356899999999999999999998 789999999997543222     34577999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      |+||||+.+|+|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            999999999999999998899999999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCCcccHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPIPDSLSKDAQDFI  374 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li  374 (415)
                      .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.....  ...+..++..+.+||
T Consensus       173 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            3445799999999999654  389999999999999999999999988776666555543332  334667899999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+||+.||.+|||+.++++||||+....
T Consensus       251 ~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-51  Score=401.50  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=223.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.....  ........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            56899999999999999999998 6899999999974211  11223456789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--CC
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--ND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--~~  296 (415)
                      +||||+.+|+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999998865 4689999999999999999999999999999999999999999999999999985432  23


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      ....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.... ..++..++.++.+||.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             ccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence            4556799999999999654  48999999999999999999999998877766666665543 44678899999999999


Q ss_pred             hhhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          377 CVQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       377 ~L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ||+.||.+||     ++.+|++||||+.+
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999999     99999999999865

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.4e-52  Score=407.40  Aligned_cols=257  Identities=28%  Similarity=0.453  Sum_probs=220.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      ...++|++.++||+|+||+||+|++ .+++.||+|++.....  ........+.+|..++..+ +||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            3467899999999999999999998 6899999999974211  1222345677899999988 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+||||||+.+|+|..++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999998865 57999999999999999999999999999999999999999999999999999854322


Q ss_pred             --CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          296 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       296 --~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                        .....+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+...++..... .++..++.++.+|
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l  254 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEML--YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGI  254 (353)
T ss_dssp             --------CCGGGCCHHHHHHHH--CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCC--cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHH
Confidence              344567999999999996544  89999999999999999999999999888777777766543 4677899999999


Q ss_pred             HHHhhhhCCCCCCCH------HHHHcChhhHhh
Q 014986          374 IKQCVQVNPNDRPTA------AQLLDHPFVKRL  400 (415)
Q Consensus       374 i~~~L~~dP~~Rps~------~eil~hp~f~~~  400 (415)
                      |++||..||.+||++      .+|++||||+.+
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999998      899999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-51  Score=408.50  Aligned_cols=257  Identities=27%  Similarity=0.482  Sum_probs=217.8

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      ..++|++.++||+|+||+||+|++ .+++.||+|++......  .......+.+|..++..+ +|||||++++++.+.+.
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            357899999999999999999998 67899999999853322  223345677899998876 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--c
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~  294 (415)
                      +||||||+.+|+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  .
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999999998875 579999999999999999999999999999999999999999999999999998532  2


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--------HHHHHHHHhcCCCCCCCCcc
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--------CMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ......+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....        ..+.+..........+|..+
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  285 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  285 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred             CccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence            334567899999999999654  48999999999999999999999996321        12223333333455678889


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCH------HHHHcChhhHhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTA------AQLLDHPFVKRL  400 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~------~eil~hp~f~~~  400 (415)
                      +.++++||++||+.||.+||++      ++|++||||+.+
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999999984      899999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-51  Score=395.14  Aligned_cols=254  Identities=28%  Similarity=0.487  Sum_probs=224.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+...+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            56899999999999999999998 6899999999974211  11123456789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      +||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ..
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-~~  161 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY  161 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BC
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-cc
Confidence            99999999999999876 46999999999999999999999999999999999999999999999999999865433 34


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..+||+.|+|||++.+.  .++.++|||||||++|+|++|..||..........++.... ..++..++.++.+||.+||
T Consensus       162 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL  238 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLI  238 (318)
T ss_dssp             CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHh
Confidence            56799999999998654  48899999999999999999999999887777777776654 3467889999999999999


Q ss_pred             hhCCCCCC-----CHHHHHcChhhHhh
Q 014986          379 QVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       379 ~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ..||.+||     ++++|++||||+.+
T Consensus       239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          239 TRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             ccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            99999999     99999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-51  Score=402.01  Aligned_cols=258  Identities=28%  Similarity=0.462  Sum_probs=223.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++......  .......+.+|..++..+ +||||+++++++.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh--hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            4467899999999999999999998 68999999999752211  112245567888888876 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--  293 (415)
                      .+|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...  
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999999876 579999999999999999999999999999999999999999999999999998643  


Q ss_pred             cCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       294 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      .......+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+.... ..++..++.++.+|
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l  248 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDL  248 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHH
Confidence            2334566799999999999654  48999999999999999999999999887777776666554 44678899999999


Q ss_pred             HHHhhhhCCCCCCCHH-HHHcChhhHhhh
Q 014986          374 IKQCVQVNPNDRPTAA-QLLDHPFVKRLL  401 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~-eil~hp~f~~~~  401 (415)
                      |.+||..||.+||++. +|++||||+.+.
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            9999999999999998 999999998763

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.4e-51  Score=396.39  Aligned_cols=256  Identities=27%  Similarity=0.467  Sum_probs=219.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  218 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  218 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++......  .......+.+|+.++..+ +||||+++++++.+.+.+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            56899999999999999999998 68999999999854322  234456788999999887 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--cC
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LN  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~~  295 (415)
                      |+||||+.+|+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            999999999999998875 579999999999999999999999999999999999999999999999999998532  22


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc---------cHHHHHHHHhcCCCCCCCCcc
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---------ECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...         ........+.. ....+|..+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~  242 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSL  242 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCCCCCTTS
T ss_pred             cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCCCCCCCC
Confidence            34556799999999999654  4899999999999999999999999642         11222223333 344577889


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCH------HHHHcChhhHhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTA------AQLLDHPFVKRLL  401 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~------~eil~hp~f~~~~  401 (415)
                      +..+++||.+||..||.+||++      .+|++||||+.+.
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            9999999999999999999995      8999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-51  Score=410.52  Aligned_cols=260  Identities=25%  Similarity=0.407  Sum_probs=224.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.++||+|+||+||+|++ .+++.||+|++......  .......+.+|+.++..++|||||++++++.+...
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3467899999999999999999998 67999999999742110  01112346789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          218 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      +||||||+.+|+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999998665443 


Q ss_pred             --cccCCCCcccccccccccccc--CCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC---CCCCCCcccHH
Q 014986          297 --VKSCRGTAFWMAPEVINNKNK--GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKD  369 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~--~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~  369 (415)
                        ....+||+.|+|||++.+...  .++.++|||||||++|+|++|+.||..........++....   ..+....++.+
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence              235679999999999965432  26789999999999999999999999888777777765432   22334579999


Q ss_pred             HHHHHHHhhhhCCCC--CCCHHHHHcChhhHhh
Q 014986          370 AQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  400 (415)
Q Consensus       370 l~~Li~~~L~~dP~~--Rps~~eil~hp~f~~~  400 (415)
                      +++||++||..+|.+  |+++++|++||||+.+
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999999988  9999999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.9e-51  Score=399.27  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=224.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .+.+.|++++.||+|+||.||+|++ .+++.||+|++........ .......+.+|+.+|+.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            4567899999999999999999998 6899999999986432211 1112356889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEeeccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  291 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~----~vkl~DFGla~~  291 (415)
                      .+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            99999999999999999875 4699999999999999999999999999999999999998777    799999999987


Q ss_pred             cccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCccc
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLS  367 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s  367 (415)
                      .... .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.+....+....+.......   .+..++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          169 IEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             cCCCCccccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            6543 34556799999999999654  48999999999999999999999999887777777776654332   225689


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ..+++||.+||..||.+|||+.++++||||+..
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999999999843

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-51  Score=393.53  Aligned_cols=257  Identities=23%  Similarity=0.363  Sum_probs=224.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.++|++.+.||+|+||.||+|++ .+++.||+|.+...      ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            467899999999999999999998 68999999998642      12335678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--CCcEEEEeecccccccc
Q 014986          219 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKL  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~--~~~vkl~DFGla~~~~~  294 (415)
                      |+||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999999999764  5999999999999999999999999999999999999987  78999999999987654


Q ss_pred             CC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---CCcccHHH
Q 014986          295 ND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKDA  370 (415)
Q Consensus       295 ~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l  370 (415)
                      .. .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+........   ...++.++
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCccccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            33 3445699999999999654  378999999999999999999999998887777777766554322   24689999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .+||.+||..||.+|||+.++|+||||++.....
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  268 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERV  268 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcChhhccCcccc
Confidence            9999999999999999999999999999765543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-51  Score=391.98  Aligned_cols=261  Identities=31%  Similarity=0.506  Sum_probs=215.3

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ...+.++|++.+.||+|+||+||+|.+.+++.||+|++.....   .......+.+|+.+++.++||||+++++++.+..
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            5567789999999999999999999998899999999864321   1223456789999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+++||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999986 788877653  499999999999999999999999999999999999999999999999999986543


Q ss_pred             C--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-----------
Q 014986          295 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----------  361 (415)
Q Consensus       295 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  361 (415)
                      .  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......+           
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CcccccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            2  23445689999999998643 347899999999999999999999998765444443332211000           


Q ss_pred             ------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          362 ------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       362 ------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                        ....++.++.+||.+||..||.+|||+.|+|+||||+.+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                              12346789999999999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.9e-51  Score=397.66  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=223.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++......  .......+.+|..++..+ +||||+++++++.+.+.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            467899999999999999999998 57899999999752211  112345677899999987 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--c
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~  294 (415)
                      +|+||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  .
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            9999999999999999876 579999999999999999999999999999999999999999999999999998643  2


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      ......+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+.... ..+|..++.++.+||
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAIC  252 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Confidence            234566799999999999654  48999999999999999999999999887777777776654 346788999999999


Q ss_pred             HHhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      .+||..||.+||+     +.+|++||||+.+
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999994     6999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.9e-51  Score=396.97  Aligned_cols=255  Identities=28%  Similarity=0.443  Sum_probs=225.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+|+.++||||+++++++.+...+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            357899999999999999999998 6899999999974221  1112346778999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      |+||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~  195 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-T  195 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-B
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-c
Confidence            999999999999998876 57999999999999999999999999999999999999999999999999999876543 3


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ...+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+...++..+. ..++..++.++.+||.+|
T Consensus       196 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~l  272 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHH
T ss_pred             ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence            456799999999999654  48999999999999999999999999887777777776654 446788999999999999


Q ss_pred             hhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          378 VQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       378 L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      |+.||.+||+     +++|++||||+.+
T Consensus       273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          273 LQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            9999999998     9999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.9e-51  Score=387.77  Aligned_cols=260  Identities=31%  Similarity=0.537  Sum_probs=215.8

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch---------------------hHHHHHHHHHHHHHH
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---------------------AKQSISQLEQEIALL  197 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~---------------------~~~~~~~~~~E~~il  197 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++........                     .....+.+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            467899999999999999999998 7899999999975332111                     112245688999999


Q ss_pred             hcCCCCcEEEeeeeeec--CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014986          198 SRFEHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV  275 (415)
Q Consensus       198 ~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl  275 (415)
                      +.++||||+++++++.+  ...+|+||||+.+++|.+++....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99999999999999886  6789999999999999887777789999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEeeccccccccCC--cccCCCCccccccccccccccC-CCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH
Q 014986          276 DANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF  352 (415)
Q Consensus       276 ~~~~~vkl~DFGla~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~-~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~  352 (415)
                      +.++.+||+|||+++......  .....||+.|+|||++.+.... ++.++|||||||++|+|++|+.||..........
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  250 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS  250 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence            999999999999998654332  2445799999999998654321 4778999999999999999999998876665555


Q ss_pred             HHhcCCC-CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          353 KIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       353 ~i~~~~~-~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      .+..... .+....++.++.+||.+||..||.+|||+.++++||||++
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            5544332 2334578999999999999999999999999999999974

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.6e-51  Score=397.18  Aligned_cols=260  Identities=27%  Similarity=0.462  Sum_probs=217.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.+.|++.+.||+|+||+||+|++ .+++.||+|++...............+.+|+.+++.++||||+++++++.+.+.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456899999999999999999998 7899999999974321111111245688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEeecccc
Q 014986          219 YIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK  290 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~---vkl~DFGla~  290 (415)
                      |+||||+.+|+|.+++...     .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999998877532     4899999999999999999999999999999999999987654   9999999998


Q ss_pred             ccccCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---CCc
Q 014986          291 ATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDS  365 (415)
Q Consensus       291 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~  365 (415)
                      ......  ....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.... ......+..+.....   ...
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence            765433  2345799999999999654  38899999999999999999999998754 334444444433222   246


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR  295 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcc
Confidence            8999999999999999999999999999999997643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.5e-51  Score=391.88  Aligned_cols=265  Identities=31%  Similarity=0.504  Sum_probs=203.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.......    ....+.+|+.+++.++||||+++++++.+++.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            45799999999999999999998 689999999997543211    2245678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          220 IFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~-------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      +||||+.+ +|.+++...       .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            99999985 899888642       4899999999999999999999999999999999999999999999999999865


Q ss_pred             ccC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----------
Q 014986          293 KLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------  359 (415)
Q Consensus       293 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------  359 (415)
                      ...  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+.....           
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            432  33455789999999998643 2478999999999999999999999988776655554422100           


Q ss_pred             ----------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCCCCC
Q 014986          360 ----------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPY  411 (415)
Q Consensus       360 ----------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~~~~  411 (415)
                                            ...+..++.++.+||.+||+.||.+|||+.++|+||||++....+..+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~  311 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGSRS  311 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---------
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhcccccc
Confidence                                  0012357889999999999999999999999999999999988776666543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-50  Score=403.54  Aligned_cols=261  Identities=28%  Similarity=0.433  Sum_probs=224.9

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ..+.++|++.+.||+|+||.||+|++ .+++.||+|++.....   .......+.+|+.+++.++||||+++++++.+.+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   83 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEG   83 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence            34567899999999999999999998 7899999999975432   2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CCCcEEEEeecccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKAT  292 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~---~~~~vkl~DFGla~~~  292 (415)
                      .+|+||||+.+|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999999987765 5699999999999999999999999999999999999998   4578999999999766


Q ss_pred             ccCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCccc
Q 014986          293 KLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLS  367 (415)
Q Consensus       293 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s  367 (415)
                      ....  .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+..+...   +....++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             cCCCceeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence            5433  3456799999999999654  4899999999999999999999999988877777777665433   2235789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +++.+||.+||+.||.+|||+.++|+||||+.....
T Consensus       242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~  277 (444)
T 3soa_A          242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV  277 (444)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccc
Confidence            999999999999999999999999999999876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=399.67  Aligned_cols=258  Identities=24%  Similarity=0.495  Sum_probs=221.4

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+|+.++|||||++++++.+...+
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357899999999999999999998 7899999999974221  1122346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-C
Q 014986          219 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-~  296 (415)
                      |+||||+.+|+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            9999999999999998764 6999999999999999999999999999999999999999999999999999865433 3


Q ss_pred             cccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCc---cHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      ....+||+.|+|||++... ...++.++|||||||++|+|++|+.||...   ........+ ......++..++..+.+
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~p~~~s~~~~~  249 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-ETTVVTYPSAWSQEMVS  249 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-HHCCCCCCTTSCHHHHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hhcccCCCCcCCHHHHH
Confidence            4567799999999998643 344889999999999999999999999742   222333333 33445577889999999


Q ss_pred             HHHHhhhhCCCCCCC-HHHHHcChhhHhh
Q 014986          373 FIKQCVQVNPNDRPT-AAQLLDHPFVKRL  400 (415)
Q Consensus       373 Li~~~L~~dP~~Rps-~~eil~hp~f~~~  400 (415)
                      ||.+||..||.+||+ ++++++||||+.+
T Consensus       250 li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            999999999999998 9999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-50  Score=408.39  Aligned_cols=257  Identities=25%  Similarity=0.445  Sum_probs=215.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.++||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            3467899999999999999999998 7899999999974211  122334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeecccccccc-
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~-  294 (415)
                      +||||||+.+|+|..++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.... 
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999999998865 568999999999999999999998 9999999999999999999999999999975432 


Q ss_pred             -CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          295 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       295 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                       ......+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...........+.... ..++..++.++.+|
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~l  379 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSL  379 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred             CcccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHH
Confidence             234556799999999999654  48999999999999999999999998887776666665543 34678899999999


Q ss_pred             HHHhhhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          374 IKQCVQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       374 i~~~L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      |.+||..||.+||     ++.++++||||+.+
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            9999999999999     99999999999876

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-50  Score=394.27  Aligned_cols=268  Identities=27%  Similarity=0.465  Sum_probs=223.7

Q ss_pred             CcceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      +....+.++|++.+.||+|+||.||+|++ .+++.||+|++...............+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            34566778999999999999999999998 78999999999753222222344567889999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhh-----------------------------------------cCCCHHHHHHHHHHHH
Q 014986          214 DESKLYIFLELVTKGSLLNLYQR-----------------------------------------YHLRDSQVSAYTRQIL  252 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~-----------------------------------------~~l~~~~~~~i~~qil  252 (415)
                      +.+.+++||||+.+|+|.+++..                                         ..+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            99999999999999999998852                                         1235677889999999


Q ss_pred             HHHHHHHHCCceecCCCCCcEEEcCCC--cEEEEeeccccccccCC------cccCCCCccccccccccccccCCCchhh
Q 014986          253 LGLKYLHDQDVVHRDIKCANILVDANG--SVKLADFGLAKATKLND------VKSCRGTAFWMAPEVINNKNKGYGLPAD  324 (415)
Q Consensus       253 ~aL~~LH~~~IiHrDLkp~NILl~~~~--~vkl~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~D  324 (415)
                      .||+|||++||+||||||+|||++.++  .+||+|||+++......      .....||+.|+|||++.+....++.++|
T Consensus       179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999999999998776  89999999998643221      2345699999999999765456899999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          325 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       325 vwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ||||||++|+|++|+.||......+....+........   ...++..+.+||.+||..||.+|||+.++|+||||+++.
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999998877777776665543322   224799999999999999999999999999999999875


Q ss_pred             h
Q 014986          402 A  402 (415)
Q Consensus       402 ~  402 (415)
                      .
T Consensus       339 ~  339 (345)
T 3hko_A          339 D  339 (345)
T ss_dssp             S
T ss_pred             H
Confidence            4

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.9e-50  Score=396.52  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=215.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHH-HhcCCCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~  216 (415)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++......  .......+.+|..+ ++.++||||+++++++.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            3467899999999999999999998 67899999999754322  12234456677776 57789999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc-
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~-  294 (415)
                      .+|+||||+.+|+|..++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999998876 4699999999999999999999999999999999999999999999999999986432 


Q ss_pred             -CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          295 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       295 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                       ......+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+.... ..++..++..+++|
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  269 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHL  269 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHH
Confidence             234556799999999999654  48999999999999999999999999888777777776653 34677899999999


Q ss_pred             HHHhhhhCCCCCCCH----HHHHcChhhHhh
Q 014986          374 IKQCVQVNPNDRPTA----AQLLDHPFVKRL  400 (415)
Q Consensus       374 i~~~L~~dP~~Rps~----~eil~hp~f~~~  400 (415)
                      |.+||+.||.+||++    .+|++||||+.+
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999986    699999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.9e-50  Score=378.50  Aligned_cols=265  Identities=27%  Similarity=0.502  Sum_probs=224.9

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            467899999999999999999998 7788999999864221  1122245688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      ++||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~  164 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  164 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence            999999999999998865 5799999999999999999999999999999999999999999999999999876665555


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+.... ..++..++..+.+||.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  241 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRL  241 (279)
T ss_dssp             ---CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             cccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHH
Confidence            666799999999998654  37889999999999999999999999877766666655443 346778999999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhhhhCCCCCC
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS  409 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~~  409 (415)
                      |..||.+|||+.++++||||+.....++...+
T Consensus       242 l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~  273 (279)
T 3fdn_A          242 LKHNPSQRPMLREVLEHPWITANSSKPSNCQN  273 (279)
T ss_dssp             CCSSGGGSCCHHHHHHCHHHHHHCSSCCCC--
T ss_pred             hccChhhCCCHHHHhhCccccCCccCcccccc
Confidence            99999999999999999999998776655443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.8e-50  Score=392.08  Aligned_cols=259  Identities=28%  Similarity=0.449  Sum_probs=223.5

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++......   ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4567899999999999999999998 68999999999754322   2345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vkl~DFGla~~~~  293 (415)
                      +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            9999999999999998865 468999999999999999999999999999999999999865   459999999998665


Q ss_pred             cCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccHH
Q 014986          294 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  369 (415)
Q Consensus       294 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~  369 (415)
                      ... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+..+....   ....++.+
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             CCcccccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            432 3456799999999998654  48899999999999999999999998887777666666554322   22467999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.+||.+||..||.+|||+.++|+||||+....
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  293 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICNRER  293 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCCCcc
Confidence            999999999999999999999999999986543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-50  Score=400.52  Aligned_cols=262  Identities=28%  Similarity=0.446  Sum_probs=211.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++.....   .......+.+|+.++..+. ||||+++++++...+
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---NSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            3567899999999999999999998 7899999999864221   2334466779999999997 999999999987544


Q ss_pred             --EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 --~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                        .+|+||||+.+ +|..++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           83 DRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CCEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence              79999999985 899999888999999999999999999999999999999999999999999999999999975432


Q ss_pred             -----------------------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHH
Q 014986          295 -----------------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL  351 (415)
Q Consensus       295 -----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~  351 (415)
                                             ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                                   112345799999999998653 34899999999999999999999999988777666


Q ss_pred             HHHhcCCCCC----------------------------------------------CCCcccHHHHHHHHHhhhhCCCCC
Q 014986          352 FKIGRGSPPP----------------------------------------------IPDSLSKDAQDFIKQCVQVNPNDR  385 (415)
Q Consensus       352 ~~i~~~~~~~----------------------------------------------~~~~~s~~l~~Li~~~L~~dP~~R  385 (415)
                      ..+......+                                              .+..++.++.+||.+||..||.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            5553211111                                              112568899999999999999999


Q ss_pred             CCHHHHHcChhhHhhhhhCC
Q 014986          386 PTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       386 ps~~eil~hp~f~~~~~~~~  405 (415)
                      ||+.|+|+||||+.+...+.
T Consensus       321 ~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             CCHHHHTTSTTTTTTCCGGG
T ss_pred             CCHHHHhCCHHHHHhcCCcc
Confidence            99999999999998765544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-50  Score=390.88  Aligned_cols=259  Identities=24%  Similarity=0.444  Sum_probs=215.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.++|++.+.||+|+||+||+|++ .+++.||+|++.....    ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            457899999999999999999998 6899999999874322    22235678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          219 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      |+||||+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999999999988754 69999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHH-HH-HhcCCCCCCCCcccHHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL-FK-IGRGSPPPIPDSLSKDAQ  371 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~-~~-i~~~~~~~~~~~~s~~l~  371 (415)
                         ....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......... .. ............++..+.
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             ccccCCCccCcCccCcHHhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence               34567999999999986543 2477899999999999999999999765432121 12 222222223357899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +||.+||..||.+|||+.|+++||||+.....
T Consensus       240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence            99999999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.6e-50  Score=380.76  Aligned_cols=255  Identities=28%  Similarity=0.474  Sum_probs=211.0

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||+||+|++ .+++.||+|++......   ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence            5799999999999999999998 68999999999754322   2234567799999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      ||||+.+ +|.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999987 55555543  57999999999999999999999999999999999999999999999999999865432  2


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCC-CCCccHHHHHHHHhcCCC----------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALFKIGRGSP----------------  359 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~----------------  359 (415)
                      .....||+.|+|||++.+. ..++.++|||||||++|+|++|..| |......+.+..+.....                
T Consensus       158 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            3445689999999998643 2378999999999999999988777 455444444444322100                


Q ss_pred             ------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          360 ------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       360 ------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                  ......++..+++||.+||+.||.+|||++|+|+||||+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                        011235789999999999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.7e-50  Score=388.12  Aligned_cols=257  Identities=27%  Similarity=0.452  Sum_probs=213.7

Q ss_pred             eecccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ..++|++.+.||+|+||.||+|++    .+++.||+|++...... ........+.+|+.+|+.++||||+++++++.+.
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            357899999999999999999987    47899999998753221 1223345678999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +.+|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            999999999999999998875 4689999999999999999999999999999999999999999999999999875432


Q ss_pred             C--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          295 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       295 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      .  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||..........++.... ..++..++..+.+
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~  250 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARD  250 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHH
T ss_pred             CCccccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHH
Confidence            2  23456799999999998654  37899999999999999999999999887777766666544 3467789999999


Q ss_pred             HHHHhhhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          373 FIKQCVQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       373 Li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ||.+||..||.+||     ++.++++||||+.+
T Consensus       251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            99999999999999     89999999999865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-50  Score=387.81  Aligned_cols=260  Identities=27%  Similarity=0.475  Sum_probs=222.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++........ .......+.+|+.+|+.++||||+++++++.+..
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3456899999999999999999998 6899999999976432211 1112456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEeeccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  291 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~----~vkl~DFGla~~  291 (415)
                      .+|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            99999999999999999865 4699999999999999999999999999999999999999887    899999999987


Q ss_pred             cccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCccc
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLS  367 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s  367 (415)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+.......   ....++
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             CCCCCccccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            6433 34456799999999998554  38899999999999999999999998877766666655443322   224678


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ..+.+||.+||..||.+|||+.++|+||||+..
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999999999999999999999999999999753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-49  Score=394.38  Aligned_cols=264  Identities=25%  Similarity=0.444  Sum_probs=217.6

Q ss_pred             ceeeecccccccccccC--CcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          137 FKRIITYWQKGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G--~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      +....++|++.++||+|  +||.||+|++ .+++.||||++.....   .......+.+|+.+++.++|||||++++++.
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            33446789999999999  9999999999 6899999999975332   2345677889999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      +.+.+|+||||+.+|+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            99999999999999999999865   469999999999999999999999999999999999999999999999999876


Q ss_pred             cccc---------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--
Q 014986          291 ATKL---------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--  359 (415)
Q Consensus       291 ~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--  359 (415)
                      ....         .......||+.|+|||++.+....++.++|||||||++|+|++|+.||......+.+..+..+..  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            4321         11233468999999999976435589999999999999999999999977554443333222111  


Q ss_pred             -------------------------------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          360 -------------------------------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       360 -------------------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                                                                 .+.+..++..+.+||.+||+.||.+|||+.++|+|||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                                                       1234567899999999999999999999999999999


Q ss_pred             hHhhhhh
Q 014986          397 VKRLLAT  403 (415)
Q Consensus       397 f~~~~~~  403 (415)
                      |+++...
T Consensus       337 f~~~~~~  343 (389)
T 3gni_B          337 FKQIKRR  343 (389)
T ss_dssp             GGGC---
T ss_pred             HHHHhhc
Confidence            9987653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-50  Score=401.87  Aligned_cols=258  Identities=28%  Similarity=0.432  Sum_probs=219.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.++||+|+||.||+|++ .+++.||+|++.....  ........+.+|..++..++||||+++++++.+.+.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            457899999999999999999998 6899999999974211  1112234577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          219 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      ||||||+.+|+|.+++.+.  .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            9999999999999999763  69999999999999999999999999999999999999999999999999998765433


Q ss_pred             ---cccCCCCcccccccccccc-----ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC----CCCCCCC
Q 014986          297 ---VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG----SPPPIPD  364 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~-----~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~~~~  364 (415)
                         ....+||+.|+|||++...     ...++.++|||||||++|+|++|+.||......+...++...    ..+..+.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence               2345799999999998632     234789999999999999999999999988777666666542    2233346


Q ss_pred             cccHHHHHHHHHhhhhCCCCC---CCHHHHHcChhhHhh
Q 014986          365 SLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRL  400 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~R---ps~~eil~hp~f~~~  400 (415)
                      .++.++++||++||. +|.+|   +++++|++||||+.+
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            799999999999999 99998   599999999999876

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-50  Score=409.26  Aligned_cols=257  Identities=27%  Similarity=0.453  Sum_probs=210.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  215 (415)
                      .+.++|++++.||+|+||+||+|++ .+++.||||++....   ........+.+|+.+|+.++||||+++++++...  
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence            4578899999999999999999998 789999999997432   2234456788999999999999999999998654  


Q ss_pred             ----CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ----~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                          ..+||||||+.++ |...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       136 ~~~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             cccCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence                4689999999874 6666543 599999999999999999999999999999999999999999999999999987


Q ss_pred             cccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--------
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--------  362 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------  362 (415)
                      .... .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+....+.+.++......+.        
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             cCCCcccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            6544 24456799999999999764  489999999999999999999999998877766665543221110        


Q ss_pred             ----------------------CCc-----------ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          363 ----------------------PDS-----------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       363 ----------------------~~~-----------~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                            +..           .+.++.+||.+||..||.+|||++|+|+||||+.+..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                                  000           1567999999999999999999999999999997654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2e-50  Score=405.19  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=220.9

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.++||+|+||+||+|++ .+++.||+|++......  .......+.+|+.++..++||||+++++++.+.+.
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            3457899999999999999999998 67899999999742111  11112347789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +||||||+.+|+|.+++.+  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            9999999999999999976  57999999999999999999999999999999999999999999999999999765433


Q ss_pred             C---cccCCCCccccccccccc---cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC----CCCCCCCc
Q 014986          296 D---VKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG----SPPPIPDS  365 (415)
Q Consensus       296 ~---~~~~~gt~~y~aPE~l~~---~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~  365 (415)
                      .   ....+||+.|+|||++..   ....++.++|||||||++|||++|+.||......+...++...    ..+.....
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            2   233579999999999862   1234789999999999999999999999988777776666432    22333356


Q ss_pred             ccHHHHHHHHHhhhhCCCC--CCCHHHHHcChhhHhh
Q 014986          366 LSKDAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  400 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~--Rps~~eil~hp~f~~~  400 (415)
                      ++.++++||++||..+|++  |++++|+++||||+.+
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            8999999999999888888  9999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.8e-50  Score=381.32  Aligned_cols=254  Identities=29%  Similarity=0.501  Sum_probs=211.6

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ++|++.+.||+|+||+||+|.+.+++.||+|++......   ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            579999999999999999999988999999999753322   11234567999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Cc
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  297 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~  297 (415)
                      |||+.+ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999986 89888865  46999999999999999999999999999999999999999999999999999765422  23


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-----------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------------  360 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------------  360 (415)
                      ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......                 
T Consensus       158 ~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             ----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            345689999999998643 34789999999999999999999999887766555544321000                 


Q ss_pred             -----------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          361 -----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       361 -----------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                                 .....++.++.+||.+||..||.+|||+.++++||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                       1124578999999999999999999999999999999853

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-49  Score=383.68  Aligned_cols=252  Identities=33%  Similarity=0.564  Sum_probs=220.6

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .|...+.||+|+||.||+|++ .+|+.||||++......     ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            466677899999999999998 58999999999753322     235577999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Cccc
Q 014986          222 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKS  299 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~  299 (415)
                      |||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ....
T Consensus       121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            99999999999999889999999999999999999999999999999999999999999999999998765433  2345


Q ss_pred             CCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CCcccHHHHHHHHHh
Q 014986          300 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQC  377 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~~~  377 (415)
                      ..||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......+....+.....+..  +..++..+.+||.+|
T Consensus       201 ~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          201 LVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             ccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            6799999999998654  488999999999999999999999988777777666665544332  346889999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      |..||.+|||+.++++||||++..
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.5e-51  Score=394.82  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=217.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4578899999999999999999998 8899999999874211  111123467899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-
Q 014986          218 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-  295 (415)
                      +|+||||+ +|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999999 678888765 467999999999999999999999999999999999999999999999999999865443 


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      .....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||..........++ ......++..++..+.+||+
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSG-GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-CSSCCCCCTTSCHHHHHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCC-CCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-HcCCCCCcccCCHHHHHHHH
Confidence            245567999999999986543 2378999999999999999999999765432222222 22233467789999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||..||.+|||+.|+++||||+.-.
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHcCCChhHCcCHHHHHhChhhccCC
Confidence            99999999999999999999998654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-50  Score=383.12  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=208.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC---CCCcEEEeeeeeec
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKD  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~  214 (415)
                      .+.++|++.+.||+|+||+||+|++ .+++.||+|++...............+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467899999999999999999998 7899999999975432211111122344666666555   59999999999877


Q ss_pred             CC-----EEEEEEeccCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEee
Q 014986          215 ES-----KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       215 ~~-----~~~lV~E~~~~gsL~~~l~~~~---l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                      ..     .+++||||+.+ +|.+++....   +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     58999999985 9999887653   899999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----C
Q 014986          287 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----P  361 (415)
Q Consensus       287 Gla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~  361 (415)
                      |+++..... ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+.+.++......    .
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC--CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999865533 334567999999999986544  899999999999999999999999887776666555321110    0


Q ss_pred             ----------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          362 ----------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       362 ----------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                            ....++..+.+||.+||+.||.+|||+.++|+||||++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                                  1135788999999999999999999999999999999754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-49  Score=390.30  Aligned_cols=262  Identities=25%  Similarity=0.442  Sum_probs=214.5

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC-
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  215 (415)
                      ..+.++|++.+.||+|+||.||+|++ .+++.||||++....   ........+.+|+.+|+.++||||+++++++... 
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            34567899999999999999999998 789999999885422   2233456788999999999999999999998765 


Q ss_pred             -----CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          216 -----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       216 -----~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                           ..+|+||||+ +++|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence                 3569999999 7799999988889999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----------
Q 014986          291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------  359 (415)
Q Consensus       291 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------  359 (415)
                      ..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+.....           
T Consensus       177 ~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          177 QADSE-MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ECCSS-CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccccc-cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            76533 4456799999999998652 3489999999999999999999999998776665554432111           


Q ss_pred             -------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          360 -------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       360 -------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                                         ..+...++..+.+||.+||..||.+|||+.++|+||||+.+.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence                               1123457899999999999999999999999999999998765443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-49  Score=396.00  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=201.0

Q ss_pred             eecccccc-cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH-hcCCCCcEEEeeeeeec--
Q 014986          140 IITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD--  214 (415)
Q Consensus       140 ~~~~y~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~--  214 (415)
                      +.++|.+. ++||+|+||+||+|++ .+++.||||++...          ..+.+|+.++ +..+||||+++++++..  
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            45567776 7899999999999998 68999999998631          2355788776 45689999999998865  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEee
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF  286 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~DF  286 (415)
                        ...+||||||+.+|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              66799999999999999999764   4999999999999999999999999999999999999997   789999999


Q ss_pred             ccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH----HHHHHhcCC---
Q 014986          287 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA----ALFKIGRGS---  358 (415)
Q Consensus       287 Gla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~---  358 (415)
                      |+++..... .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.......    ....+..+.   
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999865433 34456799999999998544  48999999999999999999999997643211    112222222   


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ..+....++.++.+||++||..||.+|||+.++++||||++..
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            2222357899999999999999999999999999999998654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.1e-49  Score=373.13  Aligned_cols=263  Identities=26%  Similarity=0.449  Sum_probs=228.0

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE--KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc--hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            357899999999999999999998 67889999998742111  111235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      |+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            999999999999998865 4699999999999999999999999999999999999999999999999999977665555


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+.... ..++..++..+++||.+|
T Consensus       170 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  246 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKL  246 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHH
Confidence            567799999999998654  37889999999999999999999998877666666655443 346778999999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                      |..||.+|||+.++++||||+.........
T Consensus       247 l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~  276 (284)
T 2vgo_A          247 LRYHPPQRLPLKGVMEHPWVKANSRRVLPP  276 (284)
T ss_dssp             SCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred             hhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence            999999999999999999999876554443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.8e-49  Score=371.78  Aligned_cols=258  Identities=27%  Similarity=0.490  Sum_probs=224.5

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|.+ .++..+|+|++......     ....+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            3567899999999999999999998 67889999998753322     23567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl---~~~~~vkl~DFGla~~~~  293 (415)
                      +|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999999999988765 468999999999999999999999999999999999999   788999999999997654


Q ss_pred             cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC---CcccHH
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP---DSLSKD  369 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~  369 (415)
                      .. ......||+.|+|||++.+.   ++.++||||||+++|+|++|..||......+....+..+......   ..++..
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ  237 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC---BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred             CccchhccCCCCCccChHHhccc---CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence            33 33456799999999998543   788999999999999999999999988877777777665443222   267999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      +.+||.+||+.||.+|||+.++|+||||++.....
T Consensus       238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            99999999999999999999999999999887654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6e-50  Score=386.15  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=208.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  216 (415)
                      ++.++|++.+.||+|+||.||+|++ .+++.||||++.....    ....+.+.+|+.+|+.++||||+++++++.+.. 
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            4567899999999999999999998 5899999999975332    223467889999999999999999999875433 


Q ss_pred             --------------------------------------------------------EEEEEEeccCCCCHHHHHhhc---
Q 014986          217 --------------------------------------------------------KLYIFLELVTKGSLLNLYQRY---  237 (415)
Q Consensus       217 --------------------------------------------------------~~~lV~E~~~~gsL~~~l~~~---  237 (415)
                                                                              .+++||||+.+|+|.+++...   
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    489999999999999999764   


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--------------cccCCC
Q 014986          238 -HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--------------VKSCRG  302 (415)
Q Consensus       238 -~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--------------~~~~~g  302 (415)
                       ...+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......              .....|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence             25666789999999999999999999999999999999999999999999998665432              233569


Q ss_pred             CccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCC
Q 014986          303 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  382 (415)
Q Consensus       303 t~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP  382 (415)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..|+..  .......+.....+......+..+.+||.+||+.||
T Consensus       239 t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  314 (332)
T 3qd2_B          239 TKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP  314 (332)
T ss_dssp             CGGGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred             CcCccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCC
Confidence            9999999999654  489999999999999999998776533  223333344433333334567889999999999999


Q ss_pred             CCCCCHHHHHcChhhHhh
Q 014986          383 NDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       383 ~~Rps~~eil~hp~f~~~  400 (415)
                      .+|||+.++++||||+++
T Consensus       315 ~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          315 TERPEATDIIENAIFENL  332 (332)
T ss_dssp             GGSCCHHHHHHSTTCCCC
T ss_pred             CcCCCHHHHhhchhhhcC
Confidence            999999999999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-49  Score=391.98  Aligned_cols=256  Identities=28%  Similarity=0.479  Sum_probs=222.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++....     ......+.+|+.+|+.++||||+++++++.+...
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            3457899999999999999999998 689999999987422     2233568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--CCcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~--~~~vkl~DFGla~~~~  293 (415)
                      +|+||||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999999999988653  6899999999999999999999999999999999999974  4789999999998765


Q ss_pred             cCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCcccHH
Q 014986          294 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  369 (415)
Q Consensus       294 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~  369 (415)
                      ... ....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+......   .....++.+
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             CCcceeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            433 3345699999999999654  4889999999999999999999999988777777666654432   234578999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +.+||.+||..||.+|||+.++|+||||+...
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999999999999999999999999998644

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-49  Score=374.57  Aligned_cols=254  Identities=31%  Similarity=0.483  Sum_probs=213.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|.+.+.||+|+||.||+|.+ .++..+|+|++......    .....+.+|+.+++.++||||+++++++.+...
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            4567899999999999999999998 78999999999753321    124567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEeeccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLA  289 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl---~~~~~vkl~DFGla  289 (415)
                      +|+||||+.+|+|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999998743     469999999999999999999999999999999999999   45688999999999


Q ss_pred             cccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCCcc
Q 014986          290 KATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSL  366 (415)
Q Consensus       290 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~  366 (415)
                      ...... ......||+.|+|||++.+   .++.++||||||+++|+|++|+.||......+....+......  .....+
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL  251 (285)
T ss_dssp             CC----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred             eecCCcccCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence            765433 2345669999999999843   3789999999999999999999999987766665555443332  222457


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            899999999999999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-48  Score=369.43  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=223.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.++|++.+.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            457899999999999999999998 6799999999975432   233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEeecccccccc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKL  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~---vkl~DFGla~~~~~  294 (415)
                      ++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999999887754 56899999999999999999999999999999999999987655   99999999976554


Q ss_pred             CC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCcccHHH
Q 014986          295 ND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDA  370 (415)
Q Consensus       295 ~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l  370 (415)
                      .. .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...........+..+...   +....++.++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CccccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            33 3446799999999998654  3789999999999999999999999887777666666554432   2335789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .+||.+||+.||.+|||+.++++||||+......
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence            9999999999999999999999999998765443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-49  Score=409.74  Aligned_cols=257  Identities=26%  Similarity=0.447  Sum_probs=220.4

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.++||+|+||.||+|++ .+++.||+|++......  .......+.+|+.+|..++|||||++++++.+.+.+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh--hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            356799999999999999999998 68999999999742211  112245678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          219 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      ||||||+.||+|..++...   .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999999999988754   3999999999999999999999999999999999999999999999999999876543


Q ss_pred             C-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhcCCCCCCCCcccHHHH
Q 014986          296 D-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDAQ  371 (415)
Q Consensus       296 ~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~l~  371 (415)
                      . ....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||....   ....+..........++..++.+++
T Consensus       340 ~~~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~  417 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR  417 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             ccccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence            2 3456799999999999654  38899999999999999999999997642   1223333333344556788999999


Q ss_pred             HHHHHhhhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          372 DFIKQCVQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      +||.+||..||.+||     +++||++||||+.+
T Consensus       418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            999999999999999     89999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-49  Score=400.03  Aligned_cols=259  Identities=30%  Similarity=0.472  Sum_probs=226.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|.+++.||+|+||.||+|++ .+++.||||++.....  ........+.+|+.+++.++||||+++++++.+.+.
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4567899999999999999999998 6899999999974221  111234578899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999999999875 469999999999999999999999999999999999999999999999999998765433


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                       ....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||..........++..+.. ..+..++.++.+||.
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLK  248 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHH
T ss_pred             cccccCCCcCeEChhhccCCC-CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHH
Confidence             44567999999999996543 247899999999999999999999998776666666665543 457789999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||..||.+|||+.+|++||||+...
T Consensus       249 ~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            99999999999999999999998754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.4e-49  Score=386.47  Aligned_cols=252  Identities=29%  Similarity=0.426  Sum_probs=212.1

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-----CCcEEEeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----HENIVQYYG  210 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~~  210 (415)
                      ...+.++|++.+.||+|+||+||+|++ .+++.||||++..      .......+.+|+.+++.+.     ||||+++++
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            345677899999999999999999998 7899999999863      1233455678999999886     999999999


Q ss_pred             eeecCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC----------
Q 014986          211 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----------  277 (415)
Q Consensus       211 ~~~~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~----------  277 (415)
                      ++...+.+|+||||+ +++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.          
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            999999999999999 88999998765   3999999999999999999999999999999999999975          


Q ss_pred             ---------------CCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCC
Q 014986          278 ---------------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  342 (415)
Q Consensus       278 ---------------~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf  342 (415)
                                     ++.+||+|||+++..... .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-HGSIINTRQYRAPEVILNLG--WDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-CCSCCSCGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC-CcCccCcccccCcHHHcCCC--CCCccchHHHHHHHHHHHHCCCCC
Confidence                           789999999999865433 34567999999999996543  899999999999999999999999


Q ss_pred             CCccHHHHHHHHhcCCCCC-------------------------CCC--------------------cccHHHHHHHHHh
Q 014986          343 APMECMAALFKIGRGSPPP-------------------------IPD--------------------SLSKDAQDFIKQC  377 (415)
Q Consensus       343 ~~~~~~~~~~~i~~~~~~~-------------------------~~~--------------------~~s~~l~~Li~~~  377 (415)
                      ......+.+..+.......                         ++.                    ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            8876665554443221110                         010                    1236788999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhH
Q 014986          378 VQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~  398 (415)
                      |+.||.+|||+.|+|+||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999996

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=378.43  Aligned_cols=259  Identities=25%  Similarity=0.449  Sum_probs=212.5

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++....   ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            46899999999999999999998 679999999886432   22334567789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      +||||+.+++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999999999988764 46999999999999999999999999999999999999999999999999999765432  2


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC------------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS------------------  358 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------  358 (415)
                      .....||+.|+|||++.+. ..++.++||||||+++|+|++|..||......+....+....                  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             -------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            3445699999999998643 347899999999999999999999998876655544332210                  


Q ss_pred             --CCCC----------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          359 --PPPI----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       359 --~~~~----------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                        ..+.          ...++..+.+||.+||..||.+|||++++++||||+++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence              0011          13578899999999999999999999999999999987544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.7e-49  Score=383.01  Aligned_cols=256  Identities=31%  Similarity=0.468  Sum_probs=215.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++......         ..+|+.++..+ +||||+++++++.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            4567899999999999999999998 68999999999753321         23677777776 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC----CcEEEEeeccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKA  291 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~----~~vkl~DFGla~~  291 (415)
                      .+|+||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++.
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999999998865 468999999999999999999999999999999999998543    3599999999986


Q ss_pred             cccC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc---cHHHHHHHHhcCCCC---CCC
Q 014986          292 TKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPP---PIP  363 (415)
Q Consensus       292 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~---~~~  363 (415)
                      ....  .....+||+.|+|||++.+..  ++.++|||||||++|+|++|..||...   ...+....+..+...   ..+
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQG--YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHH--HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCC--CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            5433  234567999999999986543  788999999999999999999999752   334445555544433   233


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      ..++.++.+||++||..||.+|||+.++++||||+.+.....
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~  289 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ  289 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSCC
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccccc
Confidence            578999999999999999999999999999999988765443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.1e-49  Score=386.38  Aligned_cols=248  Identities=26%  Similarity=0.441  Sum_probs=211.2

Q ss_pred             ccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEecc
Q 014986          147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~  225 (415)
                      .++||+|+||.||+|++ .+++.||+|++....     ....+.+.+|+.+|+.++||||+++++++.+.+.+||||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            67899999999999998 789999999997522     234467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE--cCCCcEEEEeeccccccccCC-cccC
Q 014986          226 TKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLND-VKSC  300 (415)
Q Consensus       226 ~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl--~~~~~vkl~DFGla~~~~~~~-~~~~  300 (415)
                      .+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++...... ....
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            99999988754  359999999999999999999999999999999999999  567899999999998765443 3345


Q ss_pred             CCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccHHHHHHHHHh
Q 014986          301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKDAQDFIKQC  377 (415)
Q Consensus       301 ~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~~Li~~~  377 (415)
                      .||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+.......   ....++.++.+||.+|
T Consensus       249 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  326 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL  326 (373)
T ss_dssp             CSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred             cCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence            699999999998654  48899999999999999999999999888777777766554332   2246899999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      |..||.+|||+.++|+||||+...
T Consensus       327 L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          327 LIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             cCCChhhCCCHHHHhcCcCcCCCc
Confidence            999999999999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.8e-50  Score=385.22  Aligned_cols=259  Identities=29%  Similarity=0.449  Sum_probs=210.4

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++.....    ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            5799999999999999999998 6899999999864221    1111234579999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          221 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      ||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           78 VFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             Eeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            9999985 888887653  4899999999999999999999999999999999999999999999999999765432  2


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----C----------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----I----------  362 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~----------  362 (415)
                      .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......+    +          
T Consensus       157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            3345689999999998653 347899999999999999999999998877666555543321111    1          


Q ss_pred             ---------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          363 ---------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       363 ---------------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                                     ...++.++.+||.+||+.||.+|||+.|+|+||||+.+......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  294 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK  294 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence                           12468899999999999999999999999999999998765433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.7e-49  Score=397.59  Aligned_cols=260  Identities=29%  Similarity=0.475  Sum_probs=197.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee----
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----  213 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----  213 (415)
                      .+.++|++.+.||+|+||+||+|++ .+++.||||++....   ......+.+.+|+.+|+.++|||||++++++.    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            3457899999999999999999998 689999999986432   22334567889999999999999999999984    


Q ss_pred             -cCCEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          214 -DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       214 -~~~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                       ....+|+||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence             3467999999985 5899888764 599999999999999999999999999999999999999999999999999986


Q ss_pred             cccC-----------------------------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-----
Q 014986          292 TKLN-----------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-----  337 (415)
Q Consensus       292 ~~~~-----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-----  337 (415)
                      ....                             .....+||+.|+|||++... ..++.++|||||||++|||++     
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            5421                             12345689999999987432 348999999999999999998     


Q ss_pred             ------CCCCCCCccH--------------------HHHHHHHhc-----------------------CCC-------CC
Q 014986          338 ------SQIPYAPMEC--------------------MAALFKIGR-----------------------GSP-------PP  361 (415)
Q Consensus       338 ------g~~pf~~~~~--------------------~~~~~~i~~-----------------------~~~-------~~  361 (415)
                            |+++|.+...                    .+.+..+..                       ...       ..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  6777765431                    111111110                       000       00


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ....++.++.+||.+||..||.+|||++|+|+||||+.+...
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence            123468999999999999999999999999999999998543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-49  Score=377.38  Aligned_cols=258  Identities=30%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             CCCCcceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH-hcCCCCcEEEee
Q 014986          132 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYY  209 (415)
Q Consensus       132 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~  209 (415)
                      .+......+.++|++.++||+|+||+||+|++ .+++.||||++......  .. .......|+..+ +..+|+||++++
T Consensus        47 ~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~-~~~~~~~e~~~~~~~~~h~~iv~l~  123 (311)
T 3p1a_A           47 DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--PK-DRARKLAEVGSHEKVGQHPCCVRLE  123 (311)
T ss_dssp             CTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS--HH-HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC--hH-HHHHHHHHHHHHHHhcCCCcEEEEE
Confidence            33333445567899999999999999999998 58999999987643222  12 223344555554 445999999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeec
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  287 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFG  287 (415)
                      +++.+.+.+|+||||+ +++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccce
Confidence            9999999999999999 5588887765  359999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCCCc
Q 014986          288 LAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDS  365 (415)
Q Consensus       288 la~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~  365 (415)
                      ++....... .....||+.|+|||++.+   .++.++|||||||++|+|++|..||........   +.... ...++..
T Consensus       203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~  276 (311)
T 3p1a_A          203 LLVELGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAG  276 (311)
T ss_dssp             TCEECC------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTTTCCCHHHHTT
T ss_pred             eeeecccCCCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HhccCCCcccccC
Confidence            987664332 334569999999999864   388999999999999999999777665443322   22222 2223457


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ++.++.+||.+||+.||.+|||+.++|+||||++
T Consensus       277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            8999999999999999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-48  Score=383.26  Aligned_cols=255  Identities=25%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|++......      ...+.+|+.+++.++||||+++++++.+...+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            356899999999999999999999 68999999999743221      13567999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--EEEEeecccccccc-
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKL-  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~--vkl~DFGla~~~~~-  294 (415)
                      |+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999998864 57999999999999999999999999999999999999987765  99999999974332 


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH----HHHHHHHhcCCC-CCCCCcccHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP-PPIPDSLSKD  369 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~-~~~~~~~s~~  369 (415)
                      .......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.....    ...+..+..... .+....++..
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             ---------CTTSCHHHHHCSS-CCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             CCCCCCcCCCCcCChhhhcCCC-CCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence            2334567999999999986543 124458999999999999999999976432    233333333222 2233468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +.+||.+||..||.+|||+.+|++||||+...
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            99999999999999999999999999997654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.7e-49  Score=414.87  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=224.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      ..++|+++++||+|+||.||+|++ .+++.||||++.....  ........+.+|..+|..+ +||+|+++++++.+.+.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            467899999999999999999998 7889999999974211  1122345677899999887 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc--c
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~--~  294 (415)
                      +||||||+.+|+|..++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...  .
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999999999998876 579999999999999999999999999999999999999999999999999998543  2


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      ......+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.+....+....+.... ..+|..++.++.+||
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAIC  573 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHH
Confidence            334567799999999999654  48999999999999999999999999988877777776654 457789999999999


Q ss_pred             HHhhhhCCCCCCCH-----HHHHcChhhHhh
Q 014986          375 KQCVQVNPNDRPTA-----AQLLDHPFVKRL  400 (415)
Q Consensus       375 ~~~L~~dP~~Rps~-----~eil~hp~f~~~  400 (415)
                      ++||+.||.+||++     ++|++||||+.+
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            99999999999997     999999999865

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.9e-49  Score=373.93  Aligned_cols=256  Identities=38%  Similarity=0.681  Sum_probs=228.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|++.+.||+|+||.||+|++ .+++.||+|++......    .....+.+|+.+++.++||||+++++++.+...+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            45799999999999999999998 78999999999754322    23466889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      +||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .
T Consensus        97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            99999999999999998899999999999999999999999999999999999999999999999999997654332  3


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||...........+.......++..++..+.+||.+|
T Consensus       177 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  254 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC  254 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred             CccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence            345699999999998654  378899999999999999999999998877777777777777777888999999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      |..||.+|||+.++++||||+....
T Consensus       255 l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          255 LNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             CCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             cCCChhhCcCHHHHhhChhhhcCCC
Confidence            9999999999999999999987543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-49  Score=384.40  Aligned_cols=257  Identities=24%  Similarity=0.426  Sum_probs=207.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.+.||+|+||+||+|++ .+++.||+|++....   ........+.+|+.+++.++||||+++++++.+.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            4567899999999999999999998 789999999986432   222334567799999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-----CCCcEEEEeeccccc
Q 014986          218 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-----ANGSVKLADFGLAKA  291 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-----~~~~vkl~DFGla~~  291 (415)
                      +|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++.
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999985 999988764 699999999999999999999999999999999999994     445699999999976


Q ss_pred             cccC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC-------
Q 014986          292 TKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-------  362 (415)
Q Consensus       292 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------  362 (415)
                      ....  ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||......+.+..+......+.       
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            5422  23445689999999998653 2378999999999999999999999998877666665543211110       


Q ss_pred             ----------------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          363 ----------------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       363 ----------------------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                                            +..++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                  11267899999999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.9e-49  Score=383.93  Aligned_cols=256  Identities=28%  Similarity=0.436  Sum_probs=204.2

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ..+.++|++.+.||+|+||.||+|++ .+++.||+|++....       ..+.+.+|+.+++.++||||+++++++.+..
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            34567899999999999999999998 678999999987421       2345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEeecccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT  292 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~DFGla~~~  292 (415)
                      .+++||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            999999999999999988654 5899999999999999999999999999999999999975   889999999999865


Q ss_pred             ccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH-HHHHHhcCCC---CCCCCccc
Q 014986          293 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRGSP---PPIPDSLS  367 (415)
Q Consensus       293 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~---~~~~~~~s  367 (415)
                      .... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||....... ....+.....   .+....++
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  279 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS  279 (349)
T ss_dssp             -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred             CcccccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence            4332 3456699999999999654  38999999999999999999999997655443 3334443332   23345789


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .++.+||.+||..||++|||+.++|+||||+....
T Consensus       280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            99999999999999999999999999999986543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.2e-49  Score=376.18  Aligned_cols=261  Identities=28%  Similarity=0.450  Sum_probs=207.1

Q ss_pred             eeecccccc-cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecC
Q 014986          139 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  215 (415)
Q Consensus       139 ~~~~~y~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  215 (415)
                      ++.+.|++. ++||+|+||.||+|++ .+++.||||++.....     .....+.+|+.++.++ +||||+++++++.+.
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            345678885 7899999999999998 7899999999975322     1234677999999884 799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEeeccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKA  291 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~---vkl~DFGla~~  291 (415)
                      +.+|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999999998865 46999999999999999999999999999999999999998776   99999999875


Q ss_pred             cccC---------CcccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccH------------
Q 014986          292 TKLN---------DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------------  347 (415)
Q Consensus       292 ~~~~---------~~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------------  347 (415)
                      ....         .....+||+.|+|||++.+.   ...++.++|||||||++|+|++|+.||.....            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            4322         12234599999999998642   12378899999999999999999999976421            


Q ss_pred             ---HHHHHHHhcCCCCCCC----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          348 ---MAALFKIGRGSPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       348 ---~~~~~~i~~~~~~~~~----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                         ......+..+.. .++    ..++..+++||.+||..||.+|||+.++++||||+.....+.
T Consensus       244 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~  307 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT  307 (316)
T ss_dssp             HHHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-------
T ss_pred             hHHHHHHHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCccc
Confidence               222333333322 222    357899999999999999999999999999999998765543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-48  Score=383.19  Aligned_cols=258  Identities=29%  Similarity=0.482  Sum_probs=218.2

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++....    .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            56899999999999999999998 689999999987532    2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      +||||+.+++|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  187 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  187 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence            99999999999999876 4799999999999999999999996 999999999999999999999999999976654455


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHH--------------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL--------------------------  351 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~--------------------------  351 (415)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+..                          
T Consensus       188 ~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             ---CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            566799999999999654  4899999999999999999999999765433221                          


Q ss_pred             ----------------HHHhcCCCCCC-CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          352 ----------------FKIGRGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       352 ----------------~~i~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                      ..+........ ...++.++.+||.+||+.||.+|||+.++|+||||+......
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence                            12222222222 235789999999999999999999999999999999987644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.2e-49  Score=380.53  Aligned_cols=252  Identities=28%  Similarity=0.456  Sum_probs=194.9

Q ss_pred             ccccc---ccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCC
Q 014986          142 TYWQK---GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  216 (415)
Q Consensus       142 ~~y~~---~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  216 (415)
                      ++|++   .+.||+|+||.||+|++ .+++.||+|++...        ....+.+|+.+++.+. ||||+++++++.+..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            45555   37899999999999998 68999999998631        2245678999999997 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEeecccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKAT  292 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~---~vkl~DFGla~~~  292 (415)
                      ..|+||||+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            999999999999999988764 699999999999999999999999999999999999998766   8999999999865


Q ss_pred             ccC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH-------HHHHHHHhcCCCCCCC
Q 014986          293 KLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKIGRGSPPPIP  363 (415)
Q Consensus       293 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~  363 (415)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....       .+....+..+......
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             CC----------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             CCCCCcccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            433  23455689999999998654  389999999999999999999999976432       3445555554433221


Q ss_pred             ---CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          364 ---DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       364 ---~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                         ..++.++.+||.+||..||.+|||+.++++||||+.....
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence               3579999999999999999999999999999999875443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.6e-49  Score=404.20  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=219.2

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.++||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+|+.++||||+++++++.+...+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            356899999999999999999998 6899999999974221  1112345678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          219 YIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      |+||||+.||+|..++...     .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999988653     59999999999999999999999999999999999999999999999999998765


Q ss_pred             cCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc----HHHHHHHHhcCCCCCCCCccc
Q 014986          294 LND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME----CMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       294 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      ...  ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....    .......+.. ....++..++
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p~~~s  417 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFS  417 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCCTTSC
T ss_pred             CCCcccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCCcccC
Confidence            433  2345799999999999654  48999999999999999999999997642    2333333433 3345678899


Q ss_pred             HHHHHHHHHhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      .++.+||.+||..||.+||+     +++|++||||+.+
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            99999999999999999996     5899999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-48  Score=398.67  Aligned_cols=259  Identities=29%  Similarity=0.524  Sum_probs=223.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||+||+|++ .+++.||+|++.......   .....+.+|+.+|+.++||||+++++++.+...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            4678999999999999999999998 689999999997532211   123567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CCCcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~---~~~~vkl~DFGla~~~~  293 (415)
                      +|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            9999999999999987754 6799999999999999999999999999999999999995   45679999999998654


Q ss_pred             cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCcccHH
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  369 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~  369 (415)
                      .. .....+||+.|+|||++.+   .++.++|||||||++|+|++|..||.+....+.+..+..+...   +....++.+
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             CCCccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            43 2345679999999999864   2889999999999999999999999998887777777665433   223468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +++||.+||..||.+|||+.++|+||||+.....
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence            9999999999999999999999999999986543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-48  Score=373.23  Aligned_cols=255  Identities=31%  Similarity=0.479  Sum_probs=220.6

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.++|.+.+.||+|+||.||+|++ .+++.||+|++.....     .....+.+|+.+++.++||||+++++++.+...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            457899999999999999999998 6899999999974321     1234678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEeecccccccc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKL  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl---~~~~~vkl~DFGla~~~~~  294 (415)
                      |+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999999999998764 568999999999999999999999999999999999999   7789999999999976554


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC---CCCCCcccHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPDSLSKDAQ  371 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~  371 (415)
                      .......||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+..+..   .+.+..++..+.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          162 GIMSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             BTTHHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             CccccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            444455699999999998654  488999999999999999999999988777666666655542   234467899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||.+||..||.+|||+.++++||||+...
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999999998654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=378.97  Aligned_cols=255  Identities=26%  Similarity=0.481  Sum_probs=211.6

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC--CcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~  217 (415)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|++.....   .......+.+|+.+|..++|  +||+++++++.+...
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc---chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            4567999999999999999999998899999999975332   23445678899999999986  999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||| +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 5677999988764 689999999999999999999999999999999999996 6889999999998664332


Q ss_pred             ----cccCCCCcccccccccccc---------ccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHh-cCCCCC
Q 014986          297 ----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIG-RGSPPP  361 (415)
Q Consensus       297 ----~~~~~gt~~y~aPE~l~~~---------~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~-~~~~~~  361 (415)
                          .....||+.|+|||++.+.         ...++.++|||||||++|+|++|+.||.... ....+..+. ......
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence                2345699999999998541         1347889999999999999999999997643 223333333 233445


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ++...+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            67788899999999999999999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.3e-48  Score=397.00  Aligned_cols=259  Identities=28%  Similarity=0.494  Sum_probs=219.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||+||+|++ .++..||+|++........   ....+.+|+.+++.++||||+++++++.+...
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4567899999999999999999998 6899999999975332211   23567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vkl~DFGla~~~~  293 (415)
                      +|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++....
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999999987754 579999999999999999999999999999999999999764   559999999998655


Q ss_pred             cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccHH
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  369 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~  369 (415)
                      .. .....+||+.|+|||++.+   .++.++|||||||++|+|++|..||......+.+..+..+....   ....++..
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             CCccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            33 3445679999999999853   38899999999999999999999999988877777776655432   22468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +++||++||+.||.+|||+.++|+||||+.....
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  301 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK  301 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCcccccCccc
Confidence            9999999999999999999999999999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.5e-49  Score=384.70  Aligned_cols=260  Identities=28%  Similarity=0.500  Sum_probs=217.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  215 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++...    ........+.+|+.+++.++||||+++++++...  
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            3456899999999999999999998 68999999998642    2233456788999999999999999999998654  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ---~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                         ..+|+||||+.+ +|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          100 EQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence               478999999985 9999999889999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-------
Q 014986          293 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-------  360 (415)
Q Consensus       293 ~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------  360 (415)
                      ....     .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......       
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            4322     2345799999999987533 34789999999999999999999999876554444433211000       


Q ss_pred             -----------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          361 -----------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       361 -----------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                             .....++.++.+||.+||..||.+|||+.++|+||||++.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence                                   01245788999999999999999999999999999999986543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-48  Score=377.42  Aligned_cols=261  Identities=27%  Similarity=0.461  Sum_probs=223.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++........ .......+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4567899999999999999999998 6899999999976432211 1112456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEeeccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  291 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~----~vkl~DFGla~~  291 (415)
                      .+|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            999999999999999998754 689999999999999999999999999999999999999887    799999999986


Q ss_pred             cccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCccc
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLS  367 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s  367 (415)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+.......   .+..++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          169 IEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             cCccccccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            5543 23456699999999998654  37899999999999999999999998877777766666544332   125688


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ..+.+||.+||..||.+|||+.++++||||+...
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999999997543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.6e-49  Score=386.18  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=208.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  216 (415)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||||++.....   .......+.+|+.+++.++||||+++++++.... 
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   98 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   98 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC---ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence            4567899999999999999999998 7899999999874322   2334567889999999999999999999987655 


Q ss_pred             -----EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          217 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       217 -----~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                           .+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A           99 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             cccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence                 78999999986 7888775 4699999999999999999999999999999999999999999999999999986


Q ss_pred             cccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC-------
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-------  363 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------  363 (415)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+....+.+.++......+.+       
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             -------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            5433 23446799999999999654  4889999999999999999999999988777766666543322111       


Q ss_pred             ----------------------------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          364 ----------------------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       364 ----------------------------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                                        ...+..+++||.+||..||.+|||++++|+||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                                              012568999999999999999999999999999997655

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.6e-48  Score=379.20  Aligned_cols=255  Identities=34%  Similarity=0.588  Sum_probs=220.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|++.+.||+|+||+||+|++ .+++.||||++.....  ........+.+|+.+++.++||||+++++++.+.+..|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            35688999999999999999998 7899999999975332  22344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          220 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      +||||+. |+|.+++.  ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  .
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~  207 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--A  207 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--B
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--C
Confidence            9999998 57888774  35699999999999999999999999999999999999999999999999999976543  2


Q ss_pred             ccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-CCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~  375 (415)
                      ....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||........+..+.....+. .+..++..+.+||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  287 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  287 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            345799999999998532 3347889999999999999999999998887777766666554433 35578999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +||+.||.+|||+.++++||||...
T Consensus       288 ~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          288 SCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHcccChhhCcCHHHHhhChhhhcc
Confidence            9999999999999999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.9e-48  Score=367.47  Aligned_cols=253  Identities=29%  Similarity=0.552  Sum_probs=215.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----C
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----E  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~  215 (415)
                      ...|++.+.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.+++.++||||+++++++..    .
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34688889999999999999998 7889999999875332   23345678899999999999999999998764    4


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-CCCcEEEEeeccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~-~~~~vkl~DFGla~~  291 (415)
                      ..+++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            678999999999999999976 57999999999999999999999999  99999999999998 789999999999987


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHH-HhcCCC-CCCCCcccHH
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSP-PPIPDSLSKD  369 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~-~~~~~~~s~~  369 (415)
                      ..........||+.|+|||++.+   .++.++|||||||++|+|++|+.||........... +..+.. ...+...+.+
T Consensus       182 ~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          182 KRASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ccccccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence            66666666779999999998853   278999999999999999999999987554444433 333322 2345567789


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      +.+||.+||..||.+|||+.++++||||++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-49  Score=382.96  Aligned_cols=260  Identities=28%  Similarity=0.408  Sum_probs=210.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++...............+.+|+.+++.++||||+++++++.+.+.+
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            357899999999999999999999 6799999999875332222222234677999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-
Q 014986          219 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-  295 (415)
                      ++||||+.+ +|..++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999987 888888754  4889999999999999999999999999999999999999999999999999865433 


Q ss_pred             -CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----CC--------
Q 014986          296 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----PI--------  362 (415)
Q Consensus       296 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~--------  362 (415)
                       ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+....+.+.++......    .+        
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             ccCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence             23456799999999998543 23788999999999999999999999888776666555331110    00        


Q ss_pred             ---------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          363 ---------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       363 ---------------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                     ...++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                           145678999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.5e-49  Score=389.15  Aligned_cols=263  Identities=29%  Similarity=0.447  Sum_probs=202.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ...+.++|++.+.||+|+||.||+|++ .+++.||||++....   ........+.+|+.+|+.++||||+++++++...
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            445678999999999999999999998 789999999886422   1233456778999999999999999999998654


Q ss_pred             ------CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          216 ------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       216 ------~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                            ..+|+|||++ +++|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence                  5689999999 579999888888999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--------
Q 014986          290 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------  361 (415)
Q Consensus       290 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------  361 (415)
                      +..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......+        
T Consensus       180 ~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          180 RHTADE-MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             ------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cccccc-CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            865433 3456799999999998652 347899999999999999999999998877666555443211100        


Q ss_pred             ----------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          362 ----------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       362 ----------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                                            ....++..+.+||.+||..||.+|||+.++|+||||+.+.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  323 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  323 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence                                  11246789999999999999999999999999999998765443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-48  Score=390.34  Aligned_cols=262  Identities=29%  Similarity=0.476  Sum_probs=209.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  215 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--  215 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||||++....   ......+.+.+|+.+|+.++||||+++++++...  
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            4567899999999999999999998 789999999996432   2234456788999999999999999999998766  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 ---SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ---~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                         ..+|+||||+.+ +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          100 LKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence               679999999875 999988764 599999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC------------------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCC-------
Q 014986          292 TKLND------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-------  340 (415)
Q Consensus       292 ~~~~~------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~-------  340 (415)
                      .....                        ....+||+.|+|||++... ..++.++|||||||++|+|++|..       
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccc
Confidence            54321                        2456799999999987433 348999999999999999998544       


Q ss_pred             ----CCCCcc-----------------HHHHHHHHhc-----------------------CCCCCC-------CCcccHH
Q 014986          341 ----PYAPME-----------------CMAALFKIGR-----------------------GSPPPI-------PDSLSKD  369 (415)
Q Consensus       341 ----pf~~~~-----------------~~~~~~~i~~-----------------------~~~~~~-------~~~~s~~  369 (415)
                          +|.+..                 ..+++..+..                       ......       ...++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence                443321                 1111111110                       011101       1357999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      +.+||.+||..||.+|||++|+|+||||+.+.....
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            999999999999999999999999999999865443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.2e-48  Score=396.88  Aligned_cols=261  Identities=26%  Similarity=0.431  Sum_probs=222.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch--------hHHHHHHHHHHHHHHhcCCCCcEEEee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ--------AKQSISQLEQEIALLSRFEHENIVQYY  209 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~--------~~~~~~~~~~E~~il~~l~hpnIv~l~  209 (415)
                      .+.++|++++.||+|+||+||+|++ .+++.||+|++........        .......+.+|+.+|+.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4567899999999999999999998 6789999999975322110        012346788999999999999999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEe
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLAD  285 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~---~vkl~D  285 (415)
                      +++.+...+|+|||||.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999999987754 5799999999999999999999999999999999999998776   699999


Q ss_pred             eccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--
Q 014986          286 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--  362 (415)
Q Consensus       286 FGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--  362 (415)
                      ||+++..... .....+||+.|+|||++.+   .++.++|||||||++|+|++|..||.+....+.+..+..+.....  
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            9999866543 3455679999999999853   378999999999999999999999999888877777776654321  


Q ss_pred             -CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          363 -PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       363 -~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                       ...++.++++||++||..||.+|||+.++|+||||+....
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence             2568999999999999999999999999999999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.2e-48  Score=381.02  Aligned_cols=262  Identities=27%  Similarity=0.483  Sum_probs=223.9

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHhcC-CCCcEEEeeeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRF-EHENIVQYYGTD  212 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~---~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  212 (415)
                      ..+.++|++.+.||+|+||.||+|++ .+|+.||||++......   .........+.+|+.+++.+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            34567899999999999999999998 58999999999754322   12233456788999999998 799999999999


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      ......|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            999999999999999999998875 4799999999999999999999999999999999999999999999999999886


Q ss_pred             cccC-CcccCCCCcccccccccccc----ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---C
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---P  363 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~  363 (415)
                      .... ......||+.|+|||++.+.    ...++.++|||||||++|+|++|..||...........+..+.....   .
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  329 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW  329 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            6543 34456799999999998543    22478899999999999999999999988777666666655443321   2


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ..++..+.+||.+||..||.+|||+.++++||||++
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            467889999999999999999999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.8e-49  Score=398.94  Aligned_cols=261  Identities=28%  Similarity=0.463  Sum_probs=225.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||||++.......  ......+.+|+.+++.++||||+++++++.+...
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4567899999999999999999998 689999999997543221  1224568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl---~~~~~vkl~DFGla~~~~  293 (415)
                      +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999999998754 579999999999999999999999999999999999999   467899999999998654


Q ss_pred             cCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccHH
Q 014986          294 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  369 (415)
Q Consensus       294 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~  369 (415)
                      ... ....+||+.|+|||++.+   .++.++|||||||++|+|++|..||......+.+..+..+....   ....++..
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             cccccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            332 345579999999999854   38899999999999999999999999988888777777665432   22468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      +++||.+||..||.+|||+.++|+||||+......
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~  292 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ  292 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhhccccccc
Confidence            99999999999999999999999999999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-48  Score=392.51  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=210.0

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC------CCCcEEEeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF------EHENIVQYYG  210 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~  210 (415)
                      ..+..+|++.++||+|+||.||+|.+ .+++.||||++...      ......+.+|+.+++.+      +|+||+++++
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            34567899999999999999999998 67999999998631      22334566777777666      5789999999


Q ss_pred             eeecCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--EEEEe
Q 014986          211 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLAD  285 (415)
Q Consensus       211 ~~~~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~--vkl~D  285 (415)
                      .+.....+|+||||+. ++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence            9999999999999997 5899988764   4899999999999999999999999999999999999999887  99999


Q ss_pred             eccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----
Q 014986          286 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----  361 (415)
Q Consensus       286 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----  361 (415)
                      ||+++..... ....+||+.|+|||++.+..  ++.++|||||||++|+|++|..||......+.+..+......+    
T Consensus       246 FG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          246 FGSSCYEHQR-VYTYIQSRFYRAPEVILGAR--YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             CTTCEETTCC-CCSSCSCGGGCCHHHHHTBC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccceecCCc-ccccCCCCCccChHHHhCCC--CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9999765433 44567999999999996544  8999999999999999999999998877665554433210000    


Q ss_pred             ------------------------------------------------------CCCcccHHHHHHHHHhhhhCCCCCCC
Q 014986          362 ------------------------------------------------------IPDSLSKDAQDFIKQCVQVNPNDRPT  387 (415)
Q Consensus       362 ------------------------------------------------------~~~~~s~~l~~Li~~~L~~dP~~Rps  387 (415)
                                                                            ++...+..+.+||.+||+.||.+|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                                                                  11234788999999999999999999


Q ss_pred             HHHHHcChhhHhhhhhCCCCCCC
Q 014986          388 AAQLLDHPFVKRLLATNSGSASP  410 (415)
Q Consensus       388 ~~eil~hp~f~~~~~~~~~~~~~  410 (415)
                      +.|+|+||||++...........
T Consensus       403 a~e~L~Hpw~~~~~~~~~~~~~~  425 (429)
T 3kvw_A          403 PGQALRHPWLRRRLPKPPTGEKT  425 (429)
T ss_dssp             HHHHHTSTTTC------------
T ss_pred             HHHHhCChhhccCCCCCCccccc
Confidence            99999999999987766554433

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.1e-48  Score=371.62  Aligned_cols=260  Identities=28%  Similarity=0.497  Sum_probs=213.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +.....+|++.+.||+|+||+||+|.+ +++.||+|++.....   .......+.+|+.+++.++||||+++++++.+..
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            334467899999999999999999977 688999999875332   2344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~~----l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .+++||||+.+|+|.+++....    +++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            9999999999999999997654    899999999999999999999999  9999999999999999999999999997


Q ss_pred             ccccC--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-cCCCCCCCCccc
Q 014986          291 ATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLS  367 (415)
Q Consensus       291 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s  367 (415)
                      .....  ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+....+. ......++..++
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN  265 (309)
T ss_dssp             --------------CCTTSCHHHHTTCC--CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred             cccccccccccCCCCccccChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence            54433  234456999999999996543  7899999999999999999999999887766666553 444556778899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ..+.+||.+||..||.+|||+.++++  .++.+....
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~ll~--~L~~~~~~~  300 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATIMD--LLRPLIKSA  300 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHC--
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHHhC
Confidence            99999999999999999999999987  455555443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-48  Score=384.31  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=210.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee-----
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-----  213 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----  213 (415)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|++......         ..+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            356899999999999999999998 78999999998643221         237999999999999999999883     


Q ss_pred             ---------------------------------cCCEEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHH
Q 014986          214 ---------------------------------DESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGL  255 (415)
Q Consensus       214 ---------------------------------~~~~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL  255 (415)
                                                       +...+++||||+.+ +|.+.+..     ..+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                             34458999999985 77776643     4699999999999999999


Q ss_pred             HHHHHCCceecCCCCCcEEEc-CCCcEEEEeeccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHH
Q 014986          256 KYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL  333 (415)
Q Consensus       256 ~~LH~~~IiHrDLkp~NILl~-~~~~vkl~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~  333 (415)
                      +|||++||+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+. ..++.++|||||||++|
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence            999999999999999999998 6899999999999865433 34456789999999998643 33789999999999999


Q ss_pred             HHHcCCCCCCCccHHHHHHHHhcCCCC----------------------------CCCCcccHHHHHHHHHhhhhCCCCC
Q 014986          334 EMLTSQIPYAPMECMAALFKIGRGSPP----------------------------PIPDSLSKDAQDFIKQCVQVNPNDR  385 (415)
Q Consensus       334 ell~g~~pf~~~~~~~~~~~i~~~~~~----------------------------~~~~~~s~~l~~Li~~~L~~dP~~R  385 (415)
                      +|++|+.||.+....+.+..+......                            .++..++.++.+||.+||..||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999988777666655431111                            1345688999999999999999999


Q ss_pred             CCHHHHHcChhhHhhhh
Q 014986          386 PTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       386 ps~~eil~hp~f~~~~~  402 (415)
                      ||+.|+|+||||+.+..
T Consensus       314 ~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          314 INPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCHHHHHTSGGGHHHHH
T ss_pred             CCHHHHhcCHHHHHHHh
Confidence            99999999999999865

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.6e-48  Score=365.89  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=214.5

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      ++.++|++.+.||+|+||+||+|++ .+++.||+|++......   ......+.+|+..+..+ +||||+++++++.+.+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            4567899999999999999999998 68999999998753322   22345677899999998 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-------------
Q 014986          217 KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-------------  278 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-------------  278 (415)
                      .+++||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999999865     458999999999999999999999999999999999999844             


Q ss_pred             ------CcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH
Q 014986          279 ------GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF  352 (415)
Q Consensus       279 ------~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~  352 (415)
                            ..+||+|||++.......  ...||+.|+|||++.+. ..++.++|||||||++|+|++|..++.....   ..
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ--VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC--CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH
T ss_pred             cccCCceEEEEcccccccccCCcc--ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH
Confidence                  479999999998765432  34599999999998653 2366899999999999999999988765543   33


Q ss_pred             HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       353 ~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+..+..+.++..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            455566667788999999999999999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.5e-48  Score=375.29  Aligned_cols=257  Identities=30%  Similarity=0.533  Sum_probs=224.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|.+.+.||+|+||.||++.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            46799999999999999999998 67899999998753322  2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      +||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            99999999999998875 56999999999999999999999999999999999999999999999999999865422  2


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......+....+.... ..++..++..+.+||.+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~  274 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQK  274 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHH
T ss_pred             ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHH
Confidence            3445699999999998654  37889999999999999999999998877666665555543 34677899999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ||+.||.+|||+.++++||||+....
T Consensus       275 ~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          275 MLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HccCChhHCcCHHHHhcCccccCCCc
Confidence            99999999999999999999987653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.1e-48  Score=366.88  Aligned_cols=259  Identities=30%  Similarity=0.527  Sum_probs=225.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++......  .....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            346899999999999999999998 67899999998753322  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      ++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            999999999999998875 46999999999999999999999999999999999999999999999999999865432  


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......+....+.... ..++..++..+.+||.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHH
Confidence            23445699999999998654  37889999999999999999999999877666665555443 4467789999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +||+.||.+|||+.++++||||+.....
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHcccChhhCcCHHHHhhChheecCCcC
Confidence            9999999999999999999999876543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.5e-48  Score=383.28  Aligned_cols=256  Identities=25%  Similarity=0.471  Sum_probs=213.0

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC--CCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~  217 (415)
                      ....|++.+.||+|+||.||+|.+.+++.||||++.....   .......+.+|+.+|..++  ||||+++++++...+.
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            3456999999999999999999997799999999975332   2345577889999999996  5999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||| +.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 567799998875 4689999999999999999999999999999999999995 6899999999998664332


Q ss_pred             ----cccCCCCcccccccccccc---------ccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcC-CCCC
Q 014986          297 ----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRG-SPPP  361 (415)
Q Consensus       297 ----~~~~~gt~~y~aPE~l~~~---------~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~-~~~~  361 (415)
                          ....+||+.|+|||++.+.         ...++.++|||||||++|+|++|+.||.... ....+..+... ....
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence                2345799999999998642         1247899999999999999999999997643 33344444433 3345


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ++...+.++.+||.+||..||.+|||+.++|+||||+..
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            667788999999999999999999999999999999854

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.3e-49  Score=369.69  Aligned_cols=259  Identities=30%  Similarity=0.557  Sum_probs=197.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+..
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            356899999999999999999998 7899999999874211  1112246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC-
Q 014986          219 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~-  295 (415)
                      |+||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999999876  46899999999999999999999999999999999999999999999999999865432 


Q ss_pred             -CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          296 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       296 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                       ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...........+... ....+..++.++.+||
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHH
Confidence             23345689999999998654  3788999999999999999999999876544444333322 2345677899999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .+||..||.+|||+.++++||||++....
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  272 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMSRNSST  272 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC-----
T ss_pred             HHHcccCHhhCCCHHHHhcCccccCCCCc
Confidence            99999999999999999999999875543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=369.95  Aligned_cols=262  Identities=27%  Similarity=0.481  Sum_probs=218.6

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee--ecCC
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDES  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~  216 (415)
                      +.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ........+.+|+.+++.++||||+++++++  .+..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            567899999999999999999998 78999999998742211 1112346788999999999999999999998  4556


Q ss_pred             EEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .+|+||||+.++ |.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            899999999987 7666653   469999999999999999999999999999999999999999999999999997654


Q ss_pred             cC----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          294 LN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       294 ~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ..    ......||+.|+|||++.+....++.++||||||+++|+|++|..||......+....+.... ..++..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~  239 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPP  239 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHH
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHH
Confidence            22    223456999999999986544345789999999999999999999999877766666665554 3467789999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      +.+||.+||..||.+|||+.++++||||+......
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            99999999999999999999999999999876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-48  Score=365.84  Aligned_cols=264  Identities=28%  Similarity=0.449  Sum_probs=222.2

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++........ .......+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            46799999999999999999998 5899999999976432211 111245688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEeeccccccc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKATK  293 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~----~vkl~DFGla~~~~  293 (415)
                      ++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            999999999999998865 5799999999999999999999999999999999999998877    89999999997654


Q ss_pred             cC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccHH
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  369 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~  369 (415)
                      .. ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+.......   ....++..
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             --------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             CCCcccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            33 23445699999999998654  37899999999999999999999999877766666665443322   12467899


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      +.+||.+||..||.+|||+.++++||||+.+......
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence            9999999999999999999999999999999876644

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.9e-48  Score=366.22  Aligned_cols=263  Identities=29%  Similarity=0.453  Sum_probs=205.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.+.||+|+||+||+|++ .+++.||+|++.....   .......+.++...++.++||||+++++++.+.+.
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            3457899999999999999999998 7899999999864321   22233445556666888999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .|+||||+.+ +|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999999985 88776643     4699999999999999999999998 999999999999999999999999999976


Q ss_pred             cccCC-cccCCCCccccccccccc--cccCCCchhhHHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCC-CCCCCCcc
Q 014986          292 TKLND-VKSCRGTAFWMAPEVINN--KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGS-PPPIPDSL  366 (415)
Q Consensus       292 ~~~~~-~~~~~gt~~y~aPE~l~~--~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~-~~~~~~~~  366 (415)
                      ..... .....||+.|+|||++..  ....++.++|||||||++|+|++|+.||... .....+....... ....+..+
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            54433 233469999999999732  2334789999999999999999999999752 3333333333333 33334578


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      +.++.+||.+||+.||.+|||+.++++||||+...+...
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~  278 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT  278 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccccc
Confidence            999999999999999999999999999999998776543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.6e-48  Score=377.00  Aligned_cols=262  Identities=26%  Similarity=0.460  Sum_probs=217.0

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC-
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-  215 (415)
                      ..+.++|++.+.||+|+||.||+|++ .+++.||||++...    ........+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            34567899999999999999999998 68999999998642    2233445678999999999999999999987654 


Q ss_pred             ----CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 ----~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                          ...|+||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           83 FENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             STTCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence                679999999984 899999888899999999999999999999999999999999999999999999999999976


Q ss_pred             cccCC------------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC
Q 014986          292 TKLND------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  359 (415)
Q Consensus       292 ~~~~~------------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  359 (415)
                      .....            .....||+.|+|||++... ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            54221            2234689999999987542 3478999999999999999999999988765544433321000


Q ss_pred             C-------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          360 P-------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       360 ~-------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      .                               .....++.++.+||.+||..||.+|||+.++++||||+.+...+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  317 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND  317 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence            0                               012367899999999999999999999999999999998876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.3e-48  Score=366.26  Aligned_cols=266  Identities=27%  Similarity=0.451  Sum_probs=224.5

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEeccccc----chhHHHHHHHHHHHHHHhcCC-CCcEEEeeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG----SQAKQSISQLEQEIALLSRFE-HENIVQYYGT  211 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~----~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  211 (415)
                      ..+.++|++.+.||+|+||.||+|++ .+++.||+|++......    .........+.+|+.+++.+. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34567899999999999999999998 68999999999754321    122334567889999999995 9999999999


Q ss_pred             eecCCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          212 DKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       212 ~~~~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      +.+...+++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            9999999999999999999998875 479999999999999999999999999999999999999999999999999997


Q ss_pred             ccccC-CcccCCCCcccccccccccc----ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---C
Q 014986          291 ATKLN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---I  362 (415)
Q Consensus       291 ~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~  362 (415)
                      ..... ......||+.|+|||++.+.    ...++.++||||||+++|+|++|..||...........+..+....   .
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  252 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence            65433 33455699999999998531    2347889999999999999999999998877766666665544332   2


Q ss_pred             CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       363 ~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ...++..+.+||.+||..||.+|||+.++++||||++....
T Consensus       253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            24689999999999999999999999999999999987543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-48  Score=367.03  Aligned_cols=259  Identities=24%  Similarity=0.437  Sum_probs=216.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.++|++.+.||+|+||.||+|++ .+++.||+|++.....    ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence            457899999999999999999998 6899999999975332    12346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--
Q 014986          219 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  295 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--  295 (415)
                      |+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999999988653 6999999999999999999999999999999999999999999999999999765332  


Q ss_pred             --CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH-HHHHHhcC-CCCCCCCcccHHHH
Q 014986          296 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRG-SPPPIPDSLSKDAQ  371 (415)
Q Consensus       296 --~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~s~~l~  371 (415)
                        ......||+.|+|||++.+.. .++.++||||||+++|+|++|..||....... ........ ........++..+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSS-BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             hhcccCCccccCccChHHHhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence              234456999999999986533 24778999999999999999999997654321 12222221 12222356899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +||.+||..||.+|||+.++++||||++....
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            99999999999999999999999999977544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7e-49  Score=381.26  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=215.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch---hHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---AKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++........   .......+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3567899999999999999999998 7899999999975432111   01122346689999999999999999999999


Q ss_pred             CCEEEEEEeccCCC-CHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          215 ESKLYIFLELVTKG-SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       215 ~~~~~lV~E~~~~g-sL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      .+.+++||||+.+| +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999999777 999988765 6999999999999999999999999999999999999999999999999999866


Q ss_pred             ccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHH
Q 014986          293 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  371 (415)
Q Consensus       293 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  371 (415)
                      .... .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.....      . .......+..++.++.
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~------~-~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNP-YRGPELEMWSLGVTLYTLVFEENPFCELEE------T-VEAAIHPPYLVSKELM  252 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G-TTTCCCCSSCCCHHHH
T ss_pred             CCCCceeccCCCccccChhhhcCCC-CCCCcccchhHHHHHHHHHhCCCchhhHHH------H-HhhccCCCcccCHHHH
Confidence            5433 34566999999999986543 237899999999999999999999986432      1 1222334567899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +||.+||..||.+|||+.++++||||++.
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          253 SLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999999999763

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.3e-48  Score=380.78  Aligned_cols=257  Identities=27%  Similarity=0.482  Sum_probs=222.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~--------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      ...++|++++.||+|+||.||+|.+        .++..||+|++...    ........+.+|+.+++.+ +||||++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            3457899999999999999999975        24567999988642    2234567789999999999 899999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  272 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~N  272 (415)
                      +++.+.+.+|+||||+.+|+|.+++...                 .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            9999999999999999999999998754                 37889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccH
Q 014986          273 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC  347 (415)
Q Consensus       273 ILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~  347 (415)
                      ||++.++.+||+|||+++......    .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||.....
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999998654322    2334578899999998654  48999999999999999999 9999988777


Q ss_pred             HHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          348 MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       348 ~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .+....+..+.....+..++.++.+||.+||..||.+|||+.+++++  |+.+...
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~--L~~il~~  365 (370)
T 2psq_A          312 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILTL  365 (370)
T ss_dssp             GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHH
Confidence            66777777777777888999999999999999999999999999985  6666543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.2e-48  Score=363.09  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=215.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            3467899999999999999999998 5899999999874221  112234578899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999999998865 468999999999999999999999999999999999999999999999999998654432


Q ss_pred             -cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       297 -~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                       .....||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...........+.... ...+..++..+.+||.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -----------CCTGGGTTSC-CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHH
Confidence             33456899999999986543 23689999999999999999999998877666655555443 3467788999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||+.||.+|||+.++++||||++..
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHccCChhhCCCHHHHHhChhhccCc
Confidence            99999999999999999999998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.9e-48  Score=375.83  Aligned_cols=260  Identities=30%  Similarity=0.491  Sum_probs=214.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +....++|++.+.||+|+||.||+|++ .+++.||+|++.....   .......+.+|+.+++.++||||+++++++.+.
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK   96 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC---chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence            444578899999999999999999998 6799999999865332   233445678999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +.+|+||||+.+++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999999998888765 35799999999999999999999999999999999999999999999999999976543


Q ss_pred             C--CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-------------
Q 014986          295 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------  359 (415)
Q Consensus       295 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------  359 (415)
                      .  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+....+.....             
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CccccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  23445699999999998653 2478999999999999999999999988776555444321100             


Q ss_pred             --------CC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          360 --------PP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       360 --------~~---------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                              +.         ....++..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                    00         012578999999999999999999999999999999865

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.3e-48  Score=382.72  Aligned_cols=256  Identities=27%  Similarity=0.376  Sum_probs=209.9

Q ss_pred             eeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  214 (415)
                      ....+|++.++||+|+||+||+|++..+..+|+|++......         ..+|+.+++.++||||+++++++..    
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            345689999999999999999999976667999988643221         1379999999999999999999844    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEeec
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFG  287 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~----~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-~~~~vkl~DFG  287 (415)
                        ...+|+||||+.++.+..+..    ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence              334899999999854433322    34699999999999999999999999999999999999999 78999999999


Q ss_pred             cccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC------
Q 014986          288 LAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP------  360 (415)
Q Consensus       288 la~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------  360 (415)
                      +++..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......      
T Consensus       188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAGEPNVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTTCCCCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCCCCCcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865433 34456789999999998543 34799999999999999999999999988766665554331100      


Q ss_pred             ----------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          361 ----------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       361 ----------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                            .++..++.++.+||.+||..||.+|||+.++++||||+.+....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence                                  12335789999999999999999999999999999999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6e-48  Score=376.44  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=210.4

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  214 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  214 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++........   ....+.+|+.+++.++||||+++++++.+    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            357899999999999999999998 7899999998865432221   12356689999999999999999999876    


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          215 ----ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       215 ----~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                          .+.+|+||||+.+ +|...+..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                4578999999986 77776654  4699999999999999999999999999999999999999999999999999


Q ss_pred             cccccc------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC---C
Q 014986          289 AKATKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---P  359 (415)
Q Consensus       289 a~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~  359 (415)
                      ++....      .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+....   .
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            976532      223445689999999998543 347899999999999999999999999877665555443211   1


Q ss_pred             CCCCCc----------------------------ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          360 PPIPDS----------------------------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       360 ~~~~~~----------------------------~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ......                            .++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            111111                            26789999999999999999999999999999753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=371.41  Aligned_cols=259  Identities=23%  Similarity=0.394  Sum_probs=222.8

Q ss_pred             eecccccccccccCCcEEEEEEEc-C---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ..++|++.+.||+|+||.||+|.+ .   .+..||||++....    .......+.+|+.+++.++||||+++++++.+.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            356899999999999999999998 3   34469999987421    233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      +.+|+||||+.+|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999999999864  369999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCccc
Q 014986          294 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       294 ~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      ...     .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..+...+.+..++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCC--CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            332     12234677899999996543  8899999999999999999 999999988888888888887778888999


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      ..+.+||.+||..||.+|||+.+|++  .++.+......
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~--~L~~l~~~~~~  317 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVS--VLDALIRSPES  317 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHSCC-
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHhCccc
Confidence            99999999999999999999999987  57777665443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=367.54  Aligned_cols=254  Identities=38%  Similarity=0.683  Sum_probs=214.5

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...+.|++.+.||+|+||.||+|++ .+++.||+|.+....       ....+.+|+.+++.++||||+++++++.+.+.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            4466899999999999999999998 679999999997532       12457789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +|+||||+.+++|.+++.  ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999999886  357999999999999999999999999999999999999999999999999999765433


Q ss_pred             --CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHH
Q 014986          296 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQ  371 (415)
Q Consensus       296 --~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~  371 (415)
                        ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||...........+.......  .+..++..+.
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence              23345699999999998654  37899999999999999999999998877666665554443332  3456799999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +||.+||..||.+|||+.++++||||+...
T Consensus       257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          257 DFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.3e-48  Score=372.20  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=216.9

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.++..++||||+++++++.... 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            4567899999999999999999998 7899999999975322  23345567889999999999999999999887543 


Q ss_pred             ---EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          217 ---KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       217 ---~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                         ..|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence               45999999999999999865 46999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCC
Q 014986          293 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPD  364 (415)
Q Consensus       293 ~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~  364 (415)
                      ....     .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||..................+   ...
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             ---------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            4321     2235689999999999654  48899999999999999999999999887766665555544332   234


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .++.++.+||.+||+.||.+||++.+++.|+|++......
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            6899999999999999999999999999999999765543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-48  Score=382.67  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=214.3

Q ss_pred             eecccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeec
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  214 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  214 (415)
                      ..++|++.+.||+|+||.||+|++    .+++.||||++....... .......+.+|+.+|+.+ +||||+++++++.+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            357899999999999999999987    478999999986422111 011123456789999998 69999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      ...+|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999999999998865 579999999999999999999999999999999999999999999999999997543


Q ss_pred             cC---CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhcCCCCCCCCccc
Q 014986          294 LN---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       294 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      ..   .....+||+.|+|||++.+....++.++|||||||++|+|++|+.||....   ....+.........+++..++
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  290 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence            22   223456999999999997644457899999999999999999999996422   122222222233455778899


Q ss_pred             HHHHHHHHHhhhhCCCCCC-----CHHHHHcChhhHhh
Q 014986          368 KDAQDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ..+.+||.+||..||.+||     ++.++++||||+.+
T Consensus       291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            9999999999999999999     99999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.3e-48  Score=383.39  Aligned_cols=253  Identities=27%  Similarity=0.371  Sum_probs=204.6

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC--------CCcEEE
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--------HENIVQ  207 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~--------hpnIv~  207 (415)
                      ...+.++|++.++||+|+||+||+|++ .+++.||+|++...      ......+.+|+.+++.++        |+||++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            344567899999999999999999998 78999999998631      234456788999998885        788999


Q ss_pred             eeeeee----cCCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCC
Q 014986          208 YYGTDK----DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANG  279 (415)
Q Consensus       208 l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~  279 (415)
                      +++++.    +...+|+||||+. ++|.+++..   ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999987    5678999999995 466665543   3599999999999999999999998 999999999999999775


Q ss_pred             -------------------------------------------------cEEEEeeccccccccCCcccCCCCccccccc
Q 014986          280 -------------------------------------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPE  310 (415)
Q Consensus       280 -------------------------------------------------~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE  310 (415)
                                                                       .+||+|||+++..... .....||+.|+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE  263 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCCh
Confidence                                                             7999999999876543 44557999999999


Q ss_pred             cccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc------HHHHHHHHhc--CCC-----------------------
Q 014986          311 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME------CMAALFKIGR--GSP-----------------------  359 (415)
Q Consensus       311 ~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~--~~~-----------------------  359 (415)
                      ++.+..  ++.++|||||||++|+|++|+.||....      ....+..+..  +..                       
T Consensus       264 ~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          264 VLIGSG--YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHTSC--CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             hhcCCC--CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            996544  8899999999999999999999997532      1222211111  000                       


Q ss_pred             ----------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          360 ----------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       360 ----------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                                      ..++...+..+.+||.+||+.||.+|||+.+||+||||+.
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                            0122344677899999999999999999999999999973

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-47  Score=359.45  Aligned_cols=256  Identities=22%  Similarity=0.382  Sum_probs=223.6

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.+.||+|+||.||+|.+.+++.||+|++......      .+.+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            33345689999999999999999999988899999999743221      245789999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+|+||||+.+++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999999999999999653  489999999999999999999999999999999999999999999999999976543


Q ss_pred             CC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          295 ND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       295 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ..   .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+........+..++..+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  236 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             cccccccCcccccccCCHHHhcCCC--CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHH
Confidence            22   23345778899999986543  8999999999999999999 999999988888888888877777788899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+||.+||+.||.+|||+.++++|  ++++..
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~--l~~l~~  266 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ--LAEIAE  266 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH--HHHHHH
Confidence            999999999999999999999986  555543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=362.65  Aligned_cols=258  Identities=37%  Similarity=0.610  Sum_probs=213.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|....+||+|+||.||+|.+ .+++.||+|.+....     ......+.+|+.+++.++||||+++++++.+.+.++
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            44555666899999999999998 788999999987532     223456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEeecccccccc
Q 014986          220 IFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKL  294 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-~~~vkl~DFGla~~~~~  294 (415)
                      +||||+.+++|.+++...    .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999999999998754    4678889999999999999999999999999999999987 89999999999976543


Q ss_pred             CC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCCCCCCCcccHHH
Q 014986          295 ND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA--ALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       295 ~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ..  .....||+.|+|||++.+....++.++||||||+++|+|++|+.||.......  ............++..++..+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA  255 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence            22  33456999999999986554447899999999999999999999997643222  122223344556778899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .+||.+||..||.+|||+.++++||||+.....
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            999999999999999999999999999866543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-49  Score=390.19  Aligned_cols=254  Identities=17%  Similarity=0.228  Sum_probs=203.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHH---HHHhcCCCCcEEEee-------
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYY-------  209 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~-------  209 (415)
                      .++|++.+.||+|+||+||+|++ .+++.||||++.......  ....+.+.+|+   ++|+.++|||||+++       
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            46899999999999999999998 789999999997532222  22346788999   556666899999998       


Q ss_pred             eeeecCC-----------------EEEEEEeccCCCCHHHHHhhc-CCCH-------HHHHHHHHHHHHHHHHHHHCCce
Q 014986          210 GTDKDES-----------------KLYIFLELVTKGSLLNLYQRY-HLRD-------SQVSAYTRQILLGLKYLHDQDVV  264 (415)
Q Consensus       210 ~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~-~l~~-------~~~~~i~~qil~aL~~LH~~~Ii  264 (415)
                      +++.+.+                 ..||||||+ +|+|.+++... .+++       ..+..++.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            5555443                 289999999 57999998753 3444       77788999999999999999999


Q ss_pred             ecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCcccccccccccc---------ccCCCchhhHHHHHHHHHHH
Q 014986          265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEM  335 (415)
Q Consensus       265 HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~---------~~~~~~~~DvwSlG~il~el  335 (415)
                      ||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+.         ...++.++|||||||++|+|
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            999999999999999999999999986433 3344567 999999999654         01489999999999999999


Q ss_pred             HcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          336 LTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       336 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ++|+.||...........+..     ....++.++.+||.+||..||.+|||+.++++||||+.+....
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HHCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            999999976543332222221     2357899999999999999999999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-48  Score=379.71  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=220.6

Q ss_pred             ecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++|++.+.||+|+||+||+|++      .+++.||||++...    ........+.+|+.+++.++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            56899999999999999999983      46789999988632    123344568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEE
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL  283 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~--------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~---~vkl  283 (415)
                      ....|+||||+.+|+|.+++...        .+++..++.++.||+.||.|||++||+||||||+|||++.+|   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999999999763        389999999999999999999999999999999999999655   5999


Q ss_pred             EeeccccccccC----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Q 014986          284 ADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  358 (415)
Q Consensus       284 ~DFGla~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  358 (415)
                      +|||+++.....    ......||+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..+.
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999754221    223345799999999986543  8999999999999999998 999999988888888888887


Q ss_pred             CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          359 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       359 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ....+..++..+.+||.+||+.||.+|||+.+|++|.++-.-.
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            7778889999999999999999999999999999997765443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.4e-48  Score=363.57  Aligned_cols=256  Identities=29%  Similarity=0.491  Sum_probs=222.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee--ecCCE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDESK  217 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~  217 (415)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++......   ....+.+.+|+.+++.++||||+++++++  .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            56899999999999999999998 68999999999753322   33456788999999999999999999977  45778


Q ss_pred             EEEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEcCCCcEEEEeec
Q 014986          218 LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFG  287 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~-----IiHrDLkp~NILl~~~~~vkl~DFG  287 (415)
                      +|+||||+.+++|.+++...     .+++..++.++.||+.||.|||+.|     |+||||||+|||++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999988653     3999999999999999999999999     9999999999999999999999999


Q ss_pred             cccccccCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCc
Q 014986          288 LAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS  365 (415)
Q Consensus       288 la~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  365 (415)
                      +++......  .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+..+....++..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             hheeeccccccccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            987654332  1234589999999998654  378999999999999999999999998887777777777777778889


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ++..+.+||.+||+.||.+|||+.+|++|+|+.+-.
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            999999999999999999999999999999997654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.7e-48  Score=373.35  Aligned_cols=260  Identities=26%  Similarity=0.446  Sum_probs=218.1

Q ss_pred             eeeecccccc-cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec
Q 014986          138 KRIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  214 (415)
Q Consensus       138 ~~~~~~y~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  214 (415)
                      ..+.++|.+. +.||+|+||.||+|++ .+++.||+|++........   ....+.+|+.++..+. ||||+++++++.+
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD---CRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE---CHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH---HHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3456678887 8999999999999998 6899999999975432222   2356779999999985 6999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEeecc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGL  288 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~DFGl  288 (415)
                      ...+|+||||+.+|+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            9999999999999999998754   46899999999999999999999999999999999999987   78999999999


Q ss_pred             ccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC---CCCCC
Q 014986          289 AKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPD  364 (415)
Q Consensus       289 a~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~  364 (415)
                      ++..... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+.....   .....
T Consensus       181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  258 (327)
T 3lm5_A          181 SRKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS  258 (327)
T ss_dssp             CEEC---------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ccccCCccccccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence            9866433 23446799999999998654  488999999999999999999999988777666655544332   33445


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .++..+.+||.+||..||.+|||++++|+||||+.+.-
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            78999999999999999999999999999999987643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.7e-48  Score=368.08  Aligned_cols=259  Identities=34%  Similarity=0.629  Sum_probs=217.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ...+.|++.+.||+|+||.||+|++ .+++.||+|++....     ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            3457899999999999999999998 679999999986432     2234567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc-
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~-  294 (415)
                      +++||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999998764  5699999999999999999999999999999999999999999999999998754321 


Q ss_pred             -CCcccCCCCccccccccccc---cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccH
Q 014986          295 -NDVKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSK  368 (415)
Q Consensus       295 -~~~~~~~gt~~y~aPE~l~~---~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~  368 (415)
                       .......||+.|+|||++..   ....++.++||||||+++|+|++|..||...........+.......  .+..++.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence             12234569999999999842   23347889999999999999999999999887776666665554432  3567899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+.+||.+||..||.+|||+.++++||||+.+..
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            9999999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=375.96  Aligned_cols=263  Identities=27%  Similarity=0.474  Sum_probs=228.1

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEE
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  207 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~--------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~  207 (415)
                      +....++|++.+.||+|+||.||+|++        ..+..||+|++...    ........+.+|+.+++.+ +||||++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            445567899999999999999999986        23468999998642    2234456788999999999 8999999


Q ss_pred             eeeeeecCCEEEEEEeccCCCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          208 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       208 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++++.+.+.+|+||||+.+|+|.+++....                 +++..++.++.||+.||.|||++||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999997643                 89999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||...
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998654322    2334578899999998654  48999999999999999999 99999988


Q ss_pred             cHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          346 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       346 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                      ...+....+..+.....+..++.++.+||.+||+.||.+|||+.+|+++  ++.+.+.....
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~~~~~~~  357 (382)
T 3tt0_A          298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTSNQ  357 (382)
T ss_dssp             CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHSCSC
T ss_pred             CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHHHhcC
Confidence            8888777787777777888999999999999999999999999999986  77777655443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.2e-48  Score=389.08  Aligned_cols=262  Identities=26%  Similarity=0.422  Sum_probs=205.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .+.++|.+.+.||+|+||.||+|++ .+++.||+|++.......   ........+.+|+.+|+.++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3467899999999999999999998 788999999997543211   112223457899999999999999999999754


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEeecccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAK  290 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~---~vkl~DFGla~  290 (415)
                       ..+|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence             568999999999999887754 4699999999999999999999999999999999999997544   59999999998


Q ss_pred             ccccCC-cccCCCCccccccccccc-cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH-HHHHHhcCCCCCC---CC
Q 014986          291 ATKLND-VKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRGSPPPI---PD  364 (415)
Q Consensus       291 ~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~---~~  364 (415)
                      ...... ....+||+.|+|||++.+ ....++.++|||||||++|+|++|..||....... ....+..+.....   ..
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~  370 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  370 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence            765433 345679999999999854 22347889999999999999999999997643221 2222333322222   24


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .++..+.+||.+||+.||.+|||++++|+||||+...
T Consensus       371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            6799999999999999999999999999999998653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-47  Score=382.97  Aligned_cols=253  Identities=27%  Similarity=0.409  Sum_probs=207.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----  214 (415)
                      ...|++.++||+|+||.||+|++ .+++.||||++.....         ...+|+.+|+.++|||||++++++..     
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            45799999999999999999998 6799999999864221         12379999999999999999998743     


Q ss_pred             -CCEEEEEEeccCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeec
Q 014986          215 -ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFG  287 (415)
Q Consensus       215 -~~~~~lV~E~~~~gsL~~~l~-----~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFG  287 (415)
                       ..++++||||+.+ +|.+++.     ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence             2347899999987 5665553     2469999999999999999999999999999999999999965 568999999


Q ss_pred             cccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-------
Q 014986          288 LAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------  359 (415)
Q Consensus       288 la~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------  359 (415)
                      +++..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+.++.....       
T Consensus       203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRGEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTTCCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccCCCceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865433 33456799999999998643 2489999999999999999999999998776665555432100       


Q ss_pred             ------------CC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          360 ------------PP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       360 ------------~~---------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                                  +.         ++..++.++.+||.+||..||.+|||+.|+++||||+.+....
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence                        00         2345689999999999999999999999999999999886543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.8e-48  Score=371.57  Aligned_cols=252  Identities=25%  Similarity=0.446  Sum_probs=208.3

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec--C
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--E  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~  215 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++....        ...+.+|+.+++.++ ||||+++++++.+  .
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            356899999999999999999998 789999999986321        245779999999997 9999999999987  6


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~~  294 (415)
                      ...++||||+.+++|..++..  +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             CceEEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            789999999999999998764  88999999999999999999999999999999999999777 899999999986543


Q ss_pred             C-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc-cHHHHHHHH-------------hcCCC
Q 014986          295 N-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKI-------------GRGSP  359 (415)
Q Consensus       295 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i-------------~~~~~  359 (415)
                      . ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+..+             .....
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCccccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            3 34456799999999998542 34789999999999999999999999432 222221111             11000


Q ss_pred             -----------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          360 -----------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       360 -----------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                             ...+..++.++.+||.+||+.||.+|||++++|+||||+.+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                   0112237899999999999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-47  Score=362.27  Aligned_cols=257  Identities=23%  Similarity=0.411  Sum_probs=222.6

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.+.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++..++||||+++++++.+.+
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            44556789999999999999999999988899999999743221      245789999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+|+||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999999875  5799999999999999999999999999999999999999999999999999976543


Q ss_pred             CC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          295 ND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       295 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ..   .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |+.||......+....+........+..+++.+
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  250 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV  250 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCccCcccCCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHH
Confidence            22   23344778899999986543  8999999999999999998 999999988888888888887777788899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .+||.+||+.||.+|||+.++++|  ++.+...
T Consensus       251 ~~li~~~l~~~p~~Rps~~~ll~~--L~~~~~~  281 (283)
T 3gen_A          251 YTIMYSCWHEKADERPTFKILLSN--ILDVMDE  281 (283)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH--HHHHhhc
Confidence            999999999999999999999986  5555543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-47  Score=377.55  Aligned_cols=258  Identities=28%  Similarity=0.464  Sum_probs=212.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|.+.+.||+|+||.||+|++ .+++.||+|++....   ........+.+|+.+++.++||||+++++++...+.
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            3567899999999999999999998 789999999987432   223345678899999999999999999999987765


Q ss_pred             E------EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          218 L------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       218 ~------~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .      |+||||+.+ +|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       116 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQT-DLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             STTCCCCEEEEECCCE-EHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             cccceeEEEEEccccc-cHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            4      999999984 8887764 4599999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC-----------
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------  360 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  360 (415)
                      .... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......           
T Consensus       194 ~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADAE-MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             cccC-cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            5433 3445689999999998652 34789999999999999999999999887766555544321100           


Q ss_pred             -------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          361 -------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       361 -------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                                         ..+..++..+.+||.+||+.||.+|||+.++|+||||+.+...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence                               0123568999999999999999999999999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=368.15  Aligned_cols=258  Identities=28%  Similarity=0.475  Sum_probs=210.5

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee----
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD----  212 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----  212 (415)
                      ..+.++|++.+.||+|+||.||+|.+ .+++.||+|++...     .....+.+.+|+.+++.++||||+++++++    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            34567899999999999999999998 67999999998742     234456788999999999999999999886    


Q ss_pred             ----------ecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcE
Q 014986          213 ----------KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSV  281 (415)
Q Consensus       213 ----------~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-~~~~v  281 (415)
                                .+...+|+||||+. |+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence                      34578999999998 5999999988899999999999999999999999999999999999997 56799


Q ss_pred             EEEeeccccccccC-----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc
Q 014986          282 KLADFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR  356 (415)
Q Consensus       282 kl~DFGla~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  356 (415)
                      ||+|||+++.....     ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+....+..
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999865322     22334579999999988542 3478999999999999999999999988776655544432


Q ss_pred             CCCC-----------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          357 GSPP-----------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       357 ~~~~-----------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ....                             .....++.++.+||.+||+.||.+|||+.++++||||+...-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            2111                             012457899999999999999999999999999999996543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-47  Score=364.01  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=214.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|.+.....  ........+.+|+.+++.++||||+++++++.+.+.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            4567899999999999999999998 7899999999865332  224456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          218 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999999998764 69999999999999999999999999999999999999999999999999998654332


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----CCCcccHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----IPDSLSKD  369 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~s~~  369 (415)
                         .....||+.|+|||++.+..  ++.++||||||+++|+|++|+.||..........+......+.    .+..++..
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEA--TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS  243 (294)
T ss_dssp             ---------CCSSCCHHHHHTCC--CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred             ccccCccccCccccCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence               23356999999999986543  7889999999999999999999999887766655555544332    34678999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      +.++|.+||..||.+||+..+.+.+.|.+-
T Consensus       244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          244 LSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             HHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            999999999999999996555666555443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.3e-48  Score=370.48  Aligned_cols=260  Identities=33%  Similarity=0.578  Sum_probs=196.7

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ....++|++.+.||+|+||.||+|.+ .+++.||+|.+....    .......+.+|+.+++.++||||+++++++...+
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            34467899999999999999999998 689999999876422    1233456789999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeec
Q 014986          217 KLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  287 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~---------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFG  287 (415)
                      ..++||||+.+++|.+++..         ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999998863         348999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC-------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Q 014986          288 LAKATKLN-------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP  360 (415)
Q Consensus       288 la~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  360 (415)
                      ++......       ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            98754322       12334689999999998542 23788999999999999999999999876554444443333222


Q ss_pred             C---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          361 P---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       361 ~---------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .         ....++..+.+||.+||..||.+|||+.++++||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            1         23467899999999999999999999999999999998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-48  Score=383.44  Aligned_cols=260  Identities=13%  Similarity=0.114  Sum_probs=195.2

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHH---HHHhcCCCCcEEEeee------
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYG------  210 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~------  210 (415)
                      ...|++.+.||+|+||.||+|++ .+++.||+|++......  .......+.+|+   .+|+. +||||++++.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS  137 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence            34599999999999999999998 68999999999864322  334456677784   55555 7999888653      


Q ss_pred             -eeecC-----------------CEEEEEEeccCCCCHHHHHhhc--CCCHHHH------HHHHHHHHHHHHHHHHCCce
Q 014986          211 -TDKDE-----------------SKLYIFLELVTKGSLLNLYQRY--HLRDSQV------SAYTRQILLGLKYLHDQDVV  264 (415)
Q Consensus       211 -~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~------~~i~~qil~aL~~LH~~~Ii  264 (415)
                       ++...                 ..+||||||+. |+|.+++...  .+.+..+      ..++.||+.||+|||++||+
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence             33222                 44899999999 7999998753  4544445      57779999999999999999


Q ss_pred             ecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014986          265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  344 (415)
Q Consensus       265 HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~  344 (415)
                      ||||||+|||++.+|.+||+|||+++....... ...+|+.|+|||++.+....++.++|||||||++|+|++|+.||..
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999999986643322 4457799999999965334589999999999999999999999976


Q ss_pred             ccHHHH--HHH---Hh---cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          345 MECMAA--LFK---IG---RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       345 ~~~~~~--~~~---i~---~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      ......  ...   ..   .....+....++..+.+||.+||+.||.+|||+.++|+||||+++....+
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence            532100  000   00   01111223578999999999999999999999999999999999876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=369.60  Aligned_cols=253  Identities=24%  Similarity=0.457  Sum_probs=208.6

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC--
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  216 (415)
                      ..++|++.++||+|+||+||+|++ .+++.||||++......    .....+.+|+.+++.++||||+++++++....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            456899999999999999999998 67999999998743221    12355679999999999999999999987655  


Q ss_pred             EEEEEEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEeecc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL  288 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl----~~~~~vkl~DFGl  288 (415)
                      .+|+||||+.+++|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            889999999999999999754    29999999999999999999999999999999999999    7778899999999


Q ss_pred             ccccccCC-cccCCCCcccccccccccc------ccCCCchhhHHHHHHHHHHHHcCCCCCCCc----cHHHHHHHHhcC
Q 014986          289 AKATKLND-VKSCRGTAFWMAPEVINNK------NKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRG  357 (415)
Q Consensus       289 a~~~~~~~-~~~~~gt~~y~aPE~l~~~------~~~~~~~~DvwSlG~il~ell~g~~pf~~~----~~~~~~~~i~~~  357 (415)
                      ++...... .....||+.|+|||++...      ...++.++|||||||++|+|++|+.||...    ...+.+.++..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            98664433 3456799999999998521      344889999999999999999999999632    223444444333


Q ss_pred             CCC------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          358 SPP------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       358 ~~~------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                      .+.                        .+...++..+.+||.+||+.||.+|||++|+|+||=
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            221                        122345678999999999999999999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.4e-47  Score=357.77  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=222.0

Q ss_pred             eeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ...++|++.+.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++..++||||+++++++.+...+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            345789999999999999999999888889999998743221      24578999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          219 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      ++||||+.+++|.+++...  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999999988753  59999999999999999999999999999999999999999999999999998665443


Q ss_pred             cc---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 VK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ~~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                      ..   ...+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||...........+........+..++..+.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ  236 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSE--EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccC--CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence            22   334667899999986543  7889999999999999999 99999988888888888888777778889999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ||.+||+.||.+|||+.+++++  ++.+.
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~--L~~l~  263 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS--IEPLR  263 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH--HGGGC
T ss_pred             HHHHHcCCChhhCcCHHHHHHH--HHHhh
Confidence            9999999999999999999986  44443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=365.22  Aligned_cols=259  Identities=34%  Similarity=0.637  Sum_probs=214.0

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeec
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  214 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  214 (415)
                      .....++|++.+.||+|+||.||+|++ .+++.||+|++.....      ....+.+|+.+++.+ +||||+++++++..
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            334567899999999999999999998 7899999999874322      124577899999998 79999999999876


Q ss_pred             ------CCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          215 ------ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       215 ------~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                            ...+|+||||+.+|+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                  5689999999999999999875   4699999999999999999999999999999999999999999999999


Q ss_pred             eccccccccC--CcccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Q 014986          286 FGLAKATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP  360 (415)
Q Consensus       286 FGla~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  360 (415)
                      ||++......  ......||+.|+|||++...   ...++.++|||||||++|+|++|..||...........+.....+
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            9998765432  23345699999999998532   234788999999999999999999999887776666665554333


Q ss_pred             -CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          361 -PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       361 -~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                       ..+..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence             33567899999999999999999999999999999998653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-47  Score=372.96  Aligned_cols=260  Identities=25%  Similarity=0.449  Sum_probs=220.4

Q ss_pred             eeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchh------------HHHHHHHHHHHHHHhcCCCCcEE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA------------KQSISQLEQEIALLSRFEHENIV  206 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv  206 (415)
                      ...++|++.+.||+|+||.||+|.+ +++.||+|++.........            ......+.+|+.+++.++||||+
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            4567999999999999999999999 9999999999743211100            01126788999999999999999


Q ss_pred             EeeeeeecCCEEEEEEeccCCCCHHHH------Hhh---cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEc
Q 014986          207 QYYGTDKDESKLYIFLELVTKGSLLNL------YQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVD  276 (415)
Q Consensus       207 ~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~---~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~  276 (415)
                      ++++++.+.+.+|+||||+.+|+|.++      +..   ..+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            999999999999999999999999987      543   468999999999999999999999 9999999999999999


Q ss_pred             CCCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCc-hhhHHHHHHHHHHHHcCCCCCCCccH-HHHHHHH
Q 014986          277 ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL-PADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKI  354 (415)
Q Consensus       277 ~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~-~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i  354 (415)
                      .++.+||+|||++............||+.|+|||++.+.. .++. ++|||||||++|+|++|..||..... .+....+
T Consensus       187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i  265 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI  265 (348)
T ss_dssp             TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred             CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9999999999999876655556677999999999986542 2444 99999999999999999999987665 4555555


Q ss_pred             hcCCCCCCC-------------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          355 GRGSPPPIP-------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       355 ~~~~~~~~~-------------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ..... .++                   ..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus       266 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          266 RTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             TSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            44432 233                   56899999999999999999999999999999998754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-47  Score=374.14  Aligned_cols=263  Identities=26%  Similarity=0.438  Sum_probs=209.5

Q ss_pred             eeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEeccccc------chhHHHHHHHHHHHHHHhcCCCCcEEEeeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG------SQAKQSISQLEQEIALLSRFEHENIVQYYGT  211 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  211 (415)
                      ..+.++|++.+.||+|+||.||+|++.+++.||||++......      .......+.+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            3456789999999999999999999988999999998643221      1223445778999999999999999999999


Q ss_pred             ee-----cCCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 014986          212 DK-----DESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  284 (415)
Q Consensus       212 ~~-----~~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~  284 (415)
                      +.     ....+|+||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            83     44579999999984 888877654  58999999999999999999999999999999999999999999999


Q ss_pred             eeccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-----
Q 014986          285 DFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-----  358 (415)
Q Consensus       285 DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----  358 (415)
                      |||+++..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+....     
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999754333 23445689999999998652 337899999999999999999999998876555544442210     


Q ss_pred             ------------------CC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          359 ------------------PP--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       359 ------------------~~--------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                        ..        .....++..+.+||.+||..||.+|||+.++++||||+.+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                              00        012356888999999999999999999999999999998754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=382.02  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=192.4

Q ss_pred             eeeccccc-ccccccCCcEEEEEEEcC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee--
Q 014986          139 RIITYWQK-GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--  212 (415)
Q Consensus       139 ~~~~~y~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--  212 (415)
                      ++.+.|++ +++||+|+||+||+|++.   +++.||+|++.....       ...+.+|+.+|+.++||||+++++++  
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLS   89 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence            44566777 568999999999999953   688999998864221       12467899999999999999999998  


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCC
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DAN  278 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~----------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl----~~~  278 (415)
                      .....+|+||||+.+ +|.+++...          .+++..++.++.||+.||.|||++||+||||||+|||+    +.+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence            457899999999986 787776422          38999999999999999999999999999999999999    677


Q ss_pred             CcEEEEeeccccccccC-----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH------
Q 014986          279 GSVKLADFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------  347 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------  347 (415)
                      +.+||+|||+++.....     .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.....      
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            89999999999865432     23456799999999998653 2378999999999999999999999965432      


Q ss_pred             ---HHHHHHHhcCCCCCC-------------------------------------CCcccHHHHHHHHHhhhhCCCCCCC
Q 014986          348 ---MAALFKIGRGSPPPI-------------------------------------PDSLSKDAQDFIKQCVQVNPNDRPT  387 (415)
Q Consensus       348 ---~~~~~~i~~~~~~~~-------------------------------------~~~~s~~l~~Li~~~L~~dP~~Rps  387 (415)
                         .+.+..+......+.                                     ....+..+.+||.+||..||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               122222211110000                                     0112678899999999999999999


Q ss_pred             HHHHHcChhhHhhhh
Q 014986          388 AAQLLDHPFVKRLLA  402 (415)
Q Consensus       388 ~~eil~hp~f~~~~~  402 (415)
                      ++|+|+||||+....
T Consensus       328 a~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          328 SEQAMQDPYFLEDPL  342 (405)
T ss_dssp             HHHHHTSGGGTSSSC
T ss_pred             HHHHhcChhhccCCC
Confidence            999999999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.3e-47  Score=366.91  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=211.1

Q ss_pred             eeeecccccccccccCCcEEEEEEEc--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC------cEEEee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE------NIVQYY  209 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~  209 (415)
                      ..+.++|++.+.||+|+||.||+|.+  .+++.||+|++...      ......+.+|+.+++.++|+      +|++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            34567899999999999999999987  47899999998631      23345677888888888655      499999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---------
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---------  277 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---------  277 (415)
                      +++.+.+.+|+||||+ +++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.         
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 78999988764   4889999999999999999999999999999999999987         


Q ss_pred             ----------CCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH
Q 014986          278 ----------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC  347 (415)
Q Consensus       278 ----------~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~  347 (415)
                                ++.+||+|||+++..... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCccc-cccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      668999999999765433 3455799999999999654  389999999999999999999999987665


Q ss_pred             HHHHHHHhcCCC-------------------------------------------CCCCCcccHHHHHHHHHhhhhCCCC
Q 014986          348 MAALFKIGRGSP-------------------------------------------PPIPDSLSKDAQDFIKQCVQVNPND  384 (415)
Q Consensus       348 ~~~~~~i~~~~~-------------------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~  384 (415)
                      .+....+.....                                           .......++.+.+||.+||..||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            544333221100                                           0112234678999999999999999


Q ss_pred             CCCHHHHHcChhhHhhhh
Q 014986          385 RPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       385 Rps~~eil~hp~f~~~~~  402 (415)
                      |||+.|+++||||+.+..
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=366.86  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=210.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|+++++||+|+||+||+|.+ .+++.||+|++..     ........+.+|+.+++.++||||+++++++.++...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            46899999999999999999998 7899999998853     22345577889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          220 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      +||||+.+|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999976  4699999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----------------ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH------HHHHHHh
Q 014986          298 ----------------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM------AALFKIG  355 (415)
Q Consensus       298 ----------------~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~------~~~~~i~  355 (415)
                                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......      .......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence                            145699999999999654  4889999999999999999999998642110      0000011


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       356 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                          ...+..++..+.+||.+||+.||.+|||+.++++  |++.+...
T Consensus       242 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~~  283 (310)
T 3s95_A          242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMH  283 (310)
T ss_dssp             ----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHH
T ss_pred             ----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHHh
Confidence                1235678889999999999999999999999987  78777654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-47  Score=376.76  Aligned_cols=257  Identities=25%  Similarity=0.448  Sum_probs=222.1

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +....++|++.+.||+|+||.||+|.+ .+++.||||.+...    ........+.+|+.+|+.++||||+++++++.+.
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            344457899999999999999999998 58999999988632    1233445688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      +.+|+||||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            9999999999999999998753  59999999999999999999999999999999999999999999999999997644


Q ss_pred             cCCcc----cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          294 LNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       294 ~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      .....    ...+++.|+|||++.+..  ++.++|||||||++|||++ |..||......+....+..+...+.+..++.
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD  342 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            32221    123567899999986543  7899999999999999998 9999999888777777777777788889999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .+.+||.+||+.||.+|||+.+|++  .++.+.
T Consensus       343 ~l~~li~~cl~~dP~~Rps~~~i~~--~L~~i~  373 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRPSFSTIYQ--ELQSIR  373 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHH--HHHHHH
Confidence            9999999999999999999999976  355544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-46  Score=357.42  Aligned_cols=258  Identities=29%  Similarity=0.513  Sum_probs=220.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++.......   .....+.+|+.+++.++||||+++++++.+.+.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            4567899999999999999999998 689999999997533221   224567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vkl~DFGla~~~~  293 (415)
                      +|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999999999887754 579999999999999999999999999999999999999754   469999999987654


Q ss_pred             cCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccHH
Q 014986          294 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  369 (415)
Q Consensus       294 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~  369 (415)
                      ... .....||+.|+|||++.+.   ++.++||||||+++|+|++|..||......+....+..+....   ....++.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred             CCCccccccCcccccChHHhcCC---CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence            332 3334589999999998542   7889999999999999999999999887777666665554321   22468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.+||.+||..||.+|||+.++++||||++...
T Consensus       253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            999999999999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-47  Score=370.05  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=208.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||||++......   .........+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            3457899999999999999999998 67899999998643221   1112233457899999999999999999999876


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEeecccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK  290 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~---vkl~DFGla~  290 (415)
                      .. +|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            65 8999999999999998865 46999999999999999999999999999999999999987664   9999999998


Q ss_pred             ccccCC-cccCCCCccccccccccc-cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH-HHHHHHhcCCCCC---CCC
Q 014986          291 ATKLND-VKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP---IPD  364 (415)
Q Consensus       291 ~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~---~~~  364 (415)
                      ...... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||...... .....+..+....   ...
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T 2ycf_A          166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  245 (322)
T ss_dssp             ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred             ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence            664332 223468999999999743 2334789999999999999999999999764322 1112222222222   224


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .++..+.+||.+||..||.+|||+.++++||||+..
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            678999999999999999999999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.2e-47  Score=369.62  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=188.1

Q ss_pred             ceeeeccccccc-ccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          137 FKRIITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       137 ~~~~~~~y~~~~-~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      ...+.++|++.+ +||+|+||.||+|++ .+++.||+|++...      ...   ..+....++.++||||+++++++..
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~---~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKA---RQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHH---HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHH---HHHHHHHHHhcCCCChHHHHHHHhh
Confidence            345677899854 699999999999998 68999999998631      111   1122334667799999999999876


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEE
Q 014986          215 ----ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLA  284 (415)
Q Consensus       215 ----~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~  284 (415)
                          ...+++||||+.+|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence                55689999999999999999764   5999999999999999999999999999999999999986   4559999


Q ss_pred             eeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHH----HHHh---cC
Q 014986          285 DFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL----FKIG---RG  357 (415)
Q Consensus       285 DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~----~~i~---~~  357 (415)
                      |||+++...........||+.|+|||++.+..  ++.++|||||||++|+|++|..||.........    ..+.   ..
T Consensus       174 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          174 DFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             CCTTCEEC----------------------CH--HHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             ccccceeccccccccCCCCcCccChhhhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            99999877666666677999999999985443  788999999999999999999999765433221    1111   11


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      ...+....++..+.+||.+||..||.+|||+.++++||||++.......
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  300 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT  300 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCC
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCC
Confidence            1222335789999999999999999999999999999999987665543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.5e-47  Score=365.70  Aligned_cols=258  Identities=25%  Similarity=0.413  Sum_probs=202.2

Q ss_pred             eeecccccccccccCCcEEEEEEEcC-CCc---EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISD-DGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~---~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      ...++|++.+.||+|+||.||+|++. ++.   .||+|++.....   .....+.+.+|+.+++.++||||+++++++..
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            34568999999999999999999984 333   799998864221   22345678899999999999999999999987


Q ss_pred             CCEE------EEEEeccCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 014986          215 ESKL------YIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  281 (415)
Q Consensus       215 ~~~~------~lV~E~~~~gsL~~~l~~~-------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~v  281 (415)
                      ....      ++||||+.+|+|.+++...       .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7665      9999999999999988543       48999999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhc
Q 014986          282 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR  356 (415)
Q Consensus       282 kl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  356 (415)
                      ||+|||+++......    .....+++.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCC--CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            999999997654332    22334678899999986543  8999999999999999999 9999998877777777777


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhhCCCCCCC-------HHHHHcChhhHhhh
Q 014986          357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPT-------AAQLLDHPFVKRLL  401 (415)
Q Consensus       357 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps-------~~eil~hp~f~~~~  401 (415)
                      ......+..++..+.+||.+||..||.+|||       +++++.|+|+...-
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            7777778899999999999999999999999       77888999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.6e-47  Score=356.21  Aligned_cols=250  Identities=29%  Similarity=0.526  Sum_probs=204.3

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||+|+||.||+|.+. ++.||+|++...... ......+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            467999999999999999999874 889999988643221 122335678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEcC--------CCcEEEEeeccc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDA--------NGSVKLADFGLA  289 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~---IiHrDLkp~NILl~~--------~~~vkl~DFGla  289 (415)
                      ||||+.+++|.+++....+++..++.++.|++.||.|||++|   |+||||||+|||++.        ++.+||+|||++
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            999999999999998889999999999999999999999999   999999999999986        678999999999


Q ss_pred             cccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCCCCCcccH
Q 014986          290 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSK  368 (415)
Q Consensus       290 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~  368 (415)
                      +...........||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...........+... ...+.+..++.
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (271)
T 3dtc_A          164 REWHRTTKMSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE  241 (271)
T ss_dssp             ------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cccccccccCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence            87665555566799999999998654  3899999999999999999999999987766665555443 34556788999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+.+||.+||+.||.+|||+.++++|
T Consensus       242 ~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          242 PFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.5e-47  Score=363.88  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=211.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC---CCCcEEEeeeeee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK  213 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~  213 (415)
                      ...++|++.+.||+|+||.||+|++  .+++.||+|++.........   ...+.+|+.+++.+   +||||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            4567899999999999999999998  46889999998753322111   11234566655554   8999999999987


Q ss_pred             -----cCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 014986          214 -----DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  285 (415)
Q Consensus       214 -----~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~D  285 (415)
                           ....+++||||+. |+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence                 5678999999998 5999988764   389999999999999999999999999999999999999999999999


Q ss_pred             eccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----
Q 014986          286 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----  359 (415)
Q Consensus       286 FGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----  359 (415)
                      ||+++..... ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+.+.++.....     
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9999765432 234456899999999986543  88999999999999999999999988776665555432100     


Q ss_pred             ---------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          360 ---------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       360 ---------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                           ..+...++..+++||.+||..||.+|||+.++++||||+.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                 0123468899999999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-47  Score=367.75  Aligned_cols=258  Identities=24%  Similarity=0.402  Sum_probs=222.5

Q ss_pred             eeecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  212 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  212 (415)
                      ...++|++.+.||+|+||.||+|++.      +++.||+|++....    .......+.+|+.+++.++||||+++++++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34578999999999999999999873      34899999886422    233456788999999999999999999999


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQR-------------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD  267 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~-------------------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrD  267 (415)
                      .+.+.+|+||||+.+|+|.+++..                         ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            999999999999999999999876                         4588999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEEeeccccccccC----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCC
Q 014986          268 IKCANILVDANGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY  342 (415)
Q Consensus       268 Lkp~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf  342 (415)
                      |||+|||++.++.+||+|||+++.....    ......+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC--cCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999999998754322    223445889999999986543  8999999999999999999 99999


Q ss_pred             CCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          343 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       343 ~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ......+....+..+.....+..++..+.+||.+||..||.+|||+.++++  +|+++....
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~--~L~~~~~~~  337 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMCERA  337 (343)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTTC--
T ss_pred             CCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH--HHHHHHhhh
Confidence            988888888888877777788899999999999999999999999999986  477666543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.5e-47  Score=362.57  Aligned_cols=258  Identities=25%  Similarity=0.440  Sum_probs=221.7

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG  210 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  210 (415)
                      +....++|++.+.||+|+||.||+|.+      .+++.||+|++...    ........+.+|+.+++.++||||+++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----ASPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            344567899999999999999999986      34589999988642    12344567889999999999999999999


Q ss_pred             eeecCCEEEEEEeccCCCCHHHHHhhc-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014986          211 TDKDESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVH  265 (415)
Q Consensus       211 ~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------------~l~~~~~~~i~~qil~aL~~LH~~~IiH  265 (415)
                      ++.+.+.+|+||||+.+|+|.+++...                         .+++..++.++.||+.||.|||++||+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            999999999999999999999998753                         2789999999999999999999999999


Q ss_pred             cCCCCCcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCC
Q 014986          266 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQI  340 (415)
Q Consensus       266 rDLkp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~  340 (415)
                      |||||+|||++.++.+||+|||+++......    .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC--cCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999997654332    23345788999999986543  7899999999999999999 999


Q ss_pred             CCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          341 PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       341 pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ||...........+........+..++..+.+||.+||..||.+|||+.+++++  |+.+..
T Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~--l~~~~~  311 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD--LEKMMV  311 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence            998877666666676776777788999999999999999999999999999986  666554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.2e-47  Score=368.49  Aligned_cols=257  Identities=28%  Similarity=0.459  Sum_probs=211.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|.+.+.||+|+||.||+|++ .+++.||||++....   ........+.+|+.+++.++||||+++++++.....
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            4567899999999999999999998 789999999986432   223345678899999999999999999999887654


Q ss_pred             ------EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          218 ------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       218 ------~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                            +|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             GGGCCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             cccceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence                  5999999984 88776643 599999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--------------
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG--------------  357 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--------------  357 (415)
                      .... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+....+.+..+...              
T Consensus       176 ~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADAE-MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCCC-ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            5433 3445689999999998652 34788999999999999999999999887655544433211              


Q ss_pred             ----------------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          358 ----------------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       358 ----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                                      ........++..+.+||.+||..||.+|||+.++++||||+.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                            111233467899999999999999999999999999999998754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.6e-47  Score=373.72  Aligned_cols=255  Identities=24%  Similarity=0.384  Sum_probs=208.5

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CC-----cEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HE-----NIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~  209 (415)
                      ...+.++|++.+.||+|+||+||+|++ .+++.||||++...      ......+.+|+.++..++ |+     +|++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            345678999999999999999999998 68899999998631      233456677888887774 44     599999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEc--CCCcEE
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVD--ANGSVK  282 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH--~~~IiHrDLkp~NILl~--~~~~vk  282 (415)
                      +++...+.+|+||||+.+ +|.+++...   .+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+|
T Consensus       123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            999999999999999975 999988764   4899999999999999999999  57999999999999995  478899


Q ss_pred             EEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC
Q 014986          283 LADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI  362 (415)
Q Consensus       283 l~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  362 (415)
                      |+|||+++..... .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+.+..+......+.
T Consensus       202 L~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          202 IVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGMP--YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             ECCCTTCEETTCC-CCSSCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEeccCceecccc-cccccCCccccChHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999999876433 34567999999999996543  89999999999999999999999998776665555432111000


Q ss_pred             -----------------C---------------------Cc-------------------------ccHHHHHHHHHhhh
Q 014986          363 -----------------P---------------------DS-------------------------LSKDAQDFIKQCVQ  379 (415)
Q Consensus       363 -----------------~---------------------~~-------------------------~s~~l~~Li~~~L~  379 (415)
                                       +                     ..                         .+..+.+||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence                             0                     00                         01478999999999


Q ss_pred             hCCCCCCCHHHHHcChhhHhhh
Q 014986          380 VNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       380 ~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .||.+|||++|+|+||||++..
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC--
T ss_pred             CChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999998754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=366.41  Aligned_cols=256  Identities=25%  Similarity=0.435  Sum_probs=205.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHhcC----CCCcEEEeeeeee
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRF----EHENIVQYYGTDK  213 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~-~~~~~~~~~E~~il~~l----~hpnIv~l~~~~~  213 (415)
                      +.++|++.+.||+|+||.||+|++ .+++.||+|++......... ......+.+|+.++..+    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            456799999999999999999998 78999999998643221111 11223455788888888    8999999999999


Q ss_pred             cCCEEEEEEec-cCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEeecccc
Q 014986          214 DESKLYIFLEL-VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAK  290 (415)
Q Consensus       214 ~~~~~~lV~E~-~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-~~~~vkl~DFGla~  290 (415)
                      +.+..++|||+ +.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            99999999999 788999998875 4699999999999999999999999999999999999999 78999999999998


Q ss_pred             ccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       291 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ...........||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||......      .. ....++..++..+
T Consensus       189 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~~~~~  260 (312)
T 2iwi_A          189 LLHDEPYTDFDGTRVYSPPEWISRHQ-YHALPATVWSLGILLYDMVCGDIPFERDQEI------LE-AELHFPAHVSPDC  260 (312)
T ss_dssp             ECCSSCBCCCCSCTTTSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HH-TCCCCCTTSCHHH
T ss_pred             hcccCcccccCCcccccCceeeecCC-CCCccchHHHHHHHHHHHHHCCCCCCChHHH------hh-hccCCcccCCHHH
Confidence            87766666777999999999986433 2356899999999999999999999865321      11 2234567889999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .+||.+||..||.+|||+.++++||||+.....
T Consensus       261 ~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          261 CALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             HHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence            999999999999999999999999999986543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1e-46  Score=358.64  Aligned_cols=250  Identities=30%  Similarity=0.539  Sum_probs=203.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  214 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  214 (415)
                      +.++|++.+.||+|+||.||+|++ .+++.||+|++..      .......+.+|+.+++.++||||+++++++.+    
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            457899999999999999999998 6899999999863      22345678899999999999999999998754    


Q ss_pred             ---------CCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 014986          215 ---------ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       215 ---------~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                               ...+|+||||+.+|+|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence                     45789999999999999999754  4788899999999999999999999999999999999999999999


Q ss_pred             Eeecccccccc----------------CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-
Q 014986          284 ADFGLAKATKL----------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-  346 (415)
Q Consensus       284 ~DFGla~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-  346 (415)
                      +|||++.....                .......||+.|+|||++.+.. .++.++|||||||++|+|++   ||.... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCS-CCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC-CCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999876532                1223456899999999986432 37899999999999999998   665432 


Q ss_pred             HHHHHHHHhcC---CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          347 CMAALFKIGRG---SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       347 ~~~~~~~i~~~---~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      .......+...   .+..++...+..+.+||.+||..||.+|||+.++++||||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            23333333322   223345567888999999999999999999999999999964

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-46  Score=365.64  Aligned_cols=256  Identities=24%  Similarity=0.359  Sum_probs=208.7

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCC-cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc------EEEee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN------IVQYY  209 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~-~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~  209 (415)
                      ..+.++|++.+.||+|+||+||+|++ .++ +.||+|++...      ......+.+|+.+++.++|++      ++.++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            34567999999999999999999998 444 78999998631      233456778999988887655      89999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-----------
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV-----------  275 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl-----------  275 (415)
                      +++...+.+|+||||+ +++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||+           
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            9999999999999999 55677766543   58999999999999999999999999999999999999           


Q ss_pred             --------cCCCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH
Q 014986          276 --------DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC  347 (415)
Q Consensus       276 --------~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~  347 (415)
                              +.++.+||+|||+++..... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                    56789999999999765433 3455799999999999654  389999999999999999999999987665


Q ss_pred             HHHHHHHhcCCCC-------------------------------------------CCCCcccHHHHHHHHHhhhhCCCC
Q 014986          348 MAALFKIGRGSPP-------------------------------------------PIPDSLSKDAQDFIKQCVQVNPND  384 (415)
Q Consensus       348 ~~~~~~i~~~~~~-------------------------------------------~~~~~~s~~l~~Li~~~L~~dP~~  384 (415)
                      .+.+..+......                                           ......+..+.+||.+||..||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            5444333221100                                           011123568899999999999999


Q ss_pred             CCCHHHHHcChhhHhhhhh
Q 014986          385 RPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       385 Rps~~eil~hp~f~~~~~~  403 (415)
                      |||+.++|+||||+.+...
T Consensus       325 Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCHH
T ss_pred             CcCHHHHhcChhhcCCChh
Confidence            9999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.4e-47  Score=357.25  Aligned_cols=257  Identities=27%  Similarity=0.470  Sum_probs=209.5

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  212 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  212 (415)
                      +....++|++.+.||+|+||.||+|++.    .+..||+|.+...    ......+.+.+|+.+++.++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            4445678999999999999999999873    2457999977532    2234456788999999999999999999998


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      . ++..|+||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            5 56789999999999999998754  58999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          291 ATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       291 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ......   .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+......+.+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  242 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  242 (281)
T ss_dssp             --------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred             ccCcccccccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCC
Confidence            654332   2234477899999998654  38899999999999999996 99999887777777777777777788899


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +..+.+||.+||..||.+|||+.+++++  |+.+..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~--l~~~~~  276 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTILE  276 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHH
Confidence            9999999999999999999999999874  555543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-46  Score=363.89  Aligned_cols=263  Identities=28%  Similarity=0.501  Sum_probs=194.6

Q ss_pred             cceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHH-HHhcCCCCcEEEeeeeee
Q 014986          136 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       136 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~  213 (415)
                      .+....++|++.+.||+|+||.||+|.+ .+++.||+|++.....    ......+.+|+. +++.++||||+++++++.
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            3444567899999999999999999998 6899999999975321    222334455555 778889999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEee
Q 014986          214 DESKLYIFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~------~~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                      +.+..++||||+.+ +|.+++.      ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            99999999999986 7877765      35689999999999999999999999 9999999999999999999999999


Q ss_pred             ccccccccCC-cccCCCCccccccccccc--cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH-HHHHHHhcCCCCCC
Q 014986          287 GLAKATKLND-VKSCRGTAFWMAPEVINN--KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPI  362 (415)
Q Consensus       287 Gla~~~~~~~-~~~~~gt~~y~aPE~l~~--~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~  362 (415)
                      |+++...... .....||+.|+|||++..  ....++.++|||||||++|+|++|+.||...... +.+..+..+....+
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            9997654332 233469999999999842  1234789999999999999999999999864322 22222333322222


Q ss_pred             C----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          363 P----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       363 ~----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +    ..++..+.+||.+||..||.+|||+.++++||||......
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence            2    3689999999999999999999999999999999987644

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6e-47  Score=369.96  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=215.7

Q ss_pred             ceeeecccccccccccCCcEEEEEEE-----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGI-----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~-----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      +....++|++.+.||+|+||.||+|+     + .+++.||||++...    ......+.+.+|+.++..+ +||||++++
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----CCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            33456789999999999999999997     3 56789999998642    2233456788999999999 799999999


Q ss_pred             eeeecCC-EEEEEEeccCCCCHHHHHhhcC--------------------------------------------------
Q 014986          210 GTDKDES-KLYIFLELVTKGSLLNLYQRYH--------------------------------------------------  238 (415)
Q Consensus       210 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------  238 (415)
                      +++.+.+ .+++||||+.+|+|.+++....                                                  
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9988754 4899999999999999987542                                                  


Q ss_pred             -----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC----c
Q 014986          239 -----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----V  297 (415)
Q Consensus       239 -----------------l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----~  297 (415)
                                       +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    .
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                             8899999999999999999999999999999999999999999999999998653322    2


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccH-HHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC-MAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++ |..||..... ......+........+..++.++.+||.
T Consensus       253 ~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML  330 (359)
T ss_dssp             --CEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            334588999999998654  38999999999999999998 9999987543 2333444555566678889999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||+.||.+|||+.++++|  |+.+..
T Consensus       331 ~~l~~dP~~Rps~~ell~~--L~~~~~  355 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEH--LGNLLQ  355 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHccCChhhCCCHHHHHHH--HHHHHH
Confidence            9999999999999999986  666554

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=356.57  Aligned_cols=264  Identities=30%  Similarity=0.503  Sum_probs=202.6

Q ss_pred             cceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          136 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       136 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .+....++|++.+.||+|+||.||+|++ .+++.||+|++.....   .......+.++..+++.++||||+++++++.+
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            4555678999999999999999999998 6899999999975322   12223444555667888999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .+.+|+||||+ ++.+..+...  ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999999 5566666543  5799999999999999999999995 999999999999999999999999999976


Q ss_pred             cccC-CcccCCCCccccccccccc---cccCCCchhhHHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCC--C
Q 014986          292 TKLN-DVKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPPIP--D  364 (415)
Q Consensus       292 ~~~~-~~~~~~gt~~y~aPE~l~~---~~~~~~~~~DvwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~--~  364 (415)
                      .... ......||+.|+|||++..   ....++.++|||||||++|+|++|+.||... ...+.+..+........+  .
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence            5433 2334569999999999853   2234788999999999999999999999863 344455555555444343  3


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .++.++.+||.+||..||.+|||+.++++||||++....
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL  293 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccc
Confidence            589999999999999999999999999999999986543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-46  Score=360.37  Aligned_cols=259  Identities=24%  Similarity=0.408  Sum_probs=223.2

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG  210 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  210 (415)
                      +....++|++.+.||+|+||.||+|++.      +++.||+|.+....    .......+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            4556778999999999999999999764      47889999886421    2234456889999999999999999999


Q ss_pred             eeecCCEEEEEEeccCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014986          211 TDKDESKLYIFLELVTKGSLLNLYQR-----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  279 (415)
Q Consensus       211 ~~~~~~~~~lV~E~~~~gsL~~~l~~-----------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~  279 (415)
                      ++.+.+..++||||+.+|+|.+++..           ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            99999999999999999999998864           3468999999999999999999999999999999999999999


Q ss_pred             cEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHH
Q 014986          280 SVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI  354 (415)
Q Consensus       280 ~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i  354 (415)
                      .+||+|||+++......    .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCC--CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            99999999997654322    22334688999999986543  8899999999999999999 89999988877777777


Q ss_pred             hcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC------hhhHhhh
Q 014986          355 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH------PFVKRLL  401 (415)
Q Consensus       355 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h------p~f~~~~  401 (415)
                      ........+..++..+.+||.+||..||.+|||+.++++|      ++|+.+.
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            7777777788999999999999999999999999999976      6666543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.7e-47  Score=368.96  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=200.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .....++|++.+.||+|+||.||+|++ .+++.||||++.......      ....+++..+..++||||+++++++...
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            344567899999999999999999998 689999999886432221      2345677888888999999999998653


Q ss_pred             C-------EEEEEEeccCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEcC-CCc
Q 014986          216 S-------KLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVDA-NGS  280 (415)
Q Consensus       216 ~-------~~~lV~E~~~~gsL~~~l~-----~~~l~~~~~~~i~~qil~aL~~LH--~~~IiHrDLkp~NILl~~-~~~  280 (415)
                      .       .+++||||+.++ |...+.     ...+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred             ccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence            3       389999999974 444332     246889999999999999999999  999999999999999996 899


Q ss_pred             EEEEeeccccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC
Q 014986          281 VKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  359 (415)
Q Consensus       281 vkl~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  359 (415)
                      +||+|||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+.....
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            9999999998665433 3455689999999998543 2378999999999999999999999988776665555432111


Q ss_pred             C-------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          360 P-------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       360 ~-------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      .                               ......+.++.+||.+||+.||.+|||+.++|+||||+.+.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            0                               112235789999999999999999999999999999999876544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-46  Score=350.17  Aligned_cols=252  Identities=22%  Similarity=0.387  Sum_probs=221.1

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++......      .+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            4689999999999999999999988899999998753221      2467899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC---
Q 014986          221 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~---  295 (415)
                      ||||+.+++|.+++...  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......   
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999999998764  4899999999999999999999999999999999999999999999999998765322   


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  374 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li  374 (415)
                      ......+++.|+|||++.+.  .++.++||||||+++|+|++ |..||......+....+..+.....+..++..+.+||
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence            12334578899999998654  37899999999999999999 8999998887777777877777777888999999999


Q ss_pred             HHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          375 KQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       375 ~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+||..||.+|||+.+++++  |+++..
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~--L~~l~~  264 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ--LAEIAE  264 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH--HHHHHh
Confidence            99999999999999999985  665544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.4e-47  Score=364.80  Aligned_cols=247  Identities=26%  Similarity=0.467  Sum_probs=205.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEE----EEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~v----avK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .++|++.++||+|+||+||+|++ .+++.+    |+|.+..    .........+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45799999999999999999997 556554    6665542    12233446788999999999999999999999876


Q ss_pred             CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      . .++||||+.+|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 7889999999999998875  359999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          294 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       294 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ...    .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||...........+..+...+.+..++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             CCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            332    2233468899999999654  38999999999999999999 9999988776666666667777777888999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+.+|+.+||+.||.+|||+.+++++
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999976

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-46  Score=356.08  Aligned_cols=254  Identities=27%  Similarity=0.463  Sum_probs=209.9

Q ss_pred             eecccccccccccCCcEEEEEEE----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      ..++|++.+.||+|+||+||+|+    + .+++.||+|++...     .....+.+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            35689999999999999999998    3 57899999998632     23445678899999999999999999998854


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                        ...+++||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              45689999999999999999764  49999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH----------------H
Q 014986          291 ATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----------------A  349 (415)
Q Consensus       291 ~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----------------~  349 (415)
                      ......     .....++..|+|||++.+..  ++.++||||||+++|+|++|..||......                .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCC--CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            654332     22344778899999986543  899999999999999999999998654221                2


Q ss_pred             HHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       350 ~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ....+......+.+..++.++.+||.+||+.||.+|||+.++++.  ++.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~--L~~l~~  291 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR--VDQIRD  291 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHHH
Confidence            233444555666788999999999999999999999999999863  555543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.2e-46  Score=359.88  Aligned_cols=258  Identities=28%  Similarity=0.524  Sum_probs=218.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEE--EEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~v--avK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      .++|++.+.||+|+||.||+|++ .++..+  |+|.+...    ........+.+|+.+++.+ +||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            46899999999999999999998 566655  88888642    2233445688999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  279 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~  279 (415)
                      .+|+||||+.+|+|.+++...                 .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            999999999999999998754                 489999999999999999999999999999999999999999


Q ss_pred             cEEEEeeccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcC
Q 014986          280 SVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  357 (415)
Q Consensus       280 ~vkl~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  357 (415)
                      .+||+|||+++..... ......+++.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..+
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcccc--CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            9999999998744322 223345788999999986543  7899999999999999998 99999998888777788777


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      .....+..++..+.+||.+||..||.+|||+.+++++  ++.+......
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~~~~  304 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERKT  304 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHSSSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHHhhcC
Confidence            7677788899999999999999999999999999986  6666655443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-46  Score=352.78  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=218.1

Q ss_pred             eccccccc-ccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~-~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .++|.+.+ .||+|+||.||+|.+   .++..||+|++...    ......+.+.+|+.+++.++||||+++++++. .+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence            45666666 999999999999985   36788999998743    22345677889999999999999999999994 55


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+++||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            68999999999999999854  4599999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          295 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       295 ~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ..     .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |+.||......+....+..+.....+..++.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP  240 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CcceeeccccccccccccCHHHhccCC--CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCH
Confidence            32     22334688999999986543  7899999999999999998 9999998877777777777777778889999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .+.+||.+||..||.+||++.++++|  ++.++...
T Consensus       241 ~l~~li~~~l~~~p~~Rps~~~l~~~--l~~~~~~~  274 (287)
T 1u59_A          241 ELYALMSDCWIYKWEDRPDFLTVEQR--MRACYYSL  274 (287)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH--HHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHhc
Confidence            99999999999999999999999986  55555433

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.1e-47  Score=366.20  Aligned_cols=261  Identities=28%  Similarity=0.465  Sum_probs=216.5

Q ss_pred             CCcceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHhcCC--CCcEEEee
Q 014986          134 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQYY  209 (415)
Q Consensus       134 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~-~~~~~~~~~E~~il~~l~--hpnIv~l~  209 (415)
                      ......+.++|++.+.||+|+||.||+|++ .+++.||+|++......... ......+.+|+.+++.++  |+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            334455677899999999999999999998 78999999999754322100 011234557899999986  59999999


Q ss_pred             eeeecCCEEEEEEeccCC-CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEee
Q 014986          210 GTDKDESKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADF  286 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~-gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~-~~~~vkl~DF  286 (415)
                      +++.+.+.+++|||++.+ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999999999986 899998865 5799999999999999999999999999999999999999 7799999999


Q ss_pred             ccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          287 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       287 Gla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      |+++...........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.....      +... ....+..+
T Consensus       195 g~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-~~~~~~~~  266 (320)
T 3a99_A          195 GSGALLKDTVYTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRV  266 (320)
T ss_dssp             TTCEECCSSCBCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCC
T ss_pred             ccccccccccccCCCCCccCCChHHhccCC-CCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-cccccccC
Confidence            999877666666677999999999986543 247889999999999999999999986532      1111 23356788


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.++.+||.+||..||.+|||+.+|++||||+....
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            999999999999999999999999999999987754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.2e-46  Score=369.01  Aligned_cols=253  Identities=25%  Similarity=0.452  Sum_probs=208.3

Q ss_pred             ecccccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .++|++.+.||+|+||.||+|++.    ++..||||.+....    .......+.+|+.+++.++||||+++++++.+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            458999999999999999999874    57789999886422    2334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+|+||||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999999999764  589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc-----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          295 NDV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       295 ~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ...     ....+++.|+|||++.+..  ++.++|||||||++|+|++ |+.||......+....+..+...+.+..++.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  277 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA  277 (373)
T ss_dssp             --------------CTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred             CCccceeccCCCcCCCccChhhhccCC--cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            321     1223577899999986543  8999999999999999998 9999998887777777777666667778999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .+.+||.+||+.||.+||++.+|++  .|+.+.
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~--~L~~~~  308 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVS--ILDKLI  308 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHH--HHHHHH
Confidence            9999999999999999999999987  355554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.9e-46  Score=360.57  Aligned_cols=258  Identities=27%  Similarity=0.483  Sum_probs=221.3

Q ss_pred             eeeecccccccccccCCcEEEEEEEc--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEe
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  208 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~--------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l  208 (415)
                      ....++|++.+.||+|+||.||+|.+        .++..||+|++...    ........+.+|+.+++.+ +||||+++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----CcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            33457899999999999999999986        35678999988642    1234456788999999999 89999999


Q ss_pred             eeeeecCCEEEEEEeccCCCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014986          209 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  271 (415)
Q Consensus       209 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~  271 (415)
                      ++++.+.+.+|+||||+.+|+|.+++....                 +++..++.++.||+.||.|||++||+||||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999999987542                 889999999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCcc
Q 014986          272 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  346 (415)
Q Consensus       272 NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~  346 (415)
                      |||++.++.+||+|||+++......    .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||....
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC--cChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999999997654332    23345788999999986543  7899999999999999999 999999887


Q ss_pred             HHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          347 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       347 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ..+....+..+.....+..++..+.+||.+||..||.+|||+.+++++  ++.+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~l~~~  319 (334)
T 2pvf_A          265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILTL  319 (334)
T ss_dssp             HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHhc
Confidence            777777777777777788899999999999999999999999999985  6666553

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.6e-46  Score=349.57  Aligned_cols=258  Identities=27%  Similarity=0.485  Sum_probs=221.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.+.||+|+||.||+|.+.++..||+|.+.....      ....+.+|+.+++.++||||+++++++.+ +
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence            4445678999999999999999999998888999999864321      13467899999999999999999999874 4


Q ss_pred             EEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      ..++||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            589999999999999998653   69999999999999999999999999999999999999999999999999998665


Q ss_pred             cCCc---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          294 LNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       294 ~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ....   ....++..|+|||++.+..  ++.++||||||+++|+|++ |+.||......+....+..+.....+..++..
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE  238 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CcccccccCCCCccCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHH
Confidence            4332   2344678899999986543  7899999999999999999 99999988877777777777777778889999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      +.+||.+||..||.+|||+.++++  .|+.++....
T Consensus       239 l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~~~~~  272 (279)
T 1qpc_A          239 LYQLMRLCWKERPEDRPTFDYLRS--VLEDFFTATE  272 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHC-
T ss_pred             HHHHHHHHhccChhhCCCHHHHHH--HHHHHHHhcc
Confidence            999999999999999999999987  4666655443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-45  Score=354.44  Aligned_cols=260  Identities=25%  Similarity=0.464  Sum_probs=211.2

Q ss_pred             eeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC--CCcEEEeeeeeecC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDE  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~  215 (415)
                      ....++|++.+.||+|+||.||+|.+.+++.||+|++.....   .......+.+|+.++..++  |+||+++++++.+.
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc---cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            344567999999999999999999998899999999975332   2344567889999999997  59999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +.+|+||| +.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            99999999 567799998875 4689999999999999999999999999999999999995 58999999999986543


Q ss_pred             CC----cccCCCCcccccccccccc---------ccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhc-CCC
Q 014986          295 ND----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGR-GSP  359 (415)
Q Consensus       295 ~~----~~~~~gt~~y~aPE~l~~~---------~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~-~~~  359 (415)
                      ..    .....||+.|+|||++.+.         ...++.++||||||+++|+|++|..||.... .......+.. ...
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            32    2344689999999998641         1347889999999999999999999997643 2233333332 233


Q ss_pred             CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       360 ~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ..++...+..+.+||.+||..||.+|||+.++++||||+....
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            4566778999999999999999999999999999999987544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.9e-46  Score=374.73  Aligned_cols=255  Identities=26%  Similarity=0.482  Sum_probs=221.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.+.||+|+||.||+|.+.++..||||++.....      ..+.+.+|+.+|+.++|||||++++++. ..
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            4445678999999999999999999998889999999874321      2457889999999999999999999986 56


Q ss_pred             EEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .+|+||||+.+|+|.+++...   .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            789999999999999998743   68999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          294 LND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       294 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ...   .....++..|+|||++....  ++.++|||||||++|+|++ |+.||.+....+....+..+...+.+..++..
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  413 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE  413 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             CCceeccCCCcccccccCHHHhccCC--CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            321   23344678899999996543  8999999999999999999 99999998888888888888777888899999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.+||.+||..||.+|||+.+|++  .|+.++.
T Consensus       414 l~~li~~cl~~dp~~RPt~~~i~~--~L~~~~~  444 (454)
T 1qcf_A          414 LYNIMMRCWKNRPEERPTFEYIQS--VLDDFYT  444 (454)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHTSSS
T ss_pred             HHHHHHHHccCChhHCcCHHHHHH--HHHHHHh
Confidence            999999999999999999999975  3555543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.4e-46  Score=355.05  Aligned_cols=261  Identities=28%  Similarity=0.456  Sum_probs=219.0

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      +....++|++.+.||+|+||.||+|.+      .+++.||+|.+....    .....+.+.+|+.+++.+ +||||++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            444567899999999999999999974      467899999987432    223346788999999999 899999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY-------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++.+.+..++||||+.+|+|.+++...                   .+++..++.++.||+.||.|||++||+||||||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            9999999999999999999999998754                   389999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||++........    ....+|+.|+|||++.+.  .++.++||||||+++|+|++ |..||...
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999986654432    233467889999998654  38999999999999999998 99999875


Q ss_pred             cHHHHHH-HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          346 ECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       346 ~~~~~~~-~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      ....... .+........+..++..+.+||.+||..||.+|||+.+++++  |+++.....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~~~  310 (313)
T 1t46_A          252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL--IEKQISEST  310 (313)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHTC
T ss_pred             cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH--HHHHHHHhh
Confidence            5333332 333344455567899999999999999999999999999985  777766543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.9e-47  Score=367.91  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=210.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcE----EEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~----vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .++|++.++||+|+||+||+|++ .+++.    ||+|.+.....    ......+.+|+.+++.++||||+++++++. +
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            45799999999999999999997 55665    66666543211    112234568999999999999999999886 4


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      ...++||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            5689999999999999988753  68999999999999999999999999999999999999999999999999998764


Q ss_pred             cCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          294 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       294 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ...    .....+|..|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..+.....+..++.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI  244 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred             cccccccccCCCCcccccChHHhccCC--CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence            332    23445788999999996544  8999999999999999999 9999988776666677777777777888999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ++.+||.+||..||.+|||+.++++|  |+.+.
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~--l~~~~  275 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANE--FTRMA  275 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHH--HHHHT
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence            99999999999999999999999987  55543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.1e-46  Score=360.81  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=217.4

Q ss_pred             eecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      ..++|++.+.||+|+||.||+|++      .+++.||+|.+...    ........+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            457899999999999999999983      46789999988632    12334457889999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEE
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVK  282 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~--------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~---~~vk  282 (415)
                      +....|+||||+.+++|.+++...        .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            999999999999999999999764        38899999999999999999999999999999999999844   4699


Q ss_pred             EEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcC
Q 014986          283 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  357 (415)
Q Consensus       283 l~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  357 (415)
                      |+|||++.......    .....||+.|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+..+
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            99999987543222    2234578999999998654  38899999999999999998 99999988777777777777


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .....+..++..+.+||.+||..||.+|||+.++++|.|+-.-..
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            777778889999999999999999999999999999988765443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.8e-47  Score=364.96  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=210.8

Q ss_pred             CcceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .......++|++.+.||+|+||.||+|++.+++.||+|++....     ....+.+.+|+.+++.++||||+++++++.+
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34556678999999999999999999999889999999876432     1234678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      .+.+|+||||+.+|+|.+++...     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            99999999999999999988654     4899999999999999999999999999999999999999999999999999


Q ss_pred             cccccC----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH------HHHH-HHHhcCC
Q 014986          290 KATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------MAAL-FKIGRGS  358 (415)
Q Consensus       290 ~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------~~~~-~~i~~~~  358 (415)
                      +.....    ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.....      .... .......
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCB--CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCC--CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            754322    123345899999999986543  88999999999999999999999965321      1110 0111111


Q ss_pred             ---------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          359 ---------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       359 ---------~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                               ....+..++..+.+|+.+||+.||++|||+.++++|  ++.+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~l~  315 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK--LEYALR  315 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHhh
Confidence                     112233456789999999999999999999999986  444443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.1e-46  Score=367.84  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=205.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-----------CCcEEEe
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQY  208 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l  208 (415)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++..      .......+.+|+.+++.+.           |+||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            45899999999999999999998 7899999999863      1223456778888888876           8999999


Q ss_pred             eeeeecCC----EEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEc----
Q 014986          209 YGTDKDES----KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD----  276 (415)
Q Consensus       209 ~~~~~~~~----~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~-~IiHrDLkp~NILl~----  276 (415)
                      ++++...+    .+++||||+ +++|.+++..   ..+++..+..++.||+.||.|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987654    789999999 7899998875   3599999999999999999999998 999999999999995    


Q ss_pred             --CCCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH------H
Q 014986          277 --ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------M  348 (415)
Q Consensus       277 --~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------~  348 (415)
                        ..+.+||+|||+++..... .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.....      .
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              3447999999999866543 34456999999999996543  88999999999999999999999975431      1


Q ss_pred             HHHHHHhc--CC---------------------------------------CCCCCCcccHHHHHHHHHhhhhCCCCCCC
Q 014986          349 AALFKIGR--GS---------------------------------------PPPIPDSLSKDAQDFIKQCVQVNPNDRPT  387 (415)
Q Consensus       349 ~~~~~i~~--~~---------------------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rps  387 (415)
                      ..+..+..  +.                                       ...++..++.++.+||.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11111110  00                                       01133456788999999999999999999


Q ss_pred             HHHHHcChhhHhhhhhCC
Q 014986          388 AAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       388 ~~eil~hp~f~~~~~~~~  405 (415)
                      +.++|+||||++......
T Consensus       328 ~~ell~hp~f~~~~~~~~  345 (373)
T 1q8y_A          328 AGGLVNHPWLKDTLGMEE  345 (373)
T ss_dssp             HHHHHTCGGGTTCTTCTT
T ss_pred             HHHHhhChhhhcccCccc
Confidence            999999999998765543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-45  Score=349.00  Aligned_cols=251  Identities=26%  Similarity=0.465  Sum_probs=209.8

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhH--HHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++..........  ...+.+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            356899999999999999999998 789999999986543322111  11267889999999999999999999998776


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCc-----EEEEeec
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGS-----VKLADFG  287 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~~~-----vkl~DFG  287 (415)
                        ++||||+.+|+|.+++..  ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.     +||+|||
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence              699999999999988754  36999999999999999999999999  999999999999988776     9999999


Q ss_pred             cccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH--HHHHHH-HhcCCCCCCCC
Q 014986          288 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFK-IGRGSPPPIPD  364 (415)
Q Consensus       288 la~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~-i~~~~~~~~~~  364 (415)
                      +++.... ......||+.|+|||++......++.++|||||||++|+|++|+.||.....  ...... .........+.
T Consensus       175 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 4f0f_A          175 LSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE  253 (287)
T ss_dssp             TCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred             ccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence            9975443 3445679999999999855555578999999999999999999999976432  222222 23444556778


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .++..+.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          254 DCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            89999999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.2e-46  Score=352.13  Aligned_cols=256  Identities=25%  Similarity=0.456  Sum_probs=221.3

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +....++|++.+.||+|+||.||+|.+ .++..||+|.+...      ....+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            444567899999999999999999998 67899999998642      12345688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      ..+|+||||+.+++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999999999975   34899999999999999999999999999999999999999999999999999866


Q ss_pred             ccCCc---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          293 KLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       293 ~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      .....   ....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||...........+........+..++.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  239 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCccccccCCccccCcCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence            54332   2234678899999986543  8899999999999999999 9999988776666666666666777889999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+.+||.+||..||.+|||+.++++  .|+.++.
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~--~l~~~~~  271 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQ--AFETMFQ  271 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHH--HHHHHHH
Confidence            9999999999999999999999976  4555443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.7e-46  Score=373.58  Aligned_cols=251  Identities=25%  Similarity=0.464  Sum_probs=215.8

Q ss_pred             eeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-E
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-K  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~  217 (415)
                      ...++|++.+.||+|+||.||+|.+. ++.||||++....       ..+.+.+|+.+|+.++||||+++++++.+.. .
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            34578999999999999999999874 7799999986422       2356789999999999999999999976654 7


Q ss_pred             EEEEEeccCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~---l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +||||||+.+|+|.+++...+   +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999997643   78999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      .. ....++..|+|||++.+.  .++.++|||||||++|+|++ |+.||......+....+..+...+.+..++..+.+|
T Consensus       342 ~~-~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          342 TQ-DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             ------CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cc-cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            32 233578899999999654  38999999999999999998 999998877777777777777778889999999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      |.+||..||.+|||+.++++  .|+.+..
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~--~L~~i~~  445 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLRE--QLEHIRT  445 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH--HHHHHHH
Confidence            99999999999999999986  3555543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.9e-46  Score=357.96  Aligned_cols=257  Identities=24%  Similarity=0.319  Sum_probs=206.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.++||+|+||+||+|++. ++.||||++...      ........+|+.+++.++||||+++++++.+..
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT   91 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence            4445678999999999999999999875 789999998642      222345567999999999999999999988743


Q ss_pred             ----EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCcEEEcCCCcEE
Q 014986          217 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ----------DVVHRDIKCANILVDANGSVK  282 (415)
Q Consensus       217 ----~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~----------~IiHrDLkp~NILl~~~~~vk  282 (415)
                          .+|+||||+.+|+|.+++....+++..++.++.||+.||.|||+.          ||+||||||+|||++.++.+|
T Consensus        92 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           92 SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             CCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence                479999999999999999988999999999999999999999999          999999999999999999999


Q ss_pred             EEeeccccccccCC----cccCCCCccccccccccccc---cCCCchhhHHHHHHHHHHHHcCCCCCCCcc---------
Q 014986          283 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPME---------  346 (415)
Q Consensus       283 l~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~---~~~~~~~DvwSlG~il~ell~g~~pf~~~~---------  346 (415)
                      |+|||+++......    .....||+.|+|||++.+..   ..++.++|||||||++|+|++|+.||.+..         
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            99999997654322    33356999999999986531   235678999999999999999999996421         


Q ss_pred             -------HHHHHHHHhcCCC-CCCCC-----cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          347 -------CMAALFKIGRGSP-PPIPD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       347 -------~~~~~~~i~~~~~-~~~~~-----~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                             .......+..... +..+.     ..+..+.+||.+||+.||.+|||+.++++  .++++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~--~L~~l~~  318 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE--RITQMQR  318 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence                   1112222222222 22222     23456999999999999999999999987  3665544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=361.11  Aligned_cols=252  Identities=26%  Similarity=0.463  Sum_probs=207.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEE----EEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~v----avK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .++|++.++||+|+||.||+|++ .+++.+    |+|.+....    .......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            45799999999999999999997 566655    555553221    122345678999999999999999999999876


Q ss_pred             CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      . .++||+|+.+|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 7899999999999998875  359999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          294 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       294 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ...    .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+......+.+..++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             CccccccccCCCccccccCHHHHcCCC--CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            322    22344688899999996543  8999999999999999999 9999998777667677777777778889999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ++.+||.+||..||.+|||+.++++  .|+.+.
T Consensus       247 ~l~~li~~~l~~dp~~Rps~~ell~--~L~~~~  277 (327)
T 3lzb_A          247 DVYMIMRKCWMIDADSRPKFRELII--EFSKMA  277 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH--HHHHHH
Confidence            9999999999999999999999987  355554

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-46  Score=360.72  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=213.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      +....++|++.+.||+|+||.||+|++      .++..||+|++....    .......+.+|+.++..+ +||||++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            334467899999999999999999985      356789999987421    223346788999999999 899999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhcC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRYH------------------------LRDSQVSAYTRQILLGLKYLHDQDVVH  265 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------l~~~~~~~i~~qil~aL~~LH~~~IiH  265 (415)
                      +++.+.+.+|+||||+.+|+|.+++....                        +++..++.++.||+.||.|||++||+|
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999999999999999999999987532                        788999999999999999999999999


Q ss_pred             cCCCCCcEEEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCC
Q 014986          266 RDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQI  340 (415)
Q Consensus       266 rDLkp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~  340 (415)
                      |||||+|||++.++.+||+|||++........    ....||+.|+|||++.+.  .++.++|||||||++|+|++ |..
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999986544332    233478889999998654  38999999999999999998 999


Q ss_pred             CCCCccHHHHHH-HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          341 PYAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       341 pf~~~~~~~~~~-~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ||.......... .+..+.....+..++..+.+||.+||..||.+|||+.++++|  |+.+.+..
T Consensus       274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--l~~~~~~~  336 (344)
T 1rjb_A          274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF--LGCQLADA  336 (344)
T ss_dssp             SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHC---
T ss_pred             CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH--HHHHHHHH
Confidence            998765433333 334444556677899999999999999999999999999985  56655543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.2e-46  Score=359.25  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=207.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  217 (415)
                      +.++|++.+.||+|+||.||+|++ .+++.||||++......       ..+.+|+.+++.+ +||||+++++++.+.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            456899999999999999999998 78999999998753221       2467899999999 99999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc-----EEEEeecccc
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK  290 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~-----vkl~DFGla~  290 (415)
                      .|+||||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999999 8899999874  57999999999999999999999999999999999999998887     9999999998


Q ss_pred             ccccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc---cHHHHHHHHhcCC
Q 014986          291 ATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGS  358 (415)
Q Consensus       291 ~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~  358 (415)
                      ......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...   ...+....+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            654322         2356799999999999654  4899999999999999999999999763   2233333332211


Q ss_pred             CC----CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          359 PP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       359 ~~----~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ..    .....++ ++.+||.+||..||.+||++.+|++  .|+.+...
T Consensus       237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~--~l~~~~~~  282 (330)
T 2izr_A          237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK--LFTDLFDR  282 (330)
T ss_dssp             HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHHH
T ss_pred             ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH--HHHHHHHH
Confidence            11    1122355 9999999999999999999999986  45555543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-45  Score=348.29  Aligned_cols=255  Identities=24%  Similarity=0.413  Sum_probs=217.0

Q ss_pred             eccccccc-ccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~-~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .++|++.+ .||+|+||.||+|.+   .+++.||+|++....   ......+.+.+|+.+++.++||||+++++++ ..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            46788888 999999999999954   457899999986432   1223456788999999999999999999998 566


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+++||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            789999999999999998764 5999999999999999999999999999999999999999999999999999765433


Q ss_pred             Cc-----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          296 DV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       296 ~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ..     ....+++.|+|||++.+..  ++.++||||||+++|+|++ |+.||......+....+..+.....+..++..
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCcccccccCCCCceeeChHHhccCC--CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            21     2234678899999986543  7889999999999999999 99999988877777777777777788899999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +.+||.+||+.||.+|||+.++++  .|++++..
T Consensus       249 l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~~~  280 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGFAAVEL--RLRNYYYD  280 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH--HHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH--HHHHHHHH
Confidence            999999999999999999999987  56666654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-45  Score=372.33  Aligned_cols=259  Identities=30%  Similarity=0.483  Sum_probs=219.4

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.+.||+|+||.||+|.+..+..||||++.....      ..+.+.+|+.+|+.++||||+++++++.+ .
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            3445678999999999999999999998788899999874321      12467899999999999999999999876 6


Q ss_pred             EEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .+|+||||+.+|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            78999999999999999864   358999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          294 LND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       294 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ...   .....++..|+|||++...  .++.++||||||+++|+|++ |+.||.+....+....+..+...+.+..++..
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  409 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  409 (452)
T ss_dssp             -----------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             CCceecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            332   2233467889999998654  38999999999999999999 99999998888888888888777888899999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      +.+||.+||..||.+|||+++|++  +++.++.....
T Consensus       410 l~~li~~cl~~dP~~Rpt~~~l~~--~L~~~~~~~~~  444 (452)
T 1fmk_A          410 LHDLMCQCWRKEPEERPTFEYLQA--FLEDYFTSTEP  444 (452)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHTTTSCSCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHH--HHHHHhccCCc
Confidence            999999999999999999999986  56666654433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-45  Score=354.00  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=214.8

Q ss_pred             eccc-ccccccccCCcEEEEEEE----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYW-QKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y-~~~~~LG~G~~g~Vy~~~----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++| ++.+.||+|+||+||++.    + .+++.||+|++...    ........+.+|+.+++.++||||+++++++.+
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            3444 999999999999998775    3 47899999998742    223445678899999999999999999999987


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                        ...+++||||+.+|+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence              478999999999999999999889999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH---------------HHHH
Q 014986          293 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---------------AALF  352 (415)
Q Consensus       293 ~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~---------------~~~~  352 (415)
                      ....     .....+|..|+|||++.+..  ++.++|||||||++|+|++|..||......               ....
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            5432     23345888899999996544  788999999999999999999999754321               2223


Q ss_pred             HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          353 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       353 ~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .+......+.+..++..+.+||++||..||.+|||+.++++  +|+.+...-
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~~~~  312 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVHEKY  312 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHHHhh
Confidence            34455566678889999999999999999999999999995  677776543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.8e-45  Score=343.36  Aligned_cols=252  Identities=19%  Similarity=0.372  Sum_probs=214.5

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC--CE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  217 (415)
                      ..++|++.+.||+|+||.||+|++. ++.||+|++.....   .....+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW---STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC---CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            3568999999999999999999985 88999999875322   233446788999999999999999999999887  78


Q ss_pred             EEEEEeccCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          218 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~---l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      +++||||+.+|+|.+++....   +++..+..++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999999998653   899999999999999999999999  999999999999999999999999987653


Q ss_pred             ccCCcccCCCCcccccccccccccc-CCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-cCCCCCCCCcccHHH
Q 014986          293 KLNDVKSCRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDA  370 (415)
Q Consensus       293 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l  370 (415)
                      ..   ....||+.|+|||++.+... .++.++|||||||++|+|++|+.||...........+. .......+..++..+
T Consensus       164 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          164 QS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             SC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             cc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            32   33468999999999865431 23448999999999999999999998877666655544 444566778899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+||.+||+.||.+|||+.++++  +|+.+
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~--~L~~l  268 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVP--ILEKM  268 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH--HHHHh
Confidence            99999999999999999999986  35544

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=355.54  Aligned_cols=254  Identities=25%  Similarity=0.445  Sum_probs=212.5

Q ss_pred             ecccccccccccCCcEEEEEEEcC-C----CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD-D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .++|++.+.||+|+||.||+|.+. +    +..||+|.+....    .......+.+|+.+++.++||||+++++++.+.
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            457888999999999999999873 2    2469999986422    233445788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      +.+++||||+.+|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999999999875  469999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCccc
Q 014986          294 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       294 ~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      ...     .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+..+...+.+..++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  276 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             cccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence            332     1223467889999998644  38899999999999999999 999999888777777777776777788899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ..+.+||.+||+.||.+||++.+++++  ++.+..
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~--L~~~~~  309 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSI--LDKLIR  309 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHh
Confidence            999999999999999999999999874  555543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-45  Score=351.86  Aligned_cols=269  Identities=26%  Similarity=0.345  Sum_probs=206.8

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ....++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            34467899999999999999999998 6899999998864322  22344577889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      .+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999876 46999999999999999999999999999999999999999999999999998765433


Q ss_pred             C---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCCcccHHH
Q 014986          296 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPIPDSLSKDA  370 (415)
Q Consensus       296 ~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l  370 (415)
                      .   .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...........+.....  ...+..++..+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ---------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred             ccccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence            2   2345699999999998654  478899999999999999999999988765543333333322  23456789999


Q ss_pred             HHHHHHhhhhCCCCCC-CHHHHHcChhhHhhhhhCCCCCCCCC
Q 014986          371 QDFIKQCVQVNPNDRP-TAAQLLDHPFVKRLLATNSGSASPYL  412 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rp-s~~eil~hp~f~~~~~~~~~~~~~~~  412 (415)
                      .+||.+||..||.+|| +++++++.  |+.++.......++..
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~~--l~~~l~~~~~~~~~~~  306 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSAA--AHAALATADQDRATDI  306 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHH--HHHTCC----------
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHHH--HHHHHHhhcccchhhh
Confidence            9999999999999999 88888752  5555555554444443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.6e-45  Score=354.37  Aligned_cols=255  Identities=29%  Similarity=0.489  Sum_probs=213.0

Q ss_pred             ecccccccccccCCcEEEEEEE----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee--
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--  213 (415)
                      .++|++.+.||+|+||.||+|+    + .+++.||+|++...     .....+.+.+|+.+++.++||||+++++++.  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            3589999999999999999998    3 67899999998642     2334567889999999999999999999875  


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      +...+|+||||+.+++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            56779999999999999999875  4599999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---------------HHHH
Q 014986          292 TKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---------------MAAL  351 (415)
Q Consensus       292 ~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---------------~~~~  351 (415)
                      .....     .....||+.|+|||++.+..  ++.++|||||||++|+|++|..||.....               ....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCC--CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            54332     22345888899999986543  78899999999999999999999865432               2233


Q ss_pred             HHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       352 ~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ..+..+...+.+..++..+.+||.+||..||.+|||+.+++++  |+.+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~~~~  305 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ--LDMLWSGS  305 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHC----
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHhhh
Confidence            3445555666788899999999999999999999999999865  66655433

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-45  Score=347.68  Aligned_cols=256  Identities=27%  Similarity=0.448  Sum_probs=213.8

Q ss_pred             eeeecccccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  213 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  213 (415)
                      ....++|++.+.||+|+||.||+|++.    ++..||+|.+....    .....+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            344678999999999999999999862    23469999886421    2334567889999999999999999999987


Q ss_pred             cCCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          214 DESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       214 ~~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      +. ..|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 568999999999999998753  489999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCccc
Q 014986          292 TKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       292 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      .....   .....+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||......+....+......+.+..++
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP  240 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCC
T ss_pred             cccccccccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCC
Confidence            54332   2334578899999998644  38899999999999999998 999998766555666666666677788899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +.+.+||.+||..||.+|||+.+++++  |+.+..
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~ell~~--L~~~~~  273 (281)
T 3cc6_A          241 PVLYTLMTRCWDYDPSDRPRFTELVCS--LSDVYQ  273 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHHHH--HHHHHH
Confidence            999999999999999999999999985  555543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-45  Score=351.62  Aligned_cols=258  Identities=26%  Similarity=0.441  Sum_probs=210.1

Q ss_pred             eeecccccccccccCCcEEEEEEEc-C---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~---~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      ...++|.+.+.||+|+||.||+|.+ .   ++..||+|.+.....   .......+.+|+.+++.++||||+++++++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            3457899999999999999999976 2   456899998864322   23345678899999999999999999999877


Q ss_pred             CC-----EEEEEEeccCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEE
Q 014986          215 ES-----KLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  282 (415)
Q Consensus       215 ~~-----~~~lV~E~~~~gsL~~~l~~-------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vk  282 (415)
                      ..     ..++||||+.+|+|.+++..       ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            55     35999999999999998842       3589999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcC
Q 014986          283 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  357 (415)
Q Consensus       283 l~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  357 (415)
                      |+|||+++......    .....+++.|+|||++.+.  .++.++||||||+++|+|++ |..||...........+..+
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            99999997654332    2234578899999998654  48899999999999999999 99999887776677777777


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      .....+..++..+.+||.+||..||.+|||+.+++++  |+.+...
T Consensus       266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~l~~~  309 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ--LEKLLES  309 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHh
Confidence            7777788999999999999999999999999999985  6665543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-45  Score=349.25  Aligned_cols=247  Identities=28%  Similarity=0.497  Sum_probs=207.2

Q ss_pred             ecccccccccccCCcEEEEEEE----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      .++|++.+.||+|+||.||+|+    + .+++.||+|++.....    ......+.+|+.+++.++||||+++++++.+.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            4568999999999999999998    3 6899999999874321    22346688999999999999999999999876


Q ss_pred             --CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          216 --SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       216 --~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                        ..+++||||+.+|+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              678999999999999999854  3699999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc---------------cHHHHH
Q 014986          292 TKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---------------ECMAAL  351 (415)
Q Consensus       292 ~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~---------------~~~~~~  351 (415)
                      .....     .....||..|+|||++.+..  ++.++||||||+++|+|++|..|+...               ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCC--CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            65432     23345888899999986544  788999999999999999999876432               122333


Q ss_pred             HHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          352 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       352 ~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ..+..+...+.+..++..+.+||.+||..||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            444555566678889999999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-45  Score=375.56  Aligned_cols=254  Identities=25%  Similarity=0.452  Sum_probs=219.7

Q ss_pred             eeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ....++|++.+.||+|+||.||+|++ .++..||||.+.....      ..+.+.+|+.+|+.++||||+++++++.+..
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            33456799999999999999999998 5689999999864221      2356889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .+||||||+.+|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999999999975   358999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCc---ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          294 LNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       294 ~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ....   ....++..|+|||++....  ++.++|||||||++|+|++ |..||......+....+........+..++..
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  447 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK  447 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCC--CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            4332   2334678899999986543  8899999999999999999 99999887766666677777777788899999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +.+||.+||+.||.+|||+.+|++  .|+.++
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~--~L~~~~  477 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQ--AFETMF  477 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHTSC
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHH--HHHHHH
Confidence            999999999999999999999975  355443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-44  Score=346.26  Aligned_cols=263  Identities=32%  Similarity=0.567  Sum_probs=208.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            356899999999999999999998 78999999999753322  234456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          219 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      ++||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999998864     358999999999999999999999999999999999999999999999999987654


Q ss_pred             cCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc--cHHHHHHHHhcCCCCCC-CCcccH
Q 014986          294 LND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPI-PDSLSK  368 (415)
Q Consensus       294 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~-~~~~s~  368 (415)
                      ...  .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||...  ........+.....++. ...++.
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -----------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCCccccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            332  2345689999999998654  4889999999999999999999999653  22333444444443333 367899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSA  408 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~  408 (415)
                      ++.+||.+||..||.+|||+.++++  .++++.+......
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~--~l~~l~~~~~~~~  303 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYD--VAKRMHACTASSL  303 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHHC---
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH--HHHHHHHhhhhhh
Confidence            9999999999999999999999997  5888887765543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.9e-45  Score=348.02  Aligned_cols=255  Identities=24%  Similarity=0.433  Sum_probs=213.5

Q ss_pred             ecccccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee-ecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~  215 (415)
                      ...|++.+.||+|+||.||+|++.    ....+|+|.+...    ........+.+|+.+++.++||||+++++++ ..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            346899999999999999999862    2336888887642    2234456788999999999999999999984 566


Q ss_pred             CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      +..++||||+.+|+|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            788999999999999999965  358999999999999999999999999999999999999999999999999997553


Q ss_pred             cC------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          294 LN------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       294 ~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ..      ......+|+.|+|||++.+..  ++.++||||||+++|+|++ |.+||......+....+..+.....+..+
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC  257 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             ccchhccccccCCCCCccccChHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence            22      223345788999999986543  8899999999999999999 67788777766666677777777778889


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +..+.+||.+||..||.+|||+.++++  .++.+...
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~  292 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVS--RISAIFST  292 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH--HHHHHHHh
Confidence            999999999999999999999999987  36666554

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-45  Score=346.55  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=214.0

Q ss_pred             ccccccccccCCcEEEEEEEc-CC---CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~---~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      .|++.++||+|+||+||+|.+ .+   +..+|+|.+...    ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            577789999999999999986 33   337999988642    2234457788999999999999999999999876655


Q ss_pred             -EEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc-
Q 014986          219 -YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  294 (415)
Q Consensus       219 -~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~-  294 (415)
                       ++||||+.+|+|.+++..  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             999999999999999975  4689999999999999999999999999999999999999999999999999975432 


Q ss_pred             -----CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          295 -----NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       295 -----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                           .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |.+||......+....+......+.+..++.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD  255 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             cccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence                 223345688999999999654  38899999999999999999 5556666666666666777777777888999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      .+.+||.+||..||.+|||+.++++  .++++...-
T Consensus       256 ~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~~~~l  289 (298)
T 3pls_A          256 SLYQVMQQCWEADPAVRPTFRVLVG--EVEQIVSAL  289 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH--HHHHHHHHH
Confidence            9999999999999999999999987  477766544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.2e-46  Score=350.94  Aligned_cols=250  Identities=20%  Similarity=0.383  Sum_probs=207.3

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCC-------cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  212 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~-------~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  212 (415)
                      .++|++.+.||+|+||+||+|++ .++       ..||+|.+....     ....+.+.+|+.+++.++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            56899999999999999999988 444       479999886422     22345688999999999999999999999


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--------EE
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VK  282 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~~--l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~--------vk  282 (415)
                      .+.+..++||||+.+|+|.+++....  +++..+..++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999997653  999999999999999999999999999999999999998887        99


Q ss_pred             EEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHhcCCCCC
Q 014986          283 LADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPP  361 (415)
Q Consensus       283 l~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~  361 (415)
                      |+|||++......  ....||+.|+|||++.+. ..++.++|||||||++|+|++| ..||..............  ...
T Consensus       162 l~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~  236 (289)
T 4fvq_A          162 LSDPGISITVLPK--DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQ  236 (289)
T ss_dssp             ECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCC
T ss_pred             eccCcccccccCc--cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCC
Confidence            9999998654322  234588999999998652 3479999999999999999995 556655554443333322  334


Q ss_pred             CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       362 ~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+...+.++.+||.+||+.||.+|||+.++++|  |+.++.
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~  275 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT  275 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence            556678899999999999999999999999886  666655

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-45  Score=352.82  Aligned_cols=258  Identities=26%  Similarity=0.445  Sum_probs=214.9

Q ss_pred             eeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  210 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  210 (415)
                      ....++|++.+.||+|+||.||+|.+      .+++.||+|++....    .......+.+|+.++..+ +||||+++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            33457899999999999999999973      467899999986422    233446788999999999 7999999999


Q ss_pred             eeecCC-EEEEEEeccCCCCHHHHHhhcC-----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014986          211 TDKDES-KLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  272 (415)
Q Consensus       211 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~-----------------l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~N  272 (415)
                      ++...+ .+++||||+.+|+|.+++....                 +++..+..++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987654 5899999999999999997643                 7899999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccH
Q 014986          273 ILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC  347 (415)
Q Consensus       273 ILl~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~  347 (415)
                      ||++.++.+||+|||+++.......    ....||+.|+|||++.+..  ++.++|||||||++|+|++ |..||.....
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc--ccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            9999999999999999976543321    2345788999999986543  8899999999999999998 9999977543


Q ss_pred             H-HHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          348 M-AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       348 ~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      . .....+..+.....+..++..+.+||.+||..||.+|||+.++++|  |+.+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~  311 (316)
T 2xir_A          257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQA  311 (316)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHhh
Confidence            2 3334444555566778899999999999999999999999999986  6665543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=352.64  Aligned_cols=256  Identities=24%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee----cC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----DE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~  215 (415)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++...     .......+.+|+.+++.++||||+++++++.    ..
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            45899999999999999999998 78999999998642     2344567889999999999999999999986    34


Q ss_pred             CEEEEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      ...|+||||+.+|+|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            578999999999999998865     468999999999999999999999999999999999999999999999999887


Q ss_pred             ccccCC-----------cccCCCCccccccccccccc-cCCCchhhHHHHHHHHHHHHcCCCCCCCccHH--HHHHHHhc
Q 014986          291 ATKLND-----------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECM--AALFKIGR  356 (415)
Q Consensus       291 ~~~~~~-----------~~~~~gt~~y~aPE~l~~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~  356 (415)
                      ......           .....||+.|+|||++.+.. ..++.++||||||+++|+|++|+.||......  .....+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            543211           11234799999999986432 23688999999999999999999999542110  11122233


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       357 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ....+.+..++..+.+||.+||+.||.+|||+.+++++  |+.+...
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~  307 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQPP  307 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTCCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcCCC
Confidence            33344556789999999999999999999999999985  5555443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-44  Score=343.21  Aligned_cols=254  Identities=20%  Similarity=0.285  Sum_probs=210.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++.....       ...+.+|+.++..+ +|+||+++++++.+..
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            4566899999999999999999998 7899999998864322       13466899999999 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc-----EEEEeeccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLA  289 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~-----vkl~DFGla  289 (415)
                      ..++||||+ +++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 88999999753  5999999999999999999999999999999999999987776     999999999


Q ss_pred             cccccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc---cHHHHHHHHhc-
Q 014986          290 KATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGR-  356 (415)
Q Consensus       290 ~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~-  356 (415)
                      +......         .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...   ........+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCC--CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            8654332         23456999999999986543  899999999999999999999999763   22232222221 


Q ss_pred             ---CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          357 ---GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       357 ---~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                         .........++.++.+||.+||..||.+||++.+|++  .|+++....
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~--~l~~~~~~~  285 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERL  285 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHHHT
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH--HHHHHHHhc
Confidence               1111233478999999999999999999999999987  477776654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-45  Score=353.68  Aligned_cols=259  Identities=26%  Similarity=0.469  Sum_probs=214.6

Q ss_pred             cceeeecccccccccccCCcEEEEEEEc-CCC-----cEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEe
Q 014986          136 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  208 (415)
Q Consensus       136 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~-----~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l  208 (415)
                      .+....++|++.+.||+|+||.||+|.+ .++     ..||+|.+....    .......+.+|+.+++.+ +||||+++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            3445567899999999999999999987 333     479999886422    223456788999999999 89999999


Q ss_pred             eeeeecCCEEEEEEeccCCCCHHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014986          209 YGTDKDESKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  273 (415)
Q Consensus       209 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~---------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NI  273 (415)
                      ++++.+.+.+|+||||+.+|+|.+++...               .+++..+..++.||+.||.|||++||+||||||+||
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV  195 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence            99999999999999999999999988642               478999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHH
Q 014986          274 LVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM  348 (415)
Q Consensus       274 Ll~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~  348 (415)
                      |++.++.+||+|||+++.......    ....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC--CChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            999999999999999986543322    2344678899999986543  8899999999999999998 99999875433


Q ss_pred             HHHHH-HhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          349 AALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       349 ~~~~~-i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ..... +........+..++..+.+||.+||+.||.+|||+.++++  +|+.+..
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~L~~~~~  326 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQ  326 (333)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--HHHHHHH
Confidence            33332 3334445567778999999999999999999999999987  4666543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.9e-45  Score=348.07  Aligned_cols=246  Identities=28%  Similarity=0.417  Sum_probs=196.8

Q ss_pred             eeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc--CCCCcEEEeeeeeec--
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKD--  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~--  214 (415)
                      .+.++|++.+.||+|+||+||+|++ +++.||||++....        ...+.+|..++..  ++||||+++++++.+  
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            3467899999999999999999987 78999999986321        1233455555555  899999999998543  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEEcCCCcEEEE
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKLA  284 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH--------~~~IiHrDLkp~NILl~~~~~vkl~  284 (415)
                        ...+|+||||+.+|+|.++++...+++..+..++.||+.||.|||        ++||+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence              456899999999999999999889999999999999999999999        9999999999999999999999999


Q ss_pred             eeccccccccCC------cccCCCCcccccccccccccc----CCCchhhHHHHHHHHHHHHcC----------CCCCCC
Q 014986          285 DFGLAKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTS----------QIPYAP  344 (415)
Q Consensus       285 DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~~~~----~~~~~~DvwSlG~il~ell~g----------~~pf~~  344 (415)
                      |||+++......      .....||+.|+|||++.+...    .++.++|||||||++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999997544332      223469999999999865421    245799999999999999999          888854


Q ss_pred             c----cHHHHHHHHh--cCCCCCCC-----CcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          345 M----ECMAALFKIG--RGSPPPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       345 ~----~~~~~~~~i~--~~~~~~~~-----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      .    ..........  ....+..+     ..++..+.+||.+||+.||.+|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2    1122222222  22222232     235678999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8e-45  Score=348.17  Aligned_cols=247  Identities=27%  Similarity=0.526  Sum_probs=202.6

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++.+.||+|+||.||+|.+. ++.||+|.+..       ....+.+.+|+.+++.++||||+++++++.+.  .|+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEE
Confidence            457999999999999999999874 78899998752       12345688999999999999999999988744  799


Q ss_pred             EEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCcEEEcCCCc-EEEEeecccccc
Q 014986          221 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD---QDVVHRDIKCANILVDANGS-VKLADFGLAKAT  292 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~---~~IiHrDLkp~NILl~~~~~-vkl~DFGla~~~  292 (415)
                      ||||+.+|+|.+++...    .++...+..++.|++.||.|||+   +||+||||||+|||++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            99999999999999764    37889999999999999999999   89999999999999998886 799999999765


Q ss_pred             ccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCc--cHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          293 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       293 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ... .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...  ........+..+...+.+..++..+
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          157 QTH-MTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             ---------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred             ccc-cccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence            432 2344699999999998654  4889999999999999999999999753  2334444555666667778899999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+||.+||+.||.+|||+.+++++  ++.+..
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~--L~~~~~  263 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKI--MTHLMR  263 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH--HHHHGG
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH--HHHHHH
Confidence            999999999999999999999874  444443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.1e-45  Score=344.57  Aligned_cols=251  Identities=25%  Similarity=0.457  Sum_probs=209.0

Q ss_pred             eeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC-CE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-SK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~  217 (415)
                      ...++|++.+.||+|+||.||+|.+ +++.||+|++....       ..+.+.+|+.+++.++||||+++++++.+. +.
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            3467899999999999999999987 48899999886321       235678999999999999999999986544 57


Q ss_pred             EEEEEeccCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~---l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      +|+||||+.+++|.+++....   +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            899999999999999987542   89999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      .. ....+++.|+|||++.+.  .++.++||||||+++|+|++ |..||......+....+..+.....+..++..+.+|
T Consensus       170 ~~-~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          170 TQ-DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             -------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred             cc-cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence            32 234578899999998654  38899999999999999998 999998877666666777776677788899999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      |.+||..||.+|||+.++++  .|+.+..
T Consensus       247 i~~~l~~~p~~Rps~~~l~~--~L~~i~~  273 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLRE--QLEHIKT  273 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHH--HHHHHHh
Confidence            99999999999999999987  4665544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.1e-45  Score=367.85  Aligned_cols=250  Identities=30%  Similarity=0.430  Sum_probs=194.1

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  219 (415)
                      .+.|.+.++||+|+||+||.+...+|+.||||++...        ....+.+|+.+|..+ +|||||++++++.+...+|
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   85 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY   85 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence            4456678899999999998876678999999998641        123467899999875 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcCCC--------HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-------------
Q 014986          220 IFLELVTKGSLLNLYQRYHLR--------DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-------------  278 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~--------~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-------------  278 (415)
                      |||||+. |+|.+++......        +..+..++.||+.||+|||++||+||||||+|||++.+             
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence            9999996 5999999765432        22346799999999999999999999999999999754             


Q ss_pred             CcEEEEeeccccccccCC------cccCCCCcccccccccccc-----ccCCCchhhHHHHHHHHHHHHc-CCCCCCCcc
Q 014986          279 GSVKLADFGLAKATKLND------VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  346 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~~-----~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~  346 (415)
                      +.+||+|||+++......      .....||+.|+|||++.+.     ...++.++|||||||++|+|++ |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            489999999998765432      2245699999999999652     2448899999999999999999 999997654


Q ss_pred             HHHHHHHHhcCCCCCC----CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          347 CMAALFKIGRGSPPPI----PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       347 ~~~~~~~i~~~~~~~~----~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ................    ...++.++.+||.+||+.||.+|||+.++++||||..
T Consensus       245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             THHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            3322111111111111    2245688999999999999999999999999999964

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6e-45  Score=375.05  Aligned_cols=256  Identities=30%  Similarity=0.489  Sum_probs=221.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.+.||+|+||.||+|.+..+..||||++.....      ..+.+.+|+.+|+.++|+||+++++++.+ .
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            3344678999999999999999999998788899999874321      12467899999999999999999999876 6


Q ss_pred             EEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      .+||||||+.+|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            78999999999999999964   358999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          294 LND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       294 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ...   .....++..|+|||++...  .++.++|||||||++|+|++ |+.||......+.+..+..+...+.+..++..
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  492 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  492 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCceecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            321   2234467889999998654  38999999999999999999 99999998888888888888777788899999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +.+||.+||..||++|||+.+|++  +|+.++..
T Consensus       493 l~~li~~cl~~dP~~RPt~~~l~~--~L~~~~~~  524 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERPTFEYLQA--FLEDYFTS  524 (535)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHTSSCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH--HHHHHhhc
Confidence            999999999999999999999986  46665543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-45  Score=344.58  Aligned_cols=245  Identities=27%  Similarity=0.470  Sum_probs=207.7

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec---
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  214 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  214 (415)
                      .+..+|++.+.||+|+||.||+|++ .+++.||+|.+....         ..+.+|+.+++.++||||+++++++..   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            4567899999999999999999998 589999999997532         235689999999999999999998754   


Q ss_pred             -------------CCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014986          215 -------------ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  278 (415)
Q Consensus       215 -------------~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~  278 (415)
                                   ...+|+||||+.+|+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence                         4568999999999999999864   368999999999999999999999999999999999999999


Q ss_pred             CcEEEEeeccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC
Q 014986          279 GSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG  357 (415)
Q Consensus       279 ~~vkl~DFGla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  357 (415)
                      +.+||+|||++...... ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||....  .....+.. 
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~-  233 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD-  233 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT-
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc-
Confidence            99999999998865443 23445699999999998654  37899999999999999999999885432  22222222 


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                        ..++..++..+.+||.+||..||.+|||+.++++|.+.-.
T Consensus       234 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 --GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             --TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             --ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence              2345678999999999999999999999999999977644

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-45  Score=354.04  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=205.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .....++|++.+.||+|+||.||+|.+.+++.||+|++......    .....+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            34456789999999999999999999888999999998643211    11225789999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~-----~l~~~~~~~i~~qil~aL~~LH~~---~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                      ..++||||+.+|+|.+++...     .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            999999999999999998754     389999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc--------HHHHHHHHhcC
Q 014986          289 AKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--------CMAALFKIGRG  357 (415)
Q Consensus       289 a~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~  357 (415)
                      ++......   .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||....        ..+........
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSE--ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCC--CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            98654332   23345999999999986544  7899999999999999999999996321        11111111000


Q ss_pred             C----------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          358 S----------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       358 ~----------~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      .          ....+...+..+.+|+.+||+.||.+|||+.+|++|-.-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            0          011222345789999999999999999999999987543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=365.61  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  219 (415)
                      ...|.+.++||+|+||+||.....+++.||||++.....        ..+.+|+.+|+.+ +|||||++++++.+...+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            346999999999999997765557899999999864221        1245799999998 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---C--CcEEEEeecccccc
Q 014986          220 IFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---N--GSVKLADFGLAKAT  292 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~--l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~--~~vkl~DFGla~~~  292 (415)
                      |||||+.+ +|.+++....  +.+..+..++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||+++..
T Consensus        95 lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           95 IAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            99999975 9999987653  555567899999999999999999999999999999953   2  35889999999865


Q ss_pred             ccC-----CcccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCC--CC
Q 014986          293 KLN-----DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP--IP  363 (415)
Q Consensus       293 ~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~--~~  363 (415)
                      ...     ......||+.|+|||++.+. ...++.++|||||||++|+|++ |..||...........+.......  .+
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  253 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE  253 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcc
Confidence            432     23345699999999998642 2346789999999999999999 999997654433332222222211  22


Q ss_pred             CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          364 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       364 ~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ...+..+.+||.+||+.||.+|||+.+|++||||..+.
T Consensus       254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            34567789999999999999999999999999997643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=364.33  Aligned_cols=251  Identities=24%  Similarity=0.458  Sum_probs=206.1

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC--
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  216 (415)
                      ..++|++.++||+|+||+||+|++ .+++.||+|++.....    ......+.+|+.+++.++||||+++++++.+..  
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            456899999999999999999998 6799999999874322    122355678999999999999999999987655  


Q ss_pred             EEEEEEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEeecc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL  288 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl----~~~~~vkl~DFGl  288 (415)
                      ..|+||||+.+|+|.+++...    .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            789999999999999998753    29999999999999999999999999999999999999    7778899999999


Q ss_pred             ccccccC-CcccCCCCcccccccccccc------ccCCCchhhHHHHHHHHHHHHcCCCCCCC----ccHHHHHHHHhcC
Q 014986          289 AKATKLN-DVKSCRGTAFWMAPEVINNK------NKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRG  357 (415)
Q Consensus       289 a~~~~~~-~~~~~~gt~~y~aPE~l~~~------~~~~~~~~DvwSlG~il~ell~g~~pf~~----~~~~~~~~~i~~~  357 (415)
                      ++..... ......||+.|+|||++.+.      ...++.++|||||||++|+|++|+.||..    ....+.+.++..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            9865433 23456799999999998541      13378899999999999999999999964    2234445555444


Q ss_pred             CCCC------------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          358 SPPP------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       358 ~~~~------------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      .+..                        +...++..+.+||.+||..||++||++.+++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            3321                        123456788999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-45  Score=361.02  Aligned_cols=255  Identities=24%  Similarity=0.430  Sum_probs=205.5

Q ss_pred             cccccccccccCCcEEEEEEEcC--C--CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee-cCC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISD--D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DES  216 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~--~--~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~  216 (415)
                      ..|++.++||+|+||.||+|++.  +  +..||+|.+...    ........+.+|+.+++.++||||+++++++. .++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            35788899999999999999862  2  246888877532    22334567889999999999999999999864 456


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..|+||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            889999999999999999753  588999999999999999999999999999999999999999999999999975533


Q ss_pred             CC------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCccc
Q 014986          295 ND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  367 (415)
Q Consensus       295 ~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s  367 (415)
                      ..      .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |.+||......+....+..+.....+..++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            22      2234578899999998654  38899999999999999999 788887766555566666676777788899


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       368 ~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ..+.+||.+||..||.+|||+.+++++  ++.+...-
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~--L~~i~~~~  357 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTF  357 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHTC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHhc
Confidence            999999999999999999999999875  66666543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-44  Score=342.72  Aligned_cols=249  Identities=27%  Similarity=0.536  Sum_probs=196.5

Q ss_pred             eeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      ...++|++.+.||+|+||.||+|.+..  .+|+|++.....   .....+.+.+|+.+++.++||||+++++++ ....+
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            345689999999999999999998743  599999875332   234457788999999999999999999965 45668


Q ss_pred             EEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc--
Q 014986          219 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~--  294 (415)
                      ++||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999999854  4689999999999999999999999999999999999999999999999999875432  


Q ss_pred             --CCcccCCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH-hcCCC----CCCCCcc
Q 014986          295 --NDVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSP----PPIPDSL  366 (415)
Q Consensus       295 --~~~~~~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~----~~~~~~~  366 (415)
                        .......||+.|+|||++... ...++.++||||||+++|+|++|+.||......+.+... ..+..    ......+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence              223345699999999998522 334788999999999999999999999875544443333 22222    1234578


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      +..+.+||.+||..||.+|||+.++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=348.10  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=200.8

Q ss_pred             eeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc--CCCCcEEEeeeeeecC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  215 (415)
                      ..+.++|++.+.||+|+||.||+|.+. ++.||||++....      .  ....+|..++..  ++||||+++++++...
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE------E--ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG------H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc------c--chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            345678999999999999999999875 8999999986321      1  223345555544  4899999999998877


Q ss_pred             ----CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEcCCCcEEE
Q 014986          216 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       216 ----~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~--------~IiHrDLkp~NILl~~~~~vkl  283 (415)
                          ..+|+||||+.+|+|.++++...+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence                7899999999999999999988999999999999999999999999        9999999999999999999999


Q ss_pred             EeeccccccccCCc------ccCCCCccccccccccccccCC----CchhhHHHHHHHHHHHHcC----------CCCCC
Q 014986          284 ADFGLAKATKLNDV------KSCRGTAFWMAPEVINNKNKGY----GLPADIWSLGCTVLEMLTS----------QIPYA  343 (415)
Q Consensus       284 ~DFGla~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~----~~~~DvwSlG~il~ell~g----------~~pf~  343 (415)
                      +|||+++.......      ....||+.|+|||++.+.....    +.++|||||||++|+|++|          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999976543322      2457999999999986543211    1249999999999999999          77775


Q ss_pred             Ccc----HHHHHHHH--hcCCCCCCCC-----cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          344 PME----CMAALFKI--GRGSPPPIPD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       344 ~~~----~~~~~~~i--~~~~~~~~~~-----~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ...    ........  .....+..+.     .++..+.+||.+||+.||.+|||+.++++|  |+.+....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l~~~~  333 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT--LAKMSESQ  333 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHHTT
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH--HHHHHhhc
Confidence            421    11222221  1222233332     567789999999999999999999999986  67666544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-44  Score=342.59  Aligned_cols=256  Identities=20%  Similarity=0.300  Sum_probs=202.8

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeee-eeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++.....       ...+.+|+.+++.++|++++..+. ++....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            3457899999999999999999998 7899999998764322       124678999999998877665554 457788


Q ss_pred             EEEEEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEeeccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  291 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl---~~~~~vkl~DFGla~~  291 (415)
                      ..++||||+ +++|.+++.  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            899999999 889999987  4579999999999999999999999999999999999999   7889999999999986


Q ss_pred             cccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH------HHHHH-HHh
Q 014986          292 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------MAALF-KIG  355 (415)
Q Consensus       292 ~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------~~~~~-~i~  355 (415)
                      .....         .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.....      ..... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCC--CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            54332         23456999999999986544  89999999999999999999999976321      11111 111


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       356 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      ..........++..+.+||.+||+.||.+|||+.++++  .|+.+......
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~~~~~~~~  284 (296)
T 4hgt_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHRQGF  284 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHHHHTC
T ss_pred             cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHHHHHHhCC
Confidence            11111123567899999999999999999999999987  67777765443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.5e-44  Score=339.35  Aligned_cols=256  Identities=20%  Similarity=0.301  Sum_probs=207.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeee-eeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~  216 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++......       ..+.+|+.+++.++|++++..+. ++....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            3567899999999999999999998 88999999998753321       24678999999999887655544 456788


Q ss_pred             EEEEEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CCCcEEEEeeccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKA  291 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~---~~~~vkl~DFGla~~  291 (415)
                      ..++||||+ +++|.+++.  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            899999999 889999987  34699999999999999999999999999999999999994   789999999999986


Q ss_pred             cccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH------HHHHH-HHh
Q 014986          292 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------MAALF-KIG  355 (415)
Q Consensus       292 ~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~------~~~~~-~i~  355 (415)
                      .....         .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.....      ...+. ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            54432         24456999999999986544  88999999999999999999999976321      11111 111


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       356 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                      ..........++..+.+||.+||+.||.+|||+.++++  .|+++......
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~~~~~~~~  284 (296)
T 3uzp_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHRQGF  284 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHHHTTC
T ss_pred             CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHHHHHhcCC
Confidence            11111223578899999999999999999999999987  57777765544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.1e-45  Score=356.39  Aligned_cols=259  Identities=18%  Similarity=0.258  Sum_probs=200.6

Q ss_pred             ecccccccccccCCcEEEEEEEcCC------CcEEEEEEEecccccchhH-HH-----HHHHHHHHHHHhcCCCCcEEEe
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAK-QS-----ISQLEQEIALLSRFEHENIVQY  208 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~i~~~~~~~~~~-~~-----~~~~~~E~~il~~l~hpnIv~l  208 (415)
                      .++|++.+.||+|+||.||+|.+..      ++.||+|++.......... ..     ...+.+|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998843      5889999987532111110 00     1123456677888999999999


Q ss_pred             eeeeecC----CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCCc
Q 014986          209 YGTDKDE----SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGS  280 (415)
Q Consensus       209 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~--~~~~  280 (415)
                      ++++...    ...||||||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++  .++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            9998764    5689999999 8999999876  4699999999999999999999999999999999999999  8899


Q ss_pred             EEEEeeccccccccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHH-
Q 014986          281 VKLADFGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA-  350 (415)
Q Consensus       281 vkl~DFGla~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~-  350 (415)
                      +||+|||+++......         .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........ 
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA--PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC--CCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            9999999997543221         13345999999999996544  89999999999999999999999985321111 


Q ss_pred             HHHHhcCCCC---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          351 LFKIGRGSPP---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       351 ~~~i~~~~~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ..........         .....++.++.+||..||..||.+||++.+|++  .|+.++...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~--~l~~~~~~~  331 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD--ILLQGLKAI  331 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHHHT
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH--HHHHHHHHc
Confidence            1000000000         012567899999999999999999999999986  577666543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.8e-44  Score=341.28  Aligned_cols=237  Identities=24%  Similarity=0.396  Sum_probs=192.9

Q ss_pred             eeecccccc-cccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH-hcCCCCcEEEeeeeeec-
Q 014986          139 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD-  214 (415)
Q Consensus       139 ~~~~~y~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~-  214 (415)
                      .+.++|.+. ++||+|+||.||+|.+ .+++.||+|++...          ..+.+|+.++ +..+||||+++++++.. 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            455677776 7899999999999998 78999999998631          2355788887 66799999999999876 


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEe
Q 014986          215 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD  285 (415)
Q Consensus       215 ---~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~D  285 (415)
                         ...+|+||||+.+|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               77899999999999999999764   4999999999999999999999999999999999999998   78999999


Q ss_pred             eccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---CCCCC
Q 014986          286 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---SPPPI  362 (415)
Q Consensus       286 FGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~  362 (415)
                      ||++....                      ...++.++|||||||++|+|++|..||...............   .....
T Consensus       164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  221 (299)
T 3m2w_A          164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  221 (299)
T ss_dssp             CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred             cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence            99885432                      122678999999999999999999999775443322111111   11112


Q ss_pred             C----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCC
Q 014986          363 P----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  407 (415)
Q Consensus       363 ~----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~  407 (415)
                      +    ..++.++.+||.+||..||.+|||+.++++||||++........
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~  270 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  270 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence            2    46799999999999999999999999999999999887655443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.3e-45  Score=353.74  Aligned_cols=250  Identities=20%  Similarity=0.271  Sum_probs=194.4

Q ss_pred             ecccccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHH------HHHHHHHHHHHHhcCCCCcEEEeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQ------SISQLEQEIALLSRFEHENIVQYYG  210 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~  210 (415)
                      .++|++.+.||+|+||.||+|++.    ++..+|+|++...........      ....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            458999999999999999999984    788999999875432111110      1123567889999999999999999


Q ss_pred             eeec----CCEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--cEEE
Q 014986          211 TDKD----ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--SVKL  283 (415)
Q Consensus       211 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~--~vkl  283 (415)
                      ++.+    ...+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            9887    78899999999 89999998754 699999999999999999999999999999999999999887  9999


Q ss_pred             EeeccccccccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc-HHHHHHH
Q 014986          284 ADFGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFK  353 (415)
Q Consensus       284 ~DFGla~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~-~~~~~~~  353 (415)
                      +|||+++......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.... .......
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            9999997653221         1345699999999998654  48999999999999999999999995421 1111111


Q ss_pred             HhcCCCCCCC---------CcccHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 014986          354 IGRGSPPPIP---------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  393 (415)
Q Consensus       354 i~~~~~~~~~---------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~  393 (415)
                      ........++         ..++.++.+||.+||..||.+|||+.+|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1111111111         268899999999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=374.72  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=210.1

Q ss_pred             cccccc-ccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          143 YWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       143 ~y~~~~-~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      .+.+.+ .||+|+||.||+|.+   .++..||||++.....    ....+.+.+|+.+|+.++|||||++++++.+ +.+
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            444444 799999999999976   3567899999874321    2234678899999999999999999999976 569


Q ss_pred             EEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          219 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      ||||||+.+|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999999999864  358999999999999999999999999999999999999999999999999998654332


Q ss_pred             c-----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          297 V-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       297 ~-----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      .     ....+++.|+|||++.+.  .++.++|||||||++|||++ |+.||......+....+..+.....+..++..+
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  568 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL  568 (613)
T ss_dssp             -----------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ceeeeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence            1     122356889999999654  38999999999999999998 999999988888888888888888889999999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .+||.+||..||.+||++.+|++  .|+.++
T Consensus       569 ~~li~~cl~~dP~~RPs~~~l~~--~L~~~~  597 (613)
T 2ozo_A          569 YALMSDCWIYKWEDRPDFLTVEQ--RMRACY  597 (613)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHH--HHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH--HHHHHH
Confidence            99999999999999999999965  344443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=345.88  Aligned_cols=252  Identities=25%  Similarity=0.404  Sum_probs=189.3

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeee-----
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTD-----  212 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~-----  212 (415)
                      ...+|++.++||+|+||.||+|++ .+++.||+|++...     .......+.+|+.++..+. ||||+++++++     
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            345899999999999999999998 68999999998642     2334567889999999996 99999999988     


Q ss_pred             ---ecCCEEEEEEeccCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEE
Q 014986          213 ---KDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       213 ---~~~~~~~lV~E~~~~gsL~~~l~~----~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~~~~~vkl  283 (415)
                         .....+++||||+. |+|.+++..    ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence               34556899999997 589887754    45999999999999999999999999  999999999999999999999


Q ss_pred             EeeccccccccCCc--------------ccCCCCccccccccccc-cccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH
Q 014986          284 ADFGLAKATKLNDV--------------KSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM  348 (415)
Q Consensus       284 ~DFGla~~~~~~~~--------------~~~~gt~~y~aPE~l~~-~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~  348 (415)
                      +|||+++.......              ....||+.|+|||++.. ....++.++|||||||++|+|++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            99999986543221              13458999999999832 2334788999999999999999999999765443


Q ss_pred             HHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          349 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       349 ~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .....   ....+.+...+..+.+||.+||+.||.+|||+.++++|  |+.+..
T Consensus       260 ~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~--l~~~~~  308 (337)
T 3ll6_A          260 RIVNG---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIAA  308 (337)
T ss_dssp             ---------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HhhcC---cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence            32222   22233456677889999999999999999999999987  555544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-44  Score=339.51  Aligned_cols=257  Identities=29%  Similarity=0.467  Sum_probs=205.6

Q ss_pred             eecccccccccccCCcEEEEEEEc--CCCc--EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS--DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~--~~~~--~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      ..++|++.+.||+|+||+||+|++  .+++  .||+|++.....  ......+.+.+|+.+++.++||||+++++++.+.
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            356899999999999999999985  2333  689998864321  1233456788999999999999999999999876


Q ss_pred             CEEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      . .++||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            5 8899999999999998875  459999999999999999999999999999999999999999999999999998664


Q ss_pred             cCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcC-CCCCCCCcc
Q 014986          294 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG-SPPPIPDSL  366 (415)
Q Consensus       294 ~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  366 (415)
                      ...     .....+|..|+|||++.+..  ++.++||||||+++|+|++ |+.||......+....+... ...+.+..+
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC  250 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence            332     22345788899999986543  7889999999999999999 99999988777666666543 334556789


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      +..+.+||.+||..||.+|||+.++++  +|+++..+
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~~~  285 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQPT  285 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC--
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH--HHHHhCcc
Confidence            999999999999999999999999987  57666543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.4e-44  Score=342.91  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=203.8

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEE
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  222 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~  222 (415)
                      .|..++.||+|+||.||+|.+ +++.||+|++...... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            355668999999999999987 6789999998743221 12234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          223 ELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       223 E~~~~gsL~~~l~~----~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ||+.+++|.+++..    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            99999999998863    358999999999999999999999999999999999999999999999999987654322  


Q ss_pred             --cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHH----HHHHHh----------cCCCC
Q 014986          297 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA----ALFKIG----------RGSPP  360 (415)
Q Consensus       297 --~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~----~~~~i~----------~~~~~  360 (415)
                        .....||+.|+|||++.+.   ++.++||||||+++|+|++|..||.......    ....+.          .....
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRGE---ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTTE---ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             ccccccCCCcCcCChHHhcCC---CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence              2235689999999998542   6889999999999999999999997643211    111111          11112


Q ss_pred             CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          361 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       361 ~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ..+...+..+.+|+.+||..||.+|||+.+++++  |+++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~--L~~l  304 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL--LQEM  304 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHH
Confidence            2334566789999999999999999999999874  5554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=348.37  Aligned_cols=266  Identities=24%  Similarity=0.480  Sum_probs=210.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +....++|++.+.||+|+||.||+|.+..  .+|+|++........   ..+.+.+|+.+++.++||||+++++++.+..
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED---QLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC---CCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH---HHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            33446789999999999999999998743  499998875322111   1234668999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+++||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            999999999999999999765  489999999999999999999999999999999999997 78999999999865421


Q ss_pred             -------CCcccCCCCcccccccccccc-------ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Q 014986          295 -------NDVKSCRGTAFWMAPEVINNK-------NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP  360 (415)
Q Consensus       295 -------~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  360 (415)
                             .......||+.|+|||++.+.       ...++.++|||||||++|+|++|+.||...........+..+..+
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence                   122334589999999998642       234788999999999999999999999988777777777666554


Q ss_pred             CCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCCCCCC
Q 014986          361 PIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP  410 (415)
Q Consensus       361 ~~~-~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~~~~~  410 (415)
                      ... ..++..+.+||.+||..||.+|||+.++++  .|+.+.........|
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~~~~~  310 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLSHP  310 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC----------
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhccCCCC
Confidence            433 368899999999999999999999999987  577666655444333

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.1e-44  Score=373.62  Aligned_cols=246  Identities=25%  Similarity=0.438  Sum_probs=209.6

Q ss_pred             cccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      +.||+|+||.||+|.+   .+++.||||+++.....   ......+.+|+.+|+.++|||||++++++.. +.++|||||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~  450 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND---PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM  450 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC---GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEc
Confidence            4799999999999965   45789999998753221   2234678899999999999999999999875 458899999


Q ss_pred             cCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-----cc
Q 014986          225 VTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VK  298 (415)
Q Consensus       225 ~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-----~~  298 (415)
                      +.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......     ..
T Consensus       451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            9999999998764 69999999999999999999999999999999999999999999999999998654332     22


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ...+|+.|+|||++.+..  ++.++|||||||++|+|++ |+.||.+....+....+..+.....+..++.++.+||.+|
T Consensus       531 ~~~~t~~y~APE~~~~~~--~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  608 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  608 (635)
T ss_dssp             ----CGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             CCCCceeeeChhhhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            334678899999996543  8999999999999999998 9999999888888888888888888899999999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHhhh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      |..||++||++.+|++.  |+.++
T Consensus       609 l~~dP~~RPs~~~l~~~--L~~~~  630 (635)
T 4fl3_A          609 WTYDVENRPGFAAVELR--LRNYY  630 (635)
T ss_dssp             TCSSTTTSCCHHHHHHH--HHHHH
T ss_pred             cCCCHhHCcCHHHHHHH--HHHHH
Confidence            99999999999999763  44443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=344.18  Aligned_cols=254  Identities=27%  Similarity=0.458  Sum_probs=209.9

Q ss_pred             eecccccccccccCCcEEEEEEE----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      ..++|++.+.||+|+||.||+|+    + .+++.||+|++...     .......+.+|+.+++.++||||+++++++..
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            35679999999999999999998    3 57999999998642     23345678899999999999999999998866


Q ss_pred             CC--EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          215 ES--KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       215 ~~--~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .+  .+++||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            44  789999999999999999764  48999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH----------------H
Q 014986          291 ATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----------------A  349 (415)
Q Consensus       291 ~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~----------------~  349 (415)
                      ......     .....++..|+|||++.+..  ++.++||||||+++|+|++|..||......                .
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCC--CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            664432     22345778899999986543  788999999999999999999998643110                1


Q ss_pred             HHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       350 ~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      ....+......+.+..++..+.+||.+||..||.+|||+.++++  .|+.+..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~--~L~~l~~  322 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL--RVDQIRD  322 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH--HHHHHHH
Confidence            12233344455667889999999999999999999999999986  3555543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=346.84  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=193.9

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee-----ecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-----KDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~  215 (415)
                      .++|++.+.||+|+||.||+|++ +++.||||++....     . .....+.|+..+..++||||+++++.+     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----R-QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----H-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----h-hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            56899999999999999999976 68999999987421     1 111223444445668999999999743     234


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEcCCCcEEEEee
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~---------~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                      ..+|+||||+.+|+|.+++.....++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||+||
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            4689999999999999999988889999999999999999999999         9999999999999999999999999


Q ss_pred             ccccccccC----------CcccCCCCccccccccccccc-----cCCCchhhHHHHHHHHHHHHcCCCCCCCccH----
Q 014986          287 GLAKATKLN----------DVKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----  347 (415)
Q Consensus       287 Gla~~~~~~----------~~~~~~gt~~y~aPE~l~~~~-----~~~~~~~DvwSlG~il~ell~g~~pf~~~~~----  347 (415)
                      |+++.....          ......||+.|+|||++.+..     ..++.++|||||||++|+|++|..||.....    
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            999765422          122456999999999986521     2366789999999999999999776632110    


Q ss_pred             -------------HHHHHH--HhcCCCCCCCCc------ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          348 -------------MAALFK--IGRGSPPPIPDS------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       348 -------------~~~~~~--i~~~~~~~~~~~------~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                   ......  ......+.++..      ++..+.+||.+||..||.+|||+.++++.  |+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~--L~~ll  317 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER--MAELM  317 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH--HHHHH
Confidence                         111111  112222333332      45689999999999999999999999763  55544

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=350.44  Aligned_cols=247  Identities=19%  Similarity=0.238  Sum_probs=198.1

Q ss_pred             CcceeeecccccccccccCCcEEEEEEE-----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC---CCcE
Q 014986          135 GRFKRIITYWQKGDLLGRGSFGSVYEGI-----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENI  205 (415)
Q Consensus       135 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~-----~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnI  205 (415)
                      ..+....++|.+.++||+|+||+||+|+     + .+++.||+|++....        ...+.+|+.++..++   |+||
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~~i  129 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQHMF  129 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhhhh
Confidence            3455556789999999999999999994     3 678999999986421        234567777777776   9999


Q ss_pred             EEeeeeeecCCEEEEEEeccCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--
Q 014986          206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--  277 (415)
Q Consensus       206 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~--  277 (415)
                      +++++++...+..||||||+.+|+|.+++..      ..+++..++.++.||+.||+|||++||+||||||+|||++.  
T Consensus       130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred             hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence            9999999999999999999999999999863      46999999999999999999999999999999999999998  


Q ss_pred             ---------CCcEEEEeeccccccc----cCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014986          278 ---------NGSVKLADFGLAKATK----LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  344 (415)
Q Consensus       278 ---------~~~vkl~DFGla~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~  344 (415)
                               ++.+||+|||+++...    .......+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||..
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC--CCccccHHHHHHHHHHHHhCCCcccc
Confidence                     8999999999997543    12234567999999999996644  89999999999999999999999965


Q ss_pred             ccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChh
Q 014986          345 MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  396 (415)
Q Consensus       345 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~  396 (415)
                      ......  .+ .....  ....++.+.+++..||+.+|.+|++..+.+.+.+
T Consensus       288 ~~~~~~--~~-~~~~~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          288 NEGGEC--KP-EGLFR--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             EETTEE--EE-CSCCT--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             CCCCce--ee-chhcc--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence            432100  00 01111  1234778999999999999999966555554433

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=350.91  Aligned_cols=250  Identities=21%  Similarity=0.282  Sum_probs=202.3

Q ss_pred             ecccccccccccCCcEEEEEEEcC---------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEE----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD---------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ----  207 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~---------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~----  207 (415)
                      .++|++.+.||+|+||.||+|++.         +++.||+|.+...          ..+.+|+.+++.++||||++    
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence            468999999999999999999984         3899999998742          24678999999999999987    


Q ss_pred             -----------eeeeeec-CCEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014986          208 -----------YYGTDKD-ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  272 (415)
Q Consensus       208 -----------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~N  272 (415)
                                 +++++.. ...+|+||||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                       4556554 78899999999 8999999976   479999999999999999999999999999999999


Q ss_pred             EEEcCCC--cEEEEeeccccccccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCC
Q 014986          273 ILVDANG--SVKLADFGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP  341 (415)
Q Consensus       273 ILl~~~~--~vkl~DFGla~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~p  341 (415)
                      ||++.++  .+||+|||+++......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.|
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999998  99999999997654221         1334699999999998654  489999999999999999999999


Q ss_pred             CCCcc-HHHHHHHHh---cCCCCCCC------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          342 YAPME-CMAALFKIG---RGSPPPIP------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       342 f~~~~-~~~~~~~i~---~~~~~~~~------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      |.... ....+....   ......+.      ..++..+.+||.+||..||.+|||+.+|++  .|+++.....
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~~~~~  339 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN--NLEALLQDLR  339 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHHHTT
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH--HHHHHHHhcC
Confidence            97653 112111111   11111111      246899999999999999999999999987  4777776554

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.5e-44  Score=345.16  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=207.4

Q ss_pred             eeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhc--CCCCcEEEeeeeeecC
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE  215 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~  215 (415)
                      ..+.++|++.+.||+|+||.||+|.+ +++.||+|++...        ....+.+|+.++..  ++||||+++++++...
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            34567899999999999999999987 5899999998631        12345678888877  7899999999999877


Q ss_pred             C----EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEEcCCCcEEE
Q 014986          216 S----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKL  283 (415)
Q Consensus       216 ~----~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH--------~~~IiHrDLkp~NILl~~~~~vkl  283 (415)
                      .    .+|+||||+.+|+|.+++.+..+++..+..++.||+.||.|||        +.||+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence            6    8999999999999999999889999999999999999999999        899999999999999999999999


Q ss_pred             EeeccccccccCC------cccCCCCcccccccccccccc----CCCchhhHHHHHHHHHHHHcC----------CCCCC
Q 014986          284 ADFGLAKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTS----------QIPYA  343 (415)
Q Consensus       284 ~DFGla~~~~~~~------~~~~~gt~~y~aPE~l~~~~~----~~~~~~DvwSlG~il~ell~g----------~~pf~  343 (415)
                      +|||++.......      .....||+.|+|||++.+...    .++.++|||||||++|+|++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999997654432      234569999999999865421    134689999999999999999          78986


Q ss_pred             Ccc-----HHHHHHHHhc-CCCCCCCC-----cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          344 PME-----CMAALFKIGR-GSPPPIPD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       344 ~~~-----~~~~~~~i~~-~~~~~~~~-----~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ...     .......+.. ...+.++.     .++..+.+||.+||+.||.+|||+.+|++|  |+.+..+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~--L~~i~~~  337 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQ  337 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH--HHHHHHH
Confidence            532     2222222222 22233332     345689999999999999999999999986  7766554

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-43  Score=357.48  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=205.0

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC-CcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~  216 (415)
                      .+.++|++.++||+|+||.||+|++ .+++.||||++......       .++.+|+.+++.++| ++|..+..++....
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            4567899999999999999999998 78999999988753322       236689999999986 56666777778889


Q ss_pred             EEEEEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEeeccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  291 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl---~~~~~vkl~DFGla~~  291 (415)
                      ..+|||||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999999999 889999997  4579999999999999999999999999999999999999   5889999999999986


Q ss_pred             cccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhc---
Q 014986          292 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGR---  356 (415)
Q Consensus       292 ~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~---  356 (415)
                      .....         .....||+.|+|||++.+..  ++.++|||||||+||+|++|+.||.....   .+.+.++..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            54332         12567999999999996544  89999999999999999999999976432   222222211   


Q ss_pred             -CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          357 -GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       357 -~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                       .....+...++.++.+||.+||..||++||++.+|++  .|+.++.
T Consensus       234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~--~L~~l~~  278 (483)
T 3sv0_A          234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR--LFRDLFI  278 (483)
T ss_dssp             HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHH
T ss_pred             cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence             1111223567899999999999999999999999876  3555443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.5e-45  Score=355.87  Aligned_cols=246  Identities=18%  Similarity=0.273  Sum_probs=192.5

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHhcCC---------CCcEEEe
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFE---------HENIVQY  208 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~~~E~~il~~l~---------hpnIv~l  208 (415)
                      .++|++.+.||+|+||+||+|++ +++.||||++.......   ........+.+|+.+++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46899999999999999999998 78999999998643210   11122355678888887775         5555554


Q ss_pred             -----------------eeeeec-------------CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHH
Q 014986          209 -----------------YGTDKD-------------ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL  258 (415)
Q Consensus       209 -----------------~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~L  258 (415)
                                       ++++.+             ...+||||||+.+|++.+.+.+..+++..++.++.||+.||.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence                             444443             78899999999999877777667899999999999999999999


Q ss_pred             H-HCCceecCCCCCcEEEcCCC--------------------cEEEEeeccccccccCCcccCCCCcccccccccccccc
Q 014986          259 H-DQDVVHRDIKCANILVDANG--------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK  317 (415)
Q Consensus       259 H-~~~IiHrDLkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~  317 (415)
                      | ++||+||||||+|||++.++                    .+||+|||+++.....   ..+||+.|+|||++.+.. 
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~-  253 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDG-  253 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCS-
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCC-
Confidence            9 99999999999999999887                    8999999999876533   347999999999996543 


Q ss_pred             CCCchhhHHHHHHH-HHHHHcCCCCCCCccHHH-HHHHHhc---CCCC---CCCCcccHHHHHHHHHhhhhCCCCCCCHH
Q 014986          318 GYGLPADIWSLGCT-VLEMLTSQIPYAPMECMA-ALFKIGR---GSPP---PIPDSLSKDAQDFIKQCVQVNPNDRPTAA  389 (415)
Q Consensus       318 ~~~~~~DvwSlG~i-l~ell~g~~pf~~~~~~~-~~~~i~~---~~~~---~~~~~~s~~l~~Li~~~L~~dP~~Rps~~  389 (415)
                        +.++|||||+++ .++++.|..||....+.. ....+..   ....   ..+..+++++.+||++||+.|     |+.
T Consensus       254 --~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          254 --DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             --SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             --ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence              789999998776 778889999996543211 1112221   1111   112357889999999999976     999


Q ss_pred             HHH-cChhhH
Q 014986          390 QLL-DHPFVK  398 (415)
Q Consensus       390 eil-~hp~f~  398 (415)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-43  Score=370.26  Aligned_cols=256  Identities=27%  Similarity=0.472  Sum_probs=217.0

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  212 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  212 (415)
                      +....++|++.+.||+|+||.||+|++.    .+..||+|.+...    ......+.+.+|+.+++.++||||+++++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3444678999999999999999999873    3467899977532    2234456788999999999999999999998


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      . ++.+|+||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            5 45689999999999999998754  58999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          291 ATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       291 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ......   .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||.+....+....+..+...+.+..+
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  617 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  617 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            654332   1234477899999999654  48999999999999999997 99999998888888888888878888999


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +..+.+||.+||..||.+|||+.+|++.  ++.+.
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~~--L~~il  650 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTIL  650 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence            9999999999999999999999999874  55554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.7e-44  Score=374.03  Aligned_cols=260  Identities=24%  Similarity=0.389  Sum_probs=207.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  214 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  214 (415)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++...    ........+.+|+.+++.++||||+++++++..    
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            357899999999999999999998 78999999987642    123445678899999999999999999998765    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEe
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLAD  285 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~----~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~---vkl~D  285 (415)
                        .+..|+||||+.+|+|.+++...    .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              67789999999999999999764    4889999999999999999999999999999999999997765   99999


Q ss_pred             eccccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH---------HHh
Q 014986          286 FGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF---------KIG  355 (415)
Q Consensus       286 FGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---------~i~  355 (415)
                      ||++....... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||..........         .+.
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccccccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            99998765443 3446799999999998654  48999999999999999999999997643221110         000


Q ss_pred             -----cC-----C----CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          356 -----RG-----S----PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       356 -----~~-----~----~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                           .+     .    +..+...++..+.+||.+||..||.+|||+.++++||||+.+.....
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                 00     0    01122346789999999999999999999999999999999876443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.2e-44  Score=356.76  Aligned_cols=251  Identities=18%  Similarity=0.235  Sum_probs=193.2

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC-Cc---------------
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-EN---------------  204 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h-pn---------------  204 (415)
                      ..|.+.++||+|+||+||+|++ .+++.||||++......  .....+.+.+|+.+++.+.| .|               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc--cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            4578889999999999999997 78999999988743222  22335678899999999976 21               


Q ss_pred             EEEe------eeeeec-----CCEEEEEEeccCCCCHHHHHh--------hcCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014986          205 IVQY------YGTDKD-----ESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYLHDQDVVH  265 (415)
Q Consensus       205 Iv~l------~~~~~~-----~~~~~lV~E~~~~gsL~~~l~--------~~~l~~~~~~~i~~qil~aL~~LH~~~IiH  265 (415)
                      ++.+      ...+..     ...++++|+++ +++|.++++        ...+++..+..++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            1111      111111     22467778776 469998885        234677788899999999999999999999


Q ss_pred             cCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCccccccccccc--------cccCCCchhhHHHHHHHHHHHHc
Q 014986          266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINN--------KNKGYGLPADIWSLGCTVLEMLT  337 (415)
Q Consensus       266 rDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~~DvwSlG~il~ell~  337 (415)
                      |||||+|||++.++.+||+|||+++..... ....+| +.|+|||++..        ....++.++|||||||++|+|++
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999999999999999998765543 344567 99999999832        22237889999999999999999


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          338 SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       338 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      |+.||...........+..     ....++..+.+||.+||+.||++|||+.++++||||+.+..
T Consensus       313 g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             SSCCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             CCCCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            9999987653322222221     12367899999999999999999999999999999998864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-42  Score=366.25  Aligned_cols=243  Identities=21%  Similarity=0.282  Sum_probs=200.9

Q ss_pred             eeecccccccccccCCcEEEEEEEcC--CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .+.++|++.++||+|+||.||+|++.  +++.||||++...    ........+.+|+.++..++||||+++++++...+
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            45578999999999999999999983  6899999987632    12334567889999999999999999999988765


Q ss_pred             E-----EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          217 K-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       217 ~-----~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .     .||||||+.+++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            5     7999999999999987765 89999999999999999999999999999999999999875 999999999987


Q ss_pred             cccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-CCCcccHHH
Q 014986          292 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDA  370 (415)
Q Consensus       292 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l  370 (415)
                      ....  ....||+.|+|||++.+.   ++.++|||||||++|+|++|..||.....        ...... .....+..+
T Consensus       231 ~~~~--~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~l  297 (681)
T 2pzi_A          231 INSF--GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYV--------DGLPEDDPVLKTYDSY  297 (681)
T ss_dssp             TTCC--SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEEC--------SSCCTTCHHHHHCHHH
T ss_pred             cccC--CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCccccc--------ccccccccccccCHHH
Confidence            6443  456799999999998543   48899999999999999999998875321        000000 011246789


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+||.+||..||.+||+..+++.|+|+..+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            999999999999999999999999998764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.3e-41  Score=321.21  Aligned_cols=231  Identities=15%  Similarity=0.110  Sum_probs=189.9

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++......  .......+.+|+.++..++||||+++++++.+.+.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  105 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL--PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG  105 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc--CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence            3456899999999999999999999 67999999998753322  23455778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          218 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      .|+||||+.+++|.++++.. .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|          
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999999999999654 5666788999999999999999999999999999999999999998554          


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHH---HHhcCCCC---CCCCcccHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF---KIGRGSPP---PIPDSLSKDAQ  371 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~---~~~~~~s~~l~  371 (415)
                              |++|         ++.++|||||||++|+|++|+.||........+.   +.......   .....++..+.
T Consensus       175 --------~~~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 --------TMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             --------CCTT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             --------ccCC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                    3332         6789999999999999999999998654321110   11111111   12356899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||.+||+.||.+| |+.++++  .++++..
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~--~L~~~~~  265 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLN--LMQQATA  265 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHH--HHHHHHC
T ss_pred             HHHHHHcccCCccC-CHHHHHH--HHHHHhc
Confidence            99999999999999 9999987  4666554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5e-35  Score=302.51  Aligned_cols=185  Identities=15%  Similarity=0.089  Sum_probs=133.8

Q ss_pred             ccccCCcEEEEEEEc-CCCcEEEEEEEeccc-----ccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCCEEEEE
Q 014986          149 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-----QGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~-----~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      .++.|++|.+..++. ..|+.||+|++....     .........+.+.+|+.+|+++ .|+||++++++++++..+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            467788888877766 679999999997532     1223445567899999999999 699999999999999999999


Q ss_pred             EeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Ccc
Q 014986          222 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~  298 (415)
                      |||++|++|.+++.+. .++..   .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....  ...
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            9999999999999875 45543   58999999999999999999999999999999999999999999866433  244


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCC
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ  339 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~  339 (415)
                      ..+||+.|||||++.+.   +..++|+||+|+++++|+++.
T Consensus       398 t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          398 NLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHC--------------------CCCCTTH
T ss_pred             CceechhhccHHHhCCC---CCCcccccccccchhhhcccc
Confidence            56799999999998653   566899999999988776654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=8.4e-30  Score=261.97  Aligned_cols=188  Identities=20%  Similarity=0.233  Sum_probs=146.0

Q ss_pred             ccccccccCCcEEEEEEEcCCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ...++||+|+||.||+|. ..++.+++|+........   ......+++.+|+.+|+.++||||+++..++...+..|||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            446789999999999994 457889999876533221   2223356789999999999999999555555566677999


Q ss_pred             EeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-----
Q 014986          222 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-----  296 (415)
                      |||+++++|.+++..       +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++......     
T Consensus       418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            999999999999876       6689999999999999999999999999999988  99999999998765432     


Q ss_pred             ----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCC
Q 014986          297 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  342 (415)
Q Consensus       297 ----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf  342 (415)
                          ....+||+.|||||++......|+...|+|+..+-..+...++-+|
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                1345799999999999764455888899999988888877766655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.1e-26  Score=216.53  Aligned_cols=149  Identities=17%  Similarity=0.137  Sum_probs=117.6

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccc-------------hhHHHHHHHHHHHHHHhcCCCCcEEEee
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-------------QAKQSISQLEQEIALLSRFEHENIVQYY  209 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~-------------~~~~~~~~~~~E~~il~~l~hpnIv~l~  209 (415)
                      .|.+++.||+|+||.||+|.+.+++.||+|.+.......             ........+.+|+.+++.++  | ++++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            345669999999999999999889999999986422110             00124567889999999998  4 5666


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                      +.+.. +..|+||||++||+|.+ +.     ......++.||+.||.|||++||+||||||+|||++ +|.+||+|||++
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            65443 45699999999999987 32     133567999999999999999999999999999999 999999999998


Q ss_pred             cccccCCcccCCCCcccccccccc
Q 014986          290 KATKLNDVKSCRGTAFWMAPEVIN  313 (415)
Q Consensus       290 ~~~~~~~~~~~~gt~~y~aPE~l~  313 (415)
                      +.           +..++|||.+.
T Consensus       240 ~~-----------~~~~~a~e~l~  252 (282)
T 1zar_A          240 VE-----------VGEEGWREILE  252 (282)
T ss_dssp             EE-----------TTSTTHHHHHH
T ss_pred             eE-----------CCCCCHHHHHH
Confidence            53           44578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=2.7e-22  Score=186.97  Aligned_cols=142  Identities=22%  Similarity=0.266  Sum_probs=108.0

Q ss_pred             ccccccccccCCcEEEEEEEc-CCCcE--EEEEEEecccccch-------------------hHHHHHHHHHHHHHHhcC
Q 014986          143 YWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQ-------------------AKQSISQLEQEIALLSRF  200 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~i~~~~~~~~-------------------~~~~~~~~~~E~~il~~l  200 (415)
                      .|++.+.||+|+||.||+|.+ .+|+.  ||||+++.......                   .......+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998 78999  99998754211100                   112234678999999998


Q ss_pred             CCCcE--EEeeeeeecCCEEEEEEeccCC-C----CHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCc
Q 014986          201 EHENI--VQYYGTDKDESKLYIFLELVTK-G----SLLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCAN  272 (415)
Q Consensus       201 ~hpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~l~~~~~~~i~~qil~aL~~LH-~~~IiHrDLkp~N  272 (415)
                      .|++|  ..+++.    ...+|||||+.+ |    +|.++...  .++..+..++.||+.||.||| ++||+||||||+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            87754  333332    245899999942 3    67665433  234567889999999999999 9999999999999


Q ss_pred             EEEcCCCcEEEEeecccccc
Q 014986          273 ILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       273 ILl~~~~~vkl~DFGla~~~  292 (415)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=1.3e-20  Score=183.69  Aligned_cols=142  Identities=14%  Similarity=0.134  Sum_probs=101.1

Q ss_pred             ccccccccccCCcEEEEEEEcCCCcEEEEEEEeccccc---------------chh--HHHHHHHHHHHHHHhcCCCCcE
Q 014986          143 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---------------SQA--KQSISQLEQEIALLSRFEHENI  205 (415)
Q Consensus       143 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~---------------~~~--~~~~~~~~~E~~il~~l~hpnI  205 (415)
                      -|+++++||+|+||.||+|.+.+|+.||||+++.....               ...  ........+|...|..+.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38899999999999999999999999999987532100               000  0111123456666666644433


Q ss_pred             E--EeeeeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----
Q 014986          206 V--QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----  279 (415)
Q Consensus       206 v--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~----  279 (415)
                      .  ..++.  ..  .+|||||++|++|..+..     ...+..++.||+.+|.+||++|||||||||.|||++.+|    
T Consensus       176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             SCCCEEEE--ET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCeeeec--cC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            2  22221  11  279999999988864422     223567899999999999999999999999999998776    


Q ss_pred             ------cEEEEeeccccccc
Q 014986          280 ------SVKLADFGLAKATK  293 (415)
Q Consensus       280 ------~vkl~DFGla~~~~  293 (415)
                            .+.|+||+-+....
T Consensus       247 ~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TTSEEEEEEECCCTTCEETT
T ss_pred             ccccccceEEEEeCCcccCC
Confidence                  38999999765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=3.1e-13  Score=125.32  Aligned_cols=140  Identities=13%  Similarity=0.127  Sum_probs=109.5

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  218 (415)
                      .+..|++...+|.|+++.||++... ++.+++|.........     ...+.+|+.+++.+. +..+.++++++.+.+..
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            4557888888999999999998754 6899999886421111     124678999998874 56677889888888999


Q ss_pred             EEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 014986          219 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--------------------------------------  260 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~--------------------------------------  260 (415)
                      |+||||++|.+|...+.    +......++.++..+|..||+                                      
T Consensus        86 ~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999999999876521    122345788999999999998                                      


Q ss_pred             ---------------------CCceecCCCCCcEEEcCCCcEEEEeeccc
Q 014986          261 ---------------------QDVVHRDIKCANILVDANGSVKLADFGLA  289 (415)
Q Consensus       261 ---------------------~~IiHrDLkp~NILl~~~~~vkl~DFGla  289 (415)
                                           ..++|+|+++.|||++.++.+.|+||+.+
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                 45899999999999976555679999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=1.6e-12  Score=119.78  Aligned_cols=134  Identities=19%  Similarity=0.159  Sum_probs=97.7

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc--EEEeeeeeecCCEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESKLY  219 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~  219 (415)
                      ..|.+..+.+.|..+.||++...+|..+++|.....        ....+.+|+.+++.+.+.+  +.++++++...+..+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            344554444567779999997777888999986532        1134568888888875444  456888888878899


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD-------------------------------------  262 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~-------------------------------------  262 (415)
                      +||||++|.+|.  ..  ...   ...++.+++..|..||+..                                     
T Consensus        92 ~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            999999998873  11  122   2356777778888888643                                     


Q ss_pred             ---------------------ceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          263 ---------------------VVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       263 ---------------------IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                                           ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                 9999999999999876666799999763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=3.2e-11  Score=117.14  Aligned_cols=139  Identities=13%  Similarity=0.241  Sum_probs=102.0

Q ss_pred             ccccccCCcEEEEEEEcCCCcEEEEEEEe--cccccchhHHHHHHHHHHHHHHhcCC--CCcEEEeeeeeecC---CEEE
Q 014986          147 GDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDE---SKLY  219 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~i~--~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~---~~~~  219 (415)
                      .+.|+.|.++.||++...+ ..+++|+..  ...    .......+.+|+.+++.+.  +..+.+++.++.+.   +..|
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~----~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK----LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC----CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4568999999999987754 577888654  211    1112346778999998886  34577888877765   4579


Q ss_pred             EEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 014986          220 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD---------------------------------------  260 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------------------  260 (415)
                      +||||++|..+.+.. -..++......++.+++..|..||+                                       
T Consensus       118 ~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999999997774311 1246778888999999999999997                                       


Q ss_pred             -------------------CCceecCCCCCcEEEcCCCc--EEEEeeccccc
Q 014986          261 -------------------QDVVHRDIKCANILVDANGS--VKLADFGLAKA  291 (415)
Q Consensus       261 -------------------~~IiHrDLkp~NILl~~~~~--vkl~DFGla~~  291 (415)
                                         ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               36999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=6.4e-11  Score=112.31  Aligned_cols=184  Identities=18%  Similarity=0.180  Sum_probs=119.4

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCc--EEEeeeeeecCC---EEEEE
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN--IVQYYGTDKDES---KLYIF  221 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV  221 (415)
                      +.++.|....||++.    ..+++|....       ......+.+|+.+|+.+. +..  +.+++.......   ..|+|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            458999999999874    4688887542       133466889999998773 322  334444443333   34889


Q ss_pred             EeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 014986          222 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-----------------------------------------  260 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~-----------------------------------------  260 (415)
                      |++++|.+|..... ..++......++.|++..|..||+                                         
T Consensus        95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99999988764322 356777788888999999988886                                         


Q ss_pred             -----------------CCceecCCCCCcEEEcC--CCcEEEEeeccccccccCC-cccCCCCccccccccccc----cc
Q 014986          261 -----------------QDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINN----KN  316 (415)
Q Consensus       261 -----------------~~IiHrDLkp~NILl~~--~~~vkl~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~----~~  316 (415)
                                       ..++|+|+++.||+++.  ++.+.|+||+.+....... .........-..|+.+..    .+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             13799999999999988  4567899999876532211 000000000012222110    00


Q ss_pred             c--------CCCchhhHHHHHHHHHHHHcCCCCCC
Q 014986          317 K--------GYGLPADIWSLGCTVLEMLTSQIPYA  343 (415)
Q Consensus       317 ~--------~~~~~~DvwSlG~il~ell~g~~pf~  343 (415)
                      .        ....-.+.|+++.++|.+.+|..+|-
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0        01123689999999999999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=2.7e-07  Score=87.36  Aligned_cols=133  Identities=20%  Similarity=0.160  Sum_probs=90.6

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC---cEEEeeeeee-cCCEEEEEEe
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDK-DESKLYIFLE  223 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E  223 (415)
                      +.++.|....||+.    +..+++|+-..       ......+.+|+.+|+.+.+.   .+.+++.++. ..+..|+||+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            45788999999988    56788887421       22345788999999988642   2445555553 4556789999


Q ss_pred             ccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 014986          224 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ------------------------------------------  261 (415)
Q Consensus       224 ~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~------------------------------------------  261 (415)
                      +++|..|....- ..++......++.++...|..||+.                                          
T Consensus        94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            999987765211 1234444455555555555555532                                          


Q ss_pred             ------------------CceecCCCCCcEEEcC---CCcE-EEEeecccccc
Q 014986          262 ------------------DVVHRDIKCANILVDA---NGSV-KLADFGLAKAT  292 (415)
Q Consensus       262 ------------------~IiHrDLkp~NILl~~---~~~v-kl~DFGla~~~  292 (415)
                                        .++|+|+++.|||++.   ++.+ .|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              3599999999999987   4554 89999977543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.59  E-value=3.9e-07  Score=84.28  Aligned_cols=130  Identities=13%  Similarity=0.168  Sum_probs=91.3

Q ss_pred             cccCCcE-EEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecCCEEEEEEeccC
Q 014986          150 LGRGSFG-SVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       150 LG~G~~g-~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +..|..| .||+... ..+..+++|.-..        .....+.+|+..|+.+. +--+.++++++.+.+..|+|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            3444444 6898877 4567889997652        12345678888888774 2225577788888899999999999


Q ss_pred             CCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 014986          227 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------------------------------------------  261 (415)
Q Consensus       227 ~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~---------------------------------------------  261 (415)
                      |.++.+.....   ......+..++...|..||..                                             
T Consensus       104 G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          104 GKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             SEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             CccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            98887654431   122334566666666666632                                             


Q ss_pred             -------------CceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          262 -------------DVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       262 -------------~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                                   .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                         15999999999999877777799998763

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.26  E-value=8.7e-07  Score=86.89  Aligned_cols=80  Identities=13%  Similarity=0.142  Sum_probs=47.0

Q ss_pred             ccccccCCcEEEEEEEc-CCCcEEEEEEEecccc-cchh-HHHHHHHHHHHHHHhcCCC--C-cEEEeeeeeecCCEEEE
Q 014986          147 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ-GSQA-KQSISQLEQEIALLSRFEH--E-NIVQYYGTDKDESKLYI  220 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~-~~~~-~~~~~~~~~E~~il~~l~h--p-nIv~l~~~~~~~~~~~l  220 (415)
                      .+.||.|.++.||++.. .+++.+++|....... .... ......+..|+.+|+.+..  + .+.+++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            35699999999999986 4578899997653211 0000 0012345577777776632  3 334555443  334589


Q ss_pred             EEeccCCC
Q 014986          221 FLELVTKG  228 (415)
Q Consensus       221 V~E~~~~g  228 (415)
                      |||++.+.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=9.3e-06  Score=77.32  Aligned_cols=30  Identities=20%  Similarity=0.366  Sum_probs=27.1

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          261 QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.02  E-value=1.1e-05  Score=77.70  Aligned_cols=82  Identities=4%  Similarity=-0.024  Sum_probs=49.2

Q ss_pred             cccc-ccCCcEEEEEEEcC-------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC---CcEEEeeeeeecC
Q 014986          147 GDLL-GRGSFGSVYEGISD-------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKDE  215 (415)
Q Consensus       147 ~~~L-G~G~~g~Vy~~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~  215 (415)
                      .+.| +.|....+|+....       ++..+++|..........  .....+.+|+.+++.+..   -.+.+++.++.+.
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~--~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV--FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS--SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc--CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            3557 88999999987654       267788886542110000  001234567777766632   2355666665554


Q ss_pred             ---CEEEEEEeccCCCCH
Q 014986          216 ---SKLYIFLELVTKGSL  230 (415)
Q Consensus       216 ---~~~~lV~E~~~~gsL  230 (415)
                         ...|+|||+++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               356899999988653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.81  E-value=3.1e-05  Score=76.48  Aligned_cols=78  Identities=9%  Similarity=0.087  Sum_probs=45.7

Q ss_pred             HCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-cccCC--CCcccccccccccccc-CCCchhhHHHHHHHHHHH
Q 014986          260 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCR--GTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEM  335 (415)
Q Consensus       260 ~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~--gt~~y~aPE~l~~~~~-~~~~~~DvwSlG~il~el  335 (415)
                      ...++|+|+++.|||++.++ ++|+||+.+....... .....  -...|++|+....... ......++..+...+|..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            46799999999999998776 9999999876432110 10011  1133566654421110 011234455677777777


Q ss_pred             HcC
Q 014986          336 LTS  338 (415)
Q Consensus       336 l~g  338 (415)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.81  E-value=0.00021  Score=63.31  Aligned_cols=132  Identities=19%  Similarity=0.116  Sum_probs=90.9

Q ss_pred             CHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcccCCCCcc
Q 014986          229 SLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  305 (415)
Q Consensus       229 sL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~  305 (415)
                      +|.++|+.  ..++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ +.+.          .....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~~~~~  102 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------AGEPP  102 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------ccccC
Confidence            78998875  479999999999999999888722 2222334457899999999998874 2110          12334


Q ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhh-----
Q 014986          306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV-----  380 (415)
Q Consensus       306 y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~-----  380 (415)
                      +.+||...   ...+.+.=|||||+++|..+--.+|                  ...+..+|+.+.+||..|..-     
T Consensus       103 ~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~~  161 (229)
T 2yle_A          103 PVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEADG  161 (229)
T ss_dssp             ----CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC---
T ss_pred             CCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhcccccc
Confidence            67888762   2356789999999999998853322                  223567899999999999866     


Q ss_pred             --------------------CCCCCCCHHHHH
Q 014986          381 --------------------NPNDRPTAAQLL  392 (415)
Q Consensus       381 --------------------dP~~Rps~~eil  392 (415)
                                          .+..|.++++|+
T Consensus       162 ~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi  193 (229)
T 2yle_A          162 SNDEGYEAAEEGLGDEDEKRKISAIRSYRDVM  193 (229)
T ss_dssp             -----------------CCSCCCCCCSHHHHH
T ss_pred             cccccccccccccccccccccccCcCCHHHHH
Confidence                                246889999986

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.78  E-value=7.8e-05  Score=70.56  Aligned_cols=74  Identities=18%  Similarity=0.166  Sum_probs=56.2

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC---CCcEEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      +.|+.|....+|+... ++..+++|.....        ....+.+|+..|+.+.   ...+.+++.++...+..++||||
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            4589999999999876 4677888876531        1345678888887773   35577888888778889999999


Q ss_pred             cCCCCH
Q 014986          225 VTKGSL  230 (415)
Q Consensus       225 ~~~gsL  230 (415)
                      +++..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.73  E-value=7.1e-05  Score=71.22  Aligned_cols=32  Identities=34%  Similarity=0.373  Sum_probs=27.3

Q ss_pred             CCceecCCCCCcEEEcCC----CcEEEEeecccccc
Q 014986          261 QDVVHRDIKCANILVDAN----GSVKLADFGLAKAT  292 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~----~~vkl~DFGla~~~  292 (415)
                      ..++|||+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    68999999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.60  E-value=6.9e-05  Score=70.32  Aligned_cols=29  Identities=24%  Similarity=0.420  Sum_probs=24.7

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          262 DVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       262 ~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3899999999999 5677899999987653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.58  E-value=0.00014  Score=67.83  Aligned_cols=76  Identities=17%  Similarity=0.054  Sum_probs=50.9

Q ss_pred             ccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC---cEEEeeeeeecCCEEEEE
Q 014986          145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~~~~~lV  221 (415)
                      .-.+.+|.|..+.||+.+..+|+.|.+|+........     ...+.+|+..|+.+..-   -+.+++++.  .  -++|
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv   88 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA   88 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence            3456699999999999998899999999654221111     12466888888777421   233444442  2  2789


Q ss_pred             EeccCCCC
Q 014986          222 LELVTKGS  229 (415)
Q Consensus       222 ~E~~~~gs  229 (415)
                      |||+.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.45  E-value=7.4e-05  Score=70.61  Aligned_cols=135  Identities=12%  Similarity=0.083  Sum_probs=73.9

Q ss_pred             cccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc--EEEeeee------eecCCEEE
Q 014986          148 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT------DKDESKLY  219 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~~~~~~  219 (415)
                      +.|+.|....+|+....++ .+++|......       ....+..|+.++..+...+  +.+++..      ....+..+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC-------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            4578888899999876555 67888775310       1123445666665553212  2233321      12345679


Q ss_pred             EEEeccCCCCHH-----H------H---Hh----hcCC------CHHHHHH---------------HHHHHHHHHHHHHH
Q 014986          220 IFLELVTKGSLL-----N------L---YQ----RYHL------RDSQVSA---------------YTRQILLGLKYLHD  260 (415)
Q Consensus       220 lV~E~~~~gsL~-----~------~---l~----~~~l------~~~~~~~---------------i~~qil~aL~~LH~  260 (415)
                      ++|++++|..+.     .      .   +.    ....      .......               +...+...+..++.
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999885421     0      1   11    1111      1000000               01123445555553


Q ss_pred             -------CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          261 -------QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       261 -------~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                             .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                   369999999999999876656899998664

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.31  E-value=0.00027  Score=66.88  Aligned_cols=74  Identities=14%  Similarity=0.060  Sum_probs=45.3

Q ss_pred             ccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc--EEEeeee-----eecCCEEEEE
Q 014986          149 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT-----DKDESKLYIF  221 (415)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~-----~~~~~~~~lV  221 (415)
                      .|+ |....||++...+|+.+++|.......      ....+..|..++..+...+  +.+++..     ....+..++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCC------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            466 778899998777777899998752111      1123455666666553212  3344432     1235567899


Q ss_pred             EeccCCCC
Q 014986          222 LELVTKGS  229 (415)
Q Consensus       222 ~E~~~~gs  229 (415)
                      |++++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.07  E-value=0.0041  Score=59.29  Aligned_cols=31  Identities=26%  Similarity=0.388  Sum_probs=27.3

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          261 QDVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888999999987654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.99  E-value=0.00057  Score=66.38  Aligned_cols=133  Identities=17%  Similarity=0.157  Sum_probs=76.6

Q ss_pred             cccccCCcEEEEEEEcC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc-EEEeeeeeecCCEE
Q 014986          148 DLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKL  218 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~  218 (415)
                      +.|..|-...+|++...        +++.+.+|+.-..   .   .....+.+|..+++.+..-+ ..++++.+.+    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            44767777889988763        3578888864211   0   11234457888887764222 2456666554    


Q ss_pred             EEEEeccCCCCHH--------------HHHh---hcC------CC--HHHHHHHHHHHHH-------------------H
Q 014986          219 YIFLELVTKGSLL--------------NLYQ---RYH------LR--DSQVSAYTRQILL-------------------G  254 (415)
Q Consensus       219 ~lV~E~~~~gsL~--------------~~l~---~~~------l~--~~~~~~i~~qil~-------------------a  254 (415)
                      .+||||++|..|.              +.+.   ...      ..  +.++..+..++-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            2899999875431              1111   111      11  3445555544422                   2


Q ss_pred             HHHHH----H----CCceecCCCCCcEEEcCC----CcEEEEeecccc
Q 014986          255 LKYLH----D----QDVVHRDIKCANILVDAN----GSVKLADFGLAK  290 (415)
Q Consensus       255 L~~LH----~----~~IiHrDLkp~NILl~~~----~~vkl~DFGla~  290 (415)
                      +..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            33332    2    249999999999999876    789999998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.96  E-value=0.0012  Score=65.18  Aligned_cols=71  Identities=10%  Similarity=0.027  Sum_probs=44.8

Q ss_pred             ccccccCCcEEEEEEEcC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCE
Q 014986          147 GDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESK  217 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~  217 (415)
                      .+.|+.|....||++...        ++..+++|+....  ..     ...+.+|+.++..+...++ .++++.+.+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence            356888888999998764        2578889877321  11     1233467777776642233 456665543   


Q ss_pred             EEEEEeccCCC
Q 014986          218 LYIFLELVTKG  228 (415)
Q Consensus       218 ~~lV~E~~~~g  228 (415)
                       .+||||++|.
T Consensus       148 -g~v~e~l~G~  157 (429)
T 1nw1_A          148 -GRLEEYIPSR  157 (429)
T ss_dssp             -EEEECCCCEE
T ss_pred             -CEEEEEeCCc
Confidence             3899999863

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.90  E-value=0.00039  Score=67.11  Aligned_cols=28  Identities=25%  Similarity=0.414  Sum_probs=23.7

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          262 DVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       262 ~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .++|+|+.+.|||++.++ +.|+||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            599999999999997554 8999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.58  E-value=0.015  Score=57.86  Aligned_cols=72  Identities=10%  Similarity=-0.002  Sum_probs=44.2

Q ss_pred             cccccCCcEEEEEEEcCC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCEEEEEEecc
Q 014986          148 DLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV  225 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~  225 (415)
                      +.|+.|-...+|++...+ +..+++|+.........      ...+|+.++..+...++ .++++.+.  +  .+||||+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            458888889999988754 57888887642111100      11478888887764444 46677663  2  3599999


Q ss_pred             CCCC
Q 014986          226 TKGS  229 (415)
Q Consensus       226 ~~gs  229 (415)
                      +|..
T Consensus       184 ~G~~  187 (458)
T 2qg7_A          184 DGYA  187 (458)
T ss_dssp             CSEE
T ss_pred             CCcc
Confidence            8743

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.51  E-value=0.027  Score=54.85  Aligned_cols=29  Identities=28%  Similarity=0.421  Sum_probs=24.8

Q ss_pred             ceecCCCCCcEEE------cCCCcEEEEeeccccc
Q 014986          263 VVHRDIKCANILV------DANGSVKLADFGLAKA  291 (415)
Q Consensus       263 IiHrDLkp~NILl------~~~~~vkl~DFGla~~  291 (415)
                      ++|+|+.+.|||+      +.++.+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4467899999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.32  E-value=0.024  Score=55.75  Aligned_cols=29  Identities=17%  Similarity=0.462  Sum_probs=25.6

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEeeccccc
Q 014986          262 DVVHRDIKCANILVDANGSVKLADFGLAKA  291 (415)
Q Consensus       262 ~IiHrDLkp~NILl~~~~~vkl~DFGla~~  291 (415)
                      .++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7788999999988753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.17  E-value=2.5  Score=37.13  Aligned_cols=114  Identities=9%  Similarity=0.024  Sum_probs=76.5

Q ss_pred             CCCcEEEeeeeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHH-HHHHCCceecCCCCCcEEEcCCC
Q 014986          201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLK-YLHDQDVVHRDIKCANILVDANG  279 (415)
Q Consensus       201 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~-~LH~~~IiHrDLkp~NILl~~~~  279 (415)
                      .||++  --.+-.+++.+.+.++.-.++.-+..+  ..++....++++.+|+.... ++  ..-+|--|+|+||+++.++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~  121 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL  121 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence            57777  333446777788878776554333333  34777888888888876655 44  4456778999999999999


Q ss_pred             cEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHH-HHHHHHHHHHcCCCCCC
Q 014986          280 SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW-SLGCTVLEMLTSQIPYA  343 (415)
Q Consensus       280 ~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~Dvw-SlG~il~ell~g~~pf~  343 (415)
                      .++|.=.|+-               .-++|..+       + ..|.| .+=|++..++.++..|.
T Consensus       122 ~p~i~hRGi~---------------~~lpP~e~-------~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          122 EPFFLHVGVK---------------ESLPPDEW-------D-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CEEESCCEET---------------TTBSSCSC-------C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             cEEEEEcCCc---------------ccCCCCCC-------C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999977642               12334321       2 23444 57788889998887774

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.77  E-value=2.4  Score=37.12  Aligned_cols=122  Identities=9%  Similarity=0.068  Sum_probs=79.5

Q ss_pred             HHHHHhcCCCCcEEEeeeeeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014986          193 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  272 (415)
Q Consensus       193 E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~N  272 (415)
                      |+.+|.. .||+++.. .+-.+++.+.+.++.-..+--+..+  ..++....++++.+|+....+++  .=+|--|+|+|
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~N  109 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDE  109 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGG
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecce
Confidence            4444443 57888765 4555666777777665433212222  34677888889999888774443  34677899999


Q ss_pred             EEEcCCCcEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHH-HHHHHHHHHHcCCCCCC
Q 014986          273 ILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW-SLGCTVLEMLTSQIPYA  343 (415)
Q Consensus       273 ILl~~~~~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~Dvw-SlG~il~ell~g~~pf~  343 (415)
                      |+++.++.++|.=.|+-..               ++|..       .+ ..|.| .+=|++..++.++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~---------------l~P~~-------~~-ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV---------------VDPLP-------VS-EAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT---------------BSCCC-------CC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC---------------CCCCC-------CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999997664311               22321       22 23333 67789999999988874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	415
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-82
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-82
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-81
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-79
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-78
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-78
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-78
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-74
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-74
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-73
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-73
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-71
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-70
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-68
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-68
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-67
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-67
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-66
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-65
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-64
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-64
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-63
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-63
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-63
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-62
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-62
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-61
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-58
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-58
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-57
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-56
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-55
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-54
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-53
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-52
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-49
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-38
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-28

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  254 bits (649), Expect = 1e-82
 Identities = 91/280 (32%), Positives = 137/280 (48%), Gaps = 15/280 (5%)

Query: 124 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 182
             E      P   F  +         +G GSFG+VY      +    A+K++S    G Q
Sbjct: 4   VAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQ 54

Query: 183 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRD 241
           + +    + +E+  L +  H N +QY G    E   ++ +E     +  L    +  L++
Sbjct: 55  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114

Query: 242 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 301
            +++A T   L GL YLH  +++HRD+K  NIL+   G VKL DFG A    +    S  
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV 172

Query: 302 GTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SP 359
           GT +WMAPEVI   ++G Y    D+WSLG T +E+   + P   M  M+AL+ I +  SP
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232

Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
                  S+  ++F+  C+Q  P DRPT+  LL H FV R
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (647), Expect = 1e-82
 Identities = 89/267 (33%), Positives = 143/267 (53%), Gaps = 15/267 (5%)

Query: 143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
           +W+    LG G+FG VY+  + +     A K +      +++++ +     EI +L+  +
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCD 67

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLH 259
           H NIV+       E+ L+I +E    G++  +       L +SQ+    +Q L  L YLH
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127

Query: 260 DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVI---NN 314
           D  ++HRD+K  NIL   +G +KLADFG++      +    S  GT +WMAPEV+    +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQD 372
           K++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP    P   S + +D
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247

Query: 373 FIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           F+K+C++ N + R T +QLL HPFV  
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 1e-81
 Identities = 71/257 (27%), Positives = 128/257 (49%), Gaps = 7/257 (2%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++ G  LG+G FG+VY        F  A+K +       +      QL +E+ + S   H
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
            NI++ YG   D +++Y+ LE    G++    Q+     + + + Y  ++   L Y H +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
            V+HRDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +  
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDE 183

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ N
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARDLISRLLKHN 242

Query: 382 PNDRPTAAQLLDHPFVK 398
           P+ RP   ++L+HP++ 
Sbjct: 243 PSQRPMLREVLEHPWIT 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (621), Expect = 9e-79
 Identities = 85/272 (31%), Positives = 140/272 (51%), Gaps = 19/272 (6%)

Query: 133 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE 191
           P  ++ R        + +G+G+ G+VY  +    G   A+++++L  Q          + 
Sbjct: 18  PKKKYTRF-------EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELII 65

Query: 192 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQI 251
            EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ 
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125

Query: 252 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAP 309
           L  L++LH   V+HRDIK  NIL+  +GSVKL DFG          K  +  GT +WMAP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLS 367
           EV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P+ LS
Sbjct: 186 EVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

Query: 368 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
              +DF+ +C+ ++   R +A +LL H F+K 
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 1e-78
 Identities = 82/279 (29%), Positives = 144/279 (51%), Gaps = 23/279 (8%)

Query: 131 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ 189
           +S +GRF +          +GRGSF +VY+G+ ++     A  E   L      K    +
Sbjct: 4   MSNDGRFLKF------DIEIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQR 54

Query: 190 LEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQV 244
            ++E  +L   +H NIV++Y     T K +  + +  EL+T G+L    +R+  ++   +
Sbjct: 55  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114

Query: 245 SAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR 301
            ++ RQIL GL++LH +   ++HRD+KC NI +    GSVK+ D GLA   + +  K+  
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174

Query: 302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--P 359
           GT  +MAPE+   K   Y    D+++ G  +LEM TS+ PY+  +  A +++       P
Sbjct: 175 GTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231

Query: 360 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                    + ++ I+ C++ N ++R +   LL+H F +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 3e-78
 Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 20/269 (7%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++    +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 203 ENIVQYY--GTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGL 255
            NIV+YY    D+  + LYI +E    G L ++  +      +L +  V     Q+ L L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 256 KYLHDQD-----VVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMA 308
           K  H +      V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK 368
           PE +N     Y   +DIWSLGC + E+     P+          KI  G    IP   S 
Sbjct: 183 PEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
           +  + I + + +    RP+  ++L++P +
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 5e-78
 Identities = 63/270 (23%), Positives = 123/270 (45%), Gaps = 13/270 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 62

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           EN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 317
            + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  + +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-E 181

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPPIPDSLSKDAQDFIK 375
            +  P D+WS G  +  ML  ++P+         +     + +       +       + 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 376 QCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           + +  NP+ R T   +    +  + L   +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLKKGA 271

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  234 bits (599), Expect = 1e-74
 Identities = 71/270 (26%), Positives = 133/270 (49%), Gaps = 16/270 (5%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
             +  Y+   + LG G+FG V+  +    G  F  K ++     +        ++ EI++
Sbjct: 25  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISI 79

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 254
           +++  H  ++  +   +D+ ++ + LE ++ G L +      Y + +++V  Y RQ   G
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 255 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEV 311
           LK++H+  +VH DIK  NI+ +     SVK+ DFGLA     +++      TA + APE+
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 368
           ++ +    G   D+W++G     +L+   P+A  + +  L  + R           S+S 
Sbjct: 200 VDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           +A+DFIK  +Q  P  R T    L+HP++K
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  231 bits (591), Expect = 2e-74
 Identities = 76/271 (28%), Positives = 134/271 (49%), Gaps = 15/271 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 198
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 199 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 256
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 257 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI--- 312
            LH  ++VHRD+K  NIL+D + ++KL DFG +      + ++   GT  ++APE+I   
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 313 -NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 368
            N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D  S 
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
             +D + + + V P  R TA + L HPF ++
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  233 bits (594), Expect = 6e-74
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 16/273 (5%)

Query: 136 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 194
           +   ++ ++   + LG G+FG V+       G  FA K V    +          + +EI
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEI 74

Query: 195 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQIL 252
             +S   H  +V  +   +D++++ +  E ++ G L      +   + + +   Y RQ+ 
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 253 LGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 309
            GL ++H+ + VH D+K  NI+     +  +KL DFGL         VK   GTA + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSL 366
           EV   + K  G   D+WS+G     +L+   P+        L  +              +
Sbjct: 195 EVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252

Query: 367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           S+D +DFI++ +  +PN R T  Q L+HP++  
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 3e-73
 Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 52/302 (17%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K   LG G+ G V++      G   A K + L           +Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 63

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
             IV +YG    + ++ I +E +  GSL  + ++   + +  +   +  ++ GL YL ++
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 262 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
             ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +      Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ--GTHYS 181

Query: 321 LPADIWSLGCTVLEMLTSQIPY-------------------------------------- 342
           + +DIWS+G +++EM   + P                                       
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 343 ----APMECMAALFKIGRGSPPPIPDS-LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 397
                PM     L  I    PP +P    S + QDF+ +C+  NP +R    QL+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 398 KR 399
           KR
Sbjct: 302 KR 303

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 4e-73
 Identities = 64/262 (24%), Positives = 126/262 (48%), Gaps = 11/262 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++ G +LG GSF +V           +A+K +    +    +  +  + +E  ++SR +H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDH 67

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 261
              V+ Y T +D+ KLY  L     G LL   ++     ++    YT +I+  L+YLH +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++    K
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEK 185

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKFFPKARDLVEKL 244

Query: 378 VQVNPNDRPTAAQLLDHPFVKR 399
           + ++   R    ++  +  +K 
Sbjct: 245 LVLDATKRLGCEEMEGYGPLKA 266

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (581), Expect = 5e-73
 Identities = 70/263 (26%), Positives = 123/263 (46%), Gaps = 18/263 (6%)

Query: 144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
              G  +G GSFG+VY+G        AVK   +L+  +   Q +   + E+ +L +  H 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGDV--AVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQ 261
           NI+ + G      +L I  +     SL +            ++    RQ   G+ YLH +
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 317
            ++HRD+K  NI +  + +VK+ DFGLA            +   G+  WMAPEVI  ++K
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 318 G-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSKDAQ 371
             Y   +D+++ G  + E++T Q+PY+ +     +   +GRG   P    +  +  K  +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243

Query: 372 DFIKQCVQVNPNDRPTAAQLLDH 394
             + +C++   ++RP   Q+L  
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  225 bits (574), Expect = 1e-71
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 15/264 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +   D+LG G+F  V            A+K ++        +     +E EIA+L + +H
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVLHKIKH 66

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
            NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD 
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 262 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNK 317
            +VHRD+K  N+L    D +  + ++DFGL+K      V  +  GT  ++APEV+    K
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQK 184

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFI 374
            Y    D WS+G     +L    P+          +I +       P  D +S  A+DFI
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244

Query: 375 KQCVQVNPNDRPTAAQLLDHPFVK 398
           +  ++ +P  R T  Q L HP++ 
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIA 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 8e-70
 Identities = 59/271 (21%), Positives = 119/271 (43%), Gaps = 17/271 (6%)

Query: 138 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 196
           K +   +   + LGRG FG V+  + +     +  K V +             +++EI++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54

Query: 197 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 254
           L+   H NI+  + + +   +L +  E ++   +        + L + ++ +Y  Q+   
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 255 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 311
           L++LH  ++ H DI+  NI+     + ++K+ +FG A+  K  D  +       + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 312 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 368
              ++       D+WSLG  V  +L+   P+        +  I              +S 
Sbjct: 175 H--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
           +A DF+ + +      R TA++ L HP++K+
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 1e-68
 Identities = 70/267 (26%), Positives = 125/267 (46%), Gaps = 13/267 (4%)

Query: 143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF 200
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 259
           +H N++  +   ++++ + + LELV  G L +       L + + + + +QIL G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 260 DQDVVHRDIKCANILVDANGS----VKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINN 314
              + H D+K  NI++         +K+ DFGLA      +      GT  ++APE++N 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

Query: 315 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---SPPPIPDSLSKDAQ 371
           +    GL AD+WS+G     +L+   P+        L  +             + S  A+
Sbjct: 191 E--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248

Query: 372 DFIKQCVQVNPNDRPTAAQLLDHPFVK 398
           DFI++ +  +P  R T    L HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 1e-68
 Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 14/254 (5%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              LG G FG V  G     +  A+K +       +   S  +  +E  ++    HE +V
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           Q YG    +  ++I  E +  G LLN     R+  +  Q+    + +   ++YL  +  +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGL 321
           HRD+   N LV+  G VK++DFGL++    ++  S    +    W  PEV+      +  
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM--YSKFSS 180

Query: 322 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
            +DIW+ G  + E+ +  ++PY           I +G     P   S+     +  C   
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240

Query: 381 NPNDRPTAAQLLDH 394
             ++RPT   LL +
Sbjct: 241 KADERPTFKILLSN 254

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 1e-68
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 15/265 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF- 200
           +Q G LLG G FGSVY GI   D    A+K V            + +++  E+ LL +  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 201 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 257
                +++     +      + LE       L  +  +R  L++    ++  Q+L  +++
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 258 LHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN 316
            H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  +  PE I    
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH- 184

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
           + +G  A +WSLG  + +M+   IP+   E      +I RG        +S + Q  I+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQRVSSECQHLIRW 237

Query: 377 CVQVNPNDRPTAAQLLDHPFVKRLL 401
           C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDVL 262

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 9e-68
 Identities = 74/260 (28%), Positives = 124/260 (47%), Gaps = 9/260 (3%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    +LG+GSFG V+         FFA+K +   D           + ++  L   +EH
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             +   + T + +  L+  +E +  G L+  +   +    S+ + Y  +I+LGL++LH +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGY 319
            +V+RD+K  NIL+D +G +K+ADFG+ K   L D K  +  GT  ++APE++    + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL--LGQKY 180

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
               D WS G  + EML  Q P+   +    LF   R   P  P  L K+A+D + +   
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239

Query: 380 VNPNDRPTAA-QLLDHPFVK 398
             P  R      +  HP  +
Sbjct: 240 REPEKRLGVRGDIRQHPLFR 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 1e-67
 Identities = 62/255 (24%), Positives = 116/255 (45%), Gaps = 16/255 (6%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +    +G+G FG V  G    G   AVK +           +      E +++++  H N
Sbjct: 10  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-------DATAQAFLAEASVMTQLRHSN 61

Query: 205 IVQYYGTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHD 260
           +VQ  G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
            + VHRD+   N+LV  +   K++DFGL K    +   + +    W APE +  + K + 
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEAL--REKKFS 178

Query: 321 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238

Query: 380 VNPNDRPTAAQLLDH 394
           ++   RP+  QL + 
Sbjct: 239 LDAAMRPSFLQLREQ 253

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  216 bits (551), Expect = 2e-67
 Identities = 72/265 (27%), Positives = 130/265 (49%), Gaps = 11/265 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 201
           +    ++GRG FG VY     D G  +A+K +       +  ++++  E   ++L+S  +
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 202 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 260
              IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           + VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+      Y 
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK-GVAYD 184

Query: 321 LPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
             AD +SLGC + ++L    P+     +    + ++       +PDS S + +  ++  +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 379 QVNPNDRPT-----AAQLLDHPFVK 398
           Q + N R       A ++ + PF +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFR 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-67
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 19/260 (7%)

Query: 150 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG G+FG+V +G           AVK   +L   +       +L  E  ++ + ++  IV
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
           +  G  + ES   + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VH
Sbjct: 72  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 266 RDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFWMAPEVINNKNKGYG 320
           RD+   N+L+      K++DFGL+KA              +    W APE IN     + 
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN--YYKFS 188

Query: 321 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
             +D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C  
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248

Query: 380 VNPNDRPTAAQL---LDHPF 396
            +  +RP  A +   L + +
Sbjct: 249 YDVENRPGFAAVELRLRNYY 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 1e-66
 Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 14/254 (5%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              +G G FG V+ G   +    A+K +       +   S     +E  ++ +  H  +V
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 264
           Q YG   +++ + +  E +  G L +  +      +   +      +  G+ YL +  V+
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 265 HRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           HRD+   N LV  N  +K++DFG+ +     +       +    W +PEV +     Y  
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSS 181

Query: 322 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 380
            +D+WS G  + E+ +  +IPY        +  I  G     P   S      +  C + 
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241

Query: 381 NPNDRPTAAQLLDH 394
            P DRP  ++LL  
Sbjct: 242 RPEDRPAFSRLLRQ 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-66
 Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 21/263 (7%)

Query: 150 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           LG G+FGSV +G+          A+K +         K    ++ +E  ++ + ++  IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVV 264
           +  G  + E  L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 73  RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 265 HRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKNKGY 319
           HRD+   N+L+      K++DFGL+KA   +D       + +    W APE IN   + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKF 189

Query: 320 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 378
              +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C 
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249

Query: 379 QVNPNDRPTAAQL---LDHPFVK 398
                DRP    +   +   +  
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYS 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 4e-66
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 19/262 (7%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
           +  + LG G FG V+ G  +     AVK +       Q   S      E  L+ + +H+ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQR 69

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           +V+ Y     E  +YI  E +  GSL   L       L  +++     QI  G+ ++ ++
Sbjct: 70  LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKG 318
           + +HRD++ ANILV    S K+ADFGLA+  + N+    +  +    W APE IN     
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 319 YGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 377
               +D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C
Sbjct: 189 I--KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 378 VQVNPNDRPTAAQL---LDHPF 396
            +  P DRPT   L   L+  F
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFF 268

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 7e-65
 Identities = 74/295 (25%), Positives = 116/295 (39%), Gaps = 32/295 (10%)

Query: 148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
           D LG G F +VY+    +     A+K++ L  +            +EI LL    H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVH 265
                   +S + +  + +     + +      L  S + AY    L GL+YLH   ++H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 266 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLPA 323
           RD+K  N+L+D NG +KLADFGLAK+    +        T ++ APE++    + YG+  
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-ARMYGVGV 182

Query: 324 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---------------------- 361
           D+W++GC + E+L           +  L +I      P                      
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 362 -----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPY 411
                I  +   D  D I+     NP  R TA Q L   +         G   P 
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  208 bits (529), Expect = 9e-65
 Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 13/262 (4%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +Q    LG GSFG V+   S  +G ++A+K +    +     + +     E  +LS   H
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLSIVTH 63

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 261
             I++ +GT +D  ++++ ++ +  G L +L ++     + V+  Y  ++ L L+YLH +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 321
           D+++RD+K  NIL+D NG +K+ DFG AK    +   +  GT  ++APEV+    K Y  
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCGTPDYIAPEVV--STKPYNK 180

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 381
             D WS G  + EML    P+     M    KI        P   ++D +D + + +  +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFFNEDVKDLLSRLITRD 239

Query: 382 PNDR-----PTAAQLLDHPFVK 398
            + R          + +HP+ K
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-64
 Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 18/261 (6%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
              LG+G FG V+ G  +     A+K +           S     QE  ++ +  HE +V
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 207 QYYGTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDV 263
           Q Y    +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + 
Sbjct: 76  QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKGYG 320
           VHRD++ ANILV  N   K+ADFGLA+  + N+    +  +    W APE        + 
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFT 192

Query: 321 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           + +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252

Query: 380 VNPNDRPTAAQLLD--HPFVK 398
             P +RPT   L      +  
Sbjct: 253 KEPEERPTFEYLQAFLEDYFT 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (522), Expect = 6e-64
 Identities = 63/262 (24%), Positives = 111/262 (42%), Gaps = 20/262 (7%)

Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
             ++G G FG V  G          F A+K +         ++       E +++ +F+H
Sbjct: 31  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDH 86

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHD 260
            N++   G     + + I  E +  GSL +  ++   + +  Q+    R I  G+KYL D
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCRGTAFWMAPEVIN 313
            + VHRD+   NILV++N   K++DFGL++                 +    W APE I 
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 372
              + +   +D+WS G  + E+++  + PY  M     +  I +    P P         
Sbjct: 207 --YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264

Query: 373 FIKQCVQVNPNDRPTAAQLLDH 394
            +  C Q + N RP   Q+++ 
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-63
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 17/258 (6%)

Query: 147 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           G  +G G FG V++GI     +     A+K        S  ++      QE   + +F+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK----FLQEALTMRQFDH 67

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 260
            +IV+  G    E+ ++I +EL T G L +  Q     L  + +  Y  Q+   L YL  
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKNK 317
           +  VHRDI   N+LV +N  VKL DFGL++  + +        +    WMAPE IN +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-- 184

Query: 318 GYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 376
            +   +D+W  G  + E+L     P+  ++    + +I  G   P+P +        + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244

Query: 377 CVQVNPNDRPTAAQLLDH 394
           C   +P+ RP   +L   
Sbjct: 245 CWAYDPSRRPRFTELKAQ 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-63
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 18/264 (6%)

Query: 144 WQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
            +  + LG GSFG V  G     S      AVK +          +++    +E+  +  
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 257
            +H N+++ YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVI 312
           L  +  +HRD+   N+L+     VK+ DFGL +A   ND      +  +    W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGR-GSPPPIPDSLSKDA 370
               + +   +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D 
Sbjct: 187 K--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244

Query: 371 QDFIKQCVQVNPNDRPTAAQLLDH 394
            + + QC    P DRPT   L D 
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 79/296 (26%), Positives = 140/296 (47%), Gaps = 19/296 (6%)

Query: 123 TTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLL 177
           T    +   +  G  +++ I  ++   +LG G++G V+        D G  +A+K +   
Sbjct: 4   TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK- 62

Query: 178 DQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 235
               Q  ++      E  +L        +V  +   + E+KL++ L+ +  G L   L Q
Sbjct: 63  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122

Query: 236 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KAT 292
           R    + +V  Y  +I+L L++LH   +++RDIK  NIL+D+NG V L DFGL+    A 
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182

Query: 293 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 352
           +        GT  +MAP+++   + G+    D WSLG  + E+LT   P+       +  
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242

Query: 353 KIGRG---SPPPIPDSLSKDAQDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRL 400
           +I R    S PP P  +S  A+D I++ +  +P  R       A ++ +H F +++
Sbjct: 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 6e-62
 Identities = 67/264 (25%), Positives = 119/264 (45%), Gaps = 14/264 (5%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +    LLG+G+FG V        G ++A+K +    +   AK  ++    E  +L    H
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRH 64

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
             +       +   +L   +E    G L   L +     + +   Y  +I+  L+YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGY 319
           DVV+RDIK  N+++D +G +K+ DFGL K    +        GT  ++APEV+  ++  Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDY 182

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 379
           G   D W LG  + EM+  ++P+   +       I        P +LS +A+  +   ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLK 241

Query: 380 VNPNDRP-----TAAQLLDHPFVK 398
            +P  R       A ++++H F  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 6e-62
 Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 32/277 (11%)

Query: 143 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-F 200
           Y     +LG G  G V +  +      FA+K +          Q   +  +E+ L  R  
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRAS 62

Query: 201 EHENIVQYYGT----DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILL 253
           +  +IV+              L I +E +  G L +  Q        + + S   + I  
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 254 GLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 309
            ++YLH  ++ HRD+K  N+L  +   N  +KL DFG AK  T  N + +   T +++AP
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182

Query: 310 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-------PPPI 362
           EV+  +   Y    D+WSLG  +  +L    P+     +A    +           P P 
Sbjct: 183 EVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 399
              +S++ +  I+  ++  P  R T  + ++HP++ +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  197 bits (501), Expect = 4e-61
 Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 35/285 (12%)

Query: 145 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 204
              + +G G++G VY+  ++ G  FA+K++ L  +            +EI++L   +H N
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSN 61

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 263
           IV+ Y     + +L +  E + +     L      L      ++  Q+L G+ Y HD+ V
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 264 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 321
           +HRD+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+   +K Y  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYST 180

Query: 322 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------------------- 361
             DIWS+GC   EM+     +  +     L +I R    P                    
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 362 --------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 7e-61
 Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 43/285 (15%)

Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G +LG G+FG V          +      AVK +      S+ +     L  E+ ++++ 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA----LMSELKMMTQL 97

Query: 201 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 238
             HENIV   G       +Y+  E    G LLN  +                        
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 239 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 295
              L    +  +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 296 D----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAA 350
                  + R    WMAPE +      Y + +D+WS G  + E+ +    PY  +   A 
Sbjct: 218 SNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 351 LFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
            +K+ + G     P   +++    ++ C   +   RP+   L   
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 7e-61
 Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 37/290 (12%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 260
            NIV+       E+KLY+  E + +     +       +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 261 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 318
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------------- 361
           Y    DIWSLGC   EM+T +  +     +  LF+I R    P                 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 362 -----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                      +   L +D +  + Q +  +PN R +A   L HPF + +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-60
 Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 25/269 (9%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN 204
            D++G G+FG V +     DG         + +  S  K        E+ +L +   H N
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPN 72

Query: 205 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAY 247
           I+   G  +    LY+ +E    G+LL+  ++                   L   Q+  +
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFW 306
              +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K   R    W
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 307 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDS 365
           MA E +N         +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 193 MAIESLNYSVYTT--NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250

Query: 366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
              +  D ++QC +  P +RP+ AQ+L  
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-60
 Identities = 68/304 (22%), Positives = 125/304 (41%), Gaps = 27/304 (8%)

Query: 119 DSSSTTTEPMSNISPN--GRFKRIITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVK 172
           D S+   E +  +     G    I+ +    +++GRG FG VY G   D        AVK
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHF---NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 173 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLYIFLELVTKGSLL 231
            ++ +         +SQ   E  ++  F H N++   G   + E    + L  +  G L 
Sbjct: 62  SLNRITD----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117

Query: 232 NLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 289
           N    + ++     +  +  Q+  G+K+L  +  VHRD+   N ++D   +VK+ADFGLA
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

Query: 290 KATKLNDVKS------CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 342
           +     +  S       +    WMA E +  +       +D+WS G  + E++T    PY
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT--KSDVWSFGVLLWELMTRGAPPY 235

Query: 343 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA 402
             +        + +G     P+       + + +C       RP+ ++L+    +  + +
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR--ISAIFS 293

Query: 403 TNSG 406
           T  G
Sbjct: 294 TFIG 297

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  194 bits (493), Expect = 6e-60
 Identities = 61/269 (22%), Positives = 114/269 (42%), Gaps = 18/269 (6%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++ G++LG G    V+           AVK +      ++      +  +E    +   H
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNH 66

Query: 203 ENIVQYYGTDKDESK----LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 257
             IV  Y T + E+      YI +E V   +L ++      +   +           L +
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 312
            H   ++HRD+K ANI++ A  +VK+ DFG+A+        +    +  GTA +++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD 369
             +       +D++SLGC + E+LT + P+     ++  ++  R  P P     + LS D
Sbjct: 187 --RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
               + + +  NP +R   A  +    V+
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-60
 Identities = 65/272 (23%), Positives = 122/272 (44%), Gaps = 21/272 (7%)

Query: 137 FKRIITY--WQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQ 189
             RI+    ++K  +LG G+FG+VY+G+            A+KE+          ++  +
Sbjct: 2   LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKE 57

Query: 190 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAY 247
           +  E  +++  ++ ++ +  G       + +  +L+  G LL+  + +        +  +
Sbjct: 58  ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116

Query: 248 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT 303
             QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +     +  +  
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPI 362
             WMA E I   ++ Y   +D+WS G TV E++T    PY  +        + +G   P 
Sbjct: 177 IKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234

Query: 363 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 394
           P   + D    + +C  ++ + RP   +L+  
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 7e-60
 Identities = 76/293 (25%), Positives = 122/293 (41%), Gaps = 38/293 (12%)

Query: 144 WQKGDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 201
           ++    +G G++G V++   + + G F A+K V +         S  +    +  L  FE
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 202 HENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLG 254
           H N+V+ +          E+KL +  E V +     L +     +    +     Q+L G
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 255 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVIN 313
           L +LH   VVHRD+K  NILV ++G +KLADFGLA+         S   T ++ APEV+ 
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL- 187

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------------ 361
                Y  P D+WS+GC   EM   +  +     +  L KI      P            
Sbjct: 188 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 362 --------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                             + +  +D + +C+  NP  R +A   L HP+ + L
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (494), Expect = 8e-60
 Identities = 62/293 (21%), Positives = 116/293 (39%), Gaps = 44/293 (15%)

Query: 145 QKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           +    +G G+FG V++  +      +     AVK +        +    +  ++E AL++
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMA 71

Query: 199 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------- 238
            F++ NIV+  G       + +  E +  G L    +                       
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 239 -----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 293
                L  ++     RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 294 LNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECM 348
             D      +      WM PE I      Y   +D+W+ G  + E+ +  + PY  M   
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 349 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 401
             ++ +  G+    P++   +  + ++ C    P DRP+   +     ++R+ 
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMC 300

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 16/255 (6%)

Query: 147 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 205
              LG G +G VYEG+        AVK +       +    + +  +E A++   +H N+
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 206 VQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 262
           VQ  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135

Query: 263 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 319
            +HRD+   N LV  N  VK+ADFGL++    +   +    +    W APE +      +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKF 193

Query: 320 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPPIPDSLSKDAQDFIKQCV 378
            + +D+W+ G  + E+ T  +   P   ++ +++ + +      P+   +   + ++ C 
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253

Query: 379 QVNPNDRPTAAQLLD 393
           Q NP+DRP+ A++  
Sbjct: 254 QWNPSDRPSFAEIHQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-58
 Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 19/262 (7%)

Query: 145 QKGDLLGRGSFGSVYEGISDDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 199
            +  ++G G FG VY+G+            A+K +         ++       E  ++ +
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQ 65

Query: 200 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 257
           F H NI++  G       + I  E +  G+L      +       Q+    R I  G+KY
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 312
           L + + VHRD+   NILV++N   K++DFGL++               +    W APE I
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 313 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDSLSKDAQ 371
           + +       +D+WS G  + E++T        +     +  I  G   P P        
Sbjct: 186 SYRKFTS--ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243

Query: 372 DFIKQCVQVNPNDRPTAAQLLD 393
             + QC Q     RP  A ++ 
Sbjct: 244 QLMMQCWQQERARRPKFADIVS 265

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 6e-58
 Identities = 68/309 (22%), Positives = 124/309 (40%), Gaps = 51/309 (16%)

Query: 137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 195
           F   ++ ++K   +G+G+FG V++      G   A+K+V + ++            +EI 
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIK 61

Query: 196 LLSRFEHENIVQYYGT--------DKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSA 246
           +L   +HEN+V             ++ +  +Y+  +        L          S++  
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 247 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSC 300
             + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A      ++ N   + 
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 301 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 360
             T ++  PE++  + + YG P D+W  GC + EM T             L  I +    
Sbjct: 182 VVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 361 PIPD-------------------------------SLSKDAQDFIKQCVQVNPNDRPTAA 389
             P+                                    A D I + + ++P  R  + 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 390 QLLDHPFVK 398
             L+H F  
Sbjct: 301 DALNHDFFW 309

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 9e-58
 Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 45/297 (15%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           +     +G G++G V       +    A+K++S  +  +  ++      +EI +L RF H
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR----TLREIKILLRFRH 65

Query: 203 ENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
           ENI+      +  +    K    +  +    L  L +  HL +  +  +  QIL GLKY+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVIN 313
           H  +V+HRD+K +N+L++    +K+ DFGLA+    +   +   T +     + APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 314 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------------ 361
           N   GY    DIWS+GC + EML+++  +     +  L  I      P            
Sbjct: 186 NSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 362 ------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                             +  +    A D + + +  NP+ R    Q L HP++++ 
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 1e-57
 Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 20/295 (6%)

Query: 111 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 169
            F  + ++D       P  N +   +F RI         LG GSFG V      + G  +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRI-------KTLGTGSFGRVMLVKHKESGNHY 69

Query: 170 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 229
           A+K +    Q     + I     E  +L       +V+   + KD S LY+ +E V  G 
Sbjct: 70  AMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 230 LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 288
           + + L +     +     Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG 
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 289 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM 348
           AK  K     +  GT   +APE+I   +KGY    D W+LG  + EM     P+   + +
Sbjct: 188 AKRVK-GRTWTLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

Query: 349 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR-----PTAAQLLDHPFVK 398
               KI  G     P   S D +D ++  +QV+   R          + +H +  
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 1e-56
 Identities = 77/321 (23%), Positives = 122/321 (38%), Gaps = 53/321 (16%)

Query: 121 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 179
           S  TT   +      R + + +Y     ++G GSFG VY+    D G   A+K+V     
Sbjct: 1   SKVTTVVATPGQGPDRPQEV-SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----- 53

Query: 180 GSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSLLNL 233
                Q      +E+ ++ + +H NIV+        G  KDE  L + L+ V +      
Sbjct: 54  ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 234 YQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGL 288
                 +  L    V  Y  Q+   L Y+H   + HRDIK  N+L+D + +V KL DFG 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169

Query: 289 AKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 347
           AK     +   S   + ++ APE+I      Y    D+WS GC + E+L  Q  +     
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

Query: 348 MAALFKIGRGSPPPIPD----------------------------SLSKDAQDFIKQCVQ 379
           +  L +I +    P  +                                +A     + ++
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288

Query: 380 VNPNDRPTAAQLLDHPFVKRL 400
             P  R T  +   H F   L
Sbjct: 289 YTPTARLTPLEACAHSFFDEL 309

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-56
 Identities = 72/278 (25%), Positives = 109/278 (39%), Gaps = 38/278 (13%)

Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
           G  LG G+FG V E        SD     AVK +      S        L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTEREALMSELKVLSYL 83

Query: 201 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LR 240
             H NIV   G         +  E    G LLN  +R                     L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 241 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS- 299
              + +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 300 ---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIG 355
               R    WMAPE I N    +   +D+WS G  + E+ +      P M   +  +K+ 
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTF--ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 356 R-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 392
           + G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 3e-56
 Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 35/289 (12%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++K + +G G++G+V++  + +     A+K V L D             +EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKH 60

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 261
           +NIV+ +     + KL +  E   +            L    V ++  Q+L GL + H +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 262 DVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYG 320
           +V+HRD+K  N+L++ NG +KLA+FGLA+A  +     S      W  P  +    K Y 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 321 LPADIWSLGCTVLEMLTSQIP-YAPMECMAALFKIGRGSPPP------------------ 361
              D+WS GC   E+  +  P +   +    L +I R    P                  
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 362 ----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                     +   L+   +D ++  ++ NP  R +A + L HP+    
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 34/280 (12%)

Query: 147 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 200
              LG+GSFG VYEG+       +     A+K V+     + + +   +   E +++  F
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEF 80

Query: 201 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTR 249
              ++V+  G         + +EL+T+G L +  +                 S++     
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 250 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC----RGTAF 305
           +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D             
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 306 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD 364
           WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD
Sbjct: 201 WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258

Query: 365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD------HPFVK 398
           +      + ++ C Q NP  RP+  +++        P  +
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (461), Expect = 6e-55
 Identities = 54/286 (18%), Positives = 100/286 (34%), Gaps = 34/286 (11%)

Query: 139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
           R+   ++ G  +G GSFG +Y G     G   A+K   +       K    QL  E  + 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIY 56

Query: 198 SRFEHEN-IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGL 255
              +    I        +     + +EL+      L  +         V     Q++  +
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 256 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSC---------RGT 303
           +Y+H ++ +HRD+K  N L+        V + DFGLAK  +                 GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 304 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----- 358
           A + +               D+ SLG  ++      +P+  ++      K  R S     
Sbjct: 177 ARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 359 --PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA---QLLDHPFVKR 399
                +      +   ++  C  +  +D+P  +   QL  + F ++
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-54
 Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 39/290 (13%)

Query: 147 GDLLGRGSFGSVYEGI--------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 198
           G  LG G+FG V             +     AVK +         ++ +S L  E+ ++ 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMK 73

Query: 199 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLR 240
              +H+NI+   G    +  LY+ +E  +KG+L    Q                    L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 241 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-- 298
              + +   Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D    
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 299 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IG 355
             + R    WMAPE +   ++ Y   +D+WS G  + E+ T      P   +  LFK + 
Sbjct: 194 TTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
            G     P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 299

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 4e-53
 Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 41/292 (14%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           +    +G G++G+V   +    G   A+K+   L +  Q++    +  +E+ LL    HE
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 204 NIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRYHLRDSQVSAYTRQILLGLKYL 258
           N++        +  L  F +       +      L +   L + ++     Q+L GL+Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 318
           H   ++HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEVI N    
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN-WMR 195

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPP--------------- 361
           Y    DIWS+GC + EM+T +  +   + +  L +I    G+PP                
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 362 -------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                        I  + S  A + +++ + ++   R TA + L HP+ + L
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  178 bits (451), Expect = 4e-53
 Identities = 63/298 (21%), Positives = 117/298 (39%), Gaps = 54/298 (18%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 201
           +Q    LGRG +  V+E I+  +     VK +              ++++EI +L     
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88

Query: 202 HENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 259
             NI+       D       +  E V       LYQ   L D  +  Y  +IL  L Y H
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146

Query: 260 DQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNK 317
              ++HRD+K  N+++D  +  ++L D+GLA+        + R  + ++  PE++ +  +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQ 205

Query: 318 GYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKI------------------- 354
            Y    D+WSLGC +  M+  + P+       + +  + K+                   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 355 --------------GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 398
                          R         +S +A DF+ + ++ +   R TA + ++HP+  
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-52
 Identities = 70/290 (24%), Positives = 108/290 (37%), Gaps = 50/290 (17%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 206
            + +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+
Sbjct: 8   QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENIL 60

Query: 207 QYYGTDKDE----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--- 259
            +   D  +    ++L++  +    GSL +   RY +    +         GL +LH   
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 260 -----DQDVVHRDIKCANILVDANGSVKLADFGL------AKATKLNDVKSCRGTAFWMA 308
                   + HRD+K  NILV  NG+  +AD GL      A  T         GT  +MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 309 PEV----INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK----------- 353
           PEV    IN K+      ADI+++G    E+          E     +            
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 354 -----IGRGSPPPIPDSLS-----KDAQDFIKQCVQVNPNDRPTAAQLLD 393
                  +   P IP+        +     +++C   N   R TA ++  
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-52
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 37/292 (12%)

Query: 144 WQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 197
            + G  LGRG+FG V E        +      AVK   +L +G+   +  + + +   L+
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILI 71

Query: 198 SRFEHENIVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HL 239
               H N+V   G   K    L + +E    G+L    +                    L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 240 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 296
               +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 297 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF--K 353
                R    WMAPE I   ++ Y + +D+WS G  + E+ +      P   +   F  +
Sbjct: 192 RKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 354 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 405
           +  G+    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 299

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 5e-52
 Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 41/292 (14%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           Q    +G G++GSV        G   AVK+   L +  Q+     +  +E+ LL   +HE
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 204 NIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 258
           N++            +E      +  +    L N+ +   L D  V     QIL GLKY+
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 259 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 318
           H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN-WMH 195

Query: 319 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-------------- 364
           Y    DIWS+GC + E+LT +  +   + +  L  I R    P  +              
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 365 ----------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 400
                             +  A D +++ + ++ + R TAAQ L H +  + 
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  168 bits (426), Expect = 8e-50
 Identities = 52/272 (19%), Positives = 102/272 (37%), Gaps = 29/272 (10%)

Query: 144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 202
           ++ G  +G GSFG ++EG +  +    A+K         Q +       +   LL+    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY----RTYKLLAGCTG 62

Query: 203 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 262
              V Y+G +   + L I L   +   LL+L  R       V+   +Q+L  ++ +H++ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 263 VVHRDIKCANILVDA-----NGSVKLADFGLAKATK---------LNDVKSCRGTAFWMA 308
           +V+RDIK  N L+          + + DFG+ K  +           + K+  GTA +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 309 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-------GSPPP 361
                 +        D+ +LG   +  L   +P+  ++      K  R            
Sbjct: 182 INTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 362 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 393
           +     ++   ++     +  +  P    L  
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-49
 Identities = 65/315 (20%), Positives = 124/315 (39%), Gaps = 56/315 (17%)

Query: 145 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 203
           Q    +G G+ G V            A+K+   L +  Q +    +  +E+ L+    H+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKK---LSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 204 NIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 257
           NI+          T ++   +Y+ +EL+       +         ++S    Q+L G+K+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--RMSYLLYQMLCGIKH 134

Query: 258 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKN 316
           LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEVI    
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 317 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD------------ 364
                  DIWS+GC + EM+  +I +   + +    K+      P P+            
Sbjct: 195 YKE--NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 365 -----------------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP 395
                                          +  A+D + + + ++P  R +    L HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312

Query: 396 FVKRLLATNSGSASP 410
           ++          A P
Sbjct: 313 YINVWYDPAEVEAPP 327

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (353), Expect = 1e-38
 Identities = 71/343 (20%), Positives = 122/343 (35%), Gaps = 88/343 (25%)

Query: 134 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 192
           + R+            LG G F +V+      +    A+K V         K      E 
Sbjct: 12  DARY-------ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAED 58

Query: 193 EIALLSRFEHENIVQ-------------YYGTDKDESKLYIFLELVTKG----SLLNLYQ 235
           EI LL R    +  +              +   K  + +++ +     G    +L+  Y+
Sbjct: 59  EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118

Query: 236 RYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG------SVKLADFGL 288
              +    V   ++Q+LLGL Y+H +  ++H DIK  N+L++          +K+AD G 
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178

Query: 289 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP---- 344
           A     +   S   T  + +PEV+      +G  ADIWS  C + E++T    + P    
Sbjct: 179 ACWYDEHYTNSI-QTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235

Query: 345 ---------------------------------MECMAALFKIGRGSPPPIPDSL----- 366
                                                  L  I +    P+ D L     
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295

Query: 367 -----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 404
                +K+  DF+   +Q++P  R  A  L++HP++K  L   
Sbjct: 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  107 bits (268), Expect = 4e-28
 Identities = 32/202 (15%), Positives = 63/202 (31%), Gaps = 29/202 (14%)

Query: 147 GDLLGRGSFGSVYEGISDDGFFFAVKEVSL-------------LDQGSQAKQSISQLEQE 193
           G L+G G   +V+   S+      VK   +                   +  +I     E
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 194 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 253
              L + +   + + Y  + +     + +EL+    L  +                 IL 
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE------VLDMILE 114

Query: 254 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN 313
            +   + + +VH D+   N+LV   G + + DF  +        +             I 
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR----EILERDVRNII 169

Query: 314 N-KNKGYGLPADIWSLGCTVLE 334
              ++ Y    DI S    +L+
Sbjct: 170 TYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	415
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.78
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.17
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.42
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.1

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-62  Score=454.35  Aligned_cols=254  Identities=28%  Similarity=0.528  Sum_probs=227.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      +++|++++.||+|+||+||+|++ .+++.||+|++.....  ........+.+|+.+++.++|||||++++++.+++.+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            57899999999999999999999 6899999999874221  11223456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      ||||||.+|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            99999999999998875 57999999999999999999999999999999999999999999999999999887766667


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..+||+.|||||++.+.  .++.++|||||||++|+|++|+.||......+...++.+.. ..+|..+++++++||.+||
T Consensus       163 ~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L  239 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLL  239 (263)
T ss_dssp             ETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHT
T ss_pred             ccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHc
Confidence            77899999999999664  48999999999999999999999999887777777766554 4577889999999999999


Q ss_pred             hhCCCCCCCHHHHHcChhhHh
Q 014986          379 QVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       379 ~~dP~~Rps~~eil~hp~f~~  399 (415)
                      +.||++|||++|+|+||||+.
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-61  Score=457.71  Aligned_cols=252  Identities=32%  Similarity=0.590  Sum_probs=224.5

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++......     ..+.+.+|+.+|+.++|||||++++++.+.+.+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            4689999999999999999998 78999999999754322     13567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--Ccc
Q 014986          221 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  298 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~  298 (415)
                      |||||.+|+|.+++.+..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....  ...
T Consensus        95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            999999999999998889999999999999999999999999999999999999999999999999999876433  345


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCCcccHHHHHHHHH
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li~~  376 (415)
                      ..+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+....+.+..+.....  ...+..++.++++||.+
T Consensus       175 ~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             ccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            56799999999999654  489999999999999999999999998877777666654433  33457799999999999


Q ss_pred             hhhhCCCCCCCHHHHHcChhhHhh
Q 014986          377 CVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       377 ~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      ||+.||++|||++|+|+||||+..
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-61  Score=454.78  Aligned_cols=258  Identities=24%  Similarity=0.452  Sum_probs=216.5

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.++|++.+.||+|+||+||+|++ .+++.||||++.....    ....+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc----chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            357899999999999999999998 7899999999975321    22345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  296 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-  296 (415)
                      |||||||.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999999998865 469999999999999999999999999999999999999999999999999998754332 


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CCCCCCCCcccHHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPPIPDSLSKDAQ  371 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~s~~l~  371 (415)
                         ....+||+.|||||++.+.. .++.++|||||||++|+|++|+.||..............  .........+++++.
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  237 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             cccccceeeCcCccCHhHhcCCC-CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence               34567999999999986543 246789999999999999999999976543322222222  222233457899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||.+||+.||++|||++|+|+||||++.+.
T Consensus       238 ~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         238 ALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            9999999999999999999999999986544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-60  Score=443.01  Aligned_cols=251  Identities=30%  Similarity=0.511  Sum_probs=213.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec--CCEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL  218 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~  218 (415)
                      ++|++.+.||+|+||+||+|++ .+|+.||+|++......   ....+.+.+|+++|++++|||||++++++.+  ++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            6799999999999999999998 78999999998754322   3345678899999999999999999998864  5678


Q ss_pred             EEEEeccCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          219 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-----~~l~~~~~~~i~~qil~aL~~LH~~~-----IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                      |||||||.+|+|.+++.+     ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999998853     35999999999999999999999976     99999999999999999999999999


Q ss_pred             ccccccCC--cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          289 AKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       289 a~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ++......  ....+||+.|||||++.+.  .++.++|||||||++|+|++|+.||......+...++..+....++..+
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  238 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY  238 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            98765432  3456799999999999654  4899999999999999999999999998888888888888877888899


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  397 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f  397 (415)
                      ++++.+||.+||+.||++|||++|||+|||+
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-60  Score=453.62  Aligned_cols=259  Identities=29%  Similarity=0.502  Sum_probs=218.0

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.....    .....++.+|+.+|+.++|||||+++++|.+++++|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46899999999999999999998 7899999999975322    223457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      |||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  160 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  160 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence            99999999999998865 579999999999999999999997 5999999999999999999999999999987665556


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHH---------------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA---------------------------  350 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~---------------------------  350 (415)
                      ...+||+.|+|||++.+..  |+.++|||||||++|||++|+.||.+......                           
T Consensus       161 ~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccCCccccCchHHcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            6778999999999997644  89999999999999999999999965432111                           


Q ss_pred             ---------------HHHHhcCCCCCCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          351 ---------------LFKIGRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       351 ---------------~~~i~~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                                     ...+.....+..+ ..++.++++||.+||..||++|||++|+|+||||++......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  309 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccc
Confidence                           1111111222222 246889999999999999999999999999999998776543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-60  Score=447.86  Aligned_cols=253  Identities=35%  Similarity=0.632  Sum_probs=221.9

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|++++.||+|+||+||+|++ .+++.||+|++.....     ...+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            4689999999999999999998 7899999999875322     223567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      |||||.+|+|.+++.+  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            9999999999998754  45999999999999999999999999999999999999999999999999999754322  2


Q ss_pred             cccCCCCcccccccccccc---ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCCcccHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQ  371 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~---~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~  371 (415)
                      ....+||+.|+|||++...   ...|+.++|||||||++|+|++|+.||......+.+.++.....+.  .+..++++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            3456799999999998532   3447899999999999999999999999887777777777765443  3567899999


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          372 DFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       372 ~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      +||.+||+.||.+|||++|+|+||||+.
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-60  Score=446.41  Aligned_cols=254  Identities=26%  Similarity=0.471  Sum_probs=222.4

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++++.||+|+||+||+|++ .+++.||||++.....  ........+.+|+.+|+.++|||||++++++.+++.+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            6799999999999999999998 7899999999974221  112234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC----
Q 014986          221 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~----  295 (415)
                      ||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....    
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999998765 57999999999999999999999999999999999999999999999999999876432    


Q ss_pred             CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          296 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       296 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      .....+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+...++.+.. ..+|..+++++++||+
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVE  242 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHH
T ss_pred             ccccccCCccccCceeeccCC--CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHH
Confidence            233467999999999996544  8999999999999999999999999888777777776654 3467889999999999


Q ss_pred             HhhhhCCCCCCCHHH------HHcChhhHhh
Q 014986          376 QCVQVNPNDRPTAAQ------LLDHPFVKRL  400 (415)
Q Consensus       376 ~~L~~dP~~Rps~~e------il~hp~f~~~  400 (415)
                      +||+.||.+|||++|      |++||||+.+
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999987      6899999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-59  Score=436.42  Aligned_cols=249  Identities=30%  Similarity=0.556  Sum_probs=214.0

Q ss_pred             cccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec----CCEE
Q 014986          144 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKL  218 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~  218 (415)
                      |+..+.||+|+||+||+|++ .+++.||+|++......   ....+.+.+|+++|++++|||||++++++.+    ...+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            45667899999999999998 68999999998754322   3345678899999999999999999999864    4568


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-CCCcEEEEeecccccccc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKATKL  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~--IiHrDLkp~NILl~-~~~~vkl~DFGla~~~~~  294 (415)
                      ||||||+++|+|.+++.+ ..+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++....
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999998876 47999999999999999999999998  99999999999997 578999999999987766


Q ss_pred             CCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHH-HHHhcCCCC-CCCCcccHHHHH
Q 014986          295 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL-FKIGRGSPP-PIPDSLSKDAQD  372 (415)
Q Consensus       295 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~-~~~~~~s~~l~~  372 (415)
                      ......+||+.|||||++.+   .++.++|||||||++|+|++|+.||........+ ..+..+..+ .++..+++++++
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  244 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence            66667789999999999854   3899999999999999999999999875544444 444443332 345568899999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                      ||.+||+.||++|||++|+|+|||||
T Consensus       245 li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         245 IIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-59  Score=444.85  Aligned_cols=254  Identities=33%  Similarity=0.568  Sum_probs=223.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      +.|++++.||+|+||+||+|++ .+++.||||++.....  ......+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            4589999999999999999998 7899999999975332  234456778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCccc
Q 014986          221 FLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  299 (415)
Q Consensus       221 V~E~~~~gsL~~~l~-~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  299 (415)
                      |||||.+|+|..++. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....  ...
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~  170 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS  170 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCC
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCc
Confidence            999999999876654 45799999999999999999999999999999999999999999999999999986543  345


Q ss_pred             CCCCcccccccccccc-ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-CCCcccHHHHHHHHHh
Q 014986          300 CRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDAQDFIKQC  377 (415)
Q Consensus       300 ~~gt~~y~aPE~l~~~-~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~~  377 (415)
                      .+||+.|||||++.+. ...|+.++|||||||++|+|++|..||.+....+.+.++.....+. .+..+++++++||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            6799999999998653 2348899999999999999999999999888888777777665544 3456899999999999


Q ss_pred             hhhCCCCCCCHHHHHcChhhHh
Q 014986          378 VQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       378 L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      |+.||.+|||++++|+||||++
T Consensus       251 L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CcCChhHCcCHHHHHhCHHhcC
Confidence            9999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-59  Score=447.91  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=226.4

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++++.||+|+||+||+|++ .+++.||||++.+....  ......++.+|+.+|+.++|||||++++++.+.+.+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc--CHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            56899999999999999999998 78999999999742211  1223567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      +||||+.+|+|..++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....  .
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            99999999999998876 57999999999999999999999999999999999999999999999999999865432  3


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      ....+||+.|+|||++.+..  |+.++|||||||++|+|++|+.||.+.+..+....+.... ..+|..++.++++||++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~--y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             cccceeCHHHhhhhhccCCC--CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHh
Confidence            45577999999999996544  8999999999999999999999999988777766666654 45788999999999999


Q ss_pred             hhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          377 CVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       377 ~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      ||++||.+|++     +++|++||||+.+
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             hccCCchhhcccccccHHHHHcCcccccC
Confidence            99999999994     9999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-59  Score=446.26  Aligned_cols=254  Identities=29%  Similarity=0.460  Sum_probs=208.2

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.+.|++.+.||+|+||+||+|++ .+++.||||++......    .....+.+|+.+|+.++|||||++++++.+++.+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456799999999999999999998 68999999999753221    2235678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CCCcEEEEeecccccccc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATKL  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~---~~~~vkl~DFGla~~~~~  294 (415)
                      |||||||.||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+++....
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999999998865 4799999999999999999999999999999999999995   478999999999986654


Q ss_pred             CC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCcccHHH
Q 014986          295 ND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDA  370 (415)
Q Consensus       295 ~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l  370 (415)
                      .. ....+||+.|||||++.+.  .++.++|||||||++|+|++|+.||.+....+....+......   +.+..+|+++
T Consensus       163 ~~~~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         163 GSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ----------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             CCeeeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            43 3456799999999999654  4899999999999999999999999988877777777665533   3446799999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                      ++||.+||+.||.+|||++|+++||||++
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.8e-59  Score=450.33  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=225.3

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++++.||+|+||+||+|++ .+|+.||||++....     ....+.+.+|+.+|+.++|||||++++++.+++.
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3567899999999999999999998 789999999986422     2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--CCcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~--~~~vkl~DFGla~~~~  293 (415)
                      +|||||||.+|+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999999998843  46999999999999999999999999999999999999964  5789999999998765


Q ss_pred             cCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccHH
Q 014986          294 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  369 (415)
Q Consensus       294 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~  369 (415)
                      ... .....||+.|||||++.+..  ++.++|||||||++|+|++|+.||.+....+.+..+.......   ....++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cccccceecCcccccCHHHHcCCC--CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            443 34567999999999996544  8899999999999999999999999888777777776655432   23468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +++||.+||..||.+|||++|||+||||+....
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            999999999999999999999999999987644

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-58  Score=442.84  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=225.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            46899999999999999999998 7899999999974221  11223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      +|||||.||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~  159 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY  159 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-cc
Confidence            99999999999998865 46899999999999999999999999999999999999999999999999999876533 44


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..+||+.|||||++.+..  ++.++|||||||++|+|++|+.||.+....+...++..+.. .+|..+++++.+||.+||
T Consensus       160 ~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred             cccCcccccCHHHHcCCC--CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHh
Confidence            577999999999996543  88999999999999999999999999888888777776654 467889999999999999


Q ss_pred             hhCCCCCC-----CHHHHHcChhhHhh
Q 014986          379 QVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       379 ~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ..||.+|+     |+++|++||||+++
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             hhCHHhccccchhhHHHHHcCcccccC
Confidence            99999996     99999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-58  Score=436.51  Aligned_cols=262  Identities=27%  Similarity=0.469  Sum_probs=225.6

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccc-hhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++....... ......+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            456799999999999999999998 789999999997543222 112234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEeecccccc
Q 014986          218 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKAT  292 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~----~vkl~DFGla~~~  292 (415)
                      +|||||||.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+++..
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999998865 4799999999999999999999999999999999999998776    5999999999876


Q ss_pred             ccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCCcccH
Q 014986          293 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSK  368 (415)
Q Consensus       293 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~  368 (415)
                      ... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+....+.+..+.......   .+..+|.
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             CCCccccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            543 34456799999999999654  48999999999999999999999999888888777776655432   2357899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ++++||++||+.||.+|||++|+|+||||+....+
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  280 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  280 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence            99999999999999999999999999999875443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-58  Score=447.72  Aligned_cols=255  Identities=28%  Similarity=0.480  Sum_probs=225.0

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++....     ......+.+|+.+|+.++|||||+++++|.+++.+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456899999999999999999998 789999999987532     22345678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCCcEEEEeecccccccc
Q 014986          219 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGSVKLADFGLAKATKL  294 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~--~~~~vkl~DFGla~~~~~  294 (415)
                      |||||||.||+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|+....
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            9999999999999877543  599999999999999999999999999999999999998  578999999999987765


Q ss_pred             CC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCcccHHH
Q 014986          295 ND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDA  370 (415)
Q Consensus       295 ~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l  370 (415)
                      .. .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+....+.+..+......   ..+..+++++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCceeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            43 4456799999999999654  4899999999999999999999999998888887777765543   2345789999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      .+||.+||+.||.+|||++|+|+||||+...
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            9999999999999999999999999998643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-57  Score=428.40  Aligned_cols=260  Identities=28%  Similarity=0.475  Sum_probs=226.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccc----hhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~----~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  214 (415)
                      .++|++.+.||+|+||+||+|++ .+++.||||++.......    ..+...+.+.+|+.+|++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999998 789999999998654322    22334567889999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                      ++.+||||||+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            9999999999999999999864 579999999999999999999999999999999999999999999999999998765


Q ss_pred             cC-CcccCCCCcccccccccccc----ccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC---CCCCc
Q 014986          294 LN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDS  365 (415)
Q Consensus       294 ~~-~~~~~~gt~~y~aPE~l~~~----~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~  365 (415)
                      .. ......||+.|+|||.+.+.    ...++.++||||+||++|+|++|+.||.+.........+..+...   +....
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            43 34456799999999998642    234688999999999999999999999998877777777665432   23347


Q ss_pred             ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          366 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       366 ~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      +|+++++||++||++||++|||++|||+||||++.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            89999999999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-57  Score=444.46  Aligned_cols=259  Identities=27%  Similarity=0.424  Sum_probs=220.8

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  218 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  218 (415)
                      .++|++.++||+|+||.||+|++ .+|+.||||++........ .........+++.+++.++|||||++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            46899999999999999999998 6899999999974221111 111222334567888889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCc
Q 014986          219 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  297 (415)
Q Consensus       219 ~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~  297 (415)
                      |||||||.+|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~  162 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  162 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence            999999999999998865 5689999999999999999999999999999999999999999999999999998776666


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH--HHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      ...+||+.|+|||++... ..++.++|||||||++|+|++|+.||.....  ...+.+........++..+++++++||.
T Consensus       163 ~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (364)
T d1omwa3         163 HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE  241 (364)
T ss_dssp             CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred             cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence            777899999999998532 3489999999999999999999999976432  2333444445556677889999999999


Q ss_pred             HhhhhCCCCCCC-----HHHHHcChhhHhh
Q 014986          376 QCVQVNPNDRPT-----AAQLLDHPFVKRL  400 (415)
Q Consensus       376 ~~L~~dP~~Rps-----~~eil~hp~f~~~  400 (415)
                      +||..||.+|||     +++|++||||+.+
T Consensus       242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999     7999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-57  Score=442.26  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=225.6

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      .++|++++.||+|+||+||+|++ .+|+.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            46899999999999999999998 7899999999874221  11223456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCCcc
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  298 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~  298 (415)
                      +||||+.+|+|..++.+ ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... ..
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~  196 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW  196 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BC
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cc
Confidence            99999999999998765 57999999999999999999999999999999999999999999999999999876543 34


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  378 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L  378 (415)
                      ..+||+.|||||++.+..  ++.++|||||||++|+|++|+.||.+......+.++..+.. ..+..+++++.+||++||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHS
T ss_pred             cccCccccCCHHHHcCCC--CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHh
Confidence            567999999999996644  89999999999999999999999999888777777776654 467789999999999999


Q ss_pred             hhCCCCCC-----CHHHHHcChhhHhh
Q 014986          379 QVNPNDRP-----TAAQLLDHPFVKRL  400 (415)
Q Consensus       379 ~~dP~~Rp-----s~~eil~hp~f~~~  400 (415)
                      ..||.+|+     |+++|++||||+.+
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhCHHhccccccccHHHHHcCccccCC
Confidence            99999995     99999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=434.70  Aligned_cols=259  Identities=23%  Similarity=0.366  Sum_probs=225.2

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      .+.++|++++.||+|+||+||+|++ .+++.||+|++....      .....+.+|+.+|+.++|||||++++++.++++
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3567899999999999999999998 689999999997532      122457899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--CcEEEEeeccccccc
Q 014986          218 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK  293 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~--~~vkl~DFGla~~~~  293 (415)
                      +|||||||.||+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++...
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999999999754  58999999999999999999999999999999999999854  489999999998765


Q ss_pred             cCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC---CCcccHH
Q 014986          294 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKD  369 (415)
Q Consensus       294 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~  369 (415)
                      ... .....+|+.|+|||.+.+..  ++.++|||||||++|+|++|..||......+....+........   +..++.+
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  233 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE  233 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             cCCcccccccccccccchhccCCC--CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence            443 34456999999999986544  89999999999999999999999999888887777776654321   2468999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      +++||.+||..||++|||++|+|+||||++-.....
T Consensus       234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~~  269 (321)
T d1tkia_         234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS  269 (321)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhccCccccC
Confidence            999999999999999999999999999987554433

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=434.10  Aligned_cols=255  Identities=29%  Similarity=0.426  Sum_probs=210.4

Q ss_pred             cccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          146 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      .+++||+|+||+||+|++ .+|+.||||++...............+.+|+.+|+.++|||||++++++.+++++||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            457899999999999998 7899999999875433222222345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--CcccCC
Q 014986          225 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCR  301 (415)
Q Consensus       225 ~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~  301 (415)
                      +.++++..+... ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .....+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999877766654 46899999999999999999999999999999999999999999999999999865543  234567


Q ss_pred             CCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--------------------
Q 014986          302 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------------------  361 (415)
Q Consensus       302 gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------------  361 (415)
                      ||+.|+|||++... ..++.++|||||||++|+|++|..||.+....+.+.++......+                    
T Consensus       162 gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         162 VTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             cChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            99999999998643 347999999999999999999999999888777766654321100                    


Q ss_pred             -------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          362 -------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       362 -------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                             ....+++++.+||.+||+.||++|||++|+|+||||+..-
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                   0125688999999999999999999999999999998643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-57  Score=432.99  Aligned_cols=254  Identities=28%  Similarity=0.501  Sum_probs=221.2

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHh-cCCCCcEEEeeeeeecCCEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      ++|++++.||+|+||+||+|++ .+++.||||++.....  ......+.+.+|..++. .++|||||++++++.+++.+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence            5799999999999999999999 7899999999974221  11122345566776664 689999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC--C
Q 014986          220 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~--~  296 (415)
                      |||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....  .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            99999999999999865 57999999999999999999999999999999999999999999999999999865432  3


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  376 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~  376 (415)
                      ....+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.+....+...++.... ..+|..+++++.+||++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             ccccCCCCCcCCHHHHcCCC--CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHH
Confidence            44567999999999996544  8999999999999999999999999888777777776554 45788899999999999


Q ss_pred             hhhhCCCCCCCHH-HHHcChhhHhh
Q 014986          377 CVQVNPNDRPTAA-QLLDHPFVKRL  400 (415)
Q Consensus       377 ~L~~dP~~Rps~~-eil~hp~f~~~  400 (415)
                      ||..||.+|||+. ++++||||+++
T Consensus       237 ~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         237 LFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             hcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999995 89999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-57  Score=422.74  Aligned_cols=253  Identities=30%  Similarity=0.486  Sum_probs=214.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHhcCC--CCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~-~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~  216 (415)
                      .++|+++++||+|+||+||+|++ .+++.||||++......... .....++.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46899999999999999999998 78999999999753221110 111233568999999886  899999999999999


Q ss_pred             EEEEEEeccCC-CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEeeccccccc
Q 014986          217 KLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATK  293 (415)
Q Consensus       217 ~~~lV~E~~~~-gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~-~~vkl~DFGla~~~~  293 (415)
                      .+|+||||+.+ +++.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999976 578777754 579999999999999999999999999999999999999854 799999999998777


Q ss_pred             cCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHH
Q 014986          294 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  373 (415)
Q Consensus       294 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  373 (415)
                      ........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.....      +.+. ...++..+|+++++|
T Consensus       163 ~~~~~~~~GT~~y~aPE~~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~-~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         163 DTVYTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRVSSECQHL  234 (273)
T ss_dssp             SSCBCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCCCHHHHHH
T ss_pred             cccccccccCCCcCCHHHHcCCC-CCCcccccccceeeehhHhhCCCCCCCchH------Hhhc-ccCCCCCCCHHHHHH
Confidence            66667788999999999986543 356789999999999999999999987532      2222 234677899999999


Q ss_pred             HHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          374 IKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       374 i~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      |.+||..||++|||++|+|+||||+.+.
T Consensus       235 i~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-56  Score=415.54  Aligned_cols=251  Identities=28%  Similarity=0.492  Sum_probs=218.8

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      -.++|++.+.||+|+||+||+|++++++.||||++.....      ..+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence            3568999999999999999999998889999999864221      12468899999999999999999998765 5679


Q ss_pred             EEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      |||||+.+|+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            99999999999987643   359999999999999999999999999999999999999999999999999998765432


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                         .....||+.|+|||++....  ++.++|||||||++|||+|| .+||......+.+..+..+.....|..+++++.+
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCcccccChHHHhCCC--CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence               33456899999999986543  89999999999999999994 6667777777778888888888889999999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc--ChhhHh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD--HPFVKR  399 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~--hp~f~~  399 (415)
                      ||.+||+.||++|||+++|++  |+||..
T Consensus       242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999999999999999998  777753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-56  Score=420.84  Aligned_cols=255  Identities=31%  Similarity=0.497  Sum_probs=212.3

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++++.||+|+||+||+|++ .+++.||||++.....   .......+.+|+++|++++|||||++++++.+.+++|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            5799999999999999999998 7899999999964321   12234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--
Q 014986          221 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  296 (415)
Q Consensus       221 V~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--  296 (415)
                      ||||+.++.+..+..  ..++++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......  
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            999998754444333  2469999999999999999999999999999999999999999999999999998664332  


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC----------------
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------------  360 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------  360 (415)
                      .....||+.|+|||++.... .++.++|||||||++|+|++|+.||.+....+.+.++......                
T Consensus       159 ~~~~~gt~~y~apE~~~~~~-~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ceeecccceeeehhhhcccc-CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            34457999999999985543 3688999999999999999999999987776666554321100                


Q ss_pred             -C-----------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          361 -P-----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       361 -~-----------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                       .           ....++.++.+||++||..||++|||++|||+||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             0           012467899999999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=413.90  Aligned_cols=251  Identities=23%  Similarity=0.398  Sum_probs=212.9

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ++|++.+.||+|+||+||+|++.+++.||||++.....      ..+.+.+|+.++++++|||||++++++.+++.+|+|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            46888999999999999999998889999999864221      124688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      |||+.+|+|.+++..  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......   
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999998865  458899999999999999999999999999999999999999999999999998654332   


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      .....||+.|+|||++.+..  ++.++|||||||++|||++ |.+||......+....+..+.....|..+++++.+||.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             ------CTTSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCC--CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            23356899999999996543  8999999999999999999 57778777777778888888888888999999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||+.||++|||+++|++|  |+++..
T Consensus       237 ~cl~~~p~~Rps~~~il~~--L~~i~e  261 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ--LAEIAE  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH--HHHHHh
Confidence            9999999999999999997  776643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-55  Score=417.68  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=219.5

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  215 (415)
                      +..-.++|++.+.||+|+||+||+|++ .+++.||||++.....      ..+++.+|+.+|+.++|||||++++++.+.
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            333456899999999999999999998 6799999998864221      235688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                      +.+||||||+.+|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            999999999999999998865   36899999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCcc---cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCC-CCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          293 KLNDVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       293 ~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ......   ...||+.|+|||++.+..  ++.++|||||||++|||++|..|| ...........+..+...+.+..+++
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  243 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCCCceeeccccccccccChHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence            544322   234788999999986544  899999999999999999966654 55555555555666677788889999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ++.+||.+||+.||++|||+++|++  +|+.++..
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~~~~  276 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQ--AFETMFQE  276 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTTSS
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH--HHHHHHHh
Confidence            9999999999999999999999965  67776544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=413.32  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=217.3

Q ss_pred             cccccccc-cccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDL-LGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~-LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ++|.+.+. ||+|+||+||+|++   .++..||||++...    ......+.+.+|+.+|++++|||||++++++.++ .
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e
Confidence            45777775 99999999999976   34557999998642    2234457789999999999999999999998754 5


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +||||||+++|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8999999999999998754  46999999999999999999999999999999999999999999999999999865433


Q ss_pred             C-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          296 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       296 ~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      .     .....||+.|+|||++....  ++.++|||||||++|||++ |+.||......+....+..+...+.|..++++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  240 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  240 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccccccCccccChHHHhCCC--CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            2     23446899999999996544  8999999999999999998 99999988888888888888888889999999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHH---HcChhhHh
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR  399 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~ei---l~hp~f~~  399 (415)
                      +.+||.+||+.||++|||+.+|   |+|.|+.-
T Consensus       241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999888   56777653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-55  Score=415.71  Aligned_cols=254  Identities=26%  Similarity=0.460  Sum_probs=210.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCc---EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~---~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .++|++.++||+|+||+||+|++ .+++   .||||.+...    ......+.+.+|+.+|++++|||||++++++.+.+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            35788999999999999999987 3443   5777766532    22344567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+|||||||.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988753  589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc-------ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcc
Q 014986          295 NDV-------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  366 (415)
Q Consensus       295 ~~~-------~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  366 (415)
                      ...       ....||+.|||||++.+.  .++.++|||||||++|||++ |+.||.+....+....+..+...+.+..+
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC  258 (299)
T ss_dssp             ---------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            321       123478999999998654  48999999999999999998 89999998888888888888888888999


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          367 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       367 s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +..+.+||.+||+.||++|||+.+|+++  ++++..
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~--L~~~l~  292 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIR  292 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH--HHHHhc
Confidence            9999999999999999999999999875  555443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-55  Score=406.37  Aligned_cols=245  Identities=24%  Similarity=0.430  Sum_probs=220.4

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ++|++.+.||+|+||+||+|++++++.||||+++.....      ...+.+|+.+++.++|||||++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            468899999999999999999988999999998753221      24678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          222 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      |||+.+|+|..++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999998653  478999999999999999999999999999999999999999999999999997654332   


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      .....||+.|+|||++.+..  ++.++|||||||++|||++ |+.||......+...++..+...+.|..+++.+.+||.
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCC--CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence            33456899999999996544  8999999999999999998 89999999888888888888888889999999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcC
Q 014986          376 QCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~h  394 (415)
                      +||+.||++|||+++|++|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=425.68  Aligned_cols=250  Identities=25%  Similarity=0.410  Sum_probs=206.2

Q ss_pred             eeccccccc-ccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHh-cCCCCcEEEeeeeeec--
Q 014986          140 IITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKD--  214 (415)
Q Consensus       140 ~~~~y~~~~-~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~--  214 (415)
                      +.++|++.+ +||+|+||+||+|++ .+++.||||++...          ..+.+|+.++. ..+|||||+++++|.+  
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            467898864 699999999999998 78999999998631          24568998865 5589999999999875  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEee
Q 014986          215 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF  286 (415)
Q Consensus       215 --~~~~~lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~DF  286 (415)
                        ...+|||||||+||+|.+++.+.   .+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              56799999999999999999753   5899999999999999999999999999999999999985   467999999


Q ss_pred             ccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH---hcCCCCCC
Q 014986          287 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI---GRGSPPPI  362 (415)
Q Consensus       287 Gla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~  362 (415)
                      |+|+..... .....+||+.|+|||++.+..  |+.++|||||||++|+|++|+.||.+.........+   .......+
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCC--CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            999865443 345567999999999996544  899999999999999999999999765433222222   11112222


Q ss_pred             C----CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          363 P----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       363 ~----~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      +    ..+++++.+||++||+.||.+|||+.|+++||||++..
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            2    25789999999999999999999999999999997644

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=410.95  Aligned_cols=246  Identities=25%  Similarity=0.440  Sum_probs=210.3

Q ss_pred             cccccCCcEEEEEEEc---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEEEec
Q 014986          148 DLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  224 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~  224 (415)
                      +.||+|+||+||+|.+   .+++.||||++....   ......+.+.+|+.+|++++|||||++++++.++ ..||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEc
Confidence            4699999999999975   345789999986422   1233456789999999999999999999998754 57899999


Q ss_pred             cCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC-----cc
Q 014986          225 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VK  298 (415)
Q Consensus       225 ~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-----~~  298 (415)
                      +++|+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......     ..
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            999999999876 469999999999999999999999999999999999999999999999999998654332     22


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHh
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  377 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~  377 (415)
                      ...||+.|+|||++.+..  ++.++|||||||++|||++ |+.||.+....+....+..+...+.|..++.++.+||.+|
T Consensus       169 ~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~c  246 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  246 (277)
T ss_dssp             --CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccCCCceecCchhhcCCC--CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence            346899999999996544  8899999999999999998 8999999888888888888888888999999999999999


Q ss_pred             hhhCCCCCCCHHHHH---cChhhHh
Q 014986          378 VQVNPNDRPTAAQLL---DHPFVKR  399 (415)
Q Consensus       378 L~~dP~~Rps~~eil---~hp~f~~  399 (415)
                      |+.||.+|||+++|+   +|+|++-
T Consensus       247 l~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            999999999999984   5655543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.4e-55  Score=412.83  Aligned_cols=254  Identities=29%  Similarity=0.476  Sum_probs=214.0

Q ss_pred             cccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV  221 (415)
                      ++|++.+.||+|+||+||+|++.+++.||||++......   ......+.+|+.+|+.++|||||++++++.+++..|++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            579999999999999999999999999999999754322   22245688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--cc
Q 014986          222 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  298 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~~  298 (415)
                      |||+.++.+..+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  ..
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999998777777663 569999999999999999999999999999999999999999999999999997654332  33


Q ss_pred             cCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-------------------
Q 014986          299 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------------  359 (415)
Q Consensus       299 ~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------  359 (415)
                      ...|++.|+|||.+.+. ..++.++|||||||++|+|++|+.||......+.+.++.....                   
T Consensus       159 ~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ---CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            44689999999998643 3478999999999999999999999988776666555432100                   


Q ss_pred             ---------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          360 ---------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       360 ---------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                               ......+++.+.+||++||++||++|||+.|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                     0123457899999999999999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-55  Score=414.70  Aligned_cols=258  Identities=30%  Similarity=0.486  Sum_probs=209.4

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHh---cCCCCcEEEeeeeee
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS---RFEHENIVQYYGTDK  213 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~-~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~  213 (415)
                      +..++|++++.||+|+||+||+|++ .+ ++.||||++..........   ..+.+|+.+|+   .++||||+++++++.
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH---HHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            3457899999999999999999998 44 6789999997533221111   12345666554   458999999999885


Q ss_pred             -----cCCEEEEEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEee
Q 014986          214 -----DESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  286 (415)
Q Consensus       214 -----~~~~~~lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DF  286 (415)
                           ....+|++|||+.++.+.....  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence                 3457899999999987654443  346999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC------
Q 014986          287 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------  359 (415)
Q Consensus       287 Gla~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------  359 (415)
                      |+++..... ......||+.|+|||++.+.  .|+.++|||||||++|+|++|+.||.+....+.+.++.....      
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            998765433 34556799999999999654  489999999999999999999999998877766665432100      


Q ss_pred             --------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          360 --------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       360 --------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                          ..++..+++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                                012346789999999999999999999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=408.03  Aligned_cols=248  Identities=27%  Similarity=0.507  Sum_probs=205.3

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      .++|++++.||+|+||+||+|+..  ..||||++......   ....+.+.+|+.+|++++|||||++++++.+ ..++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            467899999999999999999864  35999998654322   2345678899999999999999999998754 56899


Q ss_pred             EEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC---
Q 014986          221 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  295 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~---  295 (415)
                      |||||++|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....   
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999999864  35999999999999999999999999999999999999999999999999999765432   


Q ss_pred             -CcccCCCCccccccccccccc-cCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHH-HhcCCCC----CCCCcccH
Q 014986          296 -DVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPP----PIPDSLSK  368 (415)
Q Consensus       296 -~~~~~~gt~~y~aPE~l~~~~-~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~----~~~~~~s~  368 (415)
                       ......||+.|||||++.+.. ..++.++|||||||++|||++|+.||.+......+.. +..+...    ..+..+++
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  240 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK  240 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence             234567999999999986543 3478999999999999999999999987655444333 3333322    34567899


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      ++.+||.+||+.||++|||+.+|+++
T Consensus       241 ~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=418.87  Aligned_cols=260  Identities=25%  Similarity=0.445  Sum_probs=212.8

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC--
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  216 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  216 (415)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++....   ......+.+.+|+.+|+.++|||||+++++|...+  
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            567899999999999999999998 789999999986432   22344567889999999999999999999987654  


Q ss_pred             ----EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          217 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       217 ----~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                          .+||||||+ +++|..+++...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence                579999999 558888888889999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--------------
Q 014986          293 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--------------  358 (415)
Q Consensus       293 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------  358 (415)
                      ... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+....              
T Consensus       172 ~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 DSE-MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             CSS-CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             CCc-cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            543 4556799999999998653 346899999999999999999999998876655544332111              


Q ss_pred             ----------------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          359 ----------------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       359 ----------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                                      .......+++++.+||.+||..||.+|||+.|||+||||+.+.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~  312 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  312 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence                            01123467899999999999999999999999999999998765443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=415.03  Aligned_cols=249  Identities=26%  Similarity=0.439  Sum_probs=209.6

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCC-----cEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeee
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD  212 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~-----~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  212 (415)
                      -.++|+++++||+|+||+||+|++ ..+     ..||+|.+....    .......+.+|+.+|.++ +|||||++++++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            346899999999999999999987 332     368999876422    223345678999999988 899999999999


Q ss_pred             ecCCEEEEEEeccCCCCHHHHHhhc------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 014986          213 KDESKLYIFLELVTKGSLLNLYQRY------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDI  268 (415)
Q Consensus       213 ~~~~~~~lV~E~~~~gsL~~~l~~~------------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDL  268 (415)
                      .+.+.+|||||||++|+|.++++..                        .+++..++.++.||+.||+|||++||+||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            9999999999999999999998643                        3788999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEEeeccccccccCCc----ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 014986          269 KCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA  343 (415)
Q Consensus       269 kp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~  343 (415)
                      ||+|||++.++.+||+|||+|+.......    ....||+.|||||++.+..  ++.++|||||||++|||++ |..||.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC--CCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999986554432    2345799999999986544  8999999999999999997 899998


Q ss_pred             CccHHHHHHHH-hcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          344 PMECMAALFKI-GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       344 ~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +......+.++ ..+...+.|..+++++++||.+||+.||++|||++||++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            76554444444 4445567788999999999999999999999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.6e-54  Score=402.74  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=211.3

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  216 (415)
                      .+.++|++.+.||+|+||+||+|++ .+++.||||++.....  ........+.+|+.+|+.++|||||++++++...+ 
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            3457799999999999999999998 7899999999975332  22345567899999999999999999999987643 


Q ss_pred             ---EEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          217 ---KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       217 ---~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                         .+||||||+.||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence               48999999999999988765 47999999999999999999999999999999999999999999999999988654


Q ss_pred             ccC-----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---CCC
Q 014986          293 KLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPD  364 (415)
Q Consensus       293 ~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~  364 (415)
                      ...     .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+...++......+   ...
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             C----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             ccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            322     23445799999999999654  48999999999999999999999999888777777666654432   346


Q ss_pred             cccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhH
Q 014986          365 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  398 (415)
Q Consensus       365 ~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~  398 (415)
                      .+|+++.+||.+||+.||.+||+..+.+.|+|++
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            7899999999999999999999544555678775

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=413.36  Aligned_cols=263  Identities=27%  Similarity=0.464  Sum_probs=212.6

Q ss_pred             eeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC-
Q 014986          139 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  216 (415)
Q Consensus       139 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  216 (415)
                      .+..+|++++.||+|+||+||+|++ .+++.||||++....    .....+.+.+|+.+|+.++||||+++++++.... 
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            3456799999999999999999998 799999999987432    2334567889999999999999999999986543 


Q ss_pred             ---EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccc
Q 014986          217 ---KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  293 (415)
Q Consensus       217 ---~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~  293 (415)
                         ..+++|+|+.+|+|.++++..++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence               23444455668899999998899999999999999999999999999999999999999999999999999997543


Q ss_pred             cC-----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC----------
Q 014986          294 LN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----------  358 (415)
Q Consensus       294 ~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  358 (415)
                      ..     .....+||+.|+|||++... ..++.++||||+||++|+|++|+.||......+.........          
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            32     23445699999999998543 347899999999999999999999998766544433322110          


Q ss_pred             -----------------CC---CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCCC
Q 014986          359 -----------------PP---PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  406 (415)
Q Consensus       359 -----------------~~---~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~~  406 (415)
                                       ..   .....++.++.+||.+||..||.+|||++|+|+||||+......+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~  307 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE  307 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC
Confidence                             00   0123578899999999999999999999999999999977665433

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=402.48  Aligned_cols=251  Identities=30%  Similarity=0.485  Sum_probs=211.2

Q ss_pred             eecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  219 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  219 (415)
                      -.++|++++.||+|+||+||+|++.+++.||||++.....      ..+.+.+|+.++++++|||||++++++.+ +.++
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            3578999999999999999999998888899999864322      12468899999999999999999999865 5578


Q ss_pred             EEEeccCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~---~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      +||||+.+|+|..++..   ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999999988753   369999999999999999999999999999999999999999999999999998654332


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                         .....||+.|+|||++....  ++.++|||||||++|||++| .+||......+.+..+..+...+.+..+++++.+
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  245 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  245 (285)
T ss_dssp             --------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             ceeeccccccccccChHHHhCCC--CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence               23456899999999996544  89999999999999999995 5556666677777778888788889999999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHc--ChhhHh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLD--HPFVKR  399 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~--hp~f~~  399 (415)
                      ||.+||+.||++|||+++|++  |+||..
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            999999999999999999976  445543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=398.97  Aligned_cols=253  Identities=25%  Similarity=0.452  Sum_probs=209.8

Q ss_pred             cccccccccccCCcEEEEEEEcCC-C----cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGISDD-G----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~~~-~----~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      +.|++.++||+|+||.||+|.+.+ +    ..||||++....    .......+.+|+.+|++++|||||++++++.+.+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            467888999999999999998732 2    479999886422    2233457889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+++||||+.+|++.+++..  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999999987764  4699999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCCcccH
Q 014986          295 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       295 ~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      ..     .....||+.|+|||++.+.  .++.++|||||||++|||++| .+||......+....+..+...+.+..++.
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence            22     2234589999999998654  489999999999999999995 555666666677777778888888899999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+.+||.+||+.||++|||+.+|++  .++.+..
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~--~L~~l~~  272 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVS--ILDKLIR  272 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH--HHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHH--HHHHHhh
Confidence            9999999999999999999999987  4555543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=400.88  Aligned_cols=253  Identities=28%  Similarity=0.489  Sum_probs=209.2

Q ss_pred             ecccccccccccCCcEEEEEEEcC-C---CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      .++|++++.||+|+||+||+|++. +   +..||||.+...    ......+.+.+|+.+|+.++|||||++++++. ++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            468999999999999999999873 2   345777776432    22344567889999999999999999999986 46


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      .+|+||||+.+|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            78999999999999997754  3689999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHH
Q 014986          295 ND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  370 (415)
Q Consensus       295 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  370 (415)
                      ..   .....||+.|+|||++.+..  ++.++|||||||++|||++ |.+||......+...++..+...+++..+++.+
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  238 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  238 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CcceeccceecCcccchhhHhccCC--CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            32   23456899999999996544  8999999999999999998 899999888888888888888888999999999


Q ss_pred             HHHHHHhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          371 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       371 ~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      .+||.+||..||++|||+.+|++|  ++.+..
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~  268 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQ--LSTILE  268 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH--HHHHHH
Confidence            999999999999999999999987  666543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=412.15  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=208.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee------c
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK------D  214 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~  214 (415)
                      ..|+.+++||+|+||+||+|++ .+++.||||++.....         ...+|+.+|+.++|||||+++++|.      +
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            3689999999999999999999 7899999999975322         1237999999999999999999874      3


Q ss_pred             CCEEEEEEeccCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEeeccc
Q 014986          215 ESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLA  289 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~----~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~DFGla  289 (415)
                      ..++||||||++++.+..+..    ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence            446899999998764443332    33699999999999999999999999999999999999999775 8999999999


Q ss_pred             cccccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC---------
Q 014986          290 KATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---------  359 (415)
Q Consensus       290 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------  359 (415)
                      +..... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||......+.+.++.+...         
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         171 KQLVRGEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             EECCTTSCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhccCCcccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            866433 34556799999999998643 3489999999999999999999999988776666555432100         


Q ss_pred             ----------C---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          360 ----------P---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       360 ----------~---------~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                                .         .....+++++.+||.+||..||++|||+.|+|+||||+++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                      0         1123578999999999999999999999999999999998653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-53  Score=404.74  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=205.7

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----  214 (415)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.......   ....++.+|+.+|+.++||||+++++++..     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            57899999999999999999998 789999999986543221   223557799999999999999999998755     


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          215 ---ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       215 ---~~~~~lV~E~~~~gsL~~~l~~-~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                         ..++|+||||+.++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               4568999999988766544433 468999999999999999999999999999999999999999999999999997


Q ss_pred             ccccC------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC-
Q 014986          291 ATKLN------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-  363 (415)
Q Consensus       291 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-  363 (415)
                      .....      .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.........+........+ 
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            54322      23345699999999998653 34789999999999999999999999887666555443221111000 


Q ss_pred             ------------------------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHh
Q 014986          364 ------------------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  399 (415)
Q Consensus       364 ------------------------------~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~  399 (415)
                                                    ...+.++.+||.+||+.||++|||++|+|+||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                                          013667889999999999999999999999999984

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=410.37  Aligned_cols=264  Identities=28%  Similarity=0.421  Sum_probs=215.3

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  214 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  214 (415)
                      ...+.++|++++.||+|+||+||+|++ .+|+.||||++.....   .....+++.+|+.+|+.++|||||++++++.. 
T Consensus        13 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             EEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            344567899999999999999999998 7899999999874322   23344578899999999999999999999863 


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          215 ----ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       215 ----~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                          +...+++|+|+.+|+|.+++...++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             cccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence                2344666777889999999988899999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC---------
Q 014986          291 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---------  361 (415)
Q Consensus       291 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------  361 (415)
                      ..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+......+         
T Consensus       170 ~~~~~-~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTDDE-MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCTGG-GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccCcc-cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            65433 3446699999999987543 336889999999999999999999998876655544442211110         


Q ss_pred             ---------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          362 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       362 ---------------------~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                                           ....++.++.+||.+||..||.+|||+.|+|+||||+++.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~  312 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  312 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence                                 11357899999999999999999999999999999998765443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=394.36  Aligned_cols=255  Identities=28%  Similarity=0.449  Sum_probs=214.4

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCEEEE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  220 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  220 (415)
                      ++|++++.||+|+||+||+|++ .+++.||||+++.....   .....++.+|+.+|+.++||||+++++++.+...+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC---hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            5799999999999999999998 78999999999754322   2345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC--c
Q 014986          221 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  297 (415)
Q Consensus       221 V~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--~  297 (415)
                      ||+++.+++|..++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++......  .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            99999999988877654 78999999999999999999999999999999999999999999999999998765432  3


Q ss_pred             ccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCC-CccHHHHHHHHhcC-------------------
Q 014986          298 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA-PMECMAALFKIGRG-------------------  357 (415)
Q Consensus       298 ~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~-~~~~~~~~~~i~~~-------------------  357 (415)
                      ....+++.|+|||++... ..++.++|||||||++|+|++|+.||. .....+...++...                   
T Consensus       159 ~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             eeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            344578899999998644 336899999999999999999999864 33334433333211                   


Q ss_pred             ---------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          358 ---------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       358 ---------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                               ........+++.+.+||++||+.||++|||++|+|+||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                     0111234678899999999999999999999999999999874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=404.47  Aligned_cols=246  Identities=26%  Similarity=0.469  Sum_probs=207.8

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  216 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  216 (415)
                      ++|+++++||+|+||+||+|++ .+|+    .||+|.+...    ......+.+.+|+.++++++|||||++++++.++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            4699999999999999999987 5555    5777776532    2223346788999999999999999999999865 


Q ss_pred             EEEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          217 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..+++|||+.+|+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            56788899999999987764  3699999999999999999999999999999999999999999999999999986543


Q ss_pred             CC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHH
Q 014986          295 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  369 (415)
Q Consensus       295 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  369 (415)
                      ..    .....||+.|+|||++.+..  ++.++|||||||++|||+| |..||.+....+....+..+...+.|..++..
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~  241 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  241 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred             ccccccccccccCccccChHHHhcCC--CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            32    22345899999999996544  8999999999999999998 89999887766666777777778888999999


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHcC
Q 014986          370 AQDFIKQCVQVNPNDRPTAAQLLDH  394 (415)
Q Consensus       370 l~~Li~~~L~~dP~~Rps~~eil~h  394 (415)
                      +.+||.+||..||.+|||+.+|++|
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999988

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=406.69  Aligned_cols=260  Identities=28%  Similarity=0.463  Sum_probs=216.7

Q ss_pred             ecccccccccccCCcEEEEEEEc----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC-CcEEEeeeeeecC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDE  215 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~  215 (415)
                      +++|++++.||+|+||+||+|.+    .+|+.||||++........ ....+.+.+|+.+|++++| |||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            57899999999999999999985    3588999999864322111 1123456789999999976 8999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccccc
Q 014986          216 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  294 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~-~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~  294 (415)
                      ..+++||||+.+|+|.+++... .+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999999999988664 688999999999999999999999999999999999999999999999999976533


Q ss_pred             C---CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhcCCCCCCCCcccH
Q 014986          295 N---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSK  368 (415)
Q Consensus       295 ~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~s~  368 (415)
                      .   ......|++.|+|||.+.+....++.++|||||||+||+|++|+.||....   ....+.+.......+++..++.
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  261 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  261 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence            2   233456999999999997665567889999999999999999999996643   2233333333445567788999


Q ss_pred             HHHHHHHHhhhhCCCCCC-----CHHHHHcChhhHhhh
Q 014986          369 DAQDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRLL  401 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rp-----s~~eil~hp~f~~~~  401 (415)
                      ++.+||.+||.+||.+||     |++|+++||||+.+-
T Consensus       262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            999999999999999999     589999999998743

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-52  Score=398.63  Aligned_cols=253  Identities=24%  Similarity=0.422  Sum_probs=220.1

Q ss_pred             ecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  214 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  214 (415)
                      .++|++.+.||+|+||+||+|+.      .+++.||||++....    .....+++.+|+.+|++++||||+++++++.+
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            46799999999999999999985      346789999886422    23345678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHhhc-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 014986          215 ESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  269 (415)
Q Consensus       215 ~~~~~lV~E~~~~gsL~~~l~~~-------------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLk  269 (415)
                      .+..++||||+.+|+|.+++...                         .+++..+..++.||+.||+|||+++|+|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            99999999999999999988642                         37888999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEEeeccccccccC----CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCC-CCCCC
Q 014986          270 CANILVDANGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAP  344 (415)
Q Consensus       270 p~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~-~pf~~  344 (415)
                      |+|||++.++.+||+|||+++.....    ......||+.|+|||++.+..  ++.++|||||||++|||++|. .||..
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC--CChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999754332    223456889999999997544  899999999999999999985 68998


Q ss_pred             ccHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          345 MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       345 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                      ....+....+..+..++.+..++.++.+||.+||+.||++|||+.+|++  +|+++.
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMC  300 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTT
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhc
Confidence            8888888889888888889999999999999999999999999999954  677653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=391.75  Aligned_cols=249  Identities=24%  Similarity=0.465  Sum_probs=211.2

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-CCEEE
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY  219 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~  219 (415)
                      .++|++++.||+|+||.||+|++ .|..||||+++...       ..+.+.+|+.++++++|||||++++++.+ .+.+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            46789999999999999999988 57789999986321       23567899999999999999999998854 56689


Q ss_pred             EEEeccCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC
Q 014986          220 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  296 (415)
Q Consensus       220 lV~E~~~~gsL~~~l~~~---~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~  296 (415)
                      |||||+++|+|.+++...   .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            999999999999998643   4899999999999999999999999999999999999999999999999999875433 


Q ss_pred             cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCCCCCcccHHHHHHHH
Q 014986          297 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  375 (415)
Q Consensus       297 ~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~  375 (415)
                      .....+|..|+|||++.+.  .++.++|||||||++|||++ |++||......+....+..+..++++..+++.+++||.
T Consensus       157 ~~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             -----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             CccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            3345689999999999654  38999999999999999998 79999988888888888888888899999999999999


Q ss_pred             HhhhhCCCCCCCHHHHHcChhhHhhhh
Q 014986          376 QCVQVNPNDRPTAAQLLDHPFVKRLLA  402 (415)
Q Consensus       376 ~~L~~dP~~Rps~~eil~hp~f~~~~~  402 (415)
                      +||..||.+|||+.+|+++  |+++..
T Consensus       235 ~cl~~dP~~Rps~~~l~~~--L~~i~~  259 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQ--LEHIKT  259 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHcccCHhHCcCHHHHHHH--HHHHHh
Confidence            9999999999999999884  777654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=397.38  Aligned_cols=257  Identities=28%  Similarity=0.515  Sum_probs=218.1

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcE--EEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeeecCC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  216 (415)
                      .++|++.++||+|+||+||+|++ .++..  ||||.+...    ......+.+.+|+++|+.+ +|||||++++++.+.+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc----cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            36889999999999999999998 55554  667766532    1223456788999999998 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014986          217 KLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  279 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~  279 (415)
                      .+||||||+++|+|.+++..                 ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            99999999999999999864                 2589999999999999999999999999999999999999999


Q ss_pred             cEEEEeeccccccccCC-cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHhcC
Q 014986          280 SVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG  357 (415)
Q Consensus       280 ~vkl~DFGla~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~  357 (415)
                      .+||+|||+++...... .....||..|+|||.+.+..  ++.++|||||||++|||++| .+||......+....+..+
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCC--CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            99999999997654332 23456899999999996543  89999999999999999996 4679888888888888888


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhCC
Q 014986          358 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  405 (415)
Q Consensus       358 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~~  405 (415)
                      ...+.+..+++++.+||.+||+.||++|||+.+|++|  |+.+..+..
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~--L~~i~~~~~  288 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERK  288 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHSSS
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHHhcCc
Confidence            8888889999999999999999999999999999987  677665443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.3e-52  Score=402.35  Aligned_cols=250  Identities=25%  Similarity=0.443  Sum_probs=205.9

Q ss_pred             ecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeec--CC
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~  216 (415)
                      .++|+++++||+|+||+||+|++ .+++.||||++....        .+++.+|+.+|+.++ ||||+++++++..  ..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            46899999999999999999999 789999999986421        245779999999985 9999999999874  46


Q ss_pred             EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEeeccccccccC
Q 014986          217 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN  295 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~-~vkl~DFGla~~~~~~  295 (415)
                      .+++||||+.+++|..+.  ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       106 ~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             ceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            799999999999997664  3699999999999999999999999999999999999998665 6999999999866543


Q ss_pred             -CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccH-HHHHHHHhc-------------C---
Q 014986          296 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR-------------G---  357 (415)
Q Consensus       296 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~-------------~---  357 (415)
                       .....++|+.|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+....+..             .   
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CcccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence             34556799999999998653 3478999999999999999999999965432 111111100             0   


Q ss_pred             --------------------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          358 --------------------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       358 --------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                          ........+++++.+||++||..||++|||++|+|+||||+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                00111234789999999999999999999999999999998753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-52  Score=393.14  Aligned_cols=260  Identities=27%  Similarity=0.463  Sum_probs=219.9

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc-CC-------CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEE
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS-DD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  207 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~-------~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~  207 (415)
                      +..-.++|++++.||+|+||.||+|+. .+       +..||||++...    ........+.+|...+.++ +|||||+
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~e~~~l~~~~~HpnIv~   83 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIIN   83 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc----cChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence            333457899999999999999999986 22       247999988642    2233456678888888887 8999999


Q ss_pred             eeeeeecCCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          208 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       208 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++++.++..+++||||+.+|+|.+++...                 .+++..+..++.||+.||+|||+++|+||||||
T Consensus        84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp  163 (299)
T d1fgka_          84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  163 (299)
T ss_dssp             EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence            999999999999999999999999998643                 389999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    .....||+.|+|||.+.+.  .|+.++|||||||++|||++ |..||...
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence            99999999999999999998664432    3345689999999999654  48999999999999999998 79999988


Q ss_pred             cHHHHHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          346 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       346 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ...+....+..+...+.+..+++++.+||.+||+.||.+|||+.||++  .++++.+..
T Consensus       242 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~--~L~~i~a~~  298 (299)
T d1fgka_         242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE--DLDRIVALT  298 (299)
T ss_dssp             CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHC
T ss_pred             CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH--HHHHHhhcC
Confidence            887777788888888889999999999999999999999999999998  688887764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=405.65  Aligned_cols=255  Identities=25%  Similarity=0.429  Sum_probs=201.7

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeee-----
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-----  213 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----  213 (415)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++.....   .......+.+|+.+|+.++|||||+++++|.     
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence            457899999999999999999998 6899999999975332   2334567889999999999999999999985     


Q ss_pred             -cCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccccc
Q 014986          214 -DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  292 (415)
Q Consensus       214 -~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~  292 (415)
                       +..++|+||||+.++.+ ..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++..
T Consensus        92 ~~~~~~~iv~Ey~~~~l~-~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLC-QVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             TTCCEEEEEEECCSEEHH-HHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             ccCceeEEEEeccchHHH-Hhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence             34789999999987544 4443 46899999999999999999999999999999999999999999999999998765


Q ss_pred             ccC-CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC----------
Q 014986          293 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  361 (415)
Q Consensus       293 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  361 (415)
                      ... .....++|+.|+|||++.+.  .++.++||||+||++|+|++|+.||.+.+......++......+          
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -----------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            543 33455699999999999664  48999999999999999999999998776555444432111100          


Q ss_pred             --------------------C-----------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhh
Q 014986          362 --------------------I-----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  401 (415)
Q Consensus       362 --------------------~-----------~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~  401 (415)
                                          +           ....+.++.+||++||..||++|||++|||+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                                0           012467899999999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=394.96  Aligned_cols=256  Identities=27%  Similarity=0.450  Sum_probs=203.8

Q ss_pred             ecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEeeeeee
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  213 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  213 (415)
                      .++|++++.||+|+||.||+|++.      +++.||||++....    .....+.+.+|..++.++ +|+|||.+++++.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            468999999999999999999852      45789999886321    223345667777777665 6899999999876


Q ss_pred             c-CCEEEEEEeccCCCCHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014986          214 D-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV  275 (415)
Q Consensus       214 ~-~~~~~lV~E~~~~gsL~~~l~~~-----------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl  275 (415)
                      . +..+++|||||++|+|.+++...                 .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence            5 45689999999999999998532                 37899999999999999999999999999999999999


Q ss_pred             cCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHH-
Q 014986          276 DANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMA-  349 (415)
Q Consensus       276 ~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~-  349 (415)
                      +.++.+||+|||+|+......    .....||+.|+|||++.+.  .++.++|||||||++|||++| ..||......+ 
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999997654322    2345699999999999654  389999999999999999986 56787654333 


Q ss_pred             HHHHHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          350 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       350 ~~~~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ....+..+.....+..+++++.+||.+||+.||++|||+++|++|  ++++...|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~ilq~n  298 (299)
T d1ywna1         246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQAN  298 (299)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHHhCC
Confidence            334455666777888999999999999999999999999999998  66665443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=387.85  Aligned_cols=252  Identities=29%  Similarity=0.480  Sum_probs=204.5

Q ss_pred             cccccccccccCCcEEEEEEEc--CCC--cEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCCE
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  217 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~--~~~--~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  217 (415)
                      ++|++.+.||+|+||.||+|+.  .++  ..||||++.....  ......+.+.+|+.+|+.++|||||++++++.++ .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence            5799999999999999999985  233  3789998764322  2234456789999999999999999999999764 6


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccC
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  295 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~  295 (415)
                      +++||||+.+|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            7899999999999987654  46999999999999999999999999999999999999999999999999999876443


Q ss_pred             C-----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcC-CCCCCCCcccH
Q 014986          296 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG-SPPPIPDSLSK  368 (415)
Q Consensus       296 ~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~  368 (415)
                      .     .....|+..|+|||++.+..  ++.++|||||||++|||++ |+.||.+....+...++.+. ...+.+..++.
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCcceecCccccCcccCCHHHHhCCC--CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            2     22345788999999996543  8999999999999999998 89999998888887777554 34567788999


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHcChhhHhh
Q 014986          369 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  400 (415)
Q Consensus       369 ~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~  400 (415)
                      .+.+||.+||..||++|||+.+|+  .+|++.
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~--~~L~~~  272 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALR--DFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHH--HHHHhc
Confidence            999999999999999999999996  466653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=389.57  Aligned_cols=257  Identities=24%  Similarity=0.409  Sum_probs=222.7

Q ss_pred             eeeecccccccccccCCcEEEEEEEcC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeee
Q 014986          138 KRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT  211 (415)
Q Consensus       138 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  211 (415)
                      ....++|++++.||+|+||+||+|.+.      ++..||||++...    ........+.+|+.++++++|||||+++++
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            333578999999999999999999862      3578999988632    223345678899999999999999999999


Q ss_pred             eecCCEEEEEEeccCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc
Q 014986          212 DKDESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  280 (415)
Q Consensus       212 ~~~~~~~~lV~E~~~~gsL~~~l~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~  280 (415)
                      +..+...++||||+.+|+|.+++...           .+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence            99999999999999999999987532           3688899999999999999999999999999999999999999


Q ss_pred             EEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcC-CCCCCCccHHHHHHHHh
Q 014986          281 VKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIG  355 (415)
Q Consensus       281 vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g-~~pf~~~~~~~~~~~i~  355 (415)
                      +||+|||+++......    .....||+.|+|||.+.+..  ++.++|||||||++|||++| ..||.+....+.+..+.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCC--CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999998654332    22335899999999996544  88999999999999999998 58898888888888888


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHc------ChhhHhh
Q 014986          356 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD------HPFVKRL  400 (415)
Q Consensus       356 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~------hp~f~~~  400 (415)
                      .+...+.+..++..+.+||.+||+.||++|||+.+|++      +|+|++.
T Consensus       250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            88888888999999999999999999999999999997      7777753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=385.60  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=218.6

Q ss_pred             ceeeecccccccccccCCcEEEEEEEc------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcC-CCCcEEEee
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  209 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  209 (415)
                      +..-.++|+++++||+|+||.||+|++      .+++.||||++....    .......+.+|+.+++.+ +|||||+++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~~~~~l~~HpnIv~~~   93 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLL   93 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            333457899999999999999999974      467799999987432    223345788999999998 699999999


Q ss_pred             eeeecCCEEEEEEeccCCCCHHHHHhhc-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014986          210 GTDKDESKLYIFLELVTKGSLLNLYQRY-------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  270 (415)
Q Consensus       210 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp  270 (415)
                      +++.+...+|||||||.+|+|.+++.+.                   .+++..+..++.||+.||+|||++||+||||||
T Consensus        94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp  173 (311)
T d1t46a_          94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (311)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence            9999999999999999999999998643                   488999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEeeccccccccCC----cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 014986          271 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  345 (415)
Q Consensus       271 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~-g~~pf~~~  345 (415)
                      +|||++.++.+||+|||+++......    ....+||+.|+|||++...  .++.++|||||||++|||++ |.+||...
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998665432    2345689999999999654  38999999999999999998 66667665


Q ss_pred             cHHHHHH-HHhcCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          346 ECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       346 ~~~~~~~-~i~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                      ...+.+. .+..+..+..+..++.++.+||.+||+.||++|||+.+|++  .|++..+.+
T Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~--~L~~~i~~~  309 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEKQISES  309 (311)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHT
T ss_pred             CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhhccC
Confidence            5444433 34456667777889999999999999999999999999997  677766554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-50  Score=381.43  Aligned_cols=249  Identities=24%  Similarity=0.449  Sum_probs=207.8

Q ss_pred             ccccccCCcEEEEEEEcCC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeec-CCEEEEE
Q 014986          147 GDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLYIF  221 (415)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV  221 (415)
                      .++||+|+||+||+|++.+    ...||||++...    ......+.+.+|+.+|++++|||||++++++.+ +..+++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            5789999999999998732    236899988632    234456789999999999999999999998764 5689999


Q ss_pred             EeccCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeeccccccccCC---
Q 014986          222 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  296 (415)
Q Consensus       222 ~E~~~~gsL~~~l~~~--~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~~~~~~~---  296 (415)
                      ||||.+|+|.+++...  .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......   
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999999988754  47788899999999999999999999999999999999999999999999998654332   


Q ss_pred             ---cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCC-ccHHHHHHHHhcCCCCCCCCcccHHHHH
Q 014986          297 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDSLSKDAQD  372 (415)
Q Consensus       297 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~s~~l~~  372 (415)
                         .....||+.|+|||.+....  ++.++||||||+++|||++|..||.. ....+....+..+..+..|..+++.+.+
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~  265 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE  265 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ceecccccccccccChHHHhcCC--CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence               22345899999999986543  89999999999999999997777654 3344455566677777888899999999


Q ss_pred             HHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          373 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       373 Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                      ||.+||..||++|||+.||++|  |+.+...
T Consensus       266 li~~cl~~dP~~RPs~~ei~~~--L~~i~~~  294 (311)
T d1r0pa_         266 VMLKCWHPKAEMRPSFSELVSR--ISAIFST  294 (311)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred             HHHHHcCCCHhHCcCHHHHHHH--HHHHHHh
Confidence            9999999999999999999987  7777654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=371.37  Aligned_cols=255  Identities=26%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             ecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcEEEeeeeeecCC----
Q 014986          141 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----  216 (415)
Q Consensus       141 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  216 (415)
                      .+.|.+.+.||+|+||.||+|+. +|+.||||++....      ......+.|+..+..++|||||++++++.+.+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            35688889999999999999986 68899999886321      11222345666677889999999999987653    


Q ss_pred             EEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCcEEEcCCCcEEEEeecc
Q 014986          217 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--------QDVVHRDIKCANILVDANGSVKLADFGL  288 (415)
Q Consensus       217 ~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~--------~~IiHrDLkp~NILl~~~~~vkl~DFGl  288 (415)
                      .+||||||+.+|+|.+++++..+++..+..++.|++.||.|||+        +||+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            68999999999999999999999999999999999999999996        5999999999999999999999999999


Q ss_pred             ccccccCC------cccCCCCcccccccccccccc----CCCchhhHHHHHHHHHHHHcCCCCCCCcc------------
Q 014986          289 AKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTSQIPYAPME------------  346 (415)
Q Consensus       289 a~~~~~~~------~~~~~gt~~y~aPE~l~~~~~----~~~~~~DvwSlG~il~ell~g~~pf~~~~------------  346 (415)
                      ++......      .....||+.|+|||++.+...    .++.++|||||||++|||++|..||....            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            98654332      234569999999999865321    25778999999999999999988763211            


Q ss_pred             --HHHHHHHHh--cCCCCCCCCc-----ccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhhC
Q 014986          347 --CMAALFKIG--RGSPPPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  404 (415)
Q Consensus       347 --~~~~~~~i~--~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~~  404 (415)
                        ......+..  ....+.++..     ....+.+|+.+||+.||.+|||+.||+++  ++++..+.
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~~~  299 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQE  299 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHHHhc
Confidence              112222221  2222333332     33568999999999999999999999874  66665543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-48  Score=365.36  Aligned_cols=250  Identities=21%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCc-EEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~  217 (415)
                      +.++|++++.||+|+||+||+|++ .+++.||||++......       ..+.+|+++++.++|++ |+.+.+++.+.+.
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            446799999999999999999998 78999999988753221       23668999999998666 5566677788899


Q ss_pred             EEEEEeccCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEeecccccc
Q 014986          218 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT  292 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~--~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~---~~~vkl~DFGla~~~  292 (415)
                      .++||||+.+ +|...+.  ...+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+..
T Consensus        78 ~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9999999965 5666554  346999999999999999999999999999999999999864   457999999999865


Q ss_pred             ccCC---------cccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHHHHHHHH-------hc
Q 014986          293 KLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-------GR  356 (415)
Q Consensus       293 ~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~~~~~~i-------~~  356 (415)
                      ....         .....||+.|+|||++.+..  ++.++|||||||++|||++|+.||...........+       ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCC--CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            4322         23456999999999996544  899999999999999999999999765433222111       11


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHH---HcChhhHh
Q 014986          357 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR  399 (415)
Q Consensus       357 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~ei---l~hp~f~~  399 (415)
                      .........+|+++.+||.+||+.||++||++.+|   |+|+|.+.
T Consensus       235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            11122345789999999999999999999998755   56665543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.8e-47  Score=357.46  Aligned_cols=252  Identities=19%  Similarity=0.298  Sum_probs=204.3

Q ss_pred             eecccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCC-CcEEEeeeeeecCCE
Q 014986          140 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK  217 (415)
Q Consensus       140 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~  217 (415)
                      +.++|++++.||+|+||+||+|++ .+++.||||++......       ..+.+|+++++.+.| +||+.+++++.+...
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   75 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   75 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence            346899999999999999999998 78999999988643221       235678888988865 899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-----CCcEEEEeecccc
Q 014986          218 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-----NGSVKLADFGLAK  290 (415)
Q Consensus       218 ~~lV~E~~~~gsL~~~l~~--~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~-----~~~vkl~DFGla~  290 (415)
                      .|+||||+ +++|.+++..  ..++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99999999 5799888865  35999999999999999999999999999999999999974     5789999999998


Q ss_pred             ccccC---------CcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhc--
Q 014986          291 ATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGR--  356 (415)
Q Consensus       291 ~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~--  356 (415)
                      .....         .....+||+.|||||++.+.  .++.++|||||||++|+|++|+.||.+..   ......++..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            65322         23345799999999999654  48999999999999999999999997532   2222222211  


Q ss_pred             --CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHcChhhHhhhhh
Q 014986          357 --GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  403 (415)
Q Consensus       357 --~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~eil~hp~f~~~~~~  403 (415)
                        .....+...+|+++.+++..|+..+|++||+++.+.+  +|+++..+
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~--~l~~~~~~  279 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLER  279 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHHH
T ss_pred             CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH--HHHHHHHH
Confidence              1111234568899999999999999999999988754  56665543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-45  Score=358.86  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=194.7

Q ss_pred             cccccccccccCCcEEEEEEEc-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-----------CCcEEEee
Q 014986          142 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQYY  209 (415)
Q Consensus       142 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~  209 (415)
                      ++|++++.||+|+||+||+|++ .+|+.||||+++..      ......+.+|+.+++.++           |+||++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            3599999999999999999998 78999999998742      122345667888877764           57899999


Q ss_pred             eeee--cCCEEEEEEeccCCCCHHHH-H---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCC---
Q 014986          210 GTDK--DESKLYIFLELVTKGSLLNL-Y---QRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANG---  279 (415)
Q Consensus       210 ~~~~--~~~~~~lV~E~~~~gsL~~~-l---~~~~l~~~~~~~i~~qil~aL~~LH~-~~IiHrDLkp~NILl~~~~---  279 (415)
                      +++.  .....+++|+++..+..... .   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            8875  34667777777765543332 2   23468999999999999999999998 8999999999999998665   


Q ss_pred             ---cEEEEeeccccccccCCcccCCCCccccccccccccccCCCchhhHHHHHHHHHHHHcCCCCCCCccHH------HH
Q 014986          280 ---SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM------AA  350 (415)
Q Consensus       280 ---~vkl~DFGla~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~DvwSlG~il~ell~g~~pf~~~~~~------~~  350 (415)
                         .++|+|||.+...... ....+||+.|+|||++...  .++.++|||||||++++|++|+.||......      +.
T Consensus       167 ~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeecccccccccc-cccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               3999999998765443 3456799999999998654  3889999999999999999999999654321      11


Q ss_pred             HHH---HhcC-----------------------C---------------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHH
Q 014986          351 LFK---IGRG-----------------------S---------------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA  389 (415)
Q Consensus       351 ~~~---i~~~-----------------------~---------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rps~~  389 (415)
                      +..   +...                       .               ........++++.+||.+||..||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            111   0000                       0               0011234567899999999999999999999


Q ss_pred             HHHcChhhHhhhhhCC
Q 014986          390 QLLDHPFVKRLLATNS  405 (415)
Q Consensus       390 eil~hp~f~~~~~~~~  405 (415)
                      |+|+||||++......
T Consensus       324 e~L~Hp~f~~~~~~~~  339 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEE  339 (362)
T ss_dssp             HHHTCGGGTTCTTCTT
T ss_pred             HHhcCcccCCCCCccc
Confidence            9999999997765443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.6e-27  Score=210.25  Aligned_cols=168  Identities=18%  Similarity=0.181  Sum_probs=124.3

Q ss_pred             cccccccccCCcEEEEEEEcCCCcEEEEEEEecccc-------------cchhHHHHHHHHHHHHHHhcCCCCcEEEeee
Q 014986          144 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ-------------GSQAKQSISQLEQEIALLSRFEHENIVQYYG  210 (415)
Q Consensus       144 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~-------------~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  210 (415)
                      +.+++.||+|+||+||+|++.+|+.||||+++....             ............+|+..+..+.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            457889999999999999998899999998753110             0111222345567899999999999998886


Q ss_pred             eeecCCEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          211 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       211 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      ...    .+++|||+++..+.      .++...+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|||+|.
T Consensus        82 ~~~----~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~  150 (191)
T d1zara2          82 WEG----NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV  150 (191)
T ss_dssp             EET----TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred             ecC----CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence            643    27999999986543      34556677899999999999999999999999999999865 58999999997


Q ss_pred             ccccCCcccCCCCcccccc------ccccccccCCCchhhHHHHHHH
Q 014986          291 ATKLNDVKSCRGTAFWMAP------EVINNKNKGYGLPADIWSLGCT  331 (415)
Q Consensus       291 ~~~~~~~~~~~gt~~y~aP------E~l~~~~~~~~~~~DvwSlG~i  331 (415)
                      ....+....      |...      +.+   .+.|+.++|+||+.--
T Consensus       151 ~~~~~~~~~------~l~rd~~~~~~~f---~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         151 EVGEEGWRE------ILERDVRNIITYF---SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             ETTSTTHHH------HHHHHHHHHHHHH---HHHHCCCCCHHHHHHH
T ss_pred             cCCCCCcHH------HHHHHHHHHHHHH---cCCCCCcccHHHHHHH
Confidence            665333221      2111      111   1337889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=8.7e-08  Score=85.99  Aligned_cols=144  Identities=13%  Similarity=0.126  Sum_probs=91.8

Q ss_pred             ceeeecccccccccccCCcEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCC-CCcEEEeeeeeecC
Q 014986          137 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  215 (415)
Q Consensus       137 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  215 (415)
                      .+...+.|+..+..+-++.+.||+... +++.+++|.........     ...+.+|...+..+. +--+.+++.++.++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            344456677666655555678998754 55567788775322211     223557777776653 32245667777788


Q ss_pred             CEEEEEEeccCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------
Q 014986          216 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ----------------------------------  261 (415)
Q Consensus       216 ~~~~lV~E~~~~gsL~~~l~~~~l~~~~~~~i~~qil~aL~~LH~~----------------------------------  261 (415)
                      +..++||++++|..+.......    .....++.++...+..||+.                                  
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             CceEEEEEeccccccccccccc----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            8999999999998775533211    11222344444444445421                                  


Q ss_pred             -------------------------CceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          262 -------------------------DVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       262 -------------------------~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                                               .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     26999999999999876666799998653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=3.8e-06  Score=74.51  Aligned_cols=73  Identities=16%  Similarity=0.099  Sum_probs=49.2

Q ss_pred             cccCC-cEEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCC--cEEEeeeeeecCCEEEEEEeccC
Q 014986          150 LGRGS-FGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELVT  226 (415)
Q Consensus       150 LG~G~-~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~  226 (415)
                      +..|. -+.||+....++..+++|.......        ..+.+|+..|+.+...  .+.+++.+..+++..++||++++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            34444 3679999888888899997653221        1245666666655322  24567777778888999999998


Q ss_pred             CCCH
Q 014986          227 KGSL  230 (415)
Q Consensus       227 ~gsL  230 (415)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            7554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.78  E-value=1.7e-05  Score=75.37  Aligned_cols=80  Identities=13%  Similarity=0.123  Sum_probs=45.8

Q ss_pred             cccccCCcEEEEEEEc-CCCcEEEEEEEeccccc--chhHHHHHHHHHHHHHHhcCC---CCcEEEeeeeeecCCEEEEE
Q 014986          148 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF  221 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~--~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV  221 (415)
                      +.||.|..-.||++.+ .+++.++||.-......  ........+...|+..|+.+.   ...+.+++.+..  ...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEEE
Confidence            3489999999999988 55788999965421110  000011223345666666542   234556665543  344789


Q ss_pred             EeccCCCC
Q 014986          222 LELVTKGS  229 (415)
Q Consensus       222 ~E~~~~gs  229 (415)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.17  E-value=0.00025  Score=65.05  Aligned_cols=67  Identities=13%  Similarity=0.086  Sum_probs=42.4

Q ss_pred             EEEEEEEcCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE--EEeee-----eeecCCEEEEEEeccCCC
Q 014986          156 GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI--VQYYG-----TDKDESKLYIFLELVTKG  228 (415)
Q Consensus       156 g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI--v~l~~-----~~~~~~~~~lV~E~~~~g  228 (415)
                      =.||+++..+|..|++|+.+....      ..+++..|+..+..|...+|  +..+.     .+......+.+++++.|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479999999999999998763211      12445667777766542221  11111     234566788999999864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.42  E-value=0.0016  Score=58.92  Aligned_cols=30  Identities=27%  Similarity=0.318  Sum_probs=26.5

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEeecccc
Q 014986          261 QDVVHRDIKCANILVDANGSVKLADFGLAK  290 (415)
Q Consensus       261 ~~IiHrDLkp~NILl~~~~~vkl~DFGla~  290 (415)
                      .|+||+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999988777899999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.10  E-value=0.0052  Score=57.46  Aligned_cols=71  Identities=10%  Similarity=0.083  Sum_probs=43.8

Q ss_pred             cccccCCcEEEEEEEcCC--------CcEEEEEEEecccccchhHHHHHHHHHHHHHHhcCCCCcE-EEeeeeeecCCEE
Q 014986          148 DLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKL  218 (415)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~  218 (415)
                      +.|+-|-.=.+|++...+        .+.|.+++.-. .   ...   ....+|..+++.+.-.++ .++++++.+    
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            457878888899987533        34566665531 1   111   123478778777643333 467777653    


Q ss_pred             EEEEeccCCCC
Q 014986          219 YIFLELVTKGS  229 (415)
Q Consensus       219 ~lV~E~~~~gs  229 (415)
                      .+||||+.|..
T Consensus       117 g~I~efi~g~~  127 (395)
T d1nw1a_         117 GRLEEYIPSRP  127 (395)
T ss_dssp             EEEECCCCEEE
T ss_pred             ceEEEEecccc
Confidence            68999998753